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Hedgehog signaling promotes lymphatic differentiation of macrophages
J Asai,1,2 K Maruyama,3 M Renault,2 M Ii,2 H Takenaka,1 T Thorne,2 S Kishimoto1 and
DW Losordo2 1 Dermatology, Kyoto Prefectural University of Medicine, Kyoto, Japan, 2
Division of Cardiovascular Research and Medicine, St. Elizabeth’s Medical Center, Tufts
University of Medicine, Boston, MA and 3 Ophthalmology, Graduate School of Medical
Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
Sonic hedgehog (Shh) is a prototypical morphogen known to regulate epithelial-mesenchy-
mal interaction during embryonic development. Recent observations indicate Shh induces
capillary morphogenesis in endothelial cells and endothelial progenitor cells, however, the
function of Shh in lymphangiogenesis is unknown. Since macrophages contribute to the lym-
phatics that form during the acute phase of inflammation, we hypothesized that activation of
Hh pathway may promote lymphatic differentiation of macrophages and therefore offer a pos-
sible therapeutic target. Macrophages were collected from the peritoneal cavity or bone mar-
row of C57BLKs mice. In tube formation assay, Shh induced macrophages to form tube-like
structures. Real time PCR and Western blotting showed upregulation of LYVE-1, which is a
lymphatic specific marker, in Shh treated macrophages. Transfection of Gli1 and Gli3 plas-
mid promoted tube formation, suggesting that the capillary morphogenic effect of Shh on
macrophages was via Gli pathway. This effect was abolished by LY294002, an inhibitor of
PI3K/Akt pathway, indicating that PI3K/Akt signaling is also involved in Shh mediated effects
on macrophages. We next evaluated VEGFR3 and VEGF-C expression in macrophages, both
of which play key roles in lymphangiogenesis. Interestingly, both VEGFR3 and VEGF-C expres-
sion were upregulated by Shh in a dose dependant manner. Furthermore, we found that Shh
acts as a chemoattractant to macrophages. These data indicated that Shh promotes lymphatic
differentiation of macrophages. These findings suggest that Shh may have significant thera-
peutic potential for enhanced lymphangiogenesis in patients with lymphatic disorders such
as postmastectomy lymphedema.
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Inhibition of tumor angiogenesis and melanoma growth by T-oligos
DA Goukassian,1 D Levine,1 C Coleman,1 MS Eller,1 S Arad,1 E Bord,2 T Thorne,2 G Qin,2
R Kishore2 and BA Gilchrest1 1 Department of Dermatology, Boston University School of
Medicine, Boston, MA and 2 Northwestern University, Feinberg Cardiovascular Research
Institute, Chicago, IL
Inhibition of tumor angiogenesis is an established cancer therapy. Telomere homolog oligonu-
cleotides (T-oligos) have multiple anti-cancer effects and are understood to activate an innate
program that ensures genomic integrity. To determine if inhibition of angiogenesis is an addi-
tional mechanism by which T-oligos reduce tumor growth in mice bearing MMAN human
melanoma cell xenografts, paired dishes of MMAN cells and human microvascular endothe-
lial cells (HMVEC) were treated with an 11-base T-oligo (GTTAGGGTTAG) 40µM or diluent
alone, then processed for qRT-PCR, gel shift assay, western blot and FACS. By 24 and 48h, T-
oligo decreased the levels of angiogenic growth factors VEGF, angiopoeitin-1, and hypoxia
inducible factor-1α in both MMAN and HMVEC cells by 40-70%. T-oligo also decreased
expression of VEGF receptors 1 and 2 by 45-95% in HMVEC within 48 to 72h. T-oligo increased
by 4-5-fold the level and 2-fold the activity of E2F1 protein, known to promote apoptosis and
negatively regulate NFkB, a pro-angiogenic and pro-survival transcription factor. By FACS
analysis 96h post-treatment, there was 6-fold increase in apoptosis (sub-G0/G1 DNA content)
40.4±13.1% of T-oligo- vs 6.6±0.0% of control-treated MMAN cells (p<0.05). At 1-16h DNA
binding activity of NFkB, HIF-1α and Ap1, all known positive regulators of VEGF transcrip-
tion, were decreases by ~30-98% in T-oligo-treated vs control cells. In T-oligo-treated cells
VEGF release into MMAN culture medium, as measured by ELISA, was reduced ~30-40%
(p<0.01). Between 6-22h endothelial tube formation was disintegrated in T-oligo- but not in
control-treated cells. T-oligo injection of tumor nodules in mice reduced the capillary density
and vascular area in and around the nodules, as assessed by CD31 staining of tissue sections.
Our data strongly suggest that T-oligos exert anti-angiogenic effects on melanoma cells and
HMVEC that cooperate with pro-apoptotic effects to reduce melanoma growth in vivo.
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Perfusion of human skin equivalents with microvessels formed by circulating endothelial pro-
genitor cells
EF Kung1 and JS Schechner2 1 Medicine/Dermatology, University of Chicago, Chicago, IL and
2 Interdepartmental Program in Vascular Biology and Transplantation, Yale University, New
Haven, CT
Engraftment of bioengineered human skin equivalents (HSE) depends on post-transplantation per-
fusion. We have formed microvessels in HSE by incorporating CD34+ endothelial progenitor cells
(EPCs) isolated from adult peripheral blood. EPCs were selected in endothelial cell (EC) media. In
14 days, EPCs differentiated to ECs, as shown by morphology and expression of CD31, VEGFR-2,
Tie-2, and TNF-induced E-selectin. HSE were engineered with neonatal foreskin keratinocytes and
split thickness acellular human cadaveric dermis. EPC-derived ECs were added to the underside
of the HSE dermis. These HSE was orthotopically grafted onto the backs of SCID/beige mice. Grafts
harvested 2 weeks after implantation demonstrated numerous dermal microvessels. reactive to anti-
human CD31 antibody and UEA-1 lectin. Expression of smooth muscle α-actin antibody demon-
strated smooth muscle/pericyte investiture. Intraluminal RBCs indicated successful inosculation of
microvessels lined by human ECs to the murine circulation. Murine CD31 was limited to the
edges of the HSE grafts showing ineffective murine angiogenic response. Vascular function was
analyzed with intravenous sodium fluorescein 4 weeks post-transplantation. Fluorescein emission
was quantified in normal back skin (N=4, back), HSE seeded with EPCs (N=3, HSE/EPC), and HSE
without EPCs (N=1, control). Fluorescein emission levels were lower in both HSE/EPC and con-
trol grafts as compared to normal control skin. The peak level was measured at < 25 minutes for
the control skin compared to the HSE/EPC. The HSE/EPC had a higher peak fluorescence level and
a delayed washout period compared to the control graft. Therefore, the HSE/EPC, improved per-
fusion confirmed functional relevance of histologic findings. Hence, autologous human EC derived
from circulating EPCs can be used to vascularize bioengineered tissues. This work provides the
foundation for therapies that provide the essential perfusion needed for skin grafts.
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An unusual case of multiple mixed venous-lymphatic malformations with spontaneous regres-
sion and recurrence: a clinical, microscopic, and molecular study
V Goldburt, S Glick and A Shalita Dermatology, Downstate Medical Center, Brooklyn, NY
We present an unusual case of multiple, non-pulsatile, soft tissue tumors encompassing the
fetal upper trunk, neck, and bilateral axillae, consistent with multiple large vascular-lymphatic
malformations. These lesions were first noted via ultrasound at 23 week’s gestation, and
decreased in size throughout the remainder of gestation. At delivery, smaller subcutaneous
masses remained. The infant had no other obvious dysmorphism and laboratory and karyotype
studies were normal. After multiple imaging modalities were employed, tissue histopathology
and immunochemistry from biopsy was obtained, and the infant’s clinical course was followed
closely. Tissues were stained with specific lymphatic and vascular endothelial markers. Our
findings were consistent with mixed venous and lymphatic malformation. At 1 year of age,
some of the subcutaneous masses appeared to spontaneously resolve but subsequently they
increased in size following an upper respiratory infection. Similar malformations may be seen
in association with more complex fetal conditions including: Klippel Trenaunay, Proteus, and
Noonan’s syndromes. However, our patient’s features do not appear to fit any of these dis-
eases completely, and may represent either an incomplete form of one of these syndromes or
an error in lymphangiogenesis. We are presently monitoring these lesions and are evaluating
future treatment options.
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Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic
vessel function
K Kajiya,1,2,3 S Hirakawa3 and M Detmar2,3 1 Shiseido Life Science Research Center,
Yokohama, Japan, 2 Institute of Pharmaceutical Sciences, Swiss Federal Institute of
Technology Zurich, Zurich, Switzerland and 3 Cutaneous Biology Research Center,
Massachusetts General Hospital and Harvard Medical School, Boston, MA
Ultraviolet B (UVB) irradiation of the skin induces erythema, epidermal hyperplasia, vascular
hyperpermeability and edema formation. Previous studies have revealed that the cutaneous
blood vasculature plays a critical role in the mediation of photodamage. In contrast, the role
of lymphatic vessels - that play an essential role in the maintenance of tissue fluid balance -
in the response to UVB irradiation has remained unknown. We report that both acute and
chronic UVB-irradiation of murine skin results in prominent enlargement of lymphatic ves-
sels. Surprisingly, these enlarged lymphatic vessels are functionally impaired and are hyper-
permeable, as detected by intravital lymphangiography. The expression levels of vascular
endothelial growth factor (VEGF)-A, but not of the known lymphangiogenesis factors VEGF-
C or -D were enhanced in UVB-irradiated epidermis. Targeted overexpression of VEGF-A in
the epidermis of transgenic mice led to increased enlargement and leakage of lymphatic ves-
sels after acute UVB irradiation, whereas systemic blockade of VEGF-A signaling largely pre-
vented lymphatic vessel abnormalities and photo-damage induced by UVB. Together, these
findings indicate lymphatic vessels as novel targets for UVB-induced cutaneous photodam-
age, and they also suggest that VEGF-A mediates impairment of lymphatic vessel function and
thereby contributes to the adverse effects of UVB irradiation on the skin.
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EC-SOD suppress UVB-induced angiogenesis in transgenic mice skin
Y Kim, H Lee, H Ha, Y Kim and T Kim Dermato-Immunology, Catholic University of South
Korea, Seoul, South Korea
Superoxide dismutase (SOD) has been implicated regulation of inflammatory response includ-
ing angiogenesis. The role of EC-SOD in angiogenesis, however, has not been reported. In this
study, we aimed to investigate the effect of EC-SOD on angiogenesis using skin specific EC-
SOD transgenic mice model (EC-SOD Tg). EC-SOD Tg were irradiated with UVB, followed by
histopathological examination. The EC-SOD Tg showed significantly reduced edema, lym-
phocytic cell infiltration and vessel formation compared with wild-type mice (WT). These phe-
notypes were associated with decreased expression of pro-angiogenic factors such as VEGF
and NF-kB p65 in EC-SOD Tg. In addition, we found that phosphorylation of PKC was reduced
in UVB-induced angiogenesis whereas expression levels of iNOS and ICAM are unchanged
in EC-SOD Tg. Furthermore, UVB-triggered induction of matrix metalloproteinase 1 (MMP-1)
was significantly inhibited in those mice. Taken together, our data suggested that EC-SOD
might play an important role in the suppression of UVB-induced angiogenesis.
www.jidonline.org   S1
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The knockdown of moesin expression delays cellular senescence of human dermal microvas-
cular endothelial cells
JH Lee, JH Yoo, NS Chang, IA Hong and KH Lee Department of Dermatology & Cutaneous
Biology Research Institute, Yonsei University College of Medicine, Seoul, South Korea
Cellular senescence of endothelial cells plays a significant role in the pathophysiology of age-
related vascular diseases including some skin diseases; however, precise mechanisms for senes-
cence have not been elucidated. In previous published report, we have found aging-related
proteins using human dermal microvascular endothelial cell (HDMEC) by proteomics tool.
Among them decrease in expressions of moesin were detected in senescent cells by matrix-
assisted laser desorption ionization time of flight (MALDI-TOF) and confirmed by immunoblot-
ting, and confocal laser microscopy. Previous knockdown study using siRNA showed prob-
lem of continuity of transfection to senescent cells. Therefore, in this study we have investigated
the effect of knockdown of moesin in HDMEC on endothelial cell senescence by shRNA
technique. Moesin, the ERM(Ezrin/Moesin/Radixin) protein, is known not known for its role
in aging. To verify the role of moesin in skin aging, we inhibited the expression of gene of
moesin by shRNA and subcultured them to passage 22. Knockdown of moesin expression
showed early senescent changes in morphology, beta-galactosidase staining. The knockdown
of moesin expression resulted in early arrest in population doublings in lifespan study, and
showed increased expression of p16 protein and p16 mRNA compared with the control. The
metabolic activity was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) assay and as compared with controls, cellular metabolic activity significantly
decreased in moesin knockdown HDMECs. In conclusion, we could observe knockdown of
moesin expression by shRNA-Lentivirus delays cellular senescence of HDMECs. These results
in progress are expected to provide basic information for the characterization of aging and
can be used as aging model for validation of anti-aging agents.
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Grp78 (Glucose related protein 78) is a target of Honokiol
B Govindarajan,1 B Lefkove,1 D Foster,2 B Aggarwal3 and J Arbiser1 1 Dermatology, Emory
University, Atlanta, GA, 2 Department of Biological Sciences, Hunter College of The City
University of New York, New York, NY and 3 Department of Experimental Therapeutics, The
University of Texas M.D. Anderson Cancer Center, Houston, TX
Honokiol is a potent antitumor agent that has shown activity against multiple tumor types in
vivo and in vitro, including melanoma, breast, prostate, leukemia, sarcoma and myeloma.
Among the activities we have shown with honokiol is that it sensitizes tumor cells to multiple
stimuli, including TRAIL, tumor necrosis factor alpha, doxorubicin, taxotere, bortezomib, and
chlorambucil. Honokiol also blocks the glycolytic metabolism of tumor cells (Warburg effect),
and converts the metabolism to a normalized, respiratory metabolism. Stat3 activation and
NFkB activation are also strongly inhibited by honokiol. Finally, honokiol blocks the produc-
tion of phosphatidic acid by tumor cells, and phosphatidic acid is the major competitor of
rapamycin for binding to mTOR (mammalian target of rapamycin). In order to account for
these activities, an upstream target is indicated. Honokiol was biotin labeled, incubated with
SVR endothelial cell lysates, and pulled down with avidin beads. Among the proteins isolated
is grp78, which serves a dual function. First, grp78 serves as a endoplastic reticulum stress
protein, which is activated by chemotherapy and hypoxia. Second, grp78 serves as a cell sur-
face receptor to alpha 2 macroglobulin (α2M). Ligation of α2M to grp78 leads to activation
of phoshphoinositol 3 kinase, phospholipase D, NFkB, and mTOR, all of which are inhibited
by honokiol. Grp78 and α2M serve as potential biomarkers for tumors which may be targets
of honokiol in phase I clinical trials.
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Interleukin-12-deficiency promotes angiogenesis in UV-induced skin tumors
SK Katiyar,1,2 S Katiyar,1 CA Elmets1 and SM Meeran1 1 Dermatology, University of Alabama
at Birmingham, Birmingham, AL and 2 Birmingham VA Medical Center, Birmingham, AL
We have previously shown that an endogenous deficiency of interleukin (IL)-12 promotes pho-
tocarcinogenesis in mice. Specifically, UV-induced skin tumors in IL-12 knock out (IL-12 KO)
mice were larger in size than the tumors of their wild-type counterparts. To determine whether
IL-12-deficiency might promote angiogenesis in UV-induced skin tumors, we used IL-12p35
KO mice on a C3H/HeN background, which were unable to synthesize bioactive IL-12. IL-12
KO mice and their wild-types were subjected to a photocarcinogenesis protocol. When tumor
yield was stabilized, tumor samples and non-tumor-bearing UV-exposed skin samples were
collected and subjected to immunohistochemical, gelatinolytic zymography, real-time PCR
and western blot analysis of angiogenic factors. We found that protein and mRNA expression
and activity of the matrix metalloproteinases (MMP)-2, -3, -7 and -9, which play crucial roles
in tumor growth/angiogenesis, were significantly higher in UVB-exposed skin and tumors of
IL-12 KO mice compared with wild-type mice. With respect to the tumor neo-vasculature,
the expression of CD31-positive cells and the expression level of VEGF were higher in the
tumors of IL-12 KO mice than their wild-type counterparts. The proliferative capacity of tumor
cells of the IL-12 KO mice was significantly higher than that of wild-type mice as assessed
both by the MTT assay and by expression of cyclin D1. Because IL-12 has a reciprocal rela-
tionship with IL-23 and IL-23 promotes tumor growth, we assessed the levels of IL-23 in tumors.
The expression of IL-23 protein and its mRNA expression (IL-23p19) in tumors of IL-12 KO
mice were markedly higher than in the tumors of wild-type mice. Together, these data indi-
cate for the first time that IL-12-deficiency and/or IL-23 overexpression promotes pro-angio-
genic stimuli in UV-induced skin tumors, and suggests that endogenous enhancement of IL-
12 levels may therefore be effective in the prevention and treatment of UV-induced skin cancers.
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NADPH oxidase 4 is a key regulator of hemangioma growth in vivo
SS Bhandarkar,1 M Jaconi,2 BN Perry,1 A Sohn,1 H Augustin3 and J Arbiser1,4 1 Dermatology,
Emory University School of Medicine, Atlanta, GA, 2 Geriatrics, Geneva University Hospitals,
Geneva, Switzerland, 3 Dept. of Vascular Biology and Angiogenesis Research, DFG Priority
Research Program, Frieburg, Germany and 4 Dermatology, Atlanta VA Medical Center,
Atlanta, GA
NOX (NADPH oxidases) are a family of NADPH dependent enzymes which generate super-
oxide, and consist of at least 6 members. We have shown that nox 4 and nox 2 (mutated in
chronic granulomatous disease) are present in endothelial cells, and bEnd3 cells that are a
murine model of hemangiomas. bEnd3 cells resemble human hemangiomas in that they use
angiopoietin-2 rather than VEGF as their major angiogenesis stimulator, and blockade of ang2
results in inhibition of tumor growth. bEnd3 cells derived from mice homozygous and het-
erozygous for ang2 were studied for growth in vivo. Surprisingly, ang2 -/- cells formed heman-
giomas in vivo, but heterozygous ang2 +/- cells failed to form in vivo. Gene chip analysis of
ang2 +/- cells compared with ang2 -/- cells demonstrated downregulation of nox4 and Nrarp,
a notch regulated gene in cells incapable of hemangioma growth. Cells totally deficient in
ang2 appeared to compensate by overexpression of the endothelial chemotactic factor SDF-
1. Supporting the role of nox enzymes in hemangioma growth in vivo, we found that triph-
enylmethane dyes, including brilliant green and gentian violet, were potent nox inhibitors and
strongly inhibited the growth of hemangiomas in vivo. In order to ascertain the role of nox
genes further, bEnd3 cells were infected with a retroviral siRNA for nox4. A high degree of
nox4 knockdown was achieved as well as a nearly threefold reduction of ang2 mRNA pro-
duction compared with control cells. bEnd3 cells with nox4 knockdown showed a 50%
decrease in hemangioma growth in vivo. Our data supports the genetic use of nox blockade
to treat disorders that have excess ang2, including hemangiomas, melanoma, and psoriasis.
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Anti-angiogenic effect of tetraacetyl-phytosphingosine (TAPS)
Y Kwon,1 C Kim,1 B Kim,1 M Kim,2 C Park,3 Y Seo,1 K Suhr,4 J Park1 and J Lee1 1 Department
of Dermatology, Chungnam National University, Daejeon, South Korea, 2 AngioLab Inc,
Daejeon, South Korea, 3 Department of Chemical and Biochemical Engineering, Dongguk
University, Seoul, South Korea and 4 CNU hospital, Daejeon, South Korea
In a search for the wound healing accelerators, we found that tetraacetyl-phytosphingosine
(TAPS), a sphingolipid metabolite produced by phytosphingosine acetylation, has significant
inhibitory potential on healing of rabbit ear wound. As angiogenesis is fundamental to proper
wound healing, we examined the effect of TAPS on angiogenesis using human umbilical vein
endothelial cells (HUVEC) cultured in vitro. TAPS markedly decreased VEGF-induced chemo-
tactic migration and capillary-like tube formation. Recognizing its inhibitory potential on angio-
genesis, we further investigated the action mechanism of TAPS. TAPS significantly inhibited
VEGF-induced proteolytic enzyme production, including matrix metalloproteinase-2 (MMP-
2), urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor-1 (PAI-1).
TAPS also suppressed VEGF-induced phosphorylation of p42/44 extracellular signal-regulated
kinase (ERK) and c-Jun N-terminal kinase (JNK). In addition, TAPS abolished VEGF-induced
intracellular calcium ([Ca2+]i) increase, measured using laser scanning confocal microscopy.
Together, these results suggest that TAPS exerts its inhibitory action on angiogenesis through
the inhibition of MAPK activation and intracellular calcium increase, thereby affecting the
process of wound healing negatively.
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Calcium and cobalt chloride-induced hypoxia enhanced expression of pigment epithelium
derived factor in epidermal keratinocytes
M Zheng, X Man, X Yang and S Cai Dermatology, Second Hospital of Zhejiang University,
Hangzhou, China
The ability to control angiogenesis would offer a unique opportunity to impact a wide variety
of physiological and pathological functions. A very potent antiangiogenic factor, pigment
epithelium-derived factor (PEDF), was identified in the retina and several cell culture and ani-
mal models. PEDF is a soluble secreted 50-KDa endogenous protein initially purified from
the conditioned media of human fetal retinal pigment epithelial cells and is the most potent
natural angiogenesis inhibitor. PEDF has been detected widely throughout the human body
and exhibits multiple and varied biological activities. In the skin, PEDF was detected prima-
rily in the dermal layer and secreted mainly by dermal fibroblasts. To investigate the expres-
sion and regulation of PEDF in epidermal keratinocytes, we studied normal human skin epi-
dermis by immunofluorescence and RT-PCR, Western blot. PEDF was detected mainly in basal
stratum and suprabasal keratinocytes. Furthermore, expression of PEDF was identified by RT-
PCR and Western blot. Calcium at 0.5, 1.0, 2.0 mM could enhanced expression of PEDF in
cultured keratinocytes, and cobalt chloride at 1.0 mM could highly enhance expression of
PEDF both at mRNA and protein levels. Therefore, it seems that PEDF is expressed in epider-
mal keratinocytes and being regulated by calcium and cobalt chloride-induced hypoxia.
S2 Journal of Investigative Dermatology (2007), Volume 127
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Treatment with a VEGF receptor tyrosine kinase inhibitor alleviates chronic skin inflamma-
tion in a mouse model of psoriasis
C Halin,1 H Fahrngruber,2 JG Meingassner,2 G Bold,3 A Littlewood-Evans,3 A Stuetz2 and
M Detmar1 1 Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, ETH
Zurich, Zurich, Switzerland, 2 Novartis Institutes for Biomedical Research, Vienna, Austria
and 3 Novartis Institutes for Biomedical Research, Basel, Switzerland
Remodeling of the blood vascular and lymphatic networks has recently been shown to play
an important role in the perpetuation of inflammatory disorders. Vascular endothelial growth
factor (VEGF) is a well known pro-(lymph)angiogenic signaling molecule and is likely to be
involved in this process. Thus far, treatment of such chronic inflammatory diseases with anti-
(lymph)angiogenic therapies has received little attention. In this study, we have tested the
effects of a newly identified VEGF receptor (VEGFR) tyrosine kinase inhibitor, NVP-BAW2881,
on blood vascular and lymphatic vessel function and growth. We found that NVP-BAW2881
potently inhibits proliferation, migration and tube formation of lymphatic and blood vascu-
lar endothelial cells in vitro at concentrations from 1 nM to 1 µM, depending on the assay
used. This compound, orally applied at 25mg/kg/d, exhibited activity in an transgenic mouse
model of psoriasis, potently inhibiting psoriasis-like skin inflammation elicited on the auri-
cles of the animals. Immunohistochemical analysis of the auricular tissue showed that NVP-
BAW2881 robustly decreased the number of blood and lymphatic vessels and of infiltrating
leukocytes within few days of treatment. Furthermore, the epidermal architecture in the for-
merly inflamed ears was markedly normalized, as assessed by expression of keratinocyte-
expressed marker genes. Interestingly, topical application of NVP-BAW2881 at 0.5% onto
the inflamed auricles (b.i.d.) was almost as efficacious in reducing inflammatory symptoms
as oral administration of the compound. These data represent the first demonstration that it
may be possible to treat chronic inflammatory skin disorders such as psoriasis by application
of a VEGFR tyrosine kinase inhibitor.
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Vimentin-focal contact interactions: regulation and functional implications
R Bhattacharya and J Jones Cell and Molecular Biology, Northwestern University, Chicago, IL
Angiogenesis, involving endothelial cell (EC) migration from preexisting blood vessels, for-
mation of adhesive sites between migrating cells and ECM, and assembly of endothelial cells
into vessels, is essential for healing of wounded skin. Focal contacts (FCs) play a role in each
of these processes. We have demonstrated a novel cytoskeleton interaction of FCs in human
dermal endothelial cells; αvβ3 integrin-rich FCs associate with vimentin intermediate fila-
ments (IFs). This association depends on integrin activation since IF-FC interaction is decreased
in ECs plated onto poly-L-lysine but is restored upon addition of Mn2+. Knocking down β3
integrin expression in ECs results in a 70% decrease in FC-IF association. We have also trans-
fected β3 integrin into CHO cells which lack β3 integrin but contain vimentin. In “parental”
CHO cells vimentin is collapsed around the nucleus. In CHO cells expressing wild-type β3
integrin (CHOwtβ3), vimentin IFs extend to FCs. This recruitment is regulated by phosphory-
lation. In CHO cells (CHOβ3Y759F; CHOβ3Y747F) expressing mutated β3 integrin, there is
a decrease in vimentin-FC interaction compared to CHOwtβ3 cells. Moreover, deletion of
the 9 C-terminal residues of the β3 cytoplasmic tail (CHOβ3∆754) also decreases vimentin-
FC interaction. We studied the role of microtubule motor proteins in recruitment of vimentin
to FCs. AMP-PNP, a kinesin inhibitor, decreases vimentin-FC interaction whereas EHNA, a
dynein inhibitor, has no significant effect. Finally, we assessed the functional consequences
of IF-FC interactions. CHOwtβ3 cells exhibit greater adhesive strength than CHO,
CHOβ3Y759F, CHOβ3Y747F, and CHOβ3∆754 cells. Moreover, CHOwtβ3 cells close in
vitro wounds significantly faster than parental CHO, CHOβ3Y759F, CHOβ3Y747F, and
CHOβ3∆754 cells. In summary, our data reveal that β3 integrin is involved in recruiting
vimentin to FCs, a process that is under microtubule motor control. Moreover, vimentin-FC
interactions regulate the adhesive function of FCs and their role in migration, two essential
components of angiogenesis.
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An immunohistochemical characterization of lymphatic malformations mainly by D2-40
(and CD34)
H Kim,1 J Lee,1 S Lee,1 W Lee,1 D Kim1 and G Yoon2 1 Dermatology, Kyungpook National
University Hospital, Daegu, South Korea and 2 Pathology, Kyungpook National University
Hospital, Daegu, South Korea
Lymphatic vessels and lymphangiogenesis have been increasingly understood in recent years.
Lymphatic malformations are conventionally divided into macrocystic, microcystic and mixed
type. Lymphatic vessel in normal tissues appears thin-walled vascular channel lined with atten-
uated layer of endothelial cells, pinkish luminal material and associated lymphoid tissue. But the
distinction between lymphatic and blood vessels on microscopic sections, especially in lymphatic
malformations, is not always an easy task due to overlapping morphological features. To search
the vascular components of them, we analyzed 10 cases of lymphatic malformations which have
been diagnosed definitely based on the clinicopathologic background by experienced derma-
tologists(SL, WJL). We used the immunohistochemical markers, CD31, CD34 and D2-40 of newly
developed specific marker of lymphatics. Its immunoreactivity was classified into category A(>75%),
B(10-75%), C(<10%) according to positivity of composing lymphatic-looking vessels by 2 inde-
pendent investigators (HYK, SL). We divided lymphatic malformations arbitrarily into small and
large channels. CD31 stained endothelial cells of blood vessels and lymphatics for the most part
as category A. D2-40 stained almost small channels in category A but the large, dilated thick-
walled vascular channels did not stained well or stained weakly (at most category C). CD34 less
stained lymphatic channels positive with D2-40 in addition to D2-40 negative vascular channels
and revealed 7 category A, 2 category B and 1 category C. In conclusion, D2-40 was proved reli-
able demonstration of lymphatic malformations and its immunoreactivity is very helpful in iden-
tifying lymphatics in accordance with CD31 in addition to clinicopathologic findings. On the
contrary it is difficult to use CD34 as the differential marker of lymphatic malformation because
of low specificity although CD34 revealed some lymphatic-looking vessels.
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Hypoxia mimetics inhibit TNF-α induced chromatin remodeling associated with the vascu-
lar cell adhesion molecule-1 promoter
TV Cartee,1,2 KJ White1,2 and RA Swerlick1,2 1 Dermatology, Emory University SOM, Atlanta,
GA and 2 Dermatology, Atlanta VA Medical Center, Atlanta, GA
Previously, we reported that hypoxia and hypoxia mimetics (HM) block the transcription of
vascular cell adhesion molecule (VCAM)-1 in human dermal microvascular endothelial cells
(HDMEC). We initially postulated that this was mediated through stabilization of hypoxia
inducible factor (HIF). However, optimal VCAM-1 inhibition was not observed at concentra-
tions of HM that induced maximal expression of HIF. To scrutinize further the role of HIF in
VCAM-1 induction, we transfected HDMEC with HIF-1α siRNA. Despite successful HIF gene
silencing, VCAM-1 expression was not rescued in HM treated HDMEC. This result together
with the discordant dosing data indicated that HM-mediated transcriptional repression was
likely HIF independent. Prior research had shown that nuclear localization of NF-κB, the pri-
mary transcription factor responsible for VCAM-1 expression, was preserved in cells pretreated
with HM prior to TNF-α administration. We suspected that HM may interfere with the acces-
sibility of the VCAM-1 gene by influencing its chromatin structure. NF-κB translocates to the
nucleus within minutes of TNF-α stimulation. The relatively delayed induction of VCAM-1 after
TNF-α treatment raised the possibility that cytokine-induced alterations in chromatin struc-
ture must precede VCAM-1 transactivation. Here we demonstrated, using chromatin immuno-
precipitation experiments, that TNF-α consistently induced increases in histone 3 acetylation
and histone 3 lysine 4 trimethylation specifically associated with the NF-κB binding sites of
the VCAM-1 promoter in HDMEC. These changes were completely abrogated if cells were pre-
treated with the iron chelator 2’,2’-dipyridyl or the α-ketoglutarate (α-KG) mimetic dimethyl
oxalyl glycine. In addition to stabilizing HIF, HM have been shown to antagonize a family of
iron, α-KG, and oxygen-dependent dioxygenases involved in histone modification. Our find-
ings support a novel link between the function of these chromatin remodeling enzymes and
pro-inflammatory gene regulation.
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TNF α enhanced expression of vascular endothelial growth factor receptors in epidermal
keratinocytes
X Man, X Yang, S Cai and M Zheng Dermatology, Second Hospital of Zhejiang University,
Hangzhou, China
Vascular endothelial growth factor (VEGF), a soluble homodimeric glycoprotein, promotes
angiogenesis by stimulating capillary proliferation, migration, and permeability, and plays
important roles in neovascularization of various neoplasms and regulates growth, differentia-
tion and development of a variety of tissues. It is well known that the biological effects of VEGF
are mediated by five known receptors, VEGFR-1 (flt-1), VEGFR-2 (KDR/flk-1), VEGFR-3 (flt-4),
neuropilin-1 (NRP-1), and neuropilin-2 (NRP-2). Recently, we detected that all identified VEGF
receptors (VEGFRs) were expressed on normal keratinocytes in normal human epidermis. TNF-
α is a proinflammatory factor and plays crucial roles in some cutaneous disease. Therefore,
TNF-α at 1, 5, 10, 25, 50 and 100 mM was added to cultured epidermal keratinocytes and
incubated for 24 h. The expression of VEGFR-1, VEGFR-2 and VEGFR-3 mRNA was signifi-
cantly enhanced by TNF-α above 50 mM. Furthermore, the protein levels determined by West-
ern blot was parallel with the mRNA levels of VEGFRs. We concluded that expression of VEG-
FRs in epidermal keratinocytes was regulated by TNF-α.
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Pyogenic granuloma and tufted angioma: are they different diseases?
S Lee,1 J Lee,1 H Kim,1 B Park,1 W Lee,1 D Kim1 and H Bae2 1 Dermatology, Kyungpook
National University Hospital, Daegu, South Korea and 2 Pathology, Kyungpook National
University Hospital, Daegu, South Korea
Tufted angioma (TA), also known as angioblastoma of Nakagawa, is a rare distinctive vascular
tumor characterized by capillary tufts dispersed at various levels of dermis. Pyogenic granu-
loma (PG) is also a very common discrete disease entity with lobular proliferation of capillar-
ies. Although TA and PG have different gross morphology such as tumor depth and their stroma,
they also have similar histologic findings, characterized by the presence of angiomatous lob-
ules composed of poorly canalized vessels. It may be suggested that these two entities are
regarded as members of the “lobular capillary hemangioma” complex, so both may be on the
same disease spectrum with different angiogenic activity. To reveal possible differences in bio-
logical characteristics like proliferative activity and apoptosis between two groups, we under-
took immunohistochemical study using Ki-67, Bcl-2 and Bax of both 24 PGs and 7 TAs. The
intensity of Ki-67, Bcl-2 and Bax immunoreaction was evaluated as negative (-), weak positive
(+) and strong positive (++). The intensity of Ki-67 was calculated by counting the positively
stained nuclei in one high power field (1-10: +, >10: ++) and those of Bcl-2 and Bax were esti-
mated semi-quantitatively based on the stainability (1-50%: +, >50%: ++). As for Ki-67, five (+)
and five (++) in PG and one (+) and one (++) in TA were revealed. For Bcl-2, seven (+) and nine
(++) in PG and two (+) and three (++) in TA were detected. For Bax, PGs showed all negative
and only one TA showed weak positive reaction. In conclusion, there were no significant dif-
ferences in expression of Ki-67, Bcl-2 and Bax between PG and TA. Both showed similar lob-
ular capillary pattern histopathologically and only have differences in gross morphology like
depth of lobules, possibly epidermal collarette induction and edematous stroma with ecstatic
vessels. So we assumed that these two entities may be firmly related in histogenetically and
probably pathogenetically and they may be on different point of spectrum of same entity.
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Loss of function of the lymphvascular marker podoplanin is not rescued by EGF induced com-
pensatory effects
C Gil Girol,1,2 L Bruckner-Tuderman1 and V Schacht1 1 University Medical Center Freiburg,
Freiburg, Germany and 2 Institute of Biology I University of Freiburg, Freiburg, Germany
The glycoprotein podoplanin promotes migration and adhesion of endothelial cells by reor-
ganization of the cytoskeleton. Recently, we demonstrated strong podoplanin expression in
the invading edge of squamous cell carcinomas (SCC). Because activation of the epidermal
growth factor receptor (EGFR) is predicted to enhance the metastatic potential of SCC, and
podoplanin expression is known to be increased by epidermal growth factor (EGF) in ker-
atinocytes, a role of podoplanin in epithelial tumor progression has been proposed. In this
study we investigated the putative connection between podoplanin and EGF stimulation/EGFR
expression in tumor cell lines and primary keratinocytes in vitro, and in SCC, basal cell car-
cinomas (BCC) and psoriatic skin lesions using quantitative real time PCR, western blot analy-
sis and immunohistochemistry. About 90% of human SCC were positive for podoplanin as
compared to less than 4% of human BCC. SCC positive for podoplanin also expressed EGFR.
However, while podoplanin was mainly restricted to the edge of tumor progression, EGFR was
also seen in the middle of proliferating tumor strands. In psoriatic skin lesions, EGFR expres-
sion was demonstrated in all nucleated cell layers of the epidermis, whereas podoplanin was
found only at the suprapapillary plates. In vitro, primary human keratinocytes expressed
podoplanin. Unexpectedly, only the SCC cell line Cal39 expressed high levels of podoplanin
as compared to keratinocytes. Interestingly, this SCC cell line is known to express high levels
of epidermal growth factor, and EGF induced upregulation of podoplanin is known to enhance
significantly cell adhesion and migration. As a loss-of-function approach, we downregulated
podoplanin by siRNA in Cal39 cells; this experiment lead to significantly decreased adhe-
sion. Therefore, we conclude that synergistic effects between podoplanin and EGF/EGFR result
in specific regulation of tumor cell behaviour. However, EGF induced compensatory effects
cannot rescue the function of podoplanin.
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Non-invasive in-vivo measurement of hypoxia-induced angiogenesis in Delayed-type Hyper-
sensitivity Reactions (DTHR) using 18F-Fluoroazomycin Arabinosid (FAZA) and Positron Emis-
sion Tomography (PET)
M Kneilling,1 BJ Pichler,2 G Reischl,3 R Mailhammer,4 A Yazdi,1 D Bukala,1,2 F Cay,1,2
C Widmer,1,2 C Reitmeier,1 MS Judenhofer,1 F Maier,2 C Claussen,2 HJ Machulla3 and
M Rocken1 1 Dermatology, Eberhard-Karls-University Tübingen, Tübingen, Germany, 2
Radiology, Eberhard-Karls-University, Tübingen, Germany, 3 Radiopharmacy, Eberhard-Karls-
University, Tübingen, Germany and 4 Clinical Molecular Biology and Tumor Genetics, GSF,
Munich, Germany
Angiogenesis plays a major role in organ-specific autoimmune diseases caused by DTHR. Hypoxia
can induce angiogenesis via hypoxia inducible factor (HIF-1α) that binds to hypoxia-responsive
elements in the regulatory regions of proangiogenic mediators. For better understanding of mech-
anisms involved in angiogenesis we investigated the role of hypoxia in acute and recurrent episodes
of cutaneous DTHR using FAZA that selectively accumulates in hypoxic tissue. In our experiments
mice were sensitized and challenged with trinitrochlorobenzene (TNCB) to induce and elicit cuta-
neous DTHR. Mice were injected with 18F-FAZA and scanned in vivo using PET and computed
tomography (CT). In addition we performed autoradiography, H&E-staining, HIF-1α- and HIF-
2α-immunhistochemistry and real-time PCR (RT-PCR) analysis of gene expression patterns. 64Cu-
PTSM and PET-CT was used to exclude a perfusion effect. In vivo PET-CT images confirmed intense
18F-FAZA uptake already in the acute phase of cutaneous DTHR persisting at the same level
even after recurrent episodes of cutaneous DTHR. H&E staining indicated enhanced blood ves-
sel formation in chronic DTHR. During chronic DTHR 2% of infiltrating lymphocytes and some
endothelial cells showed nuclear expression of HIF-1α- und HIF-2α protein. RT-PCR analysis con-
firmed an enhanced expression of pro-angiogenic genes, such as TNF, IL-1β, VEGF, HIF-1α- and
HIF-α 4-24h even after the first TNCB-challenge. Thus, non invasive in vivo examination of hypoxia-
induced angiogenesis using 18F-FAZA appears to be a new powerful tool to examine early phases
of angiogenesis in autoimmune diseases such as rheumatoid arthritis.
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Keratinocyte specific overexpression of the angiopoietin receptor Tie2 leads to development
of a psoriasiform phenotype
JA Wolfram, A Lowther, GN Adams, X Chen, D Askew, AC Gilliam, TS McCormick and
NL Ward Dermatology, University Hospitals Case Medical Center and Case Western Reserve
University, Cleveland, OH
Studies examining the role of vascular specific growth factors have shown that members of
the VEGF and angiopoietin families contribute to the development and maintenance of pso-
riasis. VEGF, VEGFR2, angiopoietins and the angiopoietin receptor, Tie2 are upregulated in
involved psoriatic skin compared to uninvolved psoriatic and normal skin. Tie2 overexpres-
sion in endothelial cells (ECs) was previously reported to result in the development of a pso-
riasiform skin phenotype; however in this mouse model Tie2 was also overexpressed by basal
keratinocytes (KCs). Using a binary tetracycline repressible model, we engineered two lines
of mice that confine expression of Tie2 to either ECs (using the Tie1 promoter) or KCs (using
the K5 promoter). EC-Tie2 overexpression alone did not result in a flaky skin phenotype, even
following cutaneous insult, despite these mice having significant increases in their dermal vas-
culature. This suggests that having increased vasculature alone is not sufficient to initiate devel-
opment of cutaneous psoriasiform changes. KC-Tie2 overexpression however, did result in a
psoriasiform phenotype. VEGF protein expression in KC-Tie2 mice was increased ~5-fold com-
pared to wildtype littermate controls. Ear and back skin from KC-Tie2 mice was erythematous
and scaly. Histologically, the skin from these mice was acanthotic, contained larger, more
numerous blood vessels, and showed evidence of increased inflammatory cell infiltration.
Initial flow cytometry analysis identified the cellular infiltrate as predominately mono-
cytic/myeloid cells. Immunofluorescent staining of affected skin with antibodies against CD11c
and F4/80 confirmed an increase in dendritic cells and macrophages in the dermis of KC-Tie2
mice. In conclusion, we have developed a novel psoriasiform mouse model that bears a strik-
ing resemblance to human disease and have shown that the localized Tie-2 expression in the
epidermis is critical for the psoriasiform phenotype.
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Angiopoietin 1 can enhance wound healing in a re-epithelialization independent manner
GN Adams, E Brandt, G Torres, TS McCormick and NL Ward Dermatology, University
Hospitals Case Medical Center and Case Western Reserve University, Cleveland, OH
Angiopoietin 1 (Ang1) is a vascular growth factor that binds to the tyrosine kinase receptor
Tie2 leading to receptor phosphorylation and downstream signaling events that control angio-
genic remodeling. We have engineered a mouse overexpressing Ang1 using a keratinocyte
specific promoter (K5-Ang1) and have found increased dermal vascularization, consistent with
previous reports. Using these mice, we tested the effects of epidermal-derived Ang1 in two
different models of wound healing: the classic dorsal punch biopsy model and a contraction-
independent granulation-driven model. Following wounding using the punch biopsy model,
K5-Ang1 mice healed more quickly; wounds were closed by 9 days following initial injury
compared with 12 days in control littermates (p= 0.02, n=4). Of particular interest was the
observation that at 7 days following wounding, K5-Ang1 mice had 60% less re-epithelializa-
tion compared to littermate controls (p=0.03, n=4 controls and n=5 K5-Ang1). Using a sec-
ond wound healing model that involves splinting the tissue around the wound to prevent
contraction, we confirmed the impairment in re-epithelialization in the K5-Ang1 mice (p=0.02,
n=5). Preliminary human primary keratinocyte in vitro experiments suggest that Ang1 can
inhibit keratinocyte migration directly. In conclusion, our data suggest that Ang1 enhances
wound healing in a re-epithelialization independent manner and that Ang1-mediated impair-
ment of re-epithelialization may occur through a direct effect of Ang1 on keratinocytes.
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Epigallocatechin-galate infused cream has anti-antiogenic effects in rosacea
D Santo Domingo,1 M Camouse,1 J Miller,1 AH Hsia,1 NL Ward,1 M Matsui,2 D Maes,2
KD Cooper1 and ED Baron1 1 Dermatology, Case Medical Center/University Hospitals,
Cleveland, OH, OH and 2 Estee Lauder, Melville, NY
Green tea is an antioxidant that is of potential therapeutic interest due to its anti-inflamma-
tory and anti-carcinogenic effects. The major polyphenolic component of green tea is epigal-
locatechin-galate (EGCG). Previous studies have shown that EGCG also has antiangiogenic
properties, and therefore may be useful in treatment of dermatoses with predominantly inflam-
matory and angiogenic pathologies. Rosacea is a common skin disease that may present with
erythema and telangiectasias. In order to evaluate the clinical and molecular response of
rosacea patients to a topical cream containing EGCG, we designed a randomized double blind
study. A total of 14 subjects applied EGCG cream and placebo to separate halves of the face
twice daily for six weeks. Clinical and chromometer assessments of these areas were obtained
every two weeks. No significant differences were found clinically between EGCG vs. placebo
sides. Punch biopsies of rosacea affected areas (n=4) and control/untreated areas (n=4) were
obtained 6 weeks after treatment. Sections from these samples were immunostained with anti-
bodies against vascular endothelial growth factor (VEGF) and hypoxia inducible factor-1-alpha
(HIF-1α). The percentage area of positive staining in the epidermis for both markers was
determined using Image-Pro image analysis software on 15 measures/sample. We observed
significant decreases in HIF-1α expression, such that 28.4% of the epidermis showed positive
staining in vehicle control vs. 13.8% in EGCG treated sites (p<0.001). Significant decreases
were also found for VEGF expression (6.7% vs. 11.0%) in EGCG treated skin relative to vehi-
cle-treated skin (p<0.005). These results suggest that ECGC can downregulate HIF-1α and
VEGF expression even in the absence of clinical improvement. A more potent EGCG formu-
lation may eliminate the disparity between our clinical and histological findings. Alternatively,
angiogenic factors other than HIF-1α and VEGF may be critical in rosacea pathogenesis.
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Down-regulation of Psoriasis-associated fatty acid binding protein by RNA interference pro-
motes replicative senescence in cultured human dermal microvascular endothelial cells and
human microvascular endothelial cells
H Chung,1 H Liu,1 M Ha,2 D Bang,1 K Lee1 and K Chung1 1 Department of Dermatology and
Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, South
Korea and 2 Department of Biochemistry and Molecular Biology, Seoul National University
College of Medicine, Seoul, South Korea
Psoriasis-associated fatty acid binding protein (PA-FABP) is known to be an important intra-
cellular signal transducing molecule, a human epidermal progression amplifying factor, a can-
cer metastasis inducing factor and also associated with human keratinocyte differentiation. Our
previous study reported that the PA-FABP expression was elevated in aged endothelial cell as
well as old aged skin. Although they are thought to be involved in aging process and various
cellular signaling events, their precise functions in the cell remain unclear. In the previous study,
we used an adenoviral vector to over-express PA-FABP in human endothelial cells. Over-expres-
sion of PA-FABP showed that it played a role in the mechanism of cellular proliferation in human
endothelial cells and identified the roles of both Akt and ERK pathways in the PA-FABP-induced
proliferation. In this study, we investigated down-regulation of PA-FABP by RNA interference
in cultured human dermal microvascular endothelial cells (HMVEC) and human microvascu-
lar endothelial cells (HMEC-1). Transient transfection of RNAi probes resulted in the 5 fold reduc-
tion of mRNA level on the 2nd day and 70% decrease at the protein level on the 3rd day. Expres-
sions of p-MEK and p-ERK were decreased compared to controls which correlated with the
observed high levels of p21, and p16 expression. These results demonstrate the importance of
PA-FABP in endothelial cell proliferation and indicate that knock down of PA-FABP increases
p21 and p16 expression, resulting in promotion of replicative senescence. In conclusion, PA-
FABP may play an important role in the defense mechanism against aging process by regula-
tion of cell cycle related molecules as well as MAPK signaling.
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Plant derived extracts exhibit anti-angiogenic properties in both in vitro and in vivo systems
MD Hines, L Mangos, D Gan, TC Florence and BC Jones Skin Care Research, Mary Kay, Inc.,
Dallas, TX
The growth of new blood vessels is critical for normal growth as well as the progression of
many disease states. Telangiectasia, small blood vessels found along the skin surface, are
abnormal and are not necessary for any essential skin function. Morever, a reduction in the
appearance of these vessels can provide a more pleasing cosmetic appearance. In the pres-
ent studies, we examined the ability of plant-derived plant extracts to inhibit new microvas-
cular growth using human umbilical vein endothelial cells (HUVEC) and human dermal
microvascular cells (HMVEC). When grown in Matrigel, a reconstituted gel composed of base-
ment membrane molecules, these cells can form tubes which are similar to blood vessels.
Using tube formation as an indicator of angiogenesis, several plant-derived extracts were found
to reduce the density of the cell network without decreasing cell viability, as measured by
neutral red uptake. In addition, 10-day old chicken chorioallantoic membranes (CAM) were
exposed to the plant extracts for 48 hours and examined for loss of vasculature. We found
that two of the four plant - derived extracts which inhibited the growth of human endothelial
cells in vitro were also able to diminish the vessel network formation in vivo. These data demon-
strate the ability of plant-derived extracts to act as anti-angiogenic factors that may serve to
help reduce the appearance of telangietasia.
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Gene expression analysis in human amphiregulin transgenic mice reveal psoriasis-like pro-
files and novel immune regulatory pathways
J Lu,1 Y Asmann2 and MR Pittelkow1 1 Dermatology, Mayo Clinic, Rochester, MN and 2
Bioinformatics, Mayo Clinic, Rochester, MN
Human amphiregulin(AR) transgenic mice have been shown to induce severe skin pathology
with inflammatory T cell responses similar to psoriasis. To further understand the compli-
cated interaction between epidermis and immune system in psoriasis, we examined global
gene expression in AR transgenic mice, comparing involved ear and tail skin from transgenic
mice with normal paired specimen from wild type mice using Affymetrix Mouse 430_2.0
GeneChip Arrays that profile 45,101 transcripts. Array normalization and gene expression
measurement were performed by GC-RMA using GeneSpring software. Using the criteria of
p < 0.05 in both Wilcoxon two-sample rank test and Welch’s approximate t-test, there are
3156 gene transcripts in AR ear skin and 6754 gene transcripts in AR tail skin that are differ-
entially expressed compared with normal skin samples of wild type mice. Comparing our data
with previous published gene array studies in human psoriasis, there is marked similarity on
differentially expressed genes including STAT 1, CD44, IFN-gamma, TNF-alpha, IL-1, IL-6,
and chemokines. Ingenuity Pathway analysis (IPA) reveals that the differentially regulated genes
were enriched with immune regulatory pathways including T cell receptor signaling; antigen
presentation; cytokine signaling; interferon signaling; NF-KB signaling and JAK/STAT signal-
ing. Besides the pathways that had been reported for previous studies on human samples, our
study revealed several novel immune regulatory pathways including VGEF cascade, toll-like
receptor signaling and P38 MAPK signaling. This is the first report of gene expression analy-
sis in a psoriasis animal model. Our study demonstrates that AR transgenic mouse has great
similarity to psoriasis in gene expression profiles, making it a very robust animal model for
future study. Further investigation on these novel immune regulatory pathways will facilitate
identifying the pathogenesis of psoriasis.
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Steric hindrance of desmoglein 3 transinteraction by pemphigus vulgaris IgG
W Heupel,1 D Drenckhahn,1 D Zillikens2 and J Waschke1 1 Institute for Anatomy and Cell
Biology, University of Würzburg, Würzburg, Germany and 2 Department of Dermatology,
University of Luebeck, Luebeck, Germany
The severe skin disease pemphigus is clinically defined as pemphigus foliaceus (PF) and
pemphigus vulgaris (PV) and caused by autoantibodies against desmosomal cadherins. Whereas
PF patients show autoantibodies against desmoglein 1 (Dsg 1), sera of PV patients contain
antibodies to desmoglein 3 (Dsg 3) alone or in addition to antibodies against Dsg 1. It is still
controversially discussed whether pemphigus autoantibodies directly interfere with desmoglein
binding by steric hindrance. Using atomic force microscopy, for the first time we provide evi-
dence that PV-IgG directly interferes with Dsg 3 but not with Dsg 1 transinteraction. IgG puri-
fied from different PV sera either containing Dsg 3-specific antibodies only or antibodies
against both Dsg 1 and Dsg 3 reduced Dsg 3 binding activity in single molecule force dis-
tance cycles by 45 and 55 %, respectively, i.e. to a similar extent as Ca2+-depletion by EGTA.
AK 23, a monoclonal mouse PV antibody directed against the aminoterminal domain of Dsg
3, also reduced Dsg 3 binding by steric hindrance. However, PV-IgG containing antibodies
against both Dsg 1 and Dsg 3 as well as PF-IgG containing Dsg 1-specific antibody PF-IgG
did not block Dsg 1 transinteraction in this cell-free system. Nevertheless, all PV- and PF-IgG
used in this study caused keratinocyte dissociation in HaCat monolayers, accompanied by a
generalized loss of desmosomes under PV-IgG treatment. Taken together, these data indicate
that PV and PF profoundly differ with respect to the molecular mechanisms involved. Our
results show that PV-IgG inhibits Dsg 3 binding, indicating a contribution to pemphigus patho-
genesis. On the other hand, because epidermal blistering in PV only occurs when Dsg 1-spe-
cific antibodies are present which do not cause steric hindrance, additional autoantibody-trig-
gered cellular signalling pathways must also be involved.
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Development and characterization of a passive transfer animal model of acute and chronic
ocular cicatricial pemphigoid (CP)
Z Lazarova, E Sadler, VK Salato, A Lopez and KB Yancey Dermatology, Medical College of
Wisconsin, Milwaukee, WI
Anti-epiligrin CP (AECP) is a chronic autoimmune blistering disease of mucous membranes
and skin. Patients with AECP have IgG autoantibodies against laminin 5 (L5). Despite the fact
many AECP patients have severe ocular involvement, an animal model depicting eye lesions
that develop as a consequence of antibody mediated tissue injury does not exist. Therefore,
the goal of this study was to develop an animal model that mimics ocular CP. Our studies show
that a single, regional (i.e., not intraocular) subcutaneous injection of purified rabbit anti-L5
IgG (2.5 to 10 mg in 100 ul) into adult BALB/c mice (n=25) induces dose dependent acute
inflammatory reactions and subepithelial blisters of the conjunctiva and cornea. All mice
injected with anti-L5 IgG displayed rabbit IgG and murine C3 in conjunctival and corneal
BMs; mice injected with 10 mg of anti-L5 IgG developed extensive ocular lesions including
eye closure (onset day 2, duration 4 days), severe eye exudate (onset day 3, duration 5 days),
eyelid changes (onset day 2, duration 10 days) and periorbital hair loss (onset day 3, duration
entire period of study). Control mice (n=10) injected with identical amounts of purified nor-
mal rabbit IgG did not develop any alterations. Regional administration of anti-L5 IgG 5 mg
every other day x 3 (n=16 mice) resulted in alterations like those described above as well as
loss of PAS positive conjunctival goblet cells and conjunctival fibrosis (onset week 2, duration
entire period of study [i.e., 5 weeks]). Control mice injected with equivalent amounts of nor-
mal rabbit IgG did not develop any lesions. These studies show that regional administration
of anti-L5 IgG (i.e., without physical ocular injury) can elicit subepithelial conjunctival and
corneal blisters, loss of conjunctival mucin producing goblet cells, and conjunctival fibrosis
in mice. They also establish novel animal models of acute and chronic ocular CP that can be
used to characterize and block different stages of this sight-threatening disease.
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Expression of high mobility group box protein 1 in neutrophils
P Saitta, R McKinney, M Pahujaa and K Yin Cell Biology, University of Medicine and Dentistry
of New Jersey, Stratford, NJ
It has been shown that increased amounts of the novel cytokine high mobility group box pro-
tein 1 (HMGB-1) are passively released from the nuclei of necrotic and damaged cells. Neu-
tropenia resulting from direct lysis, as well as facilitation by phagocytic destruction, is seen in
cutaneous lupus erythematosis (CLE). HMGB-1 has recently been implicated as a source of
inflammation and necrosis in CLE. In light of these findings, we proposed to measure the
expression of HMGB-1 from human neutrophils. Blood samples were taken from healthy vol-
unteers. Peripheral blood neutrophils were isolated using dextran sedimentation, followed by
hypotonic lysis and ficol sedimentation. Neutrophils were activated using fMLP and incubated
for 30 minutes at 370C. Some neutrophils were not treated with fMLP and were used as con-
trols. Immunohistochemical staining and Western blots for HMBG-1 were performed. No sig-
nificant cytoplasmic or extracellular expression of HMGB-1 was noted in activated neutrophils
or control cells. Conflicting data exists as to whether or not neutrophils produce and secrete
HMGB-1. Our study suggests that neutrophils are not a source of HMGB-1 expression even
when activated, and thus are less likely to contribute to the pathology of CLE. However, the
local milieu of the disease entity may be conducive to neutrophil production of HMGB-1.
Therefore further studies specifically examining the relationship between HMGB-1 and neu-
trophils in CLE may prove to be beneficial.
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Pemphigus IgG cause skin splitting and keratinocyte dissociation in the presence of both
desmoglein 1 and desmoglein 3
V Spindler,1 D Drenckhahn,1 D Zillikens2 and J Waschke1 1 Institute for Anatomy and Cell
Biology, University of Würzburg, Würzburg, Germany and 2 Department of Dermatology,
University of Luebeck, Luebeck, Germany
Pemphigus is an autoimmune blistering skin disease caused by autoantibodies against desmo-
somal cadherins desmoglein (Dsg) 1 and Dsg 3 and other keratinocyte surface antigens. It is
generally believed that the Dsg compensation concept explains the different epidermal cleav-
age planes observed in pemphigus vulgaris (PV) and pemphigus foliaceus (PF). The desmoglein
compensation concept relies on distinct autoantibody profiles against Dsg 1 and Dsg 3 and
on different distribution patterns of Dsg 1 and Dsg 3 in human epidermis. According to this
model, autoantibodies to Dsg 1 in PF would only lead to epidermal splitting in those epider-
mal layers where no Dsg 3 is present to compensate the functional loss of Dsg 1. We provide
evidence that both PF-IgG containing Dsg 1- but not Dsg 3-specific antibodies and PV-IgG
with antibodies to Dsg 1 and Dsg 3 were equally effective to cause epidermal splitting in
human skin and keratinocyte dissociation in vitro. These effects were present where ker-
atinocytes expressed both Dsg 1 and Dsg 3 demonstrating that Dsg 3 does not compensate
for Dsg 1 inactivation. Rather, the cleavage plane in intact human skin caused by pemphigus
autoantibodies was similar to the plane of keratinocyte dissociation in response to toxin B-
mediated inactivation of Rho GTPases. Because we recently demonstrated that pemphigus-
IgG causes epidermal splitting by inhibition of Rho A, we propose that Rho GTPase inactiva-
tion accounts for the cleavage plane in pemphigus skin splitting and that secondary mechanisms
in chronically diseased skin contribute to the full phenotype of skin blistering in vivo.
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CD4+ regulatory T cells maintain peripheral tolerance and survival in double transgenic (K14-
sOVA x OT-I) mice
KE Nograles, F Miyagawa and SI Katz Dermatology Branch, NCI, National Institutes of
Health, Bethesda, MD
To establish an animal model for T-cell mediated autoimmune disease against an epithelium-
derived soluble antigen, we developed transgenic mice that produce a soluble model self-anti-
gen, ovalbumin (sOVA), under the control of the K14-promoter (K14). These K14-sOVA mice
express ovalbumin in stratified squamous epithelium verified by real-time PCR and Western
blot. Adoptive transfer of OT-I cells, from mice that have OVA-specific Vα2Vβ5+CD8+ T cells,
into K14-sOVA mice result in rapid weight loss and death within a week. The cause of death
is severe inflammation of tongue and esophageal epithelium preventing adequate ingestion
of nutrition. When these K14-sOVA mice are crossed with OT-I mice, 83% of the F1 progeny
die between the second and third weeks of life due to severe inflammation of the tongue and
esophagus. FACS analysis of the superficial lymph nodes from the sick mice reveals a more
prominent Vα2Vβ5+CD8+ (40%) than Vα2Vβ5+CD4+ (29%) population suggesting a failure of
deletion of autoreactive T cells. Administration of anti-CD8 depleting antibody within the first
week of life into these double transgenic mice significantly delays death in these mice con-
firming that the disease is CD8+ T cell-mediated. In contrast, the ~20% adult surviving mice
are tolerant to self-reactive T cells, and do not die despite adoptive transfer of 5x106 poten-
tially autoreactive OT-I cells. Moreover, these mice have twice the number of Foxp3+CD4+
(Treg) cells (15.83±5.07%) compared to C57BL/6 controls (7.2±2.64%). In vivo administra-
tion of depleting antibodies against either CD4+ (GK1.5) or Treg cells (PC61) overcomes this
peripheral tolerance and disease ensues in two to three weeks. In corroboration, CD4+ T cells
isolated from the adult double transgenic mice are able to suppress in vitro proliferation of
autoreactive OT-I cells by 50%. Together, these results strongly suggest that T regulatory cells
are responsible for the continued survival of adult double transgenic mice despite the pres-
ence of peripheral autoreactive T cells.
32
A novel system for evaluation of in vivo pathogenicity of desmoglein 3-reactive T cell clones:
a critical role of interleukin-4 in the mouse pemphigus vulgaris model
H Takahashi,1,2 M Amagai,1 T Nishikawa,1 Y Kawakami3 and M Kuwana4 1 Dermatology, Keio
University, Tokyo, Japan, 2 TEPCO Hospital, Tokyo, Japan, 3 Institute for Advanced Medical
Research, Keio University, Tokyo, Japan and 4 Internal Medicine, Keio University, Tokyo,
Japan
Pemphigus vulgaris (PV) is an autoimmune disease mediated by IgG anti-desmoglein 3 (Dsg3)
autoantibodies. Recently, we have established a unique in vivo system to evaluate the patho-
genicity of individual T-cell clones or lines by analyzing the production of pathogenic anti-
Dsg3 IgG in recipient Rag2-/- mice when Dsg3-reactive T-cell lines and Dsg3-/- B cells were
adoptively transferred. To identify T-cell derived factors associated with pathogenicity we ana-
lyzed 20 Dsg3-reactive T-cell lines in this system and compared various factors between Dsg3-
reactive T-cell lines with and without the pathogenicity. Evaluation of mRNA expression by
RT-PCR revealed that IL-4 and IL-10 were frequently expressed in all of 7 pathogenic T-cell
lines, but in 6 of 13 non-pathogenic lines (P = 0.04). However, there was no significant dif-
ference in those two populations in the mRNA expression of IL-2, IL-6, IFN-γ, TGF-β, CCR7,
CCR4, CXCR5, CRTH2 and CXCR3, in vivo proliferative behavior of T-cell lines in spleen as
evaluated with CFSE-labeling, Ki-67 staining and BrdU-labeling or homing capacity of trans-
ferred Dsg3-reactive T cells into either T or B cell areas of spleen. We then focused on the role
of IL-4 and IL-10 in anti-Dsg3 antibody production both in vitro and in vivo. IL-4 promoted
anti-Dsg3 antibody production from Dsg3-/- B cells in culture with soluble CD40L, but nei-
ther IL-10 nor IFN-γ did. Furthermore, an adenovirus vector harboring sIL-4Rα, that blocks IL-
4, suppressed anti-Dsg3 antibody production as well as development of the PV phenotype
when intravenously injected in recipient mice, while the vector harboring sIL-10Rα or sIFN-
γR1 did not. These results together indicate that IL-4 is a critical T-cell derived factor in the
induction of pathogenic IgG production and PV phenotype in the mouse PV model, and is a
potential therapeutic target in patients with PV.
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Major differences in inflammatory dendritic cells and their products distinguish atopic der-
matitis from psoriasis
E Guttman-Yassky,1 MA Lowes,1 J Fuentes-Duculan,1 J Whynot,1 I Novitskaya,1 I Cardinale,1
A Haider,1 A Khatcherian,1 JA Carucci,2 R Bergman3 and JG Krueger1 1 Investigative
Dermatology, Rockefeller University Hospital, New York, NY, 2 Dermatology, Weill-Cornell
Medical College of Cornell, New York, NY and 3 Dermatology, Rambam Medical Center,
Haifa, Israel
Atopic dermatitis (AD) and psoriasis are opposite poles of the Th1 versus Th2 paradigm. Both
diseases have been associated with increased numbers of dendritic cells (DCs), but the simi-
larities and differences in DC populations have not been fully defined. We aimed to charac-
terize the specific DC subsets, chemokine and cytokine environment in chronic AD compared
to psoriasis. Skin biopsies were obtained from patients with chronic AD (n=18), psoriasis (n=15)
and healthy volunteers (n=15), for microarray analysis, RT-PCR, immunohistochemistry and
double-label immunoflouresecence. Myeloid DCs upregulate CCL17 and CCL18 in AD, and
TNF and iNOS in psoriasis. Inflammatory dendritic epidermal cells (IDECs) were present in
the dermis of both diseases, but these were significantly increased in AD. We found signifi-
cantly higher numbers of CCL22 producing plasmacytoid DCs (PDCs) in AD. Th2 associated
TSLP ligand was upregulated in psoriasis, however, the TSLP receptor (TSLPR) showed signif-
icantly higher expression in AD. There are major differences in the myeloid and plasmacytoid
subsets of cutaneous DCs, and chemokine/cytokine environment between AD and psoriasis.
Distinct subsets within the CD11c+ population may influence polarization through the pro-
duction of regulatory mediators, including iNOS, TNF, CCL17, CCL18. PDCs may also influ-
ence Th2 polarization, having a more important role in AD than previously appreciated. Der-
mal inflammatory DCs and plasmacytoid DCs and/or their regulatory products may be potential
targets for future therapeutic interventions in AD.
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Maternal transfer of bullous pemphigoid autoantibodies in novel transgenic model mice
W Nishie,1 D Sawamura,1 M Goto,1 E Olasz,2 KB Yancey,2 A Shibaki1 and H Shimizu1 1
Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan and 2
Dermatology, Medical College of Wisconsin, Milwaukee, WI
Bullous pemphigoid (BP) is the most common autoimmune blistering skin disease caused by
circulating autoantibodies directed against type XVII collagen (COL17). We recently gener-
ated COL17 knockout (COL17 m-/-) mice that show a junctional epidermolysis bullosa phe-
notype. We subsequently introduced the human COL17 cDNA transgene into these COL17
m-/- mice, resulting in COL17-humanized (COL17 m-/-, h+/+) mice (Nishie et al, Nat Med, in press).
Here, we describe a novel murine BP model that closely resembled human BP disease utiliz-
ing transgenic neonatal mice and maternal transferred autoantibodies. We initially immunized
heterozygote-null COL17 m+/- female mice by grafting human COL17 cDNA transgenic mouse
skin to generate circulating mouse IgG directed against human COL17. These immunized
COL17 m+/- female mice were then mated with COL17 m-/-, h+/+ males. The resulting genetically
transformed COL17 m-/-, h+/- pups that express only human epidermal COL17 and circulating
maternally transferred anti-human COL17 mouse IgG were obtained in half the neonatal lit-
ter. As a result, these neonates demonstrated a severe BP phenotype including spontaneous
blister formation. This ‘‘neonatal BP’’ model has several notable advantages. Firstly, autoim-
munity has been directly induced by mouse IgG, but not from other species, thus demon-
strating natural activation of murine complement. Secondly, our ‘‘neonatal BP’’ model does-
n’t need administration of IgG, which avoids many drawbacks in other model systems. Thirdly,
persistent binding of pathogenic IgG to the BP autoantigen during pregnancy and after birth
can be achieved. Lastly, the autoantigen of this neonatal BP model is human (not mouse)
COL17, which is useful for further study to test treatments for human BP disease. In conclu-
sion, this novel approach, using maternal transfer of autoantibodies in genetically trans-
formed neonates, shows promise as a useful disease model.
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The expression of neutrophil elastase, but not the expresssion of eosinophil major basic pro-
tein, in blister-containing skin is related to the level of blister fluid IgG antibodies to the
NC16a domain of BP180 in human bullous pemphigoid
M Dmochowski,1 M Bowszyc-Dmochowska1 and E Kaczmarek2 1 Dermatology, University School
of Medicine, Poznan, Poland and 2 Pathology, University School of Medicine, Poznan, Poland
Both activated eosinophils and neutrophils are involved in pathogenesis of bullous pemphigoid
(BP) as suggested by human and murine data. The aim of this study was to examine whether
in human BP lesional skin the activation of either eosinophils or neutrophils or both is related
to the level of IgG antibodies to the NC16a domain of BP180 (IgG/NC16a/BP180). Alto-
gether, 24 patients with BP were studied. The expressions of neutrophil elastase (NE) and
eosinophil major basic protein (MBP) were examined in serial sections of fresh blister-con-
taining skin by the streptavidin-peroxidase immunohistochemical technique and the intensi-
ties of their expression were measured using the appropriate software to enable the statistical
analysis of morphological data. The levels of IgG/NC16a/BP180 in serum and fresh blister fluid
were evaluated by ELISA. There was a statistically significant correlation between the level of
expression of NE, but not the level of expression of MBP, in fresh blister-containing skin and
the level of blister fluid IgG/NC16a/BP180. There were no statistically significant correlations
between either the level of expression of NE or MBP in fresh blister-containing skin and the
level of serum IgG/NC16a/BP180. Moreover, the mean levels of IgG/NC16a/BP180 in fresh
blister fluid and serum were not statistically different. There was a statistically significant cor-
relation between levels of IgG/NC16a/BP180 in fresh blister fluid and serum as well. To sum
up, it seems that in human BP lesional skin the activation of neutrophils, as judged by the
expression of NE, is related to the level of IgG/NC16a/BP180, whereas the activation of
eosinophils, as judged by the expression of MBP, is not. Therefore, neutrophil-dependent
phenomena might be more influenced by plausibly pathogenic IgG/NC16a/BP180 than
eosinophil-dependent phenomena.
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The activation of brain networks during scratching
TS Patel,1 Y Ishiuji,1 RC Coghill,2 MI Hicks,1 RA Kraft,3 Y Oshiro,2 E Winnicki1 and
G Yosipovitch1,2 1 Dermatology, Wake Forest University School of Medicine, Winston-Salem,
NC, 2 Neurobiology and Anatomy, Wake Forest University School of Medicine, Winston-
Salem, NC and 3 Biomedical Engineering, Wake Forest University School of Medicine,
Winston-Salem, NC
Scratching is the most common method to inhibit itch. Previous studies using neuroimaging
have shown a central processing of itch stimuli. However, brain areas and neural networks
activated during scratching are poorly characterized. In the current study, we examined the
effects of scratching on brain activation using blood oxygen level dependent functional MRI
(BOLD fMRI). Itch and scratch stimuli were induced in the right leg of 13 healthy subjects.
The technique of subtraction analysis (scratching versus rest) showed robust activation of the
bilateral secondary somatosensory cortex (SII), insula and premotor cortex during scratching.
In order to develop a better understanding of brain networks activated during scratching, we
used a regression analysis technique to identify brain areas whose activation was significantly
related to that of SII. This showed the insula, cingulate cortex and primary somatosensory cor-
tex were correlated with the time course of SII activation. These networks are consistent with
the brain networks engaged in the processing of scratch stimuli and are most probably related
to the itch-scratch cycle.
S6 Journal of Investigative Dermatology (2007), Volume 127
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Tetracycline inhibits ATPγS-induced chemokine and ICAM-1 expression by HMEC-1 cells
T Zapolanski,1 K Carrington,1 W Ding,1 JA Wagner,2 J Siscovick1 and RD Granstein1 1
Dermatology, Weill Medical College of Cornell University, New York, NY and 2 Neurology
and Neuroscience, Weill Medical College of Cornell University, New York, NY
Tetracyclines (TCNs), largely known for their antibiotic effects, also have anti-inflammatory
activities. The anti-inflammatory properties are believed to account, in part, for therapeutic
effects in rosacea and acne. Some inflammatory skin diseases are believed to be exacerbated
by stress. One of the mediators of stress may be ATP (adenosine triphosphate), which is released
by sympathetic nerves. Previous studies suggest that release of ATP by sympathetic nerves dur-
ing stress may stimulate the release of proinflammatory chemokines by dermal vessel endothe-
lial cells, resulting in exacerbation of inflammatory skin disease. We have shown that at high
concentrations (25-400 µg/ml) TCNs inhibit the secretion of certain chemokines by a human
dermal microvascular endothelial cell line (HMEC-1) stimulated by ATPγS, a hydrolysis-
resistant ATP-analog. We have now asked whether at physiologic concentrations TCNs inhibit
the stimulated release of chemokines and/or the upregulation of intercellular adhesion mol-
ecule 1 (ICAM-1), a molecule involved in adhesion of leukocytes to endothelium during inflam-
mation. HMEC-1 cells were pre-treated for 30 minutes with varying concentrations of TCN
and then stimulated (still in the presence of TCN) with 100 nM ATPγS for 24 hrs. Supernatants
were harvested and chemokine concentrations assessed via enzyme linked immunosorbent
assay (ELISA). ICAM-1 expression was measured by flow cytometry. TCN dose-dependently
inhibited ATPγS-induced augmentation of monocyte chemoattractant protein 1, growth reg-
ulated oncogene α and interleukin-8 production as well as induced expression of ICAM-1 at
physiologic concentrations (0.03-10 µg/ml). This dose range is comparable to the serum lev-
els of patients taking oral tetracycline. Tetracycline did not affect cell viability at 24 hours.
These results suggest that TCNs may improve inflammatory disease by inhibiting the produc-
tion of inflammatory mediators by endothelial cells.
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Neuropeptides and their receptors in psoriatic skin in relation to pruritus
S Chang Dermatology, Asan Medical Center, Seoul, South Korea
Pruritus in patients with psoriasis has been reported more common than generally expected.
To determine its actual prevalence, we assessed 152 patients with chronic plaque type pso-
riasis. We also assayed the expression of neuropeptides and their receptors in skin biopsies
obtained from 10 psoriatic patients with pruritus, 10 psoriatic patients without pruritus com-
pared to non-lesinal skin of pruritic psoriasis and normal skin by confocal laser scanning
microscopy. Of the 152 psoriatic patients, 73.7% suffered from pruritus, and these patients
had a higher mean PASI score than psoriatic patients without pruritus. There was positive cor-
relation between the PASI score and the intensity of pruritus. Keratinocytes in the psoriatic
plaques of patients with pruritus showed consistently increased expression of substance P
receptor (SPR), high affinity NGF receptor (TrkA), calcitonin gene-related peptide receptor
(CGRPR) than those in the psoriatic plaques of patients without pruritus and those in the nor-
mal controls. Pruritus is a common feature in psoriasis. Considering the well known roles of
neuropeptides in pathogenesis of both psoriasis and pruritus, increased SPR, TrkA and CGRPR
may be involved in the pathogenesis of pruritus in psoriasis and the severity of psoriasis.
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Increased macrophage migration inhibitory factor (MIF) in sera of patients with bullous pem-
phigoid
Y Asano,1 T Makino,1 O Norisugi,1 H Watanabe,1 R Abe,2 H Shimizu2 and T Shimizu1 1
Dermatology, University of Toyama, Toyama, Japan and 2 Dermatology, Hokkaido
University, Sapporo, Japan
Bullous pemphigoid (BP) is an inflammatory disease of the skin associated with eosinophil
infiltration and the presence of high levels of inflammatory cytokines in the associated blis-
ter fluid. Macrophage migration inhibitory factor (MIF) is one of the immunoregulatory cytokines
involved in T-cell activation and delayed-type hepersensitivity. It is reported that eosinophils
are an important source of MIF in allergic inflammatory diseases. Little is known about the
contribution of MIF in BP. To elucidate involvement of this cytokine in the pathogenesis of BP,
we examined serum and blister fluid MIF concentrations of patients with BP. The mean serum
MIF concentration in BP patients (n = 21) was 24±1.94 ng/ml, whereas that of healthy indi-
viduals (n = 45) was 4.1±0.26 ng/ml (p< 0.0001). MIF levels in blister fluid were also ele-
vated for BP. After the treatment, the MIF concentration decreased as clinical symptoms
improved. These results suggest that MIF is involved in the pathogenesis of BP.
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The endogenous cannabinoid system alters the chemokine expression profile in the skin
during allergic contact dermatitis
E Gaffal,1 L Wang-Eckhardt,1 M Karsak,2 R Steuder,1 D Tormo,1 A Zimmer2 and T Tüting1 1
Dermatology, University of Bonn, Bonn, Germany and 2 Laboratory of Molecular
Neurobiology, University of Bonn, Bonn, Germany
Evidence has accumulated that the endogenous cannabinoid (CB) system is involved in the
regulation of inflammatory responses. Using CB-receptor deficient mice, we have shown that
endogenous cannabinoids attenuate allergic contact dermatitis. To investigate how endoge-
nous cannabinoids are able to control inflammatory responses in the skin we performed microar-
ray experiments. Contact hypersensitivity (CHS) was induced in C57Bl/6 mice lacking both
known CB-receptors (CB1/2-/-) mice as well as in wildtype control mice by application of
0,2% DNFB on the shaved abdomen. CHS was elicited by painting one ear with 0,3% DNFB.
Microarrays were performed on inflamed and normal tissue. Gene expression changes were
confirmed using RT-PCR as well as in situ hybridization. In microarray experiments immune
related probe sets represented the largest group of strongly upregulated genes in contact aller-
gic skin in both mouse strains. Importantly, CCL8/MCP-2 a member of the monocyte chemo-
tactic protein (MCP) family was differentially expressed in CB-receptor deficient animals in
comparison to wildtype mice. In situ hybridization for CCL8/MCP-2 revealed keratinocytes as
the major source of this chemokine. Our results indicate that modulation of chemokine expres-
sion may be involved in the downregulation of cutaneous hypersensitivity responses by endoge-
nous cannabinoids.
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NALP1 is a major gene for vitiligo and associated autoimmune disease
RA Spritz,1 Y Jin,1 C Mailloux,1 G Laberge,1 K Gowan,1 S Riccardi,1 P Fain1 and D Bennett2
1 Human Medical Genetics Program, University of Colorado Health Sciences Center, Aurora,
CO and 2 Div Basic Med Sci, St Georges, Univ London, London, United Kingdom
Generalized vitiligo is a autoimmune depigmenting disease due to loss of melanocytes from
involved regions. There is strong epidemiological association between generalized vitiligo and
other autoimmune/autoinflammatory diseases, particularly autoimmune thyroid disease, adult-
onset IDDM, RA, psoriasis, pernicious anemia, SLE, and Addison’s disease, with apparent mul-
tifactorial, polygenic inheritance of risk. We mapped a major locus for vitiligo and associated
autoimmune disease to chromosome 17p, co-localizing with a lupus/autoimmunity suscep-
tibility locus, SLEV1. We carried out SNP genotyping across the linkage peak in 114 Caucasian
multiplex vitiligo/multiple autoimmune disease families, finding association of both vitiligo
and an expanded autoimmunity phenotype with a strong biological candidate gene, NALP1.
To identify additional disease-associated SNPs, we sequenced 83 kb of NALP1 and its extended
promoter in 15 patients with the high-risk haplotype, and genotyped 80 NALP1 region SNPs
identified by sequencing. Association and conditional logistic regression analyses indicate
there are at least two common disease variants in the NALP1 region, with essentially additive
risks. NALP1 SNPs are also associated with SLE in African-American SLE/vitiligo families, sug-
gesting that NALP1 represents SLEV1. NALP1 is highly expressed in Langerhans cells and T-
cells, and is a key regulator of the innate immune system, responding to unknown triggers to
stimulate inflammatory and apoptotic pathways. Functional analysis of peripheral blood mono-
cytes from patients with the high-risk NALP1 haplotype shows a striking defect of apoptosis.
NALP1 and the innate immune system may provide targets for both genetic testing and novel
treatments aimed at reducing risk for vitiligo and associated autoimmune/autoinflammatory
diseases.
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TLR activation induces matrix metalloproteinase-1 and -9 expression in primary human ker-
atinocytes
Y Lee, H Kim, S Kim, J Seo, K Kim and J Chung Department of Dermatology, Seoul National
University College of Medicine, ;Laboratory of Cutaneous Aging Research, Clinical Research
Institute, Seoul National University Hospital; Institute of Dermatological Science, Seoul
National University, Seoul, South Korea
Toll-like receptors (TLRs) in the epidermal keratinocytes are a first line of defense against the
microbes’ invasion. Matrix metalloproteases (MMPs) expression in infected cells regulates
inflammation, cell migration and wound healing process. In this study, we demonstrated that
the expression of MMP-1 and MMP-9 was induced by TLR2, 3, 5 ligands (Pam3CSK4, Poly
(I:C), Flagellin, respectively). Overexpression of the adenoviral dominant negative MyD88
(Ad1MyD88TIR) blocked these TLR ligands-induced MMP-1 and MMP-9 expression. We also
showed that TLR ligands-induced MMP-1 expression was inhibited by pretreatment of the
NF-kB inhibitor BAY 11-7082 and JNK inhibitor SP600125, whereas MMP-9 expression was
inhibited by pretreatment of BAY 11-7082, SP600125 and p38 MAPK inhibitor SB203580.
TLR2, 3, 5 ligands activated MAP kinases (JNK and p38) and NF-kB, and induced IkB-a degra-
dation. Overexpression of Ad1MyD88TIR inhibited TLR ligands-induced activation of MAP
kinases (JNK and p38) and NF-kB. Our results demonstrate that TLR activation induces expres-
sion of MMP-1 and MMP-9 in human keratinocytes and MyD88-dependent signaling path-
way plays an important role in the expression of MMP-1 and MMP-9 by TLR activation.
www.jidonline.org   S7
ABSTRACTS
43
Enhanced skin blood flow and sensitivity to noxious heat stimuli in papulopustular rosacea
DA Guzman-Sanchez,1 Y Ishiuji,1 TS Patel,1 J Fountain,1 YH Chan2 and G Yosipovitch1,3 1
Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, 2 Biostatistics
Unit, Yong Loo Lin School of Medicine, Singapore, Singapore and 3 Neurobiology &
Anatomy, Wake Forest University School of Medicine, Winston-Salem, NC
Patients with rosacea often complain of burning and increased skin sensitivity; however there
has been no objective quantitative sensory testing of this phenomenon. Furthermore, cuta-
neous blood flow in these patients has not been assessed using state of the art Laser Doppler
Imaging (LDI). We assessed heat pain thresholds and skin blood flow using quantitative ther-
mal sensory testing and LDI in patients with untreated rosacea. Of the total 24 subjects enrolled,
8 had papulopustular rosacea (PPR), 8 had erythematotelangiectatic rosacea (ETR) and 8
were controls. Subjective burning perception, heat pain threshold, skin blood flow and skin
temperature was assessed in all subjects. In the ETR and PPR groups, two areas were com-
pared: affected and non-affected. Heat pain thresholds of areas affected by rosacea were lower
(higher sensitivity) than that of non-affected areas. In addition, subjective burning perception
was increased in rosacea patients when compared to controls. Although PPR affected skin had
elevated skin blood flow when compared to non-affected skin, this was not significant for ETR
affected skin. This study shows enhanced sensitivity to noxious heat stimuli in rosacea affected
skin which is more prominent in PPR.
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Itch-related brain activity in patients with atopic eczema
Y Ishiuji,1 RC Coghill,2 T Patel,1 RA Kraft,3 Y Oshiro2 and G Yosipovitch1,2 1 Dermatology,
Wake Forest University School of Medicine, Winston-Salem, NC, 2 Neurobiology and
Anatomy, Wake Forest University School of Medicine, Winston-Salem, NC and 3 Biomedical
Engineering, Wake Forest University School of Medicine, Winston-Salem, NC
Chronic itch is the principal symptom in patients with atopic eczema. Brain activity during
itch stimuli has been previously examined in healthy subjects with blood oxygen level depend-
ent functional MRI (BOLD fMRI) as well as positron emission tomography (PET). These meth-
ods have shown activity localized to the anterior cingulate cortex (ACC), supplementary motor
area and inferior parietal lobe. At present, there is no published data on the brain processing
of itch in atopic eczema. In the current study, we examined the temporal relationship between
itch response to histamine induced stimuli and brain activity in patients with atopic eczema.
We used the new technique of arterial spin labeling (ASL) MRI that can quantitatively meas-
ure regional and global changes in cerebral blood flow (CBF). All images were acquired on a
1.5 Tesla GE scanner with a standard pulsed ASL technique, Q2TIPS-FAIR. General linear mod-
eling analysis (FSL) was used to identify regional and global changes in CBF related to itch.
Itch-related activation was detected in the anterior cingulate cortex and areas of the frontal
cortex. Thus, ASL may be a useful technique to explore brain activation during chronic itch
conditions.
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Epidermal p65/RelA is essential for the crosstalk between keratinocytes and immune cells
in an IκBα-mediated mouse model of psoriasis
RA Rupec,1 B Rebholz,1 I Haase,2 B Eckelt,1 MJ Flaig,1 K Ghoreschi,3 T Ruzicka1 and
M Röcken3 1 Department of Dermatology, University of Munich, Munich, Germany, 2
Department of Dermatology and Centre of Molecular Medicine, University of Cologne,
Cologne, Germany and 3 Department of Dermatology, Eberhard Karls University Tübingen,
Tübingen, Germany
Ubiquitous deficiency of IκBα (Ikba∆/∆) results in an inflammation that resembles human pso-
riasis. In contrast, selective ablation of Ikba in keratinocytes or lymphocytes results in an inflam-
mation limited to the dermal compartment or normal skin phenotype, respectively. This empha-
sizes the important role of aberrant NF-κB activation in both, keratinocytes and lymphocytes
for epithelial changes. Moreover, IκBα deficiency in a T-cell deficient background protected
from inflammation. In addition, silencing TNF and LT signaling concomitantly rescued the
inflammatory phenotype of Ikba∆/∆ mice. The inflammatory response is initiated in a RelA
dependent manner by epidermal keratinocytes, as epidermis-specific deletion of RelA in an
IκBα-deficient background prevented the development of the psoriasis-like inflammation which
otherwise developed in IκBα-deficient mice. By conditional ablation of the genes encoding
IκBα and RelA in epidermal keratinocytes and in different immune cell populations we show
that initiation and maintenance of a psoriasis like skin disease depends on RelA mediated
interactions between IκBα deficient epidermal keratinocytes and IκBα deficient lymphocytes.
As we found a constitutive and concomitant activation of RelA in the epidermis and in the
invading immunocytes in 14% of patients with active psoriasis, our model expands the view
on the understanding of the pathogenesis of psoriasis.
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Dissection of the signal transduction pathways in sulfur mustard exposed keratinocytes.
Involvement of NF-κB / AP-1 and MAPKs
K Kehe,2 B Rebholz1 and RA Rupec1 1 Department of Dermatology, University of Munich,
Munich, Germany and 2 Bundeswehr Institute of Pharmacology and Toxicology, Bundeswehr
Institute of Pharmacology and Toxicology, Munich, Germany
Cutaneous exposure to sulfur mustard [bis(2-chloroethyl) sulfide] produces a delayed inflam-
matory skin response and severe tissue injury. The NF-κB signal transduction pathway is involved
in many cellular processes. It takes part in the immune response, inflammatory processes and
is placed at the interface between inflammation and malignancy. NF-κB is a complex formed
by homo- and heterodimerization of the NF-κB/Rel family members p50 (NF-κB1), p52 (NF-
κB2), RelA (p65), RelB and c-Rel. Their cytoplasmic receptors are members of the IκB family,
with IκBα being the most important in the cellular stress response. Activation of cells by var-
ious stimuli results in serine-phosphorylation of IκBα by the IκB kinase (IKK)-signalosom, fol-
lowed by degradation of IκBα and subsequent translocation of NF-κB to the nucleus. The aim
of this study was to analyze the function of NF-κB in the inflammatory skin response to sul-
fur mustard. In mouse keratinocytes we could show, that NF-κB is activated in a biphasic
response following stimulation by sulfur mustard. The activation was preceded by phospho-
rylation of IKKβ and IκBα and resulted in a phosphorylation of RelA. The activation of genes
coding for IL-1β and TNF, two NF-κB regulated genes, proved the functional relevance sulfur
mustard induced NF-κB activation. These findings strongly support the idea of NF-κB as key
modulator in the cellular response to sulfur mustard. In addition to NF-κB, we can show that
MAPK signaling pathways involving c-Raf, ERK1/2, MSK1 and p38, MSK1, as well as JNK sig-
naling cascades involving MLK3, MKK7, JNK1/2 and ATF-2 participate in the keratinocyte
response.
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Green tea polyphenols reduced psoriasiform lesions in a mouse model for human psoriasis
in association with caspase 14 activation
S Hsu,1 J Borke,1 DS Walsh,2 J Wood,3 H Qin,1 J Winger,1 H Pearl,1 G Schuster1 and
WB Bollag1 1 Medical College of Georgia, Augusta, GA, 2 Walter Reed Army Institute of
Research, Silver Spring, MD and 3 Eisenhower Army Medical Center, Fort Gordon, GA
The purpose of this study was to develop a novel therapeutic approach for psoriatic lesions. A
newly discovered pathological characteristic of psoriasis is the altered expression and decreased
proteolytic processing of caspase 14, a member of the caspase family that is associated with
epithelial cell differentiation, planned cell death, and barrier formation. We previously found
that GTPs, or the most abundant GTP, EGCG, are able to induce terminal differentiation in expo-
nentially growing epidermal keratinocytes. We also recently reported that 1) caspase 14 is
induced by EGCG in exponentially growing normal human epidermal keratinocytes; and 2)
human psoriatic tissues lacks normal expression and processing of caspase 14. However, the
mechanisms by which GTPs accelerate differentiation in psoriatic epidermis remain to be deter-
mined. The current study aimed to ascertain if GTPs possess therapeutic potential towards pso-
riasiform lesions in the flaky skin (fsn) mouse model, as well as the signaling pathway that medi-
ates GTP-induced caspase 14 expression. GTPs were applied topically to the skin of fsn mice
for 13 weeks, followed by pathological analysis, immunohistochemistry, and Western blotting,
as well as in vitro experiments using normal human primary epidermal keratinocytes. Our results
indicate that topical application of 0.5% GTPs significantly reduced the symptoms of epider-
mal pathology in flaky skin mice, such that caspase 14 was efficiently processed and prolifer-
ating cell nuclear antigen (PCNA) expression was reduced. In addition, GTP-induced expres-
sion of caspase 14 was found to be dependent on the mitogen-activated protein kinase (MAPK)
pathways, p38 and c-jun N-terminal kinase (JNK). Since current treatments for psoriasis are
often associated with toxicity and adverse side effects, our results suggest that GTPs may pro-
vide a nontoxic alternative therapy for treatment of skin disorders.
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The CLASI reliability and validity assessment expansion for rheumatology and dermatology
MS Krathen,1 J Von Feldt,1 SL Kolasinski,1 D Jonathan,1 P Thomas,1 J Kwan-Morley,1 A Van
Voorhees,1 C Kovarik,1 J Junkins-Hopkins,1 E Kim,1 M Rose,1 J Okawa,1 E Gaines,1 N Rogers,2
AL Weber,1 K Propert1 and VP Werth1 1 Dermatology, Rheumatology, Biostatistics, University
of Pennsylvania, Philadelphia, PA and 2 Dermatology, Tulane, New Orleans, LA
The CLASI (Cutaneous Lupus Disease Area and Severity Index) is a quantitative outcome meas-
ure for disease activity and severity in cutaneous lupus erythematosus (CLE). A previous vali-
dation study performed by dermatologists demonstrated excellent content validity, inter-rater
reliability, and intra-rater reliability. Rheumatologists may find the CLASI to be a useful research
tool in assessing patients with cutaneous features of systemic lupus erythematosus (SLE). In
this study we sought out to validate the use of the CLASI by rheumatologists via reliability test-
ing and extend the validation for dermatologists. Fourteen subjects with CLE (N=10), a mim-
icker skin disease only (N=1), or both (N=3) were rated with the CLASI by academic-based
dermatologists (N=5) and rheumatologists (N=5). Re-rating was also performed. Raters also
diagnosed three “unknown” lesions on each of five subjects selected from the overall group.
The dermatology intra-class coefficient (ICC) was r=0.92 for activity and r=0.81 for damage;
for rheumatology the ICC was r=0.82 for activity and r=0.86 for damage. For intra-rater reli-
ability, the dermatology group Spearman’s ρ was 0.94 for activity and 0.97 for damage; for
rheumatology the Spearman’s ρ was 0.91 for activity and 0.99 for damage. The sensitivity and
specificity for identifying a lesion as CLE was 1.00 and 0.74, respectively, for dermatologists
and 1.00 and 0.46, respectively, for rheumatologists. Our data confirm the reliability of the
CLASI when used by dermatologists and supports the CLASI as a reliable instrument for use
by rheumatologists. The diagnostic skill assessment data, however, demonstrates differences
in the ability to properly identify CLE lesions between the two groups and supports the role
of dermatologists with derm-rheum expertise in conducting future rheumatology-led studies
that utilize the CLASI.
S8 Journal of Investigative Dermatology (2007), Volume 127
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Norepinephrine regulation of chemokine/cytokine expression by HMEC-1 cells
LL Stohl,1 W Ding,2 JA Wagner1 and RD Granstein2 1 Neurology and Neuroscience, Weill
Medical College of Cornell University, New York, NY and 2 Dermatology, Weill Medical
College of Cornell University, New York, NY
Endothelial cells play a crucial role in cutaneous inflammation through the release of
chemokines/cytokines and expression of adhesion molecules involved in recruitment of inflam-
matory cells from the blood to tissues such as the skin. As dermal blood vessels are inner-
vated by sympathetic nerves, the sympathetic transmitter norepinephrine may play a role in
regulating expression of chemokines by endothelial cells. In order to investigate this ques-
tion, we employed the transformed human dermal microvascular endothelial cell line HMEC-
1. HMEC-1 cells were pretreated for one hour with various concentrations of norepinephrine
and then stimulated with lipopolysaccharide (LPS) at a concentration of 0.1 µg/ml. Condi-
tioned supernatants were harvested at various time points and chemokine and cytokine con-
tent was measured by ELISA. Norepinephrine upregulated LPS-induced release of interleukin
(IL)-6, as previously described, but was found to inhibit the LPS-stimulated release of IL-8,
monocyte chemotactic protein 1 (MCP-1), regulated upon activation, normal T cell expressed
and secreted (RANTES) and macrophage inflammatory protein 1α (MIP-1α). However, nor-
epinephrine had no effect on LPS-induced growth regulated oncogene α (GROα) release.
Interestingly, our previous studies have demonstrated that the purinergic agonist ATPγS (a long-
lived analog of ATP) induced expression of IL-6, IL-8, GROα and MCP-1 by HMEC-1 cells.
We now have found that norepinephrine greatly augments ATPγS-induced release of IL-6 but
has no effect on GROα induction. As ATP is a sympathetic co-transmitter, complex interac-
tions between the effect of ATP and that of norepinephrine may regulate the release certain
chemokines by dermal microvascular endothelial cells.
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Fas ligand and pemphigus sera induce desmoglein cleavage and apoptosis in human ker-
atinocytes
R Lotti, A Marconi, F Truzzi, K Dallaglio, C Vaschieri and C Pincelli Dermatology, University
of Modena and Reggio Emilia, Modena, Italy
Pemphigus is an autoimmune bullous disease characterized by loss of adhesion of keratinocytes
that round up in a process known as acantholysis. While the molecular mechanisms under-
lying acantholysis are still unclear, it is well known that cell detachment is often associated
with apoptosis. We have previously detected apoptotic keratinocytes in perilesional, yet unde-
tached, pemphigus skin. Moreover, we have observed that Fas ligand (FasL) levels are signif-
icantly higher in untreated pemphigus sera (more than 0.1 ng/ml) than in controls. As pem-
phigus sera induce apoptosis in cultured human keratinocytes, we wanted to analyze the
apoptotic mechanisms in pemphigus. We first confirmed that pemphigus lesions contain apop-
totic keratinocytes, by showing caspase-3 activation. In addition, while Fas receptor (FasR) is
expressed in the basal and partially in the suprabasal layers in pemphigus vulgaris (PV), it is
detected throughout the epidermal layers in muco-cutaneous pemphigus. Furthermore, pem-
phigus sera-induced keratinocyte apoptosis is partially prevented by pretreatment with either
caspase-8 inhibitor or anti-FasL neutralizing antibody. Moreover, caspase-8 activation induced
by untreated pemphigus sera is partially inhibited by anti-FasL antibody. Untreated pemphi-
gus sera induce the cleavage of desmoglein 1 and 3 (dsg 1, 3). Moreover, recombinant FasL
dose-dependently cleaves dsg 1 and 3 (0.1, 10, 100 ng/ml). Finally, caspase-8 inihibitor pre-
vents dsg cleavage, strongly indicating the critical role of FasL in the pathogenesis of pem-
phigus. In particular, high levels of FasL, contained in pemphigus sera exert a dual activity,
by both inducing keratinocyte apoptosis and dsg cleavage.
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Cytokines regulate S100A8 expression in human keratinocyte cell line (HaCat cell)
B Bai,1 K Yamamoto,2 H Sato,3 H Sugiura1 and T Tanaka1 1 Department of Dermatology,
Shiga University of Medical Science, Japan, Seta, Otsu, Japan, 2 Department of
Gastroenterology, Shiga University of Medical Science, Japan, Seta, Otsu, Japan and 3
Department of Biology, Shiga University of Medical Science, Japan, Seta, Otsu, Japan
S100A8 is a calcium binding protein which associates with keratinocyte differentiation, inflam-
mation and wound healing. S100A8 protein has inflammatory function, it also possess anti-
inflammatory properties. High expression of S100A8 has been found in acute and chronic
inflammation, such as rheumatoid arthritis, atopic dermatitis and psoriasis. Although S100A8
attracted much interest recently, little is known regarding its regulation in human keratinocytes.
In this study we investigated the regulation of S100A8 by IL-17 as well as IL-4, IL-13 alone
and combined in human HaCat keratinocytes. IL-17 was found to induce S100A8 transcript
expression significantly. In contrast, IL-4 and IL-13 inhibited S100A8 expression, and the induc-
tion of S100A8 by IL-17 was also reduced by IL-4 and IL-13. Furthermore, reporter assay
showed that IL-17 also increased S100A8 promoter activity. These results suggested the com-
plex regulation of S100A8 by the cytokines of keratinocytes, and thus may provide new insight
into the mechanism of S100A8 in Th2 dominant disease like atopic dermatitis.
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Neutrophil-derived NADPH oxidase is required for autoantibody-induced tissue damage in
experimental epidermolysis bullosa acquisita
MT Chiriac,1 J Roesler,2 A Sindrilaru,3 K Scharffetter-Kochanek,3 D Zillikens1 and C Sitaru1 1
Department of Dermatology, University of Lubeck, Lubeck, Germany, 2 Department of
Pediatrics, University Clinic Carl Gustav Carus, Dresden, Germany and 3 Department of
Dermatology, University of Ulm, Ulm, Germany
Type VII collagen is the autoantigen of epidermolysis bullosa acquisita (EBA), a subepidermal
autoimmune blistering disease. We have recently shown that antibodies against type VII col-
lagen, when passively transferred into mice, cause a subepidermal blistering skin disease repro-
ducing the findings in the skin of EBA patients. In addition, autoantibodies to type VII colla-
gen induce dermal-epidermal separation in cryosections of human skin when co-incubated
with human granulocytes. NADPH oxidase-derived reactive oxygen species are thought to be
critically involved in granulocyte-mediated antibody-induced tissue injury. In the present study,
we demonstrate that NADPH oxidase is a prerequisite for the antibody-induced blistering both
in the passive transfer mouse model of EBA and ex vivo. Mice deficient in the p47 subunit of
NADPH oxidase (p47phox-/-; n=10), in contrast to wild type mice (n=10), failed to develop
blistering by injection of antibodies against type VII collagen. Local reconstitution of p47phox
–deficient mice (n=5) with p47phox -sufficient granulocytes restored their susceptibility to
tissue damage by antibodies against type VII collagen demonstrating that granulocytes provide
the NADPH oxidase required for tissue damage. In addition, both the use of granulocytes from
chronic granulomatous disease patients, defective in NADPH oxidase, or specific inhibition
of NADPH oxidase from normal human granulocytes resulted in abolishment of dermal-epi-
dermal separation ex vivo. Our findings provide the first evidence of a crucial involvement of
granulocyte-derived NADPH oxidase as key molecular effector in inflammatory bullous dis-
eases. In addition, they should facilitate the development of novel strategies to prevent tissue
damage in EBA and related autoimmune diseases.
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Correlation of the CLASI (Cutaneous Lupus Erythematusus Disease Activity and Severity
Index) with spectroscopy via the DermaSpectrometer and cyberDERM Colorimeter
MS Krathen,1 G Grove,3 J Dunham,1 E Gaines,1 J Junkins-Hopkins,1 E Kim,1 SL Kolasinski,1
C Kovarik,1 J Kwan-Morley,1 J Okawa,1 N Rogers,2 M Rose,1 P Thomas,1 A Van Voorhees,1
J Von Feldt,1 A Weber,1 K Propert1 and VP Werth1 1 Dermatology, Rheumatology, Biostatistics,
University of Pennsylvania, Philadelphia, PA, 2 Dermatology, Tulane, New Orleans, LA and 3
cyberDERM, Inc., Broomall, PA
The CLASI is a subjective outcome measure for disease activity and severity in cutaneous lupus
erythematosus (CLE). The DermaSpectrometer (DS) and cyberDERM Colorimeter (cDC) are
spectroscopy instruments which determine color composition via light reflectance patterns.
Erythema and pigmentation are measured by the DS via erythema and melanin indices (EI
and MI) and by the cDC via Cr (red chromaticity) and Y (luminosity) scales. We hypothesized
that assessment of erythema and pigmentation via spectroscopy may correlate with CLASI
activity and damage scores, respectively. 13 subjects with CLE were evaluated via the CLASI
by 10 physician raters. The worst CLE activity and damage lesions were evaluated via spec-
troscopy. The average CLASI scores of activity-erythema and damage-dyspigmentation per
body region were compared with the difference in EI and MI scores, respectively, or Cr and Y
scores, respectively, recorded from lesional and non-lesional (baseline) skin. The CLASI activ-
ity-erythema score correlated poorly with the DS EI and was not significantly different from
zero correlation (Spearman’s rho (ρs)=0.28, p=0.156) yet correlated moderately with the cDC
Cr index (ρs=0.49, p=0.009). The CLASI damage-dyspigmentation score correlated moderately
with both the DS MI (ρs=0.56, p=0.001) and cDC Y index (ρs=0.43, p=0.010). The DS and
cDC scores correlated poorly for activity (ρs=0.22, p=0.278) but correlated strongly for dam-
age (ρs=0.86, p<0.001). These results question the use of objective spectroscopy instruments
in evaluating CLE lesions. Subjective, visual assessment may prove more useful in obtaining
reliable data in evaluating activity and damage in CLE given a rater’s sophisticated integration
of multiple distinct variables.
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Immunomodulatory cytokine and chemokine expression in the C3H/HeJ mouse model of
alopecia areata
A Barekatain, J Shapiro and KJ McElwee Dermatology and Skin Science, University of British
Columbia, Vancouver, BC, Canada
Alopecia areata (AA) is a chronic hair loss disease involving peri- and intra-follicular infil-
tration by mononuclear cells. Several studies suggest immunomodulatory cytokines expressed
by the inflammatory infiltrate not only act as mediators of immunity and inflammation but
also regulate cell proliferation and differentiation and, as such, may play an important part
in regulating hair growth and AA development. We examined in vivo levels of mRNA of 13
cytokines and chemokines in the skin, draining lymph nodes, spleen, and thymus of C3H/HeJ
mice with AA and normal haired littermates using quantitative RT-PCR techniques. The lev-
els of IFN-γ and IL10 were statistically significantly higher in the skin and lymph nodes of
AA-affected mice than in healthy controls while that of IL18 was lower. No statistically sig-
nificant changes were found for the mRNA expression levels of IL17, IL21 and GM-CSF. Three
main subfamilies of chemokines studied were CC chemokines, including RANTES,
macrophage inflammatory proteins α and β (MIP-1 α and β), CXC chemokines, including
CXCL1 and CXCL10, and CX3C chemokines represented by CX3CL1; all of which were found
highly expressed in skin draining lymph nodes and/or the skin of mice with AA. Chemokines
are involved in chemoattraction and activation of leukocytes to the site of inflammation and
in the induction of cytokine production and are thus key determinants of inflammatory reac-
tions and immunity. The fact that all the studied chemokines were expressed at significantly
higher levels in AA-affected mice than in controls suggests they may play an important role
in AA pathogenesi
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TGFβ1 overexpression in mouse keratinocytes delays cutaneous wound healing
CA Williams, AG Li, G Han and X Wang OHSU, Portland, OR
TGFβ1 is a secreted cytokine with a broad spectrum of actions affecting all stages of wound
healing. Although both positive and negative effects of TGFβ1 on wound healing have been
reported, the mechanisms underlying these effects are largely unknown. Previously, we found
that constitutive TGFβ1 expression in keratinocytes, which was equal to the peak level of
endogenous TGFβ1 expression during wound healing, delayed cutaneous wound healing. The
delayed wound healing correlated with excessive inflammation and reduced keratinocyte pro-
liferation and migration at the wound edge. In this study, we examined the stage-specific effects
of TGFβ1 expression on wound healing; wherein the wild type form of TGFβ1 was temporally
expressed in keratinocytes in inducible-TGFβ1 transgenic mice. The inducible transgenic mice
contain two transgenes: a transactivator under the control of the keratin 14 (K14) promoter
and the TGFβ1 target gene under the control of a mimimal tata promoter. TGFβ1 transgene
expression is induced by topical RU486 application. Transgenic and non-transgenic littermates
were subject to 6-mm full-thickness excisional wounding at 8 weeks of age, and TGFβ1 trans-
gene expression was induced by application of 5 µg RU486 to mouse skin daily throughout
different stages of wound healing. Inducible expression of TGFβ1 during the inflammation
phase of wound healing resulted in excessive inflammation and delayed reepithelialization.
The excessive inflammation correlated with increased infiltration of dendritic cells (DC) to
the migrating epidermis and underlying dermis. Numerous DC appeared in the TGFβ1 inducible
transgenic wound as early as 12 hours post wounding, compared to control wounds at the
same time point. Our study suggests that enhanced inflammation and recruitment of leuko-
cytes is a direct effect of TGFβ1 overexpression.
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Isolation of pathogenic pemphigus foliaceus (PF) monoclonal antibodies (mAbs) using an
innovative phage display approach, “non-pathogenic epitope blocking”
K Ishii,1 DL Siegel2 and JR Stanley1 1 Dermatology, University of Pennsylvania, Philadelphia,
PA and 2 Pathology, University of Pennsylvania, Philadelphia, PA
We used phage display to isolate mAbs as single chain variable fragments (scFv) from a PF
patient. Although we constructed a phage display library from this patient 3 times, panned it
on desmoglein 1 (Dsg1) 7 times, and isolated 100 Dsg1-specific clones, we found only non-
pathogenic mAbs (tested in neonatal mice and human organ culture). The mAbs were derived
from a limited number of heavy chain genes (VH1-08, VH1-18, VH3-09) and some clones
were isolated multiple times. To determine if pathogenic mAbs could be isolated from this
library, we panned the library on Dsg1 after blocking the major non-pathogenic epitopes on
Dsg1 with 4 non-pathogenic scFv derived from the clones that were previously isolated most
frequently on routine panning. We then isolated 5 unique clones that used VH3-7 and VH3-
30 genes. One of these clones (PF1-8-15) caused gross blisters in neonatal mice and typical
PF histology in mice and human skin organ culture. Another clone (PF1-8-2) caused PF his-
tology only in human organ culture. Epitope mapping of both pathogenic mAbs, using domain-
swapped Dsg1/Dsg3, showed binding to conformational epitopes in the amino-terminal 161
amino acids of Dsg1, consistent with previous reports that pathogenic Abs tend to bind the
amino termini of Dsgs. ELISA inhibition studies showed that all of 5 PF sera and 5 mucocu-
taneus pemphigus vulgaris sera (which contain anti-Dsg1 Abs) blocked binding of PF1-8-15
to Dsg1, and most blocked PF1-8-2, suggesting that these pathogenic mAbs bind to, or nearby,
epitopes shared with multiple pemphigus sera. Thus, a novel phage display panning strategy,
“non-pathogenic epitope blocking”, allowed us to isolate pathogenic PF scFv, which demon-
strates for the first time that a monovalent mAb can cause the pathology of PF. Such antibod-
ies will be useful for studying molecular mechanisms of blister formation in PF, and should
allow us to develop targeted therapies and more accurate tools to monitor disease activity.
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Blockade of VCAM-1 delays disease onset and reduces disease severity in the K14-IL-4
trangenic mouse model of atopic dermatitis
L Chen,1 S Lin,1 VI Barriuso,1 G Maggiolino,1 L Overbergh,3 C Mathieu3 and LS Chan1,2,4 1
Dermatology, University of Illinois, Chicago, IL, 2 Micro/Immunol, University of Illinois,
Chicago, IL, 3 Lab Exp Med and Endocrinol, Catholic Univ of Leuven, Leuven, Belgium and 4
Med Ser, VA Jesse Brown Medl Center, Chicago, IL
Adhesion molecules are critical factors for the leukocyte migration into the inflammatory sites.
In the current study, we investigated the roles of ICAM-1 and VCAM-1 in a keratin-14 IL-4
transgenic (Tg) mouse model of atopic dermatitis characterized by prominent inflammatory
cell infiltration. Real-time PCR performed on cDNAs reversely transcribed from total RNA
determined that the mRNAs of ICAM-1, VCAM-1, E-selectin, P-selectin, L-selectin, and PSGL-
1 significantly increased in the skin of Tg mice, especially in the chronic lesional skin.
Immunoflurosence microscopy demonstrated that the numbers of vessels with these positively
stained adhesion molecules significantly increased as the disease progressed. We tested the
hypotheses that blockade of these molecules may impede the inflammation by examining the
disease progresses in the Tg mice crossed with ICAM-1 knockout (KO) mice and Tg mice
received anti-VCAM-1 antibody treatment. While the findings that the Tg mice with ICAM-1
heterozygous or homozygous KO still developed similar skin lesions as ICAM-1 wide type
(WT)/Tg mice were surprising, a compensatory mechanism may account for it: the frequency
of VCAM-1 ligand, CD49d, on CD3+ T cells in the skin draining lymph nodes significantly
increased in the ICAM-1 KO/Tg mouse, compared to the ICAM-1 WT/Tg mice. By contrast,
anti-VCAM-1 neutralizing treatment delivered to the randomly selected ICAM-1 KO/Tg or
ICAM-1 WT/Tg mice at the before disease onset stage significantly delayed the onset of skin
inflammation in these mice compared to those treated with isotype antibody. However, anti-
VCAM-1 reduced the severity of skin inflammation only in ICAM-1 WT/Tg mice, but not in
ICAM-1 KO/Tg mice. These results suggest that VCAM-1 is a more important adhesion mole-
cule than ICAM-1 for the development of skin inflammation in the Tg mice.
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Desmocollin 1 immunoreactivity in IgA pemphigus
B Ohyama,1,2 N Ishii,1 K Nishifuji,2 T Hashimoto1 and M Amagai2 1 Dermatology, Kurume
University School of Medicine, Kurume, Japan and 2 Dermatology, Keio University School of
Medicine, Tokyo, Japan
IgA pemphigus is a rare autoimmune blistering disease that is caused by IgA autoantibodies.
IgA pemphigus is divided into two major subtypes; subcorneal pustular dermatosis (SPD) type
and intraepidermal neutrophilic IgA dermatosis (IEN) type. Using cDNA transfection and liv-
ing cell immunofluorescene method, we previously showed that desmocollin (Dsc) 1 is the
antigen in SPD-type IgA pemphigus. To investigate immunoreactivity against Dscs, we also
produced the entire extracellular (EC) domains of human Dsc1, Dsc2 and Dsc3 using bac-
ulovirus expression system and established an enzyme-linked immunosorbent assay (ELISA).
Unexpectedly, although IgA antibodies (Abs) of all SPD-type sera reacted with human Dsc1
expressed on COS-7 cells, only one serum reacted with human Dsc1 in ELISA for IgA. These
results indicated that Dscs expressed by baculovirus expression system may not adopt the
correct conformational epitopes or that Dscs may need some association with other molecules
in order to express the epitopes recognized by IgA Abs. In this study we produced the entire
EC domain of human Dsc1 expressed by eukaryotic cells (COS-7). We also produced co-
expressed recombinant proteins of entire EC domain of human Dsc1 and human desmoglein
(Dsg) 1, and Dsc1 and Dsg3 using baculovirus expression system. However, these co-expressed
proteins of Dsc1 and Dsg1 (or Dsc1 and Dsg3) existed independently in insect culture super-
natant. Therefore, we further produced hinge domain of immunoglobulin into the C-terminus
of EC domains of Dsg1 and Dsg3, resulting in dimers of Dsc1 and Dsgs. To analyze the reac-
tivity of IgA Abs in SPD-type sera, we performed the immunoprecipitation and immunoblot-
ting analysis using these recombinant proteins as substrates. However, none of these recom-
binant proteins reacted with IgA Abs. These results indicate that only EC domain Dsc1 is not
recognized by IgA Abs or that co-expression of EC domains of Dsc1 and Dsgs is not enough
to produce proper conformation for the epitope for SPD-type IgA pemphigus.
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Role of S100A8 protein in epidermal keratinocytes
S Jang,1 K Sohn,1 E Jeon,1 T Yoon,2 Y Seo,1 J Park,1 C Kim1 and J Lee1 1 Department of
Dermatology, Chungnam National University, Daejeon, South Korea and 2 Department of
Dermatology, Gyeongsang National University, Jinju, South Korea
S100A8 is a member of S100 calcium binding protein family, generally existing as the het-
erodimer with S100A9 protein in neutophil, monocyte, and activated macrophages. S100A8
expression has also been associated with epidermal keratinocytes in a variety of inflamma-
tory dermatoses. To localize the S100A8 expression, we performed in situ hybridization and
immunohistochemical staining. The results showed that S100A8 was highly expressed espe-
cially in psoriatic skin. RT-PCR analysis also confirmed the increased expression of S100A8
in the skin tissues of psoriatic patients. To investigate the role of S100A8, we made the His-
tagged recombinant protein and then tested the chemotatic and antimicrobial effects. Puri-
fied S100A8 protein did not show chemotatic and antimicrobial effects. From these results,
we postulated that S100A8 has other intracellular roles. We made another recombinant S100A8
protein tagged with newly developed PTD (protein transduction domain). We also made
S100A9 protein that can be delivered into the cell. Normal human epidermal keratinocytes
were treated with these PTD-tagged S100 proteins, and the protein transduction into the cells
was detected by Western blot and immunocytochemistry analysis. Transduction of S100A8
and A9 proteins led to up-regulation of several cytokines, suggesting that S100A8 may have
proinflammtory role in skin epidermis.
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Knockout mice reveal novel activities of interleukin-10 in wound repair
SA Eming,1 S Werner,2 P Bugnon,2 JM Davidson,3 T Krieg1 and A Roers1 1 Dermatology,
University of Cologne, Cologne, Germany, 2 Institute of Cell Biology, Department of Biology,
ETH Zurich, Zurich, Switzerland and 3 Department of Pathology, Vanderbilt University
School of Medicine, Nashville, TN
The impact of the local inflammatory response on the process of wound healing has been
debated for decades. In particular the question whether infiltrating macrophages and granu-
locytes promote or impede tissue repair has received much attention. Interleukin-10 (IL-10),
one of the most potent immunoregulatory cytokines, limits innate as well as adaptive immune
responses and is thought to protect the host from immune-mediated tissue damage. The role
of Il-10 during tissue repair is not well understood. In the present study, we show that wound
healing is accelerated in mice deficient for the anti-inflammatory cytokine IL-10. IL-10-/- mice
closed excisional wounds significantly earlier as compared with IL-10 competent control lit-
termates. This effect was due to accelerated epithelialization as well as enhanced contraction
of the wound tissue in the mutant animals. Increased a-smooth muscle actin expression in IL-
10 deficient mice suggests that augmented myofibroblast differentiation is responsible for the
enhanced contraction of wounds in mutant mice. The number of macrophages infiltrating the
wound tissue was significantly increased in IL-10-/- mice compared with control littermates
suggesting that this cell type mediates the accelerated tissue repair. Functional analysis of tis-
sue breaking strength revealed a decreased biomechanical strength of wound tissue in IL-10
deficient mice during the early phase of repair, reflecting the increased proportion of cells
and provisional wound matrix versus collagen at the wound site. However, during later stages
of repair, microscopic analysis of collagen fibrils and quantification of collagen content indi-
cated significantly increased deposition of extracellular matrix in mutant mice. These results
show for the first time that IL-10 is a negative regulator of wound repair and support the view
that activation of the innate immune response is a central event during wound healing.
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Anti-TNFalpha therapy regulates IKKalpha expression and anti-proliferative activity in pso-
riasis
M Giustizieri,1 M Koster,2 B Marinari,1 M Papoutsaki,1 M Karin,3 DR Roop,2 S Chimenti1 and
A Costanzo1 1 Dermatology, University of Rome Tor Vergata, Rome, Italy, 2 Dermatology,
Baylor College of Medicine, Houston, TX and 3 Pharmacology, University of California San
Diego, LA Jolla, CA
Although identified as a component of the TNFa signaling pathway, IKKa acts in the epider-
mis as an anti-proliferative molecule by activating target genes such as the c-myc inhibitors
Ovol1 and Mad1 independently of NFkB activation. Interestingly, the epidermis of IKKa knock-
out mice is composed of a basal layer and suprabasal layers composed by proliferating K1
positive cells that fail to exit the cell cycle. Aim of our study was to evaluate the involvement
of IKKa in the control of inflammation-induced hyperproliferation of psoriatic epidermis. We
have examined IKKa expression in 5 biopsies from normal skin and 15 biopsies from psoria-
sis plaques. We have observed the down-regulation of IKKa expression in all psoriasis biop-
sies examined, that correlated with the level of hyperproliferation. We also observed that IKKa
expression is delocalized in psoriatic plaques, being mainly cytoplasmic in upper layers. To
indagate the role of TNFa-mediated inflammation in the regulation of IKKa expression, we
performed serial biopsies in 5 patients treated with the anti-TNFa antibody Infliximab. Inter-
estingly Infliximab treatment progressively restored the expression of IKKa, its nuclear local-
ization and also the expression of IKKa-dependent genes. The role of IKKa in the activation
of proliferative genes was confirmed in primary keratinocytes by downregulating IKKa by
siRNA. IKKa-downregulated cells displayed increased levels of cyclins (D1 and E) and inflam-
matory cytokines (TNFa, IP-10 and IL-8) upon TNF stimulation suggesting the existence of a
pro-inflammatory positive feedback in IKKa deficient cells that is blocked by anti-TNFa. There-
fore we propose a model in which, the low amount of IKKa in psoriatic epidermis may delay
the exit from the cell cycle of K1 positive cells and also enhance the inflammatory responses
thus contributing to Psoriasis hyperkeratosis and inflammation.
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Analysis of protease-activated receptors-1 and -2 in human keratinocytes for drug discov-
ery
N Castex-Rizzi, H Delga, M Lévèque and M Charvéron Cell Biology Laboratory, Institut de
Recherche Pierre Fabre, Toulouse, France
Protease-activated receptors-1 and –2 have been identified in human keratinocytes. PAR-1 is
involved in skin function and the inflammatory role of PAR-2 is clearly demonstrated in cuta-
neous inflammatory diseases such as atopic dermatitis or psoriasis. Therefore, we were inter-
ested in setting up pharmacological tools for drug discovery on PAR-1 and PAR-2 in ker-
atinocyte coming from cell line (HaCaT) or isolated from skin (NHK). The functional activation
of PAR-2 was evaluated by ELISA on IL-8 released after activation of PAR-2 by the serine pro-
tease (trypsin) or the agonist peptide (SLIGKV). The direct activation of PAR-1 and PAR-2 was
measured by monitoring cytosolic calcium in cells loaded with the fluorescent calcium probe
Fluo-4, AM. The assay was miniaturized on a 96 wells format and the live calcium influx meas-
ured by a plate reader, Mithras LB940. PAR-1 activation was achieved by means of the pro-
tease (thrombin) or the agonist peptide TFLLR. Our results showed that IL-8 was released after
trypsin activation in a dose-dependent manner and inhibited by pre-treatment with soybean
trypsin inhibitor (STI). IL-8 was also produced by the agonist SLIGKV but in a lesser extend.
Moreover normal keratinocytes responded much better to trypsin than HaCaT (x 9.4 and 2.2
versus control for NHK and HaCaT respectively). As for the screening assay on the calcium
mobilization, HaCaT displayed a better response after trypsin than PAR-2 agonist SLIGKV.
Here again NHK presented a higher response to PAR-2 activation than HaCaT cell line. Pre-
treatment with STI prevented the effect of trypsin on calcium flow but was without effect on
the one of SLIGKV showing the specificity of PAR-2 agonist peptide. We characterized PAR-
1 on HaCaT through the dose-dependent calcium influx induced by thrombin and TFLLR.
The effect of thrombin was inhibited by a potent synthetic PAR-1 antagonist. In conclusion,
we have validated the HaCaT keratinocytes model as a relevant model for screening com-
pounds for a drug discovery targeting PAR-2 and PAR-1 in cutaneous inflammation.
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The highly similar S100A7/ S100A15 paralogs are differentially expressed in normal skin and
inflamed psoriasis and function as chemotactic proteins
R Wolf, H Dong, C Voscopoulos, C Cataisson, F Mascia, J Winston, P Goldsmith,
P FitzGerald, Z Howard and SH Yuspa NCI, NIH, Bethesda, MD
S100 proteins constitute the largest, multigenic family of EF-hand proteins that show distinct
tissue and cell type specific expression patterns. The human S100A7 (psoriasin) and S100A15
paralogs have evolved by gene duplications forming an innate S100-subfamily within the
Epidermal Differentiation Complex (Chromosome 1q21). Little is known about the functions
of these highly similar paralogs (>90% sequence identity), which were identified in hyper-
plastic and inflamed psoriatic skin. To discriminate between human S100A7 and S100A15,
we developed specific antibodies, analyzed the expression of the paralogs in normal and
psoriatic skin and determined the proinflammatory potential of recombinant proteins in-vitro
and in-vivo. In normal skin, both S100A7 and S100A15 are expressed in differentiated ker-
atinocytes, but only S100A15 was detected in melanocytes and Langerhans/ dendritic cells.
Compared with normal skin, both paralogs were upregulated in inflamed psoriatic epidermis
and secreted by psoriatic keratinocytes. In cultured keratinocytes, S100A7/ S100A15 levels
were increased by Th1-proinflammatory cytokines that are predominant in psoriasis. When
injected into mice, recombinant S100A7 and S100A15 provoked an inflammatory response.
Through different mechanisms, the two paralogs attracted neutrophils and monocytes, while
S100A7 also attracted lymphocytes in vitro. Our data show the highly homologous S100A7/
S100A15 paralogs are differentially expressed in normal skin, upregulated by proinflamma-
tory cytokines and elevated in the inflamed psoriatic skin and in keratinocytes from psoriatic
plaques. We identify S100A7 and S100A15 as chemotactic proteins with distinct character-
istics, suggesting both paralogs contribute synergistically to the phenotype of psoriasis and
other inflammatory diseases.
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Inhibition of experimental pemphigus in vivo by the p53 inhibitor pifithrin-alpha
N Li, Z Liu, J Wang, SJ Warren and LA Diaz Dermatology, University of North Carolina,
Chapel Hill, NC
Pemphigus foliaceus (PF) and pemphigus vulgaris (PV) are autoantibody-mediated skin blis-
tering diseases characterized by the intraepidermal cell-cell detachment (acantholysis). The
molecular mechanisms of acantholyisis remain unresolved. Recent in vitro and in vivo evi-
dence indicates that apoptosis may play a relevant role in pemphigus acantholysis. Given the
importance of p53 in regulating apoptosis, we investigated whether p53 is involved in pem-
phigus acantholysis. We first examined the expression of p53 in lesional and non-lesional skin
of PF patients by immunohistochemial staining. Skin sections from patients revealed positive
p53 staining of the epidermis, while normal controls were negative. We then examined the
sequential expression of p53 in the skin of neonatal mice injected subcutaneously with PF or
PV IgG in time course studies. Skin samples were harvested at different time points (0, 2, 4,
6, 8, and 20 h) post IgG injections and used for immunoblotting analysis. The expression of
p53 was undetectable at 0 h, but detected from 2 h through 20 h with a peak expression at 4
to 6 h. The observation that p53 induction occurs prior to the appearance of TUNEL positive-
cells (8 h) and the histological blisters (12 h) indicates that p53 induction is an upstream event
to apoptosis and acantholysis. To further document the role of p53 in pemphigus acantholy-
sis, we tested the effect of pifithrin-alpha, a small-molecule of p53 inhibitor, in the mouse
model of pemphigus. We found that mice pre-treated with pifithrin-alpha, but not vehicle
alone, became resistant to skin and histological blisters induced by PF and PV IgG. The pro-
tective effect of pifithrin-alpha was dose-dependent. Taken together, these data demonstrate
for the first time that pifithrin-alpha inhibits acantholysis in vivo and protects mice from devel-
oping pemphigus. These findings suggest that p53 may be involved in the pathogenesis of pem-
phigus.
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Increased phosphorylation of p38MAPK and HSP27 in pemphigus vulgaris patient skin
P Berkowitz,1 LA Diaz,1 R Hall2 and DS Rubenstein1,3 1 Dermatology, University of North
Carolina-Chapel Hill, Chapel Hill, NC, 2 Dermatology, Duke University, Durham, NC and 3
Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill, Chapel
Hill, NC
Pemphigus vulgaris (PV) is a human autoimmune disease in which autoantibodies directed
against desmoglein-3 (dsg3) induce blistering in the suprabasal keratinocytes. We and others
have been working to understand the mechanism by which anti-dsg3 autoantibodies cause
loss of cell-cell adhesion in PV. Using keratinocyte tissue culture and murine in vivo models,
we have previously demonstrated that anti-dsg3 PV IgG induce a rapid, time and dose depend-
ent phosphorylation of p38 mitogen activated protein kinase (MAPK) and heat shock protein
27 (HSP27) phosphorylation. These phosphorylation events are part of the mechanism by which
PV IgG cause loss of cell-cell adhesion in the skin. Blocking these events within the target
keratinocytes prevents the early cytoskeletal changes associated with loss of cell-cell adhe-
sion in tissue culture. Significantly, blocking keratinocyte p38MAPK activity prevents PV IgG
blistering in vivo. Thus, targeting this pathway represents a new approach for treating PV
patients. p38MAPK inhibitors may prove effective in treating PV; however, the phosphoryla-
tion state of p38MAPK and HSP27 in PV patient skin is unknown. To determine if increased
phosphorylation of p38MAPK and HSP27 occurred in human skin of pemphigus patients,
extracts from PV patient and control skin biopsies were separated by SDS-PAGE and
immunoblotted using monoclonal antibodies against p38MAPK, phospho-p38MAPK, HSP27,
and phospho-HSP27. Phosphorylation of both p38MAPK and HSP27 were observed in PV
skin biopsies. The observed increased phosphorylation in patient skin is consistent with a role
for p38MAPK and HSP27 in the mechanism of acantholysis and provides additional data to
support testing of p38MAPK inhibitors for the treatment of PV.
66
A flavonoid composition regulates the COX/LOX pathways and cytokine gene expression: a
potential ingredient for topical inflammation
Y Zhao, Q Jia, M Hong, J Zhao, T O’Reilly, W Ma and P Abeysinghe Unigen Pharmaceuticals,
Inc., Lacey, WA
To develop a natural product for managing inflammation related skin conditions, over 1230
organic plant extracts were screened for COX-2 inhibitory activity. Two flavonoids, catechin
(a flavan from Acacia catechu) and baicalin (a Free-B-Ring flavonoid from Scutellaria baicalen-
sis), were identified. A composition (UP566) containing 70% catechin and 15% baicalin (Patent
pending US20040220119A1) was evaluated for its anti-inflammatory activities in enzymatic,
cell based, and gene expression assays. UP566 inhibits both COX1 and COX 2 enzymes;
decreases leukotrieneB4 (LTB4) production in cells and down regulates gene expression of
several key pro-inflammatory cytokines. The IC50 for COX-1 and COX-2 was 0.47mM and 3.7
mM respectively with the ovine enzymes. UP566 decreased LTB4 content by 80% in the HT-
29 cells at 3 µg/mL, suggesting that it also acts in the 5-LO pathway. UP566 at 100 mg/ml
down-regulated gene expression of cox-2 by over 50-fold, il-1b by 45-fold and il-6 by 37-fold
in PBMCs stimulated with LPS. It also decreased the gene expression of tnfa and nfkb. We
also demonstrated that UP566 was a potent antioxidant with ORAC value higher than 19,000.
Two creams prepared with 0.5% and 1.5% of UP566 were evaluated for irritation and induc-
tion of contact sensitization by repetitive application to human skins (100 subjects in each
group). UP566 was well tolerated without causing significant irritation or sensitization. UP566
was also evaluated for phototoxicity in 27 human subjects. No evidence of significant irrita-
tion or phototoxic response was observed on irradiated sites or unirradiated sites. In conclu-
sion, UP566 is a safe natural product with multiple anti-inflammatory properties and a potent
anti-oxidant activity. The results of the study provide potentially a natural ingredient for man-
aging topical inflammation conditions.
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Genomic analyses identify abnormalities in lipid metabolism in dermatomyositis patients
B Kea,1 R Pesich,2 LS Chung,3 PO Brown2,4 and D Fiorentino5 1 School of Medicine, Stanford
University, Stanford, CA, 2 Biochemistry, School of Medicine, Stanford University, Stanford,
CA, 3 Division of Immunology and Rheumatology, Department of, School of Medicine,
Stanford University, Stanford, CA, 4 Howard Hughes Medical Institute, School of Medicine,
Stanford University, Stanford, CA and 5 Dermatology, School of Medicine, Stanford
University, Stanford, CA
Dermatomyositis (DM) is a complex autoimmune disease in which the characteristic skin
inflammation is the only constant, defining feature. Despite this, the mechanism of cutaneous
disease in DM has not been extensively investigated and remains poorly understood. We sought
to identify gene expression patterns that could lead to novel hypotheses regarding pathogen-
esis of skin disease in DM. We used printed oligonucleotide DNA microarrays that represent
nearly all human genes (44,544 70mer sets) to analyze the skin biopsies from 9 healthy con-
trols and 12 adult patients with DM. We performed SAM (Statistical Analysis of Microarray)
analysis to identify genes that discriminate between active skin disease and control subjects.
With a false discovery rate of 5%, we found 207 and 355 genes whose expression was strongly
increased or decreased, respectively, in DM relative to controls. Functional annotation clus-
tering of these genes identified two major biological processes, as defined by Gene Ontol-
ogy—that of lipid metabolism and host-pathogen interaction. These processes included a major
signature for lipid metabolism (43 genes, p=2E-13), steroid biosynthesis (10 genes, p=6E-10),
and carboxylic acid metabolism (39 genes, p=8E-14), and to a lesser extent, biotic stimulus
(54 genes, p=3.7E-8), response to pest, pathogen, or parasite (31 genes, p=2E-7), and defense
response (49 genes, p=9E-7). Our data are consistent with previous findings from muscle biop-
sies in DM indicating activation of type I interferon responsive genes, and we extend these
findings to include the intriguing possibility that lipid metabolism contributes to the patho-
genesis of skin disease in dermatomyositis.
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Effective B cell depletion therapy in a pemphigus vulgaris mouse model
Y Takae,1 Y Hamaguchi,2 TF Tedder2 and M Amagai1 1 Dermatology, Keio University School
of Medicine, Tokyo, Japan and 2 Immunology, Duke University Medical Center, Durham, NC
An active disease model for pemphigus vulgaris (PV) can be generated by adoptive transfer of
Dsg3-deficient splenocytes to Rag2-/- immunodeficient mice that express Dsg3. Recipient
mice stably produce anti-Dsg3 IgG with development of a PV phenotype, such as weight loss
due to oral erosions. In this study, the efficacy of CD20 monoclonal antibody (mAb) immunother-
apy was evaluated since B cell depletion may be an effective treatment for refractory human
PV. When anti-mouse CD20 mAb (MB20-11, 250 µg/mouse) was administered to recipient
mice two hours prior to adoptive transfer, the resulting B cell depletion blocked anti- Dsg3
antibody production (Dsg3 ELISA index; 0 ± 0 in treated mice vs. 221 ± 64 in control mice at
day 11, n=5, p=0.007) and weight loss due to oral erosions (weight change; +0.6 ± 0.1 g in
CD20 mAb-treated mice vs. –5.5 ± 2.1 g in control mice at day 11, p=0.012). CD19+IgM+
mature B cells and anti-Dsg3 antibody secreting cells were not detected in blood, spleen,
lymph nodes or bone marrow of B cell depleted mice as determined by FACS and ELISPOT
assay, respectively, at day 14 and 28. The suppressive effect of a single CD20 mAb treatment
was observed for as long as 6 weeks. When CD20 mAb was administered every two weeks
after the mice developed a PV phenotype, anti-Dsg3 ELISA titers dropped by 42 ± 4% by two
weeks (n=5, p=0.007), followed by gradual decrease without significant improvement of the
PV phenotype thereafter. The rapid decrease in anti-Dsg3 ELISA titers was due to mature B
cell elimination, while the sustained antibody production may potentially be from long-lived
plasma cells. These findings indicate that anti-CD20 immunotherapy is an effective treatment
for PV and that PV mouse model together with CD20 mAb may provide a useful tool to inves-
tigate the long-lived plasma cells that contributes to treatment-resistant antibody production.
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Expression of histamine receptors on lupus skin lesions
T Yoshimasu, N Kanazawa and F Fukukawa Dermatology, Wakayama Medical University,
Wakayama, Japan
In skin lesions of systemic lupus erythematosus (SLE), the histamine-N-methyltransferase (HMT)
activity is much lower than that of controls, and the decreased activity plays a particular role
in the development of immune-complex-mediated skin lesions (Furukawa, Dermatologica
1989). Th1 cells mainly express the histamine H1 receptor (H1R) and produce IFN-γ and Th2
cells mainly express H2R and induce immune-tolerance. We reported the expressions of H2R
and H3R in the skin lesions from MRL/lpr (l) mice at preceding SID meeting. T cell receptor
α chain knock out mice treated with 5-fluorouracil and UVB irradiation, which is a model of
drug-induced discoid lupus erythematosus (DLE) established by us. In this study, we investi-
gated the expression of histamine receptors (HRs) in skin lesions of the drug-induced DLE
model. The expressions of H2R and H3R were seen on both of CD4 lymphocytes and mast
cells in the skin lesion of the DLE model by immunohistochemical staining. The expressions
of H2R and H3R were also strongly seen in the lesional skin compared with non-lesional skin
treated with PBS by RT-PCR method. The expression of H1R was not seen in both of lesional
and non-lesional skin by immunohistochemical staining and RT-PCR method. In addition, we
investigated the relationship between human lupus skin lesions and the expressions of HRs.
Biopsy speciments of the involved and non-involved skin of lupus patients (5 SLE patients and
1 DLE patient) were provided for the study. Mast cells infiltration was assessed by toluidine
blue staining and the expressions of CD4, CD8, H1R, H2R and H3R in the skin lesions were
assessed by immunohistochemical staining. Infiltration of a number of mast cells in involved
skin lesions of lupus patients were observed compared with those of non-involved skin lesions.
The expressions of HRs in skin lesions of human lupus and the difference between the expres-
sion pattern of HRs in lupus model mice and human lupus skin lesions are now under inves-
tigations.
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Identification of BP180 pathogenic epitope using humanized BP180NC16A mice
Z Liu,1 L Leighty,1 M Zhao,1 N Li,1 C Fu,2 G Giudice,2 J Fairley,2 C Sitaru,3 D Zillikens,3
P Marinkovich4 and L Diaz1 1 Univ. of North Carolina, Chapel Hill, NC, 2 Medical College
of Wisconsin, Milwaukee, WI, 3 University of Lubek, Lubek, Germany and 4 Stanford
University, Stanford, CA
Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease associated with
autoantibodies against BP180, a transmembrane collagen and major component of the
hemidesmosome. BP autoantibodies target multiple BP180 epitopes clustered within the
non-collagen linker domain, NC16A. Due to the lack of cross-reactivity between human and
murine BP180 however, the pathogenicity of human anti-BP180 autoantibodies has not been
tested in conventional mice. To circumvent this problem, we have generated a novel mouse
strain in which the murine BP180NC14A was replaced with the homologous human
BP180NC16A epitope cluster region. The humanized NC16A (NC16+/+) mice injected with
human anti-BP180NC16A autoantibodies develop a complement-, mast cell- and neutrophil-
dependent BP-like disease. In this study, we used the NC16A+/+ mice to map the pathogenic
epitope of BP180 in vivo. BP patients’ sera were purified with affinity-columns conjugated
with BP180NC16A or different BP180NC16A deletion mutants, and the affinity-purified epi-
tope-specific autoantibodies were tested for pathogenicity in the NC16A+/+ mice. IgG pas-
sive transfer experiments identified one pathogenic epitope (referred to as BP180NC16A2.5).
BP180NC16A2.5-specific autoantibodies induced subepidermal blisters in the NC16A+/+
mice, which was abolished if the purified antibody fraction is preadsorbed with
BP180NC16A2.5. Anti-BP180NC16A2.5 autoantibodies were no longer pathogenic in the
NC16A+/+ mice pretreated i.p. with recombinant BP180NC16A2.5. The NC16A2.5-treated
mice had significantly reduced BMZ-bound and circulating pathogenic antibodies and showed
reduced complement activation, mast cell degranulation and neutrophil infiltration. Our
findings represent the first identification of a pathogenic epitope in BP, and suggest that tar-
geting the pathogenic epitope specifically could be a new therapeutic strategy to treat BP.
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IgM anti-desmoglein 1 autoantibodies are the distinguishable immunological markers of Fogo
Selvagem
LA Diaz,1 P Prisayanh,1 D Dasher,1 N Li,1 F Evangelista,1 V Aoki,2 G Hans-Filho,3 V dos
Santos,3 BF Qaqish4 and EA Rivitti2 1 Dermatology, University of North Carolina, Chapel Hill,
NC, 2 U of Sao Paulo, Sao Paulo, Brazil, 3 U Mato Grosso do Sul, Campo Grande, Brazil and
4 Biostatistics, U of North Carolina, Chapel Hill, NC
Fogo Sevagem (FS) and pemphigus foliaceus (PF) possess pathogenic IgG autoantibodies against con-
formational, Ca++ dependent and carbohydrate independent epitopes on desmoglein 1 (Dsg1).
Although PF occurs sporadically, FS is endemic in Brazil, including Limao Verde (LV) (3.4% preva-
lence). We tested for IgM anti-Dsg1 autoantibodies (IgM anti-Dsg1) in FS and PF sera, and in healthy
individuals from Brazil, US and Japan. Using a Dsg1 ELISA, IgM anti-Dsg1 were detected in FS sera
from 58% patients (n=31) living in LV. Interestingly, IgM anti-Dsg1 decreased when severe FS patients
migrate to urban hospitals: 19% from Hospital-Campo Grande (n=57), 19% from Hospital-Goiania
(n=42), and 12% from Hospital-Sao Paulo (n=56). IgM anti-Dsg1 in non-endemic PF sera showed
these results: 10% of patients from US (n=20), and 0% of patients from Japan (n=20). IgM anti-Dsg1
in pemphigus vulgaris (n=40, US & Japan), bullous pemphigoid (n=40, US), and healthy donors
(n=55, US) was negligible. A high prevalence of IgM anti-Dsg1 was also found in healthy donors
from four rural Amerindian populations (42% of 243) as compared with urban donors (14% of 81)
(p<0.001). Young healthy donors from LV exhibit IgM anti-Dsg1 in over 50%, across ages (n=98,
ages 5-20y); whereas IgG anti-Dsg1 was detected in 3% (ages 5-10y), 7% (ages 11-15y) and 28%
of donors above age 16. The Dsg1 epitopes recognized by IgM anti-Dsg1 are Ca++ and carbohy-
drate independent. These findings suggest that IgM anti-Dsg1 are distinct markers of FS and differ-
ent from those bound by pathogenic IgG anti-Dsg1. The IgM anti-Dsg1 autoantibody response may
represent the earliest event in the sensitization process leading to FS followed by a gradual IgG
response that leads to FS. Antigenic exposure likely occurs in early childhood. Significantly, IgM anti-
Dsg1 may be excellent probes to test environmental antigens linked to FS.
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Dynamic proteomic analysis of extra-cellular microenvironment in contact dermatitis by in
vivo capillary ultrafiltration sampling
C Wang,1,2 S Barnes2,3 and C Elmets1,2 1 Dermatology, Univ. of Alabama at Birmingham,
Birmingham, AL, 2 Skin diseases research center, UAB, Birmingham, AL and 3 Pharm/Tox,
UAB, Birmingham, AL
Allergic contact hypersensitivity (CHS) is a complex inflammatory skin condition that requires
the interaction of many different cellular and molecular mediators. While many of the immune
cells and cytokines have been analyzed, the dynamics of protein expression in vivo remains
unexplored. We have developed a novel in vivo sampling technique using a capillary ultrafil-
tration (CUF) probe that can be implanted into target tissues to extract interstitial fluids (IF) in the
extra-cellular matrix on a continuous basis from individual freely-moving animals during the
evolution of the CHS response. The proteins in the collected IFs can then be subjected to pro-
teomic analysis. In this study, we employed the CUF technique in C3H/HeN mice to investigate
the proteins secreted into the skin during elicitation of allergic CHS to DNFB and in irritant con-
tact dermatitis (ICD) to TPA. CUF probes were implanted into the ears of mice, and IFs were col-
lected before and over a 3-day period after treatment with DNFB or TPA. Over 400 possible pro-
tein spots with molecular weight ranges from 10 to 150 kda were detected in the IF samples
analyzed by 2D gel electrophoresis, which indicated the complexity of proteins expressed in
the extra-cellular spaces. While the patterns of protein profiles of the IFs were very similar, changes
in the protein profiles were easily observed by compared the 2D protein profiles of IFs obtained
before and after the induction of ICD and allergic CHS. These studies demonstrate the utility of
CUF as a method for in vivo delineation of the protein changes that occur in contact dermatitis
and potentially other cutaneous diseases. With the protein identification capability of current
mass spectrometry techniques, the outcome of the extra-cellular proteome may provide new
information for understanding of the proteins involved in the inflammatory response to these two
conditions and may help to identify protein profiles that distinguish irritant from allergic CHS.
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Genetic and functional evidence for a role of the interleukin-23 pathway in the pathogen-
esis of psoriasis
FO Nestle,1 F Capon,3 G Tonel,1,2 C Conrad,2 P di Meglio,1 E Oldham,4 R Kastelein,4
J Lanchberry,5 J Barker1 and R Trembath3 1 Dermatology, Kings College London, London,
United Kingdom, 2 Dermatology, University Hospital Zurich, Zurich, Switzerland, 3
Genetics, Kings College London, London, United Kingdom, 4 Schering Plough Biopharma,
Palo Alto, CA and 5 Myriad Genetics, Salt Lake City, UT
Psoriasis is one of the most common chronic inflammatory disorders with a significant inher-
ited component. To identify genes relevant to disease pathogenesis we performed a genome-
wide association study. We detected a highly significant association between psoriasis and
genetic markers in the interleukin-23 receptor (IL-23R) gene on chromosome 1p31, a finding
replicated in an independent dataset. The most significantly associated polymorphism (com-
bined p value = 1.6 x 10-5) results in an amino acid substitution (Arg381Gln) located in the
IL-23R cytoplasmic domain. The same variant has recently been implicated in the pathogen-
esis of inflammatory bowel disease, supporting a critical role of IL-23 signaling in epithelial
inflammation. As a necessary step to determine the importance of this pathway in the patho-
genesis of psoriasis, we undertook functional investigations using patient samples and a clin-
ically relevant model system. We found an increased expression of IL-23R on psoriatic helper
T cells compared to normal controls. Functional dissection of the IL-23 pathway using immuno-
suppressed AGR mice grafted with psoriatic skin revealed a key role for the IL-23 pathways
in the disease process. Administration of a neutralizing anti-human IL-23 antibody inhibited
psoriasis development comparable to the use of anti-TNF-alpha blockers. These data provide
genetic and functional evidence for a crucial role of the IL-23 pathway in cutaneous inflam-
mation and lay the foundation for new treatment strategies in psoriasis.
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Defective inside-out activation of β2 integrins inhibits cutaneous reverse passive Arthus reac-
tion in CalDAG-GEFI -/- mice
T Goerge, W Bergmeier, SM Cifuni, BH Ho-Tin-Noe and DD Wagner Dept. of Pathology,
CBR Institute, Harvard Medical School, Boston, MA
Inside-out activation of β2 integrins is a key event during the adhesion and extravasation of
leukocytes at sites of inflammation. Recently we identified CalDAG-GEFI as a major signal-
ing molecule regulating the activation of the small GTPase Rap1 and β3 integrins in platelets
(Nat Med. 2004;10(9)). To characterize the role of CalDAG-GEFI in neutrophil function, we
chose the well-characterized cutaneous reverse passive Arthus reaction (rpA). Injecting 1%
BSA intravenously and varying concentrations of anti-BSA antibody subcuataneously leading
to immunocomplex (IC) formation in the skin, the rpA allows for a dose-dependent study of
neutrophil extravasation in vivo. Integrin-dependence of the rpA has been previously docu-
mented in CD18 -/- mice. Wild-type mice showed edema formation peaking at 2 hours and
significant neutrophil infiltration starting at 4 h upon rpA induction. In CalDAG-GEFI -/-
mice, neutrophil infiltration to the site of the rpA was virtually absent at lower levels of immuno-
complex formation. In contrast, at higher levels of IC-formation, neutrophil infiltration into
the skin of CalDAG GEFI -/- mice recovered to wild type levels. In addition, CalDAG-GEFI -
/- neutrophils were defective in Rap1 and β2 integrin activation in vitro. Thus, CalDAG-GEFI
may be an interesting target for partial immunosuppression in IC-mediated disease such as
rheumatoid arthritis and lupus erythematodes without compromising the overall immuno-
competence of the patient.
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Specific mechanisms for CD8+ Tc1 and TIL-17 cells mediate allergic contact hypersensitiv-
ity
D He, L Wu, H Kim, H Li, C Elmets and H Xu Dermatology, University of Alabama at
Birmingham, Birmingham, AL
Allergen induced contact hypersensitivity (CHS) has been considered to be a delayed type
cellular immune response that is mediated by CD4+ Th1 and CD8+ Tc1 cells that produce
IFN-γ. Our recent studies have indicated that CD8+ T cells that produce IL-17 (TIL-17) play
important roles in the elicitation of CHS. Allergen sensitization induces the development of
CD8+ Tc1 and TIL-17 cells that are distinct T cell subpopulations. Here we demonstrate that
both CD8+ Tc1 and TIL-17 cells play a role in CHS and that they mediate inflammatory reac-
tions by different mechanisms. CHS was reduced but not abolished in mice that were defect
in the receptor for IFN-γ (IFN-γR-/-) or IL-17 (IL-17R-/-) compared to wild type controls. Sim-
ilar results were observed in the adoptive transfer of CHS in the gene knockout mice that
were transferred with allergen primed wild type CD8+ T cells. However, neutralization of IL-
17 in IFN-γR-/- or IFN-γ in IL-17R-/- recipient mice abrogated the transfer of CHS. It impli-
cates that both IFN-g and IL-17 signals are required for optimal responses. The infiltration of
granulocytes and macrophages in the allergen challenged skin of IL-17R-/- mice was signifi-
cantly reduced whereas it was slightly affected in IFN-γR-/- mice. However, peroxidase activ-
ity and iNOS positive cells were reduced in IFN-γR-/- mice. Moreover, analysis by real time
RT-PCR showed different patterns of chemokines and inflammatory cytokines in the allergen
challenged skin of IFN-γR-/- or IL-17R-/- mice. These data indicate that both CD8+ Tc1 and
TIL-17 cells take part in the elicitation of CHS and that specific mechanisms orchestrate Tc1
and TIL-17 mediated inflammatory reactions in the skin. The result of current studies may
provide new insights into therapeutic strategies for the disease
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Serum chemokine profiles in patients with alopecia areata
Y Kuwano,1,2 M Fujimoto,3 R Watanabe,1 N Asashima,1 H Nakashima,1 Y Ohno,1 S Yano,1
N Yazawa,1 H Okochi2 and K Tamaki1 1 University of Tokyo, Tokyo, Japan, 2 Department of
Regenerative Medicine, International Medical Center of Japan, Tokyo, Japan and 3
Department of Dermatology, Kanazawa University, Kanazawa, Japan
Alopecia areata (AA) is regarded as a tissue-specific autoimmune disease of hair follicles. How-
ever, the pathogenesis of this disease remains unresolved. Although chemokines play an impor-
tant role in various inflammatory diseases, there have been few studies about the role of
chemokines in AA. To determine serum levels of chemokines in patients with AA and their
clinical correlations. Serum samples from 85 patients with AA, 20 patients with atopic der-
matitis, 20 atients with psoriasis vulgaris and 28 normal controls were examined by the cyto-
metric bead array assay assessing MIG, RANTES, IL-8, IP-10, MCP-1, MIP-1α, MIP-1β and
eotaxin levels. Secreted chemokine levels from PBMCs of AA patients were also investigated.
Serum MIG, RANTES, IL-8 and eotaxin levels were selectively increased in patients with AA
compared with normal controls. MIG, RANTES and IL-8 levels secreted from PBMCs of AA
patients were also increased. Furthermore, elevated serum MIG and RANTES levels signifi-
cantly correlated with the disease activity. RANTES levels were not significantly associated
with a predisposition to atopy. These results suggest that MIG and RANTES play an important
role in the development of AA and are useful for the marker of the disease activity and thera-
peutic target.
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Functional dissection of interleukin-17 in the pathogenesis of psoriasis
C Conrad,1 G Tonel,2,1 J Qin,3 H Xin,3 E Oldham,4 R Kastelein,4 BJ Nickoloff3 and FO Nestle2
1 Unversity Hospital Zurich, Zurich, Switzerland, 2 Dermatology, Kings College London,
London, United Kingdom, 3 Loyola University, Chicago, IL and 4 Schering Plough Biopharma,
Palo Alto, CA
Psoriasis is one of the most common T cell mediated inflammatory diseases. It has been pro-
posed that the key effector cells in psoriasis are IFN-gamma secreting T helper (TH)-1 lym-
phocytes. Recently, a novel helper T cell subset, characterized by its production of IL-17 has
been described and its functional relevance suggested in animal models of autoimmunity.
Here, we analyzed the functional role of IL-17 in a human autoimmune-type disease i.e. pso-
riasis as well as a clinically relevant humanized animal model of psoriasis. Flow cytometry
analysis of T cells revealed a significant increase of IL-17 protein production in psoriasis patients
compared to healthy controls. We observed also a dichotomy of T cells producing either IL-
17 or IFN-gamma using intracellular cytokine staining of peripheral blood lymphocytes from
psoriasis patients suggesting the existence of a committed lineage of TH-17 cells in psoriasis.
We then functionally assessed the role of IL-17 using immunosuppressed AGR mice grafted
with skin from psoriasis patients. While injection of anti-TNF-alpha significantly reduced signs
of psoriasis pathology compared to isotype control, injection of anti-IL17 antibody did not
have a similar effect. Our data define the possible functional role of IL-17 in psoriasis and
suggest the existence of a committed IL-17 producing helper T cell population in a common
human inflammatory disease.
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Fumaric acid esters improve autoimmune diseases through DC2/Th2 induction
K Ghoreschi,1 C Weigert,1 J Brück,1 MK Racke2 and M Röcken1 1 Department of
Dermatology, University of Tuebingen, Tuebingen, Germany and 2 Department of Neurology,
The Ohio State University Medical Center, Columbus, OH
Organ-specific autoimmune diseases such as psoriasis or multiple sclerosis are dominated by
interferon γ-producing Th1 cells and interleukin (IL-)17-producing Th17 cells. In vivo devia-
tion of an inflammatory Th1 or Th17 response into an anti-inflammatory Th2 phenotype, that
is characterized by high amounts of IL-4, may improve organ-specific autoimmune disease in
rodents and humans. Therapy with fumaric acid esters (FAE) is highly effective in the treat-
ment of psoriasis. Patients with psoriasis treated successfully with oral FAE showed a strong
suppression of the IFN-γ/IL-4 ratio in peripheral blood lymphocytes during therapy. Therefore
we further investigated the effects of FAE on immune responses in vitro and in vivo. DC were
treated with FAE and activated by Toll-like receptor ligands. IL-12 and IL-23 production were
dramatically suppressed by FAE treatment, whereas IL-10 production was enhanced. These
DC promoted the development of Th2 cells when cultured with naïve or in vivo primed anti-
gen-specific Th cells, even under Th1-stimulating conditions. In contrast, production of the
disease-inducing cytokines IFN-γ and IL-17 was suppressed. Adoptive transfer of myelin anti-
gen-specific Th cells into naïve mice induced severe encephalomyelitis whereas autoreactive
Th cells primed with FAE treated DC induced no or only mild disease. FAE therapy protected
mice from severe encephalomyelitis after immunization with myelin antigen in complete Fre-
und’s adjuvant and pertussis toxin. Analysis of the draining lymph nodes showed strong sup-
pression of IL-12/IL-23p40 mRNA expression. Myelin antigen-specific stimulation of isolated
CD4+ cells revealed low IFN-γ and IL-17 production but enhanced IL-4 and IL-10 production.
Thus, improvement of autoimmune disease during therapy with FAE is mediated by the induc-
tion of autoreactive Th2 cells through IL-12/IL-23 suppression in DC.
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Epidermis is an extra-adrenal source of glucocrticoid synthesis, which contributes to patho-
genesis of chronic wounds
S Vukelic,1 O Stojadinovic,1 M Rabach,2 B Harold,3 I Pastar,1 JA Carucci,1 M Golinko3 and
M Tomic-Canic1,2 1 Dermatology, Weill Cornell Medical College, New York, NY, 2
Dermatology, NYU School of Medicine, NY, NY and 3 Surgery, Columbia Univeristy CP&S,
NY, NY
Glucocorticoids (GC), potent anti-inflammatory agents are known inhibitors of wound healing.
Here we examined the activation of GC-specific pathway in epidermis and its role in pathogen-
esis of chronic wounds. Using immunohistochemistry we detected significant level of hormone-
activated receptor (GR) in epidermis of normal skin in the absence of exogenous hormone, sug-
gesting endogenous activation, which was confirmed by cell fractionation. Activation of GR was
hormone dependant as it was blocked by antagonist, RU486.To investigate possible endogenous
synthesis we used immunohistochemistry, RT-PCR and Western blots. We identified high levels
of steroidogenic enzymes (llB-Hydroxylase (CYP11B), 17 and 21) in epidermis. CYP11B showed
specific tissue distribution: it was predominant in basal and first suprabasal layers of epidermis
identifying cell compartment responsible for GC synthesis. To further confirm keratinocyte pro-
duction of GC, we measured cortisol secretion by keratinocytes. Remarkably, cortisol level (6.5
ng/ml) was comparable to free cortisol plasma levels. To the best of our knowledge synthesis of
GC in keratinocytes has never been documented before. Cortisol production by keratinocytes
could be further stimulated by ACTH or by blocking its breakdown using the inhibitor of 11-beta
Hydroxysteroid Dehydrogenase (HSD11b2). To examine if cortisol synthesis participates in chronic
wound pathogenesis we measured CYP11B and activation of GR in biopsies of chronic wounds
using microarrays and immunohistochemistry. We found strong induction of expression of CYP11B
and prominent GR activation in epidermis of non-healing edges. We conclude that keratinocytes
produce cortisol, thus changing the paradigm in treatment of inflammatory skin disorders. Fur-
ther, modulation of cortisol production may be important regulatory mechanism in wound heal-
ing and its deregulation participates in pathogenesis of chronic wounds.
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Systemic antineoplastic and/or immune modulating drugs induce high CD30 expression in
skin lesions
RE Chirinos, L Geskin, DM Jukic and L Geskin University of Pittsburgh, Pittsburgh, PA
The objective was to evaluate the course of CD30+ lymphoproliferative disorders (LPD) in
patients with non-neoplastic inflammatory conditions treated with systemic antineoplastic
and/or immune modulating drugs. We used a retrospective review of medical records and
pathology reports in patients with inflammatory conditions on chemotherapeutic or
immunomodulating medications at the Department of Dermatology, University of Pittsburgh
from 1996 to 2006. We have identified patients with established diagnoses of inflammatory
conditions (such as lupus and rheumatoid arthritis) treated with antineoplastic and/or immune
modulating drugs (methotrexate, mycophenolate mofetil, adalimumab, and abatacept). Sub-
sequent to therapy administration, some of these patients developed erythematous to viola-
ceous papules or plaques associated with severe pruritus. Skin biopsies of these lesions revealed
clusters and/or sheets of large atypical lymphocytes with an increased number of strongly stain-
ing CD30 positive cells in the majority of the infiltrate. A diagnosis of lymphomatoid papulo-
sis (LyP) or anaplastic large cell lymphoma (ALCL) was entertained. Skin lesions significantly
worsened upon increase in immunosuppressive therapy, but improved after therapy was with-
held. Drug induced CD30+ LPDs have been previously reported. However, a specific subset
of these patients treated with antineoplastic and/or immune modulating drugs has not been
systematically evaluated. In these patients, CD30+ lesions may be significantly more florid
and possess a significant proportion of atypical CD30+ cells, making the distinction between
a drug-induced process and true LPD difficult. Nonetheless, these lesions may represent a
regulatory or reactive process induced by these medications. A dose reduction and/or drug
holiday should be considered to evaluate the possibility of a drug-induced process. Long term
follow-up and additional studies are needed to fully characterize this entity.
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Enhanced type I interferon signaling in dermatomyositis
A Somani, P Karnik, TS McCormick and KD Cooper Department of Dermatology, University
Hospital Case Medical Center and Case Western Reserve University, Cleveland, OH
We show here a Dermatomyositis (DM) lymphocyte hypersensitivity to interferon beta (IFNβ),
in association with high type I interferon (IFNα/β) receptor levels (IFNAR-1) and increased
dendritic cell production of IFNα/β. We previously reported the first case of a patient with
multiple sclerosis who had severe DM temporally induced and/or exacerbated by IFN-β ther-
apy. In vitro studies examining the effect of IFN-β treatment on peripheral blood mononu-
clear cells (PBMCs) obtained from our patient and normal controls were conducted. PBMC
samples were rested overnight then incubated with or without IFN-β (100 I.U.) for 24h, and
separated into adherent and non-adherent populations for RNA extraction. Relative expres-
sion of type I IFN-induced genes, myxovirus resistance protein A (MxA) and interferon stim-
ulated gene 15 (ISG-15), compared to 18S RNA was determined using real-time PCR. MxA
and ISG15 levels were found to be 3-4 fold higher in DM than in control samples (N=3). Our
findings suggested a hypersensitivity of non-adherent (lymphoid) cells to in vitro IFN-β stim-
ulation compared to normal controls. Similarly, we examined the relative gene expression of
IFN-α, IFN-β and IFNAR-1. We found constitutively high IFNAR-1 in DM (17±2 fold), which
remained sustained (18±2 fold) following IFN-β stimulation. In contrast normal lymphoid cells
demonstrated increased IFNAR-1 (7±2 fold) only upon stimulation. In adherent cells from DM,
levels of IFNs (α/β) expression were constitutively higher (21±3 and 18±1 fold respectively)
in DM compared to normal controls. Taken together, our results suggest that DM lymphoid
cells demonstrate hypersensitivity to IFN-β which may be explained by increased gene expres-
sion of 1) type I IFN receptor in these cells and 2) IFNs (α/β) in adherent (dendritic) cells. We
speculate that DM patients may be primed to respond to IFN-β by the presence of increased
levels of functional IFN receptor, and signaling may be promoted by the enhanced release of
endogenous IFN (α/β) from adherent cells.
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Epidermal growth factor receptor mediates, and caspases inhibit, Fas ligand-induced inflam-
mation in an organotypic model of eczematous epidermis
S Farley,1 O Ryabinina,1 D Purdy,1 P Schneider,3 E Simpson,2 J Hanifin,2 B Magun1 and
M Iordanov1 1 Cell & Developmental Biology, Oregon Health & Science University, Portland,
OR, 2 Dermatology, Oregon Health & Science University, Portland, OR and 3 Biochemistry,
University of Lausanne, Epalinges, Switzerland
The eczematous epidermis displays simultaneously apoptotic, hyperproliferating, and pro-
inflammatory activated keratinocytes. The mechanistic basis of the co-existence of these phe-
nomena during eczema is poorly understood. Recent evidence points to Fas ligand (FasL)
expressed on activated T-cells as one potential integrator of the various features of eczema-
tous epidermis. We used an organotypic model (reconstructed human epidermis, RHE) to
demonstrate that FasL-induced caspase activity (required for keratinocyte death in eczema) is,
at the same time, a potent antagonist of transcriptional pro-inflammatory gene expression
programs triggered by FasL. Thus, apoptosis in the eczematous epidermis may serve to restrict
inflammation. These results also suggest that keratinocytes inherently resistant to FasL-induced
apoptosis (e.g. due to overexpression of apoptosis inhibitors) may be hypersensitive to the pro-
inflammatory action of FasL. We speculate that such apoptosis-resistant keratinocytes may
characterize psoriatic and/or lichenified eczematous skin. We found that FasL-stimulated
autocrine production of epidermal growth factor receptor (EGFR) ligands, and the subsequent
activation of EGFR, were obligatory extracellular steps for the FasL-induced expression of a
subset of inflammatory mediators, including CXCL8/IL-8, ICAM-1, IL-1α, IL-1β, CCL20/MIP-
3α, and thymic stromal lymphopoietin (TSLP). These results expand the known physiological
role of EGFR and its ligands in the epidermis from simply mediating mitogenesis to playing
an essential role in inflammation. In summary, our results indicate that a single cytokine,
FasL, can variously regulate apoptosis, hyperproliferation, and inflammation and demonstrate
the possibility that these phenomena are indeed interdependent in the eczematous epider-
mis.
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Organ-specific reduction of Foxp3+ regulatory T cells in lupus erythematosus
B Franz,1 B Fritzsching,1 C Kretz,1 A Riehl,1 C Klemke,1 N Oberle,1 J Sykora,1 M Hartmann,2
A Enk,2 PH Krammer,1 E Suri-Payer1 and A Kuhn1 1 Division of Immunogenetics,
Tumorimmunology Program, German Cancer Research Center, Heidelberg, Germany and 2
Department of Dermatology, University of Heidelberg, Heidelberg, Germany
Recent data have suggested that a lack or suppressive defect of CD4+CD25+ T cells (Treg) is
involved in a variety of human autoimmune diseases. In this project, we analyzed the phe-
notype and function of Treg in patients with various subtypes of lupus erythematosus (LE), a
heterogeneous autoimmune disease with a broad clinical spectrum reaching from primarily
cutaneous lesions to severe systemic organ manifestation. The number of Treg in lesional skin
specimens of patients with this disease was investigated using anti-Foxp3 and anti-CD4 mon-
oclonal antibodies for immunohistochemistry. Furthermore, characterization of peripheral
blood CD4+CD25+ Treg from normal healthy donors (NHD) and from patients with various
subtypes of LE was carried out by flow cytometry, analyzing the expression of Foxp3 and Treg
subpopulations. We also purified CD4+CD25hi Treg and tested their sensitivity to CD95L-
mediated apoptosis and their inhibitory activity. The quantitative analysis of CD4+ T cells in
skin lesions of patients with LE revealed a similarly high number when compared to other
chronic inflammatory skin diseases, such as psoriasis, atopic dermatitis, lichen planus, and
chronic eczema. However, the frequency of Treg in skin lesions expressed as percentages of
Foxp3+ cells from CD4+ cells was significantly (p<0.05) lower in the inflammatory infiltrate
of LE than in control diseases. In peripheral blood, no significant differences were found regard-
ing the phenotype and number of CD4+CD25+Foxp3+ Treg or the sensitivity to CD95L-
mediated apoptosis and the suppressive capacity of CD4+CD25hi Treg in NHD and patients
with a primarily cutaneous subtype of LE. In conclusion, our data suggest an organ-specific
reduction of Treg in the skin of patients with cutaneous LE rather than a global peripheral dys-
function as in patients with an active flare of systemic organ manifestation of the disease.
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Topical N-acetyl-S-farnesyl cysteine inhibits mouse skin inflammation, and unlike dexam-
ethasone, its effects are restricted to the application site
JS Gordon,1 PM Wolanin,1 AV Gonzalez,1 DA Fela,1 K Rouzard,1 E Perez,1 G Sarngadharan,1
JB Stock1,2 and MB Stock1 1 Signum Biosciences, Princeton Junction, NJ and 2 Molecular
Biology, Princeton University, Princeton, NJ
The purpose of this study is to compare N-acetyl-S-farnesyl cysteine (AFC), a G-protein cou-
pled receptor signaling modulator, to established anti-inflammatories in a mouse model of
acute irritation. AFC inhibits neutrophil chemotaxis and other inflammatory responses in cells
in vitro. We have shown that topical AFC inhibits in vivo the acute inflammation induced by
12-O-tetradecanoyl-phorbol-13-acetate (TPA) using the mouse ear model of inflammation.
AFC inhibits edema, as measured by the increased ear weight. AFC also inhibits neutrophil
infiltration as assayed by myeloperoxidase (MPO) activity as a neutrophil marker. Here we
show that, unlike the established anti-inflammatories, dexamethasone and indomethacin AFC’s
action is restricted to the site of application. Both dexamethasone and indomethacin show
inhibition of TPA-induced edema and MPO activity in the vehicle treated, contralateral ear in
this mouse model. AFC shows no contralateral ear inhibition of either of these endpoints. To
determine the basis for the local restriction of AFC we have found that the rate of permeation
in vitro permeation of mouse skin mounted on Franz cells of AFC is approximately half of that
of dexamethasone. In addition, we found that AFC is rapidly cleaved by mouse liver but not
by skin homogenates. These results suggest that the restriction of AFC’s anti-inflammatory action
to the treated ear is the result of a combination of low permeation and rapid degradation by
liver. The restriction of AFC’s effect to the site of treatment raises the possibility of topical use
without systemic adverse effects.
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N-acetyl-S-farnesyl cysteine inhibits mouse skin inflammation due to glycolic acid treatment
DA Fela,1 PM Wolanin,1 AV Gonzalez,1 K Rouzard,1 JB Stock,2,1 MB Stock1 and JS Gordon1
1 Signum Biosciences, Princeton Junction, NJ and 2 Molecular Biology, Princeton University,
Princeton, NJ
In this study we examine whether N-acetyl-S-farnesyl cysteine (AFC), a G-protein coupled
receptor signaling modulator, inhibits the inflammatory response induced by the topical appli-
cation of the α-hydroxy acid glycolic acid (GA) in a mouse model. AFC inhibits neutrophil
chemotaxis and other inflammatory responses in cultured cells and also suppresses edema
and neutrophil infiltration in mouse ears exposed to the chemical irritant 12-O-tetradecanoyl-
phorbol-13-acetate (Gordon et. al, submitted). Acute irritation is observed in patients topi-
cally exposed to high concentrations of GA to induce photodamage repair. Since glycolic acid
irritation has not been reported in the mouse ear model, we first sought to establish the con-
ditions under which GA induces irritation. To insure even distribution and to replicate human
exposure, glycolic acid in aqueous solution was applied to the ears with a swab. A dose
dependent distribution for the induction edema measured by an increase in ear weight and
the neutrophil infiltration measured by induction of myeloperoxidase (MPO) activity was
observed. Approximately 75% of the maximum increase was observed at 50% GA, and this
concentration was used to measure the effectiveness of AFC treatment. When AFC in an aque-
ous solution at pH 6.5 is applied by swab 30 minutes prior to exposure to 50% GA, a dose
response inhibition of edema was observed with an maximal efficacy of 70% and an ED50
of 130 µg / 20 µl. These results show that AFC effectively reduces irritation in this model due
to the therapeutic agent GA.
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Detailed genetic characterization of the psoriasis-associated gene IL12B to further define
the causal variant(s)
E Beasley,1 SJ Schrodi,1 M Chang,1 KP Callis,2 MF Leppert,2 GG Krueger2 and AB Begovich1
1 Celera, Alameda, CA and 2 University of Utah, Salt Lake City, UT
Using a multi-tiered, case-control association study and a collection of over 25,000 gene-cen-
tric SNPs, we identified two psoriasis risk genes, IL12B and IL23R (Cargill et al. 2007). Given
that antibodies directed against the IL12B-encoded IL-12p40 subunit appear to be an effec-
tive therapy for a subset of psoriasis patients and that SNPs in this gene may play a role in
treatment response and/or dosage, we extended our genetic analyses of IL12B by genotyping
additional markers in this gene in three independent, white North American sample sets (>2800
individuals). To date 17 additional IL12B-region SNPs have been genotyped for a total of 48
SNPs. All markers were consistent with Hardy-Weinberg equilibrium and the LD measure r2
was calculated treating the cases and controls separately. Allelic and genotypic analyses
have been performed and preliminary haplotype analyses are complete. The data show that
the previously described 3’UTR SNP, rs3212227, is the most significant of all 48 SNPs tested
(Pcomb<10-8). This SNP is in strong LD (r2 > 0.97) with five other SNPs (three intronic and
two 3’ of IL12B) all of which are also highly significant. rs6887695, located approximately
60kb upstream of the IL12B coding region, exhibits significant association with psoriasis that
remains after adjustment for rs3212227 as do two other SNPs within 3 kb and in strong LD
(r2>0.99) with rs6887695. Alleles at these SNPs define a strongly protective haplotype as well
as a susceptible haplotype. These data suggest that association of IL12B with psoriasis is driven
by rs3212227 and rs6887695 or SNPs in significant LD with these two markers. Functional
and/or genetic studies utilizing psoriasis patients of other ethnic groups, where the patterns
of LD across the IL12B region are different, will be required to further pinpoint the causative
variants; however, the genetic results presented here provide the tools necessary to accu-
rately explore whether specific variants within IL12B correlate with treatment response.
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Identifying molecular networks and targets for alopecia areata using a mouse mode
J Sun,1 JP Szatkiewicz,1 BL King,1 S Kamdar,1 LE King2 and JP Sundberg1,2 1 Research, The
Jackson Laboratory, Bar Harbor, ME and 2 Dermatology, Vanderbilt University, Nashville, TN
Alopecia areata (AA) is a disfiguring, complex genetic, human autoimmune skin disease tar-
geting actively growing hair follicles. Skin graft and spontaneous C3H/HeJ mouse models for
AA provide effective tools to screen drugs for efficacy. Using the Affymetrix® gene expression
tools (GeneChip Mouse Genome 430 2.0 Array) combined with Ingenuity Pathways Analy-
sis® software we evaluated mice at 5, 10, 15, and 20 weeks after skin grafting and mice with
spontaneous AA compared to age and gender matched controls. This approach identified
numerous molecular networks involved in the pathogenesis of AA, including vitamin A metab-
olism and activation of Cd8+ and Cd4+ T cells. More importantly, this approach identified
dysregulated genes at specific time points in the evolution of AA whose protein products are
known targets for FDA-approved drugs. Very few dysregulated genes, especially those that
were drug targets, were significantly upregulated at all stages, suggesting that treatments
need to be designed for specific stages of AA not just the general diagnosis of AA as is cur-
rently done. This information provides a priority list for screening drugs for efficacy in treat-
ing AA and will help pharmacologists design new single and combination therapies for AA
patients. The mouse model is available both as individual mice for research or for systematic
drug efficacy screening at The Jackson Laboratory in West Sacramento
CA(http://jaxmice.jax.org/library/notes/504/504b.html?WT.mc_id=201331).
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Haplotype analysis identifies Tap2 as a key gene in C3H/HeJ mouse alopecia areata
JP Sundberg,1,2 J Sun,1 BL King,1 KA Silva,1 JP Szatkiewicz,1 S Kamdar,1 LE King2 and
DC Roopenian1 1 Research, The Jackson Laboratory, Bar Harbor, ME and 2 Dermatology,
Vanderbilt University, Nashville, TN
Alopecia areata (AA) is a cell mediated autoimmune disease targeting anagen stage hair fol-
licles. Two inbred mouse strains, C3H/HeJ (and many of its substrains) and A/J develop a
spontaneous alopecia areata-like disease. Four (Alaa1-4) QTL intervals have been defined for
C3H/HeJ AA. Haplotype analysis was performed by screening SNPs within the four Alaa1-4
QTL intervals found for C3H/HeJ AA by searching for groups of 3 or more contiguous SNPs
identical between C3H/HeJ and A/J but different for C57BL/6J and DBA/2J strains. This map-
ping approach identified the transporter 2, ATP-binding cassette sub-family B (Tap2) gene as
one of the genes within the most significant QTL (Alaa1) on chr. 17. To determine whether
there was concordance between haplotype-mapped QTL and gene expression QTL (eQTL),
gene expression studies (Affymetrix) were performed on skin from mice receiving skin grafts
from affected vs. normal mice at 5, 10, 15, and 20 weeks after grafting as well as for mice
with spontaneous AA vs. normal skin. These studies revealed a steady and significant increase
of over 3 fold in Tap2 and Tap binding protein (Tapbp) expression, in addition to the altered
expression of many other genes in the MHC class I antigen presentation and effector path-
ways. These studies suggest that allelic variation in MHC genes associated with antigen pres-
entation may confer risk for AA in mice. The homologous genes in humans are located on chr.
6 where a QTL for AA susceptibility was also mapped.
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Murine HSP70 exacerbates vitiligo in mice
CJ Denman,1 K Oyarbide-Valencia,1 JA Guevara-Patiño2 and I Le Poole1 1
Pathology/Oncology Insitute, Loyola University Chicago, Maywood, IL and 2 Surgery,
University of Chicago, Chicago, IL
HSP70 confers superior anti-tumor efficacy to some existing cancer vaccines, and our in vitro
studies suggest that HSP70 may similarly contribute to autoimmune reactivity in vitiligo. To
test the latter hypothesis in vivo, we developed a reliable mouse model where gradual depig-
mentation of the pelage is observed in response to 4 weekly gene gun vaccinations with an
expression plasmid encoding human melanocyte differentiation antigen TRP-2. To evaluate a
contribution for HSP70 to depigmentation, we cloned mouse and human HSP70 cDNA into
mammalian expression vectors and confirmed protein expression by Western blotting of trans-
fected CaSki cells. Bullets containing a combination of human TRP-2 and/or HSP70 encod-
ing plasmids were used, adding empty vector as a negative control. C57BL/6 mice (10 per
group) received 4 weekly gene gun vaccinations with 4 µg of plasmid. Depigmentation was
evaluated weekly by image analysis of scanned mice. Eight weeks after vaccination, signifi-
cant depigmentation of mice vaccinated with suboptimal doses of TRP-2 encoding plasmid
was observed only in the presence of human or mouse HSP70 (22.0 +/- 4.0 % and 19.4 +/-
5.2 % depigmentation, respectively). Importantly, progressive vitiligo away from the vaccina-
tion site was observed primarily in mice vaccinated with both TRP-2 and murine HSP70.
Immunostained frozen sections revealed that TRP-2 expressing melanocytes and CD3+ T
cells were absent from depigmented yet otherwise healthy areas of the skin. These data sup-
port a chaperone function for HSP70 that accelerates autoimmune reactivity to melanocytes
in vitiligo.
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IgE class autoantibodies against BP180 in herpes gestationis and cicatricial pemphigoid
MA Chapman,1 M Olague-Marchan,1 KB Yancey,1 GJ Giudice1,2 and JA Fairley1,3,4 1
Dermatology, Medical College of Wisconsin, Milwaukee, WI, 2 Biochemistry, Medical College
of Wisconsin, Milwaukee, WI, 3 Dermatology, University of Iowa, Iowa City, IA and 4 VA
Medical Center, Iowa City, IA
Bullous pemphigoid (BP), herpes gestationis (HG), and cicatricial pemphigoid (CP) are autoim-
mune diseases characterized by subepidermal vesiculation and deposition of immunoglobu-
lins and complement at the cutaneous basement membrane zone (BMZ). Based on past stud-
ies, IgG autoantibodies directed against the major non-collagenous segment (NC16A) of BP180,
a hemidesmosomal transmembrane protein, are thought to play a primary role in the patho-
genesis of these diseases. In addition to these IgG autoantibodies, however, most BP patients
produce IgE class autoantibodies that also react with the BP180 NC16A domain. Our research
group has recently obtained evidence that IgE produced by BP patients are pathogenic in a
human skin graft murine model. In the present study we are testing the hypothesis that IgE class
autoantibodies are not restricted to BP. Sera from patients with well characterized herpes ges-
tationis (HG; n=14) and cicatricial pemphigoid (CP; n=14) were assayed by immunoblotting
for IgE immunoreactivity with a glutathione S-transferase (GST) bacterial fusion protein con-
taining human BP180 NC16A and a C-terminal (Gly-Pro-Pro)10 peptide. The Gly-Pro-Pro
peptide sequence was shown to enhance the stability of the fusion protein. GST and normal
human sera were used as negative controls. A standard chemiluminescent protocol was used
to detect bound antibodies. Specific IgE reactivity to NC16A was detected in 8 of the 14 HG
sera (57%) and 7 of 14 CP sera (50%). Future research will be directed at determining if IgE
reactivity is found in autoimmune disorders targeting autoantigens other than BP180. As the
role of IgE in autoimmunity is further revealed, so too is the potential for establishing novel
therapeutic interventions.
www.jidonline.org   S15
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Stress up-regulates activation and migration of skin dendritic cells in a mouse model of
allergic dermatitis
S Pavlovic, M Daniltchenko, SM Blois, BF Klapp and EM Peters Cutaneous
Psychoneuroimmunology, Department of Internal Medicine and Psychosomatics, University
Medicine Charité, Berlin, Germany
Langerhans cells play an important role in allergen presentation to T-helper (TH) cells thereby
determining their development into TH1 or TH2 cells. There is overwhelming evidence that
dysbalance in these T-cell functions contribute to the pathogenesis of atopic dermatitis. Langer-
hans cells interaction with peptidergic nerve fibers, peptidergic stress mediators or stress expo-
sure affect their activation and subsequent T-cell commitment and may thereby contribute to
these abnormal functions. In order prove this connection we used a murine model of exper-
imental allergic dermatitis (AD) characterized by neuronal plasticity to test the effects of stress
and peptidergic stress mediators. We found that exposure to 24 hrs noise stress leads to a sig-
nificant up-regulation in the expression of co-stimulatory and molecules CD80 and CD86 on
dendritic cells (CD11c+) isolated from skin draining lymph nodes of AD mice. In parallel the
number of CD4+ and CD8+ cells slightly decreased, while the number of regulatory
CD4+CD25+ T cells increases. Expression of molecules involved in transmigration into the
lymph nodes such as Very Late Antigen-4 (VLA-4) and Lymphocyte Function-associated Anti-
gen-1(LFA-1) was significantly enhanced in stressed AD mice compared to AD only mice and
the number of dendritic cells emigrated from epidermal sheets was significantly elevated. Inter-
estingly, this heightened migrational activity was abrogated when an antagonist to the neu-
ropeptide and stress mediator substance P (SP) receptor neurokinin 1 receptor (NK1) was
applied prior and after stress exposure. These findings suggest a role of stress and SP in den-
dritic cell activation in allergic or atopic disease. We conclude that stress via neuropeptides
potentiates dendritic cell activity in allergic or atopic disease. The contribution of different
stress mediators and further consequences of this up-regulation on TH cell imbalance in atopic
disease pathogenesis remain to be revealed.
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Etiology of autoimmune skin disease revealed by probing the anti-Dsg1 autoantibody reper-
toire
Y Qian,1 SH Clarke2 and LA Diaz1 1 Dermatology, University of North Carolina at Chapel
Hill, Chapel Hill, NC, 2 Microbiology and Immunology, University of North Carolina at
Chapel Hill, Chapel Hill, NC and 3 Dermatology, University of North Carolina at Chapel Hill,
Chapel Hill, NC
Fogo selvagem (FS), the endemic pemphigus foliaceus (PF), is characterized by pathogenic
anti-Dsg1 autoantibodies. To study the etiology of FS, hybridomas were generated from the B
cells of 7 FS patients and an individual before the onset of FS, and the H and L chain V genes
of anti-Dsg1 autoantibodies were analyzed. Eighty one monoclonal anti-Dsg1 hybridomas
were isolated; 29 secreted IgG and 52 secreted IgM. Our evidence suggests that the anti-Dsg1
autoimmune response in FS is antigen selected. First, some H chain V gene familyies were
over-represented and others under-represented. Second, both IgM and IgG hybridomas exhib-
ited a high frequency of VH mutation, and the replacement versus silent mutation (R/S) ratio
was much higher in CDRs (3.4 and 2.9) than in FWRs (1.2 and 0.9) of both IgM and IgG
hybridomas, respectively. Third, clonally related sets of anti-Dsg1 hybridomas were identified
from individual FS patients. Interestingly, similar selection was evident among anti-Dsg1
hybridomas from a patient with prior to clinical disease. The V genes of hybridomas from a
pre-clinical stage of FS were also extensively mutated, and there was a higher R/S ratio in VH
CDRs (2.8 and 3.7) than in FWRs (1.5 and 1.2) of both IgM and IgG hybridomas, respectively.
Thus, selection of anti-Dsg1 B cells begins before the initiation of the disease. The binding of
some monoclonal anti-Dsg1 autoantibodies from FS patients to Dsg1 antigen is Ca++ depend-
ent, which is a feature of pathogenic anti-Dsg1 autoantibodies in FS. In contrast, binding of
monoclonal antibodies from pre-clinical stage of FS to Dsg1 was Ca++ independent. Thus,
while the selection of anti-Dsg1 B cells begins before clinical disease, our findings raise the
possibility that the transition from pre-clinical to clinical disease is dependent on the appear-
ance of anti-Dsg1 B cells producing Ca++ dependent antibodies.
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Dichotomy of anti-desmoglein 1 and -3 autoantibody profiles in pemphigus vulgaris (PV)
patients carrying distinct HLA alleles
J Talsma, M Stepanovich, S Chow, K Seiffert and AA Sinha Dermatology and Cutaneous
Sciences, Michigan State University, East Lansing, MI
The desmoglein (Dsg) compensation hypothesis suggests that mucosal blisters in PV are caused
by antibodies (Ab) to Dsg3, while mucocutaneous blisters arise from Ab against both Dsg1
and -3. However, the association of Ab levels with constant clinical parameters (HLA-type,
gender, and age of onset) and variable clinical parameters (history of disease morphology,
disease status, age, disease duration, and type of therapy) has not been well explored. To sys-
tematically address the outstanding questions related to autoAb responses in PV, we analyzed
anti-Dsg1 and -3 levels in 159 serum samples of 90 patients with distinct clinical profiles and
38 HLA-matched controls by ELISA. We found no significant correlation for either anti-Dsg1
or -3 with gender, age of onset, age at sample collection, disease duration, or type of therapy.
Patients in the active phase have significantly higher amounts of anti-Dsg1 and -3
(40.7±52.8U/ml; 105±64.4U/ml, respectively) than patients in remission or controls (p<0.0001
for all comparisons; general linear model analysis). We confirm that patients with active muco-
cutaneous lesions have Ab to both Dsg1 (55±49.1U/ml) and Dsg3 (110.3±56.1U/ml), while
patients with mucosal lesions predominantly have Ab within the positive range to Dsg3
(128.9±55.5U/ml). Interestingly, 6 patients with cutaneous only lesions at sampling were highly
positive for Dsg1 (133.8±44.5U/ml), but had indeterminate levels of Dsg3 (18.1±34.5U/ml).
Of particular note, we observe that patients carrying the highly disease-prevalent HLA alleles
DRB1*0402 and DQB1*0503 have significantly higher amounts of anti-Dsg3 Ab (p<0.0001;
Kruskal-Wallis test), and lower amounts of anti-Dsg1 Ab than 0402/0503 negative patients,
while the opposite, i.e. higher amounts of anti-Dsg1 than anti-Dsg3 Ab, is observed in
0402/0503 negative patients. This novel finding may indicate that the specificity of autoAb
responses is determined by different preferences for epitopes presented to autoreactive T cells
through distinct MHC molecules.
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Avidity of anti-desmoglein antibodies in patients with pemphigus vulgaris (PV) and pem-
phigus foliaceus (PF) does not correlate with disease activity or clinical improvement
KM Hassan, RD Streilein and RP Hall Dermatology, Duke University Medical Center,
Durham, NC
Anti-desmoglein 3(anti-DSG3)and anti-desmoglein 1(anti-DSG1)antibodies play a critical role
in the pathogenesis of PV and PF. These antibodies, however may persist despite clinical
improvement or remission. We hypothesized that differences in anti-DSG3 and anti-DSG1
avidity for antigen would correlate with differences in PV and PF clinical disease activity. Using
a chaotropic ion elution assay, 14 pairs of sera from 9 PV and 5 PF patients at contrasting time
points in their disease were tested for autoantibody avidity. Sera were added to DSG-3 and
DSG-1 ELISA plates, incubated and then antibody was eluted by the addition of 0, 0.5, 1.0
and 2.0 M NH4SCN. Persistent antibody binding was assessed and differences in avidity were
quantified by the ratio of antibody levels at 1.0 M NH4SCN compared to at 0 M. Clinical dis-
ease activity was scored on a 0-6 scale. Initial PV patient anti-DSG3 values varied from 30 to
1967 u/ml (mean disease activity = 2.6). PV patients analyzed a mean of 958 days later had
anti-DSG3 levels from 9 to 2714 u/ml (mean disease activity = 0.6). Initial PF patient anti-
DSG1 values ranged from 68 to 422 u/ml (mean disease activity = 1). PF sera analyzed at a
mean of 1127 days later showed anti-DSG1 levels ranging from 46 to 265 (mean disease activ-
ity = 0.4). Average avidity was similar for anti-DSG1 and anti-DSG3 antibodies with a wide
range of avidity (1.0 M mean avidity (range): DSG-1 = 27.1 % (13.3% -50.0%); DSG-3 = 31.4
% (6.6% -58.2%)). No correlation with disease activity was noted and no significant change
in antibody avidity was noted to occur at the time points studied for individual subjects. These
results demonstrate that anti-DSG1 and DSG3 autoantibodies found in patients with PV and
PF have a wide range of avidity that is relatively constant over time and does not correlate with
disease activity. These findings suggest that changes in the antigen-antibody avidity of PV
autoantibodies are not directly related to changes or differences in disease activity.
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Impact of blistering upon reproduction in a DQ2 transgenic mouse model of dermatitis her-
petiformis
EV Marietta,1,2 S Rashtak,3 MR Pittelkow,1 CS David2 and JA Murray3 1 Dermatology, Mayo
Clinic College of Medicine, Rochester, MN, 2 Immunology, Mayo Clinic College of Medicine,
Rochester, MN and 3 Gastroenterology, Mayo Clinic College of Medicine, Rochester, MN
Dermatitis Herpetiformis is tightly associated with HLA-DQ2 and HLA-DQ8. Previously we
have generated mouse models of Dermatitis Herpetiformis (DH) using DQ8 and DQ2 trans-
genic mice. When weaned and maintained on a gluten containing chow, DQ2 transgenic mice
spontaneously develop subepidermal blisters similar to DH. Transgenic mice that express DQ2
on a background deficient in endogenous MHC II (Aeo) were raised on a gluten containing
chow (GCC) or a gluten free chow (GFC) and the level of blistering and reproduction moni-
tored. When raised and maintained upon a GCC, a significant number of females and males
in the breeding pairs of Aeo DQ2 mice excessively scratched themselves, leading to both a
decreased number of litters and survival of pups. When raised and maintained on GFC, no
blistering developed and the number of litters per breeding pair increased two to three fold
as compared to those that were weaned and maintained upon a GCC. Similarly, the total num-
ber of pups per breeding pair maintained on GFC increased four fold over that of those main-
tained on GCC. While maintained on a gluten containing diet, DH-like blistering sponta-
neously develops in these AeoDQ2 transgenic breeding pairs, which then greatly diminishes
the reproductive capability of Aeo DQ2 transgenic mice.
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Plasmacytoid dendritic cells (PDCs) contribute to development of psoriatic lesions in trans-
genic mice
M Takaishi,1 K Kataoka,1 K Kiguchi,1 M Gilliet2 and J DiGiovanni1 1 Carcinogenesis, UT MD
Anderson Cancer Center, Smithvill, TX and 2 Immunology, UT MD Anderson Cancer Center,
Houston, TX
We recently reported that signal transducer and activator of transcription 3 (Stat3) was up-regu-
lated and activated in epidermal keratinocytes of human psoriatic lesion, and also psoriatic lesions
were induced in skin of transgenic mice in which Stat3 was constitutively expressed as an active
form (K5.Stat3C mice). We also showed that activation of T cells is required for the formation of
the psoriatic lesions in this mouse model for human psoriasis. Plasmacytoid dendritic cells (PDCs)
are premature dendritic cells characterized by plasma cell-like morphology and a unique surface
phenotype. PDCs play key role in innate antiviral immunity because of their capacity to produce
large amounts of interferon alpha in response to virus. Recently, some reports have revealed that
PDCs were present in skin of human psoriasis. These findings prompted us to study the contribu-
tion of PDCs in the development of psoriatic lesions in K5.Stat3C transgenic mice. Tape stripping
was carried out on the back skin of Stat3C transgenic and wild type littermates. Accumulation of
PDCs in the lesion was visualized with immunostaining using anti-PDC antibody. We have found
that PDCs infiltrate the skin of both transgenic and non-transgenic mice as early as 8 hours after
tape stripping. However, PDCs accumulated in much greater number and were retained for a sig-
nificantly longer period of time in transgenic mice in skin of K5.Stat3C mice. Furthermore, admin-
istration of the anti-PDC antibody led to reduction in severity of psoriatic lesions. In this regard,
epidermal thickness as well as the size of capillaries in the lesional area were significantly reduced
in the anti-PDC antibody injected group in comparison with that of the control group. Current
studies are examining the role of IFNα in addition to PDCs in the development of psoriatic lesions
in K5.Stat3C mice. The current results suggest that PDCs may play a role in the initial develop-
ment of psoriatic lesion in the Stat3C transgenic mouse model.
S16 Journal of Investigative Dermatology (2007), Volume 127
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WBI-1001: a stilbene with unique anti-psoriasis activities
L Tang,1,2 G Chen,1,2 B Li,1,2 Q Liu3 and J Webster1,2 1 Welichem Biotech Inc., Burnaby, BC,
Canada, 2 Simon Fraser University, Burnaby, BC, Canada and 3 Shanghai Institute of
Pharmaceutical Industry, Shanghai, China
Currently, there is no therapeutic cure of psoriasis. To develop a more effective, safer, cos-
metically acceptable and readily administered psoriasis drug, in vitro and in vivo assays were
done on the metabolites of certain symbiotic bacteria to test for their anti-inflammatory and
anti–psoriasis activities. Arising from this, a fully synthesized hydroxylated stilbene (named
WBI-1001), was found to be potentially an ideal topical treatment for psoriasis. Firstly, the
compound’s cytotoxicity was significantly greater against activated human T-cells and neona-
tal keratinocytes as compared with other human cells. Secondly, it significantly inhibited T
cell migration towards LTB4 in vitro in a dose dependent manner at sub-toxic doses. Thirdly,
WBI-1001 selectively inhibited IL-2 and IFN-γ production in vitro in human T cells and sig-
nificantly inhibited the production of TNF-α in mice, while IL-4 was not affected. In addition,
WBI-1001 significantly inhibited VEGF production induced by TGF-α in human keratinocytes.
Furthermore, strong and direct anti-inflammatory activity of WBI-1001 was demonstrated using
the mouse ear edema model. When topically applied to the TPA-induced ear edema, WBI-
1001 exhibited a dose-dependent response in reducing both skin redness and thickness. To
demonstrate WBI-1001’s pre-clinical anti-psoriatic activities, two mouse models were tested:
mouse vaginal mucosa and mouse tail, which mimics the hyperproliferation of psoriatic epi-
dermis and the abnormal form of keratinization (parakeratosis) in psoriasis, respectively. When
tested as a 0.5, 1 or 2% cream, WBI-1001 showed significant and dose-related efficacy in
both models. In conclusion, due to its unique properties that target the major pathogenic fea-
tures of psoriasis, including keratinocyte proliferation/differentiation, activated T-cells and their
infiltration into the skin, pro-inflammatory cytokines and angiogenesis, WBI-1001 could be
developed into an effective, novel treatment modality for psoriasis.
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Bullous pemphigoid IgE stimulates IL-8 production by human keratinocytes
A DeGueme,2 GJ Giudice,2 CL Fu2 and JA Fairley1,3 1 Dermatology, University of Iowa, Iowa
City, IA, 2 Dermatology, Medical College of Wisconsin, Milwaukee, WI and 3 VA Medical
Center, Iowa City, IA
Bullous pemphigoid (BP) is an autoimmune disease characterized by subepidermal vesicula-
tion and deposition of immunoglobulins and complement at the cutaneous basement mem-
brane zone (BMZ). BP patients produce both IgG and IgE class autoantibodies directed against
the hemidesmosomal protein BP180 (collagen XVII). Based on recent data from our group, it
appears that both classes of autoantibodies participate in the pathogenesis of BP. We have also
shown that mast cells from BP patients degranulate in response to in vitro treatment with a
BP180 peptide, suggesting one mode of action for the IgE autoantibodies. This study is designed
to test the hypothesis that BP IgE can also interact directly with keratinocytes (presumably
through BP180) and trigger a signal that leads to the release of pro-inflammatory cytokines.
IgE was purified from the sera of two BP patients and normal controls. Human keratinocytes
cultures were treated with 60 ng/ml of BP or control IgE. Culture supernatants were collected
after overnight incubation and the presence of 18 cytokines were assayed by cytokine anti-
body arrays. IL-8 signals were increased in BP IgE-treated keratinocyte supernatants compared
to controls (n=4). In order to verify this finding, keratinocytes were treated with a similar pro-
tocol and the IL-8 content of the supernatants was measured by IL-8 ELISA. BP IgE produced
a two-fold increase in IL-8 expression compared to normal IgE. To determine if there may be
relevance to BP patients, serum IL-8 levels were measured in 22 untreated BP patients by
ELISA and were compared to levels in normal controls (n=11) using the Mann-Whitney test.
The serum IL-8 levels in BP patients (mean = 150 pg/ml) were significantly higher than con-
trols (mean = 22 pg/ml, p=0.01). These data suggest that IgE class autoantibodies in BP may
have a direct effect on keratinocytes via binding to their target autoantigens at the BMZ, and
thereby promote an inflammatory reaction.
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Real-time imaging of neutrophil infiltration during skin wound healing
W Liu,1 M Kim,2 F Liu,1 RR Isseroff1 and SI Simon2 1 Dermatology, UC, Davis, Davis, CA and
2 Biomedical Engineering, UC Davis, Davis, CA
Neutrophil infiltration is an early event of the inflammatory phase during skin wound heal-
ing. Aberrant neutrophil infiltration in the skin dermis is a hallmark of chronic inflammation
and can lead to wound scarring. Here we introduce a real-time imaging technique to quan-
titate neutrophil infiltration to an aseptic skin wound. EGFP-lysozyme transgenic mice develop
green fluorescent neutrophils which can be visualized with the Xenogen IVIS system. Neu-
trophil infiltration of a 6 mm dorsal mid back full-thickness circular wound was monitored in
animals that had received either 0.9% saline ip or GM-CSF (10µg/kg) ip daily for 10 days. As
few as 0.1 million neutrophils could be detected in the wound and the fluorescence signal
increase linearly up to 10 million cells. GM-CSF treated mice expressed significantly higher
average radiance level in the wound and peri-wound area over the course of wound healing,
which represented a 1.5-fold increase in neutrophil infiltration compared to the saline con-
trol. Peak neutrophil infiltration was observed on day 2-3 post wounding and returned to base-
line after day 9. Although ip administration of GM-CSF persistently increased the systemic
neutrophil count and in proportion the number infiltrating the skin wound area, both GM-
CSF and control mice cleared neutrophils from the wound by day 9 correlating with wound
healing. Our study demonstrates that Xenogen IVIS system combined with genetic labeling
of neutrophils provides high sensitivity and real-time imaging for non-invasive quantification
of inflammation of skin wounds.
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Unexpectedly high frequency of regulatory T cells in psoriasis
K Darabi, J Duculan, I Novitskaya, T Kikuchi, MA Lowes and JG Krueger The Rockefeller
University, NY, NY
To date few studies have examined regulatory T cells (Tregs) in psoriasis and these studies have
defined Tregs as Foxp3 mRNA expressing CD4+CD25+/hi cells. More recently, Tregs have been
described as Foxp3+ CD4+ T cells expressing low levels of CD127 in addition to high levels
of CD25. In an attempt to gain more insight into Treg frequencies in psoriasis we applied
these recently suggested phenotypic markers of Tregs and measured the frequency of Tregs
defined as CD3+CD4+CD25highCD127low cells (alternative definition) by 6-color flow cytom-
etry and compared them to Tregs defined as CD3+CD4+CD25+ cells (conventional defini-
tion). Consistent with previous reports, after applying the “conventional” Treg definition the
frequency of Tregs did not differ between PBMCs of normals and psoriatics. Interestingly, when
defining Tregs with the “alternative” markers CD25hi127lo, we observed a significant increase
in Treg frequency and per cell Foxp3 expression in PBMCs of psoriatics (5.6% ± 0.4 SE with
78.5% ± 2 being Foxp3+) when compared with normals (3.6 ± 0.8 with 63.8% ± 7 being
Foxp3+) (p<0.05; n=4). In addition, we also detected enrichment of Foxp3+ cells in the
CD25hi127lo populations of both psoriatic and normal blood when compared with their
respective “conventional” CD4+25+ populations. Within psoriatic lesional skin Treg frequencies
were almost 5-fold higher than in peripheral blood (25hi127lo Tregs 29% ± 10 with 71% ± 3
being Foxp3+). We were able to confirm the observed increase of Treg frequency by immuno-
fluorescent staining of psoriatic skin sections. In summary, by utilizing Foxp3 staining and
recently suggested “alternative” Treg surface markers we were able to detect unexpectedly
high frequencies of Tregs in psoriatic blood and even more so in lesional psoriatic skin. Apply-
ing the suggested “alternative” Treg phenotype would enable selection and functional studies
of a Treg population that is less contaminated with activated T cells than T-cell populations
defined by “conventional” markers. Therefore, the functional activity of Tregs in psoriasis needs
to be revisited.
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TNF-alpha induces ROS and inflammatory cytokines in primary human keratinocytes: Impli-
cations for psoriasis
CN Young,1 JI Koepke,2 LJ Terlecky,2 M Borkin,1 B Savoy1 and SR Terlecky3 1 Dermatology,
Wayne State University, Detroit, MI, 2 EXT Life Sciences, Inc., Detroit, MI and 3
Pharmacology, Wayne State University, School of Medicine, Detroit, MI
Psoriasis is an inflammatory skin disease of largely unknown etiology. It often occurs sponta-
neously, but can also be induced by trauma, stress and bacterial or fungal infections of the
skin. Although the biochemical and histological features of psoriasis have been well described,
the cellular and molecular basis for the disease’s initiation and progression remain poorly
understood. The overall goal of this research is to examine the link between reactive oxygen
species (ROS) and the downstream production of inflammatory cytokines in primary human
keratinoctyes. Such a link may provide molecular targets for therapeutic intervention in the
treatment of psoriasis. Primary keratinocytes were obtained from human foreskins under Wayne
State University School of Medicine IRB-approved methodologies. TNF-alpha-induced ROS
were measured using the Amplex Red TM reagent (Molecular Probes/Invitrogen). Degrada-
tion of the NF-kappaB inhibitor, IkBa, was monitored by western blotting. Expression of the
cytokines IL-6, IL-8 and IL-1b was determined by RT-PCR. The proinflammatory cytokine
TNF-aplha induced primary keratinocytes to produce ROS in a dose- and time-dependent
manner. TNF-alpha, perhaps via ROS, also induced rapid degradation of the NFkB inhibitor,
IkBa. Accompanying these effects was expression of the downstream cytokines, IL-6, IL-8,
and IL-1b. Importantly, the effects of TNF-alpha were blocked to varying degrees by pretreat-
ment of cells with a novel transducible form of the antioxidant enzyme, catalase. TNF-alpha
exerts its effects of primary keratinocytes by inducing ROS production and the accompany-
ing effects on cytokine expression. The results of the study suggest a novel target for treatment
of psoriasis. Controlling cellular ROS levels may inhibit the cascade of events associated with
progression of this inflammatory skin disease.
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A retrospective analysis of cutaneous lupus erythematosus patients recalcitrant to traditional
antimalarial therapy
SA Savory, C Hansen and M Costner Dermatology, University of Texas Southwestern Medical
Center at Dallas, Dallas, TX
The focus of this study was to compare a cohort of patients demonstrating poor clinical response
to traditional antimalarial therapy for cutaneous lupus erythematosus (CLE) with those patients
displaying a better outcome in order to describe epidemiology, clinical features, and possible
prognostic characteristics in recalcitrant patients. A retrospective clinical database was devel-
oped from 192 patients with documented CLE who attended the rheumatic skin disease clinic
at UT Southwestern between January 2000 and April 2006. Ninety patients in the database met
the following inclusion criteria: had no or “mild” systemic disease at the time of initial visit;
were not on systemic medication at the time of initial visit; and returned for a minimum of 3 fol-
low-up visits. From this cohort of 90 patients were selected 45 who became refractory to stan-
dard therapy as exhibited by starting a second line systemic agent and documented history of
minimal clinical response to one or more antimalarials. Study participants were 89% female,
72% Caucasian. Comparison between favorable and poor responders at initial visit showed no
significant difference between the two groups in terms of smoking history or family history of
lupus, but poor responders were more likely to have lesions on the extremities. After follow-up,
22 (49%) poor responders were still recalcitrant to all attempted therapies, and ≈10% devel-
oped side effects to one or more medications requiring discontinuation. Only 7 progressed to
systemic disease compared to 6 of the favorable responders. Although no measured demographic
features are predictive of treatment response, involvement of certain body sites increases likeli-
hood of recalcitrant disease. Fortunately, poor response does not appear to predict increased
risk of systemic disease development; however, recalcitrant patients often do not respond to any
therapy and are more likely to suffer medication side effects that may be severe enough to war-
rant discontinuation. New treatment strategies for these patients are clearly warranted.
www.jidonline.org   S17
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Percutaneous absorption and topical anti-inflammatory activity of the neurokinin receptor
antagonist Spantide II for the treatment of inflammatory skin disease
S Fulzele,1 M Singh,1 R Babu,1 R Prado,2 Y Lu,2 C Armstrong2 and J Ansel2 1 College of
Pharmacy, Florida A&M University, Tallahassee, FL and 2 Dermatology, University of
Colorado, Aurora, CO
The peptide spantide II (MW 1668.76) specifically binds to the SP neurokinin-1 receptor and
blocks inflammation associated with substance P. In this study we investigated the penetra-
tion and distribution of Spantide II through hairless rat skin and examined its topical anti-
inflammatory effect in an allergic contact dermatitis (ACD) mouse model. Preliminary stabil-
ity of Spantide II was assessed in various dermatological vehicles and stability conditions in
which the Spantide II lotion formulations were prepared with or without penetration enhancers
[cysteine HCl (CH) and 2-methyl-1-pyrrolidone (NMP)]. Spantide II lotion formulations were
studied for in vitro permeation and distribution through hairless rat skin using Franz diffusion
cells. The anti-inflammatory effect of Spantide II lotion formulations was evaluated by reduc-
tion of ACD in the ears of C57BL/6 mice. The cutaneous experiments without CH and NMP
lotion formulations showed little permeation in the skin 48 hours after topical application of
spantide II. The use of CH and NMP significantly (P<0.05) enhanced the penetration of Span-
tide II in the epidermis and dermis. Spantide II lotion formulations containing CH and NMP
also showed a significant dose dependent reduction of the ACD response in mice. The anti-
inflammatory effects of Spantide II formulations containing CH or NMP in ACD was similar
to dexamethasone (0.05mM) and was significantly higher compared to untreated or vehicle
treated skin. The result of this study indicate that the specific neurokinin-1 receptor antago-
nist Spantide II delivered in CH and NMP topical vehical lotions demonstrated significant cuta-
neous penetration and anti-inflammatory activity in ACD. These studies indicate that topical
neuromodulatory compounds may be novel therapeutic agents for the treatment of inflam-
matory skin diseases.
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Detailed genetic characterization of the psoriasis-associated gene IL23R
SJ Schrodi,1 M Chang,1 N Matsunami,2 MF Leppert,1 GG Krueger2 and AB Begovich1 1
Celera, Alameda, CA and 2 University of Utah, Salt Lake City, UT
Using a multi-tiered, case-control association design, scanning over 25,000 gene-centric SNPs,
we recently identified two psoriasis susceptibility genes: IL12B and IL23R (Cargill et al, 2007).
One of the IL23R missense SNPs implicated in psoriasis has also been strongly associated with
predisposition to inflammatory bowel disease (Duerr et al, 2006). To refine our initial associ-
ation results and further investigate the region involved in psoriasis risk, we extended our
genetic analysis by resequencing this gene in 96 psoriatic individuals. Twelve novel IL23R
SNPs were discovered including one missense, two synonymous and three 3’ UTR SNPs. Using
a series of selection criteria, we identified 42 additional IL23R–linked SNPs which were
genotyped in our three independent, white North American sample sets (>2800 individuals
in toto). Single marker and preliminary haplotype analyses have been performed on the full
set of interrogated SNPs. A sliding window of haplotype association demonstrates co-local-
ization of psoriasis susceptibility within the boundaries of IL23R across all sample sets, thereby
decreasing the likelihood that neighboring genes, particularly IL12RB2 which lies directly adja-
cent to IL23R, are driving the association of this region with psoriasis. A permutation routine
is underway to further dissect the truly correlated genetic markers away from markers impli-
cated because of linkage disequilibrium and lastly, statistical analyses will be performed to
assess the probability of psoriasis given particular susceptible genotypes. The refinement of
disease association patterns within IL23R to specific predisposing and protective genetic vari-
ants will play an important role in the elucidation of the causes of psoriasis and possibly addi-
tional autoimmune phenotypes as well as the role of IL23R genetic variants in response to
therapy and dosage.
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Percutaneous absorption and anti-inflammatory effect of α-melanocyte stimulating hormone
M Singh,1 S Fulzele,1 R Babu,1 L Kikwai,1 R Prado,2 Y Lu,2 C Armstrong2 and J Ansel2 1
College of Pharmacy, Florida A&M University, Tallahassee, FL and 2 Dermatology, University
of Colorado at Denver and Health Sciences Center, Aurora, CO
The purpose of this study was to investigate in vitro permeation and distribution of α-melanocyte
stimulating hormone (α-MSH) through hairless rat skin and study its topical anti-inflamma-
tory effect in an allergic contact dermatitis (ACD) mouse model. The in vitro permeation and
skin retention kinetics of α-MSH was studied as saturated solutions in various vehicle systems
[ethanol, propylene glycol (PG), polyethylene glycol (PEG)-400, transcutol, labrasol, ethyl
oleate, isopropyl myristate and lauro glycol FCC]. The studies were carried out with hairless
rat skin using Franz diffusion cells. The skin retention and permeation samples of α-MSH
were analyzed by HPLC. The anti-inflammatory effect of selected topical formulations [0.25
and 0.5% of α-MSH, with or without 10% N-methyl-2-pyrrolidone (NMP) as penetration
enhancer in 50% w/v aqueous ethanol, propylene glycol, transcutol and labrasol] was eval-
uated in ACD mouse model. The reduction in dinitrofluorobenzene induced ear inflamma-
tion was measured using dexamethasone as a positive control. The skin permeation experi-
ments demonstrated maximum permeation of α-MSH with ethanol (6.984 ± 0.226 µg), TC
(6.885 ± 0.304 µg) and PG (6.678 ± 0.917 µg) at the end of 24h. Ethanol also showed maxi-
mum epidermal retention (2.0 µg /mg) compared to other vehicles (retention < 1.0 µg /mg).
α-MSH (0.25% and 0.5% w/v) formulations in ethanol and PG with NMP (penetration enhancer)
showed similar efficacy compared to dexamethasone (P > 0.05) in the treatment of ACD
response in mice. Labrasol and transcutol formulations containing 0.25% α-MSH without
NMP showed promising anti-inflammatory activity, which was statistically (P > 0.05) differ-
ent from untreated and vehicle treated mice. α-MSH can be formulated for effective topical
delivery into skin layers to demonstrate significant anti-inflammatory activity in an ACD mouse
model.
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Association of phenotypic characteristics of psoriasis with the IL-12B and IL-23R psoriasis-
risk single nucleotide polymorphisms (SNPs)
T Rakkhit,1 B Wong,1 T Nelson,1 CB Hansen,1 JS Papenfuss,1 J Panko,1 D Goldgar,1
SJ Schrodi,2 AB Begovich,2 KP Callis1 and GG Krueger1 1 Dermatology, University of Utah,
Salt Lake City, UT and 2 Celera Inc, Alameda, CA
A multi-tiered case-control association study using more than 25,000 gene-centric SNPs has
led to the identification of four SNPs – two in IL-12B and two in IL-23R – that are associated
with psoriasis risk. Alleles at these associated SNPs define both psoriasis-susceptible and -
protective haplotypes and one of the IL-23R psoriasis-associated SNPs has also been associ-
ated with risk for inflammatory bowel disease. The purpose of this study was to determine
whether these IL-12B and IL-23R SNPs/haplotypes are associated with specific phenotypic
characteristics in a case only analysis. We examined age of onset, family history, psoriatic
arthritis, nail disease, Koebner phenomenon, plaque thickness, gender, smoking status, and
HLA-C*0602 genotype. Response to methotrexate, pregnancy, and infection were also exam-
ined. The analysis pointed to associations with gender (p=0.035) and response to infection
(better vs worse with) (p=0.029). This led to further analysis of these two variables in two large
case-control populations, with 2000 cases and controls. Preliminary results from the case-con-
trol analyses recapitulate our case-only analysis and support that IL-12B risk SNPs may have
a stronger association with psoriasis in males than in females. Further, the effect of the IL-12B
3’ UTR SNP, rs6887695, displays significant difference when stratifying by response to infec-
tion. Patients with protective SNPs for IL-12B were more likely to report worsening of psoria-
sis with infection than those expressing risk SNPs. Remaining selected phenotypic associa-
tions did not show a significant difference between risk and protective haplotypes. While initial
phenotype pools had more than 100 subjects, stratification into risk and protective subsets
ultimately limited power. Lack of phenotype association does not preclude risk or protective
haplotype expression from modulating immune/inflammatory activity or potential response to
biologic therapy.
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Molecular evidence reveals complex link between ultraviolet radiation and melanoma
TH Hocker,1 MK Singh1 and H Tsao1,2,3 1 Harvard Medical School, Boston, MA, 2
Department of Dermatology, Massachusetts General Hospital, Boston, MA and 3 Wellman
Center for Photomedicine, Massachusetts General Hospital, Boston, MA
Despite the large body of mutational data available for melanoma and epidemiological stud-
ies linking this cancer to ultraviolet radiation (UVR), the fundamental carcinogenic mecha-
nisms involved in melanoma remain largely unknown. To this end, we systematically reviewed,
extracted and analyzed mutational data from the extant melanoma literature in an effort to gain
more insight into its early pathogenic events. We searched PubMED (1966-January 2006) for
original reports containing the words “mutation” AND “melanoma” in the title or abstract. Out
of 2095 possible publications, there were 203 eligible studies, which were subsequently extracted,
analyzed and compared to existing Locus Specific Databases of Mutations (LSDM). We cata-
logued 8201 somatic and cultured melanoma specimens and annotated 2041 reported somatic
sequence variants. Although the single BRAF c.1799T>A (p.Val600Glu) alteration is the most
prevalent variant described in melanoma, other A:T>T:A transversions are quite uncommon
suggesting a sequence-specific bias for the c.1799T>A mutation. A set of 4 highly recurrent, non-
ultraviolet B (UVB) changes account for most of the variants detected in NRAS and BRAF. Muta-
tions at tumor suppressor loci harbored statistically higher rates of UVB signature changes
(CDKN2A-64.2%, TP53-52.4% and PTEN/MMAC1-69.2%) than those at oncogenic loci (NRAS-
15.3% and BRAF-2.4%) even after correcting for cytosine content. More specifically, melanomas
showed a significantly higher proportion of UVB signature mutations at both TP53 and CDKN2A
when compared to non-skin cancers using data from LSDM. In conclusion, there is sufficient
molecular evidence to support a role for direct UVB damage as a mutagenic stress in melanoma,
especially at TP53 and CDKN2A. For oncogenes, the role for UVB is less clear since function-
ally-activating changes are uncommon and are subject to sequence constraints.
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Application of microarray-based comparative genomic hybridization on archival tissues of
cutaneous squamous cell carcinomas
S Kim,1 B Nickoloff,2 JG Einspahr,3 A Prasad,3 R Krouse,3 DS Alberts3 and M Bittner1 1 TGen,
Phoenix, AZ, 2 Loyola University of Chicago Medical Center, Maywood, IL and 3 Arizona
Cancer Center, Tucson, AZ
Formalin fixed paraffin embedded (FFPE) tissue has been the standard for archival tissue stor-
age for many decades. Unfortunately, macromolecules such as RNA and DNA are irreversibly
modified in FFPE tissue limiting researchers’ ability to accurately measure these species using
molecular biology techniques, such as microarray-based comparative genomic hybridization
(aCGH). To find a way to use archival tissue, we developed a new protocol for preparing and
labeling DNA from FFPE specimens, and have applied it to archival tissue from cutaneous
squamous cell carcinomas (SCC).We collected one case of normal skin, two cases of SCC in
situ and four cases of invasive SCC. Single or replicate samples of DNA from each of these
cases were extracted. The DNA was subjected to array comparative genomic hybridization to
obtain a copy number estimate for genes in the tumor compared to normal reference DNA.
This produced copy number estimates on the normal skin replicates that were near the qual-
ity of fresh tissue. The samples of SCC and SCC in situ showed statistically significant copy
changes at a very small number of chromosomal locations. We found a small common loss
at 10q26.3 in both invasive SCC and in SCC in situ. Among the known genes located in this
region is a phosphatase, inositol polyphosphate-5-phosphatase (INPP5A). The product of this
gene has the same Ins(1,4,5)P3 signaling termination effect as that achieved by the tumor sup-
pressing gene PTEN. A decrease in INPP5A activity is known to be associated with cellular
transformation, posing a possible role of INPP5A in early stage of SCC. This and other early
genomic alterations will be evaluated as targets for chemoprevention in early skin cancer.
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Prediction of antioxidant chemopreventive effect against environmental mutagens using a
two-step in vitro assay
E Lomonte,2 F Maccario,2 P Lafitte,1 L Valenti2 and J Nicolay1 1 Exsymol S.A.M., Monaco,
Monaco and 2 Sedifa Laboratoire, Monaco, Monaco
Exposure to environmental mutagens, in connection with tobacco smoking or urban air pol-
lution, probably is a risk factor for skin cancer although risk estimation remains difficult to
achieve. Many environmental toxicants are oxidants or pro-oxidants generating reactive oxy-
gen-derived species considered as key-players in the tumor initiation phase. Therefore, antiox-
idants were expected to be effective as chemopreventive agents, and a screening procedure
was designed for selection of the most appropriate compounds. Two in vitro assays were
combined. First, a cytotoxicity assay was carried out with V-79 Chinese hamster fibroblasts
exposed to cytotoxic amounts of model genotoxics hydrogen peroxide (H2O2) and formalde-
hyde (HCHO). Cytoprotective agents against one or both genotoxics were then involved in a
genotoxicity assay. We used the micronucleus assay for the measurement of chromosome
breakage (clastogenesis) and identification of “genomic instability”. V-79 fibroblasts were
exposed to clastogenic concentrations of H2O2 and HCHO, and finally to a cigarette smoke
condensate (CSC). Representative antioxidants, free radical scavengers and electrophilic species
scavengers were tested. N-acetyl-cysteine (NAC), used as a positive reference, was cytopro-
tective and anti-clastogenic against both model genotoxics, although NAC auto-oxidation was
problematic. NAC could also protect V-79 fibroblasts from the strong clastogenic effect of CSC,
thus validating our screening procedure. Very few compounds were successful in the
micronuleus assay with CSC, and high concentrations were required. Cytoprotection against
model genotoxics was always predictive for genoprotection in the micronucleus assay. No
false positive or false negative responses were found. Interestingly, efficacy against both H2O2
and HCHO was predictive for effective genoprotection against CSC. This screening procedure
appears as a useful tool for structure-activity relationship studies and some positive structural
features were identified.
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Mutant CDK4 increases the penetrance and decreases the latency of UV-induced, metasta-
sizing melanoma in the skin of C57BL/6 HGF mice
E Gaffal,1 J Landsberg,1 J Kohlmeyer,1 D Tormo,1 J Wenzel,1 G Merlino2 and T Tüting1 1
Dermatology, University of Bonn, Bonn, Germany and 2 Laboratory of Cell Regulation and
Carcinogenesis, NCI, Bethesda, MD
Novel mouse models of melanoma are being generated which recapitulate the histopathology
and molecular pathogenesis observed in the human disease. Deregulated receptor tyrosine kinase
signalling and impaired cell cycle control are hallmarks of both familial and sporadic melanoma.
We previously observed that C57BL/6 mice which carry a mutant cyclin-dependent kinase 4
(CDK4R24C mice) and overexpress hepatocyte growth factor (HGF) rapidly develop multiple pig-
mented primary melanomas in the skin following carcinogen treatment. These carcinogen-induced
autochthonous melanomas spontaneously metastasize in lymph nodes and lungs. Here we inves-
tigated the impact of neonatal UVB exposure on melanomagenesis in CDK4R24C x HGF C57BL/6
mice. New born mice were irradiated with a total dose of 6 kJ/m2 UVB. In a cohort of 12 UV-
treated CDK4R24C x HGF mice nevi (1mm Ø) appeared at an age of 4-6 months in all animals.
Every mouse developed progressively growing either nodular or superficially spreading melanomas
(>2mm Ø) at an age of 6-9 months. When sacrificed, each mouse displayed enlarged and heav-
ily pigmented draining lymph nodes, 3-10 mm in diameter, and numerous small black nodules
on the lung surfaces. Histopathologic examination confirmed primary melanoma of the skin
with lymph node and lung metastases. 1 of the 12 mice also showed prominent melanoma metas-
tases in liver and kidney. Importantly, tumors of other histology were not observed. Untreated
CDK4R24C x HGF mice developed nevi between 8-12 months and first melanomas appeared
in their second year of life. UV-treated HGF C57BL/6 mice developed melanocytic tumors sev-
eral months later and showed progressively growing melanomas only in part of the mice. We con-
clude that mutant CDK4 in addition to HGF increases the penetrance and decreases the latency
of UV-induced melanoma. This new experimental mouse model can now be exploited to further
study the biology of melanoma and evaluate new treatment modalities.
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Autoregulation of sequential expression of nicotinic receptor subtypes associated with ker-
atinocyte differentiation
J Arredondo,1 A Chernyavsky,1 KE Pinkerton2 and SA Grando1 1 Dermatology, University of
California Davis, Sacramento, CA and 2 Center for Health and the Environment, University
of California Davis, Sacramento, CA
Tobacco products and nicotine alter the cell cycle and lead to premature differentiation (squama-
tization) of epidermal and oral keratinocytes (KCs). Activation of nicotinic acetylcholine recep-
tors (nAChRs) elicits Ca2+ influx that varies in magnitude between different nAChR subtypes.
During differentiation, KCs sequentially express α3, α5 and α7 subunits that form channels with
increasing Ca2+ permeability. By quantitative immunofluorescence, maximal expression of α5
was observed 24 h and that of α7—96 h after exposure to cigarette smoke (CS) or an equivalent
concentration of nicotine. This could be abolished by mecamylamine and α-bungarotoxin with
different efficacies, suggesting the following sequence of autoregulation of the expression of nAChR
subtypes: α3(β2/β4) > α3(β2/β4)α5 > α7 > α7. This conjecture was corroborated by results of
quantitative assays of subunit mRNA and protein levels, using nAChR-specific pharmacologic
antagonists and small interfering RNAs. The genomic effects of CS and nicotine involved the tran-
scription factor GATA-2 that showed a multifold increase in quantity and activity in exposed KCs.
Using protein kinase inhibitors and dominant negative and constitutively active constructs, we
characterized the principal signaling cascades mediating genomic effect of each nAChR sub-
type. Cumulative results indicated that the α3(β2/β4) to α3(β2/β4)α5 nAChR transition involved
the protein kinase C, α3(β2/β4)α5 to α7 nAChR transition—Ca2+/calmodulin-dependent protein
kinase II, and α7 self-upregulation—the p38 MAPK/Akt pathway and JAK-2. The Ras > Raf-1 >
MEK1 > ERK cascade mediated nicotinic effects on GATA-2 expression. These results provide a
novel mechanistic insight in the genomic effects of CS and nicotine and describe novel paradigm
of autoregulation of stepwise overexpression of nAChR subtypes with increasing Ca2+ perme-
ability, which, taken together, identifies new mechanism of receptor-mediated tobacco toxicity.
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Chronic UVA irradiation of human HaCaT keratinocytes induces malignant transformation:
role of PI3K/PTEN/AKT signaling
Y He,1 J Pi,2 J Huang,1 BA Diwan,3 MP Waalkes2 and CF Chignell1 1 LPC, NIEHS/NIH,
Research Triangle Park, NC, 2 LCC, NCI/NIH at NIEHS/NIH, Research Triangle Park, NC and
3 Science Applications International Corporation-Frederick, NCI/NIH at Frederick, Frederick,
MD
Ultraviolet A (UVA, 315-400 nm), constituting about 95% of ultraviolet irradiation in natural
sunlight, represents a major environmental challenge to the skin and is clearly associated
with human skin cancer. It has proven difficult to show direct actions of UVA as a carcinogen
in human cells. Here we demonstrate that chronic UVA exposure of human HaCaT keratinocytes
at environmentally relevant doses in vitro can induce malignant transformation associated with
acquired apoptotic resistance. As evidence of carcinogenic transformation, UVA-Long-Treated
(24 J/cm2 once/week for 18 weeks) HaCaT (ULTH) cells showed increased secretion of matrix
metalloproteinase (MMP-9), overexpression of keratin 13, altered morphology and anchor-
age-independent growth. Malignant transformation was established by the production of aggres-
sive squamous cell carcinomas after inoculation of ULTH cells into Nude mice. ULTH cells
were resistant to apoptosis induced not only by UVA but also by UVB and arsenite, two other
human skin carcinogens. ULTH cells also became resistant to apoptosis induced by etopo-
side, staurosporine and doxorubicin hydrochloride. Microarray study showed that ULTH cells
exhibited reduced expression of phosphatase and tensin homologue deleted on chromosome
10 (PTEN), a key tumor suppressor mutated or deleted in many human cancers. As a critical
negative regulator for PI3K/AKT pathway, decreased PTEN expression led to elevated phos-
phorylation and therefore activation of AKT in ULTH cells. The resistance of ULTH cells to
UVA-induced apoptosis was reversed by either inhibition of phosphatidylinositol 3-kinase
(PI3K) or adenovirus expression of PTEN or dominant negative AKT. These data indicate that
UVA has carcinogenic potential in human keratinocytes and that the decreased PTEN expres-
sion resulted in increased PI3K/AKT signaling and may contribute to apoptotic resistance and
malignant transformation.
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Bisabolol, ectoin and silymarin demonstrate anti-oxidant function via modulation of reac-
tive oxygen species in normal human skin fibroblasts
J Jagdeo,1,2 N Stern,2 M Abramowitz,2 J Silverberg,2 J Sieminska,2 J Michl,3 S Bradu2 and
N Brody2 1 Brown Medical School Department of Dermatology, Providence, RI, 2
Department of Dermatology, SUNY Downstate Medical Center HSCB, Brooklyn, NY and 3
Department of Pathology, Anatomy and Cell Biology, Microbiology and Immunology, SUNY
Downstate Medical Center HSCB, Brooklyn, NY
The study of free radicals is particularly relevant in the context of human skin carcinogenesis
and photoaging because of their ability to induce DNA mutations and damaging lipid perox-
idation byproducts. Therefore, it is important to identify and evaluate agents with the ability
to modulate intracellular free radicals. The purpose of this research is to investigate the abil-
ity of anti-oxidants bisabolol, ectoin and silymarin, to modulate the hydrogen peroxide (H2O2)-
induced upregulation of reactive oxygen species (ROS) free radicals in normal human skin
fibroblast cells in vitro. These anti-oxidants were selected for evaluation because of their anti-
aging, anti-inflammatory and anti-mutagenic properties. H2O2 is a well known generator of
free radicals that occurs during endogenous and UV-induced oxidation processes in the human
skin and was used to upregulate free radicals in normal human fibroblast cells. Using a flow
cytometry-based assay, the results demonstrate at various concentrations, bisabolol, ectoin
and silymarin are able to inhibit the upregulation of H2O2-generated free radicals in human
skin fibroblasts in vitro.
114
Keratinocyte-specific Smad2 ablation promotes skin carcinogenesis via affecting genes related
to tumor invasion
KE Hoot,3 AG Li,1,2,3 S Lu,1,2,3 G Han,1,2,3 W Ju,4 EP Bottinger4 and X Wang1,2,3 1 Department
of Dermatology, OHSU, Portland, OR, 2 Department of Otolaryngology, OHSU, Portland,
OR, 3 Department of Cell and Developmental Biology, OHSU, Portland, OR and 4
Department of Medicine, Mount Sinai School of Medicine, New York, NY
Transforming growth factor β (TGFβ) has roles in both tumor suppression and promotion.
Although Smad2 and Smad3 are TGFβ signaling mediators, their functions in mediating TGFβ
signaling during cancer development remain to be determined. We have examined expres-
sion patterns of Smad2 and Smad3 in human skin SCCs, and found that over 95% of tumor
samples retain Smad3 whereas 70% of SCCs have lost the Smad2 protein. Previously, we
have shown that Smad3 knockout mice are resistant to skin carcinogenesis due to abrogation
of TGFβ-mediated tumor promotion effect. In the current study, we assessed the role of Smad2
in skin carcinogenesis by generating mice with keratinocyte-specific Smad2 deletion. While
conditional Smad2 knockout mice did not develop spontaneous skin tumors, when exposed
to a two-stage chemical carcinogenesis protocol, they exhibited accelerated tumor formation
and malignant progression compared to wildtype mice. Smad2-/- tumors were more poorly
differentiated in comparison with tumors from wildtype mice. At the papilloma stage, Smad2-
/- tumors exhibited molecular alterations usually associated with late-stage SCC progression
and epithelial-mesenchymal transition (EMT), e.g., a significant elevation of Keratin K8, Snail,
Twist, Tenascin C and Vimentin. Since these molecules are documented or potential TGFβ tar-
get genes, we examined TGFβ1 levels in Smad2-/- tumors. We found that neither the TGFβ1
level nor Smad3 activation was elevated in Smad2-/- tumors. Thus, our study suggests that
Smad2 loss results in the elevation of tumor invasion-associated genes via a mechanism inde-
pendent of TGFβ levels.
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Effect of an apple extract(Applephenon-tm)on normal and transformed keratinizing epithe-
lial cells
JJ Wille Research Center, Bioderm Technologies, Inc., Eastampton, NJ
A purified extract prepared from green apples, Applephenon-tm (AP-SH), manufactured by
Nikki Whiskey,Tokyo,JP, is enriched in anthcyanidins and phenols(60%). Our HPLC studies
confirm previous work demonstrating the presence of catechin, epicatechin, caffeic acid, and
phloretin glycoside. Differences we found include a dominant chlorogenic acid peak reported
to be lost during AP-SH purification. Also, we found no p-coumeric acid peak that matches
up with our caffeic acid peak. Our previous studies reported a potent antibacteral activity that
is related to its antioxidant activity as measured by the DPPH bleaching assay. The free-radi-
cal scavenging levels are simnilar to green tea extracts. Here, we examined the effect of an
aqueous extract of AP-SH on the proliferation and differentation of serum-free cultures of nor-
mal human keratinocytes (NHK) and on serum-grown cultures of HeLa cells, A431 epider-
moid carcinoma cells, and the HaCat keratinocyte cell line. Proliferation of NHK cells is strongly
inhibited at concentrations above 0.0013%, and is cytotoxic above 0.005%. Phase microscopy
of live and crystal violet stained cells indicate an increased intercellular separation and induc-
tion of keratinzing stratification. The growth of Hela, A431 and HaCat cells were also strongly
inhibted but at AP concentrations above 0.01%, and all to a lesser extent than NHK cells. Puri-
fied samples of two isoflavones, genestein and diadzin tested, indicated that the former was
slightly inhibitory of HeLa cell growth, whereas similar concentrations of diadzin were not. A
highly purified sample of epicatechin (81ug/nl)did not inhibit HeLa cells growth, but did inhibit
NHK cells. The possible influence of serum in the Hela culture medium is under review.
Overall, these findings suggest that certain purified fractions of the polyphenol-enriched apple
extract(AP) may have potential anticancer activity.
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TNFalpha induces Akt and impairs the S-G2/M cell cycle checkpoint in keratinocytes with
UVB-induced cyclobutane pyrimidine dimers
A Faurschou,1 R Gniadecki,1 D Calay2 and H Wulf1 1 Department of Dermatology, University
of Copenhagen, Bispebjerg Hospital, Copenhagen, Denmark and 2 Department of Histology-
Embryology, Faculty of Medicine, University of Namur, Namur, Belgium
Tumor necrosis factor alpha (TNFα) is induced by ultraviolet B radiation (UVB) and has been
implicated in the early stages of photocarcinogenesis. In this study, we show that in normal
and transformed keratinocytes (lines HaCaT and A431) TNFα stimulates protein kinase B/Akt,
which results in activation of the survival complex mTORC1 (mammalian target of rapamycin
complex 1) and inhibition of the proapoptotic proteins Bad and FoxO3a. In UVB irradiated
cells (10-50 mJ/cm2) TNFα increased the proportion of cycling cells, enhanced the rate of
early apoptosis but blocked late apoptotic cell death. A significantly higher proportion of
UVB-treated HaCaT cells containing unrepaired cyclobutane pyrimidine dimers (CPD) escaped
the G2/M cell cycle checkpoint in the presence of TNFα (12.9% versus 8.2%). In the pres-
ence of the PI3K inhibitor LY294002 alone or in combination with TNFa only respectively
3.1% and 3.9% of CPD-containing cells were actively cycling. Our data suggest that even
though TNFα decreases the overall amount of cells with UV-induced DNA lesions via
enhanced apoptosis, this cytokine overrides the G2/M checkpoint and allows for some cells
containing unrepaired CPD to enter the cell cycle. The effect of TNFα seems to be depend-
ent on the activation of Akt and may constitute a relevant mechanism enhancing mutagen-
esis and tumor development.
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Cyclooxygenase-2 expression correlates with local chronic inflammation, tumor invasion
and tumor neovascularization in human basal cell carcinoma
S Jee, J Tjiu, J Chen, C Chu, S Lin and Y Liao Dermatology, National Taiwan University College
of Medicine and  National Taiwan University Hospital, Taipei, Taiwan
Chronic inflammation is linked to the development of many human cancers. Cyclooxygenase-
2 (COX-2) may play a role in cancer cell invasion and angiogenesis. This study aimed to
investigate whether the expression of COX-2 in human basal cell carcinoma (BCC) was cor-
related with chronic inflammation, tumor invasion and angiogenesis. Immunohistochemical
analysis of 92 human BCC specimens for COX-2 expression and the correlation with
macrophage densities, tumor invasion depth and CD31-marked microvessel density (MVD)
were performed. Double immunostaining was used to elucidate the interaction between tumor
COX-2 and macrophage and microvessel. The results revealed that tumor COX-2 expression
was detected heterogeneously in all 92 specimens, with high expression (more than 50% of
positive stained tumor cells) in 44 specimens. Foci of chronic inflammation were found in all
92 samples. High COX-2 specimens were associated with high macrophage densities than
low COX-2 specimens (P < 0.0001). MVD and tumor invasions were also found higher in
high COX-2 specimens than in low COX-2 ones (P = 0.001). In multivariate regression analy-
sis, tumor COX-2 and macrophage densities were shown to be independent determinants for
neovasculization and invasion depth. This study showed a novel relationship between COX-
2 expression in BCC tumor and the local chronic inflammation, the increased angiogenesis
and tumor invasion. Together with our previous in vitro data revealing COX-2 in BCC cell line
cells induces angiogenesis via up-regulating the secretion of bFGF and VEGF, it is likely that
up-regulation of COX-2 in BCC tumor cells results in angiogenesis and tumor invasion via
both recruiting macrophages and increasing the tumor derived angiogenesis factors. These
findings suggest that COX-2 may be a critical therapeutic target in BCC treatment.
118
Increased expression of collagenase-3, matrilysin-1 and gelatinase B in epidermolysis bul-
losa-associated cutaneous squamous cell carcinomas
AK Kivisaari,1 J McGrath,2 JW Bauer,3 D Sawamura,4 KC Sato-Matsumura,4 H Shimizu4 and
V Kähäri1 1 Department of Dermatology, University of Turku, Turku, Finland, 2 St John’s
Institute of Dermatology, London, United Kingdom, 3 Salzburg General Hospital, Salzburg,
Austria and 4 Hokkaido University Graduate School of Medicine, Sapporo, Japan
In this study, we have investigated the role of collagenase-3 (matrix metalloproteinase-13,
MMP-13), matrilysin-1 (MMP-7) and gelatinase B (MMP-9) in cutaneous squamous cell car-
cinomas (SCC) arising in patients with recessive dystrophic epidermolysis bullosa (RDEB), and
for comparison in sporadic cutaneous SCCs and Bowen’s diseases. Immunohistochemical
analysis in 25 SCCs complicating RDEB, 61 sporadic SCCs and 28 Bowen’s diseases was car-
ried out using monoclonal antibodies for MMP-13, MMP-7 and MMP-9. Expression of MMP-
13 was detected in 96 % of RDEB associated SCCs, in 100% sporadic SCCs and in 69% Bowen’s
diseases studied. 60% of RDEB associated SCCs, 80 % of sporadic SCCs and 13% of Bowen’s
diseases were regarded as high-expressing tumors (over 50% tumor cells positive). Expression
of MMP-7 was noted in 100% of RDEB associated SCCs, in 98% of sporadic SCCs and in
68% of Bowen’s diseases. Intensity of MMP-7 staining was stronger in RDEB associated than
in sporadic cutaneous SCCs. No MMP-9 staining was detected in tumor cells, but number of
MMP-9 positive adjacent inflammatory cells was elevated in RDEB associated and sporadic
SCCs compared to Bowen’s disease and non-malignant skin. In this study, we show for the
first time that MMP-13 is expressed in RDEB associated SCCs. Expression of MMP-7 was up-
regulated more in RDEB associated than sporadic SCCs. Our results imply that up-regulation
of MMP-13 and MMP-7 expression in malignantly transformed keratinocytes and MMP-9
expression in adjacent inflammatory cells can contribute to the aggressive behaviour of the
RDEB-associated cutaneous SCCs. In conclusion, these matrix metalloproteinases can be con-
sidered as potential therapeutic targets to inhibit the growth and invasion of both sporadic
and RDEB associated cutaneous SCCs.
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Differential CCR4 expression and function in cell lines of cutaneous T cell lymphoma: indi-
cation for skin homing mechanism
M Wu and C Liao Dermatolgy, China Medical University/Hospital, Taichung, Taiwan
Cutaneous T cell lymphoma (CTCL) is a clonal epidermotropic malignancy of memory T cells
primarily involving the skin. There are various subtypes of CTCL, with diverse clinical appear-
ances and behaviors but commonly sharing a unique nature, the ability to home to skin. The
mechanisms governing CTCL skin homing, however, are still largely unknown. It has been
shown that certain chemokine receptors are up-regulated in CTCL cells, but it remains unan-
swered whether these chemokine receptors may play a critical role in the skin homing dynam-
ics of CTCL. Using three CTCL cell lines, we have shown higher CCR4 expression by those
lines (MJ and HH) derived from mycosis fungoides (MF) and non-MF CTCL tumor patients,
compared with the line from Sezáry syndrome (Hut78). In specific responses to CCL22 (a CCR4
ligand) treatments, MJ cells showed significant chemotactic migration, enhanced activation
and adhesion of certain integrins (CD29 and CD49d) in vitro, while control cells (Hut78,
CD4+CD45RO+ memory T cells, and Jurkat cells) did not. Furthermore, compared with Hut78
cells, MJ cells manifested significantly more transendothelial migration, in responses to treat-
ments with either CCL22 or condition medium from dendritic cells in vitro. These results have
provided further dynamic evidences, in line with multi-step cascade paradigm for leukocyte
transendothelial migration, to support CCR4’s critical role in the CTCL homing to skin.
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The inflammatory gene expression response to basal cell carcinoma development
BK Lo, M Yu, B Cowan, D Zloty, L Warshawski, J Shapiro and KJ McElwee Department of
Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada
Basal cell carcinoma (BCC) is the most common cutaneous skin malignancy amongst the Cau-
casian population. Although BCCs rarely metastasize and cause death, they can behave aggres-
sively with deep invasive properties resulting in significant morbidity for the patient. While the
fundamental mechanism of BCC growth initiation requires genetic mutation in one or more
genes of the sonic hedgehog pathway, knowledge of the molecular basis of BCC development
is incomplete. Using microarray analysis, we previously identified differentially expressed gene
patterns associated with BCC growth, with known function from other biological contexts (e.g.
host immune response, proinflammation). In this study, in order to further elucidate the com-
plex alterations in BCC-associated gene expression, we defined a panel of 35 immune func-
tion-associated genes and applied the techniques of real-time RT-PCR and immunohisto-
chemistry to determine differential gene expression in three major BCC subtypes: 1) nodular
2) superficial and 3) morpheiform, as compared with normal skin epithelium. Based on the
data analysis, chemokines of the C-X-C subfamily, particularly CXCL9, CXCL10, and CXCL11
were upregulated significantly in BCCs as compared to normal skin epithelium (27.35 fold,
11.20 fold and 32.28 fold respectively), while expression of cytokines such as IL6, IL7, and
IL12α were significantly reduced in the tumors (65.49 fold, 3.39 fold, and 3.89 fold respec-
tively). The differential gene expression in BCCs as compared to normal skin may provide some
insights into the role of the intrinsic factors and inflammation in the etiopathogenesis of BCCs.
The identified genes may be active participants in an inflammatory response against BCCs.
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Gene expression profiling distinguishes morpheifrom from superficial and nodular subtypes
of basal cell carcinoma
M Yu,1 D Zloty,1 L Warshawski,1 B Cowan,1 N Carr,2 J Shapiro,1 Bk Lo1 and KJ McElwee1 1
Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada and
2 Surgery, University of British Columbia, Vancouver, BC, Canada
Basal cell carcinoma (BCC) is the most common malignant neoplasm in humans. It may occur
in a variety of morphological presentations with some more aggressive than others. A key goal
is to relate a cancer phenotype to a list of defining molecular principles. Here we determined
differences in gene expression patterns between different morphological presentations of BCC
(8 superficial, 8 nodular, 7 morpheiform, versus 8 normal skin epithelium) using microarray
analysis (21K cDNA glass arrays). Selected genes were validated using quantitative RT-PCR
analysis using an expanded set of 31 BCC samples. Six global gene expression profiles between
each respective BCC subtype, and different subtypes compared with normal skin, were dis-
tinguished by unpaired T test with greater than 1.5 fold expression. Based on the Gene Ontol-
ogy (GO) database, we identified different categories represented in assigned biological
processes, molecular functions, and cellular components with different gene expression pro-
files. Notably, angiogenesis associated genes, oncogenes, and immune response genes were
uniquely upregulated, in morpheiform BCCs which may reflect the relative aggressiveness of
this BCC form. Gene ontology analysis also indicated significant variation in genes associ-
ated with MAPK pathways. Our results indicate a relative similarity in gene expression pat-
terns between nodular and superficial BCC subtypes while morpheiform BCCs are relatively
distinct with gene expression patterns present that were not observed in other BCC subtypes.
The data may help us to better understand the complex behavior of BCC subtypes and lead
to improved prognostication and tailor-made therapeutic strategies.
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Meta-analysis of non-melanoma skin cancer microarray datasets reveals lack of consensus
genes but common altered pathways in disease
RM Van Haren, DA Feldman, S Chow and AA Sinha Dermatology and Cutaneous Sciences,
Michigan State University, East Lansing, MI
DNA microarray technology has recently been utilized to study basal cell carcinoma (BCC)
and squamous cell carcinoma (SCC) by a number of groups that collectively report high
numbers of dysregulated genes of potential disease relevance. The biological relevance and
validity of these datasets remain to be determined. For further insight regarding the patho-
genesis of BCC and SCC, we performed a systematic analysis of all experimental microarray
data published to date (7 studies total, including 2 studies from our laboratory) to determine
the level of consensus among reported differentially expressed genes (DEGs). Among the 909
total DEGs reported across all studies, a limited number of overlaps (50) were observed; 17
DEGs overlap in SCC study comparisons, 12 DEGs overlap in BCC study comparisons, and
21 DEGs overlap in BCC vs. SCC study comparisons. We next systematically evaluated a range
of statistical and experimental variables that may have contributed to the overall low levels
of consensus DEGs. Differences in a number of experimental parameters were documented,
including: sample type used, tissue procurement and handling, microarray chip, and statisti-
cal analysis. Despite extensive variations in DEG profiles between studies, we did observe
some commonality in the prominence of specific altered functional pathways across studies.
Specifically, signal transduction, structural/adhesion, and enzymatic pathways contained the
most DEGs (364) across all studies. Finally, we performed a network analysis of DEGs derived
from our own BCC and SCC studies to identify key nodal genes/proteins within disease asso-
ciated networks that may serve as future diagnostic and therapeutic targets.
125
p75 neurotrophin receptor (NTR) is up-regulated by chemotherapy and induces apoptosis
in melanoma cells
A Marconi, F Truzzi, R Lotti, K Dallaglio and C Pincelli Dermatology, University of Modena
and Reggio Emilia, Modena, Italy
Melanoma is the most aggressive form of skin cancer and is notoriously resistant to chemother-
apy. Failure of anticancer drugs to work in melanoma is reportedly due to alteration of the
apoptotic machinery. The low-affinity neurotrophin (NT) receptor p75 (NTR) cooperates with
the high-affinity NT receptors trk for inducing survival signals, whereas, in absence of trk, it
mediates apoptosis through its own signal transduction. The aim of the present work is to eval-
uate the role of the NT receptors in melanoma chemoresistance. WM266-4, WM115 and
Skmel28 melanoma cell lines express both p75NTR and trks, though at different levels. Treat-
ment with cisplatin, carmustine or dacarbazine up-regulate p75NTR at the mRNA and at the
protein level. On the contrary, chemotherapeutic agents down-regulate trkA, trkB and trkC.
Despite this effect, chemotherapy only induces a low rate of apoptosis. Beta-amyloid which
specifically binds p75NTR induces apoptosis in melanoma cell lines, as a function of p75NTR
expression levels. Combined treatment with beta-amyloid and chemotherapeutic agents induce
a higher rate of apoptosis than chemotherapy alone in all melanoma cell lines, by MTT and
subG1 peak analysis. To provide evidence that apoptosis is actually mediated by p75NTR,
we infected WM266-4 cell line with p75NTR siRNA. We show that beta-amyloid fails to
induce apoptosis in p75NTR si RNA treated cells. These results indicate that up-regulation
and binding of p75NTR induce apoptosis and overcome chemoresistance in melanoma.
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Cyclosporine A modulates cell death in keratinocytes through mitochondrial effects
KG Norman1,2,3 and JE Sligh1,2,3 1 VA Tennessee Valley Healthcare System, Nashville, TN, 2
Division of Dermatology, Vanderbilt University, Nashville, TN and 3 Cell and Developmental
Biology, Vanderbilt University, Nashville, TN
Organ transplantation has been advanced by agents such as cyclosporine A (CsA). Unfortu-
nately, these drugs dramatically increase the incidence of skin cancer, with squamous cell car-
cinoma (SCC) being the most prevalent. The aggressive nature of SCCs in these patients is
thought to be a result of impaired immune surveillance, but emerging evidence suggests that
CsA can directly modify cellular behavior by a cell-autonomous mechanism. To investigate
the role of CsA in the pathogenesis of SCC, we are exploring the biology of the keratinocyte
rather than the deficiency in cellular immunity. We hypothesize that CsA’s interaction with
cyclophilin D (CypD) at the mitochondrial permeability transition pore (MPTP), a key regula-
tor of cell death, may allow for an escape from cell death by inhibition of pore opening. We
exposed HaCaT cells to physiological doses of UVA in the presence of CsA and measured
cell death using AnnexinV, and PPI/7-AAD staining. Our results indicate that there is an effect
of the CypD-binding drugs, CsA and non-immunosuppressive Nim811, to repress cellular
death, whereas the immunosuppressive FK506 (which binds cytosolic immunophilins but not
CypD) had a negligible effect on cell death. These findings suggest that CsA’s effect on UVA-
induced cell death is due to its binding of CypD at the MPTP, and is independent of its T-cell
effects. To specifically determine the cellular consequences of the CsA-CypD interaction we
monitored the MPTP by using calcein AM. We have found that incubating HaCaTs with CsA
or Nim811 leads to an accumulation of calcein in the mitochondria, corresponding with sta-
bilization of the MPTP, as compared to FK506-treated and control cells. We suspect that this
stabilization of the pore is responsible for cell-autonomous effects such as inhibition of cell
death, and are investigating the ability of CsA to enable an accumulation of DNA damage in
keratinocytes.
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Ubiquitin proteasomal pathway mediated degradation of p53 in melanoma
A Anwar, YG Shellman, DA Norris and M Fujita Dermatology, UCDHSC @ Fitzsimons, RC-1
South, Aurora, CO
The ubiquitin proteasomal pathway (UPP) is the principle mechanism for protein catabolism
in the mammalian cytosol and nucleus. The highly regulated UPP affects a wide variety of
cellular processes and substrates such as apoptosis, cell cycle and division, and inflamma-
tion. These pathways are critical for the survival and proliferation of cells, in particular can-
cerous cells. Proteasome inhibition is a potentially attractive anti-cancer therapy. In an attempt
to exploit the UPP inhibition in the treatment of melanomas we attempted to investigate p53
as a target gene in our studies. p53 is one of the major tumor suppressor genes in humans and
regulates cell cycle and apoptosis. Most human melanomas maintain wild-type p53, which
is known to be ubiquitinated and degraded by the proteasome. We analyzed the effect of UPP
inhibitor, MG132, in the upregulation of p53 using mouse melanoma cells, 8B20, which har-
bor mutant H-ras, deletion of CDKN2A and wild-type p53. Upon treatment with MG132
cytosolic levels of p53 dramatically increased in the 8B20 melanoma cells, while no effect
was seen upon treatment of these cells with serine and cysteine inhibitors (PMSF & E-64).
Increased levels of high molecular weight adducts of ubiquitinated p53 was detected on the
western blots in the cells treated with MG132, which is a hall mark of UPP inhibition. MG132
treatment led to an increase in the survival of p53 protein in 8B20 cells compared to untreated
cells suggesting the potential role of UPP in the targeted destruction of p53 in cancers. MG132
treatment of 8B20 cells also resulted in the growth arrest in G1 phase of the cell-cycle and
increased cell death in a dose-dependent manner. However, the MG132 treatment did not
result in the phosphorylation of ser 15 and ser 20 residues of p53 in 8B20 cells ruling out the
possibility of DNA damage. In vivo study showed the reduction of tumor size after the MG132
treatment in genetically-engineered mice that spontaneously develop melanoma. Results
obtained from this study offer a potentially attractive anti-melanoma therapy and will be fur-
ther discussed.
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Transcriptional regulation of FAS expression by CTCL cells determines sensitivity to FAS-lig-
and mediated apoptosis and can be altered by enhancer region mutations
J Wu,1,2 J Siddiqui,1,2 M Nihal1,2 and G Wood1,2 1 Dermatology, University of Wisconsin
Madison, Madison, WI and 2 Dermatology, VAMC, Madison, WI
We reported previously that expression of CD95/FAS varies widely among CTCL cases and
is often relatively low, even in early stages of disease. This led to our hypothesis that early
CTCL is more of a lymphoaccumulative disorder than a lymphoproliferative disorder due to
defects in apoptotic pathway function that confer resistance to programmed tumor cell death.
To explore this hypothesis, we used Northern blotting, real-time RT/PCR, FAS-L/FLAG/anti-
FLAG apoptotic assays, and flow cytometry to analyze CTCL cell lines with varying levels of
FAS expression to determine if there is a direct correlation among FAS transcript levels, cell
surface FAS protein levels and susceptibility to FAS ligand-mediated apoptosis. The results
showed a strong correlation among transcript level, protein level and apoptotic sensitivity.
In prior studies, we reported that many cases of CTCL harbor FAS promoter mutations in the
enhancer region. To test one potential mechanism for decreased FAS expression, we created
luciferase reporter constructs with AP1 and GABP mutations identical to those we detected
in a CTCL sample. Relative to wild-type controls, the mutant FAS enhancer regions resulted
in a significant reduction in FAS promoter function in both Jurkat and CTCL cell lines. In
aggregate, these findings show that FAS expression in CTCL varies widely, is transcription-
ally regulated, directly affects sensitivity to apoptosis, and could be induced potentially by
FAS promoter mutations affecting the enhancer region. In a companion abstract at this meet-
ing, we show that it is possible to upregulate FAS expression by CTCL in-vitro using nontoxic
modalities. Such strategies may prove useful for novel therapies aimed at enhancing CTCL
tumor cell death in vivo.
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p38δ is required for tumor formation in a mouse model of skin carcinogenesis
EM Schindler,1 EM Gribben,1 SC Arthur2 and T Efimova1 1 Division of Dermatology,
Department of Internal Medicine, Washington University, St. Louis, MO and 2 MRC Protein
Phosphorylation Unit, Faculty of Life Sciences, University of Dundee, Dundee, United
Kingdom
Our recent in vitro studies demonstrate that p38δ mitogen-activated protein kinase (MAPK)
functions as a regulator of keratinocyte differentiation and apoptosis. However, the potential
in vivo role of p38δ MAPK in regulation of skin tumorigenesis has not been evaluated. In the
present study, we have assessed the impact of p38δ deficiency on skin tumor development by
subjecting p38δ knockout (KO) mice to a two-stage 7,12-dimethylbenz(a)anthracene
(DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA) chemical skin carcinogenesis protocol.
We report that mice lacking p38δ gene exhibited a considerable resistance to the develop-
ment of DMBA/TPA-induced skin papillomas. The onset of tumors was delayed, and the
tumor incidence, tumor multiplicity and tumor size were greatly reduced in p38δ KO mice in
comparison with wild-type (WT) mice. Analysis of epidermal cell proliferation following a sin-
gle topical application of TPA showed that the number of 5-bromo-2-deoxyuridine (BrdU)-
labeled keratinocytes (cells in the S-phase of cell cycle) was significantly reduced in TPA-
treated p38δ-deficient skin as compared with TPA-stimulated WT skin. Moreover, p38δ-null
skin exhibited marked resistance to TPA-induced epidermal hyperplasia relative to similarly
treated WT skin. These results indicate that the observed resistance to tumor development in
p38δ-deficient skin may, at least in part, be due to a decrease in epidermal proliferation dur-
ing tumor promotion. Notably, TPA-mediated activation of extracellular signal-regulated kinases
1 and 2 (ERK1/2) and expression of activator protein 1 (AP1) family members were lower in
the p38δ KO epidermis than in WT epidermis. Altogether, our data suggest an essential pre-
viously unrecognized role for p38δ MAPK in Ras-driven epidermal oncogenesis in vivo.
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Ptc1+/-/SKH-1 hairless mice developed rhabdomyosarcomas spontaneously with high-pen-
etrance
L Zhang,1 X Tang,1 AL Kim,1 L Kopelovich,2 DR Bickers1 and M Athar1 1 Dermatology,
Columbia University, New York, NY and 2 Division of Cancer Prevention, NCI, Bethesda, MD
Rhabdomyosarcomas are soft tissue neoplasms that often occur in children particularly in
patients with familial cancer syndromes such as Li-Fraumeni and Gorlin syndromes. In addi-
tion, in Gorlin syndrome patched gene mutations and consequent activation of sonic hedge-
hog (shh) signaling are associated with the augmented risk for the development of basal cell
carcinoma, odontogenic keratocysts, and medulloblastoma in addition to rhabdomyosarco-
mas. Most murine models that have been developed to study shh signaling related tumors
also show low incidence (<10%) of rhabdomyosarcomas. We developed Ptc1+/-/SKH-1 hair-
less mice to study the pathogenesis of UVB-induced non-melanoma skin cancers. However,
these mice develop numerous spontaneous rhabdomyosarcomas mostly on their hind limb.
The incidence of these tumors reaches to about 40% at the age of 32 weeks. However, they
begin to appear by week 16. Majority of tumor bearing mice show only one tumor but some
develop tumors on both limbs that bear these tumors. Histologically these tumors are similar
to human rhabdomyosarcomas. We found that these tumors show high expression of ptc1,
ptc2 and gli1/2 transcripts. In addition, we also found high expression of cyclin D1 and D3
but not D2 at both mRNA and protein levels. Cyclin D3 expression was not present in BCCs
that developed on these animals. The immunohistochemical staining for cyclin D1 revealed
its nuclear localization. These tumors also showed high expression for the proliferation marker,
PCNA, which is consistent with their fast growth rates. These data reveal that Ptc1+/-/SKH-1
hairless mice provide a novel model for the study of pathogenesis and prevention of rhab-
domyosarcomas.
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Use of genetically engineered murine models to assess the chemoprevention of nonmelanoma
skin cancer (NMSC) by alpha-difluoromethylornithine (DFMO)
X Tang,1 AL Kim,1 L Kopelovich,2 DR Bickers1 and M Athar1 1 Dermatology, Columbia
University, New York, NY and 2 Division of Cancer Prevention, NCI, Bethesda, MD
Solar ultraviolet B (UVB) induces ornithine decarboxylase (ODC), which drives tumor devel-
opment. DFMO is an ornithine analog that irreversibly inhibits ODC activity and this agent is
a potent inhibitor of skin tumorigenesis. In this study we utilized various relevant genetically
engineered murine models to further assess its mechanism of action. Topical application of
DFMO to SKH-1 mice diminishes UVB carcinogenesis. Similar protective effects of orally
administered DFMO occur in UVB-irradiated Ptc1+/- and ODC/Ptc1+/- mice, which develop
mostly BCCs and some SCCs. DFMO also inhibits UVB tumorigenesis in Ptc1+/-/SKH-1 hair-
less mice, which are highly susceptible to developing both BCCs and SCCs. To probe the mech-
anism by which DFMO reduces skin carcinogenesis, we investigated its effects on cell prolif-
eration by assessing PCNA immuno-staining in UVB-irradiated murine skin. In un-irradiated
control mice, only the basal layer of epidermis stained with anti-PCNA, whereas in chroni-
cally UVB-irradiated skin both basal and suprabasal layers stained positive for PCNA. DFMO
treatment reduced both UVB-induced epidermal hyperplasia and suprabasal PCNA staining.
DFMO treatment induces apoptosis in UVB-induced SCCs as assessed by TUNEL staining.
We have employed anti-CD34 antibody to map microvessel density in UVB-induced skin
tumors and show that DFMO treatment substantially diminishes microvascular density and
VEGF expression in UVB-induced BCCs and SCCs in these models. Over-expression of ODC
in Ptc1+/- mice activates Akt signaling whereas DFMO treatment abrogated this response.
These results show that ODC blockade by DFMO can alter the activity of multiple pathways
driving the growth of NMSCs.
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A conditional mouse model defines temporal and spatial requirements for deregulated Hedge-
hog signaling in medulloblastoma
LE Michael, J Liu, A Wang, JE Ferris, M Grachtchouk, AN Ermilov and AA Dlugosz
Dermatology, University of Michigan, Ann Arbor, MI
Patients with Gorlin’s Syndrome carry mutations leading to deregulated Hedgehog (Hh) sig-
naling activity and an increased risk for developing basal cell carcinoma and medulloblas-
toma, a pediatric brain tumor. To study the role of aberrant Hh signaling in medulloblastoma
development, we generated a novel mouse model of Hh pathway activation using SmoA1, an
oncogenic allele of the Hh signaling effector Smo, placed under the control of a tetracycline
response element. We crossed SmoA1 animals with GFAP-tTA animals, harboring the tetra-
cycline transactivator driven by the glial fibrillary acidic protein promoter. Immunohisto-
chemical analysis of GFAP-tTA;SmoA1 animals revealed widespread expression of SmoA1
throughout the cerebrum and cerebellum. However, tumor development was limited to medul-
loblastomas arising in the cerebellar external granular layer, a transient neural precursor pop-
ulation believed to be the site of origin for human medulloblastomas. We have generated
over 110 GFAP-tTA;SmoA1 animals between three SmoA1 lines, 100% of which have devel-
oped medulloblastomas that are detected as early as 14 days of age. These highly prolifera-
tive tumors also have a significant baseline level of apoptosis. Immunophenotyping, in situ
hybridization and real-time PCR analysis of the tumors indicate a marker profile similar to
that of human medulloblastomas and previously published mouse models, including expres-
sion of synaptophysin, NeuN, p27, GFAP, GABRA6, Ptch1, Ptch2, Gli1, Gli2, N-Myc, and
Math1. In contrast to the complete tumor penetrance following SmoA1 activation during
embryogenesis, no tumors were detected in GFAP-tTA;SmoA1 mice following initiation of
transgene expression three weeks after birth, at a time when external granule cells have ter-
minally differentiated. Our findings point to the external granular layer of cerebellum as the
obligatory progenitor cell population giving rise to medulloblastoma, and reveal a remark-
able ‘unresponsiveness’ of other CNS cell populations to oncogenic Smo.
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Recurrent genetic alterations in Merkel cell carcinoma revealed by array-comparative genomic
hybridization
B Lemos,1 K Garneski,1 B Feng,2 L Chin2 and P Nghiem1 1 Medicine/Dermatology, University
of Washington, Seattle, WA and 2 Dana-Farber Cancer Institute, Boston, MA
Merkel cell carcinoma (MCC) is a rare, highly lethal and poorly understood neuroendocrine
cancer of the skin. It has a mortality of 33% and an incidence that has tripled in the past 15
years, yet little is known about the molecular basis of this cancer. Comparative genomic
hybridization (CGH) is a technique that has been used to identify genetic aberrations in many
types of cancer, and the newest microarray technologies can detect gene copy number alter-
ations in regions as small as 50,000 base pairs, often resolving single or small groups of
genes. We performed oligonucleotide array-CGH on 25 paraffin-embedded MCC tumor sam-
ples generating the most detailed analysis of the MCC genome yet reported in an effort to iden-
tify candidate tumor suppressors and oncogenes. We identified 119 minimum common regions
of aberration that were recurrent between these samples. Validation of a focal and highly ampli-
fied region at chromosome 14q11.2-12 was performed using quantitative PCR. This indicated
that amplification had indeed occurred as predicted by array-CGH in a region adjacent to but
not within the coding region of any known gene. We also compare our high-resolution data
with that from 56 MCC samples in the literature that used low-resolution CGH. The general
patterns were similar, but our study identified several focal alterations that were missed using
the older technology. Many of these regions of aberration are promising for further investiga-
tion due to the magnitude and focal nature of the alterations. The data indicate that regions
encoding 2 traditional kinases, 6 known microRNAs and 6 known cancer genes are ampli-
fied or deleted in a recurrent fashion among the MCC tumors. We will prioritize these targets
using further genetic and functional approaches including comparison with fresh tumor sam-
ples and correlation with mRNA expression.
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p53 loss before or after exposure to ionizing radiation accelerates BCC carcinogenesis in
Ptch1+/- mice
J Hebert,1 P So,1 Y Khaimskiy,1 D Albertson,2 B Huey2 and EH Epstein Jr.1 1 Dermatology,
UCSF, San Francisco, CA and 2 Comprehensive Cancer Center, UCSF, San Francisco, CA
p53 is an important tumor suppressor that is mutated in 40-100% of basal cell carcinomas
(BCCs). Since Ptch1+/- p53-/- mice all develop fatal early onset medulloblastomas, we utilized
mice in which basal keratinocyte (floxed) p53 could be deleted by tamoxifen (tam)- activa-
tion of K14-Cre-ER to test the effects of p53 loss on experimental BCC formation in Ptch1+/-
mice. Ptch1+/- mice develop multiple microscopic BCCs after exposure to ionizing radiation
(IR) at age 8 weeks, and about 50% (depending on genetic background) of these mice develop
macroscopic BCCs. Basal keratinocyte specific deletion of p53 by tam administration at age
6 weeks (2 weeks before IR) or at age 9 weeks (1 week after IR) produces rapid and equiva-
lent acceleration of BCC carcinogenesis. Thus, keratinocyte p53 deleted Ptch1+/- mice develop
multiple visible BCCs as early as age 5 months, in contrast to their IR-treated Ptch1+/- non-
p53 deleted siblings, which developed one or two visible BCCs no earlier than age 10 months.
Furthermore, Ptch1+/- p53 deleted mice developed visible BCC tumors by age 9 months even
without IR treatment. CGH analysis indicated that global genome changes were similar in
BCCs irrespective of keratinocyte p53 status. Cell lines could be established from BCCs from
p53 deleted Ptch1+/- irrespective of whether or not IR had been given. These studies indicate
(i) that p53 functions to restrain the effect of epithelial carcinogenesis AFTER repair of acute
DNA damage, consistent with recent publications that have suggested a role of p53 in oppos-
ing “oncogene stress” (ii) that the mechanism of BCC acceleration by p53 loss does not involve
marked changes in DNA copy number (iii) that acceleration of carcinogenesis in Ptch1+/- mice
by p53 loss is not limited to the previously reported cerebellar tumors and (iv) that p53 loss
plus hemizygosity for functioning PTCH1 is sufficient for the development of BCCs even
without further imposed mutagenic insult.
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Chemical and ultraviolet induced carcinogenesis in mice expressing dominant negative ATR
in skin
M Kawasumi,1,2 B Lemos1 and P Nghiem1,2 1 Medicine/Dermatology, University of
Washington, Seattle, WA and 2 Cutaneous Biology Research Center, Massachusetts General
Hospital/Harvard Medical School, Charlestown, MA
ATR (Ataxia Telangiectasia and Rad3-related) is a protein kinase involved in the replication
checkpoint of dividing cells and plays an important role in maintaining the fidelity of the
genome. ATR senses DNA damage and stalls the replication fork to allow for repair prior to
initiation of chromatin condensation. Previously we have demonstrated that in vitro inhibi-
tion of ATR causes premature chromatin condensation in cells with DNA damage induced by
ionizing or ultraviolet (UV) radiation. To elucidate the in vivo role of ATR in chemical and UV
carcinogenesis in skin, we generated transgenic FVB mice with a dominant negative kinase-
dead construct of ATR (ATR-kd) under the keratin 14 promoter. Compared to endogenous
levels, expression of ATR-kd was low, as demonstrated by real time RT-PCR and western blot.
Transgenic mice (n=35) and their wild type littermates (n=23) were shaved weekly and treated
by topical application to skin once with 25ug DMBA (7,12-dimethyl benzanthracene) fol-
lowed by weekly treatment with 5ug TPA (12-O-tetradecanoylphorbol-13-acetate) for 20
weeks. The ATR-kd transgenic mice demonstrated a significantly shorter latency to first tumor
development and a higher number of tumors per mouse. The findings suggest that chronic
low-level suppression of replication checkpoint function amidst chemical carcinogenesis may
promote genomic instability and augment carcinogenesis. Due to the high resistance of FVB
mice to UV carcinogenesis, the ATR-kd mice were then crossed with xeroderma pigmento-
sum C (XPC) mice. The XPC/ATR-kd transgenic mice (n=43) and their ATR-wild type XPC-lit-
termates (n=43) were treated with a thrice weekly UV-B dose titrated to erythema in 5% of
mice. Papilloma development began by week 13, and UV treatment and tumor development
continue. Although ongoing, these data support a role for ATR in the maintenance of genomic
fidelity and prevention of skin carcinogenesis.
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R alfa-lipoic acid triggers elimination of cells with abnormal nuclei in human carcinoma epi-
dermoid cell line A431
O Kisurina-Evgenieva,1 E Smirnova,1 M Krioutchkova,2 R Korneeva2 and G Onishchenko1 1
Cell Biology ang Histology, Moscow State University, Biology faculty, Moscow, Russian
Federation and 2 Skin Cell Biology Group, Faberlic Center for Research and Development,
Moscow, Russian Federation
Skin is often exposed to adverse environmental conditions (UV irradiation, temperature, chem-
ical agents) that may cause pathological cell proliferation and the appearance of cells with
abnormal chromosome number. These cells may enter apoptosis or survive, and undergo trans-
formational changes leading to the development of malignant cells. The purpose of this inves-
tigation was to determine the pathways of elimination of cells with abnormal chromosome
number. We have used the cultured cells of human epidermoid carcinoma A431, which in
standard conditions of cultivation have 6-11.5% of cells with the abnormal nuclear mor-
phology (the presence of polymorphous nuclei and micronuclei). Generally, the presence of
such nuclear forms indicates the instability of the genome/chromosomes and is typical for the
malignant cells. Out studies showed that antioxidant alfa-lipoic acid inhibited the prolifera-
tion of cells in dose-dependent manner. Alfa-lipoic acid induced pathological mitosis, yet it
did not increase the number of the cells with abnormal nuclear morphology. This may indi-
cate that the abnormal cells undergo the mitotic catastrophe. The cells with polymorphous
nuclei and micronuclei were able to activate p53-dependent pathway of apoptosis mediated
by caspase 3 dependent mechanism. We have also evaluated the effect of: R form and the
mixture of R and S forms of alfa-lipoic acid. Our studies showed that R form had more promi-
nent effect on the normalization of the nuclear morphology, than the mixture of R and S forms.
We conclude that alfa-lipoic acid stimulates the mechanisms of elimination of cells with abnor-
mal chromosome number from the total population of cells. We suggest that the latter is upreg-
ulated by the activation of the checkpoints and induction of apoptosis.
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Independent origins for multifocal skin tumors in tuberous sclerosis complex
J Wang,1 S Li,1 Q Fan,2 G Pacheco-Rodriguez,2 J Moss2 and TN Darling1 1 Dermatology,
Uniformed Services University, Bethesda, MD and 2 Pulmonary-Critical Care Medicine
Branch, National Heart, Lung, and Blood Institute, Bethesda, MD
Patients with tuberous sclerosis complex (TSC) develop multiple skin and internal tumors due
to a mutated tumor suppressor gene, commonly TSC2. Studies of renal angiomyolipomas
(AMLs) and pulmonary lymphangioleiomyomatosis (LAM) have revealed a common genetic
origin for these two types of TSC tumors, and we have shown the presence of LAM cells in
patient blood. Our goal was to determine whether TSC skin tumors, at different sites in the
same patient, share a single origin or arise independently. We obtained samples of normal-
appearing skin, facial angiofibromas, periungual fibromas, blood and urine from three TSC
patients. Fibroblast-like cells grown from an angiofibroma and a periungual fibroma from
patient 1 both showed loss of heterozygosity (LOH) at the TSC2 locus. The markers showing
LOH spanned a larger region of DNA in the periungual fibroma than the angiofibroma, sug-
gesting that the tumors arose independently. In patients 2 and 3, LOH at the TSC2 locus was
likewise documented in angiofibromas and periungual fibromas. Some tumors exhibited clonal
inactivation of different X chromosomes, supporting independent origin. In addition, one peri-
ungual fibroma from each patient was distinctive in showing “second-hit” point mutations in
TSC2 rather than LOH, a frame-shift mutation in patient 2 and a nonsense mutation in patient
3. These point mutations presented a unique opportunity to test for shared origin, since they
were more specific than patterns of LOH or clonality. The respective point mutations were
not detectable in any other sample from either patient, including other skin tumors, blood, or
urine, or even an adjacent periungual fibroma in one case. These data demonstrate that indi-
vidual tumors in patients with TSC can arise independently by different genetic mechanisms
rather than spread of neoplastic cells. It may be inferred that that complete eradication of early
skin tumors is unlikely to affect the development of future lesions.
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IKKα regulates the TGFβ anti-proliferative activity in the development of squamous cell car-
cinomas
B Marinari,1 F Moretti,1 ML Giustizieri,1 A Giunta,1 C Ballaro’,2 M Papoutsaki,1 S Alema’,2
S Chimenti1 and A Costanzo1 1 Dermatology, University of Rome Tor Vergata, Rome, Italy
and 2 Institute of Cell Biology, CNR, Rome, Italy
Invasive growth of epithelial tumor cells is a major cause of death in humans. Transforming
growth factor beta is regarded as a major tumor suppressor during early tumor development
because of his strong anti-proliferative activity on epithelial cells that is mediated mainly by
the downregulation of c-myc activity. However, dedifferentiated late stage tumors are resist-
ant to growth inhibition by TGF-beta, and often overproduce TGF-beta that acts as a promoter
of invasiveness and metastasis. In this study we have uncovered a novel function of the pro-
tein kinase IKKα that acts as a key mediator of TGF-beta anti-proliferative activity in the devel-
opment of squamous cell carcinomas (SCC). IKKα was found to be progressively downregu-
lated in the development of SCC arising from stratified epithelia and to lose its nuclear
localization when an in situ SCC becomes invasive. We have observed that IKKα is rapidly
translocated into the nuclei of TGFβ-stimulated epithelial cells and functions as an activator
of Mad1 and Ovol1 genes that in turn downregulate the transcription and the activity of c-
myc, allowing the cell cycle arrest. SCC cells are resistant to TGFβ mediated cell cycle arrest,
and unable to shuttle IKKα into the nucleus, but regain the ability to arrest the cell growth
upon the reintroduction of nuclear IKKα. Our results attribute an additional role to IKKα as a
potential tumor suppressor gene acting on the control of c-myc activity.
134
Biological characteristics of a novel melanoma cell line, SMYM-PRGP, established from radial
growth phase of acral melanoma
H Murata, M Takata, A Ashida and T Saida Dermatology, Shinshu University School of
Medicine, Matsumoto, Japan
Recent studies showed that acral melanomas may have unique pathogenesis characterized
by frequent gene amplifications from the early stage of development and a low frequency of
NRAS/BRAF mutations. We have established a cell line (SMYM-PRGP) from a radial growth
phase lesion of a 69-year old acral melanoma patient. SMYM-PRGP was wild-type for NRAS
and BRAF genes. Cytogenetic analyses using array CGH and FISH showed amplification of
the hTERT and CCND1 genes. The CDKN2A gene was wild-type with no copy number loss.
TRAP assay confirmed the activity of telomerase. Growth of this cell line was strongly stimu-
lated by endothelin-1, and extracellular calcium ion had synergistic effect. BQ788, a blocker
of type B endothelin receptor, blocked the stimulus effect of endothelin-1, but BQ123, a blocker
of type A endothelin receptor, did not show any effect by cell viability assay using WST-8. RT-
PCR analysis showed the expression of SCF, basic FGF, TGF-alpha, c-Kit and EGF receptor
mRNAs suggesting the existence of autocrine loops of these growth factors and their recep-
tors. Western blot analyses showed that the combination of endothelin-1 and calcium induced
the accumulation of CCND1 proteins within 6 hours but the phosphorylation of Rb protein
was not increased. The p16 and CDK4 proteins were strongly expressed during the stimula-
tion with endothelin-1 and calcium. These results suggest that SMYM-PRGP uses signaling
pathway similar to that of normal human melanocyte, and that the amplifications of hTERT
and CCND1 are probably key mutations for oncogenesis of acral melanoma in early stage.
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Mutations within two branch point sequence (BPS) in an intron of the XPC gene disrupt U2
snRNP - BPS interaction resulting in mild versus severe XP phenotypes
SG Khan, K Yamanegi, Z Zheng, J Boyle, K Imoto, KS Oh, N Armstrong, CC Baker and
KH Kraemer National Cancer Institute, Bethesda, MD
Sequences within introns and exons of a human gene are critical for correct and efficient
splicing of its pre-mRNA. We previously showed that cells from a severely-affected xero-
derma pigmentosum sibling (XP101TMA) had undetectable levels of XPC mRNA, while
cells from a mildly-affected sibling (XP72TMA) had 3 % of normal levels (Hum. Mol. Genet-
ics, 13: 343 - 352, 2004). These cells have mutations within -4 and -24 branch point sequence
(BPS) of XPC intron 3 that disrupt XPC pre-mRNA splicing. Minigenes containing these muta-
tions were transfected into XP-C cells harboring other XPC gene mutations and revealed the
same abnormal XPC pre-mRNA splicing as seen in the patients cells. We analyzed the inter-
action of U2 small nuclear ribonucleoprotein (snRNP) with normal and mutant BPS of the
XPC pre-mRNA intron 3 by use of DNA oligo-directed RNase H digestion. We found that
both -4BPS and -24BPS mutations disrupt these interactions. Further the normal -24BPS
demonstrated the greater function. Post-UV cell survival and ELISA assays for UV-induced
lesions in genomic DNA revealed markedly greater reduction in DNA repair capabilities in
cells from the severely-affected patient (XP101TMA) than from the mildly-affected patient
(XP72TMA). XP101TMA had no detectable XPC protein on Western blotting, while XP72TMA
had barely detectable levels. Immunofluorescence studies of XP101TMA cells exposed to
UV through 5 micron pore filters revealed a failure of localization of XPC and XPG proteins
to the UV-induced lesions in genomic DNA. In contrast, XP72TMA cells showed localiza-
tion of a small amount of XPC protein to UV-induced lesions followed by localization of other
NER proteins. This study provides evidence that two BPS in XPC intron 3 are functional.
Their mutations differentially affect the expression of full-length XPC proteins that relate to
mild versus severe clinical disease in the XP-C patients.
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The role and regulation of extracellular matrix protein tenascin-C (TNC) in basal cell carci-
noma
H Sikder,1 R Fishelevich,1 AA Gaspari1 and DJ Kouba1,2 1 Dermatology, University of
Maryland School of Medicine, Baltimore, MD and 2 Medicine, University of California, David
Geffen School of Medicine, Los Angeles, CA
We sought to find out whether the invasive nature of the human basal cell carcinoma (BCC)
is linked with any extracellular matrix (ECM) component that promotes local invasion. Most
invasive human BCC overexpress Gli transcription factors and skin-targeted overexpression
of Gli1 in transgenic mouse produces BCC like tumors. On the other hand ECM protein tenascin-
C (TNC) is shown to have a role in local invasion in several forms of tumor. Through real time
PCR analysis we found a striking increase in Gli1 and TNC messages in human BCC tumors
compared to the patient-matched normal skin. To test the possibility that TNC might be under
the transcriptional control of Gli transcription factors, we cloned the promoter region of human
TNC into plasmid pGL3-Basic that allows promoter analysis and checked the TNC promoter
activity by co-transfecting normal human epidermal keratinocytes. We found that all of the
three Gli proteins tested (Gli1, Gli2 and Gli3) had a positive regulatory function on the TNC
promoter region and that Gli3 had the highest effect. We found a putative Gli binding site in
the TNC promoter region. Deletion of this site reduces the TNC promoter activity by 70%,
which indicates the importance of this site for Gli mediated transcriptional regulation. Our
data shows that extracellular matrix protein TNC is transcriptionally controlled by Gli tran-
scription factors that is involved in the BCC pathogenesis. As anti-TNC approach has been
used in diagnosis and therapy of several cancers, TNC may be a very good diagnostic marker
and therapeutic target for BCC.
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Profiling proteome and in vivo secretome of progressive and regressive UV-induced fibrosar-
coma cell lines: Understanding the tumor and host cell interaction from in vivo secreted pro-
teins
C Huang,1,2 Y Shi,3 CA Elmets4 and RL Gallo1,2 1 Division of Dermatology, University of
California, San Diego and Veterans Medical Research Foundation, San Digeo, CA, 2 VA San
Diego Healthcare Center, San Diego, CA, 3 The Burnham Institute, San Diego, CA and 4
Dermatology, University of Alabama at Birmingham, Birmingham, AL
The tumor formation creates a state of immunosuppression that tumor and host cells coun-
teract each other to gain maximum survivals. Although it has been known that many proteins
are released from tumor and/or host cells during tumor growth, the complete mechanism by
which tumors and their hosts interact is far from understood. One difficulty in studying the
tumor-host cell interaction is to obtain the comprehensive tumor proteome and in vivo secre-
tomes of tumor and host cells. Two UV-induced skin tumor cell lines (UV-2237 and UV-2240)
derived from fibrosarcoma produced in the skin of C3H/HeN mice were used in this study.
The UV-2237 cell line has been characterized as a progressive tumor cell line, which, when
implanted subcutaneously into mice, gives rise to tumors that grow continuously. The UV-
2240 cell line is a regressive cell line which when injected subcutaneously into mice gives
rise to tumors that grow for three weeks, and then regress and eventually disappear. Here we
employed a novel method, termed isotope-coded protein label (ICPL), which is capable of
high-throughput quantitative proteome profiling on a global scale. More than 350 proteins
were identified via ICPL in conjunction with LTQ mass spectrometry. Thirty-six proteins includ-
ing secreted S100A4, profiling and galectin-1 have differential expressions in UV-2237 vs. UV-
2240. A newly designed tissue-chamber model was employed to obtain the in vivo secretome.
Fifty two in vivo secreted proteins in tissue-chamber fluids were identified and quantified.
Two secreted proteins (hemopexin and serpina1b), which have never reported to be associ-
ated with tumor-host cell interaction, have distinct amounts in vivo secretomes of mice
implanted with UV-2237 and UV-2240.
141
Topical pTT treatment reduces UV-induced BCC development in Ptch-1 +/- mice
DA Goukassian,1 S Arad,1 E Zattra,1 J Hebert,2 EH Epstein2 and BA Gilchrest1 1 Department
of Dermatology, Boston University, Boston, MA and 2 Department of Dermatology,
University of California, San Francisco, CA
Ultraviolet B (UVB) induces basal cell carcinomas (BCC) in Ptch-1 +/- mice, and topical
application of thymidine dinucleotide (pTT) reduces UV-induced mutations and squamous
cell carcinomas (SCC) in hairless mice. To determine whether pTT also can reduce UV-induced
BCC carcinogenesis, Ptch-1 +/- mice were treated topically with pTT (n=9) or vehicle alone
(n=11) 5d/week and UVB irradiated 3 times/week for 7 months, a protocol known to induce
microscopic BCC. Animals were sacrificed 24h after the last UVB exposure. By computer-
assisted image analysis, pTT reduced BCC cross-sectional area by 57% (p<0.001) and num-
ber of microscopic BCC/cm of epidermal length by ~35% (p<0.001). The rate of UV-induced
DNA damage repair was assessed using antibodies to cyclobutane pyrimidine dimers (CPD)
and 8-oxo-7,8-dihydro-2’-deoxyguanosine (8-oxo-dG). By 24h, pTT reduced (+) cells/100µm
linear epidermis ~45% for CPD (p<0.0002) and ~60% for 8-oxo-dG (p<0.01) compared to
vehicle-control. p53 tumor suppressor gene status was evaluated by immunostaining with an
antibody specific for mutated p53. There were ~74% fewer (p<0.01) mutated p53 (+) patches
in pTT-treated vs. control mice. In pTT-treated skin, Ki67 (+) presumably proliferative cells
were decreased 57% (p<0.008) per unit length of tumor-free epidermis and in BCC tumor nests
were decreased 73% (p<0.001) per unit area. By immunostaining using anti-Cox-2 antibod-
ies, there was ~80% decrease (p<0.01) in epidermal Cox-2 expression in pTT-treated vs. con-
trol mice. We conclude that frequent topical pTT treatment during a prolonged period of
UVB exposures decreases the number and size of UV-induced BCC through several biologi-
cally relevant cancer preventative processes: enhanced DNA repair capacity, reduced muta-
tions in p53 and presumptively also Ptch-1, and reduced epidermal and BCC proliferative rate.
Reduction in Cox-2 expression, while striking in pTT-treated mice and shown to be protective
against SCC carcinogenesis, may or may not affect BCC development.
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The role of collagen XVII in ras-driven human epidermal tumorigenesis
T Makino,1,2 NT Ngyun,1 CH Chen,1 T Shimizu,2 AC Rizzo1 and MP Marinkovich1 1
Dermatology, Stanford University, Stanford, CA and 2 Dermatology, University of Toyama,
Toyama, Japan
Collagen XVII, a type II transmembrane protein in hemidesmosome, is involved in the anchor-
age of stratified epithelia to the underlying mesenchyme. COL17A1 mutations are associated
with absent collagen XVII expression in generalized atrophic benign epidermolysis bullosa
(GABEB). This causes defective epidermal adhesion, however, the role of collagen XVII in epi-
dermal tumorigenesis has not been clearly demonstrated. In order to study the effects of col-
lagen XVII in tumorigenesis, we analyzed the neoplastic potential of primary human GABEB
keratinocytes in a well described tumor model in which primary keratinocytes overexpress-
ing Ras/IKBa produce human SCC tumors in immunodeficient mice. In this model, GABEB
keratinocyes showed markedly impaired tumorigenesis. Retroviral transfer of the wild-type
collagen XVII genes into these cells restored their tumor-forming capacity. We next expressed
a series of collagen XVII fragments in GABEB keratinocytes to identify the collagen XVII
sequences responsible for tumor formation in mice. The ectodomain sequence (nt.1683-4596),
which has a BM40 signal peptide at N-terminus restored tumorigenecity to GABEB cells,
whereas the endodomain sequences (nt.1-1682) and the C-turminal deleted sequences (nt.1-
3669) did not. Furthermore we analyzed signaling pathways for tumorigenesis in GABEB ker-
atinocytes, and found transformed GABEB keratinocytes showed reduced PI3-kinase activity
compared to normal transformed keratinocytes. However retroviral transfer of PI3-kinase cDNA
to GABEB cells did not restore tumorigenesis. These results suggest that collagenXVII, espe-
cially ectodomain sequences of collagen XVII, is required for human SCC tumorigenesis through




Inflammation and skin cancer are linked by protein kinase Cα in a mouse model for inducible
cutaneous inflammation
C Cataisson, R Ohman, A Pearson, M Tsien, H Hennings and SH Yuspa Laboratory of Cancer
Biology and Genetics, NCI, Bethesda, MD
A single application of 12-O-tetradecanoyl-phorbol-13- acetate (TPA) to the skin of trans-
genic mice that overexpress PKCα in the epidermis (K5-PKCα mice) produces acute intraepi-
dermal neutrophilic inflammation, keratinocyte apoptosis and a strong hyperplastic response.
This provides a model to study the contribution of cutaneous inflammation to skin carcino-
genesis. K5-PKCα mice were initiated with topical 7, 12-dimethylbenz[a]anthracene and
promoted with a low dose TPA. This protocol yielded a 55% skin papilloma incidence in K5-
PKCα mice while wildtype mice did not develop tumors at this TPA dose. Depletion of cir-
culating neutrophils in K5-PKCα mice does not alter the epidermal hyperplasia following TPA
application. Genetic ablation of CXCR2, the receptor for KC and MIP-2 chemokines, virtually
eliminated the inflammatory response and delayed epidermal hyperplasia. These results indi-
cated that the hyperplastic response of K5-PKCα transgenic skin to TPA does not require neu-
trophil infiltration but is related to CXCR2 expression. Transduction of cultured keratinocytes
with oncogenic ras increased the expression of both KC and MIP-2 as well as all five EGFR
ligands expressed by keratinocytes. Keratinocytes express CXCR2, and treatment of primary
keratinocytes with MIP-2 or KC causes a transient activation of ERK while co-treatment with
TGFα is synergistic for ERK activation. This suggests that an autocrine or paracrine mecha-
nism may be contributing to the sensitivity of K5-PKCα mice to tumor formation, and this sen-
sitivity may be enhanced by ras transformation. Tumors evolving from v-rasHa initiated ker-
atinocytes expressing CXCR2 grew to a large size while CXCR2 deficient tumors remained
small. Together, these results suggest that the sensitivity of K5-PKCα transgenic skin is associ-
ated with CXCR2 and EGFR signaling leading to enhanced growth of neoplastic clones.
S24 Journal of Investigative Dermatology (2007), Volume 127
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Hormones at age-specific levels regulate the expression of tumor-associated genes :Newest
results of the explorative project in the German National Genome Research Network II
(NGFN-2) “Genetic aetiology of longevity”
E Makrantonaki,1,3 J Adjaye,2 R Herwig,2 TC Brink,2 B Hermes,1 D Groth,2 C Hultschig,2
H Lehrach2 and CC Zouboulis1,3 1 Laboratory for Biogerontology, Dermato-Pharmacology
and Dermato-Endocrinology, Charité University Medicine, Berlin, Germany, 2 Vertebrate
Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany and 3 Dermatology
and Immunology, Dessau Medical Center, Dessau, Germany
Aging is characterized by gradual decline in several body functions, among them a func-
tional decline of endocrine gland function and a reduction in the levels of circulating hor-
mones. Hormone replacement therapy has been associated with increased risk of prostate,
lung, ovarial, endometrial, and breast cancer. Within the scope of the NGFN-II explorative
project “Genetic aetiology of longevity” human SZ95 sebocytes were incubated under a hor-
mone-substituted environment consisting of growth hormone, insulin-like growth factor-I,
estrogens, androgens, and progesterone in concentrations corresponding to 20- (f20) and 60-
(f60) year-old women. Expression profiling employing a cDNA microarray composed of 15,529
cDNAs identified 899 genes with altered expression levels at f20 vs. f60. In order to identify
pathways that were altered due to hormonal induction, we computed a statistical analysis of
entire pathways, with pathway annotation taken from the KEGG database. The most signifi-
cantly altered signaling pathway identified was that of transforming growth factor-β (TGF-β).
A differential expression of TGF-β isoforms, activins, BMPs, MADHs/SMADs, and other com-
ponents of the TGF-β signaling cascade was shown at f60. A disturbed function of this cas-
cade has been associated with tumorigenesis, i.e, in pancreatic, prostate, intestine, breast,
and uterine cancer. These data suggest that age-specific hormonal changes are likely to play
a determining role not only in the healthy aging process, but also in tumorigenesis.
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Cyclooxygenase-2 (COX-2) inhibition by nimesulide blocks ultraviolet-B (UVB)-induced pho-
tocarcinogenesis in mouse skin
A Wu,1 Y Zhu,1 X Tang,1 AL Kim,1 L Kopelovich,2 DR Bickers1 and M Athar1 1 Dermatology,
Columbia University, New York, NY and 2 Division of Cancer Prevention, NCI, Bethesda, MD
COX-2 inhibition is known to be a potent blocker of UVB-induced carcinogenesis in the skin
and we have shown that COX-2 is overexpressed in UVB-induced squamous cell carcinomas
(SCCs). In addition, celecoxib, a specific inhibitor of COX-2 has been shown to inhibit UVB-
induced papillomas in murine skin. However since COX-2 inhibitors of this type are associ-
ated with an increased risk of adverse cardiovascular events we decided to study a different
class of COX-2 inhibitor, nimesulide, which is a N-arylmethanesulfonamide derivative and
not known to have these untoward effects. To assess the anti-tumor promoting effects of
nimesulide, ninety mice were equally divided into three groups. Group-I received no test agent
or UVB and served as age-matched controls, group-II were irradiated with UVB (180 mJ/cm2,
twice weekly for thirty five weeks) and group-III received 300 ppm nimesulide in drinking
water and were irradiated with UVB as described for group-II. Nimesulide treatment reduced
the growth of UVB-induced papillomas both in terms of tumor number and volume. By week
25, 30, and 35 the reduction in tumor numbers in the nimesulide-treated group was 79, 49
and 53% respectively of the number occurring in UVB-treated animals whereas tumor vol-
ume was reduced 69, 54 and 53% respectively. Nimesulide also inhibited the malignant pro-
gression of SCCs. The reduction in tumorigenesis was paralleled by a decrease in cell cycle
regulatory proteins (cyclins A, B1, D1, E, CDK2/4/6) and antiapoptotic proteins (Bcl2) and an
increase in proapoptotic (PARP and caspase-3) proteins. Nimesulide also decreased ODC
expression. These results show that alternative classes of COX-2 inhibitors may have an
improved therapeutic index as a cancer chemopreventive agent.
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Accumulation of CCL27 protein in skin-draining lymph node (LN) in the absence of CCL27
transcription may contribute to CCR10-mediated nodal metastasis
V Huang,1,2 T Kakinuma,1,2 T Murakami1,2 and S Huang1,2 1 Dermatology Branch, NCI,
Bethesda, MD and 2 Dermatology Branch, CCR, NCI, Bethesda, MD
The chemokine receptor, CCR10, is expressed by melanoma cells in patient tumors and con-
tributes to skin tumorigenesis, in part by activating prosurvival pathways (e.g., Akt). It is less
clear if CCR10 promotes LN metastasis (a clinically important prognostic indicator) and if LN
cells express the CCR10 ligand, CCL27, which is thought to be primarily constitutively pro-
duced by keratinocytes. Herein, we analyzed LN expression of CCL27 by real-time RT-PCR,
Western blot, and ELISA. We performed LN metastasis assays by injecting 1x10e5 B16 murine
melanoma cells transduced with cDNA encoding CCR10 (CCR10-B16) or vector alone (vec-
tor-B16) into the mid-dermis of ears of syngeneic CB7BL/6 mice. Injection of CCR10-B16 cells
resulted in grossly visible nodal metastasis (0.2-4 mm in size) in >95% of mice. In contrast,
injection of vector-B16 cells resulted in visible LN metastasis in <10% of mice. Surprisingly,
mRNA transcripts for CCL27 in skin-draining LN were virtually undectable although CCL27
mRNA was abundant in skin. By Western blot and immunohistochemistry, however, we read-
ily detected CCL27 in skin-draining LN. By ELISA assay from whole LN cell suspensions of
skin-draining LN from unmanipulated mice, CCL27 was present at 6- and 100-fold higher lev-
els compared to mesenteric LN and spleen, respectively. Upon treatment of skin with 2,4-
dinitro-1-fluorobenzene in organic vehicle, CCL27 protein (normalized to total LN protein)
increased ~13- and 4- fold at 1 and 6 hr, respectively, compared to baseline. An increase in
nodal CCL27 mRNA was not detected, suggesting regulation of CCL27 transport from skin to
LN upon topical stimulus. In summary, CCR10 expression by B16 cells markedly enhances
nodal metastasis. Despite the apparent absence of CCL27 mRNA transcripts in the LN, CCL27
protein, possibly transported from skin via lymphatics, is readily detectable in skin-draining
LN. These data suggest a novel physiological basis for CCR10-mediated nodal metastasis.
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Overexpression of Ets1 induces dysplastic transformation in squamous epithelia
P Nagarajan, L Garrett-Sinha and S Sinha Biochemistry, State University of New York at
Buffalo, Buffalo, NY
The Ets1 transcription factor is overexpressed in 60-80% of human squamous cell carcinomas,
and its expression is correlated with increased incidence of metastasis and poor prognosis.
This association may be explained by the role of Ets1 in transcriptionally regulating the expres-
sion of various matrix metalloproteases (MMPs), which degrade extracellular matrix proteins,
thus facilitating tumor invasion. Therefore, Ets1 is thought to act predominantly in the later
stages of carcinogenesis to promote an invasive and metastatic phenotype. To better define
the role of Ets1 in epithelial cancers and to elucidate the molecular mechanisms involved in
carcinogenic transformation, we utilized a Tet-inducible system to overexpress Ets1 in differ-
entiated epidermal and oral keratinocytes of transgenic mice. Overexpression of Ets1 in the
developing embryo results in epidermal hyperproliferation, defective differentiation and
impaired epidermal barrier function resulting in perinatal death. Induction of Ets1 for only a
few weeks in adult mice leads to a severe skin phenotype consisting of extensive hair loss,
erythema, crusting and open sores. Upon histological examination, the skin and oral mucosa
display major alterations in epithelial organization as a result of hyperproliferation and cur-
tailed terminal differentiation. The lesions range from epidermal hyperplasia and papillomas
to dysplastic lesions such as carcinoma-in-situ. These observations suggest that overexpres-
sion of Ets1 can initiate tumorigenesis. Analysis of Ets1 target genes in the transgenic animals
reveals that the dysplastic transformation is accompanied by altered expression of several cell
cycle regulators and MMPs as well as increased expression of pro-angiogenic and growth
factors. Collectively, our data demonstrate that by promoting the development of dysplastic
lesions in squamous epithelia, Ets1 can function in tumor initiation in addition to its previ-
ously defined roles in late stages of carcinogenesis.
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Noggin overexpression promotes skin carcinogenesis via stimulation of Shh signaling path-
way
AA Sharov,1 AN Mardaryev,1,2 TY Sharova,1 M Grachtchouk,3 R Atoyan,1 AV Sargsyan,1
HR Byers,1 P Overbeek,4 AA Dlugosz3 and VA Botchkarev1,2 1 Dermatology, Boston
University School of Medicine, Boston, MA, 2 Medical Biosciences, School of Life Sciences,
University of Bradford, Bradford, United Kingdom, 3 Dept Dermatology and Comprehensive
Cancer Center, University of Michigan, Ann-Arbor, MI and 4 Molecular and Cellular Biology,
Baylor College of Medicine, Houston, TX
Bone morphogenetic protein (BMP) signaling plays pivotal roles in the control of skin devel-
opment and is also implicated in the control of skin carcinogenesis. The role of BMP antago-
nist noggin in skin carcinogenesis was examined using K14-Noggin mice, which showed grad-
ual hair loss and formation of spontaneous hair follicle-derived tumors resembling human
trichofolliculoma. Strongly reduced pSmad1/5 expression was observed in both murine and
human trichofolliculomas suggesting that alterations in the BMP-Smad pathway are involved
in pathogenesis of these tumors. Global gene expression profiling revealed that in contrast to
hair matrix cells obtained from anagen hair follicles of wild-type mice, epithelial cells obtained
from trichofolliculoma-like tumors of K14-Noggin mice showed markedly increased expres-
sion of growth regulatory molecules involved in the control of cell proliferation including
several members of the Shh signaling pathway (Shh, Smo, Gli1, Ptc1). Cultured tumor cells
also showed a marked increase in Shh expression, compared to non-malignant keratinocytes.
Furthermore, treatment of K14-Noggin mice with the Shh inhibitor cyclopamine resulted in
significant retardation of tumor formation associated with a strong decrease in expression of
Shh target genes, such as cyclin D2 and Ptc1. Our findings strongly support the concept that
loss of BMP function in skin predisposes to follicle-derived tumor development, and uncover
a previously unknown requirement for Shh signaling in the development and maintenance of
these tumors.
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Interaction of p53 and sonic hedgehog signaling pathways in the development of ultravio-
let-B (UVB)-induced basal cell carcinomas (BCCs) in murine skin
M Athar,1 X Tang,1 KH Kim,1 AL Kim,1 L Kopelovich2 and DR Bickers1 1 Dermatology,
Columbia University, New York, NY and 2 Division of Cancer Prevention, NCI, Bethesda, MD
Mutations in sonic hedgehog (shh) signaling genes including patched (ptch), and smoothened
(smo) activate transcription factors of the Gli family that regulate target genes that drivethe
growth of BCCs. Additional mutations in the tumor suppressor gene p53 occur in BCCs. The
cross-talk between the p53 and shh signaling pathways are poorly understood, particularly as
it affects the pathogenesis of BCCs. Here we show that chronic irradiation of Ptc1+/- knock-
out mice with UVB or acutely with ionizing radiation (IR) induces BCCs and trichoblastomas
with activated shh signaling. In addition, we developed Ptc1+/-/SKH-1 hairless mice, which
show accelerated development of BCCs and SCCs compared to parent Ptc1+/- mice. Tumors
excised from either UVB or IR irradiated animals carry p53 mutations. To ascertain whether
inactivated p53 contributes to tumor pathogenesis, we treated these mice with CP-31398, a
small molecular weight styrylquinazoline known to restore tumor suppressor functions of
mutant p53 protein. CP-31398 administration prior to UVB inhibited the induction of BCCs
in Ptc1+/- mice. Next, we asked whether CP-31398 can restore wild-type p53 function in
UVB-irradiated Ptc1+/- mice. CP-31398 (50 mg/kg/12hr, i.p.) restored wild-type p53 and
augmented expression of p53-responsive genes such as p21 and mdm2 in these animals. Fur-
thermore, CP-31398 reduced UVB-induced overexpression of Bcl-2, PCNA and cyclin D1 and
enhanced pro-apoptotic Bcl-XS expression. To further show that p53 inactivation influences
the growth of BCCs, we crossed our Ptc1+/-/SKH-1 hairless with p53+/-/SKH-1 hairless mice
to develop Ptc1+/-/p53+/-/SKH-1 hairless mice. These mice developed multiple BCCs spon-
taneously on both on the dorsal and ventral skin, whereas their littermates carrying only p53+/-
or ptc1+/- had no such lesions. Our data confirm that p53 status is a critical determinant of
the growth rate of UVB-induced BCCs.
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Elevated polyamine biosynthesis activates ATM and stabilizes p53 in DNA damage signaling
in normal keratinocytes
G Wei, CS Hayes, K DeFeo and SK Gilmour Lankenau Institute for Medical Research,
Wynnewood, PA
Although elevated levels of ornithine decarboxylase (ODC), a key rate-limiting enzyme in
polyamine biosynthesis, stimulate proliferation of primary normal keratinocytes, the cells
undergo apoptosis following five days in culture. This apoptotic cell death is polyamine-depend-
ent since it can be prevented by treatment with DFMO, a specific inhibitor of ODC activity.
Physical stress and chemical agents can damage the genome and cause stabilization and acti-
vation of the tumor suppressor p53 via different post-translational modifications, including
acetylation and phosphorylation. Levels of p53 protein were elevated in both transgenic mouse
skin and primary cultures of keratinocytes in which ODC activity is increased, and this p53
accumulation in keratinocytes was blocked by the ODC inhibitor DFMO. Both phosphoryla-
tion and acetylation of p53 was induced in ODC transgenic mouse skin compared to normal
littermate skin. Chromatin immunoprecipitation (ChIP) analyses showed that the p53 accu-
mulation in ODC overexpressing transgenic skin and keratinocytes was accompanied by
increased recruitment of p53 to the p21 proximal promoter and increased expression of p21.
Deregulated ODC expression in primary keratinocytes induced DNA damage, as measured
by the comet assay, and activated the nuclear kinase ATM as evidenced by phosphorylation
of ATM and its endogenous substrate, H2AX. These results suggest that elevated polyamine
biosynthesis activates ATM and stabilizes p53 in DNA damage signaling in normal nontu-
morigenic skin and keratinocytes. Although the immediate result is protective via cell cycle
arrest and apoptosis of ODC overexpressing cells, it may also create a selection pressure for
inactivation of ATM or p53, thus leading to genetic instability and tumor progression. (Sup-
ported by NIH grant CA95592)
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WRN-mediated telomere-associated DNA damage responses occur at sites of telomere repli-
cation and serve to protect genomic integrity
MS Eller, A Shariftabrizi and BA Gilchrest Dermatology, Boston University School of
Medicine, Boston, MA
Telomeres (tels) cap chromosome ends and prevent them from being recognized as DNA
breaks. Tels shorten with each round of DNA replication and, when critically short, induce
senescence or apoptosis (S/A), presumptive anti-cancer defenses. Tels end in a 3’ overhang of
TTAGGG repeats that inserts into the duplex DNA to form a loop. Experimental loop disrup-
tion also causes S/A. Recent data suggest that tels are recognized as damaged DNA during
replication and proteins subsequently recruited to the tel may facilitate tel replication and/or
restoration of the loop. To further define the role of tel-based signaling, we used as a probe
oligonucleotides homologous to the TTAGGG sequence (T-oligos) known to induce DNA dam-
age responses including phosphorylation of histone H2AX (γH2AX), ATM and p53 with cell
cycle arrest, followed in malignant but not normal cells by S/A. T-oligo treatment produced
γH2AX foci that localized to tels, demonstrating a tel site of action of these oligos. These
responses were greatly diminished in cells deficient in WRN, the exonuclease/helicase mutated
in the progeroid, cancer-prone Werner Syndrome (WS). Double immunostaining of these tel-
associated γH2AX foci (TAGs) revealed many at tel doublets, consistent with replicating or
post-replicated tels. TAGs were also detected at tels of metaphase chromosomes using an
immuno-FISH assay. T-oligo-induced TAGs also contained PCNA, 53BP1, Mre11 and Rad51,
proteins known to participate in DNA damage recognition, recombination and repair and/or
tel maintenance. These data suggest that WRN-processing of tel DNA occurs at times of repli-
cation and induces DNA damage-like responses that promote tel replication and restoration
of the loop. Failure of these functions in WS could contribute to accelerated tel shortening,
early aging and cancer predisposition. We also propose that T-oligos mimic tel single-stranded
DNA and are also processed by WRN at the tel, producing exaggerated responses that mini-
mally affect normal cells, but in dysregulated malignant cells lead to S/A.
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Nuclear factor Kappa B (NFκB) blockade inhibits its activation by ultraviolet B (UVB) and
UVB-induced photocarcinogenesis in murine skin
DR Bickers,1 X Tang,1 AL Kim,1 Y Zhu,1 L Kopelovich2 and M Athar1 1 Dermatology, Columbia
University, New York, NY and 2 NCI, Bethesda, MD
NFκB activation drives cell proliferation as well as resistance to apoptosis and thus may con-
tribute to carcinogenesis. Paradoxically under certain experimental conditions, NFκB block-
ade induced by overexpressing IκB and ras promotes the growth of lesions resembling SCCs
in skin. In this study, we determined whether inhibition of UVB-induced carcinogenesis can
be inhibited by NFκB blockade. We employed pyrrolidine dithiocarbamate (PDTC), a known
inhibitor of NFκB, to assess its effects on the induction of SCCs by chronic UVB irradiation in
SKH-1 mice. For this experiment sixty mice were recruited and divided into two groups of
thirty animals each. Group-I mice received tap water, whereas group-II mice received PDTC-
supplemented tap water (0.05%, w/v, in drinking water fed ad libitum) throughout the UVB-
irradiation. In addition, a group of ten mice receiving no treatments served as age-matched
controls. Both groups of mice were irradiated with UVB (180 mJ/cm2 twice a week for thirty
five weeks). Oral administration of PDTC delayed tumor formation, and decreased tumor
incidence, number and volume by more than 90%. Furthermore, NFκB DNA binding activ-
ity was decreased by PDTC as assessed by electrophoretic mobility shift assay (EMSA). PTDC
reduced the levels of NFκB constituent proteins p50, p52 and p65 as assessed in the nuclear
extracts whereas p-IκB levels were significantly increased. NFκB target genes such as cyclin
D1, COX-2 and ODC were also substantially decreased. The NFκB inhibitor also reduced the
levels of cell cycle regulatory proteins (cyclins A/B1/D/E, cdk2/4/6, p53, and chk1) and the
proliferation marker, PCNA to levels comparable to non-irradiated controls. Apoptosis of tumor
cells was enhanced as assessed by TUNEL assay which was paralleled by decreased anti-
apoptotic protein, Bcl2 and increased caspase-3 and PARP cleavage. Our results show that
UVB-induced NFκB is important the pathogenesis of SCCs and its inhibition substantially abro-
gates UVB-induced skin carcinogenesis in mice.
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The role of endoplasmic reticulum mediated apoptotic cell death in hyperthermia induces
cytotoxicity in melanomas and basal cell carcinoma
YG Shellman, WR Howe, D Ribble, LA Miller, T Pacheco and DA Norris Dermatology,
University of Colorado at Denver Health Sciences Center, Aurora, CO
Hyperthermia treatment is undergoing revitalization, and it is a promising approach for can-
cer treatment. To understand the underlying mechanisms of hyperthermic killing of cancer
cells, we examined the hyperthermic cytotoxic effects on various cutaneous cells in vitro using
MTS and apoptotic morphological assays in melanoma cell lines and a basal cell carcinoma
cell line. We found that hyperthermia induced dose and time dependent cytotoxicity in these
cells. In addition, a middle range of hyperthermia doses induced caspase 3/7 activation, and
pan caspase inhibitor reduced the cytotoxicity of these conditions. These data reveal “a win-
dow of opportunity” to induce apoptosis in these cells. To further investigate which apoptotic
pathways hyperthermia triggers, we examine the activation of extrinsic (Caspase 8) and intrin-
sic (caspase 9) apoptotic pathways, and found that hyperthermia did not activate these cas-
pases, suggesting a non-conventional apoptotic pathway. Last, we examined whether hyper-
thermia induces endoplasmic reticulum (ER)-mediated apoptosis by analyzing expression of
Grp78, CHOP, and caspase 4 or caspase 12 activation. Our preliminary data suggest that
hyperthermia treatment induces apoptosis in a non-conventional way that is not via the extrin-
sic or intrinsic pathways but rather through ER-mediated apoptosis — providing a scientific
basis for combination treatment with chemo- or radiation therapies.
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Gene expression profiling of melanoma tissues identifies polo-like kinase 1 as a cell cycle
regulator and a critical gene in human melanoma
A Moser,1 M Pashenkov,1 A Jalili,1 C Wagner,1 G Stingl,1 S Ramaswamy,2 J Brunet,2 GR Todd2
and SN Wagner1 1 DIAID, Department of Dermatology, Medical University of Vienna,
Vienna, Austria and 2 The Broad Institute of Harvard University and Massachusetts Institute
of Technology, Cambridge, MA
Melanoma is a very rapidly growing and lethal cancer. Disruption of the cell cycle regulation
has been implicated in the development and progression of malignant melanoma albeit the
exact underlying factors and mechanisms are not characterized yet. We used cDNA microar-
ray technique to evaluate gene expression of 125 samples including melanocytic nevi, pri-
mary melanomas and melanoma metastases. By combining pathway enrichment analysis
(GSEA & Biocarta) with top 50 gene expression in primary melanomas and melanoma metas-
tases as compared to nevi we could identify cell cycle pathway and its member polo-like kinase
1 (plk1, a mitotic serine/threonine kinase) but not plk2, 3 or 4 to be significantly overexpressed
in primary melanomas and melanoma metastases. This finding could be confirmed using
real-time RT-PCR analysis on an independent set of specimens. In in vitro analysis of human
melanoma cell lines we observed the peak expression of the plk1 to be at the G2/M phase of
the cell cycle. To explore the role of plk1 in human melanoma cell biology, melanoma cell
lines (n = 4) were transfected with pDNA vector transcribing plk1 siRNA (pDNA-plk1 siRNA).
This strategy as compared to control pDNA vector led to: (i) significant reduction of plk1 mRNA
and protein, (ii) reduced cell proliferation, (iii) G1 phase arrest with increased number of octo-
ploid cells, (iv) cell death with apoptotic features and, (v) induction of chemosensitization to
campthotecin. This study shows that: (i) plk1 expression is dynamically regulated during the
cell cycle of human melanoma cell lines and (ii) knock down of plk1 can lead to inhibition
of human melanoma cell proliferation, survival and induction of chemosensitization. Our data
suggest plk1 to represent a potentially attractive target in melanoma therapy.
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Creation of a model system for the study of mitochondrial dysfunction in cutaneous neo-
plasia
RL Chen1 and JE Sligh1,2 1 Division of Dermatology, VA Tennessee Valley Health Care System
and Vanderbilt University Medical Center, Nashville, TN and 2 Cell and Developmental
Biology, Vanderbilt University, Nashville, TN
Neoplastic transformation has been understood traditionally as a series of accumulated “hits”
to the nuclear genome that ultimately lead to uncontrolled cellular proliferation. In recent
years, however, accumulating evidence is also pointing to the mitochondria and its genome
as important players in cancer biology. In particular, somatic mutations of mitochondrial
DNA (mtDNA) have been observed in a wide variety of human tumors, and we have observed
them in nonmelanoma skin cancers (NMSCs). In order to investigate the role of specific mtDNA
changes in the role of neoplasia in keratinocytes, we are utilizing cytoplasmic hybrid cells, or
cybrids, which involves the stable introduction of exogenous mitochondria of interest into ker-
atinocyte host cell lines that have been previously made devoid of mtDNA. These cybrids can
then be subjected to functional assays to ascertain the phenotypic expression of specific mtDNA
mutations. We have generated clones of rho-zero HaCat cells by prolonged exposure of HaCat
cells to low concentrations of ethidium bromide which selectively ablates the mtDNA. These
cell lines were auxotrophic for uridine and pyruvate which are biochemical features of rho-
zero cells. In addition, these cells have been confirmed by genetic analysis to be devoid of
mtDNA. To better understand the functions of certain commonly accumulated mtDNA muta-
tions in human NMSCs as well as photoaged skin, work is currently underway to fuse exoge-
nous mutant mitochondria recovered from human actinic keratoses and NMSCs into the uni-
form nuclear background of the HaCat rho-zero cells. These cybrids are being screened for
behaviors relevant to neoplasia, such as the ability to proliferate and resist cell death. These
novel rho-zero cells of keratinocyte origin will have broad utility for studies of somatic cell
genetics in cutaneous aging, photobiology, and cancer biology.
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Activity of telomere-homologous oligonucleotides is determined by formation of G-quadru-
plex structures
A Shariftabrizi, MS Eller, M Yaar and BA Gilchrest Dermatology, Boston University School of
Medicine, Boston, MA
Guanine (G)-rich DNA such as human telomeres (tels), repeats of TTAGGG, can form 4-stranded
G-quadruplex (G-qx) structures containing base pairing between G residues. We and others have
shown that treatment of mammalian cells with G-rich DNA oligos homologous to the tel sequence
(T-oligos) induces DNA damage responses including phosphorylation of histone H2AX (γH2AX)
and apoptosis. γH2AX in T-oligo-treated cells occurs at tels, demonstrating a tel site of action.
Also, these responses are diminished in cells deficient in WRN, the protein mutated in the progeroid,
cancer prone Werner syndrome. We have found that some G-rich oligos other than 100% tel-
homologous DNAs, such as (GGTT)4 are potent inducers of these responses, yet the G-rich oligo
GCCGGGGCCAG (GC oligo) is not. Because of the potential for these oligos to form G-qx and
the known affinity of WRN for these structures, we asked if the activity of T-oligos correlated with
formation of G-qx, measured by the binding of a qx-specific dye, NMM, that shifts to an absorbance
maximum to 400nm when bound to DNA. GTTAGGGTTAG (11mer), GTTAGGGTTAGGGTTA
(16mer) and (GGTT)4 (all at 20 µM) induced apoptosis in 33.1±1.9%, 43.8±4.7% and 73.6±2%,
respectively, of melanoma cells in vitro and showed the same pattern of activity in inducing γH2AX
in fibroblasts. The GC oligo was inactive in both assays. Although both the 11mer and 16mer
formed G-qx, the 11mer structure was unstable: the total abs >390nm (minus that for dye alone)
for the 11mer decreased from 12.7 to 4.6 over 1 hr but increased from 8.3 to 9.2 for the 16mer.
The most active oligo, (GGTT)4, displayed an initial abs of 12 and this value increased to 14.8
within 1 hour. The inactive GC oligo had the lowest initial abs of 6.1 and this value remained
unchanged. The abs profiles for the inactive complements of the 11mer and 16mer were the same
as MNN alone. These data suggest that formation of G-qx by T-oligos is essential but not the sin-
gular feature to confer activity and suggest other effects of sequence and/or length.
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p53 regulates the number of label-retaining cells in mice
T Kangsamaksin,1 E Li,1 CS Potten2 and RJ Morris1 1 Columbia University, New York, NY and
2 EpiStem, Manchester, United Kingdom
It is believed that cancers may arise from mutations in adult stem cells. Several lines of evi-
dence suggest that adult stem cells undergo selective segregation of immortal DNA strands
as a way to limit the accumulation of mutations and, thus, to protect their genome. During
asymmetric cell division, adult stem cells cosegregate to one daughter cell chromosomes bear-
ing old parental DNA strands and pass on all of the newly synthesized DNA strands to the
other which subsequently represents a differentiating cell. In addition, it has been shown in
an engineered cell line that p53 plays an important role in the regulation of asymmetric cell
division through IMP dehydrogenase (IMPDH). We, therefore, hypothesized that p53 may also
be involved in the regulation of immortal strand segregation and tested this hypothesis using
the mouse epidermal stem cells. To follow the template DNA strands, tritiated thymidine
(3HTdR) was given as a series of injections three days after birth to p53-null, heterozygous,
and wild-type female mice. Skin samples were taken from these mice when they were eight
weeks old, and the 3HTdR label-retaining cells (LRCs) were observed through autoradiogra-
phy. The epidermis from the p53 wild-type mice contained approximately 2.88% label-retain-
ing cells (n = 4 +/- 0.007), while that from the p53-null mice contained 8.85% LRCs (n = 4+/-
0.015). The significant increase in the number of LRCs may result from random segregation
of the labeled template DNA strands due to the absence of p53 activity. Interestingly, the epi-
dermis from each of the p53-heterozygous mice contained either the low number of LRCs as
the wild-type or the high number as the p53-null mice. We suggest that the discrepancy in
the LRC numbers in these mice depends on which template strand, functional or non-func-
tional allele of p53, was initially labeled. Therefore, p53 seems to be associated with selec-
tive segregation of immortal DNA strands.
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mtDNA mutations promote hyperproliferation and neoplasia in mouse epidermis
M Shi,1,2 A Eshaghian,1,2 K Norman,1,2 M Li,1,2 LE King,1,2 GP Stricklin1,2 and JE Sligh1,2 1 VA
TN Valley Healthcare System, Nashville, TN and 2 Division of Dermatology, Vanderbilt
University Medical Center, Nashville, TN
mtDNA mutations are found in many human malignancies and are thought to contribute to
neoplasia by either providing a biochemical environment promoting neoplastic growth or by
inhibition of cell death pathways. One barrier to the study of the exact role of mtDNA muta-
tions in cancer has been that humans have substantial mtDNA variability which is likely to
be important in tumor susceptibility, but makes studies of specific pathogenic mutations
more difficult. We exploited the homogeneous nature of the mouse mitochondrial genome
to investigate the role of mtDNA mutations in skin cancer. We irradiated hairless mice with
UV to induce cutaneous neoplasia. Benign and malignant epidermal tumors were excised
and screened for mtDNA mutations using temperature gradient capillary electrophoresis, a
high-throughput heteroduplex detection system. A mutation hotspot in the mtDNA was iden-
tified in which one third of the tumors harbored mutations. The functional consequences of
these mutations were studied in a cybrid system by transfer of mitochondria into murine fibrob-
last rho zero cells (which lack mtDNA.) In an identical nuclear background, the mtDNA
changes were found to significantly enhance cellular proliferation. The mutations resulted in
an altered biochemical profile in the cybrids, including diminished amounts of complex I pro-
tein, less oxygen comsumption, and lower cellular ATP levels. There were also significantly
higher levels of reactive oxygen species present in the mutant cybrids, both at rest and after
stimulation. The transfer of the mtDNA mutation to the cybrid cells also conferred a resist-
ance to UV-induced apoptosis which may contribute directly to the neoplastic phenotype.
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Characterization of C/EBP transcription factor isoforms in non-melanoma skin cancer
JA Ebner,2,1 S Anand,1 S Keevey,1 C Gasbarre2 and E Maytin2,1 1 Biomedical Engineering, The
Cleveland Clinic, Cleveland, OH and 2 Dermatology, The Cleveland Clinic, Cleveland, OH
The CCAAT/enhancer binding proteins (C/EBP), a family of six transcription factors (C/EBP
α,β,γ,δ,ε,ζ), are involved in the regulation cell growth and differentiation. They also appear to
play a role in hematologic and solid organ malignancies, including breast and colon carci-
noma. In breast carcinoma tissue, expression of C/EBPα is diminished, while C/EBPβ is gen-
erally increased. However, there is almost no data on the expression of C/EBP’s in human skin
cancer. We examined C/EBP expression in frozen specimens of human skin cancers, via
immunohistochemical staining. While C/EBP levels were not dramatically affected in basal
cell carcinoma, the levels of C/EBPα were decreased while C/EBPβ and C/EBPδ were increased
in squamous cell carcinomas compared to internally matched normal skin. C/EBPα and C/EBPβ
are each transcribed as a single mRNA that can be translated into alternative protein isoforms.
For C/EBPβ, these proteins are called LIP, LAP, and LAP*. Using western analysis, we studied
the differential expression of these protein isoforms in cell cultures and skin biopsies. Com-
paring normal adult human keratinocytes (NHEK) with a human squamous cell carcinoma cell
line (SCC-13), we found an overall increase in C/EBPβ levels, and a relative increase in each
of the isoforms (LIP, LAP, and LAP*) in the SCC-13 cells. Interestingly, LAP* was the predom-
inant isoform in both NHEK and SCC-13 cells when measuring both whole cell and nuclear
protein extracts. Normal human skin contains high levels of LAP and LAP*, but minimally
detectable LIP. Several reports in breast cancer suggested that an increase in the LIP:LAP ratio
may correlate with tumorigenesis. To test this possibility in non-melanoma skin cancer, we
are currently characterizing the C/EBP isoforms in frozen sections of human basal and squa-
mous cell carcinomas.
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Effects of retinoid-related agents on skin carcinogenesis in the UV-irradiated Patched1+/-
mouse
P So, MA Fujimoto and EH Epstein University of California San Francisco, San Francisco
94110, CA
Basal cell nevus syndrome patients are heterozygous (+/-) for PTCH1 and develop many BCCs.
Similarly, Ptch1+/- mice develop BCCs after exposure to ionizing- (IR) or ultraviolet (UV) radi-
ation. UV-exposed Ptch1+/- mice also develop dermal spindle cell tumors (SpCTs) and squa-
mous cell carcinomas (SCC). Previously we found that topical treatment with Tazarotene (a
RARβ/γ agonist) has remarkable chemopreventive efficacy against radiation-induced BCCs in
Ptch1+/- mice. This effect was sustained after drug withdrawal and was effective against pre-
existing microscopic BCCs. To further investigate retinoid signaling in BCC carcinogenesis, we
tested the effects of other retinoid receptor agonists and of a pan-RAR antagonist on BCC
tumorigenesis. Tazarotene was the most effective in preventing microscopic and visible BCC
development, as well as SpCT development, while the pan-RAR agonist, all-trans retinoic acid
and the pan-RXR agonist were almost as effective. Activation of RARα only moderately
decreased microscopic BCC number and size. However, visible BCC number was substan-
tially decreased, concomitant with increased visible SpCT number. The RAR antagonist increased
microscopic and visible BCC number. Immunohistochemistry showed that, in our untreated
BCCs, RARγ and RXRα proteins localized to the epithelial tumor nests, while RARα protein
was detected in the stroma. In vitro, Tazarotene and the RXR agonist inhibited our murine
epithelial BCC cell line, ASZ001, while the RARα agonist or the RAR antagonist did not. Also,
Gli1 mRNA was reduced by Tazarotene and the RXR agonist, but not by the RARα agonist or
the RAR antagonist. Collectively, these data suggest that (i) Tazarotene is the tested retinoid
most effective against BCC carcinogenesis, most likely via RARγ on BCC tumor cells, (ii) RXR
agonists may also prevent BCC carcinogenesis (iii)RARα activation can suppress visible BCC
growth, but can also increase cutaneous SpCT development, and (iv) physiological RAR sig-
naling is necessary to antagonize BCC development.
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Ultraviolet radiation carcinogenesis involves activation of PKCε and its interaction with Stat3
MH Aziz, HT Manoharan, JM Sand, NE Dreckschmidt and AK Verma Human Oncology,
University of Wisconsin, Madison, WI
Chronic exposure to ultraviolet radiation (UVR), especially the UVA and UVB wavelengths of
the sunburn spectrum, is a major etiologic factor in the development of human skin cancers
including squamous cell carcinoma (SCC). Protein Kinase C epsilon (PKCε), a Ca2+-inde-
pendent, phospholipid-dependent serine/threonine kinase is among the six PKC isoforms
expressed in both mouse and human epidermis. PKCε is linked to the development of SCC by
UVR. Similarly, the transcription factor, Stat3 is activated during UVR carcinogenesis. How-
ever, a link, if any between PKCε and Stat3 is unknown. We now present that PKCε interacts
with Stat3, phosphorylates Stat3Ser727 and regulates its transcriptional activity. The associa-
tion of PKCε with Stat3 is PKCε isoform specific and dependent on UVR treatment. Biochemical
evidences that PKCε physically interacts with Stat3 include: 1) in reciprocal immunoprecipi-
tation/ blotting experiments, Stat3 co-immunoprecipitated with PKCε but not with other PKC
isoforms (α,βI, βII, γ, δ, ζ, η, θ, and λ), 2) PKCε but not other kinases (Raf-1, MEK1/2, p38, and
ERK1/2) co-immunoprecipated with Stat3, 3) in an immunocomplex kinase assay, immunop-
ure PKCε phosphorylated Stat3Ser727, and 4) PKCε depletion attenuated Stat3Ser727 phos-
phorylation. The association of PKCε with Stat3 was further confirmed by double immuno-
fluorescence staining of paraffin-fixed skin samples from UVR-exposed PKCε transgenic mice.
PKC forms complexes with several proteins (e.g., anchoring, scaffold) to be positioned to inter-
act with its substrate. PKCε is activated by UVR. PKCε interaction with Stat3 may involve assem-
bly of multiprotein complexes. PKCε overexpression in epidermis sensitizes skin to UVR
induced phosphorylation of Stat3Ser727, the expression of Stat3-regulated genes (c-myc, cyclin
D1, cdc25A, and COX-2) and development of SCC. We present for the first time that PKCε
associates with Stat3 in vivo. We conclude that PKCε and Stat3 are the key molecular com-
ponents of UVR-induced skin cancer.
www.jidonline.org   S27
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Skin tumor formation from hair follicle bulge keratinocytes in Krt1-15CrePR1;R26R mice
H Park,1 S Li,1 C Trempus,2 G Cotsarelis3 and RJ Morris1 1 Department of Dermatology,
Columbia University College of Physicians and Surgeons, New York, NY, 2 Cancer Biology
Group, NIEHS, Research Triangle Park, NC and 3 Department of Dermatology, The
University of Pennsylvania School of Medicine, Philadelphia, PA
The purpose of this investigation was to trace skin tumor development from hair follicle bulge
keratinocytes in Krt1-15CrePR1;R26R mice initiated once with 400 nmol of DMBA, treated
once daily for 5 days with RU486, and promoted twice weekly thereafter with 17 nmol TPA.
At intervals as early as 4 weeks of tumor promotion, blue exophytic squamous hyperplastic
foci were observed to involve multiple blue hair follicles. At later intervals, papillomas were
initially blue, but as promotion progressed, became a mixture of blue and white areas. When
RU486 was applied prior to DMBA, papilloma development was similar. We determined the
percentage of blue cells using the Carl Zeiss Axiovision software and found an average of
32.6% blue cells (maximum of 65%, minimum of 10%) in 28 papillomas analyzed. To study
the signature A to T transversion in codon 61 of the Ha-ras gene, we used laser capture microdis-
section followed by codon 61 sequencing of captured DNA following PCR amplification. We
collected 32 blue samples and 33 non-blue samples from 24 papillomas between 9 and 20
weeks of promotion. 31.3% of the blue regions and 72.7% of the non-blue regions expressed
the mutation. We also observed that multiple blue samples within the same papilloma differed
in expression of the Ras signature. These results support a bulge origin for papillomas, but
suggest that skin tumor development may be more complex than originally thought.
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Genome wide expression profiles associated with 5-Aza-2’-deoxy-cytidine-induced apopto-
sis in melanoma cells 
A Molinaro,1 M Krauthammer,2 Y Kluger,9 E Cheng,3 M Deng,3 G Mor,4 L Brailey,3 M Sznol,5
H Kluger,5 S Ariyan,6 J McNiff,2 D Narayan,6 P Shivakumar,7 M Pelizzola,1 D Kovacs,8
M Picardo8 and R Halaban3 1 Epidemiology and Public Health, Yale University, New Haven,
CT, 2 Pathology, Yale University, New Haven, CT, 3 Dermatology, Yale University, New Haven,
CT, 4 Ob/Gyn, Yale University, New Haven, CT, 5 Comprehensive Cancer Center Section of
Medical Oncology, Yale University, New Haven, CT, 6 Surgery, Yale University, New Haven,
CT, 7 Computational Biology and Bioinformatics, Yale University, New Haven, CT, 8 San
Gallicano Dermatological Institute, Rome, Italy and 9 Cell Biology, New York University
School of Medicine, New York, NY
Aberrant changes in gene activity due to chromatin remodeling are frequent in cancer cells.
One such process involves methylation/demethylation of cytosine at cytosine-guanine (CpG)
pair rich islands in promoter regions. Aberrant gain or loss of DNA methylation causes altered
expression of genes involved in tumorigenesis and maintenance of the malignant phenotype.
The reversible nature of epigenetic changes in chromatin is the rationale for clinical devel-
opment of the DNA demethylation agent 5-Aza-2’-deoxy-cytidine (5-Aza-CdR) as an anti-can-
cer agent. Dose-response analysis of several melanoma cell strains revealed differential sen-
sitivity to the drug. The highly sensitive melanoma cells underwent apoptosis as revealed by
caspase 3 activity assay. We then identified genes altered in response to 5-Aza-CdR in melanoma
cells by whole genome differential gene expression analyses, and determined the methyla-
tion status of CpG rich islands in promoter regions of selected genes, some of which are related
to known apoptotic pathways.
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Keratin 14-FynY528F transgenic mice represent a novel model of spontaneous squamous cell
carcinoma
W Li, L Mei and JT Seykora Department of Dermatology, University of Pennsylvania,
Philadelphia, PA
Src-family tyrosine kinases (SFKs) are prevalent non-receptor tyrosine kinases that play impor-
tant roles in regulating cell proliferation, differentiation, and adhesion. To characterize the in
vivo role of Fyn in epidermal homeostasis, we generated keratin-14 FynY528F transgenic mice,
which over-express an activated form of Fyn. K14-Fyn Y528F founder mice exhibit focal
thickening of the skin similar to that seen with K14-Fyn founder transgenic mice. Crosses with
C57 mice generated K14-Fyn Y528F progeny that exhibited a prominent scaly skin pheno-
type involving the head and back; this phenotype is seen in approximately 57% of the geno-
type positive mice (N=65). Equivalent numbers of genotype negative littermate controls have
not exhibited the scaly skin phenotype. The scaly skin phenotype of K14-Fyn Y528F mice is
comparable to that seen in K14-Fyn mice, and tends to resolve by about 5 weeks of age. Micro-
scopic analysis of phenotypic skin demonstrates marked epidermal hyperplasia associated
with an increased Ki-67 labeling index and increased levels of activated SFKs. Of the 37 mice
with an antecedent phenotype, seven mice (19%) spontaneously developed hyperkeratotic
lesions between 7-12 weeks, exhibiting clinical features suggestive of squamous cell carci-
noma (SCC). Some mice developed up to 6 tumors. All tumors arose after the initial hyper-
proliferative phenotype has resolved. Histologic analysis of these hyperkeratotic, nodular
lesions demonstrated SCC. Immunohistochemical analysis demonstrates marked SFK activa-
tion in the SCC tumors in association with increased Ki-67 immunohistochemistry. In contrast,
K14-Fyn mice (N=40) did not demonstrate SCC formation over the same time frame. These
data demonstrate that K14 Fyn Y528F mice represent a novel model of SCC formation, and
comparison of these mice with K14 Fyn mice may provide unique insights into the mecha-
nism of keratinocytic carcinogenesis.
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Copper(II)-dependent, reactive oxygen species (ROS)-mediated induction of senescence by
resveratrol is regulated by anti-apoptotic BCL-2-like protein, Bfl-1 via NF-kappa B
JH Back,1 Y Zhu,1 KH Kim,1,2 SS Kim,1 M Athar,1 DR Bickers1 and AL Kim1 1 Department of
Dermatology, Columbia University, New York, NY and 2 Hallym University College of
Medicine, Anyang, South Korea
ROS enhance mutagenesis caused by DNA damage and augment protein oxidation. Oxida-
tive stress-induced mutations can be diminished by dietary antioxidant polyphenols. Resver-
atrol (3,4’,5-trihydroxy-trans-stilbene), a polyphenol found in grape skin and other fruits, is a
known antioxidant and cancer chemopreventive agent. We previously showed that resvera-
trol inhbits proliferation of A431 epidermoid squamous cell carcinoma cells lacking functional
p53. Here, we demonstrate that resveratrol induces cellular senescence in these cells, as evi-
denced by p53-independent increases in the p21CIP1 cell cycle inhibitor and senescence-
associated beta-galactosidase (SA-β-Gal) activity. We further show that resveratrol-induced
senescence is mediated through copper-dependent ROS generation. Pre-treatment of A431
cells with neocuproine, a copper chelator, blocked ROS-mediated senescence, and inhibited
resveratrol-induced p21CIP1 and SA-β-Gal activity. A cDNA microarray analysis of senescent
A431 cells revealed a dose-dependent upregulation of Bfl-1, the Bcl2-related protein A1, which
at 100 µM resveratrol concentration showed a 200-fold induction compared to proliferating
control cells. The transcript levels of other Bcl-2 family members were unchanged. Bfl-1 is a
direct transcription target of NF-kappa B. We further show that resveratrol-induced Bfl-1 upreg-
ulation is mediated by NF-kappa B, as it is blocked by a specific NF-kappa B inhibitor. Bfl-1
knockdown in A431 cells using siRNA attenuated resveratrol-induced senescence and p21CIP1
induction. Furthermore, resveratrol treatment of Bfl-1 knockdown A431 cells were shown to
enter apoptosis, associated with caspase-3 activation, wherease senescence was decreased in
these cells. Our findings show that resveratrol faciltates induction of senescence through ROS
generation, and that the balance between senescence and apoptosis may be mediated by Bfl-
1 via NF-kappa B.
167
Polo-like kinase 1 is overexpressed in skin cancer cells and human skin cancers: A novel tar-
get for intervention
TL Schmit, M Nihal and N Ahmad Dermatology, University of Wisconsin, Madison, WI
Skin cancer is the most common form of cancer in the Unites States. A more complete under-
standing of the molecular mechanism of skin cancer development could be useful in design-
ing novel target-based approaches for the management of skin cancers. Polo-like kinases (Plks)
are a family of highly conserved serine/threonine kinases with multiple distinct and overlap-
ping roles, especially in cell division. Plk, the best-characterized member of the human Plk
family plays many crucial functions in the precise regulation of cell division. These include
centrosome maturation, bipolar spindle formation, activation of Cdk1/Cyclin B1 cascade pro-
moting entry into mitosis and finally regulation of anaphase promoting complex (APC) tar-
geted degradation which is necessary for mitotic exit. Studies have shown elevated levels of
Plk1 in many human cancers. However, its precise role in skin cancers is not well-studied.
Here, employing several skin cancer cell lines viz. human squamous cell carcinoma A253
cells, human metastatic melanoma Hs-294T cells, and human epidermoid carcinoma A431
cells, normal human epidermal keratinocytes (NHEK) and human tissue arrays containing a
variety of skin tumors and normal skin tissues, we studied the expression of Plk1 in skin can-
cers versus normal tissues. The immunoblot as well as quantitative real time PCR analyses
demonstrated that Plk1 is significantly overexpressed in A253, Hs-294T and A431 cells com-
pared to the NHEKs. Further, this increase in Plk1 was found to be accompanied with an
increased expression in the protein levels of it’s downstream targets viz. Cdc25C, Cdk1 and
CyclinB1. Furthermore, in our preliminary experiments with human tissue arrays, we found
that Plk1 immunostaining is markedly upregulated in a wide range of skin tumors compared
to the normal no-cancerous skin. Thus, based on our data, we suggest that Plk1 could serve
as a potential target for designing novel approaches for the management of skin cancer. How-
ever, further in-depth mechanistic studies are needed to support and confirm this suggestion.
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Down-regulation of receptor type protein tyrosine phosphatase-kappa activates epidermal
growth factor receptor and stimulates proliferation in squamous cell carcinoma cells
Y Xu, JJ Voorhees and GJ Fisher Dermatology, University of Michigan, Ann Arbor, MI
Epidermal growth factor receptor (EGFR) plays a critical role in tumorigenesis, in a variety of
solid tumors, including squamous cell carcinoma (SCC). EGFR function is dependent on intrin-
sic tyrosine kinase activity, which phosphorylates tyrosine residues in its own intracellular
domain. This auto-phosphorylation promotes assembly of signal transduction complexes that
activate down-stream effectors. EGFR tyrosine phosphorylation is tightly regulated by protein
tyrosine phosphatases, which dephosphorylate the receptor and thereby attenuate signal trans-
duction. Receptor type protein tyrosine phosphatase-kappa (RPTP-κ) is a key regulator of EGFR
activation in human keratinocytes. RPTP-κ reduces both basal and ligand-induced EGFR
tyrosine phosphorylation, thus restraining downstream signal transduction. We have investi-
gated RPTP-κ regulation of EGFR in SCC and SCC-derived SCC-1 cells. Immunohistology
revealed that RPTP-κ is co-expressed with EGFR in suprabasal keratinocytes in normal skin.
In the basal layer, RPTP-κ expression is low. Therefore, the ratio of EGFR to RPTP-κ is rela-
tively high. In SCC, EGFR is abundant, while RPTP-κ is near the limit of detection. Therefore,
SCC, similar to basal keratinocytes, has a relatively high ratio of EGFR to RPTP-κ. Treatment
of SCC-1 cells with the specific EGFR inhibitor PD169540 inhibits growth 75% (N=3), indi-
cating proliferation is EGFR dependent. The level of total EGFR protein is similar while the
level of tyrosine-phosphorylated EGFR in SCC-1 cells is 2-fold higher than in normal human
keratinocytes (N=3, p<0.05). Furthermore, RPTP-κ mRNA level is 4-fold lower in SCC-1 cells
than in normal human keratinocytes (N=2, p<0.05). Adenovirus-mediated over-expression of
RPTP-κ reduces proliferation 80% (N=3, p<0.05). These data indicate that down-regulation
of RPTP-κ could contribute to aberrant EGFR-dependent growth control in SCC, and raise the
possibility that RPTP-κ functions as a heretofore unrecognized tumor suppressor.
S28 Journal of Investigative Dermatology (2007), Volume 127
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Resveratrol suppresses ultraviolet B (UVB)-induced SCC formation in p53+/- /SKH-1 hair-
less mice through modulation of mediators of epithelial to mesenchymal transition (EMT)
KH Kim,1,2 Y Zhu,1 JH Back,1 X Tang,1 L Kopelovich,3 M Athar,1 AL Kim1 and DR Bickers1 1
Department of Dermatology, Columbia University, New York, NY, 2 Hallym University
College of Medicine, Anyang, South Korea and 3 Division of Cancer Prevention, National
Cancer Institute, Bethesda, MD
Resveratrol (trans-3,4’,5-trihydroxystilbene) is a phytoalexin found in grape skin that arrests
the growth of human epidermoid squamous cell carcinoma A431 cells, triggering activation
of a DNA damage checkpoint pathway and p53-independent upregulation of p21CIP1. A cDNA
microarray analysis of the genes regulated by resveratrol in A431 cells suggested involvement
of mediators of EMT which describes a process whereby cancer cells acquire a fibroblast-like
phenotype during tumor progression, including invasion and metastasis. Here we show that
the in vitro invasiveness and migration capacity of A431 cells were largely abrogated by resver-
atrol treatment, which was associated with increased expression of an epithelial marker, E-
cadherin, but downregulation of a mesenchymal marker, snail. We next employed both p53
null and p53+/-/SKH-1 hairless mice to further assess the effect of resveratrol on EMT. Orally
administered resveratrol (200 mg/kg body weight, three times a week for 10 weeks) dramati-
cally suppressed epidermal hyperplasia induced by UVB irradiation (180 mJ/cm2, twice a week).
p53-independent induction of p21CIP1 protein was detected in the skin of the resveratrol-
treated p53 null mice. In p53+/-/SKH-1 hairless mice, oral resveratrol inhibited UVB-induced
skin tumorigenesis. At week 25, resveratrol-treated mice showed a substantial reduction in both
total skin tumor number and size, showing 43% and 79% decreases, respectively, compared
to the UVB-irradiated control mice. Furthermore, the number of SCCs in the resveratrol-treated
mice was 70% less than in the UVB-only group. Immunohistochemical studies indicate a
decrease in snail and an increase in E-cadherin in SCCs harvested from resveratrol-treated mice,




Link between desmosomal protein expression, deregulation of signaling pathways, and skin
tumor development
D Brennan, Y Hu, J Uitto, U Rodeck and MG Mahoney Dermatology and Cutaneous Biology,
Thomas Jefferson University, Philadelphia, PA
Desmoglein 2 (Dsg2) expression correlates with invasion and metastasis of human squamous
cell carcinomas. Here we show that Dsg2 contributes to the malignant phenotype of mouse
keratinocytes (in vivo and in vitro). Enhanced expression of Dsg2 in the epidermis of trans-
genic mice resulted in extensive hyperplasia and increased keratinocyte proliferation poten-
tially due to high level of expression of the pro-survival protein Bcl-XL and the proto-onco-
gene c-Myc. Dsg2 expression also enhanced activation of multiple growth and survival signaling
pathways including PI-3-kinase/AKT, MEK/MAPK, and NF-κB. We observed an increase in
p65 expression and nuclear localization in transgenic compared to wild-type skin indicative
of NF-κB activation. Epidermal overexpression of Dsg2 was associated with the development
of intraepidermal skin lesions resembling precancerous papillomas and rendered the trans-
genic epidermis more susceptible to chemically induced carcinogenesis. Cultured keratinocytes
from transgenic mouse skin showed enhanced cell survival in the anchorage-independent
state that was critically depended on EGF receptor activation and NF-κB activity. Dsg2 expres-
sion did not alter plakoglobin expression or subcellular localization but did significantly reduce
the cytoplasmic and nuclear levels of β-catenin, a transcriptional cofactor in Wnt signaling.
This work establishes a previously unrecognized link between desmosomal protein expres-
sion, deregulation of signaling pathways, and squamous cell carcinoma development.
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Mutant mtDNAs exhibit UV signatures and establish genetic dominance in non-melanoma
skin cancers
JE Sligh1,2 and W Girald-Rosa1,2 1 VA TN Valley Healthcare System, Nashville, TN and 2
Division of Dermatology, Vanderbilt Univ Medical Center, Nashville, TN
Mitochondrial DNA (mtDNA) mutations have been found in a variety of human malignan-
cies, although their exact role in disease pathophysiology remains to be completely under-
stood. Proposed theories to explain the role of these mtDNA changes in tumorigenesis have
included that they impart a possible selective growth advantage to the cells, or contribute to
resistance to apoptosis. We explored the role of mitochondrial DNA (mtDNA) changes in non-
melanoma skin cancer (NMSC). Paired tissue specimens of NMSC tumors and tumor-free
margin skin were obtained from surgical excisions. Total genomic DNA was isolated and poly-
merase chain reaction was used to amplify the mtDNA. We analyzed mtDNAs from the tumors
at the single base level for point mutations by temperature gradient capillary electrophoresis
(TGCE) screening or DNA sequencing of mitochondrial genomes. TGCE is a high throughput
mutation discovery system based on heteroduplex detection which allows for screening of
over five entire human mitochondrial genome equivalents in a multiplexed fashion on a sin-
gle microplate. Homoplasmic point mutations in the mtDNA were detected including protein
synthesis mutations in the mtDNA-encoded rRNA subunits and specific missense mutations
affecting subunits of Complex I and IV. Most of the mtDNA variants found were G to A and C
to T base transitions. A dipyrimidine CC to TT transition in the CO2 gene sequence of the
complex IV was found in a SCC tumor sample. In addition, homoplasmic tRNA mutations
have been detected in NMSC cell lines. These DNA changes are consistent with the types of
changes that are seen in the nuclear genome in response to ultraviolet radiation. However,
their establishment from single copy events to become the only mtDNA type in the cells (homo-
plasmy) is a process that can only be explained by a genetic dominance of the mutant alleles
over the wildtype alleles. The functional consequences and mechanisms of dominance of these
point mutations is currently being evaluated in a cytoplasmic hybrid system.
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Induction of senescence by resveratrol in epidermoid squamous cell carcinoma cells involves
activation of the cell cycle checkpoint regulator, Chk2
Y Zhu,1 JH Back,1 KH Kim,1,2 M Athar,1 DR Bickers1 and AL Kim1 1 Department of
Dermatology, Columbia University, New York, NY and 2 Hallym University College of
Medicine, Anyang, South Korea
Cellular senescence is a state of irreversible terminal growth arrest that is emerging as an attrac-
tive cancer treatment strategy. The cell cycle checkpoint regulator, Chk2, is a key DNA dam-
age signal transducer which, in response to DNA damage, inhibits Cdc25C phosphatase and
stabilizes the tumor suppressor protein p53, leading to cell cycle arrest in G1. Mutations in
Chk2 have been linked with Li-Fraumeni syndrome and confer a predisposition to various
human cancers. Here we show that resveratrol, a phytoalexin derived from grapes, induces
cellular senescence in various human and murine skin carcinoma cell lines, including both
squamous cell (A431 and SCC13) and basal cell (AZ001) carcinomas. Transcriptionally silent,
senescence-associated heterochromatin foci (SAHF) are known to be dependent on the pRb
tumor suppressor pathway and may repress proliferation-promoting genes. In A431 cells, het-
erochromatic structures were found to accumulate in resveratrol-treated senescent cells. This
included increases in heterochromatin protein 1 (HP1). Furthermore, resveratrol-induced senes-
cence is associated with the phosphorylation-dependent activation of Chk2, upregulation of
p21CIP1 and p27KIP1, hypophosphorylation of pRb, and downregulation of cyclin D1. This
resveratrol-mediated p21CIP1 induction is p53-independent, since A431 cells carry mutant
p53. We also found that resveratrol induces p53-independent senescence in epidermal ker-
atinocytes derived from UVB-irradiated p53-/-SKH-1 hairless mice, but not in cells from non-
irradiated mice, indicating that senescence induction in the skin requires activation of the DNA
damage pathway. Our data suggest that the induction of cancer cell senescence by resvera-
trol could be a potentially useful novel strategy for the treatment and prevention of human
non-melanoma skin cancer.
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MAGE-A and C antigens form complexes with Kap1 and p53, and suppress apoptosis in MAGE
positive tumor cells
B Yang, SM O’Herrin, J Wu, S Reagan-Shaw, Y Ma, KM Bhat, V Setaluri and BJ Longley
Dermatology, University of Wisconsin, Madison, WI
The MAGE-A and C antigens are Class-I Cancer Testes antigens that are normally expressed
in sperm, but may be aberrantly expressed in melanomas and other malignancies. The func-
tions of most MAGE proteins are unknown but accumulating evidence hints that expression
of MAGE proteins may provide a survival advantage to tumors. Kap-1 is an ~106 kD protein
that is a known co-repressor of p53 and has recently been shown to localize to nuclear sites
of DNA strand breakage and to participate in DNA repair. Here we show that MAGE-A and
MAGE-C proteins, and p53, form complexes with Kap-1 and that siRNA suppression of MAGE-
A and MAGE-C genes causes increased expression of p53. Furthermore, we have shown that
suppression of MAGE genes induces apoptosis in malignant mast cells and in melanoma cells
in vitro and that treatment with MAGE specific siRNA suppresses growth of these cells in vivo.
Thus MAGE gene expression may protect cells from programmed cell death due to DNA
damage, and may actively contribute to the development of malignancies by promoting sur-
vival. Since the expression of Class I MAGE proteins is limited in normal tissues, inhibition of
MAGE antigen expression or function represents a novel and specific treatment for melanoma
and diverse malignancies. Thus MAGE proteins represent a novel target for drug discovery
and development.
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Growth of murine basal cell carcinomas (BCCs) in a transplantation model
K Zhang,1 PL So,1 J Hebert,1 ML Mancianti,2 E Epstein1 and R Ghadially1 1 Dermatology,
University of California, San Francisco, San Francisco, CA and 2 Pathology, Alta Bates
Medical Center, Berkeley, CA
A murine model of BCC would be of great utility to study the molecular mechanisms of BCC.
Previous efforts to transplant human BCCs into immunodeficient mice produced little or no
growth [Grimwood and Tharp, 1991]. Furhermore, transplanting of murine skin containing
visible BCCs onto the backs of immunodeficient mice was followed by retention of the graft
but loss of the tumor (unpublished data, Epstein lab). In these studies we isolated single cell
suspensions from macroscopic murine BCCs (Ptc +/- mice) and assayed these cells in vivo for
tumor initiating capability using the in vivo competitive repopulation assay with normal mouse
epidermal keratinocytes [Schneider, et al., 2003]. The BCC test cells are beta-galactosidase
positive. We found beta-galactosidase+ colonies that resembled microscopic BCCs in situ,
with clusters of beta-galactosidase+ cells around follicle-like structures. Such structures have
not been seen in more than 20 previously-studied preparations from normal keratinocytes. We
also seeded BCC cell line (ASZ001) cells into the chambers with or without normal mouse
keratinocytes. Chambers prepared with only ASZ001 cells had tumors filling the stroma but
lacked a surface epithelium whereas those prepared with ASZ001 cells and normal mouse
keratinocytes had both stromal tumors and surface epidermis. This strongly suggests that the
ASZ001 cell line retains BCC characteristics when placed under the proper environmental
conditions. Our ability to dependably transplant murine BCCs and the BCC cell line ASZ001
onto immunodeficient mice and have them grow well is in marked contrast to previously
published efforts, and may reflect the placement of the BCC cells in the proper environmen-
tal conditions.
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Hairless mutation in SKH1 mice confers susceptibility to ultraviolet-B (UVB)-induced tumori-
genesis via disruption of NFκB signaling
H Kim,1 A Casta,2 T Cirman,3 X Tang,3 DR Bickers,3 M Athar3 and AM Christiano1,2,3 1
Genetics and Development, Columbia University, New York, NY, 2 Inst. of Human Nutrition,
Columbia University, New York, NY and 3 Dermatology, Columbia University, New York, NY
SKH1 mice are the classical model for UVB-tumorigenesis studies, since they are convenient to
irradiate due to the absence of hair, and are highly susceptibility to tumors. We asked whether
SKH1 carry a mutation in the hairless (Hr) gene, and further, we postulated that the disruption
of Hr itself may confer tumor susceptibility in SKH1 mice. Molecular analysis of SKH1 identi-
fied the proviral insertion in the Hr gene, allelic with hr/hr. We first performed a long-term UVB-
tumorigenesis protocol with hr/hr and compared tumor latency with SKH1. SCCs developed by
week 38 in hr/hr vs. week 25 in SKH1, whereas wt littermates remained free of tumors at week
50. To gain mechanistic insights into HR function, we performed a microarray analysis which
unexpectedly revealed differential expression of NFκB target genes. FACs, epidermal morphometry
and Ki-67 staining revealed that SKH1 keratinocytes demonstrate an increased level of basal pro-
liferation at homeostasis. Following short-term UVB irradiation, SKH1 keratinocytes showed
decreased apoptosis, failure to upregulate p53, and attenuated G1 arrest, as well as sustained
proliferation. We found constitutively elevated levels of NFκB/p65 and decreased IκB in SKH1
epidermis at homeostasis, and increased NFκB/p65 response to UV. Using an NFκB activity
reporter construct, we observed elevated basal NFκB signaling in Hr mutant cells. The defect
was rescued and normal NFκB activity was restored by introduction of HR into mutant cells, in
a dose-dependent manner. Finally, to test whether SCCs could be attenuated in SKH1 animals
by blockade of NFκB signaling in vivo, we administered the NFκB inhibitors pyrrolidinedithio-
carbamate and sulfasalazine, and found that UVB-induced tumor incidence was reduced by
~90%. We have uncovered a novel mechanistic role of Hr as a repressor of NFκB signaling,
which upon mutation confers susceptibility to UVB-induced tumorigenesis.
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Toward creating epidermal cancer stem cells by reactivation of an embryonic stem cell tran-
scriptional program
DJ Wong,1 H Liu,1 TW Ridky,1 D Cassarino,2 E Segal3 and HY Chang1 1 Program in Epithelial
Biology, Stanford University, Stanford, CA, 2 Department of Pathology, Stanford University,
Stanford, CA and 3 Department of Computer Science and Applied Mathematics, Weizmann
Institute, Rehovot, Israel
Stem cells and cancer share the property of self-renewal, but whether aberrant activation of a
stem cell self-renewal program is a central mechanism of cancer has remained unclear. Using
a module map to systematically relate gene expression programs in embryonic and adult tis-
sue stem cells as well as human cancers, we found that human cancers of various tissue types
commonly activate an embryonic stem (ES) cell gene expression program compared to their
normal tissue counterparts. Tumors with an activated ES cell transcriptional program are sig-
nificantly associated with higher tumor grade and increased risk of metastasis and death. We
found that the ES cell transcriptional program can be reactivated in adult epithelial cells by c-
Myc, but not other oncogenes, such as H-ras, E2F3, Src, and β-catenin. By regenerating human
squamous cell carcinomas in vivo with defined genetic elements in primary keratinocytes, we
show that addition of c-Myc to cells transformed by H-ras and IkB is sufficient to reactivate
the ES cell gene program, inhibit tumor differentiation, and increase the efficiency of tumor
initiation by over 100-fold.
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Characterization of cells with cancer stem cell properties in skin squamous cell carcinoma
K Murao,1 W Buitrago1 and DR Roop1,2 1 Molecular and Cellular Biology, Baylor College of
Medicine, Houston, TX and 2 Dermatology, Baylor College of Medicine, Houston, TX
Recent studies in leukemias and some solid tumors have identified a population of cancer
stem cells (CSCs) that share characteristics of tissue-specific stem cells (SCs) but are malignant.
The epidermis and skin adnexal structures are renewed by SCs found in the basal layer of the
interfollicular epidermis and in the bulge region of the hair follicles. The long lifespan of skin
SCs predisposes them to accumulate mutations induced by environmental insults. Therefore,
human skin and skin adnexal tumors are thought to arise from mutated SCs that renew these
tissues. However, to date, CSCs have not been isolated from these tumors. We isolated cells
derived from mouse squamous cell carcinomas (SCCs) and characterized them with respect
to CD49f (α6-integrin) and CD34 staining, which are markers for SCs in the bulge region of
mouse hair follicles. 75% of the cells were positive for CD49f and 3% for CD34, while 2%
were positive for both markers. We then determined the tumor formation capacity of these
cell populations in vivo. We transplanted 10,000 CD49f+/CD34+, CD49f+/CD34-, CD49-
/34+, and CD49-/34- cells respectively along with 1 million normal keratinocytes and fibrob-
lasts onto nude mice. All populations but the CD49-/34- cells produced secondary tumors that
retained the original cellular heterogeneity and could be serially passed indicating enrichment
for skin CSCs. Grafts containing CD49-/34- cells or cells expressing intermediate levels of
CD49f and/or CD34, even in large numbers (200,000 or more), failed to produce new tumors.
We also utilized a novel sorting method which is based on the discovery that SCs from a vari-
ety of tissues and tumors have the capacity to efflux Hoechst dye. This population is termed
“Side Population” or “SP” cells. We showed that SCCs have SP cells and that, in the grafting
assays, as little as 2,600 SP cells give rise to secondary tumors while the non-SP cells do not.
Our results suggest that the SP sorting method may be an alternative procedure for the further
enrichment of skin CSCs.
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Loss of the Xeroderma Pigmentosum C (Xpc) gene enhances melanoma photocarcinogene-
sis in Ink4a-Arf-deficient Mice
G Yang,1 M Bosenberg3 and H Tsao1,2 1 Wellman Center for Photomedicine, MGH, Boston,
MA, 2 MGH Cancer Center, MGH, Boston, MA and 3 Pathology, University of Vermont,
Burlington, VT
Despite an extensive body of evidence linking ultraviolet radiation (UVR) and melanoma
tumorigenesis, a clear mechanistic understanding of this process is still lacking. Since herita-
ble mutations in both INK4a and the nucleotide excision repair (NER) pathways predispose
individuals to melanoma development, we set out to test the hypothesis that abrogation of
NER, by deletion of the Xeroderma Pigmentosum C (Xpc) gene, heightens melanoma photo-
carcinogenesis in an Ink4a-Arf-deficient background. Experimentally, we generated a strain of
mice doubly deficient in Xpc and Ink4a-Arf and subjected wild-type, Xpc-/-Ink4a-Arf+/+, Xpc-
/-Ink4a-Arf-/- and Xpc+/+Ink4a-Arf-/- mice to a single neonatal (P3) dose of UVB without addi-
tional chemical promotion. Indeed, there was a significant increase in the development of der-
mal spindle/epithelioid cell melanomas in Xpc-/-Ink4a-Arf-/- mice when compared to
Xpc+/+Ink4a-Arf-/- mice (P=0.005); wild-type and Xpc-/-Ink4a-Arf+/+ mice failed to develop
tumors. These neoplasms bore a striking histological resemblance to melanomas that arise in
the Tyr-vHRAS/Ink4a-Arf-/- context and often expressed melanocyte differentiation marker
Tyrp1 thus supporting their melanocytic origination. All strains except wild-type mice devel-
oped pigmented and non-pigmented epidermal-derived keratinocytic cysts while Xpc+/+Ink4a-
Arf-/- mice exhibited the greatest propensity for squamous cell carcinoma development. We
then screened for NRas, HRas, KRas and BRaf mutations in tumor tissue and detected a higher
frequency of rare KrasQ61 alterations in tumors from Xpc-/-Ink4a-Arf-/- mice compared to
Xpc+/+Ink4a-Arf-/- mice (50% vs. 7%, P=.033). Taken together, results from this novel UV-
inducible melanoma model suggest that NER loss, in conjunction with Ink4a-Arf- inactivation,
can drive melanoma photocarcinogenesis possibly through signature Kras mutagenesis.
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Cross linkage in the extracellular matrix of the dermis – a role in intrinsic skin ageing?
MI Fowler, LJ Wainwright and G Jenkins LifeScience, Unilever R&D, Sharnbrook, United
Kingdom
Intrinsic skin ageing is unavoidable and inevitable in every human being. The common his-
tological features of intrinsically aged skin include a gradual reduction in the extracellular
matrix integrity. Advanced Glycated End products (AGEs) accumulate in long-lived proteins
such as collagen and may be a significant contributor to skin ageing. In order to test this hypoth-
esis, we have established a synthetically glycated 2-dimensional skin model in vitro and believe
this model mimics that of an intrinsically aged dermis. Collagen gels were treated with vari-
ous concentrations of ribose solutions for 2 days. The gels were washed thoroughly with PBS
to remove any remaining ribose, and then used as a scaffold for the growth of primary dermal
fibroblasts. The presence of AGEs in the glycated collagen gels was quantitated by fluores-
cence measurements at 360/460nm. We demonstrated a dose response increase in fluores-
cence signal indicating an increase in AGE products in ribose-glycated dermal equivalents in
vitro. Subsequent growth of skin fibroblasts of these gels resulted in significant reduction in
the expression of Procollagen 1 and Fibrillin 1, and increases in Collagenase (MMP-1) and
Stromelysin (MMP-3). These changes in extracellular matrix markers are indicative of an in
vitro intrinsically aged skin model.
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Calcium metabolism and proteolysis of cytoskeletal proteins in psoriasis: glycoproteomic,
peptidomic and immunochemical study of human plasma
T Plavina,1,2 M Hincapie,2 E Wakshull1,3 and WS Hancock2 1 Biogen Idec, Inc., Cambridge,
MA, 2 Barnett Institute and Department of Chemistry and Chemical Biology, Northeastern
University, Boston, MA and 3 Genentech, Inc., South San Francisco, CA
Psoriasis is an autoimmune disease targeting the skin and characterized by inflammation,
hyperproliferation and abnormal differentiation of keratinocytes, and angiogenesis. To iden-
tify candidate protein or peptide biomarkers of psoriatic pathology, 20 plasma samples from
psoriasis patients and 20 matched plasma samples from healthy donors were analyzed using
two mass spectrometry-based methods. The first method evaluated changes in levels of gly-
coproteins, known to play an important role in autoimmune disorders, and comprehensively
surveyed the plasma proteome. In this method, removal of abundant plasma proteins and
multi-lectin affinity chromatography enabled enrichment of plasma glycoproteins and their
targeted analysis. The second method, peptidomics, allowed evaluation of potential changes
in proteolytic activity of certain classes of proteases via analysis of low molecular weight com-
ponent of plasma. The experimentation identified a number of cytoskeletal, extracellular matrix
and Ca2+ metabolism-related proteins and their proteolytic fragments present at different
levels in plasma of psoriasis patients and healthy donors; several of them were verified by
ELISA. In addition, activity of calpain, a neutral calcium-activated cysteine protease, that tar-
gets cytoskeletal proteins, was shown to be elevated in plasma of psoriasis patients as com-
pared to healthy donors. Finally, the occurrence of auto-antibodies against natural calpain
inhibitor, calpastatin, and against cytoskeletal proteins was shown to be more frequent in
plasma of psoriasis patients as compared to plasma of healthy donors. These findings suggest
an involvement of the calcium homeostasis, proteolytic system, and cytoskeletal proteins in
the psoriatic disease process, and may further the understanding of the autoimmune patho-
genesis of the disease and its modulation by current and emerging therapeutics.
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Regulation of phosphorylation status of adhesion molecules in pemphigus
SA Grando,1 A Chernyavsky,1 J Arredondo,1 M Sato-Nagai2 and Y Kitajima2 1 Dermatology,
University of California, Davis, CA and 2 Dermatology, Gifu University, Gifu, Japan
Inhibitors of serine/threonine, and tyrosine kinases as well as cholinergic agonists have been
shown to block PVIgG-induced acantholysis. PVIgG alters cell shape and intercellular adhe-
sion of keratinocytes (KCs) via biochemical events downstream of desmoglein and non-
desmoglein targets of autoantibodies. In this study, we identified signaling events downstream
of each class of self-antigens using Dsg 1 and/or Dsg 3 silencing by RNA interference. Cell
shrinkage and disassembly of desmosomes were caused by signaling events involving Src
and EGF receptor kinases, whereas activation of p38 MAPK was associated with collapse of
the cytoskeleton. The extent of acantholysis in keratinocyte monolayers correlated closely with
the degree of PV IgG-induced phosphorylation of p120- and β-catenins. To establish the
pathway downstream of keratinocyte acetylcholine receptors that protect KCs from acan-
tholysis, we investigated effects of the muscarinic and nicotinic agonists pilocarpine and AR-
R17779, respectively. Pilocarpine blocked phosphorylation of both p120- and β-catenins,
whereas AR-R17779 inhibited phosphorylation only of p120-cateinin, which could be abol-
ished by the muscarinic and nicotinic antagonists, respectively. Okadaic acid abolished pro-
tective effects of agonists on phosphorylation of β-catenin, and pervanadate on that of p120-
catenin. Stimulation of KCs with pilocarpine significantly (p<0.05) elevated activities of both
serine/threonine and tyrosine phosphatases. AR-R17779 did not affect phosphatase activities
but decreased PVIgG-induced Src activity, which was abolished in the presence of antago-
nist, indicating that keratinocyte nicotinic receptor can directly inactivate Src. Furthermore,
interruption of ACh signaling in intact KCs trough α7 nAChR released Src activity and caused
acantholysis. These findings identified novel paradigm of regulation of signaling kinases asso-
ciated with nicotinic receptors, and provided mechanistic explanation of therapeutic activity
of cholinomimetics in PV patients.
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Kindlin-1 is important in human keratinocyte cell adhesion, spreading, migration and pro-
tection from apoptosis in vitro
JR McMillan,1,2 H Qiao,1,2 M Akiyama,1 K Yasukawa,1 M Goto,1 D Sawamura,1 R Abe,1
A Shibaki1 and H Shimizu1 1 Department of Dermatology, Hokkaido University Graduate
School of Medicine, Sapporo, Japan and 2 Creative Research Initiative Sousei, Hokkaido
University, Sapporo, Japan
Kindler syndrome (KS) is a rare disorder leading to keratinocyte fragility, poikiloderma and
palmar hyperkeratosis (OMIM173650). Defects in the actin/focal contact associated protein
kindlin-1 encoded by the gene KIND1 have been shown to underlie this disease. We assessed
the function of kindlin-1 in human keratinocytes and fibroblasts using RNAi knockdown. RNAi
treatment reduced KIND1 message by 72% and 63% in cultured keratinocytes and fibrob-
lasts, respectively. RNAi treatment reduced cultured keratinocyte but not fibroblast cell adhe-
sion to plastic. Furthermore, kindlin-1 depletion reduced keratinocyte (but not fibroblast) sur-
vival by increasing rates of adherent keratinocyte apoptosis, as detected by TUNEL staining.
Kindlin-1 depleted keratinocytes demonstrated an initial delay in cell spreading and filopo-
dia formation (as observed by scanning EM) but were associated with some focal adhesion /
contact assembly (as visualized by vinculin staining). Keratinocyte (but not fibroblast) migra-
tion was increased after kindlin-1 depletion. Taken together our data suggest that kindlin-1
plays important roles in keratinocyte cell-substrate adhesion, spreading, migration and in
keratinocyte survival in vitro. These observations may explain the loss of keratinocyte-base-
ment membrane adhesion in the pathogenesis of KS induced skin fragility. Furthermore, reduc-
tions in keratinocyte survival and/or increased rates of apoptotic cell death may underlie the
early-onset poikiloderma observed in KS cases.
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Existence of a DNA element between -332 and -402 of the human COL1A1 promoter that
elevates the transcription of COL1A1
T Yoshida, H Ikeda, H Suzuki, Y Kitamura, S Yamazaki and A Hatamochi Dokkyo University
School of Medicine, Mibu, Japan
The regulation of type I collagen gene expression plays an important role in fibrosis and skin
atrophy. However, a deletion analysis of the 5-flanking region of the humanα1(I) collagen gene
(COL1A1) to investigate the transcriptional activity of human COL1A1 has not been satisfac-
torily performed. We report the existence of a DNA element located between -332 and -402
that elevates promoter activity and the existence of a factor that binds to this region. Methods:
Dermal fibroblasts were plated and cultured to 50% confluence in 60-mm dishes, then co-
transfected using a COL1A1 luciferase construct and a CMV renilla luciferase construct using
a FuGene 6 kit. COL1A1-luciferase constructs containing 2,300, 804, 610 and 332 bp of the
5-flanking region of COL1A1 were used. Plasmids containing COL1A1 luciferase constructs
with -610, -529, -481, -402 and -332 bp deletions of the 5-flanking region were also used.
Forty-eight hours later, the cells were harvested and lysates were prepared; the luciferase activ-
ity was then determined. A gel mobility shift assay was also performed. Results: The relative
luciferase activity remained unchanged when DNA containing -804 bp or -610 bp of COL1A1
were transfected, whereas when DNA containing 332 bp of COL1A1 was transfected, the rel-
ative luciferase activity was remarkably reduced. We then analysed the promoter activity using
more precise deletion constructs and found a clear reduction when the -402 to -332 pro-
moter region was deleted. We also identified a binding factor that binds to the short DNA
fragment between -402 and -332. These results suggest the presence of a DNA element between
-332 and -402 of the COL1A1 5-flanking region that activates the transcription of COL1A1
and the existence of a DNA binding factor related to this activity.
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Proteomic investigation of human wounds by 2D-difference gel electrophoresis and mass
spectrometry
AC Pollins, DB Friedman and L Nanney Vanderbilt Medical Center, Nashville, TN
In humans, thermal cutaneous injury represents a serious traumatic event that induces a host
of dynamic alterations. Unfortunately the molecular mechanisms that underlie these serious
perturbations remain poorly understood. We applied a global analysis method to identify
dynamically changing proteins within the cutaneous burn environment. Protein extracts of
normal/unwounded skin and burn wound skin were assayed by 2D difference gel elec-
trophoresis (DIGE), a proteomic technology by which abundance levels of intact proteins
(including isoforms) were simultaneously quantified from multiple samples with statistical con-
fidence. Through unsupervised multivariate principal component analysis, protein expression
patterns from individual samples were appropriately clustered into their correct temporal heal-
ing periods grouped into postburn periods of 1-3 days, 4-6 days or 7-10 days after injury. Forty-
six proteins were subsequently selected for identification by matrix assisted laser desorp-
tion/ionization-time of flight-mass spectrometry (MALDI-TOF-MS). Twenty proteins, some with
multiple isoforms, were identified with differential temporal patterns of expression. These
included predictable cytoskeletal proteins such as vimentin, and keratins 1, 5, 6, 16, and 17.
Other identified proteins with potential involvement in wound healing included HSP90, mem-
bers of the serpin family (Serpin B1, SCCA1 & 2), haptoglobin, gelsolin, eIF4A1, IQGAP1,
and TCTP. We have utilized the combined technique, DIGE/MS, to capture new insights into
cutaneous responses to burn trauma and the subsequent processes of early wound healing in
humans. This pilot study provides a proteomic snapshot of temporal events that can be used
to weave together the interconnected processes that define the wound healing response to
serious cutaneous injury.
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The slingshot family of phosphatases mediates Rac1 regulation of cofilin phosphorylation,
laminin-332 organization and motility behavior of keratinocytes
KR Kligys, JN Claiborne, PJ DeBiase, SB Hopkinson and JC Jones Cell and Molecular Biology,
Northwestern University, Chicago, IL
The directed motility of keratinocytes is an essential component of the closure of skin wounds
and the development of epidermal tumors. In vitro, the specific motile behavior of keratinocytes
is dictated by the assembly of laminin-332 tracks, a process that is dependent upon α6β4
integrin signaling to Rac 1 and the actin severing protein cofilin. Here we have analyzed how
cofilin phosphorylation is regulated by certain phosphatases [the slingshots (SSHs) or chronophin
(CIN)] downstream of signaling mediated by α6β4 integrin/Rac 1 in human keratinocytes. Ker-
atinocytes express all known members of the SSH family (SSH-1, -2, -3) and CIN. However,
in keratinocytes, expression of dominant negative SSH-1, -2, -3, but not dominant inactive
CIN, results in a phosphorylation/inactivation of cofilin, changes in actin cytoskeleton organ-
ization, loss of cell polarity, assembly of circular arrays of laminin-332 and aberrant cell motil-
ity. SSH activity is regulated by 14-3-3 protein binding, and, intriguingly, 14-3-3-α6β4 inte-
grin protein interaction is required for keratinocyte migration. Thus, we wondered whether
14-3-3 proteins function as molecular switches regulating the mechanism by which Rac1 deter-
mines keratinocyte migration patterns. In support of our hypothesis, inhibition of Rac1 results
in an increase in 14-3-3 protein association with SSH and a concomitant loss of 14-3-3 pro-
tein interaction with α6β4 integrin. In contrast, initiation of keratinocyte migration results in
an increase in 14-3-3 association with α6β4 integrin and a decrease in 14-3-3-SSH interac-
tion. Together these data allow us to propose a novel mechanism in which α6β4 integrin sig-
naling via Rac1, 14-3-3 proteins and SSH family members regulates cofilin activation, cell
polarity and matrix assembly, leading to specific epidermal cell migration behavior.
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Ultrastructural changes in differentiating preadipocytes treated with an “uncoupling protein-
like” peptide
GK Menon,1 C DalFarra2 and N Domloge2 1 New Technology, Avon Products, Inc., Suffern,
NY and 2 Vincience Research Center, Sophia Antipolis Cedex, France
The aim of this study was to evaluate the effects of a peptide designed to mimic the uncou-
pling protein, on differentiated preadipocytes (3T3L). We compared the gross lipid staining at
light microscopic level and ultrastructural features of control, differentiated, as well as differ-
entiated cells that were treated with the peptide at different concentrations. Light microscopy
after dose and time course studies showed a reduction of cellular lipid content following pep-
tide treatment versus differentiated controls. Transmission electron microscopy (TEM) did not
reveal expected ultrastructural alterations in the mitochondria, the site of uncoupling of oxida-
tive phosphorylation. However, TEM provided insights as to an unexpected mode of action of
the peptide which enhances lipolysis. These results provide supporting rationale for use of
this peptide as a cosmetic ingredient to regulate dermal adiposity.
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A new anti-aging rice extract enhances collagen I and III synthesis
R Chabert, E Bauza, C Gondran, G Bressier, T Marchand, C Dal Farra and N Domloge
Vincience, ISP Global Research Center, Sophia Antipolis, France
One of the main challenges in the fields of dermatology and cosmetology is understanding
cutaneous alterations which contribute to skin aging. Structural changes occurring in aged
skin are mainly attributed to modifications of the dermal compartment, and, in particular, mod-
ifications in collagen I and III—the main targets of physiological aging and photoaging. Not
only do collagen I and III play a crucial role in maintaining the structural integrity of the skin,
but they are also strongly implicated in tissue remodeling, wound healing, cell adhesion, and
cell migration. Alterations in collagen structure, as well as decreased collagen synthesis, can
result in sagging skin and wrinkle formation. Therefore, restoring the collagen network appears
to be an important step in anti-aging strategies for the skin. For this purpose, we developed a
new rice extract and tested its activity on collagen I and III expression in cultured human der-
mal fibroblasts and in skin biopsies. Immunoblotting studies on human fibroblasts revealed
that treatment of fibroblasts with 1% of the new extract for 48 hours enhanced collagen I syn-
thesis by +42%. Moreover, this treatment of cells significantly enhanced collagen III synthe-
sis by +110%. These results were confirmed by immunostaining experiments on cultured
human fibroblasts, which showed an increase in collagen I and III synthesis when the cells
were treated with 1% and 3% of the extract for 24 and 48 hours. Moreover, immunostaining
of human ex vivo skin, treated for 24 h and 48 h with 1% and 3% of the new extract, revealed
an enhancement of collagen expression in these skin samples over the control skin. Taken
together, these results suggest that this new rice extract can be of great use in anti-aging skin
care products.
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An antioxidant (Cys-Gly)2 dimer peptide that exhibits very interesting protection against gly-
cation stress
A Perrin, E Bauza, I Imbert, G Bressier, T Marchand, C Dal Farra and N Domloge Vincience,
ISP Global Research Center, Sophia Antipolis, France
The skin is constantly exposed to different stresses, including environmental stress such as UV
irradiation, and nutritional stress. These stresses, in turn, generate oxidative stress and the gly-
cation process in the skin, which lead to damaged skin structure and early aging. Glycation
is a non-enzymatic process that involves the binding of proteins or lipid molecules to sugars,
which leads to impaired functioning of cell biomolecules. Stress also leads to free radical for-
mation and the damaging oxidative stress that results from free radicals. All this is very harm-
ful for the functional and structural properties of the cell. Therefore, we were interested in eval-
uating the antioxidant and protective against glycation properties of the new (Cys-Gly)2
dimer peptide. In this study, we investigated the effect of 1% of the dimer peptide on SOD Mn
and catalase activity, protein carbonylation, and glycation, after UVA and methyl glyoxal stress,
in cultured human fibroblasts and ex vivo human skin. These studies showed that treatment
of cells with 1% of the dimer peptide, for 24 h before UVA stress with 9 J, and 4 h after, increased
SOD Mn and catalase activity by 25% and 17%, respectively, and significantly diminished
protein carbonylation (-394%). Moreover, treatment of cells with the dimer peptide signifi-
cantly increased their viablility by +8.61% (p=0.0445), after glycation stress with 0.5mM of
methyl glyoxal. This protective result was highly significant and reached 14.3% (p=0.0033)
when cells were stressed with 1mM of methyl glyoxal. These results were confirmed by stud-
ies on ex vivo human skin, even when doses of methyl glyoxal reached 5mM and 10mM. Taken
together, these results suggest that the (Cys-Gly)2 dimer peptide possesses antioxidant prop-
erties and exhibits interesting protection against glycation stress, that can be of great use in
anti-aging skin care products.
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Effect of Ac-SDKP, ramipril, and spironolactone on skin fibrosis in murine bleomycin-induced
scleroderma
S Desai,1 OA Carretero,2 N Rhaleb,2 H Peng2 and HW Lim1 1 Dermatology, Henry Ford
Health System, Detroit, MI and 2 Hypertension and Vascular Research, Henry Ford Health
System, Detroit, MI
Murine bleomycin(BLM)-induced scleroderma demonstrates localized skin fibrosis similar to
that seen in human scleroderma. Ac-SDKP is an endogenous peptide which has been shown
to inhibit cardiac fibrosis, by blocking a TGF-β-mediated profibrotic pathway in animal mod-
els of hypertension. Angiotensin-converting enzyme inhibitors (ACEi) reduce hydrolysis of
Ac-SDKP, and both ACEi and Ac-SDKP reduce profibrotic cytokines and collagen levels in ani-
mal models. Aldosterone-receptor antagonists (ARA) reduce cardiac fibrosis in animal mod-
els of cardiomyopathy. We have characterized the effects of Ac-SDKP, ramipril (ACEi), and
spironolactone (ARA) in murine BLM-induced scleroderma to see if these anti-fibrotic med-
ications reduce skin fibrosis. We determinted the skin collagen content (SCC) of treated ani-
mals by using a hydroxyproline assay. SCC is expressed as mean collagen content (µg/dry tis-
sue weight) +/- standard error. SCC was increased two-fold in untreated BLM-injected animals
versus controls (292.6 +/- 18.1 vs. 143.8 +/- 17.2, p<0.0001). SCC was reduced in BLM-
injected animals treated with Ac-SDKP alone (237.8 +/- 16.0, p=0.03) and ramipril alone
(230.2 +/- 16.7, p=0.01), but not in animals treated with spironolactone (258.0 +/- 16.4,
p=0.16). There was no significant difference in SCC between the Ac-SDKP and ramipril treated
groups. There was no additional decrease in SCC gained by combining treatment with spirono-
lactone and either Ac-SDKP or ramipril. Consistent with previous studies showing the antifi-
brotic effects of Ac-SDKP and ACEi, both decrease SCC and therefore skin fibrosis in murine
bleomycin-induced scleroderma. Spironolactone has no effect on skin fibrosis. Ac-SDKP and
ACEi may decrease skin fibrosis by inhibiting the TGF-β-mediated profibrotic pathway and
future studies will characterize TGF-β levels and markers of TGF-β pathway activation in the
skin of treated animals.
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Propionibacterium acnes stimulates metalloproteinase 2 via TNF-alpha production in human
dermal fibroblasts
J Choi,1 M Piao,1 J Lee1 and S Lee1,2 1 Dermatology, Chonnam National University, Gwangju,
South Korea and 2 Clinical Trial Center, Chonnam National University Hospital, Gwangju,
South Korea
Among known factors in acne pathogenesis, Propionibacterium acnes (P. acnes) has a major
role to induce inflammation in acne. Besides its obvious role in acne geneisis as a microor-
ganism, we were interested in a novel function of P. acnes to modulate matrix metallopro-
tease (MMP) in the dermis. In this study, we evaluated the modulation of pro-matrix metallo-
protease-2 (pro-MMP-2) expression and MMP-2 activity by P. acnes in human dermal fibroblasts
(hDFs), Results from our experiments demonstrated that P. acnes induced pro-MMP-2 expres-
sion at transcriptional level, which increased MMP-2 activities in hDFs. P. acnes up-regulated
TNF-a expression in hDFs, which leaded to the activation of NF-kB pathway from the result
that P. acnes induced IkBa degradation at 30 min and recovered 1 h after treatment. The P.
acnes-induced pro-MMP-2 expression as well as MMP-2 activity was inhibited by doxycy-
cline treatment in a dose-dependent manner. In together, P. acne-induced MMP-2 activation
is mediated by TNF-alpha in hDFs, which is supposed to contribute to induce acne inflam-
mation in the skin.
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Complement- and leukocyte-activating capacity of antibodies against type VII collagen deter-
mines their blister-inducing potential
A Sesarman,1 S Mihai,1 JM Thurman,2 F Olaru,1 MT Chiriac,1 D Zillikens1 and C Sitaru1 1
Department of Dermatology, University of Lubeck, Lubeck, Germany and 2 Departments of
Medicine and Immunology, University of Colorado Health Sciences Center, Denver, CO
Epidermolysis bullosa acquisita (EBA) is a skin disease characterized by tissue- bound and cir-
culating autoantibodies to type VII collagen. When passively transferred into mice, rabbit IgG
against type VII collagen induces Fc-dependent activation of complement, the recruitment of
leukocytes into the skin and subepidermal blistering. In addition to these inflammatory mech-
anisms, it was speculated that IgG against type VII collagen might induce blisters by disrupt-
ing the ligand function in a Fc-independent manner. In the present study, to address this ques-
tion, we injected mice with anti-type VII collagen chicken IgY antibodies, which cannot bind
to complement and Fc receptors of mammalian origin. Like rabbit IgG, chicken IgY antibod-
ies against type VII collagen bound to the dermal-epidermal junction of skin sections. How-
ever, in contrast to rabbit IgG, IgY antibodies did not fix complement C3 in ELISA and immuno-
fluorescence complement-binding assays. In addition, in contrast to IgG, IgY antibodies did
not recruit granulocytes and induce dermal-epidermal separation ex vivo. Following their pas-
sive transfer into Balb/c mice (n=4), chicken IgY antibodies against type VII collagen bound
at the dermal-epidermal junction, but did not fix complement C3 or recruit granulocytes.
Importantly, these mice did not develop skin blisters. In contrast, BALB/c mice (n=4) injected
with rabbit IgG against type VII collagen developed a blistering phenotype, associated with
deposits of IgG and complement C3 as well as granulocytic infiltration at the dermal-epider-
mal junction. Control mice injected with normal rabbit IgG or chicken IgY (n=2 per group)
did not develop skin disease. These findings demonstrate that Fc-dependent engagement of
humoral and cellular inflammatory factors by pathogenic antibodies is required for subepi-
dermal blistering in experimental EBA.
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Salicyoyl-phytosphingosine: a novel agent for the repair of aged and photodamaged skin
M Farwick, Y Schiemann and P Lersch Degussa Personal Care, Goldschmidt GmbH, Essen,
Germany
Sphingolipids, especially ceramides, are major constituents of the extracellular matrix in the
stratum corneum. They have been reported to also improve epidermal differentiation espe-
cially the shorter chain variants and as biological modifiers they also influence gene tran-
scription. Salicylic acid and its variants have been reported to improve skin condition and
reduce the signs of aging. The agent of interest is the particular synthetically-derived sphin-
golipid salicyoyl-phytosphingosine. We investigated in vivo and in vitro if its application could
influence the presence of epidermal and dermal biomarker proteins. After application of sal-
icyoyl-phytosphingosine on cultured human primary keratinocyte cultures the gene expres-
sion patterns obtained by DNA-Chip technology indicated a strong stimulatory effect espe-
cially on processes related to barrier formation. This effect was proven in vivo by significantly
improved barrier repair after detergent challenge and barrier disruption. In addition to this
stimulatory effect on keratinocytes, we also found a positive effect on the procollagen I syn-
thesis of cultured human primary fibroblasts. The in vivo relevance of this result was verified
by a biopsy study on photodamaged skin, showing that Fibrillin and Procollagen synthesis
was significantly increased and MMP1 expression was significantly decreased. Subsequently
the penetration properties of salicyoyl-phytosphingosine were analyzed on pig skin with respect
to different cosmetic oils used as vehicle. The penetration ratio varied between 19% to 31%
depending on the polarity of the cosmetic oil. Finally using fast optical in vivo topometry of
human skin, salicyloyl-phytosphingosine was proven to alleviate the appearance of perior-
bital wrinkles compared with placebo cream. This is the first report of a sphingolipid such as
salicyloyl-phytosphingosine possessing anti-aging activity and highlights the plethora of ben-
efits that can be derived from this molecule.
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Adhesion of fibroblasts to collagen is essential for the formation of collagen fiber bundles
N Kida, A Kanamaru and A Tada SKIN RESEARCH & TECHNOLOGY DEPARTMENT, POLA
Chemical Industries, Inc., Yokohama, Japan
We have already reported that the formation of wrinkles and the reduction in skin elasticity
are accompanied with the destruction of dermal collagen fiber bundles(DCFB) structure in
the photodamaged skin. Fibroblasts are major cells to be involved in the formation and the
destruction of collagen fiber bundle structure. However, their ability to adhere to both colla-
gen and fibronectin is reduced in the photodamaged skin. Thus, we hypothesized that the
close adhesion of fibroblasts to collagen or fibronectin is crucial for the formation of
DCFB.Therefore in this study, the relationship between the expression of adhesion factors of
dermal fibroblasts such as VLA-2 and VLA-5, and the formation of DCFB structure was stud-
ied in vitro. To conduct the study, the fibroblasts with the reduced adhesion ability was pre-
pared by siRNA, knocking down technique targeting VLA-2 and VLA-5. The VLA-2 or VLA-5
knockdown fibroblasts were cultured in the collagen gel and the formation of collagen fiber
bundle was evaluated by SEM observation. As a result, quality of collagen fiber bundle formed
in the VLA-2 or VLA-5 knockdown fibroblast cell culture was inferior to those cultured with
normal fibroblasts. Based on these results, we searched for compounds which enhance cell
adhesion ability in normal fibroblasts, and discovered a flavanon derivative, Farrerol to be
most effective. In our further study, it was revealed that Farrerol (10-6M) also had an effect on
enhancing cell migration ability as well as enhancing cell adhesion ability when examined
in the collagen gel culture system. From the results, it was suggested that the cell adhesion
factors VLA-2 and VLA-5 expressed on the fibroblasts cell surface are essential for the forma-
tion of collagen fiber bundle.
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Desmoglein 1 governs subcellular allocation of plakoglobin, coordinating adhesion-depend-
ent and -independent roles in epidermal morphogenesis
CL Simpson,1 S Getsios,1 L Sheu,1 RL Dusek,1 S Kojima,2 R Daugherty,3 CJ Gottardi3 and
KJ Green1 1 Pathology and Dermatology, Northwestern University Feinberg School of
Medicine, Chicago, IL, 2 Cell & Molecular Biology, Northwestern University, Chicago, IL and
3 Medicine, Northwestern University, Chicago, IL
Desmoglein 1 (Dsg1) is essential for epidermal integrity, evidenced by blistering when targeted
by autoantibodies in pemphigus or a bacterial protease in bullous impetigo. However, Dsg1
haploinsufficiency causes hyperkeratosis in striate palmoplantar keratoderma, suggesting Dsg1
also regulates epidermal differentiation and homeostasis. By retroviral delivery of shRNA or
miRNA, Dsg1 deficiency resulted in abnormal intermediate layer morphology and decreased
spinous markers in human keratinocyte raft cultures, an organotypic epidermal model. In con-
trast, this phenotype was not reproduced by chronic treatment with exfoliative toxin A (ETA),
which cleaves the adhesive ectodomain of Dsg1 and produces subcorneal acantholysis in acutely
treated rafts; these results imply an adhesion-independent function for Dsg1. Immunostaining
of ETA-treated rafts showed retention of cleaved Dsg1 at intercellular borders along with plako-
globin, an armadillo protein with junctional and nuclear functions; moreover, Pg immunopre-
cipitated with cleaved Dsg1. Thus, we hypothesized that the Dsg1 cytodomain, which is retained
in ETA-treated rafts but decreased in knock-down cultures, plays a non-adhesive role during
keratinocyte differentiation via interaction with Pg. Supporting this, we detected increased cyto-
plasmic and nuclear pools of Pg in Dsg1-deficient cultures using subcellular fractionation and
immunohistochemistry. Changes in Pg distribution were accompanied by alterations in activated
beta-catenin levels. As well, we found Dsg1 was capable of modulating Wnt-stimulated TOP-
Flash reporter activity. Our data are consistent with a model in which the Dsg1 cytodomain
governs the subcellular distribution of Pg, regulating its availability to complete non-junctional
functions in signaling or cytoskeletal organization required for epidermal morphogenesis.
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Cytoprotective effects of adipose tissue derived stromal cells
D Lee,1,2 E Song,3,4 K Chu,3,4 C Won,1,2 K Kim1,2 and J Roh3,4 1 Department of Dermatology,
Seoul National University College of Medicine, Seoul, South Korea, 2 Department of
Dermatology, Seoul National University Boramae Hospital, Seoul, South Korea, 3 Stroke &
Neural Stem Cell Lab, Seoul National University Hospital, Seoul, South Korea and 4
Department of Neurology, Seoul National University College of Medicine, Seoul, South Korea
Adipose tissue derived stromal cells (ADSC) are known to be a kind of the mesenchymal stem
cells and have multi-potentiality of differentiation into various mesodermal tissues and neu-
ral lineage cells. ADSC may become the stem cells of choice in the future for regenerative
medicine; since they are readily available from essentially anyone, are easily cultured and
expanded, are highly pluripotent, and do not carry the ethical issues the embryonic and fetal
stem cells do. In addition, secretion of trophic factors such as vascular endothelial growth
factor (VEGF) and hepatocyte growth factor (HGF), anti-apoptosis of endothelial cells have
been proved. The aim of this study is to prove the cytoprotective effect of these cells and its
mechanism. Apoptotic cell death of rat pheochromocytoma cell line (PC12 cell line) induced
with OGD(oxygen-glucose deprivation) or staurosporine was evaluated with addition of nor-
moxic or hypoxic conditioned media of ADSC. Fluorescent labeling of these cells and intra-
venous injection to rat brain focal ischemia were performed, then histologic evaluation of
brain section with fluorescent microscope was done. In vivo implantation assay by intravenous
injection of human ADSC, was performed using rats, and behavioral test was done. We con-
firmed the osteogenic, chondrogenic and adipogenic potential of stromal cells isolated from
adipose tissue. Hypoxic conditioned media showed anti-apoptotic effect in OGD and stau-
rosporine induced apoptosis via VEGF signaling. Intravenous injected cells migrated to peri-
infarction areas in a few days. Functional recovery of behavior was confirmed in the brain-
ischemia induced rats. In conclusion, this study suggests that ADSC have in vitro cytoprotective
effects and intravenous injection of these cells may be a promising cell transplantation ther-
apy for ischemic injury.
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A critical role for protein kinase C α in keratinocyte migration
A Jerome1 and MF Denning1,2 1 Molecular Biology Program, Loyola University Medical
Center, Maywood, IL and 2 Pathology Department, Loyola University Medical Center,
Maywood, IL
Protein kinase C (PKC) α had been implicated in epidermal granular layer differentiation and cuta-
neous inflammation, and we recently showed that PKCα was also involved in inducing an irre-
versible growth arrest in terminally differentiating keratinocytes (KCs). Consistent with this, down-
regulating PKCα with siRNA in organotypic raft cultures resulted in increased basal and suprabasal
proliferation. A surprising finding was that PKCα downregulated rafts consistently showed reduced
epidermal thickness, despite the enhanced KC proliferation. One possible explanation for the
defect in stratification in PKCα siRNA rafts is an inability of KCs to migrate suprabasally. To test
this, we performed an in vitro scratch assay on serum-starved KCs cultured in low calcium (0.07mM)
media. Control KCs migrated completely into the scratch by 30 hrs, while KCs with downregu-
lated PKCα were significantly (p<0.001) delayed in their migration. Migration was also inhibited
when KCs were treated with pharmacological inhibitors of general PKCs (Bisindolylmaleimide I)
and classical PKCs (i.e. PKCα, Gö6976). Furthermore, at eight hours control migrating KCs had
a polarized appearance with fanlike structures (lamellipodia) at the leading edge and a tapered
trailing edge, whereas KCs lacking expression of PKCα displayed lamellipodia but remained
attached to the KCs in the wound edge. Consistent with this, actin was reorganized in a similar
manner in both control and siPKCα KCs, however, siPKCα KCs had fewer polarized cells within
the scratch itself. E-cadherin was diffusely localized in both the control and siPKCα KCs in low
calcium media, but Gö6976 treatment caused E-cadherin to localize at cell-cell junctions through-
out the cell monolayer. Consistent with a role in cell-cell junctions, PKCα is localized to sites of
cell-cell contact in human epidermis. Thus, PKCα is required for normal human KC migration,
possibly due to an inability to remodel cell-cell adhesive junctions, and this defect may underlie
the reduced stratification in raft cultures lacking PKCα.
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The human hair follicle bulge: immunohistological examination of potential stem cell-niche
elements, and further indications that it displays relative immune privilege
KC Meyer,1 JE Kloepper,2 S Tiede1 and R Paus1 1 Department of Dermatology and Allergy,
University of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany and 2 Department of
Biochemistry, Max Planck Institute, Martinsried, Germany
Since the discovery of epithelial hair follicle stem cells (eHFSCs) in the bulge region of human
HFs, it has been an ongoing quest to identify immunohistological markers for their identifi-
cation in situ, and characterize the bulge SC niche. In addition, gene profiling data have raised
the possibility that not only the anagen hair bulb, but also the bulge may display an immuno-
privilege. We show by immunohistology, that in addition to keratin15, extra cellular matrix
proteins such as tenascinC, fibronectin, fibrillin2, the transcription factor Lhx2 and the
immunoregulatory antigen CD200, which is found e.g. in immunoprivileged tissues, are upreg-
ulated in the bulge region. Similar to what has been reported in murine HFs these may con-
tribute to the niche conditions of human eHFSCs. In contrast, β1integrin, α6integrin, nidogen
and LTBP1, show no upregulation in the human bulge region. Contrary to what has been
reported in mice, nestin immunoreactivity (IR) was not usually seen inside the human bulge
epithelium. Since connexin43 and CD34 failed to show any IR in this region, they may be
exploited as useful negative markers for human bulge eHFSCs. Regarding to the quest of
immune privilege, we show that MHC class Ia and class II protein expression are downregu-
lated in the bulge region of human HFs, whereas both CD200 receptors and locally gener-
ated potent immunosuppressants like TGFβ1 and αMSH are upregulated. These observations
demonstrate a useful panel of positive and negative human eHFSC markers, as a first prag-
matic approach to the immunohistological characterization of the human bulge region and
suggest that the bulge indeed represents an additional area of relative immune privilege in
human skin. Protection and therapeutic restoration of the bulge immune privilege may become
a strategy in the – still very frustrating – management of cicatricial alopecia.
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Expression of elafin in internal elastic laminae of polyarteritis nodosa: A defensive role against
neutrophil-mediated vascular damage
J Muto,1 K Chen,2 N Fujimoto,1 K Kuroda,1 M Yamada,3 S Suzuki3 and S Tajima1 1
Dermatology, National Defense Medical College, Tokorozawa, Japan, 2 Dermatology,
Saiseikai Central Hospital, Tokyo, Japan and 3 Internal Medicine, National Defense Medical
College, Tokorozawa, Japan
Elafin has a primary structure with two functional domains; a transglutaminase substrate domain
at the N-terminus and a protease inhibitor domain at the C-terminus. Elafin expression in the
arterial vascular walls in the subcutis of the cutaneous polyarteritis nodosa (CPN) (6 cases) and
in the kidney of the systemic polyarteritis nodosa (PAN) (5 cases) was immunohistochemi-
cally examined. The arterial changes during the evolution of arteritis were classified into acute,
subacute, healing and healed stages. In the subacute stage which was characterized by par-
tial destruction of the internal elastic laminae, elafin immunoreactivity was observed in the
internal elastic laminae where the adjacent inner endothelial cells remained intact. In con-
trast, elafin expression disappeared in the sites where the inner endothelial cells were dam-
aged with disruption of the internal elastic laminae and subsequent fibrinoid deposition in
the disrupted vessel wall. Elafin expression in cultured human umbilical vein endothelial
cells (HUVEC) was not detected but was induced by IL-1β treatment, a major proinflamma-
tory cytokine, at both mRNA and protein levels. Elastin peptides induced the migration of neu-
trophils with a maximum response at 10-9 M. Chemotactic activity of nuetrophils to elastin
peptides was significantly inhibited by elafin. Because it has been recently shown that elafin
interacts with elastin via a transglutaminase substrate domain and protects elastin from elas-
tolytic degradation, elafin induced by vascular endothelial cells, appears to protect elastic lam-
inae from vascular damage in PN. Elafin seems to play protective roles in PN; by inhibiting
both neutrophil chemotactic activity and neutrophil-induced elastolytic degradation of vas-
cular walls.
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The relationship between hemidesmosomes and focal contacts in stable and/or motile ker-
atinocytes
T Ozawa,1,2 D Tsuruta,2 H Kobayashi,2 K Ikeda,4 A Kawada,3 M Ishii2 and T Harada1 1 Plastic
and Reconstructive Surgery, Osaka City University Graduate School of Medicine, Osaka,
Japan, 2 Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan, 3
Dermatology, Kinki University Medical School of Medicine, Osaka, Osaka, Japan and 4
Anatomy, Osaka City University Graduate School of Medicine, Osaka, Japan
Keratinocytes-extracellular matrix adhesion is composed of dual adhesion systems, hemidesmo-
somes (HDs) and focal contacts (FCs). Recent studies including ours suggested that both HDs
and FCs are dynamic. However, there have no studies focused on the relationship between
HDs and FCs in stable and/or motile keratinocytes. In order to characterize them, we con-
ducted the live cell imaging of stable and motile keratinocytes. We used dynamics of HDs
probed with YFP-tagged beta4 integrin and FCs probed with CFP-tagged actinin-1 under sub-
confluent, confluent, or wound culture conditions of live HaCat keratinocytes. In addition,
drugs which affect cytoskeletons for keratinocytes (nocodazole and cytochalasin D) were added
onto the same culture conditions. As the results, while HDs and FCs are independently dynamic
under subconfluent and confluent culture, FCs firstly appeared in the leading edge of migrat-
ing keratinocytes, and then HDs filled into the “FC-rich” region when FCs rapidly disassem-
bled under the wound culture condition. FCs in the leading edge of wound were highly dynamic
compared to the subconfluent or confluent keratinocytes. On the contrary, when KCs was
treated with Nocodazole or cytochalasin D, FCs were elongated and not dynamic, and no
assembly of HDs occur. At the same time, the movement of KCs did not occur. From these
results, the dynamics of HDs and FCs were associated in only migration of KCs, and the dynam-
ics of HDs follows after those of FCs. In addition, the movement of KCs in themselves were
induced by FCs and related cytoskeletons.
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Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering in vivo via
p38MAPK dependent signaling
P Berkowitz,1 Z Liu,1 LA Diaz1 and DS Rubenstein1,2 1 Dermatology, UNC-CH, Chapel Hill,
NC and 2 Lineberger Comprehensive Cancer Center, UNC-CH, Chapel Hill, NC
Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are two autoimmune blistering diseases
of the skin in which autoantibodies targeting desmoglein-3 (dsg3) and desmoglein-1 (dsg1),
respectively, induce blistering. We previously demonstrated that anti-dsg3 IgG from PV patients
activate intracellular signaling mediated by p38 mitogen activated protein kinase (p38) and
HSP27 and that activation of p38 is part of the acantholytic mechanism. The similar immuno-
biology of PF and PV suggests that PF IgG might also activate signaling. This study was under-
taken to investigate the ability of PF IgG to activate p38 and HSP25, the murine HSP27 homolog,
and to determine if inhibitors of p38 could prevent PF IgG induced blistering. Neonatal C57BL/6J
mice were injected with purified PF or control IgG. After 18 hours, mice were examined clin-
ically and skin biopsies were obtained for histological examination, immunohistochemical
staining, and biochemical analyses. Pretreatment with the p38 inhibitors SB202190, SB203580,
or the inactive analog SB202474, followed by passive transfer of PF IgG was used to deter-
mine if p38 inhibition blocked PF IgG mediated acantholysis in vivo. PF IgG treated mice
developed intraepidermal blistering and skin extracts demonstrated increased phosphoryla-
tion of p38 and HSP25. Blistering was blocked in mice pretreated with the p38 inhibitors
SB202190 or SB203590, but not those treated with the inactive analog SB202474. Importantly,
the inhibitors did not block systemic absorption or keratinocyte binding of PF IgG indicating
that the inhibitors act downstream of antibody binding to the target keratinocytes consistent
with the proposed role for p38 and HSP25/27 in the mechanism of acantholysis. These obser-
vations suggest that analogous to PV, (i) PF IgG activate intracellular signaling, (ii) these sig-
naling events are part of the mechanism by which pathogenic PF autoantibodies induce acan-
tholysis, and (iii) p38 inhibitors may prove effective in the treatment of PF.
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Hyaluronan triggers an innate immune response through CD44, TLR4 and a Cryopyrin/NALP3-
dependent pathway
K Yamasaki,1,4 H Goodarzi,1,4 K Taylor,1,4 A Di Nardo,1,4 J Bertin,3 EP Grant,3 AJ Coyle,3
A Misaghi,2 HM Hoffman2 and RL Gallo1,4 1 Dermatology, University of California San
Diego, San Diego, CA, 2 Pedriatrics, University of California San Diego, San Diego, CA, 3
Millenium Pharmatheuticals, Cambridge, MA and 4 VA Medical Center, San Diego, CA
Hyaluronan, (HA) is a glycosaminoglycan and major component of the extracellular matrix.
Recent findings reveal that HA triggers cytokine release when it is degraded to small molec-
ular weight forms, thus serving as a danger signal to alert the immune system that injury has
occurred. We recently found that HA induces CXC chemokines (human IL-8 and mouse MIP-
2) through the action of CD44 working together with the TLR4 signaling complex. Recently,
mutations of the CIAS1 gene were identified as the cause of familial cold autoinflammatory
syndrome (FCAS). The CIAS1 gene product cryopyrin/NALP3, is activated in FCAS patients,
and comprises part of the inflammasome with caspase-1 to process proIL-1β to active IL-1β.
To examine the involvement of HA signaling in vivo, we developed mouse models of sterile
injury by freezing with liquid nitrogen spray or injection of sterile cytodex beads. These ster-
ile skin injuries resulted in focal deposition of HA at the injured site and significantly increased
MIP-2 and IL-1β expression (injured versus non-injured was MIP-2; 475.0 and 15.6, and IL-
1β; 192.2 and 69.8 pg/lesion, respectively). MIP-2 induction by HA and sterile injury was not
observed in TLR4-deficient mice and was significantly decreased in CD44-deficient mice. HA-
dependent IL-1β induction was abolished in macrophages from NALP3-deficient mice. More-
over, NALP3-deficient mice showed a significant decrease of IL-1β induction in the sterile skin
injury models (injured wt; 159.5, injured ko; 83.3, non-injured mice; 72 pg/lesion). These data
suggest HA triggers danger signals by multiple pathways including CD44/TLR4~CXC chemokine
and via the NALP3/inflammasome~IL-1β pathway. These findings are consistent with the hypoth-
esis that HA is an important signal of injury and suggest HA may participate in the pathology
of FCAS.
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Expression of DSG4 in prostate epithelium and its loss during the progression of prostate
cancer
AG Barber,1 H Bazzi,1 R Buttyan3 and AM Christiano1,2 1 Genetics and Development,
Columbia University, New York, NY, 2 Dermatology, Columbia University, New York, NY and
3 Ordway Cancer Center, Ordway Research Institute, Albany, NY
Desmosomes are intercellular junctions which are typically found in tissues that undergo a high
degree of mechanical stress. Desmosomal cadherins, which in humans include four desmogleins
(DSG 1-4) and three desmocollins (DSC 1-3), are an essential component of the desmosome
acting to anchor cells to one another. In our previous studies we found that DSG4 is expressed
in the more differentiated suprabasal layers of the epidermis as well as the more differentiated
layers of the hair follicle. Our recent studies have focused on determining the expression of DSG4
in other human tissues, with an emphasis on secretory epithelial tissues, such as the prostate.
Using immunofluorescence analysis, we found that DSG2 and DSG4 are colocalized in the
highly differentiated secretory luminal cells of the human prostate while DSG1, DSG3, DSC1
and DSC3 are absent from this tissue. To further examine the endogenous expression of DSG4
in vitro, we utilized a non-tumorigenic, immortalized, human prostate epithelial cell line, BPH-
1, to establish differentiated cell cultures. We then examined these cultures for the expression
of DSG4 and found that endogenous DSG4 expression is detected in highly differentiated BPH-
1 cells. Interestingly, LOH of human chromosome 18q12.1—the chromosomal region contain-
ing the desmosomal cadherin gene cluster and DSG4—is frequently deleted in metastatic prostate
cancers. This led us to examine the expression of DSG4 in metastatic prostate cell lines, where
we found that in cells of a low metastatic potential, DSG4 is present but mislocalized, while in
cells of a high metastatic potential DSG4 is essentially absent. We are now examining the expres-
sion of DSG4 in human prostate cancer tissues at various stages of cancer progression to deter-
mine if this pattern of expression is recapitulated in vivo, and using gene dosage analysis, we
will determine if the loss of expression is due to genetic or epigenetic alterations of DSG4.
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Kindlin-1 is a migfilin-binding protein which associates with kindlin-2 at focal contacts
JE Lai-Cheong,1,3 S Ussar,2 K Arita,1 R Faessler,2 I Hart3 and JA McGrath1 1 Genetic Skin
Disease Group, St John’s Institute of Dermatology, King’s College London, London, United
Kingdom, 2 Max-Planck Institute for Biochemistry, Munich, Germany and 3 Tumour Biology
Laboratory, Institute of Cancer, Bart’s and The London, London, United Kingdom
Kindlin-1 is a novel actin cytoskeleton-related protein that shows reduced or absent expres-
sion in the rare autosomal recessive genodermatosis, Kindler syndrome (KS). To further char-
acterize the disease pathophysiology of KS, we focused on identifying the protein binding part-
ners of kindlin-1. Clues to potential binding proteins of kindlin-1 emerged from
immunofluorescence microscopy studies on frozen skin sections obtained from 14 patients
with KS. Immunolabeling using rabbit polyclonal anti-kindlin-1, anti-kindlin-2 and anti-migfilin
antibodies demonstrated reduction or absence of expression of all three proteins in seven
cases. We then demonstrated by Western Blotting that all three proteins were expressed endoge-
nously in an immortalized keratinocyte cell line (HaCat). Subsequently we have shown, by
co-immunoprecipitation on cell lysates obtained from HaCat keratinocytes, that these three
proteins are binding partners. Finally HaCat keratinocytes were lipid-transfected with EGFP-
kindlin-1 and FLAG-migfilin using oligofectamine and probed for endogenous kindlin-2 expres-
sion (anti-kindlin-2 antibody). Confocal microscopy performed on these transfected cells
showed that the three proteins co-localize at focal contacts. This study has identified bio-
chemical interactions between kindlin-1 and two other actin-binding proteins, migfilin and
kindlin-2, and provides new insight into the cell biology and function of kindlin-1 in both
normal and disease states.
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Genetically engineered human dermal microvascular endothelial cells given intravenously
as potential therapy for dystrophic epidermolysis bullosa and chronic skin wounds
D Woodley, X Wang, J Remington, Y Hou and M Chen Dermatology, University of Southern
California, Los Angeles, CA
Patients with dystrophic epidermolysis bullosa (DEB) have incurable skin fragility, blistering
and multiple chronic skin wounds because of mutations in the gene that encodes for type VII
collagen (C7). Although of different etiologies, patients with spinal cord injuries, diabetes,
varicose veins and stasis dermatitis also suffer chronic non-healing skin wounds. Human der-
mal microvascular endothelial cells (HDMECs) do not endogenously express C7. In this study,
we transduced HDMECs with lentiviral vectors containing C7 cDNA. Transduction of the vec-
tor into HDMECs achieved a 95% tranduction efficiency which resulted in high levels of syn-
thesis and secretion of the 290 kDa full-length C7 alpha chain. In comparison with normal
HDMECs, the genetically engineered HDMECs overexpressing C7 demonstrated enhanced
cell migration, reduced cell-substratum adhesion, and increased growth potential in vitro.
We then created skin wounds in athymic hairless mice or in human skin grafted onto the
mice and intravenously (IV) injected 2 to 4 million HDMECs expressing human C7. The IV
injected, molecularly-engineered HDMECs homed to the murine and human skin wounds
and continuously delivered C7 at the wound site where it incorporated into the skin’s base-
ment membrane zone and formed anchoring fibril structures. Further, compared with con-
trols (no cells or non-modified HDMECs), IV injected genetically engineered HDMECs induced
marked acceleration of wound healing in both murine and human skin. These data provide
the first evidence that IV injected molecularly engineered HDMECs can deliver C7 to skin
wounds and promote wound healing. Our studies open the possibility of using IV injection
of genetically engineered endothelial cells to treat DEB and promote healing of skin wounds.
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Effects of blue algae pigmentary extract on H2O2-induced senescent human skin fibrob-
lasts
MJ Haure,1 M Segur-Derai,2 R Tarroux,2 H Hernandez-Pigeon,1 P Bogdanowicz1 and
M Charvéron1 1 Laboratoire de Biologie Cellulaire Cutanée, Institut de Recherche Pierre
Fabre, Toulouse cedex 3, France and 2 Laboratoire de Pharmacochimie, Institut de
Recherche Pierre Fabre, 31322 Castanet Tolosan, France
The mechanical properties of the dermis are determined, primarily, by the extracellular matrix
(ECM). These mechanical properties change dramatically as a function of age, as a direct
result of the known age-related changes in the molecules of the dermal ECM (collagens,
elastin and matrix metalloproteinases (MMP)). In order to evaluate blue algae pigments
extracts (from Phormidium uncinatum) on skin aging, we have developed an in vitro model
of stress-induced premature senescence (SIPS). SIPS is closely related to replicative senes-
cence or chronological-aging. H2O2-induced SIPS represent valuable in vitro model to eval-
uate the efficacy of anti-aging compounds against the skin aging processes induced by free
radicals. The aim of this study was to evaluate the effects of blue algae pigmentary extract
on MMP and ECM components, which are dysregulated during skin aging. The antioxydant
capacity of the blue algae pigmentary extract was evaluated by chemiluminescence: a potent
scavenging superoxide anions activity was shown. By using quantitative RT-PCR, we clearly
show that catabolic enzymes are up regulated in SIPS human fibroblasts, since we meas-
ured an increase of MMP-1 and MMP-3 expression. On the other hand, we observed a
decrease of mRNA level of two ECM components: type I collagen and elastin. We have also
showed that pre-incubation of SIPS human fibroblasts with blue algae pigmentary extract
strongly reduced senescence effects, since we measured an inhibition of MMP over-expres-
sion and a induction of type I collagen and elastin mRNA level. In conclusion, our results
demonstrate the anti-aging properties of blue algae pigmentary extract on H2O2-induced
senescent human skin fibroblasts.
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Knock-down of type VII collagen in squamous cell carcinoma increases migration and inva-
sion with loss of differentiation
VL Martins,1 JJ Vyas,1 KJ Purdie,1 M Chen,2 JA McGrath,3 A Storey,1 AP South1 and
EA O’Toole1 1 Centre for Cutaneous Research, ICMS, Queen Mary, University of London,
London, United Kingdom, 2 Department of Dermatology, University of Southern California,
Los Angeles, CA and 3 St John’s Institute of Dermatology, Guy’s, King’s College & St Thomas’
School of Medicine, London, United Kingdom
Metastatic squamous cell carcinoma (SCC) is the major cause of mortality in recessive dystrophic
epidermolysis bullosa (RDEB). Because reduction in type VII collagen (ColVII) expression is a hall-
mark of RDEB, we investigated whether ColVII levels affect proteinase expression or cell migra-
tion/invasion, factors involved in tumor progression. SCC cell lines derived from patients with and
without RDEB, as well as COL7A1-transduced RDEB SCC cell lines were established. RNAi was
used to down-regulate ColVII in a non-RDEB SCC cell line. Levels of metalloproteinases (MMPs)
and serine proteinase expression were measured in the different cell lines by Western blotting and
gelatin zymography. Functional studies included scratch assays, time-lapse microscopy, and organ-
otypic cultures on collagen gels and de-epidermalized dermis. A RDEB SCC cell line with absent
expression of ColVII showed reduced levels of MMP-2 and the serine proteinase PAI-1, and increased
expression of the MMP inhibitor TIMP-1, after COL7A1-transduction. RNAi for COL7A1 in MET1
cells (siMET1) resulted in complete knock-down of ColVII expression in media. siMET1 cells showed
a 60% (n=3) increase in cell motility, and increased expression and activity of MMP-2. Organ-
otypic cultures of siMET1 had a significant decrease in epidermal involucrin and K10 staining when
compared to controls, suggesting that loss of ColVII results in loss of differentiation. Triplicate Illu-
mina gene expression arrays comparing siMET1 to control revealed differentially expressed genes
involved in migration, proliferation and tumorigenesis. Our data suggest that ColVII directly mod-
ulates proteinase activity and cell migration and also plays a role in regulating SCC differentiation,
factors which may contribute to the aggressive behavior of RDEB SCC.
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Fibroblast migration requires co-operative rearward and forward traction gradients across
the whole cell and the nucleus, respectively
Z Pan,1 RA Clark,1 K Ghosh,1 Y Liu,1 X Shu,2 T Nakamura,1 G Prestwich2 and M Rafailovich1
1 Stony Brook Univ, Stony Brook, NY and 2 Univ Utah, Salt Lake City, UT
Cell migration plays an important role in many normal and pathological processes, such as
embryonic development, tissue morphogenesis and regeneration, wound healing, and tumor
metastasis. After protrusion of the leading edge, the cell is stabilized by formation of focal con-
tacts and adhesions. Traction forces are generated by contractile elements of the cytoskeleton
to deform cell shape, disrupt cell-substrate attachments at the rear and make the cell body
move forward. Relative contribution of traction forces across the cell to forward movement
has never been previously delineated in detail at the nanometer scale. Here the traction
forces that make this happen are mapped and traction gradients analyzed. With cell-substrate
adhesiveness controlled by ligand type and density in a physiologically relevant extracellular
matrix (ECM) mimic composed of fibronectin functional domains (FNfds) tethered to inter-
molecularlly crosslinked hyaluronan (HA-DTPH), cellular traction distribution and mechani-
cal work done by adult human dermal fibroblasts (AHDF) were quantitatively determined with
optical Digital Image Speckle Correlation (DISC) technique and Finite Element analysis Method
(FEM). By correlating the cellular mechanical responses with corresponding time-lapse-quan-
tified cell migration, traction gradients between the front and the rear of cells were found to
directly correlate with cell migration speed rather than the adhesion strength or the magni-
tude of tractions over the whole cell. Besides maximum tractions located at 10-20 mm behind
the cells’ leading edge, substantial perinucular tractions were mapped and a traction gradi-
ent across the nucleus was found to be a previously unrecognized factor in cell migration and
inversely proportional to the overall traction gradient. This push-pull mechanism of cell migra-
tion is much like human walking: the front foot pulls while the back foot pushes forward.
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EBA autoantibodies inhibit the binding of type IV collagen and fibronection to CMP and FNIII
subdomains of type VII collagen: a possible pathogenic mechanism of EBA
M Chen, A Jack, B Basseri, P Bandyopadhyay, Y Hou and D Woodley Dermatology,
University of Southern California, Los Angeles, CA
Type VII (anchoring fibril) collagen (C7) mediates epidermal-dermal adherence and is the tar-
get for autoantibodies from patients with epidermolysis bullosa acquisita (EBA). We previously
demonstrated that the large, amino, globular non-collagenous 1 domain (NC1) of C7, had
affinity for type IV collagen within the lamina densa of the basement membrane zone (BMZ)
and fibronectin, a large glycoprotein in the papillary dermis, suggesting a mechanism by which
C7 is critical in mediating the integrity of the BMZ. In this study, we refined the type IV col-
lagen and fibronectin binding sites within the NC1 domain using a panel of NC1 deletion
mutant proteins generated in 293 cells or recombinant fusion proteins generated in bacteria
using a solid-phase ligand, antigen-to-antigen affinity assay. We mapped the type IV collagen
binding site to a 158 amino acid subdomain (residues 202-360) within one of the fibronectin
type III-like repeats (FNIII) homology domain of NC1. We also mapped the fibronectin bind-
ing site to a 68 amino acid subdomain (residues 159-227) of the cartilage matrix protein (CMP)
homology domain of NC1 at the amino terminus. Further, autoantibodies in EBA sera bound
to these newly identified subdomains by epitope mapping and inhibited C7 affinity for type
IV collagen and fibronectin in the matrix affinity assay, whereas IgG from normal sera had no
inhibitory effect. These data support the hypothesis that EBA autoantibodies cause disruption
of the BMZ via inhibiting C7 affinity with type IV collagen and fibronectin and that these sub-
domains on the C7 molecule are critical for epidermal-dermal adherence.
210
Synthetic extracellular matrix composed of fibronectin functional domains and hyaluronan
markedly accentuates wound repair: Possible role of growth factor loading
K Ghosh, S Shirsat, S McClain, X Ren and RA Clark SUNY Stony Brook, Stony Brook, NY
Effective repair of acute and chronic wounds continues to pose a major health challenge despite
the development of various tissue-engineered therapies. We evaluated whether acellular hydro-
gels, composed of fibronectin functional domains (FNfds) coupled to a thiol-functionalized
HA (HA-DTPH), significantly accentuated the repair of porcine full-thickness excisional wounds
when supplemented with platelet-derived growth factor-BB (PDGF-BB). When the tissue-engi-
neered construct was added to such wounds, healing increased approximately 2-fold at 4 days
compared to no treatment or HA gel controls as judged by re-epithelialization, granulation
tissue formation and angiogenesis – a remarkable response in nascent healing of normal
wounds. RGD (arginine-glycine-asparatic acid) tethered to HA-DTPH hydrogels plus PDGF-
BB failed to produce similar accentuation even at a 1000-fold higher bulk density of RGD
(260 µM) compared to FNfds bulk density (0.260 µM). Remarkably, the enhancement in wound
repair was observed when only 15 ng of PDGF-BB was added to the FNfds-HA-DTPH con-
struct, a dose 10-fold lower than previously demonstrated to positively affect cutaneous wound
healing. The observation suggested that the incorporated PDGF-BB was bound to the hydro-
gels. Follow-up in vitro studies showed that PDGF-BB binds these hydrogels and remains active,
as judged by the ability of the PDGF-BB-preloaded hydrogels to support fibroblast migration.
Such robust, acellular constructs have potential use in applications where rapid tissue forma-
tion is needed.
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β1-integrin-mediated signalling in the human hair follicle
JE Kloepper,1 E Bodo,2 S Tiede,2 MJ Humphries3 and R Paus2 1 Molecular Medicine, Max-
Planck-Institue, Martinsired, Germany, 2 Dermatology, University of Lübeck, Lübeck,
Germany and 3 Welcome Trust Centre for Cell-Matrix Research, University of Manchester,
Manchester, United Kingdom
Integrins are transmembrane adhesion proteins whose signalling properties range from the
control of cell proliferation, death, differentiation to immunomodulatory functions. In human
skin and hair follicle (HF) biology, β1-integrin and its ligands are of particular interest con-
cerning epithelial stem cell characteristics and since its functional deletion in mutant mice
induces severe hair follicle defects. However, it is as yet entirely unknown whether β1-inte-
grin plays any role in the regulation of human hair growth, and the expression pattern of β1-
integrin in the human pilosebaceous unit remains ill-defined. Here, we show that expression
for β1-integrin can be found in distinct compartments of human scalp HFs in situ and in vitro.
β1-integrin was most prominent in the outermost layer of the outer root sheath and the sur-
rounding connective tissue sheath, but was not upregulated in the bulge, the major seat of
epithelial HF stem cells. When microdissected, organ-cultured human scalp HFs in the growth
stage of the hair cycle (anagen VI) were exposed to β1-integrin-antibodies in vitro, the acti-
vating anti-β1-integrin antibodies (12G10 (+) and TS2/16 (+)) promoted hair growth: they
caused a significant increase in hair shaft elongation, inhibited catagen development and stim-
ulated significantly the proliferation of hair matrix keratinocytes. A β1-integrin-inhibitory
antibody (mAb13 (-)) did not exert significant hair growth-modulatory effects. The current
results support the concept that β1-integrin-mediated signalling is also functionally important
in the control of human hair follicle growth and cycling and invite one to further explore the
targeted, local stimulation of HF β1-integrin-mediated signalling as an innovative new strat-
egy for hair loss management.
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Protein therapeutics for junctional epidermolysis bullosa
V Alexeev, O Igoucheva, A Kelly and J Uitto Dermatology and Cutaneous Biology, Thomas
Jefferson University, Philadelphia, PA
Inherited junctional epidermolysis bullosa (JEB) is a mechanobullois disease, characterized by
the reduced adherence of the epidermal keratinocytes to the dermal anchoring fibers, which
often caused by the absence of functional laminin 3,3,2 due to the absence of its β3 chain.
As there are no specific therapies for the JEB, here we tested whether protein replacement strat-
egy could be applicable for the restoration of the laminin 3,3,2 assembly and reversion of the
JEB phenotype in human keratinocytes that lack β3 subunit. Here, we developed the proto-
col for the production and purification of the biologically active recombinant β3 chain. We
also demonstrated that delivery of this recombinant polypeptide into the endoplasmic retic-
ulum complex of the β3-null keratinocytes led to the restoration of the laminin 3,3,2 assem-
bly, secretion and its deposition into the basement membrane zone, as confirmed by Western
blotting and confocal immunofluorescent microscopy in vitro and in organotypic cultures of
human H-JEB skin. Although, the extent of the laminin 3,3,2 produced by protein-treated
cells is somewhat lower than that in normal human keratinocytes our results showed the appli-
cability of the recombinant proteins for the JEB treatment and open new perspectives for the
development of the novel therapeutics for this inherited skin disorder.
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Extracellular heat shock protein-90alpha: linking hypoxia to skin cell motility and wound
healing
W Li,1,2 Y Li,1 S Guan,1 J Fan,1,2 C Cheng,1 A Bright,1 C Chin,1 M Chen1 and D Woodley1,2 1
Dermatology, University of Southern California, Los Angeles, CA and 2 The Greater Los
Angeles Veterans Administration Health System, Los Angeles, CA
Hypoxia plays a critical role in the pathophysiology of a variety of human disorders, such as
ischemic cardiovascular disease, stroke, chronic lung disease, acute skin wounds and cancer.
After acute injury, the microenvironment of a skin wound is hypoxic, likely due to vascular
disruption and high oxygen consumption by cells at the edge of the wound and in granula-
tion tissue. Previous studies showed that hypoxia supports wound healing by promoting human
skin cell motility. The mechanism of how hypoxia promotes cell motility is not known. Here,
we provide evidence that hypoxia promotes human dermal fibroblast (HDF) migration by
inducing the secretion of heat shock protein-90alpha (hsp90alpha) into the extracellular
environment through hypoxia inducible factor-1alpha (HIF-1alpha). The secreted hsp90alpha
in turn executes hypoxia’s pro-motility effect. Expression of an activated HIF-1alpha mimicked
hypoxia-induced hsp90alpha secretion and HDF migration. In contrast, the expression of an
inactive HIF-1alpha or down-regulation of endogenous HIF-1alpha blocked these events. Inter-
estingly, the hypoxia-HIF-1 pathway-induced hsp90alpha secretion required no changes in
the steady-state mRNA level or in the promoter activity of hsp90alpha. The addition of recom-
binant hsp90alpha fully duplicated the hypoxia’s pro-motility effect on HDFs. Inhibition of
extracellular hsp90alpha function completely blocked the hypoxia-HIF-1 pathway-stimu-
lated HDF migration. Most convincingly, topical application of hsp90alpha accelerated wound
healing by increased re-epithelialization in mice. This study has demonstrated a novel mech-
anism of hypoxia > HIF-1 > hsp90alpha secretion > skin cell migration > wound healing and
identified extracellular hsp90alpha as a potential therapeutic agent for skin wounds.
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Functions of laminin alpha5 in keratinocyte migration and attachment
M Zhang,1 J Chen2 and J Li2 1 Department of Dermatology, Nanjing Medical University,
Nanjing, China and 2 Department of Dermatology & Cutaneous Surgery, University of
Miami, Miami, FL
Laminin-10 (alpha5, beta1, gamma1) is a new member of laminin family and a major com-
ponent of epithelial basement membrane. Its function in epidermal cells is not clear. The alpha
chain of laminins has been shown to contain the primary binding sites for cell surface recep-
tors that mediate the cell attachment and migration. In this study we evaluated the role of
laminin alpha5 chain in kerationocytes by gene knockdown. Laminin alpha5 chain specific
small interfering RNA (Lamα5 siRNA) was used to transfect normal human skin keratinocyte
NIK cells. After 72 hours of transfection, reverse transcription and polymerase chain reaction
(RT-PCR) was used to evaluate the laminin alpha5 mRNA expression level. Cells were tested
for their abilities of migration and attachment. For migration study, 2×105 cells/well were placed
on the top of migration chamber membrane for 6 hours, cells migrated through the mem-
brane were stained and observed under microscope. Cell attachment assay was performed
with 96 well, 6×104 cells/well, incubated for 45 minutes and analyzed with colorimetric method
at OD 570 nm. The results demonstrated that Lamα5 siRNA transfected cells migrated at
markedly reduced rate at 6 hours, 91 % less than control cells. Cells transfected with Lamα5
siRNA exhibited a reduced ability of attachment by 11 % at 45 minutes compared with con-
trol cells. RT-PCR analysis showed the Lamα5 siRNA transfected cells had 38% of gene knock-
down. Our data suggest that laminin alpha5 chain plays an important role in keratinocyte func-
tion in cell attachment and migration.
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Plakoglobin and β-catenin regulate the expression of desmocollin genes in vitro
X Cheng,1 E Müller3 and PJ Koch1,2 1 Department of Molecular and Cellular Biology, Baylor
College of Medicine, Houston, TX, 2 Department of Dermatology, Baylor College of
Medicine, Houston, TX and 3 Molecular Dermatology, University of Bern, Bern, Switzerland
Desmocollins (Dsc) form a subfamily of transmembrane glycoproteins that are sequence-related
to classical cadherins, such as E-cadherin. Together with desmogleins (Dsg) they form the trans-
membrane core of desmosomes, organelles that are crucial for cell-cell adhesion, in particu-
lar in the heart and the skin. Three Dsc genes have been identified in mammals. All of these
genes are expressed in the epidermis and epidermal appendages. The expression patterns of
these genes are complex, suggesting that the correct cell type-specific expression of Dsc genes
is essential for normal development of epidermal tissues. Surprisingly, very little is known about
the gene regulatory pathways that control Dsc expression. We used an in vitro reporter sys-
tem to define signaling pathways that control Dsc expression. In the present study, we focused
on the role of the armadillo proteins β-catenin and plakoglobin (Pg) in this process. Our results
demonstrate that the proximal promoters of the Dsc2 and Dsc3 genes are controlled by β-
catenin and Pg. A Pg/Lef-1 complex binds to and activates the proximal Dsc2 promoter. Pg
also appears to activate the Dsc3 promoter; however, it does so indirectly by preventing β-
catenin/Tcf/Lef-mediated repression. The observation that β-catenin can inhibit Dsc3 promoter
activity is interesting in the light of our observation that during the early stages of hair follicle
development (e.g. invasion of placode keratinocytes into the dermis during hair follicle for-
mation), classical Wnt pathway activation and Dsc3 gene expression are mutually exclusive.
Our results demonstrate that armadillo proteins affect Dsc gene expression in vitro, thus pro-
viding the rationale for further studies aimed at elucidating the role of these proteins in desmo-
somal gene expression in vivo.
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Intracellular signaling and desmoglein endocytosis are coupled to disruption of keratinocyte
adhesion by pemphigus vulgaris antibodies
MD Kottke,1,2 JM Jennings,2,1 E Delva,2,1 CC Calkins2,1 and AP Kowalczyk2,1 1 Dermatology,
Emory University School of Medicine, Atlanta, GA and 2 Cell Biology, Emory University
School of Medicine, Atlanta, GA
Pemphigus Vulgaris (PV) is an autoimmune blistering disease in which antibodies disrupt the
adhesive function of desmoglein-3 (Dsg3). Previous work demonstrated that PV antibodies trig-
ger internalization of Dsg3 from the cell surface, suggesting that destabilization of desmosomal
components causes loss of adhesion. To define the mechanism of Dsg3 endocytosis, clathrin and
clathrin-independent endocytic pathways were examined. The results, along with co-localiza-
tion between Dsg3 and caveolin-1, suggest that the PV IgG-Dsg3 complex is internalized in a
clathrin-independent manner that involves caveolae or lipid rafts. Time lapse fluorescence imag-
ing of live keratinocytes revealed that Dsg3 is internalized from both non-junctional and junc-
tional pools. Retrospective immunolocalization analysis of time lapse series revealed that PV
IgG-Dsg3 from non-junctional pools rapidly entered early endosomes. Interestingly, junctional
pools of Dsg3 first reorganized into linear streaks extending away from cell-cell borders. These
linear arrays of Dsg3 at the cell surface contained desmoplakin (DP) and keratin filaments, as
well as caveolin-1. However, as Dsg3 dissociated from these structures it was no longer detectable
at the cell surface and lost its association with DP. To block Dsg3 internalization, keratinocytes
were treated with the tyrosine kinase inhibitor genistein, a known inhibitor of clathrin-inde-
pendent endocytosis. Time lapse imaging, analysis of fixed cells, and biochemical studies indi-
cated that genistein prevented Dsg3 endocytosis and blocked Dsg3 down-regulation. Further-
more, gensitein treatment also prevented the loss of keratinocyte cell-cell adhesion in functional
assays. Together, these findings suggest that Dsg3 internalization through a clathrin-independ-
ent pathway occurs upon dissociation from DP and that these pathogenic alterations in desmo-
some dynamics can be prevented by blocking tyrosine kinase activity.
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Loss of desmocollin 3 in the epidermis of mice causes epidermal blistering and telogen hair
loss
J Chen,1 Z Den,1 M Merched-Sauvage1 and PJ Koch1,2 1 Dermatology, Baylor College of
Medicine, Houston, TX and 2 Molecular and Cellular Biology, Baylor College of Medicine,
Houston, TX
Desmocollin 3 (Dsc3) is a transmembrane glycoprotein that belongs to the cadherin family
of calcium-dependent cell adhesion molecules. Together with desmogleins, Dsc3 forms the
transmembrane core of desmosomes, a multiprotein complex required for epidermal cell adhe-
sion and anchorage of the intermediate filament cytoskeleton at the plasma membrane. To test
the hypothesis that Dsc3 is required for epidermal homeostasis, we generated conditional
DSC3 null mice. Mice carrying a floxed DSC3 allele (Dsc3FL/FL) were crossed with trans-
genic mice expressing Cre recombinase under the control of the K14 promoter (K14-Cre).
Newborn mutant mice (Dsc3FL/FL/K14-Cre) showed a peeling skin phenotype. Mice that
survived into adulthood developed severe skin erosions. A histological analysis revealed intra-
epidermal blistering which occurred just above the basal cell layer. These histo-pathological
findings were identical to those we previously reported for DSG3 null mice, an animal model
for pemphigus vulgaris (PV). Furthermore, similar to DSG3 null mice, the conditional DSC3
null mice developed cyclic telogen hair loss. These data demonstrate that Dsc3 is required to
maintain cell adhesion in the epidermis. The similarity in the histo-pathological findings of
PV and the epidermal DSC3 null phenotype suggests the possibility that Dsc3 could be a tar-
get for auto-antibodies in certain cases of PV.
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Induced production of pro-collagen in normal human fibroblasts by plant derived extracts
MD Hines, TC Florence, D Gan and BC Jones Skin Care Research, Mary Kay, Inc., Dallas, TX
Natural materials are routinely added to skin care products to induce collagen production for
skin benefit. We examined glycolic extracts derived from plants to examine potential effect
on collagen production in a multi-assay approach. First, collagen production was measured
by determining the amount of procollagen released by human, dermal fibroblasts into the
medium as measured by enzyme-linked immunosorbant assay (ELISA). The concentration of
collagen secreted after three-day exposure to the plant extracts was compared to diluent con-
trols. We found four materials that showed significant increases in collagen production.
These materials were able to increase procollagen secretion (51%-134%) compared to con-
trols. Additionally, several of these materials also stimulated the activity of the collagen I pro-
moter (15%-65%) using a luciferase-based reporter assay. Further, these extracts were for-
mulated into a simple cosmetic base and topically applied on to a three-dimensional skin
equivalent; demonstrating a 48% increase in the production of soluble collagen. Together,
these data demonstrate that natural plant extracts can increase the regulation of collagen pro-
duction as demonstrated by substantially different assay methods.
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Alpha-ketoglutarate stimulates collagen production in cultured human dermal fibroblasts,
and decreases UVB-induced wrinkle formation following topical application on the dorsal
skin of hairless mice
E Son, H Kim, H Choi, I Chang and J Hwang Amorepacific, Yongin-si, South Korea
Alpha-ketoglutarate is a key intermediate in the Krebs cycle, and a rate-limiting cofactor of
prolyl-4-hydroxylase. It also has a potent effect on increasing the proline pool during colla-
gen production, but the details underlying the boosting effect on collagen production by α-
ketoglutarate remain as yet unreported. To investigate the effects of α-ketoglutarate on colla-
gen production and wrinkle formation, we conducted experiments in cultured human dermal
fibroblast and UVB-irradiated hairless mice. Based on ELISA measurements, α-ketoglutarate
(10µM) stimulated collagen production in fibroblasts by 25.6%±4.6% compared to vehicle-
treated control cells. Western blot analysis of type I collagen confirmed this result. Also, we
demonstrated that α-ketoglutarate increased enzyme activities of prolidase, which is known
to play an important role in collagen metabolism, in fibroblasts and carbobenzyloxy L-pro-
line, prolidase inhibitor, inhibited procollagen synthesis by α-ketoglutarate in fibroblasts. To
determine the effect of topically applied α-ketoglutarate on wrinkle formation, α-ketoglu-
tarate(1%) and vehicle(70% propylene glycol, 30% ethanol) were applied to the dosal skin
of UVB-induced hairless mice for twelve weeks. We found that α-ketoglutarate decreased
wrinkle formation upon long-term topical application. These results suggest that α-ketoglu-
tarate diminishes UVB-induced wrinkle formation by increasing collagen production, through
a pathway that involves prolidase activation. Therefore, application of α-ketoglutarate may
represent an effective anti-wrinkle agent for the cosmetic field.
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ADAM12: a potential target for treatment of chronic wounds
A Harsha,1 O Stojadinovic,2 CA Loomis,1 CP Blobel3 and M Tomic-Canic2 1 Pathology, NYU
School of Medicine, New York, NY, 2 Dermatology, Weill Cornell Medical College, New York,
NY and 3 Research, Hospital for Special Surgery, New York, NY
Wound healing is a complex process involving multiple cellular processes, such as cell pro-
liferation, migration, and tissue remodeling, coordinated by plethora of signaling molecules.
ADAM12 (a disintegrin and metalloprotease 12) is a membrane anchored metalloprotease,
implicated in ECM remodeling and activation/inactivation of various growth factors, includ-
ing HB-EGF and IGF binding proteins, which play an important role in wound healing. We
used microarray analyses to evaluate the role of ADAM12 in wound healing and its patho-
genesis. Analyses of the non-healing edge of chronic ulcers revealed a five-fold increase in
ADAM12 expression in patients’ biopsies when compared to normal skin. This was confirmed
by immunohistochemistry using an ADAM12 specific antibody. We found pronounced increase
in membranous and cytoplasmic signal for ADAM12 in the epidermis of chronic wounds com-
pared to controls. These findings prompted us to evaluate keratinocyte migration of Adam12-
/- mice or WT controls and their response to EGF. Skin explants from knockout or WT mice
taken at birth were placed in tissue culture, and used to quantify keratinocyte migration over
a period of seven days. We found a statistically significant increase in keratinocyte migration
of Adam12-/- keratinocytes compared to WT controls in both untreated (P=.0001) and EGF
treated (P=.028) samples. Also, a preliminary histological analysis of skin sections from Adam12-
/- mice showed differences in the dermis, smooth muscle layer and a increased number of
hair follicles in anagen compared to WT controls. In summary, the upregulation of ADAM12
in chronic wounds, and the increased migration of keratinocytes in the absence of ADAM12
suggests that ADAM12 is an important mediator of wound healing. We hypothesize that
increased expression ADAM12 in chronic wounds impairs wound healing through the inhi-
bition of keratinocyte migration, and that topical ADAM12 inhibitors might be useful to pro-
mote the healing of chronic wounds.
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Porous silicone: A promising material for sealing the skin-biomaterial interface
Z Tavakkol,1 M Usui,1 A Marshall,2 P Fleckman,1 B Ratner2 and J Olerud1 1 Medicine
(Dermatology), University of Washington, Seattle, WA and 2 Bioengineering, University of
Washington, Seattle, WA
Use of percutaneous medical devices such as central venous catheters and prosthetic limb
anchors, is often complicated by infection. Stable attachment of skin cells to the device could
reestablish barrier function of the skin at the interface and reduce infection risk. We have pre-
viously shown that poly 2-hydroxyethyl methacrylate [poly(HEMA)], engineered with tightly
controlled pore and throat sizes, permits migration and attachment of skin cells into the pores
when implanted percutaneously. Our studies have expanded to determine skin cellular response
to porous silicone, a biomaterial frequently used in the medical device market. In cell adhe-
sion studies, we found that keratinocytes attach to untreated silicone at comparable levels to
chemically modified poly(HEMA). We also evaluated cutaneous cellular response to implanted,
precision-engineered porous silicone rods in both organ culture and mouse models. In the
organ culture model, keratinocytes integrated into silicone pores, similarly to previous obser-
vations in porous poly(HEMA). In the mouse model, porous silicone rods showed both epi-
dermal and dermal cellular migration. We also observed by immunohistochemistry the expres-
sion of basement membrane proteins, such as collagen VII, laminin 5 and β4 integrin, within
the silicone pores. The presence of basement membrane proteins could indicate that in addi-
tion to migrating into the pores, keratinocytes also begin to form stable attachments to the sil-
icone. Stable anchorage at this interface is a critical part of reestablishing epidermal barrier
function and healing wounds around percutaneous implants. Porous silicone may be an ideal
candidate for sealing the skin-biomaterial interface, which could significantly expand the pos-
sibility of long-term uses of percutaneous devices.
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Laminin-10 gene knockdown correlates with reduced MMP-2 expression and decreased
melanoma cell invasiveness
J Li and J Chen Dermatology and Cutaneous Surgery, University of Miami, Miami, FL
Laminn-10 (α1,β1,γ1) is a major matrix protein in epithelial and endothelial basement mem-
branes. We previously reported the observation of increased expression of laminin-10 in inva-
sive skin cancers. In this study we blocked laminin-10 expression in melanoma cells using small
interfering RNA (siRNA), and evaluated the role of laminin-10 in melanoma cell invasiveness.
The laminin-10 alpha5 chain (Lam A5) sequence-specific 21-nt siRNAs (Lam A5 siRNA) were
transfected into melanoma cell line Mel-28, the mRNA expressions of Lam A5 and matrix met-
alloproteinase-2 (MMP-2) were detected 48 hours later by RT-PCR. A migration chamber with
8-micron pore filter was used to study the effects on cell migration. An invasion chamber with
Matrigel-coated filter was used to investigate cell invasion. RT-PCR showed that the mRNA
expression of Lam A5 was blocked effectively with Lam A5 siRNA. Compared with control cells,
the Mel-28 cells with reduced Lam A5 expression had dramatically decreased migration rate
by 77% and 59% at 12 and 24 hours, respectively. The Mel-28 cells transfected with Lam A5
siRNA also exhibited significantly reduced ability of invasion by 92% and 37% at 12 and 24
hours, respectively. In addition, MMP-2 mRNA expression level was significantly lower in those
cells. The ability of tumor cells to transverse the Matrigel-coated filter correlates with their abil-
ity to invade and metastasize in animals, and there is a correlation between cell migratory activ-
ity and its metastatic potential. MMP family is involved in the process of matrix degradation
and remodeling which contributes to tumor metastasis. This study revealed that laminin-10 plays
important roles in melanoma invasiveness via promoting cell migration and invasion. The cor-
relation of reduced mRNA expression of MMP-2 in tumor cells with Lam A5 gene knockdown
suggests the involvement of MMP-2 in laminin-10 mediated cell activities. Our data supports
the concept that the interaction of tumor cells with laminin-10 is a key event in melanoma inva-
sion and metastasis, in part via laminin-10-induced activity of MMP-2.
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Clinical associations between ichthyosis vulgaris, disease severity, and allergic respiratory
disease in atopic dermatitis
SF Bremmer, JM Hanifin and EL Simpson Department of Dermatology, Oregon Health and
Sciences University, Portland, OR
Mutations in the gene encoding filaggrin have recently been shown to underlie ichthyosis vul-
garis (IV) and are found more commonly in patients with atopic dermatitis (AD) than in control
populations. Recent genetic studies have shown that filaggrin mutations may also predispose
patients with AD to allergic respiratory disease (ARD), although the mechanism by which this
occurs is unknown. Our objective was to determine whether a clinical diagnosis of IV was asso-
ciated with the presence of ARD in a large cohort of patients with AD and whether the clinical
severity of IV influences AD severity, AD age of onset, or the probability of having ARD. We
reviewed data collected from the initial visits of 1187 patients with AD over a 20-year period.
Asthma symptoms were found more commonly in AD patients with IV than in those without
(39.9% vs. 32.9%, OR 1.35, P=0.050). Our data showed a stronger association between severe
IV and asthma symptoms (OR 2.52, P=0.002). Using logistic regression, odds ratios were cal-
culated controlling for age, sex, and baseline severity of AD. The presence of IV remained sig-
nificantly associated with asthma symptoms (OR 1.65, P=0.035), and severe IV continued to
show a stronger association (OR 3.26, P=0.014). Symptoms of allergic rhinitis were also more
common in AD patients with IV (61.8% vs. 53.2%, OR 1.42, P=0.018). Logistic regression also
confirmed this association (OR 1.95, P=0.005) and showed a stronger association between severe
IV and allergic rhinitis symptoms (OR 3.16, P=0.032). Further analyses revealed that the pres-
ence of IV is associated with earlier onset AD, and that the severity of IV significantly correlates
with the severity of AD (r=.245, p=1.4 x 10^-7). These results provide clinical confirmation of
recent genetic studies that implicate IV and filaggrin mutations to be predisposing factors for the
development of ARD in patients with AD. Furthermore, the severity of IV influences the proba-
bility of having concomitant ARD independent of AD disease severity.
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The expanding therapeutic spectum of topically applied Hyaluronic Acid sodium salt 0.2%
(HA)
C Ditre,1 V Cirillo-Hyland2 and O Mills3 1 Dermatology, University of Pennsylvania, Radnor,
PA, 2 Dermatology, Bryn Mawr Dermatology, Bryn Mawr, PA and 3 Dermatology, Robert
Wood Johnson Medical School, New Brunswick, NJ
Hyaluronic acid and its salts are polymeric mucopolysacharides which are film formers and
slowly release the HA into the epidermis and dermis. HA can hold up to 400-1000 times its
weight of water and about 56% of the total is found in the skin. HA’s ability to repair and restore
healthy skin at the cellular level cannot be underestimated. Applications of HA to treatment
induced skin breakdown have been reported earlier. This presentation highlights additional
case studies of patients from clinical practice. These case studies underline new or modified
uses. One previously unreported area of application is in patients using retinoid therapy to
counter the signs and symptoms also induced by retinoid administration. A controlled post
intense pulsed light therapy study has also been conducted. Case reporting shows the many
patient variables possible in clinical practice with resurfacing and laser treatments. Also detailed
are cases of patients having been treated with 5-fluorouricil followed by HA. Key to any drugs
use is evaluation in the practicing dermatologist’s office. This setting has many patient varia-
tions on which to test the efficacy of a relatively new material. It would appear at this point
that HA may indeed be helpful in many treatment induced situations.
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New long acting topically applied treatments with bioadhesive hydrogel delivery system
K Shah,1 T Vlahovic2 and O Mills3 1 Polytherapeutics Inc, Bridgewater, NJ, 2 Temple
University School of Podiatric Medicine, Philadelphia, PA and 3 Dermatology, Robert Wood
Johnson Medical School, New Brunswick, NJ
Two new dermatological products have been developed with hydroquinone 4% and urea 40%,
for the treatments of hyperpigmentation and ichthyosis respectively. These products are for-
mulated with skin penetration optimizing excipients and a novel bioadhesive polymer
[poly(N,N-dimethylacrylamide-co-acrylic acid-co-polystyrene ethyl methacrylate]. Upon appli-
cation to skin, these products form a bioadherent hydrogel film, which has been shown to be
retained on skin for 24 hours and provide controlled release of the actives. The formed film is
invisible, imperceptible, and breathable. A practical advantage of the hydrogel film formation
is that the actives would not be removed from the skin by perspiration and/or contact with arti-
cles of clothing because of its incorporation in a relatively moisture (perspiration) resistant
polymer matrix. The polymer along with other formulation excipients also helps to moistur-
ize the skin. Key potential benefits of these controlled release products are (1) long lasting
treatment of the affected skin site with a once/day application, (2) greater effectiveness, (3)
minimization of skin irritation, and (4) improved patient convenience/compliance due to less
frequent administration.
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Effect of chymase inhibitor SUN13834 on animal models for atopic dermatitis; 2) effect on
NC/Nga mice
N Watanabe,1 Y Tomimori,2 M Terakawa,2 K Ishiwata,1 A Wada,3 T Muto,2 T Tanaka,2
H Maruoka,2 K Nagahira,2 T Nakatsuka2 and Y Fukuda2 1 Department of Tropical Medicine,
The Jikei University School of Medicine, Tokyo, Japan, 2 Biomedical Research Laboratories,
Daiichi Asubio Pharma Co Ltd, Osaka, Japan and 3 The Laboratory Animal Facilities, The Jikei
University School of Medicine, Tokyo, Japan
NC/Nga mice are known to spontaneously develop dermatitis similar to atopic dermatitis in
conventional condition. Oral administration of a novel chymase inhibitor SUN13350 (free
from of SUN13834) at 30 mg/kg once a day for 3 weeks inhibited increase in clinical skin
score of NC/Nga mice. The SUN13350 treatment also inhibited accumulation of mast cells
and eosinophils in the skin of the mice. In addition, the serum levels of IgE and interleukin-
18 were reduced by the treatment with SUN13350. In in vitro studies, SUN13350 inhibited
chymase-induced processing of stem cell factor (SCF), which is the major cytokine for growth
and differentiation of mast cells. Furthermore, SUN13350 inhibited chymase-induced migra-
tion of eosinophils in chemotaxis analysis. These results suggest that accumulation of mast
cells and eosinophils in NC/Nga mice may be at least in part related to the ability of chy-
mase to process SCF and to stimulate eosinophil migration, respectively, and that the improve-
ment of dermatitis of the mice by SUN13350 might be due to the inhibition of these mech-
anisms. Taken together, the novel compound SUN13350 is thought to be promising for
treatment of AD.
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Differentiation of tumor-phase mycosis fungoides, psoriasis vulgaris, and normal controls in
a pilot study using serum proteomic analysis
EW Cowen,1 C Liu,2 SM Steinberg,3 S Kang,4 EC Vonderheid,5 H Kwak,4 S Booher,1
EF Petricoin,6 LA Liotta6 and ST Hwang1 1 Dermatology Branch, National Cancer Institute,
NIH, Bethesda, MD, 2 Clinical Proteomics Reference Laboratory, SAIC-Frederick, Inc.,
Gaithersburg, MD, 3 Biostatistics and Data Management Section, National Cancer Institute,
NIH, Rockville, MD, 4 Department of Dermatology, University of Michigan Medical School,
Ann Arbor, MI, 5 Departments of Dermatology and Oncology, Johns Hopkins Medical
Institutes, Baltimore, MD and 6 Center for Applied Proteomics and Molecular Medicine,
Department of Molecular and Microbiology, George Mason University, Manassas, VA
This pilot study was designed to determine if serum protein patterns could be used to distin-
guish patients with tumor phase mycosis fungoides (MF) from patients with a benign inflam-
matory skin condition (psoriasis) and/or patients with healthy skin. Serum was analyzed from
45 patients with tumor-phase MF, 56 patients with psoriasis, and 47 controls using two mass
spectrometry (MS) platforms of differing resolution. An artificial intelligence-based classifica-
tion model was constructed using ~70% of randomly selected sera from each patient group.
Based on data from an independent testing set (13 to 16 patients in each group), MF was dis-
tinguished from unaffected controls with 61.5% (or 71.4%) sensitivity and 91.7% (or 92.9%)
specificity (depending on the MS platform used). MF was distinguished from psoriasis with
78.5% (or 78.6%) sensitivity and 86.7% (or 93.8%) specificity, while sera from psoriatic patients
were distinguished from those of non-affected controls with 86.7% (or 93.8%) sensitivity and
75% (or 76.9%) specificity (depending on the MS platform used). In addition, a secondary sur-
vival analysis using 11 MS peaks identified significant survival differences between two MF
groups (all p-values <0.05). Serum proteomics should be further investigated for its potential
to identify patients with neoplastic skin disease and determine disease prognosis.
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Does quality-of-life in cutaneous lupus erythematosus correlate with disease severity?
E Gaines,1 Z Bonilla-Martinez,1 J Albrecht,1 L Taylor,1 J Okawa1 and V Werth1,2 1 University
of Pennsylvania, Philadelphia, PA and 2 Philadelphia V.A., Philadelphia, PA
The purpose of this study was to assess the relationship between the change in cutaneous lupus
erythematosus (CLE) disease severity, as measured by the CLASI, and the change in quality-of-
life (QoL), as measured by the Skindex-29. This was a prospective, longitudinal study from base-
line (Day 0) to Day 56, done at a University hospital cutaneous autoimmunity outpatient
clinic. Nine patients with biopsy-confirmed CLE (5 DLE, 2 SCLE, 2 DLE/SLE) were enrolled. Four
patients were enrolled with skin type 5-6 and five patients were enrolled with Fitzpatrick skin
type 1-3. Patients were only included if they were about to begin new or change current ther-
apy. At each visit, patients filled out the CLE-modified Skindex-29, which included three ques-
tions assessing photosensitivity. The PI evaluated disease severity, with the CLASI and evalu-
ated skin health on a scale from 0-10. Using Pearson Correlation, there was a moderate correlation
(r=0.59, p=0.12, n=8) between change in activity, as measured by the CLASI, and change in
concern about skin symptoms, as assessed by the Skindex. Neither change in concern about
emotion or function correlated with change in activity. There was no correlation between any
subscales of the Skindex with damage. There were poor correlations between change in physi-
cian-rated skin health and change in each Skindex subscale. Patients consistently scored the
three CLE-specific questions high. Skindex scores for patients with subacute CLE were, on
average, lower and changed less over time than Skindex scores for patients with discoid cuta-
neous LE. Change in QoL and change in disease activity and damage measure largely distinct
elements of general health. Improvement in QoL may lag behind improvement in disease
activity and such improvement in QoL may not have been detected by the Skindex within the
time frame of this study. Given the different disease courses and likelihood of permanent dam-
age, skin-related QoL may differ fundamentally across different subtypes of CLE.
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Depletion of human CD4+CD25+ regulatory T cells: in vivo kinetics and analysis of anti-
melanoma immune responses
K Mahnke,1 K Schoenfeld,1 S Ring,1 S Karakhanova,1 K Wiedemeyer,1 TS Johnson,1 V Storn,1
S Schallenberg,1,2 E Suri-Payer2 and AH Enk1 1 Department of Dermatology, University of
Heidelberg, Heidelberg, Germany and 2 German Cancer Research Center, Heidelberg,
Germany
The aim of this study was to investigate whether depletion of CD4+CD25+ regulatory T cells
(Treg) from melanoma patients affects immune responses against tumors. By application of
recombinant IL-2-diphteria toxin fusion protein, also known as Ontak, we were able to sig-
nificantly reduce the frequency of Treg in peripheral blood. The average percentage of
CD4+CD25+FoxP3+ cells among the CD4+ population dropped from 5% to 1.5%, whereas
other cell populations remained unaffected. The reduction of Treg started within one day after
the first bolus of Ontak with a dose of 5 µg Ontak per Kg bodyweight and lasted for 13 days
with subsequent recovery thereafter. However, the number of Treg stagnated at approx 1.5%
and even successive rounds of Ontak applications did not further reduce the number of cir-
culating Treg. Using the contact sensitizer DCP we show, that all patients developed vast
eczema after Treg depletion, whereas no or only mild eczematous reactions were detectable
before Ontak treatment. Corresponding induction of DCP-specific CD4+ and CD8+ T cells
were detectable. Moreover, after immunization of ONTAK treated patients with tumor anti-
gen peptides, MelanA/MART-1 and gp100, significant induction of peptide specific CD8+ T
cells, as indicated by tetramer staining, could be observed in 90% of the patients treated. These
cells also displayed effector functions, as they were able to lyse peptide-pulsed target cells in
an in vitro killer assay and secreted IFN-γ upon restimulation. On the whole, our data indi-
cate that Ontak depletes Treg in vivo significantly, resulting in enhanced immune functions
and substantial development of antigen specific CD8+ T cells in vaccinated individuals.
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Urine metabolic profiling using high-resolution nuclear magnetic resonance (NMR) spec-
troscopy in male genital lichen sclerosus (MGLSc)
CB Bunker,1 J Cox,2 H Williams3 and EV Edmonds1 1 Dermatology/Chelsea & Westminster
Campus, Imperial College School of Medicine, London, United Kingdom, 2 Imaging
Sciences/Hammersmith Campus, Imperial College School of Medicine, London, United
Kingdom and 3 Medicine/Hammersmith Campus, Imperial College School of Medicine,
London, United Kingdom
Lichen sclerosus (LSc) is a chronic inflammatory and atrophic disorder of the genitalia. The
pattern of disease in both sexes suggests that untoward urinary contact with genital mucosa
is important. Metabolic profiling describes the generation of metabolic information based on
the analysis of biofluids or tissue samples and provides an opportunity to study specific dis-
eases based on underlying metabolic processes. High-resolution nuclear magnetic reso-
nance (NMR) spectroscopy techniques allow the simultaneous acquisition of multiple bio-
chemical parameters from which high-density spectral profiles are generated. These may be
analysed by computer-based pattern recognition software to give information pertaining to
physiology and disease that has already resulted in the identification of distinctive NMR
spectroscopic profiles for a variety of conditions in humans. Urine samples have been obtained
from two highly selected caucasoid groups of patients with male genital (MG) LSc (n=8) and
healthy controls (n=8). We are focussing on molecules that might be involved in the patho-
genesis of MGLSc and its sequelae, given that these involve inflammatory, fibrotic and neo-
plastic processes. A preliminary result of potential interest is that the osmolyte or ‘chaperone
molecule’ trimethylamine-N-oxide is not significantly different between the two groups. The
analysis of other urinary metabolites that might be incriminated is underway.
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Effects of dietary squalene supplementation on aging skin in human skin in vivo
S Cho,1,2,3 C Choi,1,2 C Won,2,3 S Lee,2 M Lee2 and J Chung1,2 1 Dermatology, Seoul National
University College of Medicine, Seoul, South Korea, 2 Institute of Dermatological Science,
Seoul National University, Seoul, South Korea and 3 Dermatology, Seoul National University
Boramae Hospital, Seoul, South Korea
Since most of the dietary squalene is known to accumulate in the skin and act to remove harm-
ful reactive oxygen species, squalene may have anti-aging effects in the skin. However, evi-
dence to support this is lacking. The aim of this study was to determine whether dietary squa-
lene improves cutaneous photoaging. Forty healthy female subjects over the age of 50 were
recruited and received 2 different doses (low-dose, 13.5 g/d; high-dose, 27 g/d) of squalene
supplementation for 90 days. At baseline, 45 days and completion of study, facial wrinkles
were measured by taking skin replica, and facial erythema and pigmentation by spectropho-
tometer. Skin samples were taken before and after squalene intake and processed to compare
procollagen type I and matrix metalloproteinase 1 mRNA levels by real-time RT-PCR. Skin
samples were also taken 24 hours after 2 MED of UV irradiation before and after squalene
intake to assess keratinocytic apoptosis, thymine dimer formation, and neutrophil/macrophage
infiltration in response to UV. After squalene intake, facial wrinkles and erythema decreased
significantly (p<0.05) only in the high-dose group, and procollagen type I mRNA levels were
increased in both groups. MED increased in both groups after squalene intake, albeit not sig-
nificantly. After UV irradiation, keratinocytic apoptosis and thymine dimer staining were sub-
stantially reduced in both groups after squalene intake. Since squalene significantly decreases
wrinkles and erythema in photoaged human skin in a dose-dependent manner, with increase
in collagen production and decrease in UV-induced epidermal keratinocytic damage, it is
strongly suggested that squalene prevents and repairs cutaneous photoaging.
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Novel method for epidermal drug delivery with non-pathogenic monoclonal pemphigus anti-
bodies
JR Stanley,1 C Lin1 and DL Siegel2 1 Dermatology, Univ. of Pennsylvania, Philadelphia, PA and
2 Pathology, Univ. of Pennsylvania, Philadelphia, PA
In previous work we isolated monoclonal antibodies as single chain variable fragments (scFv)
from patients with pemphigus using phage display. Most of these scFv, although they bound
strongly to desmogleins (Dsg) and epidermis, were non-pathogenic when injected into neona-
tal mice or human skin organ culture. We hypothesized that such antibodies might be useful
for targeted drug therapy to epidermis because in addition to not causing blisters they: a) are
small and diffuse well; b) lack the effector region of IgG that causes inflammation; c) are derived
from humans so would be minimally immunogenic; d) can be produced in unlimited quan-
tities. Intraperitoneal injection of anti-Dsg3 scFv with an HA epitope tag into adult mice showed
diffusion and binding to the cell surface of all epidermis and its adnexal structures (i.e. hair
follicle and eccrine glands) as detected by anti-HA immunofluourescense. This scFv bound
the cell surface unchanged for at least 2 days without pathology. To show that such an scFv
could deliver an attached protein to the epidermis, we created a modular baculovirus vector
with restriction sites to insert any phage-cloned scFv, a short linker, then green fluorescent pro-
tein (GFP) in a NotI site (that could be used to substitute any cDNA) with a 6x-His tag for Nickel
purification. Several non-pathogenic anti-Dsg (3 or 1) scFv-GFP chimeric proteins were each
produced and secreted by baculovirus-infected insect cells. Nickel purification yielded a sin-
gle band on Coomassie Blue gels and anti-HA immunoblots. GFP fluorescence showed high
titer cell surface binding to monkey esophagus sections and binding to epidermal and adnexal
keratinocyte cell surfaces when injected into mice or human skin organ culture. In this mod-
ular delivery system GFP could be replaced with, e.g., biologics, enzymes that activate drugs,
or protease inhibitors; and scFv cloned by phage display from other autoimmune patients
(e.g. pemphigoid or Goodpasture’s Disease) could be used to change the target.
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The expression of the chemokine receptor CCR5 in psoriasis and the results of a randomized
placebo controlled trial with a CCR5 receptor inhibitor
M de Groot, DI Picavet, MA de Rie, MB Teunissen and JD Bos Dermatology, Academic
Medical Center, University of Amsterdam, Amsterdam, Netherlands
In literature there are several indications that the chemokine receptor CCR5 and its ligands,
especially CCL5 (formerly known as RANTES), may play a role in the pathogenesis of psoria-
sis. The purpose of this investigation was to examine the expression of CCR5 and its ligands
in chronic plaque psoriasis and to evaluate the effect of a CCR5 receptor inhibitor on this dis-
ease. Lesional and non-lesional skin biopsies, taken from 9 patients with severe chronic plaque
psoriasis, were immunohistochemically double-stained for CCR5 and CD3 or CCR5 and CD68
and manually quantified with light microscopy. RNA microarray was performed to determine
the mRNA expression of CCR5 and ligands (CCL4, CCL5) using quantitative reverse tran-
scriptase – polymerase chain reaction (RT-PCR) for confirmation. Furthermore, 32 patients par-
ticipated in a randomized placebo controlled trial for 28 days with a CCR5 receptor inhibitor
(SCH351125). Clinical efficacy was measured with the Psoriasis Area and Severity Index (PASI).
Additionally, immunohistochemical single-staining (CD3, CD161, K16, elastase) of lesional
biopsies taken on baseline and day 28 were analysed with digital image analyser and confo-
cal scanning microscopy. The number of CCR5+CD3+ and CCR5+CD68+ cells showed a sig-
nificant increase in lesional versus non-lesional skin. In contrast, the RNA micro-array and
quantitative RT-PCR data did not reveal such difference in CCR5 expression. CCL5, but not
CCL4, mRNA expression was significantly increased in lesional skin. Treatment with SCH351125
did not cause a significant difference in PASI or any immunohistochemical marker in com-
parison to placebo. We concluded that although CCR5 expression might be increased in pso-
riatic lesions, this receptor does not play a crucial role in the pathogenesis of psoriasis.
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CX-659S, a MEK1/2 inhibitor, diminishes epidermal nerve elongation in chronic dermatitis
M Kido, S Takeuchi, S Hayashida and M Furue Dermatology, Graduate School of Medical
Sciences, Kyushu University, Fukuoka, Japan
It is thought that not only histamine, but also other factors such as nerve fiber structure or
neuropeptides (substance P: SP, calcitonin gene-related peptide: CGRP etc), may play an impor-
tant role in the pathophysiology of pruritic skin disorders. Indeed, unusual epidermal nerve
fiber elongation in the skin lesion of chronic dermatitis has been reported. CX-659S (CX), a
MAPK/ERK kinase (MEK) 1/2 inhibitor, has been developed as a new anti-inflammatory drug
(Uchi H et al. J Invest Dermatol 2003). Since some of other MEK1/2 inhibitors reportedly inhibit
neurite elongation in vitro, we hypothesized that, in addition to the anti-inflammatory prop-
erties, CX might inhibit epidermal nerve elongation in vivo, thereby beneficial to reduce pru-
ritus of dermatitis. To test this idea, we used a mouse model of chronic dermatitis by repeti-
tive picryl chloride (PC) painting. C57BL/6 mice were painted with 0.5% PC solution every
other day, and some of them were also topically treated with CX, FK506 (FK) or betametha-
sone valerate (BV) everyday. On day 7, the effects of these agents on epidermal nerve elon-
gation as well as various skin inflammatory factors were examined. CX, FK and BV signifi-
cantly (P<0.05) reduced PC-induced ear swelling (mean % inhibition: -26.5%, -58.5% and
-63.4%, respectively), the dermal inflammatory infiltrates (-26.6%, -57.7% and -67.6%) and
the dermal mast cells (-28.3%, -22.4% and -30.5%), as compared to those of positive control.
All of CX, FK and BV significantly (P<0.05) reduced PC-induced epidermal PGP9.5 positive
(+) nerve elongation (-45.6%, -53.5% and -46.0%). CX and FK, but not BV, significantly (P<0.05)
inhibited the epidermal SP+ sensory nerve elongation (-60.1%, -59.2% and -40.7%), while
the epidermal CGRP+ sensory nerve elongation was unaffected. In conclusion, despite of the
rather moderate anti-inflammatory properties, CX demonstrates equal to significantly better
inhibition of epidermal SP+ sensory nerve elongation, as compared to BV or FK, suggesting
that CX could also be a potential itch inhibitor.
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Development of a new skin equivalent model using de-epithelialized amnion membrane
L Yang,1 Y Shirakata,2,1 X Dai,1 S Tokumaru,1 S Hirakawa,1 K Sayama1 and K Hashimoto1 1
Dermatology, Ehime University Graduate School of Medicine, Ehime, Japan and 2
Regenerative Medicine Research Center, Ehime University Graduate School of Medicine,
Ehime, Japan
The presence of pre-existing basement membrane (BM) components improves the morpho-
genesis of epidermis and BM in constructing a human living skin equivalent (LSE). De-epithe-
lialized amniotic membrane (AM) retains key BM components and might be a good candidate
matrix in constructing LSE. Therefore we have investigated whether AM is useful for LSE. De-
epithelialized AM was overlaid upon type I collagen gel embedded with fibroblasts, and then,
normal human keratinocytes (NHK) were seeded upon the epithelial side of the AM to con-
struct an AM-LSE. Conventional LSE was constructed by seeding NHK on fibroblasts-popu-
lated type I collagen gel. When keratinocytes reached confluence, the LSE was lifted to air-liq-
uid interface and cultured for up to 3 weeks. Samples were harvested at different time points
and manipulated for morphological, immunohistochemical and ultrastructural investigation. In
AM-LSE, the epidermis was better stratified with more compact, polarized and columnar basal
cells, and the expression of differentiation and proliferation markers was in a more similar way
to normal human skin compared with LSE without AM. Alpha smooth muscle actin, which plays
an important role for hypertrophic scar formation, was expressed beneath the dermo-epider-
mal junction in conventional LSE, whereas it was not detected in AM-LSE. A more continuous
BM and better-developed hemidesmosomes were found in AM-LSE. The epidermis of AM-LSE
outgrew much faster than that of LSE without AM. Both LSEs transplanted onto nude mouse
took well, however, AM-LSE graft showed better morphogenesis of epidermis, BM and
hemidesmosomes. In conclusion, we have developed a new skin equivalent model using de-
epithelialized amnion membrane. The better epidermal morphology and better-developed BM
in AM-LSE in vitro or in vivo indicated its priority to LSE without AM in clinical application.
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Efficacy of a 5-HT1A partial agonist in atopic dermatitis
S Kawana, Y Kato and T Shimoda Dermatology, Nippon Medical School, Tokyo, Japan
Atopic dermatitis (AD) can be aggravated by psychological stress. To evaluate the efficacy of
anxiolytic drugs in treatment of AD, we studied changes in anxiety levels, depression symp-
toms and the clinical severity of AD after administration of tandospirone citrate, a serotonin
(5-HT) partial agonist for the 5-HT1A receptor subtype. We examined 24 patients who were
administered tandospirone citrate at 30 mg/day for 4-6 weeks and 21 control patients who
did not receive the drug. Standard treatment for AD was continued in all patients. The sever-
ity of AD and pruritis were evaluated using the SCORAD index and a VAS score, respectively,
and Profile of Mood States (POMS) scores were determined as measures of several types of
psychological stress. Before tandospirone citrate administration, all scores were high in the
treatment and control groups. POMS scores for tension-anxiety (p<0.02) and depression-dejec-
tion (p=0.052) and the SCORAD index (p<0.0001) markedly decreased in patients who received
tandospirone citrate, whereas patients in the control group did not show significant changes
in psychological and clinical symptoms. In a subsequent experiment, we demonstrated that
pre-administration of tandospirone citrate at 10 mg/kg significantly inhibited mast cell degran-
ulation in mouse skin following induction by intermittent foot shock stress for 1 hour (p<0.003).
These data suggest that anxiolytic drugs such as 5-HT1A partial agonists are useful in clinical
management of stress-associated aggravation of AD. Inhibition of stress-induced mast cell
degranulation may be one of the mechanisms underlying the clinical efficacy.
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The clinical effect of Phellinus linteus grown on germinated brown rice in the treatment of
mild to moderate atopic dermatitis in children
W Hong,1 H Lee,1 J Shin,1 G Choi,1 Y Lee2 and D Park3 1 Dematology, INHA University,
Incheon, South Korea, 2 Cosmetology, Hyejeon College, Hongsung, South Korea and 3
Applied Biology and Chemistry, Konkuk University, seoul, South Korea
Phellinus linteus has been used as a traditional herb medicine for years in oriental countries.
Recent preliminary animal experiments suggest that Phellinus linteus grown on germinated
brown rice(PGBR) is effective in chronic inflammatory disease. The aim of this study is to
evaluate the efficacy of PGBR in the treatment of mild to moderate atopic dermatitis(AD) in
children. A total of 35 patients group with mild to moderate AD was treated with PGBR per
oral, 6~12g/day adjusted by the body weight, divided three for up to 12 weeks without other
treatment except topical emollients. The disease activity has been monitored by SCORAD
index. The severity of the pruritus was measured by using a visual analogue scale(VAS). In
addition, the global assessments of clinical response were also monitored by patients or their
parents. The level of serum IgE was checked before and after the treatment. In results, the mean
SCORAD indices of 35 patients decreased from 31.28±10.01 to 22.39±15.59(p<0.05). And
the mean symptom score of pruritus assessment decreased from 7.37±1.33 to 4.6±2.3(p<0.05).
The patient’s global assessment of clinical response were also improved down through the
period of treatment(p<0.05). The changes of serum IgE level were not significant. There was
no signicant adverse effect except transient aggravation of the skin lesion during early two or
three days of the study. In conclusion, We suggest that PGBR may be a safe and good adju-
vant treatment for mild and moderate AD.
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Effect of chymase inhibitor SUN13834 on animal models for atopic dermatitis; 1) effect on
acute biphasic dermatitis in mice
Y Tomimori, M Terakawa, T Muto, T Tanaka, H Maruoka, Y Fujieda, K Nagahira, A Ogata,
T Nakatsuka and Y Fukuda Biomedical Research Laboratories, Daiichi Asubio Pharma Co.,
Ltd., Mishima-gun, Osaka, Japan
Atopic dermatitis has 10-20% prevalence in the US. Current treatments include topical bar-
rier creams and steroids or immunosuppressants. Skin from human atopic dermatitis patients
shows dermal infiltration with mast cells. Chymase is exclusively stored in secretory granules
of mast cells and, when injected intradermally to mice, produces a biphasic skin reaction.
The kinetics of this reaction was analogous to the biphasic skin reaction induced by 2,4,6-
trinitro-1-chlorobenzene (TNCB) in passively sensitized mice. SUN13834 is a specific inhibitor
for chymase, i.e. the Ki values of SUN13834 for human chymase and mouse chymase (mouse
mast cell protease-4) are 0.161 µM and 0.063 µM, respectively. Oral administration of
SUN13834 inhibited both of early- and late-phase skin reactions in the TNCB-mediated bipha-
sic dermatitis in the sensitized mice; the statistical significance was shown at more than 10
mg/kg for early-phase reaction and at more than 2 mg/kg for late-phase reaction. These results
show chymase to be a potential new therapeutic target for atopic dermatitis.
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Reflectance confocal microscopy of surgically exposed tissue
JA Lieb, S Mandal, AL Agero, Y Patel, AC Halpern, M Rajadhyaksha and K Nehal
Dermatology, Memorial Sloan-Kettering Cancer Center, New York, NY
Reflectance confocal microscopy (RCM) is a research tool for the in-vivo assessment of
melanocytic and non-melanocytic skin lesions. While RCM provides sufficient optical sec-
tioning, resolution and contrast to permit the recognition of nuclear and cellular elements in
intact skin, this has not been demonstrated in surgically exposed tissues. We demonstrate RCM
for the imaging of surgically exposed tissues after shave biopsies were performed. Twenty-five
patients who had a shave biopsy of the skin with adequate hemostasis were imaged. A sterile
immersion medium (either sterile water or Surgilube) was applied to the biopsy site and cov-
ered with a sterile optically clear dressing (Tegaderm, 3M). A sterilized stainless steel ring
with an optical window (either polycarbonate, glass or air) was attached to the dressing and
was magnetically coupled to the objective lens of the reflectance confocal microscope (Vivas-
cope 1500, Lucid Inc) to stabilize the skin during imaging. Illumination was with a near-infrared
wavelength of 830nm. Images were captured with a 30X, 0.9 numerical aperture that dis-
plays a 0.5mm field of view, with an optical section thickness of 3µm and lateral resolution
of 1µm. Stacks of images at 5µm depth increments were obtained. Mosaics of 8 x 8 images
were created to display a 4mm x 4mm field at approximately 4X magnification. These images
were captured near the peripheral and deep areas of the exposed tissue. Confocal imaging of
surgically exposed tissue is possible. Tegaderm does not degrade optical sectioning, resolu-
tion or image quality. Aluminum chloride, used for hemostasis, strongly enhances the bright-
ness, contrast and detectability of nuclei in surgically exposed tissue. Images show that nuclear
and cellular structures may be identified within a surgical field. Deep dermal structures, such
as collagen, hair follicles and sebaceous glands, are better visualized in surgically exposed
tissues than in intact skin. In conclusion, this suggests the feasibility of RCM imaging of sur-
gically exposed tissues to detect residual tumor.
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Comparison of the effects of extractum cepea, heparin sodium and allantoin in an experi-
mental model of scar formation: an immunohistochemical and ultrastructural study
MT Sahin,1 S Inan,2 S Ozturkcan,1 S Muftuoglu,3 C Bilac,1 G Giray2 and E Guzel3 1
Department of Dermatology, Celal Bayar University Medical Faculty, Manisa, Turkey, 2
Department of Histology and Embryology, Celal Bayar University Medical Faculty, Manisa,
Turkey and 3 Department of Histology and Embryology, Hacettepe University Medical
Faculty, Ankara, Turkey
Extractum cepae together with heparin sodium and allantoin exerts a softening and smoothing
effect on indurated, hypertrophic, painful and cosmetically disfiguring scar tissue. In this study
we aimed to compare and discuss the effects of extractum cepae, heparin sodium and allantoin
in the rat model. We investigated the immunohistochemical and ultrastructural effects of these
agents on the scar tissues of the experimentally produced wounds of thirty-two rats. These rats
were divided into four groups: three test and a control group (group 1). After their wounds healed
completely, a mixture of extractum cepae, heparin sodium, and allantoin in a gel base was top-
ically applied daily to group 2; while as a monotherapy heparin sodium was applied to group
3, and allantoin was applied to group 4. On the 30th day of each treatment, scar tissues of all
the animals were excised to investigate immunohistochemical and ultrastructural effects of
these agents. Immunohistochemical examination was performed by using TGF-beta and two
extracellular matrix proteins: laminin, fibronectin, which are highly effective in wound healing.
While increased immunoreactivities of laminin, fibronectin and TGF-beta were observed in con-
trol group, moderate immunoreactivities observed in heparin and allantoin groups, and mild
immunoreactivity in extractum cepea mixture group respectively. Electron microscopic exami-
nation of the sections revealed more thicker epidermis and active fibroblasts with granulation
tisue-like connective tissue in dermis of control group, whereas group 2 showed the most thinnest
epidermis of the four groups. This shows that the extractum cepae mixture, with both keratinolytic
and collagenase effects, reduces the scar formation more effectly than heparin and allantoin.
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Diagnostic in vivo confocal laser-scanning microscopy of actinic keratoses
M Horn,1 A Gerger,2 V Ahlgrimm-Siess,1 W Weger,1 S Koller,1 H Kerl,1 H Samonigg,2
J Smolle3 and R Hofmann-Wellenhof1 1 Department of Dermatology, Medical University of
Graz, Graz, Austria, 2 Department of Internal Medicine, Divison of Oncology, Medical
University of Graz, Graz, Austria and 3 Institute for Medical Informatics, Statistics and
Documentation, Medical University of Graz, Graz, Austria
Recently a wide range of new non-invasive therapies have been introduced in the treatment
of actinic keratoses. These treatment options do not provide tissue for histopathological exam-
inations, therefore in vivo confocal laser-scanning microscopy may become important to offer
a reliable diagnosis. The objective of the present study was to validate the diagnostic confo-
cal examination of actinic keratoses. 30 actinic keratoses and unsuspicious skin fields from
the contra-lateral side of the patients were consecutively sampled and examined using a con-
focal microscope. Stored images were rated by four independent observers. Distinct diag-
nostic morphologic features could be visualized by the imaging system. Overall, sensitivity
of 93.34% and specificity of 88.34% could be achieved by two clinical dermato-oncologists
(positive predictive value 88.94%, negative predictive value 93.15%). Assessment of distinct
confocal microscopy features showed a moderate interobserver correlation (kappa 0.4-0.6 in
5 of 7 criteria). Classification and regression tree analysis yielded a 1-step algorithm based on
only one criterion (irregular keratinocyte cell borders), facilitating a correct classification in
86.67% of actinic keratoses and 85% of unsuspicious normal skin. This study provides a set
of well-described morphologic criteria with obvious diagnostic impact which should be used
in further investigations.
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Topical application of 4-n-Butylresorcinol reduces hyperpigmentation of facial senile lentigo
Y Nomura1 and A Tada2 1 Nomura Dermatology Clinic, Yokohama, Japan and 2 POLA
Chemical Industries, Inc., Yokohama, Japan
4-n-Butylresorcinol (Rucinol®) has inhibitory effects on both tyrosinase and tyrosinase related
protein-1 activities. It was reported that a lotion containing 0.3% Rucinol® had therapeutic
effects on human hyperpigmentation of melasma and the disappearance of pigmentation after
laser therapy. In this study, we examined the effect of a topically applied cream containing
0.3% Rucinol® on the pigmented area of facial senile lentigo. Practical usage test was con-
ducted on 25 healthy female subjects with facial senile lentigo. Their ages range from 35 to
66 years old. The study started in April and ended in October 2006 in Yokohama, Japan. The
cream containing 0.3% Rucinol® was applied to the face twice a day for 24 weeks and the
subjects were prohibited from using any other topical skin whitening preparations and aes-
thetic dermatological therapy. All subjects were given written informed consent. The test pro-
tocol was approved by the regulatory and safe review committee for human testing of POLA
CHEMICAL INDUSTRIES, INC. After 24 weeks application, the effect of the 0.3% Rucinol®
cream on facial senile lentigo was assessed as marked useful in 4 (16%), moderate useful in
15 (60%) and slight useful in 6 (24%) out of 25 subjects. In some subjects, the size of hyper-
pigmented areas were reduced and the color was lightened at 12 weeks onset the test. These
changes were also perceived by the subjects’ self-assessment after a few months treatment.
No adverse skin reactions were observed during the test period. In conclusion, we have demon-
strated for the first time that daily use of a cream containing 0.3% Rucinol® was effective for
the reduction of hyperpigmentation in facial senile lentigo.
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Basal cell nevus syndrome: resistance to chemopreventive effects of oral celecoxib
M Aszterbaum,1 D Bickers,3 C Cappola,3 N Estevez,1 E Epstein,1 E Hawk,4 J Hwang,2
L Kopelovich4 and Y Lu2 1 Dermatology, UCSF, San Francisco, CA, 2 Comprehensive Cancer
Center, UCSF, San Francisco, CA, 3 Dermatology, College of Physicians and Surgeons,
Columbia University, New York, NY and 4 Division of Cancer Prevention, NCI, Bethesda, MD
BCNS patients develop enough basal cell carcinomas (BCCs) to permit the rapid accumula-
tion of statistically significant clinical trial data. We tested the anti-BCC chemopreventive effect
of celecoxib, which reduces human pre-malignant colonic polyps, in a randomized, double-
blind study in BCNS subjects; half received active drug (200 mg bid), and half received placebo.
All 60 subjects were enrolled and randomized but the trial was discontinued before the com-
pletion of the planned two years of treatment + one year of post-treatment observation when
data emerged elsewhere indicating an increased incidence of serious cardiovascular events
in patients receiving celecoxib. No such adverse events occurred in this study. Assessment of
numbers of new BCCs was confounded by the frequent appearance, disappearance, and reap-
pearance of BCCs between study visits. Therefore we focused on changes in the total num-
ber of BCCs of diameter 3 mm. We found no statistically significant change in these num-
bers during the course of the trial, irrespective of whether the subjects were taking celecoxib
or placebo (Year 1 p=0.699, Year 2 p=0.903, Year 3 p=0.289). This was true whether consid-
ering those who entered the trial with 15 BCCs or those who began with 14 BCCs (p=0.078
and 0.357, respectively). This lack of significant anti-BCC chemopreventive effect in PTCH1+/−
humans mirrors our findings in our preclinical model of BCNS, the Ptch1+/− mouse. Our
results suggest (i) that oral celecoxib does not inhibit BCC carcinogenesis, at least in BCNS
patients, (ii) that clinically typical BCCs may disappear spontaneously, thus emphasizing the
importance of careful controls for any preventive or therapeutic trial of this cancer, and (iii)
that this patient population is a valuable resource for cancer chemoprevention studies.
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Growth inhibitors of adult-onset mastocytosis mast cells
J Humphrey, I Chan and MD Tharp Dermatology, Rush University Medical Center, Chicago,
IL
KIT-D816V mutation is important in the development of adult-onset mastocytosis, which has
no cure to date. Our laboratory has previously found that the JAK3 specific inhibitor, Whi-
P131, effectively retards the growth of the mastocytosis mast cell line HMC-1.2, which expresses
two auto-activating mutations, KIT-V560G and KIT-D816V. Recently, it has been shown that
the tyrosine kinase inhibitor, imatinib, and the mTor inhibitor, rapamycin, selectively block
the growth of KIT-V560G(+) and KIT-D816V(+) mastocytosis mast cells respectively. To further
investigate the combined growth inhibitory effect of Whi-P131 with either imatinib or
rapamycin, HMC-1.2 cells were incubated with different concentrations of these drugs for 1
to 4 days. Cell growth inhibition was determined using a MTT assay and cell viability was
assessed by trypan blue exclusion method. Whi-P131 (20µM), imatinib (20µM) and rapamycin
(100nM) alone over 4 days inhibited the growth of HMC-1.2 by 60%, 5% and 70% respec-
tively, compared to medium control. When combined with Whi-P131 (20µM), imatinib (20µM)
did not augment the growth inhibitory effect of Whi-P131, although imatinib alone inhibited
(≥92%) the growth of HMC-1 mast cells that expresses only KIT-V560G but not KIT-D816V
mutation. When Whi-P131 was combined with rapamycin (100nM), a slightly increased growth
inhibition (80%) of HMC-1.2 was observed. These results indicate that the Jak3/Stats pathway
and the mTor are important growth regulators in KIT-D816V(+) signaling, and Whi-P131 and
rapamycin in combination may prove useful for the treatment of adult-onset mastocytosis.
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Kinetics of response to conventional treatment in patients with pemphigus vulgaris
A Czernik and JC Bystryn Dermatology, NYU School of Medicine, New York, NY
It is difficult to evaluate the effectiveness of new therapies for pemphigus vulgaris (PV) as lit-
tle is known about the frequency and time it takes for active pemphigus to respond to con-
ventional treatment. To address this problem we evaluated the kinetics of response to con-
ventional treatment with prednisone in 29 patients with PV who had a flare in disease activity
as evidenced by the appearance of new lesions while on tapering doses of steroids. Median
(range) of disease duration was 7 months (2 mo to 11 yrs). The median dose of prednisone at
which the flare occurred was 2.5 (0-32) mg/day. The flare was treated by increasing the dose
of prednisone in all patients. No adjuvant was added. The median time to control disease activ-
ity (no more than 1 new lesion/wk) from increasing steroid dose was 3 (1-17) weeks, and the
median maximum dose of prednisone required was 40 (15-90) mg/day. Disease was controlled
2 wks after raising the prednisone dose in 41% of pts and after 3 wks in 62% of pts. The dose
of prednisone could be reduced after a median of 4 (1-17) wks and was reduced by 50% of
the maximum level required to control disease activity after a median 7 (1-30) wks from start
of treatment. After 4 months, 38% of pts achieved a partial remission (no lesion, on <15 mg/day
prednisone) and 62% after 9 months. Complete remissions (no lesion, no systemic Rx) was
achieved in 0% of pts at 4 mo and in 21% at 9 mo. There was one grade 2 (by CTCAE v3.0
criteria) and no severe (grade 3) steroid complications during this 9 mo period. Thus, flares in
the activity of PV can usually be rapidly and safely controlled by increasing the dose of pred-
nisone. These results provide a benchmark against which the results of newer therapies can
be evaluated.
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Rat mesenchymal stem cells improve wound healing in a 3-dimensional collagen gel model
M Cho,1 J Park,1 K Whang1 and J Won2 1 Dermatology, SoonChunHyang University Hospital,
Seoul, South Korea and 2 Hematology, SoonChunHyang University Hospital, Seoul, South
Korea
Mesenchymal stem cells are self-renewing and are potent in differentiating into adi-
pogenic,osteogenic,chondrogenic lineage. There is progress on clinical application of stem
cells. It has been reported that mesenchymal stem cells with skin-substitute had improved
wound healing. However, we have yet to find feasible skin-substitute methods for this. The
objective of our work was to investigate the effects of rat mesenchymal stem cells on wound
healing. In the process, we used a 3D collagen gel in rat model. Three skin and tissue defects
of 2x2 cm in size were excised on the backs of SD-rats and Two different sites were replaced
with male 2 million rat mesenchymal stem cells (rMSCs) with 3d collagen gel and 3d colla-
gen gel. The other site was negative control. Results indicated that three different wound size
from different rats show a significant size change in mesenchymal stem cells treated site. This
data suggest that MSCs in a 3D collagen gel model accelerate wound healing and the 3D col-
lagen gel model should be useful for future wound healing studies.
www.jidonline.org   S41
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Hydroa vacciniforme-like primary cutaneous NK/T-cell lymphoma
J Wang1 and F Wang2 1 Dermatology, The Fourth People’s Hospital Of Shenzhen, Shenzhen,
China and 2 Dermatology, Fuyang Skin Hospital, Fuyang, China
Objective: The aim of this paper was to report and study a case of Hydroa vacciniforme-like
natural killer (NK)/T-cell lymphoma with only presentation in the skin. Methods: Study of a
patient who had had erythematic plaques and blisters on his face and hands for 4 years and
infiltrating plaques and necrosis on his extremities for 4 months. Clinical data were collected
and routine blood test, chest X-ray, computed tomographic scan of nasal cavity and bone
marrow examination were done. Biopsy taken from the skin and nasal mucosa and histopatho-
logical findings were recorded. Immunophenotyping, TCR-γ gene rearrangement, and in situ
hybridization for Epstein-Barr virus-encoded nuclear RNA (EBER) were determined. Results:
No primary nasal involvement was found.A few atypical mononuclear cells were found in
the infiltrated cells in the biopsy of dermis from the face 2 years .The biopsy skin specimen
from the leg revealed that 1/4 of the epidermis disappeared caused by massive necrosis and
ulceration. Large amount of atypical proliferation of medium-sized, pleomorphic, lymphoid
cells were observed infiltrating into the remained epidermis, dermis and the subcutaneous
tissues. The tumor cells were distributed in cell nests and some angiocentric proliferation of
the tumor cells were observed. Immunohistochemical studies revealed that the immunoreac-
tivity for CD3 was present in the perinuclear region, but absent in the neoplastic cell mem-
branes. CD56, CD45RO, and TIA-1 were strongly positive (+++), Part of the tumor infiltrated
cells showed CD30 and Ki 67 positive (++). But CD1a, TdT were negative. CD20, CD79 and
CD68 were only positive in reaction cells and negative in tumor cells. In situ hybridization
for Epstein-Barr virus-encoded nuclear RNA (EBER) was positive.The result for TCR-γ gene
rearrangement were positive. Conclusions: A diagnosis of hydroa vacciniforme-like primary
cutaneous NK/T-cell lymphoma was made. It is a rare case of slow aggressive and long sur-
vival for longer than 51 months with only involvement in the skin.
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A new rice extract that exhibits an interesting moisturizing effect and improves skin barrier
function
E Bauza, G Oberto, A Berghi, T Marchand, D Peyronel, C Dal Farra and N Domloge
Vincience, ISP Global Research Center, Sophia Antipolis, France
The skin’s appearance reflects the health of a person and hydration level is one of its most
important parameters. Skin moisturizers are becoming increasingly popular as women and
men continue to grow in awareness of the importance of the health of their skin. In line with
this trend, we developed a new active ingredient that helps skin hydration and studied its effect
in the following double-blind study. As our prior in vitro studies have shown that our new rice
extract increases collagen synthesis, we were interested in investigating the effects of 1% of
the extract on human skin hydration and barrier function in the following in vivo studies.
Double-blind studies against placebo were performed on the forearms of 16 and 20 healthy
volunteers, age 24 to 55, for two different periods of time. First, to see the rapid and immedi-
ate effect of the extract, a short study of 3 hours in duration was performed. The results on
hydration were highly significant after 1 h (p=0.00228) and also for the 3-hour test as a whole
(p=0.00231); hydration was improved compared to placebo by 111% and 74%, respectively.
In another study, the TEWL measurement diminished significantly after 1 h (p=0.0147) and
was also highly significant for the 3-hour test as a whole (p=0.00305, -73%). In order to demon-
strate the long-term effect of the rice extract, a double-blind study, against placebo, was con-
ducted for 28 days. The results showed that the extract significantly improved skin hydration
(p=0.0129) and diminished the TEWL very significantly (p=0.0061). Over all of the studies,
56% to 70% of volunteers had improved, and volunteer questionnaires as well as clinical
observation confirmed the abovementioned results. These studies demonstrate that this rice
extract can be of great use in moisturizing skin care products and in dry skin treatments.
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Nitrogen mustard (NM) ointment formulation containing propylene glycol (PG) is active in
treating mycosis fungoides (MF)
SR Lessin Fox Chase Cancer Center, Philadelphia, PA
NM (mechlorethamine) compounded into petrolatum or Aquaphor® has been shown to be
an effective topical treatment of MF, a form of cutaneous T-cell lymphoma. A PG-containing
ointment formulation has been developed as an alternative to these heavy ointment vehicles
which can be difficult to apply to the skin and can compromise patient compliance. The objec-
tive of this case series was to determine if a compounded PG-containing ointment formula-
tion of NM (NM-PG) is active in treating MF. 21 MF patients presented over a 10 mo. period
and were prescribed NM-PG as clinically indicated. They were followed from 3-31 mos.
(median = 22 mos.). Responses were recorded by physician global assessment. Patients ini-
tially applied 0.01% NM-PG to affected areas daily. In patients without a complete response
(CR), concentrations were increased to 0.02% and 0.03% sequentially, every 3-4 months to
maximize responses. Patients included stages Ia (16), Ib (3), IIa (1) and IV (1). All but one had
prior treatments (range = 1 to 8; median = 2). Patients applied NM-PG from1 to11 months.
19/21 patients were initiated on 0.01% NM-PG; one was initiated on 0.02% NM-PG and one
was initiated on 0.03% NM-PG. Overall response rate (ORR) to 0.01% NM-PG was 63%
(12/19) with 26% (5/19) CR, 37% (7/19) partial response (PR) and 37% (7/19) stable disease
(SD). 8 patients initiated on 0.01% NM-PG and without a CR, were escalated to 0.02% NM-
PG without concomitant therapies. 50% (4/8) improved (1 CR (from PR); 1 PR (from SD) and
2 SD). The ORR of 0.01% - 0.02% NM-PG was 68% (13/19). 4/8 patients with no response
to 0.02% were escalated to 0.03% NM-PG and all 4 converted to a CR from a PR. The ORR
of 0.01% - 0.03% NM-PG was 68% (13/19) with 47% (9/19) CR; 21% (4/19) and 32% (6/19)
SD. 2/21 patients developed allergic contact dermatitis with one associated with a CR. Two
patients developed an irritant dermatitis and received other therapies. NM-PG is an active
agent in the treatment of MF. These preliminary results support the need for a controlled clin-
ical trial assessing the safety and efficacy of NM-PG in MF.
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Leucocyte trafficking of 8-MOP treated leucocytes after photopheresis in humans
U Just,1 E Grumbeck,2 R Knobler,1 G Klosner,1 E Ivancic,1 H Greinix,3 A Becherer4,2 and
F Trautinger5,1 1 Dept of Special and Environmental Dermatology, Univ of Vienna, Vienna,
Austria, 2 Dept of Nuclear Med, Univ of Víenna, Vienna, Austria, 3 Dept of Internal Med,
Univ of Vienna, Vienna, Austria, 4 Dept of Nuclear Med, LandesKH Feldkirch, Feldkirch,
Austria and 5 Karl Landsteiner Inst for Dermatol Research, LandesKH St Pölten, St Pölten,
Austria
Photopheresis is an established treatment for cutaneous T-cell lymphoma, systemic sclerosis,
graft-vs-host-disease and other autoimmune diseases. During photopheresis a leucocyte frac-
tion(buffy coat) of peripheral blood is extracorporally exposed to 8-methoxypsoralen and UVA
before reinfusion into patients. The precise mechanisms of photophesesis is not yet known.
The aim of the present study was to investigate the fate of UVA irradiated cells after reinfu-
sion. For this purpose a fraction of UVA-irradiated buffy coat(28 ml) was sampled prior to
reinfusion, separated into lymphocytes(LC) and neutrophils(PMN) and labelled with Indium111
before being reinjected into the patient. Scans were acquired at 10min, 3h and 24h after injec-
tion. Regions of interest(ROIs) were drawn over liver, spleen, spine, right lung and heart. Pixel-
normalised ratios of organ to background were calculated with correction for physical decay.
Each patient was investigated separately for migration of labelled LC and PMN with intervals
of 4 weeks. Three patients have been included in the study. Using trypan blue we found that
viability of 8-MOP/UVA treated LC and PMN was minimally affected by labelling and that
our technique results in sufficiently strong signals to follow labelled cells for 24h. The most
prominent difference between migration patterns of LC and PMN observed in all 3 patients is
retention of LC but not PMN in lungs immediately within first 3h after injection. LC were
cleared rapidly from blood pool while PMN showed a blood pool activity over first 3h. These
preliminary results show for the first time that specific radiolabelling of blood cells after pho-
topheresis in humans is feasible with a high yield and low cell damage and that 8-MOP/UVA
treated LC and PMN have different and specific migration patterns.
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Photoadaptation diminishes in vivo antifibrotic response to ultraviolet A1 phototherapy
F Wang, L Garza, G Fisher, R Kafi, S Cho, C Hammerberg, J Voorhees and S Kang
Dermatology, University of Michigan, Ann Arbor, MI
Ultraviolet (UV) A1 phototherapy softens sclerotic plaques dramatically in some patients, but
only modestly in other patients. We hypothesized that increased pigmentation may be one
mechanism that explains the latter situation. To test this hypothesis, we irradiated normal human
skin with UVA1 and quantified induction of MMP-1 mRNA by RT-PCR. We correlated MMP-
1 induction with skin pigmentation, as determined by chromameter (L value). We found that
increased baseline pigmentation diminished the UVA1 response. Following a single exposure
to increasing doses of UVA1 (70, 90, 110, 130, or 150 J/cm2), skin with light pigmentation
(L>65, N=8) demonstrated robust MMP-1 induction, with maximal upregulation (1150 fold)
seen at 130 J/cm2. This induction was markedly different (P<0.05) from that observed in medium
pigmented (L 55-65, N=8) and darkly pigmented (L<55, N=12) skin, in which no statistically
significant MMP-1 induction was seen. Furthermore, higher UVA1 doses induced robust tan-
ning in light skin (L=73.1, N=8). After a single dose of 150 J/cm2, light skin color was darkened
substantially and altered to medium pigmentation (L=63.8, P<0.05). Further tanning occurred
with additional exposures to 150 J/cm2. Lastly, we found that MMP-1 induction became atten-
uated after repeated exposure to 130 J/cm2. Lightly pigmented subjects (L=71.6, N=10) were
exposed to UVA1 once per week to minimize rapid tanning. Whereas upregulation of MMP-1
was 289 fold after the first exposure, induction was reduced to 32 fold after 3 treatments (P<0.05).
At the same time, L values fell a mean of 12.2 compared with pre-treatment, translating into a
change to medium pigmentation (L=59.4, P<0.05). These data indicate that attenuation of UVA1-
induced antifibrotic response (MMP-1 induction) is associated with increased pigmentation,
whether preexisting (naturally dark skin) or induced by acute or repeated UVA1 irradiation.
Thus, we conclude that UVA1 irradiation may be most effective for antifibrotic therapy in lightly
pigmented subjects who are incapable of robust tanning responses.
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Early inflammatory changes in the “peri-lesional skin” of psoriatic plaques: Is there interac-
tion between dendritic cells and keratinocytes?
M Komine,1 M Karakawa,1 T Takekoshi,1 N Sakurai,1 Y Minatani,1 H Mitsui,1 Y Tada,1
H Saeki,1 A Asahina2 and K Tamaki1 1 Dermatology, University of Tokyo, Tokyo, Japan and 2
Dermatology, Sagamihara National Hospital, Sagamihara, Japan
Peri-lesional skin of psoriatic plaques has been considered to possess very early changes of
psoriatic inflammation. In order to detect the very early inflammatory changes in psoriatic
plaques in the light of dendritic cells (DCs), we investigated immunohistochemically with a
panel of antibodies to DCs, the normal appearing skin adjacent to the plaques (peri-lesional
skin), lesional skin, and distant uninvolved skin from psoriasis patients. We have biopsied peri-
lesional and lesional skin samples from 11 psoriatic patients, and distant area skin samples
from 3 of these patients. Peri-lesional epidermis contained numerous CD1a-poitive Langer-
hans cells (LCs), some of which expressed HLA-DR, CD83, CD80 and CD86, at the same
time expressing Langerin. These LCs were highly dendritic. There were also numerous CD83-
positive, CD11c-positive, Langerin-negative DCs in the epidermal-dermal junction of peri-
lesional skin, which were considered to be dermal dendritic cells. The numbers of these LCs
and DCs in the peri-lesional skin were comparable to those of psoriatic lesion. On the other
hand, CD3-positive T lymphocytes were sparse in the peri-lesional skin, while there was dense
infiltration of CD3-positive cells in the lesional skin. Peri-lesional epidermis expressed keratin
K6 and K16, inflammatory keratins, and C/EBPβ, a transcription factor related to inflamma-
tory cytokines. Our results demonstrated for the first time the abundant distribution of acti-
vated DCs in the peri-lesional skin of psoriatic plaques in contrast to scares existence of CD3-
positive T cells, where inflammatory changes occur in keratinocytes such as expression of
inflammatory keratins. Our observation suggests the involvement of activated DCs in the provo-
cation of epidermal inflammation in the peri-lesional epidermis prier to T cell infiltration, and
further pathogenic roles in the formation of psoriatic plaques.
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The role of corticotropin releasing hormone on dendritic cells from atopic dermatitis patients
JH Lee, HJ Lee, MR Roh and KH Lee Department of Dermatology & Cutaneous Biology
Research Institute, Yonsei University College of Medicine, Seoul, South Korea
Dendritic cells (DCs) play an important role in the generation and regulation of immune
responses, but also are considered to represent the link between allergen uptake and the clin-
ical manifestation of allergic disease, such as atopic dermatitis. Recent evidence suggests
that crosstalk between mast cells, neurons and keratinocytes might be involved in exacerba-
tion of the inflammatory conditions by stress, but the mechanism still remains unclear. Cor-
ticotropin releasing hormone (CRH), which activates the hypothalamic-pituitary-adrenal axis
under stress, also has proinflammatory peripheral effects. However, there have been no reports
about CRH receptor expression and functional role of CRH in DCs. The purpose of this study
was to investigate the expression of CRH receptors and the functional role of CRH in the
peripheral blood mononuclear cell (PBMC)-derived DCs of atopic dermatitis patients. We
detected mRNA for CRH-R1α, 1β, as well as CRH-R1 protein. CRH-R2α (but not R2β or R2γ)
mRNA and CRH-R2 protein were present in PBMC-derived DCs. Exposure of DCs to
lipopolysaccharide (LPS) or thymic stromal lymphopoietin (TSLP), which activate DCs, didn’t
alter the expression of CRH receptors. Exposure of DCs to CRH resulted in increase of IL-3,
IL-10, IL-18. Therefore, CRH-induced increased expression of cytokine could be involed in
atopic dermatitis, which worsen by stress.
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Induction of apoptosis and inhibition of STAT6 activation in dermal lymphocytes are asso-
ciated with clinical response to vorinostat in cutaneous T-cell lymphoma patients
B Li, C Zhang, C Kelly, X Ni and M Duvic Dermatology, U. T. M. D. Anderson Cancer Center,
Houston, TX
Vorinostat (suberoylanilide hydroxamic acid, SAHA), an inhibitor of class I and II histone
deacetylase(HDAC), induces differentiation, growth arrest and/or apoptosis of tumor cells both
in vitro and in vivo, and is currently being tested in the clinic for a variety of indications. In
particular, vorinostat was approved for cutaneous T cell lymphoma (CTCL) based on response
rates of 24-30% [Blood 109: 31-9, 2006; J Clin Oncol 24: 18S, 2006]. Defective apoptosis of
T-cells and abnormal STAT (signal transducer and activator of transcription) signaling are impli-
cated in the pathogenesis of CTCL and may be potential therapeutic targets for this disease.
We previously showed that vorinostat can selectively induce T-cell apoptosis and inhibit STAT6
activation in CTCL cell lines and patients’ PBMCs in vitro [J Invest Dermatol 125: 1045-54,
2005]. To further identify whether induction of T-cell apoptosis and inhibition of STAT6 acti-
vation are associated with clinical response to vorinostat, TUNEL and immunohistochemistry
were used to examine apoptosis index and p-STAT6 expression in paired skin lesion biopsy
specimens from 20 CTCL patients on the vorinostat Phase II b clinical trial. There was no sig-
nificant difference in apoptosis index of dermal lymphocytes between responders (n=10) and
non-responders (n=10) at baseline. After vorinostat treatment, apoptosis index in dermal lym-
phocytes was increased in skin lesion specimens from 50% of responders and 33% of non-
responders at weeks 3-4, and from 63% of responders and 14% of non-responders at weeks
6-12. Moreover, p-STAT6 staining in dermal lymphocytes was decreased in skin lesion spec-
imens from 40% of responders and 22% of non-responders at weeks 3-4, and from 50% of
responders and 29% of non-responders at weeks 6-12. In conclusion, our results suggest that
induction of apoptosis and inhibition of STAT6 activation in dermal lymphocytes may be asso-
ciated with clinical response to vorinostat in patients with CTCL and may represent thera-
peutic targets.
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Smoldering ATL in an HTLV-1 infected Romanian immigrant in Wisconsin
J Siddiqui,1,2 NM Fett,1,2 CH Cresswell,1,2 R Lloyd1,2 and GS Wood1,2 1 Dermatology, UW,
Madison, Madison, WI and 2 Dermatology, VAMC, Madison, WI
Human T-cell leukemia virus-1(HTLV-1) infection is endemic in certain areas throughout the
world but not the Midwestern United States. Adult T-cell leukemia/lymphoma (ATL) is a rare
lymphoproliferative disorder in humans arising from HTLV-1 infected CD4+ T cells. ATL in its
acute form is a rapidly fatal disease. It can also present less commonly as one of several more
clinically indolent variants. Here, we report a case of ATL in a 37 year-old HTLV-1-infected
Romanian female immigrant living in Madison, WI. She presented with a pruritic, atypical
papulosquamous eruption that was ultimately diagnosed as smoldering ATL. Narrow band
UVB phototherapy and mid-potency topical steroids resulted in skin clearing for approxi-
mately 5 months after diagnosis; however, she relapsed subsequently with disease refractory
to both narrow band UVB and PUVA, and progressed to acute ATL. She developed severe
neurological decline thought secondary to herpes virus 6 encephalopathy, and expired within
one month of her progression to acute ATL. HTLV-1 infection was confirmed by immunoen-
zymatic and Western blot analyses of blood. Both the patient and her husband (an asympto-
matic carrier) were repeatedly seropositive. Her two teenage children were seronegative. In
addition, the presence of HTLV-1 proviral DNA was documented by PCR amplification and
DNA sequencing using a lesional skin sample. Although it is possible that she contracted the
HTLV-1 infection from her husband, the patient suspected she acquired it via repeated finger
sticks with re-used lancets during obstetrical hospitalizations in Romania more than a decade
ago. Review of the literature identified some other reports of HTLV-1 related diseases from
Romania and suggests the possibility of an under-reported endemic pocket there. This case is
also interesting because of its unusual clinical presentation, the ethnicity of the patient, and
the initial response to narrow band UVB phototherapy.
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A 2 week multiple ascending dose, double-blind placebo controlled study to evaluate the
safety, tolerability, pharmacokinetics and efficacy of oral AEB071, a protein kinase C inhibitor,
in moderate to severe psoriasis patients
H Skvara,1 M Dawid,1 T Kopp,1 E Kleyn,2 H Knight,3 T Dumortier,3 Y Hijazi,3 C McGeown,3
P Marbach,3 C Griffiths,2 G Stingl1 and T Jung3 1 Dermatology, Div of Immunology, Allergy
and Inf Diseases, Medical University of Vienna, Vienna, Austria, 2 Dermatology, University of
Manchester, Manchester, United Kingdom and 3 Novartis, Novartis Exploratory
Development, Basel, Switzerland
AEB071, a novel, selective inhibitor of Protein Kinase C (PKC), is being developed as an oral
formulation for the treatment of autoimmune diseases and the prevention of transplant rejec-
tion. Here, we report data from the first multiple dose trial in psoriasis. A total of 32 patients
with moderate to severe plaque psoriasis were sequentially randomised to one of four doses
of the study drug (25, 100, 200 and 300 mg bid AEB071) or placebo. Patients were treated for
2 weeks and followed-up for another 2 weeks off treatment. AEB071 concentrations in blood
increased linearly. Skin concentrations were 2-4-fold lower than blood levels. AEB071 was
well tolerated at all test doses, and different laboratory parameters did not indicate a specific
safety signal. Clinically, a remarkable dose-dependent improvement of the disease was observed
reaching a mean of 70% change of the PASI score after 2 weeks over baseline in the 300 mg
bid cohort, which compares favorably with what has been reported for potent TNF-α antago-
nists. Comparably, a dose-dependent reduction of infiltrating T cells in the epidermis and der-
mis was observed after 2 weeks. The number of Ki-67 proliferating keratinocytes tended to
decrease already after one week of treatment. AEB071 levels in blood correlated well with
PASI changes and sIL-2R levels in plasma. In conclusion, this first multiple dose study in patients
with psoriasis demonstrates that AEB071 is not only well tolerated at doses up to 300 mg bid,
but also, induces a clinically significant reduction in PASI scores in 14 days. Considering these
data, AEB071 might be a promising addition to the therapeutic armamentarium in patients
with psoriasis in the future.
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A phase I study of ICX-RHY, a suspension of allogeneic human dermal fibroblasts, adminis-
tered intradermally
NJ Lowe,1 PL Lowe,1 R Patnaik2 and J St Clair Roberts3 1 The Cranley Clinic, London, United
Kingdom, 2 Clinical Research Specialists Inc., Santa Monica, CA and 3 Intercytex plc,
Cambridge, United Kingdom
ICX-RHY, a suspension of allogeneic human dermal fibroblasts, is being developed by Inter-
cytex plc for intradermal use. A single-blind, placebo-controlled, phase I study to assess safety,
tolerability and histological change was undertaken among ten adult volunteers. Each subject
received three intradermal injections of fibroblasts (3.2 x 10^7 cells) and placebo concurrently
into contralateral upper arms. Each set of injections was given with a minimum 2-week inter-
val and subjects were followed for a further 2 weeks following final injection. Safety was
assessed throughout and a punch biopsy was taken at the final time point for histological analy-
sis. ICX-RHY was well tolerated with no serious adverse events reported; no subjects with-
drew from the study. Treatment-emergent injection site adverse events were reported in 9 of
10 (90%) subjects with the majority being mild or moderate in severity. Adverse events included
pain, erythema, induration, bruising and pruritis. No treatment-emergent systemic adverse
events were reported. All events were self-limiting and resolved spontaneously except in one
subject where induration was ongoing at the final visit. There were no significant clinical lab-
oratory findings. Histologically there was a lymphocytic infiltrate seen in the fibroblast-treated
arm in all subjects. Additionally, all biopsies from the active arm showed thickening of both
the epidermis and dermis compared to placebo, with a marked increase in the number of der-
mal fibroblasts present. These data demonstrate that ICH-RHY is well tolerated and support
its further clinical development.
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Novel in situ vaccination with intratumoral injection of CpG 7909, a TLR 9 agonist, com-
bined with radiation in mycosis fungoides and primary cutaneous B-cell lymphoma
AV Morales,1 W Ai,2 R Hoppe,3 S Shah,2 R Levy2 and Y Kim1 1 Derm, Stanford Univ, Stanford,
CA, 2 Med Onc, Stanford Univ, Stanford, CA and 3 Rad Onc, Stanford Univ, Stanford, CA
Mycosis fungoides (MF) and primary cutaneous B-cell lymphomas (CBCL) are rare types of
non-Hodgkin’s lymphomas presenting initially in the skin. CpG 7909 belongs to a new class
of immunomodulators, which activate B cells and plasmacytoid dendritic cells through TLR
9. We have developed a novel immunotherapy approach that combines low-dose radiation
(RT) with intra-tumoral injection of CpG for MF and CBCL. Having demonstrated the validity
of this hypothesis in animal models, a clinical trial was designed for patients with MF and
CBCL. Our primary objective was to test the safety of this novel immunotherapy. The secondary
objective was to assess systemic anti-tumor effect by monitoring tumor regression at sites other
than the irradiated/injected site. Patients received low-dose RT to a single tumor site on day
1, 2 (2 Gy each day). CpG injections were administered at a dose of 6 mg into the same tumor
site within the 24 h before and after RT. Weekly injections of CpG were then administered
into the previously irradiated tumor site for 8 additional doses. The clinical response was
assessed by SWAT in MF and tumor volume in CBCL. 5 MF patients (4 Stage IIB, 1 Stage IB)
and 1 CBCL patient have been treated to date. All patients experienced injection site reac-
tions, including erythema, swelling, and tenderness. 6/6 had fever, 5/6 experienced fatigue,
4/6 experienced myalgias and arthralgias, and 2/6 had headache. All adverse events were clas-
sified as grade 1-2. Three MF patients have completed treatment. One patient (Stage IB) had
partial response with tumor regression observed at all non-irradiated sites, while the other
two patients (Stage IIB) had stable disease. The CBCL patient achieved partial response at week
4. Correlative studies characterizing antitumor immune response are pending. This novel in
situ vaccination with intratumoral injection of CpG 7909 combined with low-dose RT is an
encouraging and safe treatment in MF and CBCL.
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Clinical presentation of Merkel cell carcinoma: can delayed diagnosis be avoided?
M Heath, B Lemos, N Jaimes and P Nghiem Medicine/Dermatology, University of
Washington, Seattle, WA
Merkel cell carcinoma (MCC) is an uncommon, aggressive neuroendocrine cancer of the skin.
Currently there are about 1000 cases of MCC per year in the United States. With a 33% mor-
tality, MCC is more lethal than melanoma (15% mortality), and its incidence has tripled in the
past 15 years. Diagnosis is often delayed as definitive clinical features are not well established,
and a detailed description of its clinical presentation has not been reported. We completed
an analysis of the medical records of 141 patients with a pathologic diagnosis of MCC seen
at academic oncology centers in Boston and Seattle between 1983 and 2005. In our cohort,
the median age at diagnosis was 70. Chronic severe immune suppression (HIV, CLL or solid
organ transplant), an important risk factor for MCC, was present in 9% of cases. Among patients
for whom data were available, there was a median delay from lesion appearance to biopsy of
3 months (range 1-54 months). Eighty-four percent of the lesions were non-tender. Most
appeared on sun-exposed skin, but one in six presented on the scalp, buttock or other mini-
mally sun-exposed site. When one was listed, the presumed clinical diagnosis was that of a
benign lesion in 56%, with a cyst/acneiform lesion being the single most common presump-
tive diagnosis (35% of diagnoses). Our findings suggest that the presence of certain clinical
features in an otherwise benign-appearing lesion should raise suspicion of MCC. We have cre-
ated a mnemonic - “USE RAD” - to aid in identification of this lethal skin cancer and also to
urge clinicians to consider adjuvant radiation, given the evidence supporting its efficacy in
preventing loco-regional recurrences in MCC. USE RAD: UV exposed location, Skin type I or
II (Fitzpatrick), Elderly, Rapid growth, Asymptomatic (non-tender), Decreased immunity. If sev-
eral of these features are present, a biopsy may be indicated. As stage at time of diagnosis is
highly correlated with survival, these clinical clues may assist clinicians in recognizing this
highly lethal skin cancer at an earlier and potentially more curable point.
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Psoriasis and obesity
J Ahdout, J Kim and MW Chiu Medicine, UCLA, Los Angeles, CA
Psoriasis is a non-contagious inflammatory skin disease which has been found to lead to the
development of obesity. The intent of this study was to identify the factors which contribute to
obesity in psoriatic patients. At the time of the interview, the Psoriasis Area and Severity Index
(PASI) score was measured to determine the extension of lesions and a questionnaire was admin-
istered to assess stress level, exercise, and other medical conditions such as arthritis. A total of
66 subjects were recruited from UCLA Dermatology clinics; twenty seven subjects were pso-
riasis patients (average age=50.33 years,16 males,11 females), while 39 subjects (average
age=50.49 years,20 males,19 females) served as control non-psoriasis patients. Our prelimi-
nary results indicate that psoriasis patients (x=27.75,SD=5.81) did not have a significantly higher
average body mass index (BMI) than control patients (x=25.79,SD=4.25, p=0.118). A signifi-
cant positive correlation was found between BMI and PASI (r=0.45, p=0.02). Psoriasis patients
with arthritis (x=28.81,SD=5.89) were not found to have a significantly higher average BMI than
those without arthritis (x=24.16,SD=2.42, p=0.514). Psoriatic arthritis patients (x=2.33,SD=2.40)
were not found to exercise significantly more than psoriasis controls (x=1.97,SD=2.09,p=0.69).
Psoriasis patients (x=2.09 times/week,SD=2.16) did not report engaging in strenuous exercise
significantly less than control patients (x=1.91 times/week,SD=2.05,p=0.73). Lastly, psoriasis
patients did not report significantly more stress (x=21.26,SD=8.13) than controls
(x=19.84,SD=8.83,p=0.51). According to this preliminary data, there is a significant positive
correlation between BMI and increased severity of psoriatic disease as measured by PASI. How-
ever, significant data was not found to show that psoriatic patients have a higher BMI, increased
stress, and less physical activity than controls. In addition, psoriatic arthritis patients were not
found to exhibit a significantly higher BMI and exercise more than psoriasis control patients.
Again, these are preliminary results, and we are planning to increase our power in the future
by enrolling a total of 200 subjects in our study.
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Evidence for T-regulatory cell abberrations in Sezary syndrome and mycosis fungoides
N Apisarnthanarax, JV Massari, WA Goodman, TS McCormick and KD Cooper Dermatology,
Univ. Hosp. Case Medical Center and Case Western Reserve University, Cleveland, OH
We have identified and isolated a population of large CD25+Hi FoxP3+ T-regulatory cells (Tregs)
by flow cytometry from Sezary Syndrome (SS) and mycosis fungoides (MF) patients that dis-
play potent suppression in mixed lymphocyte (MLR) cultures. Multiple PBMC samples from
5 SS patients (n=15), 2 MF patients staged IB and III (n=3), and corresponding normal con-
trols (NC) were examined. Flow cytometric analysis of all SS and MF patients revealed a skewed
CD25+Hi population (Treg) with greater CD4 expression and increased forward scatter (FSC,
size) that was not present in NC. Among CD4+ SS cells, CD25+Hi cells represented a mean of
1.16% of CD4+ cells compared to 1.5% in NC. However, the SS/MF CD25+Hi putative Tregs
contained cells with significantly elevated CD4 and FSC; using CD25- resting T cell mean flu-
orescence intensity (MFI) as an intra-sample reference, CD4+ MFI and FSC of SS CD25+Hi
cells were greater than NC (p=0.00001, CD4; p=0.0004, FSC). The skewed CD4+HiCD25+Hi
large cell subset was quantified using CD4+Hi CD25+Lo cells as an internal standard: Skewed
cells accounted for a mean of 75% and 63% of CD25+Hi cells in SS and MF, respectively,
compared to only 18.7% of NC CD25+Hi cells (p=0.0008). Among the skewed CD4+Hi large
cell subset, the SS cells were significantly larger and higher in CD4 than NC (p=0.01, CD4;
p=0.03, FSC). To assess whether the skewed Treg population was functional, we performed
MLR assays on sorted cells, including a CD127 sort to enhance specificity for Treg selection.
In a representative independent SS and MF patient, the skewed Treg population suppressed as
well as the phenotypically normal CD4+LoCD25+Hi cells, and as well as, or greater than NC
Tregs. Concordantly, the skewed CD25+Hi population expressed higher levels of FoxP3 mRNA
at 1.42 times NC Treg expression. Thus the cells appear to contain phenotypically abnormal,
yet functional Tregs. In conclusion, SS patients appear to be distinguishable by flow cytome-
try from normal patients based on aberrations in their Treg cells.
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Stromelysin 3 expression in the differential diagnosis of dermatofibroma and dermatofi-
brosarcoma protuberans: Comparison with CD34 and Factor XIIIa
H Kim, J Lee and T Yoon Dermatology, College of Medicine, Chungbuk National University,
Cheongju, South Korea
The distinction between dermatofibroma (DF) and dermatofibrosarcoma protuberans (DFSP)
is an especially well-known challenge for dermatopathologists. Histology is still the best method
to distinguish them, however, some cases of DF may be difficult to differentiate from DFSP
even with excisional biopsy. Therefore, immunohistochemical staining to CD34 and factor
XIIIa have been used to distinguish these 2 conditions, but these markers show an overlap
and lack of specificity. Recently, stromelysin 3 (ST3) used as a useful marker for the differen-
tial diagnosis in DF and DFSP. The aim of this study was to assess the expression of ST3 in DF
and DFSP and ascertain whether ST3 differentiates between DF and DFSP, by comparing the
result with CD34 and factor XIIIa expression. Immunohistochemical staining was performed
on 23 cases of DF and 17 cases of DFSP, using antibodies to ST3, CD34, and factor XIIIa. Pos-
itive staining was evaluated for all 3 antibodies within the tumor using a semiquantitative scor-
ing system (0-3) by intensity of the staining. The evaluation was performed by the two of the
authors in a blinded fashion. ST3 was expressed strongly in all cases of DFs, but only one
case showed weakly positive staining in DFSP. CD34 was weakly expressed in 3 cases, and
strongly expressed in 1 case of the 23 DFs. CD34 was strongly expressed in 15 of 17 DFSPs.
But in the remaining 2 cases, one was weakly positive and the other was negative for CD34.
Strong expression of factor XIIIa was seen in 22 of 23 DF cases, and a weak expression in 1
case. In contrast, factor XIIIa was not expressed in the 12 of 17 cases, and weakly expressed
in 5 of the 17 DFSPs. Immunohistochemical staining to ST3 can be a positive marker for DF,
and it is more reliable than factor XIIIa in identifying DF. Since ST3 is not absolutely negative
in all cases of DFSP in the present study, a combination of staining patterns with CD34 can




Soft, topical immunosuppressants derived from cyclosporin A for the treatment of atopic der-
matitis
L Burgess, KW Hunt, D Chantry, J Pheneger, SA Brown and PA Lee Array BioPharma,
Boulder, CO
Topical immunosupppressants such as pimecrolimus and tacrolimus are efficacious thera-
peutics for the treatment of atopic dermatitis and other dermatological conditions. When deliv-
ered topically, these calcinuerin inhibitors offer several advantages over topical steroids;
however, these marketed drugs have received a “black box warning” because of a potential
cancer risk. We speculated that systemic exposure of these drugs over long term use may con-
tribute to the cancer risk. Accordingly, we have designed and discovered a series of “soft”
cyclosporin A (CsA) derivatives as potentially safer calcineurin inhibitors. In general, soft drugs
are engineered, via medicinal chemistry, to be effective upon local delivery but upon sys-
temic exposure they are rapidly inactivated by metabolic pathways. In this way, exposure of
active drug to distal organs is greatly minimized resulting in a significant enhancement in ther-
apeutic index. Our drug discovery efforts around soft CsA derivatives including structure-activ-
ity relationships and in vivo data will be presented.
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Human β-defensin 1 polymorphism is associated with allergic sensitization in atopic der-
matitis
A Kalus,1 LP Fredericks,4 R Livingston,2 A Sonesson,3 O Bäck3 and BA Dale4 1 Dermatology,
University of Washington, Seattle, WA, 2 Genome Sciences, University of Washington,
Seattle, WA, 3 Dermatology, Lund University, Lund, Sweden and 4 Oral Biology, University
of Washington, Seattle, WA
Most patients with the common skin condition atopic dermatitis progress to develop allergic
sensitization to common environmental allergens such as commensal fungi. Epidermal bar-
rier defects are considered central to the pathophysiology of atopic dermatitis but the factors
that modify allergic sensitization are unknown. The antimicrobial peptides are attractive can-
didates to study given that their role in epithelial defense and innate immunity places them
directly at the interface of the patient, the environment, and the immune response. We stud-
ied 256 adult subjects with atopic dermatitis. Study subjects with positive skin prick tests and
yeast specific serum IgE levels >3.5kU/L were compared to subjects with negative skin prick
tests and no specific IgE to yeast allergens. We sequenced DNA samples for a single nucleotide
polymorphism (SNP rs1800972) in the human β-defensin 1 (HBD-1) gene. This SNP is located
at position -44 in the 5’ untranslated region of DEFB1. The genotypes were tested for associ-
ation with allergic sensitization and eczema severity. The variant genotypes (C/G or G/G) at
the -44SNP were associated with a protective effect against developing allergic sensitization
in these patients. Patients with the variant genotypes were nearly half as likely (OR 0.54
95%CI=0.31 to 0.95;p=0.03) to have allergic sensitization compared to the wild-type (C/C).
This effect was independent of eczema severity. Here we show that in atopic dermatitis the -
44SNP variant genotypes are protective against developing allergic sensitization character-
ized by skin prick tests and serum IgE levels. This SNP may be one factor that differentiates
extrinsic from intrisic eczema. We propose that HBD-1 expression modifies the host-envi-
ronment interaction and subsequent allergic sensitization in the disrupted epithelium of atopic
dermatitis patients.
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Successful treatment of recalcitrant pyoderma gangrenosum with Raptiva
WP Gulliver NewLab Clinical Research Inc., St. John’s, Newfoundland and Labrador, NF,
Canada
The aim is to study and understand the benefits of efalizumab therapy in the treatment of Recal-
citrant Pyoderma Gangrenosum. AB is a 53¬ year old gentlemen with a 16 year history of
psoriasis. Past medical history included alopecia areata. There is a family history of lichen
planus both in his mother and sister (his mother has also had SCC of the tongue related to
lichen planus). Psoriasis was initially controlled with phototherapy. October of 2002 he devel-
oped multiple ulcers in the mid and upper back consistent with recalcitrant pyoderma gan-
grenosum. Over the next four years he was treated with a multitude of therapies including:
Cyclosporin 200 mg per day; Cyclosporin 200 mg per day in combination with Methrotrax-
ate 7.5 mg weekly. His psoriasis remained under excellent condition but his pyoderma gan-
grenosum did not clear. On the first of May 2006, efalizumab treatment was initially at 0.7
ml (weight 108.6 kilograms) and then 1 ml SC weekly. September 25, 2006 the pyoderma
gangrenosum was in complete remission as was the psoriasis. Between September 25th and
November 25th the patient’s Methrotraxte and Cyclosporin were tapered. As a result, the
patient’s pyoderma gangrenosum and psoriasis remain in remission. In conclusion, Efalizumab
is a successful treatment for patients with recalcitrant pyoderma gangrenosum.
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Differences in the effect of topical corticosteroids and calcineurin inhibitors on the skin bar-
rier - Implications for therapy
MJ Cork,1 J Varghese,1 J Hadcraft,2 M Lane,2 A Ferguson,3 M Moustafa,1 RH Guy4 and
S Ward1 1 School of Medicine & Biomedical Sciences, University of Sheffield, Sheffield,,
United Kingdom, 2 The School of Pharmacy, University of London, London, United Kingdom,
3 Dermatology, Derbyshire Royal Infirmary, Derby, United Kingdom and 4 Department of
Pharmacy & Pharmacology, University of Bath, Bath, United Kingdom
Topical corticosteroids (TCS) represent a very efficacious short-term treatment for flares of atopic
dermatitis (AD). However, if they are applied for prolonged periods, particularly on sensitive
skin sites such as the face, they can induce severe thinning of the stratum corneum, which can
facilitate allergen penetration and lead to a flare of AD. This might explain TCS addiction and
rebound after discontinuing TCS. The objective of this study was to compare the effect of mod-
erately potent and potent TCS (m-pTCS and pTCS, respectively) with no treatment and with the
calcineurin inhibitor, pimecrolimus, on the integrity of the skin barrier in healthy volunteers
(assessed using the tape-stripping and transepidermal water loss (TEWL) assay). Betamethasone
valerate, 0.1% or 0.025% (pTCS and m-pTCS, respectively), was applied to the right forearm.
A similar area was treated on the left forearm with either no treatment or with pimecrolimus
cream 1%. Following treatment with pTCS, b.i.d. for 14 days, there was a significantly greater
TEWL after removing 16, 18 & 20 strips than at the site treated with pimecrolimus (p< 0.05);
similar results were achieved with m-pTCS applied b.i.d. for 30 days, after removal of 20 and
25 tape strips (p<0.05). The sites treated with pimecrolimus cream had similar results to untreated
skin sites. Biopsies of the skin treated with m-pTCS revealed a much thinner stratum corneum
than the sites treated with pimecrolimus. These results confirm earlier findings showing dam-
age to the skin barrier by super-potent corticosteroids, and show that these deleterious effects
are also seen with TCS strengths and periods of use therapeutically relevant for AD. These effects
are in part caused by the induction of skin protease gene expression.
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Rationale and formulation development of cream with sun protection factor with onion
extract for therapy of scars
W Jones, M Kaur, S Drewes, M Heberer and B Hardas Merz Pharmaceuticals, Greensboro,
NC
The purpose of this study is to develop a topical application therapy to reduce the appearance
of scars while protecting the scar tissue from sunlight. According to the American Academy
of Dermatology, scars are particularly sensitive to sunlight and can sunburn faster than healthy
skin. Once a scar becomes sunburned, it can remain discolored or darkened. For this reason,
the American Academy of Dermatology recommends that all patients with newly healing
wounds/scars utilize a high-level sun block to prevent worsening of the cosmetic appearance
of the scar (www.aad.org). Additionally, extensive market research among our core consumer
base consistently shows that women in the US believe that scars should be protected from the
sun, and they perceive a need for a scar product with SPF (Sun Protection Factor) when treat-
ing scars, especially new scars. Onion extract product for scar therapy is one of the main prod-
ucts recommended by doctors. Therefore, the addition of SPF to onion extract will be helpful
in improving and protecting scars. Currently available scar therapy gel with onion extract was
reformulated to become a light cream without using irritating emulsifiers. A new depot-build-
ing agent was added to provide the advantage of staying within stratum corneum (does not
penetrate into epidermis). Combining three different sunscreens exceeded the targeted mini-
mum SPF of 20. The SPF was determined by in vitro testing and will be further confirmed by
in vivo testing. The selected formulation went through release testing of onion extract from the
matrix of the new formulation so that formulation equivalence could be established between
new and currently marketed formulation of the scar gel. Launching onion extract product
with SPF 20+ would provide consumers with a new, doctor-recommended product that
improves the cosmetic appearance of scars while protecting them from the sun.
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Comorbidities associated with psoriasis in the Newfoundland and Labrador founder popu-
lation
WP Gulliver,1,2 Z Tomi1,2 and R Alaghehbandan3 1 NewLab Clinical Research Inc., St. John’s,
Newfoundland and Labrador, NF, Canada, 2 Memorial University of Newfoundland, St.
John’s, NF, Canada and 3 Newfoundland Centre for Health Information, St. John’s, NF,
Canada
Psoriasis is a common inherited inflammatory disorder of the skin that affects 1 to 2 percent
of the population. The relationship between psoriasis and psoriatic arthritis has been well estab-
lished clinically and genetically. Recently researchers have suggested that there may be other
comorbidities such as lymphoma, obesity, type 2 diabetes, dyslipidemia, hypertension, car-
diovascular disease and lymphoma and melanoma and non melanoma skin cancer linked to
psoriasis. Using the Newfoundland and Labrador founder population through the New-
foundland & Labrador Centre for Health Information (NLCHI) we have undertaken the task of
studying 3400 psoriasis patients with respect to these comorbidities. Initial investigation of
100 patients with mild and severe psoriasis showed increased rates of heart disease, diabetes,
and hypertension with under representation of asthma. The present study has analyzed 3400
patients for these and other comorbidities, as well as, 800 patients who have been genotyped
for HLACw6 and TNF-alpha 238 will have comorbidities and the genetic markers linked. This
study demonstrates that the use of the Newfoundland and Labrador founder population and
its comprehensive health information data base linked to genetic analysis will be a powerful
tool in understanding the genetics of comorbidities linked to psoriasis. Other significant find-
ings include the association between early age of onset and HLACw6 as well as the presence
of psoriatic arthritis and genetic markers.
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Topical calcineurin inhibitors in the management of anogenital lichen sclerosus unrespon-
sive to ultra-potent corticosteroids: our experience
R Bilenchi, C Pisani, A Andreassi, S Poggiali, L De Padova, M Fimiani and L Andreassi
Dermatology, University of Siena, Siena, Italy
Lichen sclerosus (LS) is a chronic disease with evidence of a lymphocyte- mediated origin.
Corticosteroids have been the mainstay of therapy for LS. The potential for side-effects and
tachyphylaxis limit their utility in providing long-term disease control. Topical calcineurin
inhibitors (TCIs) (tacrolimus and pimecrolimus) approved for atopic dermatitis, have a poten-
tial in other inflammatory skin diseases. We investigated the efficacy and safety of tacrolimus
ointment 0.1% and pimecrolimus 1% cream in anogenital LS unresponsive to ultra-potent cor-
ticosteroids.Ten patients (four woman and six men) aged between 52 and 76 years with his-
tologically proven active anogenital LS, were treated for 16 weeks twice daily with either top-
ical tacrolimus (one woman and three men) or pimecrolimus (three woman and three men)
in an observational study. Clinical examination and recording of patients symptoms were per-
formed before, after four and eight weeks, and after three and four months of therapy, respec-
tively.Of the ten subjects enrolled, one individual (a man treated with tacrolimus) discontin-
ued the study due to severe pain at week 2. Eight patients experienced improvement in
symptoms with remarkable relief of pain and pruritus after the first weeks of treatment. At the
end of therapy, complete remission of symptoms was achieved in eight patients, and clear-
ance of active LS was reached in two cases (one woman treated with tacrolimus and one man
treated with pimecrolimus). Partial resolution was reached in six patients (one woman and one
man treated with tacrolimus, two woman and two men treated with pimecrolimus). All patients
showed no recurrence of disease activity during the follow-up period of 21 months. In our
opinion TCIs seem to be effective in LS, expecially in anogenital LS unresponsive to ultra-
potent corticosteroids.
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Skin specific defects in cathelicidin antimicrobial peptide expression of subjects with atopic
dermatitis and psoriasis
T Hata, D Udall, D Zaccaro, A Paik, P Kotol and R Gallo Dermatology Division, University
of California San Diego, La Jolla, CA
Antimicrobial peptide expression is low in lesional skin of patients with atopic dermatitis
(AD) but elevated in lesions of patients with psoriasis (PS).As part of the NIAID funded Atopic
Dermatitis Vaccinia Network, the objective of our study was to determine if this local dysreg-
ulation was also reflected in systemic expression of cathelicidin. Saliva, blood and 2mm punch
biopsies of uninvolved skin were collected from 14 subjects with PS, 9 AD, and 14 normal
controls (NL). AD and PS subjects also received punch biopsies of lesional skin. Cathelicidin
mRNA was measured by Q-RT-PCR and was highest in lesional PS with a median value of
2.63 relative copy numbers (RCP), significantly higher than lesional AD skin (.352 RCP) and
NL skin (.064 RCP), (p=.02). Non-lesional skin of PS also trended higher than non-lesional
AD skin and NL with median values of .274 RCP,and .051 RCP respectively (p=.06). Saliva
cathelicidin was measured by ELISA to evaluate expression by a different epithelial cell type
and was not significantly different in PS or AD compared to NL (37.1units vs.13.3 units vs.
37.6 units). Similarly, blood neutrophil cathelicidin analyzed by FACS did not show any sta-
tistical difference in mean fluorescent intensity between the PS, AD and NL. Pearson correla-
tion analysis revealed no correlation between cathelicidin levels in the skin with blood or
saliva. These results confirm previous studies showing cathelicidin is induced in PS lesional
skin and that AD is not increased as expected with inflammation. New findings reveal that
cathelicidin in nonlesional PS skin is increased, suggesting generalized upregulation in skin.
The lack of correlation between skin, saliva and blood of all groups suggests that there is a
skin specific dysregulation of cathelicidin in AD and PS patients that does not affect their saliva
or blood. These observations support the clinical findings of susceptibility to infection only in
the skin of AD, and support the feasibility of skin-specific modulation of antimicrobial pep-
tide expression.
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Rosacea: Is it necessary to have photoprotection?
B Moncada,1 DV Hernandez-Blanco,1 DJ Martinez-Ramirez,2 FJ Gonzalez2 and AB Torres-
Ruvalcaba3 1 Dermatology, University of San Luis Potosi, San Luis Potosi, Mexico, 2 Institute
for Optical Communications, University of San Luis Potosi, San Luis Potosi, Mexico and 3
Social Medicine, University of San Luis Potosi, San Luis Potosi, Mexico
Etiology of rosacea remains unknown. Pathogenesis includes increased blood flow to the der-
mis, and pilosebaceous unit abnormalities.In some patients it is clear the relationship between
rosacea and exposure to heat.Although apparently sun exposure plays a role, this concept
has been challenged since no relationship has been found between skin sun damage and
rosacea in recent observations. Nevertheless general textbooks of dermatology recommend
photoprotection which at this moment, is exerted almost always with topical sunscreens. We
feel that applying a layer of any topical cream vehicle can increase the skin temperature and
that this fact may lead to worsening of the disease or at least to difficulties in management. In
order to prove that, 8 patients with rosacea had their skin temperature measured with a infrared
camera (FlexCam-S Infrared Solutions Plymouth MN) before and five minutes after the appli-
cation of a cream containing a sunscreen.The thermal image showed that over the central
part of the face there was a significant increase in temperature between the pre and post read-
ings (p= 0.01); this was not true for reading in lateral aspects of face or in normal people. Given
our findings in this study regarding temperature augmentation after cream application, we sug-
gest that the topical application of sunscreens and as a matter of fact of any other cream should
be avoided in patients with rosacea. Of course if a patient strongly needs sun protection for
other reasons regardless of the presence of rosacea it should accepted that this could be detri-
mental for the control of rosacea.In the long run using a sunscreen could be very expensive
especially for people in third world countries but when the relation cost/effectiveness is high
their use is justified. We would like to stress the point that this fact is questionable in rosacea.
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Alemtuzumab in patients with erythrodermic cutaneous T-cell lymphoma (E-CTCL)
C Querfeld,1 ST Rosen,1,2 J Guitart,1,3 B Martone1,2 and TM Kuzel1,2 1 Robert H. Lurie
Comprehensive Cancer Center, Northwestern University, Chicago, IL, 2 Internal Medicine,
Div. of Hematology/Oncology, Northwestern University, Chicago, IL and 3 Dermatology,
Northwestern University, Chicago, IL
The anti-CD52 monoclonal antibody alemtuzumab has been shown to be effective in the treat-
ment of hematological malignancies. We conduct a phase II study to evaluate alemtuzumab in
pts with advanced stage CTCL. Preliminary results of this ongoing phase II trial and the clinical
use of alemtuzumab showed efficacy particularly in pts with E-CTCL. Alemtuzumab was IV
administered at a dose of 30 mg t.i.w. for 4 weeks followed by SQ administration for 8 weeks
with unchanging dosage and schedule.19 pts with refractory or relapsed E-CTCL have been
treated to date. The ORR was 79% (15 pts) with CR in 47% (9) and PR in 32 % (6) of patients
clearing effectively circulating Sézary cells. 4 pts (21%) developed PD with the development of
cutaneous tumors in one pt despite complete clearing of circulating Sézary cells. Median response
duration was 7 months (range, 1-39 months). The median overall survival of all pts was 18 months
(range, 1-50 months). 10 pts (53%) have died, 7 (37%) attributable to MF. Minimal residual dis-
ease was detected in 11 patients who achieved CR and PR. Treatment was well tolerated, with
the majority of toxicities being Grade 2 in severity and transient. The major side effect was T-cell
depletion (lymphopenia Grade 4) with a risk of infectious complications in 4 pts (Grade 2 and
3) and neutropenic fever in one patient. 5 pts developed grade 3 or 4 leukopenia with pancy-
topenia in 2 pts requiring withholding and/or discontinuation from treatment. One pt developed
a second B-cell lymphoma 6 months after completing alemtuzumab. One pt died of aplastic
anemia. Common cytopenias and prolonged immunosuppression required prophylactic treat-
ment with TMP-sulfa, acyclovir, and diflucan until immune reconstitution. Alemtuzumab shows
promising clinical activity in pts with E-CTCL with acceptable toxicities. Combined strategies
with alemtuzumab may achieve molecular remissions with longer response durations in E-CTCL.
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Hydrochlorothiazide as a putative risk factor for cutaneous T-cell lymphoma 
J Vu and M Duvic Dermatology, The University of Texas MD Anderson Cancer Center,
Houston, TX
Mycosis fungoides (MF), the most common cutaneous T-cell lymphoma (CTCL), is hypothe-
sized to result from chronic antigen stimulation and has an associated class II HLA-DR5,DQB*03
predisposition. To study risk factors associated with MF and other CTCLs, a Microsoft access
database was established from records of 1180 CTCL patients evaluated after 1987 to the pres-
ent. In a retrospective analysis, 200 CTCL patients who reported a history of hypertension were
predominantly MF stage IA (43%) or IB (28%), IIA(6%), IIB(5%), III (6%), IVA,B (4%) or other
CTCL (8%). Of the 200, 87 or 44% took hydrochlorothiazide (HCTZ) and 77% of 87 started
HCTZ prior to developing CTCL. The proportion of patients taking HCTZ was higher than that
of other anti-hypertensives, including beta-blockers (15.5%), calcium channel blockers (14.5%),
angiotensine-converting enzyme inhibitors (12.5%), angiotensin II receptor blockers (7.5%),
other diuretics (5.5%), or unknown (1%) (p<0.0001,chi-square goodness of fit test). Median
duration of HCTZ treatment prior to a biopsy diagnosis of MF/CTCL was 5 years (range 0-28
yrs). Twenty-one (24.1%) patients started HCTZ within 1 year of developing their first skin rash,
and five with preceding MF or 5.7% worsened when HCTZ was started. Sixteen (18.4%) patients
had complete resolution or marked improvement after stopping HCTZ therapy. One MF patient
with erythroderma fulfilled Koch’s postulate. She started HCTZ 4 years before diagnosis, cleared
after stopping HCTZ, restarted it 4 yrs later and relapsed within 4 months. While furosemide
has been associated with sub-acute lupus and Ro/La antibodies, the more common diuretic,
hydrochlorothiazide, appears to have a role in triggering MF.
275
Sebum excretion in response to chronic stress: beyond the myth and into reality
GA Aguilar-Hernandez1,2 and B Moncada1,2 1 Dermatology, Hospital Central Dr Ignacio
Morones Prieto, San Luis Potosi, Mexico and 2 Dermatology, Autonomous University of San
Luis Potosi, San Luis Potosi, Mexico
It is generally accepted not only by sufferers but Dermatologists that stress plays a determi-
nant roll on skin disease affecting the amount of naturally occurring substances like sebum,
the aim of this study is to dilucidate and to valuate in an objective manner the assumed asso-
ciation between chronic stress and facial sebum, exploring innovating techniques for skin bio-
metry in an observational, analytic, prospective study. We made clinical evaluations and apply
stress questionnaires on a volunteer sample of 56 individuals exposed to high levels of stress,
either healthy or with mild degree acne (comedogenic or mild papulo-pustular), and meas-
ure facial sebum. High level of stress was found in 60.7% (34 individuals), there was no cor-
relation between mean facial sebum and chronic stress (R= 0.157, P= 0.4249), mean surface
sebum was similar between healthy individuals and individuals with mild acne, we found a
higher level of sebum excretion in male compared to female participants (4.34 vs 14.36%,
respectively; P= 0.023). In a prospective evaluation after an acute effective stressor stimulus
we still found no evidence of a correlation between mean facial sebum and chronic stress.
Our study suggests that chronic stress does not produce a clinical or statistical change in sebum
on skin surface and, more important, it is not a determinant factor for skin disease, even with
the presence of acute stress peaks.
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The cutaneous renin angiotensin system: a proinflammatory pathway in pityriasis rubra pilaris?
A Meves and MR Pittelkow Dermatology, Mayo Clinic, Rochester MN, Rochester, MN
Pityriasis rubra pilaris (PRP) is a molecularly undefined but clinically distinct, chronic inflam-
matory skin disorder of unknown etiology. Whereas a number of detailed observations and
intriguing hypotheses on the molecular underpinning of PRP have been made, a comprehen-
sive list of genes and pathways that correlate with the unique clinical picture of PRP is still
elusive. We have taken the approach of gene expression microarray analysis of skin biopsies
from patients with PRP. Adult patients with Type I disease (Griffith classification) who were
found by history and physical exam to likely suffer from PRP were asked to participate in an
IRB approved research study. Biopsies were collected from involved and adjacent uninvolved
skin. Differentially expressed genes were subjected to gene function analysis using the GO
Ontology Database and pathway analysis using the Ingenuity Pathways software. The most sig-
nificantly enriched GO categories reflected the hyperproliferative nature of PRP and included
genes for keratin 16, involucrin, transglutaminase 1, cornifin and others. We also found STAT1
to be upregulated, a transcription factor recently identified to be a marker of hyperprolifera-
tive skin disease. In addition, preliminary pathway analysis suggests a role for the cutaneous
renin angiotensin system (RAS) in the pathogenesis of PRP and we hypothesize that RAS has
pro-inflammatory properties in human skin. Cross validation studies are ongoing to confirm
these novel findings.





Correlations among different types of skin lesions and internal organ involvement in tuber-
ous sclerosis complex
C Hong,1,2,3 F Takeuchi,2 S Aldrich,2 L Hathaway,3 J Moss,3 C Lee4,5 and TN Darling2 1
Dermatology, Tainan Hospital, Department of Health, Executive Yuan, Tainan, Taiwan, 2
Dermatology, Uniformed Services University of the Health Sciences, Bethesda, MD, 3
Pulmonary-Critical Care Medicine Branch, National Heart, Lung, and Blood Institute,
National Institutes of Health, Bethesda, MD, 4 Dermatology, Kaohsiung Medical University,
Kaohsiung, Taiwan and 5 Dermatology Branch, National Cancer Institute, National Institutes
of Health, Bethesda, MD
Tuberous sclerosis complex (TSC) is an autosomal dominant syndrome characterized by hamar-
tomas in multiple organs. Expression is highly variable and there is delayed but progressive
appearance of many types of tumors. Our goals were to determine whether TSC skin findings
predicted other skin findings, and whether skin disease correlated with internal organ involve-
ment, including lungs, kidneys, eyes, heart, and brain. Sixty-two adult patients meeting diag-
nostic criteria for TSC were evaluated for skin and internal disease. All patients were female,
since the patients were recruited for studies of lymphangioleiomyomatosis (LAM), a TSC-asso-
ciated pulmonary disease that occurs almost exclusively in adult women. Among the differ-
ent types of skin lesions, the strongest correlation was between the extent of facial angiofi-
bromas and the total number of ungual fibromas (correlation coefficient 0.501, p<0.001).
Positive correlations were also observed among these lesions and oral fibromas and forehead
plaque, but not with shagreen patch, hypomelanotic macules, or confetti-like lesions; con-
fetti-like lesions correlated with hypomelanotic macules. Correlations were not observed
between the severity of angiofibromas or ungual fibromas and internal disease. These results
suggest that the growth of angiofibromas and ungual fibromas are regulated by shared fac-
tors, but that these may be different from those involved in development of other skin lesions
or internal disease.
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Identification of a new effect of herbal medicines on dendritic cells by screening analysis
–isolation of falcarindiol from Notopterygii Rhizoma
S Mitsui, H Fukui, H Mizukami and A Morita Dermatology, Nagoya City University Medical
School, Nagoya, Japan
Dendritic cells (DCs) have a major role in regulating immune responses, including tumor
immunity and peripheral tolerance. We identified a novel effect of herbal medicines on DCs
by screening analysis. We selected 99 herbal medicines that are the main ingredients of 210
Chinese medicines approved for use by the Ministry of Health, Labor, and Welfare in Japan.
Ethanol extracts were prepared from the 99 herbal medicines. The murine epidermal-derived
Langerhans cell line XS106 was used to screen the extracts. Notopterygii Rhizoma highly sup-
pressed MHC class II expression of XS106. We isolated an active ingredient from Notoptery-
gii Rhizoma by fractionation with organic solvents, column chromatography, and HPLC, and
identified it as falcarindiol (FD). FD (1-5 µM) suppressed MHC class II expression of XS106
in a dose dependent manner (17.9%-37.9%). Fresh-isolated bone marrow- derived DCs (BM-
DCs) were then examined for surface phenotypes, i.e., MHC class II, CD80, CD86, and inter-
leukin (IL)-12p70, IL-10 production. Treatment with 5 µM FD significantly inhibited the acti-
vated phenotypes and the secretion of cytokines induced by lipopolysaccharides in BM-DCs,
and inhibited MHC class II activation with CD40 ligation (23.4%), but not with PMA + ion-
omycin or IL-12. Finally, a delayed-type hypersensitivity model with ovalbumin was exam-
ined. Topical application of 0.002% and 0.01% FD before sensitization suppressed delayed-
type hypersensitivity responses in a dose-dependent manner (p<0.01). These results indicate
that FD induces immunosuppressive effects in vitro and in vivo and might thus be a new
pharmacologic lead for immunotherapy for autoimmune or allergic diseases.
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Differential impact of pimecrolimus compared to betamethasone treatment on gene expres-
sion profile in atopic dermatitis
A Scherer,1 C Wanke,1 JM Jensen,2 M Braeutigam,1 R Foelster-Holst,2 F Staedtler,1 J Kehren,1
M Zuehlsdorf1 and E Proksch2 1 Biomarker Development, Novartis Pharma AG, Basel,
Switzerland and 2 Department of Dermatology, University of Kiel, Kiel, Germany
We investigated the effect of topical treatment with pimecrolimus cream 1% or betametha-
sone valerate 0.1% (BMV) on gene expression profiles in lesional skin of atopic dermatitis
(AD). Ten patients were treated topically on the upper limbs with pimecrolimus cream on one
arm and with BMV on the other arm. Skin biopsies were taken at baseline and after 3 weeks
of treatment. Total RNA was labeled and hybridized to human genome specific HG-U133Av2
microarrays (Affymetrix Inc., CA). Primarily, analysis focused on the correlation of gene expres-
sion changes to pEASI score. Both treatments resulted in a reduction of mRNA levels coding
for lymphotactic chemokines (e.g. CCL2, CCL26, CCL19), epidermal inflammatory proteins
(e.g. calgranulin A,B, psoriasin1), and other genes encoding proinflammatory proteins whereby
a more pronounced effect was noted with BMV as compared to pimecrolimus. This is in line
with the observed higher clinical efficacy (pEASI score) of the corticosteroid in AD as described
before (JID 2006;126:s19). The anti-inflammatory effect of BMV was also associated with a
significant reduction of RNA levels of markers of Langerhans cells and other DC subtypes
(e.g. CD1A, CD83, LAMP3) as well as of general APC genes, such as MHC. In addition, only
BMV treatment selectively down-regulated the expression of genes coding for collagens, cor-
relating with the known side-effect of skin atrophy. BMV treatment also resulted in a stronger
dysregulation of genes involved in epidermal integrity (e.g. keratins, involucrin, elafin) as com-
pared to pimecrolimus. In conclusion, data suggest a more selective anti-inflammatory effect
of pimecrolimus as compared to BMV in AD.
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In vivo confocal raman spectroscopy measurements of skin through adhesive substrates
CT Cunningham and DW Koenig Skin Care & Treatments, Kimberly-Clark Corporation,
Neenah, WI
The objective of this pilot study was to determine the utility of in vivo confocal Raman spec-
troscopy to directly measure skin biochemical characteristics though an adhesive substrate.
The study focused on the impact of the adhesive material on clarity of spectral measurements
as well as methodological treatments to discern the interface between the adhesive substrate
and the skin surface. The pilot study employed measurements on adult forearms covered with
an adhesive tape. Specifically, Cuderm™, Tegaderm™, and Blenderm™ were applied to the
volar forearm for a 4 hour period. Before and during this period, z-directional profiles of water,
and Natural Moisturizing Factor (NMF) concentrations were quantified employing confocal
Raman spectroscopy. The water and NMF distribution in the stratum corneum was normal for
untapped skin and did not vary greatly with time. Patching the skin with the tape produced
slightly elevated water levels during the study period. The optical clarity and thickness of the
tape played an important role in obtaining the spectral measurements. There was some site to
site variation but overall the trends observed were consistent between sites. Multiple data treat-
ments allowed for the measurement of substrate thickness and detection of the skin surface.
Overall, detailed and specific information of the skin biochemical processes could be derived
from the Raman spectroscopy skin measurements without removal of the adhesive tape from
the skin. The ability to perform Raman spectroscopy of the skin through an attached substrate
without removal of that substrate opens the door for a range of future fundamental studies on
skin health that were not previously possible.
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Comparison of toxicological side effects and antimicrobial potencies of silver sulfadiazine
and nanoscalic silver – an in vivo and in vitro study
O Brandt,1 M Mildner,1 A Egger,2 M Groessl,2 C Hartinger,2 C Strupp,3 B Mueller,3 B Keppler2
and G Stingl1 1 Dept. of Dermatology, Division of Immunology, Allergy and Infectious
Diseases, Medical University of Vienna, Vienna, Austria, 2 Institute of Inorganic Chemistry,
University of Vienna, Vienna, Austria and 3 Dept. of Research and Development, Spirig
Pharma Ltd., Egerkingen, Switzerland
The increasing number of bacterial resistances against topically applied antibiotic agents is a
serious problem in the treatment of skin infections. Silver-containing creams, particularly sil-
ver sulfadiazine (AgSD), possess effective antimicrobial activities, and resistances against these
substances are rarely reported. Hence, AgSD has become a standard treatment for burns and
skin infections over the past decades. However, there is serious concern that silver ions applied
to inflamed and/ or denuded skin might be absorbed in significant amounts, holding the risk
of silver deposition in and, perhaps, injury of inner organs. In light of these facts we com-
pared the percutaneous absorption and the antimicrobial potency of AgSD with a new com-
position where nanoscalic silver is linked to an inorganic carrier material (NSAg) leading to a
highly stable complex that is less likely to be absorbed via the skin. The backs of hairless mice
(SKH-hr1) were treated on five consecutive days with AgSD 1%, NSAg 1%, and NSAg 0.1%,
respectively. While both AgSD and NSAg showed strong antimicrobial activities against Staphy-
lococcus aureus, Pseudomonas aeruginosa, and Escherichia coli already at very low concen-
trations of 0.01%, quantification of silver ions in organs, blood and faeces revealed signifi-
cantly lower absorption rates in the NSAg-treated animals than in the AgSD group. These results
suggest that NSAg-containing creams are well suited for the prevention and treatment of skin
infections, even when applied to large surfaces.
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Polypseudolysine, a carrier molecule-based approach to transport agents into skin 
P Kumar,1 M Fara,2 M Bradley,2 P Friedmann1 and E Healy1 1 Dermatopharmacology,
University of Southampton, Tremona Road, Southampton, United Kingdom and 2
Department of Chemistry, University of Edinburgh, Edinburgh, United Kingdom
Cell penetrable peptide(CPP) based carrier molecules such as penetratin, Tat and transportan
are used to deliver a range of compounds into cells in vitro. To date only a few CPPs are capa-
ble of transporting various molecules across the stratum corneum into skin. We have devel-
oped a novel carrier molecule (pseudopolylysine; PPL), and have investigated whether this
compound has the ability to transport compounds which influence skin pigmentation into cells
and skin. The cargo molecules studied include alpha-melanocyte stimulating
hormone(alphaMSH), a 19-mer antisense oligonucleotide(ASO) targeting the translational start
site of the tyrosinase gene and a 15-mer peptide-nucleic acid(PNA) also targeting tyrosinsase.
Functional studies based on pigmentation and ligand binding have shown that alphaMSH con-
jugated to PPL remains capable of binding to the melanocortin 1 receptor and stimulating
melanin synthesis. In vitro penetration studies using confocal microscopy have demonstrated
that, in contrast to fluorescein-conjugated alphaMSH alone, fluorescein-labelled alphaMSH-
PPL (10-5M) readily enters into a variety of cells at a 3 hour time point. Ex vivo assays on mouse
and human skin show good penetration of fluorescein-alphaMSH-PPL into skin at 10-3M
whereas fluorescein-alphaMSH does not enter into the skin. The ability of PPL to deliver PNA
and ASO compounds was tested in an in vitro B16F10 cell based tyrosinase and melanin assay.
The results show that the pigmentation induced by alphaMSH (10-10M)in B16F10 cells was
significantly inhibited by PNA-PPL (10-5M) but not be PNA alone, and that PPL-PNA (10-5M)
decreased alphaMSH (10-10M) induced tyrosinase activity in each of three separate experi-
ments. In addition, PPL-ASO (10-5M) reduced baseline and alphaMSH (10-10M) stimulated
tyrosinase activity (n=3). Further work is ongoing however, the results indicate that a PPL based
approach may be used to deliver a range of compounds into cells and skin.
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Development of a minimally invasive epidermal abrasion device for clinical skin sampling
and its applications in molecular biology
J Lee, R Carson, A Christina, S Iobst, A Wunder, M Mahajan, M Barratt and C Feinberg Skin
Bioscience, Unilever R&D Trumbull, Trumbull, CT
An abrasion tool (US patent US7087063 B2) has been developed for collecting epidermal
samples. This device includes a central shaft that holds the probe in a split chuck. Of the vari-
ety of probe designs tested, the laser-cut hollow tubing probe abraded the basal layer of the
epidermis most consistently, resulting in representative epidermal skin samples. Compared to
traditional clinical methods, the abrasion method allows for high-throughput epidermal skin
collection with minimal invasiveness to the volunteer subjects. A large number of abrasion
samples have been collected in various clinical studies with no adverse effects observed. Epi-
dermal abrasion, when used appropriately and with the optimized probes, can yield high qual-
ity tissue samples that are representative of the epidermis. A sufficient quantity of RNA and
protein can be obtained for many subsequent molecular and biochemical applications. Because
of its minimal invasiveness and high-throughput nature, the abrasion method can be a valu-
able tool to investigate topically applied skin care products and for investigative dermatology.
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Long term survival in CTCL patients treated with denileukin diftitox 
R Talpur,1 R Bassett2 and M Duvic1 1 Dermatology, University of Texas MD Anderson Cancer
Center, Houston, TX and 2 Biostastics, University of Texas MD Anderson Cancer Center,
Hosuton, TX
Denileukin diftitox (Dd) Ontak, a fusion protein of diptheria toxin fused to full-length IL-2
protein, targets high and intermediate human IL-2 receptors but is approved for patients whose
lesions stain for (CD25), a low affinity receptor. Dd was approved for cutaneous manifesta-
tions of CD25+ cutaneous T-cell lymphomas (CTCLs) most commonly mycosis fungoides (MF)
and Sézary syndrome (SS), the leukemic variant. We retrospectively reviewed outcomes of 48
MF or SS patients between 1996 and 2006 who received at least one cycle of Dd givne IV for
5 days every 21 days at 18 or 9 ug/kg per day. There were 22 males and 26 females (20-80
yrs) with median age of 61 who had received a median of 3 (range 1-8) previous therapies.
Partial responses (PR) was seen in 23 patients (48%). Eighteen of 28 pts (64%) with >20%
CD25 immunostaining had PRs, compared with 5/20 patients (25%) with low expression (p
= 0.01, Fisher’s exact test). Overall survival was compared between groups using log-rank tests.
There were no differences in survival by race (p=0.90) or gender (p=0.76). SS pts (n=15) had
a significantly shorter OS than other advanced MF patients (n= 33)with median survival of 1.2
yrs vs 2.4 yrs (p=0.045). Overall survival was significantly associated with stage: 4 of 4 stage
I-IIA patients are alive compared to 9/15 IIB, 3/3 III, and 13/25 IVA&B (p=0.021) Patients with
2-3 prior therapies had best survival (only 6 of 17 died) compared to patients with 0-1 thera-
pies (median: 2.8 years) and >3 therapies (median 1.2 yrs) (p=0.019). Adverse events of any
grade included capillary leak (42%), fatigue (33%), nausea (31%), elevated liver function
tests (21%), rash (14%), thyroiditis (4%), and retinal detachment (2%). In conclusion, Dd is
an effective therapy for advanced CTCL patients with a 58% response rate seen if lesions express
>20% CD25 antigen. Overall survival following denileukin diftitox was lower in SS patients
and in patients receiving >3 prior therapies.
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Microarrays identify more than 500 genes modulated by T-oligo in melanoma
I Panova, M Yaar, Y Gao, M Keady, M El-Hajahnmad, J Bhawan and BA Gilchrest
Dermatology, Boston University School of Medicine, Boston, MA
Telomere homolog oligonucleotides (T-oligos) activate DNA damage responses leading to
apoptosis and senescence of melanoma cells. To examine T-oligo modulated genes, we
hybridized DNA microarrays containing 14,500 characterized human genes with cDNA from
a melanoma cell line (AN) treated with T-oligo (TTAGGGTTAGGGTTAG, 40uM) or diluent
alone. Within 48 hrs, T-oligo altered by >2-fold 588 genes encoding for apoptosis, DNA dam-
age/repair, cell cycle regulation, senescence and differentiation proteins. Induced genes included
[fold change in ()] serpin peptidase inhibitor, an anti-tumor protein that inhibits VEGF synthesis
(>9); a G protein receptor involved in interaction between retinoid acid and G protein sig-
naling pathways (>8.5); thioredoxin interacting, a proapoptotic protein promoting oxidative
stress (>6.5); DENN/MADD, a death domain activating kinase (>6); TNF and a TNF induced
protein (~4 and >4.5, respectively); p21 (>4); ras induced senescence-1 (>3); the DNA dam-
age Rad51-associated, BRCA1-interacting and BRCA2 (3 each); and the melanocyte differen-
tiation markers Mart1 (4) and Rab27a (>3). Suppressed genes included myc (>4) and cdc42
that promotes pRb phosphorylation (4). Further, SCID mice were injected with AN cells into
the flank or IV to generate metastases, treated with T-oligo on days 3-8 (10 IV injections,
60nmoles/injection) and sacrificed 30 days after the last injection. Flank tumor volume was
154±38 mm3 in control vs 17±4 mm3 in T-oligo-treated mice. Metastatic tumor volume and
number of metastases in the T-oligo vs control group were 87% (p<0.003) and 71% (p<0.04)
reduced, respectively. By immunohistochemistry, the levels of VEGF and the apoptosis inhibitor
survivin were substantially reduced in T-oligo treated tumors, and many tumor cells had high
TNF-α levels. Conversely, Mart1 and Trp1 differentiation markers were elevated in T-oligo
tumors. The DNA array data show an extensive, rapid impact of T-oligo treatment on gene tran-
scription in melanoma cells and correlate well with treatment outcome in murine models of
the disease.
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Long term survival in erythrodermic CTCL patients with blood involvement
KA Vidulich,1 R Talpur,1 RL Bassett2 and M Duvic1 1 Dermatology, MD Anderson Cancer
Center, Houston, TX and 2 Biostatistics, MD Anderson Cancer Center, Houston, TX
Sezary Syndrome (SS) is the leukemic variant of Mycosis Fungoides (MF) with historic overall
survival (OS) of 1.5-3 years. Criteria defining SS in erythrodemic MF patients are evolving
with technology. ISCL recently published guidelines for SS require erythroderma plus >1 of
the following: (1) manual Sezary cell count >1000 cells/mm3 (2) CD4/CD8 ratio of > 10 due
to circulating T cells and/or an aberrant loss or expression of pan-T cell markers (CD7 or 26);
(3) increased lymphocyte counts with evidence of a T-cell clone in blood; or (4) a cytogenetic
chromosome abnormality from blood. Among 1197 MF patients evaluated since 1987, retro-
spective analysis identified 120 (10%) with erythroderma with B1 or B2 criteria, 24 and 96
respectively. Median age was 63 (range 31-89); 68 males and 52 females. Median OS by log-
rank test was determined for the following groups. Overall survival of all erythrodermic patients
with B1 or B2 was 5.4 years [range=0.4-18.6]. Surprisingly, there were no significant differ-
ences in OS between patients with B1 vs. B2 blood involvement (7.6 vs 5.3 yrs, p=0.665), +/-
lymph node involvement (6.5 vs 5.2, p=0.853), +/- bone marrow involvement (6.0 vs 6.5 yrs,
p=0.73), +/- skin clonal T-cell receptor (7.6 vs 5.1 yrs, p=0.315), or +/- staphylococcus aureus
(SA) skin colonization (6.5 vs 5.2 yrs, p=0.20). Improvement of erythroderma with antibiotics
was associated with median OS of 9.8 vs 5.4 yrs (p=0.65). Overall survival was not affected
by treatment with photopheresis (p=0.26), denileukin diftitox (p=0.6), or combination
chemotherapy (p=0.17) but was decreased in patients receiving single agent chemotherapy
(4.2 vs 6.5 yrs, p=0.056). In summary, at MDACC, erythrodermic MF with blood involvement
of B1 or B2 (SS) represented 10% of MF patients, degree of blood involvement did not affect
median overall survival, and OS appears to be better than previously reported.
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CT327: a novel mini-PEGylated compound for topical treatment of psoriasis
L Bertarione Rava Rossa,1 S Traversa,1 V Mainero,1 D Barone,1 C Oderda,1 S Fumero,1
C Pincelli2 and A Marconi2 1 Creabilis Therapeutics Spa, Colleretto Giacosa, Italy and 2
University of Modena and Reggio Emilia, Modena, Italy
Nerve growth factor (NGF) is synthesized and released by human keratinocytes. NGF pro-
tein levels are increased in psoriatic as compared to non-lesional and normal skin, and pso-
riatic keratinocytes express higher amounts of NGF than normal keratinocytes. K252a, a high-
affinity NGF receptor (TrkA) blocker, has been shown to improve psoriasis by inhibiting the
NGF-induced proliferation of human keratinocytes. Creabilis Therapeutics has selected and
developed a novel K-252a derivative specifically designed for the topical treatment of pso-
riasis. The main purpose was to obtain a molecule which, still maintaining the capacity to
enter the keratinocytes and exploit its biological activity on NGF receptor TrkA, has improved
toxicity profile and/or reduced systemic absorption compared to K-252a. K-252a conju-
gated to a 2 kDa linear PEG chain (CT327) satisfies the above conditions. The PEGylation
has conferred drugability to K-252a, a molecule which could hardly become a drug as such,
because of its intrinsic toxicity due to accumulation in cell membranes. CT327 shows an
extremely favorable toxicity profile and has been proven to be non-irritant and non-muta-
genic. The ongoing regulatory pre-clinical studies reveal no acute toxicity, no relevant sign
of toxicity after 14 day (iv and dermal route, rodent) and 28 day (dermal, rabbit) administra-
tion. Safety pharmacology assays (Irwin test, HERG) show that CT327 is a very well tolerated
molecule. Principal features of CT327 are: high kinase selectivity, IC50 on TrkA in the nM
range, antiproliferative activity on keratinocytes, high solubility, dramatically reduced sys-
temic absorption after dermal administration and high stability. No K-252a has been detected
in plasma after systemic and topical administration. CT327 is neither a pro-drug nor a deliv-
ery system. The CTA/IND filing and the subsequent Phase I study in volunteers are planned
for the second quarter of 2007.
S48 Journal of Investigative Dermatology (2007), Volume 127
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Perception of sensorial irritation in different ethnic groups
J O’Leary, V Foy and H Meldrum Unilever R & D, Trumbull, CT
Sensorial irritation is defined as an unpleasant response to the topical application of skin care
products. The objective was to investigate sensory response to glycolic acid across different
ethnic populations – Chinese, Caucasian and Japanese. In these studies, subjects recorded
sensory responses to 4% and 8 % aqueous glycolic acid (pH 3.8) over 7.5 minutes. In one
study, we compared Caucasian subjects with Japanese subjects using a monadic half face
design. In a second study, Caucasian subjects were compared with Chinese subjects using a
full face study design. Studies were conducted in the US. Over 90% of Chinese and Caucasian
panellists reported sensorial irritation to 4% and 8% Glycolic acid applied to the entire face.
Both Chinese and Caucasian subjects initially reported more sting than itch to 4% glycolic
acid and at the end of the 7.5 minute trial, this response changed to more itch than sting in
both ethnic groups. The 8% glycolic acid response mimicked the 4% glycolic acid response
pattern for both the Caucasian and Chinese populations. In a half face design with 4% gly-
colic acid, we saw a similar trend in responses for the Caucasian and the Japanese, which
matched the Chinese trends. 8% Glycolic acid in water was not tested in this study. In con-
clusion, the trends for sensorial irritation are similar in all three populations.
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Psoriasis and pruritus: characteristics of disease associated with itch
AR Taintor,1 B Wong,1 TS Nelson,1 CB Hansen,1,2 JS Papenfuss,1,3 J Panko,1 T Rakkhit,1
GG Krueger1 and KP Callis1 1 Department of Dermatology, University of Utah School of
Medicine, Salt Lake City, UT, 2 Department of Dermatology, University of Texas
Southwestern Medical Center, Dallas, TX and 3 Department of Dermatology, Medical
University of South Caroline, Charleston, SC
Itch in psoriasis has been poorly characterized. The purpose of our study was to describe the
characteristics of psoriasis associated with pruritus in a well-characterized cohort of patients
in the Utah Psoriasis Initiative (UPI). The UPI is a data collection tool containing medical and
genetic information from participants. 302 subjects enrolled in the UPI completed question-
naires, either during a clinical visit or as part of a longitudinal follow-up. The National Psori-
asis Foundation Psoriasis Severity Score questions were used to assess itch and patient global
severity scores (on a 0–5 scale, zero indicating no itch or no disease); plaque thickness was
assessed by the patient using the National Psoriasis Foundation psoriasis induration card. Neg-
ative impact on quality of life was reported by the patient on a 0–100 scale (zero indicated
no impact). ANOVA analyses were conducted to compare mean itch scores for the following
categorical variables: thickness of plaque, Koebner phenomenon, psoriatic arthritis, and nail
disease. Pearson correlations were calculated to compare itch scores with impact on quality
of life and patient global assessment. Results indicate thin plaque disease had significantly
less itch than both thick and in-between plaque disease (p-value < 0.001). Itch scores also
significantly correlated with worsening impact on life quality (p-value < 0.001) and the patient’s
global psoriasis assessment (p-value < 0.001). Itch did not associate with presence of Koeb-
ner phenomenon, psoriatic arthritis, or nail disease. These findings support our previous hypoth-
esis that there are meaningful phenotypic differences in thin and thick plaque psoriasis. Fur-
ther studies into the molecular basis of thin or thick plaques in the untreated state are warranted
to better understand the association of pruritus with psoriasis phenotypes.
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Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray
accelerate healing in murine and human cutaneous wounds
V Falanga,1,2 S Iwamoto,1,2 M Chartier,1 T Yufit,1,2 J Butmarc,1,2 N Kouttab,2 G Colvin2 and
P Carson1,2 1 Dermatology, Roger Williams Medical Center, Providence, RI and 2 Center of
Biomedical Research Excellence (COBRE), Roger Williams Medical Center, Providence, RI
The non-hematopoietic component of bone marrow includes multipotent mesenchymal stem
cells (MSC). Here we describe the culture, delivery system, and successful use of topically
applied MSC to accelerate the healing of human and murine wounds. A single bone marrow
aspirate of 35-50 ml was obtained from patients with acute (n=5) and chronic, non-healing
lower extremity wounds (n=8). Cells were grown in vitro in conditions favoring the propaga-
tion of MSC, and flow cytometry and immunostaining showed a profile (CD29+, CD44+,
CD105+, CD166+, CD34-, CD45-) consistent with published reports of human MSC. The MSC
could be induced to differentiate into bone, cartilage, and adipose tissue. The autologous MSC
were applied up to 4 times to the wounds with a fibrin polymer spray system using a double-
barreled syringe. Both fibrinogen (containing the MSC) and thrombin were diluted to opti-
mally deliver a polymerized gel. Sequential adjacent sections from biopsy specimens of the
wound bed after MSC application showed elongated spindle cells, similar to their in vitro coun-
terpart, which immunostained for MSC markers. Generation of new elastic fibers was evident
by both special stains and by antibodies to human elastin. The application of cultured cells
was safe, without treatment-related adverse events. A strong direct correlation was found between
the number of cells applied (greater than 1X106 cells per cm2 of wound area) and the subse-
quent decrease in chronic wound size (p=0.0058). Topical application of autologous mouse
MSC also stimulated closure of full-thickness wounds in diabetic mice (db/db). Tracking of GFP+
MSC in mouse wounds suggests that the applied cells do not persist but may act by stimula-
tion of the wound repair process. These findings indicate that autologous bone marrow-derived
cultured MSC can be safely and effectively delivered to wounds using a fibrin spray system.
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Methotrexate enhances protoporphyrin IX accumulation in skin carcinoma cell lines and
organotypic epithelial cultures: Implications for enhanced photodynamic therapy
S Anand,1 JA Mack,1,2 T Hasan3 and EV Maytin2,1 1 Biomedical Engineering, Cleveland Clinic,
Cleveland, OH, 2 Dermatology, Cleveland Clinic, Cleveland, OH and 3 Wellman Center for
Photomedicine, Harvard Medical School, Boston, MA
Photodynamic therapy (PDT) is an emerging binary treatment for a number of non-melanoma
cancers of the skin. Aminolevulinic acid-mediated PDT (ALA-PDT) involves the administra-
tion of a precursor photosensitizer, ALA, which is selectively accumulated and metabolized
in target cells to form protoporphyrin IX (PpIX), followed by local irradiation with visible light
to induce cell death. We previously discovered that human prostate cancer cells (LNCaP),
when induced to undergo cellular differentiation by pretreatment with methotrexate (MTX),
became more susceptible to ALA-PDT through accumulation of higher levels of PpIX {Sinha
et al. Brit J Cancer 95, 485-495, 2006}. For this study we utilized two human skin cancer cell
lines, namely SCC13 and HEK1, along with a 3D-organotypic culture model of rat epidermal
keratinocytes (REKs). The latter were grown for 4 days at the air-liquid interface on a basement
membrane. Both the monolayer and 3D cultures were incubated with different concentrations
(.001-1.0 mg/L) of MTX for 72h followed by 4h of ALA prior to harvest. No-treatment and ALA-
only controls were also included in the study. Confocal images were captured from live cells
or frozen sections of 3D cultures and analyzed using IP Lab software to determine the rela-
tive PpIX increase among the samples. Both in monolayer cultures and in the 3D model of
epidermis, a significant PpIX increase (2.5-4.5 fold) was observed as compared to ALA-only
controls. This effect was observed at very low concentrations of MTX (nM-uM range) and
dropped off at higher MTX concentrations associated with growth arrest and toxicity. These
results suggest that use of a differentiating agent such as MTX, in a short term combination
therapy regimen given prior to ALA-PDT, can increase the production of PpIX in cancer cells
and thus enhance ALA-PDT efficacy.
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High throughput screening identifies WRN binding small molecules with anti cancer effects
M Yaar,1 I Panova,1 Y Gao,1 V Figueroa,1 MS Eller,1 P Nghiem2 and BA Gilchrest1 1
Dermatology, Boston University School of Medicine, Boston, MA and 2 Univ Washington,
Seattle, WA
Telomere homolog oligonucleotides (T-oligos) mimic telomere loop disruption and induce apop-
tosis and/or senescence in malignant cells. We identified the Werner (WRN) protein, a DNA heli-
case and exonuclease, as the nuclear sensor transducing T-oligo effect. To identify small non-
DNA molecules that might substitute for T-oligos as cancer therapeutics, a high throughput screen
for binding to WRN was performed using a library of >11,000 well characterized small mole-
cules. There were ~30 “positives” (reproduced in 3 independent runs), all belonging to the class
of spirooxindoles, M.W. ~600-1000 Da. In dose response experiments, two enantiomers, Sp-1
and Sp-2, tested at 2.5-80 uM, by day 4 significantly decreased cell yields of melanoma (AN)
lung carcinoma (H460) and breast carcinoma (MCF-7) cells by 44±2%, 38±1% and 80±0.5%,
(p<0.004, p=0.05 and p<0.001), respectively at concentrations 40-80uM, compared to a 16 base
T-oligo with 100% telomere homology at 20-40 uM that decreased the yields by 70±2%, 41±1%
and 87±9% (p<0.002, p<0.001, p<0.04), respectively. Like T-oligo, Sp compounds induced apop-
tosis as determined by caspase-3 activation (PARP cleavage) in MCF-7 cells or by increase in
sub G0/G1 in AN cells (45±5% Sp vs 10+1% diluent, p<0.02). Also like T-oligo, Sp-1 and Sp-2
activated (phosphorylated) ATM (ataxia telangiectasia mutated) kinase, induced phosphorylation
of the histone variant H2AX (γH2AX) and produced γH2AX foci, events characteristically induced
by DNA damage. Furthermore, in melanoma, lung carcinoma and breast carcinoma cells, within
48 hours Sp-1 and Sp-2 decreased the level of the anti-apoptotic caspase inhibitor survivin to
non detectable levels. In a T-oligo resistant melanoma line, Sp minimally affected growth, sug-
gesting that Sp are not non-specifically toxic. These data validate the high throughput screen as
a means of identifying small molecule substitutes for a DNA therapeutic and support a role for
WRN binding as critical to the T-oligo mechanism of action.
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Is Morphea a systemic disease?
H Jacobe,2 R Haley,1 PR Bergstresser1 and J Leitenberger1 1 Dermatology, UT Southwestern
Medical Center, Dallas, TX and 2 Internal Medicine, Division of Epidemiology, The University
of Texas Southwestwestern Medical Center, Dallas, TX
Morphea is thought to be a localized cutaneous disorder with few systemic implications. A
systematic review using the MEDLINE citation database revealed that our knowledge about
morphea is from case reports and case series, with little data from large scale studies. This level
of evidence, according to Cochrane’s clinical evidence hierarchy, is insufficient. We aim to
address this deficiency by describing the epidemiological, autoimmune, and genetic charac-
teristics of morphea in children and adults via a prospective cohort study. This will be accom-
plished in three steps: 1. ICD-9 based searches for study subjects with chart review, 2. Estab-
lishment of the cohort via a case control study using matched scleroderma and “normal”controls,
and 3. Long term follow-up. We envision 2 morphea subsets: Subset 1, “autoimmune pheno-
type” identifiable by segregation into specific clinical, autoimmune, and genetic profiles (gen-
eralized and linear). Subset 2, without autoimmune associations (limited plaque). We report
results of the descriptive phase of the study. Data were derived from chart reviews of 71 patients.
Demographics are similar to prior reports. Our data suggests that generalized morphea is under-
diagnosed and many patients with “plaque morphea” meet criteria for generalized disease. Fur-
ther, our data supports a new subtype of morphea, mixed, represented by a combination of lin-
ear and generalized/plaque morphea (20% of subjects, making it the third most common subtype).
Morphea may be a risk factor for development of rheumatic autoimmune disorders (10% of
patients reported SLE, RA, Sjogren’s syndrome, or spondyloarthropathy) producing a relative
risk (RR) of 2.78. Other autoimmune disorders were present in 8% (psoriasis, Hashimoto’s thy-
roiditis, IDDM), RR 2.91. The subtype most associated with autoimmunity is generalized mor-
phea (23% patients with autoimmunity). This data suggests generalized morphea is within spec-
trum of systemic autoimmune disease and may be underdiagnosed and underappreciated.
www.jidonline.org   S49
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TNF-α-bearing macrophages- a target for TNF-α inhibitors in non-infectious granulomatous
diseases?
C Bangert, S Kohlhofer, R Kunstfeld, N Selenko-Gebauer, F Karlhofer, G Stingl and T Kopp
Department of Dermatology, Medical University of Vienna, Vienna, Austria
TNF-α antagonists have revolutionized the treatment of non-infectious inflammatory skin dis-
eases such as psoriasis, M. Behcet and pyoderma gangrenosum. One serious side effect of
this form of treatment is the reactivation of infectious processes such as tuberculosis. In this
case, the spread of mycobacteria is apparently due to a granuloma-disrupting effect of anti-
TNF-α agents. We therefore reasoned that these agents could be promising tools in the treat-
ment of widespread, non-infectious granulomatous processes such as disseminated granuloma
anulare(GA), sarcoidosis and others. To test this hypothesis, we initiated i.v. treatment with
the TNF-α inhibitor Infliximab (5 mg/kg/day at weeks 0, 2, 6, 14, 22 etc.) in four female patients
with disseminated GA. The clinical effects were quite dramatic. GA lesions began to regress
already during the first two weeks of treatment and had completely disappeared after 4 admin-
istrations of infliximab. By immunohistology, untreated GA lesions displayed increased num-
bers of CD207+ epidermal Langerhans cells and, most notably, palisading granulomas con-
sisting predominantly of CD11b+/CD14+ macrophages and CD3+ T cells. These latter cell
types also exhibited pronounced anti-TNF-α reactivity. For reasons yet unknown, the expres-
sion density of MHC class II on LC and macrophages was greatly reduced compared to that
of normal skin. After 4 administrations of infliximab, LC and macrophages were greatly
decreased and TNF-α expression had disappeared. T cells, by contrast, were still present, albeit
at a slightly reduced frequency. We conclude that infliximab is an effective treatment for recal-
citrant disseminated GA and that TNF-α-producing macrophages are the main target of its
action. It is tempting to speculate that an infliximab-induced macrophage apoptosis might
induce immunological events resulting in the downregulation of the inflammatory process.
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Adalimumab treatment clears localized pustular psoriasis of palms and soles
RE Schopf and E Beis Dermatology, Johannes Gutenberg Univ., Mainz, Germany
Localized pustular psoriasis of palms and soles (pustulosis palmaris et plantaris, PPP) is a neu-
trophilic disease. Treatment of PPP is difficult; although Adalimumab, a fully human anti-
TNF-alpha monoclonal antibody, has been reported to clear T-cell mediated plaque type pso-
riasis, its efficacy in PPP has been unknown. We describe the successful treatment of PPP
with Adalimumab. We treated 7 patients with long-standing PPP. No other treatment except
for emollients was allowed. At week 0, patients received a loading dose of 80 mg Adalimumab,
then 40 mg every other week starting at week 1 until week 11 by subcutaneous injection.
Week 12 was the end of observation. Skin biopsies for staining with H&E, anti-neutrophilic
elastase, CD3, CD4, CD8, MIB-1 (Ki67), keratin 16, involucrin, filaggrin were taken at weeks
0 and 12. In addition clinical photographs were taken at weeks 0 and 12. We found that Adal-
imumab treatment cleared PPP in 6 out of 7 patients; by pathohistology the massive neu-
trophilic invasion of intraepidermal cavities with the characteristic spongiform pustules in the
walls vanished after treatment in these patients. Staining for anti-neutrophilic elastase disap-
peared after successful treatment. By contrast, the T-cell markers CD3, CD4 and CD8, as well
as the proliferation marker K16 and the differentiation markers involucrin and filaggrin remained
practically unchanged after healing. Our results demonstrate that successful treatment of local-
ized pustular psoriasis of palms and soles (PPP) with Adalimumab causes neutrophils to dis-
appear while leaving T cell and epidermal proliferation and differentiation markers practi-
cally unchanged. This suggests that anti-TNF-alpha treatment inhibits pathogenic neutrophils
in localized pustular psoriasis of palms and soles.
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Anti-proliferative and pro-apoptotic effects of EGCG and EGCG/IFNα in human melanoma
and CTCL lines
M Nihal,1,2 C Creswell1 and GS Wood1,2 1 Dermatology, University of Wisconsin, Madison,
WI and 2 Dermatology, Wm. S. Middleton VAMC, Madison, WI
We evaluated the anti-proliferative potential of (-)-epigallocatechin-3-gallate (EGCG), the major
polyphenolic antioxidant found in green tea, against human melanoma and CTCL derived cell
lines representing different subtypes of disease. EGCG (5 µM; for 48 hours) resulted in a sig-
nificant inhibition of tumor cell proliferation, depolarized mitochondrial membrane potential,
modulated cell cycle arrest and induced apoptosis. Tumor cells expressing abnormal or reduced
Fas are resistant to apoptosis and thus accumulate in lesional tissues. New therapeutic
approaches for reversing resistance of apoptosis in these malignancies may play a novel role
in their treatment. In this context, we evaluated the potential of EGCG and IFNα to up-regu-
late cell surface expression of FAS by melanoma and CTCL lines. Our preliminary findings
indicated that these agents, alone and in combination, generally resulted in increased Fas tran-
script by quantitative real time (QRT) PCR. The change in transcript correlated with a parallel
increase of the FAS cell surface protein level as assessed by flow cytometry. Based on this study,
we suggest that EGCG could be developed as a chemopreventive agent or as an adjuvant
therapy for the management of cutaneous malignancies. However, further detailed mecha-
nistic and in vivo studies will be needed to confirm this approach.
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Characterizing the penetration of the novel silicon phthalocyanine photosensitizer Pc 4 for
photodynamic therapy
M Guo,1 AH Hsia,2 D Santo Domingo,2 JL Matevish,2 ME Kenney,1 NL Oleinick,3
KD Cooper2 and ED Baron2 1 Chemistry, University Hospitals Case Medical Center, Case
Western Reserve University, Cleveland, OH, 2 Dermatology, University Hospitals Case
Medical Center Case Western Reserve University, Cleveland, OH, OH and 3 Radiation
Oncology, University Hospitals Case Medical Center, Case Western Reserve University,
Cleveland, OH
Silicon phthalocyanine Pc 4 is a second generation photosensitizer that is in Phase I clinical
trial for photodynamic therapy of cutaneous malignancies. Adequate cutaneous penetration
is necessary to ensure sufficient concentration of the photosensitizer in the target areas. The
objective of this study was to characterize the penetration properties of topically applied Pc
4 formulated in 70% ethanol:30% propylene glycol, using a topical and transdermal diffu-
sion cell system (TTDC) based on standard vertical Franz diffusion cells. Three different mem-
branes were utilized: 1) synthetic silicone 2) pig skin and 3) human epidermis from suction
blister roofs. Pc 4 was applied on the surface (stratum corneum side) of the samples, which
were then mounted in their respective chambers. The amount of Pc 4 that permeated the mem-
branes and went into the receptor medium was then measured by UV-vis at regular intervals.
Each experiment was conducted in triplicates and analyzed. Data from synthetic membranes
and full thickness pig skin were comparable and showed that it took 4 hours for Pc 4 to be
detected in the receptor medium. However, using epidermal suction blister roofs from nor-
mal human skin, Pc 4 was detectable within an hour of application. Variations in thickness
and properties of these membranes account for the observed differences. Interestingly, in human
skin, the data suggest that significant levels of Pc 4 can traverse the epidermis and be present
in the dermis within an hour. Although the formulation can be further optimized, this study
suggests that it is indeed feasible to utilize topical Pc 4 for cutaneous PDT, and supports the
encouraging results from clinical trials being conducted currently.
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Unresponsive Zoon’s vulvitis and balanitis treated with topical pimecrolimus: our experi-
ence
R Bilenchi, L Andreassi, C Pisani, S Poggiali, L De Padova, A Andreassi and M Fimiani
Dermatology, University of Siena, Siena, Italy
Unresponsive Zoon’s vulvitis/balanitis treated with topical pimecrolimus: our experience Zoon’s
vulvitis and balanitis are notorious for their recalcitrant nature to conservative topical and
some surgical therapy, and frequently balanitis requires circumcision as a curative meas-
ure.Topical calcineurin inhibitors (tacrolimus and pimecrolimus) approved for atopic der-
matitis, have a potential in other inflammatory skin diseases. We investigated the efficacy and
safety of pimecrolimus 1% cream in Zoon’s vulvitis and balanitis unresponsive to conserva-
tive topical therapy with a follow-up period of 18 months. Eleven patients (four woman and
seven uncircumcised men ) aged between 45 and 78 years with histologically proven Zoon’s
vulvitis or balanitis, were treated for 16 weeks twice daily with pimecrolimus 1% cream in
an observational study. Clinical examination and recording of patients symptoms was per-
formed before, after four and eight weeks, and after three and four months of therapy, respec-
tively. All cases had photographs taken before and after treatment. All patients experienced
improvement in symptoms with remarkable relief of pruritus and burning after the first weeks
of treatment. At the end of therapy, clinical resolution was observed in ten patients (four woman
and six men). Partial resolution was reached in one man. All patients showed no relapse dur-
ing the follow-up period. On the basis of our case observations, pimecrolimus seems to be
effective in Zoon’s vulvitis and balanitis unresponsive to conservative topical therapy. We
emphasize its possible use as an alternative therapy expecially in men who declines circum-
cision.
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Topical application of plant-derived extracts to skin equivalents to increase breakdown of
triglycerides
TC Florence, H Pham, MD Hines, D Gan and BC Jones Skin Care Research, Mary Kay, Inc.,
Dallas, TX
Natural materials that reduce fat accumulation are routinely added to skin care products,
with the goal of decreasing the appearance of cellulite. We have previously reported on the
ability of natural extracts that increased lipolysis (272-620%) or reduced lipid accumulation
(34-60%) in primary human adipocytes. In the current studies, these plant derived extracts
were formulated into a skin care product base and topically applied to a 3D skin model, com-
prised of normal human keratinocytes and a collagen matrix containing normal human der-
mal fibroblasts and normal human adipocytes seeded below the skin equivalent. We found a
significant increase in the breakdown of triglycerides following topical application of formu-
lations containing plant-derived extracts compared to a formula without extracts. Cytotoxic-
ity tests revealed no loss of viability in the skin equivalents following either treatment. Fur-
thermore, we evaluated the clinical efficacy of these formulas in improving the appearance
of cellulite and cellulite-associated parameters in a study of 44 women presenting mild to
moderate cellulite on thighs. Following 12 weeks of product use, 74-100% of panelists showed
improvement in skin texture, firmness, elasticity, and the appearance of cellulite. In addition,
71% of panelists showed up to 1⁄ 2 inch reduction in thigh circumference. There was no sig-
nificant change in body mass index. Together, these data demonstrate that plant extracts shown
to reduce fat accumulation in vitro can be formulated into products that effectively improve
the appearance of cellulite in vivo.
S50 Journal of Investigative Dermatology (2007), Volume 127
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A topical lipophilic niacin derivative increases NAD, epidermal differentiation and barrier
function in photodamaged skin
EL Jacobson,1,2,3 H Kim,1,3 M Kim,1,3 JD Williams,1 DL Coyle,1,3 W Coyle,1,3 G Grove,5
RL Rizer,4 M Stratton2 and MK Jacobson1,2,3 1 Pharmacology & Toxicology, University of
Arizona, Tucson, AZ, 2 Arizona Cancer Center, Tucson, AZ, 3 Niadyne Development Inc,
Tucson, AZ, 4 TJ Stephens & Assoc Inc, Colorado Springs, CO and 5 Skin Study Center,
Broomall, PA
The effects of myristyl nicotinate (MN), a nicotinic acid derivative designed to deliver nico-
tinic acid to skin without vasodilation, on subjects with photodamaged skin have been stud-
ied. MN increased skin cell NAD by 25% (p = 0.001) demonstrating effective delivery of nico-
tinic acid to skin. Relative to placebo, MN treatment of photodamaged facial skin increased
stratum corneum thickness by approximately 70% (p = 0.0001) and increased epidermal thick-
ness by approximately 20% (p = 0.001). In two separate studies, MN treatment increased rates
of epidermal renewal by 6% (p = 0.003) to 11% (p = 0.001) and increased the minimal ery-
themal dose by 8.9% (p = 0.07) and 10% (p = 0.05) relative to placebo. MN treatment resulted
in reductions in the rates of transepidermal water loss (TEWL) of approximately 20% relative
to placebo on cheeks (p = 0.012) and arms (p = 0.017) of study subjects. Results of a tape
stripping challenge before and after MN treatment demonstrated a significant correlation (p
= 0.03) between increased skin NAD content and resistance to changes in TEWL for MN
treated but not placebo subjects. Rates of TEWL changed more rapidly and to a greater extent
in atopic subjects compared to normal subjects. The results show that MN enhances epider-
mal differentiation and skin barrier function in skin, suggesting that this method of nicotinic
acid delivery may prove useful in limiting progression of actinic skin damage and possibly in
treating other conditions involving skin barrier impairment.
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Computer-assisted alignment and tracking of acne lesions indicate that most inflammatory
lesions arise from comedones and also de novo
S Zarkhin, T Do, D Sachs, J Orringer, J Voorhees and S Kang Dermatology, University of
Michigan, Ann Arbor, MI
It is generally accepted that inflammatory lesions of acne (papules, pustules and nodules) are
derived from comedones. Utilizing studio quality digital photographs and a software pro-
gram (Picture Window Pro 4.0), which aligns images based on chosen landmarks, we exam-
ined the natural progression of facial acne lesions. Twenty-five subjects (mean age=21; 78%
male) with moderate acne were enrolled in a split face acne treatment study where one side
was treated with non-ablative pulsed dye laser (λ=585nm) and the other was untreated. Both
sides were photographed in a standardized manner every 2 weeks for 12 weeks. For the
untreated side of each patient, a region of interest (ROI area = 4002pixels or 3.7cm2) from
either the temple or cheek was selected. After the photographs (7 images per subject) were
aligned, each patient’s ROIs were superimposed across time. Six pre-defined lesion types
(open/closed comedones, erythematous macules, inflammatory papules, pustules, and nod-
ules) were identified and counted by two trained evaluators. Of 3,099 total lesions, closed
comedones had the highest frequency (42%), followed by erythematous macules (25%), inflam-
matory papules (15%), open comedones (14%), pustules (3%) and nodules (1%). The relative
proportions of the lesion types were steady over the 12 week observation period. Inflamma-
tory lesions (papules, pustules, nodules) arising after baseline were marked upon first appear-
ance and tracked over the 12 week observation period. Of the 219 counted, 54% were pre-
ceded by comedones, 28% by normal-appearing skin, 12% by erythematous macules and
6% by scars. Our results indicate that the majority of inflammatory lesions arise from come-
dones as expected, but interestingly also arise de novo (more than a quarter). The de novo
sites may represent micro-comedos that are not clinically detectable. Nonetheless, our find-
ings suggest that comedones may not be a prerequisite for the generation of inflammatory
acne.
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Topical application of neuroimmunophilin ligands alters epidermal nerve fiber density and
sensory nerve function in C57bl/6J mice
ME Ericson,1 N Gallus1 and JP Steiner2 1 Dermatology, University of Minnesota, Minneapolis,
MN and 2 Neurology, Johns Hopkins, Baltimore, MD
The epidermis is innervated by small unmyelinated nerve endings (C-fibers) and thin, myelinated
nerve endings (A-delta fibers). A reduction in epidermal nerve fiber (ENF) density and a change
in ENF morphology are often observed in skin biopsy specimens of patients afflicted with sen-
sory peripheral neuropathy from diabetes or HIV. Treating the underlying disease may relieve the
peripheral neuropathy but in some cases it can only be managed. We investigated the potential
of using topically-applied neurotrophic/neuroprotective compounds as a potential treatment for
sensory peripheral neuropathy. The small molecule neuroimmunophilin ligand analog GPI-1046
has been shown to enhance neurite outgrowth in vitro and stimulate sprouting following partial
deafferentation in numerous in vivo models of neurodegenerative diseases (Steiner et al., PNAS
(1997) 94:2018-24). We hypothesized that the synthetic neurotrophic, non-immunosuppresive
neuroimmunophilin ligand analogs GPI-1046 and GPI-1511, and the immunosuppresive parent
compound FK506 would increase epidermal nerve fiber density when applied to the dorsal skin
of the C57Bl/6J mouse for 42 days. Alterations in sensory nerve function were determined by
measuring the current perception threshold of A-beta-, A-delta- and C-fibers at the drug applica-
tion site using the Neurometer CPT (Neurotron, Inc. Baltimore, MD). ENFs were quantified by
morphometric analysis of skin biopsy specimens imaged by confocal microscopy and multi-
immunostained with antibodies to: PGP9.5 - pan-neuronal marker, GAP43 - marker for new nerve
growth/neural plasticity, CGRP – neuropeptide, Collagen IV - basement membrane marker and
LYVE1, a marker for lymphatic vessels. We found: 1) significant increases in PGP-immunoreac-
tive ENF density in FK506 vs. vehicle-treated mice, 2) significantly less ENF density in the non-
immunosuppressive (GPI compounds) vs. immunosuppressive ligand (FK506)-treated groups, and
3) significantly greater ENF density in 6- vs. 1-micromol GPI-1046 treated mice.
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Myristyl nicotinate mitigates skin barrier impairment and improves tolerability of retinoic
acid therapy
MK Jacobson,1,2 H Kim,1,2 W Coyle,1,2 M Kim,1,2 DL Coyle,1,2 RL Rizer3 and EL Jacobson1,2 1
College of Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, AZ, 2
Niadyne Development Inc, Tucson, AZ and 3 TJ Stephens & Assoc Inc, Colorado Springs, CO
Retinoic acid (RA) therapy results in numerous beneficial changes in chronically photodam-
aged skin but is accompanied by impaired skin barrier function leading to irritation and dis-
continuation of therapy. The hypothesis that skin barrier impairment contributes to RA irrita-
tion was tested by examining its combined use with myristyl nicotinate (MN), a lipophilic
derivative of niacin that enhances skin barrier function, in subjects with mild to moderate facial
photodamage. A double blinded, placebo controlled study compared the effects of MN used
concurrently with RA in female subjects randomized into 3 groups. For 30 days prior to initi-
ation of RA, two groups applied a placebo (P) and the third group applied a 5% MN cream.
Upon initiation of 12 weeks of 0.025% RA therapy, group 1 continued with P (P/P), a group
2 initiated use of MN (P/MN), and group 3 (MN/MN) continued use of MN. Stratum corneum
(SC) thickness and transepidermal water loss (TEWL) were determined as surrogate measures
of barrier function, tolerability was evaluated by clinical grading, and efficacy was assessed
by clinical grading, patient self-assessment, and analysis of biopsies for epidermal thickness.
RA therapy in the P/P group resulted in SC compaction of 25% (p=0.006 vs. baseline). This
compaction was not observed in either group using MN (p<0.005). TEWL in the P/P group
increased by 45% (p=0.001 vs. baseline). Use of MN reduced the increase in TEWL and the
MN/MN treatment was the most effective (p=0.056 vs. P/P). MN reduced the incidence of
tightness/dryness, stinging, and burning. All subjects showed clinical improvement thus, the
use of MN did not interfere with any efficacy parameters. These results support the hypothe-
sis that skin barrier impairment contributes to skin irritation associated with RA therapy and
use of MN can mitigate skin barrier impairment and improve tolerability of RA therapy for
facial photodamage
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Topical 17-β-estradiol stimulates collagen synthesis in sun-protected aged skin, but not in
photoaged human skin in vivo
L Rittie, S Kang, JJ Voorhees and GJ Fisher Dermatology, University of Michigan, Ann Arbor,
MI
Reduced estrogen production after menopause is associated with progressive loss of skin colla-
gen. The aim of this study was to determine whether topical 17-β-estradiol (E) stimulates type I
procollagen (COL) synthesis in sun-protected, naturally aged (buttock) and photoaged (forearm
and face) skin of post-menopausal women. ELISA, immunohistochemistry, and real-time RT-
PCR were used to measure COL in skin, after seven days treatment with E or vehicle. E treatment
increased procollagen levels in naturally-aged skin, in a dose-dependant manner: COL1A1 mRNA
was significantly induced 2.6±0.4, 3.6±0.6, and 6.5±3.2-fold (p<0.05, n=6), and COL protein
was elevated 1.5±0.3, 2.3±0.5, and 2.8±1.0-fold (p<0.05, n=6), after 0.1, 1, and 2.5% E, respec-
tively, versus vehicle-treated skin. There was a modest correlation between magnitude of COL
protein induction after 1% E treatment and age (R2=0.058, n=18). Immunohistochemistry revealed
that COL synthesis was increased in fibroblasts throughout the dermis. Surprisingly, no signifi-
cant changes of COL mRNA or protein were observed following E treatment of photoaged fore-
arm (n=6) or face skin (n=5), despite similar expression of estrogen receptor (ER-α, -β, and GPR30)
transcripts in aged and photoaged skin.. Induction of the estrogen-responsive gene GREB1 by E
was similar in buttocks, forearm and face, indicating that penetration of topical E, and genomic
response to E receptor activation were similar in each of the three anatomical sites. Taken together,
these data indicate that E significantly stimulates COL production in sun-protected buttocks skin,
but does not alter COL synthesis in photoaged forearm or face skin, in post-menopausal women.
Our findings support the concept that E decline, which occurs following menopause, is respon-
sible, at least in part, for reduced collagen production in sun-protected skin. Importantly, alter-
ations induced by chronic sun exposure override the ability of topical E to stimulate collagen
production; a key consideration for using E to treat aging/photoaging skin.
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Several plant derived extracts may be used in a complimentary manner to provide skin ben-
efits
D Gan, MD Hines, TC Florence and BC Jones Mary Kay Inc, Dallas, TX
Extracts from natural botanicals have been found to have distinct biological effects. In a pre-
vious study, we observed 14 plant derived extracts which displayed anti-oxidant and anti-
inflammatory properties. Several of these plant derived extracts were found to possess prop-
erties which make them potential ingredients for use in skin care products to address some of
the signs of aging caused by photo damage. Upon further investigation, we determined two
particular plant derived extracts were found to have complementing properties. Both materi-
als reduced intracellular peroxide levels in epidermal keratinocytes upon addition of exoge-
nous hydrogen peroxide, while one was found to also reduce baseline intracellular peroxide
levels in epidermal keratinocytes. In addition, both botanical extracts were found to have com-
plimenting abilities to inhibit an array of inflammatory cytokines. These extracts were then
tested in vivo to examine their ability to reduce skin inflammation. These data support that,
while individual plant derived extracts may provide certain benefits to the skin, specific extracts
used in combination may synergistically provide broadened and enhanced skin benefits,
such as reduced skin inflammation.
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Development and validation of an allele-specific quantitative RT-PCR assay for pachyony-
chia congenita
L Pho,1 R Hickerson,2 R Kaspar,2 K Boucher,3 WH McLean,4 F Smith4 and SA Leachman1 1
Dermatology, University of Utah, Salt Lake City, UT, 2 TransDerm, Inc., Santa Cruz, CA, 3
Cancer Center Biostatistics, Huntsman Cancer Institute, Salt Lake City, UT and 4 Human
Genetics Unit, University of Dundee, Dundee, United Kingdom
Pachyonychia congenita (PC) is a rare autosomal dominant disorder caused by mutations in
K6a, K6b, K16, or K17. We are developing a mutation-specific siRNA that targets the K6a
N171K (MX) allele over the K6a wild type (WT) allele in tissue culture and animal models. In
order to establish endpoints for this siRNA in future clinical trials, we have developed and
validated a quantitative RT-PCR assay that discriminates between the WT and MX alleles. WT-
and MX-specific primer/probe oligonucleotides were developed to assess absolute copy num-
bers of each allele in a real-time PCR assay. The assay was validated with plasmid constructs
containing either the WT or MX sequence, and with total RNA from a participant carrying a
K6a N171K mutation. After 40 cycles, “no template” controls demonstrated no amplification.
Eight independent extractions of 100 mg of stratum corneum from the affected plantar surface
resulted in a range of 0.61-2.7 µg total RNA recovery. In two independent experiments, the
average allelic copy number in 20 ng of total RNA was determined to be 48.3 ± 16.6 (WT)
and 140.2 ± 25.7 (MX); and 6.3 ± 1.6 (WT) and 28.0 ± 3.8 (MX) copies, respectively. The
coefficient of variation in these experiments was 16%-30% with 20 ng of total RNA, demon-
strating functional sensitivity at that concentration of template. Specificity was assessed through
mixing experiments of WT and MX plasmid DNA. The WT probe demonstrates an average bias
of 17% and the bias does not appear to change with the proportion of MX-containing plas-
mid. The average MX probe bias was 3.5% and increased to a high of 16% with increasing
WT probe. These values demonstrate significant specificity of each probe for the correspon-
ding template. This assay will permit a mutation-specific, sensitive evaluation of the molecu-
lar effects of our siRNA candidate in upcoming clinical trials.
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A fat specific bioluminescent mouse to study intralesional treatments for sub-cutaneous fat
accumulations
M Yu, K Pang and MS Kolodney Division of Dermatology, Harbor-UCLA Medical Center,
Torrance, CA
Medical disorders of sub-cutaneous fat distribution are stigmatizing and can result in social
isolation. Moreover, sub-cutaneous fat deposits are considered unattractive by many individ-
uals who seek out fat removing surgical procedures such as liposuction. Recently, many prac-
titioners have begun offering injections of a non-FDA approved formula containing phos-
phatidylcholine, as it supposed active ingredient, for the purpose of reducing localized fat
accumulations. To study the mechanism of injectable treatments for localized fat, we have
developed a bioluminescent reporter mouse. This transgenic mouse strain emits light from liv-
ing adipocytes due to expression of the firefly luciferase enzyme driven by an adipocyte spe-
cific promoter. Using this strain, we can image viable sub-cutaneous fat in living animals using
a deeply cooled CCD camera. Images of sub-cutaneous fat can be used to determine the mech-
anism of drugs designed to treat disorders of sub-cutaneous fat. Using these mice, we have
shown that injection of deoxycholate, the active component of the phosphatidylcholine for-
mula, rapidly kills adipocytes adjacent to the injection site. We are currently using this approach
to determine the temporal and spatial parameters of adipocyte killing after deoxycholate injec-
tions.
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A brief psychological stressor in the laboratory delays skin barrier recovery in humans
T Robles Psychology, University of California, Los Angeles, Los Angeles, CA
This study tested whether a brief psychological stressor could delay skin barrier recovery, and
whether social support prior to the stressor could speed recovery The specific aims of this
study were to: 1) Replicate previous research on acute stress-induced delays in skin barrier
recovery; and 2) Determine whether a social support manipulation before acute psycholog-
ical stress would speed skin barrier recovery. Prior to randomization, 85 healthy participants
underwent tape-stripping, a procedure that disrupts normal skin barrier function. Participants
were then randomly assigned to a No Stress condition (reading alone), a Stress condition
(public speaking and mental arithmetic), or a Stress + Social Support condition, involving
support and encouragement from a laboratory confederate prior to the Stress task. Skin bar-
rier recovery was assessed by measuring transepidermal water loss from disrupted skin up to
2 h after tape-stripping. The results supported the hypothesis that stress would delay skin bar-
rier recovery. The No Stress group showed 40 - 45% recovery 2 h after tape-stripping, while
the Stress and Stress + Support groups showed 30-35% recovery by the same period (p < .05).
However, support provided by a confederate before the acute stressor did not speed skin
barrier recovery. This study replicated the effects of short-term laboratory stressors on skin
barrier recovery, further establishing the relevance of skin barrier recovery for future research
on stress and restorative processes like wound healing. The limited effectiveness of the social
support manipulations in influencing wound healing relative to real-world and longer-term
supports (stable social conditions in rodents, marital support in humans) and stressors (social
disruption in rodents, academic exams and marital discord in humans) suggests that future
work would benefit from a focus on real-world stressors and conditions. Portions of this data
were presented at the 2005 American Psychosomatic Society conference in Vancouver, BC,
Canada in March 2005.
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Time to development of psoriatic arthritis decreases with smoking prior to psoriasis onset
and increases with smoking after psoriasis onset
T Rakkhit, B Wong, TS Nelson, CB Hansen, JS Papenfuss, J Panko, D Goldgar, KP Callis and
GG Krueger Dermatology, University of Utah, Salt Lake City, UT
The Utah Psoriasis Initiative (UPI) is a phenotypic database currently with more than 800 cases.
The database has developed as a tool to identify unique psoriasis phenotypes and to facilitate
discovery of genotype-phenotype relationships. The standardized enrollment process gener-
ates a broad range of phenotypic variables, including age of onset, distribution, co-morbid
states, response to therapy, etc. While genetic variation affects phenotypic expression of pso-
riasis (Ps), the effects of environmental influence are unknown. The UPI identifies two major
cohorts: smokers and nonsmokers; we used this to focus on phenotypic features that might be
influenced by smoking. In our population, the mean age of onset of Ps in smokers compared
to nonsmokers is 29.4 versus 26.1 years. Common events occur in the natural course of Ps,
most notably the onset of psoriatic arthritis (PsA) about 10 yrs after Ps onset and an often related
component, nail disease. Age of onset of PsA is often examined with respect to the onset of
cutaneous disease. With the exception of the less common case where PsA occurs before skin
manifestations in ≈ 15% of cases, the mean time to onset of PsA after developing Ps in the UPI
is 12.4 years. The time (mean years ± SD) remains unchanged when comparing smokers (12.2
± 11.7) to nonsmokers (12.5 ± 12.6). Assessment of a smoking timeline with respect to skin
disease onset reveals a significant difference in time to develop PsA. Those who smoke prior
to Ps onset have a mean time to PsA onset of 8.2 ± 9.3 years. Those who smoke after Ps onset,
but before PsA onset, have a dramatically longer time to onset of PsA, 23.2 ± 15.3 years
(p=0.005). This observation shows that onset of PsA can be modified. The health hazards of
smoking are well known; our data support the concept that agents without such detrimental
effects could be used to delay and possibly prevent the onset of this significant co-morbid state.
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Altered peripheral nerve function in alopecia areata
E Cornatzer,2 M Ericson,1 G Wicox,1 C Boeck1 and M Hordinsky1 1 Dermatology, University
of Minnesota, Minneapolis, MN and 2 School of Medicine, University of North Dakota,
Grand Forks, ND
Alopecia areata is an immune-mediated skin disease. For over a century, it has been sug-
gested that alopecia areata is also influenced by the nervous system. Recent studies have shown
that some patients prominently express Substance P (SP) in affected scalp skin. Low serum lev-
els of Calcitonin Gene Related Peptide (CGRP) have also been reported, as has an exagger-
ated vasodilatory response to local injection of CGRP. Moreover in long-standing (>2 years
duration) extensive alopecia areata perifollicular innervation appears condensed and arranged
differently as compared to normal anagen follicle innervation. These observations have led us
to explore whether patients with alopecia areata demonstrate normal peripheral nerve func-
tion. Scalp nerve function was tested on 39 control subjects and 20 patients (9M, 11F), ages
24-65, who had either patchy or extensive scalp alopecia areata for an average of 15 years.
Sensory nerve conduction threshold (sNCT) for three sensory fiber subtypes: A-beta (2000 Hz),
A-delta (250 Hz) and C fibers (5 Hz) was determined using transcutaneous electrical stimu-
lation with the Neurometer CPT (Neurotron, Inc. Baltimore, MD). Dermatomes C2, C6 and
Trigeminal V1 were studied. In patients with patchy disease, sNCT measurements were taken
from both affected and unaffected areas of the scalp and only from one site in patients with
extensive hair loss. Sensory nerve abnormalities were detected in the C6 dermatome among
the smaller diameter fibers in the alopecia areata patients when compared to controls. Both
A-delta and C-fiber thresholds were altered (P<0.05), corresponding to a hyperaesthetic state
compared with healthy controls. These results support the hypothesis that peripheral nerve
function is altered in alopecia areata, particularly in patients with long standing disease.
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Antinuclear antibodies in patients with vitiligo
PE Grimes, N Ekeke and M Cole Vitiligo & Pigmentation Institute of Southern California, Los
Angeles, CA
There is minimal published data on the presence of antinuclear antibodies in patients with
vitiligo. The present investigation assessed the frequency and significance of antinuclear anti-
bodies in patients with vitiligo vulgaris. Detailed histories and physical examinations were
performed in 100 patients with vitiligo. Laboratory assessments included complete blood
counts, comprehensive metabolic panels and a lupus panel. The panel included the follow-
ing antibodies: Anti-centromere, Anti-Scl 70, Anti-Sm, Anti-RNP, Anti-Ro, Anti-La, Anti- DS
DNA, Anti-chromatin, Complement C3, Complement C4, Anti-Cardiolipin, and thyroid per-
oxidase antibodies. Thirty percent had positive antinuclear antibodies. Five percent of patients
had titers of 1:1280 or higher. Anti DS-DNA antibodies were observed in 6 % of patients. The
majority had speckled patterns. Eight percent had cardiolipin antibodies and four percent had
chromatin antibodies. Sixteen percent had elevated complement levels. Thirty five percent had
thyroid peroxidase antibodies. Fifteen percent had overt thyroid disease. Three patients were
subsequently diagnosed with systemic lupus erythematosus. Sixty percent had strong family
histories of autoimmune disease. Our conclusion is that the presence of antinuclear antibod-
ies are key markers for autoimmune vitiligo.
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Optimal removal of tattooed skin pigment at a single phototherapeutic session: a compara-
tive clinicohistologic analysis and pathophysiologic evaluation
T Kossida1,2 and D Rigopoulos1 1 Dermatology, Athens Medical School, Athens, Greece and
2 Histology-Embryology, Athens Medical School, Athens, Greece
Presently, repeated and costly nanosecond-domain laser sessions are required to eliminate
tattoo ink paticles. Despite the inherent heterogeneity of pigment granules, the mechanism
of removal consistently correlates with transient skin whitening occurring immediately after
treatment. Black amateur and professional human tattoos (SPT III-IV) were partly irradiated
with a sequence of multiple pulses at a wavelength of 755 nm within a single therapeutic ses-
sion. A single impact technique was used as the standard control in a treatment management
study. Immediate whitening response faded between pulses, followed by more prominent pur-
pura. Histologically, pigment exposed to a train of pulses was hardly detected in over half
patients. Extensive collagen denaturation localized to regions of tattoo ink, perivascular and
occasionally, adnexal neutrophilic infiltrate, rupture of individual phagocytic cells and redis-
tribution of pigment particles at a depth of 1,000 microns was noticed in the rest. At high
energy fluences and frequencies, less selective dermal injury occurred at greater depths. Resid-
ual pigment significantly diminished with pulse additivity and modification of optical scat-
tering coefficient. Pigment structural alteration associated with dermal highly refractive defor-
mation obviously modulated rephagocytosis, thus laser irradiation impact can vary in a size
dependant manner. Additionally, the study endpoint of clinicohistological correlation was met
regardless of different pigment composition and density. Consecutive pulse delivery produced
cumulative damage in the majority of tattoos with minimal risk of scarring. Conventional
modality though required higher radiant doses and longer treatment intervals to achieve
complete clearance, even with lighter skin complexes. These findings confirm that existing
high-intensity pulses may offer the optimal clinical outcome at the above administered param-
eters.
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Pimecrolimus and tacrolimus attenuate neuronal desensitization in murine sensory neurons in
vitro
M Steinhoff,1 S Ständer,1 A Steinhoff,1 M Fischer,3 H Ständer,1 S Seeliger,2 P Reeh3 and T Luger1
1 Dermatology, University Hospital Münster, Münster, Germany, 2 Pediatrics, University Hospital
Münster, Münster, Germany and 3 Physiology, University Hospital Erlangen, Münster, Germany
We investigated whether topical calcineurin inhibitors (CI), pimecrolimus and tacrolimus, may be capa-
ble of stimulating neuropeptide release, and induce sensitization or desensitization in murine primary
afferent neurons. Three studies were performed: (A) Murine dorsal root ganglia neurons (DRG) were iso-
lated and cultured. DRGs were treated with pimecrolimus (0.1%) or tacrolimus (0.001%) at various pH
and/or capsaicin stimulation for activation of transient receptor potential vanilloid type-I (TRPV1); (B) The
skin of healthy Balb/c mice was treated with 1% pimecrolimus cream; untreated or vehicle-treated mice
served as controls. Skin specimens were investigated for inflammatory infiltrate and nerve density; and
(C) pimecrolimus cream (1%), cream vehicle, and the topical irritant benzalkonium chloride (inducing
irritant contact dermatitis), were applied to murine ears, followed by pimecrolimus treatment after 6 hours.
Ear tissue was harvested for ELISA after 30 min. CI dose-dependently attenuated the capsaicin-induced
desensitization of sensory neurons in a pH-dependent manner, suggesting an interaction of CI with the
TRPV1. Pimecrolimus induced the release of substance P and calcitonin gene-related peptide from pri-
mary afferent nerve fibers of murine skin indicating a role of CI during neurogenic inflammation. West-
ern blot analysis of mouse cultured DRGs showed activation of the PKC-pathway after treatment with
pimecrolimus (0.01%) which is induced by various receptors regulating nociception. Moreover, pime-
crolimus cream (1%) induced an enhanced release of SP and CGRP in the early phase after pime-
crolimus treatment of mouse ears. Finally, protein concentrations for SP were slightly enhanced in the
experimentally-induced contact dermatitis model, indicating a greater release of SP in inflammatory skin
as compared to controls in vivo. We speculate that CI directly control neuronal function by interacting
with TRPV1, activating the PKC pathway and stimulating the release of neuropeptides from sensory nerves.
This may explain some of the beneficial (anti-inflammatory, antipruritic) as well as certain side effects (burn-
ing and pruritus at early stages of therapy) of topical CI during the treatment of various skin diseases.
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Tolerability and efficacy of O6Benzylguanine and topical BCNU in a Phase I trial for cuta-
neous T-cell lymphoma
D Doshi,1 N Apisarnthanarax,1 L Liu,2 P Fu,2 AC Gilliam,1 GS Wood,1 SL Gerson,2
SR Stevens1 and KD Cooper1 1 Dermatology, University Hospitals Case Medical Center and
Case Western Reserve Univ., Cleveland, OH and 2 Oncology, Ireland Cancer Center,
Cleveland, OH
O6Benzylguanine (O6BG) inactivates the DNA repair protein O6-alkylguanine DNA alkyltransferase
(AGT), which is active in malignancies as a mechanism for resistance against nitrosoureas. Inacti-
vation of AGT prevents DNA damage repair and allows cancer cells to become vulnerable to
nitrosoureas. Interim data on O6BG and BCNU therapy for cutaneous T-cell lymphoma have been
previously reported by our institution, and the final data from the completed trial are now pre-
sented. Between 1998-2006, a Phase I trial was conducted to evaluate 21 mycosis fungoides (MF)
patients (Stage IA-IIA) treated biweekly with intravenous O6BG (120 mg/m,2) followed by low-dose
topical BCNU. BCNU was started at 10 mg per cycle, and was dose-escalated in 10 mg increments
in 3 patient cohorts. Despite completing the 40 mg BCNU dose level, the maximum tolerated dose
(MTD) was not reached. Given the sufficient safety and efficacy within the tested dose range, and
the expected initiation of a follow-up Phase II trial, the Phase I trial was closed. Frequent toxicities
included Grade I transient post-therapy headaches (38%), fatigue (38%), and nausea (29%). One
case of Grade III headache and 2 cases of Grade III hepatic transaminase elevation occurred at the
30 mg BCNU dose level, and 1 case of Grade III contact dermatitis occurred at the 40 mg dose; all
were transient. Baseline AGT activity from CTCL lesional biopsies was diminished by a median of
100% at 6 hrs and 24 hrs following O6BG infusion, but recovered by 1 wk (78% of baseline). Clin-
ical disease reduction correlated positively with baseline AGT activity (p = 0.044, ρ = 0.454) and
inversely with area-under-the-curve of AGT over 1 wk (p = 0.0002, ρ = -0.745). Across all dose lev-
els, 13 PRs and 3 CRs (76% OR) were observed. Given these results, a Phase I/II multi-center trial
is being initiated to evaluate an alternate dosing schedule to optimize efficacy.
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The development and evaluation of an electronic visit (e-visit) program for the management
of acne
H Bergman, A Watson, C Williams and J Kvedar Dermatology, Center for Connected Health
- Massachusetts General Hospital, Harvard Medical School, Boston, MA
Internet technology offers new ways to increase access to care for dermatology patients. User
satisfaction and efficiency of such services has not previously been reported. We conducted
a randomized controlled trial comparing asynchronous e-visits (online surveys and digital
images) with conventional office care for the management of mild-moderate acne. We report
efficiency, satisfaction and clinical outcomes for the first 35 subjects. The mean age of sub-
jects was 28.0 (SD 7.68, range 14-47) years old; most were white (68.6%) and female (71.4%).
On average, usual care subjects spent 22 min (range 15-35 min) in the office of which only
21% was with the dermatologist. In addition, most (60%) spent 30 min – 1 hr traveling to the
office. 88.2% of intervention subjects completed their e-visit, including completing a survey
and taking and uploading images, in less than 20 min. Dermatologists took comparable lengths
of time to complete e-visits and office visits (5:05 min vs. 4:24 min, p= 0.5218). Subjects in
the control and intervention groups reported similar satisfaction with their care (94% vs.
88%) and improvement in their acne (83% vs. 82%). Of the e-visit patients, 94% would con-
sider using an e-visit for their acne in the future and 65% believed that the dermatologist could
assess their acne using an e-visit system as well as they could have in person. The most ben-
eficial aspects of e-visits were reported to be that there was no travel time involved, no need
to take time off work or to wait for an appointment. Dermatologists’ satisfaction with the
improvement in their patients’ acne was similar in both control and intervention groups (76%
vs. 71%). In 85% of cases, dermatologists were satisfied with their ability to assess acne using
digital images. E-visits provide an effective alternative to office visits, producing comparable
clinical outcomes and user satisfaction. They are an efficient way for patients to receive care,
offering dermatologists a more convenient way to effectively manage non-urgent cases.
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Acute complications of patients treated with PUVA in Razi Hospital
M Barzegari and M Valikhani Razi Hospital, Tehran Univ. of Medical Science, Tehran, Iran
PUVA is one of the most useful therapeutic options for many cutaneous disorders like vitiligo,
psoriasis, atopic dermatitis, mastocytosis, mycosis fungoides and etc. Alongside its benefits,
PUVA has a number of well- known adverse effects. The Objective is to study the prevalence
of acute complications of PUVA therapy in patients treated in Razi hospital. In this open trial
we studied 200 patients who was undergone PUVA therapy. The following variables were
noted: age, gender, skin phototype, the primary cutaneous diagnosis, family history, and out-
come of the treatment with modalities other than PUVA, pattern of dose increments, total dose
of UVA and the dose of UVA that complications appeared with. All these data were analyzed
using SPSS. In the studied population the average age was 31.73 years, 60.5% were female
and majority of the patients (64.5%) were skin phototype 3 or 4. The most common primary
skin diagnosis was vitiligo (51.5%). The average initial dose of PUVA was 3.02±2.74 j/cm2
and the average total dose of PUVA was 243.521 j/cm2. The average time of PUVA therapy
was 13.65±8.8 months. In 96.5% of the patients, PUVA was used as a long-term and low-
dose therapy and in 70.5% of the patients, partial cure of the cutaneous disorder obtained.
The following adverse effects were observed: erythema (32.5%), ultraviolet burning (19.5%),
itching (16.5%), nausea and vomiting (14%), burning sensation (16.5%), seborrheic- like der-
matitis (7.5%), headache (3.5%), skin dryness (6.5%) and severe skin pain (3.5%).In conclu-
sion, the most common side effect of PUVA therapy in this study is erythema. In comparison
with other reports in the literature, we observed more adverse effects. We encountered no oph-
tolmic complication and in a few cases a slight increase in liver enzymes, were seen. Side
effects were mainly in the unexposed sites.
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Henna extract vs. aluminum chloride for palmar hyperhidrosis: A randomized controlled trial
N Markazi-Moghaddam,1,3 F Gorouhi,2 A Ansar3 and A Firooz2 1 Undersecretary of
Research, Artesh University of Medical Sciences, Tehran, Iran, 2 Center for Research &
Training in Skin Diseases & Leprosy, Tehran University of Medical Sciences, Tehran, Iran and
3 Department of Dermatology, Hamadan University of Medical Sciences, Hamadan, Iran
Palmar hyperhidrosis is a common disorder characterized by excessive sweating of the pal-
mar surface of the hands. It is a disabling condition causing not only social but also psycho-
logical and occupational problems. The purpose of this study was to determine efficacy and
safety of henna extract lotion in comparison with aluminum chloride 20% lotion in treating
palmar hyperhidrosis. In this randomized, parallel-design, active-controlled trial, Seventy
palmar hyperhidrosis cases screened from the students of four major high schools of a province
capital - 35 patients in henna extract group and 35 patients in aluminum chloride group –
were enrolled in the study. Patients were randomly assigned to receive henna extract lotion
vs. aluminum chloride 20% lotion nightly for two weeks and then followed up for another two
weeks. The primary end point was Investigator’s Global Assessment (IGA). Secondary end-
points were Likert scale patient satisfaction, Dermatology life quality index (DLQI) score,
relapse rate and occurrence of any adverse event. After four weeks, henna extract maintained
the therapy of hyperhidrosis better than aluminum chloride in terms of mean IGA score (1.4
± 0.7 vs. 1.7 ± 0.6, p=0.006), mean patient satisfaction score (3.2 ± 0.6 vs. 2.6 ± 0.8, p= 0.01)
and mean DLQI score (5.7 ± 2.2 vs. 7.5 ± 2.9, p=0.004). Relapse rates were 17 (48.6%, [95%
CI: 33.0 – 64.4]) and 32 (91.4%, [95% CI: 77.6 – 97.0]) for henna and aluminum groups,
respectively. (p<0.001) Adverse event rates were significantly more frequent in patients treated
with aluminum chloride than henna. This study showed similar effects of henna in compari-
son with aluminum chloride in treating palmar hyperhidrosis with significantly more mainte-
nance effect in follow-up session and less side effects.
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The effect of oral famciclovir in pityriasis rosea
J Lee,1 J Baek,1 J Roh1 and A Lee2 1 Dermatology, Gil Medical center, In-cheon, South Korea
and 2 Dermatology, Dongguk University hospital, Goyang, South Korea
Pityriasis rosea is a common, acute self-limiting papulosquamous disorder in which many stud-
ies suggested viral causative factors in its pathogenesis. Recently, the link between pityriasis
rosea and the reactivation of human herpes virus-6(HHV-6) and HHV-7 infection was sug-
gested. With these evidences, treatments which target HHV-6 or HHV-7 may be effective in
pityriasis rosea. We treated pityriasis rosea patients with oral famciclovir to investigate the
effect of oral famciclovir in pityriasis rosea. Ten patients with pityriasis rosea were treated
with oral famciclovir (250mg 3 times daily for 7 days). Clinical evaluation at 0,1,2 week, skin
biopsy, polymerase chain reaction analysis of HHV-6 from skin specimen was performed. On
the 7th day after oral famciclovir treatment was started, 1 patient(10%) was regressed com-
pletely and 2 patients(20%) were regressed partially. On the 14th day, 5 patients (50%) had
achieved more than partial regression. On the 7th day, systemic symptoms had improved in
all patients. Clearance of skin lesions was achieved in average 8 days in patients who had
regressed completely. Histologic examination of patients was compatible with pityriasis rosea
and polymerase chain reaction analysis of HHV-6 was negative in all 9 patients. Famciclovir
may be effective in the treatment of pityriasis rosea.
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Inhibition of IL-4 and IL-13 with an IL-4 mutein (Aeroderm) protects against flares in atopic
eczema
RW Groves,1 D Wilbraham,2 R Fuller3 and M Longphre3 1 St. John’s Institute of Dermatology,
Kings College, London, United Kingdom, 2 Guy’s Drug Research Unit, Quintiles, Ltd.,
London, United Kingdom and 3 Aerovance, Inc., Berkeley, CA
Aeroderm is an IL-4 mutein that potently inhibits binding of IL-4 and IL-13 to their respective
receptors. Because of the importance of these cytokines in the pathogenesis of atopy we sought
to evaluate the therapeutic effect of Aeroderm in adult patients with uncontrolled moderate-to-
severe atopic eczema receiving topical corticosteroids and/or calcineurin inhibitors. In this ran-
domized, double-blind, placebo-controlled, parallel group Phase 2a trial, 25 subjects with atopic
eczema (>18 years old) received 30 mg Aeroderm or placebo s.c. twice daily for 28 days. Adverse
events, including eczema flares, were recorded at daily visits. An Eczema Area Severity Index
(EASI) score was assessed weekly. Levels of total IgE and T-cell subsets (including CD3+CD4+,
CD3+CD8+ lymphocytes) were also evaluated on Days 1 and 28. EASI improved in both the Aero-
derm and placebo groups over the course of the 28 day study (-56% and -34%, respectively).
When compared with placebo there was a greater improvement with Aeroderm in total EASI
although this change did not reach statistical significance. Patients receiving Aeroderm, however,
showed a 65% improvement in eczema exacerbations relative to placebo (p<0.001), a 25%
decrease in total circulating IgE (p=0.003) and a normalization of T-cell subset ratios (CD3+CD4+
cells decreased by 12%, p=0.097; CD3+CD8+ cells increased by 38%, p=0.066), all strongly
suggestive of improved immune function. Aeroderm was well tolerated and no serious adverse
events were identified. This study provides compelling evidence for the role of IL-4 and IL-13 in
the early stages of atopic eczema. Although 28 days of treatment was insufficient to permit sig-
nificant improvements in EASI score relative to placebo, the observed improvements in immune
biomarkers during this treatment interval supports the hypothesis that Th2-driven immunology is
key to the pathogenesis and that Aeroderm may be beneficial in the treatment of atopic eczema.
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Safety and efficacy of the fully human IL-12/-23 monoclonal antibody, ABT-874, in the treat-
ment of moderate to severe plaque psoriasis: Results from a Phase II trial
AB Kimball,1 KB Gordon2 and JM Valdes3 1 Harvard Medical School, Boston, MA, 2 Evanston
Northwestern Healthcare, Evanston, IL and 3 Abbott Laboratories, Abbot Park, IL
INTRODUCTION: ABT-874 is a fully human antibody against interleukin 12 (IL-12) and IL-
23. It binds with great affinity to the p40 subunit common to both IL-12 and IL-23, validated
targets in the treatment of psoriasis (Ps). The objective of this Phase II study was to investigate
the efficacy and safety of subcutaneous injections of ABT-874 in the treatment of moderate to
severe plaque Ps. METHODS: Adults with Ps affecting ≥10% body surface area (BSA) and a
PASI score ≥12 were eligible for this 12-wk, double-blind, placebo-controlled study. Patients
were randomized to 1 of 6 arms: 1) 100-mg ABT-874 every other week (eow) for 12 wks; 2)
one 200-mg ABT-874 dose at Wk 0; 3) 200-mg ABT-874 every wk for 4 wks; 4) 200-mg ABT-
874 eow for 12 wks; 5) 200-mg ABT-874 every wk for 12 wks; or 6) placebo. The primary
endpoint was a ≥PASI75 response at Wk 12. Patients who met the primary endpoint entered
a 36-wk blinded/retreatment phase and were monitored for time to loss of response. All patients
were evaluated for safety through Wk 54. RESULTS: A total of 180 patients enrolled, 30 in each
arm. Baseline characteristics were similar between arms (mean values presented except %
male): age, 46 yrs, 74% male; 21 yrs duration of Ps; PASI=19; and 25% BSA affected. At Wk
12, the %s of patients with ≥PASI75 were statistically significantly greater in each of the 5 ABT-
874 arms vs. placebo (93%, 63%, 90%, 93%, 90%, vs. 3%, respectively, p<0.001, NRI). Dur-
ing the 12-wk, double-blind phase, infectious AEs for the ABT-874 groups ranged from 23–43%
and for the placebo group was 23%, with the most common being nasopharyngitis (7–17%
for ABT-874; 3% for placebo). There were no statistically significant differences between arms.
No serious infectious AEs were reported, and no deaths occurred. CONCLUSIONS: ABT-874
was significantly more efficacious than placebo in the treatment of moderate to severe plaque
Ps, and appears to have a favorable safety profile.
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A three step regiment approach to the treatment of acne
N Muizzuddin, D Maes and T Mammone Estee Lauder, Melville, NY
Acne is a multi-factual problem that consists of four essential elements. These four elements
are excessive sebum, improper keratinization, increased microbial load, and inflammation.
To successfully address acne then a multi-prong approach is required. We are reporting on a
regiment of products that uses technology to address all four of the major components of acne.
This resulted in a significant reduction of acne lesion size and inflammation as early as 24
hours after treatment. Lesion size and erythema where reduced by 80% within 6 days of treat-
ment with this regiment. This treatment also results in a 63% and 83% reduction in non-
inflamed and inflamed lesions, respectively, over 6 weeks of treatment. This suggests that a
multi-prong approach regiment to treating acne is highly effective and more effective then
single ingredient treatments.
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Glucose oxidase generated hydrogen peroxide reduces acne lesions and inflammation
T Mammone, D Maes, S Schnittger and N Muizzuddin Research & Development, Estee
Lauder, Melville, NY
A major component to the etiology of acne is the growth and invasion by P. Acnes. The con-
trol of acne lesions is then dependent on the use of strong antimicrobial ingredients such as
benzyl peroxide. Hydrogen peroxide is also an excellent antimicrobial but is unstable in most
formulations. We have developed a hydrogen peroxide generation system using the enzyme
glucose oxidase and glucose. This system is stable in a simple formulation was non-irritating.
In the Short-term, 6 days, this formulation was effective in reducing size and inflammation of
acne lesions. There was 68% reduction in acne induced erythema and 61% reduction in acne
size within 6 days of treatment. In a longer-term clinical, 6 weeks, we observed 30%, 49%
and 56% reduction in inflamed lesions and a 18%, 30% and 45% reduction in non-inflamed
lesions at 2,4, and 6 weeks. This suggests that enzymatically generated hydrogen peroxide
may help remediate acne.
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Association of staphylococcal superantigens with corticosteroid resistant atopic dermatitis:
Clinical response to Pimecrolimus cream 1%
DY Leung,1 B Abrams,2 S Wisseh2 and PM Schlievert3 1 Pediatrics, National Jewish Medical
and Research Center, Denver, CO, 2 Novartis Pharmaceuticals, East Hanover, NJ and 3 Univ.
Minnesota, Minneapolis, MN
Atopic dermatitis (AD) is associated with a wide spectrum of responsiveness to corticosteroid
(CS) therapy. Previous in vitro studies have demonstrated that superantigens (SAgs) induce CS resist-
ance of T cells and could thereby complicate treatment of AD. The purpose of this study was to
examine the potential association of SAgs with CS-resistant AD (primary) and determine whether
such patients had a clinical response to pimecrolimus (PIM) (exploratory). All patients entering
this study had a history of poor CS response, and during a 2-week screening with prednicarbate
cream showed a median percent change in Eczema Area and Severity Index (EASI) of 0.83 (i.e.
slight worsening). The efficacy of PIM was evaluated in a 6-week 2:1 randomized PIM:placebo
controlled study of 72 CS-resistant AD patients. In this CS-resistant population, there were signif-
icant positive correlations between S. aureus and outcomes measured by Investigator Global
Assessment, pruritus severity, and patient assessment (but not EASI) indicating an increase in bac-
terial counts correlated with poorer responses to treatment over 6 weeks. S. aureus isolated from
AD patients in this study expressed an average of 8 SAgs. Of these, the gene for SEJ was most
common, present in 84% of the isolates. SEB, SEC, and TSST-1 was found in 72% of AD isolates,
whereas 40% of mucosal isolates from healthy individuals produced one of these SAgs (p=0.001).
At the end of the 6-week treatment period, median improvement in EASI scores was 13% in PIM
vs 8% in the placebo group; differences in patients with moderate AD (Baseline EASI of 5 to<19)
were most notable (45% improvement in PIM vs 12% in placebo). Facial disease, which had
shown no response to CS from screening to baseline, showed a significant median improvement
to PIM in head/neck EASI at week 6 (57% in PIM vs 25% in placebo). This study suggests a role
for topical calcineurin inhibitors in the management of CS-resistant AD.
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Cefdinir once daily for 7 days vs cephalexin 4 times daily for 10 days for uncomplicated
skin and skin structure infections
GJ Murakawa,1,2 D Fortunato,2,1 NM Luszczyk2,1 and K Yeung Yue3 1 DermCenter, Troy, MI,
2 Somerset Skin Centre, Troy, MI and 3 Dermatology, Wayne State University, Detroit, MI
Uncomplicated skin and skin structure infections (USSSIs) are localized infections that pri-
marily affect superficial tissues (i.e.-folliculitis, furuncles, simple abcesses, impetigo, and cel-
lulitis). Staphylococcus aureus and Streptococcus pyogenes are the most common pathogens.
Thus, antimicrobial agents that primarily target these pathogens are highly efficacious. Both
cefdinir (300 mg po bid x 10 d) and cephalexin (250 mg po qid) are approved for the treat-
ment of USSSIs. In this randomized investigator-blind study, cefdinir at a once daily dose for
7 days was compared to the standard cephalexin dosage to determine the efficacy, tolerabil-
ity, compliance, and safety. A total of 74 patients were enrolled, and 38 patients were ran-
domized to the Cephalexin arm and 36 patients were randomized to the Cefdinir arm. Both
arms were similar in patient demographics and diagnoses treated. The most common diag-
noses included folliculitis (17%), furuncle/carbuncle (20%), impetigo (31%). After excluding
patients from protocol deviations, a total of 32 patients were evaluable on each arm. 31/32
(97%) patients on the Cephalexin arm and 30 of 32 (94%) patients on the Cefdinir arm were
cured. S. aureus was the most common organism isolated (52%) among patients; 7/26 (27%)
of patients grew MRSA; all patients had clinical cures. In the Cefdinir cohort, all patients
were compliant, whereas 6 patients were noncompliant in the Cephalexin arm. This suggests
that the single dosing and shorter treatment schedule may increase compliance. Patient sat-
isfaction was high for both groups. There were no serious related adverse events and minor
adverse events were similar in both arms. In summary, cefdinir 600 mg once daily for 7 days
is a highly effective therapeutic regimen for the treatment of USSSIs, and is comparable to
cephalexin 250 mg four times daily for 10 days.
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Phase I gene transfer study of H5.020CMV.PDGF-b in venous leg ulcer
D Margolis,1 T Crombleholme,2 S Thom,1 J Filip1 and M Herlyn3 1 University of
Pennsylvania, Philadelphia, PA, 2 Cincinnati Children Hospital, Cincinnati, OH and 3 Wistar
Institute, Philadelphia, PA
Chronic wounds yearly account for more than 9.7 billion dollars in US healthcare costs. At
any time between 500,000 and 2 million Americans have a venous leg ulcer. The use of
lower limb compression is the standard therapy used to treat venous leg ulcers, but is fre-
quently unsuccessful. The goals of this dose escalation phase I study are to determine the acute
safety of an intra-ulcer injection of H5.020CMV.PDGF-b, which is an adenoviral vector con-
taining DNA for platelet derived growth factor, and to show proof of concept. We have fully
enrolled three of four dose groups and are now enrolling our highest dose group, which is a
single intradermal injection of 1.1 X 109 particles per ulcer of H5.020CMV.PDGF-b. To date
we have enrolled ten study subjects and have not observed any dose-limiting-toxicity nor seri-
ous adverse events. Using immunohistologic staining of wound biopsies we can demonstrate
successful transfection of the fibroblasts local to the injection site and that they are produc-
ing PDGF. Additional immunohistologic staining has shown that at the wound edge there is
an increase in the number of endothelial precursor cells(EPC). Within the four weeks of close
study observation, all transfected wounds have gotten smaller and 8 of 10 have had changes
in their wound size highly predictive, based on four previously published surrogate meas-
ures, of a wound healing by 20 weeks of care. Three of 10 wounds healed in four weeks (no
wound was expected to heal in 4 weeks based on historical data). We have also observed
healing in non-target wounds of four of the study subjects. Finally, in the two study subjects
that we tested, we have confirmed an increase in circulating EPC by immunohistologic stain-
ing for CD34, CD133, VEGFR2, and CXCR4 using flow cytometry of peripheral blood sam-
ples. In conclusion, this is the first report of successful transfection of human venous leg ulcer
with an adenovirus and a growth factor. It may be having both local and distant pro-healing
effects.
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A retrospective study to investigate ethnic variations in the treatment of psoriasis with etan-
ercept
S Shah,1 A Arthur,2 Y Yang,3 S Stevens3 and A Alexis1 1 St. Luke’s-Roosevelt Hospital, NY, NY,
2 39th Airlift Squadron, Dyess AFB, TX and 3 Amgen Inc., Thousand Oaks, CA
Few studies have examined interethnic differences in the burden of psoriasis. The purpose of
this study was to use data from a phase 4 etanercept trial to compare efficacy, safety and health
related quality of life (QOL) in patients of diverse ethnic groups treated with etanercept for plaque
psoriasis, covering ≥10% body surface area (BSA). Demographics, baseline characteristics,
response to treatment, and adverse events of patients in an open-label, randomized trial were
analyzed based on the following ethnic groups: Caucasian (Cauc;n=2164), African-American
(AA;n=98), Asian (n=76), and Hispanic (Hisp;n=173). Outcome variables included %BSA, Der-
matology Life Quality Index (DLQI), Physicians Global Assessment (PGA), and adverse events.
At baseline, PGA was similar across all groups. Significant differences in %BSA existed between
the groups (p<0.0001) with the highest %BSA in the Asian group. The Cauc group had the low-
est DLQI scores compared to the other groups at baseline. When controlling for %BSA and PGA,
a significant difference in the DLQI remained between the Cauc and AA group (p=0.0012) and
Hisp group (p<0.0001). At week 12, the PGA among the groups was similar. Response to etan-
ercept based on percent improvement in %BSA and improvement in PGA was similar between
groups. The mean DLQI scores at week 12 were as follows: Cauc 3.53; AA 4.45; Hisp 3.75;
Asian 5.21. A significant difference existed between the Asian and Cauc group (p=0.0007), Asian
and Hisp group (p=0.0126), and AA and Cauc group (p=0.0363), which persisted when con-
trolling for %BSA and PGA. Adverse event rates were similar for all groups. Our results show
that significant differences in baseline %BSA and DLQI scores exist between the four ethnic
groups. After 12 weeks of treatment ethnic differences in DLQI remain, despite similar improve-
ment in psoriasis severity following etanercept treatment. Future studies investigating ethnic dif-
ferences in enrollment into clinical trials and in the QOL impact of psoriasis are warranted.
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Pimecrolimus but not betamethasone treatment improves stratum corneum barrier structure
in atopic dermatitis
J Jensen,1 S Pfeiffer,2 M Witt,1 PM Elias,3 R Fölster-Holst1 and E Proksch1 1 Dermatology,
University of Kiel, Kiel, Germany, 2 Central Microscopy, University of Kiel, Kiel, Germany and
3 Dermatology, VA Hospital, University of San Francisco, San Francisco, CA
In atopic dermatitis (AD) a defective skin barrier leads to the penetration of allergens into the
skin and results in immunological reactions. In 15 patients with mild to moderate AD we inves-
tigated whether treatment with pimecrolimus 1% (PIM) or betamethasone valerate 0.1% (BMV)
cream twice daily for three weeks improves the skin barrier. Both PIM and BMV improved AD
regarding the clinical score. Also, transepidermal water loss (TEWL), a marker of the inside-
outside barrier, decreased in both groups. However, electron microscopy (EM) studies of the
barrier structure at the stratum granulosum/corneum (SG/SC) interface showed much more
regular lamellar bodies (LBs) and regular SC lipid bilayers after treatment with PIM compared
with BMV. Quantification of the EM analysis revealed that in the skin of healthy volunteers
about 91% of LBs were filled with regular lamellar sheets, whereas in lesional skin of AD only
13% of LBs were filled. After PIM treatment 82% of LBs were filled, whereas after BMV treat-
ment the number of filled LBs did not improve (9% of LBs filled). The reason for the absence
of repair of the barrier function after BMV treatment may be related to the antiproliferative
effect and to the suppression of protein and lipid synthesis. BMV treatment resulted in a 74%
reduction in epidermal proliferation in AD which led to epidermal thinning; the reduction seen
with PIM treatment was 49% and no epidermal thinning occurred. The reduced TEWL in AD
after treatment with BMV may be due vasoconstrictive effects which reduces the influx of water
into the skin. This indicates that BMV mimics an improvement of the skin barrier in AD when
only biophysical measurements are performed. In contrast, the EM studies revealed that nor-
malization of SC barrier structure occurred only after PIM treatment. This repair of the skin
barrier hinders the entry of irritants and allergens into the skin and may prevent relapse of AD.
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A randomized controlled trial comparing pimecrolimus cream 1% and vehicle in patients
with head & neck atopic dermatitis who are intolerant of, or dependent on topical corti-
costeroids: Quality of Life outcomes
DF Murrell,1 VC Ho,2 A Glendenning3 and CF Paul4 1 Dept. of Dermatology, University of
NSW, Sydney, NSW, Australia, 2 Division of Dermatology, University of BC, Vancouver, BC,
Canada, 3 Novartis Pharma AG, Basel, Switzerland and 4 Dept. of Dermatology, Purpan
Hospital, Toulouse, France
To evaluate quality of life (QoL) in patients (≥12 years of age) with mild to moderate head and
neck atopic dermatitis (AD) intolerant of, or dependent on, topical corticosteroids in a ran-
domised controlled trial of pimecrolimus cream 1% vs vehicle. Using a multicentre, double-
blind parallel group design, 200 patients were randomized to either pimecrolimus 1% or a
vehicle cream (both bid) until skin clearance or for a maximum of 6 weeks followed by a 6-
week open-label phase. QoL was assessed at baseline and at Days 43 and 85 using three val-
idated assessment tools: Euro QoL Health Questionnaire (EQ-5D), Dermatology Life Quality
Index (DLQI) and Quality of Life in Atopic Dermatitis (QoLIAD). At Day 43, there was a sig-
nificant difference in QoL change from baseline in favor of pimecrolimus compared to vehi-
cle as assessed by the EQ-5D Weighted Health State Index (relative improvement 46% vs rel-
ative decrease 1%; p<0.001) and in the DLQI total score (relative improvement 31% vs relative
decrease 19%; p<0.001). There were borderline differences in QoLIAD (relative improve-
ment 27% vs relative decrease 20%; p=0.07) and the EQ-5D Visual Analogue Scale (relative
improvement 9.8% vs relative decrease 3.5%; p=0.07). At Day 85, after all patients had had
access to pimecrolimus treatment, the improvement in QoL was similar between the two
groups. In patients with AD in sensitive skin areas who are intolerant of, or dependent on top-
ical steroids, pimecrolimus has been shown to offer significant QoL benefits, which become
apparent within 6 weeks of initiating therapy.
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The ability of onion extract gel to improve healing and cosmetic appearance in post surgi-
cal wounds
ZD Draelos Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC
Superior wound healing with excellent cosmesis is critical in superficial dermal wounds cre-
ated when cosmetically unacceptable lesions are removed from the body. Dermatologists fre-
quently remove seborrheic keratoses, nevi, and angiomas from the body with a superficial
shave excision. The excision is designed to minimize dermal scarring while removing the
unsightly skin growth. This study was undertaken to evaluate the ability of an onion extract
gel to improve wound healing and cosmetic appearance in these superficial dermal wounds.
40 subjects with symmetrical superficial lesions at least 8 mm in diameter on the right and
left upper chest were enrolled. The lesions were removed by a scalpel shave following local
anesthesia with 2% lidocaine plus epinephrine. The surgical sites were allowed to heal for two
weeks at which time the subjects returned to the research center for randomization to either
the onion gel treatment group or the no treatment group. 27 subjects in the active treatment
group were further randomized as to the site of study product application. 13 subjects applied
the onion extract gel 3 times daily to the right upper chest wound and nothing to the left
upper chest wound. 14 subjects applied nothing to the right upper chest wound and the
onion extract gel 3 times daily to the left upper chest wound. The remaining 13 control sub-
jects applied nothing to either wound. Subjects returned to the study center at weeks 2, 4, 6,
and 10 for photography, subject and investigator wound assessment, dermospectrophotome-
try, transepidermal water loss, and skin elasticity assessments. This study utilized visual and
noninvasive engineering assessments to follow the progression of wound healing with and
without the onion gel treatment.
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Validity assessment of the CTCL-SI in advanced mycosis fungoides/Sézary syndrome
KL Goldfeder,1 AB Troxel,2 CE Introcaso,1 AH Rook1 and EJ Kim1 1 Dermatology Dept.,
University of Pennsylvania, Philadelphia, PA and 2 Center for Clinical Epidemiology and
Biostatistics, University of Pennsylvania, Philadelphia, PA
Patients with advanced stage mycosis fungoides (MF)/Sézary syndrome (SS) have increased
morbidity/mortality. Since 1979, the TNM(B) classification system has been used for disease
staging and is an important prognostic measure. In the field of nodal non-Hodgkin’s lym-
phomas, validated prognostic indices (IPI, FLIPI) are commonly used for risk stratifying patients.
Klemke et al. recently developed the cutaneous T-cell lymphoma-severity index (CTCL-SI) to
quantitatively evaluate disease extent independent of the TNM(B) as well as to calculate esti-
mated individual 5-year survival (SR5). Our study retrospectively assessed the generalizabil-
ity of the new CTCL-SI/SR5 as a prognostic measure in advanced MF/SS patients at our cen-
ter. We determined TNM(B) staging, CTCL-SI score(based on skin involvement, presence of
tumors, lymph node/visceral/blood involvement), and SR5 (SR5=124-2x[CTCL-SI]) at initial
diagnosis in 50 patients with Stage IIA-IVA disease. We calculated 1)overall survival by the
Kaplan-Meier method, 2)prognostic significance of TNM(B) staging vs. the CTCL-SI using Cox
proportional hazards models, and 3)the quality of the individual predictions using Brier score.
Most patients had Stage III/IV disease. The median actuarial overall survival was 58 months.
By disease stage, the overall 5 year survival was 70% (Stage IIA), 48% (Stage IIB-IIIB), 36%
(Stage IVA). In our cohort, the CTCL-SI/SR5 was predictive of overall survival (p=0.028). Com-
pared to TNM(B) staging, CTCL-SI/SR5 appeared to be modestly more predictive (Brier score
0.29 vs 0.34). In summary, we found the CTCL-SI simple to use and with comparable prog-
nostic value to TNM(B) staging in our advanced CTCL cohort. While larger multi-center col-
laborative studies are necessary to fully validate it, the CTCL-SI is a potentially useful adjunct
to the TNM(B) system for individual prognostication and for the evaluation of treatment out-
comes, particularly in clinical trials.
332
Oral antioxidant complex protects against ultraviolet irradiation-induced erythema and imme-
diate pigment darkening in human skin in vivo
J Leverett,1 GJ Fisher,2 KK Randolph,3 GS Seehra,1 S Cantor4 and K Lorantin4 1 Artistry Center
for Skin Health Research, Access Business Group, Ada, MI, 2 Dermatology, University of
Michigan, Ann Arbor, MI, 3 Nutrilite Center for Optimal Health, Access Business Group,
Buena Park, CA and 4 Cantor Research Laboratories, Blauvelt, NY
Acute exposure to solar ultraviolet (UV) irradiation causes DNA damage, immune suppression,
inflammation and hyperpigmentation. Chronic UV irradiation is the major cause of cutaneous
cancer and premature aging. The deleterious effects are largely mediated through photochemi-
cal and enzymatic generation of reactive oxygen species. We have investigated the ability of an
oral antioxidant complex from Nutrilite®, containing alpha lipoic (15 mg) acid, n-acetyl cys-
teine (200 mg), green tea extract (100 mg), turmeric extract (25 mg) and quercetin (25 mg), to
protect skin against UV-induced erythema and hyperpigmentation. Subjects (lightly pigmented,
skin type II, N=10), were UV-irradiated on sun-protected lower back. Minimal erythema dose
(MED) and minimal persistent pigmentation dose (MPPD) were determined for each subject by
increasing time of exposure to full spectrum solar-simulated UV irradiation, or solar-simulated
UVA (UVB removed by 3mm WG-335 filter), respectively. Skin reddening and darkening were
quantified by a CM-2600d spectrophotometer. Following baseline measurements, subjects took
the antioxidant supplement 3x daily for 28 days. After completion of oral supplementation, the
mean energy required to induce a 2x MED response increased by 29%, from 661 J/m2 to 855
J/m2 (p<0.001). Furthermore, oral supplementation raised the dose of UVA required to illicit 2x
MPPD 13%, from 289 kJ/m2 to 327 kJ/m2 (p<0.01). These data provide evidence that an oral
antioxidant supplement can provide significant protection against the inflammatory and pig-
mentary alterations associated with damage to skin caused by UV irradiation. Oral antioxidant
supplementation, in combination with judicious use of sunscreens, could enhance skin protec-
tion and reduce the incidence of skin cancer and retard sun-induced premature aging.
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Wait-times are shorter for patients seeking cosmetic services with dermatologists
SB Lipton1 and JS Resneck2 1 University of California, Los Angeles School of Medicine, Los
Angeles, CA and 2 Department of Dermatology and Institute for Health Policy Studies,
University of California, San Francisco School of Medicine, San Francisco, CA
The field of dermatology is reportedly experiencing a physician workforce shortage. Previous
studies have shown wait-times averaging over 30 days for dermatology patients seeking appoint-
ments for both routine and urgent medical problems. Many dermatologists are spending increas-
ing time performing cosmetic services, and no evidence has been gathered on wait-times for
patients desiring to pay cash for these services. To evaluate access for patients requesting cos-
metic services, we performed scripted patient telephone calls to all dermatologists in active
practice in twelve metropolitan statistical areas (MSAs). These MSAs represent a variety of geo-
graphic regions with diverse healthcare markets, and are the same areas that have been fol-
lowed for previous dermatology wait-time studies. During a 2-week period in October, 2006,
calls were placed to the 898 dermatologists meeting inclusion criteria to assess wait-times for
an appointment to receive cosmetic botulinum toxin injections. About half of dermatologists
(455, 50.7%) offered appointments for cosmetic botulinum toxin injections. Among those offer-
ing injections, the mean wait-time for an appointment was 15.6 days (median 8 days). Accep-
tance rates and wait-times varied greatly by geographic area (range of mean wait-times 6.0 –
42.6 days). About half of the appointments offered (45.9%) were within one week of the request
(vs 23.7% of appointments in a previous study of patients calling with a changing mole, an
indicator of a possible malignancy). The metropolitan areas sampled represented about one-
tenth of practicing dermatologists in the USA, and no remote or highly rural communities were
included. Wait-times for patients paying cash for cosmetic botulinum toxin injections face
wait-times less than half as long as those reported for patients with medical dermatology
complaints.
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MD/PhDs are more likely than MDs to choose a career in academic dermatology
JJ Wu,1 KF Davis,1 CC Ramirez,2 CA Alonso,3 B Berman4 and SK Tyring3 1 Dermatology,
University of California, Irvine, Irvine, CA, 2 Dermatology, University of Chile School of
Medicine, Santiago, Chile, 3 Dermatology, University of Texas Health Science Center,
Houston, TX and 4 Dermatology and Cutaneous Surgery, University of Miami School of
Medicine, Miami, FL
It is well known that there is a growing shortage of academic dermatologists in the U.S. Many
believe that MD/PhDs are more likely to pursue academic careers due to their significant
research background and experience. Our objective is to determine the total number of
MD/PhDs who were full-time faculty members at U.S. dermatology residency programs as of
December 2004 in order to assess the likelihood of MD/PhDs entering academic dermatol-
ogy compared to MDs. In this retrospective study, we collected names of all full-time faculty
members of 107 U.S. dermatology residency programs that were active as of December 2004.
We determined the degrees of these faculty members through extensive Internet searches and
email correspondences with dermatology residency coordinators and faculty members. As of
December 2004, there were 812 full-time faculty MDs and MD/PhDs who completed allo-
pathic dermatology residency in the U.S. Of these, 72 (8.9%) were MD/PhDs. By estimating
the total number of residency graduates who were MD/PhDs versus those who were MDs, we
calculated that MD/PhDs were about 50% more likely than MDs to establish a career in full-
time academics. Programs with the highest numbers of MD/PhDs who were full-time faculty
were University of North Carolina (5); and University of California, San Francisco (5). Pro-
grams with the highest percentage of MD/PhDs who were full-time faculty were UMDNJ-
Robert Wood Johnson, New Brunswick (100%); SUNY Stony Brook (57.1%); and Roger Williams
Medical Center (37.5%). There were 6 programs that had MD/PhDs who served as the chair/chief
of dermatology. It is the conclusion that MD/PhDs are about 50% more likely than MDs choose
a career in academic dermatology. MD/PhDs comprise of a significant proportion of full-time
faculty members at U.S. dermatology residency programs.
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Immunomodulators for seborrheic dermatitis: A systematic review of randomized controlled
trials
F Gorouhi, M Mohammadipour, L Sayyah, H Salmasian and A Firooz Center for Research &
Training in Skin Diseases & Leprosy, Tehran University of Medical Sciences, Tehran, Iran
Seborrheic dermatitis is a chronic, relapsing inflammatory disease that presents with erythema,
scaling and pruritis primarily on the face, scalp and chest. It affects about 3% to 5% of gen-
eral population. There is no complete and permanent cure for this disease. The purpose of this
study was to systematically search the literature to find the best evidence about the efficacy
and safety of immunomodulators in the treatment of seborrheic dermatitis. We searched
Medline, Embase and Cochrane CENTRAL up to the end of 2006, to find relevant random-
ized controlled trials. Strategies of search to locate trials of seborrheic dermatitis and
immunomodulators were: “((seborrh* AND (dermat* OR eczema)) OR dandruff OR pityriasis
capitis OR steatoid pityriasis OR pityriasis simplex OR cradle cap)” and “(pimecrolimus OR
tacrolimus OR sirolimus OR FK-506 OR ASM 981 OR immunomodulator)” respectively. Adverse
events were searched with a separate strategy to find all possible unwanted side effects even
in non-randomized studies. After comprehensive search, we found nine potentially relevant
articles to be considered. Out of them, three randomized controlled trials were entered the
study. All of them were assessed pimecrolimus in comparison with placebo (one trial) and
active routine controls (two trials). Surprisingly, there was not any trial on tacrolimus cream.
Meta analysis could not be performed due to clinical heterogeneity of included studies. Pime-
crolimus is an effective alternative for corticosteroids with acceptable and transient side effects.
Larger sample sizes for such trials are highly recommended to provide conclusive results. Ran-
domized controlled trials on tacrolimus, sirolimus and other similar immunomodulators are
essential to calculate their exact effect sizes and considering their cost in this context.
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Malignant melanoma and Spitz nevus incidence in the pediatric population
P Ecker, RH Weenig, AL Weaver, X Li and MR Pittelkow Dermatology, Mayo Clinic,
Rochester, Rochester, MN
Background: Skin cancer in the United States is increasing overall. Whereas the increased inci-
dence of skin cancer and melanoma has been well documented in adults, there is sparse lit-
erature documenting an increased incidence of melanoma and Spitz nevus in the pediatric
aged group. The Rochester Epidemiology Project (REP), a complex array of medical record
data as well as medical and surgical indexing systems, provides accurate incidence data for
diseases diagnosed in Olmsted County and was used to calculate incidence data for pediatric
melanoma and Spitz nevus. Methods: All cases of melanoma and Spitz nevus were identified
from 1950-2003 through the REP. Review of over 225 charts was performed to identify clini-
cal characteristics and diagnoses. Review of pathology was performed by a dermatopatholo-
gist (RHW) to confirm diagnoses and further delineate pathologic characteristics. Cases found
not to be consistent with melanoma or Spitz lesions were excluded. Variables considered
included age, sex, diagnosis, treatment, recurrence, metastasis, mortality and follow-up time.
Results: Six cases of melanoma, 52 cases of Spitz nevus, and one case of atypical Spitzoid
tumor were identified. There was one death due to melanoma. The age and sex-adjusted inci-
dence rate for melanoma was 0.42 per 100,000 (95% CI 0.08-0.75). The age and sex-adjusted
incidence rate for Spitz lesions was 3.50 per 100,000 (95% CI 2.56-4.45). The mean age of
diagnosis for melanoma was 11.2 and for Spitz lesions was 8.0. Most melanomas and Spitz
lesions were on the extremities (66.6% and 62.3%, respectively). There was an increased
incidence over time for Spitz lesions, but no trend was identified for melanoma. All melanomas
were thin with depth <0.5 mm. Conclusion: The incidence of melanoma over a 53-year time
period appears to be stable or decreasing for the pediatric age group compared to previously
published reports, despite other studies that suggest an increasing incidence of pediatric
melanoma in the United States; the incidence of Spitz lesions, however, may be increasing.
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Body dysmorphic disorder symptoms among patients with acne vulgaris
WP Bowe,1 JJ Leyden,1 CE Crerand,2 DB Sarwer3 and DJ Margolis1,4 1 Derm, UPENN,
Philadelphia, PA, 2 Psych, Plastic, Reconstructive Surg, CHOP, Philadelphia, PA, 3 Psych &
Surg, UPENN, Philadelphia, PA and 4 Biostats & Epi, UPENN, Philadelphia, PA
Acne is one of the most common concerns of patients with body dysmorphic disorder (BDD),
a psychiatric condition defined as a preoccupation with a slight or imagined defect in appear-
ance that causes significant disruption in daily functioning. BDD patients are at an increased
risk for attempting to take their own lives and are also more likely to threaten healthcare
providers legally and physically. The objective of this cross sectional study was to screen for
BDD symptoms among acne patients across a spectrum of acne severity. A validated self-
report questionnaire was administered to each subject, and an objective assessment of acne
severity performed by a single observer. More stringent objective criteria for BDD required
patients to have an Allen and Smith grade of 0 (0 to a few scattered comedones or papules),
five or fewer post-inflammatory (erythematous or hyperpigmented) macules, and no scars.
Less stringent criteria allowed acne patients to have any amount of acne ranging from no vis-
ible acne lesions to 25% facial involvement with small papules and comedones. 128 acne
patients presenting for dermatologic treatment participated. Rates of BDD ranged from 14.1%
(CI 13.6%, 14.6%) using more stringent criteria to assess acne severity to 21.1% (CI 14.9%,
29.0%) using less stringent criteria. Patients with a history of prior or current use of systemic
isotretinoin appear to be twice as likely to meet criteria for the diagnosis of BDD as com-
pared to acne patients who declined ever using isotretinoin. In particular, of those acne patients
who met our less stringent definition for mild acne, a prior or current history of isotretinoin
use was associated with a significantly increased risk of being diagnosed with BDD (OR=2.55,
CI 1.071, 6.067; p=.034). Based on these findings, a significant proportion of patients, regard-
less of their acne severity at the time of exam, suffer from substantial distress and preoccu-
pation related to their facial appearance.
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Partner’s role in skin self-examination performance
JK Robinson,1 J Stapleton2 and R Turrisi2 1 Dermatology, Northwestern Univ Feinberg School
of Medicine, Chicago, IL and 2 Biobehavioral Health and Prevention Research Center,
Pennsylvania State University, University Park, PA
Almost 1/2 of US melanoma deaths occur in men 50 years of age and older. Loss of a life
partner may be expected in older adults. Men without partners have reduced ability to ben-
efit from health care interventions, such as SSE. The objective is to determine the influence of
partners’ relationship dynamics on SSE performance. 130 patients with a history of melanoma
and their cohabitating adult partners were randomized to either a solo-learning or a partner-
learning condition(skills training). Relationship dimensions (satisfaction, cohesion, consen-
sus, and affectional expression) were assessed by responses to the Dyadic Adjustment Scale.
The partner’s self -reported ability to function as a mediator of change was assessed with 3
subscales adapted from the Treatment Mediation Inventory (coefficient alpha = .825, .924,
.949). Interaction effects between the intervention condition (solo or dyadic learning) and the
moderator variables were evaluated by the SSE outcome. The results indicated that each rela-
tionship dimension had significant moderating effects on SSE (p<. 01). By regression analy-
sis, SSE performance varied at different levels of relationship variables. The mean difference
between learning groups was greatest when the patients’ dyadic adjustment scores were above
average (2.293 couple and .959 solo). At low levels of dyadic satisfaction, those in the part-
ner- learning condition were more likely to perform SSE (.384 couple and 0.33 solo). Partner
as a mediator of change significantly influenced SSE (p<. 01). Self-efficacy scores were high-
est in the partner-learning program at all levels (p <. 001). In the solo-learning group, the mod-
erator effect of the partner as a mediator of change was not significant. The partner/relation-
ship characteristics influenced how the patient feels about his/her ability to effectively perform
SSE, which affects whether they perform screening. SSE is sustained by the relationship qual-
ity, partner perceptions, and the partner’s ability to help.
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Dermatology resident career path choices: was the Society for Investigative Dermatology
Resident Retreat helpful?
LK DeLong,1 M Pennie,1 C Slade,2 E Veledar1 and SC Chen1,3 1 Emory School of Medicine,
Atlanta, GA, 2 Society for Investigative Dermatology, Cleveland, OH and 3 Atlanta VAMC,
Atlanta, GA
The Society for Investigative Dermatology (SID) Resident Retreat was established in 2001 to dis-
cuss the advantages and future of academic dermatology with a secondary objective of determin-
ing whether the SID retreat is helpful in the career path decision for graduating dermatology resi-
dents. The SID has contacted all graduating residents annually from 2004-2006 via mailing of a
survey. Of the 290 graduating resident respondents, 44% (n=129) entered private practice (PP),
30% (n=86) entered an academic position (ACA), and 26% entered a fellowship or other career
path. Of the 215 respondents who entered PP or ACA, age, gender, martial status, having a men-
tor, and amount of household debt were not statistically significant predictors of a choice of ACA
by multiple logistic regression (p>0.05). Attendance at the SID Retreat was a statistically significant
predictor of a career in ACA and remained so when controlling for the other characteristics above
(p<0.001). Of graduating resident respondents, 23% (66/290) had attended the SID Retreat and of
those, 73% (48/66) felt that it had helped their career decision. A statistically significantly higher
proportion of those entering ACA vs. PP (41% (35/86) vs. 15% (19/129), p<0.001) had attended
the SID retreat. However, a higher percentage of residents entering PP, 89% (17/19), felt that the
retreat had helped their career decision compared to 66% (23/35) of those who entered ACA. The
SID Resident Retreat meets its objective of informing residents early in their training about a career
in academia and appears to be helpful in a resident’s career path choice. Residents entering both
PP vs. ACA found the retreat beneficial which may reflect that the SID Retreat may not only rein-
force those already interested in academics but inform those who are undifferentiated. A limita-
tion is a selection bias towards residents attending the retreat who are already committed to aca-
demics, although programs are encouraged to send all residents.
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Number, characteristics, & classification of dermatomyositis patients seen by dermatology
& rheumatology at a large tertiary medical center
RD Quain,1 V Teal2 and VP Werth1,3 1 Derm, UPenn, Phila, PA, 2 Ctr for Clinical Epidemiology
& Biostatistics, UPenn, Phila, PA and 3 Derm, VA Med Ctr, Phila, PA
The goal of this study was to evaluate differences in clinical manifestations of dermatomyosi-
tis (DM) seen by dermatology relative to rheumatology. We hypothesized that there may be
departmental differences in prevalence of patients with minimal to no muscle disease, often
termed hypomyopathic DM (HDM) and amyopathic DM (ADM) respectively, with more severe
myositis, termed classic DM (CDM), presenting to rheumatology. We performed a retrospec-
tive chart review at the Hospital of the University of Pennsylvania to classify spectrum, pres-
entation, and complications from DM seen by department. 131 (64.9%) dermatology, 58
(28.7%) rheumatology, and 13 (6.4%) patients from both departments were identified by CPT
billing code 710.3 from 7/1/03 to 6/30/06. Patients with mixed connective tissue diseases or
miscoded with DM were excluded. 84 (67.2%) dermatology, 30 (24.0%) rheumatology, and
11 (8.8%) patients from both departments were included, with 67 (53.6%) CDM, 35 (28.0%)
ADM, and 23 (18.4%) HDM identified. 27/30 (90.0%), 1/30 (3.3%), 2/30 (6.7%) rheumatol-
ogy patients were classified as CDM, ADM, and HDM respectively, and differed significantly
from dermatology where CDM comprised 32/84 (38.1%), ADM 35/84 (41.7%) and HDM
17/84 (20.2%) of the population, respectively (p<0.0001). Gender, ethnicity, and rates of inter-
stitial lung disease (ILD) differed between departments, with more males (p=0.0042), African
Americans (p=0.0093), and ILD (p=0.005) seen in rheumatology. While ILD differed between
departments, there was no difference in rates of ILD between ADM and CDM (p=0.1481).
Degree of muscle involvement did not correlate with rates of DM-associated malignancy
(p=0.7019). Few ADM patients had muscle biopsy (n=1) or EMG (n=7) testing. Positive anti-
Jo-1 was seen in 2/96 (2.1%; 1 CDM, 1 ADM; both with ILD), reflecting a potential problem
with the laboratory assay. There is a clear difference in DM presentation to dermatology and
rheumatology by degree of myositis-complicated disease.
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Evaluating dermatology fellows: program compliance with accreditation council for gradu-
ate medical education guidelines
S Freeman,1 C Nelson,2 K Lundahl1 and R Dellavalle1 1 Dermatology, University of Colorado
at Denver and Health Sciences Center, Denver, CO and 2 University of Nevada School of
Medicine, Reno, NV
Faculty evaluation of dermatology fellows is required by the Accreditation Council for Grad-
uate Medical Education (ACGME). Trainee evaluation methods used by ACGME accredited
dermatology fellowship programs have not been described. A 22 item questionnaire assess-
ing evaluation methods was mailed to the 79 ACGME accredited (2006-2007) dermatopathology
and procedural dermatology fellowship programs. The survey response rate was 62.0% (49/79),
and 93.9% (46/49) of returned surveys were completed by fellowship directors. 79.6% (39/49)
of respondents reported that dermatology faculty evaluate dermatology fellows, and 71.8%
(28/39) reported that the evaluations were very important in determining the successful com-
pletion of the fellowship. 76.9% (30/39) of respondents reported that the evaluations of fel-
lows were never completed anonymously and 15.4% (6/39) reported that the evaluations were
always completed anonymously. Most forms used to evaluate fellows were developed by fel-
lowship directors (71.8%) and most respondents (69.2%) reported that these forms have been
modified over time. Evaluation forms were most commonly distributed to dermatology fac-
ulty electronically (43.6%), either by email, a link to a website, or both. One in five ACGME
accredited dermatology fellowship training programs reported that faculty do not evaluate
fellows. Evaluation form content and distribution methods vary widely across programs. As
demonstrated in other specialty residency training programs, electronic systems designed to
deliver and manage fellow evaluations are increasingly used and may facilitate compliance
with ACGME regulations.
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Employment migration patterns of dermatology residents
EP Tierney1 and AB Kimball2 1 Dermatology, Henry Ford Health System, Detroit, MI and 2
Dermatology, Massachusetts General and Brigham & Women’s Hospitals, Boston, MA
A geographic maldistribution of dermatologists is currently affecting access to dermatologic
care in the U.S.. Since location preference is a key determinant in initial job selection, we
evaluated migratory patterns of residents pre- and post training. In previous studies, 40-65%
of all types of residents typically remain in the state and region of their training. Data col-
lected at the Galderma Board Review Course between 1999 and 2004, (annual response
rates were 66-82%, n=632) was used to determine residency and practice location for grad-
uating dermatology residents. Cumulative data is presented. In 2004 only, data was also col-
lected about the trainee’s “home state,” as defined as where the respondent went to high school.
During the years 1999-2004, 53% (n=333) of dermatology residents stayed in the state where
they trained for their first job and an additional 17% (n= 107) stayed in the same region where
they trained for their first job. The lowest percentage of residents staying in the same state to
practice were in the MidAtlantic (n=23, 30%) and Midwest (n=86, 44.3%), and the highest
proportion of residents staying to practice were in the Northeast (n=95, 53.7%) and West Coast
(n= 87,65.9%). The largest net migrations of dermatology residents into new regions to prac-
tice was from the Midwest (-54 residents) and into the West (+44 residents). Those leaving the
Midwest included both residents from the Midwest originally and those who moved to the
area for residency. Correspondingly, the Midwest has 27% of all residency positions but only
14% of residents between 1999-2004 decided to practice in the Midwest. In contrast, the West
coast has 19% of residency positions, but attracted 32% of graduates between 1999-2004. In
dermatology, home state and state of residency are very important in predicting where resi-
dents will seek jobs post residency. The number of residency positions in the Midwest has not
ensured a proportional increase in number of practicing dermatologists in the area.
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Cancer incidence among patients with and without atopic dermatitis in the UK
A Arana,1 CE Wentworth,5 C Fernandez-Vidaurre,4 R Schlienger,5 E Conde3 and
FM Arellano1,2,5 1 Risk Management Resources, Zaragoza, Spain, 2 University of New South
Wales, Sydney, NSW, Australia, 3 Servicio Hematologia, Hospital Valdecilla, Santander, Spain,
4 Global Epidemiology, Novartis Pharmaceuticals, East Hanover, NJ and 5 Global
Epidemiology, Novartis Pharma AG, Basle, Switzerland
The association between atopic dermatitis (AD) and cancer in general, and lymphoma in par-
ticular, is unclear. The objective is to describe the occurrence of cancer (general, lymphoma,
non-melanoma skin cancer and melanoma) in the general population and AD patients. We
conducted a cohort study in patients of all ages enrolled for ≥6 months in the THIN database
of the UK from Jan 1, 1992 to Mar 23, 2006. We defined two sub-cohorts based on the pres-
ence or absence of AD at the index date. Cases were identified by the presence of a READ
code for cancer in general, lymphoma, non-melanoma skin cancer or melanoma after the
index date. We calculated the incidence rate (IR) of cancer per 10,000 person-years and age-
standardized IR (ASR) of cancer per 10,000 person-years in the general population and in
patients with and without AD. The ASR (per 10,000 person-years) of cancer in the general pop-
ulation was 55.2 in males and 49.2 in females, which is compatible with that of the general
population in the UK according to data obtained by the International Agency for Research on
Cancer (IARC). The IR in AD patients was not greater than in patients without AD (45.8 in
males and 38.7 in females with AD, 55.5 and 49.5, respectively in subjects without AD). The
ASR of lymphoma was 2.2 in males and 1.3 in females with AD and 2.0 and 1.5 respectively
in subjects without AD. The ASR of melanoma was 1.7 in males and in females with AD, and
1.5 in males and 1.9 in women without AD. The ASR of non-melanoma skin cancer was 9.2
in males and 6.9 in females with AD, and 13.5 in men and 10.7 in women without AD. These
results suggest that the IR for cancer in general, and for the specific cancer subtypes studied
was not higher in patients with AD compared to non-AD patients in the UK.
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Survival differences between head/neck melanoma and melanoma of other sites in the Sur-
veillance, Epidemiology, and End Results (SEER) Program
AM Lachiewicz,1 CL Wiggins,2 M Berwick2 and NE Thomas1 1 Dermatology, University of North
Carolina, Chapel Hill, NC and 2 Internal Medicine, University of New Mexico, Albuquerque, NM
The head/neck region is more heavily exposed to ultraviolet light than other body regions.
Controversy remains over whether cutaneous melanoma of the head/neck (HNM) is biologi-
cally different or has survival differences from melanoma of other sites (MOS). We used the
National Cancer Institute’s population-based Surveillance, Epidemiology, and End Results 13
Registries Database to examine first invasive primaries among non-Hispanic white adults diag-
nosed from 1992-2003. Clinical features and age-adjusted incidence rates (2000 US standard
population) were examined for 9,490 HNM and 42,214 MOS. Melanoma-specific survival was
analyzed using Kaplan-Meier estimates and multivariate Cox proportional hazards models.
Compared to MOS patients, HNM patients are older (median age, 65 vs. 53 years), are more
often male (69% vs. 53%), and are more likely to have lentigo maligna melanoma (LMM) sub-
type (22% vs. 3%). HNM are also significantly thicker (median thickness, 0.70mm vs. 0.62mm;
p<0.001), are more likely to be ulcerated (6% vs. 5%), and are less likely to have lymph node
involvement (5% vs. 6%) than MOS. Age-specific incidence rates show site-specific patterns:
MOS rates increase sharply with age until age 65 years when they begin to decline, while HNM
rates rise continuously throughout older age. A significant survival difference was detected using
Kaplan-Meier estimates (log rank test, p=0.0003) with lower 10-year survival rates for HNM
than for MOS (83.8% vs. 86.7%). After adjusting for sex, age, thickness, ulceration, and lymph
node involvement in a multivariate Cox model, HNM patients die at 1.23 times (95% CI, 1.10-
1.37) the rate of MOS patients. This hazard ratio increased when LMM was excluded (1.31;
95% CI, 1.17-1.46). After adjustment for important prognostic factors, a modest survival dif-
ference remains between HNM and MOS. Studies are needed to understand the biological or
environmental factors leading to survival differences by anatomic site.
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Accuracy of teledermatology for skin neoplasms
E Warshaw,1,2 J Grill,2 F Lederle,2 V Kaye,1 P Lee,1 K Bohjanen,1 K Chen,1 H Rabinovitz,3
R Johr,3 R Wenner,1 S Bowers,1 S Askari,1 P Cham,1 D Kedrowski,1,2 L Fortier,2 A Bangerter2
and D Nelson2 1 Dermatology, Mpls VAMC, Minneapolis, MN, 2 Center for Chronic Disease
Outcomes Research, Mpls VAMC, Minneapolis, MN and 3 Dermatology, Univ of Miami,
Miami, FL
Background: Preliminary evidence suggests that teledermatology may be less accurate for skin neo-
plasms. Objective: To determine the diagnostic accuracy of store-forward teledermatology using stan-
dard macro images for skin neoplasms. Secondary objectives included appropriateness of manage-
ment plans of teledermatologists (TD) as compared to clinic dermatologists (CD). Methods: This study
was a repeated-measures equivalence trial. Eligible patients included either those referred for eval-
uation of a skin neoplasm or evaluated in the dermatology clinic for a skin neoplasm. Each lesion
was examined first by a CD and then, at a later time, by a TD; both generated a primary diagnosis,
up to two differential diagnoses, and a management plan. Histopathology served as the gold stan-
dard. A sample size of 2080 was calculated to provide a power of >80% to assess both primary and
secondary outcomes for both pigmented and non-pigmented lesions. Results: 2,152 patients were
enrolled; the majority were male (2082, 97%) and Caucasian (2098, 98%). Mean age was 68 yrs.
45% (967/2145) of the target lesions were located on the face or ears. A quarter of the 1270 biop-
sied target lesions were basal cell carcinomas (303, 24%) followed by benign keratoses (173, 14%)
and squamous cell carcinomas (165, 13%). 3% (36) were melanomas. Equivalence testing found
that diagnostic accuracy of TD and CD were not equivalent. The accuracy rates of CD were signifi-
cantly better than TD, for both pigmented and non-pigmented lesions. For melanoma, the average
accuracy for CD was 17-25% better than TD. Appropriateness of management plans of TD and CD
were equivalent overall, however, the severity of mismanaged cases by TD was significantly higher
than CD. 2 and 9 melanomas were mismanaged by CD and TD, respectively. Conclusion: For skin
neoplasms, the diagnostic accuracy of CD is superior to TD using standard macro images.
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Pilot evaluation of associations between location, duration, and size of biopsy-proven basal
cell carcinoma, squamous cell carcinoma, melanoma, and seborrheic keratosis in an elderly
population
P Suwattee1,2 and EM Warshaw1,2 1 Dermatology, Minneapolis VAMC, Minneapolis, MN and
2 Dermatology, University of Minnesota, Minneapolis, MN
Skin neoplasms in easily-visible locations may prompt patients to seek care early. To evaluate
associations between location, duration, and size of various skin tumors—basal cell carci-
noma (BCC), squamous cell carcinoma (SCC), malignant melanoma (MM), and seborrheic ker-
atosis (SK). This pilot study was part of a larger study on teledermatology involving 3,039 skin
neoplasms in 2,152 patients at the Minneapolis VAMC. Participants were asked about dura-
tion of specific skin lesions. Location and size of each lesion were recorded. For statistical
analysis, location categories were collapsed into three groups: Scalp, face/ears, neck (GR 1);
chest, back, abdomen, groin, buttocks (GR 2); and arm, hand, leg and foot (GR 3). Duration
was categorized into less than 1 yr, 1-5 yrs, and >5 yrs. Pearson Chi-square test and ANOVA
were used for statistical analyses. 411 BCC, 238 SCC, 39 MM, and 224 SK biopsy-proven neo-
plasms identified in 748 participants (average age 72.8 yrs) were included. There were signif-
icant associations between duration and location for BCC (p<0.001), MM (p =0.0115), and
SK (p=0.002), but not for SCC. Location was associated with size for BCC (p<0.0001), SCC
(p=0.0045), and SK (p=0.0204), but not for MM. Location was also associated with size; for
BCC, lesions in GR 2 were 5.01 mm larger than in GR 1 (95% CI 3.36-6.66) and 2.86 mm
larger than in GR 3 (95% CI 0.31-5.40). For SCC, lesions in GR 3 were 2.60 mm larger than
in GR 1 (95% CI 0.51-4.69). For SK, lesions in GR 2 were 2.16 mm larger than in GR 1 (95%
CI 0.23-4.09). Duration and size were associated for BCC only (p=0.05). Limitations include
1) small numbers of MM; 2) male and elderly study population; 3) patient-reported duration;
4) univariate analysis. This pilot study suggests that certain skin neoplasms, especially BCC,
located in easily visible sites, may prompt patients to seek care sooner.
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Authors guidelines for human research ethics committee approval disclosure in medicine
and dermatology journals
S Freeman,1 K Lundahl1 and R Dellavalle2,1 1 Dermatology, University of Colorado at Denver
and Health Sciences Center, Denver, CO and 2 Dermatology, Dept. of Veterans Affairs
Medical Center, Denver, CO
Independent research ethics committees (in the USA - institutional review boards) safeguard
participants in human research. We examined the online instructions for authors of 102 med-
icine journals and 36 dermatology journals for information on human research ethics guide-
lines for manuscript publication in December 2006. Ethics committee approval for human
research was required by 85/102 (83%) medicine journals vs. 18/36 (50%) of dermatology
journals. Most journals required a statement of ethics committee approval in the manuscript
[71/85 (84%) of medicine journals, 15/18 (83%) of dermatology journals]. No ethical guide-
lines for human research appeared in the instructions to authors of 8/102 (8%) medical jour-
nals vs. 17/36 (47%) of dermatology journals (P< .0001). No journals required authors to pro-
vide readers the protocols approved by the corresponding ethics committee as online
supplements to their published articles. Dermatology journal guidelines for human research
ethics committee approval disclosure are laxer than medicine journal guidelines and are in
need of improvement. As concerns continue to increase regarding the integrity of published
scientific research, all biomedical journals should consider establishing a new standard in
human research transparency by requiring the submission and posting of all approved human
research protocols and ethical committee certification letters as journal online supplemen-
tary information.
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Non-infectious dermatologic diseases associated with chronic exposition to mining tailings
in San Mateo de Huanchor, Peru
W Ramos,1 C Galarza,1 G Ronceros,1 F de Amat,1 M Teran1 and AG Ortega-Loayza2,1 1
Instituto de Investigaciones Clinicas de la UNMSM, Lima, Peru and 2 University of North
Carolina at Chapel Hill, Chapel Hill, NC
Mining contributes heavily to the Peruvian economy, and may result in the deposit of toxic
wastes near populated areas. Mining tailings, one such waste product, are associated with
adverse health effects of individuals residing in those locales. We conducted an observational
case control study to examine the correlation between chronic exposure to mining tailings
and the risk factor of non-infectious dermatologic diseases from November 2003 to February
2004 in the district of San Mateo de Huanchor, Lima, Peru. The study consisted of three phases:
1) selection of areas according to environmental impact, 2) epidemiological census of the pop-
ulation and 3) evaluation of the pediatric and adult populations. A dermatologic physical exam-
ination was conducted for both groups and performed a multivariable analysis with control
variables of age, sex, occupation, and altitude of the communities. We evaluated 121 exposed
and 109 non-exposed subjects in the adult population finding in the exposed group, 71.1%
showed some non-infectious dermatologic disease while in the non-exposed group the fre-
quency was 33.9% (p<0.001; OR=5.40; CI= 95%:3.02-9.68). A statistically significant differ-
ence was found for arsenical dermatitis, non pruritic papulovesicular eruption, atopic der-
matitis, contact dermatitis, seborrheic dermatitis, and xerosis. In the pediatric population, 71
exposed and 64 non-exposed children were evaluated; 69.0% of the exposed group showed
some non-infectious dermatologic disease versus 29.6% in the non-exposed group (p<0.001;
OR=6.00; CI= 95%: 2.71-13.31) with a statistically significant difference for xerosis and atopic
dermatitis. Therefore, we can conclude that the chronic exposition to mining tailings repre-
sents a risk factor to develop non-infectious dermatologic diseases in both adults and children.
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Comparison of the reliability & validity of outcome instruments for cutaneous dermato-
myositis
RD Quain,1 CC Bangert,2 M Costner,2 MK Connolly,3 E Dugan,4 A Tanikawa,5 J Okawa,1
M Rose,1 SS Fakharzadeh,1 D Fiorentino,6 LA Lee,7 RD Sontheimer,8 L Taylor9 and
VP Werth1,10 1 Derm, UPenn, Phila, PA, 2 Derm, UTSW, Dallas, TX, 3 Derm, UCSF, SF, CA, 4
Derm, WHC, Wash, DC, 5 Derm, Keio U, Tokyo, Japan, 6 Derm, Stanford U, Stanford, CA, 7
Derm, U Colorado, Denver, CO, 8 Derm, U Oklahoma, Oklahoma City, OK, 9 Epi & Biostat,
UPenn, Phila, PA and 10 VAMC, Phila, PA
There is a need for reliable and validated measures of skin disease severity for cutaneous der-
matomyositis (DM). The CDASI (Cutaneous DM Disease Area & Severity Index), DSSI (DM Skin
Severity Index) and CAT (Cutaneous Assessment Tool) have been developed as outcome instru-
ments. Ten dermatologists scored the same 12-16 patients. CDASI, DSSI, and CAT scores ranged
from 0-76 (mean 25.5±16.0), 0-56 (4.8±7.3), and 0-59 (16.9±10.4), respectively, with higher
scores correlating with worse disease. DSSI scores were positively skewed to the low-end of the
scale. CDASI and CAT were normally distributed (Shapiro-Wilks W normality test). Reliability
studies demonstrated an intra-class correlation coefficient (ICC) for test-retest intra-rater relia-
bility of 0.86 for CDASI (95%CI=0.74-0.99), 0.93 for DSSI (0.87-1.00), and 0.45 for CAT (0.06-
0.83). Inter-rater reliability studies showed an ICC of 0.83 (0.71-0.94) for CDASI, 0.44 (0.23-
0.65) for DSSI, 0.60 (0.41-0.79) for CAT, and 0.61 (0.42-0.80) for Global Physician Score (GPhS).
Three clinical validation measures-GPhS, Global Patient Score (GPaS), and Global Itch Score
(GIS)-were administered to physicians (GPhS) and patients (GPaS & GIS) as visual 0 to 10 scales.
The 3 scales were correlated with GPhS (CDASI r=0.79; DSSI r=0.82; CAT r=0.73), GPaS (CDASI
r=0.53; DSSI r=0.49; CAT r=0.43), and GIS (CDASI r=0.61; DSSI r=0.63; CAT r=0.51) (p<0.0001
for correlations). In summary, the DSSI is skewed to the low-end of the scale, making demon-
stration of responsiveness more challenging, while the CAT displays low reliability relative to
the CDASI. All scales correlate better with physician than patient global skin measures. Thus, it
appears that the CDASI may be the optimal outcome measure for studies of cutaneous DM.
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Strength of association of MC1R variants with BRAF mutations in melanoma remains an open
question
NE Thomas,1 PA Kanetsky,2 SN Edmiston,1 A Alexander,1 A Hummer,3 RC Millikan,1
P Groben,1 H Hao,1 M Berwick,4 CB Begg,3 K Busam,3 D Mattingly,1 DW Ollila1 and
K Conway1 1 Dermatology, Epidemiology & Surgery, Univ. of North Carolina, Chapel Hill,
NC, 2 Center for Clinical Epidemiology & Biostatistics, Univ. of Pennsylvania School of
Medicine, Philadelphia, PA, 3 Biostatistics & Pathology, Memorial Sloan-Kettering Cancer
Center, New York, NY and 4 Medicine, Univ. of New Mexico, Albuquerque, NM
Melanocortin-1 receptor (MC1R) variants were recently reported to be strongly associated with
BRAF-mutant melanomas with little histologic evidence of chronic sun damage (non-CSD) (Landi
et al., Science 2006;313:521). To test this finding, we examined 202 first primary invasive cuta-
neous non-acral melanoma cases from North Carolina, a site in the population-based Genes, Envi-
ronment, and Melanoma study. We sequenced MC1R from buccal DNA, determined tumor-spe-
cific BRAF mutations in and around codon V600 using single strand conformation polymorphism
analysis and radiolabeled sequencing, and graded CSD. Presence of any non-synonymous germline
MC1R variant demonstrated a non-significant increase in the likelihood of having a BRAF-mutant
melanoma among the 141 non-CSD cases (odds ratio [OR] 1.7, 95% confidence interval [CI] 0.6
to 5.1, p = 0.36) adjusting for age at diagnosis and phenotypic characteristics, but no increase was
observed among the 61 CSD cases. For non-CSD cases, finer MC1R categorization revealed that
carriage of one MC1R variant conferred greater odds of having a BRAF-mutant melanoma (OR 2.2,
95% CI 0.7 to 6.9, p = 0.09) than carriage of two variants (OR 1.1, 95% CI 0.3 to 3.9, p = 0.57).
Our data do not support a strong association of MC1R variants with BRAF mutations, but a modest
association cannot be excluded. Differences in the observed estimates may be due, in part, to vari-
ant-specific effects of distinct MC1R variants, the frequencies of which differ somewhat between
study populations or to differing risk-modifying effects of MC1R variants between the populations.
Further investigation is necessary to clarify the relationship of MC1R variants and BRAF–mutant
melanomas.
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Percutaneous penetration via hand eczema is the major accelerating factor for systemic
absorption of toluene and xylene during car spray painting
R Hino, D Nishio, K Kabashima and Y Tokura Department of Dermatology, University of
Occupational and Environmental Health, KItakyushu, Japan
The percutaneous absorption is expected to be an important factor of acute high dose expo-
sure to organic solvents, but the skin has not been estimated as a critical route to determine
the threshold limited values in chronic low dose exposure. The aim of this study is to deter-
mine whether the skin, if disordered, is one of the major routes of organic solvent absorption.
Seventy two male workers who painted the car body for 8 hours in the painting booth of a
Japanese car company were participated in this study. The severity of hand eczema was eval-
uated by a dermatologist in dryness, erythema, scaling, dyshidrosis, fissuring, and lichenifi-
cation using simple visual scoring: 0 = none, 1 = mild, 2 = moderate, and 3 = severe. The
skin severity index was represented by the sum of these values. Urinary hippuric acid and
methylhippuric acid are the most frequently used biomarkers in the biological monitoring of
occupational exposure to toluene and xylene. Urine samples were collected prior to the last
day of the working week, and measured urine hippuric acid and methylhippuric acid, respec-
tively. The skin severity index in the workers ranged from 0 to 6 points. The correlation coef-
ficiency between the skin severity index and the urinary concentration of hippuric acid (r=0.610,
p<0.001) or methylhippuric acid (r=0.338, p<0.005) was statistically significant. There was
no significant correlation between their urinary values and the air concentration of organic
solvents. For absorption of organic solvents, the respiratory tract is well known as the major
site, but our study demonstrated that percutaneous absorption is one of the critical routes in
some workplaces.
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Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002
VD Criscione1,2 and MA Weinstock1,2 1 Dermatology and Community Health, Brown
University, Providence, RI and 2 Dermatoepidemiology Unit, VA Medical Center, Providence,
RI
We sought to describe incidence trends for cutaneous T-cell lymphoma (CTCL) in the United
States. Data from 4,783 cases of CTCL were obtained from 13 population-based cancer reg-
istries of the Surveillance Epidemiology and End Results (SEER) Program of the National Can-
cer Institute for 1973-2002. The overall annual incidence was 6.4 per million (all incidence
rates are age-adjusted to the 2000 US population). Annual incidence increased by 2.9 per mil-
lion per decade over the period of study. Incidence was higher among men (8.7 per million)
than among women (4.6 per million) and was highest among blacks (9.0 per million, vs. 6.1
among whites and 4.9 among other racial groups). The racial differences in incidence decreased
with age while the gender differences increased with age and have decreased over time. Sig-
nificant geographic variation in incidence was observed among the 13 registries. Incidence
was correlated with high physician density, high family income, high percentage of popula-
tion with bachelor’s degrees, and high home values. Changes in International Classification
of Diseases for Oncology (ICD-O) morphologic definitions have shifted the distribution of
CTCL cases among specific sub-classifications. The continued increase in incidence of CTCL
is substantial, and the cause uncertain. The racial, ethnic, gender and geographic differences
in incidence may be of etiologic importance. Changes in ICD-O have made it difficult to
evaluate incidence trends for sub-classifications of CTCL such as mycosis fungoides. Addi-
tionally, these changes resulted in the creation of ambiguous histologic codes which may have
caused coding errors. Population-based epidemiological investigation is important for identi-
fying risk factors and understanding the cause of this cancer.
350
History of eczema, calcineurin inhibitor use, and the risk of basal cell carcinoma
RK Dyer,1,2,3 MA Weinstock1,2,3 and . VATTC Trial Group4 1 VA Medical Center, Providence,
RI, 2 Brown Medical School, Providence, RI, 3 Rhode Island Hospital, Providence, RI and 4
Department of Veterans Affairs, Washington, DC
History of eczema and other allergic conditions has been associated with an increased risk of
certain cancers in some studies, and a decreased risk of certain cancers in other studies. In
addition, the use of the calcineurin inhibitors tacrolimus and pimicrolimus to treat eczema
has raised concerns about their potential for carcinogenesis. We examined the association
between history of eczema and future BCCs in a population of 1131 veterans diagnosed with
at least two keratinocyte carcinomas (BCCs and SCCs) in the previous five years who partici-
pated in a randomized trial of topical tretinoin for prevention of new keratinocyte carcinomas.
History of eczema was determined by patient report of being told by a doctor that they had
eczema, while use of calcineurin inhibitors was determined by examination of medical records.
Fifty-two patients reported a history of eczema; none of these patients had used tacrolimus or
pimecrolimus. Cox proportional hazards regression was used to estimate the adjusted hazard
rate ratios (HRR) and 95% confidence intervals (CI) of potential predictors of time to first new
BCC. The median follow up was 3.7 years; 44% of the participants developed new BCCs dur-
ing the study. After controlling for treatment group and other risk factors, history of eczema
was an independent predictor of future BCCs (HRR = 1.70, 95% CI 1.15-2.50). Other pre-
dictors included the number of BCCs in the five years prior to enrollment, a summary meas-
ure of sun sensitivity, family history of skin cancer, and age. Lower patient education level
was associated with shorter time to BCC. Factors not associated included the number of SCCs
in the 5 years prior to enrollment, current or prior cigarette smoking, residential history, and
history of severe sunburn at various ages. These results suggest that history of eczema may be
a risk factor for BCCs in the absence of the use of calcineurin inhibitors. Analyses of effects of
calcineurin use should take this observation into account.
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Patients with severe psoriasis have an increased risk of mortality
SK Kurd, JL Lewis, AB Troxel, DJ Margolis, BL Strom, DB Shin, X Wang and JM Gelfand
University of Pennsylvania, Philadelphia, PA
Psoriasis is associated with obesity, cardiac disease, diabetes, smoking and alcohol. The pur-
pose of this study was to determine if psoriasis is associated with excess mortality. We per-
formed a population-based cohort study of patients 18 or older who were followed by gen-
eral practitioners participating in the General Practice Research Database (GPRD) in the United
Kingdom from 1987-2002. The GPRD has been previously shown to validly identify psoria-
sis and accurately capture information from specialists. Patients were classified as having pso-
riasis if they had a medical record of psoriasis. Psoriasis patients with no record of systemic
therapy were classified as mild, whereas those who received a therapy consistent with severe
psoriasis (e.g. methotrexate, psoralen, etc) were classified as severe. Up to 5 patients with no
history of psoriasis (e.g., unexposed controls) were selected randomly from the same practice
and time period as patients with mild and severe psoriasis. We performed Cox models adjusted
for age and sex to determine the hazard ratio (HR) of death associated with psoriasis. We
matched 133,568 patients with mild psoriasis to 560,358 controls, and matched 3,911 patients
with severe psoriasis to 15,075 controls. Severe psoriasis patients had an increased risk of mor-
tality (HR 1.14, 95% CI 1.004, 1.30), whereas no increased risk of mortality was observed in
patients with mild psoriasis (HR 1.00, 95%CI 0.97, 1.02). Similar results were obtained when
patients with psoriatic arthritis were excluded and results were robust to several sensitivity
analyses. The increased risk of mortality in severe psoriasis may translate to a significant num-
ber of years of life lost given that patients with psoriasis have the disease for decades. For exam-
ple, the median age at death of female and male patients with severe psoriasis was 5.87 and
2.81 years younger (P<0.001) respectively than patients without psoriasis who died. Future
studies are necessary to determine which factors account for the increased risk of mortality
observed in patients with severe psoriasis.
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Deaths due to cutaneous t-cell lymphoma (CTCL): bias of certification and revised estimate
of national mortality
DA Barzilai and MA Weinstock Dermatology, VAMC and Brown Medical School, Providence,
RI
We sought to quantify national mortality from CTCL and assess death certificate underesti-
mation. A cohort of 1272 patients diagnosed with CTCL in the Surveillance Epidemiology
and End Results (SEER) registries from 1984 to 1994 was analyzed. Patients were followed from
diagnosis until death or censoring. Relative survival was utilized to estimate excess deaths in
this cohort compared to population controls matched by race, sex, age, and date at which
age was coded. Estimation bias of mortality based on death certification was computed as a
ratio, within the SEER cohort, of the number of death certificates with CTCL (mycosis fun-
goides/sezary syndrome) listed as the cause of death, to the number of estimated CTCL deaths
calculated from relative survival. Estimation bias of 1.0 and 0.6 represent no bias and a 40%
underestimate, respectively. Mortality for the entire U.S. based on death certification was
obtained from the Centers of Disease Control. We calculated an estimation bias of 0.44 at 10
years and 0.43 at 20 years. Estimation bias was significantly improved when cause of death
included all lymphoma: 0.82, and 0.81 respectively for 10 and 20 years. Estimation bias deter-
mined at 5 year intervals following diagnosis varied (p=.014), and was greatest (least under-
estimation) between years 5-10 following diagnosis at 0.63. This compared with 0.41 during
the first 5 years after diagnosis, 0.33 from years 10-15, and 0.24 from 15 to 20 years. These
findings suggest poor sensitivity of death certificate data for CTCL mortality, and that mis-
classification of CTCL as other or not specified lymphoma on the death certificate is substan-
tial. In addition, there are a substantial number of deaths not attributed at certification to any
type of lymphoma that are indeed attributable to CTCL, perhaps due to increased vulnerabil-
ity of these patients to other illnesses. Based on our estimates, the 591 deaths in the U.S. from
1999-2003 attributed on death certificates to CTCL excluded approximately 750 of the esti-
mated 1340 deaths due to CTCL during that period.
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Journal editor and Cochrane Skin Group author experiences co-publishing Cochrane Library
systematic reviews
RE Greene,1 SR Freeman,1 K Lundahl1 and RP Dellavalle2,1 1 Dermatology, University of
Colorado at Denver and Health Sciences Center, Denver, CO and 2 Chief, Dermatology
Service, Eastern Colorado Health Care System, Department of Veterans Affairs, Denver, CO
Publication of Cochrane Library systematic reviews in peer-reviewed journals (co-publication)
may increase dissemination of evidence-based healthcare information. Guidelines set forth
by the online Cochrane Library may differ from those of traditional print journals. These dif-
ferences may hinder co-publication. Questionnaires were mailed to 63 editors of peer-reviewed
print journals and to 28 authors of Cochrane Skin Group systematic reviews to assess their
attitudes and experiences with Cochrane Library systematic review co-publication. The sur-
vey response rates were 52% (33/63) for editors and 76% (22/29) for authors. Many journal
editors [52%, (17/33)] indicated that their journal did not allow co-publication of Cochrane
reviews, and three editors wrote in that they considered co-publication a form of duplicate
publication that increases redundancy in the medical literature and decreases journal citation
rates. Among Cochrane review authors, 33% (7/21) had co-published, 33% (7/21) were in the
process of co-publishing, and 33% (7/21) were not considering co-publication. Authors reported
from 20 to more than 80 additional hours of work are necessary to co-publish a review.
Cochrane Skin Group authors have co-published their systematic reviews in many high pro-
file journals including BMJ, JNCI, JAAD, and Archives of Dermatology. One third of authors,
however, have not sought co-publication possibly due to the significant time investment needed
to accommodate individual journal policies. Early familiarization with journal policies and
pursuit of co-publication in journals that have previously co-published Cochrane systematic
reviews is advised.
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Effectiveness of psoriasis treatments: a patients’ perspective
T Tejasvi,1 RP Nair,1 PE Stuart,1 JJ Voorhees1 and JT Elder1,2 1 Dermatology, University of
Michigan, Ann Arbor, MI and 2 VA Hospital, Ann Arbor, MI
To investigate the genetic basis of drug effectiveness in psoriasis, we are conducting a survey
of psoriatics enrolled in a large genetic study. Their responses provided a basis to examine the
effectiveness of various psoriasis treatments from a patient perspective. The questionnaire col-
lected information on self assessed PASI, TBSA when symptoms were worst, and a visual ana-
logue score (0-5) of the effectiveness of various medications used, along with demographic,
personal and family history. 711 patients responded (374 females, 337 males). The mean age
was 54.7 years, mean BMI 29.3 (men 28.9,women 29.7) and mean disease duration was 22.6
years. Patients were predominantly Caucasian (n = 638, 89.7%), 52% had a family history of
psoriasis, and 96.8% had chronic plaque psoriasis. Physician-assessed PASI was recorded in
329 (mean 5.15 ± 4.22), another 356 self-assessed their PASI (mean 8.96 ± 8.04) and 349 self
assessed their worst TBSA (mean 23.10 % ±22.53). The mean number of medications tried was
3.4 with a median of 3. Patients tended to start with two medications, increased to an aver-
age of three and four (range 0-6) by 15 and 35 years respectively, and later persisted with
same number. The most commonly used topical medication was a steroid (n = 549 patients)
with mean effectiveness (ME) of 3.27, followed by calcipotriene (n = 474, ME = 2.30). Among
the systemic drugs, methotrexate was the most used (n = 168, ME = 3.00), followed by acetritin
(n = 60, ME = 3.28). The preferred phototherapy was UVB (n = 263, ME = 3.65) compared to
PUVA (n = 127, ME = 3.48). The most commonly used biological was etanercept (n = 133,
ME = 3.62), followed by infliximab (n = 27, ME = 3.41). 23 patients (3.2%) did not report any
treatment for their psoriasis. To summarize, UVB and etanercept were reported as the most
effective treatments for extensive psoriasis. Among topical treatments, steroids were the most
effective. We also observed that our patients had significantly higher BMI than NHANES con-
trols (BMI 29.3 ± 6.6 for cases vs. 25.1 ± 7.2 for controls, mean ± SD, p <0.001).
358
Participant responses to health educator questions, at enrollment and three weeks follow-
up, predict performance of thorough skin self-examination throughout the Check-It-Out Pro-
ject trial
S Nakib,1 MA Weinstock,2 PM Risica,3 D Upegui3 and W Rakowski3 1 University of
Minnesota, Minneapolis, MN, 2 Dermatology, Brown University, Providence, RI and 3
Institute for Community Health Promotion, Brown University, Providence, RI
We sought to assess whether participant responses to health educators early in the Check It
Out Project trial predict later thorough skin self-examination (TSSE) performance. Cross-sec-
tional analyses were done to examine the association between responses to health educator
questions and TSSE. Stating that they shared the intervention materials with others or found
the materials to be helpful or useful was positively associated with TSSE performance and
stating that they did not have an opinion of the intervention materials was inversely associ-
ated with TSSE (P<0.05). Responses to health educator questions can be used to predict TSSE
performance.
359
Solar elastosis is not associated with melanoma metastasis
CC Wriston, JA Brauer, KD Hudacek, AI Rubin, A Schaffer, DB Shin, AB Troxel and ME Ming
University of Pennsylvania, Philadelphia, PA
A recent cohort study unexpectedly found an inverse association between solar elastosis at
the primary site and melanoma-specific death, suggesting that elastosis could have clinical
relevance. We sought to determine whether the event more proximal to melanoma-specific
death, namely metastasis, was associated with elastosis through a case-control study of
melanoma patients seen in the Pigmented Lesion Clinic of the University of Pennsylvania from
1972 to 2003. We compared 250 cases who presented with local disease only and who later
developed metastases to 250 controls with melanoma and who never developed metastases.
Dermal elastosis surrounding the primary tumor site was graded on a 4-point scale (none,
mild, moderate, severe) by two blinded dermatopathologists. Discrepancies were resolved by
consensus. No, mild, moderate, and severe elastosis were found in 33.6%, 41.2%, 13.2%,
and 12.0% of cases and 30.8%, 40.0%, 21.6%, and 7.6% of controls, respectively. Univari-
ate analysis revealed an association between degree of elastosis and metastasis (overall
p=0.047), but no trend (odds ratio (OR)=0.94, 0.56, and 1.44 for mild, moderate, and severe
elastosis, respectively, compared to none; p for trend=0.78). A multivariate model incorpo-
rating elastosis, sex, age, tumor thickness, ulceration, vertical growth phase, body site, and
mitotic count did not find a significant association between elastosis of any degree and metas-
tasis (p=0.98, 0.57, and 0.61 for mild, moderate, and severe elastosis, respectively; p=0.91
for overall likelihood-ratio test). Dichotomizing elastosis using varied cut points did not reveal
any significant associations in multivariate analysis. Our work does not support an independent
association between melanoma metastasis and solar elastosis, and does not confirm the pre-
vious suggestion of a clinically important link between solar elastosis and melanoma.
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Acne epidemiology among adolescents in New Jersey
B Irwin,1 A Pappert1 and A Kimball2 1 Robert Wood Johnson Medical School, Piscataway, NJ
and 2 Harvard Medical School, Boston, MA
The purpose of this study was to establish the self-reported frequency, severity, help seeking
behavior, and treatment methods of acne among students aged 10-19 based on gender, age,
race, and ethnicity. To answer these questions, a non-randomized, non-controlled survey of
1,214 students was conducted in 2006 in New Jersey. The frequency of acne was higher in
whites vs. non-whites (p<0.05), Asians vs. non-Asians (p<0.025), and ages 10-13 vs. ages 14-
19 (p<0.001) A significantly lower percentage of blacks than non-blacks reported never hav-
ing acne (33% vs. 23%, p<0.025). The severity of acne was also statistically greater for white
vs. non-white (p<0.001), black vs. non-black (p<0.05), and ages 10-13 vs. ages 14-19 (p<0.001).
The number of respondents reporting they had acne of no severity vs. acne of some severity
was statistically significant for whites vs. non-whites (p<0.001) and Asians vs. non-Asians
(p<0.05). As shown in previous studies, approximately 50% of respondents indicated they
treat their own acne (47% male, 53% female, 48% Hispanic, 53% non-Hispanic, 46% Asian,
56% white, and 37% black.) Also consistent with previous studies, approximately 80% of par-
ticipants reported they had never seen a health professional for their acne (81% Hispanics, 84%
non-Hispanics, 86% Asians, 84% white, 80% blacks, 82% female, 84% male.) 80% of students
aged 14-19 had never seen a health professional whereas 86% of students aged 10-13 had
never seen a health professional (p<0.01). The distribution of health professionals seen by stu-
dents aged 10-13 vs. the distribution seen by students aged 14-19 was significantly different
with 6% vs. 7% visiting a pediatrician, 6% vs. 12% visiting a dermatologist, 2% vs. 1% visit-
ing another type of health professional, and 86% vs. 80% never visiting a health professional
(p<0.05). This distribution was not statistically significant for respondents of different genders,
ethnicities, or races. The self-reported frequency, severity, help seeking behavior, and treatment
methods of acne patients of different ages, races, and ethnicities do vary and merit further study.
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Serious adverse events in infliximab-treated patients compared with general and psoriasis
populations
M Bala,1 J Diels,1 S Li1 and JM Gelfand2 1 Centocor R&D, Malvern, PA and 2 U of
Pennsylvania, Philadelphia, PA
Data from moderate-to-severe psoriasis pt trials(EXPRESS,EXPRESSII,SPIRIT)compared SAEs in
IFX pts to general and psoriasis populations.IFX doses included 3 to 5mg/kg induction and sched-
uled or PRN maintenance(EXPRESS,EXPRESSII).SMRs compared mortality in IFX pts to that
expected in the US.Mortality data for the psoriasis population were obtained from UK medical
records databases(GPRD,THIN).The MarketScan Claims Database was used to determine hos-
pitalization and serious infection rates in US psoriasis population.Observed malignancies(exclud-
ing nonmelanoma skin cancers)were compared to the general US population using the SEER.Num-
ber of pts in the IFX & PBO grps were 1373 & 334,respectively.SMR for IFX pts was 0.17(95%
CI:0.00,0.92);mortality rate ratio for a similar cohort of psoriasis pts in GPRD & THIN were
1.13(95%CI:1.01,1.27) & 1.26(95 CI:0.65,2.21),respectively.Hospitalization incidence rates
were 7.69 per 100 pt-yrs[95%CI:6.13,9.54] & 7.02 per 100 pt-yrs[95%CI:3.03,13.84] for com-
bined IFX & PBO grps,respectively & 8.05 per 100 pt-yrs(95%CI: 6.5,9.9) for the US psoriasis
population.Serious infection incidence rates were 1.82 per 100 pt-yrs [95%CI:1.11,2.81] & 1.73
per 100 pt-yrs[95%CI:0.21,6.23] for combined IFX & PBO grps,respectively & 1.40 per 100 pt-
yrs (95%CI: 0.80,2.27)for the US psoriasis population. Serious opportunistic infection incidence
rates were 0.18 per 100 pt-yrs [95%CI:0.02.0.65] & 0 per 100 pt-yrs [95%CI:0.00, 2.58]for com-
bined IFX & PBO grps,respectively.Malignancy SIRs were 0.41[95%CI:0.05,1.49] &
0[95%CI:0.00,5.75] for combined IFX & PBO grps,respectively.Mortality,hospitalizations,and
serious infections rates were comparable between IFX and PBO;opportunistic infection and
malignancy rates were higher with IFX.Compared to the general US and psoriasis popula-
tions,mortality rates were lower in IFX pts;rates of serious infections,and hospitalization were
similar in IFX pts vs the psoriasis population.Malignancy rates were similar to that expected in
the general population.Long term follow-up studies are necessary to confirm these results.
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Incidence of skin cancer in a cohort of vitiligo patients
CL Hexsel,1 R Krajenta,2 M Eide,1 C Johnson,2 HW Lim1 and I Hamzavi1 1 Dept. of
Dermatology, Henry Ford Hospital, Detroit, MI and 2 Dept. of Biostatistics & Research
Epidemiology, Henry Ford Hospital, Detroit, MI
Background: Despite areas of loss of melanocytes, there have been only a small number of
case reports of skin cancer in patients with vitiligo. Our objective was to quantify the inci-
dence of skin cancer in a cohort of vitiligo patients from the Henry Ford Health System (HFHS).
Using the HFHS database, 518 patients were identified by the ICD-9 code for vitiligo recorded
at least twice from January 2001 until July 2006. Medical record abstraction was performed
to validate cases of vitiligo (n=479, 92%) and to identify patients who developed biopsy-con-
firmed skin cancer within the inclusion period. Of the 479 vitiligo patients, 33% were less
than 18 years old (n= 156), 39% were 18 to 49 years old (n= 189) and 28% were over 50
years old (n=128). Overall, 52% were female and 48% male; 42% were Caucasian, 29%
African American, 6% Asian/Pacific Islander, 2% Hispanic, 2% Middle-Eastern, 2% Ameri-
can Indian and unavailable race in 17%. Six patients developed skin cancer: 4 basal cell car-
cinomas (BCC) and 2 squamous cell carcinomas (SCC). Skin cancer patients were 5 Caucasian
males and 1 Caucasian female. The age at diagnosis of skin cancer ranged from 61 to 89
years (mean of 78.2). The annual incidence rate of non melanoma skin cancer (NMSC) in the
cohort was 250.5 per 100,000 population. Stratified annual incidence rates of NMSC are as
follows: 895.5/100,000 for all individuals over 50 years of age, 594/100,000 in Caucasians,
1643.8/100,000 in Caucasians over 50 years old, 0/100,000 for all races other than Caucasian.
The annual incidence rate of the overall cohort was 167/100,000 for BCC and 83.5/100,000
for SCC. We report incidence rates of NMSC in a cohort of patients with vitiligo. NMSC was
found in elderly Caucasian patients with vitiligo, which may reflect cumulative sun exposure.
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An examination of the relationship between melanoma and other malignancies using the
Surveillance, Epidemiology and End Results (SEER) Registry
DB Shin, JA Brauer, CC Wriston, AB Troxel and ME Ming University of Pennsylvania,
Philadelphia, PA
Others have examined whether melanoma is associated with certain malignancies such as chronic
lymphocytic leukemia and breast cancer using SEER or other datasets, but we are unaware of any
previous comprehensive investigation of the relationship between melanoma and other cancers
using a dataset as large as that of SEER. We used SEER data for histologically confirmed malig-
nancies diagnosed from 1973 to 2003 and examined both the risk of developing melanoma after
a previous cancer diagnosis and the risk of developing subsequent cancers after a previous
melanoma. Standardized incidence ratios (SIRs) for cancer development were created by com-
paring the number of observed subsequent cancers to the number expected based on person-
years of follow-up and age-, gender-, and race-specific SEER incidence rates. To adjust for multi-
ple comparisons, the Hochberg procedure was used to determine significance. For the 77,814
patients with melanoma, we found an increased overall risk of subsequent cancer (SIR=1.19,
p<0.00001). Of cancers previously linked to melanoma, we confirmed an association with soft
tissue malignancy (SIR=2.18, p<0.00001), thyroid cancer (SIR=1.76, p<0.00001), and non-Hodgkin
lymphoma (NHL) (SIR=1.17, p=0.007). For the 2.25 million SEER patients with a cancer diagno-
sis, we found an increased risk of subsequent melanoma (SIR=1.38, p<0.00001). We again con-
firmed previously hypothesized associations between melanoma and NHL (SIR=1.40, p<0.00001)
and soft tissue malignancy (SIR=1.81, p=0.0001). For common cancers that had not been previ-
ously evaluated for a relationship with melanoma, we found that melanoma patients had a lower
rate of subsequent lung cancer (SIR=0.75, p<0.00001) and colorectal cancer (SIR=0.87, p=0.00008),
while patients with bladder cancer (SIR=0.85, p=0.002) had a lower rate of subsequent melanoma.
The inverse association of melanoma with bladder and lung cancer may be related to their asso-
ciation with smoking, which some have found to be associated with lower melanoma incidence.
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Prevalence of cardiovascular risk factors by psoriasis severity in biologic-treated patients:
the RESPONSE cohorts
A Ehrlich,1 S Fretzin,2 W Werther,3 Y Chen,3 I Caro3 and D Pariser4 1 George Washington
University, Washington DC, DC, 2 Dawes Fretzin Dermatology Group, Indianapolis, IN, 3
Genentech, Inc., South San Francisco, CA and 4 Eastern Virginia Medical School, Norfolk, VA
It is known that psoriasis patients experience cardiovascular disease (CVD) at higher rates than
non-psoriasis patients, but little is known about CVD risk and psoriasis severity. The Raptiva
Epidemiologic Study of Psoriasis Outcomes and Safety Events (RESPONSE) is an observa-
tional study with two cohorts of psoriasis patients—an efalizumab (E) cohort and a compari-
son (C) cohort treated with other biologics—that will be assessed for safety events for 5 years.
The objective of this analysis was to describe the prevalence of known CVD risk factors in
biologic-treated psoriasis patients of varying psoriasis severity. As of December 2006, base-
line data were available for 745 E patients and 428 C patients. Patients’ psoriasis was rated as
mild, moderate, and severe based on physician’s assessment. The majority of patients was
undergoing continuous therapy with a biologic (83% of the E cohort and 97% of the C cohort)
This may explain why the majority of patients had a disease severity of mild (53% of the E
cohort and 52% of the C cohort). Known CVD risk factors were identified as hypertension,
diabetes, hyperlipidemia, current tobacco smoking, and obesity (Body Mass Index ≥30). The
prevalence of hypertension (14–17%), diabetes (9–14%) and hyperlipidemia (9–13%) were
similar for both cohorts at all severity levels. In both cohorts, patients with moderate or severe
psoriasis smoked at almost twice the rate (~28%) of patients with mild disease (~15%). The
percent of obese patients was similar in both cohorts; however, 46% of severe E and 57% of
severe C patients were obese. Biologic-treated patients with moderate or severe psoriasis were
more likely to be current smokers than patients with mild psoriasis. Other CVD risk factors
were similarly distributed among psoriasis severity groups. The E and C cohorts had similar
profiles of CVD risk factors.
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Patient satisfaction with care among psoriasis patients depending on health-care provider
type
A Boker,1 E Horn2 and AB Kimball1 1 Dermatology, Brigham and Woman’s Hospital, Harvard
Medical School, Boston, MA and 2 National Psoriasis Foundation, Portland, OR
In chronic skin conditions such as psoriasis, patient satisfaction with their health care provider
could have a substantial impact on compliance and overall health outcomes. Survey data from
405 respondents to a 2006 National Psoriasis Foundation questionnaire was stratified depend-
ing on health care provider type to include categories “Dermatologist” (n=281), “General prac-
titioner” (n=37), “Rheumatologist” (n=35), “Dermatologist plus other health care provider’
(n=71) or “None” (n=41). Overall patient satisfaction with care was collected using a 10-
point response scale with a score of 1 being “Very unsatisfied” and 10 being “Very satisfied”.
The mean response scores of each variable are presented with a 95% confidence interval.
Patients who saw a dermatologist reported a higher overall satisfaction with their care (x=5.45,
CI [5.08-5.82]) when compared to patients who saw a general practitioner only (x=2.89, CI
[2.12-3.67]) (p<0.05). 387 patients (86%) saw one to two different doctors in the past two
years, with the highest number of doctors seen in patients who currently see no physician for
their psoriasis (x=3.46, CI [1.68-2.05]) compared to all other groups (x=2.09, CI [1.92-2.22])
(p<0.05). 117 patients (26%) use between five and 10 moisturizers for their psoriasis, while
nearly one-tenth of respondents (n=41, 9%) use more than 10 moisturizers. 95 patients (21%)
use between five and 10 medications (prescription or over the counter) while 26 (6%) use
more than 10 medications. A better knowledge of skin pathophysiology and available treat-
ment options may account for a superior quality of care delivered by a dermatologist and thus
positively affect patient satisfaction with care.
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The effectiveness of teledermatology in pigmented skin
J Hu,1,2 MW Chiu,3,5 J Cotliar,3,5 J Kim*3,5 and D Peng*4,5 1 David Geffen School of Medicine
at UCLA, Los Angeles, CA, 2 UCLA School of Public Health, Los Angeles, CA, 3 Division of
Dermatology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 4 Department of
Dermatology, Keck School of Medicine at USC, Los Angeles, CA and 5 Division of
Dermatology, Veterans Affairs Greater Los Angeles Healthcare Center, Los Angeles, CA
In the United States, disparities in both health status and health care access exist in the med-
ically uninsured and Medicaid population. These patients, who are mostly ethnic minorities,
must frequently depend on safety-net facilities, which often offer only limited or no specialty
care services, including dermatology. Store-and-forward teledermatology has been used as a
method of increasing access to dermatology care, particularly in rural areas. However, to date,
studies that support the usefulness of teledermatology in providing dermatologic care have not
specifically identified its utility in ethnic minority patients. To assess whether this technology
would be useful in safety-net facilities that regularly care for a large proportion of uninsured
and Medicaid patients in an urban setting, this novel randomized clinical study evaluates the
accuracy of teledermatology in patients with darkly pigmented versus lightly pigmented skin
as a primary outcome, while randomizing the use of a clinical information tool in an effort to
improve diagnostic concordance rates. The findings of this study may be significant in increas-
ing access to dermatology services for ethnic skin populations that otherwise have difficulty
receiving much needed dermatologic care.
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Out on a limb: prognostic factors in primary cutaneous anaplastic large cell lymphoma
DK Woo,1,2 CR Jones,1 S Kohler,1,3 K Cobb,2 GD Friedman,2 S Reddy,4 R Adrani,4 R Hoppe5
and Y Kim1 1 Dermatology, Stanford Univ, Stanford, CA, 2 Health Research and Policy,
Stanford Univ, Stanford, CA, 3 Pathology, Stanford Univ, Stanford, CA, 4 Med Onc, Stanford
Univ, Stanford, CA and 5 Rad Onc, Stanford Univ, Stanford, CA
Primary cutaneous anaplastic large cell lymphoma (pcALCL) has a favorable prognosis, but it
has been suggested that pts with extensive regional single limb disease (ERSL-D) have a worse
outcome. This study assessed potential prognostic factors in a single-center cohort of pcALCL
pts. In particular, we studied the role of ERSL-D, defined as extensive single limb involvement
at presentation or rapid progression in a regional fashion with lack of durable response to treat-
ment. The study included pts with pcALCL evaluated at Stanford from 1990 to 2005. Overall
survival (OS) and disease-specific survival (DSS) were calculated from the date of diagnosis
and plotted using the Kaplan-Meier technique. Univariate and multivariate analyses of poten-
tial prognostic factors (age, sex, ERSL-D, skin lesion extent and location, histology, sponta-
neous regression, progression to extracutaneous disease) were performed using Cox propor-
tional hazards regression. cDNA microarrays were used to identify gene signature patterns that
may correlate with outcome. A total of 48 pts (39 M, 9 F) were included, with median age of
54yrs (20yrs-84yrs). OS was 76% at 5yrs and 70% at 10yrs. DSS was 85% at 5 and 10yrs. In
univariate analyses, prognostic factors significant for OS were ERSL-D (HR 8.03, p=0.005) and
age at diagnosis (HR 1.99 per 10yrs, p=0.014), while ERSL-D (HR 37.61, p=0.002) was the
only factor significant for DSS. In multivariate analysis, age remained a significant factor for
OS (HR 1.79 per 10yrs, p=0.047) while ERSL-D showed a trend toward significance (HR
3.76, p=0.086). Microarray analysis revealed that pts with ERSL-D (n=3) clustered separately
from those without (n=6). STAT5A, IL2RA, HIPK2 and WDR10 were more highly expressed
in the ERSL-D subset. In conclusion, our data suggest that pcALCL pts with ERSL-D have a
more aggressive course associated with a differential gene expression profile.
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The prevalence and age of onset of asthma and seasonal allergy among patients with atopic
dermatitis
R Kapoor,1 C Menon,1 O Hoffstad,1 W Bilker,1 P Leclerc2 and D Margolis1 1 Dermatology,
Epidemiology, Biostatistics, University of Pennsylvania, Philadelphia, PA and 2 Novartis
Pharmaceutical Corporation, East Hanover, NJ
Atopic dermatitis (AD) is often associated with other atopic illnesses such as asthma and sea-
sonal allergies. While many studies have documented the prevalence of these other atopic dis-
eases among patients with AD, their pattern of occurrence with AD has not been clearly
described. The aim of this study is to describe the occurrence of these other atopic diseases
within a large longitudinal study of children with physician-confirmed AD. This is a cross-sec-
tional study of children ages 2 to 17 years of age enrolled in the PEER (Pediatric Eczema Elec-
tive Registry) study, which is an FDA-requested post-marketing study. All study subjects were
first confirmed by a physician to have AD and to have used pimecrolimus cream 1% to treat
their AD for a minimum of 6 weeks (or more) within 6 months prior to study entry. Additional
information was obtained using a questionnaire that focused on many comorbidities and
family history. The presence of asthma or seasonal allergy was determined by questionnaire
using queries from the International Study of Asthma and Allergies in Childhood (ISAAC). For
this report, we analyzed the first 2,270 individuals enrolled in PEER. Of those enrolled, in addi-
tion to having AD, 1,618 (71.3%) reported either asthma or seasonal allergies: 33.3 percent
reported either asthma or seasonal allergies alone, and 38.0 percent reported both. Children
with AD and family history of any of the three atopic diseases were at least twice as likely to
have asthma or seasonal allergies. By 3 years of age, the percentage of children that devel-
oped at least one additional form of atopy (79.6%) remained relatively constant across all age
groups. We also noted that the presence of asthma and seasonal allergies was associated with
more active AD. In conclusion, by age 3, a majority of the children with AD develop other
forms of atopy which in turn correlates with disease activity.
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Trend analysis of melanoma stage at diagnosis among Hispanics, blacks, and whites in Florida
from 1995–2004
S Hu, F Ma and K Robert Dermatology, University of Miami Miller School of Medicine, Miami, FL
Backround: Florida is among the top five US states with the largest Hispanic populations and
has greater than the national average of black population. The overall prevalence of melanoma
in Florida is the second highest in the US, thus offering unique advantages of studying the tem-
poral trends in melanoma among minority populations. Objective: 1)To compare proportion of
early (localized) stage melanoma at diagnosis among white Hispanics (WH), white non-Hispanic
(WNH) and blacks in Florida from 1995-2004. 2)To characterize the temporal trend of melanoma
stage at diagnosis among WH, WNH, and blacks in Florida from 1995-1999 to 2000-2004. Meth-
ods: Invasive melanomas from Florida Cancer Data System for WH, WNH, and blacks was strat-
ified by stages at diagnosis: local, regional and distant. Trends in melanoma stage for each pop-
ulation was analyzed from the earlier five-year interval, 1995-1999, to the later five-year interval,
2000-2004. Results: From 1995-2004, 703 invasive melanomas were recorded in WH, 23,514
in WNH, and 159 in blacks. Over the ten years, 31% of melanomas in blacks were at advanced
stage (regional or distant) compared to 15% in WNH (odds ratio = 2.53, 95% CI=1.81, 3.55).
WH were also more likely to have late stage melanoma (23%) at diagnosis (odds ratio=1.69,
95%CI=1.41, 2.02). From 1995-1999 to 2000-2004, there was no significant change in pro-
portion of local stage melanoma in WH (76.9% to 77.2%, P= 0.93) and WNH (85.2% to 84.9%,
P=0.39). Although more localized melanomas were detected at presentation among blacks
(72.4%) in 2000-2004 compared to that (66.3%) in 1995-1999, this was not significant (P=0.40).
Conclusion: In Florida from 1995-2004, both blacks and WH were more likely to be diagnosed
with advanced stage melanoma compared to WNH. Blacks also have the highest proportion of
late stage melanoma at diagnosis. The percentages of melanomas diagnosed at localized stage
changed little over the 10 year time period, suggesting the need for improvement in secondary
prevention and public health policies in melanoma care in Florida.
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Validation of a questionnaire for self-diagnosis of pigmentary disorders in Chinese individ-
uals
A Wuu and AG Pandya Dermatology, University of Texas Southwestern Medical Center,
Dallas, TX
Although common, there is limited information on the prevalence of hyperpigmentation dis-
orders in Chinese women. In order to determine prevalence, a tool for self-diagnosis of these
disorders must be validated. The goal of this study was to validate a questionnaire in Chinese
that could be used to determine the prevalence of lentigines, post-inflammatory hyperpig-
mentation and melasma in Chinese women. A questionnaire was validated by collecting data
on self-diagnoses followed by a physical exam of 69 Chinese pre-menopausal women in Hous-
ton, Texas. All data were collected from a limited population at one location. The question
regarding self-diagnosis of lentigines had a sensitivity of 93.18±3.80% and a specificity of
96.00±3.92%. For post-inflammatory hyperpigmentation, the sensitivity was 100.00% and
specificity was 92.11±4.37%, whereas the question on melasma had a sensitivity of
81.82±11.63% and a specificity of 93.10±3.33%. The questionnaire is determined to be valid
for lentigines and post-inflammatory hyperpigmentation, and can be used to assess the preva-
lence of the two conditions in Chinese women. The sensitivity of the melasma question appears
to be slightly low, suggesting that it should be altered and tested again with a larger sample
size to assess validity.
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Risk of lymphoma among users of topical corticosteroids and topical calcineurin inhibitors
FM Arellano,1,3,2 A Arana,1 CE Wentworth,2 C Fernandez-Vidaurre,5 R Schlienger4 and
E Conde6 1 Risk Management Resources, Zaragoza, Spain, 2 RiskMR, LLC, Bridgewater, NJ, 3
Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia, 4 Global
Epidemiology, Novartis Pharma AG, Basle, Switzerland, 5 Global Epidemiology, Novartis
Pharmaceuticals, East Hanover, NJ and 6 Servicio Hematologia, Hospital Valdecilla,
Santander, Spain
In a recent study the risk of developing lymphoma in patients with atopic dermatitis (AD) increased
with age, use of oral steroids and severe AD. Use of topical calcineurin inhibitors (TCI) was not
associated with an increased lymphoma risk, while the odds ratio (OR; 95% confidence intervals
[CI]) for high-potency topical corticosteroids (TCS) was 1.2; 0.8 – 1.8. Our objective was to assess
the risk of lymphoma associated with the use of TCS or TCI in the UK general population. We
conducted a nested case-control study in patients aged 0-79 years without known risk factors for
lymphoma in the UK THIN database from Jan 1, 1992 to Mar 23, 2006. Cases were identified by
the presence of a READ code for lymphoma. Four controls for each case, matched by age group,
gender and practice, were randomly selected. We calculated OR with 95% CI for lymphoma using
logistic regression conditional on case-sets. There were 2,829 cases of lymphoma (1,162 non-
Hodgkin, 431 Hodgkin, and 1,236 cases for which further information is being sought). The OR
showed an increase in the lymphoma risk in TCS users (OR 1.54; 95% CI 1.39-1.69), which was
dependent on TCS potency, with a higher risk among users of high-potency TCS (OR 1.92; 95%
CI 1.65-2.24). The number of TCI users was insufficient to perform any meaningful analyses. No
lymphoma case was identified among TCI users. In this preliminary analysis, pending classifica-
tion of 1,236 cases, we found a possible increased risk of lymphoma in TCS users in the UK. This
result should be interpreted with caution. We are in the process of determining whether any
increase is limited to a particular type of lymphoma and performing analyses adjusting for sever-
ity of AD and use of oral steroids among other potential confounders.
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Ocular manifestations in rosacea
T Dannemann,1 K Nicholson,2 J Estaris2 and S Chen2,3 1 Medical College of Georgia, Augusta,
GA, 2 Dermatology, Emory University, Atlanta, GA and 3 Dermatology and HRS&D, Atlanta
VAMC, Atlanta, GA
The National Rosacea Society has recently categorized the various manifestations of rosacea into
primary features (symptoms which must be present for diagnosis) and secondary features (symp-
toms with variable presence). Ocular manifestations of rosacea are secondary features of particu-
lar interest because undetected ocular disease in rosacea patients can have serious outcomes such
as corneal involvement progressing to blindness. Our purpose is to better understand the preva-
lence and symptomatology of ocular rosacea in cutaneous rosacea patients. Data were collected
by a phone survey administered to cutaneous rosacea patients at Emory University and assessed
with chi-square and t-tests. Of 628 patients called, 135 completed the survey (99 female, mean
age: 56.5 years). Presence of ocular symptoms was described by 94 of the 135 patients (70%). The
two statistically significant demographic differences between patients with and without ocular
rosacea were age (59.0 vs. 51.3 years, p=0.003) and marital status (74/94, 78% vs. 25/41, 61%
married; p=0.031). Among the patients with ocular symptoms, 19% (18/94) experienced one ocu-
lar symptom while the majority (55%) experienced ≥3 symptoms. Dryness was the most reported
ocular symptom (68/94, 72.3%), followed by burning or stinging (60%), watery or bloodshot eyes
(52%), photophobia (49%), and feeling of foreign body sensation (46%). There were no statistically
significant differences in the proportion of ocular involvement between the erythematotelangiectatic,
papulopustular and phymatous cutaneous rosacea subtypes or between the duration of cutaneous
disease and number of ocular symptoms experienced. Our study demonstrates that ocular rosacea
is a prevalent co-morbidity of cutaneous rosacea with more than two thirds of the patients experi-
encing both manifestations of disease. In addition, patients with ocular disease are most often bur-
dened with multiple symptoms. With such a significant presence, patients diagnosed with cuta-
neous rosacea should concurrently be screened and followed for related ocular disease.
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Quality of life of women with vulvodynia
M Ponte,1 E Klemperer,1 A Sahay2 and M Chren1,2 1 Dermatology, University of California,
San Francisco, San Francisco, CA and 2 Veterans Affairs Medical Ctr, San Francisco, CA
Patient reports are central to the definition and care of vulvodynia, a complex pain syndrome
that is under-recognized. The effects of vulvodynia on quality of life, however, are poorly
understood. To understand the quality of life of women with vulvodynia, we performed a cross-
sectional study of new patients in a vulvar disorders clinic. Vulvar diagnoses were made
using established definitions. Skin-related quality of life was measured with a vulvar-specific
version of Skindex-29; scores varied from 0 to 100 (worst quality of life), and are reported in
three domains: Symptoms, Emotional effects, and effects on social Functioning. We defined
poor quality of life as a Skindex score below the median for the sample. The response rate
was 95%: 101 patients (36%) had vulvodynia, and 179 patients (63%) had other vulvar con-
ditions such as lichen simplex chronicus and lichen sclerosus. Overall, women with vulvo-
dynia reported many quality-of-life effects. For example, 56% reported that their vulvar con-
dition often or always affected their relationships, and 36% reported that their vulvar condition
made them feel hopeless. In addition, women with vulvodynia had significantly worse qual-
ity of life than patients with many other dermatologic conditions, and worse Functioning
than women with other vulvar conditions (mean Functioning scores (+SD) of women with
psoriasis, other vulvar conditions, and vulvodynia were 23+27, 34+24, and 44+22, respec-
tively, P=0.05). In the entire sample, a diagnosis of vulvodynia was the strongest independ-
ent correlate of poor quality of life (e.g., for poor Functioning, OR=1.8, 95% CI 1.0-3.1).
Finally, among women with vulvodynia, those who reported a history of depression were sig-
nificantly more likely to have poor quality of life in all domains than those without a history
of depression (eg, for poor Functioning, OR=4.9, 95% CI 1.8-13.5) . We conclude that vul-
vodynia had broad and substantial effects on quality of life, and a history of depression was
strongly associated with poor quality of life in women with vulvodynia.
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Psoriasis e-communities: exploring the benefits of online support
SZ Idriss,1,2 JC Kvedar1,2 and AJ Watson1,2 1 Center for Connected Health, Boston, MA and
2 Dermatology, Massachusetts General Hospital, Boston, MA
There has been a recent rise in availability of online psoriasis support sites, however, little is
known about the users or the benefits of these communities. A link to an online survey was
posted on 5 psoriasis support websites. We collected data on user demographics, attitudes
and usage patterns. We created a participation score combining logon frequency with usage
patterns. We report initial results from the first 211 respondents. The mean age of respondents
was 39.7 years old (SD 11.6, range 18-75), most were white (72.25%), male (56.4%), and
82.4% had attended college. 57.7% reported having mild to moderate psoriasis, and 79.2%
rated their overall health as average or above. The median DLQI score was 9 [interquartile
range 4,15]. The Internet was more commonly cited as a source of support than physicians
(87% vs. 55.3%). 57.6% of users have been using the site for over a year. Key factors associ-
ated with use of online support sites included convenience (93.7%), availability of resources
(92.4%), access to good advice (92.2%), and the lack of embarrassment when dealing with
personal issues (90.2%). The most common activities were posting messages (66%) and search-
ing for information (65.1%). Improvement in social support since joining included having
someone to provide information (77.25%), someone to count on to listen (61.1%) and some-
one to help deal with personal issues (56.2%). DLQI scores were associated with disease
severity (p<0.001) but not with level of participation. Higher participation scores were asso-
ciated with improved quality of life (QOL) since joining the site (p=0.0154) and younger age
(p<0.05) but were not associated with improvements in psoriasis severity. Our findings reveal
that online support site users are generally young, educated and want access to information.
Frequent usage is associated with improved quality of life although is not linked to absolute
quality of life or disease severity. Our data demonstrates that psoriasis e-communities offer
users both a valuable resource and a source of social support.
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A comprehensive epidemiologic review of vitiligo in Olmsted County Minnesota from 1957
through 2002
CJ Rinaldi, M al-Hashimi, S Srinivasan, A Weaver and MR Pittelkow Mayo Clinic Rochester,
Rochester, MN
Vitiligo is a depigmentation disorder whose characteristics remain largely ill-defined. This
study was designed to analyze the epidemiology and clinical profile of patients with vitiligo.
A population based analysis was conducted of residents in Olmsted County, Minnesota diag-
nosed with vitiligo from 1957 through 2002. 344 patients diagnosed with vitiligo over this
period were identified and reviewed. The overall incidence of vitiligo was 7.54 per 100,000
person-years. This incidence did not vary significantly over time. The ratio of females to males
was 1.3:1 for this population. The mean age at diagnosis was 33.9 years. Race–ethnicity was
predominantly European American (78.5%) in the population composed largely of this group.
The majority (60%) of patients received a diagnosis of vitiligo within one year of disease onset.
The most common sites involved were: upper extremity (60.2%), face (39.8%), lower extrem-
ities (35.8%), chest (19.5%), and ano-genital area (17.4%). Forty-four percent had patchy,
33.4% had isolated, 16.9% had extensive and 5.5% had unspecified involvement. The preva-
lence of hypothyroidism (21.5%), type II diabetes mellitus (8.1%), alopecia areata (6.4%),
hyperthyroidism (5.2%) and psoriasis (4.1%) among the vitiligo cohort was significantly greater
than that of the general population. Only half of the patients with vitiligo received treatment,
of which the most common interventions were sunscreens and corticosteroids. In conclu-
sion, the prevalence and age at diagnosis for vitiligo in this study population is different from
that previously reported. The majority of patients presented early after the appearance of pig-
mentation changes but only a few received treatment or follow-up evaluation. These findings
support the association of vitiligo with other autoimmune conditions.
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A community-based study of acne-related health preferences in adolescents
CL Chen,2 M Kuppermann,3,4,5 AB Caughey3,4 and LT Zane1 1 Dermatology, UCSF, San
Francisco, CA, 2 School of Medicine, UCSF, San Francisco, CA, 3 Obstetrics, Gynecology, and
Reproductive Sciences, UCSF, San Francisco, CA, 4 Epidemiology and Biostatistics, UCSF, San
Francisco, CA and 5 Medical Effectiveness Research Center for Diverse Populations, UCSF,
San Francisco, CA
The purpose of this study was to examine preferences for acne-related health outcomes in ado-
lescents utilizing a community-based cross-sectional survey. 266 adolescents with acne were
recruited from four public high schools in San Francisco. Health utilities for current acne state
and three hypothetical acne-related states representing degrees of improvement (100% clear-
ance, 50% clearance, 100% clearance but with residual scarring) were assessed with the
time trade-off metric in a self-administered written survey. Mean and median utilities for cur-
rent acne state using the time trade-off metric were 0.961 and 0.985, respectively. 100% acne
clearance received a higher utility score (mean 0.978, median 0.994) than 50% clearance
(0.967, 0.992, P<0.001 by Wilcoxon signed-rank test) and 100% clearance with scarring
(0.965, 0.992, P<0.001). A significant association with subject-rated severity was observed in
both univariate analysis (P = 0.007) and after adjustment for income, duration of acne, and
having seen a doctor for acne (P=0.04). Acne-QoL score was positively correlated with util-
ity score (P<0.001). Adolescents were willing to pay a median of $275 (IQR $100-$1000) to
have never had acne in their lifetime, and would pay significantly more for 100% clearance
than for 50% clearance or 100% clearance but with scarring (both P<0.001). We describe
community-based adolescents’ acne-related health state utilities. Compared to current acne
state utility, partial (50%) and total clearance with scarring are substantially less preferable
than total lesion clearance. Subject’s self-rated disease severity correlates with current acne
state utility. A self-administered paper instrument can effectively assess adolescents’ acne-
related preferences in community-based samples.
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Improving access to dermatologic care via teledermatology within the VA hospital system:
outcomes study
JD Miller,1,3 D Santo Domingo,1,3 S Ober,2 L Drumm2 and E Baron1,3 1 Dermatology,
University Hospitals Case Medical Center/Case Western Reserve University, Cleveland, OH,
2 Internal Medicine, Louis Stokes VA Medical Center, Cleveland, OH and 3 Dermatology,
Louis Stokes VA Medical Center, Cleveland, OH
Telemedicine uses multi-media communication technologies to remotely diagnose, treat, and
monitor patients, conduct consultations, or transfer medical data and education. One of the
biggest areas of growth within telemedicine is the field of dermatology. Across the United
States, a geographically mal-distributed workforce of dermatologists exists, a problem that is
projected to worsen. Patient access to dermatologic care is threatened, especially in rural loca-
tions. The dermatology workforce shortage has resulted in long wait times for appointments,
especially for new patients. Teledermatology has received much attention as a solution to the
preceding problems. A pilot study was conducted to incorporate “store and forward” teleder-
matology consults (e-consults) into the Cleveland VA hospital system while studying its impact
on clinical outcomes, satisfaction, and wait-times. A prospective randomized controlled trial
of 50 patients was completed, 25 serving as controls and 25 receiving teledermatological inter-
vention. The use of teledermatology e-consults resulted in statistically significant shorter wait-
times for patients (wait-times were reduced from an average of 88.28 days to 7 days) and simul-
taneously, maintained both patient and provider satisfaction in the level of care. Teledermatology
e-consults also improved clinic workflow, and enabled urgent cases to be seen earlier. Our
results demonstrate the feasibility of utilizing a teledermatological consult service as an effec-
tive alternative to the traditional consultation process.
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Patient satisfaction with treatments of nonmelanoma skin cancer
M Asgari,1 D Bertenthal,2 S Sen,2,3 A Sahay2 and M Chren2,3 1 Division of Research, Kaiser
Permanente Northern CA, Oakland, CA, 2 San Francisco VA Medical Ctr, San Francisco, CA
and 3 University of California, San Francisco, San Francisco, CA
Patient satisfaction is an important aspect of patient-centered health care, but has not been
systematically studied after treatments of nonmelanoma skin cancer (NMSC), the most preva-
lent cancer. The aim of this study was to compare patient satisfaction one year after different
treatments for NMSC. In a prospective cohort study, 682 patients were enrolled before treat-
ment of NMSC at a university practice or a VA clinic. Patient satisfaction was measured one
year after therapy with a global item about overall satisfaction with treatment. Scores varied
from 1 (least satisfied) to 5 (most satisfied). Treatments were electrodessication and curettage
(16%), excision (40%) and Mohs surgery (44%). 506 patients (74%) responded at one year
after treatment. Overall, mean satisfaction with treatment was high (4.1+1.1). In unadjusted
analyses, satisfaction was associated (P<0.05) with patient, tumor, and care characteristics:
patients with higher satisfaction were more likely to be white, married, healthier, and with
higher pre-treatment skin-related quality of life; they were more likely to have tumors on the
head and neck and less likely to have been treated by a nurse practitioner. In multivariable
regression models adjusting for patient, tumor, and care characteristics, higher satisfaction was
independently associated (P<0.05) with younger age, white race, better pre-treatment mental
health, better pre-treatment skin-related quality of life, and with treatment with Mohs surgery.
We conclude that patient satisfaction with treatments of NMSC is related to pre-treatment
patient characteristics as well as treatment type. These results should be combined with data
about other outcomes to inform decision making for NMSC.
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Cardiovascular risk in a well characterized cohort of the Utah psoriasis population
GE Korver, K Callis, T Nelson, R Wong and G Krueger Dermatology, University of Utah, Salt
Lake City, UT
Several groups have reported elevation in cardiovascular risk factors as well as increased risk
of cardiovascular disease in the psoriatic population. The Utah Psoriasis Initiative (UPI) is cur-
rently a cohort of over 800 psoriatic subjects of moderate to severe psoriatic patients where
enrollment focuses on phenotypes. Patients enrolled in the UPI have elevated cardiovascular
risk similar to that reported for other populations. Many risk factors for cardiovascular disease
are increased significantly in patients enrolled in the UPI compared with the general Utah
population. The prevalence in the UPI vs the Utah population: for diabetes was 9.1% vs
5.5%; for hypertension 24.5% vs 18.4%; for stroke 1.8% vs 1.3%; and for myocardial infarc-
tion (MI) 3.5% vs 3.3% (controls include all types of heart disease). The percentage of smok-
ers in the UPI was 36.2% vs 11.9% in the Utah population. As in other populations, severity
of disease in the UPI correlates with increasing cardiovascular risk. We divided patients into
severe psoriasis (at worst ever = BSA>10) and mild psoriasis (at worst ever = BSA 3 or less). A
statistically significant increase in hypertension (26.6% vs 18.1%) and smoking (39% vs 25%)
was noted in patients with severe disease. While not statistically significant, diabetes mellitus
was more common in severe disease (11.4% vs 6.5%), as was stroke (1.7% vs 1.4%), myocar-
dial infarction (3.7% vs 3.3%) and depression (22% vs 17%). Similarly, when we compared
patients with psoriatic arthritis to those without arthritis we saw a trend toward worsening risk
factors and increased myocardial infarction prevalence. Depression prevalence was signifi-
cantly higher (23% vs 16%) in patients with psoriatic arthritis. We conclude that cardiovas-
cular risk in subjects in the Utah Psoriasis Initiative is similar to that reported by other groups.
This increased risk associates with elements that alter quality of life, severity of disease, depres-
sion and psoriatic arthritis.
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Sun exposure, vitamin D receptor polymorphisms and risk of melanoma
R Mandelcorn-Monson,1 M Berwick,2 I Orlow,3 B Armstrong,6 C Rosen4 and L Marrett5 1
University of Toronto, Toronto, ON, Canada, 2 University of New Mexico, Albuquerque, NM,
3 Memorial Sloan-Kettering Cancer Center, New York, NY, 4 University of Toronto, Toronto,
ON, Canada, 5 Cancer Care Ontario, Toronto, ON, Canada and 6 University of Sydney,
Sydney, NSW, Australia
Sun exposure plays a role in the development of melanoma, but the precise mechanisms are unclear.
Sunlight also potentiates synthesis of vitamin D in the skin, and vitamin D inhibits tumor cell growth
in melanoma and other cancers in vitro and in vivo. Sunlight may therefore exert competing influ-
ences in melanoma: harmful, in promoting melanoma, and beneficial, in promoting vitamin D syn-
thesis. Vitamin D effects are mediated through the vitamin D receptor (VDR) and VDR co-activa-
tors. Known VDR polymorphisms include a functional 5’ end variant (FokI), a 3’ region cluster (BsmI,
ApaI, TaqI and polyA tail variants) and an AIB1 co-activator variant. VDR polymorphisms have been
identified in melanoma. We hypothesized that genetic variation in VDR might affect the relation-
ship of sun exposure to melanoma risk. A population-based case-multiple case study, where ‘mul-
tiple cases’ were patients with multiple primary melanoma and ‘cases’ were patients with single
primary melanoma, was performed to investigate the interaction between VDR polymorphisms and
sun exposure. 825 multiple cases and 1301 cases were identified via population-based cancer
registries in New Jersey (USA), New South Wales (Australia) and Ontario (Canada) in a 4-year period.
Data on sun exposure and other risk factors were collected via questionnaire and telephone inter-
view, and genotyping for FokI, BsmI and AIB1 co-activator variants, was performed. Interaction was
seen between the BsmI variant and weekly and occupational sun exposure in adults (weekly sun
exposure ORBB=0.57, ORBb=0.87, ORbb=1.18; occupational ORBB=0.4, ORBb=0.86, ORbb=1.46)
where BB appeared to have a protective effect. No associations were noted for FokI and AIB1 poly-
morphisms. The results indicate that BsmI modifies the effect of sun exposure in melanoma patients
and may contribute to variation in cancer susceptibility.
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Dermatologic procedural coding trends in Medicare claims data
MJ VanBeek,1 K Wright,2 C Jenkins,1 D Kadyk,1 S Singh2 and M Voelker2 1 Dermatology,
University of Iowa, Iowa City, IA and 2 Epidemiology, University of Iowa, Iowa City, IA
There is considerable literature examining the increasing incidence of skin cancer among Cau-
casians in the United States. Heightened public awareness, fear of litigation, and economic
pressure may result in providers having a lower threshold to biopsy skin lesions compared to
typical practices of the previous decade. We examined the rate of Current Procedural Termi-
nology (CPT) codes in carrier and outpatient claims per 1000 eligible beneficiaries recorded
in the 5% SEER-Medicare data for skin biopsy, excision and Mohs procedure claims from 1993
to 2002. The total number of skin biopsy CPT codes identified per 1000 beneficiaries increased
from 54.9 in 1993 to 91.7 in 2002. During this same time, the rate of malignant excision CPT
codes identified increased from 25.9 to 27.0; and the number of Mohs CPT codes more than
tripled from 3.7 to 11.8. Assuming the total malignant excision and Mohs CPT codes repre-
sent the sum of treatment procedures for malignant skin lesions, there has been an incongru-
ent increase in the number of these treatment procedures relative to the larger proportional
increase in skin biopsy rates. This might indicate that physicians are biopsying a greater pro-
portion of benign lesions over time. Such an increase in the number of biopsy procedures
over time may be warranted considering the increasing incidence of skin cancer. However, if
the same clinical criteria were used to determine the need for a biopsy, we would expect to
find a stable ratio of skin biopsies to malignant procedures. Procedural costs are a significant
portion of health expenditures. Consequently, it is important to recognize procedural trends
and determine if such changes are substantiated by the medical need of a population. Changes
in CPT coding, reimbursement rates, patient population characteristics, practice standards,
and perceived litigation risk may all contribute to variation in the number of procedures coded
over time. For this reason, caution is warranted in drawing conclusions about these trends
without further study.
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Knowledge, attitudes and behaviors of elementary school students regarding sun exposure
and skin cancer
P Rouhani,1 F Ma,1 AG Bessell,2 T Peay3 and RS Kirsner1 1 Dermatology, University of Miami,
Miami, FL, 2 Education, University of Miami, Miami, FL and 3 Richard David Kahn Melanoma
Foundation, West Palm Beach, FL
Florida has among the most ambient sunlight in the United States and as a result Florida’s
school children are at increased risk of excessive ultraviolet light exposure, the most impor-
tant modifiable risk factor for skin cancer. As part of NIH sponsored research we assessed the
knowledge, attitudes and behaviors of the 3rd to 5th graders toward sun safety and skin can-
cer prevention in Palm Beach County, Florida. From a random sample of 17 elementary schools,
4,450 students (2,319 boys, 52%) completed the skin cancer prevention survey. Among stu-
dents surveyed, 1,545 (37%) were white, 1,020 (25%) were white Hispanics, and 1,010 (25%)
were black. We found over one fifth (21%) of students reported spending more than 2 hours
in the sun on a weekday, and more than one third (35%) reported spending more than 2 hours
in the sun on a weekend day. Over half (56%) of students considered people with tans to look
healthier and a similar number (55%) believed suntan is good for skin (55%). We found a sta-
tistically greater number of black students who believed people with dark skin could not get
skin cancer compared to white students (50% vs. 36%, p < 0.001). With regard to sun pro-
tective behavior, few students wore sunscreen, SPF 15 or more when outdoors. 12% wore sun-
screen most of the time and 15% always wore sunscreen. Girls were more likely to have applied
sunscreen when compared to boys (31% vs. 24%, p < 0.001). Notably, over 60% of students
did not know what sun protection factor (SPF) should be used. These results indicate that ele-
mentary students in Florida lack knowledge about sun safety and skin cancer prevention, lack
positive sun safe attitudes and do not practice sun protective behavior. Further work will deter-
mine whether educational intervention will alter knowledge, attitudes and behaviors in ele-
mentary school children as these students are an excellent target for both further evaluation
and intervention.
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Vascular disease in patients with psoriasis
F Ma,1 S Prodanovich1 and R Kirsner1,2,3 1 Dermatology, University of Miami, Miami, FL, 2
Epidemiology and Public Health, University of Miami, Miami, FL and 3 Dermatology,
Veterans Administration Medical Center, Miami, FL
T-lymphocytes are the main driving force in the development of psoriatic lesions. This inflam-
matory response is believed to cause an oxidative stress state that can potentially lead to the
development of vascular disease. This cross-sectional study compared prevalence of vascular
disease between psoriasis and non-psoriasis patients. Included in the analysis were 3,236
patients with psoriasis and 2,500 randomly selected control patients who did not have psori-
asis from the Miami Veterans Medical Center database at the end of 2005. The patients with
psoriasis were older (mean age ± SD; 67.9 ± 14.1) than the controls (65.1 ± 17.6). The pro-
portion of females among non-psoriasis patients (11.8%) was significantly greater than that
among patients with psoriasis (4.5%). The multivariate logistic regression results found that,
after controlling for age, gender, co-morbidity including diabetes mellitus, dyslipidemia, hyper-
tension, and smoking status, the odds of psoriasis patients having ischemic heart disease, cere-
bral vascular disease, or peripheral vascular disease were significantly greater than the patients
without psoriasis. The odds ratio (95% confidence interval) for ischemic heart disease, cere-
bral vascular disease, and peripheral vascular disease were 1.8 (1.5 – 2.1), 1.7 (1.3 – 2.2), and
2.0 (1.4 – 2.8), respectively. Overall, patients with psoriasis were 1.9 times more likely to suf-
fer from vascular diseases relative to the control patients (95% CI: 1.6 – 2.2). These findings
suggest that patients with psoriasis may have an increased risk of vascular disease, independent
of the presence of vascular risk factors.
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Dermatological problems with prosthetic roll-on liners
M Hall,2 D Shurr,2 MJ VanBeek1 and M Zimmerman3 1 Department of Dermatology,
University of Iowa, Iowa City, IA, 2 American Prosthetics, Iowa City, IA and 3 Biostatistics,
University of Iowa, Iowa City, IA
The Icelandic roll-on silicone socket (ICEROSS) is now the standard treatment for transtibial
amputees. Manufacturers claim superior comfort, suspension, and relief of dermatological
problems. However, published literature lacks data on the prevalence and type of dermato-
logic problems thought to be common among transtibial amputees. The purpose of this study
is to establish an incidence of dermatological problems with roll-on liners in transtibial
amputees. A questionnaire determined demographic information, skin type, hygiene and pros-
thetic habits, co-morbidities and self-reported skin problems. All participants were offered a
free examination by a dermatologist to verify medical history and document current skin prob-
lems. A chi-square, trend, and rank-sum test were used. Forty-one percent of 290 possible
surveys were returned complete and 23 subjects (19%) received skin exams with a dermatol-
ogist. The population included 92 men and 27 women with a mean age of 58.3 years (range
19-85 yrs). The mean time since amputation was 10.1 years (range 0.1-57 yrs). Skin problems
were self-reported in 91% of respondents; dermatologic diagnoses were confirmed in 22%.
Amputees who shaved the limb were more likely to complain of excessive sweating than those
who did not shave (p=0.0473). Compared to fair skinned subjects, more medium or dark
skinned subjects reported excessive sweating (76%, p=0.0238) and itching (70%, p=0.0262).
Liner design and hygiene, race, hair color, co-morbidities, and prosthesis wearing time and
fit were unrelated to skin problems. The skin exam data indicated a history of ulcers (52%),
contact/irritant/frictional dermatitis (35%), and folliculitis (30%). Subjects commonly presented
with lichenification (30%) and contact/irritant/frictional dermatitis (26%). A direct correlation
between amputee habits and skin problems is not clear. In this study, a greater number of
transtibial amputees utilizing roll-on liners had dermatological problems than previously
reported.
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Are community-based psoriasis sufferers at an increased cardiovascular risk? An analysis
from National Health and Nutrition Examination survey
S Singh and M Van Beek Dermatology, Univ. of Iowa, Iowa City, IA
There is some evidence to suggest that patients with psoriasis are at an increased risk for car-
diovascular events when compared with general population. There is little evidence in this
regard from population-based studies from United States. We decided to compare preva-
lence of cardiovascular risk factors in participants who reported that they were suffering with
psoriasis in NHANES 2003-04 with those reported that they were not suffering with psoria-
sis. 34 cases(p) and 1247 controls(nc) were selected, based on availability of sufficient labo-
ratory and questionnaire data to permit risk-factor profile analysis. Prevalence of risk factors
in both groups was compared using chi square tests and two- sided p values were calculated
using the exact method where appropriate. Data was analyzed using SAS version 9.1. Preva-
lence of various major and minor cardiovascular risk factors was as follows: age(> 55 yrs in
females and >45 yrs in males): 11.8% in p and 16.6% in nc; high Cholesterol( >240 mg/dl):14.7
% in p and 14.5 % in nc; hypertension 15.6% in p and 10.9% in nc; smoking 41.1% in p and
47.4 % in nc; low HDL (<40 mg/dl) 20.6 % in p and 23.9 % in nc (* p value=.05) ; high
HDL(>60 mg/dl) 11.8 %in p and 27.8* in nc (* p value = .05); high Triglycerides (>200 mg/dl)
23.5% in p and 17.5% in nc; high LDL (>160 mg/dl) 9.4% in p and 11.6% in nc; Obesity
(BMI>30 kg/m2) 41.2% in p and 34.4% in nc ; presence of CHD equivalents ( medical his-
tory of myocardial infarction, angina, stroke) 8.8% in p and 3.4% in nc; diabetes 5.9% in p
and 7.7% in nc; high C Reactive Protein (>3 mg/dl) 2.9 % in p and 2.1% in nc. In general,
we observed a more adverse risk factor profile in patients with psoriasis when compared with
general population. However these differences, except for HDL (low and high), did not achieve
statistical significance. More research using community-based samples and prospective design
is warranted to study factors leading to an increased burden of cardiovascular risk factors and
disease in psoriasis patients.
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Three-dimensional analysis of stratum corneum lamellar structure by transmission electron
microtomography
Y Katayama,1 T Yoshida,1 M Hatta,2 J Okada,1 H Kawada,1 T Sano1 and H Jinnai2 1 Skin Care
Research Labs., Kao Corp., Tokyo, Japan and 2 Macromolecular Science and Engineering,
Kyoto Institute of Technology, Kyoto, Japan
The outermost layer of the epidermis, the stratum corneum (SC), is composed of corneocytes
and intercellular lipids (ICL). In the skin ICL form the lamellar structure between corneocytes.
Not only the component but also the organized structure of ICL plays the crucial roles in both
the main skin barrier and the pathway of various substances. Therefore, to observe the lamel-
lar structure of ICL in three-dimension (3D) is critical to understand the appropriate organ-
ized 3D structure, and will lead to clarify the molecular mechanism in the function of SC. In
this study, with 3D images obtained from transmission electron microtomography (TEMT),
we tried to illustrate 3D lamellar structure. Pig and human skin were examined, which were
cut in a direction perpendicular to skin surface. In the TEMT experiments, an ultra-thin sec-
tion was tilted from about 60 to –60 degrees (1°increment) against an arbitrary axis parallel
to the sectioning direction. The projections at different tilt angles are used to reconstruct to
obtain 3D image on the basis of the computerized tomography. Colloidal gold particles were
used as fiducial markers to align the tilt series. With the use of high-resolution tomograms,
the following new findings were obtained. Viewed in nanometer-scale, 1) the lamellar struc-
ture formed by ICL has had some degree of undulation. And 2) the lamellar structure appeared
to be frequently interrupted, not continuous. Morphologically irregular undulation and dis-
continuity were observed both direction parallel and perpendicular to the sectioning direc-
tion. The middle layers as well as the upper layers of SC has had these findings. In conclu-
sion, we have become successful to observe 3D structure of ICL in SC by TEMT, and obtained
new findings, that is to say, undulation and discontinuity of lamellar structure.
389
DHCR24-/- mice demonstrate impaired maturation of the epidermis with an increased expres-
sion of aquaporin-3 (AQP3), affecting the epidermal hydration
R Mirza,1 S Hayasaka,2 F Kambe,1 K Maki,1 T Kaji,3 Y Murata2 and H Seo1 1 Department of
Endocrinology, Research Institute of Environmental Medicine, Nagoya University, Nagoya,
Japan, 2 Department of Genetic Research, Research Institute of Environmental Medicine,
Nagoya University, Nagoya, Japan and 3 Pharmaceutical Research Unit, Mitshubishi Pharma
Corporation, Yokohama, Japan
DHCR24 (3β-hydroxysterol-∆24 reductase) gene encodes an enzyme catalyzing conversion of
desmosterol to cholesterol. Desmosterolosis is an autosomal recessive disease due to mutation
in DHCR24 gene, with low cholesterol and high desmosterol levels. To understand the patho-
physiology of this disease, we utilized DHCR24 knockout mice and reported that DHCR24-/-
mice die soon after birth. Their skin was less wrinkled, shiny and revealed features of lethal
restrictive dermopathy associated with severe defect of epidermal maturation and barrier func-
tion (J Invest Dermatol 126: 638-47, 2006). Markedly increased trans-epidermal water loss (about
4.5 fold increased) in DHCR24-/- led us to examine the role of aquaporin 3 (AQP3) in DHCR24-
/- mice, because this is the only water/glycerol transporting channel expressed in the epidermis.
Expression of AQP3 was studied by Western blot analysis and immunohistochemistry in the
epidermis of DHCR24-/- and wild type newborn mice. Glycerol uptake was determined in the
isolated keratinocytes and glycerol content in the epidermis was assayed by an enzymatic method.
AQP3 is expressed only in the cells of stratum basale in control mice, indicating its expression
in immature keratinocytes. In DHCR24-/- mice, AQP3 expression is markedly increased in the
epidermis where immature keratinocytes expressing keratin 14 are present throughout. Glycerol
uptake and the glycerol content of the epidermis are also significantly increased in DHCR24-/-
mice. This is associated with a marked increase in water content of the epidermis. This is the first
demonstration that lack of DHCR24 leads to impaired maturation of epidermal keratinocytes,
leading to increased AQP3 expression associated with retention of epidermal water.
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PPAR and LXR activators regulate ABCA12 expression in human keratinocytes
Y Jiang,1 B Lu,1 P Kim,1 PM Elias2 and KR Feingold1 1 Metabolism, NCIRE, VAMC, UCSF, San
Francisco, CA and 2 Dermatology Service, NCIRE, VAMC, UCSF, San Francisco, CA
ABCA12, a member of the ATP-binding cassette superfamily, is a cellular membrane lipid trans-
porter that facilitates lamellar body (LB) formation in keratinocytes, which is critical for per-
meability barrier function. Recently, gene mutations of ABCA12 were found to underlie Har-
lequin Ichthyosis (HI), a devastating skin disorder characterized by abnormal LB and barrier
function. Hence, understanding the factors that regulate ABCA12 expression in human ker-
atinocytes is of great importance. Previously we and others have demonstrated that PPARs and
LXR, are expressed in keratinocytes, and their activation stimulates keratinocyte differentia-
tion and lipid synthesis, increases LB secretion, and improves epidermal permeability barrier
homeostasis. In this study we examined whether PPAR or LXR activators regulate ABCA12
expression in cultured human keratinocytes (CHK). PPAR-γ and –δ activators markedly stim-
ulate ABCA12 mRNA expression (5~12-fold) in CHK in a dose- and time-dependent manner.
This increase in ABCA12 mRNA levels is accompanied by an increase in ABCA12 protein lev-
els, suggesting biological importance of this up-regulation. LXR activators also increase ABCA12
mRNA levels in CHK but to a lesser extent (2~3-fold). In contrast, activators of PPAR-α, RAR,
RXR or VDR have no effect on ABCA12 expression. Interestingly, two major ABCA12 alterna-
tive transcripts (ABCA12-L and –S) are expressed and both are up-regulated by PPAR-γ, -β/δ
and LXR activators in both undifferentiated and differentiated CHK, suggesting a common
mechanism controlling these two distantly-spaced transcripts (106 kb apart). Correspondingly,
their proteins (293- and 257-KDa), are also up-regulated (1.8~3.2 fold) by PPAR-γ and -β/δ
activators in these cells. Together, our data demonstrate that PPAR and LXR activators increase
ABCA12 expression, which could facilitate lipid movement and LB formation, thereby pro-
viding another mechanism by which PPAR and LXR activators promote epidermal permeability
barrier homeostasis.
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Nevi distribution in a college population with high artificial tanning
MJ VanBeek,1 J Ritchie,3 J Coughlin2 and L Dennis2 1 Dermatology, University of Iowa, Iowa
City, IA, 2 Epidemiology, University of Iowa, Iowa City, IA and 3 Biostatistics, University of
Iowa, Iowa City, IA
UV radiation is a risk factor for cutaneous melanoma and is associated with increased num-
ber of nevi. Several studies have examined the association of sun exposure on the number
and distribution of nevi in children. However, little is published on the relationship between
the distribution of nevi and artificial tanning exposure. The purpose of our study was to exam-
ine the distribution of nevi in a college population with a history of high frequency of tanning
bed use via a cross-sectional survey. One hundred and sixty-eight college sorority and frater-
nity students completed a self-administered questionnaire on tanning habits and sun sensi-
tivity factors. All participants underwent a full skin exam during which skin color, eye color,
hair color, and number of nevi were recorded. The study population was predominantly female
(73%) and white (99%) with 51% self reporting their skin color as fair, 46% as medium, and
3% as dark. For all body sites, females had higher mean nevus counts than males. This differ-
ence was significant for total body counts (56 to 35, p=0.02) and for 7 of 9 body sites. As
expected, mean total body nevus counts were significantly higher among those with self-
reported fair skin compared to medium/dark skin (59 to 42, p=0.04). Of the male fraternity
students, 42% reported a history of using a tanning bed; 99% of female sorority students
reported using such devices. In contrast to our findings, published studies consistently report
higher average nevus counts on males compared to females. The increased number of nevi in
this female population with an extremely high rate of artificial tanning, suggests regular use
of artificial UV devices may also contribute to a greater number of nevi. Since our study pop-
ulation was specifically selected as a population at high risk of using tanning beds, our results
should be interpreted within the context of a young population with high artificial UV expo-
sure. Prospective, longitudinal studies are necessary to confirm this relationship.
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Improvements in stratum corneum barrier function from a probiotic yogurt containing bor-
age oil, green tea polyphenols and vitamin E
S Samson,1 AV Rawlings,2 D Guyonnet1 and T Lassel1 1 Danone Research, Paliseau, France
and 2 AVR Consulting LTD, Northwich, United Kingdom
There is ample evidence demonstrating that topical application of skin-improving ingredients
via creams and lotions can improve and provide protection to the skin. However, ingestion of
appropriately selected nutrients may provide a more widespread delivery to act on skin func-
tionality. We evaluated the effect of a probiotics- containing yogurt that also was formulated
with borage oil, green tea polyphenols and vitamin E. Firstly, we evaluated the oral bioavail-
ability of the ingredients clinically. It was established, compared to borage oil alone, that the
probiotic-containing yogurt increased the absorption of borage oil in the chylomicron lipopro-
tein fraction in the blood. Not only was the time to maximal absorption decreased for the pro-
biotics-containing yogurt (4.55h vs. 2h; P<0.01, the total amount absorbed was almost dou-
bled (Area under the curve =15.2µg/ml/h vs. 27.9µg/ml/h; P<0.001). So, borage oil was absorbed
more quickly and to a greater extent in the probiotic-containing yogurt compared with the oil
alone. In contrast, moderate changes in the blood levels of green tea polyphenols were observed.
Secondly a single-centre, randomised, double-blind, clinical trial in healthy female volunteers
(BMI <25) conducted over a period of six months to demonstrate the effects of the probiotic-
containing yoghurt on the barrier function of the skin. We established that the our product
improved stratum corneum barrier function compared to a control product as early as 6 weeks
after the oral supplementation (4.2g/m2/ vs. h 6g/m2/h; P<0.01). On average there was a 22.3
% reduction in transepidermal water loss (TEWL) for the treatment group with a maximum of
25% after 18 weeks consumption. The reduction in TEWL related to placebo was maintained
throughout the trial despite seasonal differences. In conclusion, we have demonstrated for the
first time that a yogurt containing probiotics and several nutrients improved skin barrier func-
tion as measured by a reduction of skin water loss.
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Claudin-2 mrna and protein is present in human keratinocytes, and is regulated by all-trans
retinoic acid
D Telgenhoff, S Ramsay, S Hilz, P Slusarewicz and B Shroot Central Research, DFB
Pharmaceuticals, San Antonio, TX
The purpose of this study was to evaluate the presence of claudin-2 in keratinocytes in vitro
as well as in vivo. Claudin-2 protein is expressed in epithelial tight junctions characterized
as leaky due to a decrease in trans-epithelial resistance. Claudin-2 protein forms a cation
selective channel which confers increased permeability in renal epithelial cells and in the
intestine where its expression is restricted to the leaky epithelium. Two studies have deter-
mined that neither claudin-2 mRNA nor protein is present in keratinocytes in culture or intact
skin. Here we demonstrate the presence of claudin-2 protein and mRNA in neonatal ker-
atinocytes and adult skin. Immunohistochemical staining revealed claudin-2 staining in mono-
layer neonatal keratinocyte cultures, which also showed a shift in staining pattern following
a switch to high calcium. Staining was also present in the granular layer of adult epidermis.
Western blot analysis was performed using Madin-Darby Canine Kidney (MDCK) II cells
and human kidney as positive controls, and MDCK I cells as the negative control. Analysis
of western blots revealed bands corresponding to the molecular weight of claudin-2 in MDCK
II cells, human kidney, adult skin, and neonatal keratinocytes. We also performed rtPCR on
mRNA isolated from all of the same tissues as described above, and using cDNA sequence
analysis we found a 99% sequence homology between our cDNA and human claudin-2 (NIH
Blast Sequence). Further, we show that all-trans retinoic acid increases the expression of
claudin-2 in keratinocytes in a dose-dependent manner. The discovery of claudin-2 transcript
and protein in the skin could be of importance in epidermal differentiation, barrier function,
and pathological conditions.
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Permeability barrier requirements regulate keratinocyte cornification: role of caspase 14 and
the protease-activated receptor type 2
M Demerjian,1 J Hachem,2 E Tschachler,3 G Denecker,4 W Declercq,4 P Vandenabeele,4
TM Mauro,1 D Crumrine,1 T Roelandt,2 E Houben,2 PM Elias1 and KR Feingold1 1
Dermatology and Medicine, UCSF and VAMC, San Francisco, CA, 2 Dienst Dermatologie,
Academisch Ziekenhuis-Vrije Universiteit Brussel, Brussels, Belgium, 3 Dermatology,
University of Vienna Medical School, Vienna, Austria and 4 Molecular Biomedical Research,
VIB/UGent, Gent, Belgium
Stratum corneum comprises a multilayer of corneocytes, embedded in a lipid-enriched extracellu-
lar matrix resulting from secreted lamellar body (LB) contents. Insults to the permeability barrier
stimulate rapid secretion of preformed LB from the outer granular layer (OSG), regulated through
modulations in ionic gradients and serine protease (SP)/protease-activated receptor type 2 (PAR2)
signaling. Since corneocytes also are required for barrier function, we hypothesized that the termi-
nal transition of OSG into corneocytes is also regulated by permeability barrier requirements. Abro-
gation of the permeability barrier by two unrelated methods initiates a wave of cornification, assessed
as TUNEL+ cells in the OSG and newly-cornified cells by electron microscopy, first apparent by 30
min, in a dose-dependent fashion. Since this wave of cornification is blocked by occlusion, cor-
neocytes form specifically in response to permeability barrier requirements. Although the 30 min
lag time allows prior secretion of most preformed LB, remaining LB become entombed in nascent
corneocytes. Moreover, SP inhibition by either topical hyperacidification or treatment with the plas-
minogen-activator inhibitor, t-AMCHA, blocks new corneocytes formation after barrier disruption.
While SP activation of PAR2 inhibits LB secretion, we show that the cornification wave is delayed
in PAR2 ko mice. Finally, while markers of classical apoptosis (PARP, Casp3) remain unchanged, we
show that cornification activates Casp14, is blocked by a topical pan-Casp inhibitor and is delayed
and structurally aberrant in Casp14 ko mice. Thus, permeability barrier requirements dictate not only
extracellular matrix formation, but also the coordinate transition of OSG into corneocytes.
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Topical application of tuhuai extract inhibits epidermal proliferation in an epidermal hyper-
proliferative model
Y Shi,1 S Lee,2 M Derjian,3 S Chang,3 KR Feingold,3 PM Elias3 and M Man3,1 1 Dermatology,
Dalian Skin Disease Hospital, Dalian, China, 2 Dermatology, University of California School
of Medicine, San Francisco, CA and 3 Dermatology, Yonsei University School of Medicine,
Seoul, South Korea
Psoriasis is one of the most common skin disorders, but safe, effective and inexpensive treat-
ments are still not available. Chinese herbal medicine has been used for centuries in the treat-
ment of psoriasis. Clinical studies suggest that Tuhuai mixture is effective in the treatment of
psoriasis. However, the mechanism by which this herbal medicine improves psoriasis is not
clear yet. We investigated here whether topical application of Tuhuai extract inhibits epider-
mal proliferation and inflammation, which would provide a scientific basis for topical treat-
ment of psoriasis with Tuhuai extract. To assess proliferation, we use an epidermal hyperpro-
liferative model resulting from repeated barrier disruption. Either Tuhuai extract or vehicle was
topically applied to both flanks of hairless mice for 3 days, after which skin biopsies were
obtained. Epidermal proliferation, differentiation, and keratinocyte apoptosis were evaluated
by immunohistochemistry. To assess inflammation, mouse ears were treated with TPA followed
by either ethanol or Tuhuai extract and ear thickness was measured at 24 hrs. Our studies
showed that topical Tuhuai inhibited epidermal proliferation with a reduction of epidermal
thickness while decreasing the expression of keratinocyte differentiation markers in epider-
mal hyperproliferative model; No effect on keratinocyte apoptosis was observed. A significant
reduction in inflammation by Tuhuai was found. We conclude that topical Tuhuai extract inhib-
ited epidermal proliferation in an epidermal hyperproliferative model and is anti-inflamma-
tory in the TPA model. Therefore Tuhuai extract could be useful as a relatively safe and effec-
tive topical agent to treat psoriasis. Further clinical studies are required to determine its clinical
efficacy.
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Contrasting mechanisms of exfoliation with a mushroom derived cathepsin D-like protease
and lactic acid
WP Smith,1 M Bishop2 and G Gillis2 1 Dermac F, Wellington, FL and 2 Biochemistry, Actifirm
Inc, Louisville, TX
A Mucor miehei derived cathepsin D-like acid protease (CLPE)induces exfoliation which, over
time, modifies epidermal and dermal structure and improves skin appearance. Herein we com-
pare the mechanism of exfoliation with CLPE and lactic acid (LA). Sqames released by pro-
tease treatment (microscopic evaluation) were individual and small clumps of cells, and the
size of released squames was not concentration dependent (5%-30% CLPE). LA treatment
released progressively larger clumps of squames as concentration increased from 2% to 12%
(pH 3). Skin dryness (impedance) and flakiness (clinical grading) strongly correlated with
increasing LA concentration but not with CLPE treatment. To test the hypothesis CLPE induces
exfoliation only at exposed desmosomes, we evaluated activity wherein desmosomes should
be less accessible. Skin stripping experiments demonstrated CLPE is active at the skin surface
and after removal of about 5 stratum corneum (sc) cell layers. After removal of 10, 15 and 20
layers, no exfoliation is observed. LA however, exfoliated regardless of the number of cell lay-
ers removed and as expected, became irritating as more of the sc barrier is removed. CLPE
was more active on the lower outer calf (a dry, thickened sc) and less active on the upper
inner arm (an organized, thinner, intact sc). While active on surface of the upper arm, almost
all exfoliative activity is lost after removal of less than 2 cell layers (1.8) while on the lower
calf, activity is observed after removal of 6.3 cell layers. Finally we observed supplementing
the skin with a protective sphingolipid barrier, while not affecting CLPE surface exfoliation
inhibited all activity when 2 cell layers were removed. This was not true for lactic acid induced
exfoliation. While both CLPE and lactic acid promote changes in skin structure and appear-
ance via exfoliation, they do so in quite different ways. CLPE activity appears restricted to the
outer sc where desmosomes are more accessible. This difference results in a controlled and
less irritating exfoliation.
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Stem/progenitor cell-like properties of Desmoglein 3dim cells in primary and immortalized
keratinocyte lines
H Wan,1 M Yuan,2 C Simpson,3 K Allen,3 FN Gavins,4 MS Ikram,2 S Basu,2 N Baksh,5
EA O’Toole5 and IR Hart1 1 Tumour Biology Lab, Inst Cancer, Queen Mary’s School Of
Medicine, London, United Kingdom, 2 Molecular Oncology Lab, Inst Cancer, London, United
Kingdom, 3 FACS Lab, CRUK, LRI, London, United Kingdom, 4 Centre of Biochemical
Pharmacology, William Harvey Res Inst, London, United Kingdom and 5 ICMS, Queen Mary’s
School of Medicine, London, United Kingdom
We showed previously that primary keratinocytes selected for low Dsg3 expression levels exhibited
increased colony forming efficiency and heightened proliferative potential relative to cells with higher
Dsg3 expression levels; characteristics consistent with a more “stem/progenitor cell-like” phenotype.
Here we have confirmed that Dsg3dim cells derived from cultured primary human adult keratinocytes
have comparability with a6bri/CD71dim stem cells in terms of colony forming efficiency. Moreover,
these Dsg3dim cells exhibit increased reconstituting ability in in vitro organotypic culture on de-epi-
dermalized dermis; they are small, actively cycling cells and they express elevated levels of various
p63 isoforms. In parallel, using the two immortalized keratinocyte cell lines HaCaT and NTERT, we
obtained essentially similar though occasionally different findings. Thus enhanced colony forming effi-
ciency by Dsg3dim cells consistently was observed in both cell lines though the cell cycle profile and
levels of p63 isoforms differed between these two cell lines. Dsg3dim cells from both immortalized
lines produced thicker and better-ordered hierarchical structural organization of reonstituted epidermis
relative to Dsg3bri and sorted control cells. Dsg3dim HaCaT cells also show sebocyte-like differentia-
tion in the basal compartment of skin reconstituted after 4 weeks organotypic culture. No differences
in percentages of side population cells (also a putative marker of stem cells) were detected between
Dsg3dim and Dsg3bri populations. Taken together our data indicate that Dsg3dim populations from
primary human adult keratinocytes and long-term established keratinocyte lines possess stem/progen-
itor cell-like properties though the side population characteristic is not one of these features.
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Tight junctions are involved in intercellular divalent cation permeability in cultured normal
human epidermal keratinocytes
S Kuroda,1 M Kurasawa,1 Y Ito,1 T Yamamoto1 and H Sasaki2 1 Skin Research and Technology
Department, POLA Chemical Industries, Inc., Yokohama, Japan and 2 Division of Molecular
Cell Biology Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
In epithelia, tight junctions (TJs) seal neighboring cells and control paracellular pathway of
solutes. TJs also have ionic selectivity. Recent studies show that TJs also exist in epidermal ker-
atinocytes, especially in epidermal granular layer in vivo. Divalent cations such as Ca2+ and
Mg2+ are distributed with gradient in the epidermis in vivo. These ions are highly concen-
trated in granular layer, and are considered to be responsible for keratinocyte differentiation.
Thus, we hypothesized that TJs should be involved in the regulation of intercellular ion gra-
dient formation in the epidermis. Either Ca2+ or Mg2+ permeability through TJs was studied
using in vitro permeability assay in cultured normal human epidermal keratinocytes (NHEK).
NHEK were seeded on the semipermeable membrane (Transwell,Corning) and cultured in
medium with low (0.15mM) or high (1.45mM) calcium concentration. Transepithelial elec-
trical resistance (TER) and the divalent cation permeability through the cell sheet were meas-
ured. As a result, TER in high calcium-treated cells increased. Immunofluorescent microscopy
showed that in high calcium-treated cells, the TER increase was dependent on the formation
of TJs. Additionally, Ca2+ and Mg2+ flux through high calcium-treated cell layer decreased.
Western blot analysis revealed that the expression of claudin-1 correlated with TER. Further-
more, when we transiently knocked down claudin-1 in NHEK by using RNA-interference tech-
nique, claudin-1 knock-down cells showed lower TER, and higher Ca2+ and Mg2+ permeabil-
ity than those in control cells. These results suggest that claudin-1 should relate to intercellular
transport of divalent cations such as Ca2+ and Mg2+ in cultured NHEK.
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Effects of topically applied acitretin in reconstructed human epidermis and the rhino mouse
E Hsia,1 M Johnston,2 R Houlden,2 W Chern1 and H Hofland1 1 Connetics Corporation, Palo
Alto, CA and 2 Connetics Australia, Melbourne, QLD, Australia
Oral administration of acitretin is currently indicated for the treatment of severe psoriasis in
adults, but its use is limited by systemic side effects and teratogenicity. Topical administration
of acitretin may lessen the risk of systemic toxicity while increasing local bioavailability in
the skin. The effects of topically applied acitretin on reconstructed human epidermis (RHE)
and in the Rhino mouse, a well characterized model for retinoid efficacy, were investigated
and compared to those of other currently marketed topical retinoids: tretinoin, tazarotene,
and adapalene. In RHE cultures treated with acitretin, there was a reduction in keratohyalin
granules in the stratum granulosum, a loss of keratin 10 expression in the stratum spinosum,
a loss of filaggrin expression in the stratum granulosum, and an increase in keratin 19 expres-
sion in all viable cell layers. All retinoids showed similar signs of activity in the RHE model
with the exception of adapalene. Furthermore, the release of pro-inflammatory cytokines, IL-
1α and IL-8, in RHE cultures was less pronounced with acitretin compared to tretinoin and
tazarotene, suggesting that acitretin may be less irritating. In the Rhino mouse, acitretin induced
a dose-dependent reduction in utricle diameter at the site of application after seven daily der-
mal doses. A similar effect was observed in tretinoin- and tazarotene-treated mice. Our data
suggest that dermal application of acitretin may have a therapeutic benefit in the local man-
agement of keratinization disorders.
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Loss-of-function mutations in the filaggrin gene predispose to early but not to adult onset
atopic eczema
E Greisenegger,1 A Zimprich,2 F Zimprich,2 M Weber,3 G Stingl1 and T Kopp1 1 Department
of Dermatology, DIAID, Medical University of Vienna, Vienna, Austria, 2 Clinical Department
of Neurology, Medical University of Vienna, Vienna, Austria and 3 Department of Radiology,
Medical University of Vienna, Vienna, Austria
Recently, two loss-of-function mutations in the filaggrin gene (FLG) (R501X and 2282del4)
were shown to be major predisposing factors for the chronic inflammatory skin disease atopic
eczema (AE). In this study we wanted to evaluate the influence of the two FLG mutations on
AE phenotypes in the Austrian population.We genotyped a cohort of 219 AE patients and 184
control individuals. At this we observed a highly significant association of the null mutations
with AE. Phenotype analysis revealed a clear overrepresentation of mutation carriers among
adult patients with early age of onset and persisting disease, whereas no association was
observed with adult onset AE. Furthermore, we found a higher frequency of the null alleles
in AE patients additionally suffering from asthma when compared to AE patients without this
co-morbidity as well as an association with high total serum IgE levels. Importantly, we have
identified a novel null mutation at amino acid position 488 (1464delC) in one patient. Our
data point towards a key role of the mutations in the pathogenesis of early onset but not adult
onset AE and support the hypothesis of facilitated allergic sensitization by an impaired epi-
dermal barrier. With the 1464delC variant we have found a novel FLG mutation. This is the
fourth FLG mutation described in literature and deserves further evaluation in other study pop-
ulations.
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The B2-adrenergic receptor is a negative regulator of wound healing in vivo
CE Pullar1 and R Isseroff2 1 Cell Physiology and Pharmacology, University of Leicester,
Leicester, United Kingdom and 2 Dermatology, University of California, Davis, Davis, CA
We have established a role for the B2 adrenergic receptor (B2-AR) in regulating human skin
wound re-epithelialisation and contraction using in vitro and ex vivo models. Here we use a
mouse model to determine if the B2-AR regulates wound healing in vivo. Murine keratinocytes
and dermal fibroblasts were isolated from 1-2 day old neonates. Two 6mm full-thickness
wounds were created along the dorsal mid-line of 8-12 week old mice. Wounds were treated
daily, topically, with gel alone or gel containing 0.1% B2-AR agonist or antagonist (n = 5) and
excised after 3/5 days, fixed, embedded and sectioned for both hematoxylin/eosin and smooth
muscle-α-actin (SmαA) immunostaining. B2-AR agonists decrease while antagonists increase
ERK phosphorylation, migration and galvanotaxis of murine keratinocytes, respectively. In
contrast, both B2-AR agonists and antagonists increase ERK phosphorylation and motility in
murine dermal fibroblasts. Finally, we measured epinephrine in keratinocyte extracts. Untreated
wounds are 50% re-epithelialized after 5 days. B2-AR agonist-treatment decreases (30%),
while B2-AR antagonist-treatment increases wound re-epithelialization (57%), respectively.
While untreated wounds are 86% of their original size by day 2, the size of B2-AR agonist-
treated wounds is virtually unchanged. In contrast, B2-AR antagonist-treated wounds are
only 70% of their original size. Wound contraction correlates with the appearance of SmαA
expressing myofibroblasts in the granulation tissue. While SMαA staining is reduced (62%)
in B2-AR agonist-treated wounds, it is markedly increased in B2-AR antagonist-treated wounds
(2.2 fold). In summary, we have demonstrated that while B2-AR agonist treatment delays wound
healing, antagonist treatment significantly augments wound healing in vivo, by modulating
both re-epithelialization and wound contraction. Our work demonstrates that the B2-AR is a
negative regulator of wound healing in vivo and B2-AR antagonists could be a potential ther-
apy for promoting healing in chronic wounds.
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L-ergothioneine is a natural part of the skin’s antioxidant system
N Damaghi, KK Dong, KA Smiles and DB Yarosh AGI Dermatics, Freeport, NY
L-ergothioneine (EGT) is a stable antioxidant found in edible plants such as corn, oats, and
other grains. Its presence has also been identified in animal tissue undergoing relatively high
levels of oxidative stress such as erythrocytes, the liver, and kidneys. The cellular receptor and
transporter for EGT, OCTN-1, has recently been identified and has been shown to be present
in tissues of the lungs, ileum, trachea, kidney, and spinal cord, though limited data has been
recorded for skin cells. In order to determine the significance of EGT in skin biology, we ana-
lyzed the mRNA expression and protein production of OCTN-1 in cultured human epidermal
keratinocytes (NHEK) and human dermal fibroblasts (NHDF), since expression of this trans-
porter is responsible for the intracellular accumulation of EGT. We also compared the perox-
ide scavenging abilities of EGT and idebenone (a stable analog of the antioxidant, coenzyme
Q10) in simple solution as well as in NHDF cultures exposed to solar-simulated UVA340 radi-
ation. OCTN-1 mRNA synthesis and protein production in NHEK and NHDF were measured
through real-time RT-PCR and western blotting, respectively. At the same time, fluorometric
assays were used to evaluate the abilities of the two antioxidants to scavenge for reactive oxy-
gen species (ROS) induced directly by H2O2 or indirectly through UVA340 irradiation. OCTN-
1 mRNA was shown to be synthesized and readily detectable in both NHEK and NHDF as
measured by real-time RT-PCR. In addition, the OCTN-1 protein (~70 kDa) was identified in
NHDF on a western blot membrane. After addition of 1mM H2O2 to media, samples treated
with EGT consistently showed lower levels of peroxides than those treated with idebenone
over a 2h period. Additionally, NHDF treated with EGT following 100 kJ/m2 UVA340 had
lower levels of peroxides over a 1h period than those treated with idebenone. Together, these
results suggest that EGT is a powerful antioxidant that plays a natural, protective role in skin
biology.
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Changes in intercellular potassium levels regulate epidermal barrier homeostasis
M Denda,1 M Tsutsumi,1 K Inoue,1 D Crumurine,2 PM Elias2 and KR Feingold2 1 Life Science
Research Center, Shiseido Research cemter, Yokohama, Japan and 2 Dermatology and
Medicine Services, VAMC and Department of Medicine and Dermatology, UCSF, San
Francsico, CA
Maintenance of a competent permeability barrier in the face of external and internal stressors
requires signals between the stratum corneum (SC) interface and the metabolic machinery in
the underlying nucleated layers. For example, reductions in the ion gradients for Ca++ after
acute barrier disruption stimulate lamellar body (LB) secretion, a response required to restore
barrier homeostasis. Though alterations in external K+ levels also regulate barrier recovery
after acute insults, the mechanisms whereby K+ regulates barrier function remain unknown.
Single applications of either K+ channel openers (i.e., 1-EB10, minoxidil, diazoxide) or the
K+ ionophore, valinomycin, accelerate barrier recovery after acute insults to murine skin,
paralleled by a reduction in intracellular K+ levels in CHK. In contrast, applications of K+
channel blockers (i.e., gilbenclamide, dequalinium) delay barrier recovery. Alterations in intra-
cellular K+ regulate barrier homeostasis by either stimulating (reduced K+) or inhibiting (ele-
vated K+) lamellar body secretion. Finally, development of epidermal hyperplasia, a down-
stream consequence of barrier disruption, is also inhibited by agents that reduce intracellular
K+ levels. These results demonstrate that changes in K+ levels that can be presumed to occur
after barrier disruption, signal metabolic responses; i.e., lamellar body secretion, which accel-
erates normalization of barrier function. More generally, these results support the concept of
the keratinocyte as an electrophysiologic sensor, whereby modulations in ionic gradients, in
response to stressors, regulate functional responses at the interface of the epidermis and the
external environment.
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IL-1 and TNFα accelerate permeability barrier development in fetal rats
Y Jiang,1 B Lu,1 D Crumrine,2 M Man,2 PM Elias2 and KR Feingold1 1 Metabolism, NCIRE,
VAMC, UCSF, San Francisco, CA and 2 Dermatology Service, NCIRE, VAMC, UCSF, San
Francisco, CA
The ontogenesis of the epidermal permeability barrier, which is critical for life outside the
womb, is a complex process and not fully understood. Previously, we showed that classical
hormones (glucocorticoids, thyroid and estrogen) and activators of LXR and PPARs accelerate
barrier formation in fetal rats. In adult mice, cytokines have improved permeability barrier
homeostasis. Here we determined the effect of cytokines (IL-1α, IL-1β, TNFα) on barrier devel-
opment in fetal rodents. The expression of IL-1α peaked in fetal rat epidermis at gestational
age d19-20 (91~142 folds increase vs. d17 as control), a critical period of time coincident
with the formation of a competent barrier. A similar expression pattern occurred for IL-1β but
not TNFα. Using a rat skin explant model, we demonstrated that treatment of d17 explants for
2 days with either IL-1α, IL-1β, or TNFα accelerates barrier formation in a time- and dose-
related fashion, evidenced by a decrease in trans-epidermal water loss attributable to the
presence of mature lamellar membranes, a multi-layered SC, and an increase in the expres-
sion of corneocyte envelop (CE) structural proteins (involucrin, loricrin). To further assess the
physiological significance of cytokines on barrier development, we studied TNF type I (p55)
receptor and IL-1 type I (p80) receptor, double knock out (k/o) mice and demonstrated that
there was a delay in both barrier formation and CE protein expression in epidermis of d17 k/o
vs. wild-type (WT) mice (correspond to ~d19 in rat). Concurrently, there were immature, incom-
pletely processed intracellular lamellae in k/o mouse epidermis at days 17-18. These differ-
ences were less pronounced at later stages of gestation (d18, correspond to ~d21 in rat), and
undetectable after birth. These results indicate that IL-1 and TNFα play a physiological role in
regulating the late stages of stratum corneum formation and permeability barrier ontogenesis.
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Chemical peeling normalizes keratinization and suppresses pre-malignant change in photo-
damaged skin
T Dainichi,1 S Amano,2 Y Matsunaga,2 S Iriyama,2 T Hirao,2 T Hariya,2 T Hibino,2 C Katagiri,2
M Takahashi,2 S Ueda,3 T Hashimoto4 and M Furue1 1 Department of Dermatology, Graduate
School of Medical Sciences, Kyushu University, Fukuoka, Japan, 2 Shiseido Life Science
Research Center, Yokohama, Japan, 3 Ueda-Setsuko Clinic, Fukuoka, Japan and 4 Department
of Dermatology, Kurume University School of Medicine, Kurume, Japan
Chemical peeling improves the cosmetic appearance of photo-aged skin. We previously reported
that chemical peeling for cornified layer by salicylic acid in polyethylene glycol vehicle (SA-
PEG) suppresses skin tumor development in hairless mice irradiated with UVB. To examine
the effect, hairless SKH/hr1 mice irradiated with UVB for 10 weeks were weekly treated with
SA-PEG, and immunohistochemically evaluated. Human volunteers were treated with SA-PEG
on the face and three-dimensional pattern of the surface and maturity of cornified envelopes
(CEs) were evaluated. Epidermal dose of prostaglandin (PG) E2 was determined in mice irra-
diated with UVB followed by SA-PEG treatment. Among UVB-irradiated mice, the structural
atypia and expression of p53 protein in keratinocytes were suppressed in the SA-PEG-treated
mice. Incomplete expression of filaggrin and loricrin from the control mice was improved in
the SA-PEG-treated mice. In photo-exposed human facial skin, the depth of furrows transiently
reduced in 3 hours and fragile, immature CEs were replaced with rigid, mature CEs in 4
weeks by single treatment with SA-PEG. Epidermal dose of PGE2 was not affected by treat-
ment with SA-PEG in UVB-irradiated mice. Restoration of photodamaged stratum corneum
by treatment with SA-PEG may modify a mechanical burden on keratinocytes in the epider-
mis. Reportedly, alterations of mechanical properties for the cells can affect their differentia-
tion and malignant behavior in vitro. These results suggests a new theory that stratum corneum
functions as a brace on epidermis and plays a protective role against carcinogenesis. SA-PEG
provides a novel strategy for the prevention of photo-induced skin tumors, especially in white
people resident in endemic areas with high levels of UV exposure.
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SIRT1 regulates differentiation of normal human keratinocytes in vitro
G Blander,1 A Bhimavarapu,1 MS Matsui,2 RC Fry,1 T Mammone2 and L Guarente1 1 MIT,
Cambridge, MA and 2 The Estee Lauder Companies, Melville, NY
Sir2 regulates life span in many model organisms. This gene encodes an NAD+-dependent
deacetylase, and is broadly conserved from bacteria to higher eukaryotes. The human Sir2
gene family comprises seven members, SIRT1-7. SIRT1, the human ortholog, is an NAD+-
dependent deacetylase with enzymatic properties indistinguishable from the yeast Sir2. Inter-
estingly, SIRT1 regulates skeletal muscle and white adipose differentiation. Our main goal was
to examine the involvement of SIRT1 in keratinocyte replicative capacity and keratinocyte
differentiation. We found that a SIRT1 inhibitor, nicotinamide, inhibited expression of con-
fluence-induced differentiation markers, and a SIRT1 activator, resveratrol, enhanced the expres-
sion of differentiation under the same conditions. Corroborating results were obtained in ker-
atinocytes manipulated to over-express or under-express SIRT1. By using a micro-array analysis
we found 20 genes whose expression was induced in SIRT1 overexpressing cells and decreased
in the SIRT1 knockdown cells. Virtually all 20 genes have previously been associated with ker-
atinocyte differentiation. Finally, we found that SIRT1 regulates the keratinocyte replication
capacity. Therefore, it is likely that SIRT1 plays an important role in normal human keratinocyte
replication and differentiation.
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Skin blister: a minimally invasive method to study the human epidermis
I Panoutsopoulou,1 G Wendelschafer-Crabb,2 GL Wilcox,1,3 MK Hordinsky3 and
WR Kennedy2 1 Department of Neuroscience, University of Minnesota, Minneapolis, MN, 2
Department of Neurology, University of Minnesota, Minneapolis, MN and 3 Department of
Dermatology, University of Minnesota, Minneapolis, MN
The purpose of this study was to determine the utility of the suction skin blister as a minimally
invasive method to study epidermal nerve fibers (ENFs), Langerhans cells (LCs) and melanocytes
(MCs). Twenty 3 mm skin blisters were made on the forearm and the thigh of normal volun-
teers by applying a suction capsule to the skin. The epidermal roof of the blister was excised
and fixed in Zamboni solution. The specimens were immunostained using a series of anti-
bodies including PGP9.5 (panneuronal cytoplasmic marker), Gαo (G-protein marker), β-tubu-
lin (cytoskeleton marker), GAP43 (neuronal growth cone marker), S100 (nuclear and cyto-
plasmic marker for LCs, MCs and Schwann cells), CD1a (specific marker for LCs) and MelanA
(specific marker for MCs) and studied with fluorescent microscopy. Observations on mor-
phology and distribution of ENFs, LCs and MCs were possible, because all cells and nerves
were contained within the intact, unsectioned blister roof on one slide. Coexpression of PGP9.5
and Gαo, as well as PGP9.5 and β-tubulin was observed on all ENFs. ENFs also expressed
GAP43 protein. Coexpression of S100 and β-tubulin was observed on LCs and MCs. Also,
coexpression of CD1a and S100 exists in LCs; however a subpopulation of CD1a positive LCs
express S100 in lesser amounts or not at all. There was no specific pattern of the LC distribu-
tion that correlated to the ENF distribution, since the LC distribution was homogenous, whereas
the ENFs were present in some epidermal areas and absent in others. The study showed that
the blister method is well tolerated, is not associated with scar formation and bleeding and
provides an integrated view of 3mm field of observation. In conclusion, the skin blister method
is a minimally invasive method to visualize and study human epidermal nerve fibers and
cells. It could also be used to study the epidermis in diseases such as vitiligo and after manip-
ulations such as UV irradiation.
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Selective hyaluronan-CD44 activation of keratinocyte proliferation, differentiation, lamellar
body formation and secretion in normal and aged epidermis
LY Bourguignon,1 G Wei,1 E Gilad,1 M Man,2 D Crumrine,2 WM Holleran2 and PM Elias2 1
Medicine, University of California-San Francisco, San Francisco, CA and 2 Dermatology,
University of California-San Francisco, San Francisco, CA
In this study we investigated whether hyaluronan (HA)-CD44 (a HA receptor) interaction influ-
ences epidermal functions in normal and aged skin. Using a variety of biochemical, physio-
logical and genetic approaches, we found that HA activates CD44-mediated keratinocyte pro-
liferation, differentiation and lamellar body (LB) formation/secretion. Our data also showed
reduced HA staining in CD44 knock-out (k/o) mouse skin, with marked alterations in epider-
mal barrier function, proliferation, differentiation and lipid synthesis in these animals. Most
recently, we observed that epidermal aging is associated with abnormal CD44 and HA stain-
ing leading to a marked thinning of aged epidermis vs. young mouse skin. A significant delay
in the barrier recovery (following acute barrier disruption) occurs in aged vs. young mouse
skin. To assess the basis for these alterations in aged mouse epidermis, we determined that ker-
atinocyte proliferation and differentiation markers are greatly reduced in the epidermis of aged
vs. young mice. Both LB formation and secretion are also significantly downregulated lead-
ing to slower barrier recovery in aged mouse epidermis. In fact, the spectrum of abnormali-
ties in HA/CD44 expression and keratinocyte functions detected in CD44 k/o mouse skin is
quite similar to the defects in epidermal functions observed in aged murine epidermis. These
findings all suggest the importance of HA/CD44 interaction for several key keratinocyte func-
tions and epidermal physiology. We believe that HA-CD44 interaction plays a critical role in
regulating epidermal proliferation, differentiation and lipid synthesis/secretion, which in turn
influence permeability barrier homeostasis. Manipulation of HA-CD44 interaction could pro-
vide a novel approach to the treatment of various aging-related skin disorders characterized
by abnormalities in proliferation, differentiation, lipid synthesis, and/or barrier function.
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Epinephrine mediated stress response impairs burn wound healing
RK Sivamani, CE Pullar, RC Carlsen, DG Greenhalgh and R Isseroff Dermatology, Physiology,
and Surgery, Univ of California, Davis, CA
Burn wound stress is associated with both immediate and prolonged elevation of circulating
epinephrine (Epi) levels. Here we ask whether these elevated Epi levels can impact on cuta-
neous burn wound repair. We found that exogenously added Epi (10 nM) impaired keratinocyte
migration in vitro, as well as re-epithelialization of an ex vivo human skin burn wounds. Endoge-
nous tissue generation of Epi was induced in the ex vivo cultured skin by burn wounding: a
fifteen-fold increase in Epi levels immediately post burn, and a ten-fold increase at 24 hrs,
likely mediated by the observed increase in the Epi-synthesizing enzyme phenylethanolamine
N-methyltransferase (PNMT) in the peri-burn wound tissue. Treatment of ex vivo burn wounds
with the beta- adrenergic receptor (B-AR) antagonist timolol (10uM), improved wound re-
epithelialization. Timolol treated wounds completely re-epithelialized while control and B-
AR agonist treated wounds only achieved 75% re-epithelialization at day 10 after burn wound-
ing. Because keratinocytes only express the beta-2 adrenergic receptor (B2-AR) variant of the
B-AR, we hypothesized that Epi-induced impairment of re-epithelialization was B2-AR medi-
ated. To test this latter hypothesis, we treated 20% body surface area burn wounded mice
with the B2-AR specific blocker ICI-118,551 (ICI, 0.7 kg/mg/day) using continuous infusion
via implanted osmotic pumps. The burn wound re-epithelialization rate was accelerated by
50% at day 5 and by 48% at day 10 post-burn in ICI treated mice. Re-epithelialization rates
did not differ between control and B2-AR agonist treated mice. Our results demonstrate that,
in addition to increasing circulating levels of Epi, burn wounding also induces local tissue syn-
thesis that impairs wound repair. Furthermore, our in vivo findings show that B2-AR blockade
improves burn wound re-epithelialization and hastens wound healing. We conclude that phar-
macologic manipulation of the B2-AR may offer a novel therapy to improve wound healing
and outcomes in burn wound patients.
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Iron status affects human sebocyte survival
KR Smith,1 A Nelson,1 Z Cong1 and D Thiboutot1,2 1 Jake Gittlen Cancer Research
Foundation, Pennsylvania State College of Medicine, Hershey, PA and 2 Department of
Dermatology, Pennsylvania State University College of Medicine, Hershey, PA
Iron status has been shown to be important in cell homeostasis. Most notably an increase in
the intracellular iron can cause formation of free radicals and induce cells to undergo apop-
tosis. The effect of iron state (depletion and overload) on sebocyte survival was examined in
the temperature sensitive sebocyte cell line (TSS-1). The TSS-1 cell line is transfected with a
temperature sensitive SV40 mutant in which the function of the SV40 large T antigen is shut
off at higher temperature (39oC). TSS-1 cell line has shown to accumulate intracellular lipids
by Oil Red O staining, and express the differentiation markers, androgen receptor and mela-
cortin 5 receptor at the restrictive temperature. In order to test the effect of iron depletion and
overload we treated the cells with deferoxamine (DFO) and ferric citrate respectively. A semi-
quantitative western analysis for h-ferritin was performed in order to determine the iron sta-
tus after treatment. To test the effect of iron status on apoptosis we performed semi-quantita-
tive western analysis for cleaved caspase-3 and flow cytometry for Annexin V-FITC positive
cells. The results show that DFO decreases h-ferritin levels, and increases cleaved caaspase-
3 levels and numbers of Annexin V-FITC positive cells. Treatment with ferric citrate increases
h-ferritin, cleaved caspase-3 levels, and numbers of Annexin V-FITC positive cells. These data
indicate that iron depletion and overload can each induce apoptosis in sebocytes, suggesting
that alteration of sebocyte iron status might represent an alternative means to reduce sebum
production and improve acne.
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Hop is upregulated during the process of stratification of normal human epidermal ker-
atinocytes and controls the expression of its late differentiation marker genes
G Park, E Kim, H Kim and J Yang Dermatology, Samsung Medical Center, Sungkyunkwan
University School of Medicine, Seoul, South Korea
Hop is an unusual homeodomain protein and originally identified as a key regulator of car-
diac development. However, it has little known that the biological role of Hop in other tis-
sues such as skin. In this study, we demonstrate the expression of Hop is dependent on the
calcium-induced differentiation of normal human epidermal keratinocytes (NHEK) and its
absence affect on the expression of late differentiation markers. By performing Northern blot,
RT-PCR, and Western blot analyses, we found that the expression of Hop was induced dur-
ing the late stage of NHEK differentiation by calcium. In epidermis tissues, Hop is differen-
tially expressed in upper suprabasal layers. To elucidate the possible relationship with differ-
entiation of NHEK, RNA interference silencing was used to down-regulate Hop expression in
the differentiated NHEK. Comparing to the control experiment, knockdown of Hop expres-
sion resulted in the increase of the late differentiation markers, not early ones such as ker-
atin1 and 10. Especially, loricrin was dramatically induced. Microarray gene profiling of Hop
RNAi knockdown experiments also showed that the keratinocytes differentiation related genes
located in epidermal differentiation complex (EDC, 1q21) and other reported genes as epi-
dermal differentiation markers such as corneodesmosin and transglutaminase 5 were also
induced by knockdown of Hop. These results suggest that Hop is differentially expressed in
the differentiated keratinocytes and controls the genes associated with terminal differentia-
tion of NHEK.
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Dry skin – new insight into its understanding
Y Milner,1 AE Sagiv2 and S Dikstein2 1 Myers Skin Biol. and Biochem. Lab - Institute of Life
Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel and 2 Cell Pharmacology,
School of Pharmacy, The Hebrew University of Jerusalem, Jersualem, Israel
Dry Skin (DS) is a skin problem found in many diseased states. We developed a guinea pig
model for DS that enables comparison of the effectiveness of known and potential moisturiz-
ers. We have studied the connection between the in vitro humectant property of a material
and its in vivo moisturization ability and the connection of DS to epidermal cells proliferation
and differentiation (prol.&diff.). DS was induced on the shaved skin on one side of guinea pigs
by daily application of 2% sodium lauryl sulphate (SLS) for 3 days (other side served as a con-
trol). The skin was treated for 6 days with potential moisturizers for curing. Measurement of the
in vivo moisturizing effect was carried out non-invasively by Corneometer CM 825® (con-
ductivity) and Mexameter MX 16® (erythema). The skin of the euthanized animals was exam-
ined biochemically and immunohistochemically for cell prol.&diff. Flow cytometry was used
to gauge envelopes formation, Immunoblots conducted to follow PK-C activation. In vitro
humectancy was measured using the isopiestic method (water vapor pressure at isothermal
equilibrium). Number of hydroxyl groups in set of polyhydroxyalkanes (glycerol-3, diglycerol-
5 and triglycerol-7) increases the humectancy in vitro linearly but not the water content (mois-
ture), in skin in vivo. Glycerol is the most potent polyol to cure skin dryness (abolishing ery-
thema and increase water content). This indicates that ability to moisturize skin is not equivalent
to humectant ability! Indeed, using mM-µM concentrations of secondary messengers (c-GMP,
PK-C inhibitors, urokinase inhibitors etc.) cured DS! Furthermore, inhibition of keratinocyte
prol.&diff. (i.e. by colcemid, etc.) prevented experimental dry skin. DS cure involve biochem-
ical processes that include epidermal cell prol.&diff. This is in total contrast to the common
biophysical concept which relates humectancy to skin moisturization.
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Avocado sugars are effective inducer of cutaneous defensive functions
S Bredif, S Garnier, N Piccardi and P Msika Centre R&D, Laboratoires Expanscience,
Epernon, France
The presence of D-manno-heptulose and perseitol as the predominant sugars in avocado fruits
is of considerable interest for the metabolic growth of the fruit. In this work, we have explored
the effect of these specific sugars on skin defense mechanisms. We have focused our work on
different protective cutaneous functions including antimicrobial barrier, structural organization
and inflammatory response. For the first time, we were able to show the cosmetic relevance of
these patented naturally occurring sugars as inducers of the epidermis defensive response.
Cultures of NHEK or NHDF were stimulated with a blend of avocado sugars (AV). ELISA tests
were performed to determine whether anti-microbial peptides and inflammatory cytokines were
stimulated. Moreover, we have simulated atopic dermatitis (AD) conditions in vitro and we
have evaluated hBD-2 production in this model. The effects of AV on skin barrier were also
checked on different parameters: keratinocytes proliferation and differentiation, stratum corneum,
dermal-epidermal junction. Finally, AV were evaluated on a model of PMA-induced inflam-
mation. We have shown that AV are able to significantly stimulate the production of hBD-2,
hBD-3 and LL-37 by NHEK without enhancing pro-inflammatory response. Decrease expres-
sion of hBD-2 following IL-1 beta stimulation was demonstrated in the in vitro AD simulated
conditions (NHEK + IL-4). In this model, AV treatment increases hBD-2 production. Barrier
function of the skin is also associated with permeability barrier homeostasis. AV stimulates
keratinocytes proliferation (+27%), differentiation (+49%) and enhances the production of
desmoglein (+41%) as well as collagen VII (+199%) and beta-4 integrin (+58%). Moreover, AV
are able to inhibit PMA-induced inflammation measured by IL-1 alpha and VEGF release. This
specific blend of 7-carbons sugars from avocado may helps the skin (normal and pathologic)
to preserve the equilibrium between the different cutaneous defensive mechanisms by enhanc-
ing the structural organization of the epidermis as well as the antimicrobial barrier.
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Skin surface electric potential as an indicator of skin condition: A new, non-invasive method
to evaluate epidermal pathology 
E Kawai,1 J Nakanishi,1 N Kumazawa2 and M Denda1 1 Shiseido Research Center, Yokohama,
Japan and 2 Ibaraki University, Mito, Japan
We previously demonstrated that the skin surface electric potential, which has been long rec-
ognized as a parameter of emotional or physiological state, is generated by epidermal ker-
atinocytes and is strongly associated with the ion concentration gradient in the epidermis.
Thus, at temperatures below the threshold of sweating, the potential provides a measure of
the epidermal ion concentration gradient, which in turn is related to epidermal homeostasis
and pathology. In the present study, we established a new, non-invasive method to measure
skin surface electric potential, and examined the relationship of this potential to two other
parameters commonly used to evaluate skin condition, i.e., transepidermal water loss (TEWL)
and skin surface conductance. The skin surface potential was significantly correlated with
TEWL, as well as with skin surface conductance. Moreover, environmental humidity affected
the potential, whereas temporary hydration of the stratum corneum did not affect it. These
results suggest that the skin surface electric potential may be an indicator of the pathophysi-
ology of the living layer of epidermis, and thus may be useful as a new parameter to evaluate
skin condition.
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New nutraceutic for post-partum body remodelling. In vitro evaluation by investigations of
the different skin layers
M Moreau, S Bredif, D Naaimi, C Baudouin and P Msika R & D Center, Laboratoires
Expanscience, Epernon, France
A patented innovative food supplement, composed of borage oil, fish oil, magnesium oxide,
pineapple extract, zinc sulfate and a blend of vitamins B has been specifically formulated for
post-partum women body remodelling. Its efficacy has been evaluated in vitro on each part
of the skin: hypodermis, dermis, dermal-epidermal junction and epidermis. Normal human
adipocytes have been treated by borage and fish oils. Lipolysis was evaluated by measurement
of glycerol release and lipogenesis was followed by measurement of incorporated 14C-acetate.
Borage and fish oil have been shown to stimulate lipolysis and inhibit lipogenesis. Normal
human dermal fibroblasts as well as normal human epidermal keratinocytes have been treated
by the blend of vitamins B with the trace elements (Mg, Zn). We examined cell proliferation
(MTT assay), keratinocytes differentiation (involucrin, cytokeratin 10), fibroblasts metabolism
(total proteins synthesis), synthesis of extracellular matrix proteins (collagen I, elastin, fibronectin)
and synthesis of dermal-epidermal junction molecules (collagen VII). We have shown that the
mixture of vitamins B and trace elements activated keratinocytes proliferation and differenti-
ation; stimulated fibroblasts metabolism and synthesis of extracellular matrix key compo-
nents and stimulated collagen VII synthesis. By this study, we demonstrated that this new
nutraceutical is able to restructure and firm up post-partum skin by acting at each level of the
skin organization. Actually, it promotes reduction of adipose tissue, enhances dermis elastic-
ity and density, reinforces epidermal-dermal junction and activates renewal of epidermis. These
results are supported by a clinical evaluation conducted on post-partum women. Together,
the in vitro and in vivo studies confirm that the nutraceutical accelerates the decrease of fat
accumulated during pregnancy and improves skin aspect.
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Regulatory effects of a cathepsin D-like acid protease on key epidermal and dermal genes
WP Smith,1 G Gillis2 and MA Bishop2 1 Dermac F, Wellington, FL and 2 Biochemistry,
Actifirm, Louisville, TX
A cathepsin D-like acid protease (CLPE) derived from Mucor miehei induces exfoliation which
over time modifies epidermal and dermal structure resulting in improved skin appearance.
Herein we examined mechanism of action by analyzing its effects on gene regulation using
the Matek skin full thickness tissue model and DNA array analysis. CPLE caused an upregu-
lation in genes involved in the formation of keratin (Type 1, 2 and hair keratin) as well as col-
lagen (Type 1α1, IVα1, Vα2, VIα3). CPLE also induced an upregulation of the genes involved
in the production of CAMS including integrins, E-Cadherin and Desmocollin 1. The PAK pro-
tein p21 (cdkn1a)-activated kinase 3, an effector that links Rho GTPases to cytoskeleton reor-
ganization and nuclear signaling, was also upregulated. CPLE induced a number of genes
involved in the cell cycle. Upregulation of cyclin-dependent kinase inhibitor 1a (p21,cip1), a
regulator of cell cycle progression at G1 via p53-dependent cell cycle G1 phase arrest in
response to a variety of stress stimuli, was observed. Genes coding for other cell cycle G1 reg-
ulators, CDC34, chk2 checkpoint homolog, polo-like kinase 1 and p19 were also upregulated.
These proteins also play a regulatory role in S phase DNA replication, DNA damage repair
and the execution of apoptosis following caspase activation. CPLE also upregulated genes cod-
ing for proteins involved in proepithelin conversion to epithelin including granulin (cell growth
regulator), secretory leukocyte peptidase inhibitor (inhibitor for trypsin, chymotrypsin, cathep-
sin G and HLE), and ets variant gene 3 (represses MMP1 promoter activity). These data indi-
cate a moderation of the inflammatory response during chronic exfoliation. Taken together,
these results indicate that topical application of CPLE may result not only in chronic exfolia-
tion but also induces other metabolic systems such as cytoskeletal reorganization, cell cycle
control and a controlled inflammatory response.
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Antiglycation effects of skincare active materials during a simulated glycation process on the
skin ex vivo
C Korwin-Zmijowska,1 L Peno-Mazzarino,1 P Gasser,1 B Djian,1 E Lati,1 F Arnold2 and
M Mercier2 1 Centre de Recherches Biologiques et d’Expérimentations Cutanées, Clamart,
France and 2 MMP Sarl, Issy les Moulineaux, France
Glycation (also referred as the Maillard reaction) is a slow nonenzymatic reaction which
takes place between amino residues in proteins, i.e. primarily lysine and a reducing sugar such
as glucose or ribose. In skin this reaction creates new residues and formation of cross-links in
proteins of the extracellular matrix (Advanced Glycation End Products or AGEs). Some of these
AGEs have been identified as pentosidine and N-carboxymethyl-lysine (CML). AGEs accu-
mulate on elastin and collagen fibers, interfering with normal skin function and altering the
physical and mechanical properties of the matrix. The dermis and elastic fiber network become
glycated in people over 35 years of age and solar irradiation appeared to enhance it. The aim
of our study is to evaluate ex vivo the effects of skincare active materials on dermal glycation
in a model of skin explants maintained in survival. In this model, testing conditions have first
been set to accelerate the glycation process by addition of the a glycation agent (methylgly-
oxal). The living skin explants are treated by direct incorporation of the glycation agent and
the tested products in the culture medium under the previously set conditions. A well-known
antiglycation agent (aminoguanidine hydrochloride) has been used as the reference. Some of
the tested actives have a use in diabetis or in the regulation of glucose uptake in traditional
asian medicin or food supplements. General morphology of the skin, expression of pentosidin,
N-carboxymethyl-lysine, fibrillin are observed after specific staining and immunostainings.
SOD and catalase are determined in the culture medium. In this experimental model, the
incorporation of the actives tested induces a modulation of the different parameters. The results
show that in addition to the AGEs, fibrillin is a good marker to monitor glycation in this
model. The flavonoids tested show that they can inhibit or decrease the glycation process.
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A New cell Energy-inducing active ingredient that remarkably enhances cell energy and
defense against stress
A Perrin, E Bauza, I Imbert, C Gondran, R Chabert, C Dal Farra and N Domloge Vincience,
ISP Global Research Center, Sophia Antipolis, France
Oxidative stress and glycation are recognized as key factors in skin aging. As cell energizers
can play an essential role in mitochondrial energy synthesis and antioxidative stress protec-
tion, we were interested in developing a new cell energy-inducing active ingredient (CE), and
testing its effect on cultured cells and ex vivo human skin. Total cellular ATP was evaluated in
dose course studies and showed that fibroblasts treated with the new CE for 3 h exhibited an
increase in cellular ATP of 57%, 63% and 42%, when treated with 0.5%, 1%, and 3% of CE,
respectively. Moreover, time course studies showed an increase in cell ATP of 17% at 1 h, and
67% at 3 h of treatment with 1% of CE. Interestingly, additional studies showed that cells
treated with 1% of CE exhibited a 30% decrease in protein carbonylation. Similarly, after UV
stress with 50 mJ/cm2 of UVB, or after a stress with 2mM of H2O2, a decrease of 20% in pro-
tein carbonylation was found in CE-treated cells, in addition to a net decrease in the apopto-
sis marker annexin V. Parallel studies were performed on ex vivo human skin, treated with 1%
of CE and then exposed to UVB irradiation with 100mJ/cm2, or to glycation stress with 5mM
or 10mM of methyl glyoxal. H&E staining of ex vivo skin samples treated with CE confirmed
the above mentioned results by revealing a clear protection of skin structure from UV and gly-
cation damage, compared to the untreated skin. These studies demonstrate the interesting anti-
aging effect that this new active ingredient possesses by enhancing cell energy and ATP syn-
thesis, and by considerably improving cell protection from oxidative and glycation damage.
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A newly developed active ingredient that enhances aconitase activity and prevents oxida-
tive damage
C Gondran, E Bauza, I Imbert, G Bressier, A Perrin, J Botto, C Dal Farra and N Domloge
Vincience, ISP Global Research Center, Sophia Antipolis, France
Mitochondria are organelles that are essential to the production of cell energy. Among the
enzymes implicated in mitochondrial activity, aconitase plays a crucial role in energy pro-
duction and mitochondrial DNA protection, preventing energy decline induced by oxygen
radicals. In the present study, we evaluated the effects of a new aconitase-inducing active ingre-
dient (AC) on aconitase activity, cell viability after different stresses, DNA protection, and ATP
level. Human fibroblasts were pretreated with 1% of AC for 24 or 48 hours, then submitted
to different stresses such as UVB (100 mJ/cm2), H2O2 (5 mM for 30 minutes), or nitric oxide
(NO) stress generated by the NO-donor DETA-NO (0.5 mM for 24 h or 48 h). These studies
showed that total aconitase activity, as well as mitochondrial aconitase activity, were signifi-
cantly increased by AC treatment. Similar results were found after UVB stress. Moreover, the
MTT assay revealed a significant enhancement in cell viability (+21%) in unstressed fibrob-
lasts treated with AC. A significant increase in cell viability was also observed in treated cells
after UVB and H2O2 exposure (+21% and +25%, respectively). Furthermore, cellular energy
assessed by ATP level was significantly increased by AC treatment (+43% at 1 hour). H&E stain-
ing of fibroblasts stressed with NO revealed improvements in cellular morphology in AC-
treated cells, compared to the altered control. Moreover, H&E staining of ex vivo skin, stressed
with H2O2 or NO, revealed that AC-treated skin samples exhibited a better preservation of
epidermal structure than the untreated control. In addition, comet assays were performed on
UVB exposed fibroblasts and showed a significant decrease in tail moment (25%) due to AC
treatment. Taken together, these results demonstrate that the AC is of prime interest for mito-
chondrial protection and for the maintenance of mitochondrial activity, especially when the
skin is submitted to a stressful environment.
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A new cytochrome c-inducing active ingredient that enhances mitochondrial membrane
potential and functioning
A Perrin, R Chabert, E Bauza, I Imbert, C Gondran, J Botto, C Dal Farra and N Domloge
Vincience, ISP Global Research Center, Sophia Antipolis, France
Cytochrome c, a highly conserved protein that spans the spectrum of species, is closely asso-
ciated with the inner membrane of mitochondria and is essential for electron transfer, cell
energy, and life in general. Thus, we developed a new cytochrome c-inducing active ingredi-
ent (CI) that helps cells reinforce mitochondrial potential and, consequently, improves cell
functioning. In order to study this new cytochrome c-inducing active ingredient, cytochrome
c expression in cells was evaluated by immunofluorescence staining and Western blot stud-
ies, after CI was applied. A net increase in cytochrome c expression in fibroblasts treated with
the 1% of CI was observed, compared to untreated cells. This effect was consistent in unstressed
cells, and when cells were stressed with UVB (50 and 75mJ/cm2) or H2O2 (1mM). In order
to further investigate the effects of CI on cytochrome c, cytochrome oxidase activity assays
were performed on human fibroblasts. These studies showed that treatment of the cells with
CI greatly enhanced cytochrome oxidase activity by 250% and 850% after 3 hours and 24
hours of application, respectively. Interestingly, a significant increase in ATP content after 1 h
(+41%) and 3 h (+27%) was observed in the CI-treated cells and correlated well with the
improvement of mitochondrial functioning. In order to further confirm these results, studies
were performed on JC-1, a new marker of mitochondrial membrane potential. CI-treated cells
showed a higher membrane potential (red fluorescence corresponding to JC-1 aggregates) than
control untreated cells (green fluorescence corresponding to JC-1 monomers). Similar results
were obtained with cells stressed with UVB or H2O2. These studies demonstrate the signifi-
cant effect of this new cytochrome c-inducing active ingredient on improving mitochondrial
potential and cell functioning, and strongly suggest that it can be of great use in skin ener-
gizing and skin care products.
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A new active ingredient that improves skin defense and protection by enhancing mitochon-
drial cytochrome c expression
E Bauza, A Perrin, R Chabert, I Imbert, C Gondran, C Dal Farra and N Domloge Vincience,
ISP Global Research Center, Sophia Antipolis, France
Cytochrome c is an essential protein for mitochondrial functioning and cell survival. It is, unlike
other cytochromes, a soluble protein, and is a vital component of the electron transfer chain,
cell energy production, and breathing. Parallel studies of ours have demonstrated that cell
treatment with a new cytochrome c-inducing active ingredient (CI) enhances cytochrome c
expression and mitochondrial potential. Consequently, we were interested in studying further
the effects of this new active ingredient on skin defense and protection. Ex vivo studies revealed
that, after UVB irradiation with 100mJ/cm2, human skin pretreated with 1% of CI exhibited
enhanced protection against UV damage, reduced sunburn formation, and improved preser-
vation of skin structure. Moreover, glycation experiments were performed on human skin using
5mM or 10mM of methyl glyoxal. These studies showed that skin pretreatment with 1% of CI
remarkably reduced skin glycation stress signs. Furthermore, antioxidant studies revealed an
interesting decrease in protein carbonylation, that reached –35%, after treatment with 1% of
CI for 48 h. Interestingly, this effect was also seen after UVB stress (100mJ/cm2). Parallel cell
death studies using the annexin V marker (a marker of early apoptosis) confirmed the above
results and showed that cells pretreated with 1% of CI, and stressed with UVB (50mJ/cm2) or
2mM of H2O2, exhibited a net decrease in annexin V expression and cell death. Taken together,
these studies demonstrate the important effect of the new cytochrome c-inducing active ingre-
dient on reinforcing mitochondrial functions, and improving skin protection and defense.
This new cytochrome c-inducing active ingredient can thus be of great use in protective
active ingredients for the skin, and in skin care products.
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Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic
dermatitis
T Nomura,1 A Sandilands,2 M Akiyama,1 H Liao,2 AT Evans,3 K Sakai,1 M Ota,4 H Sugiura,5
K Yamamoto,5 H Sato,5 C Palmer,6 F Smith,2 I McLean2 and H Shimizu1 1 Department of
Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan, 2
Epithelial Genetics Group, Human Genetics Unit, Division of Pathology and Neuroscience,
University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom, 3
Department of Pathology, Tayside University Hospitals NHS Trust, Dundee, United Kingdom,
4 Department of Dermatology, Oji General Hospital, Tomakomai, Japan, 5 Department of
Bioscience, Shiga University of Medical Science, Otsu, Japan and 6 Population
Pharmacogenetics Group, Biomedical Research Centre, University of Dundee, Ninewells
Hospital and Medical School, Dundee, United Kingdom
Filaggrin is a key protein involved in skin barrier function. Recently, mutations in the filaggrin gene,
FLG, were identified in European families with ichthyosis vulgaris (IV) and shown to be an impor-
tant predisposing factor for atopic dermatitis (AD). In this study, the known filaggrin mutations
were studied by genotyping and new mutations identified by DNA sequencing. The European-
specific mutations R501X and 2282del4 were absent from 315 Japanese individuals. We there-
fore sequenced the FLG gene in ten Japanese families with IV and identified two novel mutations,
3321delA and S2554X. Immunohistological and ultrastructural observations indicated that both
truncation mutations lead to a striking reduction of keratohyalin granules in the epidermis. We
screened 143 Japanese AD patients for these null FLG mutations and identified them in 8 AD
patients (5.6%), including S2554X in 6 patients (4.2%) and 3321delA in 2 patients (1.4%). Both
null variants were absent from 156 unrelated Japanese non-atopic and non-ichthyotic controls,
giving a significant statistical association between the FLG mutations and AD (χ2 P value 0.0015).
This is the first report of FLG mutations in a non-European population. Our data indicate that FLG
mutations in Japanese population are unique from those found in European-origin populations.
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UVB irradiation down-regulates Rac1 and aPKC, and inhibits the formation of functional
tight junctions in cultured keratinocytes
T Yuki,1 A Haratake,1 Y Sugiyama,1 K Morita,2 M Muto,2 Y Miyachi3 and S Inoue1 1 Basic
Research Laboratory, Kanebo cosmetics Inc., Odawara, Japan, 2 Department of
Dermatology, Yamaguchi University Graduate School of Medicine, Ube, Japan and 3
Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
Tight junctions (TJs) in mouse epidermis and cultured normal human keratinocytes (NHK) con-
tribute to the permeability barrier (M. Furuse et al. 2002; T. Yuki et al. 2007). In this study, we
investigated changes in the permeability barrier of TJs in mouse epidermis and NHK after UVB
irradiation. Biotin injected intradermally into the back skin of hairless mice diffused through
the intercellular spaces from basal layer to the prickle layer, with diffusion stopping at the TJs
in the granular layer. Disruption of the permeability barrier of the TJs was observed at 48 and
72 hours after UVB irradiation (150 mJ/cm2), suggesting that the basal and prickle cells had
lost their ability to form functional TJs. To examine the effect of UVB irradiation on the for-
mation of functional TJs in keratinocytes, we analyzed the expression and localization of TJ
proteins in NHK exposed to UVB (10-40 mJ/cm2). In non-irradiated NHK, TJ proteins (Occludin,
Claudin-1, -4, ZO-1) were concentrated within a plasma membrane and formed a continu-
ous network during Ca2+-induced differentiation. In UVB-irradiated NHK, however, the TJ pro-
teins were improperly localized into dot-like shapes and formed a discontinuous network.
Furthermore, UVB-irradiated NHK failed to form a mature permeability barrier. The expres-
sion levels of TJ proteins and phosphorylated forms of Occludin were not influenced by UVB
irradiation. Therefore, we examined the activation state of Rac1 and aPKC, which are crucial
for the continuous formation of TJs. Activation analysis showed that UVB irradiation markedly
decreased the active forms of Rac1 (GTP-Rac1) and aPKC (phospho-aPKC). These findings
suggest that inactivation of Rac1 and aPKC by UVB irradiation causes the formation of a dis-
continuous network of TJ proteins concomitant with the impaired permeability barrier in NHK.
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Ceramide deficient mice specifically in epidermis reveal the outside-inside mechanism for
development of dermatitis
M Terao,1 S Sano,1 S Kitaba,1 H Murota,1 J Takeda2 and I Katayama1 1 Dermatology, Osaka
University Graduate School of Medicine, Suita, Japan and 2 Social Environmental Medicine,
Osaka University Graduate School of Medicine, Suita, Japan
Ceramides in the stratum corneum (SC) are essential for skin barrier function, but the under-
lying mechanism still remains elusive. Here, we generated Sptlc2 targeted mice whose ker-
atinocytes were devoid of serine palmitoyltransferase, the rate-limiting enzyme for sphin-
golipid synthesis. The level of ceramides in SC was much decreased in newborn K5.Sptlc2-/-
mice (referred to as KO mice), which exhibited shiny, xerotic skin with decreased skin water
retention. Electromicrograph demonstrated that KO mice’s epidermis harbored lamellar bod-
ies (LBs) with abnormal structure. Although their permeability barrier was normal at birth,
recovery from acute barrier disruption with tape stripping was significantly delayed. From two
weeks of age, their permeability barrier became devastated, accompanied by a decrease of
LB number. At the same time, their skin exhibited severe phenotypic changes including hyper-
keratosis, acanthosis and dermatitis. RT-PCR analyses revealed that higher levels of proin-
flammatory cytokines were detected in KO mice’s epidermis at pre-symptomatic stage, com-
pared with those in age-matched wild-type controls. They included IL-1α, TNF-α, GM-CSF,
the overexpressions of which were previously shown to be followed by barrier disruption.
Thus, ceramide deficiency of cornified layer not only resulted in disruption of water retention
capability and permeability barrier, but also predisposed to skin inflammation through over-
expression of epidermal cytokines. Furthermore, our results favor the previous notion that
primary dysfunction of epidermis triggered skin inflammation, referred to as “outside-inside
theory”, by which the pathomechanism of atopic dermatitis has been recently characterized.
425
Caspase-14 protects against epidermal UVB photo-damage and water loss
G Denecker,1 E Hoste,1 B Gilbert,1 T Hochepied,1 P Ovaere,1 S Lippens,1 C Van den
Broucke,2 P Van Damme,2 K D’Herde,2 J Hachem,3 G Borgonie,2 R Presland,4 L Schoonjans,5
C Libert,1 J Vandekerckhove,2 K Gevaert,2 P Vandenabeele1 and W Declercq1 1 Department
of Molecular Biomedical Research, University of Ghent - VIB, Gent, Belgium, 2 Ghent
University, Ghent, Belgium, 3 University of Brussels, Brussels, Belgium, 4 University of
Washington, Seattle, WA and 5 University of Leuven, Leuven, Belgium
Caspase-14 belongs to a conserved family of aspartate-specific proteinases. It is a short
prodomain caspase whose expression is almost exclusively restricted to the suprabasal lay-
ers of the epidermis and the hair follicles. Moreover, its proteolytic activation of caspase-14
is associated with stratum corneum formation. In order to determine the role of caspase-14,
we generated caspase-14 deficient mice. The skin of these was shiny and lichenified, indi-
cating an altered stratum corneum composition. However, no major histomorphological or
immunohistochemical differences were observed. Electron microscopic analysis revealed a
significantly higher number of alveolar keratohyalin F-granules, the profilaggrin stores, in the
caspase-14 deficient epidermis. Accordingly, caspase-14 deficient epidermis is characterised
by an altered profilaggrin-processing pattern and by reduced skin hydration levels and
increased water loss. We show that recombinant caspase-14 can directly cleave profilaggrin
in vitro. Importantly, the skin of caspase-14 deficient mice was highly sensitive to the for-
mation of cyclobutane pyrimidine dimers upon UVB irradiation, leading to increased levels
of UVB-induced apoptosis. Our data indicate that the UVB filtering capacity of the stratum
corneum is reduced in the absence of caspase-14. Taken together, these results demonstrate
that caspase-14 deficient mice can serve as a model to better understand the pathways that
lead to proper development of skin barrier functions preventing water loss and protecting
against UVB light.
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Chemical structure modification of a new rhamnoside derivative enhances its dermal absorp-
tion : assessment through in vitro compartmental analysis and autohistoradiography
V Raufast and A Mavon Laboratoire de Pharmacocinétique Cutanée, Institut de Recherche
Pierre Fabre, Castanet-Tolosan, France
Rhamnose is known to reduce inflammatory cytokines release in the keratinocytes but its pres-
ents a low skin bioavailability due to its hydrophilicity. In order to enhance its transdermal
delivery, a pentyl-rhamnoside was synthesized, and the aim of this study was to determine the
relevance of this chemical structure modification. Dermal absorption studies were carried out
on ex vivo human skin for 24H using flow-through diffusion cell, and topical applications of
formulations containing [3H]-rhamnose or [3H]-pentyl-rhamnoside. Dermal absorption was
analyzed by compartmental analysis combined with quantitative scintillation counting and
with qualitative autohistoradiographic technique. This combination allows an accurate tissu-
lar localization of radiolabelled compounds. The quantitative compartmental analysis showed
that 65 % of rhamnose remained at the skin surface, less than 15% was found stratum corneum
(SC) and only 3 % in the viable epidermis. A higher diffusion was observed with pentyl-rham-
noside. About 30% was found in the SC, and up to 8 % in the epidermis. In addition, less than
1% of both compounds was found in the receptor fluid. The autohistoradiographic observa-
tions showed that rhamnose was distributed throughout the epidermis, without specific local-
ization. In contrast, the pentyl-rhamnoside derivative was mostly located in the keratinocyte
membranes. Altogether these results demonstrates that the chemical structure modification of
rhamnose into pentyl-rhamnoside induces a keratinocyte-membrane targeting, providing a
higher epidermal bioavailability of this new rhamnoside derivative.
422
Lactate dehydrogenase is a relevant endpoint biomarker to study irritation and solar radia-
tion-induced cellular damages in pig skin organ culture
D Bacqueville, M Boisson and A Mavon Laboratoire de Pharmacocinétique Cutanée, Institut
de Recherche Pierre Fabre, Castanet-Tolosan, France
Porcine skin has been reported to be very similar to human skin. However, its relevance as an
alternative model to human tissue in both irritation and irradiation responses is poorly known.
Therefore, we developed an ex vivo organ culture system by seeding pig ear skin explants in
gelatin-coated polycarbonate cell culture inserts and feeding them using Dulbecco’s Modi-
fied Eagle’s Medium (DMEM) supplemented with pyruvate, glutamine, fungizone and antibi-
otics. Thereafter, the explants were irritated with sodium dodecyl sulfate (SDS) or solar irradi-
ated, and different biochemical tests were performed to determine relevant endpoint parameters
to these cytotoxic agents. Skin viability was assessed using the classical tetrazolium salt reduc-
tion (MTT) assay, but also by measuring remaining glucose, lactate production and lactate
dehydrogenase enzyme (LDH) activity released into the culture medium. All assays were val-
idated from fresh and frozen skin samples cultured for 24 hours. Topical application of 2%
SDS during 24 hours greatly increased LDH activity in culture medium whereas the glucose
consumption slightly decreased. The same effects were observed after solar exposure at a 5
DEM equivalent dose. Moreover, LDH release was time and dose-dependent in response to
both cytotoxic stimuli which cellular damages were confirmed by histological analysis after
hematoxylin eosin staining. In contrast to LDH assay, both MTT test and lactate production
were not enough sensitive to detect significant variations in pig skin viability following irrita-
tion or irradiation. Finally, MTT reduction clearly decreased under similar solar irradiation
conditions in a model of reconstructed human epidermis, reinforcing data that this endpoint
is not adapted to our organ culture system. Altogether, our results demonstrate that LDH is a
relevant endpoint biomarker to assess irritation and irradiation-induced skin injuries in ex
vivo porcine skin organ culture.
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Identification and characterization of filaggrin as a caspase-14 substrate
E Hoste,1 G Denecker,1 P Van Damme,2 RB Presland,3 J Vandekerckhove,2 K Gevaert,2
P Vandenabeele1 and W Declercq1 1 Department for Molecular Biomedical Research, VIB-
Ghent University, Zwijnaarde, Belgium, 2 Department of Medical Protein Research, Ghent
University, Ghent, Belgium and 3 Department of Oral Biology and Medicine (Dermatology),
University of Washington, Seattle, WA
Caspase-14 is expressed in a tissue-restricted manner and active cleaved caspase-14 has only
been shown in the cornified layers of skin and of the rodent forestomach. Caspase-14 defi-
cient mice exhibit a defect in epidermal barrier function(1). So far no in vivo substrates of cas-
pase-14 have been reported. We made use of a gel-free proteomic approach called COFRADIC
(combined fractional diagonal chromatography) to identify caspase-14 substrates(2). This analy-
sis showed that a number of peptides derived of filaggrin, was only present in wild-type epi-
dermis, while others emerged only in caspase-14 deficient epidermis. In addition we were
able to identify two putative caspase-14 cleavage sites. Filaggrin is an important structural pro-
tein in skin and is initially expressed as a large polyprotein precursor named profilaggrin which
is cleaved to its functional monomeric filaggrin unit. In stratum corneum this unit is further
degraded into free amino acids. As we observed in caspase-14 deficient skin an accumula-
tion of aberrant low molecular weight filaggrin fragments by western blotting, we treated cas-
pase-14 deficient epidermal extracts with enzymatically active recombinant caspase-14. Upon
addition of caspase-14 the aberrantly processed filaggrin fragments were further degraded.
By means of in vitro transcription/translation assays we show that caspase-14 is capable of
direct processing of profilaggrin. Currently we are determining the profilaggrin cleavage sites.
The identification of caspase-14 substrates will shed light on the molecular mechanisms by
which caspase-14 plays a role in barrier function of skin.
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The impact of aging on the expression of selected genes (heat shock proteins, elastin, fib-
rillin, and steroid hormone receptors) in human skin
G Klosner,2 MS Matsui,3 N Muizzuddin,3 C Kokesch,2 R Grabner,2 E Hofstätter,2 M Binder2
and F Trautinger1,2 1 Karl-Landsteiner-Institute for Dermatological Research, St. Pölten,
Austria, 2 Department of Dermatology, Medical University of Vienna, Vienna, Austria and 3
Estee Lauder Reserach, Melville, NY
Changes in steroid hormones and their receptors, extracellular matrix proteins, and heat shock
proteins (hsp) have been discussed as causes and/or consequences of intrinsic skin aging. In
the present study mRNA expression of estrogen receptors 1 and 2 (esr1, esr2), progesterone
receptor (pgr), elastin (eln), fibrillin 1 (fbn1), and heat shock proteins 27, 72, and 90 (hsp27,
hsp72, hsp90) were quantified in punch biopsies from sun protected skin of healthy female
volunteers of different ages (phototypes II and III; group 1: ages 19-28, n=22; group 2: ages
55-65, n=22). Gene expression was quantified by real-time RT-PCR and immunohistochem-
istry was used to investigate hsp27, hsp72 and fbn1 at the protein level. Elastic fibers were
visualized by Weigert’s stain. Baseline expression of hsp27, hsp72, hsp90, esr1, esr2, and pgr
mRNAs showed considerable variation with no significant difference between age groups.
Independent of age, ex vivo heat shock induced a strong increase in the intensity of hsp72
immunostaining. However, a significant induction of hsp27 was observed in the young group,
but not in the older group. Both fbn1 and eln were significantly increased in the aged group
in contrast to the young group, and when visualized fibrillin-rich microfibrills were rarified,
irregular and appeared severly damaged after heat shock. The age-independent stable expres-
sion of steroid receptors and baseline hsp in sun protected healthy female skin between 19
and 65 years indicate that these factors are essential for skin physiology. The reduced inducibil-
ity of hsp27 may indicate an age related impaired adaptive capacity. In addition, the increased
expression of eln and fbn1 and the alterations of fibrillin-rich microfibrills demonstrate an age-
related dysregulation of extracellular matrix formation that contributes to the phenotype of
aged human skin.
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The structure of the skin barrier and its relationship to pruritus in end-stage renal disease
G Yosipovitch,1,2 MI Hicks,1 BI Freedman,3 DA Guzman-Sanchez,1 Y Ishiuji,1 T Patel,1
YH Chan,4 D Crumrine5 and PM Elias5 1 Dermatology, Wake Forest University School of
Medicine, Winston-Salem, NC, 2 Neurobiology & Anatomy and Regenerative Medicine,
Wake Forest University School of Medicine, Winston-Salem, NC, 3 Internal Medicine, Wake
Forest University School of Medicine, Winston-Salem, NC, 4 Biostatistics Unit, Yong Loo Lin
School of Medicine, Singapore, Singapore and 5 Dermatology, University of California, San
Francisco, CA
Current understanding, conceptualizes the stratum corneum as a two compartment “brick and
mortar” complex. At present, there is a lack of published data describing the structure of the
stratum corneum in end-stage renal disease (ESRD). The aim of the present study was to assess
the ultrastructure of the stratum corneum in ESRD and its relationship to pruritus. Cutaneous
punch biopsies from 7 ESRD patients were examined under electron microscopy with partic-
ular reference to the lipid structure of the stratum corneum as well as the stratum granulo-
sum/stratum corneum interface. The glycerol content of the stratum corneum was obtained
using D-squames tape strips. Electron microscopy revealed no significant ultrastructural abnor-
malities of lipid structure. In addition, there was no significant difference in glycerol content
between ESRD patients with and without pruritus as well as with and without xerosis. This
study shows a normal structure of the skin barrier in ESRD patients with particular reference
to the structural organization of lipids in the stratum corneum.
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Hairless is a transcriptional repressor of ODC
A Casta,1 H Kim,2 T Cirman3 and AM Christiano2,3,1 1 Institute of Human Nutrition, Columbia
University, New York, NY, 2 Genetics and Development, Columbia University, New York, NY
and 3 Dermatology, Columbia University, New York, NY
Hairless (Hr) is a transcriptional co-repressor critical for hair cycling and has recently been
suggested to act as a histone demethylase via its jmjC domain. Phenotypic similarities between
Hr mutant mice and transgenic mice of genes involved in polyamine biosynthesis, such as
overexpression of ODC and SSAT, suggest an involvement of Hr in the control of cell prolif-
eration. ODC is an enzyme that catalyzes a rate-limiting step of the synthesis of polyamines,
which are molecules required for the regulation of cell proliferation. Previous work in our lab
characterized K6-ODC transgenic mouse skin and hair phenotype, showing striking similari-
ties with Hr mutants. Similarly to SKH1 Hr mutant mice, the ODC transgenic mice are also
sensitive to UV and chemically-induced skin carcinogenesis. Treatment of SKH1 skin with an
ODC inhibitor (DFMO) markedly attenuates tumor formation in carcinogenesis protocols, sug-
gesting that ODC might be upregulated in Hr mutant epidermis. In this study, we asked whether
Hr is a transcriptional co-repressor of ODC expression. First, we compared the levels of ODC
protein in SKH1 and hr/hr mutant epidermis with wild type skin by isolation of mouse ker-
atinocytes at several time points after UVB irradiation. SKH1 mutant shows increased basal
levels of ODC, as well as a deregulated response to UVB. hr/hr mutant keratinocytes show an
early upregulation of ODC levels in response to UVB irradiation. We also compared the tran-
scriptional activity of the ODC promoter by a luciferase assay in keratinocytes from a hr-/-
human patient and normal human keratinocytes. In this case, the relative luciferase signal is
7-fold higher in the hr mutant cells. These results suggest that Hr functions as a transcriptional
co-repressor of ODC, affecting the rate of polyamine biosynthesis and cell proliferation. We
hypothesize that one mechanism by which Hr mutations lead to tumor susceptibility in the
skin is due to increased ODC and polyamine levels, leading to uncontrolled proliferation.
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Psychological and physiological stress increases susceptibility to skin infection by Group A
Streptococcus due to glucocorticoid-mediated changes in innate immune function 
KA Radek,1 P Elias2 and RL Gallo1 1 Medicine/Dermatology, University of California, San
Diego, La Jolla, CA and 2 Dermatology, University of California, San Francisco, San Francisco,
CA
Barrier function and antimicrobial peptide (AMP) release can be altered by stress and the sub-
sequent release of glucocortidoids (GCs) and catecholamines. In the present study, we sought
to extend these observations by examining susceptibility to infection by Group A Streptococ-
cus (GAS). Two distinct models of stress were tested: psychological stress (PS) induced by alter-
ing mouse housing conditions with light and sound, or hypoglycemic stress induced by insulin.
Stress was followed by s.c. injection with GAS on the dorsum. GAS lesions in normal mice
were smaller at day 4 post-injection compared to stressed mice (PS- 58.1 ±12.8 vs. 95.3
±14.6 mm2; Insulin- 9.2±3.3vs. 17.4 ±8 mm2) and contained fewer surviving bacteria (Insulin-
2.1x10^6±2.1x10^6 vs. 4.5x10^8±4.9x10^8 CFU/ml). In both stress models, increased lesion
size and surviving GAS was reversible by i.p. injection with RU-486 (6 mg/kg), suggesting
that the stress-induced susceptibility to infection is mediated partially through GC. To explore
the mechanism of this susceptibility, skin of insulin-stressed mice was extracted and sub-
jected to HPLC purification, then tested for AMP activity in a radial diffusion assay against an
AMP-susceptible mutant of S. aureus (mprF mutant). AMP fractions from insulin-treated mice
exhibited little or no zone of inhibition compared to normal skin, demonstrating less AMP
activity in skin from stressed animals. Furthermore, normal human keratinocytes treated in
culture with insulin showed reduced expression of cathelicidin after 6 hours, while norepi-
nephrine and epinephrine reduced the expression of human beta defensin-2, both measured
by qPCR. These observations demonstrate that stress results in a decrease in innate immunity
through GC and catecholamine action, an effect that is pharmacologically reversible.
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Intracellular calcium mobilization is mediated by melanocortin receptors in SZ95 sebocytes
S Jeong,1 S Hwang,2 S Choi,2 J An,3 J Seo,3 CC Zouboulis4 and S Lee1,2 1 BK21 Project for
Medical Sciences, Yonsei University, Seoul, South Korea, 2 Department of Dermatology,
Yonsei University College of Medicine, Seoul, South Korea, 3 Department of Oral Biology,
Yonsei University College of Dentistry, Seoul, South Korea and 4 Department of Dermatology
and Immunology, Dessau Medical Center, Dessau, Germany
Among the several pathogenic factors for acne, increased sebum secretion is considered as the
most important one. Previous studies suggested that the α-melanocyte stimulating hormone
(α-MSH) and melanocortin 5 receptor (MC5R) are closely related to sebum formation and secre-
tion in animal models. Activation of melanocortin receptors, which belong to the seven trans-
membrane G-protein coupled receptors, results in increased intracellular free calcium ions.
Recently, localization of melanocortin 1 receptor (MC1R) was reported in both primary cul-
tured human sebocyte and SZ95 sebocytes, while MC5R was only expressed in differentiated
primary sebocytes. In this study, we investigated the intracellular calcium changes induced by
α-MSH treatment in SZ95 sebocytes. Treatment of either α-MSH or testosterone resulted in
increased numbers of intracellular lipid droplets. MC5R expression, detected by confocal LASER
microscopy, was intense in testosterone-treated SZ95 sebocytes, while a very low level of MC5R
expression was observed in undifferentiated SZ95 sebocytes. Interestingly, measurement of intra-
cellular calcium mobilization by fura-2/AM revealed that increased intracellular free calcium
concentrations ([Ca2+]i) was observed only in testosterone-treated SZ95 sebocytes, but not in
undifferentiated SZ95 sebocytes. Therefore, the intracellular calcium signaling induced by α-
MSH is mainly mediated through MC5R. The increase in [Ca2+]i was thapsigargin- and 2-APB-
sensitive. Treatment with caffeine or U-73122, a phospholipase C inhibitor, also blocked [Ca2+]i
increase. These results suggest that the increase of calcium ions in SZ95 sebocytes, induced by
α-MSH treatment, is mediated by the inositol triphosphate pathway. In conclusion, differenti-
ated SZ95 sebocytes express MC5R, which mediates the [Ca2+]i increase induced by α-MSH.
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Caveolin-1 scaffolding domain peptide inhibits phosphatidylglycerol synthesis and keratinocyte
differentiation in response to an elevated extracellular calcium concentration
H Qin and WB Bollag Institute of Molecular Medicine and Genetics, Medical College of
Georgia, Augusta, GA
Previous reports indicate that in the HaCaT human keratinocyte cell line, phospholipase D2
(PLD2) interacts with caveolin-1 in low-density membrane microdomains, and that the activ-
ity of this caveolar PLD2 can be regulated by a caveolin-1 scaffolding domain peptide (CSDP).
Previous studies in our laboratory have suggested that PLD2 and aquaporin 3 (AQP3) associ-
ate in these microdomains in order to synthesize phosphatidylglycerol (PG), a novel lipid mes-
senger that we propose inhibits keratinocyte proliferation and promotes early differentiation.
We hypothesized that CSDP would disrupt signaling molecule localization in microdomains
by interfering with the scaffolding function of endogenous full-length caveolin-1, thereby dis-
turbing the association of AQP3 and PLD2 and resulting in reduced PG synthesis. Therefore,
we treated primary mouse epidermal keratinocytes with a cell-permeable CSDP and stimulated
differentiation using a moderately elevated extracellular calcium concentration (125 µM cal-
cium). Proliferation and differentiation were monitored, as was total PLD activity, PG synthe-
sis and AQP3 activity. CSDP had little or no effect itself on the activities of AQP3, total PLD or
transglutaminase (a marker of late differentiation) or on proliferation, but prevented the changes
induced by 125 µM calcium; whereas a negative control peptide did not. In addition, CSDP
inhibited PG synthesis stimulated by 125 µM calcium. The distribution of PLD2, but not AQP3,
in membrane microdomains appeared to be altered by CSDP. We conclude that CSDP regu-
lates both the inhibition of proliferation and the stimulation of differentiation in response to an
elevated extracellular calcium concentration, at least in part, through effects on PG production.
We propose that reduced AQP3 and PLD2 interaction resulting from disruption of PLD2 local-
ization to membrane microdomains by CSDP may underlie the observed decrease in elevated
extracellular calcium–induced PG synthesis and keratinocyte differentiation.
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Expression of plasminogen activator inhibitor-2 (PAI-2) during keratinocyte differentiation
C Kim,1 S Jang,1 K Sohn,1 K Lee,1 T Yoon,2 Y Seo,1 J Park1 and J Lee1 1 Department of
Dermatology, Chungnam National University, Daejeon, South Korea and 2 Department of
Dermatology, Gyeongsang National University, Jinju, South Korea
Plasminogen activator inhibitor-2 (PAI-2) is an enzyme inhibitor which is involved in cell dif-
ferentiation, tissue regrowth and regeneration. Although PAI-2 has been originally isolated as
an extracellular inhibitor of urokinase plasminogen activator (uPA), recent studies indicate
that PAI-2 has other intracellular function in keratinocyte, such as the component of corni-
fied envelope. To investigate the expression of PAI-2 during the keratinocyte differentiation,
we treated the normal human epidermal keratinocytes with 1.2 mM calcium and performed
RT-PCR and Western blot analysis. Results showed that PAI-2 expression was increased time-
dependently at both mRNA and protein levels. To further investigate the role of PAI-2 in ker-
atinocytes, we made recombinant adenovirus harboring the expression cassette for PAI-2. PAI-
2 protein level was highly increased after adenoviral transduction, confirming that our
adenovirus worked well. We hypothesized that PAI-2 may affect the cell cycle, and deter-
mined the levels for several cell cycle-related proteins. Interestingly, over-expression of PAI-
2 led to the increased levels of Rb and p53 proteins. It is thought that the increased Rb and
p53 levels may be due to the increased stability of those proteins, rather than up-regulation
of Rb and p53 expression. These results suggest that PAI-2 may have a role of arresting the
cell cycle during the keratinocyte differentiation process.
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Elastase 2 is a new epidermal serine protease that contributes to skin barrier function in
vivo
C Bonnart,1 C Deraison,1 C Besson,1 A Briot,1 A Robin,1 M Gonthier,2 B Monsarrat,2 J Segre3
and A Hovnanian1 1 INSERM U563, Toulouse, France, 2 CNRS - IPBS, Toulouse, France and
3 NIH, Bethesda, MD
Netherton syndrome (NS) is a severe genetic skin disorder with a profound defect in skin bar-
rier, caused by mutations in SPINK5. SPINK5 encodes LEKTI, a Kazal-type serine proteinase
inhibitor expressed in the granular layer (GL) of the epidermis. Spink5-deficient mice display
abnormal desmosome cleavage in the GL resulting from hyperactivity of KLK5 (SCTE) and
KLK7 (SCCE). Here we identified by mass spectrometry, pancreatic elastase 2 (Ela2) as a new
epidermal protease hyperactivated in Spink5-/- epidermis. We confirmed its epidermal origin
by RT-PCR and showed that Ela2 is expressed and active in the GL and the stratum corneum
(SC). In order to investigate the role of Ela2 in vivo, we engineered mEla2 transgenic mice
using an involucrin (INV) promoter-bearing cassette. We obtained 3 INV-Ela2 transgenic mice,
the phenotype severity of which correlated with the number of integrated transgene copies.
The first two mice displayed less than 50 transgene copies, appeared normal at birth but devel-
oped a thick and wrinkled skin with generalized scaling five days after birth. Surprisingly, their
phenotype improved as hair grew. The third mouse had more than 200 integrated transgene
copies, displayed a more severe skin phenotype and died at birth. Histological and immuno-
histochemical analyses revealed moderate acanthosis of the epidermis and up-regulation of
the K6 hyperproliferation marker. The SC was abnormally compact and slightly hyperkera-
totic. Electron microscopy examination showed disorganisation of the corneocyte layers and
delayed lamellar body secretion. These observations suggest an intrinsic defect of SC forma-
tion, with no evidence of premature detachment of SC. This phenotype is clearly distinct
from the NS phenotype but is likely to cause a lethal defect in skin barrier function. Our study
provides the first in vivo evidence for a role of Ela2 in a proteolytic cascade involved in the
cornification process.
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Optical Coherence Tomography – a new and highly sensitive non-invasive method for the
determination of epidermal thickness
R Aschoff, P Knuschke and MF Meurer Department of Dermatology, Technical University of
Dresden, Dresden, Germany
Optical Coherence Tomography (OCT) is a new, non-invasive method using infrared radia-
tion for producing images of skin sections with an axial optical resolution of 8 µm (i.e. about
10-times higher than with a 20 MHZ ultrasound equipment). Using OCT, epidermal thick-
ness was measured in 77 healthy subjects (36 females) aged from 3 months to 92 years.
Thickness varied considerably according to body site (mean values): cheek (63 µm), forehead
(73 µm), volar forearm (84 µm), back (87 µm), back of hand (101 µm). Results were highly
reproducible across patients both with regard to localization and time; influence of age or
gender on the reproducibility was minimal.. Compared to volunteers aged between 8 to 60
years (n=52), epidermal thickness was higher (+ 9.2%) in children (<8 years; n=8) but lower
(about -9%) in elderly subjects (>60 years; n=17) at all body sites with the exception of the
forehead where epidermal thickness was similar in all age groups. In an open pilot study in
one healthy subject, OCT was used to evaluate the effect of topical treatment with betametha-
sone-17-valerate (left/right comparison with DAC-Basiscreme). After 5 weeks of bid treat-
ment with the corticosteroid epidermal thickness had decreased by 40%. In contrast, in a sim-
ilar study with the non-steroid pimecrolimus cream 1% no effect on epidermal thickness was
noted. A subsequent open within-patient study compared the effect of pimecrolimus cream
1% bid and hydrocortisone cream 1% od in three healthy volunteers when administered to
the forehead for 5 weeks. Hydrocortisone treatment reduced the epidermal thickness by up
to 29% whereas no significant change in skin thickness was observed with pimecrolimus
cream. In conclusion, OCT proved to be a simple, quick, and non-invasive method to study
the morphology of the epidermis. The atrophogenic effect of topical corticosteroids on the
epidermis, as well as the non-atrophogenicity of pimecrolimus creme 1%, could be confirmed.
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Transgenic mice provide in vivo evidence that KLK5 initiates the proteolytic cascade of desqua-
mation
C Deraison,1 C Bonnart,1 A Robin,1 A Briot,1 C Besson,1 J Segre2 and A Hovnanian1 1
INSERM U563, Toulouse, France and 2 NIH, Bethesda, MD
LEKTI is a 15-domain serine protease inhibitor whose defective expression causes the severe
autosomal recessive ichthyosiform skin condition, Netherton syndrome (NS). LEKTI is a key
regulator of epidermal proteases and we have shown that Spink5–/– mice display enhanced
epidermal protease activity, including KLK5, KLK7 and the newly identified pancreatic elas-
tase 2. These proteolytic hyperactivities resulted in desmosomal protein degradation and accel-
erated proteolytic-processing of filaggrin. In order to document the consequences of unregu-
lated KLK5 activity in the terminally differentiated layers of the epidermis, we have developed
a tissue-specific hKLK5 transgenic mouse in which KLK5 expression is under the control of
the involucrin promoter (INV). Three newborn transgenic mice (INV-KLK5) showed dramatic
skin fragility with severe superficial peeling. They died shortly after birth suggesting a profound
defect in skin barrier function. Histological analysis showed intercellular separation at the
granular layer-stratum corneum interface. Ultrastructural analysis showed asymmetrical splits
of desmosomes underlying stratum corneum detachment. This correlated with a marked reduc-
tion of desmoglein-1 staining in suprabasal epidermis. Interestingly, no keratohyalin granule
could be observed which was concordant with decreased filaggrin immunostaining. A fourth
INV-KLK5 mouse expressed the transgene at lower level and showed erythema and scaling
predominant on the back a few days after birth. Scaling became more pronounced and was
associated with failure to thrive. From day 13, the mouse has shown signs of itch and alopecic
lesions resulting from intense scratching. Our study demonstrates a direct role of KLK5 in the
desquamation process in vivo. INV-KLK5 mice show a much more severe phenotype than
transgenic KLK7 mice and reproduce the main features of Spink5-/- mice. This demonstrates
that KLK5 over-activity is responsible for key features observed in NS. These results also iden-
tify KLK5 as a relevant therapeutic target for NS.
434
CLIC4 mediates and is required for calcium induced keratinocyte differentiation
KS Suh, M Mutoh, T Mutoh, L Li, A Ryscavage, J Crutchley, R Dumont, C Cheng and
SH Yuspa Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda,
MD
Keratinocyte differentiation requires integrating signaling among intracellular ionic changes,
kinase cascades, sequential gene expression, cell cycle arrest, and programmed cell death.
We now show that Chloride Intracellular Channel (CLIC)4 expression is increased in both
mouse and human keratinocytes undergoing differentiation induced by calcium, serum and
the activator of Protein Kinase C (PKC), 12-O-tetradecanoylphorbol-13-acetate (TPA). Eleva-
tion of CLIC4 is associated with signaling by PKC-delta, and knockdown of CLIC4 protein by
antisense or short-hairpin RNA (shRNA) prevents calcium-induced keratin1, keratin10 and
filaggrin expression and cell cycle arrest in differentiating keratinocytes. CLIC4 is cytoplasmic
in actively proliferating keratinocytes in vitro, but the cytoplasmic CLIC4 translocates to the
nucleus in keratinocytes undergoing growth arrest by differentiation, senescence or TGF-beta
treatment. Targeting CLIC4 to the nucleus of keratinocytes via adenoviral transduction increases
nuclear Cl- content and enhances expression of differentiation markers in the absence of ele-
vated calcium. In vivo, CLIC4 is localized to the epidermis in mouse and human skin, where
it is predominantly nuclear in quiescent cells. These results suggest that CLIC4 participates in
epidermal homeostasis through both alterations in level of expression and subcellular local-
ization. Nuclear CLIC4, possibly by altering the Cl- and pH of the nucleus, contributes to cell
cycle arrest and the specific gene expression program associated with keratinocyte terminal
differentiation. Expression of A-Fos, a dominant negative mutant for AP1 (Activator Protein-
1), blocks upregulation of CLIC4 and other differentiation markers, and the promoter sequences
of the mouse and human CLIC4 gene contain putative AP1 binding sites, suggesting CLIC4 is
one of the key down-stream elements of AP1 signaling in keratinocyte differentiation.
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Mcl-1 functions as major survival protein required for proper keratinocyte differentiation
LA Sitailo,3,1 A Jerome2,1 and MF Denning3,1,2 1 Oncology Institute, Loyola University
Chicago, Maywood, IL, 2 Molecular Biology Program, Loyola University Chicago, Maywood,
IL and 3 Pathology, Loyola University Chicago, Maywood, IL
The anti-apoptotic protein Mcl-1 is unique among Bcl-2 family members in that the knock-
out mouse is embryonic lethal, suggesting that Mcl-1 performs functions not compensated for
by other proteins. We have previously shown that down-regulation of Mcl-1 is required for
apoptosis induction by both PKCδ and UV, indicating important roles for Mcl-1 in epidermal
pathology. To evaluate the specific role of Mcl-1 in normal keratinocyte function, human ker-
atinocytes were infected with Control or Mcl-1 shRNA retroviruses and induced to differenti-
ate in either organotypic raft cultures or methylcellulose suspension cultures. Hematoxylin
and eosin staining of Mcl-1 shRNA raft cultures showed reduced granular and cornified lay-
ers compared to Control shRNA rafts. TUNEL and active caspase-3 immunostaining revealed
a high level of spontaneous premature apoptosis in Mcl-1 shRNA rafts. Late differentiation
markers (filaggrin and loricrin) were normally expressed in Control shRNA rafts, but were
prematurely expressed at reduced level in Mcl-1 shRNA rafts. Mcl-1 shRNA-infected ker-
atinocytes also produced lower levels of cross-linked protein in suspension culture and the
general caspase inhibitor z-VAD increased cornified protein formation, suggesting that the
reduced cornification was due to premature apoptosis. It was especially interesting to exam-
ine the effects of Mcl-1 down-regulation on caspase-14, which is associated with epidermal
differentiation and not with apoptosis. Caspase-14 was induced in the granular layer and pro-
teolyticaly processed (activated) in Control shRNA rafts, but was only weakly expressed and
minimally activated in Mcl-1 shRNA rafts. Based on the results, we conclude that Mcl-1 is a
major anti-apoptotic protein in epidermal keratinocytes that serves two important functions:
1) inhibiting premature apoptosis in the spinous and granular layers, and 2) promoting proper
differentiation by insuring the robust induction of late differentiation markers.
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Hr is repressed by TNFa via the NFkB signaling pathway
A Casta,1 H Kim,2 T Cirman,3 A Engelhard3 and AM Christiano2,3,1 1 Institute of Human
Nutrition, Columbia University, New York, NY, 2 Genetics and Development, Columbia
University, New York, NY and 3 Dermatology, Columbia University, New York, NY
Hairless (Hr) is a single zinc-finger domain protein with an essential role in hair follicle devel-
opment and biology. Although it has been shown that downstream it acts as a transcriptional
co-repressor and it is a potential histone demethylase via its jmjC domain, the factors that reg-
ulate Hr expression are largely unknown. It is known that UVB irradiation induces TNFa pro-
duction in human keratinocytes, and that the TNFa-dependent pathway is essential for the ade-
quate response of keratinocytes to the irradiation. In tumor formation, TNFa mediates
transformation of normal cells activating the NFkB signaling cascade leading to the expres-
sion of proliferative genes and the attenuation of the apoptosis induced by TNFa. In addition,
TNFa knockout mice are resistant to multistage skin carcinogenesis, suggesting a critical role
of this signaling in epidermal malignant transformation. It has been shown that crossing the
Hr mutant mice strain SKH1 with the TNFR knock out mice reduces the tumor formation after
UV irradiation in the SKH1 tumor susceptible animals. This study suggests a functional rela-
tionship between Hr and the TNFa pathway. In this study, we ask whether Hr is repressed by
the TNFa signaling cascade. We analyzed the levels of Hr mRNA in HaCaT cells after TNFa
treatment, and we show that Hr transcription is significantly repressed after 12 hours of treat-
ment. We also show that Hr mRNA levels are repressed by the TNFa pathway in a concentra-
tion-dependent manner. Using a luciferase system, we show that TNFa represses the Hr pro-
moter activity in a concentration-dependent manner. In addition, using deletion mutants of
the Hr promoter, we show that an NFkB binding site located at 860 bp upstream in the Hr
promoter mediates the repression of Hr in response to TNFa. Our findings demonstrate that
the TNFa pathway represses Hr transcription. We postulate that the TNFa-dependent repres-
sion of Hr contributes to UVB-induced malignant transformation of keratinocytes in human
epidermis.
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Topical application of a signaling-sphingolipid / barrier-lipid-mixture: improvement of skin
performance in humans addressed at a physiological and molecular level
M Farwick, Y Schiemann and P Lersch Degussa Personal Care, Goldschmidt GmbH, Essen,
Germany
Beyond their known role in the epidermal barrier formation, sphingoid bases and barrier
ceramides additionally show gene regulatory function in primary human keratinocytes. These
regulatory features of ceramides have been systematically explored in vitro by DNA-Chip
analysis. Based on these data the effect of the topical application of a fine-tuned composition
consisting of gene-regulatory medium chain ceramides combined with barrier lipids was
assessed. The sphingoid bases sphingosine and phytosphingosine and their corresponding
medium- and long chain ceramide derivatives were applied on cultured human primary ker-
atinocyte cultures. The gene expression patterns were compared using DNA-Chip technol-
ogy. We observed strong stimulatory effects on genes involved in the differentiation process,
especially with the short and medium chain ceramides. These signaling sphingolipids were
combined with selected long-chain phytosphingosine- and sphingosine-derived ceramides,
cholesterol and long chain fatty acids. The mixture mimics the stratum corneum physiologi-
cal lipid composition. During a time course of four weeks a significant improvement of the
overall skin performance was obtained: TEWL decreased, skin moisturization increased and
elasticity improved. In the same study skin biopsies were taken and analysed for changes in
gene expression by RT-PCR. Transcripts of marker genes of epidermal keratinocyte differenti-
ation, such as involucrin, transglutaminase-1, filaggrin and loricrin, have been found to be sig-
nificantly increased in treated buttock versus an untreated control. We were able to show the
link between the improvement of classical skin performance markers and molecular processes
occurring in the epidermis after topical application of signaling and barrier lipids.
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A novel skin-pH activated delivery system for retinol
SK Klee, Y Schiemann, P Lersch and M Farwick Degussa Personal Care, Goldschmidt GmbH,
Essen, Germany
The skin is the major organ that functions as a protective barrier against the environment, how-
ever biologically functional active ingredients can only act when they are taken up by the skin.
Therefore delivery plays an important role. In addition several active ingredients show sensi-
tivity towards light, oxygen, or heat. Thus the performance of active ingredients can only be
ensured if both delivery and stability are guaranteed. Herein, we present a novel delivery sys-
tem for the stabilization of active ingredients. We have chosen retinol as model active ingre-
dient, since it plays a pivotal role in many skin functions, e.g. inducing collagen synthesis,
and displays high sensitivity towards external stimuli. The newly developed delivery system is
based on an amino-functional methacrylate copolymer matrix which incorporates the active
ingredient. These retinol-loaded microparticles demonstrate stabilization of retinol of up to
75 % after 3 months at 45 °C in an O/W formulation. This is in contrast to free retinol, which
is almost completely degraded under these conditions. Upon contact with the skin, the natu-
ral acidic mantle at pH 4-6 will trigger the breakdown of the polymer due to protonation of
the inherent amino-functional groups of the copolymer. Thus the entire amount of encapsu-
lated retinol is released from each individual microparticle. As a consequence of the polymer
breakdown, a polymer film is formed which gives rise to areas with micro-occlusive condi-
tions. This occlusivity was measured by corneometry and demonstrates that the surface of the
skin becomes shielded by an isolating layer. Ex vivo penetration experiments on pig skin have
shown that the bioavailability of the released retinol is comparable to free retinol. A novel
delivery system has been presented which displays a skin-activated release mechanism that
is triggered by the skin’s natural acidic mantle. In addition, it demonstrates significant stabi-
lization of highly sensitive active ingredients, and an optimal penetration rate of the released
active ingredient, retinol.
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BMP4 from ESC-conditioned medium increases the developmental potency of epidermal
stem cells (EpiSCs), which then can be directed to produce specified functional cells of
alternative cell lineages
JR Bickenbach, KL Grinnell and MM Stern Anatomy and Cell Biology, and Dermatology, The
University of Iowa, Iowa City, IA
Embryonic stem cells (ESC) in culture produce various growth modulatory proteins that are
capable of sustaining Oct-4 expression. In this study, we examined whether ESC-conditioned
medium could directly reprogram keratinocytes. We found that keratinocytes were stimulated
to express Oct-4 and its pluripotency-associated target transcripts by ESC-secreted factors, and
that at least one of the reprogramming factors was bone morphogenetic factor-4 (BMP4). We
also determined that the responsive keratinocytes were primarily the epidermal stem cells
(EpiSCs), but that a small percentage of transit-amplifying (TA) cells also responded, implying
a continuum of multipotent responsiveness. This led us to test a directed reprogramming reg-
imen. Using two cell culture models, one optimized for neurogenesis and one optimized for
B-lymphopoiesis, we determined that reprogrammed EpiSCs could be directed to cross line-
age boundaries and produce specified cell types. The morphology, gene expression, and pro-
tein profiles of the newly generated cells resembled those of neuronal cells and B lympho-
cytes, respectively. Further, the neuronal-generated cells expressed the cell surface synaptic
receptor proteins, GluR1 and NR1, and produced tyrosine hydoxylase, the enzyme responsi-
ble for catalyzing conversion of L-tyrosine to dihydroxyphenylalanine (DOPA), a precursor to
dopamine. The B lymphocyte-generated cells expressed the B cell surface receptors B220,
CD19, and CD45, as well as the genome rearrangement enzymes Rag1 and Rag2, and the
transcription factor Pax5. They also underwent VDJ rearrangement of their heavy chain
immunoglobulin gene locus, a process necessary to produce specific antibodies and found
only in the genome of lymphocytes. These results indicate that EpiSCs can serve as an easily
accessible source of cells that can be directed to cross cell lineages and produce functional
cells to be used in cell-based therapies.
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Sequential metabolism of provitamin D3 (7-dehydrocholesterol) to 5,7-diene products in the
adrenal gland
AT Slominski,1 I Semak,2 MA Zmijewski,1 T Sweatman,3 Z Janjetovic,1 J Wortsman4 and
RC Tuckey5 1 Pathology and Laboratory Medicine, University of Tennessee HSC, Memphis,
TN, 2 Biochemistry, Belarus State University, Minsk, Belarus, 3 Pharmacology, University of
Tennessee HSC, Memphis, TN, 4 Internal Medicine, Southern Illinois University, Springfield,
IL and 5 School of Biomedical, Biomolecular and Chemical Sciences, University of Western
Australia, Crawley, WA, Australia
We previously found that P450scc transforms 7-dehydrocholesterol (7-DHC) to 7-dehydropreg-
nenolone (7-DHP). To further define this novel pathway we incubated 7-DHC with fragments of adre-
nal glands and monitored sequential metabolism of 7-DHC. There was a rapid, time and dose depend-
ent metabolism of 7-DHC by adrenals from rats, pigs, rabbits and dogs with production of more polar
5,7-dienes as detected by RP-HPLC with UV spectral analysis of products. Based on retention time
(RT) relative to synthetic standard, UV spectra and mass spectrometry, we identified one of these
products as 7-DHP. Two other major products with longer RT were identified as 20-hydroxy-7-DHC
and 20,22-dihydroxy-7-DHC, respectively, based on their sequential metabolism to 7-DHP by iso-
lated adrenal mitochondria. The involvement of P450scc in this adrenal metabolic transformation
was further shown by its inhibition by aminoglutethimide. The metabolism of 7-DHC and subse-
quent production of 7-DHP was stimulated by forscolin indicating involvement of cAMP depend-
ent pathways. Some of the minor but more polar 7-DHC products had the same RT as products
from incubation of 7-DHP with adrenal glands. Their production was attenuated by trilostane with
a concomitant increase in 7-DHP content indicating the involvement of 3bHSD. Thus, we provide
evidence at the organ level that provitamin D3 can be metabolized in vivo to 7-DHP, with further
transformation to its hydroxy-derivatives through existing steroidogenic enzymes. Potential for anal-
ogous conversion in the skin is supported by the recent finding of 7-DHC conversion to 7-DHP by
purified skin mitochondria and the documented expression of steroidogenic enzymes in skin
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Developing a tetracycline-inducible system for analyzing Dlx3 function in mouse keratinocytes
D Lee,1 O Duverger,1 F Jaisser2 and M Morasso1 1 Developmental Skin Biology Unit,
NIH/NIAMS, Bethesda, MD and 2 INSERM U772, Collège de France, Paris, France
Dlx3 is a homeodomain transcription factor that promotes the development of epidermal cells.
It has been previously shown that ectopic expression of Dlx3 in mouse epidermis alters basal
cell differentiation, inhibiting basal cell proliferation and producing abnormal skin, which
causes death shortly after birth. As a result, thriving animal models of Dlx3 and its mutants,
such as that causing the ectodermal dysplasia tricho-dento-osseus (TDO), are difficult to manip-
ulate in temporal studies. We are developing a tetracycline-inducible (Tet) system in which
exogenous Dlx3 and its TDO-causing form can be activated with the application of doxycy-
cline. For the cellular model, we stably transfected the PAM212 mouse keratinocyte cell line
with the prtTA-M2/IRES-Neo plasmid transactivating doxycycline sensitivity. 76% of the iso-
lated clones exhibited greater than a twentyfold induction of reporter activity in a screening
for Tet efficiency. 25% of these positive clones showed both high induction and low back-
ground. Upon further analysis of these latter clones, we maintained one clone with normal
morphology and with predicted expression of differentiation markers. Subsequently, we sta-
bly transfected these cells with the bidirectional plasmid pBi4 containing the combinations
of reporter gene GFP and v5Dlx3, GFP/v5TDO, or flagTDO/v5Dlx3. Preliminary results from
a transient transfection of these cells with the GFP-containing plasmids indicate that expres-
sion of the genes of interest is detectable 24 hours following application of doxycycline, allow-
ing for adjustment to the antibiotic. By using the Tet system, we will be able to synchronize
and control the expression of Dlx3 in its normal and TDO forms to observe changes in epi-
dermal development.
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A novel regulatory system for ceramidase activities that protects human keratinocytes against
UVB-initiated ceramide-Induced apoptosis
Y Wang, S Douangpanya, PM Elias, WM Holleran and Y Uchida Dermatology, Univ
California San Francisco & V.A. Medical Ctr, San Francisco, CA
Alterations in cellular levels of ceramide (Cer) and its distal metabolites, sphingosine/sphin-
gosine-1-phosphate, modulate cellular proliferation, differentiation and apoptosis, while bulk
stratum corneum Cer are essential components of the epidermal permeability barrier. As such,
regulation of ceramidase (CDase) activities, which hydrolyze Cer to sphingosine, are critical
for epidermal function. N-oleoyl-ethanolamine (NOE), a member of a family of endogenous
N-acyl-ethanolamines (NAE), has been shown to inhibit CDase activities. Endogenous NAE
(including N-arachidonyl-ethanolamine, a ligand for cannabinoid receptors) are synthesized
in mammalian cells, and their production increases in response to cell stress; e.g., UV irra-
diation or xenotoxic compounds. Conversely, the enzymes NAE amidohydrolase (NAEase),
fatty acid amidohydrolase (FAAH) and NAE-hydrolyzing acid amidase (NAAA), play impor-
tant roles in regulating endogenous NAE levels. We hypothesized NAE and FAAH/NAAA coor-
dinately regulate cellular Cer levels by modulating CDase activities. We demonstrate here
that: 1) NAE (NOE, N-arachidonyl-ethanolamine and N-palmitoyl-ethanolamine) inhibit both
acidic- and neutral-CDase in HaCaT keratinocytes; 2) mRNA and enzyme activities for both
FAAH and NAAA are present in cultured human keratinocytes (CHK); 3) blockade of
FAAH/NAAA activities by an inhibitor of NAEase, CAY10401 (CAY), amplifies the NOE-induced
inhibition of CDase and elevates cellular Cer levels. We previously reported that increased
Cer levels are important in UVB-induced apoptosis in CHK. Blockade of NAEase by CAY fur-
ther increased Cer levels following UVB, and further sensitized CHK to UVB-induced apop-
tosis. Thus, NAE and NAEase have opposing effects on CDase activities and Cer levels in CHK:
NAE inhibits CDase and increases Cer levels, while FAAH/NAAA activities attenuate the impact
of NAE. These results demonstrate a novel endogenous mechanism that coordinately regu-
lates cellular Cer levels in response to UVB stress.
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Loss of functional ELOVL4 eliminates very long-chain fatty acids (>C28) and unique ω-O-
acylceramides in skin leading to neonatal death
Y Uchida,1 V Vasireddy,2 NL Alderson,3 H Hama,3 PM Elias,1 R Ayyagari2 and WM Holleran1
1 Dermatol, Univ of California San Francisco & VAMC, San Francisco, CA, 2 Ophthalmol,
Univ of Michigan, Ann Arbor, MI and 3 Med, Med Univ of South Carolina, Charleston, SC
Mutations in the fatty acid (FA) elongation enzyme, ELOVL4 are associated with autosomal-
dominant Stargardt-like macular degeneration, with a 5 base-pair (5-bp) deletion resulting in
the loss of 51 carboxy-terminal amino acids. In addition to the retina, Elovl4 is expressed in
a limited number of tissues, including skin, with unknown function(s). Mice heterozygous for
the 5-bp deletion (knock-in) mutation exhibit progressive photoreceptor degeneration. Unex-
pectedly, homozygous mice (del/del) display scaly, wrinkled skin, have severely compromised
epidermal permeability barrier function, and die shortly after birth. Although del/del mice dis-
played no apparent abnormalities in vital internal organs, skin histology and ultrastructure
showed an abnormally compacted stratum corneum (SC), deficient epidermal lamellar body
contents, and a lack of normal SC lamellar membranes required for barrier function. Neither
the expression patterns of protein markers of epidermal differentiation (keratin K1, loricrin,
filaggrin) nor the content of key epidermal permeability barrier lipids (ceramide [Cer], free FA
& cholesterol, and precursors of SC Cer, glucosylCer [GlcCer] & sphingomyelin), were altered
in del/del vs. Wt epidermis. However, GC-mass analysis revealed a significant decrease in
very long-chain FA (VLFA) (>C28) in both the Cer/GlcCer & the free FA fractions. Strikingly,
both HPTLC and LC-MS/MS analyses showed that del/del skin was devoid of both epider-
mal-unique ω-O-acylCer, key components of SC extracellular lamellar membranes in the SC,
and their immediate precursors, ω-O-acylGlcCer, while levels of other Cer species were
unchanged. These findings not only demonstrate that ELOVL4 is required for generating VLFA
critical for epidermal barrier function, but that the lack of epidermal ω-O-acylCer is incom-
patible with mammalian survival, defining the in vivo importance of these unique lipids.
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Comparative profiling of epidermal ceramides from ELOVL4-deficient mice using modern
tandem mass spectrometry
J Brown,1 Y Uchida,2 V Vasireddy,3 R Ayyagari3 and WM Holleran2 1 Applied Biosystems,
Framingham, MA, 2 Dermatology, Univ California San Francisco & V.A. Medical Ctr, San
Francisco, CA and 3 Ophthalmology, Univ. of Michigan-Kellogg Eye Ctr, Ann Arbor, MI
Epidermal ceramides (Cer) and their glucosylated counterparts consist of heterogeneous molec-
ular species, which include different sphingol headgroups combined with amide-linked fatty
acids containing non-hydroxy-, α-hydroxy- or ω-hydroxy-fatty acids. The epidermal-unique
ω-O-acylCer species are formed by the addition of another fatty acid, primarily linoleic acid,
to the ω-hydroxy group. This Cer molecular heterogeneity is critical for epidermal permeability
barrier function required for mammalian survival. Given that alterations of Cer molecular pro-
files are evident in numerous cutaneous diseases, including atopic dermatitis, psoriasis, and
at least two ichthyoses, a facile, accurate, and reproducible method for assessing the struc-
tural complexity of epidermal Cer species would represent a powerful tool for cutaneous
research. Here we describe a liquid chromatography (HPLC)-tandem mass spectrometry assay
system in which a non-aqueous reverse phase gradient allows for very high chromatographic
resolution over a wide range of lipid types within a single sample injection. Broad ranges of
lipids can be injected onto a C18 column and eluted with sufficient resolution to allow this
modern mass spectrometer to distinguish signal levels simultaneously from hundreds of indi-
vidual intact lipid molecular species. Statistical analysis then reveals changes to individual
lipid levels. We recently determined that homozygous mice deficient in the fatty acid elon-
gation enzyme (Elovl4) have severely compromised epidermal permeability barrier function.
This novel HPLC-tandem mass spectrometry technique not only revealed the complete loss
of epidermal ω-O-acylCer species in this murine model, but also yielded an extensive profile
of amide-linked fatty acid and sphingol species in both normal and affected epidermis.
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Ca++-binding protein Scarf function during epidermal development
O Kalinin, J Hwang, M Hwang and MI Morasso Developmental skin biology unit,
NIH/NIAMS, Bethesda, MD
The Ca++-binding protein Scarf is expressed specifically in the differentiated layers of epi-
dermis. To better understand the function of Scarf during mouse embryonic development,
Scarf-null mice were recently generated through targeted homologous recombination, where
the Scarf gene is replaced by the beta-galactosidase gene placed under the control of the
endogenous Scarf promoter. Analysis of the expression of the beta-galactosidase reporter in
the heterozygous mice, verified our previous findings that Scarf expression starts at embry-
onic day 15.5 (Hwang and Morasso, 2003; Hwang at al., 2005). This expression is first detected
at the dorsal part of the embryo and consequently extends to the ventral part of the embryo.
This pattern is similar to formation of the skin barrier at E16 – E17, as visualized by dye per-
meability assay (Hardman et al, 1998). Mice homozygous for the targeted allele are born
alive and present no overt abnormalities. Detailed characterization of Scarf-null mice is now
in process. We are currently performing epidermal barrier permeability assays and analysis of
the expression of other epithelial proteins in homozygous mice at different embryological ages
to determine whether epidermal barrier formation is affected by Scarf gene ablation and to
determine possible mechanisms for the Scarf function compensation.
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Vitamin D3 hydroxylation by P450-scc originates 20-hydroxycholecalciferol that stimulates
keratinocytes differentiation
Z Janjetovic,1 B Zbytek,1 MA Zmijewski,1 EH Jones,1 T Sweatman,2 IV Semak,3 J Wortsman,4
RC Tuckey5 and A Slominski1 1 Pathology, University of Tennessee Health Science Center,
Memphis, TN, 2 Pharmacology, University of Tennessee Health Science Center, Memphis,
TN, 3 Biochemistry, Belarus State University, Minsk, Belarus, 4 Internal medicine, Southern
Illinois University, Springfield, IL and 5 School of Biomedical, Biomolecular and Chemical
Sciences, The University of Western Australia, Crawley, WA, Australia
We documented that the P450scc cytochrome system metabolized vitamin D3 to 20-hydrox-
ycholecalciferol and 20,22-dihydroxycholecalciferol in a sequential and stereospecific man-
ner with initial formation of 20(S)-hydroxyvitamin D3 (FEBS Journal 272, 480-4090). The 20-
hydroxycholecalciferol represented the major reaction product indicating easy release from
the active site of the enzyme. We also found that in isolated rat adrenal mitochondria 20-
hydroxycholecalciferol but not 20,22-dihydroxycholecalciferol was produced by a P450scc.
To define the biological significance of this pathway we tested the effect of the 20-hydroxyc-
holecalciferol on the keratinocyte differentiation using HaCaT and adult human epidermal
keratinocytes. By real-time PCR 20-hydroxycholecalciferol stimulated mRNA production of
cytokeratin 1 and of involucrin in both HaCaT and normal epidermal keratinocytes and inhib-
ited mRNA production of cytokeratin 14 in normal keratinocytes. Flow cytometry comple-
mented these analyses by showing stimulation of involucrin protein expression in keratinocytes.
Moreover, the cell size and granularity increased, as shown by the analysis of forward and side
scatter, respectively. By comparison, vitamin D3 precursor was without any discernible effect,
25-dihydroxycholecalciferol had lower and 1,25-dihydroxycholecalciferol had similar potency.
Thus, 20-hydroxycholecalciferol is an inducer of keratinocyte differentiation, at least as potent
as calcitriol. The data, suggest that this novel pathway of vitamin D3 metabolism may have
wider biological repercussion on the adrenal gland an cutaneous levels.
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EGFR is involved in H2O2-induced down-regulation of BCO1 and BCO2 in cultured human
skin keratinocytes
C Ji,1,3,4 C Cao,1 L Beveridge,1 C O’Brien,1 A Sowa,1 L He,4 Z Bi,3 G Hu,3 N Kouttab2 and
Y Wan1 1 Biology, Providence College, Providence, RI, 2 Roger Williams Medical Center,
Providence, RI, 3 the First Affiliated Hospital of Nanjing Medical University, Nanjing, China
and 4 Kunming Medical College, Kunming, China
Damages to human skin as a consequence of chronologic and photoaging are considered to
deplete epidermal vitamin A. The β-carotene cleavage reaction is known to be the initial step
in the mechanism that provides human with vitamin A. There are two possible cleavage path-
ways leading to vitamin A, one is the oxidative central cleavage pathway, which is catalyzed
by β-carotene 15’, 15’-monooxygenase (BCO1), and the other is the excentric cleavage path-
way, which is catalyzed by β-carotene 9’, 10’-monooxygenase (BCO2). However, the func-
tions of BCO1 and BCO2 in human skin remain unclear. In this study, we demonstrate that
both BCO1 and BCO2 are expressed in cultured keratinocytes (HaCaT cells). Since oxidant
stresses are believed to underlie changes associated with both natural aging and photoaging,
we tested whether BCO1 and BCO2 are affected by oxidant stresses. We found that H2O2
down-regulates BCO1 and BCO2 significantly in a time and dose dependent manner, which
is recovered by pretreatment of a well known antioxidant, N-acetyl-l-cysteine (NAC). We also
observed that p38 inhibitor SB203580 protects against H2O2-induced BCO1 and BCO2 down-
regulation, whereas EGFR inhibitor PD153035 and PI3K inhibitor LY294002 aggravate H2O2-
induced BCO1 and BCO2 down-regulation. Collectively, we conclude that both BCO1 and
BCO2 are expressed in HaCaT cells, and are down-regulated by oxidant stresses such as H2O2.
EGFR and AKT activation serves as an intrinsic protective mechanism against loss of BCO1
and BCO2 in response to H2O2.
www.jidonline.org   S75
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Mammalian epithelial development, homeostasis and Raf-induced hyperplasia rely on Mek1/2
MAPK kinases
FA Scholl,1 PA Dumesic,1 DI Barragan,1 K Harada,1 V Bissonauth,2 J Charron2 and
PA Khavari1 1 Dermatology, Stanford University, Stanford, CA and 2 Centre de recherche en
cancérologie, Université Laval, Québec, QC, Canada
The extracellular signal-regulated kinase (Erk), also called mitogen-activated protein kinase
(MAPK), cascade includes Raf MAPK kinase kinases, Mek1/2 MAPK kinases and Erk1/2 MAPKs.
To completely disrupt this signaling pathway at a single level in mammals, and to investigate
functional redundancy between Mek1 and Mek2, we deleted these genes in murine and human
epidermis. Loss of either protein alone produced no phenotype in mice, while combined dele-
tion of Mek1/2 abolished Erk1/2 phosphorylation and led to abnormal epidermal develop-
ment, tissue hypoplasia, skin barrier defects, and perinatal death. Mice with a single copy of
either Mek allele, however, developed normally and survived to adulthood. In adult mice,
inducible deletion of Mek1/2 caused rapid apoptosis of the epidermis and lethality, indicat-
ing that Mek function is also required for survival during adulthood. Furthermore, inducible
activation of Raf in adult skin caused hyperproliferation and hyperplasia that could be sup-
pressed by the combined loss of Mek1/2, but not by the loss of either Mek1 or Mek2 alone.
Regenerated human epidermal tissue deficient in either Mek isoform was normal, whereas
combined loss of both Mek proteins via RNA interference led to hypoplasia. This defect was
rescued by expressing active Erk2. These data indicate that Mek1/2 are functionally redun-
dant in the contexts of epithelial development and homeostasis, where they are required to
phosphorylate Erk1/2 and promote cell survival and proliferation.
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Effects of novel ceramide derivatives, K6PC-9 and K6PC-9P, on a mouse model of chronic
dermatitis induced by repeated application of 1,4-dinitrochlorobenzene (DNCB)
S Jeong,1,2 J Bae,1 J Youm,1,2 K Choi,3 S Ahn,4 E Choi4 and S Lee5 1 Neopharm Co., Ltd.,
Daejeon, South Korea, 2 BK21 project for Medical Science, Yonsei University, Seoul, South
Korea, 3 Electron Microscopy Laboratory, Seoul Health College, Seoul, South Korea, 4
Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, South
Korea and 5 Department of Dermatology, Yonsei University College of Medicine, Seoul, South
Korea
Recently, we have synthesized novel ceramide derivatives, K6PC-9 and K6PC-9P, and reported
thier anti-inflammatory activity in 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin
inflammation model and Nc/Nga mouse. In this study, the efficacy of both derivatives was
evaluated in a chronic dermatitis model, using 1, 4-dinitrochlorobenzene (DNCB). Female
hairless mice were sensitized with 1% (w/v) DNCB application on day -7, followed by repeated
application every 2 days for 36 days from day 0. After cessation of topical DNCB application,
each groups of mice were treated once daily for 8 days with a 0.01% dexamathasone in ace-
tone, 1% K6PC-9 in acetone, 1% K6PC-9P in acetone, acetone-only or were left untreated.
During the remission period, the trans-epidermal water loss, as a representation of epidermal
permeability barrier function, rapidly restored in all groups. Skin surface hydration, however,
remained low in all groups. Reduction of skin fold thickness was observed in all groups, whereas
a significant decrease was observed in the dexamethasone treated groups, which showed an
atrophic effect of glucocorticoid. Histologic observations showed significant decrease in num-
bers of mast cell, eosinophil, CD4+ and CD8+ T cells. Significant increase in antimicrobial
peptide, CRAMP and mBD3, was observed in DNCB applied skin and restored its normal lev-
els after 8 days. This study suggests that the novel ceramide derivatives, K6PC-9 and K6PC-9P,
have anti-inflammatory effects in DNCB-induced chronic dermatitis model, and might be used
for the treatment of chronic skin inflammatory diseases.
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Anti-inflammatory effects of novel ceramide derivatives, K6PC-9 and K6PC-9P, in phorbol
ester-induced skin inflammation and Nc/Nga mouse model
J Youm,1,2 J Kang,3 S Han,3 H Kim,3 S Jeong,1,2 B Park1 and S Lee4 1 Neopharm Co., Ltd.,
Daejeon, South Korea, 2 BK21 Project for Medical Science, Yonsei University, Seoul, South
Korea, 3 Bioevaluation Center, Korea Research Institute of Bioscience and Biotechnology,
Chungbuk, South Korea and 4 Department of Dermatology, Yonsei University College of
Medicine, Seoul, South Korea
In this study, we have investigated the anti-inflammatory activity of novel ceramide deriva-
tives, K6PC-9 and K6PC-9P. In order to explore the anti-inflammatory activity of both deriva-
tives in vitro, nitric oxide (NO) production in mouse peritoneal macrophage was measured.
Mouse peritoneal macrophages were treated with lipopolysaccharide (LPS), either in presence
of K6PC-9, K6PC-9P, or control buffer. As a result, both derivatives potently suppressed the
NO production in macrophage, without obvious cytotoxicity. 12-O-tetradecanolyphorbol-13-
acetate (TPA) model was adopted to investigate the anti-inflammatory activity of both deriva-
tives in vivo. TPA was applied to the ear of Balb/C mice and ear thickness was measured. Both
derivatives significantly prevented the ear swelling, in a dose-dependent manner. The anti-
inflammatory activity against the chronic inflammation was also examined using Nc/Nga mice.
Induction of chronic inflammation was done with topical application of either Der-
matophagoides pteronyssinus extract or Dermatophagoides farinae extract. Topical applica-
tion of both derivatives showed significant reduction of ear swelling, whereas K6PC-9P was
more potent than K6PC-9. In order to observe the immune-modulating activity, cytokine expres-
sion in T lymphocytes was measured: K6PC-9 did not affect interleukin (IL)-2 nor IL-4 pro-
ductions in mouse T lymphocytes. K6PC-9P, however, elicited increase of IL-2 and decrease
of IL-4 productions, without affecting the viability or proliferation of T lymphocytes. This
study suggests that the novel ceramide derivatives, K6PC-9 and K6PC-9P, have an anti-inflam-
matory potential and might be used as a topical agent for the treatment of AD.
454
K6PC-5, a sphingosine kinase activator, improves long-term ultraviolet light exposed aged
murine skin
H Park,1 J Youm,2,3 J Bae,3 M Kwon,3 B Park,3 S Lee2,4 and E Choi1 1 Department of
Dermatology, Yonsei University Wonju College of Medicine, Wonju, South Korea, 2 Brain
Korea 21 Project for Medical Science, Yonsei University, Seoul, South Korea, 3 The 1st
Research Department, Neopharm Co., Ltd., Deajeon, South Korea and 4 Department of
Dermatology, Yonsei University College of Medicine, Seoul, South Korea
Sphingosine-1-phosphate (S1P) is formed by the phosphorylation of sphingosine catalysed by
sphingosine kinase (SphK). S1P is a multifunctional mediator of a variety of cellular responses
including proliferation, differentiation, motility, and survival. Recently newly-synthesized
K6PC-5 is expected to increase S1P level as a SphK activator. It has already been demonstrated
that K6PC-5 shows anti-aging effect on intrinsic aged murine skin by increasing fibroblasts,
collagen synthesis and eventually dermal thickness, and also promotes epidermal differenti-
ation. However, photoaging has very different clinical and histopathological findings from
intrinsic aging. In this study, we developed a photoaged murine model (64-week old) using
aged mice exposed to UVB and UVA for 8 weeks and investigated whether K6PC-5 also has
anti-aging effect on photoaged murine skin as a SphK activator and describe the mechanism.
K6PC-5 increased dermal collagen density in photoaged skin through an increase of fibrob-
last and collagen production. K6PC-5 treated photoaged murine skin showed an increase in
the integrity of the stratum corneum (SC) by increasing corneodesmosome density identified
by electron-microscopy and improved barrier recovery rate. Matrix metalloproteinase 13
showed no change. From these results, it is concluded that topical K6PC-5 application improves
photoaged skin by improving skin barrier state and increasing fibroblast count and function.
In conclusion, K6PC-5 as a SphK activator improves long-term UVB and UVA exposed aged
skin as well as intrinsic aged skin.
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K6PC-5, a sphingosine kinase activator, prevents retinoic acid-induced epidermal hyperpla-
sia of aged murine skin
J Youm,1,2 M Kwon,2 S Jeong,1,2 B Park,2 E Choi3 and S Lee1,4 1 Brain Korea 21 Project for
Medical Science, Yonsei University, Seoul, South Korea, 2 Neopharm Co., Ltd., Daejeon,
South Korea, 3 Department of Dermatology, Yonsei University Wonju College of Medicine,
Wonju, South Korea and 4 Department of Dermatology, Yonsei University College of
Medicine, Seoul, South Korea
Sphingosine-1-phosphate (S1P), a bioactive sphingolipid metabolite, regulates multiple cellular
responses such as Ca2+ signaling, growth, survival and differentiation, and regulates both ker-
atinocyte differentiation and proliferation. Because sphingosine kinase (SphK) is the enzyme
directly responsible for S1P production, many factors that regulate SphK activity and subse-
quent S1P levels have been identified. In this study an investigation was done to determine
whether K6PC-5 as a SphK activator prevents retinoic acid (RA)-induced epidermal hyperplasia
in aged murine skin. Retinoids are widely used in the treatment of aged skin to improve dermal
structures, but retinoid-induced scaling is still a major deterrent in topical use. For this study, 1%
K6PC-5 and vehicle were applied on each flank of 56 week-old hairless mice after topical treat-
ment of 0.025% RA for 2 weeks, and both epidermal and dermal effects of K6PC-5 were eval-
uated. RA induced scaling as basal TEWL increases, but K6PC-5 prevented this barrier impair-
ment effectively. K6PC-5 also prevented a decrease in skin hydration and SC integrity with
corneodesmosome density that was induced by the RA, although the result was not significant.
K6PC-5 prevented RA induced epidermal proliferation and PCNA-positive keratinocytes effec-
tively. K6PC-5 inhibited the excessive expression of differentiation marker proteins including
involucrin, filaggrin, loricrin, K5 and K10 as a result of the RA-induced proliferation. K6PC-5
did not show a synergy in the RA induced dermal effects including fibroblast proliferation and
dermal thickness. Together, these results suggest that K6PC-5 prevents RA-induced side effects
including epidermal hyperplasia and provides a useful tool for use with retinoids for aged skin.
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Topical vitamin D improves impairment of epidermal barrier induced by topical steroid
Y Oh, M Kim, H Jeon and E Choi Dermatology, Yonsei Wonju College of Medicine, Wonju,
South Korea
Vitamin D is a fat soluble hormone synthesized in response to UV radiation on the skin. 7-
dehydrocholesterol is converted to a hormonally active form, calcitriol (1α,25-dihydroxyvit-
amin D3) through several steps, and this active form of vitamin D has anti-proliferate and dif-
ferential effects. Vitamin D and its analogues are widely used for proliferate skin diseases such
as psoriasis with or without topical steroids. Recently it was found that topical steroids disrupt
epidermal barrier in spite of short-term use. This study was done to determine the effect of vita-
min D on epidermal permeability barrier and to determine how to improve the impairment
of epidermal barrier induced by topical steroids. 0.03% topical calcitriol and vehicle were
applied on each flank at 20 minutes after treatment of topical clobetasol propionate at 12 hour
intervals for 7 times (3.5 days). Twenty-four hours after the last application, functional, immuno-
histochemical and electron microscopic studies and lipid analysis were performed. Basal
transepidermal water loss showed slight elevation, but no difference between sites. Stratum
corneum(SC) integrity in calcitriol sites was better than vehicle only. SC hydration was decreased
in calcitriol sites. Barrier recovery after tape stripping was improved in calcitriol sites. Nile
red stain, lipid analysis and lamellar body analysis showed superior epidermal lipids in cal-
citriol sites. Immunohistochemical stains of IL-1α and antimicrobial peptides such as mBD3
and CRAMP increased in calcitriol sites. In conclusion, topical vitamin D improves the impair-
ments in the epidermal permeability barrier and defense function induced by topical steroids.
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Upregulation of hyaluronic acid and CD44 by sonophoresis in mouse skin and the involve-
ment of TNF-α in sonophoresis-induced expressions of hyaluronic acid and CD44
S Lee,1 J Jun,1 E Choi2 and S Lee1 1 Dermatology, Yonsei University College of Medicine,
Seoul, South Korea and 2 Dermatology, Yonsei University Wonju College of Medicine,
Wonju, South Korea
Hyaluronic acid (HA), a major extracellular matrix component in the epidermis, has been
demonstrated to be accumulated in the epidermis by disruption of the stratum corneum. We
performed this study to identify whether sonophoresis without barrier disruption could increase
the epidermal HA and CD44 expressions and investigated the role of TNF-α as one of the fac-
tors which may be involved in sonophoresis-induced HA and CD44 expressions. We previ-
ously reported that sonophoresis at energies that do not provoke a barrier abnormality stim-
ulate epidermal cytokine expression and lamellar body secretion with altered calcium levels.
TNF-α was demonstrated to enhance the HA synthesis via the induction of HA synthase on
myofibroblasts and upregulate the expressions of CD44 in langerhans cells. Sonophoresis at
the energies that do not change trans-epidermal water loss (TEWL) was applied to the skin of
hairless mouse. And we used etanercept (Enbrel®) intraperitonealy to block TNF-α and
sonophoresis was performed. After sonophoresis, the expressions of HA and CD44 was
increased within the basal and spinous layers in the intercellular space compared to non-
treated control as well as in tape-stripped skin as a positive control. TNF-α blockade via Enbrel
administration attenuated the expressions of HA and CD44 in the epidermis treated with
sonophoresis as well as in tape-stripped skin, suggesting that TNF-α may be related to the
sonophoresis induced expressions of HA and CD44. However tape-stripped skin followed by
occlusion showed slight increased expressions of HA and CD44 compared to nontreated con-
trol. The present study demonstrates that sonophoresis without barrier disruption could upreg-
ulate epidermal HA and CD44 expressions and suggests that increased TNF-α by sonophore-
sis may play a role in sonophoresis-induced expressions of epidermal HA and CD44
independent of changes in barrier function.
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Epidermal calcium translocation visualized by fluorescence lifetime imaging
MJ Behne,1 N Kirschner,1 S Sanchez,2 I Moll1 and E Gratton2 1 Dermatology, Univ. Med. Ctr.
Hamburg-Eppendorf, Hamburg, Germany and 2 Laboratory for Fluorescence Dynamics,
Irvine, CA
Calcium controls an array of processes in keratinocytes and epidermis. Localized changes in
Ca2+ concentrations and their regulation are therefore especially important to assess in epi-
dermal barrier homeostasis and repair, neonatal barrier establishment, in differentiation, sig-
naling, cell adhesion, and in various pathologic states, such as e.g., Hailey-Hailey disease.
Yet, tissue- and cellular Ca2+ concentrations in physiologic and diseased states are only par-
tially known, and difficult to measure. Here we report a method using Calcium Green as the
calcium sensor to quantitatively assess and visualize dynamic changes of Ca2+ in ex-vivo biop-
sies of unfixed epidermis, exploiting fluorescence lifetime imaging. Comparing undisturbed
epidermis with epidermis following a barrier insult revealed major shifts from intra- to extra-
cellular, and, more importantly, a mobilization of high amounts of Ca2+ shortly following bar-
rier disruption, presumably from intracellular stores. These results partially contradict the con-
ventional view, where barrier insults abrogate a Ca2+ gradient towards the Stratum granulosum.
Methodologically, the latter is based on Ca2+ precipitation followed by electron microscopy,
or proton-induced x-ray emission, both techniques requiring considerable tissue processing,
with results limited in their biological relevance. Employing a novel microscopic setup, we
now can image intra- and extracellular Ca2+ at both high resolution and speed, heretofore
technically not feasible. First results using our LaVision TriM scope are presented, where we
demonstrate how to overcome prior technical limitations in the observation of Ca2+ dynam-
ics, contributing to elucidating Ca2+ physiology in epidermis.
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Increase of anti-microbial peptides in epidermis by long-term application of low concen-
trated salicylic acid
S Jeong,1,2 S Lee,3 J Jeon,3 M Kim,3 E Choi,4 S Ahn4 and S Lee3 1 Neopharm Co., Ltd., Daejeon,
South Korea, 2 BK21 Project for Medical Science, Yonsei University, Seoul, South Korea, 3
Department of Dermatology, Yonsei University College of Medicine, Seoul, South Korea and 4
Department of Dermatology,Yonsei University Wonju College of Medicine, Wonju, South Korea
Previously, we have reported that topical application of high concentrated glycolic acid resulted
in an increase of lamellar body secretion to stratum corneum - stratum granulosum (SC-SG) junc-
tion in murine model, due to, at least in part, its chelating effect on calcium ion. Salicylic acid
(SA), with its structural property, can also chelate calcium ions, and it can be hypothesized that
topical application of SA may also result in an increase of lamellar body secretion in SC-SG junc-
tion. Recently, localization of anti-microbial peptides (AMP) in lamellar body was reported, and
in this study, we investigated the effect of topical salicylic acid on AMP expression in epidermis.
SA treatment induced a decrease of [Ca2+]i in cultured human keratinocyte. When the low con-
centrated SA (5%) was topically applied to hairless mouse twice a daily for 2 weeks, epidermal
expression of cathelicidin-related antimicrobial peptide (CRAMP), mouse beta-defensin 3 (mBD3)
was significantly increased, mainly in upper SG. In order to examine the role of other factors
involved in AMP production, tumor necrosis factor (TNF)-α and involucrin were also measured.
Immunohistochemical staining for both TNF-α and involucrin showed a significant increase in
epidermis, which suggests that topical SA induce an inflammatory reaction, as well as differen-
tiation of kerationocyte. In order to clarify whether the TNF-α is responsible for the AMP increase,
TNF-α antagonist was treated by intraperitoneal injection and epidermal barrier function was
acutely disrupted by tape-stripping. As a result, TNF-α antagonist significantly inhibited the epi-
dermal expression of AMP after barrier disruption. These results suggest that modulation of epi-
dermal calcium gradient by topical salicylic acid, as well as increased TNF-α in epidermis, may
trigger an increase of AMP expression in epidermis.
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Effects of Avene thermal spring water on normal human keratinocyte differentiation in vitro
F Belaubre, S Julie and M Charveron Cell Biology Laboratory, Institut de Recherche Pierre
Fabre, Toulouse, France
The therapeutic properties of Avene Spring Water (ASW) in dermatological diseases, particu-
larly atopic dermatitis and psoriasis, have been described for long. In atopic dermatitis skin
barrier is disrupted whereas in psoriasis, skin lesions are characterized by hyperproliferative
keratinocytes leading to a significant thickening of the epidermis and disregulation of ker-
atinocyte differentiation. In order to evaluate the ASW effect on keratinocyte differentiation,
we have used an in vitro model using Normal Human Keratinocytes. Keratinocytes are iso-
lated from skin and cultured in calcium and magnesium free-MCDB media dissolved with
either ASW (ASW medium) or distilled water (DW medium). Cells are analyzed following a
three or six day period culture using real time quantitative PCR. Our results show that mRNA
expression of classical epidermal differentiation markers such as K1 and K10 of cells cultured
in DW medium supplemented with 1.3 mM calcium and 1.23 mM magnesium (Ca-Mg-DW
medium) is up regulated after three days of culture (K1 : x12.6 and K10 : x1.7). For cells cul-
tured in ASW medium (naturally containing 1.3 mM Ca and 1.23 mM Mg), we can also show
a significant increase of the K1 and K10 mRNA (K1 : x52 and K10 : x12.6). This up regulation
is increased compared to cells cultured in 1.3 mM Ca, 1.23 mM Mg distilled water medium.
Those data are confirmed after six days of culture. Keratin 1 and 10 are early epidermal dif-
ferentiation markers. Later epidermal differentiation markers such as transglutaminase 1, filag-
grin, FATP4, ABCD1 and ABCG1 are under investigations. Calcium is a well known keratinocyte
differentiating inducer. As demonstrated in this study, Avene Spring Water can induce differ-
entiation due to the natural mineralization. But this study also shows that specific compo-
nents of AWS enhance the differentiation process. The clinical benefits observed at Avene Ther-
mal Spa with atopic dermatitis and psoriasis patients confirm the role of these components in
the therapeutic properties of Avene Spring Water.
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Antimicrobial peptide expression in non-lesional foreskin between atopic and non-atopic
groups
J Goo,1 H Jeon,1 M Kim,1 M Cho,2 S Lee3 and E Choi1 1 Department of Dermatology, Yonsei
University Wonju College of Medicine, Wonju, South Korea, 2 Department of Pathology,
Yonsei University Wonju College of Medicine, Wonju, South Korea and 3 Department of
Dermatology, Yonsei University College of Medicine, Seoul, South Korea
Recurrent skin infection is one of the main complications for atopic dermatitis (AD) patients,
and partly explained by a decreased expression of antimicrobial peptides (AMP). In the human
epidermis, human β-defensin 2(hBD-2) is packed in the lamellar body (LB), and LL-37, a human
cathelicidin, is co-localized with intercellular lipid lamellae of the stratum corneum. Com-
plicated skin infection usually correlates with AD severity, and non-lesional skin of atopic indi-
viduals is frequently also infected in clinical settings. In this study, we investigated whether
decreased AMP expression in AD patients is a constitutional feature or not. Circumcised non-
lesional foreskin was taken from AD patients (n=7, median IgE=192 IU/ml) and non-atopic
individuals (n=7, median IgE=68 IU/ml). The skin was processed to observe differences of LB
by the electron microscope and expression patterns of hBD-2, LL-37 and IL-1α by immuno-
histochemial stain, western blot, and RT-PCR. As a result, there were no statistical significant
differences between the two groups. From these results, we concluded that decreased AMP
expression is not a congenital or constitutional feature of AD patients, and probably is induced
by local factors of Th2-derived cytokines such as IL-4, 10, and 13.
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Dual parameter skin irritation testing using est-1000
JJ Hoffmann, E Heisler, D Thomas and HW Fuchs R&D, CellSystems Biotechnologie Vertrieb
GmbH, St. Katharinen, Germany
The reliability of skin corrosivity testing using the reconstructed epidermis Epidermal Skin Test
(EST-1000) was shown already in different studies. The results of those blinded multicenter tri-
als fulfilled all criteria of OECD TG 431: “In Vitro Skin Corrosion: Human Skin Model Test”.
The findings include the intact barrier function which was confirmed by the resistance against
several solutions of detergents over a long period and reliable classification of all twelve ref-
erence compounds mentioned in the guideline. To support our data the proper morphology
of EST-1000 is demonstrated by an extensive histological and immunohistochemical charac-
terization. Additionally we present first data on EST-1000 used for the more subtle task of in
vitro skin irritation testing. Dermal irritation is generally defined as “the production of reversible
inflammatory changes in the skin”. The potential of chemicals to induce skin irritation has to
be taken into account when establishing procedures for the safe handling, packing and trans-
port of chemicals. Up to now classification of irritants is usually performed in vivo by the Draize
rabbit test. But the skin irritating potential of a substance may be predicted by in vitro systems.
These are sufficiently complex to mimic human skin barrier and cell reactivity. As shown by
this study, EST-1000 was able to correctly classify a large number of tested compounds in
vitro according to EU classification system (R 38 or no label). With these data we demonstrate
the adaption of EST-1000 to an actual demand of hazard identification. In respect to in vivo
tests this adaptability is one major advantage of in vitro skin models.
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An in vitro sytem for predicting skin irritation of liquid antiperspirants
SJ McPhail, AC Lanzalaco, J Kolodzik and R Osborne The Procter and Gamble Company,
Cincinnati, OH
Topical skin care products differ substantially in their composition, yet all need to be accept-
ably mild to the skin. Small-scale clinical screening is often used to carefully evaluate the irri-
tation potential of novel formulations prior to larger-scale clinical efficacy testing. Clinical test-
ing is time and cost-intensive, and requires development of near finished formulations, often
requiring resources to overcome formulation challenges that may not be justified prior to
early evaluation of irritation potential. The goal of the current work was to evaluate human
skin equivalent cultures as a preclinical approach to characterize the skin irritancy of proto-
type liquid antiperspirant formulations. A set of prototype liquid antiperspirant formulations
spanning a range of irritancy typical for this product type, based on historical clinical data,
was selected for methods development and validation. An in vitro screening protocol was
developed utilizing topical application of test formulations to the stratum corneum surface of
three dimensional human skin equivalent cultures (MatTek EpiDerm model). Cell viability
(MTT metabolism) and inflammatory cytokine expression were measured as endpoints. Pro-
totype formulations were tested blind using the in vitro protocol. The in vitro results correlated
with historical in vivo clinical data. In addition, excellent reproducibility was obtained between
independent experiments. These results indicate that in vitro testing of prototype liquid antiper-
spirant formulations in human skin equivalent cultures is a useful approach to confirm skin
mildness prior to clinical evaluations.
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Sudden changes in external humidity modifies gene expression in skin epidermis
G Bellemere, O Von Stetten, C Pepin and T Oddos Pharmaco-toxicology Laboratory, Johnson
& Johnson Consumer, Val De Reuil, France
Sudden modifications in external humidity that occur during seasonal changes or after shower
are linked to abnormalities in skin barrier function sometimes leading to disorders such as
irritations or atopic dermatitis. We have studied the effect of sudden changes in external humid-
ity on the expression of genes involved in skin inflammatory responses (interleukin 8, IL8),
proteins involved in water transport (aquaporin 3, AQP3) and skin barrier function (filaggrin
and transglutaminase). Our study demonstrates that transfer of skin explants from a very humid
(relative humidity = 100%) to a normal environment (relative humidity = 40-70%) induces a
strong increase in IL8 gene expression without modifying AQP3, filaggrin and transglutami-
nase genes. Interestingly, transfer of skin biopsies from normal atmosphere to humid envi-
ronment leads to a progressive decrease in IL8 gene expression. These data suggest that abrupt
drying of atmosphere is more likely to induce inflammatory responses, while atmosphere
humidification tends to reduce these signs.
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Delineating relative roles for IFNγ versus IL-23 in psoriasis using human skin reconstructs
JZ Qin,1 H Xin,1 FO Nestle2 and BJ Nickoloff1 1 Pathology, Loyola University, Maywood, IL
and 2 St. John’s Institute of Dermatology, London, United Kingdom
Dysregulated cytokine production within psoriatic lesions (PP skin)is regarded as a hallmark
of this chronic inflammatory disease, mediating cross-talk between immunocytes and ker-
atinocytes (KCs). Previously we and others observed immunocytes activated by bacterial super-
antigen (SEB) induce PP skin using SCID-Hu model, and application of SEB also provoked
lesions. To define roles for specific cytokines in PP skin, we focused on IFNγ and IL-23.
Peripheral blood mononuclear cells (PBMC) stimulated by SEB(72h) revealed secretion of both
IFNγ (5-20 ng/ml) and IL-23 (50-300 pg/ml). Recent mouse skin results indicate IL-23 indi-
rectly induces epidermal hyperplasia. To explore potential direct effects of IL-23 using human
KCs, RT-PCR was performed on RNA from epidermal equivalents (EEs) composed solely of
stratified KCs. mRNA coding for both subunits of IL-23 receptor (IL-12Rβ1 and IL-23R) were
detected (n=3 EEs). Immunostaining of normal, pre-psoriatic and PP skin confirmed expres-
sion of IL-23R on epidermal KCs. To dissect relative roles for IFNγ vs IL-23, a reconstituted
human skin equivalent (HSE) was used composed of KCs derived from normal skin and con-
tracted collagen gel. When KCs are seeded without exposure to cytokines, and raised to air/liq-
uid interface(5 days), an epithelium resembling normal skin is created. Exposure of HSEs to
IFNγ induced cytopathic effects on KCs with loss of cell cohesion accompanied by apopto-
sis. Exposure of HSEs to IL-23 altered epidermal differentiation, but did not induce apoptosis.
Thus, the ability of IFNγ and IL-23 to influence epidermal KCs may involve both indirect inflam-
matory effects, as well as direct KC effects. Creating HSEs provides a high throughput oppor-
tunity for dissecting cytokine networking operative in PP skin. Future studies are indicated by
which distinct immunocyte subsets are combined with fibroblasts in HSEs to delineate roles
for cytokines such as IFNγ and IL-23, when added singly or in combination, to reprogram over-
lying KCs and create a bona fide psoriatic epidermal phenotype.
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Cutaneous tissue angiotensin converting enzyme may participate in pathogenesis of psoria-
sis
H Bak, S Chang, D Rhee and J Choi University of Ulsan College of Medicine, Asan Medical
Center, Seoul, South Korea
Many studies have shown that up-regulation of angiotensin-converting enzyme (ACE) partic-
ipates in adverse wound healing such as hypertrophic scar or keloid. Although recent studies
about pathogenesis of psoriasis focused on complex processes involved in regulation of inflam-
mation, tissue repair, and remodeling, the relationship between ACE and psoriasis, remains
unknown. This study was carried out to examine ACE in normal skin and psoriatic skin lesion.
Skin biopsies were obtained from patients and normal control subjects. Localization of ACE
was assessed by immunohistochemistry. Confocal laser scanning microscopy was performed.
The ACE activity in psoriatic lesions was significantly higher than in normal control subjects.
Immunohistochemical studies demonstrated that epidermis of psoriatic skin lesions were stained
with anti-ACE antibody. These results suggest that up-regulated ACE may participate in patho-
genesis of psoriasis.
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Validation of real-time PCR methods for measurement of skin barrier biomarkers in vitro
TL Farmer,1 SJ McPhail,1 EM Kincaid,1 WM Holleran2 and KJ Mills1 1 The Procter and
Gamble Co., Cincinnati, OH and 2 Dept. Dermatology, University of California San
Francisco, San Francisco, CA
The integrity of the stratum corneum is intimately linked to skin health and relies on the con-
certed action of a number of epidermal differentiation pathways involving lipid and protein
biosynthesis and their respective processing. Deficiencies in epidermal permeability barrier
are characteristic of many skin diseases, most notably atopic and contact dermatitis, psoria-
sis, and seborrheic dermatitis. Topical barrier therapy is known to be helpful in alleviating
symptoms associated with these diseases. In vitro evaluation of the effects of various low molec-
ular weight compounds on key biomarkers of epidermal differentiation is one approach to
the identification of novel barrier therapeutics. The purpose of this work is two-fold: 1) to
develop real-time quantitative PCR (qPCR) techniques to monitor expression of key biomark-
ers associated with barrier integrity, including epidermal differentiation and lipid processing
steps during chemically-induced differentiation in cultured normal human keratinocytes (NHEK);
and 2) to rigorously evaluate the utility of a variety of housekeeping genes for normalization
of resultant data sets. Methods for technique optimization including stringent requirements for
primer validation, rigorous criteria for selection of endogenous controls, and assay validation
using an established agent of epidermal differentiation (calcium) are presented. Using these
techniques, we show that calcium stimulation dose-dependently increases transglutaminase
1, acid sphingomyelinase, and glucocerebrosidase in NHEK. The observed responses of filag-
grin, involucrin, glucosyl ceramide synthase, and serine palmitoyl transferases 1 and 2 to cal-
cium stimulation are significantly affected by the selection of the endogenous control gene.
Results from these studies reveal the critical need for rigorous application of quality control
criteria to development and utilization of qPCR assays used for identification of novel barrier
therapeutics.
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Sucralfate is a regulator of epidermal regeneration : examination of biological mechanisms
in vitro
H Duplan, I Ceruti, H Sung, G Torkomian and M Charveron Cell Pharmacology, Pierre Fabre
Research Institute, Toulouse, France
Epidermal regeneration is a crucial step in cutaneous wound healing. It involves the combina-
tion of two cellular processes, proliferation and migration, temporally and locally orchestrated
by specific molecular mediators (growth factors, cytokines, ECM, integrins and enzymes). Sucral-
fate, a basic salt of sulphated sucrose, has proven its efficacy in the healing process of skin
wounds. The purpose of our study was to examine its action on proliferation and migration of
human epidermal keratinocytes in culture and elucidate some of the molecular mechanisms
involved. HaCat cells were submitted to 72h-treatment with increasing concentrations of sucral-
fate. Cell proliferation was assessed by the measurement of BrdU incorporation and migration
were analyzed with the Boyden Chamber assay. Then we performed a HaCat culture kinetic
model based on 2 h to 24h-treatments with EGF or TGFβ, both specific growth factors released
during wound healing. We assayed the expression of molecular mediators involved in the reg-
ulation of both cellular processes at the transcriptional level with real-time RT-PCR. Once
selected for their ability to be modulated in our cell culture kinetic model, molecular targets
were analyzed following sucralfate treatments. Our results showed that sucralfate was able to
affect positively cell processes especially by improving cell migration at optimal concentration
of 30 µg/mL. In our cell culture kinetic model, we demonstrated that the expression of molec-
ular markers such as Hyaluronane synthase (Has), some MMPs and laminin 5 was significantly
regulated, with specific kinetics of induction. Following sucralfate treatment, our results showed
that the expression of Has2 (proliferation) and MMP9 (migration) was significantly induced with
kinetic characteristics close to those of our positive controls. Together, the present data obtained
in vitro supported the positive action of sucralfate on skin wound healing by improving epi-
dermal reepithelization through the specific regulation of the expression of molecular actors.
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Chronic low-dose UV irradiation altered epidermal permeability barrier in murine skin
S Hong,1 H Bak,2 E Choi,1 S Lee3 and S Ahn1 1 Department of Dermatology, Yonsei Wonju
College of Medicine, Wonju, South Korea, 2 Department of Dermatology, Asan Medical
Center, Ulsan University College of Medicine, Seoul, South Korea and 3 Department of
Dermatology, Yonsei University College of Medicine, Seoul, South Korea
It is well-known that UV light causes skin cancer, decreases immune function and promotes
skin aging. In regard to the epidermal barrier, exposure of mammalian skin to acute high-
dose UV resulted in variety of cutaneous alterations, including delayed disruption of the per-
meability barrier, compensatory changes in stratum corneum lipid content and subsequent
barrier recovery. However, there is little documented data on epidermal barrier function in
skin exposed to low-dose UV over a long term. To investigate alterations of epidermal barrier
function after chronic low-dose UV irradiation, hairless mice were irradiated 3 times weekly
for 15 weeks with 1⁄ 3 MED of UV (UVB: 20 mJ/cm2; UVA:14 J/cm2). There was an increase
in basal transepidermal water loss and a decrease in skin hydration. Epidermal hyperplasia,
a loss of the epidermal calcium gradient, impaired and fragmented lipid lamellae, widened
intercellular spaces, lacunae formation, decrease in the number of lamellar bodies and their
abnormal transformation, and an increased expression of differentiation markers on immuno-
histochemical stain were observed. These features seemed to be more prominent with cumu-
lative exposure time. In conclusion, chronic low-dose UV irradiation disrupts the epidermal
permeability barrier.
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Altered expression of epithelial proteins observed in nonlesional skin of atopic dermatitis
subjects
A De Benedetto,1 LY McGirt,2 LR Latchney,1 C Cheadle,2 DY Leung,3 KC Barnes2 and
LA Beck1 1 University of Rochester, Rochester, NY, 2 Johns Hopkins University, Baltimore,
MD and 3 National Jewish Medical and Research Center, Denver, CO
Genetic studies have demonstrated strong linkage of Atopic Dermatitis (AD) to the Epidermal
Differentiation Complex (EDC) on Ch. 1q21. This region codes for proteins found in the stratum
corneum, thought to be crucial for cutaneous barrier function. Additionally, proteins involved
in cell-to-cell junctions (adherens, gap and tight) are also critical for an effective barrier. As part
of the NIAID-funded Atopic Dermatitis Vaccinia Network, this study was carried out to better
characterize the mRNA expression of these key epithelial proteins in subjects with AD. High-
throughput expression profiling was performed on nonlesional epithelium (from skin blister roofs)
of AD subjects (n=5) and nonatopic, healthy controls (NA; n=5). These profiles were generated
using Illumina’s Sentrix HumanRef-8 Expression BeadChips (>23,000 sequences) and analyzed
using Gene Set Matrix Analysis. Genes with Z ratio values ±2.0 were considered significantly
affected. Although several gene clusters were affected, the genes found in the EDC were quite
uniformly altered. AD subjects had greater mRNA expression of S100A proteins (A8, A7, A9)
and Small Proline-Rich Proteins (SPRR1B, 2A) compared to NA. In contrast, several Late Corni-
fied Envelope Proteins (LCE2B,2D,1B) and Loricrin were downregulated in AD compared to NA.
Our array data also show that proteins related to intercellular junctions are dysregulated in AD
compare to NA. For example, Claudin-1 and 23 were downregulated, while GJB2 (Connexin
26) was overexpressed in AD compared NA. These results strongly support the hypothesis that
there are defects (acquired or genetic) in keratinocyte proteins that explain the observed defect
in barrier function in AD subjects and possibly their susceptibility to cutaneous viral pathogens.
The observation that these altered expression patterns can be observed in nonlesional skin
highlights the central role that epithelium plays in the development of this disease.
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Perception of sting and response to irritants is associated with a weak barrier
V Foy,1 W Shingleton,2 J Alicea,1 J O’Leary,1 B Maddison,2 F McGlone3 and H Meldrum1 1
Unilever R & D, Trumbull, CT, 2 Unilever R & D, Colworth, United Kingdom and 3 Unilever
R & D, Port Sunlight, United Kingdom
Sensitive skin is a multifactorial condition often used to describe an individual’s response to
irritants. In this study, we have investigated whether a weak skin barrier is associated with
increased response to sting across different ethnic populations. The facial skin of age-matched
Caucasian and Japanese women was characterised as ‘sensitive’ if a stinging sensation was
perceived following topical application of glycolic acid (4%, half face, 7 minutes). Histamine
(1%) was applied topically and by iontophoresis. Response to histamine was assessed by skin
blood flow monitoring using Laser Doppler. Transepidermal water loss (TEWL) was assessed
on each side of the face over a 14 month period. Japanese women (45%) were found to be
more sensitive to glycolic acid than Caucasian women (30%). The increase in blood flow in
response to topically applied histamine was found to be greater in Japanese women compared
to Caucasian women, which provided objective evidence of increased sensitivity of Japanese
women compared to Caucasian. However, when histamine was iontophoresed into the skin
Japanese women had a similar blood flow response to Caucasian women. This demonstrated
that the fundamental histamine response in both populations was similar. The increased
response of Japanese women to topically applied histamine suggested they have a weakened
stratum corneum barrier that allowed penetration of topically applied histamine. Integrity of
the stratum corneum was further investigated by taking TEWL measurements from the same
group of women at 7 different time points over 14 months. Japanese women had significantly
increased TEWL compared to Caucasian women at 6 of the 7 time points. Using objective
measures, we have shown that at Japanese women are more sensitive to topical irritants than
Caucasian women; this increased sensitivity was associated with weakened barrier function.
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Cannabinoid receptor 1 regulates epidermal permeability barrier and keratinocyte differ-
entiation
C Heughebaert,1 M Opsomer,1 Y Uchida,1 T Roelandt,2 C Giddelo,1 D Crumrine,1 C Ledent,2
KR Feingold,3 PM Elias4 and J Hachem2 1 Dermatology, Academisch Ziekenhuis van de Vrije
Universiteit, Brussel, Brussels, Belgium, 2 Dermatology Research, VA medical center, UCSF,
San Francisco, CA, 3 Institut de Recherches en Biologie Humaine et Moleculaire, Univesite
Libre de Bruxelles, Brussels, Belgium and 4 Metabolism, VA medical center, UCSF, San
Francisco, CA
Epidermal keratinocytes possess the biochemical machinery for endocanabinoid signaling, includ-
ing a functional type-1 cannabinoid receptor (CB1). Since CB1 is expressed in the suprabasal
layers of the epidermis, we hypothesized that endocannabinoid signaling could regulate per-
meability barrier homeostasis and epidermal differentiation. To address CB1 function, we com-
pared permeability homestasis in CB1 knockout mice (-/-) and wild type littermates (+/+) assessed
as rates of permeability barrier recovery after consecutive stratum corneum tape stripping. A delay
in barrier recovery was observed in -/- mice 3 hours following barrier disruption which was par-
alleled by incompletely processed lamellar bilayers and premature lamellar bodies secretion
within the nucleated layers of the epidermis. Accordingly, Western immunoblotting for 2 lipid
processing enzymes, β-glucocerebrosidase and acidic sphygomyelinase was decreased both
prior and following barrier abrogation. Second, we assessed whether absence of CB1 in -/- ani-
mals affects epidermal proliferation and/or differentiation. Both epidermal thickness and PCNA
staining were increased under basal conditions prior barrier disruption. In addition, immuno-
histochemical and Western immunoblotting for the epidermal differentiation markers (filaggrin,
loricrin amd involucrin) were found to be downregulated in CB1 -/- mice. Finally, markers of
terminal differentiation (cornification), including caspase 14 activation and phospho-caveolin-
1 incorporation into lipid rafts were decreased in CB1 -/- mice following barrier disruption. In
conclusion, these results unequivocally demonstrate that CB1 regulates permeability barrier func-
tion, differentiation and terminal differentiation of epidermal keratinocytes.
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Electron microscopical analysis of the subepidermal nerve plexus
C Reinisch,1 D Födinger1 and E Tschachler1,2 1 Department of Dermatology, Medical
University of Vienna, Vienna, Austria and 2 Centre de Recherches et d Investigations Épider-
miques et Sensorielles (CE.R.I.E.S.), Neuilly, France
As the most distal part of the nervous system, the subepidermal nerve plexus is located in the
papillary dermis. Its network of fine nerve fibers embraces our whole body surface and enables
us to perceive stimuli from our environment. It contains the most delicate fibers, which are
composed of axons ensheathed by terminal Schwann cells. Being interested in the ultrastruc-
ture of the fine fibers in the subepidermal nerve plexus, we performed electron microscopy
on immunohistochemically stained horizontal sections of papillary dermis. Native dermal
sheet preparations were incubated with Nerve Growth Factor receptor antibody and fixation
was done after incubation in primary antibody and completed with postfixation at the end of
the staining procedure. We analysed a total of 9 sections containing 61 nerve fibers in detail.
The thickness of the single nerve fibers ranged from 1244nm to 35303nm with a median diam-
eter of 4737nm. The median axon number ensheathed per Schwann cell was 2 with a range
from 1 to 27. Axon diameter ranged from 197nm to 1925nm with a median caliber of 610nm.
Approximately 15% of axons were found to be only incompletely invaginated by terminal
Schwann cells being closely associated to the extracellular space. All of the nerve fibers
found were unmyelinated. But 5 nerve fibers contained axons which were wrapped by two
or three layers of the mesaxon and strikingly all of these fibers additionally contained further
axons wrapped by only one layer of mesaxon. Potentially, this rudimental multi-layered sheath
depicts the beginning of myelination in the periphery. However, myelinated and unmyelinated
axons have never been shown to occur in one Schwann cell. With our analysis, we were able
to specify morphological data being useful in the further evaluation of physiological and patho-
logical changes of the superficial dermal nerve plexus. As skin biopsies are increasingly dis-
covered an exciting tool to evaluate peripheral neuropathies, this is of emerging importance.
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Characterization of a hapten-induced, murine model of atopic dermatitis
M Man,1,2 Y Hatano,1 SH Lee,3 M Man,2 Y Shi,2 S Chang,1 KR Feingold,1 DY Leung,4
W Holleran,1 Y Uchida1 and PM Elias1 1 Dermatology & Metabolism Services/Dermatology
& Medicine, VAMC/UCSF, San Francisco, CA, 2 Dalian Skin Disease Hospital, Dalian, China,
3 Dermatology, Yonsei University School of Medicine, Seoul, South Korea and 4 Pediatrics,
National Jewish Medical Research Center, Denver, CO
Atopic dermatitis (AD) is a chronic inflammatory dermatosis that bears some clinical histo-
logical and immunologic similarities to allergic contact dermatitis (ACD). In contrast to ACD,
AD shows a Th2 predominance, prominent permeability barrier abnormality and frequent col-
onization with S. aureus. An appropriate AD animal is essential not only for investigation of
pathogenesis of AD but also for assessment of potential AD therapies. We previously reported
an AD-like model [JID, 2006:126(S1);p57], produced by repeated oxazolone challenges to
hairless mice (OxzMice), that displayed abnormal barrier function, delayed barrier recovery
kinetics, increased surface pH, decreased SC hydration and inflammatory infiltrate. Here we
further characterize OxzMice by assessing alterations in stratum corneum (SC) lipid compo-
sition, epidermal proliferation/differentiation, innate immunity, Th2 status, and serine protease
(SP) activity, each of which is associated with AD pathogenesis. Consistent with AD, both NP
(non-hydroxy-phytosphingosine) ceramide and the ratio of total ceramide to cholesterol in SC
were diminished; epidermal hyperproliferation was evident (increased PCNA); both the con-
tent and distribution of differentiation-specific proteins, i.e., filaggrin, loricrin and involucrin,
were abnormal; expression of two lamellar body-derived antimicrobial peptides, CRAMP and
mBD3, were diminished; and serum IgE levels and mast cell numbers in skin were both promi-
nently elevated. Finally, an increase in epidermal serine protease activity was evident by in
situ zymography. These results demonstrate that this oxazolone mouse model has the princi-
pal epidermal and immunologic features of human AD. Moreover, because of its reproducibility,
predictability, and low cost, this model can be used as a convenient animal model of AD.
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Proteomic characterization of molecular signatures for keratinocyte stem cells, transit ampli-
fying keratinocytes and melanocytes in human epidermis
A Terunuma, G Patel, J Blonder, V Kapoor, W Telford, T Veenstra and J Vogel National Cancer
Institute, Bethesda, MD
To better understand the biological differences between human keratinocyte stem cells (KSC)
and transit amplifying (TA) cells on a molecular level, we quantitatively compared the pro-
teomes of purified KSC and TA cells using 2-dimensional liquid chromatography and tandem
mass spectrometry (2D-LC MS/MS). KSC were detected as BrdU-positive label-retaining-cell
keratinocytes (LRC-KC) in human neonatal foreskin grafts established on the backs of nude
mice, and collected by flow sorting. Actively dividing TA cells were purified as pulse-labeled-
cell keratinocytes (PLC-KC) from human skin grafts on nude mice pulse-labeled with BrdU.
As a reference control, CD117(+) melanocytes were collected from both LRC-KC- and PLC-
KC-containing grafts. Microsomal fractions from these 3 populations of human epidermal cells
(LRC-KC, PLC-KC, and melanocytes; 14 million of each) were purified, trypsinized, fraction-
ated, and analyzed by 2D-LC MS/MS. We identified 6409, 9392 and 8839 proteins in LRC-
KC, PLC-KC and melanocytes, respectively. The relative abundance of each distinct protein in
the 3 cell populations was semi-quantitatively compared. The validity of this approach was
confirmed by detecting many known melanocyte proteins in melanocytes (including tyrosi-
nase, DCT and MART-1) but not in LRC-KC or PLC-KC. Proteins upregulated in LRC-KC or
PLC-KC were analyzed by Ingenuity pathway analysis software and were determined to have
“tissue development,” “embryonic development,” ”organ morphology” and “organismal devel-
opment” as primary functions significantly activated in LRC-KC consistent with their expected
role as primitive cells responsible for tissue regeneration, while PLC-KC upregulated proteins
associated with “cell cycle,” “cellular assembly and organization” and “DNA replication,
recombination and repair.” The list of differentially expressed proteins generated by this global
proteomic approach allows us to further characterize the unique biological identities of these
cell populations in human epidermis.
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Differences in sensory & nerve fiber distribution between ethnic (sub) populations
B Maddison,1 V Foy,2 J Civil,1 S Singleton1 and F McGlone3 1 Unilever R & D, Colworth,
United Kingdom, 2 Unilever R & D, Trumbull, CT and 3 Unilever R & D, Port Sunlight, United
Kingdom
Sensory sensitivity could vary between individuals due to a number of factors such as eth-
nicity, gender, age. Here, we have investigated the hypothesis that the quantity & distribution
of nerve fibers in hairline facial skin in Japanese and Caucasian panellists and correlated with
quantitative sensory testing (QST). A number of approaches were developed to investigate
nerve fibers in skin. Biopsies were collected and stained for PGP9.5 using immunohisto-
chemistry. An image analysis algorithm was designed that could extract and semi-quantify
from immunohistochemically stained biopsy sections an array of parameters such as staining
amount per unit area, clustering and intensity. This approach revealed that Caucasians had a
12-fold increase in PGP9.5 staining compared to Japanese (P<0.01) at the hairline. There was
no difference between the populations in warm and cold sensation, hot pain and cold pain
thresholds. However, von Frey (pressure) measure showed Caucasians were significantly more
responsive (2.35+/- 0.7 vs. 2.82+/- 0.6mN; P=0.0037). In addition, there were no significant
relationships between age and QST responses. However, correlation of the staining for PGP9.5
with the QST at the hairline revealed that Caucasians with increasing neuronal amount showed
less sensitivity to warm and cold thresholds (P=0.01 & 0.03, respectively) but this was not
mirrored in Japanese panellists. Overall, our data demonstrates that there was a difference in
nerve fiber innervation between Caucasian and Japanese panellists. Nerve fiber quantity, dis-
tribution and the expression of receptors may play an important role in determining sensory
response. We have developed capability to investigate this phenomenon further.
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Development of inflammation in normal skin requires additive effects of selected exoge-
nous stressors
J Hachem,1 M Denda,2 M Man,3 T Roelandt,1 C Heughebaert,1 C Giddelo,1 D Roseeuw,1
KR Feingold3 and PM Elias3 1 Dermatology, Academisch Ziekenhuis Vrije Universitiet Brussel,
Brussels, Belgium, 2 Shiseido Research Center, Shiseido, Yokohama, Japan and 3 dermatology
Research  and Metabolism, VA medical center, USCF, San Francisco, CA
The stratum corneum (SC)’s acid mantle regulates at least 2 key functions — permeability bar-
rier homeostasis and SC integrity/cohesion. Both because alkaline soaps are often irritating,
and because inflammatory dermatoses invariably exhibit an elevated pH, we hypothesized
that pH could also regulate inflammation. Raising SC pH to neutrality with single or multiple
topical applications of the ‘superbase,’ tetramethylguanidine (TMG) stimulated increased
expression of multiple primary cytokine (IL-1α, IL-1β, TNFα) in a serine protease (SP)-depend-
ent fashion; i.e., co-applied SP inhibitors blocked cytokine activation. One protective mech-
anism could be massive, parallel upregulation of IL-1ra. We then explored whether addition
of one or more exogenous stressors would trigger inflammation through its/their additive,
adverse effects on barrier function. Applications of TMG do not induce inflammation in psy-
chologically-stressed mice, presumably because pH and PS impact barrier function by unre-
lated mechanisms. Conversely, TMG applications to mice maintained at a low relative humid-
ity (RH) triggered inflammation, apparently due to mechanistic convergence-pH increases still
further; barrier function deteriorates quickly; and cytokine plus downstream markers increase
in an SP-dependent fashion. These results are of broad clinical relevance, because they explain:
1) why normal individuals rarely are irritated by alkaline soaps, and conversely, 2) how indi-
viduals with pre-existing barrier defects (e.g., atopics) are commonly irritated under similar
circumstances, and 3) demonstrate that certain combinations of exogenous stressors, specifi-
cally pH and RH, can converge to trigger inflammation, and presumably favor disease devel-
opment.
478
Cholesterol depletion and raft disruption induce lipid phase separation and blebbing in
HaCaT keratinocytes
D Vind-Kezunovic,1 C Hélix Nielsen,2 U Wojewodzka1,3 and R Gniadecki1 1 Department of
Dermatology, Bispebjerg Hospital, Copenhagen, Denmark, 2 Technical University of
Denmark, Lyngby, Denmark and 3 Department of Cell Ultrastructure, Polish Academy of
Sciences, Warsaw, Poland
Lipid rafts are plasma membrane microdomains receiving an increasing attention because of
their regulatory role in crucial cellular processes, including signal transduction, protein and
lipid membrane trafficking, motility and apoptosis. Lipid rafts are also involved in the regula-
tion of membrane curvature, as exemplified in the raft-enriched structures such as caveolae.
Rafts are mainly composed of cholesterol and sphingolipids in a liquid-ordered (Lo) state in
contrast to the bulk membrane lipids, which are predominantly in the liquid-disordered (Ld)
phase. We visualized rafts by confocal microcopy in cultured HaCaT keratinocytes using
cholera toxin B subunit labeled fluorescein-isothiocyanate (FITC-CTx), which binds specifi-
cally to the abundant lipid raft component ganglioside GM1. As Ld marker we used 1,1’-
dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine perchlorate (DiI-C18). In intact HaCaT
cells, FITC-CTx and DiI-C18 spatially merge at the basal portion of the cell suggesting phase
mixing. By contrast, in the apical portion of the cell, we noticed the presence of 1µm large
vesicles stained selectively with DiI-C18. Cholesterol depletion by methyl-β-cyclodextrin fur-
ther enhanced this Ld/Lo phase separation with formation of more DiI-C18 stained vesicles
budding off the plasma membrane. Transmission electron microscopy confirmed the observed
phenomenon of blebbing. We analyzed the vesicular budding process in terms of curvature
and line tension energy models and found that the line tension between separated Lo/Ld phases
is of sufficient magnitude to explain the budding.
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Epidermal targeting using a multivesicular emulsion (MVE) system
N Barai, RK Pillai, BM Kiedaisch, D Aust and TW Morris DFB Pharmaceuticals, Fort Worth,
TX
Previous in vitro silicone membrane studies have demonstrated controlled release of the lipid
soluble antifungal agent econazole nitrate from a novel Multivesicular Emulsion (MVE) topi-
cal drug delivery system. MVE formulations are two phase, oil in water emulsion systems with
multi-lamellar structures consisting of multiple concentric spheres of oil and water. Here, the
previous in vitro MVE studies were extended by comparing percutaneous diffusion charac-
teristics of the lipophilic dye nile red in an ex vivo porcine skin diffusion cell model. Parallel
MVE and non MVE (classic oil in water emulsion) formulations containing 0.0004% nile red
were topically applied to 0.8 mm thick porcine skin samples in Franz diffusion cells held at
35oC. At 1, 3, 6 and 16 hours post application treated skin samples were collected, embed-
ded by rapid freezing in OCT media, and microtomed into 10 µm vertical sections for light
microscopy. Brightfield and fluorescent images of each section were merged to facilitate visual
inspection of dye partitioning plus quantitative image analyses of nile red fluorescence in the
stratum corneum and epidermal compartments. Qualitative and quantitative results confirmed
that both formulations delivered equivalent, low levels of fluorescent dye to the stratum corneum
at all times. In contrast, visual and quantitative analyses of nile red fluorescence in the epi-
dermal space revealed marked differences between the formulations. Direct comparisons of
nile red penetration at 3, 6 and 16 hours post application showed that the MVE formulation
consistently delivered 3-fold to 6-fold less fluorescent marker to the epidermal space over this
sustained period. These results further demonstrate the utility of MVE based topical formula-
tions for controlled targeting of therapeutic agents to the epidermal compartment.
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Deregulation of keratinocyte differentiation and activation pathways in chronic wounds
O Stojadinovic,1 MG Mahoney,2 H Brem,3 I Pastar,1 S Vukelic,1 M Golinko3 and M Tomic-
Canic4,1 1 Tissue Repair Program, Hospital for Special Surgery, New York, NY, 2 Dermatology,
Thomas Jefferson University, Philadelphia, PA, 3 Surgery, Columbia University CP&S, New
York, NY and 4 Dermatology, Weill Cornell Medical College, New York, NY
Epidermal morphology of chronic wounds differs from that of normal epidermis suggesting
incomplete keratinocyte activation and differentiation. Biopsies of non-healing edges obtained
from patients with chronic wounds show thick and hyper-proliferative epidermis with mitosis
present suprabasaly. We have shown previously that chronic wound edge keratinocytes are
proliferating but are unable to migrate due to overexpression of c-myc. Also, we found that
chronic wound edge epidermis is hyperkeratotic and parakeratotic. To identify molecular
changes that lead to pathogenic alterations in keratinocytes activation and differentiation path-
ways we used Affymetrix HU133 chips and mRNA isolated from biopsies obtained from non-
healing edges of five venous ulcers patients. Transcriptional profiles were compared to those
obtained from normal, unwounded skin. We identified 1,560 differentially regulated genes in
a statistically significant manner. As indicated by histology, we found deregulation of differ-
entiation and activation markers. Early differentiation markers, keratins K1 and K10 and a
subset of small proline rich proteins (SPRRs) along with late differentiation markers filaggrin
were suppressed, whereas late differentiation markers involucrin, transgultaminase 1 and
another subset of SPRRs were induced. Desomosomal components were also found to be
deregulated. Keratinocyte activation markers keratin K6/K16 were induced whereas keratin
K17 was not. We also found differential regulation of signaling molecules that regulate these
two processes, such as Notch, KLF, PLD1, PLD2, and PI3K. These findings were confirmed by
immunohistochemistry. We conclude that keratinocytes at the non-healing edge are not senes-
cent but rather incapable of executing either of the two pathways: activation and differentia-
tion, resulting in thick callus formation at the edge of a chronic wound.
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Coordinated expression of E-cadherin, β-catenin, and Slug in organotypic cultures of human
keratinocytes following recovery from oxygen deprivation
JA Straseski and B Allen-Hoffmann Pathology, University of Wisconsin-Madison, Madison, WI
The effects of hypoxia and recovery from oxygen deprivation in normal stratified squamous
epithelium are largely unknown. We investigated the affects of oxygen deprivation and recov-
ery on proliferation, differentiation and expression of cell-cell adhesion molecules in a fully
stratified organotypic model of human skin. NIKS keratinocytes were grown to full stratifi-
cation in organotypic culture for 12 days under normoxic conditions. Using modular incu-
bator chambers, tissues were then exposed to anoxia (5%CO2/95%N2) for 2, 4, 8, 12, 24,
or 48 hours. Tissue recovery was studied by reintroducing oxygen for 24, 48, 72 or 96 hours
following 24 hours of anoxic exposure. E-cadherin mRNA and protein as well as Ki67 expres-
sion decreased dramatically following oxygen deprivation. These losses were reversible within
24-48 hours of re-oxygenation. Compared to normoxic tissue controls at both 24 and 48
hour timepoints, anoxic tissues exhibited a 6-fold increase in Slug mRNA, a transcriptional
repressor of E-cadherin. mRNA levels of Snail, a closely related transcription factor, remained
relatively stable over the timecourse. After 24 hours of re-oxygenation, Slug mRNA levels
decreased compared to anoxic tissue. This corresponded with an 11-fold increase in E-cad-
herin mRNA. Interestingly, despite a dramatic loss of membrane-associated E-cadherin, tis-
sues remained intact at all anoxic timepoints. Desmosomal and adherens junction proteins
underwent remodeling in the suprabasal epidermal layers. β-catenin protein levels were
diminished whereas cytoplasmic desmoglein levels were less affected. These alterations in
intercellular junctional proteins were reversible upon re-oxygenation. These data implicate
Slug in the cell-cell junctional changes occurring in stratified squamous epithelium during
limited oxygen availability.
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Curcumin suppresses AP1 transcription factor-dependent differentiation and activates apop-
tosis in human epidermal keratinocytes
S Balasubramanian and RL Eckert Departments of Biochemistry and Molecular Biology, and
Dermatology, University of Maryland School of Medicine, Baltimore, MD
The diet-derived agent, curcumin, has been proposed for use in the treatment of various skin
diseases, including psoriasis. Recent studies indicate that topical treatment with curcumin can
reduce the severity of psoriasis. However, its mechanism of action is not known and its effect
on normal human keratinocyte differentiation, proliferation and apoptosis has not been ade-
quately studied. Involucrin (hINV) is a marker of keratinocyte differentiation and a useful model
for the study of chemopreventive agent action. We show that curcumin suppresses differen-
tiation agent-dependent activation of hINV gene expression and that an AP1 transcription fac-
tor DNA binding site in the hINV gene is required for this regulation. A PKC, Ras, MEKK1,
MEK3 signaling cascade controls hINV expression by regulating AP1 factor level. Curcumin
treatment inhibits the nPKC-, Ras- and MEKK1-dependent activation of hINV promoter activ-
ity and reduces the differentiation agent-dependent increase in AP1 factor level and DNA
binding. This reduction requires proteasome function. In addition, curcumin treatment reduces
cell number, which is associated with a reduced cyclin and cdk1 levels. Curcumin treatment
also suppresses Bcl-xL level, leading to reduced mitochondrial membrane potential, and
increased cleavage of procaspases and PARP. These studies provide important insights regard-
ing the mechanism whereby curcumin may act to regulate disease states in epidermis.
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Pemphigus vulgaris identifies non-junctional desmoglein 3 as regulator of tissue homeosta-
sis via plakoglobin signaling
K Schulze, C Lietti, C Strauss, L Williamson, MM Suter and EJ Muller Molecular
Dermatology, Institute Animal Pathology, University of Bern, Bern, Switzerland
We recently reported that the pathomechanism in the autoimmune blistering skin disease
pemphigus vulgaris (PV) relies on c-Myc upregulation secondary to antibody-induced dis-
ruption of adhesion between non-junctional desmoglein (Dsg) 3 (e.g. Williamson et al, Embo
J 25, 2006). In PV patients, c-Myc upregulation correlates with sustained proliferation. This
event relates to lack of glycogen-synthase kinase (GSK) 3β inhibition, plakoglobin degrada-
tion and impaired plakoglobin-mediated transcriptional suppression of c-MYC. In vivo, in a
passive transfer study, inhibitors to GSK3β or c-Myc prevent blister formation, an approach
which has been deposited as IP in view of a novel therapeutic treatment for PV patients.
Together these results suggested that non-junctional Dsg3 links intercellular adhesion to cell
cycle regulation via plakoglobin. We now report that one of the central elements in the sig-
naling cascade initiated by PV antibodies is the survival kinase Akt (PKB) which under nor-
mal conditions is activated by phosphatidylinositol 3 kinase downstream of cadherins. The
clinically important aspect for the patient is that c-Myc was also upregulated in the bulge
area of the hair follicle, where the regenerative cell pool of the epidermis, the stem cells, are
thought to reside. Consistent with depletion of stem cells due to high c-Myc, expression of
β1 integrin known to be important for maintenance of the stem cell compartment was reduced.
As Dsg3 is expressed by epidermal stem cells, we went on to investigate the possibility that
the signaling cascade identified downstream of PV antibody-bound Dsg3 also involves stem
cell depletion. Analyses of the clonal efficiency of primary isolated keratinocytes and the
expression of potential stem cell markers in neonatal mice after injection of PV antibodies
are currently under way.
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Proposing a guide for the exact and reproducible evaluation of neuronal plasticity skin and
hair follicle innervation
S Hendrix,2 B Picker2,1 and EM Peters1 1 Cutaneous Psychoneuroimmunology, Department
of Internal Medicine and Psychosomatics, University Medicine Charité, Berlin, Germany and
2 Institute of Cell Biology and Neurobiology, Center for Anatomy, University Medicine
Charité, Berlin, Berlin, Germany
Cutaneous innervation is constantly remodeled and may serve as an instructive example for
neuronal plasticity in the peripheral nervous system. Nerve fibers in skin display dramatic plas-
ticity not only during morphogenesis, but also in adult tissue remodelling, in the course of skin
diseases and after skin nerve lesions. In order to recognize even subtle changes or abnormal-
ities of cutaneous innervation under different experimental conditions, it is critically impor-
tant to use a quantitative approach to determine nerve fiber densitiy, target interaction and
subtype dominance. Here, we introduce a simple, fast and reproducible quantitative method
based on immunofluorescence histochemistry for the exact quantification of peripheral nerve
fibers. Computer-generated schematic representations of cutaneous innervation in defined skin
compartments are presented with the aim of standardizing reports on gene and protein expres-
sion patterns. This guide should become a useful tool when screening new mouse mutants,
disease models affecting innervation or mice treated with pharmaceuticals for discrete mor-
phologic abnormalities of skin innervation in a highly reproducible and quantifiable manner.
Moreover, this method can be easily transferred to other densely innervated peripheral organs.
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“Poly-protection” against oxidative stress by an extract of Blue Malagasy Ginger – Zingiber
Officinale
C Wallaert,1 AD D’Arcangelis,1 P Bhatt,1 EV Fedorova,1 M Mildner,2 E Tschachler2 and
C Lasserre1 1 Skin Cell Biology Laboratory, Chanel, Inc., Piscataway, NJ and 2 Department of
Dermatology, Medical University of Vienna, Vienna, Austria
Exposure of skin to UV irradiation induces a wide range of short and long term effects such
as erythema, DNA damage, formation of reactive oxygen species (ROS), apoptosis, inflam-
mation, aging and photoaging. Several free radicals such as superoxide anion, hydroxyl rad-
ical, peroxinitrite and halogenated oxidants are known to be harmful to skin cells. The ability
of the cellular antioxidant defense system to maintain the balance between radical genera-
tion and elimination is altered with age. Superoxide dismutase (SOD) is a metalloenzyme that
plays a crucial role in the cellular anti-oxidant enzyme defense system. The skin is further
protected from environmental stress, such as UV irradiation, by the expression of endothelial
growth factor VEGF. Repair of skin damage has been shown to associate with the expression
of two other growth factors, HB-EGF and TGFα. A novel extract of Blue Malagasy Ginger was
evaluated for direct antioxidant activity, as well as any indirect effect on the antioxidant enzy-
matic system, and any effect on VEGF, HB-EGF and TGFα expression. Several concentrations
of ginger extract were tested against superoxide anion, hydroxyl radical, peroxinitrite and halo-
genated oxidants. Further, keratinocytes treated with the extract at several concentrations for
24 hours were then evaluated for SOD activity as well as VEGF, HB-EGF and TGFα expres-
sion. These experiments revealed that ginger extract significantly inhibits all radicals tested. It
also stimulates SOD activity and expression of VEGF, HB-EGF, and TGFα. This extract of Blue
Malagasy Ginger demonstrates strong multiple biological activities that not only provide mul-
tidimensional protection of skin from oxidative stress but also improve and maintain the qual-
ity of microcirculation and skin repair. Therefore, Blue Malagasy Ginger extract provides excel-
lent global protection of skin from environmental stresses.
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The effects of iron in a keratinocyte-derived post-menopausal cellular model
E Pelle,1,2 J Dai,2 J McCarthy,1 T Mammone,1 D Maes1 and X Huang2 1 Skin Biology, Estee
Lauder Res Labs, Melville, NY and 2 Environmental Medicine, New York University School of
Medicine, New York, NY
Skin of post-menopausal women is characterized by thinning epidermis, loss of elasticity, and
wrinkle formation. Although the causes for these phenomena are multi-factorial, the loss of
estrogen, which correlates to the onset of menopause, is a well known contributing factor.
Iron, which increases in serum as menstruation ceases, is a previously unexamined factor
related to menopause which may also contribute to these skin patho-physiological processes.
To determine iron’s role in post-menopausal skin, a cellular model system was developed in
normal human epidermal keratinocytes (NHEK) that were treated with low levels of estrogen
and increased levels of ferritin and transferrin. In contrast, NHEK were also prepared under
pre-menopausal conditions: high estrogen, low ferritin and transferrin, including an untreated
control. Using this prototype we found increased levels of reactive oxygen intermediates and
lipid peroxidation, as well as reduced levels of vascular endothelial growth factor (VEGF) in
the post-menopausal cells; all of which correlate to post-menopausal skin. Further, the reduc-
tion in VEGF was found to decrease in a dose-dependent manner as a function of increased
ferritin levels. In addition, DNA microarray analysis of the post-menopausal cells indicated
336 genes up-regulated and 237 genes down-regulated as compared to the untreated control
after 48 hours incubation. Lastly, hypoxia inducible factor-1-alpha (HIF-1-α), a signaling mol-
ecule which transduces VEGF production, was reduced in the presence of iron when post-
menopausal cells were subjected to hypoxic conditions. HIF-1-α reduction may be due to iron
acting as a co-factor to HIF prolyl hydroxylase which leads to HIF-1-α hydroxylation and even-
tually ubiquitination and proteasomal degradation. In conclusion, these data present a new
cellular paradigm for studying post-menopausal skin and identify iron as an important factor
in those changes associated with post-menopausal skin.
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Keratin 16 expression in human cutaneous wounds
ML Usui,1 RA Underwood,1 WG Carter2,3 and JE Olerud1 1 Medicine/Div. Dermatology,
University of Washington, Seattle, WA, 2 Pathobiology, University of Washington, Seattle, WA
and 3 Fred Hutchinson Cancer Research Center, Seattle, WA
Keratin 16 (K16), an intermediate filament, is associated with activated keratinocytes in cuta-
neous wounds and hyperproliferative skin diseases (i.e. psoriasis, skin cancers, viral infections)
and is not expressed in normal interfollicular keratinocytes. In acute wounds, K16 protein
expression, as detected by immunohistochemistry, is present approximately 8-12 hours post-
wounding. Expression is localized to post-mitotic, differentiated suprabasal migrating ker-
atinocytes along and immediately proximal to the margin of cutaneous wounds. Upon wound
closure, K16 expression becomes increasingly restricted to the epithelia covering the new
wound matrix. Based on immunohistochemical studies, a few K16 immunoreactive ker-
atinocytes can be seen along the newly formed basement membrane of 7 to 28 day human
incisional wounds. Our data indicate that presence of K16 expressing keratinocytes along the
basement membrane are either: suprabasal keratinocytes capable of de-differentiation within
a basal keratinocyte niche or basal keratinocytes capable of expressing K16 post-wounding
within an intact epithelium. K16 expression in wound keratinocytes may not only function to
facilitate migration but may play a yet undetermined role within the closed, non-migrating
wound epithelium.
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Multiple PKCδ tyrosine residues are required for PKCδ-dependent activation of keratinocyte
differentiation - A key role of PKCδ-Y311
L Zhu and RL Eckert Departments of Biochemistry and Molecular Biology, and Dermatology,
University of Maryland School of Medicine, Baltimore, MD
The protein kinase c-delta (PKCδ) isoform is an important regulator of human keratinocyte
differentiation that is known to be tyrosine phosphorylated. However, a comprehensive analy-
sis of the role of individual tyrosine residues has not been performed in normal human ker-
atinocytes. Involucrin is a keratinocyte differentiation marker that is expressed in the suprabasal
epidermal layers, and is increased in the presence of PKCδ. Our present studies indicate that
multiple tyrosine residues influence the ability of PKCδ to increase hINV gene expression. Indi-
vidual mutation of PKCδ tyrosine residues 52, 64, 155, 187 or 565 does not reduce the abil-
ity of PKCδ to increase hINV promoter activity. However, simultaneous mutation of these five
tyrosine residues markedly reduces activity. Moreover, restoration of any one of these tyrosine
residues results in nearly full restoration of activity. PKCδ tyrosine 311 is known to have an
important role in several systems. We observed that phosphorylation of tyrosine 311 is reduced
in the five tyrosine mutant and subsequently showed that mutation of tyrosine 311 results in
a reduction in PKCδ activity comparable to that observed in the five tyrosine mutant. Restora-
tion of any one of the tyrosine residues in the five tyrosine mutant restored tyrosine 311 phos-
phorylation and biological activity. In addition, the inactivating tyrosine mutations do not alter
PKCδ membrane localization; therefore, the reduced activity is not due to altered subcellular
distribution. Reduced phosphorylation of tyrosine 311 of endogenous PKCδ is observed when
keratinocytes are treated with the dietary agents, apigenin or curcumin, and is associated
with reduced hINV expression. These findings indicate that PKCδ function requires tyrosine
311 plus a second tyrosine residue; however, any of several tyrosine residues can serve in the
secondary role. These novel findings shed new light on the role of tyrosine phosphorylation
as a regulator of PKCδ function in epidermis.
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Inhibition of AP1 factor function in epidermis causes epidermal hyperproliferation and der-
mal fibrosis
R Jans, G Adhikary, EA Rorke, JF Crish, AC Gilliam and RL Eckert Departments of
Biochemistry and Molecular Biology, and Dermatology, University of Maryland School of
Medicine, Baltimore, MD
Previous studies indicate that multiple members of the activator protein one (AP1) transcrip-
tion factor family are expressed in the epidermis during keratinocyte differentiation. How-
ever, the role of these factors in the basal versus suprabasal epidermis is not well understood.
A key question is whether these factors have a different role in the individual epidermal lay-
ers. A previous study indicates that inactivation of AP1 factor function in the epidermal basal
layer does not alter the skin phenotype in resting epidermis. In the present study we examine
the impact of inactivating AP1 factor function in the suprabasal epidermis. FLAG-tagged
dominant-negative c-jun (TAM67-FLAG) was expressed in the suprabasal epidermis using an
involucrin promoter-targeted tetracycline-inducible system. In tetracycline-treated mice, TAM67-
FLAG is detected in the nucleus of suprabasal keratinocytes. This expression is associated
with a four-fold increase in epidermal thickness. In addition, bromodeoxyuridine incorpora-
tion is increased ten-fold in the basal epidermal layer of TAM67-FLAG expressing mice. No
increased labeling is detected in the dermis. Expression of the K1 and filaggrin keratinocyte
differentiation markers appeared normal; however, K14 expression, a marker associated with
keratinocyte hyperproliferation, was observed in the basal and suprabasal layers. These ani-
mals also manifest an additional remarkable phenotype - the development of scleroderma-
like dermal fibrosis with increased immune cell invasion. Development of this phenotype is
rapid - within days after induction of TAM67 expression. The presence of a scleroderma phe-
notype is remarkable, since it develops in response to perturbation of epidermal and not der-
mal function. These animals provide a remarkable model for the study of AP1 factor function
in the suprabasal epidermis and for the study of scleroderma.
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Role of Dlx3 in the regulation of cell cycle proteins
V Pietroni,1 Y Rivera,1 N Radoja,1 S Stimpson,1 DE Anderson,2 M Blumenberg3 and
M Morasso1 1 Developmental Skin Biology Unit, NIH/NIAMS, Bethesda, MD, 2 Proteomics
and Mass Spectometry Facility, NIH/NIDDK, Bethesda, MD and 3 Departments of
Dermatology and Biochemistry, NYU, New York, NY
Dlx3 is a homeodomain transcription factor involved in the regulation of epidermal gene
expression and is expressed in the differentiated layers of the epidermis, ectodermal appendages
and osteoblasts. Previous work has indicated that Dlx3 overexpression leads to a reduction in
cell proliferation in normal and transformed human epithelial cells. Using microarray analy-
sis, we determined that overexpression of Dlx3 regulated cell cycle genes such as p21 and
Cdk4. To determine if the Dlx3-dependent p21 induction occurs through direct transcriptional
regulation by Dlx3, we analyzed the p21 promoter for potential Dlx3 responsive elements.
We found a putative Dlx3 consensus element at -2416 of the transcription start site, and pro-
ceeded to determine the role of this site by generating p21 promoter/luciferase vectors con-
taining the -2863/+1 region with wt, deleted and mutated Dlx3 element to be tested in trans-
fection assays in keratinocytes. Luciferase assay results show that in presence of Dlx3, there
is activation of the p21 promoter containing the wt Dlx3 consensus site. EMSA analysis with
this p21-putative Dlx3 regulatory element confirmed the direct binding in vitro. To verify this
direct binding in vivo, we are currently performing Chromatin Immunoprecipitation (ChIP).
In related studies, we are analyzing protein-protein interactions between Dlx3 and cell cycle
proteins. Whole cell lysate of cells transduced with Dlx3-Flag were utilized in immunopre-
cipitation with anti-Flag affinity beads. After resolving the proteins and consequent mass spec-
trometry analysis, preliminary results indicate that Cdk4 is a binding partner of Dlx3.
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Enrichment of cytosolic, membrane, nuclear, and cytoskeletal proteins of human keratinocytes
for proteomic analysis using liquid chromatography mass spectrometry
E Benlhabib,1 MK Hordinsky,1 MM Ericson,1 BA Witthuhn,3 KA Squillace,4 MR Pittelkow4
and GL Wilcox1,2 1 Dermatology, University of Minnesota, Minneapolis, MN, 2
Neuroscience, University of Minnesota, Minneapolis, MN, 3 Biochemistry, Molecular
Biology, and Biophysics, University of Minnesota, Minneapolis, MN and 4 Dermatology,
Mayo Clinic College of Medicine, Rochester, MN
This study illustrates simple and rapid sequential methods for characterizing proteins in four
major subcellular fractions (cell compartments) for global proteomic analysis of normal human
keratinocytes (NHK) using liquid chromatography mass spectrometry (LC/MS/MS) are pre-
sented in his study. In cell biology and proteomics, an essential objective is to identify and
characterize proteins within their representative cellular compartments. This study constructed
a comprehensive protein profile of cell compartments in NHK populations for protein analy-
sis utilizing a high-throughput strategy. These methods were applied to enrich four major cell
fractions cytosolic, membrane, nuclear, and cytoskeletal from cultured NHK that were (i) sol-
ubilized, (ii) tryptically digested, (iii) desalted, (iv) subfractionated using off-line strong cation-
exchange column liquid chromatography (SCXLC), and (v) subjected to Linear Ion Trap (LTQ)
MSn. An array of 2305 proteins was identified in cytosolic (1084), membrane (576), nuclear
(493), and cytoskeletal (188) compartments. The efficacy of the technique was based on the
protein identifications that were accepted if they could be verified at greater than 80.0% prob-
ability and contained at least 2 identified peptides. Based on these criteria, 647 proteins were
identified belonging to all cell fractions with 341, 182, 104, and 20 proteins belonging to
cytosolic, membrane, nuclear, or cytoskeletal fractions, respectively. Based on its simplicity,
efficacy, and absence of MS contaminants, this technique has great utility for the global pro-
tein analysis of NHK subjected to various physico-chemical challenges, as well as to other
cultured cell types.
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Cholesterol regulates ceramide formation in human epidermal keratinocytes via the nuclear
hormone receptor LXR
JF Kerbleski,2,1 S Douangpanya,1 KJ Mills,1 K Feingold,1,2 PM Elias,1,2 Y Uchida1,2 and
WM Holleran1,2 1 Dermatology Research Unit, SF VAMC, San Francisco, CA and 2
Dermatology, UCSF, San Francisco, CA
Since formation of the three key epidermal barrier lipids, ceramides (Cer), cholesterol (Chol)
and free fatty acids, is simultaneously elevated during epidermal differentiation and critical
for permeability barrier homeostasis, we are investigating mechanisms for the coordinate
regulation of their biosynthetic pathways. Here we explored whether changes in Chol for-
mation/levels influence Cer formation and the role of the nuclear hormone receptor LXR,
normally activated by the endogenous ligand 25OH-Chol, in this regulation. TO-901317 (TO),
a synthetic, non-sterol LXR agonist, in combination with 9-cis-retinoic acid (9cRA), increased
promoter-luciferase activity, mRNA, protein, and enzyme activity for serine palmitoyltrans-
ferase 2 (SPT2), a key Cer synthesis enzyme, in cultured human keratinocytes. And, as expected,
neither TO nor TO/9cRA affected HMG-CoA reductase mRNA, which is regulated primarily
via an alternate (SREBP-dependent) mechanism. Lovastatin (Lov), an inhibitor of HMG-CoA
reductase, significantly decreased both Chol and Cer syntheses at 24 h. Real-time quantita-
tive PCR revealed expected elevations in HMG-CoA mRNA levels following Lov, but SPT2
mRNA levels were simultaneously decreased at 7 h. This Lov-mediated inhibition in Cer syn-
thesis, as well as the divergent Lov effects on HMG-CoA and SPT2 mRNA, was overridden
by the addition of sterols or precursors (i.e., 25OH-Chol, low-density lipoprotein, or meval-
onate), consistent with Chol levels regulating Cer synthesis. TO and TO/9cRA both also over-
rode the Lov-mediated decrease in Cer synthesis and SPT2 mRNA levels, revealing a role of
LXR in this coordinate regulation. These results demonstrate LXR activation both up-regulates
Cer synthesis and overrides the diminished Cer production that occurs in response to low-
ered Chol levels, revealing a coordinate, ‘feed-forward’ regulatory mechanism for the pro-
duction of Chol and Cer in mammalian epidermis.
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The relation between age and ammonium levels of the skin surface – a comparative inves-
tigation between smokers and non-smokers
T Reuther, S Schröder and M Kerscher Division of Cosmetic Sciences, Department of
Chemistry, University of Hamburg, Hamburg, Germany
As it is known that ammonium of the skin surface may be due to conversion from ammonia, skin
surface ammonium might be a quantitative measure for exposure of skin with highly ammonia
containing cigarette smoke. In order to gain baseline data necessary for interpretation of ammo-
nium values in smokers the aim of the present study was to analyze skin surface ammonium val-
ues of different sites with respect to age both in non-smokers and smokers. Overall 40 women
(20 non-smokers: 10 aged 18-30, 10 aged 31-58; 20 smokers: 10 aged 18-30, 10 aged 31-54)
were included. Sites of assessment were forearm, forehead and palms. Ammonium was deter-
mined using an assay based on the Berthelot reaction (Spectroquant, Ammonium-Test®, Merk).
For statistical analysis a comparison of the average ammonium values of the volunteers aged <30
with the volunteers aged>30 as well as a correlation of age and ammonium was performed for
all volunteers together and for non-smokers and smokers separately. On the forearm and on the
forehead no significant differences between the ammonium values of the volunteers aged <30
and >30 could be found. Correlation analysis revealed significant results when analyzing all vol-
unteers together (r=0,356, p=0,024; r=0,329, p=0,038) and when analyzing the non-smokers
(r=0,472, p=0,036; r=0,494, p=0,027). On the palms there was a significant difference between
the volunteers aged <30 and >30 (p=0,049) when analyzing the smokers. No significant corre-
lation between ammonium and age was found. For the age range investigated the results obtained
indicate a site-dependent relation between skin surface ammonium levels and age both in non-
smokers and smokers. They also indicate that smoking changes the relation between age and
ammonium and that this influence might be of use for quantification of cigarette smoke exposure
to the skin. Further investigations are required to gain more information about the way smoking
changes the relation between age and ammonium levels of the skin surface.
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Confocal Raman microscopy imaging of the prodrug-to-drug transformation of a 5¬Fluo-
rouracil derivative in skin
DJ Moore,1 R Mendelsohn,2 G Zhang,2 KB Sloan3 and CR Flach2 1 R&D, ISP, Wayne, NJ, 2
Chemistry, Rutgers University, Newark, NJ and 3 Medicinal Chemistry, University of Florida,
Gainesville, FL
The widespread adoption of transdermal drug delivery has been limited by the barrier prop-
erties of the outermost layer of the epidermis, the stratum corneum (SC). A variety of approaches
have been developed to overcome the barrier, including the use of a prodrug form of an active
therapeutic agent to enhance transdermal delivery. Once in the epidermis, the pro-molecule
is converted to the active drug by endogenous enzymes or simple chemical hydrolysis. The
prodrug selected for the current studies, 1-ethyloxycarbonyl-5-fluorouracil, is known to enhance
transdermal delivery of 5-fluorouracil, an important systemic antitumor drug. Using confocal
Raman microscopy on pigskin biopsies treated with prodrug, we are able to image the spa-
tial distribution of both prodrug and drug in the SC and viable epidermis, thereby providing
information about permeation and metabolism. This approach may readily be extended to a
variety of dermatological processes.
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Rapid adhesion to collagen IV enriches for clonogenicity in vitro but not long-term repop-
ulating ability in vivo
L Strachan,1 J Lawrence2 and R Ghadially1 1 Dermatology, UCSF & SFVAMC, San Francisco,
CA and 2 Hematology and Oncology, UCSF & SFVAMC, San Francisco, CA
The relationship between the in vitro and in vivo behavior of putative epidermal stem cells
remains unclear. Although both human and mouse keratinocytes that rapidly adhere to the
basement membrane protein collagen IV produce large colonies in vitro, it is unknown whether
all of these cells are true long-term repopulating stem cells in vivo. Since it has been proposed
that adhesion receptor expression may help epidermal stem cells maintain a stationary posi-
tion in their niche, we examined whether selecting for the most collagen-adhering neonatal
murine keratinocytes would isolate and enrich for a small number of cells with very potent in
vivo repopulating ability. Surprisingly, we found that while rapid adhesion to collagen IV within
5 minutes did indeed select for cells with increased colony forming ability in vitro, these cells
did not have increased long-term (over 9 weeks) repopulating ability in vivo. Both adhesive
and non-adhesive keratinocytes expressed integrin alpha2, a collagen receptor prominently
expressed in basal keratinocytes, indicating that α2 may not be a promising candidate marker
for epidermal stem cells. We also analyzed the expression of integrin alpha1 and alpha6, and
the transferrin receptor, CD71. We conclude that collagen-adhering murine keratinocytes are
enriched in colony forming cells but not in long-term repopulating stem cells. Thus, for future
studies of epidermal stem cell markers a first step of collagen IV adhesion may not be a use-
ful separation step. In addition, these data support the premise that short-term clonogenic
assays in vitro are not an accurate surrogate for long-term in vivo assays to identify epidermal
stem cells.
494
Early provisional matrix produced in the human 3D in vitro skin model AccuWound
B Schnegelsberg, K Chui and W Hoeffler Xgene Corporation, Sausalito, CA
AccuWoundTM is based on our AccuskinTM 96-well product, both are composed of a mixed
cell slurry of normal primary human fibroblasts and keratinocytes spontaneously cell sorted
in transwell inserts in a patented process to produce distinct epidermal and dermal layers. The
technical accuracy of our AccuSkinTM platform becomes more compelling because we are
able to recapitulate normal dynamic physiological responses, such as wound healing, by mod-
ification of the base model, a feat unmatched by static composite models. AccuWoundTM is
uniform in response over all areas of the well because the disrupted cells are added en masse,
whereas in situ wounds vary in character from normal uninjured boarder areas to areas of
greatest reorganization at the tongue of migrating keratinocytes. In a process driven by the
addition of TNF-α and other inflammatory cytokines, keratinocytes migrate to the bottom of
the chamber forming a layer of K16 positive keratinocytes attached to the filter to seal off the
wound. Surprisingly, K16 negative keratinocytes above these create a spongy matrix structure
that we interpret as initial provisional matrix, where a decline in keratinocyte viability noted
by DAPI suggests an alternative terminal differentiation, indicating that keratinocytes in a
wound become a unique cell type we call a “wundecyte” that is sacrificed to create a scaf-
fold. Thus, even in the absence of platelets, fibrin, and fibrinogen, which were thought to pro-
vide the necessary signals to form the provisional matrix associated with the formation of the
clot, keratinocytes are capable of forming the beginning of the matrix. A distinctly separate
cell sorted layer of fibroblasts forms above the matrix but as expected without a BMZ, indi-
cating events prior to their attraction into the matrix by blood cells to form full granulation tis-
sue. Re-epithelialization is noted at the top of some cultures, where even a single cell layer
of keratinocytes triggers BMZ protein production of Collagen IV, VII, and laminin-5. Larger
samples of AccuWoundTM (or its derivative AccuGraftTM ) may be ideal for grafting due to
potentially improved vascularization.
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The epithelial sodium channel is involved in the galvanotaxis of mouse and human ker-
atinocytes
H Yang,1 R Charles,2 E Hummler2 and RR Isseroff1 1 Derm, Univ California, Davis, Davis, CA
and 2 Pharm Tox, Univ Lausanne, Lausanne, Switzerland
Endogenous electric fields in the embryo and in wounds can direct migratory responses in motile
cells (galvanotaxis) and modulate embryonic differentiation and adult tissue repair. We have stud-
ied the process of galvanotaxis in human, skin-derived keratinocytes which are responsible for
wound re-epithelialization. These cells respond to electric fields equivalent to those found in
human skin wounds (50-100 mV/mm) with persistent directional migration toward the cathode.
Here we evaluate the role of the mammalian epithelial sodium channel (ENaC) in this process.
ENaC is expressed in human and mouse epidermis, where it is believed to mediate some aspects
of epidermal differentiation. To analyze whether ENaC is involved in galvanotaxis, keratinocytes
from wild type and knockout (αENaC+/+ and -/-) mice were isolated. The speed and the direc-
tional route of keratinocytes in an 100mV/mm electric field was recorded by time-lapse imag-
ing. Whereas keratinocytes from αENaC-/- mice migrated at same rate as cells from wild type
mice, the directional migration of the keratinocytes was lost and cells migrated randomly instead
of moving toward the cathode (as did the +/+ cells) in the electric field (p<0.005). A similar
decrease in the directionality to the field was observed when normal human keratinocytes were
treated with 10µM phenamil, a specific ENaC inhibitor. Migration speed was equivalent in treated
and control cells, but the directional migration of the cells to the cathode decreased by 30%
(p<0.005). Since directional keratinocyte migration is required for wound re-epithelialization,
we examined the effect of ENaC inhibition by phenamil on re-epithelialization using an ex vivo
wound healing assay with adult human skin. Application of 10µM phenamil decreased the re-
epithelialization by 85%, while control wounds, incubated in 10%FCS-containing medium,
healed completely. These results demonstrate that ENaC has a potentially important function to
mediate the directional migration and wound healing in keratinocytes.
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Superior barrier function of pigmented skin can be attributed to the stratum corneum acid-
ification in a melanosome dependent fashion
BA Shoo,1,2 E Kim,1,2 PM Elias1,2 and T Mauro1,2 1 Dermatology, UCSF, San Francisco, CA and
2 VAMC, San Francisco, CA
Individuals with type V/VI pigmentation, (Fitzpatrick I - VI classification), display superior per-
meability barrier function to those with type II/III pigmentation. We examined two mecha-
nisms that could account for this difference: 1) altered acidification of the stratum corneum
(SC) extracellular spaces, or 2) changes in the epidermal Ca2+ gradient. The Ca2+ gradient in
pigmented vs. nonpigmented areas of C57BL6/J-Mitf mi-vit/J mice, dorsal skin of C57BL/6J-
Tyrc-2J/J albino vs. C57BL/6J mice, and skin types V/VI vs. II/III showed no differences, exclud-
ing [Ca2+] as the basis for superior function in pigmented skin. Since barrier recovery is a
pH-dependent function, variations in the bulk pH of the SC, or pH within SC microdomains,
could account for the functional differences between pigment extremes. Decreased surface
pH and pH gradient have been noted previously in skin types V/VI vs. II/III. We hypothesized
that these differences could be secondary to either variations in melanosome size, shape and
distribution, which occur among skin types, or to melanocyte biology and its effects on neigh-
boring keratinocytes. Here, we studied melanin’s role in barrier recovery using C57BL6/J-Mitf
mi-vit/J mice which have mutations in microphthalmia associated transcription factor (Mitf)
and lose their coat color in patches secondary to melanocyte apoptosis. We abrogated the epi-
dermal permeability barrier in pigmented vs. nonpigmented areas of these mice by tape-strip-
ping, and then compared barrier recovery over time. Barrier recovery was significantly faster
at 6 and 24 hr in pigmented vs. nonpigmented areas. Using FLIM, increased acidity levels
were found in the perifollicular and interfollicular SC of pigmented vs. nonpigmented skin,
and pH increased with distance from pigmented hair follicles. These results show that pig-
mented skin has superior barrier function to nonpigmented skin in our mouse model, corre-
lating with pH variations within the SC, suggesting that these acidification differences could
be secondary to melanosome distribution.
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Kinetics of barrier reformation in stratum corneum following thermal perturbation: IR stud-
ies of lipid structural reorganization
DJ Moore,1 R Mendelsohn2 and RD Pensack2 1 R&D, ISP, Wayne, NJ and 2 Chemistry, Rutgers
University, Newark, NJ
Stratum corneum, the outermost layer of the epidermis, constitutes the primary barrier to per-
meability in skin. As such, it has been the target of many approaches for dermal and trans-
dermal drug delivery based on methods involving transient modifications of the barrier, par-
ticularly focusing on the extracellular lamellar lipids of the SC. An infrared (IR) spectroscopic
method has been developed to monitor the kinetics of barrier restoration following an exter-
nal perturbation. In the current case, temperature perturbation was selected as a convenient
means to induce structural changes in the barrier. The method is based on the observation
that the ordered lipid phases of the barrier in isolated human stratum corneum exist in part in
orthorhombically packed subcells. Such phases display a characteristic splitting of the CH2
rocking vibrations with component frequencies at 720 and 729 cm-1. The latter is reliably
diagnostic for orthorhombic phases and is markedly reduced in intensity following a thermal
perturbation to 55 °C. The kinetics of barrier recovery following quenching to either 25 °C or
30 °C were monitored by tracking the restoration of the 729 cm-1 band intensity. In the ini-
tial stages of structural reorganization, the kinetic processes were dominated by exponential
growth, followed by linear increases at longer times. The half lives for exponential growth
regimes were 52.4 hours for the 25 °C quench and 13.8 hours for the 30 °C quench. These
values are in reasonable accord with those determined with more phenomenological
approaches, typically based on restoration of some barrier function. This novel method for
monitoring structural reorganization kinetics in intact stratum corneum can readily be extended
to evaluate barrier recovery following a variety of treatments used to enhance drug delivery.
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Confocal Raman studies of the skin permeation of an anti-inflammatory tocopheryl phos-
phate lipophilic complex
DJ Moore,1 X Bi,1 L Wang,2 M Gorcea1 and CR Flach2 1 R&D, ISP, Wayne, NJ and 2
Chemistry, Rutgers University, Newark, NJ
Tocopheryl phosphate (TP) is a naturally occurring form of tocopherol that exhibits anti-inflam-
matory properties and anti-oxidant properties, but no free radical scavenging capability. In
vitro studies from this laboratory have demonstrated that the biological mechanisms of toco-
pheryl phosphate include inhibition of prostaglandin E2 (PGE2) release from keratinocytes. In
addition, several clinical studies of stressed skin have demonstrated that tocopheryl phosphate,
when topically applied as a lipophilic complex, can significantly mediate skin inflammation.
The current study utilized confocal Raman spectroscopy to measure the skin permeation of a
lipophilic complex of tocopheryl phosphate into full thickness skin. The penetration of toco-
pheryl phosphate was observed into the deep stratum corneum (15 microns) within hours of
a single application. In addition, no chemical breakdown of tocopheryl phosphate into toco-
pherol was observed in the skin which is consistent with tocopheryl phosphate being chem-
ically stable and biologically active in the phosphorylated molecule. The current study demon-
strates that confocal Raman microscopy can non-destructively measure the skin permeation
of a lipophilic tocopheryl phosphate molecule and simultaneously monitor the physico-chem-
ical properties of such molecules in the skin.
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Vibrational microscopy and imaging of skin: from single cells to intact tissue
DJ Moore,1 CR Flach,2 R Mendelsohn2 and G Zhang2 1 R&D, ISP, Wayne, NJ and 2 Chemistry,
Rutgers University, Newark, NJ
Vibrational microscopy and imaging offer several advantages for a variety of dermatological
applications, ranging from studies of isolated single stratum corneum cells (corneocytes) to
characterization of endogenous components in intact tissue. Two applications are described
to illustrate the power of these techniques for skin research. First, the feasibility of tracking
structural alterations in the components of individual corneocytes is demonstrated. Two sol-
vents, DMSO and chloroform/methanol, often used in skin research protocols, are shown to
induce large reversible alterations (alpha-helix to beta-sheet) in the secondary structure of ker-
atin in isolated corneocytes. Second, factor analysis of image planes acquired with confocal
Raman microscopy to a depth of 70 µm in intact pigskin, demonstrates the delineation of spe-
cific skin regions. Two particular components that are difficult to identify by other means
were observed in the epidermis. One small region was formed from a conformationally ordered
lipid phase containing cholesterol. In addition, the presence of nucleated cells in the tissue
(most likely keratinocytes) was revealed by the spectral signatures of the phosphodiester and
cytosine moieties of cellular DNA.
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Catecholamine modulation of oral keratinocyte migration: implications for aphthous stom-
atitis
RE Huntley,1 P Steenhuis,1 BA Dale,2 N Fazel1 and RR Isseroff1 1 Dermatology, University of
California,Davis, Davis, CA and 2 Oral Biology, University of Washington, Seattle, WA
The catecholamines epinephrine (Epi) and norepinephrine are present in saliva (nM range) and
acute stress can increase these levels at least 4 fold. Since stress has been associated with the
exacerbation of the non-healing oral ulcers of aphthous stomatitis, we examined the hypoth-
esis that stress-induced increases in salivary catecholamines could impair oral keratinocyte
migration required for oral wound healing. Human oral keratinocytes were isolated from
healthy gingiva attached to extracted third molars and cultivated in serum-free keratinocyte
growth medium at 0.03mM calcium. Cultured oral keratinocytes were imaged and their migra-
tory speeds measured by tracking their locomotory paths. Incubation with the beta1/2 adren-
ergic receptor (AR) agonist Epi, at levels equivalent to those found in normal saliva (0.3 nM),
resulted in no significant change in migratory speed, while incubation with Epi at higher con-
centrations (3.0 nM- 1µM) resulted in a 31-38% decrease in migratory speed (1.63micron
µm/min ±0.03 (control) vs 0.88- 1.13 µm/min±0.04 (treated). Incubation with the beta1/2 AR
agonist, isoproterenol (1 µM) also resulted in a 39% decrease in migratory speed. The beta1/2
AR blocker, timolol (20 µM), was able to reverse the Iso isoproterenol-induced decrease in
migration, indicating that the observed response is a beta adrenergic-mediated effect. Finally,
pre-incubation of the cells with timolol (20 µM) prior to exposure to Epi (1 µM), completely
reversed the Epi-induced decrease in migration, and, in fact, resulted in migratory rates that
exceeded those of the untreated control. These findings suggest that elevated salivary cate-
cholamines may contribute to non-healing oral ulcers in aphthous stomatitis, and that beta1/2
AR blockade may provide a novel therapeutic approach to the treatment of these ulcers in this
disease.
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Ultrastructural basis of low-frequency sonophoresis for stratum corneum permeability assessed
using tracers
K Choi,1 B Ahn,2 E Choi,3 S Ahn3 and S Lee2 1 Electron microscopy Laboratory, Eulji
University, Seongnam, South Korea, 2 Dermatology, Yonsei University College of Medicine,
Seoul, South Korea and 3 Dermatology, Yonsei University Wonju College of Medicine, Wonju,
South Korea
With transdermal drug delivery becoming more attractive, investigators have tried to overcome
the permeability barrier. The permeability barrier, however, is a major limitation in applying
transdermal drug delivery. To overcome the low permeability limitation, innovative technolo-
gies have been developed to increase transdermal drug delivery. Sonophoresis is a non-inva-
sive method, using ultrasound to increase percutaneous drug absorption. The propagation of
ultrasonic waves within the skin has two main physical consequences: heating and cavita-
tion. The overall consequence is increased skin permeability. This could be due to increased
intercellular lipid fluidity from heating, mechanical stress and/or by enlarging intercellular
space. Cavitation could create permanent or transient holes through corneocytes and ker-
atinocytes. Finally, convection could drive the drug and vehicle through the permeabilized
skin. In this study, we performed an ultrastructural morphological study of the effect of low
frequency sonophoresis by assessing penetration of tracers. We observed the features of tracer
penetration at superficial SC(sSC) portion and deep SC and viable epidermis (dSC) portion sep-
arately. And we also observed it with and without barrier disruption. At the sSC, without bar-
rier disruption, direct penetration of tracers into the corneocytes was seen. Several micro-pores
on the surface of corneocytes were also observed. When the barrier was disrupted, the trac-
ers penetrated into dSC portion mostly via intercellular space. In this study, we suggest that
the direct penetration of tracers into the corneocytes and diffusion of tracers via intercellular
space are main two effects of low frequency sonophoresis. And cavitation effect and acoustic
streaming effect may be responsible for these two effects respectively.
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Embryonic stem cells improved early provisional matrix formation in the human 3D in vitro
skin model AccuWound™
K Chui,1 B Schnegelsberg,1 M West2 and W Hoeffler1 1 Xgene Corporation, Sausalito, CA and
2 Advanced Cell Technology, Alameda, CA
There is clinical interest in embryonic stem cells (ESCs) for a variety of applications, with
their potential to assist in wound healing being one of the most often cited. While clonal purifi-
cation of fetal and adult fibroblasts exhausts their replicative potential, ESC-derived clones
are more robust and their clonal origin and capacity to be scaled in vitro offers unique poten-
tial for therapeutic applications. AccuWound™ is based on our Accuskin™ 96-well product,
both are composed of a mixed cell slurry of normal primary human fibroblasts and keratinocytes
spontaneously cell sorted in transwell inserts in a patented process to produce distinct epi-
dermal and dermal layers. We used ESC-derived embryonic progenitor clones chosen from
over 230 ESC-derived embryonic progenitor clones chosen on the basis of microarray gene
expression data for dermal markers, including Col1, 3, and 7, DPT, and Dermo-1. Two ESC
derived cell lines B2 and B30 were successfully incorporated into our AccuWound™ model,
where the ESCs were able to migrate within the newly forming human skin layers. We used
two fluorescent cell markers, CFDA-SE and Quantum dot 655 to distinguish the ESCs from
the primary keratinocytes. When 50% of B30 when mixed in with an equal ratio of primary
keratinocytes, almost complete cell sorting was observed by H&E staining, comparable to
what we typically observe with primary dermal fibroblasts but formed tighter layers under
comparable conditions. AccuWound™ made with both stem cell lines had a 2-fold higher
expression of fibronectin protein as measured in multiplex bead assays using Skin Panel Mark-
ers. The formation of an early provisional matrix formed in AccuWound™ was enhanced mor-
phologically and by increased matrix protein levels consistent with enhanced wound heal-
ing potential even surpassing the neonatal fibroblasts used in our control samples. The results
suggest that ESCs may be ideal for production of skin equivalents for grafting (AccuGraft™).
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The common filaggrin mutation R501X in a Japanese family with ichthyosis vulgaris
T Hamada, S Sakaguchi, B Ohyama, S Yasumoto and T Hashimoto Department of
Dermatology, Kurume University School of Medicine, Kurume, Japan
The common inherited skin disorder ichthyosis vulgaris (IV; OMIM 146700) results from muta-
tions in the gene encoding filaggrin (FLG), the keratin filament aggregating protein. Recently,
the homozygous or compound heterozygous mutations R501X and 2282del4 in FLG have
been first identified in moderate or severe IV from Ireland, Scotland and the USA. These vari-
ants are carried by ~9% of population of European origin. Here, we report a Japanese family
with IV who were screened for the common mutations R501X and 2282del4 by direct
nucleotide sequencing and restriction endonuclease digestion. The family included three
affected individuals from two generations. The most severely affected patient was 7-year-old
male who later developed severe atopic dermatisis. The 4-year-old younger sister of this patient
also showed severe IV phenotype with mild atopic disease. The mother showed mild IV phe-
notype at a younger age. The mutation analysis revealed a heterozygous R501X in FLG in both
the severe and mild phenotypes. Our Japanese family with IV represents the first cases of
R501X mutation of non-European ethnic background. In addition, the R501X variant was not
found in 200 control chromosomes selected from matched subjects of Japanese origin. This
indicates that the R501X variant is far less common in Japanese subjects, suggesting that the
position 501 of filaggrin might represent one of the most frequent mutation ‘hot-spots’. Fur-
thermore, IV shows a semidominant inheritance pattern: a mild phenotype is heterozygous
and a severe phenotype is homozygous or compound heterozygous for FLG mutations. There-
fore, the severe phenotypes in this family might predict the existence of another mutation on
the other allele in addition to R501X. Further molecular study will be necessary to define the
pathogenetic profile more precisely in this family.
509
Differential expression of pyloric atresia in junctional epidermolysis bullosa with novel ITGB4
mutations
N Dang,1,8 S Klingberg,2 AI Rubin,1 M Edwards,3 S Borelli,4 J Relic,5 P Marr,6 K Tran,6,8
A Turner,7 N Smith9 and DF Murrell1,7,8 1 Dept of Dermatology, St. George Hospital, Sydney,
NSW, Australia, 2 Dept of Chemical Pathology, Royal Brisbane Hospital, Brisbane, QLD,
Australia, 3 Hunter Genetics & University of Newcastle, Newcastle, NSW, Australia, 4 Triemli
Hospital, Zurich, Switzerland, 5 John Hunter Hospital, Newcastle, NSW, Australia, 6 Dept of
Anatomical Pathology, St George Hospital, Sydney, NSW, Australia, 7 EB Clinic, Sydney
Children’s Hospital, Sydney, NSW, Australia, 8 University of New South Wales, Sydney, NSW,
Australia and 9 Dept of Pathology, Queen Elizabeth II Hospital, Perth, WA, Australia
Junctional epidermolysis bullosa with pyloric atresia (JEB-PA) is an autosomal recessive blistering dis-
ease including lethal and nonlethal variants due to mutations in ITGB4and ITGA6. It is unclear whether
pyloric atresia (PA) is caused directly by the mutations in these genes or other factors. Skin biopsies
from EB patients were processed for IF mapping.When staining for integrin β4 or α6 was absent or
reduced, ITGB4 was screened for mutations. A review of known mutations of ITGB4 and the pheno-
types of the patients with JEB-PA was undertaken. Three novel ITGB4 mutations were identified in
three families with JEB-PA: two splice-site and one insertion mutation. Two families with lethal phe-
notypes were due to combinations of PTC and missense mutations (658delC/R252C and
3903dupC/G273D, respectively). One family had a brother with JEB-PA and a sister with JEB without
PA. Both had mild skin involvement with blistering of the feet in the summertime. Both were homozy-
gous for ITGB4 264G-A/3111-1G-A. Two cases in our report had no gastrointestinal symptoms or
signs of PA. One was an infant born at 33 weeks gestation, with marked aplasia cutis of the neck, promi-
nent subcutaneous veins, and dysmorphic facies, who died after 1 day. The other was the sister described
above. Pyloric atresia is an inconstant feature of the subtype of EB caused by ITGB4 mutations. Most
likely, multiple factors influence the development of PA. Perhaps institutions which do not routinely
screen IFM for alpha 6 beta 4 integrin staining in the absence of PA are missing this form of EB.
508
Gene expression profiling in male genital lichen sclerosus (MGLSc)
EV Edmonds,1 S Buisson,2 G Barton,3 N Francis4 and CB Bunker1 1 Dermatology/Chelsea &
Westminster Campus, Imperial College School of Medicine, London, United Kingdom, 2
Immunology/Chelsea & Westminster Campus, Imperial College School of Medicine, London,
United Kingdom, 3 Centre for Bioinformatics/South Kensington Campus, Imperial College,
London, United Kingdom and 4 Histopathology/Charing Cross Campus, Imperial College
School of Medicine, London, United Kingdom
Lichen sclerosus (LSc) is a chronic inflammatory and atrophic disorder of the skin. Male gen-
ital (MG) LSc causes sexual and urinary dysfunction but penile squamous cell carcinoma (SCC)
is the most serious complication (4-9.5%). MGLSc appears to have a bi-modal distribution
affecting both children and adults but children do not develop penile SCC. MGLSc is there-
fore capable of manifesting the gamut of pathological processes-inflammatory, fibrotic and
neoplastic. DNA microarrays/mRNA transcriptosomes allow the expression patterns of several
thousands of genes to be observed simultaneously in one single experiment. Other studies
are delineating characteristic mRNA expression patterns in the fundamental pathological
processes as well as distinctive patterns in specific diseases. The expression pattern of LSc has
not previously been determined. We have used DNA microarrays to study differences in gene
expression in prepuces obtained at circumcision in adult males with MGLSc (n=4), paediatric
LSc (n=2) and healthy paediatric foreskin (n=4). Data was pre-processed using Robust Multi-
chip Average (RMA) processing. A t-test was used to determine differentially expressed genes.
This resulted in 854 differentially expressed genes-414 genes up-regulated in normal skin, 440
genes up-regulated in diseased skin (p=0.01). A gene ontology map was generated to deter-
mine if the differentially expressed gene list was over-represented for any particular gene ontol-
ogy. Results showed that genes in the immune response/cellular defence ontology groups were
over-represented, indicating that there is a relationship between MGLSc and immune
response/cellular defence.
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Role of Sp1 in transcription of human ATP2A2 gene in keratinocytes
A Takagi,1,2 C Nishiyama,2 H Kawada,1,2 K Maeda,2 T Tokura,2 Y Niwa,1,2 N Nakano,2
N Mayuzumi,1 M Nishiyama,3 K Okumura,2 S Ikeda1 and H Ogawa2 1 Dermatology,
Juntendo University School of Medicine, Tokyo, Japan, 2 Atopy Research Center, Juntendo
University School of Medicine, Tokyo, Japan and 3 Biotechnology Research Center, The
University of Tokyo, Tokyo, Japan
Purpose; ATP2A2 is a gene encoding Ca2+ pump, SERCA2 sarco/endoplasmic reticulum (ER) cal-
cium ATPase protein located in ER. Darier’s disease (DD) is caused by mutations of ATP2A2.
Analysis of ATP2A2 expression mechanism is important for treatment of DD, because it is believed
that DD is caused by a decreased expression of ATP2A2 gene by haploinsufficiency. Method; To
examine ATP2A2 promoter activity and identify a transcription factor binding to ATP2A2 protein,
we performed reporter assay, electrophoretic mobility assay (EMSA), and chromatin immunopre-
cipitation (ChIP) assay. To confirm the involvement of Sp1 to ATP2A2 promoter, we analyzed ker-
atinocyte, whose Sp1 level was down regulated by siRNA. Conclusion; We identified four critical
regions, -550/-529, -488/-472, -390/-362 and -42/-21, which are essential for cis-enhancing activ-
ity of the human ATP2A2 promoter in primary keratinocytes by reporter assay. The result of EMSA
suggested that a transcription factor Sp1 binds to -550/-524 and -488/-465 of human ATP2A2
gene. In vivo binding of Sp1 but not Sp3 to the human ATP2A2 promoter in keratinocytes was con-
firmed by ChIP assay. Knockdown of Sp1 by siRNA resulted in the marked decrease of ATP2A2
promoter activity and ATP2A2 mRNA level in keratinocytes, suggesting that Sp1 involves in tran-
scription of human ATP2A2 gene. In the present study, Sp1, whose involvement has been reported
in previous studies regarding gene expression in keratinocytes, was indicated to play an important
role in human ATP2A2 transcription in keratinocytes. Considering that SERCA2 activity plays an
important role in the regulation of Ca2+-dependent nuclear transport of Sp1, dysfunction of SERCA2
affects expression of differentiated keratinocyte-specific genes including ATP2A2 itself. Therefore,
we believe that normalization of Sp1 activity in DD keratinocytes is useful for treatment of DD.
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Retrospective diagnosis of lethal BP180-deficient non-Herlitz junctional epidermolysis bul-
losa suggested by IF antigen mapping of parental carriers bearing enamel defects
DF Murrell,1 AM Pasmooij,2 HH Pas,2 P Marr,3 S Klingberg,4 E Pfendner,5 J Uitto,5
S Sadowski,5 F Collins,6 R Widmer7 and MF Jonkman2 1 Dermatology, St George Hospital,
University of New South Wales, Sydney, NSW, Australia, 2 Dermatology, University Medical
Center, Groningen, Netherlands, 3 Anatomical Pathology, SEALS, St George Hospital, Sydney,
NSW, Australia, 4 Protein Lab, Royal Brisbane Hospital, Brisbane, QLD, Australia, 5
Dermatology, Jefferson Medical College, Philadelphia, PA, 6 Clinical Genetics, Children’s
Hospital at Westmead, Sydney, NSW, Australia and 7 School of Dentistry, University of
Sydney, Sydney, NSW, Australia
Two children of consanguineous Iraqi parents had widespread blistering from birth with no hoarse cry
and died at ages 9 months and 4 weeks. The parents and brother were phenotypically normal except
for enamel pitting/ridging. Prenatal diagnosis was sought. Skin biopsies from the parents were processed
for IFM and TEM. The LAMA3,LAMB3,LAMC2 and COL17A1 genes were screened for mutations. Ker-
atinocytes were cultured from skin biopsies for COL17A1 mRNA and BP180 protein characterization
studies. IFM identified reduced expression of BP 180 (1D1 & 1A8c) in the parents. Mutation analysis
identified the heterozygous presence of a novel COL17A1 mutation 823delA in both parents and the
brother. This mutation predicts a frameshift and premature termination codon downstream. Digenic muta-
tions in LAMA3,LAMB3and LAMC2were excluded. RT-PCR of cultured keratinocytes showed no aber-
rant mRNA transcripts of the mutated allele. Immunoblot revealed only the wild-type BP180 protein.
The fetus tested at 10w gestation by CVS was a carrier of the COL17A1 mutation and a normal baby was
born who at 24 months had no enamel defects. Traditionally IFM is normal in carriers of mutations that
cause JEB but in this case, staining with two antibodies against BP180 was reduced, which suggested
that COL17A1 was the candidate gene. This is the first time this technique has been used in heterozy-
gous carriers where the probands were already deceased and no tissue was available. This technique
could save resources by indicating if COL17A1 should be screened before other candidate genes.
www.jidonline.org   S85
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Novel and recurrent mutations in KRT5 and KRT14 in epidermolysis bullosa simplex in Aus-
tralasia
FW Yan,1 S Klingberg,2 L Lloyd,2 N Trisnowati,1 A Turner3 and DF Murrell1,3 1 Dermatology,
St George Hospital, University of New South Wales, Sydney, NSW, Australia, 2 Protein Lab,
Royal Brisbane Hospital, Brisbane, QLD, Australia and 3 Multidisciplinary EB Clinic, Sydney
Children’s Hospital, Sydney, NSW, Australia
The purpose of this study was to investigate the keratin 5 and keratin 14 gene mutations in EB
Simplex (EBS) and the relationship between genotype and phenotype in Australasian patients. EBS
was clinically diagnosed and confirmed by transmission electron microscopy and immunofluo-
rescence mapping examination of a biopsy from rubbed skin and then waiting for a blister to
develop or after walking to induce a fresh blister, in milder cases of EB. Genomic DNA was extracted
from peripheral blood leucocytes and mutation analysis of KRT5 and KRT14 was performed by
direct sequencing of PCR products, excluding the KRT14 pseudogenes by the use of long range
PCR initially, in patients from Australia and New Zealand. We have diagnosed 32 EBS families
and screened 17 of these for KRT5 and KRT14 mutations. 7 mutations were identified in KRT14
and 5 in KRT5. 10/12 were de novo mutations and 9/12 were in “hot spot” codons. In 5 cases,
no mutations were found. 7/12 mutations had not been previously published when identified,
including KRT14 M119T, M119V, M272T and KRT5 E168D, 429delRNKLA, D197E, G138E. A
consanguineous family of Turkish origin with recessive EBS, had negative staining for K14 on IFM
and the homozygous mutation KRT14 Y204X. We identified KRT14 A413T in affected and unaf-
fected individuals in 4 families of English, Greek and Chinese (2 families) descent. In 3 of these
families, the proband also carried a different KRT5 mutation. A polymorphism screen with 50 Aus-
tralian caucasian and 62 Greek controls was negative for KRT14 A413T. The majority of KRT5
and KRT14 mutations in our series occurred de novo. In one third of cases, no mutations were
found. At least half the mutations were novel when discovered, 4 of which are newly reported
here, which further expand the complex genotype-phenotype relationship in EB simplex.
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Study on the exceptional expression of transforming growth factor beta 1 receptor II DNA
poly A site and CA repeat sequence in keloid
S Fan,1 J Cai1 and G An2 1 ShanDong university, JiNan, China and 2 Qianfeshan hospital,
JiNan, China
To investigate DNA mutation of transforming growth factor beta1 receptor II(TGF-β1RII) of
keloid and normal skin fibroblasts in polyA site and CA repeat sequence, we preliminary study
the unusually proliferative cause of keloid from gene level. By PCR, Perpendicular Caraphoresis
and the Single Strand Confirmation Polymorphism (SSCP) methods, we analyze 20 keloid and
8 normal skin samples and compare the results of them. The TGF-β1RII DNA fragment of polyA
site is abnormally in 4 keloid samples and its molecule is smaller than that of normal skin sam-
ples and one A base is deleted compare to the GENBANK. Analogous changes are not found
in normal skin. There is one abnormal swim strip and the molecule is smaller than that of nor-
mal skin samples in the CA repeat sequence site of TGF-β1RII DNA in keloid samples. TGF-
β1RII CA repeat sequence of keloid and normal skin samples are both the same as GENBANK
after sequencing. PolyA site and CA repeat sequence exceptional expression of TGF-β1RII
DNA may have implication for the unusually proliferation in keloid fibroblasts.
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A mouse model of congenital trichorrhexis nodosa
J Chen,1 JP Sundberg,3 PJ Koch1,2 and DR Roop1,2 1 Molecular and Cellular Biology, Baylor
College of Medicine, Houston, TX, 2 Dermatology, Baylor College of Medicine, Houston, TX
and 3 The Jackson Laboratory, Bar Harbor, ME
We have previously generated a genetically engineered mouse line with a semi-dominant
mutation in the mouse keratin 6hf gene, Krt6hf. The mutation, a deletion of asparagine residue
158 in Krt6hf, caused congenital hair shaft breakage in the mutant mice, which resembles
inheritable trichorrhexis nodosa, one of the most common hereditary hair fragility syndromes
in humans. Histologic analyses revealed eosinophilic bulbous swellings at various stages of
hair formation, most notably in the precortical region of anagen hair follicles as well as along
the hair fibers. This defect resulted in transverse breakage of pelage hair fibers. This bulbous
hair phenotype could be recapitulated when the epidermal keratinocytes from the mutant mice
were grafted onto immune compromised nude (Foxn1nu) mice. Therefore, this mouse model
is an ideal in vivo tool to study the disease mechanisms underlying trichorrhexis nodosa, and
to test novel therapeutic strategies to treat trichorrhexis nodosa and other hair fragility syn-
dromes.
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IL-5 and IL-5 receptor alpha polymorphisms were associated with atopic dermatitis in Kore-
ans
H Cho,1 J Namkyun,1 J Lee,2 E Kim,1 S Kim,2 E Shin,2 E Cho2 and J Yang1 1 Dermatology,
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
and 2 DNA link, INc, Seoul, South Korea
Eosinophils are recruited into the affected tissue of asthma and atopic dermatitis (AD) patients.
IL-5 and IL-5R are highly expressed in the AD skin, yet the reported levels of IL-8 have been
controversial. To evaluate the associations of single nucleotide polymorphism (SNP) in the IL-
5, IL-8 and their receptor genes, we genotyped 17 SNPs from five genes for the 1,120 case-
control samples (646 AD patients and 474 normal controls). The rs2522411 SNP in the IL-5
gene was significantly associated with the extrinsic type (ADe) of AD and the serum IL-5 con-
centration was higher in ADe patients than that in the intrinsic (ADi) patients without any cor-
relation with rs2522411 SNP. In IL-5RA gene, the rs334809 SNP showed association with AD
and the rs6771148 SNP had an effect on the blood eosinophil counts and the serum ECP lev-
els in AD patients. However, we could not detect any relationship between SNPs in the IL-8
and its receptor genes and AD. Our data suggest that genetic variation of the IL-5 gene and
the serum IL-5 levels can be markers to differentiate ADe from ADi, and that IL5RA has a role
for controlling eosinophils in the peripheral blood.
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Association of the single nucleotide polymorphisms and the haplotype of the IL-18 gene with
atopic dermatitis in Koreans
E Kim,1 J Lee,2 J Namkung,1 J Park,1 S Kim,2 E Shin,2 E Cho2 and J Yang1 1 Dermatology,
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
and 2 DNA link, Inc, Seoul, South Korea
IL-18 is a proinflammatory cytokine that plays an important role for Th1 and Th2 cytokine in
the presence/absence of IL-12. It’s been recently shown that human IL-18 plays a role in atopic
dermatitis (AD) by enhancing IL-4 and IL-13 production and stimulating the synthesis of IgE.
To evaluate the associations of single nucleotide polymorphism (SNP) and the haplotype in
the IL-18 gene, we performed genotyping for three SNPs in the IL-18 gene (646 AD patients
and 474 normal controls), and measured serum IL-18, IL-4 and IL-13 concentrations by ELISA.
The rs795467 and rs 4937113 SNPs and haplotype T-T-C were significantly associated with
AD, and especially between the ADe and normal control groups (p= 0.0004, 0.013 and 0.0003).
The serum IL-18 concentration was higher in the AD group than the normal controls without
any correlation with rs795467 polymorphism. Although we did not find any correlations
between the serum IL-18 levels and the serum IL-4 and IL-13 levels, we found that the two
SNPs and the haplotype T-T-C were strongly associated with allergic type of AD, but not with
the non-allergic intrinsic type. However, more experiments will be needed to prove the in vivo
involvement of Th2 cytokine.
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Association analysis of sphingomyelinase 2 polymorphisms for the extrinsic type of atopic
dermatitis in Koreans
J Namkung,1 H Shin,2 E Kim,1 T Park3 and J Yang1 1 Dermatology, Samsung Medical Center,
Sungkyunkwan University School of Medicine, Seoul, South Korea, 2 Genetic epidemiology,
SNP genetics, Seoul, South Korea and 3 Staticstics, Seoul National University, Seoul, South
Korea
Atopic dermatitis (AD) is a chronic inflammatory skin disease that’s accompanied with itchy,
dry skin and a typical distribution of the dermatitis according to the patients’ ages. AD is sub-
divided into the extrinsic (ADe) and intrinsic (ADi) types according to the serum level of IgE
and the presence or absence of specific allergens. The neutral sphingomyelinase (SMPD2) gene
was hypothesized to be a candidate gene for AD. In an effort to discover the polymorphisms
implicated in AD, we investigated the genetic distribution of the SMPD2 variations in 284 ADe
patients, 251 ADi patients, 248 psoriasis patients and 188 normal controls. In the present study,
15 SNPs were identified in the SMPD2 gene by sequencing 24 unrelated Koreans; among
them, 8 SNPs were genotyped in 971 Koreans. We did not find any correlations between the
individual SNPs of the SMPD2 gene and AD; however, we found a significant association of
a haplotype (-89G>A, +8C>T, +276A>C, +716G>C, +1231C>T) GCCGC with the ADe group.
Our findings suggest that polymorphisms in the SMPD2 gene might be one of genetic factors
for the extrinsic type of AD.
S86 Journal of Investigative Dermatology (2007), Volume 127
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Proximal versus distal filaggrin mutations in ichthyosis vulgaris
R Gruber,1,2 A Terron-Kwiatkowski,3 A Sandilands,3 G Utermann,2 PO Fritsch,1 A Janecke,2
WH McLean3 and M Schmuth1 1 Dermatology, Innsbruck Medical University, Innsbruck,
Austria, 2 Medical Genetics, Innsbruck Medical University, Innsbruck, Austria and 3 Human
Genetics Unit, Division of Pathology and Neuroscience, University of Dundee, Dundee,
United Kingdom
Ichthyosis vulgaris (IV) is characterized by generalized fine scaling, palmar hyperlinearity with
or without keratosis pilaris and atopy. Recently, the molecular basis of IV was ascribed to
loss-of-function mutations in the gene encoding filaggrin (FLG), namely p.R501X and
c.2282del4 in the proximal first of the 10-12 FLG repeats of exon 3. We here confirm the pres-
ence of these two mutations in 15 out of 21 IV-patients and in 3 of these individuals report
compound heterozygosity for a new mutation located more distally in repeat 7, namely
p.R2447X, which results in loss of the stratum granulosum. Moreover, in an isolated case a
novel 2 bp deletion in FLG repeat 6, c.6867delAG, was found in addition to p.R501X. Sur-
prisingly, the epidermis of this compound heterozygous patient clearly shows a granular
layer and FLG expression on immunohistochemistry. Taken together, these novel FLG muta-
tions confirm that FLG is a major IV gene, but point to the existence of additional modifiers
of the disease.
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Major regulators of phosphate homeostasis modulate and respond to changes in expression
of GALNT3, a gene associated with Familial Tumoral Calcinosis
I Chefetz,1 R Bergman,1 J Uitto,2 G Richard3 and E Sprecher1 1 Rambam Medical Center,
Haifa, Israel, 2 T. Jefferson University, Philadelphia, PA and 3 GeneDx, Gaithersburg, MD
Hyperphosphatemic Familial Tumoral Calcinosis (HFTC) is a rare disorder featuring cutaneous
calcinosis caused by increased renal phosphate reabsorption. The disorder is due to muta-
tions in GALNT3, encoding ppGalNacT3, which mediates the glycosylation of FGF23, a potent
phosphaturic protein. To gain insight into the disease pathogenesis, we assessed the influ-
ence of molecules regulating phosphate (Pi) homeostasis on GALNT3 expression. While extra-
cellular calcium (Ca) concentrations were found to decrease GALNT3 transcription, Pi was
shown to induce GALNT3 expression. This effect could be blocked by phosphonoformic acid,
a known inhibitor of Pi transport. GALNT3 expression was strongly induced by vitamin D3
which increases circulating Pi levels but not by PTH which is mainly responsible for main-
taining normal Ca levels. These data showed that GALNT3, whose absence leads to hyper-
phosphatemia, responds to physiological stimuli that are known to raise Pi levels. Although
hyperphosphatemia in HFTC is generalized, calcinosis is mostly limited to the skin. Recently,
the dermally expressed keratinocyte growth factor (KGF), was shown to display potent phos-
phaturic activity. We found that KGF mRNA and protein expression is up-regulated in fibrob-
last cultures established from HFTC patients. Moreover, siRNA-mediated GALNT3 down-
regulation in Caco-2 cells led to significant up-regulation of KGF expression. Of interest,
elevated Pi concentrations also induced KGF expression. Thus these data suggest a model
whereby decreased GALNT3 expression (and/or resulting hyperphosphatemia) drives KGF
overexpression, possibly in an attempt to correct hyperphosphatemia. These observations may
be of relevance to the pathogenesis of HFTC since KGF is a known inducer of metallopro-
teinases (MMP), which have been implicated in extraosseous calcification. Accordingly, KGF
induction in HFTC fibroblasts was associated with a marked increase in MMP9 expression.
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Defective lamellar granule secretion in ARC syndrome caused by a mutation in VPS33B
D Hershkovitz,1 H Mandel,1 A Ishida-Yamamoto,2 I Chefetz,1 B Hino,3 A Luder,3
M Indelman,1 R Bergman1 and E Sprecher1 1 Rambam Medical Center, Haifa, Israel, 2
Asahikawa Medical College, Asahikawa, Japan and 3 Sieff Hospital, Safed, Israel
Arthrogryposis, renal dysfunction and cholestasis (ARC) syndrome is a rare and usually fatal
autosomal recessive disorder which has recently been shown to result from mutations in
VPS33B located on 15q26.1. Neurological signs and ichthyosis almost invariably accom-
pany the disease. In the present study, we assessed a consanguineous family with 2 identical
twins presenting at birth with normal skin, facial dysmorphism, multiple limb contractures,
renal Fanconi syndrome and cholestatic jaundice. Severe lamellar ichthyosis developed at the
age of 6 weeks. Both children died at age 11 months. Complete sequencing of the VPS33B
gene revealed a homozygous missense mutation (D234H) which segregated with the disease
in the affected family. In silico analysis suggested that the mutation may interfere with the
normal splicing of exon 9. Direct sequencing of RT-PCR products encompassing exons 8-12
revealed aberrant splicing resulting in exon 9 or, exons 9 and 10 skipping, predicted to lead
to early truncation of the VPS33B protein. VPS33B encodes a homolog of the class C yeast
vacuolar protein sorting molecule, Vps33 that regulates vesicle-to-target SNARE complex for-
mation. Through the study of CEDNIK syndrome, another neurocutaneous syndrome, we
recently showed that lamellar granule maturation and secretion is dependant upon normal
function of SNAP29, a major SNARE protein. Interestingly, examination of skin biopsies obtained
from one of the 2 ARC patients revealed many entombed lamellar granules in the cornified
cells although some granules were secreted normally. Lamellar granules themselves looked
ultrastructurally normal with typical laminated internal structures. Thus, the present observa-
tions suggest that VPS33B deficiency results in abnormal secretion of lamellar granules in the
epidermal granular layers, underscoring the importance of SNARE-mediated vesicle fusion
during normal epidermis differentiation.
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Normophosphatemic Familial Tumoral Calcinosis is caused by loss-of-function mutations in
SAMD9, encoding a TNF-alpha responsive protein
I Chefetz,1 D Ben Amitai,2 O Topaz,1 M Indelman,1 J Uitto,3 R Bergman,1 G Richard4 and
E Sprecher1 1 Rambam Medical Center, Haifa, Israel, 2 Schneider Children Hospital, Petach
Tikva, Israel, 3 T. Jefferson University, Philadelphia, PA and 4 GeneDx, Gaithersburg, MD
Normophosphatemic Familial Tumoral Calcinosis (NFTC; MIM610455) is an autosomal reces-
sive disorder exclusively found in Yemenite Jews and featuring skin and mucosal calcified
deposits associated with unremitting pain and life-threatening skin infections. NFTC bears
striking resemblance to acquired dystrophic calcinosis, associated with vascular disease, can-
cer, and autoimmune disorders. Although a missense mutation (K1495E) in SAMD9 was recently
shown to cause NFTC in 5 families (Am J Hum Genet 79:759), the function of this gene prod-
uct and the mechanisms underlying the effects of SAMD9 mutations remained elusive. In the
present study, we studied another NFTC kindred of Jewish Yemenite ancestry. All patients were
found to carry two heterozygous mutations in SAMD9: K1495E and a novel nonsense muta-
tion, R344X. K1495E and R344X were found in an heterozygous state in 1 and 3 healthy con-
trols of Jewish Yemenite extraction respectively, but not in 600 individuals of other origins;
healthy carriers shared a common hemihaplotype with the patients. These data are suggestive
of positive selection, considering the rarity of NFTC and the small size of the Jewish Yemenite
population. Examination of skin biopsies obtained from the patients suggested that SAMD9
may be involved in the response to tissue injury. TNF-alpha was found to significantly induce
the expression of wildtype SAMD9 in vitro. In contrast, R344X was found to cause a marked
reduction in SAMD9 gene expression as assessed by qRT-PCR. Although mutation K1495E
did not significantly affect SAMD9 mRNA expression, it resulted in a drastic down-regulation
of protein levels. Proteosome inhibition led to a reversal of the deleterious effect of K1495E,
indicating that this mutation induces protein degradation. Thus, the present results demon-
strate that NFTC results from loss-of-function mutations in a gene coding for a TNF-alpha-
responsive protein.
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KRT14 haploinsufficiency results in increased susceptibility of keratinocytes to TNF-alpha-
induced apoptosis and causes Naegeli-Franceschetti-Jadassohn Syndrome
J Lugassy,1 J McGrath,2 P Itin,3 A Ishida-Yamamoto,4 JJ DiGiovanna,5 HR Murphy,6 JJ Verbov,6
J Uitto,7 R Bergman,1 G Richard8 and E Sprecher1 1 Rambam Medical Center, Haifa, Israel, 2
King’s College, London, United Kingdom, 3 Basel University, Basel, Switzerland, 4 Asahikawa
College, Asahikawa, Japan, 5 Brown Medical School, Providence, RI, 6 Royal Liverpool
Children’s Hospital, Liverpool, United Kingdom, 7 T. Jefferson University, Philadelphia, PA
and 8 GeneDx Inc, Gaithersburg, MD
Naegeli-Franceschetti-Jadassohn syndrome (NFJS) is a rare autosomal dominant disorder char-
acterized by complete absence of dermatoglyphics, reticulate hyperpigmentation of the skin,
palmoplantar keratoderma, abnormal sweating, and other subtle developmental anomalies of
the teeth, hair, and skin. NFJS was previously shown to map to 17q11.2-q21. In 6 affected fam-
ilies, we identified a total of 4 different heterozygous nonsense or frameshift mutations (Q7X,
17delG, 26delC, C18X) affecting the nonhelical head (E1/V1) domain of KRT14. Using a mod-
ified quantitative fluorescent PCR-RFLP assay, we found that mutant cDNA levels were decreased
7- and 28-fold relative to mutant gDNA in patients carrying the C18X and the Q7X mutations
respectively, indicating that NFJS-causing mutations induce significant mRNA decay. Ultra-
structural examination of skin biopsies from patients showed increased apoptotic activity in
the epidermal basal cell layer. Since previous data suggested that keratin head domain may
confer resistance to TNF-alpha-induced apoptosis in epithelial cells, we exposed HaCat cells
to TNF-alpha in the presence of KRT14-specific siRNA or scrambled siRNA and measured apop-
tosis using TUNEL assay. When cells were treated to reduce K14 expression by 50% and sub-
sequently exposed to 3 ng/ml recombinant TNF-alpha, the number of TUNEL-positive cells
increased from 32% to 96%. Thus, our results indicate that NFJS results from haploinsuffi-
ciency for K14 and suggest that increased susceptibility of keratinocytes to pro-apoptotic sig-
nals may be involved in the pathogenesis of this ectodermal dysplasia syndrome.
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Incontinentia pigmenti with NEMO mutation presenting anticipation of onset age in a Chi-
nese family
G Zhang,1,2 H Shi,1,2 X Du2,1 and Q Zhou2,1 1 Department of Dermatology, The Wuxi First
Affiliated Hospital of Nanjing Medical University, Wuxi, China and 2 Department of
Dermatology, Wuxi No.1 People’s Hospital, Wuxi, China
The objective of this study is to detect the NEMO gene mutation in a Chinese family with famil-
ial incontinentia pigmenti. Familial incontinentia pigmenti (IP; MIM 308310) is a genodermatosis
that segregates as an X-linked dominant disorder and is usually lethal prenatally in males. The
reasons for cell death in females and in utero lethality in males are unknown. In affected females
it causes highly variable abnormalities of the skin, hair, nails, teeth, eyes and central nervous
system. The prominent skin signs occur in four classic cutaneous stages: perinatal inflammatory
vesicles, verrucous patches, a distinctive pattern of hyperpigmentation and dermal scarring. IP
is caused by mutations in a gene called NEMO(IKKγ)gene, which encodes a regulatory compo-
nent of the IΚB kinase complex. NEMO is required for the activation of the transcription factor
NF-ΚB and is therefore central to many immune, inflammatory and apoptotic pathways. Recently,
a second nonfunctional copy of the gene, ∆NEMO was identified, opposite in direction to NEMO.
To our knowledge, almost 90% of IP whose gene mutation type had been recognized have a
recurrent genomic deletion of exons 4-10 of the NEMO, called NEMO∆4–10. In the present
report, we describe a large consanguineous family with IP of China origin, which shows antic-
ipation of onset age. According to the gene characteristics of IP, NEMO∆4-10 deletion in NEMO
gene was tested with specific primers In2/JF3R, and NEMO∆4-10 deletion in pseudogene ∆NEMO
was checked out by primers Rev-2/JF3R. By PCR measurement, we identified this recurrent
genomic deletion in both NEMO gene and pseudogene ∆NEMO. Our study provided the first
family with IP from China, which shows anticipation of onset age, and NEMO∆4-10 deletion in
NEMO gene responsible for it. The results suggest the molecular basis of IP in this Chinese fam-
ily and provide further evidence that the mutation in NEMO underlie Chinese IP.
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Gene expression profiling of intrinsic skin aging
G Klosner,2 R Varecka,3 MS Matsui,4 N Muizzuddin,4 C Kokesch,2 M Binder2 and
F Trautinger1,2 1 Karl-Landsteiner-Institute for Dermatological Research, St. Pölten, Austria, 2
Department of Dermatology, Medical University of Vienna, Vienna, Austria, 3 Boehringer-
Ingelheim Austria GmbH, Vienna, Austria and 4 Estee Lauder Research, Melville, NY
Gene expression profiling was used to assess age-related alterations in sun-protected normal
human skin. Punch biopsies were taken from the upper inner arms of 43 healthy female vol-
unteers (phototypes II and III) and total RNA was extracted and pooled according to age
group (group I: age 19 – 28, n=23; group II: age 55 – 65, n=20). The expression of over 47,000
transcripts in each pool was analyzed by Affymetrix Human Genome U133 Plus 2.0 microar-
rays. We found statistically robust changes in 1,657 genes of which 1,371 were upregulated
and 286 showed downregulation. 301 of these transcripts were induced (n=148) or suppressed
(n=153) > 2-fold. According to Ingenuity Pathway Analysis (IPA, www.ingenuity.com) the genes
with induction > 2-fold belong to the following functional groups: “cellular growth and pro-
liferation” (n=39), “cellular movement” (n=13), “immune response” (n=16), “cellular assem-
bly and organization” (n=12), “cell to cell signaling and interaction” (n=20). Functional groups
of transcripts showing suppression > 2-fold are: “lipid metabolism” (n=22), “small molecule
biochemistry” (n=26), “molecular transport” (n=10), “behaviour” (n=1), “carbohydrate metab-
olism” (n=3), “cell death” (n=7). In addition, composite functional categories were analyzed
by ADGO (array.kobic.re.kr/adgo): A significant upregulation was found for genes annotated
with “integral to plasma membrane/receptor activity” (n=23). Downregulation was detected
for genes associated with “intermediate filaments” (n=37) and with the composite annotation
“intermediate filament/structural molecule activity” (n=14). According to these results intrin-
sic skin aging is associated with the increased expression of genes mainly associated with
regulatory cellular functions and concomitant suppression of genes mainly related to metab-
olism and structure.
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Retinoic acid synthesis enzymes and binding proteins are increased in human patients with
central centrifugal cicatricial alopecia
AS Valet,1 LE King,1 JP Sundberg,2,1 DE Ong1 and HB Everts1 1 Vanderbilt University School
of Medicine, Nashville, TN and 2 The Jackson Laboratory, Bar Harbor, ME
Central centrifugal cicatricial alopecia (CCCA) is a disorder of the sebaceous gland marked
by inflammation of the upper hair follicle, which results in irreversible hair loss and reduction
in the number of visible follicular ostia. Little is known about the etiology and pathogenesis
of this disease, and precise molecular markers have not been identified which might distin-
guish CCCA from other primary cicatricial alopecias. Retinoic acid (RA), the active form of
vitamin A, is used as a topical therapeutic agent for many dermatologic disorders, including
CCCA. We observed an altered system of retinoic acid biosynthesis in the asebia mutant mouse
(Scd1abJ, Scd1ab2J), a model for human CCCA. A complete description of the binding proteins
and enzymes of endogenous retinoic acid biosynthesis in the hair follicles, sebaceous glands,
and epidermis of human skin affected by cicatricial alopecia provides clues as to the etiology
and pathogenesis of this disfiguring disease, provides markers to distinguish CCCA from other
primary cicatricial alopecias, and predicts novel therapeutic targets. We performed immuno-
histochemistry with antibodies against cellular retinol binding protein (CRBP), cellular retinoic
acid binding protein type II (CRABP2), retinal dehydrogenases types I, II, and III (ALDH1A1,
ALDH1A2, ALDH1A3), and dehydrogenase/reductase member 9 (DHRS9) against human skin
samples of CCCA, lichen planopilaris (LPP), acne keloidalis nuchae (AKN), and folliculitis
decalvans (FD), as well as appropriate controls including forms of non-scarring alopecia. Over-
all, immunoreactivity of RA synthesis enzymes and binding proteins were stronger in CCCA
than LPP, AKN, FD, and controls with no alopecia. This result was more significant in the
outer root sheath of the isthmus with Dhrs9; and the epidermis with ALDH1A1, ALDH1A2,
and ALDH1A3. Since toxic RA leads to follicular dystrophy similar to early changes in CCCA,
local RA toxicity may be key to the pathogenesis of CCCA.
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Transcriptional regulation of peptidylarginine deiminase 1,2,3 genes driven by Sp1/Sp3 in
human keratinocytes
S Ying,1 S Dong,1 T Kojima,1 T Kanno,1 M Shiraiwa,1 A Kawada,2 M Méchin,3 S Chavanas,3
G Serre,3 M Simon3 and H Takahara3 1 Department of Applied Biological Resource Sciences,
Laboratory of Biochemistry and Molecular Biology,Ibaraki University, Ami, Japan, 2
Department of Dermatology, School of Medicine, Kinki University, Osaka, Japan and 3
INSERM, CNRS, CHU Toulouse-Purpan, Université Paul Sabatier, Toulouse, France
Peptidylarginine deiminase (PAD), which has five isoforms(PAD1-4,6), catalyzes the conver-
sion of protein-bound arginine residues to citrulline residues in a Ca2+-dependent manner.
Three of them are expressed in the epidermis. PAD1 is detected throughout the whole epi-
dermis; PAD2 is located in stratum spinosum and granulosum. PAD3 is restricted to the gran-
ular and the lower cornified layers. In order to investigate the mechanism of PADI1, PADI2
and PADI3 transcriptions in the human epidermis, we cloned the 5’-flanking regions and iden-
tified the transcriptional start sites of PADI1, PADI2 and PADI3 were at 84bp, 80bp and 41bp
from upstream of the translation initiation codon (ATG), respectively. Reporter gene experi-
ments suggest that about 195bp, 132bp and 129bp upstream from the transcription start site
of PADI1-3, respectively, are sufficient to normal transcription. Our data revealed the binding
of Sp1 and Sp3 is required for the control of the promoter activities of the three genes both in
vitro and in vivo. Interestingly, Sp1 small interfering RNA(siRNA) impaired the three genes
expression, but Sp3 siRNA did not interfere the expression in keratinocytes. Additionally, it
was also found MZF1 was involved in PADI1 transcription, while NF-Y was involved in PADI3
transcription, respectively. These results indicated the cooperation of Sp1/Sp3 drives the tran-
scription of PADI1, PADI2 and PADI3 and probably help to expatiate the basal and distin-
guishable regulation of the three genes in the human epidermis.
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Mutation analysis of keratin 9 in a Chinese family with diffuse epidermolytic palmoplantar
keratodermas
L Yang,1,2 M Li1,2 and X Zhu1,2 1 Dermatology, The Wuxi Second Affiliated Hospital of Nanjing
Medical University, Wuxi, China and 2 Dermatology, Wuxi No.2 People’s Hospital, Wuxi,
China
The objective of this study is to detect the keratin 9 gene mutation in a Chinese family with
diffuse epidermolytic palmoplantar keratodermas (EPPK). Epidermolytic plamoplantar kera-
toderma (EPPK, MIM 144200) is an autosomal dominantly inhereted disease first describe by
Vorner in 1901, which hyperkeratosis is confined to the palms and soles, often presenting with
a yellowish hue. There is usually a distinct erythematous margin at the border of the normal
appearing skin. EPPK usually appears 3 to 12 months after birth. It was first mapped to chro-
mosome 17q11-q23 by Reis and then many missense mutations were identified in a number
of EPPK families. To date, a total of 21 kinds of mutations have been found in EPPK patients.
Most of these mutations are missense mutations occurring in the highly conserved coil 1A
domain of the KRT9. A mutation in a different region of the gene has been reported in one
studied case only. Here we reported clinical and molecular findings of a Chinese multi-gen-
eration families. A heterozygous mutations of keratin 9 was identified, which is c.485 G>A
(R162Q). In our study, the GÇA transition results in a R162Q change in the 1A segment of
the highly conservedα–helical rod domain of keratin 9.The rod domain is thought to play an
essential role in the dimerization of type I and type II keratin chains and disaggregation of ker-
atinfilaments. A filament dissassembly study also showed that residue positions 7-16 of the
coil 1A segment are critical for the stability of keratinfilaments .11The residue at position 162
of keratin 9 is the eleventh residue of the coil 1A domain. Mutations in the boundary peptides
are highly disruptive to filament assembly, which cause tonofilament aggregation, and gener-
ally lead to more severe phenotypes. Here, we reported this missense mutation in the 1A seg-
ment of α–helical rod domain of KRT9 in a Chinese family with EPPK, this result demon-
strates the prevalence of this mutation in diverse population.
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Identification of two novel mutations in Chinese patients with dyschromatosis symmetrica
hereditaria
M Li,1,2 X Dai,1,2 L Yang1,2 and X Zhu1,2 1 Dermatology, The Wuxi Second Affiliated Hospital
of Nanjing Medical University, Wuxi, China and 2 Dermatology, Wuxi No.2 People’s Hospital,
Wuxi, China
The objective of this study is to detect the DSRAD gene mutations in two Chinese families with
dyschromatosis symmetrica hereditaria (DSH). DSH is a pigmentary genodermatosis of autoso-
mal dominant inheritance characterized by a mixture of hyperpigmented and hypopigmented
macules distributed on the dorsal aspects of the hands and feet. It is caused by the mutations of
RNA-specific Adenosine Deaminase(DSRAD) gene. DSRAD, also called ADAR1, spans 30 kb
and contains 15 exons. It encodes RNA-specific adenosine deaminase composed of 1226 amino
acid residues, with a calculated molecular mass of 139 kDa. The enzyme converts adenosine to
inosine in dsRNA, which destabilizes the dsRNA helix. Here we reported clinical and molecu-
lar findings of two Chinese multi-generation families. Two novel heterozygous mutations of
DSRAD were identified, which are c.3159delG (p.L1053fsX1076) and c.3125G>A (R1042H).
The missense mutation (R1042H) alters a conserved amino acid residue at 1042 in exon 12,
which is located in the putative deaminase domain, so the amino acid residue at 1042 is sus-
pected to play an important role in the conformation of the catalytic site of the enzyme, and the
mutation at this position could probably influence enzyme activity. The frameshift mutation
c.3159delG (p.L1053fsX1076) was found in patients but not in normal people. This mutation
leads to frameshift and premature translation termination within exon 12. The truncated pro-
teins with no functional activity would be synthesized from the gene with this mutation. We spec-
ulated that the conserved amino acid sequence containing in exon 12 is important to three-
dimensional structure and activity of the enzyme. Therefore, these mutations may alter
conformation of the protein by different amino acid and different electric charge, which results
in defective activity. Our data add new variants to the repertoire of DSRAD mutations in DSH.
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PU.1-mediated gene regulation mechanism between mast cells and monocytes (dendritic cells)
Y Niwa,1,2 C Nishiyama,2 N Nakano,2 A Kamei,3 H Kato,3 K Okumura,2 H Ogawa2 and
S Ikeda1 1 The Department of Dermatology, Juntendo University School of Medicine, Tokyo,
Japan, 2 Atopy Research Center, Juntendo University School of Medicine, Tokyo, Japan and
3 Graduate School of Agricultural and Life Science, The University of Tokyo, Tokyo, Japan
We have previously reported that overexpression of PU.1 in bone marrow-derived mast cells
(BMMC) causes functional and morphological changes toward monocytes. In brief, cell sur-
face expression of c-kit was reduced, expression of CD11b, CD11c, and MHC class II was
induced, IgE-mediated degranulation reaction was down-regulated, and response to lipopolysac-
charide via TLR-4 was up-regulated. In this study, we analyzed gene expression of PU.1 over-
expressing BMMC to further elucidate the mechanism of PU.1-mediated gene regulation. Total
RNAs were extracted from following three samples; PU.1-overexpressing BMMC (PU.1/BMMC),
which was prepared by using retrovirus expression system, control BMMC, and bone marrow-
derived dendritic cell (BMDC), and were reverse transcribed to cDNA. We analyzed gene expres-
sion of each cDNA by using microarray, and mast cell- and monocyte-specific gene expression
was quantitatively analyzed by real-time PCR. One-way ANOVA statistic analysis on the microar-
ray data showed that 2411 probe sets were significantly changed among three samples, and
these probes were clustered into 7 major groups by hierarchical clustering analysis. MHC class
II pathway was identified to be most significant pathway in one cluster consistent of the genes,
whose expression were low in control BMMC and high in PU.1/BMMC and in BMDC by KEGG
pathway analysis. Similarly, FcεRI pathway was found in another cluster (high in BMMC and
low in PU.1/BMMC and BMDC). In BMDC, the transcriptional level of IRF-4 and IRF-8 which
form hetero-dimeric complexes with PU.1 were markedly higher, whereas the transcriptional
level of GATA-1 and -2, which involve in mast cell-specific gene expression, were significantly
lower in compared with those of BMMC. In PU.1/BMMC, transcriptional level of IRF-4 was
up-regulated suggesting that IRF-4 transcription is under the control of PU.1.
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Novel and recurrent mutations of SCN9A in patients with primary erythermalgia
Y Yang,1 Z Lin,1 L Zhang1 and Z Xu2 1 Dermatology, Peking University First Hospital, Beijing,
China and 2 Dermatology, Beijing Children’s Hospital, Beijing, China
Primary erythermalgia is an autosomal dominant disorder characterized by recurrent burning
pain and redness in the extremities in response to mild thermal stimuli or exercise. We first
identified missense mutations in SCN9A gene in 2 Chinese cases with primary erythermal-
gia. Here we report 5 new cases, 3 of which have recurrent mutations: I848T and N395K; 2
of which have novel mutations: V872G and L823R. Neither of these mutations was found in
50 unaffected control subjects. By now, 15 cases of primary erythermalgia with SCN9A
mutation were reported, 9 of them are located in L858, I848 and N395. Subsequently, L858,
I848, and N395 may be mutation hot spots in Nav1.7α subunit in primary erythermalgia.
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Positional cloning of susceptibility genes for atopic dermatitis in the epidermal differentia-
tion complex
N Morar,1 P Edster,2 TL Street,2 S Weidinger,3 W Di,6 AL Dixon,2 M Taylor,2 R Holt,2
J Broxholme,2 N Kloop,7 N Novak,5 A Bockelbrinck,3 J Ragoussis,2 T Illig,7 JI Harper,6
WO Cookson1 and MF Moffatt1 1 Molecular Genetics, Imperial College London, London,
United Kingdom, 2 Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom, 3
Department of Dermatology and Allergy, Technical University, Munich, Germany, 4 National
Heart and Lung Institute, Imperial College London, London, United Kingdom, 5 Department
of Dermatology and Allergy, University of Bonn, Bonn, Germany, 6 Great Ormond Street
Hospital and Institute of Child Health, London, United Kingdom and 7 GSF-National
Research Centre for Environment and Health, Munich, Germany
Genome screens have linked Chromosome 1q21 to atopic dermatitis (AD). This region harbours the
epidermal differentiation complex (EDC)which comprises several genes expressed during terminal
differentiation of the epidermis. Recently mutations in an EDC gene, filaggrin (FLG), has been asso-
ciated with AD. We genotyped these mutations in two panels of families ECZ1 and MRCE (totalling
426), recruited through a proband with severe AD.Using familial tests of association we replicated
the FLG associations (P=0.0001). We reanalysed data for the previously reported highly linked marker
D1S498 on Chromosome 1q21. For AD, evidence of linkage to the markers was a total LOD score
of 3.57. This fell to 2.03 after accounting for the FLG mutations, indicating the presence of other genetic
variants influencing AD at this locus. We systematically resequenced genes and examined public
databases to identify SNPs within the EDC. Initially 100 markers were genotyped in the ECZ1 panel
using Sequenom. Associations (P =<0.01) were confirmed in the MRCE panel. Regions of confirmed
association were saturated with a further 30 SNP markers. We found two regions of highly replicated
genetic association with AD (P=7.9E-05 and P= 0.001) within the EDC. Both markers were not in
linkage disequilibrium with each other indicating independent genetic effects. The results indicate
that the genes of the EDC may have multiple effects on epidermal immunity and barrier formation.
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Fine mapping of psoriasis susceptibility locus PSORS2 on chromosome 17q
RP Nair,1 PE Stuart,1 ZS Qin,2 GR Abecasis,2 S Jenisch,3 M Weichenthal,3 HW Lim,4
E Christophers,3 JJ Voorhees1 and JT Elder1,5 1 Dermatology, University of Michigan, Ann
Arbor, MI, 2 Biostatistics, University of Michigan, Ann Arbor, MI, 3 Dermatology and
Immunology, University of Kiel, Kiel, Germany, 4 Dermatology, Henry Ford Hospital, Detroit,
MI and 5 Ann Arbor VA Hospital, Ann Arbor, MI
Several genetic linkage analyses have found evidence for a susceptibility locus for psoriasis
on distal chromosome 17q termed PSORS2. Although a fine mapping study of this locus
identified associated SNPs, these findings have not been consistently replicated. We there-
fore undertook a high-density association analysis of 11 Mb of the linked region using HapMap
tag-SNPs. Using the Illumina genotyping platform, we genotyped 1536 tag-SNPs in 470 pso-
riasis cases and 470 controls. After eliminating SNPs and samples that did not pass quality
control checks, 1167 SNPs (average 1 SNP/9.4 kb) were analyzed for psoriasis association in
the remaining 433 cases and 436 controls by the Cochran-Armitage test for linear trend of
association. Eleven markers yielded nominal association p-values less than 0.01. Of these
markers, only one remained significant after Bonferroni correction (corrected p-value = 0.026).
However, three SNPs within 50 kb of this marker had nominal association p values less than
0.01. Even though all markers were tag-SNPs, a haplotype analysis was performed under the
premise that there is enough residual linkage disequilibrium to yield valuable information.
Two-, 3 and 4-marker sliding window haplotype analysis showed significant association with
p values in the range 0.0001 to 0.001 centered around the same marker that gave the best
single marker association. Work to confirm this observed association is currently underway,
including testing of additional closely spaced markers, and replication in additional cohorts.
532
Genomewide scan for linkage reveals evidence of several susceptibility loci for Alopecia
Areata
L Petukhova,1 A Zlotogorski,3 A Martinez-Mir,1 D Gordon,4 J Mo,1 T Gilliam,5,2 D Londono,6
C Haynes,7 J Ott,7 M Hordinsky,8 K Nanova,3 D Norris,9 V Price,10 M Duvic11 and
AM Christiano1,2 1 Dermatology, Columbia University, New York, NY, 2 Genetics &
Development, Columbia University, New York, NY, 3 Dermatology, Hadassah-Hebrew University
Medical Center, Jerusalem, Israel, 4 Genetics, Rutgers University, Piscataway, NJ, 5 Human
Genetics, University of Chicago, Chicago, IL, 6 Epidemiology and Biostatistics, Case Western
Reserve University, Cleveland, OH, 7 Laboratory of Statistical Genetics, Rockefeller University,
New York, NY, 8 Dermatology, University of Minnesota, Minneapolis, MN, 9 Dermatology,
University of Colorado Health Science, Denver, CO, 10 Dermatology, University of California,
San Francisco, CA and 11 Dermatology, MD Anderson Cancer Center, Houston, TX
Alopecia areata (AA) is a genetically determined, immune-mediated disorder of the hair folli-
cle with a lifetime risk of approximately 2%, making it one of the most common autoimmune
diseases. It is defined by a spectrum of severity that ranges from patchy localized hair loss on
the scalp to the complete absence of hair everywhere on the body. In an effort to define the
genetic basis of AA, we performed a genomewide search for linkage in 20 families with AA.
Our analysis revealed evidence of at least four susceptibility loci on chromosomes 6, 10, 16
and 18, by use of several different statistical approaches. Fine-mapping analysis with addi-
tional families yielded a maximum multipoint LOD score of 3.93 on chromosome 18, a two-
point affected sib pair (ASP) LOD score of 3.11 on chromosome 16, several ASP LOD scores
>2.00 on chromosome 6q, and an HRR LOD of 2.00 on chromosome 6p in the region of the
MHC locus. Our findings confirm previous studies of association of the MHC locus with human
AA, as well as the C3H-HeJ mouse model for AA. The major loci on chromosomes 16 and 18
coincide with loci for psoriasis reported elsewhere and the locus on chromosome 18 corre-
sponds to a region that shows linkage to hereditary hypotrichosis simplex. Our results suggest
that these regions may harbor gene(s) involved in a number of different skin and hair disorders.
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Novel N-terminal mutation in LAMA3A isoform causing late onset Herlitz junctional epi-
dermolysis bullosa with features of laryngo-onycho-cutaneous syndrome
KJ Hamill,2 J Uitto,3 E Figueira,1,5 A Crotty,4 K Moran,5 L Lloyd,6 S Klingberg,6 I McLean2 and
DF Murrell1,5 1 Dermatology, St George Hospital, University of New South Wales, Sydney,
NSW, Australia, 2 Human Genetics Unit, Dundee University, Dundee, United Kingdom, 3
Dermatology & Cutaneous Biology, Jefferson University, Philadelphia, PA, 4 Pathology, John
Hunter Hospital, Newcastle, NSW, Australia, 5 Medicine, University of NSW, Sydney, NSW,
Australia and 6 Chemical Pathology, Royal Brisbane Hospital, Brisbane, QLD, Australia
A Caucasian boy was diagnosed with JEB at 9 months of age following investigation of loss of fin-
gernails, erosions with thickened tissue in the mouth and hoarseness. At 15 months, blisters on
the eyelid margins developed into red papules whose pathology showed non-specific granula-
tion tissue. He subsequently developed notched teeth and underwent a tracheostomy, gastros-
tomy and urostomy. IF mapping and EM of the unaffected skin was taken after rubbing to induce
a blister. IFM showed a lamina lucida split with normal staining with the antibodies to the Lam
332 (laminin 5) chains and integrins. Genetic screening for mutations in the LAMB3, LAMC2,
and LAMA3 genes revealed three putative pathogenic changes within LAMA3; a maternally inher-
ited 50T>A mutation in exon 39 causing I17N and two paternally inherited changes, 4685+1G>A
at the exon/intron boundary of exon 72 and 4034C>T within exon 68 causing R1331C. cDNA
analysis revealed the paternal mutations to affect splicing of the C-terminus of both laminin alpha3a
and alpha3b splice isoforms whereas the maternal mutation resides within an exon specific to the
amino terminus of laminin alpha3a and presumably affects folding and/or deposition of the mature
protein. Previously a founder mutation 151insG was identified as being causative for laryngo-ony-
cho-cutaneous syndrome in patients from the Punjab. 151insG resides within exon 39 of LAMA3,
leading to N-terminal truncation of the alpha3a isoform. The fact that LAMA3 is the causative gene
in these cases, suggests that laryngo-onycho-cutaneous syndrome is allelic to JEB; can be con-
sidered as part of the EB spectrum of disorders; and may not be fully restricted to the Punjab.
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Aberrant mineralization of connective tissues in a mouse model of pseudoxanthoma elas-
ticum: systemic and local regulatory factors
Q Jiang, Q Li and J Uitto Dermatology and Cutaneous Biology, Thomas Jefferson University,
Philadelphia, PA
Pseudoxanthoma elasticum (PXE) is caused by mutations in the ABCC6 gene, but the cellular
and molecular events leading to aberrant mineralization of soft tissues are unknown. To char-
acterize the mineralization process, we examined a PXE animal model, the Abcc6-/- mouse,
with respect to specific proteins serving as inhibitors of mineralization. The levels of calcium
and phosphate in serum of these mice were normal, but the Abcc6-/- serum had less ability
to prevent the mineral deposition induced by inorganic phosphate in a cell culture system.
Addition of fetuin-A to the culture system prevented the mineralization. The calcium x phos-
phate product was markedly elevated in the mineralized vibrissae of Abcc6-/- mice, an early
biomarker of the mineralization process, consistent with histopathologic findings. Levels of
fetuin-A were slightly decreased in Abcc6-/- serum, and positive immunostaining for matrix-
gla-protein (MGP), fetuin-A, and ankylosis protein (Ank) as well as alkaline phosphatase activ-
ity were strongly associated with the mineralization process. In situ hybridization demonstrated
that the genes for MGP and Ank were expressed locally in vibrissae, while fetuin-A was
expressed highly in the liver. These data suggest that the deposition of the bone-associated pro-
teins spatially coincides with mineralization and actively regulates this process locally and
systemically.
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Retinoic acid synthesis enzymes and binding proteins are increased in mouse models of cen-
tral centrifugal cicatricial alopecia
PP Shah,3,1 JP Sundberg,2,1 LE King,1 DE Ong1 and HB Everts1 1 Vanderbilt University Medical
Center, Nashville, TN, 2 The Jackson Laboratory, Bar Harbor, ME and 3 University of
Louisville, Louisville, KY
Human Central Centrifugal Cicatricial Alopecia (CCCA) is a form of irreversible hair loss marked
by inflammation of the upper hair follicle. Several mouse models of cicatricial alopecia exist
with primary defects in sebaceous glands including asebia (Scd1abJ, Scd1ab2J) mice. These mice
have mutations in the Stearoyl-CoA desaturase 1 gene (Scd1) and similar phenotypes consis-
tent with scarring alopecia, hypoplastic sebaceous glands, and defects in the release of the
hair fiber. Scd1 is the rate-limiting enzyme in monounsaturated fatty acid synthesis, which may
be a substrate for retinyl ester formation from free retinol via diacylglycerol acyltransferase 1.
Since retinoic acid (RA) regulates proliferation and lipogenesis in cultured sebocytes and ini-
tial studies localized components of retinoic acid synthesis to the sebaceous gland in a hair
cycle dependent manner, we examined the expression of this system in these mutant mice.
Immunohistochemistry was performed on samples of mutant and wild type adult Scd1abJ/
Scd1abJ and Scd1ab2J/ Scd1ab2J mice with antibodies against retinol (Dhrs9) and retinal (Aldh1a2
and Aldh1a3) dehydrogenases, cellular retinol (Crbp) and retinoic acid (Crabp2) binding pro-
teins. Overall, retinoic acid synthesis components were greater in these mutants compared to
wild type mice, with a few exceptions. We found strain differences in Dhrs9 expression and
Scd1ab2J mice displayed more sex dependent differences. We found a similar correlation in
samples from human patients with CCCA (presented separately). These data suggest that RA
synthesis is increased in these mouse models of cicatricial alopecia. Lack of Scd1 function
may block the storage of excess retinol, leading to increased RA synthesis. Since Scd1 is
expressed primarily in the sebaceous gland where pharmacological doses of RA reduce seba-
ceous gland function, it suggests that toxic RA synthesis within the sebaceous gland may be
key to the pathogenesis of CCCA.
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Targeted ablation of Abcc1 or Abcc3 in Abcc6-/- mice does not modify the ectopic miner-
alization process: Insights into the phenotypic variability of pseudoxanthoma elasticum
Q Li,1 Q Jiang,1 J LaRusso,1 A Sartorelli,2 M Belinsky,3 G Kruh3 and J Uitto1 1 Dermatology
and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA, 2 Comprehensive
Cancer Cancer, Yale University School of Medicine, New Haven, CT and 3 Medical Science
Division, Fox Chase Cancer Center, Philadelphia, PA
Pseudoxanthoma elasticum (PXE) is a heritable disorder characterized by ectopic mineraliza-
tion of connective tissues, with considerable both intra- and interfamilial phenotypic vari-
ability. PXE is caused by mutations in the ABCC6 gene, which encodes a transporter protein,
MRP6, and targeted ablation of Abcc6 recapitulates PXE. In this study, we examined the hypoth-
esis that the expression of other members of the Abcc family may be altered in Abcc6-/- mice,
a mouse model for PXE, possibly explaining the phenotypic variability. We first measured the
mRNA transcripts of Abcc1-10 and 12 in the liver of Abcc6-/- mice by quantitative RT-PCR.
As expected, there was no expression of Abcc6 while the levels of other Abcc mRNAs were
not significantly different from the wild-type mice. Next, we developed Abcc6/1-/- and Abcc6/3-
/- double knock-out mice and examined them for tissue mineralization. Histopathologic exam-
ination, coupled with computerized morphometric analysis, and chemical assay of calcium
x phosphate product in the vibrissae of Abcc1-/- and Abcc3-/- mice did not reveal evidence
of mineralization. In contrast, Abcc6/1-/- and Abcc6/3-/- double knock-out mice exhibited
connective tissue mineralization, but the degree of involvement was similar to that noted in
Abcc6-/- mice alone. These results emphasize the importance of the Abcc6 gene in the ectopic
mineralization process and further suggest that other members of the Abcc family, particu-
larly Abcc1 and Abcc3, do not modulate the effects of Abcc6 in this mouse model. These
findings suggest a role for environmental/lifestyle factors in modulating the phenotypic sever-
ity of PXE.
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Aberrant mineralization of connective tissues in pseudoxanthoma elasticum: A mouse graft-
ing model
Q Jiang,1 M Endo,2 N Udagawa,1 Q Li1 and J Uitto1 1 Dermatology and Cutaneous Biology,
Thomas Jefferson University, Philadelphia, PA and 2 The Children’s Hospital of Philadelphia,
Philadelphia, PA
Aberrant mineralization of connective tissues is a characteristic of pseudoxanthoma elas-
ticum (PXE), a heritable disorder caused by mutations in the ABCC6 gene expressed prima-
rily in the liver and kidney, and at very low levels in tissues affected by PXE. The pathomech-
anistic details of mineralization as a result of ABCC6 mutations are currently unclear, and two
hypotheses, viz. “metabolic” (systemic) vs. “PXE cell” (local) have been suggested. We have
developed a mouse model for PXE by targeted ablation of the Abcc6 gene. An intriguing fea-
ture of this mouse model is early mineralization of the connective tissue capsule surrounding
the vibrissae. In this study, we examined the mineralization in this mouse model by trans-
planting muzzle skin, containing the vibrissae, to the back skin of mice. Three different exper-
imental designs (5-8 mice per group) were utilized. Group 1: Muzzle skin from Abcc6-/- mouse
(donor) at the age of 4 weeks was grafted onto the back of a gender- and age-matched Abcc6+/+
mouse (recipient). Group 2: The same set-up as Group 1, except that Abcc6+/+ mouse was
the donor and Abcc6-/- mouse was the recipient. Group 3: Both the donor and recipient was
an Abcc6+/+ mouse. Two months after transplantation the grafts were examined for mainte-
nance by PCR-based genotyping, and mineralization was examined by histopathology and
electron microscopy. The survival rate of skin grafts was 75%, and non-specific T-cell infiltra-
tion was observed in all three groups. However, the connective tissue capsule of vibrissae
grafted from the muzzle skin of Abcc6+/+ mouse to the back of Abcc6-/- mouse developed
characteristic mineralization, while no such mineralization was observed in groups 1 and 3.
These data support the notion that PXE is a systemic metabolic disorder with secondary min-
eralization of connective tissues.
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Trimethylamine N-oxide reduces keratin aggregate formation in cells expressing mutant
keratins
D Santos and E Rugg Dermatology, University of California Irvine, Irvine, CA
Mutations in keratin genes are the cause of several inherited skin disorders. The observation
that intracellular keratin aggregates are a feature of many of these conditions has led us to
hypothesize that agents that promote protein-folding might ameliorate the cellular effects of
mutant keratins. We have previously shown that the chemical chaperone, trimethylamine N-
oxide (TMAO), reduces the effects of hyperosmotic stress in keratinocytes expressing mutant
keratin 5. In the present study we present evidence that the effects of TMAO are independent
of mutation or cell-type. The coding sequences for normal keratin 17 (K17) and mutant
K17:Asp92Ser, which causes pachyonychia congenita type 2, were cloned into the expres-
sion vector pIRES2-EGFP (Clonetec) and expressed in MCF-7 cells. Fluorescence-activated cell
sorting was used to select for cells expressing EGFP and K17 expression was detected by
immunocytochemistry. Cells expressing normal and mutant K17 were exposed to hyperos-
motic stress for various times by incubation with culture medium containing 300 mM sor-
bitol. In some experiments cells were treated with TMAO for 24 hrs prior to exposure to sor-
bitol. Under normal growth conditions both K17 and K17:Asp92Ser formed filaments in most
cells, although keratin aggregates were seen in a few cells expressing the mutant protein. Expo-
sure of cells to sorbitol led to keratin aggregate formation in cells expressing normal and mutant
keratins. However, the keratin aggregates formed more rapidly and in more cells expressing
K17:Asp92Ser compared to those expressing normal K17. Preincubation with TMAO signifi-
cantly reduced the percentage of cells containing keratin aggregates under normal incuba-
tion conditions and following exposure to sorbitol. These results demonstrate that TMAO
reduces keratin aggregation and that this is not mutation or cell-type specific. The results sug-
gest that chemical chaperones, or similar agents that promote normal protein-folding, may
provide a pharmacological strategy for treating keratin disorders.
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Transcriptional coactivator mediator is required for proliferation, differentiation and apop-
tosis of epidermal keratinocytes
Y Oda,1 MH Ishikawa,1 KR Feingold,1 RJ Chalkley,2 AL Burlingame,2 Q Yun3 and DD Bikle1
1 Endocrinology, UCSF/VAMC San Francisco, San Francisco, CA, 2 Pharmaceutical
Chemistry, UCSF, San Francisco, CA and 3 Medicine, University of Pennsylvania,
Philadelphia, PA
The Mediator/DRIP is a multi-subunit complex that plays a central role in regulating tran-
scription by directly recruiting RNA polymerase transcriptional machinery to the promoter.
We have previously purified and identified Mediator/DRIP complex as a VDR binding pro-
teins from keratinocytes. Several subunits were further identified by mass spectrometry, not
previously found in the Mediator/DRIP complex in other cells, suggesting a specific role of
these subunits in keratinocytes. Silencing of the major subunit of Mediator, DRIP205/MED1,
by siRNA decreased VDR transcription. LXR function was also decreased as shown by 22R
hydroxycholesterol induced ABCA1 expression. DRIP205 silencing resulted in hyperprolifer-
ation of epidermal keratinocytes and decreased apoptosis. The hyperproliferation was accom-
panied by decreased cell cycle inhibitor p21 expression and decreased p21 promoter activ-
ity. DRIP205 silencing also resulted in specific differentiation defects shown by decreased
expression of the early differentiation markers keratin 1 and keratin 10 and late differentiation
markers loricrin and filaggrin, but not the middle differentiation markers involucrin and trans-
glutaminase. These differentiation defects may stem from altered adhesion capability of ker-
atinocytes, which was demonstrated by loss of E-cadherin translocation to plasma mem-
brane. DRIP205 was localized in human epidermis with characteristic pattern. These results
indicate that DRIP205 facilitates a specific coregulatory role in keratinocyte proliferation, dif-
ferentiation and apoptosis through transcriptional regulation.
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Mutation detection in the ABCC6 gene and analysis in a large international cohort affected
by pseudoxanthoma elasticum
EG Pfendner, SF Terry, S Vourthis, P McAndrew, MR McClain, S Fratta, A Marais, S Hariri,
PJ Coucke, O Vanakker, M Ramsay, M Khoury, D Viljoen, A De Paepe, J Uitto, PF Terry and
LG Bercovitch PXE Consortium, PXE International, Washington, DC
Pseudoxanthoma elasticum (PXE) is an inherited disorder in which mutations in the ABCC6
gene (ATP binding cassette family C member 6), which encodes the MRP6 (multidrug resist-
ance-associated protein 6), lead to ectopic mineralization of connective tissues. Multiple organs
are affected, including the skin, eyes, and the cardiovascular system, and the pathogenic
changes include lax and inelastic skin, angioid streaks of the retina, and mineralization of the
mid-laminar layer of blood vessels of the gastrointestinal tract and cardiovascular system. In
this study, both mutation and phenotype data were collected on an international cohort of 198
individuals. A dHPLC-based assay was developed to screen for mutations in all 31 exons elim-
inating co-amplification of the neighboring pseudogenes. Overall 328 mutant alleles in ABCC6
were identified in 198 probands, including 46 novel mutations. Mutations were found to
cluster in exons 24 and 28 corresponding to the second nucleotide binding fold and the last
intracellular domain of the protein. Together with recurrent R1141X and del23-29 mutations,
these mutations accounted for 68.5% of the total individual mutations identified in this cohort.
Genotype-phenotype correlation analysis failed to reveal a significant correlation between the
types of mutations identified or their predicted effect on the expression of the protein versus
the age of onset and severity of the disease. A mutation detection strategy involving screen-
ing for the most common mutations in exons 24 and 28 followed by screening of the remain-
ing exons is suggested by these data.
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Skin gene therapy: systemic delivery of the anti-hypertensive atrial natriuretic peptide (ANP)
by genetically-modified human skin equivalents (HSE)
J Therrien,1 A Terunuma,1 CL Tock,1 W Pfuztner,3 M Ohyama1,2 and JC Vogel1 1 Dermatology
Branch, NATIONAL CANCER INSTITUTE / NIH, Bethesda, MD, 2 Department of
Dermatology, Keio Univ. School of Med., Tokyo, Japan and 3 Department of Dermatology,
University of Marburg, Marburg, Germany
Skin is a very attractive organ for targeted gene therapy to deliver therapeutic proteins sys-
temically in order to treat cancers, skin diseases or systemic diseases. To achieve long-term
stable expression of a therapeutic gene, we have developed an in vivo system using a bicistronic
retroviral vector expressing the desired therapeutic gene linked to a multi-drug resistant gene
(MDR) to create genetically-modified HSE. After grafting the HSE onto immunocompromised
mice topical colchicine treatment is used to select and enrich for genetically-modified ker-
atinocyte stem cells. To validate this approach we have chosen the anti-hypertensive ANP as
a therapeutic gene. In vitro, HSE expressing ANP/MDR demonstrate normal differentiation
and stratification histologically. ANP expression and secretion by bioengineered HSE was con-
firmed by immunohistochemistry labeling and by radio-immuno assay (RIA). RIA shows that
bioengineered HSE were able to secrete high levels of ANP (40 000 pg/ml/4h) into the cul-
ture media and that these levels can be increase by more than 2-fold after colchicine selec-
tion. To demonstrate biological activity of secreted ANP, an assay measuring cGMP induction,
a downstream mediator of the ANP pathway, in target kidney cells shows that ANP secreted
by the bioengineered HSE is the desired pro-form of ANP (inactive) that can be converted
into an active form by cells expressing the ANP convertase (corin receptor). When grafted to
immunocompromised mice bioengineered HSE produce and secrete significative levels of
human ANP into the bloodstream. Currently, grafted bioengineered HSE are being selected
with topical colchicine prior to blood pressure monitoring. These results suggest that geneti-
cally-modified HSE combined with topical colchicine treatment have potential for long-term
systemic delivery of therapeutic molecules.
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The genetic advances of vitiligo in China
Y Liang,1,2 S Yang,1,2 Y Zhou,1,2,5 J Gui,4 J Chen,1,2 X Fan,1,2 L Sun,1,2 F Xiao,1,2 M Gao,1,2
Y Ren,1,2 W Du,1,2 Q Fang,1,2 S Xu,3 J Liu,1,2,6 W Huang3 and X Zhang1,2 1 Institute of
Dermatology & Department of Dermatology, No.1 Hospital, Anhui Medical University,
Hefei, China, 2 Key Laboratory of Gene Resource Utilization for Severe Diseases, Ministry of
Education, Hefei, China, 3 Chinese National Human Genome Center at Shanghai, Shanghai,
China, 4 Vitiligo Clinic of the Railway Hospital, Xiangfan, China, 5 Chieng Genomics Center,
Vancouver, BC, Canada and 6 Genome Institute of Singapore, Singapore, Singapore
Introduction:Vitiligo is an acquired depigmentation disorder of the skin and hair caused by
the selective destruction of melanocytes from the epidermis. However, the genetic compo-
nents of vitiligo have never been investigated in Chinese population.To explore the genetic
aspects of vitiligo in the pathogenesis of generalized vitiligo in Chinese Hans.Results: Infor-
mation from 2247 patients and members in their families was used. Genetic models and her-
itabilities were analyzed by software SAGE. The allelic frequencies of HLA class I and II by
using PCR-SSP method were performed with case-control analysis in Chinese Hans. 106 vitiligo
families used in genome-wide scanning and additional 37 vitiligo families were put on the
following fine mapping study.Complex segregation analysis indicated the polygenic feature
of vitiligo. Significant association between HLA alleles and vitiligo was observed, such as
HLA-A*2501, -A*30, -B*13, -B*27 and -Cw*0602 significantly increasing in vitiligo patients.
Furthermore, two-locus and extensive risk HLA haplotypes were observed in all types of vitiligo
of Chinese origin, such as HLA-A25-B13-Cw*0602. By linkage analysis, we identified three
novel susceptible loci of vitiligo, respectively in the chromosome region 4q13-q21 (AIS4),
6p21-p22 and 22q12. Three other suggestive loci were also observed, 6q, 14q and 1p36,
harboring mild or moderate risk factors of vitiligo. Conclusion: Genetic factors played an
important role in the pathogenesis of vitiligo.
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A single intradermal injection of allogeneic fibroblasts can increase type VII collagen expres-
sion in recessive dystrophic epidermolysis bullosa for at least 3 months
T Wong,1,2 L Gammon,2 L Liu,1 L Ozoemena,1 PJ Dopping-Hepenstal,1 JF Pacy,1 C Jones,1
AP South,2 IM Leigh,2 H Navsaria2 and JA McGrath1 1 St John’s Institute of Dermatology,
London, United Kingdom and 2 Institute of Cell and Molecular Science, London, United
Kingdom
Recessive dystrophic epidermolysis bullosa (RDEB) is a severe inherited skin blistering con-
dition characterized by skin fragility, erosions and mutilating scarring. The disease is due to
mutations in the COL7A1 gene resulting in reduced type VII collagen expression and defec-
tive anchoring fibrils at the dermal-epidermal junction (DEJ). Recent murine studies have
shown that intradermal injections of low passage cultured allogeneic fibroblasts at sufficient
cell density can lead to type VII collagen deposition and new anchoring fibrils at the DEJ. In
our study of five individuals with RDEB (4M, 1F; aged 21-40 years), we investigated the ther-
apeutic potential of fibroblast cell therapy following single intradermal injections of low pas-
sage (P2) autologous (non-gene corrected) or allogeneic fibroblasts (5x106 cells in phosphate
buffered saline) with follow-up skin biopsies at 2 weeks and 3 months. Immunofluorescence
microscopy of skin from injected allogeneic sites showed an increase in type VII collagen
expression at the DEJ at both 2 weeks and 3 months in 3/5 subjects; no increase at 3 months
was observed with autologous fibroblasts. At 3 months, transmission electron microscopy
revealed focal evidence of new anchoring fibril formation at allogeneic cell injection sites.
No clinical evidence of rejection was seen at any stage and immunofluorescence microscopy
did not reveal any detectable anti-type VII collagen antibodies in skin or serum over the 3
months. Furthermore, skin biopsies showed only a mild, transient (at 2 weeks but not 3 months)
inflammatory cell infiltrate (macrophages and mixed T lymphocytes) compared to baseline.
Our observations suggest that cell based therapy using human fibroblasts from unrelated donors
may be clinically useful in this severe genodermatosis.
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Towards a gene therapy for dominant dystrophic epidermolysis bullosa
D Allen, PF Kenna, P Humphries and GJ Farrar Genetics, Trinity College Dublin, Dublin 2,
Ireland
The dominant dystrophic form of Epidermolysis Bullosa (dDEB) is a dominantly inherited blis-
tering skin disorder involving a mutant collagen VII gene (COL7A1). The dominant nature of
dDEB suggests that any successful gene therapy approach may require suppressing expres-
sion of the mutant COL7A1. RNA interference (RNAi) represents a powerful tool with which
to achieve suppression. This study involved suppression of COL7A1 expression in human epi-
dermal keratinocytes using short hairpin RNA (shRNA). To obtain higher efficiency of transfer
to keratinocytes, cells were nucleofected using nucleofector kit V (amaxa). Additionally AAV-
mediated delivery was explored. Suppression of human COL7A1 mRNA expression was eval-
uated using real-time rtPCR. Critically, for real-time rtPCR to yield meaningful results, it is nec-
essary to normalise with a stably expressed endogenous control gene. The expression profile,
in keratinocytes, of 11 putative housekeeping genes was established ensuring accurate quan-
tification of the gene of interest. The 2-ddCT method was used to determine mean fold changes
in gene expression between treatments. Finally, shRNA can potentially activate a type-1 inter-
feron response. The mRNA expression levels of interferon stimulated genes were determined
using real-time rtPCR to ensure our suppressors were not eliciting a type-1 interferon response.
Based on the analyses of the 11 housekeeping genes tyrosine 3-monooxygenase-tryptophan
5-monooxygenase activation protein gene (YWHAZ) and the ubiquitin C gene (UBC) were
selected as the reference genes for real-time rtPCR analyses. The shRNAs evaluated suppressed
COL7A1 expression by 60-90% in human epidermal keratinocytes endogenously expressing
the protein. Furthermore, shRNA-based suppressors were not found to elicit a significant
type-1 interferon response. In summary, this study represents the first step towards a gene
therapy for dDEB with potent shRNA-mediated suppression of expression of the human type
VII collagen achieved in human epidermal keratinocytes.
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Intronic insertion of a neomycin-phosphotransferase expression cassette suppresses synthe-
sis of collagen VII and generates a viable mouse model for dystrophic epidermolysis bullosa
A Fritsch,1 S Löckermann,1 A Braun,2 M Bösl,2 D Berens von Rautenfeld,3 I Hausser,4
R Fässler2 and L Bruckner-Tuderman1 1 Molecular Dermatology, University Medical Center
Freiburg, Freiburg, Germany, 2 Max-Planck-Institute for Biochemistry, Martinsried, Germany,
3 Hannover Medical School, Hannover, Germany and 4 University of Heidelberg,
Heidelberg, Germany
Dystrophic epidermolysis bullosa (DEB), a hereditary skin blistering disorder caused by muta-
tions in the collagen VII gene COL7A1, is a prime target for gene-, protein- or cell-based ther-
apies. However, despite successful proof-of-principle experiments, the evaluation of efficacy
and adverse effects of the therapeutic approaches have been impeded by the lack of suitable
animal models. Successful treatment depends considerably on the immunogenicity of the intro-
duced collagen VII, but most studies have relied on skin grafts on athymic mice to demonstrate
therapeutic effects. Immunocompetent models with COL7A1 mutations exist, but they are
either difficult to maintain (sheep, dogs) or die too early for therapy induction and follow-up
(collagen VII null mice). By intronic insertion of a PGK-Neo cassette into Col7a1 we gener-
ated a collagen VII hypomorphic mouse with a phenotype that closely resembles moderately
severe human DEB. Homozygous mice show blistering of skin and oral mucosa and nail dys-
trophy. Blistering of oral epithelia causes malnutrition, growth retardation and death within 9
weeks. The intronic introduction of the PGK-Neo cassette interferes with collagen VII mRNA
splicing and, consequently, protein levels in the skin are reduced to 10%, leaving only sparse
anchoring fibrils to facilitate epidermal-dermal anchorage. Deletion of the PGK-Neo cassette
reverts the phenotype and produces normal mice. As the collagen VII hypomorph shows all
symptoms of moderately severe DEB, survives to adulthood and is immunocompetent, it is an
ideal model for the evaluation of therapeutic strategies in DEB as well as for the analysis of
cutanous and extracutanous symptoms of the disease.
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Ectopic mineralization of connective tissue in Abcc6-/- mice: effects of dietary modulation
and a phosphate binder
J LaRusso, Q Jiang, Q Li and J Uitto Dermatology and Cutaneous Biology, Thomas Jefferson
University, Philadelphia, PA
Pseudoxanthoma elasticum (PXE) is a heritable disorder characterized by progressive mineral-
ization of connective tissue in the skin, retina, and cardiovascular system. PXE is caused by
mutations in the ABCC6 gene which encodes for MRP6, an ATP-binding cassette membrane
transporter. We have developed a mouse model for PXE by targeted inactivation of the Abcc6
gene. This study was designed to investigate the effects of sevelamer hydrochloride (Renagel),
a phosphate binder, and specific mineral content of diet on ectopic mineralization of connec-
tive tissue in Abcc6-/- mice. Female Abcc6-/- mice were divided into three groups and fed a
specific diet. The first group received a standard rodent diet, the second one was given a stan-
dard rodent diet supplemented with sevelamer hydrochloride, and the third group was fed a
custom experimental diet with specific mineral modulations (high phosphorus, low magne-
sium). The degree of mineralization was determined in H&E stained sections using computer-
ized morphometric analysis, and chemical assays were utilized to measure the calcium and
phosphorus content of the vibrissae. Results indicated a statistical difference between the Abcc6-
/- control mice fed a standard diet and Abcc6-/- mice fed a diet with mineral modifications uti-
lizing the computer analysis (p<0.05) and the chemical assay (p<0.005). There was not a sta-
tistical difference between Abcc6-/- control mice and Abcc6-/- mice fed a diet supplemented
with Renagel (p>0.1), as determined by computerized morphometry, however, there was evi-
dence based on the chemical assay that addition of a phosphate binder to the diet did improve
mineral deposition of the muzzle skin (p<0.005). These results suggest that the mineralization
process in PXE may be exacerbated by changes in dietary mineral intake and mitigated by phos-
phate binders. The role of phosphorus and magnesium, as well as phosphate binders, in ectopic
mineralization of PXE, and potentially its prevention, merits further investigation.
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Patients with defects in the interacting nucleotide excision repair proteins ERCC1 or XPF
show xeroderma pigmentosum with late onset severe neurological degeneration
K Imoto,1,2 J Boyle,1 K Oh,1 S Khan,1 T Ueda,1 C Nadem,1 H Slor,3 S Orgal,3 N Gadoth,3
D Busch (deceased),4 NG Jaspers,5 D Tamura,1 JJ DiGiovanna1,6 and KH Kraemer1 1 Basic
Research Laboratory, National Institutes of Health, Bethesda, MD, 2 Dermatology, Nara
Medical Univ, Nara, Japan, 3 Genetics, Tel Aviv Univ, Tel Aviv, Israel, 4 AFIP, Washington, DC,
5 Genetics, Erasmus Univ, Rotterdam, Netherlands and 6 Dermatology, Brown Med School,
Providence, RI
Xeroderma pigmentosum (XP) is a rare autosomal recessive disease characterized by sun sen-
sitivity and a high incidence of skin cancer in association with defective nucleotide excision
repair (NER). XP patient (XP202DC) had progressive neurodegeneration with dementia, severe
generalized brain atrophy beginning at age 15 years, and death by 37 years. The ERCC1 gene
in her cells had heterozygous mutations: one nonsense mutation (K226X) and one splice muta-
tion (IVS6-26G>A). The delayed onset and severe neurological degeneration with general-
ized brain atrophy were very different from other XP patients but very similar to three XP
patients in 2 new families (XP48DC and siblings CO14TA and CO107TA) who were het-
erozygous for a missense mutation (R788W) in the XPF gene. XPF and ERCC1 form a het-
erodimer that functions as a 5’ endonuclease in a late stage of the NER reaction. XPF and
ERCC1 interact in the region that is disrupted by the mutations found in our patients. The sim-
ilarity of the neurologic abnormalities among the patients with ERCC1 and XP-F defects sug-
gests that dysfunction of the XPF/ERCC1 complex causes this unusual form of severe neuro-
logical degeneration. These findings describe an important new role of NER proteins in
maintaining the integrity of the central nervous system.
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Controlling transgene-specific immune responses in cutaneous gene therapy
S Ghazizadeh Oral Biology and Dermatology, Stony Brook University, Stony Brook, NY
Immune elimination of genetically modified keratinocytes presents a major impediment to
cutaneous gene therapy. Controlling immune responses to the therapeutic antigen is therefore
critical for effective gene therapy. Using a murine model of ex vivo epidermal gene transfer,
we have shown that the rejection of ex vivo transduced keratinocytes was associated with
Th2/eosinophilc responses and intense inflammation. As many effector mechanisms of inflam-
mation are abolished after the CD40/CD154 blockade, the potential of a transient blockade
of this costimulatory pathway on restricting transgene-specific immune responses was explored.
Using GFP as a model antigen, it was shown that transient blockade of CD40/CD154 inter-
action with an anti-CD154 antibody (MR-1) at the time of cell transplantation resulted in
long-term (> 20 weeks) engraftment of genetically modified keratinocytes expressing a neoanti-
gen. In control mice, GFP expression was lost by 4 weeks post grafting. Analysis of humoral
and cellular immune responses in MR-1-treated mice indicated suppression of transgene-spe-
cific immune responses and a lack of tissue inflammation in GFP-expressing epidermis. When
these mice were challenged by a second graft of GFP-expressing keratinocytes, GFP-specific
immune responses were developed, resulting in the loss of newly implanted keratinocytes by
4 weeks post-grafting. This indicated that the initial CD154 blockade did not induce long-lived
transgene-specific tolerance. Interestingly, however, despite the induction of GFP-specific
immune responses and loss of the second graft, there was no sign of inflammation in the orig-
inal graft in which GFP continued to be expressed for at least 10 more weeks. This demon-
strated that despite a lack of long-lived antigen-specific tolerance, genetically modified ker-
atinocytes were protected from destructive transgene-specific immune responses. These results
thus indicate that restriction of host immune-mediated cytolysis of neoantigen-expressing
keratinocytes is achievable by transient blockade of CD40/CD154 interaction.
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Physiological characterization of vitamin D receptor mutants with distinct coregulator bind-
ing patterns
A Teichert,1 N Nguyen,2 Y Oda,1 P Webb,2 J Baxter2 and D Bikle1 1 Endocrine Unit, UCSF,
San Francisco, CA and 2 Diabetes Center, UCSF, San Francisco, CA
The vitamin D receptor (VDR) regulates a diverse set of genes that control a variety of processes
including bone mineral homeostasis, immune function and hair follicle cycling. Upon bind-
ing of its ligand, 1α,25(OH)2D3, the VDR undergoes a conformational change that allows the
release of corepressor proteins and the binding of coactivator proteins necessary for gene tran-
scription. Based on the homology between the VDR and the Thyroid hormone receptor (TR)
and the amino-acids known in the TR to be involved in NCoR binding, we engineered five
single amino-acid nonconservative substitutions in the VDR at residues that are critical for co-
regulator binding. All these mutations are in different regions of the ligand binding domain of
the VDR and are located either in regions overlapping the surfaces described in other nuclear
receptors for binding of coactivators and corepressors or in the Activation Fonction-2 domain.
Thus, mutant A binds to the coactivators SRC2 and DRIP205, in presence of 1α,25(OH)2D3,
but not to the corepressors NCoR and Hairless. Mutant B binds to SRC2, in presence of
1α,25(OH)2D3, and to both corepressors but not to DRIP205. Mutants C, D and E do not
bind to any of the coregulators tested. Based on these different coregulator binding patterns,
we characterized physiologically these mutants, in terms of 1α,25(OH)2D3, association with
RXR, activation of transcription, hairless mediated repression of transcription and control on
hair cycling through a hair graft assay. This work is the first comprehensive identification of
amino acids in the VDR required for specific coregulators binding in the presence or absence
of 1α,25(OH)2D3. These different mutants of the VDR may be used to develop inhibitors block-
ing selective VDR coregulator interactions involved in specific physiological regulations by
the VDR, thus facilitating the goal of developing tissue and gene specific vitamin D response
modulators.
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Inhibition of chaperone function by geldanamycin induces normal keratinocyte differentia-
tion and inhibits proliferation of squamous cell carcinoma
MH Ishikawa, DD Bikle and Y Oda Endocrinology, UCSF/VAMC San Francisco, San
Francisco, CA
The vitamin D receptor (VDR) controls keratinocyte proliferation and differentiation through
transcriptional regulation. Previously we have demonstrated that molecular chaperones (heat
shock proteins Hsp) regulate VDR mediated transcription. Here we examined the impact of a
chaperone inhibitor on keratinocytes. We utilized an ansamycin antibiotic, geldanamycin,
which binds to ATP and inhibits the function of Hsp90. Treatment of primary keratinocytes
with geldanamycin increased 1,25(OH)2D3 transactivation accompanied with increased
recruitment of VDR and coactivator DRIP205 to the vitamin D response elements in the pro-
moter of 1,25(OH)2D3 regulated gene. Geldanamycin also initiated early keratinocyte dif-
ferentiation. It increased the expression of the early differentiation markers keratin 1 (K1) and
K10 but not the middle markers transglutaminase and involucrin or late markers loricrin and
filaggrin in keratinocytes grown in low calcium (0.03mM). Geldanamycin inhibited keratinocyte
proliferation, but more effectively in squamous carcinoma cells (SCC12B2) (EC50 8nM) com-
pared to normal primary keratinocytes (EC50 15 nM). To evaluate the mechanism for this drug
effect, we blocked the expression of VDR by siRNA. Silencing VDR partially prevented gel-
danamycin induced differentiation but did not alter the effects on proliferation. These results
indicate that chaperone inhibitor increase VDR transcription and promote keratinocyte dif-
ferentiation. As ansanamycin antibiotics are under clinical trial to treat breast cancer, our stud-
ies also suggest a potential application of this type of drug to treat squamous cell carcinoma.
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Study of the functional alterations in the mutated DLX3 isoform responsible for Tricho-Dento-
Osseous syndrome
O Duverger, D Lee and M Morasso Developmental Skin Biology Unit, NIH/NIAMS,
Bethesda, MD
The homeodomain protein Distal-less-3 (Dlx3) plays a crucial role during embryonic devel-
opment. This transcription factor is known to be essential for placental formation, and to be
involved in skin and skeletal organogenesis. In humans, a frameshift mutation in the coding
sequence of the DLX3 gene (just downstream of the DNA-binding domain) results in an ecto-
dermal dysplasia called Tricho-Dento-Osseous syndrome (TDO). Different clinical manifes-
tations are observed within TDO families. The main features of the syndrome are defects in
the formation of hair (kinky curly hair at birth), teeth (enamel hypoplasia, enlarged pulp
chamber and molar taurodontism) and bone (increased bone density). In order to investigate
the functional alterations caused by the TDO mutation ex vivo, we developed keratinocyte
and osteocyte cell lines in which the expression of Dlx3 and/or TDO is tetracycline-inducible.
Immunocytochemical analysis revealed that both Dlx3 and TDO recombinant proteins are tar-
geted to the nucleus. However, as demonstrated by Electrophoresis Mobility Shift Analysis
(EMSA), the mutated transcription factor is not able to bind to Dlx3 responsive elements. We
are currently investigating the differential effects of Dlx3 and TDO overexpression on the induc-
tion of Dlx3 target genes, in keratinocytes and osteocytes. In order to further characterize the
effects of this mutation in vivo, we are in the process of generating a mouse model of the TDO
syndrome by introducing a similar mutation in the mouse genome using the recombineering
technology.
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Mini-type VII collagen corrects murine dystrophic epidermolysis bullosa
D Woodley, X Wang, J Remington, J Burnett, G Kim and M Chen Dermatology, University of
Southern California, Los Angeles, CA
Dystrophic epidermolysis bullosa (DEB) is a family of inherited mechano-bullous disorders
caused by mutations in the type VII collagen (C7) gene. We previously generated a recombi-
nant C7 “minigene” containing intact noncollagenous domains, NC1 and NC2, and half of
the central collagenous domain and demonstrated that the “minigene” product retained the
function and characteristics of full-length C7 and, when expressed in RDEB keratinocytes,
induced reversion of the RDEB cellular phenotype. In this study, we evaluated if mini-type VII
collagen (Mini-C7) could reverse RDEB in preclinical, C7 null, RDEB mice. We intradermally
injected purified Mini-C7 (10-15 microgram/per injection) daily for 3 days into the mid-back
of 1 day old RDEB mice (N = 30) that exhibited blisters mostly on the paws and ventral sur-
face. Skin biopsies were obtained at various times after injection and subjected to immunos-
taining and immunoelectron microscopy using an antibody specific for human C7. We found
that the injected Mini-C7 transported and incorporated into the mouse’s basement membrane
zone (BMZ) as early as 2 days after injection and formed anchoring fibrils. Most interestingly,
the injected Mini-C7 was not only detected at the BMZ of injection sites, but also at remote
areas far away from the injection site. The expression of Mini-C7 corrected the RDEB disease
features, including dermal-epidermal separation, new blister formation, and anchoring fibril
defects. In addition, Mini-C7-mediated therapy also significantly increased the life span of
the animals. Our studies provide the first evidence for using Mini-C7 to correct RDEB in a
preclinical animal model. One potential advantage over full-length C7 is that Mini-C7 is highly
stable and lacks the 39 amino acid interruption in the helical sequences which contains a site
highly susceptible to degradation by proteases. The enhanced stability of Mini-C7 over authen-
tic C7 may better withstand proteolytic digestion in RDEB wounds and provide a more sus-
tained gene product in patients.
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Follow-up analysis of 180 Chinese families:Identification of a novel locus for psoriasis at
2p22.3-11.2
L Sun,1,2 S Yang,1,2 Y Liang,1,2 X Fan,1,2 C Yang,1,2 K Yan,1,2 F Xiao,1,2 M Gao,1,2 Y Cui,1,2
Y Ren,1,2 S Xu,1,2 W Du,1,2 K Zhang,3 W Huang,3 J Liu1,2,4 and X Zhang1,2 1 Institute of
Dermatology & Department of Dermatology, No.1 Hospital, Anhui Medical University,
Hefei, China, 2 the Key Laboratory of Gene Resource Utilization for Severe Diseases, Ministry
of Education, Hefei, China, 3 Chinese National Human Genome Center at Shanghai,
Shanghai, China and 4 Human Genetics Lab Genome Institute of Singapore Agency for
Science, Technology and Research, Singapore, Singapore
Introduction:Psoriasis is a common inflammatory and hyperproliferative skin disease.Eight
linkage loci (PSORS1-6, PSORS7 and 9) were identified and accepted by the OMIM and addi-
tional 16 susceptibility loci were suggested so far. To further investigate three suggested pso-
riasis susceptibility loci at 2p22.3-11.2, 13q21-32 and 17q22-25.3 in Chinese population and
verify whether they are Chinese Han psoriasis susceptibility loci or not. Results:. A total of
180 Chinese Han families with psoriasis vulgaris were used. Two-point and multipoint para-
metric and nonparametric linkage analyses were performed on 2p,13q and 17q by using the
total 180 families and 61 original and 119 new families respectively.At the region 2p,a max-
imum multipoint NPL score of 4.11 was identified at locus D2S337(p=0.000003), and a
maximum multipoint HLOD score of 4.93(a=54%) was identified at the same locus by analy-
sis the 180 families. However, at the region 13q21-32, the analysis of the 180 families iden-
tified a maximum multipoint HLOD score of 0.10 (a=7%) and NPL score of 0.95 (p=0.14) at
locus D13S1315. At the region 17q22-25.3, the analysis of the 180 families identified a max-
imum multipoint HLOD score of 0.08 (a=6%) and NPL value of 0.94(p=0.14) at locus
D17S802.Conclusions: Therefore, our study indicates that 2p22.3-11.2 is a novel psoriasis
susceptibility locus in Chinese Han population and confirms that psoriasis is a genetically het-
erogeneous disease.
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Identification of a novel distal hyperacetylated region within the ATF3 gene
BP Pollack,1 B Sapkota1 and JM Boss2 1 Dermatology, Emory University, Atlanta, GA and 2
Microbiology and Immunology, Emory University, Atlanta, GA
The transcription factor ATF3 is induced in response to a wide variety of cellular stresses includ-
ing ultraviolet radiation (UVR). While the initial characterization of the ATF3 gene suggested
a genomic length of 16 kb, recent analysis of available databases suggests that the gene includes
a much larger 5’ region and spans 55 kb. Given the crucial role of ATF3 in the cellular response
to stress and its ability to activate or repress many other genes, we sought to evaluate this dis-
tal 5’ region (D5R). Using chromatin immunoprecipitation, we have found that the D5R, which
is 42 kb upstream of the known ATF3 TATAA sequence, is highly acetylated on histones H3
and H4. The D5R is acetylated on histones H3 and H4 to similar levels as the known ATF3
promoter region. Analysis of a region between the 5DR and the known ATF3 promoter as
well as the distal 3’ region of the ATF3 gene contain only low levels of histone acetylation. In
addition, twenty-four hours after UVR exposure, there is an increase in histone acetylation
within this region as well as histone H3 phosphorylation. Sequence analysis reveals multiple
putative transcription factor binding sites exist within this region. This analysis suggests that
the ATF3 gene includes a much larger region than previously reported and that the D5R may
play a role in the regulation of ATF3.
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Array profiling of skin from patients on isotretinoin provides insights into potential media-
tors of its apoptotic effect on sebaceous glands
AM Nelson,1,3 KL Gilliland,1,3 W Zhao2 and DM Thiboutot1,3 1 Jake Gittlen Cancer Research
Foundation, Penn State University College of Medicine, Hershey, PA, 2 Department of Health
Evalulation Sciences, Penn State University College of Medicine, Hershey, PA and 3
Department of Dermatology, Penn State University College of Medicine, Hershey, PA
Isotretinoin (13-cis RA) is the most potent agent in the treatment of acne, yet its mechanism
of action is still unknown. This is the first study to examine the effects of oral 13-cis RA on
gene expression in the skin of acne patients. Gene expression analysis was performed on seven
patients before and at one-week of treatment and eight patients before and after 8-weeks of
treatment as well as in our cell culture models: SEB-1 sebocytes and HaCaT keratinocytes.
These early-gene changes can provide insight into the initial effects induced by this drug.
Genes significantly changed are broadly categorized as tumor suppressors, protein proces-
sors or genes involved in transfer or binding of ions, amino acids, lipids or retinoids, includ-
ing lipocalin 2. Lipocalins are small molecular weight proteins that regulate processes such
as immune response, retinol transport, and prostaglandin synthesis. The lipocalin 2 gene prod-
uct, neutrophil galactosidase (NGAL), is known to function in innate immunity and can induce
apoptosis. Immunohistochemistry on patient skin biopsies revealed increased NGAL after
isotretinoin treatment with localization to the basal layer of the sebaceous gland and upper
sebaceous duct. Our previous studies indicated that 13-cis RA can induce apoptosis in sebo-
cytes. Purified NGAL protein induced significant apoptosis at 48 hours post-treatment in
SEB-1 sebocytes, lending support to NGAL mediating the apoptotic actions of 13-cis RA.
Together, these data provide rationale for further study of candidate genes, including lipocalin
2, that mediate retinoid response in the skin.
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Two isoforms of kindlin-1 in intestinal epithelia are associated with gastrointestinal symp-
toms in Kindler syndrome
JS Kern,1 C Herz,1 E Haan,2 P Greiner,1 D Moore,2 A Schmitt-Graff,1 O Opitz,1 L Bruckner-
Tuderman1 and C Has1 1 University, Freiburg, Germany and 2 Women’s and Children’s
Hospital, North Adelaide, SA, Australia
Kindlin-1, the Kindler syndrome (KS) protein, is an epithelial-specific focal contact compo-
nent, which attaches the actin cytoskeleton to the keratinocyte plasma membrane. Kindlin-1
deficiency is associated with skin blistering, poikiloderma, and photosensitivity. Some patients
exhibit gastrointestinal symptoms, but it has remained unclear whether these represent a dis-
ease feature of KS or a coincidence. Here we examined the expression of kindlin-1 in human
gastrointestinal epithelia. Immunofluorescence staining with domain specific kindlin-1 anti-
bodies yielded positive signals in oral mucosa and in different segments of the gastrointestinal
tract, including the colon. In two colon epithelial cell lines, HT29 and CaCo2, RT-PCR analy-
sis revealed high levels of KIND1 mRNA expression. In CaCo2 cell lysates, in addition to the
74 kDa kindlin-1 protein, a shorter 37 kDa isoform was detected, which resulted from alter-
native splicing including exon 7 into the coding sequence. This lead to a protein of 352 amino
acids. Two KS patients, who presented with severe hemorrhagic diarrhoea in the first months
of life, were examined. Patient 1, homozygous for KIND1 c.910G>T, continued to have strong
intestinal involvement, which led to colon resection. Histologic examination revealed features
of severe ulcerative colitis. Patient 2, homozygous for KIND1 c.676insC, experienced improve-
ment with age, but mild abdominal pain, flatulence and intermittent episodes of diarrhoea con-
tinued. Histology demonstrated detachment of the epithelium from the underlying mesenchyme
in all segments of the colon, mild chronic inflammation with eosinophilia, and discrete mucosal
atrophy, thus mirroring the changes in KS skin. Taken together, these data show that, in addi-
tion to cutaneous anomalies, KS can present with an intestinal phenotype, which may be under-
diagnosed. We hypothesize that in some cases, the short intestinal kindlin-1 isoform may func-
tionally compensate for lack of the full-length protein.
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Suppression of type VII collagen-induced immune responses in RDEB mice: implications for
gene therapy
J Remington, P Bandyopadhyay, M Yadegari, V Chan, D Woodley and M Chen Dermatology,
University of Southern California, Los Angeles, CA
Recessive dystrophic epidermolysis bullosa (RDEB) is a mechano-bullous disease caused by
mutations in type VII collagen (C7). Using a preclinical RDEB mouse, we show that the RDEB
phenotype could be normalized by intradermal injection of gene-corrected RDEB cells, a
lentiviral vector expressing C7 or the C7 protein itself. Nevertheless, introducing C7 may invoke
an untoward immune response such as the production of anti-C7 autoantibodies and invoke
an anti-C7 autoimmune bullous disorder akin to epidermolysis bullosa acquisita (EBA). In the
present study, we found that RDEB mice in which C7 was introduced by the above three strate-
gies had a robust humoral immune response and generated C7 autoantibodies. Using this
model, we experimented with strategies to prevent this undesirable response. Specifically, we
compared transient immunosuppression versus the induction of tolerance to C7. Two groups
of mice were injected intradermally with recombinant C7 simultaneously with cytotoxan or
a monoclonal antibody against murine CD40 ligand (MR1). Control animals (100%) devel-
oped circulating anti-C7 IgG 4 weeks after C7 administration. The most effective immuno-
suppressant was MRI in which 90% of the animals did not exhibit anti-C7 antibodies and had
sustained correction of the RDEB phenotype. In contrast, only 50% of the cytoxan-treated
animals had a delay of the onset of autoantibody production. In two other groups of mice, we
induced tolerance to C7 by oral administration or intravenously injected C7 within 24 hr after
birth. Regardless of the route, 50% of the treated animals were immune tolerant to the inject
C7 and failed to generate anti-C7 antibodies. We conclude that the CD40-CD40L interaction
is the most promising single target for inhibiting C7-induced immune responses in RDEB mice.
Tolerance regimens (intravenous or oral administration of C7) induce long-term tolerance in
many RDEB mice. Optimizing tolerance, in combination with immunosuppressants, will likely
inhibit untoward immune responses in treated RDEB patients.
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Chromatin immunoprecipitation (ChIP) in primary mouse keratinocytes reveals novel target
genes of ∆Np63 including Runx1
K Ortt and S Sinha Biochemistry, SUNY at Buffalo, Buffalo, NY
The development of the epidermis involves coordinated and dynamic processes of keratinocyte
proliferation, stratification and differentiation. The transcription factor p63 has been shown to
play a critical role in these steps and is thought to function by regulating specific sets of tar-
get genes. Recently, numerous p63 target genes have been identified by microarray and ChIP-
ChiP experiments. So far these studies have been primarily limited to transformed human ker-
atinocyte cell lines such as HaCaT and ME180. We have employed a genomic screening
strategy to identify bona fide p63 response elements in primary mouse keratinocytes. For this
purpose we performed an improved chromatin immunoprecipitation (ChIP) assay utilizing spe-
cific polyclonal antibodies against ∆Np63, the predominant isoform expressed in keratinocytes.
Analysis of such p63-ChIP-derived DNA segments from primary mouse keratinocytes has
revealed more than 200 potential target loci located close to or embedded within known and
predicted genes. Many of these target genes uncovered in our studies include the mouse coun-
terpart of human genes that have been previously implicated to be regulated by p63 thus val-
idating our approach. Among these genes we have identified Runx1, a transcription factor
known to play a critical role in hair follicle development. Biochemical studies including gelshift
and ChIP reveal that ∆Np63 binds to a p63-response element that is located within a well-
conserved intronic enhancer of the Runx1 gene. Furthermore reduction of ∆Np63 levels in
human and mouse keratinocytes alters the expression of Runx1. Taken together our data sup-
port the notion that p63 directly regulates Runx1 gene expression through a novel enhancer
element and suggests a role for these two transcription factors in dictating skin keratinocytes
and appendage development. Collectively, these studies have offered novel insight into the
regulatory networks controlled by ∆Np63.
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Role of NF-kB and JNK signaling pathways in skin appendegeal neoplasia predisposed by cyld
genetic mutations
M Benson, B Leshin, TM Hensley, RN Harris, Y Jin, AM Selim and JY Zhang Medicine, Duke
University, Durham, NC
Loss-of-function mutation in cylindromatosis (cyld) predisposes multiple types of familial and
sporadic skin appendageal neoplasia, indicating that CYLD functions as a tumor suppressor.
The molecular mechanisms underlining the pathogenesis due to CYLD deficiency, however,
remain controversial. The canonical NF-kB pathway was previously predicted to be the cen-
tral mediator in the pathogenesis of cylindromas based on the biochemical data demonstrat-
ing that CYLD inhibits signal transduction from cell surface receptors to downstream NF-kB
signaling. This idea was recently challenged by the latest findings revealing that the TPA induced
hyperproliferation of cyld-/- mouse keratinocytes is independent on RelA, the predominant
NF-kB subunit, and that induction of NF-kB inhibits surface epidermal cell growth. In con-
trast to NF-kB, JNK and its downstream AP1 proteins are required for the epidermal hyper-
plasia and neoplasia associated with NF-kB inhibition, as demonstrated in our recent work.
Based on these findings, we hypothesize that the JNK/AP1 signaling pathway, another down-
stream target of CYLD, plays a dominant role in the skin appendegeal neoplasia associated
with CYLD deficiency. Consistent with this hypothesis, our preliminary studies found that JNK
but not RelA was induced in all 12 cylindromas examined. Currently, we are in the process
of generating transgenic mouse models as well as genetically engineered human skin grafts
on immune-deficient mice to determine the role and the functional mechanisms of JNK/AP1
signaling cascade in the pathogenesis associated with CYLD deficiency.
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Dissecting the mechanism of transcriptional regulation of the CTLA-4 gene using aden-
ovirus 2 E1A
HM Gibson and HK Wong Dermatology Research, Henry Ford Health System, Detroit, MI
CTLA-4 is a member of the co-stimulatory molecule, which negatively regulates T cell acti-
vation. The gene is inducible in normal T cells and is constitutively expressed in Treg cells.
The mechanism regulating the CTLA-4 gene is unclear. To understand the mechanism regu-
lating the human CTLA-4 gene, we cloned the upstream promoter and identified a proximal
regulatory region within the first 500bp that confers inducible regulation using transient reporter
assays in human T cells, both in Jurkat cells and in primary T cells. By mobility shift assay, we
show that NFAT1 can bind to the CTLA-4 proximal promoter. We also show that NFAT1 acts
at this promoter by chromatin immunoprecipitation (ChIP) assays. In reporter assays with addi-
tional upstream sequences, there is minimal promoter activity, suggesting the role of tran-
scriptional inhibition. These findings support that other factors are needed in regulating the
CTLA-4 gene. To study the role of transcriptional cofactors, we asked whether E1A could alter
CTLA-4 promoter activity. The E1A protein is an oncoprotein that affects transcription regula-
tion via three highly conserved domains. Conserved region (CR) 1 binds the p300/CEBP tran-
scription regulator, CR2 binds the p105Rb protein, and CR3 interacts with transcription fac-
tors. E1A cotransfection studies with CTLA-4 promoter reporter plasmids show that the NFAT
site of the CTLA-4 promoter is repressed by E1A CR1 and CR2, suggesting the role of p300
and pRb acting on the NFAT site. Interestingly, E1A plasmids encoding CR3 have the ability
to increase the activity of plasmids with the distal CTLA-4 promoter, supporting the role of
transcription inhibition acting at the distal promoter. These E1A studies support the role of CR1
and CR2 dependent E1A coactivators acting at the proximal CTLA-4 promoter through NFAT
to regulate CTLA-4 expression. Furthermore, the increase in reporter activity of CTLA-4 con-
structs with upstream region with E1A CR3 support the role of inhibition as a mechanism reg-
ulating CTLA-4 gene in T cells.
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Comprehensive analysis of the filaggrin gene reveals a spectrum of prevalent and rare muta-
tions in ichthyosis vulgaris and atopic dermatitis
A Sandilands,1 A Terron,1 PR Hull,1 H Liao,1 Y Zhao,1 M Schmuth,2 MA van Steensel,3
CS Munro,4 CN Palmer,1 FJ Smith,1 AD Irvine5 and W McLean1 1 University of Dundee,
Dundee, United Kingdom, 2 Univ Innsbruck, Innsbruck, Austria, 3 Univ Maastricht,
Maastricht, Netherlands, 4 SGH, Glasgow, United Kingdom and 5 OLCH, Dublin, Ireland
The FLG gene encodes profilaggrin, a protein essential for formation and hydration of the stra-
tum corneum. We have shown that FLG null mutations cause ichthyosis vulgaris (IV), a com-
mon keratinizing disorder often associated with atopic dermatitis (AD). Furthermore, we have
shown that two prevalent null mutations in FLG, R501X and 2282del4, predispose individu-
als to AD and other atopic diseases. The FLG DNA sequence is highly repetitive and shows
size variation, making full sequence analysis difficult. By identifying and validating repeat-
specific primers, we devised a PCR strategy that allows comprehensive analysis of the entire
gene. Using this approach, we sequenced European patients with a severe IV phenotype and
identified 7 novel FLG null mutations, two of which are recurrent. These are nonsense and
frameshift mutations are located in FLG repeats 5, 6, 7 9 and 10. Histological and ultrastruc-
tural analysis of skin biopsies from affected persons revealed very reduced or absent kerato-
hyalin. Immunoblotting revealed low levels of truncated profilaggrin but no processed filag-
grin was detected. We also screened a cohort of 188 Irish children with moderate-severe AD
for both new and previously published variants. Comparing the combined allele frequencies
for 5 recurrent mutations in the AD cohort versus 736 Irish controls gave a highly significant
association, chi-square P=2.12x10-51. We sequenced FLG in selected AD patients from this
cohort and identified 3 additional family-specific mutations in repeats 4 and 10. In total, ~47%
of our AD cohort carry one or more FLG null alleles. In conclusion, our strategy has identi-
fied a spectrum of null mutations in the European population which cumulatively contribute
to the overall risk for AD and will allow identification of recurrent and rare FLG mutations in
other ethnic groups.
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Mutations in R-spondin 4 (RSPO4), a novel secreted protein involved in Wnt signaling, under-
lie inherited anonychia
Y Ishii,1 M Wajid,1 H Bazzi,2 KA Fantauzzo,2 AG Barber,2 DC Blaydon,3 JS Nam,4 JK Yoon,4
DP Kelsell3 and AM Christiano1,2 1 Dermatology, Columbia University, New York, NY, 2
Genetics & Development, Columbia University, New York, NY, 3 Centre for Cutaneous
Research, Institute of Cell & Molecular Science, University of London, London, United
Kingdom and 4 Center for Molecular Medicine, Maine Medical Center Research Institute,
Scarborough, ME
Congenital absence of the nails in humans is referred to as anonychia/hyponychia congenita
(OMIM 206800), a rare autosomal recessive condition in which the only phenotype is the
absence or severe hypoplasia of all fingernails and toenails. Using homozygosity mapping,
we recently identified a region of linkage on chromosome 20p13 and identified a variety of
mutations in the R-spondin 4 (RSPO4) gene in several affected families from India, Pakistan,
Finland and the UK. Here, we studied five consanguineous families from Pakistan (N1-N5)
that show recessive inheritance of anonychia/hyponychia. Screening of the five families for a
mutation in the RSPO4 gene revealed homozygous mutations in RSPO4 in all families. Fam-
ilies N1, N2 and N4 have a novel splice site mutation at the exon 2/intron 2 boundary (IVS-
1G>A). Family N3 has a 26 bp deletion, which includes the start codon in exon 1. N5 has a
missense mutation changing the initiating methionine of RSPO4 to isoleucine (M1I). Each of
these mutations is predicted to severely impair the synthesis of a functional RSPO4 protein.
In order to localize the expression of Rspo4 and Rspo3 during early nail development, we
performed whole mount in situ hybridization on e14.5 mouse embryos. We found that Rspo4
and Rspo3 are exclusively expressed in the mesenchyme underlying the digit tip epithelium.
These findings identify the R-spondin family of proteins as group of potential novel activators
of wnt signaling expressed in the mesenchyme during nail development.
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Therapeutic siRNAs for treatment of pachyonychia congenita
FJ Smith,1 RP Hickerson,2 J Sayers,1 RE Reeves,3 CH Contag,3 D Leake,4 RL Kaspar2 and
W McLean1 1 University of Dundee, Dundee, United Kingdom, 2 TransDerm Inc., Santa
Cruz, CA, 3 Stanford University, Stanford, CA and 4 Dharmacon, Layfayette, CO
Pachyonychia congenita (PC) is a rare autosomal dominant keratin disorder characterised by
hypertrophic nail dystrophy, palmoplantar keratoderma, and oral leukokeratosis. PC is divided
into two main types, PC-1 due to mutations in keratin K6a or K16 and PC-2 by mutations in
K6b or K17. Currently there are no therapies for PC or the most painful aspect of the disorder,
plantar keratoderma, which can lead to wheelchair confinement. The soles of the feet are there-
fore the initial tissue target for therapy. Here we present studies aimed at using RNAi for treat-
ing PC and demonstrate its utility for other autosomal dominant disorders of the skin. The goal
is local reduction of expression from both K6a alleles (mutant and wildtype) by treatment
with siRNAs to locally alleviate the symptoms in PC patients with K6a mutations. Four siR-
NAs were designed against the unique 3’UTR region of K6a and tested both in a cell culture
model and in a mouse model. In culture, we demonstrated knockdown of endogenous K6a
in two keratinocyte cell lines, HaCaT and NEB1 by transient transfection of the four K6a siR-
NAs independently, resulting in almost 100% reduction of K6a as visualised by protein gels
and immunoblotting. Other keratins present in HaCaT and NEB1 cells were virtually unaf-
fected, and specificity for K6a was further demonstrated in a cell culture model of K6a and
K6b expression. The lead K6a-3’UTR siRNA was then tested in a mouse model using luciferase
activity as an in vivo readout. In the mouse model, imaging using an IVIS camera (Xenogen
Corp.), demonstrated that the specific siRNA (but not non-specific controls) strongly inhibited
bicistronic (a single mRNA encoding both K6a and the firefly luciferase) gene expression in
mouse skin (intradermal injection into footpads). These data suggest that with siRNA we can
specifically target mutated genes in PC as a potential therapy, and that loss of K6a would be
compensated for by other keratins including K6b.
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Small molecule library screening to identify compounds that regulate keratin 6a expression
Y Zhao, W McLean and FJ Smith Human Genetics Unit, University of Dundee, Dundee,
United Kingdom
Dominant-negative mutations in keratin K6a are the most common cause of pachyonychia
congenita (PC), a genodermatosis that is characterized by particularly painful and debilitating
plantar keratoderma, accompanied by nail dystrophy and a range of other ectodermal fea-
tures. Transgenic mouse models imply that complete loss of K6a expression may be less detri-
mental than expression of a heterozygous dominant mutant K6a, due to compensatory expres-
sion of the K6b isogene. Thus, down-regulating K6a expression in PC patients carrying K6a
mutations is predicted to be therapeutic. Here, we took a chemical biology approach to iden-
tify new classes of small molecules that might up- or down-regulate the human K6a gene. A
~6 kb genomic DNA fragment containing the human K6a promoter was isolated and used to
drive a firefly luciferase reporter gene. Both transient and stable transfection experiments
showed that the isolated promoter is regulated exactly as expected with agents known to mod-
ulate K6a expression, such as retinoic acid. A clone of the keratinocyte cell line HaCaT sta-
bly expressing the K6a-f.Luc construct was used to screen a small-scale chemical library of
2522 small molecules. Renilla luciferase expression was used as a cell viability control. Fol-
lowing live cell screening in triplicate, 110 compounds consistently decreased K6a expres-
sion by >40%, with 59 of these decreasing activity by >50%, which was comparable to or
more potent than retinoic acid. In addition, 61 compounds increased K6a expression by >40%,
comparable to the K6a inducer sulforaphane. These compounds had no obvious detrimental
effects on cell viability. An additional 146 compounds appeared to modulate K6a expression
but were discarded as false positives due to non-specific effects on cell viability or on luciferase
expression. This initial set of library hits will form the basis of further more stringent screen-
ing procedures, including off-target effects on other keratin genes, to hopefully identify novel
chemical entities that might regulate K6a expression to therapeutic effect.
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Inheritance pattern in familial keloids
J Clark,1,2 ML Turner3 and JB Kopp1 1 National Institute of Diabetes & Digestive & Kidney
Diseases, National Institutes of Health, Bethesda, MD, 2 Duke University School of
Medicine, Durham, NC and 3 National Cancer Institute, National Institutes of Health,
Bethesda, MD
Keloids represent an exuberant wound healing response following cutaneous injury. Some
keloids are familial and certain population groups (particularly those of African descent) are
at increased risk, suggesting a genetic cause. Bloom reviewed 31 mostly European keloid pedi-
grees, including one of African origin, (New York State J Med 1956) and Marneros et al. reported
14 American keloid pedigrees (Arch Dermatol 2001); these studies suggested autosomal dom-
inant inheritance. Omo-Dare, et al. however, analyzed 34 pedigrees in Nigeria and identi-
fied recessive inheritance (J. Nat Med Assoc 1975). Recently, genetic loci have been identi-
fied in two families with keloids manifesting autosomal dominant inheritance, at 2q23 (Japanese
family) and 7p11 (African-American family) (Marneros et al., J Invest Derm 2004). The latter
locus was subsequently excluded in a Chinese family with keloids (Chen et al., Nan Fang Yi
Da Xue Xue Bao 2006). We have undertaken studies of the phenotype and genetics of fami-
lies with at least three affected individuals. We have recruited 5 multigenerational families for
evaluation at the NIH Clinical Center: 3 African American families, 1 Afro-Caribbean family
and 1 Asian-American family (Indian origin). Recruitment of new families continues. Age of
onset varied considerably, from 4 to 52 years of age; variability was seen both within and
across families. Of 16 generations among the 5 families, only one generation lacked an affected
individual; this is consistent with autosomal dominant inheritance. The fraction of affected
individuals was 47%, 50%, 57% and 80% (data are incomplete in one family); these data sug-
gest high penetrance. Keloid number and morphology differed greatly within families, sug-
gesting variable expressivity, and between families, suggesting possible locus heterogeneity
or genetic modifiers. We conclude that autosomal dominant inheritance is common among
multigenerational families with keloids.
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Paternal germline mosaicism in pachyonychia congenita
L Pho,1 H Liao,2 F Smilth,2 D Konecki,3 S Bale,3 WH McLean,2 B Cohen,4 M Eliason1 and
SA Leachman1 1 Dermatology, University of Utah, Salt Lake City, UT, 2 Human Genetics
Unit, University of Dundee, Dundee, United Kingdom, 3 GeneDx, Gaithersburg, MD and 4
Dermatology, Johns Hopkins, Baltimore, MD
Pachyonychia congenita (PC) is a rare autosomal dominant keratin disorder that is associated
with mutations in keratins K6a, K6b, K16, or K17. We describe the first case of germline
mosaicism in PC, verified by mutation testing. Although the disorder appears to be completely
penetrant, the spectrum and severity of disease manifestations in PC can vary considerably.
The most prominent manifestations of the condition include a painful, usually focal palmo-
plantar keratoderma, thickened nails, pilosebaceous cysts (including steatocystomas), oral
leukokeratosis, follicular keratoses, and sometimes natal or pre-natal teeth. This case began
with the birth of an affected female infant to non-consanguineous parents. Sequence analy-
ses revealed a K6a, N171del mutation. Family history and clinical examinations of her par-
ents revealed no PC-related features. Their next child, a son, was born with similar pheno-
typic features and was found to carry the same K6a N171del mutation. The parents consented
to genetic testing of a buccal swab sample, which revealed homozygous wildtype alleles.
However, sperm collected from the father revealed carriage of the K6a N171del mutation.
Thus, the father possessed a germ cell mutational mosaicism, but not a somatic mutation,
that was transmitted to both of his children. This case demonstrates the need for caution
when counseling clinically unaffected parents without a family history about PC recurrence
risk in additional children.
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Constitutive activation of Stat3 in mouse epidermis (BK5.Stat3C) is linked to hair growth
deficiency and cytoskeletal network damage: Gene expression profiling of BK5.Stat3C mice
DJ Kim,1 PK Riggs,2 K Kataoka1 and J DiGiovanni1 1 Carcinogenesis, The University of Texas
M.D. Anderson Cancer Center, Smithville, TX and 2 Animal Science, Texas A&M University,
College Station, TX
Signal transducer and activator of transcription 3 (Stat3) is one of a family of cytoplasmic pro-
teins that participate in normal cellular responses to cytokines and growth factors as tran-
scription factors. Stat3 modulates various physiological functions including cell survival, cell
cycle regulation, and tumor angiogenesis through regulation of gene expression, and its con-
stitutive activation is associated with a number of human epithelial cancers. Our recent stud-
ies, using skin-specific gain and loss of function transgenic mice, have shown that Stat3 is
required for the development of skin tumors induced by chemical carcinogenesis regimens,
implying its critical role in skin cancer. In these studies, global gene expression patterns in
the epidermis of BK5.Stat3C mice were examined by mouse whole-genome oligo microarray
analysis. Approximately 70 genes were significantly upregulated in epidermis by constitutive
activation of Stat3. Thirty three of these genes were hair follicle related genes. These genes
included trichohyalin, hair keratins, and keratin-accociated proteins that are expressed in hair
shaft and inner root sheath as essential structural components for hair growth. Aberrant expres-
sion of these genes can cause severe hair growth defects. Interestingly, 26 of the 33 hair fol-
licle genes are located on mouse chromosomes 11 and 16. The abnormal expression of hair
follicle genes reflects the phenotypic appearance of Stat3C mice, most notably hair loss. Of
63 significantly downregulated genes, 26 genes encode cytoskeletal proteins including myosin-
related proteins, indicating that Stat3 may exert negative effects on maintenance of keratinocyte
shape and motility by destabilizing cytoskeletal proteins. Collectively, these results show that
Stat3 can modulate genes involved in hair growth and cytoskeleton, in addition to its critical
role in regulation of genes involved in skin carcinogenesis.
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Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes
and alters clinical symptoms in an off-label study in pachyonychia congenita patients
RL Kaspar,1 RP Hickerson,1 L Pho2 and SA Leachman2 1 TransDerm, Santa Cruz, CA and 2
Department of Dermatology, University of Utah, Salt Lake City, UT
Pachyonychia congenita (PC) results from mutations in keratin 6a (K6a), K6b, K16, or K17 and
is a nail and skin disorder with painful palmoplantar keratoderma. The macrolide sirolimus
(rapamycin) has been shown to selectively block translation of mRNAs containing a terminal
5’ oligopyrimidine (TOP) tract (Hay and Sonenberg, Genes & Dev 18:1926, 2004). Analysis
of the 5’ untranslated regions of the inducible keratins K6a, K6b, K16, and K17 revealed the
presence of putative TOP regulatory elements. Treatment of human HaCaT keratinocytes treated
with various rapamycin concentrations (1-30 nM) resulted in decreased K6a expression as
assayed by western blot. For example, a concentration of 3 nM rapamycin led to a 73% decrease
of K6a expression as compared to untreated cells. Under these conditions, there was little or
no change in K5, K14, or the non-keratin control Lamin A/C protein levels. In parallel, rapamycin
has been used in an off-label application in three PC patients. These three patients have tol-
erated therapeutic doses of rapamycin (10-12 ng/ml) for greater than one month without seri-
ous side effects. Well tolerated, previously described side effects include folliculitis and aph-
thous ulcers. Clinical responses of PC patients to rapamycin have been measured with a pain
and activity diary, the validated Dermatology Quality of Life (DQOL) scale, and digital pho-
tography. Preliminary data at one month suggest a therapeutic response in callus character
and subjective improvement. Follow-up data will be available.
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Aberrant filaggrin processing in matriptase deficient mice: potential model for atopic der-
matitis?
T Scharschmidt,1,3 K List,2 R Szabo,2 T Bugge2 and J Segre1 1 Genetics & Molecular Biology
Branch, NHGRI, NIH, Bethesda, MD, 2 Oral & Pharyngeal Cancer Branch, NIDCR, NIH,
Bethesda, MD and 3 Research Scholars Program, HHMI, Bethesda, MD
The purpose of this study is to further elucidate the role of the skin barrier and the structural pro-
tein filaggrin (FLG) in development of atopic dermatitis (AD) and systemic atopy. AD is a chronic
skin disorder affecting ~15% of children in the U.S. More than half of severe AD patients progress
to develop asthma and/or allergic rhinitis, disorders with significant morbidity. Recent human
genetic studies have identified common mutations in the gene encoding FLG that confer pre-
disposition to AD. Moreover, FLG mutations are also associated with asthma in conjunction
with AD, suggesting that an impaired barrier may facilitate atopic progression (McLean, 2006).
FLG is proteolytically processed in the granular layer of the epidermis into ~37kD repeat pep-
tides thought to bundle keratin intermediate filaments. The serine protease matriptase (MAT) plays
a key role in this process, and MAT -/- mice die perinatally due to a severely impaired skin bar-
rier. We are currently characterizing mice expressing a hypomorphic allele of MAT (<2% of WT
expression) as a potential model for AD. MAThypo mice display impaired processing of FLG and
exhibit ichthyosis on the body surface until hair eruption and on the ears through adulthood.
Histology shows acanthosis and parakaratosis. Quantitative PCR demonstrates upregulation of
numerous FLG-like genes as well as antimicrobial peptides. The former may represent a com-
pensatory response to lack of processed FLG, while the latter suggests barrier impairment, also
found in lesional and non-lesional skin of AD patients. We are currently determining whether
FLG deficiency confers innate susceptibility to systemic atopy by testing epicutaneous sensiti-
zation with antigens from S aureus bacteria, known to colonize AD skin and perhaps facilitate
the disease. Using this model we hope to gain a better understanding of why AD patients are at
increased risk of asthma and ultimately to identify therapeutic targets to halt the atopic march.
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Corrective gene therapy for epidermolysis bullosa simplex in an inducible mouse model
W Buitrago1 and DR Roop1,2 1 Molecular and Cellular Biology, Baylor College of Medicine,
Houston, TX and 2 Dermatology, Baylor College of Medicine, Houston, TX
Epidermolysis bullosa simplex (EBS) is an autosomal-dominant blistering disease. No effec-
tive treatment is available for EBS making gene therapy the only permanent corrective option.
We generated a mouse model that mimics EBS at the genetic and phenotypic level in which
the expression of the mutant K14 allele (mtK14) can be restricted to a small area of the skin.
Focal activation of the mtK14 gene by a topical inducer results in formation of blisters that
heal after a few weeks and never reappear. We showed that the mtK14 gene is activated in
epidermal stem cells (ESCs) and the EBS-ESCs are replaced by normal ESCs migrating from
the untreated areas. We also demonstrated that EBS keratinocytes have diminished capacity
to repopulate graft sites compared to normal keratinocytes and that EBS-ESCs have a selective
disadvantage over normal ESCs in a graft environment. These observations explain the lack of
mosaic forms of EBS and suggest that if EBS-ESCs are removed from a patient, genetically cor-
rected and returned to a blistered area, they have a selective growth advantage over defective
EBS- ESCs. Mice expressing the mtK14 allele at levels about 50% of wild type K14 (wtK14)
fail to exhibit a phenotype, suggesting that if the wtK14:mtK14 ratio is above a threshold, the
skin will have a normal appearance and function. Thus, gene therapy for EBS may only require
alteration of the wtK14:mtK14 ratio towards the wtK14 allele without the need for correcting
or completely suppressing the mtK14 allele, but rather by partially suppressing the mtK14
allele or by overexpressing the wtK14 allele. We developed lentiviral vectors encoding siRNA
constructs that specifically cleave the mtK14 transcripts and others carrying the wtK14 gene.
We demonstrated that they effectively transduce keratinocytes with long-term transgene expres-
sion in tissue culture and in vivo. We were able to correct the EBS phenotype as we showed
that EBS keratinocytes form a normal epidermis when transduced with these lentiviral vectors
and are grafted onto nude mice.
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Hair abnormalities are rare in pachyonychia congenita
L Pho,1 S Florell,1 R Harris,1 A Bowen,1 C Munro,2 H Liao,3 F Smith3 and SA Leachman1 1
Dermatology, University of Utah, Salt Lake City, UT, 2 Dermatology, Southern General
Hospital, Glasgow, United Kingdom and 3 Human Genetics Unit, University of Dundee,
Dundee, United Kingdom
Pachyonychia congenita (PC) is a rare autosomal dominant keratoderma associated with muta-
tions in keratins (K) 6a, 6b, 16, and 17. PC is sub-classified into two major subtypes: PC1 (K6a
and K16) and PC2 (K6b and K17). Both subtypes are associated with thickened nails, palmo-
plantar keratoderma, pilosebaceous cysts, follicular keratoses, and oral leukokeratosis. An
additional feature observed in PC2 but not in PC1 includes hair abnormalities (including pro-
tuberant eyebrows and pili torti), but a systematic examination of hair from multiple PC patients
has not previously been performed. We analyzed 47 PC individuals from 34 families to deter-
mine the frequency of hair abnormalities in PC. Mutation status was known on 68% (N=32).
We examined scalp hair samples from 18 subjects (16 families) with K6a mutations, 10 sub-
jects (10 families) with K16 mutations, 1 subject with a K6b mutation and 3 subjects (2 fam-
ilies) with a K17 mutation (PC-2). Microscopic hair shaft analysis revealed one subject with a
K17, N92D mutation that showed microscopic features suggestive of pili torti (versus mechan-
ical trauma), but a family member with the same mutation did not share this feature. The
remaining hair samples with unknown mutation status also showed no features of pili torti or
other hair abnormalities (32%, N=15). Interestingly, despite the fact that K6a/K16 mutation
carriers manifest follicular keratoses, there is apparently no hair abnomalities in PC-1 scalp
hair. Unfortunately too few cases of PC-2 were available to permit confirmation of previous
reports of scalp hair involvement. Additional cases of mutation tested PC-2 patients and fam-
ily members will be analyzed in our ongoing investigation of etiology of hair abnormalities in
PC.
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Stability study of unmodified siRNA and shRNA and relevance to clinical use
RP Hickerson,1 AV Vlassov,2 D Leake,3 Q Wang,4 CH Contag,4 BH Jonhston2 and RL Kaspar1
1 TransDerm, Santa Cruz, CA, 2 Somagenics, Santa Cruz, CA, 3 Dharmacon, Lafayette, CO
and 4 School of Medicine, Stanford, Stanford, CA
RNA interference offers a novel approach for developing therapeutics for dominant genetic
disorders by selectively inhibiting mutant gene expression over wild-type. We have developed
a siRNA (K6a.12) that selectively targets the mutant form of keratin 6a (K6a) responsible for
the rare monogenic skin disorder pachyonychia congenita (PC). A number of chemical mod-
ifications designed to provide nuclease resistance or enhance delivery were tested in tissue
culture and mouse models and were found to have similar potencies when compared to the
unmodified version. However, in some instances, these chemical modifications resulted in
loss of single nucleotide specificity. Here we present a stability study of unmodified K6a.12
and EGFP siRNAs and their shRNA counterparts under conditions relevant to clinical use.
Our results indicate that neither repeated freeze/thaw cycles nor extended incubations (up to
28 days at 4 or 21°C) have any effect on si/shRNA integrity as measured by PAGE and func-
tional activity assays. Furthermore, no degradation was observed at high temperatures (65
and 85°C for 2 hr) nor following contact with hair/skin. Incubation at 95°C (2 h) showed minor
siRNA degradation but no change in functional activity; however, the shRNA counterparts
showed degradation and loss of activity after only 30 min at 95°C. Incubation in fetal bovine
serum for 5 h at 37°C showed near complete degradation and loss of activity, whereas incu-
bation in human serum showed only partial degradation, even after 48 h. Interestingly, par-
tial degradation observed by gel electrophoresis did not always correlate with loss of activity,
suggesting that partially degraded si/shRNAs can retain full functional activity. Additionally,
we demonstrate the ability to knockdown EGFP expression in a transgenic EGFP mouse model
by intradermal injection of unmodified EGFP-specific siRNAs. Taken together, these data sug-
gest that unmodified siRNAs and shRNAs are viable candidates for drug development.
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Epidermal-specific deletion of GATA-3 results in selective barrier deficiency
C de Guzman Strong,1 S Patel,1 PW Wertz,3 C Wang,1 F Yang,2 PS Meltzer,2 T Andl,4
SE Millar,4 I Ho,5 S Pai6 and JA Segre1 1 National Human Genome Research Institute,
Bethesda, MD, 2 National Cancer Institute, Bethesda, MD, 3 University of Iowa, Iowa City,
IA, 4 University of Pennsylvania, Philadelphia, PA, 5 Brigham and Women’s Hospital, Boston,
MA and 6 Dana Farber Cancer Institute and Children’s Hospital, Boston, MA
The epidermis functions as a semipermeable barrier that prevents water loss and entry of harm-
ful agents such as toxic substances and infectious agents. The barrier is comprised of pro-
teinaceous cornified envelopes and lipid lamellar structures in the stratum corneum that form
the “bricks and mortar” of the epidermis. We have recently identified GATA-3 as a transcrip-
tion factor necessary for the establishment of the epidermal barrier and ex utero survival by
characterizing mice with an epidermal-specific deletion of GATA-3. Lipid profile analysis of
the epidermis and ruthenium-tetroxide stained lipid electron micrographs revealed a lipid
defect that likely confers the observed barrier deficiency. This finding corroborates the microar-
ray analysis of GATA-3 deficient skin transcriptomes at critical stages of epidermal develop-
ment which also highlights defects in lipid biosynthesis and a delay in differentiation. Con-
served GATA-3 binding sites in the first intron of the lipid acyltransferase gene AGPAT5 were
identified using genomics (comparative sequence alignment) and bioinformatics (TRANS-
FAC) and in vivo binding of GATA-3 to this region was demonstrated using chromatin immuno-
precipitation. We are currently extending these studies to identify other genes potentially reg-
ulated by GATA-3 that were misregulated in our GATA-3-deficient skin microarrays.
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Sphingosine 1-phosphate triggers apoptotic signal for B16 melanoma cells via prolonged ERK
and caspase-8 activation
J Shin, H Lee, M Cha and G Choi Dermatology, Inha University, Incheon, South Korea
The bioactive sphingolipid metabolite sphingosine 1-phosphate (S1P), recently was reported
to induce apoptosis of some cancer cells and neurons, although it is generally known to exert
mitogenic and antiapoptotic effects. We had previously presented that S1P induced time- and
dose-dependent apoptosis in B16 melanoma cells. In that study, apoptosis induced by S1P
was found not to be associated with cell membrane receptors for S1P but caspase-3 activa-
tion. In this study, we aim to investigate the exact mechanism of apoptosis of cultured B16
melanoma cells treated with 10 µmol of S1P using caspase assay, FACS, and Western blot
assays for p-ERK, Fas, Bcl-2 family and cytochrome C proteins. In results, we reconfirmed that
more than 12 hours of S1P treatment with more than 5 µmol induced apoptosis of B16
melanoma cells. S1P induced B16 cell apoptosis by caspase-8, -9, and -3 activations, in the
order. S1P increased Bcl-2/Bax protein expression in the early 12 hours of the treatment.
Cytochrome C wasn’t changed by S1P treatment. Fas was not expressed by S1P. Interestingly,
S1P induced prolonged expression of ERK and U0126, the specific MEK inhibitor, reversed
cell death. In conclusion, S1P induces apoptotic signal on B16 melanoma cells by prolonged
ERK activation and caspase-8 may be the messenger of ERK. S1P also appears to exert anti-
apoptotic signal by increasing Bcl-2 protein.
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Signaling through α9 acetylcholine receptor is critical for initiation of keratinocyte migra-
tion
A Chernyavsky, J Arredondo and SA Grando Dermatology, University of California Davis,
Sacramento, CA
Epithelialization, a major component of wound healing, depends on keratinocyte (KC) migra-
tion. The launching of migration relies upon the ability of KCs to free themselves from neigh-
boring cells and basement membrane. The local cytotransmitter acetylcholine (ACh) controls
KC adhesion and locomotion through different classes of ACh receptors (AChR). In this study,
we explored signaling pathways downstream of the α9 AChR subtype that controls cell shape
and cytoplasm mobility. Inactivation of α9 signaling by pharmacologic antagonism and RNA
interference in KC cultures and null mutation in knockout mice delayed wound re-epithe-
lization in vitro and in vivo, respectively, and diminished the extent of colony scattering and
cell outgrowth from the megacolony. Although KCs at the leading edge elongated, produced
filopodia and moved out from the culture substrate, most of them remained anchored to the
substrate by long cytoplasmic processes that stretched during their migration instead of retract-
ing the uropod. Since the velocity of KC migration was not altered, we investigated the role
of α9 in assembly/disassembly of the cell-cell and cell-matrix adhesion complexes. Stimula-
tion of α9 upregulated in a time-dependent fashion phosphorylation of the adhesion mole-
cules comprising focal adhesions (FAK, paxillin) and intercellular junctions (β-catenin,
desmoglein 3) as well as cytokeratins. Stimulation of α9 was associated with activation of phos-
pholipase C, Src, EGF receptor kinase, protein kinase C, Rac and Rho, whereas inhibition of
this receptor interfered with phosphorylation of adhesion and cytoskeletal proteins, and also
altered KC shape and adhesion. We conclude that signaling through α9 AChR is critical for
completion of the very early stages of KC migration. By activating α9 AChR, ACh can control
the dynamics and strength of cell-cell cohesion, disabling of a trailing uropod and disassem-
bly and re-assembly of focal adhesions, thus facilitating crawling locomotion of KCs.
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Global regulation of CRF signaling through CRFR1 receptor splicing
MA Zmijewski and AT Slominski Pathology and Laboratory Medicine, UTHSC, Memphis, TN
Corticotropin releasing factor receptor type 1 (CRFR1) plays a fundamental role in central
responses to stress. CRFR1 is also expressed in human skin, where it undergoes alternative
splicing to produce multiple isoforms of which CRFR1α plays the most important role in sig-
nal transduction. Since biological role of alternative splicing of CRFR1 is unknown, in-depth
spatial and functional analyses of CRFR1 splicing variants have been performed in human ker-
atinocytes. CRFR1 isoforms α and c were predominantly localized to the plasma cell mem-
brane. However, the isoform c was not fully active, because of a partial deletion of substrate
binding domain. Isoforms d, f and g showed partial deletions of C terminal fragment resulting
in their intracellular localization. Moreover, co-expression of CRFR1α with d, f or g isoforms
resulted in retention of both isoforms in Golgi complex, apparently leading to attenuation of
CRH signaling. The soluble isoforms e and h lacking 7-TM domains were detected in culture
medium and isoform h was also localized in endoplasmic reticulum but it did not co-local-
ized with CRFR1α after double transfection experiment. Co-expression of CRFR1α with e or
h resulted in further stimulation of transcriptional activity of cAMP and IP3 responding ele-
ments, when compared with CRFR1α alone. Furthermore, expression of CRFR1h further stim-
ulated ligand dependent POMC expression. Additional experiments have shown that expres-
sion pattern of CRFR1 depended on cell culture conditions, e.g., proliferating subconfluent
keratinocyte cultures expressed multiple CRFR1 isoforms, while confluent cultures expressed
solely CRFR1α of which concentration was significantly increased. Similar change in expres-
sion pattern of CRFR1 immunoreactivity was observed in human skin biopsies. In conclusion,
our data indicate that expression of alternatively spliced CRFR1 isoforms affect localization
and modulate function of the main isoform CRFR1α. Thus, alternative splicing of CRFR1 in
skin keratinocytes, represents an important regulatory point deciding on the cellular pheno-
type.
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Roles for TGFβ signaling pathway kinases in the keratinocyte wound-related hypermotility
and growth arrest response activated by a precursor form of laminin-332 (laminin 5)
C Bouez,1,2 E Natarajan,1,2 Z Guo,1,2 P Hercule,1,2 M Bai,1,2 J Jones3 and JG Rheinwald1,2 1
Dermatology, Brigham and Women’s Hospital, Boston, MA, 2 Harvard Skin Disease Research
Center, Harvard Medical School, Boston, MA and 3 Cell and Molecular Biology,
Northwestern University Medical School, Chicago, IL
Laminin-332 (LN332) (old nomenclature LN5) and p16INK4A are expressed coordinately by
keratinocytes at the migrating fronts of skin wounds and microinvasive dysplastic lesions in
vivo, and of scratch wounds made in confluent cultures grown on plastic. p16 expression is
also induced in keratinocytes plated on surfaces coated with the γ2 chain precursor form of
LN332 (LN332’). Cells plated on LN332’ immediately exhibited persistent, directional hyper-
motility and then expressed p16 and ceased dividing—-a mechanism that we have termed
the “hypermotility/growth arrest (HM/GA) response”. Plating cells on LN332’ triggered imme-
diate phosphorylation and nuclear translocation of smad3, a downstream consequence of
TGFβ receptor I kinase activation. Cells on uncoated dishes treated with TGFβ became direc-
tionally motile after a 1d lag and growth-arrested by a p16-independent mechanism. A drug
inhibitor of TGFBRI kinase blocked smad3 translocation, hypermotility, and growth arrest in
response to LN332’ or TGFβ. Drug inhibitors specific for two smad-independent signal path-
way kinases downstream of TGFBRI kinase activation—-p38MAPK and p160ROCK, sub-
stantially protected cells from LN332’-induced growth inhibition while having different effects
on LN332’-induced motility. Stable expression of smad4 or p160ROCK-1 siRNAs did not
impair keratinocyte growth under control conditions and disclosed the relative roles of these
signaling proteins in HM/GA. Our results reveal some similarities but also important differ-
ences between the effects of LN332’ and TGFβ on keratinocyte hypermotility and growth inhi-
bition. These human cell culture systems can be applied as sensitive and specific screening
assays to identify drugs that may be useful therapeutically in promoting wound healing or
interfering with neoplastic invasion.
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Role of the Fanconi anemia/BRCA pathway in mediation of telomere loop opening and clos-
ing
TM Ruenger, A Rees, J Dunn, M Potter, MS Eller and BA Gilchrest Dermatology, Boston
University School of Medicine, Boston, MA
After certain types of DNA damage, the Fanconi anemia (FA)/BRCA signaling pathway mediates
DNA recombination repair of double strand breaks, DNA crosslinks, or stalled replication forks.
Activation of this pathway during S-phase also occurs in the absence of DNA damage, either
spontaneously, or following treatment with oligonucleotides homologous to the telomere 3’ over-
hang (T-oligos) that arrest cells in S-phase. In order to clarify the function of FA/BRCA proteins in
these DNA damage-independent responses, we analyzed spontaneous and T-oligo-induced acti-
vation of the FA/BRCA pathway in primary human fibroblasts. Detailed cell cycle analysis using
bivariate FACS analysis of BrdU-pulsed synchronized cells revealed in both cases that activation
of the FA/BRCA pathway, as assayed by formation of FANCD2 nuclear foci, occurs only in late S-
phase. A DNA recombination function was suggested by co-localization of FANCD2 foci with the
recombination proteins BRCA1 and Rad51. FANCD2 foci were also juxtaposed to TRF1, a protein
found exclusively at telomeres. A TUNEL assay modified to detect telomere ends after opening of
the loop structure demonstrated them only in late S-phase, at the same cell cycle phase and in the
same percentage as cells with activated FA/BRCA pathway. This suggests that telomere opening in
late S-phase occurs together with the DNA damage-independent activation of the FA/BRCA path-
way. DNA staining of cells with open telomere ends showed slightly condensed DNA and local-
ized open telomeres to the edge of pre-condensed chromosomes, consistent with telomeres being
the final sequences to replicate in late S-phase. Cells from FA patients failed to demonstrate open
telomeres, even in cycling cells. We hypothesize that the DNA damage-independent activation of
the FA/BRCA pathway mediates recombination-like processes to open telomere loops, a prereq-
uisite for telomere replication. Failure to properly open and re-close the telomere loop may explain
accelerated telomere shortening, S/G2 delay, and spontaneous chromosomal instability of FA cells.
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Granulocyte-macrophage colony-stimulating factor expression is regulated by epidermal
growth factor receptor pathway
F Mascia,1 V Mariani,2 C Cataisson,1 S Yuspa1 and S Pastore2 1 LCGB lab, NCI/NIH, Bethesda,
MD and 2 Laboratory of Cutaneous Physiopathology, IDI, Rome, Italy
As the EGFR pathway is now recognized to control distinct immune/inflammatory functions
in the epidermis, we studied the role of EGFR in the regulation of keratinocyte GM-CSF
expression. GM-CSF was highly expressed in hyperplastic epidermis of patients with aller-
gic contact dermatitis or psoriasis, two skin diseases characterized by increased levels of
EGFR. To further understand the relationship of EGFR and GM-CSF, we studied human and
murine keratinocytes following pharmacological or genetic ablation of the EGFR pathway.
In cultured human keratinocytes, proinflammatory cytokines such as TNF-alpha and IFN-
gamma synergized with TGF-alpha in the induction of GM-CSF mRNA and protein. Incu-
bation with a specific EGFR tyrosine kinase inhibitor, PD168393, not only prevented TGF-
alpha synergy but also impaired both TNF-alpha and IFN-gamma driven GM-CSF mRNA
expression. Using a CAT reporter assay, we detected a strong inhibition of GM-CSF pro-
moter transactivation exerted by the pharmacological blockade of EGFR or ERK1/2 kinases.
In keratinocytes isolated from EGFR knockout mice, GM-CSF mRNA and protein levels as
well as GM-CSF promoter activity were reduced compared to littermate controls after treat-
ment with TPA or TNF-alpha. These data demonstrate that the EGFR pathway is critical for
the upregulation of keratinocyte GM-CSF expression after proinflammatory stimuli. GM-
CSF is known to contribute to tumor progression in vivo through stromal activation by pro-
moting tumor invasion, stimulating angiogenesis and enhancing the recruitment of inflam-
matory cells. The efficacy of the anti EGFR therapy in several epithelial tumors could be in
part related to its effect on GM-CSF expression.
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Regulation of 12-Lipoxygenase gene expression by Insulin-like growth factor-II promotes cell
proliferation through ERK and PI3K pathway in human keratinocytes
H Yoo, S Kim, Y Kim, H Lee and T Kim Dermatology, Catholic University of Korea, Seoul,
South Korea
Insulin like growth factor II (IGF-II) is known to induce the growth of keratinocytes and to be
significantly elevated in fluid of bullae developed from psoriasis patients. However, the role
of IGF-II in psoriasis is not well elucidated. We found that IGF-II up-regulated the expression
levels of 12-LOX. In this study, we tried to investigate whether IGF-II is involved in the reg-
ulating gene expression of 12-Lipoxygenase (12-LOX) which is already known to be over-
expressed in keratinocytes of germinal layer in psoriatic lesions. To further examine the cel-
lular mechanism of IGF-II actions, we have studied the effects of IGF-II on two major signal
transduction pathways: extracellular signaling-regulated kinase (ERK)-mitogen activated
protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K). IGF-II-induced 12-LOX up-
regulation was attenuated by pretreatment of selective inhibitors or overexpression of dom-
inant negative MEK. In addition, when we treated HaCaT cells with 12-LOX metabolite, 12(S)-
HETE, it directly stimulated DNA synthesis and mitogenesis, and IGF-II injection into mice
skin induced hyperplasia of epidermis in vivo. Taken together, increased expression of 12-
LOX gene by IGF-II might be involved in cell proliferation through the ERK-MAPK and PI3K
pathway.
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Ablation of TAK1 in mouse keratinocytes disturbed hair follicle development
K Sayama,1 K Kajiya,2 Y Shirakata,1 Y Hanakawa,1 S Hirakawa,1 H Nagai,1 X Dai,1 S Akira,3
J Kishimoto2 and K Hashimoto1 1 Dermatology, Ehime University, Toon, Japan, 2 Shiseido Life
Science Research Center, Yokohama, Japan and 3 Osaka University, Osaka, Japan
Transforming growth factor-β-activated kinase 1 (TAK1) is a member of the MAP kinase fam-
ily and is involved in IL-1- and TNF-α-induced NF-κB activation. Previously, we generated
keratinocyte-specific TAK1-knock out (TAK1-KO) mice by breeding TAK1 flox/flox mice with
K5-cre mice. The skin of the TAK1-KO mice was roughened and wrinkled. Histological analy-
sis of the TAK1-KO mice showed thickening of the epidermis with foci of keratinocyte apop-
tosis. Immunohistochemical analysis revealed abnormal expression patterns of keratins 5, 14,
1, and 10 in the TAK1-KO mouse epidermis. Ablation of TAK1 in cultured mouse keratinocytes
resulted in apoptosis, indicating that TAK1 regulates the differentiation and apoptosis of ker-
atinocytes. In this study, we focused on hair development in TAK1-KO mice. Hair develop-
ment was analyzed histologically in embryo and newborn mice. Dermal condensation was
noted in control (TAK1 flox/+/K5-cre) mice at E15.5, when hair germ formation commences,
while dermal condensation was absent in TAK1-KO mice. At E16.5, the epidermis was depressed
and elongated, and hair peg formation was obvious in control mice. Although dermal con-
densation was noted, hair development was apparently delayed in the TAK1-KO mice. At P1-
6, there were fewer hair follicles than in the controls and the hair development was retarded
in the TAK1-KO mice. Since TAK1-KO mice die by P7, we transplanted the mouse skin at P1
to nude mice. Normal hair growth was observed in the transplanted skin of control mice, while
hair elongation was absent on the transplanted skin of TAK1-KO mice. Therefore, TAK1 has a
pivotal role for normal hair follicle development.
582
Human cutaneous carcinomas show decreased GM2/GD2 synthase expression, leading to
ganglioside 9-O-acetylGD3 expression and increased cell proliferation and survival
AS Paller, P Sun, H Iordanov, S McDaniel and X Wang Dermatology, Northwestern Univ Med
Sch, Chicago, IL
Gangliosides of human keratinocytes (KC) regulate cell proliferation and survival. The most strik-
ing difference in ganglioside profile of normal and neoplastic KCs is the significant presence of
an acetylated derivative of ganglioside GD3, 9-O-acetylGD3, which is undetectable in normal
KCs and epidermal tissue. We hypothesized that expression of the enzymes that regulate gan-
glioside content may be altered in carcinomas, leading to increases in 9-O-acetylGD3 that impact
tumor cell behavior. Real-time PCR showed decreased expression of GM2/GD2 synthase in
squamous cell (SCC) and basal cell (BCC) carcinomas. Enzyme suppression by GM2/GD2 syn-
thase antisense treatment led to a marked increase in 9-O-acetylGD3 and mild suppression of
ganglioside GT1b expression in cultured SCC12 cells; stable overexpression of GM2/GD2 syn-
thase led to decreased 9-O-acetylGD3 content. Antisense treatment also increased SCC12 cell
proliferation, as shown by cell counting, incorporation of BrdU, and expression of PCNA, and
protected cells from staurosporine-induced apoptosis. In contrast, overexpression of GM2/GD2
synthase inhibited cell proliferation and induced cell apoptosis. To test the possible effect of
increased 9-O-acetylGD3, rat 9-O-acetyltransferase was stably transfected into SCC12 cells. The
resultant increase in 9-O-acetylGD3 was associated with hyperproliferation and increased cell
survival, but not with an increase in cell invasiveness. SCC and BCC tumor tissue did not show
increased GD3 synthase, which converts GM3, the predominant ganglioside of KCs and carci-
noma cells, to GD3 and 9-O-acetylGD3. We propose that the decreased expression of GM2/GD2
synthase in carcinomas leads to increased 9-O-acetylGD3, probably through transient accumu-
lation of GD3 and activation of 9-O-acetyltransferase. The increase in 9-O-acetylGD3 contributes
to the hyperproliferative phenotype of these carcinomas and promotes cell survival. 9-O-acetylGD3
may be an important target for novel medical therapy against cutaneous carcinomas.
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Stimulation of dermal fibroblast proliferation and migration in vitro by estrogens and related
compounds: implications for wound healing
S Stevenson,1 D Sharpe1 and J Thornton2 1 Burns & Plastic Surgery Unit, Medical Biosciences,
University of Bradford, Bradford, United Kingdom and 2 Medical Biosciences, University of
Bradford, Bradford, United Kingdom
Post-menopausal women have a reduced rate of wound healing, which is reversed by estro-
gen therapy. To investigate the role of estrogens in wound healing we evaluated the effect of
17β-estradiol, specific ERα and ERβ agonists, tamoxifen, raloxifene and the precursor hor-
mones DHEA and androstenedione on human dermal fibroblast proliferation and migration
in an in vitro wound healing assay. Primary cultures of dermal fibroblasts were established
from female abdominal skin (n=5). Cells were cultured in serum-free, phenol red-free medium
+/- either 17β-estradiol, an ERα agonist, an ERβ agonist, tamoxifen, raloxifene, DHEA,
androstenedione or an aromatase inhibitor (Arimidex). Combinations of tamoxifen and ralox-
ifene with 17β-estradiol or DHEA and androstenedione with Arimidex were also included.
Following mechanical wounding cell migration and 3H-thymidine incorporation were eval-
uated. 17β-estradiol significantly accelerated migration; with a further significant increase in
the presence of the ERα agonist, while the ERβ agonist had no effect. Tamoxifen and ralox-
ifene alone had no effect on migration and did not abolish the 17β-estradiol stimulatory effect.
Androstendione had no effect on migration, but DHEA had a greater stimulatory effect than
17β-estradiol, which was abolished in the presence of an aromatase inhibitor. Although 17β-
estradiol and the ER agonists had no effect on DNA synthesis, tamoxifen, raloxifen, androstene-
dione and DHEA all significantly increased DNA synthesis. The effect of tamoxifen wea abol-
ished in the presence of 17β-estradiol, while the effect of DHEA was reversed in the presence
of Arimidex. These results demonstrate that estrogens, SERMs and estrogen precursors have
differential effects on dermal fibroblast proliferation and migration in vitro. A greater under-
standing of their mode of action will be important in the development of improved therapies
for cutaneous wound healing, particularly in postmenopausal women.
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Sphingosylphosphorylcholine-induced interleukin-6 production is mediated by protein kinase
C and p42/44 extracellular signal-regulated kinase in human dermal fibroblasts
J Lee,1 Y Kwon,1 Y Lee,1 K Sohn,1 Y Piao,1 S Back,1 Y Seo,1 K Suhr,2 J Park1 and C Kim1 1
Department of Dermatology, Chungnam National University, Daejeon, South Korea and 2
CNU hospital, Daejeon, South Korea
Sphingosylphosphorylcholine (SPC) has been reported as a novel lipid mediator that exerts
various actions on wound healing process. The aim of this study is to evaluate the involve-
ment of interleukin-6 (IL-6) in SPC-induced wound healing acceleration. We performed
immunohistochemisty analysis to demonstrate the IL-6 induction by SPC. To analyze the sig-
naling events, skin fibroblasts were treated with SPC, and then RT-PCR, ELISA, and Western
blot analyses were carried out. SPC markedly induced interleukin-6 (IL-6) expression in rab-
bit ear wound. SPC also induced IL-6 expression at both mRNA and protein levels in human
dermal fibroblasts cultured in vitro. SPC rapidly phosphorylated p42/44 extracellular signal-
regulated kinase (ERK). Pretreatment with PD 98059, a specific MAPK kinase 1/2 inhibitor,
markedly suppressed SPC-induced IL-6 expression in a dose-dependent manner. Protein kinase
C (PKC) activation by phorbol myristate acetate (PMA) potentiated IL-6 mRNA expression,
whereas PKC inhibition by bisindolylmaleimide blocked SPC-induced p42/44 ERK phospho-
rylation and IL-6 expression. Over-expression of PKCα markedly induced the IL-6 expression
and p42/44 ERK activation. These results suggest that SPC-induced IL-6 production is medi-
ated by PKC-dependent p42/44 ERK activation in human dermal fibroblasts cultured in vitro.
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Influence of substance-P on the cultured sebocytes
W Lee, S Lee, D Kim, H Jung, K Park and H Sung Dermatology, Kyungpook National
University Hospital, Daegu, South Korea
Acne is a complex, chronic and common skin disorder of pilosebaceous units. Although it is
known that exacerbation of acne results from emotional stress, the nature of the association
between stress and acne remains unclear. This is due in part to the lack of substantial evi-
dence regarding the participation of cutaneous neurogenic factors in the pathogenesis of acne.
Culture of sebocytes provides a new insight into the participation of neuropeptides, notably
substance P(sub-P), in the pathophysiology of acne. To examine the possible involvement of
neurogenic factors in the etiology of acne, we used immunohistochemistry to compare the
expression of interleukin-1(IL-1), interleukin-6(IL-6), tumor necrosis factor-α(TNF-α), peroxi-
some and proliferators-activated receptors-γ(PPAR-γ) on the cultured sebocytes stimulated by
sub-P. In addition, we used RNA amplification for IL-1, IL-6, TNF-α, and PPAR-γ and microar-
ray hybridization using TrichoGene chip as a source of cDNA chip. IL-1 is primarily proin-
flammatory cytokines by their ability to stimulate the expression of genes associated with
inflammation. IL-6 is a pleiotropic cytokine with a wide range of biological activities and reg-
ulate inflammation. TNF-α is a pleiotropic pro-inflammatory cytokine that exerts multiple
biologic effects. PPAR-γ is a nuclear hormone receptor and plays a unique role in stimulating
sebocyte lipogenesis. More numerous immunoreactivity to IL-1, IL-6 and TNF-α and increased
RNA amplification for IL-1, IL-6, TNF-α and PPAR-γ were observed after addition of sub-P
compared with the control. In microarray hybridization, multiple genes such as thioredoxin
interacting protein, chitinase 3-like 2, and steroid sensitive gene 1 were more dominantly
expressed. This study reveals that sub-P is involved in the pathogenesis of acne.
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S100A8/A9, a key mediator for positive feedback growth stimulation and inflammation of
normal human keratinocytes
R Ehama,1 T Nukui,2 C Katagiri,1 M Sakaguchi,2 H Sonegawa,2 N Huh2 and T Hibino1 1
Shiseido Life Science Research Center, Yokohama, Japan and 2 Department of Cell Biology,
Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan
S100A8 and S100A9 are known to be up-regulated in hyperproliferative and psoriatic epi-
dermis. The genes are encoded in the psoriasis susceptibility region PSORS4, however, bio-
logical functions of S100A8 and S100A9 in epithelial cells remain largely unknown. We aimed,
therefore, in addressing whether S100A8/A9 shows a direct effect on epidermal keratinocytes.
First we investigated whether S100A8 and S100A9 are secreted by cultured normal human
keratinocytes (NHK). We found that they are mostly secreted into medium in a growth fac-
tors-dependent manner. cDNA microarray analysis demonstrated that exogenously added
S100A8/A9 stimulated NHK to produce a number of cytokines such as IL-8/CXCL8, CXCL1,
CXCL2, CXCL3, CCL20, IL-6, and TNFa that are known to be up-regulated in psoriatic epi-
dermis. These were also confirmed with quantitative RT-PCR. The S100A8/A9-induced cytokines
in turn enhanced the production and secretion of S100A8 and S100A9 in NHK. Furthermore,
recombinant S100A8/S9, at a concentration as low as 1 ng/ml, stimulated the growth of NHK,
which was much stronger than known growth factors including EGF. These results indicate
the presence of a positive feedback loop for growth stimulation involving S100A8/A9 and the
cytokines in human epidermal keratinocytes, implicating its relevance to the etiology of hyper-
proliferative skin diseases including psoriasis.
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Erythropoietin and the hair follicle: Intracutaneous expression of a tissue protective hor-
mone/cytokine
E Bodo,1 A Kromminga,2 W Funk,4 W Jelkmann3 and R Paus1 1 Dermatology, University of
Lübeck, Luebeck, Germany, 2 Institute for Immunology, Clinical Pathology, Molecular
Medicine, Hamburg, Germany, 3 Dept. of Physiology, University of Lübeck, Luebeck,
Germany and 4 Klinik Dr. Kozlowski, University of Lübeck, Munich, Germany
Erythropoietin (EPO), the main regulator of red blood cell production, seems to exert multiple
functions beyond erythropoiesis. Apparently, EPO serves as a tissue-protective hormone/cytokine
in several cell populations, can inhibit apoptosis in pathological circumstances (e.g. ischemic
and toxic stress), and reportedly even stimulates wound healing and angiogenesis in mice. There-
fore, we have asked whether EPO and its receptor (EPOR) have any relevance in human skin and
hair follicle (HF) biology under normal, hypoxic and/or pathologic conditions. By real time RT-
PCR, we detected specific PCR products for both EPO and EPOR in normal human scalp skin and
microdissected humans HFs. By immunohistology, specific EPO immunoreactivity was confined
to the skin epithelium: EPO immunoreactivity was most prominent in the central outer root
sheath of human anagen VI HFs. Since EPO synthesis in the kidney classically is induced by hypoxia
(via hypoxia induced factor [HIF]), we performed PCR analysis of hypoxia-treated HFs. Just like
in the kidney, hypoxia (as evidenced by up-regulated Glut-1mRNA expression) up-regulated the
EPO expression, while HIF mRNA remained unchanged. Microarray analysis of EPO-treated human
HFs revelaed that e.g. RAS-like, kinesin and hemoglobin gene expression was significantly up- or
down-regulated. Chemotherapy-induced intrafollicular apoptosis in situ was inhibited by prior
and concomitant EPO administration to microdissected, organ-cultured human scalp HFs. These
data provide the first evidence that normal human skin expresses EPO and functional EPO-R in
situ and that human scalp HFs are important targets and sources of EPO. While the functional sig-
nificance of EPO/EPO-R-mediated signaling in human skin and HF biology remains to be further
dissected, one such function may be that of an endogenous HFs cytoprotectant.
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Activation of the transcription factor PPAR delta in psoriasis
M Romanowska,1 N al Yacoub,1 H Seidel,2 S Donandt,1 S Phillip,1 M Artuc,1 W Sterry1 and
JP Foerster1 1 Dermatology, Charite Hospital, Berlin, Germany and 2 Enabling Technologies,
Schering Bayer, Berlin, Germany
The nuclear hormone receptor peroxisome proliferator activated receptor delta (PPAR delta)
is induced by TNF alpha, is upregulated in psoriasis, and plays a role in wound healing and
keratinocyte differentiation. Here we report that a large group of dysregulated transcripts in
lesional psoriasis is related to fatty acid signalling and adipocyte differentiation, exhibiting a
pattern consistent with the activation of PPAR delta. In primary keratinocytes, PPAR delta is
induced by the transcription factor AP1, in particular by junB, but not by canonical WNT sig-
nalling, in contrast to its regulation in colon carcinoma cells. In keratinocytes, activation of
PPAR delta enhances proliferation and directly induces heparin-binding EGF-like growth fac-
tor (HB-EGF), known to cause epidermal hyperplasia. We also show that PPAR delta is expressed
in activated T cells and that it is a direct transcriptional target of type 1 interferon. In activated
T cells, PPAR delta blocks apoptosis. The present data suggest that activation of PPAR delta
contributes to the hyperproliferative phenotype in keratinocytes and resistance to T cell apop-
tosis in psoriasis. Since PPAR delta is a major regulator of fatty acid and glucose metabolism,
deranged intermediary metabolism or overt metabolic syndrome, often present in psoriasis,
may significantly influence frequency and severity of disease flares.
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Characterization of a novel cell cycle checkpoint triggered by the tumor suppressor PKCδ
EL LaGory,1 LA Sitailo2 and MF Denning2,1 1 Molecular and Cellular Biochemistry Program,
Loyola University Chicago, Maywood, IL and 2 Department of Pathology, Loyola University
Chicago, Maywood, IL
Tumor suppressor proteins often perform vital functions in the initiation of apoptosis as well
as limiting cellular proliferation by triggering cell cycle checkpoints. The novel protein kinase
C isoform, PKCδ, is a key participant in the UV-induced apoptotic cascade in keratinocytes
(KCs) and activation of this serine/threonine protein kinase triggers mitotic arrest. Retroviral
expression of the PKCδ catalytic fragment (PKCδ-cat) resulted in a pronounced G2/M arrest
in both normal human KCs as well as the HaCaT KC cell line. In addition, expression of the
PKCδ-cat was associated with an increase in the number of polyploid cells, indicative of aber-
rant mitosis and endoreduplication. To identify the stage of mitotic arrest triggered by PKCδ-
cat, KCs were released from nocodazole-induced metaphase arrest, PKCδ-cat was activated,
and KCs were monitored for their ability to complete mitosis. While control KCs progres-
sively divided and entered G1, PKCδ-cat infected cells were unable to successfully complete
mitosis. This indicates a role for PKCδ-cat in arresting cells in the later stages of mitosis,
which include the spindle assembly checkpoint and cytokinesis. Expression of PKCδ-cat also
induced phosphorylation of histone H3 on Ser 10 (P~H3) in both HaCaT and normal KCs,
consistent with the an arrest in mitosis. Intriguingly, in normal KCs the mitotic marker P~H3
was present not only in cells with 4N DNA content, but also in cells with 2N DNA. Immuno-
fluorescent microscopy revealed that PKCδ-cat induced P~H3 in KCs with intact nuclear lamin
B and de-condensed chromatin, both features of cells in interphase. Inhibition of the classi-
cal mitotic H3 kinase, Aurora B, failed to prevent this induction, indicating a role for PKCδ-
cat in a non-canonical pathway of H3 phosphorylation. These results identify a novel cell
cycle checkpoint triggered in late mitosis by PKCδ-cat that may contribute to its tumor sup-
pressor functions by limiting cell proliferation.
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Phosphatidylinositol 4-phosphate 5-kinase 1α is required for calcium-induced human ker-
atinocyte differentiation
Z Xie and DD Bikle Endocrine Unit, VA Medical Center / UCSF and NCIRE, San Francisco,
CA
Keratinocytes proliferate and differentiate in vitro in a manner recapitulating the process of
epidermal differentiation in vivo. Calcium is a major regulator of keratinocyte differentiation
in vitro, and appears to play that role in vivo, but the mechanism is not completely under-
stood. We have previously demonstrated that calcium-induced human keratinocyte differen-
tiation requires an intracellular calcium rise caused by phosphatidylinositol 3-kinase (PI3K)
dependent activation of phospholipase C-γ1 (PLC-γ1). Since both PI3K and PLC-γ1 in the
plasma membrane utilize phosphatidylinositol 4,5-bisphosphate (PIP2) as their substrate, stim-
ulation of PIP2 synthesis in the plasma membrane would be a critical step to sustain the activ-
ities of PI3K and PLC-γ1. Phosphatidylinositol 4-phosphate 5-kinase 1α (PIP5K1α) is a major
enzyme synthesizing PIP2 in the plasma membrane. In this study we sought to determine the
role of PIP5K1α in mediating the ability of calcium to induce keratinocyte differentiation. We
found that treatment of human keratinocytes in culture with calcium resulted in increased
PIP5K1α level and activity, as well as PIP2, IP3 and intracellular calcium levels. Knocking-
down PIP5K1α expression in human keratinocytes using RNA interference (RNAi) blocked
calcium-induced increases in PIP2, IP3 and intracellular calcium, as well as keratinocyte dif-
ferentiation markers keratin 1, involucrin and transglutaminase. Co-immunoprecipitation stud-
ies revealed that calcium stimulated complex formation of PIP5K1α with E-cadherin/catenins
in the plasma membrane. These results indicate that PIP5K1α recruited by calcium-depend-
ent E-cadherin/catenins to the plasma membrane is a critical enzyme to continuously supply
the substrate PIP2 for PI3K and PLC-γ1, and is required for calcium-induced keratinocyte dif-
ferentiation. This work was supported by the NIH grant P01AR39448.
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Evidence for altered Wnt signaling in psoriatic skin
JE Gudjonsson,1 A Aphale,1 JJ Voorhees1 and JT Elder1,2 1 Dermatology, University of
Michigan, Ann Arbor, MI and 2 Dermatology, Ann Arbor Veterans Affairs Health System, Ann
Arbor, MI
Wnt5a, a member of the noncanonical Wnt pathway, was recently demonstrated to be upregulated
in lesional psoriatic skin. However, the source of Wnt5a and its role in psoriasis pathogenesis is
unknown. We subjected 40 paired biopsies from lesional (PP) and uninvolved (PN) psoriatic skin
and 40 biopsies from normal control skin (NN) to global gene expression profiling using Affymetrix
HU 133 Plus 2.0 gene arrays. Wnt5a was upregulated 5-fold in PP skin whereas no changes were
observed for Wnt3a, Wnt4, Wnt5b, Wnt 7b, Wnt11 or Wnt16. WIF-1, a secreted antagonist of the
Wnt proteins, was markedly downregulated in lesional skin (>10-fold) whereas no changes were
observed for other Wnt antagonists. Expression results were confirmed with QT-PCR on 10 PN, 10
PP and 10 NN samples. Immunohistochemistry of PN and PP skin revealed decreased staining for
WIF-1 in PP epidermis, whereas Wnt5a staining was increased, with foci of intense staining within
the dermal papillae. Staining for Frizzled-5, a receptor for Wnt5a, was positive in both PN and PP
epidermis. QT-PCR of cytokine-stimulated normal human keratinocytes (NHK) revealed constitu-
tive expression of Wnt5a, whereas WIF-1 expression was undetectable. Wnt5a expression in PBMC
was stimulated 3-4-fold by LPS and was 6-7 fold higher in LPS-activated PBMC compared to NHK,
suggesting that leukocytes are a major source of Wnt5a in PP skin. Wnt5a exerted modest growth
suppression in NHK, whereas a slight increase in proliferation was observed in WIF-1, anti-Wnt5a
and Wnt3a treated cells. Wnt5a enhanced defect closure in scratched NHK monolayers, albeit to
a lesser extent than Wnt3a. We confirmed that Wnt3a signals through the mTOR pathway in NHK,
whereas no activation was observed with Wnt5a. Our results suggest that the non-canonical Wnt
pathway is driven by Wnt5a expression in infiltrating leukocytes in PP skin, and that homeostatic
inhibition of Wnt signaling by WIF-1 may be impaired. Further studies are needed to define the pre-
cise role(s) of Wnt signaling in the pathogenesis of psoriasis.
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Inactivation of calcium sensing receptor inhibits the E-cadherin-mediated cell-cell adhesion
and calcium-induced differentiation in human epidermal keratinocytes
C Tu and DD Bikle Endocrine Unit, VA Medical Center, San Francisco, CA
Calcium-induced keratinocyte differentiation is associated with the engagement of E-cadherin-
mediated cell-cell adhesion, which plays a critical role in orchestrating cellular signals medi-
ating cell survival and differentiation. The calcium sensing receptor (CaR) is also important for
mediating calcium signaling and calcium-induced differentiation in epidermal keratinocytes.
To investigate the functional link between CaR and E-cadherin, we examined the role of CaR
in the assembly of the E-cadherin/catenin cell-cell adhesive complex. Fluorescence immunolo-
calization revealed that initiation of E-cadherin mediated cell-cell adheren junction formation
occurs within 5 minutes after switching calcium concentration from 0.03 to 2 mM. Calcium
enhanced the co-localization of α-, β-, and p120-catenin with E-cadherin in the adheren junc-
tions. The assembly of E-cadherin/catenin complex was sensitive to the pharmacologic inhi-
bition of Src family tyrosine kinases and phospholipase C, but was not affected by the treat-
ment with agents that prevent the calcium-induced increase of intracellular free calcium.
Inactivation of the endogenous CaR gene by adenoviral expression of a CaR antisense cDNA
suppressed the formation of E-cadherin/catenin complex. Western analyses of total cell lysates
indicated that the expression of E-cadherin, β- and p120-catenin was not decreased by inhi-
bition of CaR. Cell fractionation studies demonstrated that calcium promotes translocation of
E-cadherin, β-catenin and the protein tyrosine kinase Fyn to the cell membrane in control
keratinocytes, whereas the levels of membrane-associated E-cadherin, β-catenin, and Fyn were
markedly reduced in the cells lacking CaR. Furthermore, inactivation of CaR significantly
decreased cell proliferation and calcium-induced expression of differentiation markers, while
increased the number of apoptotic cells. Our results indicate that CaR plays an important role
in E-cadherin mediated cell-cell interactions that impact on cell proliferation, survival and
differentiation.
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The Role of SCF and c-KIT in keloid pathogenesis.Can Gleevec do the job!
A Mukhopadhyay,1,3 Cs Yung,3 LL Uung,3 LB Hui,2 WM Yi,3 AY Khoo1 and TT Phan1,2 1
Surgery, National University of Singapore, Singapore, Singapore, 2 Bioengineering, National
University of Singapore, Singapore, Singapore and 3 Pharmacy, National University of
Singapore, Singapore, Singapore
Keloids are fibroproliferative disorders characterized by increased deposition of extracellular
matrix components. SCF and its receptor c-KIT are expressed in a wide variety of cells and
have also been demonstrated to be important modulators of the wound healing process. Thus
the SCF/c-KIT system could be an important player in keloid pathogenesis. Our results demon-
strated that both SCF and c-KIT were upregulated in keloid scar tissues in vivo thus corrobo-
rating our hypothesis. They were also upregulated in cultured fibroblasts on stimulation with
serum highlighting their importance in the initial phase of wound healing. In addition we
demonstrated that epithelial-mesenchymal interactions, mimicked by coculture of keratinocytes
and fibroblasts in vitro, not only stimulated secretion of soluble form of SCF in keloid cocu-
lutres but also brought about shedding of the extracellular domain of c-KIT perhaps by upreg-
ulation of TACE. TACE was also shown to be upregulated in keloid scars in vivo and keloid
cocultures in vitro. We finally demonstrated gleevec, a tyrosine kinase inhibitor, to be a pos-
sible therapeutic agent for keloids.
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Lack of evidence for activation of the Hedgehog pathway in psoriasis
A Aphale,1 JE Gudjonsson,1 M Grachtchouk,1 T Johnson,1 JJ Voorhees,1 A Dlugosz1 and
JT Elder1,2 1 Dermatology, University of Michigan, Ann Arbor, MI and 2 Dermatology, Ann
Arbor Veterans Affairs Health System, Ann Arbor, MI
Psoriasis is a common chronic inflammatory and hyperproliferative skin disorder. Recent reports
have suggested that the Hedgehog (Hh) pathway is activated in lesional psoriatic skin and that
pharmacological inhibition of this pathway may lead to rapid resolution of the disease. To
assess Hh pathway activity in psoriasis, we isolated RNA from lesional (PP) and uninvolved
(PN) skin of 40 psoriatic patients, and from 40 normal control subjects (NN), and subjected
these samples to global gene expression profiling on Affymetrix HU133 Plus 2.0 gene arrays.
To validate the microarray results, quantitative real-time PCR (QRT-PCR) was performed on
10 PP, 10 PN and 10 NN samples and 12 basal cell carcinomas (BCC). We also performed in
situ hybridization for PTCH1 and GLI1, two target genes whose expression it tightly linked to
Hh pathway activity. The microarray data demonstrated a negligible decrease in expression of
GLI1 and PTCH1 in lesional skin when compared to PN or NN skin (1.1 and 1.2 fold for
GLI1, p <0.05; 1.8 fold and 2.1 fold for PTCH1, p<0.001). No differences in mRNA expres-
sion levels were observed for the ligands SHH, DHH and IHH. QT-PCR confirmed these find-
ings, and revealed the expected high-level expression of PTCH1 and GLI1 in BCC, which is
caused by constitutive Hh pathway activation. In situ hybridization for GLI1 and PTCH1 was
positive in BCC tumor cells, but was below the level of detection in any cell type in uninvolved
or lesional psoriatic skin. These results demonstrate that two reliable markers of Hh signaling
are not upregulated in lesional psoriatic skin, indicating that the Hh pathway is not activated
in this disease, and raising questions regarding the proposed use of Hh antagonists as anti-
psoriatic agents.
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Small interference RNA of c98 attenuates the anti-apoptotic action of insulin-like growth
factor 1 to mouse skin keratinocytes
H Su,1 S Liu,2 M Dong1 and SR Gilmour3 1 Biotechnology, Pingtung University, Pingtung,
Taiwan, 2 Veterinary Medicine, Pingtung University, Pingtung, Taiwan and 3 Medicine,
Auckland University, Auckland, New Zealand
Insulin-like growth factor 1 (IGF-1) is a potent mitogen and plays as a survival factor in the
skin of mammals. We have previously identified a gene, c98 (GenBank accession number:
AY170344) that is induced by IGF-1 and homologous to bcl-2 in mouse keratinoctes(BBA
1676:127-137, 2004). The aims of this paper are to further investigate the anti-apoptotic action
of c98 in mediating IGF-1 receptor (IGF1-R)using RNAi (RNA interference) technolog. Indi-
vidual IGF-1 and IGF1-R, and their synergistic effects on the survival of skin were examined
in a mouse keratinocyte cell line using dexamethasone (DEX) as an anti-cancer drug. IGF-1,
IGF1-R, and IGF-1-IGF1-R were all found to be able to protect epidermal keratinocytes from
DEX-induced apoptosis, based on the findings that after the cells were treated with DEX,
DNA laddering present in the control cells but not in those treated with IGF-1, IGF1-R, and
IGF-1-IGF1-R. Using a photometric enzyme-linked immunoassay to quantitate keratinocyte
death, we found that after addition of DEX, the reduced amounts of IGF-1, IGF1-R, and IGF1-
IGF1-R, were 49%, 68%, and 87%, respectively. To assess the inhibitory role of c98 siRNA in
restoring these anti-apoptotic processes, we have generated a recombinant plasmid that con-
tains an expression vector and c98-siRNA and transfected this plasmid into the keratinocytes
without IGF-1 treatment. Expression of the c98-siRNA protein was found to completely (p>0.05)
restore DEX-induced apoptosis after cell transfection. Taken together, our current data demon-
strated that IGF-1 and its receptor play anti-apoptotic roles in DEX-induced apoptosis in epi-
dermal keratinocytes and this, at least in part, may be mediated through c98.
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Defects in the cAMP-protein kinase A signal transduction pathway lead to spotty pigmenta-
tion and endocrinopathy
D Levy and B Safai Dermatology, New York Medical College, New York, NY
We review the cAMP-protein kinase A (PKA) signal transduction pathway and demonstrate where
defects along this pathway are implicated in several genodermatoses. These defects translate
into similar phenotypes which feature spotty skin pigmentation and endocrinopathy. Examples
include: McCune-Albright (MA), Peutz-Jeghers (PJ), Multiple Endocrine Neoplasia type 1 (MEN1),
and Carney Complex (CNC). We present a case of CNC and highlight the clinical overlap with
other genodermatoses which share defects in the same pathway. CNC is a familial multiple neo-
plasia disorder with characteristic cutaneous and internal neoplasms. The skin findings include
generalized lentigines, blue nevi and myxomas. Internal findings include: schwannomas, tes-
ticular tumors, and myxomas of the breast, bone, and heart. The cardiac myxomas often have
fatal consequences. Many patients have endocrine dysfunction secondary to a primary adrenal
form of hypercortisolism or growth-hormone producing pituitary adenomas. Clinical genetic
analyses have shown that CNC is transmitted in an autosomal dominant mode and is caused by
mutations of the PRKAR1A tumor suppressor gene, which encodes the 1-alpha subunit of pro-
tein-kinase A (PRKAR1A). This defect results in the disinhibition of PKA which leads to hyper-
active signal transduction along this pathway. While CNC, MA, PJ, and MEN1 have their pathog-
nomonic cutaneous and internal findings, patients with these syndromes share noteworthy features.
Patients with CNC and MA experience precocious puberty and have bone dysplasia. Patients
with CNC and PJ have perioral lentigines and develop hormone-producing testicular tumors. In
addition to endocrinopathies, mucosal lentigines and hypopigmented macules are found in both
CNC and MEN1. A young patient with numerous lentigines and an endocrinopathy should raise
suspicion for a syndrome that originates from a defect in the cAMP-PKA pathway. Recognition
of the classic cutaneous manifestations of each syndrome is important in order to promptly
diagnose and treat the associated life-threatening internal diseases.
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Role of the cannabinoid system in the regulation of human sebocyte functions
N Dobrosi,1 BI Tóth,1 G Nagy,2 A Szegedi,2 CC Zouboulis3 and T Biro1 1 Department of
Physiology, University of Debrecen, Debrecen, Hungary, 2 Department of Dermatology,
University of Debrecen, Debrecen, Hungary and 3 Departments of Dermatology and
Immunology, Dessau Medical Center, Dessau, Germany
Among cannabinoid receptors (CB), up to date, CB1 was mostly described on central nerv-
ous system structures whereas CB2 was e.g. found on various non-neuronal cell types. These
receptors can be efficiently activated by certain endocannabinoid ligands such as the arachi-
donic acid (AA)-derivative anandamide (N-arachydonoil-ethanolamide). It is also known that
AA remarkably stimulates differentiation of human sebocytes, a process that can be quantita-
tively assessed by measuring the elevated lipid accumulation in the cells. Therefore, in the cur-
rent study, we investigated the functional role of the cannabinoid system in biological processes
of human immortalized SZ95 sebocytes. Using immunocytochemistry and Western blot tech-
niques, we successfully identified the expression of CB2 (but, importantly, not of CB1) on SZ95
sebocytes. Consistent with these findings, the CB2-specific synthetic agonist JWH-015 markedly
stimulated lipid synthesis in the cells (assessed by quantitative microfluorimetric determina-
tion of Nile Red release), induced apoptosis (measurement of the suppressed mitochondrial
membrane potential), and decreased cell viability (Sytox Green staining, MTT assay). In con-
trast, the synthetic CB1 agonist ACEA did not modify the above processes. Moreover, we have
also shown that the endocannabinoid anadamide dramatically (approximately 250-300 %
increase compared to control) stimulated lipid accumulation (which effect by far exceeded
the effect of AA) and decreased cell viability. Taken together, our findings strongly suggest the
existence of a functional (endo)cannabinoid system in human sebaceous gland-derived SZ95
sebocytes which (most probably via CB2-mediated signaling mechanisms) may play a key role
in the regulation of differentiation, lipid synthesis, and survival of the cells.
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Fibroblast survival and proliferation requires platelet-derived growth factor bound to one of
3 distinct fibronectin domains on a surface
F Lin,1 K Ghosh,1 X Ren,1 M Tonnesen2,1 and RA Clark1 1 SUNY Stony Brook, Stony Brook,
NY and 2 VAMC, Northport, NY
Survival or death is a fundamental choice that all tissue cells face multiple times during their
life span. Survival signals emanate most often from growth factors and extracellular matrix
molecules while programmed cell death or apoptosis stems from a variety of stress signals.
Platelet-derived growth factor (PDGF) and fibronectin (FN) are both documented survival fac-
tors for mesenchymal cells. Here for the first time it is demonstrated that PDGF-BB bound to
FN on a surface is required for fibroblast survival and proliferation. Radiolabeled PDGF-BB
bound intact FN with a KD of 10 nM and similar affinities were observed with PDGF-BB
equilibrium binding to the FN 1st type III repeat (FNIII1), the 12-13th type III repeat (FNIII12-
13) or the IIICS domain. No binding was seen to the amino-terminal end of FN (FN70), FNIII3-
6, or the RGD-containing central cell binding domain (FNIII-8-11). Similar data were obtained
with kinetic binding using Plasmon Surface Resonance regardless of which binding partner
served as ligand. Although 30 ng/ml PDGF-BB stimulated adult human dermal fibroblast migra-
tion when bound to FN growth factor-binding domains (FN-GFBD) in solution or tethered to
a 3-D matrix, fibroblast survival and proliferation required PDGF bound to FN-GFBD on a sur-
face. FN-GFBD and FNIII8-11 tethered to intermolecularly crosslinked hyaluronan plus 15 ng
PDGF-BB markedly enhanced porcine cutaneous wound healing at 4 days as judged by re-
epithelialization (47%), granulation tissue formation (44%) and angiogenesis (56%)(P<0.01
by ANOVA and post-hoc Tukey analysis) compared to non treatment controls or PDGF-BB in
RGD-HA gels. This study suggests that FN and its bound PDGF stimulate co-operative signal-
ing through integrins and PDGF receptors required for mesenchymal cell survival. In addi-
tion, the study has important implications for the delivery of GFs using engineered biomate-
rials containing FN- GFBD for wound healing treatments.
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Role of the c-Jun N-terminal kinases in human epidermal neoplasia
RN Harris,1 S Tao,2 A Fox,3 Y Jin1 and JY Zhang1 1 Medicine, Duke University, Durham, NC,
2 Stanford University, Stanford, CA and 3 Tulane University, New Orleans, LA
The c-Jun N-terminal kinase (JNK) proteins, including JNK1, JNK2 and JNK3, comprise one
family of the three major mitogen-activated protein kinases (MAPK) along with Erk and p38.
Our recent studies have demonstrated that the uncontrolled epidermal proliferation due to
impairment of NF-kB function is dependent on JNK and its downstream target AP1. We have
also shown that JNK/AP1 induction by expression of active MKK7, the immediate activator of
JNK, can synergize with oncogenic Ras to transform normal human epidermal cells into malig-
nancies resembling squamous cell carcinoma (SCC). It is not clear, however, whether JNK1,
JNK2 and JNK3 play redundant or differential roles in human epidermal growth and neopla-
sia. To address this, we first established that JNK1 and JNK2, as well as JNK3 which was pre-
viously thought to be restricted to brain and testis, are highly expressed in human epidermal
cells by western blotting. In order to determine the sufficiency and requirement of each JNK
proteins in epidermal neoplasia, we generated retroviral expression systems for stable expres-
sion of active JNK proteins or shRNAs specifically designed to down regulate each JNK pro-
tein in human keratinocytes. Our preliminary studies revealed that JNK2 but not JNK1 was suf-
ficient to induce epidermal malignancies in skin grafts regenerated on immune-deficient
mice with primary human keratinocyes transduced to express active JNK1 or JNK2 along with
oncogenic Ras. The JNK2-induced neoplasia is dependent on intact AP1 function as AP1 inhi-
bition by dominant negative c-Jun abrogated invasive tumor growth. We are currently in the
process of investigating the role of JNK3 in Ras-driven tumorigenesis and the effects of down
regulating JNK proteins on human epidermal tumorigenesis induced by MKK7 and Ras, as
well as spontaneous SCC cells both in vivo and in vitro.
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IGF-1 secreted by fibroblasts alters the UVB-response of keratinocytes
DA Lewis1 and DF Spandau1,2 1 Dermatology, Indiana University School of Medicine,
Indianapolis, IN and 2 Biochemistry, Indiana University School of Medicine, Indianapolis, IN
The maintenance of homeostasis in the skin is critically dependent on the synergistic interac-
tions between dermal fibroblasts and epidermal keratinocytes. The proliferation, differentia-
tion, and stress response of keratinocytes are greatly altered when deficiencies in dermal fibrob-
lasts occur. We hypothesize that the normal UVB-response (defined as protection from
carcinogenic initiation) of keratinocytes is also highly dependent on the functional status of
dermal fibroblasts. As previously reported, we have defined conditions where the appropri-
ate UVB-response of normal human keratinocytes is altered by differential activation of the
receptor for insulin-like growth factor-1 (IGF-1); keratinocytes grown in conditions where the
IGF-1 receptor is inactive have increased sensitivity to UVB-induced apoptosis and retain the
capacity to replicate in the presence of UVB-induced DNA damage. We believe these in vitro
culture conditions that alter the UVB-response of keratinocytes mirror instances of deficient
fibroblast function in vivo. We now demonstrate that normal human fibroblasts can produce
a diffusible protective factor which restores the normal UVB response of keratinocytes. Neu-
tralizing antibodies to IGF-1 can inhibit this protective effect on UVB-irradiated keratinocytes.
Through the use of quantitative RT-PCR, we have shown that cultured normal human fibrob-
lasts express the IGF-1 gene while normal human keratinocytes do not. Using IGF-1-specific
siRNA we are able to inhibit the expression of IGF-1 in fibroblasts. Normal human fibroblasts
treated with IGF-1-specific siRNA failed to protect keratinocytes from UVB-induced apopto-
sis. Therefore, the inhibition of normal fibroblast production of IGF-1 negatively alters the
appropriate UVB-response of normal keratinocytes. These data support our hypothesis that
alterations in IGF-1 expression in dermal fibroblasts have profound effects on the response of
epidermal keratinocytes to UVB irradiation, perhaps consequentially propagating initiating
carcinogenic DNA mutations.
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Ozone exposure of human epidermal keratinocytes results in activation of aryl hydrocar-
bon receptor leading to increased expression of cytochrome P450: Role of phosphorylation
of EGFR
H Mukhtar,1 M Abu Zaid,1 F Afaq,1 DN Syed,1 E Pelle,2 MS Matsui2 and D Maes2 1
Dermatology, University of Wisconsin, Madison, WI and 2 Biological Research, The Estee
Lauder Research Laboratories, Melville, NY
Ozone (O3), one of the main components of photochemical smog, represents an important
source of environmental oxidative stress to which the skin is exposed especially during ozone
alert days. O3 exposure has been shown to induce antioxidant depletion as well as the oxi-
dation of lipids and proteins in the skin. Enzymes of the cytochrome P450 (CYP) superfamily
are important class of drug-metabolizing enzymes with an important role in the health, dam-
age, and function of skin. For example, induction of the CYP1A family of isoforms is respon-
sible for enhanced cutaneous cytotoxicity. The present study was designed to determine the
effect of O3 on CYP isoforms in normal human epidermal keratinocytes (NHEK). Ozone
(0.3/ppm for 20 min) treatment of NHEK resulted in increased expression of CYP1A1, CYP1A2
and CYP1B1 both at protein and mRNA levels. Because the aryl hydrocarbon receptor (AhR)
induces transcription of CYP1A genes, we determined the effect of O3 on AhR. O3 treatment
resulted in increased expression of AhR protein and mRNA in NHEK. Since AhR is known to
“cross-talk” with the epidermal growth factor receptor (EGFR), we next examined the effect
of O3 on phosphorylation of EGFR. O3 treatment of NHEK resulted in an increased phos-
phorylation of EGFR. We then determined the effect of O3 on downstream events of EGFR and
found that it resulted in an increased: (i) activation of PI3K, (ii) phosphorylation of AKT, and
(iii) phosphorylation of ERK1/2, JNK1/2 and p38. Taken together, these results suggest that O3
exposure of NHEK resulted in activation of AhR leading to increased expression of CYP1A
isoforms as well as phosphorylation of EGFR with concomitant activation of PI3K/AKT and
phosphorylation of MAPK. These studies could lead to development of novel skin care prod-
ucts for ameliorating O3-induced toxic effects in the skin.
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The expression levels of TGFbeta receptor II determine activation or de-activation of the
ERK1/2 pathway without participation of TGFbeta receptor I/Alk5 in human skin cells
B Bandyopadhyay, M Chen, D Woodley and W Li Dermatology, University of Southern
California, Los Angeles, CA
During wound healing and subsequent wound remodeling, the TGFbeta family cytokines
stimulate the resident cells to synthesize and deposit extracellular matrices (ECMs) into the
wound bed. The extracellular signal-regulated kinases (ERK1/2) mediate the signaling from acti-
vated TGFbeta receptor complex to the promoter activity of ECM genes. However, it has long
been a mystery why TGFbeta stimulation causes ERK1/2 activation in some cell types and either
no activation or even de-activation of ERK1/2 in other cell types. Now we have found that
answer by comparative studies between human epidermal keratinocytes (HKs) and dermal
fibroblasts (DFs). We report here that the naturally occurring TGFbeta Receptor II (TbetaRII) lev-
els determine how TGFbeta stimulation affects ERK1/2 activity. High TbetaRII levels in DFs acti-
vate ERK1/2, whereas low TbetaRII levels in HKs further reduce the basal ERK1/2 activity. Down-
regulation of TbetaRII in DFs or up-regulation of TbetaRII in HKs reverses their levels of ERK1/2
activation in response to TGFbeta stimulation. Moreover, the presence of betaglycan/TbetaRIII
in DFs, which is missing in HKs, is also required for maximum activation of ERK1/2. These
findings were further confirmed using previously well-established MV1LU (mink lung epithe-
lial cells) and its derived mutant, R1B and DR26, cell lines. MV1LU cells express both Tbe-
taRI/Alk5 and TbetaRII, but not TetabRIII/betaglycan. R1B cells express only TbetaRII and
DR26 cells express only TbetaRI/Alk5. Increased expression of TbetaRII and TbetaRIII in MV1LU
cells caused the maximum activation of ERK1/2. Similar results were obtained in R1B cells
overexpressing TbetaRII and TbetaRIII, indicating TbetaRI is not required for ERK activation.
Overexpression of TbetaRI alone or TbRI plus TbRIII in DR26 cells was unable to cause ERK
activation in the cells. Thus, this study has provided the answer for how TGFbeta stimulation
selectively activates ERK1/2 and subsequent ECM gene expression in certain cell types.
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Induction of the immediate early transcription factor early growth response-1 in a sodium
lauryl sulfate model of irritant contact dermatitis
KJ White1 and RA Swerlick2,1 1 Dermatology, Atlanta VA Affairs Hospital, Decatur, GA and 2
Dermatology, Emory University, Atlanta, GA
Research studies have examined the effects of irritants in vivo and in vitro, focusing primarily on
events hours to days after irrtant contact. Molecular events occuring immediately after contact
with the skin remain incompletely defined. We hypothesized that characterization of early events
would lead to the identification of key molecular signals necessary for the production of inflam-
matory mediators responsible for the signs and symptoms of irritant contact dermatitis (ICD).
Cultured keratinocytes or HaCaT cells treated with sodium lauryl sulfate (SLS), a model irritant,
were used to examine early molecular events in ICD. We examined various concentrations
(0.001-0.008%) and exposure times (30 min – 4 hrs) and determined that >85% of the cells sur-
vived after 4 hrs of exposure to 0.004% SLS. Immunofluorescence microscopy and western
analysis showed SLS mediated induction of nuclear early growth response 1 (egr-1), a tran-
scription factor capable of regulating genes responsible for hyperproliferation, angiogenesis, and
inflammation, hallmarks of ICD. De novo egr-1 expression was associated with increases in the
expression of both egr-1 mRNA and hnRNA, supporting transcriptional activation of the egr-1
gene. Use of pharmacological inhibitors of p38 or MEK1 demonstrated that SLS-induction of
egr-1 mRNA, hnRNA, and protein were dependent on MEK1, but not p38 signaling. Because
SLS-induced egr-1 was more robust in A431 cells, a human epithelial carcinoma cell line with
marked over-expression of epidermal growth factor receptor (EGFR), we hypothesized that SLS
could signal via EGFR. Pre-treatment of HaCaT cells with the potent EGFR inhibitor AG1478
showed complete abolition of both SLS-induced egr-1 protein and mRNA at concentrations as
low as 62.5 nM AG1478. These data suggest that SLS may trigger proinflammtory pathways by
activating EGFR and inducing egr-1 through MEK1. These studies propose a novel mechanism
of EGFR activation in keratinocytes and provide insight into the mechanisms of ICD.
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A novel “TGFalpha > Hsp90alpha secretion > keratinocyte migration” pathway promotes
skin re-epithelialization and wound closure: evidence for extracellular Hsp90alpha as a potent
autocrine motogen for human keratinocytes
W Li,1 C Cheng,1 S Guan,1 J Fan,1 M Fedesco,1 B Bandyopadhyay,1 A Bright,1 J Fields,1
Y Han,2 M Chen1 and D Woodley1 1 Dermatology, University of Southern California, Los
Angeles, CA and 2 Surgery, University of Southern California, Los Angeles, CA
Re-epithelialization is a critical event in human skin wound healing, in which epidermal ker-
atinocytes are induced to migrate laterally to close a wound. In chronic wounds, the re-epithe-
lialization process is blocked and the wounds remain open, causing patient morbidity and
even fatality. The lack of effective therapeutic targets in this process remains as a major chal-
lenge for new and effective treatments. Transforming growth factor-alpha (TGFalpha) is a crit-
ical inducer of human keratinocyte (HK) migration. Therefore, we investigated how TGFalpha’s
pro-motility signal travels in HKs following TGFalpha stimulation. First, we found that TGFal-
pha-induced secretion of HKs retains the full HK migration-promoting effect of TGFalpha. Sec-
ond, protein purification followed by mass spectrometry analyses of the secretion allowed us
to identify the heat shock protein-90alpha (hsp90alpha) as the secreted protein that carries
the full TGFalpha’s pro-motility effect on HKs. In HKs, TGFalpha rapidly stimulates hsp90alpha
membrane translocation and secretion in the absence de novo protein synthesis. Third, highly
purified hsp90alpha fully duplicates TGFalpha’s pro-motility effect. However, unlike the chap-
eron action of intracellular hsp90alpha, extracellular hsp90alpha promotes HK migration in
the absence of ATP binding, ATPase activity or binding to co-factors. Fourth, inhibition of the
extracellular action of hsp90alpha completely blocks TGFalpha-induced HK migration. Finally,
topical application of recombinant hsp90alpha markedly accelerated wound re-epithelial-
ization and closure in mice. Thus, this study has identified the extracellular hsp90alpha as a
potent autocrine motogen for HKs.
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IGF-1R-dependent regulation of FOXO proteins in human keratinocytes
DA Lewis1 and DF Spandau1,2 1 Dermatology, Indiana University School of Medicine,
Indianapolis, IN and 2 Biochemistry, Indiana University School of Medicine, Indianapolis, IN
Although skin cancer can occur at any age, there is a strong correlation between the devel-
opment of skin cancer and increasing age. Previous reports from our lab have identified the
importance of the insulin-like growth factor-1 receptor (IGF-1R) in maintaining the appropri-
ate response of keratinocytes to UVB irradiation. Interestingly, evidence from longevity stud-
ies in invertebrate and mammalian models has demonstrated a critical role for the IGF-1R sig-
naling pathway in the aging process. Subsequent reports have identified a key role for the
IGF-1R in regulating the response of cells to oxidative stress. The critical downstream com-
ponents of the IGF-1R signaling pathway are members of the O class of the forkhead family
of transcription factors; FOXO1, FOXO3, and FOXO4. Because very little is known about the
presence or role of these proteins in human epidermal keratinocytes, we have begun to exam-
ine the influence of IGF-1R activation on FOXO proteins in primary normal human ker-
atinocytes. Integrating data obtained from qRT-PCR, immunofluorescence, and immunoblot-
ting, FOXO1 is the most abundant member of the FOXO family in primary keratinocytes and
FOXO4 is the least abundant. FOXO1 is found primarily in the cytoplasm; FOXO3 is almost
exclusively nuclear, and FOXO4 is found diffusely in both the nuclear and cytoplasmic com-
partments. The total amounts of each protein are the same in keratinocytes with active or
inactive IGF-1Rs; however, there are distinct changes in the post-translational modification of
the FOXO proteins. In keratinocytes containing functional IGF-1Rs, FOXO1 is acetylated while
FOXO3 is not acetylated. In IGF-1R(-) keratinocytes, FOXO1 becomes deacetylated and FOXO3
is acetylated. We also examined the expression of two genes known to be regulated by FOXO
proteins, GADD45a and MnSOD. In the absence of IGF-1R function, the expression of
GADD45a and MnSOD increased five-fold. These measurements of FOXO activity will serve
as baseline parameters to compare the response of FOXO proteins to UVB irradiation.
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p38α and p38δ mitogen-activated protein kinase isoforms regulate invasion and growth of
head and neck squamous carcinoma cells
M Junttila,4 R Ala-aho,1 T Jokilehto,4 J Peltonen,1 M Kallajoki,2 R Grenman,3 P Jaakkola,4
J Westermarck4 and V Kahari1 1 Dermatology, University of Turku, Turku, Finland, 2
Pathology, University of Turku, Turku, Finland, 3 Otorhinolaryngology, University of Turku,
Turku, Finland and 4 Turku Centre for Biotechnology, Turku, Finland
Cellular specificity of p38 mitogen-activated protein kinase (MAPK)-mediated cellular stress
responses is determined by the expression pattern of the distinct p38 isoforms. Here, we have
analyzed the function of distinct p38 isoforms in the growth and invasion of head and neck squa-
mous cell carcinomas (HNSCC). Activation of p38 MAPK by arsenite resulted in inactivation of
the ERK1,2 signaling pathway by dephosphorylation of MEK1,2 in primary human epidermal
keratinocytes (HEKs), whereas in HNSCC cells this p38-mediated inhibition of the ERK1,2 path-
way was absent. Quantitation of p38 pathway component mRNA expression in HNSCC cell lines
(n=42) compared to HEKs (n=8) revealed that p38α and p38δ isoforms are predominantly
expressed in both cell types and that MKK3 is the primary upstream activator expressed. Inhibi-
tion of endogenous p38α or p38δ activity by adenoviral delivery of dominant negative p38α
and p38δ potently reduced MMP-13 and MMP-1 expression, and suppressed the invasion of
HNSCC cells through collagen. Dominant negative p38α and p38δ inhibited SCC cell prolifer-
ation and inhibition of p38α activity also compromised survival of SCC cells. p38α and p38δ
were predominantly expressed in HNSCCs (n=24) and non-neoplastic epithelium in vivo (n=6),
with MKK3 being the primary upstream activator. Activation and expression of p38α and p38δ
by tumor cells was detected in HNSCCs in vivo (n=16). Adenoviral expression of dominant neg-
ative p38α or p38δ in cutaneous SCC cells potently inhibited their implantation in skin of SCID
mice and growth of xenografts in vivo. These results indicate that p38α and p38δ specifically
promote the malignant phenotype of SCC cells by regulating cell survival, proliferation, and inva-
sion, suggesting these p38 MAPK isoforms as potential therapeutic targets in HNSCCs.
www.jidonline.org   S101
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Gene expression and signaling pathways in acute wound healing
J Lai,1 YW Asmann,2 K Squillace1 and MR Pittelkow1 1 Dermatology, Mayo Clinic College of
Medicine, Rochester, MN and 2 Biomedical Informatics, Mayo Clinic College of Medicine,
Rochester, MN
A better understanding of the normal wound healing process is required to more effectively
treat chronic ulcers. This study was designed to comprehensively profile gene expression pat-
terns during acute wound healing. The complete wound healing-closure program was exam-
ined in individual human subjects. Four healthy volunteers were recruited and consented. Four
3-mm punch biopsies were performed on the lower calf of each subject and the skin speci-
mens were collected as control. One, 3, 10, and 14 days after wounding, one wound was
collected by a 5-mm punch biopsy. Total RNA extracted was used in genetic studies with
Affymetrix HG-U133 Plus 2.0 GeneChip arrays. Genes whose expression changed greater than
2-fold over at least one time point were clustered into 5 groups using supervised clustering
algorithm. Each cluster was analyzed using Ingenuity Pathway Analysis. Group 1 was upreg-
ulated and returned to baseline, and included IL-6 and TIMP 1. Significant pathways included
IL-10, Leukocyte Extravasation, and Natural Killer Cell. Group 2 was upregulated and included
cyclins and topoisomerase II. Pathways included Complement/Coagulation, Cell Cycle, and
Antigen Presentation. Group 3 was downregulated and returned to baseline, and included
laminin and integrins. Pathways included Wnt/β-catenin, Eicosanoid, and Phospholipid Degra-
dation. Group 4 was unchanged then upregulated, and included complement components
and collagen I. Pathways included Complement and Coagulation, Integrin, and Leukocyte
Extravasation. Group 5 was downregulated and remained low, and included epiregulin and
betacellulin. Pathways included Valine/Leucine/Isoleucine Degradation, Neuregulin, and
Butanoate Metabolism. Complement/Coagulation, Lysine Degradation, PDGF signaling, and
β-alanine Metabolism pathways appeared in all groups. These findings are being interrogated
to correlate expression patterns with overall function and compare them with non-healing
ulcers to identify gene products that could be utilized to develop better treatment modalities.
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Inducible expression of amphiregulin-specific small hairpin RNA blocks autocrine prolifer-
ation of human keratinocytes
SW Stoll,1 JL Johnson1 and JT Elder1,2 1 Dermatology, University of Michigan, Ann Arbor, MI
and 2 Ann Arbor VA Hospital, Ann Arbor, MI
Aberrant EGFR signaling has been implicated in various hyperproliferative skin disorders includ-
ing psoriasis and skin cancer. Human keratinocytes (KC) express multiple EGFR ligands in an
autocrine fashion including amphiregulin (AR), HB-EGF and TGF-α. We have previously shown
that KC express and shed much more AR than TGF-α or HB-EGF and that autocrine KC growth
can be selectively and potently blocked with anti-AR antibodies. To confirm and extend these
findings, we asked whether RNAi-mediated inhibition of AR expression would block KC growth.
To this end, we used an inducible lentivirus system (Invitrogen) that allows tetracycline (Tet)-
regulated expression of small hairpin RNA (shRNA). Immortalized, nontransformed human KC
(N-TERT2G) were infected with a TET repressor lentivirus to generate a stable cell line (N-
TERT-TR). These cells were infected with constructs encoding various shRNAs targeting AR,
EGFP, or lamin, and AR gene expression was assessed using QRT-PCR. We found that an AR-
specific shRNA (shAR) reduced AR mRNA expression by >75% after 24h and 48h of Tet treat-
ment, whereas shRNAs targeting EGFP (shEGFP) or lamin had no effect. Similarly, expression
of shAR but not shEGFP strongly reduced AR protein in 48 hr conditioned medium (shAR: 98%,
shEGFP: 18%, n=2, ELISA assay). To assess the effect of shAR on proliferation, KC were incu-
bated under autocrine conditions in the presence or absence of Tet. Growth of KC expressing
shAR, but not shEGFP, was strongly reduced in the presence of Tet (> 84% inhibition, n=4).
Addition of insulin (5 ug/ml) did not overcome the growth-inhibitory effect of shAR. Our data
demonstrate that AR is necessary for autocrine growth of human KC in the presence or absence
of insulin, and validate this system as a versatile tool for regulating the expression of endoge-
nous genes in nontransformed human KC. Targeting AR mRNA expression might be of thera-
peutic potential in hyperproliferative skin conditions.
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Increased activity of Src-family tyrosine kinases in psoriasis and cutaneous neoplasia
E Ayli, W Li, R Elenitsas and JT Seykora Department of Dermatology, University of
Pennsylvania, Philadelphia, PA
Src-family tyrosine kinases (SFKs) are important regulators of keratinocyte growth and differ-
entiation. In general, persistent activation of SFKs correlates with increased cell proliferation.
In this study, we wanted to determine if SFK activity is increased in common hyperprolifera-
tive epidermal disorders such as psoriasis, squamous cell carcinoma (SCC), and precursor
lesions of SCC. Randomly selected formalin-fixed tissue samples were retrieved from archives
and included: 14 psoriasis biopsies, 6 actinic keratoses (AKs), 5 squamous cell carcinomas in
situ (SCIS), 4 invasive SCCs, and 6 specimens of unremarkable epidermis. Using a phospho-
rylation-state specific antibody, staining for activated SFKs was detected in a membrane-pat-
tern with a lesser degree of cytoplasmic staining; nuclear staining was not seen. All psoriasis
specimens displayed significant staining for activated SFKs, compared with sections of unre-
markable skin. In addition, the intensity of activated SFK staining was proportional to the degree
of psoriatic epidermal hyperplasia. Of the AKs, SCISs, and SCCs, all demonstrated more exten-
sive staining for activated SFKs than did sections of unremarkable epidermis. Furthermore,
actinic keratoses, potential precursor lesions for SCC, displayed less staining than SCC spec-
imens. No discernable difference was seen between in situ and invasive specimens. The results
of our study show, for the first time, the presence of elevated levels of SFKs in human biopsy
specimens of psoriasis and cutaneous neoplasia. This data provides direct evidence for the
role of activated SFKs in the pathogenesis of hyperproliferative epidermal disorders.
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Srcasm-dependent Ras downregulation requires the Srcasm binding site for Grb2
E Ayli, C Marshall, W Li and JT Seykora Department of Dermatology, University of
Pennsylvania, Philadelphia, PA
Supraphysiologic levels of activated Ras are associated with many human carcinomas, and
Ras is an important downstream effector of tyrosine kinases, including Src and Fyn. Much
experimental work has shown that Grb2, Shc, and Sos are part of a mechanism linking tyro-
sine kinase activity to Ras activation. However, our understanding is incomplete regarding
mechanisms linking tyrosine kinase activity to Ras deactivation. Herein, we report that Srcasm
downregulates Ras activation in a manner that requires phosphorylation at tyrosine 392, its
Grb2 binding site. Srcasm is a substrate of Src-family tyrosine kinases which can downregu-
late activated Src kinases by decreasing kinase protein levels. In COS cells, Srcasm can be
phosphorylated at tyrosine 392 when co-transfected with Fyn; phosphorylation of Srcasm at
Y392 promotes association with Grb2, an activator of Ras. In this study, we characterize the
effect of Srcasm and Srcasm Y392F upon EGF-dependent Ras activation in COS cells. In qui-
escent COS cells, levels of activated Ras are low. COS cells transfected with Fyn exhibit
increased levels of Ras activation as assessed by a GST-Raf pulldown assay. EGF-stimulation
of COS cells transfected with Fyn results in higher levels of Ras activation than with Fyn
alone. Co-transfection of native Srcasm with Fyn results in lower levels of activated Ras than
with Fyn alone, and Ras deactivation by Srcasm is more pronounced in EGF-treated cells. Co-
transfection of Srcasm Y392F with Fyn did not promote Ras de-activation. Both native Srcasm
and Srcasm Y392F downregulate Fyn levels, and the Srcasm Y392F appears to be a more potent
downregulator of Fyn. These data suggest that Srcasm negatively regulates of Ras after EGF
stimulation, and the ability of Srcasm to downregulate Ras requires its Grb2 binding site. The
ability of Srcasm to downregulate Ras activity appears to be independent of its ability to down-
regulate Fyn. Therefore, Srcasm appears to be a novel negative regulator of Ras, and this down-
regulatory mechanism may be an important inhibiting aberrant Ras signaling.
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The effects of Wnt/β-catenin signaling in a murine melanoma model
EC Moore,1 AS Lonsdorf,2 ST Hwang,2 RT Moon1 and AJ Chien1 1 University of Washington
School of Medicine, Seattle, WA and 2 Dermatology, NIH, Bethesda, MD
There is significant controversy in the literature regarding the role of Wnt signaling and nuclear
β-catenin in the development and progression of melanoma. In this study we used the murine
B16 melanoma system to explore the effects of Wnt3a, which activates the canonicle Wnt/β-
catenin pathway, and Wnt5a, which activates a non-canonicle β-catenin-independent signal
transduction pathway. Using B16 melanoma lines stably transduced with lentivirus to over-
express Wnt3a, Wnt5a or GFP, we tested the effect of Wnts on cell division, cell proliferation
and cell migration. In vivo, we measured the effect of Wnts on tumor growth and metastatic
spread in a mouse model and observed that tumors overexpressing Wnt3a exhibited signifi-
cantly decreased growth as compared to cells overexpressing either GFP (p = .0004) or Wnt5a
(p = .0012). Unexpectedly, fewer metastases were seen with tumors overexpressing either
Wnt3a (p = .0025) or Wnt5a (p = .002). Metastases were detected in all animals with B16:GFP
cells (4 of 4 animals), while no metastases were detected in animals with either B16:Wnt3a
or B16:Wnt5a tumors (0 of 4 animals for both lines). In vitro, we observed that both murine
and human melanoma cells overexpressing Wnt3a exhibited decreased cell proliferation as
compared to the control cells or cells overexpressing Wnt5a. On cell cycle analysis, melanoma
lines overexpressing Wnt3a showed an increased percentage of cells in the G1 phase when
compared to control cells or cells overexpressing Wnt5a, which both had similar cell cycle
profiles. Of note, cells overexpressing Wnt3a and Wnt5a migrated into scratches faster than
control cells, supporting the hypothesis that Wnt signaling promotes changes in melanoma
cell motility. Overall, our results suggest that Wnt3a can promote migration in vitro while
negatively regulating tumor growth in melanoma cells in vivo and in vitro, providing a poten-
tial explanation for the relative lack of β-catenin signaling observed in advanced tumors.
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The roles of Src-kinases and Srcasm in wound healing
J DelPriore, E Ayli, W Li and JT Seykora Department of Dermatology, University of
Pennsylvania, Philadelphia, PA
Wound healing requires coordinated molecular events that promote epidermal restoration. To
correct the epidermal deficit, keratinocytes must proliferate and migrate over the wound bed.
SFKs play important roles in regulating keratinocyte motility and proliferation. Srcasm is a sub-
strate of SFKs that is rapidly phosphorylated after EGF or TGF-alpha stimulation of primary human
keratinocytes and increased Srcasm expression promoted decreased levels of activated SFKs.
Given the central role of SFKs and Srcasm in regulating keratinocyte growth and differentiation,
we characterized activation of Src-family tyrosine kinases (SFKs) and Srcasm levels in acute human
wound tissue and in in vitro wound healing models. Acute healing wounds from re-excision
specimens were analyzed for levels of activated SFKs, SFKs, Srcasm, and Ki-67. Biopsy speci-
mens analyzed were selected for an incomplete epidermal layer, which correlates with a re-
epithelializing epidermis, and no residual nevus or carcinoma. A total of 14 wound biopsies
were analyzed, and this set of wounds had an average age of 20.4 days (range 3 - 42 days).
Specimens from both the extremities (35.7%) and trunk (64.3%) were analyzed. Specimen slides
also were pre-selected to contain sufficient uninvolved, unremarkable epidermis adjacent to the
wound site to provide an internal staining control. Immunohistochemical staining demonstrates
that the leading epidermal edge of acute human wounds demonstrates increased SFK activity
and decreased Srcasm levels compared to adjacent unremarkable epidermis. The levels of SFK
activity were proportional to the Ki-67 index and inversely proportional to Srcasm levels. In
vitro wounding assays were performed using adenoviruses transducing Fyn and/or Srcasm into
monolayers of primary human keratinocytes. Increasing Fyn expression via adenovirus enhances
keratiocyte migration into the cell gap, supporting the in vivo staining results. These data suggest
that activation of SFKs may be important for wound re-epithelialization and Srcasm levels may
be important in controlling SFKs during wound healing.
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Wounding alters the beta2-adrenergic signaling pathway in cultured keratinocytes
PE Griffiths,1 B Shi,1 RK Sivamani,1 C Holmes,2 DS Goldstein2 and RR Isseroff1 1 Department
of Dermatology, University of California Davis, Davis, CA and 2 Clinical Neurocardiology
Section, National Institute of Neurological Disorders and Stroke, National Institutes of
Health, Bethesda, MD
Wounding of keratinocytes initiates a number of repair mechanisms. We examined the effects
of wounding on the beta2-adrenergic receptor (beta2-AR) and catecholamine signaling sys-
tem. Human neonatal keratinocytes were cultured to confluence and then wounded using a
multiple wound template so that >20% of the culture plate area was wounded. Immunoblot
analysis of cell lysates of the wounded cultures taken at multiple times after wounding revealed
that the level of beta2-ARs decreased by 75-80% within 1 h of wounding, then returned to
baseline levels as the wounds healed, reaching pre-wounded levels by 6 h. Expression of tyro-
sine hydroxylase, the rate-limiting enzyme in the synthesis of dopamine and norepinephrine,
was downregulated by 50-60% at 30 min to 1 h after wounding. Similarly, the expression of
phenylethanolamine-N-methyltransferase, which catalyses conversion of norepinephrine to
epinephrine, was downregulated by 70-80%. Catecholamine analysis by HPLC with electro-
chemical detection after batch alumina extraction detected DOPA and dopamine but no nor-
epinephrine or epinephrine in cultured keratinocytes. There was about a 50% decrease in cel-
lular dopamine content detected by 30 min post wounding and lasting at least 4 h. This study
indicates that wounding of keratinocytes results in down-regulation of beta2-ARs, dopamine
content, and expression of catecholamine synthesizing enzymes. Since agonist occupation
of beta2-ARs induces a decrease in keratinocyte locomotion, wounding may evoke self-reg-
ulatory mechanisms to limit this phenomenon, and thus enhance wound healing and hasten
re-epithelialization.
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Dermal fibroblasts and hair follicle dermal sheath cells have similar responses to estrogens,
distinct to hair follicle dermal papilla cells, in an in vitro wound healing assay
S Stevenson,1 D Sharpe1 and J Thornton2 1 Burns & Plastic Surgery Unit, Medical
Biosciences, University of Bradford, Bradford, United Kingdom and 2 Medical Biosciences,
University of Bradford, Bradford, United Kingdom
Wound healing is delayed in post-menopausal women, but improves with estrogen therapy. In
addition, the improved wound healing rate of hairy skin may involve mesenchymal hair folli-
cle cells. Since we have previously reported that human hair follicles express estrogen recep-
tors, we have compared matched cultures of scalp dermal fibroblasts, dermal papilla and der-
mal sheath cells in response to 17beta-estradiol in a wound healing assay. Primary cultures
were established from female scalp, mechanically wounded and cultured +/- 10nM 17beta-
estradiol in phenol red-free, serum-free medium for up to 48h. Cell migration, 3H-thymidine
uptake, collagen synthesis and VEGF secretion were evaluated. Dermal fibroblasts and dermal
sheath cells migrated at similar rates, but dermal papilla cells migrated significantly faster. Incu-
bation with estradiol significantly increased migration of dermal fibroblasts, but had no effect
on hair follicle fibroblasts. Post wounding, all cells demonstrated a significant increase in
DNA synthesis, but estradiol had no effect. Wounding significantly increased collagen secre-
tion by all cell types, while estradiol had no effect. All cell types secreted similar levels of
VEGF, which was significantly increased by wounding dermal fibroblast and dermal sheath
cells. Estradiol had no effect on VEGF secretion by dermal fibroblasts, but significantly increased
secretion by wounded dermal papilla cells. In contrast, estradiol significantly decreased VEGF
secretion by wounded dermal sheath cells. These results demonstrate differences in the responses
of follicular and interfollicular scalp fibroblasts to estradiol in a wound healing assay, and pro-
vide further support for the role of mesenchymal hair follicle cells in the wound healing process.
Further understanding of the role of estrogen in cutaneous wound healing may have important
implications for the management of chronic wounds and scarring.
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Isolation and characterization of multipotent stem cells from keloid scars
Q Zhang,1 A Kelly,2 T Yamaza,1 S Shi,1 S Shi1 and AD Le1 1 Center for Craniofacial Molecular
Biology, University of Southern California, Los Angeles, CA and 2 Division of Dermatology,
Charles R Drew University of Medicine and Science, Los Angeles, CA
Recently, multipotent adult stem cells, termed skin-derived precursors (SKPs), have been iso-
lated from rodent and human dermis with both neural and mesodermal differentiation capa-
bilities. In this study, we described the isolation, expansion, and characterization of multipo-
tent stem cells from a pathological fibro-proliferative cutaneous scar, specifically keloid. Similar
to SKPs, keloid-derived stem cells (KSCs) grew in suspension as neuro-spheres in the pres-
ence of fibroblast-growth factor-2 (FGF-2) and epidermal growth factor (EGF), expressed nestin,
β-catenin, fibronectin, and characteristic embryonic transcriptional factors. These neurosphere
cells were also positively stained for Endoglin (CD105), Muc18 (CD146), SH2.3 (CD73) and
Stro-1, frequently expressed mesenchymal surface antigens, but not with specific hemapoi-
etic markers CD34 and CD45. Under defined growth conditions KSCs can differentiate into
several lineages, including progeny types not residential to the dermis such as neurons, glia,
adipocytes, and osteoblasts. Immunohistological studies reveal abundant clusters of nestin
and Oct-4 stained cells in the cell-dense areas, however, scattered spindle-like cells residing
the collagen nodules were only positive for nestin, not Oct-4. These findings suggest charac-
teristic scar-like stem cell niches in the hyper-cellular zone of the dermis favorable for the
self-renewal and stemness maintenance of nestin-positive KSCs, and abundant ECM matrices
of the collagen nodules conducive to residential cell differentiation. Together, these data indi-
cate that resident KSCs are multipotent precursor cells and may function to replenish both
neural and mesodermal progeny types at injury site to initiate a continuing cascade of tissue
repair, thus contributing to the pathogenesis of keloid formation and recurrence.
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Epithelial cells in the bulge region of the hair follicle do not contribute to epidermal regen-
eration after glucocorticoid-induced cutaneous atrophy
I Budunova, D Chebotaev, A Yemelyanov and RM Lavker Dermatology, Northwestern
University, Chicago, IL
One of the major adverse effects of glucocorticoid therapy is cutaneous atrophy often followed
by the development of resistance to steroids (tachyphylaxis). It is accepted that epithelial stem
cells (SC) located in the hair follicle bulge divide during times of epidermal proliferative need.
We determined whether follicular epithelial SCs and their transit amplifying progeny were
stimulated to proliferate in response to the chronic topical application of glucocorticoid flu-
ocinolone acetonide (FA). Using immunofluorescence and FACS analysis of a6-integrin+/CD34+
keratinocytes, we found that the glucocorticoid receptor is expressed in bulge keratinocytes
rendering them sensitive to glucocorticoids. After two applications of FA, keratinocyte prolif-
eration in the interfollicular epidermis and hair follicles was minimal and resulted in signifi-
cant epidermal hypoplasia and reduced cellularity. We show here that only after there was a
50% reduction in epidermal thickness did the epidermal keratinocytes develop resistance to
FA and begin to proliferate in an effort to maintain the epidermal homeostasis. Unexpectedly,
less than 2% of the proliferating keratinocytes were located in the bulge region of the hair fol-
licle, 16% were located in the upper part of hair follicle, whereas 82% were interfollicular
basal keratinocytes. Our results indicate that bulge keratinocytes including follicular SCs: (i)
are more sensitive to the anti-proliferative effect of glucocorticoids than basal keratinocytes;
and, (ii) do not significantly contribute to the restoration of the epidermis after glucocorticoid-
induced cutaneous atrophy. These findings imply that “bulge activation” as related to epider-
mal repair is stimulus-dependent.
614
Modulation of ER calcium pump by taurine during heat-induced cell damage in human pri-
mary keratinocytes
CN Young, M Krishnan, M Borkin and B Savoy Dermatology, Wayne State University, Detroit,
MI
Taurine, a sulfur-based amino acid, has many therapeutic properties including those involved
in thermoregulation, a process designed to protect cells from heat stress. Heat stress, defined
as a prolonged rise in body core temperature exceeding the physiologic range 37oC +/- 1oC,
results in cell injury and often leads to cell death. Keratinocytes, the predominant cell type
found in skin, are most vulnerable to environmental temperature extremes. Therefore, taurine
was applied in heat-induced keratinocytes to better understand the mechanism of taurine-
based thermoregulatory properties. Primary human keratinocytes were exposed to high tem-
perature (42oC +/- 0.5oC) in the presence or absence of taurine for a period of two hours.
Electron microscopy revealed that heat-treated keratinocytes contained hyperextended vesi-
cles, swollen mitochondria, shrunken nucleolus and disturbed plasma membrane whereas
taurine treatment reduced intracellular damage and cells looked similar to control cells (no
heat). Taurine-mediated protection of intracellular organelles such as the mitochondria within
a short time frame suggested that taurine signals, in part, through calcium. To this end, we
also preformed the Assay of mitochondrial Na+-Ca2+ exchange (NCE) to assess whether cal-
cium stores in the endoplasmic reticulum (the major source of intracellular Ca2+) were affected
by taurine. Results showed that Taurine modulates ER store and therefore Taurine reduces
resting Ca2+ homeostatic levels.
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Additive function of Notch paralogs in mouse skin homeostasis and carcinogenesis
S Demehri, Y Pan and R Kopan Molecular Biology and Pharmacology, Division of
Dermatology, Washington University in St. Louis, St. Louis, MO
The Notch pathway plays important roles in regulating at least three processes in skin: sup-
pression of neoplastic transformation, regulation of fate selection in bulge stem cells, and main-
tenance of homeostasis. To define the role of individual Notch paralogs in these functions, we
examined single and compound loss-of-function (LOF) Notch pathway mutants. When assessed
individually, Notch2 or Notch3 LOF mutants lack the tumor suppressor activity possessed by
Notch1; however, in a Notch1 deficient background, progressive deletion of additional Notch
paralogs leads to earlier onset of papillomas due to the increased progenitor numbers and with
that, the likelihood of a second genetic hit. Such expansion of epidermal progenitors and hyper-
proliferation is found to be in part due to an RBP-J-dependent additive activity of Notch
receptors in descendents of both epidermal and bulge stem cells promoting selection of alter-
native fates (differentiated epidermis and hair progenitor, respectively) over the default epi-
dermal basal cell fate. Therefore, a functional Notch pathway is required for hair follicle fate
selection in the bulge. Surprisingly, at the molecular level, progressive loss of Notch signal-
ing in neonates does not result in increased soluble beta-catenin or AKT phosphorylation, but
rather is associated with down-regulation of Erk signaling, which contributes to epidermal
hyperproliferation (Bourcier et al, 2006). Interestingly, a yet to be defined RBP-J-independent
Notch target(s) contribute(s) to the activity of the Notch pathway in skin: RBP-J null animals
display a milder phenotype than those lacking Notch1/Notch2 or g-secretase. This is incon-
sistent with a simple canonical pathway; using triple knockouts lacking g-secretase and RBP-
J, we were able to confirm the existence of a bifurcation in the Notch pathway.
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Inhibition of hair growth by oxidants in the neonatal rat model: Effects on DNA synthesis
EA Connelly,1 JJ Jimenez,2 LM Mauro,3 B Roberts,1 G Elgart1 and LA Schachner1 1
Dermatology, University of Miami, Miami, FL, 2 Hematology/Oncology, University of Miami,
Miami, FL and 3 Molecular Biology, University of Miami, Miami, FL
Alopecia is a multipathophysiological disorder with negative psychological implications. The
exact mechanisms underlying the development of alopecia remain to be elucidated; however
a link has been established between oxidation and alopecia. Nevertheless, little is known
about the effect of oxidants on anagen hair growth in vivo. The young rat model is suitable to
study the human hair follicle cycle, and has been used to study chemotherapy induced alope-
cia. Thus, the current study was conducted to determine the effect of oxidants on anagen hair
follicles. To this effect, two known oxygen radical generators, tert-butyl hydroperoxide (TBH)
and cumene hydroperoxide (CH) were administered subcutaneously daily to 4-day-old rats
for 5 days. Morphological and DNA synthesis changes were assayed upon cessation of oxi-
dant treatment. It was observed that both TBH and CH inhibited hair growth at the site of injec-
tion. Histological evaluation of the treated hair follicles showed evidence of hair follicle dam-
age. However, hair regrowth was noted after termination of treatment without any long term
damage. Pretretatment with the antiodixant butylated hydroxyanisole (BHA) protected hair
follicles in both TBH and CH-treated rats without any toxicity. Taken together, these results
strongly suggest that oxidants reversibly inhibit anagen hair growth. Additionally, treatment
with the antioxidant BHA modulated the effect of both TBH and CH. These observations may
provide interesting insight into the mechanisms underlying the development of alopecia in
humans.
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Microtissue culture of dermal papilla cells by use of controlled biomaterial surface
S Lin,1 C Lee,2 J Chan,1,3 C Hsu1 and H Chiu1 1 Department of Dermatology, National Taiwan
University Hospital and College of Medicine, Taipei, Taiwan, 2 Institute of Biomedical
Engineering, National Taiwan Univeristy, Taipei, Taiwan and 3 Department of Dermatology,
Cathay General Hospital, Taipei, Taiwan
The ability of dermal papilla cells to guide the transdifferentiation of epidermis into follicu-
lar structures can be preserved when they are kept in multicelllar aggregates or microtissues,
an intercellular organization similar to that in vivo. In the field of tissue engineering, there
have been no efficient methods to produce dermal papilla microtissues in large scales. In
this work, we demonstrate a method that facilitates microtissue formation of dermal papilla
cells on EVAL (poly (ethylene-co-vinyl-alcohol) ) surface. We show that EVAL is able to sup-
port the cell proliferation of dermal papilla cells. Seeded above a critical number in on
EVAL, dermal papilla cells spontaneously grow into dense multi-cellular microtissues on
EVAL surface after 3 days in culture. The cells are viable in the microtissue and are able to
grow when they are reseeded. The differentiation markers of dermal papilla cells are pre-
served in dermal papilla microtissue. We further demonstrate that cell densities on a smaller
scale, rather than the overall cell number or the overall cell density, is key to the self-assem-
bly of dermal papilla cells on EVAL surface. The poorer cell attachment to EVAL surface that
facilitate cell migration and the decreased intercellular distance may contribute to the increased
the frequency of intercellular collision. The intrinsic aggregative nature of dermal papilla cells
may lead to the formation of dermal papilla microtissues. With further development, this
system may help to produce dermal papilla microtissues with desired sizes for clinical appli-
cations and pharmaceutical testing.
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DGAT1 is required for vitamin A homeostasis in the skin
MY Shih,1,2 CL Yen,2 P Zhou2 and RV Farese1,2,3 1 Biomedical Sciences Graduate Program,
University of California, San Francisco, San Francisco, CA, 2 Gladstone Institute of
Cardiovascular Disease, San Francisco, CA and 3 Departments of Medicine and of
Biochemisty & Biophysics, University of California, San Francisco, San Francisco, CA
Retinol (vitamin A) regulates important processes in the skin through its conversion to retinoic
acid and modulation of transcriptional activity through retinoic acid receptors. The factors that
regulate retinoid homeostasis in the skin are incompletely understood. We recently determined
that the microsomal enzyme acyl CoA:diacylglycerol acyltransferase 1 (DGAT1) possesses in
vitro acyl CoA:retinol acyltransferase (ARAT) activity (the acylation of retinol to form retinyl
esters). We now show that DGAT1 plays an important role in maintaining retinoid homeostasis
in the skin. Chow-fed DGAT1-deficient (Dgat1–/–) mice had reduced ARAT activity in the skin
and exhibited signs of retinol toxicity, including flaky skin, atrophy of sebaceous glands, and
excessive hair shedding that causes cyclical alopecia. They also exhibited altered hair cycling,
with a prolonged first anagen phase and an early onset of the second anagen phase. The expres-
sion of genes regulated by retinoic acid were increased in Dgat1–/– skin, suggesting that more
retinol is metabolized to retinoic acids in the absence of DGAT1. Vitamin A depletion of
Dgat1–/– mice by feeding a diet low in retinol abrogated the alopecia phenotype, and re-feed-
ing retinol to these mice restored the alopecia phenotype. Selective deletion of DGAT1 in the
epidermis was sufficient to cause the alopecia phenotype, indicating that the retinoid home-
ostatic functions of DGAT1 are tissue autonomous. We conclude that DGAT1 functions as an
ARAT in the skin, where it most likely plays a role in preventing retinol toxicity.
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∆Np63α regulates basement membrane integrity by inducing Fras1
MI Koster1,2 and DR Roop1,2 1 Baylor College of Medicine, Houston, TX and 2 University of
Colorado at Denver and Health Sciences Center, Aurora, CO
The p63 gene encodes a group of transcription factors that are essential for normal epidermal
morphogenesis. Of these, ∆Np63 proteins are predominantly expressed in late embryonic and
postnatal epidermis. We recently demonstrated that downregulating ∆Np63 expression in post-
natal epidermis causes severe epidermal defects, including aberrant keratinocyte differentia-
tion and impaired basement membrane formation, culminating in the development of severe
skin erosions. Similarly, impaired ∆Np63 function causes differentiation and basement mem-
brane defects in patients with the skin fragility syndrome, AEC. We previously demonstrated
that ∆Np63α directly induces IKKα, thereby promoting keratinocyte terminal differentiation.
However, unlike ∆Np63 knockdown mice, IKKα-/- mice do not display basement membrane
defects. To identify novel ∆Np63 target genes, we performed a comparative analysis of global
gene expression changes in ∆Np63 knockdown mice and IKKα-/- mice. Analysis of these
microarray data revealed that the keratinocyte-produced extracellular matrix protein Fras1 was
a putative ∆Np63α target gene. We confirmed that Fras1 was downregulated in ∆Np63 knock-
down skin. In addition, ∆Np63α could induce endogenous Fras1 expression and a reporter
construct based on the Fras1 promoter. Finally, ∆Np63α directly interacts with the Fras1 pro-
moter in mouse embryonic skin. Taken together, our data demonstrate that ∆Np63α directly
induces Fras1 expression, thus contributing to proper basement membrane development and
maintenance. Based on these and previous data, we propose that ∆Np63α initially induces
Fras1, which is required for maintaining the integrity of the epidermal-dermal interface at the
basement membrane. Subsequently, induction of IKKα by ∆Np63α initiates epidermal termi-
nal differentiation. Our data provide novel insights into the role of ∆Np63α in epidermal
morphogenesis and homeostasis, and may contribute to our understanding of the pathogenic
mechanisms underlying disorders caused by p63 mutations.
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Localization of retinoic acid synthesis and signaling in hair follicle morphogenesis
N Yoo,1 JP Sundberg,2,1 DE Ong,1 LE King1 and HB Everts1 1 Vanderbilt University School of
Medicine, Nashville, TN and 2 The Jackson Laboratory, Bar Harbor, ME
Retinoic acid (RA) is necessary for the development and differentiation of many organ sys-
tems including the skin and hair follicle. Previously we demonstrated that components of RA
synthesis and signaling localized to specific structures in the adult cycling hair follicle, which
may regulate its cycling. Our aim in this study is to better understand the role of RA in hair
follicle development by localizing the components of RA synthesis and signaling during fol-
licle morphogenesis. Based on studies in the mature hair cycle we chose 5 of the 9 compo-
nents of RA synthesis and signaling to study. Immmunohistochemistry was performed on dor-
sal skin from 0-9 day old C57BL/6J mice using antibodies against retinol dehydrogenase (Drhs9),
retinal dehydrogenase (Aldh1a2, Aldh1a3), cellular retinoic acid binding protein 2 (Crabp2),
and retinoic acid receptor alpha (Rara) to study the eight stages of follicle morphogenesis. We
found that the localization pattern for the components of retinoic synthesis and signaling shows
similarities to the adult follicle. All components sufficient for retinoic acid synthesis were found
in the precortex area when the follicle begins to differentiate into its various layers early in
development using Aldh1a3 and in the bulge late in morphogenesis using Aldh1a2. The seba-
ceous gland likewise contains all components of retinoic acid synthesis, with RA synthesis
enzymes localizing to the less differentiated cells and RA signaling proteins localizing to the
nucleus of more differentiated sebocytes as we saw during the adult cycle. In addition, Aldh1a2
and Aldh1a3, although similar in function, uniquely localized to the epidermal plug and bulge
versus the companion layer, precortex, inner root sheath, and dermal papilla respectively.
These data suggest that RA synthesis and signaling may regulate growth and differentiation of
all layers of the hair follicle during morphogenesis similar to the adult mouse hair cycle.
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Expression profile of cuticle-related keratin associated protein gene in intact human hair
follicle
T Yoshino, A Naito and M Oodera Biological Science Research Laboratories, LION
Corporation, Odawara, Japan
Recent studies had revealed the genomic construction of non-fibrous keratin protein, keratin
associated protein (KAP), and had demonstrated that there were 23 KAP families with several
members within individual family. Although genetic information of KAP was fully under-
stood, the function of KAP against hair properties had be still unclear. In KAP families, KAP10
and KAP 12 expressed restricted within cuticle layer and assumed to be responsible for the
lateral linkage of keratin intermediate filament bundles in trichocytes. We hypothesized that
the expression profile of KAP10 or KAP12 resembled the characteristic feature of human hair,
such as hair glossy, hair toughness against physical stress, and therefore, we started to inves-
tigate the expression pattern of KAP10 and KAP12 family first. We investigated the expression
pattern of 10 members of KAP10 and 2 members of KAP12 using cDNA from intact hair fol-
licles plucked from six male healthy volunteers by means of quantitative PCR. The results
revealed that KAP10.3, KAP10.6, and KAP12.2 were highly expressed in human hair and these
KAP members were resided two regions of KAP10 &12 gene cluster on CHr. 21q22. The expres-
sion contents of these KAP members varied among subjects and there was no significant cor-
relation with age of subjects. Interestingly, the expression contents of these KAP members
within the highly expressed regions were mutually correlated (e.g. correlation coefficient
between KAP10.3 and KAP10.6 was 0.95). This result indicated that there were particular
expression contents of KAP members specific to the individual and it was suggested that these
content related to the characteristics of the hair.
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Akt activation promotes new hair cycle
M Tarutani,1 K Murayama,2 T Kimura,2 T Nakano,2,4 S Itami3 and I Katayama1 1 Dermatology,
Osaka University, Suita, Japan, 2 Pathology, Osaka University, Suita, Japan, 3 Regenerative
Dermatology, Osaka University, Suita, Japan and 4 Graduate School of Frontier Biosciences,
Osaka University, Suita, Japan
Phosphoinositide 3-kinase (PI3K)/Akt signaling is implicated in the regulation of prolifera-
tion, cell growth, cell death, adhesion and tumorigenesis. To analyze the biological signifi-
cance of Akt activation in adult skin, we applied 4OHT topically to the shaved area of the
back skin of beta actin driven Akt-ERtm transgenic mice whose mice were activated Akt with
4OHT treatment. The transgenic mice skin treated with 4OHT was wrinkled due to keratinocyte
hyperplasia. New hair growth was observed until day 26 after the initiation of 4OHT treat-
ment and their hair coats were ruffled and shaggy. In the 4OHT-treated transgenic mice ker-
atinocytes, the CD34+α6low population was increased significantly than ETOH treated ker-
atinocytes. Moreover a number of Ki67-positive cells was detected throughout the outer root
sheath in the 4OHT-treated transgenic mice. Our results showed that PI3K/Akt signaling induces




P-cadherin is a p63 target gene with a critical role in the developing limb bud and hair fol-
licle
Y Shimomura,1 M Wajid1 and AM Christiano1,2 1 Dermatology, Columbia Univeristy, New
York, NY and 2 Genetics and Development, Columbia University, New York, NY
P-cadherin is a member of the classical cadherin family that forms the transmembrane core
of adherens junctions. Mutations in the P-cadherin gene (CDH3) have been shown to cause
two inherited diseases in humans; hypotrichosis with juvenile macular dystrophy (HJMD;
OMIM 601553) and ectodermal dysplasia, ectrodactyly, macular dystrophy (EEM syndrome;
OMIM 225280). The common features of both diseases are sparse hair and macular dystro-
phy of the retina, while only EEM syndrome also shows the additional finding of split hand/foot
malformation (SHFM). We recently identified four consanguineous Pakistani families with
either HJMD or EEM syndrome, and detected pathogenic mutations in the CDH3 gene of all
four families. In order to define the role of P-cadherin in hair follicle and limb development,
we performed detailed expression studies of P-cadherin in the mouse embryo, and demon-
strated the predominant expression of P-cadherin not only in the hair follicle placode, but
unexpectedly, also at the apical ectodermal ridge (AER) of the limb buds. Based on the evi-
dence that mutations in the p63 gene also result in hypotrichosis and SHFM (EEC syndrome;
OMIM 604292), and that its expression co-localizes to the hair follicle placode and AER along
with P-cadherin, we postulated that CDH3 could be a direct transcriptional target gene of
p63. To test this hypothesis, we performed promoter assays and chromatin immunoprecipita-
tion, which revealed that p63 directly interacts with two distinct regions in the CDH3 pro-
moter. These findings are consistent with recent evidence that in epithelial cells, p63 orches-
trates a transcriptional program consisting largely of genes involved in cell adhesion. We
conclude that P-cadherin is a newly-defined transcriptional target gene of p63, with a criti-
cal role in hair follicle morphogenesis, as well as in the AER during limb bud outgrowth.
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Identification of human keratinocyte stem cells using adhesiveness to collagen type IV and
genome-scale analysis
S Chang Dermatology, Asan Medical Center, Seoul, South Korea
The renewal of human epidermis is governed by keratinocyte stem cells (KSC). Identification
of KSC markers is important for the clinical application of epithelial cell therapy as well as for
studies on epithelial tumorigenesis. However, neither highly specific KSC markers have yet
been identified nor pure KSC cultures are available. In this study, we isolated KSC from human
tonsilar keratinocytes utilizing the adhering capability of KSC to collagen IV-coated plate and
further screened for the differentially expressed markers of KSC by genome-scale analysis of
differentially expressed genes. ACP-based differentially displayed PCR revealed that levels of
mitochondria-related gene expression were lower in KSC compared to other fractions. West-
ern blot analysis confirmed that mitochondrial complex I, complex IV, peroxiredoxins (I, II,
IV) expression were lower in KSC than in other fractions. Mitochondrial membrane potential
were also lower in KSC. In addition, after irradiation of cultured normal skin keratinocytes with
ultraviolet B (UVB), flow cytometry with alpha6 integrin and p63 showed that alpha6+/p63+
cells were enriched upto 92.80%. Taken together, our results suggest the low function or less
differentiated state of mitochondria may be one of the important characteristics of KSC. Reduced
mitochondrial contents may be related to resistance of KSC to UV radiation. In addition, adhe-
sion assay, UV and combination of markers could enrich the fraction of KSC. Additional stud-
ies on resistance of KSC on ionizing radiation and cytotoxic therapy are essential to further
define KSC.
626
Specific citrullination essential for forming a globular Ca2+-bound S100A3 homotetramer
by peptidylarginine deiminases in hair follicle
K Kizawa,1 H Takahara,2 H Troxler,3 P Kleinert,3 U Mochida2 and CW Heizmann3 1 Basic
Research Laboratory, Kanebo Cosmetics Inc, Odawara, Japan, 2 School of Agriculture, Ibaraki
University, Ami, Inashiki, Japan and 3 Division of Clinical Chemistry and Biochemistry,
University of Zurich, Zurich, Switzerland
S100A3 is a unique member of the S100 protein family that exhibits the highest cysteine con-
tent and Zn2+ binding affinity, while its affinity to Ca2+ is very weak. This protein is abundant
in mature hair cuticles, and it is localized prominently in the differentiating cuticular cells
within the hair follicle. Previous studies suggest a close association of S100A3 with epithelial
differentiation leading to hair formation, but its molecular function is still unknown. By 2D-
PAGE-western blot analyses using a modified citrulline antibody, we found more than half of
arginine residues in native S100A3 were progressively converted to citrullines by Ca2+-depend-
ent peptidylarginine deiminases. Confocal immunofluorescent microscopy showed that the
cytoplasmic S100A3 distribution within the cuticular layer is co-localized almost completely
with type III isoform of peptidylarginine deiminase (PAD3) and partially with PAD2, but rarely
with PAD1. Citrulline contents in recombinant S100A3 protein modified in vitro and
MALDI/TOF-MASS analyses of the peptides released from its digest revealed that recombinant
PAD1 and PAD2 are capable of converting all 4 ariginines in S100A3, whereas PAD3 specif-
ically converted Arg-51 exposed symmetrically from an S100A3 dimer plane. Native PAGE
and gel filtration analyses showed that Cit-51 harboring S100A3 efficiently assembles a glob-
ular homotetramer in a Ca2+-dependent manner. A prototype structural model of the Ca2+-
bound S100A3 tetramer could be deduced from the location of citrulline residues orderly con-
verted by PAD enzymes.
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Features of both xeroderma pigmentosum and trichothiodystrophy presenting in patients
with mutations in the XPD gene
T Rao,1,2 JJ DiGiovanna,1,3 DTamura,1 T Ueda,1 J Boyle,1 C Nadem,1 K Oh,1 S Khan,1 N Patronas,1
R Schiffmann,1 BP Brooks1 and KH Kraemer1 1 National Institutes of Health, Bethesda, MD, 2
CRTP Fellow, NIH, Bethesda, MD and 3 Dermatology, Brown Med School, Providence, RI
Mutations in the XPD gene have been found in patients with the rare genetic disorders, xero-
derma pigmentosum (XP) or trichothiodystrophy (TTD). The XPD helicase is part of the DNA
nucleotide excision repair (NER) pathway and also a component of the basal transcription
factor complex, TFIIH. Only 2 patients have been reported with features of both XP and TTD
(XP/TTD). We have identified 7 new XP/TTD patients (4 female, 3 male) from 4 families, rang-
ing in age from 8 to 30 years. To date, mutations in the XPD gene have been found in 6 of our
patients. Features common to both XP and TTD include early onset of severe sun-sensitivity
(7 patients), dry skin (5), dry eyes (4), and developmental delay (4). All 7 patients had the typ-
ical XP feature of pigmentary changes of the skin in sun-exposed areas and 3 had pterygia of
the eye. The risk of developing skin cancer is significantly elevated in XP but not in TTD. One
XP/TTD patient had skin cancer. The hallmark feature in TTD of tiger tail banding of the hair
under polarizing microscopy was present in all patients but was less prominent in some. Sur-
prisingly, 5 patients had long, full, non-brittle hair and did not demonstrate the typical TTD
hair shaft abnormalities. Other features of TTD that we found in our patients include abnor-
mal myelination of the brain on MRI (7), congenital cataracts (6), recurrent upper respiratory
infections (5), neutropenia (5), a thalassemia-like elevation in hemoglobin A2 (5), and low
MCV (4). In XP patients the role of XPD in NER is demonstrated in the development of skin
cancer and in neurologic degeneration. In TTD the role of XPD in transcription is manifested
as congenital or developmental abnormalities. The relationship among the genotype/pheno-
type correlations in XP, TTD, and XP/TTD will be instrumental in characterizing the relative
molecular roles of the XPD gene in transcription and repair.
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Trichothiodystrophy includes a broad spectrum of multisystem abnormalities and may have
a high mortality at a young age
S Faghri,1,2 JJ DiGiovanna,1,2 D Tamura1 and KH Kraemer1 1 Basic Research Laboratory,
National Institutes of Health, Bethesda, MD and 2 Dermatology, Brown Med School,
Providence, RI
Trichothiodystrophy (TTD) is a rare, autosomal, recessive disease, in which patients present
with brittle, sulfur-deficient hair. TTD patients display a wide variety of clinical findings includ-
ing skin, neurologic, growth and developmental abnormalities. We attempted to find all pub-
lished case reports of TTD to determine the frequency of reported clinical features. A total of
94 articles (from 1968 to 2005) were included, containing data on 112 patients who fit our
criteria for TTD. They ranged in age from 12 weeks to 47 years (median 6 years). Common
features reported (in addition to hair abnormalities) were developmental delay or intellectual
impairment (86%), short stature (73%), ichthyosis (64%), ocular abnormalities (55%), infec-
tions (46%) and photosensitivity (42%). Reduced DNA repair was reported in 37% with a
defect identified in 3 different genes in photosensitive patients (XPD [27 patients], XPB [1],
TTDA [1]). A defect in TTDN1 was reported in 6 non-photosensitive patients. Sixty one per-
cent of reported patients had abnormal characteristics at birth and 23% had reported preg-
nancy complications indicating a possible role of TTD genes in maintaining normal pregnancy
and fetal development. Surprisingly, in the 112 reported patients there were 20 deaths (13
infection-related) which occurred at a median age of 3 years (range 12 wks-47 yrs). The acronyms
PIBIDS (Photosensitivity, Ichthyosis, Brittle hair, Intellectual impairment, Decreased fertility,
and Short stature), IBIDS, and BIDS are poor descriptors of the disease since most patients who
fit these criteria also had other clinical manifestations. TTD is a rare multi-system disorder with
a wide spectrum of clinical involvement, which includes pregnancy and developmental com-
plications, and patients may have a high mortality at a young age.
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Localization of Shh expression by Wnt and Eda controls axial polarity and shape of hairs
B Hammerschmidt and T Schlake Max-Planck Institute of Immunobiology, Freiburg, Germany
Axial patterning is a recurrent theme during embryonic development. To elucidate its funda-
mental principles, the hair follicle is an attractive model due to its easy accessibility and dis-
pensability. Hair follicle asymmetry is evident from its angling and the localization of associ-
ated structures. However, axial patterning is not restricted to the follicle itself but also generates
rotational hair shaft asymmetry which, for zigzag hairs, generates 3-4 bends that alternately
point into opposite directions. Here we show by analyzing mutant and transgenic mice that
WNT and ectodysplasin signaling control the molecular and morphological asymmetry of the
follicle and the associated hair shaft, respectively. Asymmetry is established by polarized WNT
and ectodysplasin signaling in mature hair follicles. When endogenous signaling is impaired,
molecular asymmetry is lost and mice no longer form zigzag hairs. Both signaling pathways
control the polarized expression of Shh which likely functions as a directional reference for
hair shaft production in all follicles. We propose that this regulatory pathway also establishes
follicular asymmetry during morphogenesis. Moreover, the identified molecular hierarchy offers
a model for the periodic patterning of zigzag hairs mechanistically similar to mesodermal
segmentation.
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Overexpression of mIGF-1 in proliferating keratinocytes accelerates hair follicle formation
and cycling and improves wound healing in mice
E Semenova,1 S Werner,2 H Koegel,2 S Pastore,4 S Hasse,3 R Paus3 and N Rosenthal1 1 Mouse
Biology Unit, Campus “A. Buzzati-Traverso”, European Molecular Biology Laboratory (EMBL),
Rome, Italy, 2 Institute of Cell Biology, Department of Biology, ETH Zurich, CH-8093 Zurich,
Switzerland, 3 Department of Dermatology, University Hospital Schleswig-Holstein,
University of Luebeck, Luebeck, Germany and 4 Laboratory of Tissue Engineering and
Cutaneous Physiopathology, Istituto Dermopatico dell’Immacolata, IRCCS, Rome, Italy
This study is aimed at analyzing the potential of using a local isoform of IGF-1 (mIGF-1) to
promote wound healing and/or hair growth. To that end, we have generated a transgenic mouse
model in which mIGF-1 is expressed under the control of the keratin 14 promoter. Transgenic
mice appear healthy, with the exception of a cataract-like phenotype in about 50% of mIGF-
1 animals, likely as a consequence of K14 driven corneal mIGF-1 expression. The IGF-1 serum
level is not increased, and there is no evidence of spontaneous tumor formation. Prolifera-
tion, as measured by BrdU incorporation, is comparable in back skin and tail epithelia of trans-
genic and wild type littermates. Significant abnormalities in differentiation- (keratin 10, lori-
crin) and proliferation-associated markers (keratin 14, keratin 6) are absent. However,
quantitative histomorphometry shows that the final stages of hair follicle morphogenesis as
well as anagen development during the first hair cycle are accelerated in transgenic compared
to wild type mice. In line with these findings, mIGF-1 overexpression accelerates efficient
wound closure and enhances keratinocyte proliferation and migration within the hyperprolif-
erative epithelium. In addition, mIGF-1 transgenics show mitigated contact hypersensitivity
response, suggesting that intraepithelially expressed mIGF-1 has anti-inflammatory activities.
In summary, while constitutive overexpression of mIGF-1 in proliferating keratinocytes does
not result in major skin abnormalities at steady state, it accelerates hair follicle formation and
cycling, improves healing of full-thickness wounds, and reduces inflammation.
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Bone morphogenetic protein signaling is necessary for hair induction by dermal papilla cells
M Rendl and E Fuchs Rockefeller University, New York, NY
New hair follicle formation in embryonic and adult skin is initiated when specialized mes-
enchymal dermal papilla (DP) cells send cues to multipotent epithelial stem cells. Later dur-
ing active hair growth, DP cells form a niche with neighboring epithelial cells to orchestrate
the complex program of hair shaft differentiation. When taken outside the niche into culture,
however, DP cells lose their hair follicle inducing properties. To explore what lies at the heart
of these processes, we recently developed methods to isolate and characterize the molecular
identity of the DP and its niche as cell-type specific gene signatures. Using growth factors from
these signatures, we tested cultured DP cells to maintain their molecular identity and hair fol-
licle inductivity. Of all the applied signaling factors, only bone morphogenetic proteins (Bmps)
maintained molecular DP signature features in vitro and modestly preserved hair induction in
vivo. Conversely, Bmp receptor ablation specifically in DP cells in a novel in vitro/in vivo
hybrid knockout assay revealed that Bmp signaling is necessary for hair follicle induction.
These results put the Bmp pathway squarely at the center of DP’s function of hair induction.
However, since Bmps are not sufficient to fully maintain hair inductivity, we propose that com-
binatorial application with other factors will prove useful to unleash their full potential in the
future.
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Identification of downstream molecular targets of TRPS1 during murine hair follicle mor-
phogenesis
KA Fantauzzo,1 M Tadin-Strapps,1 H Bazzi,1 E Magnusdottir,3 KL Calame4 and
AM Christiano1,2 1 Genetics and Development, Columbia University, New York, NY, 2
Dermatology, Columbia University, New York, NY, 3 Biological Sciences, Columbia
University, New York, NY and 4 Microbiology, Biochemistry and Molecular Biophysics,
Columbia University, New York, NY
Tricho-rhino phalangeal syndrome I (TRPS1) is a vertebrate protein containing a GATA-type zinc fin-
ger and two Ikaros-like zinc fingers. Patients with TRPS1 have sparse scalp hair, craniofacial and
skeletal abnormalities. The mouse homolog is a sequence-specific repressor of transcriptional activa-
tion by other GATA factors. Mice in which the GATA domain of TRPS1 has been deleted (TRPS1gt/gt)
have a reduced number of pelage follicles and lack vibrissae follicles. We characterized the expres-
sion of TRPS1 during murine hair follicle morphogenesis and postnatal hair cycling. TRPS1 expres-
sion was detected in the snout, limbs, and in the mesenchyme surrounding the vibrissae and pelage
follicles during embryogenesis by in situhybridization analysis. Immunofluorescence analysis revealed
a dynamic pattern of TRPS1 expression, first appearing in the dorsal epidermis at e14.0, and later in
the dermal papilla and the mesenchymal cells surrounding the hair follicle starting from e16.5. Post-
natally, TRPS1 continues to be expressed in the dermal papilla, localizing to the nucleus during telo-
gen and anagen. Microarray hybridization analysis was performed comparing expression patterns in
the whisker pads of e12.5 wild-type versus TRPS1gt/gt mice. Prdm1, Sox18 and Dkk4 were among
genes downregulated in the mutant animals. Prdm1 is expressed in the inner root sheath precursors
and dermal papilla, Sox18 is expressed in the mesenchyme surrounding the hair follicles, and Dkk4
is expressed in the epidermis, all of which coincide with sites of TRPS1 expression. In overexpression
and promoter reporter assays, TRPS1 significantly altered mRNA or reporter gene levels for each of
the target genes. Our findings suggest that these genes may be regulated by TRPS1, and provide evi-
dence linking transcriptional pathways active in developing skin and hair follicle.
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Dlx3 gene expression in lacZ knock-in mice and its function in hair development
J Hwang and M Morasso Developmental Skin Biology Unit, NIH/NIAMS, Bethesda, MD
Dlx (Distal-less) homeodomain proteins are a family of transcription factors that play crucial
roles in developmental processes and differentiation of individual tissues. Disruption of the
human DLX3 coding sequence is linked to the autosomal dominant human disorder Tricho-
Dento-Osseus (TDO) syndrome, that is characterized by defects in hair and teeth, and increased
bone density. For the comprehensive analysis of Dlx3 gene expression throughout develop-
ment, we generated a knock-in mouse carrying the reporter gene beta-galactosidase (lacZ)
under the control of the endogenous Dlx3 promoter. Whole-mount or local X-gal staining
shows the temporal and spatial expression of the Dlx3 gene in various tissues and organs
including hair, teeth and bone. The function of Dlx3 in hair development is currently being
investigated. The DNA binding sequence of Dlx3 is similar to that of Hoxc13, an established
transcriptional regulator of hair keratin gene expression. We have identified numerous puta-
tive Dlx3 binding sites in the promoter region of hair keratin genes (hHa5, hHa2 and hHa7)
as well as in the Hoxc13 promoter performing electrophoretic mobility shift assays (EMSA).
To provide evidence for direct binding of Dlx3 in vivo, chromatin immunoprecipitation (ChIP)
assays are being performed, as well as colocalization analysis of Dlx3 and hair proteins using
confocal microscopy. Our initial findings suggest that Dlx3 is a regulator of hair keratin gene
expression during hair development.
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Adult hair follicle stem cell compartment changes in androgenetic alopecia demonstrate
maintenance of progenitor stem cells with loss of descendant CD200high A6 integrinhigh
expressing cells
LA Garza,1 M Lee,1 Y Liu,1,4 D Stanton,2 L Carrasco,2 J Tobias3 and G Cotsarelis1 1
Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia,
PA, 2 Department of Oral and Maxillofacial Surgery, University of Pennsylvania, Philadelphia,
PA, 3 Bioinformatics Core, University of Pennsylvania, Philadelphia, PA and 4 Merck &
Company, Wales, PA
The status of adult stem cell compartments in tissue specific disease has not been thoroughly
addressed. We tested the hypothesis that hair follicle stem cells might be depleted in andro-
genetic alopecia (AGA), which is characterized by drastic miniaturization of the hair follicle.
To compare hair follicle stem cell numbers between paired haired and bald scalp samples
from the same individuals, we used flow cytometry to quantitate cell cycle, cell size, and
expression of CYTOKERATIN 15 (KRT15), FOLLISTATIN (FST), CD200 and alpha-6 integrin.
We found a gradient of stem cell characteristics, as defined by a high degree of KRT15 and
FST expression, cellular quiescence and small cell size. This gradient is not grossly altered
between haired and bald scalp, and stem cells are maintained in bald scalp. However, a spe-
cific CD200 high alpha-6-integrin high population, which has characteristics of early stem
cell progeny, is lost in bald scalp. Consistent with the loss of the immunosuppressive CD200
protein, array based expression profiling demonstrates significant increases in inflammation
associated genes in androgenetic alopecia. Previous reports of CD200 loss leading to alope-
cia in mouse models suggest that AGA may be exacerbated or caused by CD200 downregu-
lation in the human hair follicle stem cell compartment.
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BMP activity defines refractory and competent hair follicle populations during the propa-
gation of regenerative waves
M Plikus,1 R Baker,2 J Mayer,1 R Maxson,1 P Maini2 and C Chuong1 1 Pathology, University
of Southern California, Los Angeles, CA and 2 Oxford, Oxford, United Kingdom
Hair cycle can be regulated by molecular oscillation within the follicle (autonomously) or by
dynamic changes in the inter-follicular environment (non-autonomously). While human hair
follicles largely cycle autonomously, cycling of mouse hair follicles is affected by the status
of adjacent follicles. Thus hair cycle progression can advance like a transverse wave on the
surface of the skin. Observations of the dynamic hair cycle domains on the skin of wild type
and Msx2-/- mice show that each hair cycle domain is made of an initiation site, a propagat-
ing wave, and boundaries. Analyses of patterns of wave propagation and boundary formation
led us to identify a novel stage in telogen. In the first stage of telogen, hair follicles are refrac-
tory to the anagen spreading wave, thus forming a sharp domain boundary. Refractory telo-
gen is characterized by multiple site expression of Bmp4/Bmp2 intra-follicularly and inter-
follicularly. These Bmps sustain BMP reporter activity within follicles throughout refractory
stage of telogen. Telogen follicles become competent to respond to anagen initiation signals
after Bmp 2/4 loss. Hair plucking can induce anagen in competent follicles, but not refrac-
tory ones. In KRT14-NOG mice there is drastic shortening of the refractory telogen, and fast
anagen re-entry. Individual follicle cycles faster and the wave dynamics of follicle populations
are altered. Transplantation of a piece of KRT14-NOG skin to normal skin microenvironment
results in restoration of Bmp signaling activity and refractory telogen. Our data identifies two
new stages of telogen, refractory and competent. They are defined by the ability of telogen
follicles to re-enter anagen, and based on the on-and-off switches of Bmp2/4 expression within
and surround the follicle. This study presents a novel population approach to the study of hair
cycling, and gives a more systematic and integrative explanation to the hair follicle behaviors
observed in classical literatures.
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Reactive oxygen species (ROS)-mediated androgen-inducible TGF-β1 regulation in dermal
papilla cells
H Yoo, Y Kang, M Sung, S Kim, O Kwon, K Kim, H Eun and K Cho Department of
Dermatology, Seoul National University, College of Medicine, Laboratory of Cutaneous Aging
and Hair Research, Clinical Research Institute, Seoul National University Hospital and
Institute of Dermatological Science, Seoul National University, Seoul, South Korea
Intracellular signaling roles of reactive oxygen species (ROS) generated in response to andro-
gen hormone in hair follicle dermal papilla cells are not well defined. To assess the correla-
tion of ROS (hydrogen peroxide) known to increase in aging process to hair loss, the rat vib-
rissae dermal papilla cell line (DP-6) overexpressed with AR was investigated to evaluate the
role of ROS on androgen-induced increase of TGF-β1 secretion. The AR stably-transfected DP-
6 cells were incubated with synthetic androgen, R1881. Intracellular production of ROS
markedly increased with R1881 treatment in DP-6 cells, which was measured by flow cytom-
etry and laser scanning confocal microscopy. Moreover, androgen-inducible TGF-β1 was sig-
nificantly suppressed by several species of ROS scavenger or inhibitors. Luciferase reporter
assays showed suppression of TGF-β1 promoter signaling by ROS scavengers. In conclusion,
our study shows for the first time that androgen-induced TGF-β1 regulation would be medi-
ated by ROS and prevented by antioxidants or ROS inhibitors in hair follicle dermal papilla
cells. We suggest that antioxidants could be one of the candidates to control androgen-medi-
ated pattern hair loss.
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A role of CYLD in hair cycling mouse
K Moriwaki,1 D Tsuruta,1 K Sugawara,1 H Kobayashi,1 R Massoumi2 and M Ishii1 1
Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan and 2
Molecular Medicine, MaxPlanck-Institute for Biochemistry, Martinsried, Germany
CYLD is a tumor suppressor gene mutated in familial cylindromatosis, an autosomal-dominant
condition that predisposes to multiple skin tumors. The gene product, CYLD, is a deubiquiti-
nating enzyme recently implicated in modulation of the NF-κB pathway. Recent report by Mas-
soumi R. et al (2006) described that CYLD protein is prominently expressed in the inner root
sheath of normal human scalp hair follicles. Thereupon we considered CYLD might have some
effect in normal hair cycle thru NF-κB signaling. To investigate a role of CYLD during hair
cycling, we adopted C57BL/6 hair cycling model mouse, and characterized changes in their
expression by semiquantitative RT-PCR and western immunoblot and immunohistochemistry
for protein. We found that CYLD at mRNA level increased from anagen stage to catagen
stage, as well as protein level in immunobolt. In immunohistochemistry, CYLD protein is
expressed in surrounding bulge areas. Moreover, we assessed whether CYLD regulate hair
growth using in vitro hair culture. Recombinant CYLD inhibited hair growth. In conclusion,
our results indicate that CYLD function on conversion from anagen stage to catagen stage.
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Keratinocyte-specific expression of c-myb is dependent on growth and differentiation state
JM Luna,1 ML Clarke,2 J Frampton2 and A Engelhard1 1 Department of Dermatology, College
of Physicians and Surgeons, Columbia University, New York, NY and 2 Institute of Biomedical
Research, University of Birmingham Medical School, Edgbaston, United Kingdom
Many genes with a role first defined in hematopoiesis have recently been shown to define
stem cell niches and regulate essential cellular processes in the skin. In hematopoietic cells,
c-myb expression is required for proliferation but prohibitive of differentiation. Viral trans-
duction of truncated c-myb causes leukemia in chickens, and murine c-myb null mutation
is lethal at e15, due to the failure of hematopoiesis. Here, we examined the expression pat-
tern of the c-myb transcription factor in keratinocytes to determine if it might also regulate
cell growth and differentiation in the skin. Upon release from serum starvation, absolute quan-
tification of c-myb RNA levels demonstrated cell cycle-regulated expression in cultured human
keratinocytes. Temporal studies of c-myb RNA levels during calcium-induced differentiation
defined downregulation of c-myb expression as a late marker of keratinocyte differentiation.
Both results are consistent with the expression pattern of c-myb in hematopoietic cell lines.
Furthermore, immunohistochemistry on normal murine skin revealed that c-myb protein is
present not only in the proliferating basal layer of the interfollicular epidermis, but also in
the suprabasal layer. In the hair follicle, c-myb is expressed in a hair cycle-dependent man-
ner. During late anagen, c-myb is expressed in the hair matrix and the outer root sheath and
is absent from the inner root sheath, cortex and dermal papillae. This expression pattern
extends into early catagen, but c-myb nuclear staining is not detected in telogen. The tem-
poro-spatial expression pattern of c-myb suggests that it is a novel regulator of keratinocyte
proliferation and differentiation in the epidermis and hair follicle. Conditional ablation in the
epidermis is ongoing, and is expected to reveal in vivo functions as well as insights into down-
stream transcriptional target genes.
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Global microarray analysis of the follicular and glandular types of epidermal differentiation:
a role for BMP signaling in suppressing trans-differrentiation of the foot pad epidermis towards
folliculogenesis
AA Sharov,1 TY Sharova,1 AN Mardaryev,1,2 AV Sargsyan1 and VA Botchkarev1 1
Dermatology, Boston University School of Medicine, Boston, MA and 2 Medical Biosciences,
School of Life Sciences, University of Bradford, Bradford, United Kingdom
During skin development, epithelium and mesenchyme interact with each other and give raise
the formation of epidermis and a variety of appendages (hairs, nails, glands). To characterize
global gene expression profiles associated with distinct types of epidermal differentiation (fol-
licular versus glandular), epithelial buds of the hair follicles (HFs) and sweat glands (SWGs),
as well as the matrix and epithelium of fully-developed HFs and SWGs were obtained from
embryonic and adult mouse foot pads and ventral skin using laser capture microdissection.
Epithelial buds of the HFs and SWGs showed expression of the bud-specific adhesion mole-
cules, signaling/transcription components, as well as appendage-specific markers such as
HF-specific keratins (Krt1-c29, Krt2-6g) or SWG-specific ion channels (Clcn3, Bcng-3a). Fully
developed SWGs were characterized by strong downregulation of over 4000 genes com-
pared to the epidermis and by upregulation of SWG-specific genes involved in regulation of
the ion exchange/water metabolism, while HFs showed less prominent differences in gene
expression versus the epidermis. In addition, SWG buds and fully developed SWGs showed
strongly reduced expression of Bmp7 and Smad1/4 compared to the epidermis and HFs.
Interestingly, K14-Noggin and Bmpr-Ib knockout mice showed ectopic formation of the HFs
in foot pads accompanied by decreased expression of Engrailed 1, a potent repressor of the
dorsal phenotype in ventral epidermis. These data suggest that HFs and SWGs are character-
ized by markedly different gene expression profiles, which may underlie fundamental differ-
ences in their functions, and that BMP signaling suppresses trans-differentiation of the foot pad
epidermis towards folliculogenesis at least in part via stimulating the Engrailed 1 expression.
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EEDA is associated with early steps in differentiation
DG Ryan and RM Lavker Dermatology, Northwestern University, Chicago, IL
We wished to develop a transgenic reporter mouse capable of recapitulating the expression
charactaristics of the Early Epithelial Differentiation Associated (EEDA) gene. Early Epithelial
Differentiation Associated protein is expressed in the suprabasal compartment of the epider-
mis, hence its name. EEDA was originally identified in the basal cells of the corneal epithe-
lium. Our studies have shown that EEDA is expressed in a variety of epithelial tissues of ecto-
dermal origin. The highest levels of EEDA were found in the precortical zone of the anagen
hair follicle. The EEDA gene is located next to plakophilin 4 on chromosome 2. The gene is
comprised of four exons which encode a highly conserved 12 KDa protein. Genomic sequences
upstream from the transcription start site were fused to β-galactosidase and assessed for their
ability to reproduce the expression pattern of EEDA in transgenic mice. Mice generated with
a 1.4 Kbp fragment of proximal upstream sequence produced β-galactosidase in all relevant
epithelial tissues with the exception of those of ocular origin. Consistent with immunohisto-
logical findings, high levels of β-galactosidase were seen in the precortical zone of the ana-
gen hair follicle. β-galactosidase was also detected in the spleen and thymus of adult trans-
genic mice. The most notable expression in embryonic tissues (E13.5) was seen in the ventricles
of the developing brain. Significant levels of β-galactosidase were also detected in the apical
ectodermal ridge (AER) of developing limb buds. Inclusion of an additional 5 Kbp of upstream
sequence confirmed the specificity of expression observed with the shorter promoter but failed
to retrieve the ocular expression. We conclude that EEDA is active in a much wider range of
tissues than we had originally reported. The spatial and temporal nature of these expression
patterns both reinforces and extends the idea that EEDA is intimately associated with early
differentiation events occuring not only in stratified squamous epithelia but also in neural and
immunological tissues.
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Molecular mechanisms of chemotherapy-induced hair loss: global changes in expression of
apoptotic and non-apoptotic genes during early hair follicle response to doxorubicin
TY Sharova,1 AA Sharov,1 R Atoyan,1 AN Mardaryev1,2 and VA Botchkarev1 1 Dermatology,
Boston University School of Medicine, Boston, MA and 2 Medical Biosciences, School of Life
Sciences, University of Bradford, Bradford, United Kingdom
Chemotherapy induces DNA damage in rapidly proliferating hair follicle (HF) keratinocytes
followed by initiation of apoptosis via recruitment of the p53-dependent and independent
pathways. To analyze mechanisms involved in initiation of the HF response to chemotherapy,
late anagen HFs isolated from scalp of healthy individuals were cultured ex vivo with dox-
orubicin (30 min) and were harvested three hours after treatment. Hair matrix cells were
obtained from control and doxorubicin-treated HFs using laser capture microdissection. Global
microarray data validated by the real-time PCR revealed that about 1300 genes show 2-fold
and higher differences in expression in doxorubicin-treated HFs compared to the control. The
vast majority of these genes encoded molecules that are involved in cell adhesion/extracel-
lular matrix remodeling, cytoskeleton/motility, cell signaling/transcription and cell metabo-
lism. Interestingly, doxorubicin-treated HFs showed strong increase in the expression of genes
encoding keratin-associated proteins, while expression of the hair keratin genes decreased
compared to control. Among the genes involved in apoptosis/cell cycle regulation, substan-
tial changes in expression were seen in those involved in p53/Fas-dependent cell death
(P53AIP1, FAS, CFLAR), TNF signaling (TNFSF10), as well as genes encoding cyclin-depend-
ent kinase inhibitors (p21, p57). Thus, these data suggest that the response of HF keratinocytes
to chemotherapy is more complex than previously appreciated and include involvement of a
large number of genes whose functions are not directly associated with apoptosis. These data
also suggest that p53/Fas and TNF signaling are involved in the initiation of the HF response
to chemotherapy and that pharmacological modulation of these pathways may be important
for prevention of chemotherapy-induced hair loss.
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Defining Hoxc13-controlled hair follicle differentiation pathways
CS Potter,1 ND Pruett,1 DF Jacobs,1 MJ Kern,2 JP Sundberg3 and A Awgulewitsch1 1 Dept. of
Medicine/Rheumatology and Immunology, MUSC, Charleston, SC, 2 Dept of Cell Biology
and Anatomy, MUSC, Charleston, SC and 3 The Jackson Laboratory, Bar Harbor, ME
Although members of the Hox family of transcriptional regulators have been shown to play
key roles in hair follicle differentiation and cycling, relatively few specific Hox targets have
been identified, and only limited work has been accomplished in understanding mechanisms
of Hox mediated target gene regulation. Much of the current knowledge of Hox gene func-
tion has been obtained using loss or gain-of-function models; however, data from these mod-
els is often complicated by the redundant functionality of co-expressed paralogous Hox genes,
as well as the occurrence of frequent perinatal lethality, making study difficult in non embry-
onic tissues. Both Hoxc13 null (Hoxc13-neo) and Hoxc13 over-expressing mice (GC13) exhibit
severe hair and skin defects without excessive perinatal lethality. Many basic developmental
mechanisms are recapitulated in the formation of skin appendages such as hair and mam-
mary gland and Hox gene transcriptional regulators have been implicated in the development
of both. Gene array analysis performed on postnatal skin of GC13 mice revealed a group of
hair medulla-specific genes which were differentially regulated when compared to normal
controls. These included the transcription factors Foxq1, and Junb, the hair keratin genes Krt2-
16 and Krt2-6b, the desmosomal cadherin gene Dsc2, as well as the epididymal gene Crisp1,
which previously was not known to be active in hair. Using expression analysis combined with
DNA binding studies (EMSA, ChIP), and transient co-transfection assays, we provide evi-
dence that these genes act in a common Hoxc13–controlled pathway. We are using this rudi-
mentary pathway of hair medulla differentiation as a conceptual nucleus for defining addi-
tional pathway components. This is being accomplished by using gene network analysis
bioinformatics tools in conjunction with the analysis of additional mouse mutants affecting
hair medulla formation.
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Self-reported trigger factors preceding onset of alopecia areata
N Barahmani,1,8 A Lopez,2 M Hernandez,2 Q Zhang,3 M Hordinsky,4,8 V Price,5,8 D Norris,6,8
A Christiano7,8 and M Duvic1,8 1 Dermatology, UT-MD Anderson Cancer Center, Houston,
TX, 2 Biostatistics, UT-MD Anderson Cancer Center, Houston, TX, 3 Epidemiology, UT-MD
Anderson Cancer Center, Houston, TX, 4 Dermatology, University of Minnesota, Minneapolis,
MN, 5 Dermatology, University of California, San Francisco, San Francisco, CA, 6
Dermatology, University of Colorado, Denver, CO, 7 Dermatology, Columbia University, New
York, NY and 8 NAAR, UT-MD Anderson Cancer Center, Houston, TX
Alopecia areata (AA) is an organ-specific,T cell-mediated, autoimmune response to hair fol-
licles causing partial (AAP) or total baldness (AT/AU). AA is a complex multigenic trait with
inherited predisposition and environmental triggers. To investigate environmental factors, we
analyzed self-reported epidemiological data from the National Alopecia Areata Registry from
families ( >1 affected member) and sporadic cases with either patchy, persistent AA (AAP) >1
year (n=947) or total scalp (AT) (n=424) and body hair loss (AU) >1 year (n=1,059). Mean age
and sex were similar in AAP vs AT/AU. Patients reporting one of 5 environmental trigger groups
prior to first onset of AA are reported as % of AAP or AT/AU patients as follows: [1] physio-
logic; 3.4% vs 3.9% [2] immunological; 6.3% vs 11.1% [3] emotional; 17.9% vs 18.1 [4]
other; 3.9% vs 3.3% and [5] no event; 68.5% vs 63.5%. The distribution of triggering factors
differed between AAP and AT/AU patients (Chi-square test, p value= 0.001). In a multivariate
logistic model controlling for age, sex, and family history, there was almost two fold increased
odds of having an immunologic trigger versus no reported trigger in the AT/AU group com-
pared to AAP (OR=1.84; 95%CI (1.35-2.51); p=0.002). These data support the relation between
an immunologic event (infection, allergy,vaccination) and the phenotypic severity of AA. Fur-
ther investigation will include analysis of individual triggering factors to help in understand
the underlying mechanism causing AA.
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Chemotherapy-Induced Alopecia (CIA) in a novel adult rat model
EA Connelly,1 LM Mauro2 and JJ Jimenez3 1 Dermatology, University of Miami, Miami, FL, 2
Biochemistry and Molecular Biology, University of Miami, Miami, FL and 3 Clinical Medicine,
University of Miami, Miami, FL
Alopecia is one of the most dreaded side effects of chemotherapy, with profound negative psy-
chological connotations.It is known that anagen hair follicles are particularly susceptible to
chemotherapy toxicity.In the present study, we sought to develop an adult rat model counter-
part to the neonatal rat model to study CIA. For the first cycle of anagen hair growth, chemoter-
apy was given to 7-day old rats.A second cycle of anagen hair growth was induced by shav-
ing the back of 31-day old rats; and chemotherapies were given on day 36 intraperitoneally.
Ten rats were used for each experimental group. Alopceia was recorded 7 days after the last
dose. Full body alopecia was observed in 100% of the 7-day old rats after administration of
chemotherapy.Using the 36-day old rat model, alopecia was seen in all areas previously shaven
after administration of chemotherapy; in contrast to unshaven areas where there was no hair
loss. In conclusion, shaving adult rats induces an anagen hair cycle which has not been pre-
viously described in this model. Secondly, the results of this study indicate that inducing ana-
gen phase by shaving renders adult rat hair follicles susceptible to chemotherapy. Thus, the
adult rat model may be a useful tool to screen for protective agents in the treatment of CIA.
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An in vitro model for the exploration of cutaneous stress responses: Substance P inhibits
growth, induces mast cell degranulation, up-regulates p75NTR -expression and causes immune
privilege collapse in cultured human anagen hair follicles
EM Peters,1 S Liotiri,4 E Bodo,4 T Bíro,3 PC Arck2 and R Paus4 1 Cutaneous
Psychoneuroimmunology, Department of Internal Medicine and Psychosomatics, University
Medicine Charité, Berlin, Germany, 2 Psychoneuroimmunology, Biomedical Research Center,
University Medicine Charité, Virchow Campus, Berlin, Germany, 3 Laboratory for Cellular
and Molecular Physiology, Department of Physiology, University of Debrecen, Debrecen,
Hungary and 4 Department of Dermatology, University Hospital Schleswig-Holstein,
University of Lübeck, Lübeck, Germany
In the mouse, substance P (SP) and nerve growth factor (NGF) are key mediators of systemic
stress responses that inhibit hair growth (by catagen induction). Whether this also applies to
human skin, is completely unclear. Here, we introduce a simple new in vitro model for study-
ing the local effects of classical stress mediators, using normal, microdissected, organ-cultured
human scalp hair follicles (HFs). We show that HFs prominently express the SP receptor
(NK1) on the gene and protein level, and respond to SP stimulation by premature hair growth
termination (catagen induction), down-regulation of NK1 and up-regulation of neutral endopep-
tidase (degrades SP). This is accompanied by mast cell degranulation in the HF connective tis-
sue sheath, indicating neurogenic inflammation. SP down-regulates the immunoreactivity for
the growth-promoting NGF receptor (TrkA), while it up-regulates NGF and its apoptosis- and
catagen-promoting receptor (p75NTR). In addition, MHC class I and β2-microglobulin
immunoreactivity are up-regulated and detected ectopically, indicating a collapse of the HF
immune privilege. In conclusion, this new human organ culture assay displays striking sensi-
tivity to prototypic peptide and growth factor stress-mediators, e.g. SP and NGF, and allows
one to sketch an evidence-based biological explanation for how psychoemotional stress may
trigger or aggravate telogen effluvium and alopecia areata.
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Mutation in Mpzl3, a novel gene encoding a predicted adhesion protein, in the rough coat
(rc) mice
T Cao, P Racz, KM Szauter, G Groma, GY Nakamatsu, B Fogelgren, E Pankotai, Q He and
K Csiszar John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI
The rough coat (rc), an autosomal recessive mutation, arose spontaneously in the C57BL/6J
inbred mouse strain. Homozygous rc mice are born indistinguishable from their normal lit-
termates, but develop severe skin and hair abnormalities, including cyclic and progressive
hair loss and sebaceous gland hypertrophy. Additionally, more than half of the rc/rc mice
over one year old develop spontaneous and persistent ulceration in the skin, suggesting a
defect in epidermal maintenance. Scanning electron microscopy revealed that hair loss in
the rc/rc mice was not due to hair shaft breakage. The rc locus was previously mapped to
Chromosome 9. To elucidate the genetic basis underlying the rc phenotype development, we
carried out positional cloning, and mapped the rc locus to a 246-kb interval. We identified a
missense mutation within a novel open reading frame in the rc/rc mice, which is predicted to
encode a cell adhesion molecule with the highest homology to Myelin Protein Zero and MPZ-
like 2 (MPZL2, also called Epithelial V-like Antigen). We therefore named this gene Mpzl3
(Myelin Protein Zero-like 3). The mutation in the rc/rc mice occurred at a highly conserved
residue within the conserved immunoglobulin V-type domain, thus likely altering the MPZL3
protein function. RT-PCR and Western blot analyses revealed expression of the Mpzl3 gene
in various adult organs, including the skin. Using indirect immunofluorescence, we detected
MPZL3 protein within the keratinocytes and sebocytes in the skin. Results from this study iden-
tified a novel gene encoding a predicted adhesion protein whose mutation in the rc/rc mice
likely caused the rc phenotype.
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Allelic mutations in Foxq1 help define gene networks involved in hair fiber production
B Wu,1 KA Silva,1 CS Potter,2 RE Seymour,1 KA Giehl,3 A Awgulewitsch2 and JP Sundberg1 1
Research, The Jackson Laboratory, Bar Harbor, ME, 2 Department of Medicine, Medical
University of South Carolina, Charleston, SC and 3 Department of Dermatology, Ludwig-
Maximilian University, Munich, Germany
The spontaneous, autosomal recessive mouse satin mutation (Foxq1sa) on the SB/LeJ inbred
background results in mice with abnormalities in hair fiber medulla formation. A new allelic
mutation, Foxq1sa-J, arose spontaneously on the MRL/MpJ-Faslpr strain. Scanning electron
microscopy and X-ray element analysis demonstrated that hair fibers in both mutations had
structurally normal cortical surfaces. However, light microscopic evaluation, using both white
and polarized light, of mounted hair fibers and transmission electron microscopy of digested
hairs revealed abnormalities in the hair medulla. Ultrastructural changes indicated loss of
cellular organization. Sequencing the Foxq1sa-J allele revealed a C to T transition at base 490
according to the Ensambl database, which caused the 164th Arginine (R, Arg) to become a
Cysteine (C, Cys). By contrast, we confirmed 2 mutations in the open reading frame of Foxq1sa
allele to be a 67 base deletion at nucleotides 685 to 751 followed by a two base change (GA
to AT) at nucleotides 766-767 which resulted in total amino acid mismatch after the 229th
amino acid. These changes alter the protein characteristics of Foxq1. Morphologic changes
in the satin phenotype were somewhat similar to those seen in Hoxc13 transgenic mice
(Tg(Hoxc13)61B1Awg) which also have downregulation of Foxq1 in the premedulla of the
bulb by in situ hybridization. Mutations in the Foxq1 gene result in essentially no expression
of transcripts in the premedulla while Hoxc13 transcripts are essentially normal. DNA bind-
ing and transient co-transfection assays suggested that this downregulation was due to direct
interaction of Hoxc13 with cognate binding sites located in the Foxq1 promoter region, thus
implicating both genes in the same pathway of medulla differentiation.
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A mechanism for minoxidil’s effect on human hair growth: action via potassium channels in
the follicle
K Shorter,1 N Farjo,2 S Picksley1 and VA Randall1 1 Biomedical Sciences, University of
Bradford, Bradford, United Kingdom and 2 Farjo Medical Centre, Manchester, United
Kingdom
Minoxidil, diazoxide and other drugs stimulate hair growth as side effects. How they act is unclear,
despite minoxidil’s use as a topical hair growth-promoting agent for 20 years. Suggestions include
acting on blood supply or follicle cells. Understanding this mechanism should enable more potent
therapies. All these drugs open ATP-sensitive potassium (K+ATP) channels which control K+ flow
across many tissues’ membranes regulating many processes e.g. pancreatic insulin secretion. They
contain 2 sub-units, the regulatory sulphonurea receptor, SUR, and the pore-forming Kir, which
allows K+ across membranes. We recently demonstrated that minoxidil and other drugs stimulated
deer follicle growth in vitro (Davies et al J Invest Dermatol 125, 686-694, 2005). Similar human stud-
ies often report no minoxidil effect, though a recent small study showed stimulation at high levels
in young men. To see whether K+ATP channels were present in human follicles we cultured them in
minoxidil for 7 days and used RT-PCR to see whether channel component genes were expressed.
Scalp follicle growth rate was inhibited by high levels of minoxidil in 5 young men with no effect
on numbers of follicles growing. Follicles (n=5) expressed genes for both components of K+ATP chan-
nels: receptors SUR1 and SUR2B and pore Kir6.1 and Kir6.2. These results disagree with the recent
growth study, but accord with earlier work; they show human follicles can respond to minoxidil in
vitro. Presumably K+ATP channels are already open in human follicle culture conditions so no more
stimulation can occur. Human follicles also express genes for at least 2 K+ATP channels with differ-
ing drug sensitivities; in deer drugs acting via both receptors increased hair growth. Only SUR2B
channels respond to minoxidil. These results suggest minoxidil acts directly on K+ATP channels in
human follicles and that novel drugs acting via SUR1 channels alone, or combined with drugs like
minoxidil working via SUR2B channels, may stimulate greater human hair growth.
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Constitutive activation of β-catenin signaling in embryonic surface epithelium results in a
global switch from epidermal to hair follicle fate
Y Zhang,1 T Andl,1 F Liu,1 S Yang,2 M Taketo,3 A Dlugosz2 and S Millar1 1 Department of
Dermatology, University of Pennsylvania, Philadelphia, PA, 2 Department of Dermatology,
University of Michigan, Ann Arbor, MI and 3 Kyoto University, Kyoto, Japan
Wnt/β-catenin signaling is required for embryonic hair follicle induction, and K14 promoter-
driven expression of stabilized β-catenin causes ectopic hair follicle formation postnatally,
suggesting a key role for this pathway in determining hair follicle fate. However the conse-
quences of forced activation of β-catenin signaling in embryonic skin are unknown. To address
this question we mutated the endogenous β-catenin gene to a dominant active form in embry-
onic surface epithelial cells in vivo. Hair follicle placode induction was markedly accelerated
in mutant embryos; however the placodes failed to invaginate, instead forming large evagi-
nations. Activation of the TOPGAL Wnt reporter was widespread in E14.5 mutant skin, unlike
its normal pattern in developing placodes. Analysis at E17.5 revealed a global failure of epi-
dermal differentiation in the mutant, indicated by lack of expression of suprabasal and termi-
nal differentiation markers K10, involucrin and loricrin. Instead, the surface epithelium broadly
expressed the hair shaft cortex marker AE13. Consistent with global adoption of hair follicle
fate, the molecular regulators of hair follicle development Bmp2, Shh and Edar were expressed
broadly in mutant epithelium, and the follicular dermal condensate markers Bmp4 and alka-
line phosphatase were expressed throughout the upper dermis. The hair follicle outer and inner
root sheath markers Sox9 and GATA3 were not expressed, indicating specific adoption of hair
shaft cortex fate by mutant epithelial cells. These data demonstrate that Wnt/β-catenin sig-
naling is a master regulator of cell fate in the embryonic surface ectoderm, suppressing squa-
mous differentiation and activating hair follicle initiation and cortex-like differentiation. In
addition, both formation of a patterned array of hair follicle placodes and hair germ invagi-
nation require controlled downregulation of β-catenin signaling.
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The wnt inhibitor, dickkopf 4, is induced by canonical wnt signaling during ectodermal
appendage morphogenesis
H Bazzi,1 KA Fantauzzo,1 GD Richardson,3 CA Jahoda3 and AM Christiano2,1 1 Department
of Genetics and Development, Columbia University, New York, NY, 2 Department of
Dermatology, Columbia University, New York, NY and 3 Department of Biological Sciences,
University of Durham, Durham, United Kingdom
Ectodermal appendage morphogenesis requires continuous epithelial-mesenchymal cross-talk
during development. Canonical Wnt signaling has been shown to be pivotal during this process
and its inhibition leads to the absence of any morphological or molecular signs of appendage
formation, including hair follicles (HFs). In the mouse, primary HFs arise in utero starting just
before E14.5, when the first morphological signs of a placode are discernible. In this study,
our goal was to identify novel factors expressed during primary HF morphogenesis. We per-
formed transcriptional profiling of the developing epidermis at 12 hour intervals between E12.5
and E15.5. One of the significantly differentially expressed genes was the Wnt inhibitor Dick-
kopf 4, Dkk4. We show that Dkk4 mRNA increases sharply in the dorso-lateral epidermis
around E14 and then decreases until E15.5. Using whole mount in situ hybridization, we show
that Dkk4 mRNA is localized to the pre-placodes at sites of presumptive epithelial-mesenchymal
interactions during appendage morphogenesis, including the dental lamina, mammary gland,
eccrine gland, and primary and secondary HFs. In silico analysis, reporter gene assays as well
as in vitro transfections of LEF1 and β-Catenin show that Dkk4 is a potential downstream tar-
get of canonical Wnt signaling. In addition, we demonstrate a direct physical interaction
between LEF1/β-Catenin complex and the DKK4 promoter using ChIP, showing that Dkk4 is
a direct downstream target of this pathway. We propose that Dkk4 acts in a negative feedback
loop to attenuate canonical Wnt signaling via a reaction-diffusion mechanism, and may facil-
itate the non-canonical Wnt planar cell polarity (PCP) pathway that maybe involved in cell
movements during appendage morphogenesis.
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Site-specific induction of epidermal fates by dermal HOX transcriptional program
JL Rinn,1 JK Wang,1 N Allen,2 AJ Mikels,3 R Nusse,3 JA Helms2 and HY Chang1 1
Dermatology, Stanford University, Stanford, CA, 2 Surgery, Stanford University, Stanford, CA
and 3 Developmental Biology & HHMI, Stanford University, Stanford, CA
Site-specific development of skin is shaped by reciprocal epithelial-mesenchymal interactions.
Adult dermal fibroblasts have recently been discovered to possess extensive site-specific dif-
ferentiation and maintain the embryonic pattern of HOX gene expression. HOX genes encode
a family of transcription factors that specify positional identity of cells during development,
but their functional roles in adult dermal fibroblasts are unclear. Here we show that the dis-
tal-specific HOXA13 is continually required to maintain the distal-specific transcriptional pro-
gram genome-wide in adult fibroblasts. Genetic deletion of HOXA13 during development or
acute depletion of HOXA13 in adult dermal fibroblasts abrogated expression of WNT5A, a
morphogen required for distal-specific development. RNAi-mediated depletion of HOXA13
abrogated the ability of distal fibroblasts to induce the expression of keratin 9, a distal-spe-
cific differentiation marker, in co-cultured keratinocytes, but addition of purified, recombinant
WNT5A fully rescued keratin 9 induction by HOXA13-depleted fibroblasts. These results sug-
gest that HOX genes are necessary and their transcriptional targets are sufficient to differen-
tially pattern the overlying epithelia. Thus, maintenance of appropriate HOX gene expression
in adult fibroblasts may serve as a source of positional memory for skin during homeostasis
and regeneration.
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Transgenic mice reveal novel roles for ∆Np63 in de novo hair follicle formation and seba-
ceous gland development
R Romano and S Sinha Biochemistry, State University of New York at Buffalo, Buffalo, NY
The transcription factor p63 plays an important role in the development of stratified epithe-
lium of the skin and its appendages as evident by studies in knockout and transgenic mice. In
particular, p63 null mice exhibit striking defects in the formation of the embryonic epidermis
resulting from a lack of stratification. However, understanding the molecular mechanisms
that underlie this phenotype has been complicated by both the early postnatal lethality of p63
null mice and the existence of multiple p63 isoforms. The fact that all isoforms of p63 are
absent in the knockout mouse has thus precluded the studies on the biological role of indi-
vidual p63 proteins, in particular the ∆Np63 isoforms, which are predominantly expressed in
the skin. To address the in vivo role of ∆Np63 in epidermal development, we have generated
transgenic mice over expressing ∆Np63α, or a shorter isoform ∆Np63β, which lacks an impor-
tant protein-protein interaction module, the SAM domain. These proteins were targeted to the
proliferative cells of the epidermis in a tetracycline inducible fashion using the K5 promoter.
In transgenic mice expressing either isoform, upon a short induction period, dramatic defects
were observed in the skin that included dry, scaly, eroded skin as well as epidermal hyper-
plasia. Striking developmental abnormalities were also apparent in a variety of epidermal
appendages including hair follicles and sebaceous glands. In particular, these transgenic ani-
mals exhibit defective embryonic hair follicle development and altered postnatal hair cycling,
resulting in hair loss. Interestingly induction of ∆Np63 results in postnatal epithelial invagi-
nations of the interfollicular epidermis associated with de novo hair follicle structures includ-
ing hypertrophic and enlarged sebaceous glands. Our transgenic mouse models have uncov-
ered novel functions of ∆Np63 and will be valuable in teasing out the relative roles of ∆Np63α
and ∆Np63β in influencing the transcriptional events and signaling pathways that govern the
developmental processes underlying epidermal lineage commitment.
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Hedgehog controls hair follicle regeneration through a novel dermal signaling pathway
W Woo, H Zhen and A Oro Dermatology, Stanford University Medical Center, Stanford, CA
Hair follicle (HF) morphogenesis requires precise reciprocol signaling between HF epithelial
stem cells and the dermal papilla (DP). While the interaction is well known, the mechanisms
of signaling cross talk between cells remains poorly understood. One of the key inductive sig-
nals is Sonic hedgehog (Shh), which is normally expressed only in the epithelial compartment
and required for HF morphogenesis. Aberrant Shh target gene induction in the epithelium
results in basal cell carcinoma. While both compartments express Shh target genes, previous
studies have supported a role for Shh only on epithelial cells. To better understand a potential
role for Shh in the DP, we have developed a rapid, genetically tractable hair regeneration sys-
tem allowing gene knockdown in either the epithelial or DP cell populations. Sustained knock-
down of the critical Shh transducer Smoothened (Smo) in the DP resulted in greater than 90%
reduction in Shh target gene induction. Hair regeneration with Smo knockdown DP cells and
wild type epithelial cells resulted in dramatic reduction in HF number and length. While growth
delayed, the remnant mutant HF displayed normal HF differentiation markers. Smo mutant DP
cells expressed reduced levels of DP markers such as alkaline phosphatase, suggesting Smo
may regulate some aspects of DP differentiation. We conclude that Shh controls epithelial HF
progenitor proliferation indirectly through a novel DP signaling pathway.
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The miRNA processing enzyme Dicer is required for hair follicle maintenance in adult skin
T Andl,1 E Murchison,3 A Nagy,2 G Hannon3 and S Millar1 1 Dermatology, UPenn,
Philadelphia, PA, 2 Lunenfeld Institute, Mount Sinai Hospital, Toronto, ON, Canada and 3
Howard Huhges Institute, CBH Laboratory, Cold Spring Harbor, NY
MicroRNAs (miRNAs) are endogenous approximately 22 nt RNAs that regulate gene expres-
sion by binding the 3’ untranslated regions of protein coding mRNAs, resulting in mRNA cleav-
age or inhibition of translation. Conserved vertebrate miRNAs are predicted to target several
hundred genes, suggesting broad roles in biology. We, and others previously demonstrated
that multiple miRNAs are expressed in developing and postnatal skin and hair follicles, and
that constitutive deletion of the miRNA processing enzyme Dicer in embryonic mouse skin
causes failure of hair folliclulogenesis and subsequent follicular degradation. Here we inves-
tigate whether Dicer and miRNA function is also required in established hair follicles in the
adult mouse. For these experiments we generated K5-rtTA tetO-Cre Dicerfl/fl mice in which
the Dicer gene can be inducibly deleted in the basal epidermis and hair follicle outer root
sheath, including hair follicle stem cells, by dosage with oral doxycycline. Inducible Dicer
deletion starting at postnatal day (P) 20, when hair follicles are just entering the first postna-
tal growth cycle, resulted in loss of external hair starting within 10 days of doxycycline treat-
ment. Histological analysis at P45 revealed that mutant hair follicles remained in an abnor-
mal growth phase, while hair follicles in control littermate skin had entered telogen. Expression
of the hair follicle stem cell markers K15 and S100A6 was lost from affected mutant hair fol-
licles, despite maintenance of expression of the outer root sheath marker Sox9. Analysis at
P70 and P90 showed that the mutant hair follicles degenerated, similar to the phenotype seen
in constitutive epidermal Dicer mutant mice. These data demonstrate that in addition to its
essential role in embryonic hair follicle morphogenesis, Dicer function is required in mature
skin for normal timing of the hair follicle growth cycle, and for maintaining the hair follicle
epithelial stem cell population and follicle integrity.
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Deregulated RAS in mice causes cutaneous manifestations of Costello syndrome
BD Yu Division of Dermatology, Department of Medicine, University of California, San Diego,
La Jolla, CA
Mutations in RAS are frequently found in cancer. In humans, germline mutations in RAS
oncogenes have also been identified in three closely related syndromes, Costello, Noonan,
and cardiofaciocutaneous (CFC) syndromes. Costello syndrome is exclusively associated
with strongly activating HRAS mutations and the most severe skin phenotype while Noonan
and CFC syndrome patients are found to have weaker mutations in KRAS. To test whether skin
disease in Costello syndrome is specific to HRAS, we have generated mice expressing a strongly
activated allele of Kras in the skin. Such mice develop redundant skin, thickened palmar skin,
sparse hair, coarse facies, and papillomas by two weeks of age. These findings closely resem-
ble the cardinal features of Costello syndrome and indicate that in congenital disorders, dif-
ferent levels of RAS-MAPK activation account for differences in clinical outcome.
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Hedgehog-driven epithelial bud development is associated with activation of canonical Wnt
signaling
S Yang, V Grachtchouk, A Wang, J Liu, L Syu and A Dlugosz Department of Dermatology,
University of Michigan, Ann Arbor, MI
The Hedgehog (Hh) and Wnt signaling pathways have distinct functions in normal hair folli-
cle development: canonical Wnt signaling initiates follicle development, Hh signaling drives
epithelial proliferation needed to assemble the maturing follicle, and Wnt signaling then pro-
motes terminal differentiation to produce hair. Interestingly, de novo, hair bud-like structures
are seen in human superficial basal cell carcinoma (BCC), which is caused by constitutive Hh
signaling. This observation raises the possibility that Hh signaling in skin may lead to ectopic
epithelial bud development indirectly, via activation of canonical Wnt signaling. We explored
this idea using mouse models expressing an activated form of Smoothened (SMO*) to focally
activate Hh signaling in hairless volar epidermis. SMO* expression led to activation of multi-
ple Hh target genes and formation of de novo epithelial buds resembling those seen in human
superficial BCC. The SMO*-induced buds shared features in common with embryonic hair
buds, including expression of the follicle outer root sheath markers keratin 17 and Sox9, the
hair matrix marker CDP, and increased proliferation. Volar skin from SMO*-expressing mice
revealed induction of multiple Wnts, which are undetectable in control volar skin. β-catenin
was present in the cytoplasm and nucleus of epithelial bud cells, and non-phosphorylated
(active) β-catenin was detected via Western blotting, indicating activation of the canonical
Wnt signaling pathway. In addition, Wnt target genes, including Axin2, Cyclin D1, and Lef-
1, were also upregulated in SMO*-expressing volar skin. Cell-autonomous activation of Hh
signaling in interfollicular epidermal cells is thus capable of triggering a subset of changes
that accompany early stages of normal follicle development. Moreover, ectopic Hh signaling
appears to drive bud development indirectly, via upregulation of Wnt genes and consequent
stimulation of the canonical Wnt signaling pathway.
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Hair follicle stem cell-specific PPAR gamma deletion causes scarring alopecia
P Karnik,1,2 Z Tekeste,1,2 M Smith,1,2 A Gilliam,1,2 TS McCormick,1,2 KD Cooper1,2 and
P Mirmirani1,2 1 Dermatology, Case Western Reserve University, Cleveland, OH and 2 Univ
Hosp Case Medical Center, Cleveland, OH
We previously showed reduced PPAR gamma mRNA and PPAR gamma regulated pathways
(peroxisome biogenesis and lipid metabolism) by microarray analysis of scalp hair follicles
from individuals with lichen planopilaris, a scarring alopecia. Specific agonists of PPAR gamma
but not other PPAR subtypes were effective in inducing peroxisomal and lipid-metabolic
gene expression in human keratinocytes. We designed a knockout mouse in order to study
these pathways and determine their importance to the cicatricial alopecias. It is thought that
in the cicatricial alopecias, inflammation damages the bulge of the hair follicle where stem
cells are found. The hair follicle is permanently destroyed leading to replacement with scar
tissue. We used the Cre-Lox system to selectively delete PPAR gamma from the bulge. Floxed
PPAR gamma mice were crossed with Keratin 15-Cre mice to yield stem cell specific knock-
out of PPAR gamma. The phenotype of the PPAR gamma-deficient mice resembled the human
scarring alopecias and was as follows: 1) Progressive alopecia after 4 weeks ending with total
alopecia by 4 months 2) Histology of hair follicles showing perifollicular inflammation, dilated
plugged follicles, multiple hairs/follicle, and partially cornified sebaceous lobules. 3) Increased
lipid accumulation in the follicular ostia and around the hair shaft reminiscent of that seen in
human scalp biopsies of LPP patients. This mouse model provides strong evidence that the
PPAR gamma-signaling pathway and lipid metabolism may be critical in the scarring alope-
cias. These studies suggest that PPAR gamma is essential for healthy pilosebaceous units and
loss of this function underlies the pathogenesis of these disorders. We propose that PPAR
gamma targeted therapy represents a new strategy in the treatment of these disorders.
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Expression of antimicrobial peptides according to    changes of TEWL levels in atopic der-
matitis
T Han,1 M Jeong,2 S Seo1 and C Hong1 1 Dermatology, Chung-Ang University, Seoul, South
Korea and 2 Chung-Ang University Hospital Research Center, Seoul, South Korea
The innate immune system of human skin contains antimicrobial peptides(AMP) known as
cathelicidins(LL-37) and human beta-defensins(hBD)-2. These peptides immediately respond
to intruded microbes for prevention of further invasion. Although atopic dermatitis(AD) is
recurrent inflammatory skin disease, it is known that antimicrobial pepetides have suppressed
activity in atopic dermatitis. Current research was to identify the expressions of antimicrobial
peptides according to changes of transepidermal water loss(TEWL) levels in atopic dermati-
tis. The involved and uninvolved sites of patients diagnosed as having atopic dermatitis were
evaluated using TEWL. And the expression of LL-37 and hBD-2 in skin biopsy specimens
from involved and uninvolved sites of these patients were determined by Real-time reverse-
transcriptase-polymerase(RT-PCR), Western blotting and immunohistochemical staining(IHC).
The TEWL levels increased in both uninvolved and involved sites, more increased in involved
sites. It implicated that permeability barrier function was more disrupted in involved sites of
atopic dermatitis. In real time-sequential analyses of AMP mRNA expression by RT-PCR, the
expression levels of hBD-2 and LL-37 mRNA were down-regulated in both uninvolved and
involved sites, more decreased in involved sites. In Western blotting of hBD-2 and LL-37 pro-
teins, the levels of hBD-2, LL-37 protein expressions of uninvolved sites were determined to
be more intense than those observed in the involved sites. These tendency were also con-
firmed by IHC. Our results demonstrate that expression of antimicrobial peptides downregu-
lated according to increasing TEWL levels in atopic dermatitis lesions. Therefore, this defi-
ciency may account for the susceptibility of patients with atopic dermatitis to skin infection,
also implicate that localized skin barrier disruption play a role for suppressing the expression
of antimicrobial peptides.
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Galectin-2 suppresses contact allergy by inducing apoptosis in activated CD8+ T cells
K Loser,1 S Balkow,1 A Sturm,2 A Dignass,3 TA Luger1 and S Beissert1 1 University of
Muenster, Department of Dermatology, Muenster, Germany, 2 Charite, Department of
Internal Medicine, Berlin, Germany and 3 Markus-Hospital, Frankfurt, Germany
Galectins are a family of animal lectins known to affect cell survival, cell adhesion, and cell
migration. Since galectin-2 was shown to regulate inflammatory bowel disease in mice, we
were interested to investigate the role of galectin-2 in cutaneous immunity. Therefore, groups
of mice were systemically treated with galectin-2 before sensitization to contact allergens to
analyze the effects of galectin-2 on contact hypersensitivity (CHS) responses. Interestingly,
upon epicutaneous immunization followed by a local challenge at the ear, galectin-2 treated
mice demonstrated a significantly decreased CHS response compared to controls. Even after
re-challenge with the same hapten after a two-week interval galectin-2 injected mice mounted
a reduced CHS response suggesting the induction of tolerance. Since CHS responses in mice
can be controlled by regulatory T cells we analyzed the numbers and suppressive activity of
CD4+CD25+ T cells in galectin-2 treated mice. Surprisingly, numbers and function of regu-
latory T cells were normal but we detected dramatically decreased levels of total CD8+ T
cells in the challenged ears and in skin draining lymph nodes of galectin-2 treated mice com-
pared to non-treated controls. This reduction in cell numbers was even more pronounced in
activated compared to naive or memory CD8+ T cell subsets. Additionally, galectin-2 exposed
and activated CD8+ T cells demonstrated an increased expression of annexin V indicating that
galectin-2 treatment induced apoptosis in CD8+ T cells. Importantly, the pro-apoptotic effects
of galectin-2 on activated CD8+ T cells could be reversed by addition of the pan-caspase-
inhibitor zVAD. Together, these data indicate that galectin-2 is an inducer of apoptosis in
activated CD8+ T cells. These results furthermore suggest a potential therapeutic use of galectin-
2 in CD8 mediated skin disorders such as contact allergy.
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Combination cytokine therapy induces tumor regression and tumor-specific CTL responses
in a murine melanoma model
AN Kalaaji,1 J Lu,1 SN Markovic,2 E Celis3 and MR Pittelkow1 1 Dermatology, Mayo Clinic
Rochester, Rochester, MN, 2 Hematology, Mayo Clinic Rochester, Rochester, MN and 3
Immunology, Mayo Clinic, Rochester, MN
Various cytokines including IFNα, TNFα and GMCSF have been utilized as adjuvant, single
agent therapy for advanced stage melanoma with mixed results and dose dependent toxic-
ity. The studies reported here were initiated to investigate the therapeutic efficacy of IFNα,
GM-CSF, and TNFα when combined in a B16 F10 murine melanoma model. C57/BL6 Mice
were challenged with a B16 F10 melanoma cell line intradermally into hind footpads then
treated with either a single cytokine or combined intratumoral cytokine cocktail. Tumor
growth was assessed as well as anti-tumor T cell responses. Our results show that intratu-
moral GMCSF, IFNα and TNFα, when injected in combination, result in significant inhibi-
tion of tumor growth. Tumor regression correlated with local tumor necrosis and infiltration
of T cells. In addition, this intratumoral cytokine cocktail injection also induced lym-
phadenopathy with an increase in both CD4+ and CD8+ T cells in the draining lymph nodes.
Interestingly, tumor-specific CD8+ T cells were identified from draining lymph nodes. Our
findings indicate that IFNα, GM-CSF, and TNFα when used in combination in a melanoma
murine model significantly potentiate the therapeutic efficacy beyond that achieved with sin-
gle cytokine adjuvant therapy.
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S100A8 and A9 proteins control autoreactive CD8+ T cell development during CD40L-induced
systemic autoimmunity
K Loser,1 K Klimmek,1 S Balkow,1 C Kerkhoff,2 W Nacken,2 TA Luger1 and S Beissert1 1
University of Muenster, Department of Dermatology, Muenster, Germany and 2 Department
of Experimental Dermatology, Muenster, Germany
CD40-CD40L signaling is involved in the development of autoimmunity. Within the skin transgenic
(tg) overexpression of CD40L in basal keratinocytes spontaneously leads to systemic autoimmunity
as evidenced by autoantibodies, nephritis, proteinuria, and autoimmune dermatitis, which can be
adoptively transferred by injecting CD8+ T cells into naive recipient mice. To identify genes involved
in the development autoreactivity gene expression profiling of sorted CD8+ T cells from CD40L tg
mice before and after onset of disease was performed. Surprisingly, an increased expression of S100A8
and A9 genes both members of the S100 family of Ca-binding proteins was detected in CD8+ T cells
after onset of autoimmune disease. To determine the functional relevance of S100A8/A9 expression
for the development of autoimmunity in vivo, CD40L tg mice were crossed to S100A8/A9-/- mutants.
Interestingly, CD40LxS100A8/A9-/- mice showed significantly reduced autoimmune dermatitis and
markedly decreased numbers of skin lesion infiltrating lymphocytes. Since CD40L tg mice show
renal IgG/IgM depositions, glomerulonephritis, and proteinuria, renal function was analyzed in
CD40LxS100A8/A9-/- mice. Importantly, CD40LxS100A8/A9-/- mice showed a complete loss of
nephritis, renal immunoglobulin depositions, and proteinuria indicating normal kidney function.
Additionally, the activation status of splenic and lymph node CD8+ T cells was determined in
CD40LxS100A8/A9-/- mice demonstrating a decreased expression of cytotoxic/autoreactive mark-
ers like CD43 and granzyme B. CD8+ T cells isolated from CD40LxS100A8/A9-/- mice produced
significantly reduced amounts of IL-17 a cytokine which has been suggested to mediate the inflam-
mation associated with several autoimmune diseases. These data indicate that the expression of
S100A8/A9 proteins may be critically involved in the pathogenesis of autoreactive MHC class I-
restricted T cells in CD40L-induced systemic autoimmunity.
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Leukotriene B4 enhances tumor necrosis factor-α-induced CCL27 production in human ker-
atinocytes
N Kanda, T Shimizu, Y Tada and S Watanabe Dermatology, Teikyo University, School of
Medicine, Tokyo, Japan
Background: A chemokine CCL27 recruits skin-homing T cells. CCL27 production by ker-
atinocytes is dependent on nuclear factor-κB (NF-κB) activity and is enhanced in skin lesions
with atopic dermatitis, allergic contact dermatitis, or psoriasis vulgaris. A lipid mediator
leukotriene B4(LTB4) may be involved in the development of these dermatoses. LTB4 acts on
cell surface G-protein-coupled receptors, BLT1 and BLT2. We examined in vitro effects of LTB4
on CCL27 production in human keratinocytes. Methods: Keratinocytes were incubated with
tumor necrosis factor-α (TNF-α) and LTB4. CCL27 secretion and mRNA levels were analyzed
by ELISA and RT-PCR, respectively. NF-κB activities were analyzed by luciferase assays. Pro-
tein levels or phosphorylation status were analyzed by cell-based ELISA.Results: LTB4 alone
did not enhance CCL27 production and modestly enhanced NF-κB activity in keratinocytes.
However, LTB4 potently enhanced TNF-α-induced CCL27 secretion and mRNA expression
and NF-κB activity. LTB4 alone or together with TNF-α- induced phosphorylation and degra-
dation of inhibitory NF-κB α and phosphorylation of NF-κB p65. These effects of LTB4 were
suppressed by BLT1 antagonist U75302, pertussis toxin, phosphoinositide-3 kinase (PI3K)
inhibitor LY294002 and extracellular signal-regulated kinase (ERK) kinase inhibitor U0126,
but not by BLT2 antagonist LY255283. LTB4 induced phosphorylation of ERK and Akt, down-
stream kinase of PI3K; LY294002 suppressed phosphorylation of both kinases while U0126
suppressed only the former. Conclusions: These results suggest that LTB4 may enhance TNF-
α-induced CCL27 production by activating NF-κB via BLT1/Gi/o/PI3K/ERK pathway. LTB4 may
promote T cell infiltration into lesions of inflammatory dermatoses via the enhancement of
CCL27 production.
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The expression of Foxp3+ T cells in the elicitation phase of murine contact hypersensitivity
K Masuda, N Katoh, R Tamagawa-Mineoka, F Soga and S Kishimoto Dermatology, Kyoto
Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan
Contact hypersensitivity (CHS) is a T-cell-mediated immune reaction that occurs after epicu-
taneous sensitization and challenge with reactive haptens. Recent experiments indicate that
CD8+ Tc1 are effector cells whereas regulatory CD4+ T cells have down-regulating proper-
ties in CHS. It has become clear that CD4+CD25+ regulatory T cells (Tregs) play a crucial role
in the control of autoimmunity, transplantational tolerance, anti-tumor immunity and bacter-
ial infection through the control of T-cell response. However, regulatory mechanisms of CHS
or the role of Tregs in CHS is not clear. Thus, we investigated the involvement of Tregs in the
CHS reaction kinetically. Trinitrochlorobenzene was applied to the skin of male BALB/c mice
and the expression of Foxp3 of the challenged ear lobe was estimated at various times after
the challenge by reverse transcription-polymerase chain reaction and immunohistochemical
examination. During the elicitation phase, CD8+ T cells were found in the skin as early as 6h
after challenge and CD4+ T cells appeared first 12 h afterward. The number of CD8+T cells
decreased and CD4+ T cells increased 24 h after challenge. The expression of Foxp3 was found
6 and 12 h, then increased 24, 48 and 72 h and decreased 5 days after the challenge. The
expression of Foxp3 was associated with the peak of the CHS response and the beginning of
resolution of skin inflammation. These results suggest that Tregs may play an important role in
regulating CHS.
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Langerhans cells but not bone marrow–derived dendritic cells direct UV-induced regulatory
T cells into the skin
A Schwarz, A Maeda and T Schwarz Department of Dermatology, University Kiel, Kiel,
Germany
UV-induced regulatory T cells (UV-Treg) inhibit the sensitization but not the elicitation of
contact hypersensitivity (CHS) when injected intravenously (i.v.). This is due to the fact that
UV-Treg migrate primarily into the lymph nodes but not into the skin, since they express the
lymph node homing receptor CD62L but not skin homing receptors. To utilize UV-Treg in a
therapeutic fashion, emigration into the skin is crucial. Coincubation of UV-Treg with Langer-
hans cells (LC) downregulated CD62L and induced the skin homing receptor PSGL-1. Accord-
ingly, i.v. injection of UV-Treg pretreated in such a way inhibited the elicitation but not the
sensitization of CHS. In contrast, coincubation with bone marrow-derived dendritic cells (BM-
DC) did neither alter the migratory behavior nor the expression of homing receptors of UV-
Treg. The same was observed for UV-Treg coincubated with DC from spleen or from lymph
nodes, implying that DC from peripheral organs reprogram the migratory behavior of UV-Treg
into the periphery, but not DC from lymphoid organs. Upon i.v. injection, CFSE-labelled UV-
Treg could only be detected in the skin, when Treg were preincubated with LC but not with
BM-DC. Upon coincubation with BM-DC the majority of labelled cells were found in the
lymph nodes and the spleen when injected i.v. Double staining with CD25 confirmed that the
CFSE-labelled cells were UV-Treg which express CD4 and CD25. To exclude that the sup-
pressive activity of UV-Treg is altered by the coincubation with BM-DC and thereby do not
suppress the elicitation of CHS, UV-Treg after coincubation with BM-DC were injected intra-
cutaneously into the ears of sensitized mice which resulted in a pronounced inhibition of the
ear challenge. This confirmed that coincubation with DC alters the tissue homing but not the
activity of UV-Treg. Taken together, this shows that the migratory behavior of UV-Treg can be
altered by tissue-specific DC. This may have input on strategies trying to utilize Treg not only
for the prevention but also for the treatment of immune-mediated disorders.
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Promotion of hair growth by T cells from lymph nodes of repeated skin application of hap-
ten
K Sugita,1 K Kabashima,1 D Nakashima,1 R Hino,1 T Ito2 and Y Tokura1 1 Dermatology,
University of Occupational and Environmental Health, Kitakyushu, Japan and 2
Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan
It is well known that contact dermatitis induces hair growth. For example, squaric acid
dibutylester (SADBE) is clinically used for the treatment of alopecia areata. Murine contact
hypersensitivity (CHS) to hapten is an experimental model of T cell mediated, cutaneous
delayed-type hypersensitivity. The degree of CHS responses depends on the hair cycle. While
skin of anagen hair cycle is resistant to CHS sensitization, telogen skin is effective for sensiti-
zation. Therefore, mice with ages from 7 to 10 weeks, corresponding telogen hair cycle are
usually used for CHS experiments. To examine the association between CHS and hair growth,
8-week-old BALB/c mice were sensitized with 0.1% 2,4-dinitro-fluorobenzene (DNFB) 6 times
at 2-day intervals. Significant hair growth was induced in mice sensitized with repeated appli-
cation of DNFB. Lymph node cell (LNC) suspensions were prepared from 8-week-old BALB/c
mice 6 times after sensitization with DNFB. The cells were injected through a tail vein into
naïve 8-week-old recipient mice. The LNC transfer induced remarkable hair growth in the
recipient mice 21 days later. Since repeated application of hapten is known to induce Th2
cells, we cultured immune LNCs (1 x 106 /well) for 72 h, and the culture supernatants were
subjected to cytometric beads array to quantify interferon- γ (IFN-γ), interleukin (IL) -4 (IL-4),
and IL-10. Immune LNCs produced Th2 cytokine IL-4 and IL-10 at higher levels than control.
Th1 cytokine IFN-γ was also produced by LNCs. These findings indicate that hair growth is
inducible with T cells, and a possible role for Th2 cytokines is suggested.
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HLA-C alleles 0602 and 0701 have opposing effects on severity of psoriasis during pregnancy
AK Brimhall,1,2 B Wong,2 J Capper,3 P Krausa,3 JS Papenfuss,2 CB Hansen,2 JM Panko,2
T Nelson,2 GG Krueger2 and KP Callis2 1 University of North Texas Health Science Center,
Fort Worth, TX, 2 Dermatology, Utah Psoriasis Initiative, University of Utah, Salt Lake City, UT
and 3 Atria Genetics, South San Francisco, CA
Psoriasis has been shown to improve in about one-third of patients during pregnancy. Improve-
ment associates with the HLA-Cw*0602 allele. 138 patients with onset of psoriasis prior to
pregnancy in the Utah Psoriasis Initiative (UPI) completed a written or phone survey, physi-
cal assessment, and HLA-C genotyping. 37, 22, and 41 percent reported improvement, exac-
erbation, or no change of psoriasis severity during pregnancy, respectively. HLA-Cw*0602 was
more common in patients reporting improvement versus those who worsened (n=80, chi2=6.52,
p=0.01). HLA-Cw*0701 was more common in patients who worsening during pregnancy
(n=80, chi2=3.99, p=.05). Exacerbation of psoriasis was also associated with postpartum state
(n=56, chi2=2.95, p=.003), menopause (n=58, chi2=29.49, p<.001), and bilateral oophorec-
tomy (n=20, chi2=7.20, p=.007). The analysis was repeated when patients were grouped into
HLA-C functional groups C1 (including HLA-Cw*0701, *0101, *0302, *0303, *0304,
*0701/06/18, *0702, *0704/11, *0801, *0802, *1202, *1203, *1402, and *1601), and C2
(including Cw*0602, *0611, *1502, *1505, *1602, and *1701/02/03). The majority of patients
who exacerbated during pregnancy were found to be homozygous for C1, while patients who
experienced remission were more frequently heterozygous or homozygous for C2 (chi2=5.76,
p=.02). HLA-C is expressed on placental tissue and thought to play a central role in natural
killer (NK) cell fetal allograft tolerance through interaction with Killer Immunoglobulin-Like
Receptors (KIRs). C1 interacts with KIR2DL2, KIR2DS2, and KIR2DL3 distinct from KIR2DL1
and KIR2DS1 which interact with C2 alleles. We conjecture that the HLA-Cw*0602 allele may
preferentially inhibit NK cells during pregnancy and could play a role in improvement of pso-
riasis, with the reverse being true for HLA-Cw*0701.
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Dendritic cells transduced with novel autoantigen FCRLA induce cytotoxic lymphocytes
and vaccinate against murine B cell lymphoma
T Inozume,1 N Shibagaki,1 H Mitsui,1 T Okamoto,1 Y Matsuzaki,2 Y Kawakami2 and
S Shimada1 1 Dermatology, University of Yamanashi, School of Medicine, Nakakoma-gun,
Japan and 2 Division of Cellular Signaling, Institute for Advanced Medical Research, Keio
University School of Medicine, Shinanomachi, Japan
We previously demonstrated that the human Fc receptor-like A (hFCRLA) was a novel antigen
that was specifically expressed in melanocytes, melanoma cells, and some B cell states, and
was recognized by IgG antibodies from melanoma patients. Recently, it has been reported that
hFCRLA is expressed in most human B cell lymphoma tissues. In this study, we investigated the
potential of FCRLA as a tumor-associated antigen (TAA) of B cell lymphoma for immunotherapy.
We confirmed that murine FCRLA (mFCRLA) was expressed and distributed in murine tissues
similar to hFCRLA. Therefore, we used mFCRLA for vaccine immunotherapy against B cell lym-
phoma in a murine model. We also have shown that polyarginine-protein-transduction-domain
(R9-PTD)-mediated protein delivery to dendritic cells (DC) could cross-present Ag onto MHC
class I and MHC class II molecules abundantly, and vaccination with PTD-containing Ag-trans-
duced DC elicited strong antitumor effects both in vitro and in vivo by inducing Ag-specific T-
cell activation and Ab production, using OVA as a model TAA. Then recombinant mFCRLA fusion
protein was constructed with R9-PTD (rR9-HA-mFCRL), and was transduced into bone marrow-
derived dendritic cells (DC) ex vivo. BALB/C mice immunized with rR9-HA-mFCRL-treated DC
primed CTL that killed the B cell lymphoma cell line (A20), which express mFCRLA abundantly.
In a tumor challenging study, A20 tumor growth inoculated in skin was significantly suppressed
in mice vaccinated with rR9-HA-mFCRL-treated DC, compared with control mice. These results
indicated that FCRLA is a potential target antigen in immunotherapy for B cell lymphoma. In
addition, our experimental system using R9-PTD-containing full-length proteins might be a use-
ful method to analyze the immunogenicity of novel candidates of TAA in vivo.
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Galectin-3 is critical for the development of the allergic inflammatory response in a mouse
model of atopic dermatitis
J Saegusa, DK Hsu, H Chen, L Yu and F Liu Dermatology, UC Davis, Sacramento, CA
Galectin-3 (gal3) is a member of a family of β-galactoside-binding animal lectins and is
expressed by a variety of cells and tissues, including activated B and T cells, macrophages,
dendritic cells, mast cells, neutrophils and eosinophils. Atopic dermatitis (AD) is a chronic
inflammatory skin disease characterized by spongiotic skin lesions that are attributable to Th2-
mediated inflammatory responses. To establish the role of gal3 in the development of AD, we
used a mouse model of allergic skin inflammation induced by repeated epicutaneous sensi-
tization with ovalbumin (OVA), which displays many of the features of human AD, including
pronounced local and systemic Th2 responses. OVA-treated gal3–/– mice exhibited reduced
epidermal thickening, lower eosinophil and mast cell infiltrations in the dermis, and lower
total and antigen-specific IgE levels but higher antigen-specific IgG2a/IgG1 ratio in the serum,
compared to similarly treated gal3+/+ mice. In addition, the former had lower IL-4 mRNA
expression, but higher IFN-γ mRNA expression than the latter in the OVA-treated skin sites.
Moreover, following in vitro restimulation with OVA, splenocytes and draining lymph node
cells from OVA-sensitized gal3–/– mice secreted less IL-4, but more IFN-γ and IL-12 than those
from similarly treated gal3+/+ mice. Significantly, gal3+/+ mice that received T cells from gal3–/–
mice backcrossed to OVA-specific TCR transgenic (gal3–/–/OVA-TCR tg) mice developed a
markedly lower Th2 response and appreciably reduced dermatitis after exposure to OVA, com-
pared to those receiving T cells from gal3+/+/OVA-TCR tg mice. The results indicate that endoge-
nous gal3 in T cells regulates Th1/Th2 polarization. We conclude that gal3 is critical for the
development of the allergic inflammatory response to epicutaneously introduced antigens and
may play a key role in atopic dermatitis.
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Calcitonin gene-related peptide (CGRP) induces production of the TH2 chemokines CCL17
and CCL22 but inhibits the stimulated production of the TH1 chemokines CXCL9 and CXCL10
by Langerhans cells (LCs)
W Ding,1 L Stohl,2 T Zapolanski,1 A Kakimi,1 JA Wagner2 and RD Granstein1 1 Dermatology,
Weill Medical College of Cornell Univesity, New York, NY and 2 Neurology and
Neuroscience, Weill Medical College of Cornell University, New York, NY
CGRP inhibits the ability of LCs to present antigen and intradermal administration of CGRP to
mice inhibits the induction of contact hypersensitivity at the site of injection. We have now exam-
ined the ability of CGRP to regulate chemokine expression by LCs. By RT-PCR, the murine epi-
dermis-derived dendritic cell lines XS52 (BALB/c) and XS106 (A/J), as well as freshly-obtained
LCs (fLCs, purified from BALB/c epidermis by FACS using anti-I-Ad mAb), expressed mRNA for
components of the functional CGRP receptor [receptor activity modifying protein (Ramp)1, Ramp2,
Ramp3, CGRP-receptor component protein (CRCP) and calcitonin receptor-like receptor (CRLR)].
CXCL9 and CXCL10 are two ligands for CXCR3, preferentially expressed on Th1 cells; CCL22
and CCL17 act on CCR4, CCR8 and are preferentially expressed on Th2 cells. XS52 cells and
XS106 cells, as well as fLCs, were pretreated for 1 h with varying concentrations of CGRP and
then stimulated with or without gamma interferon (IFNγ) or CD40L. Supernatants were collected
at 12 to 72 h and chemokine concentrations were assessed by enzyme-linked immunosorbent
assay (ELISA). Production of CCL17 and CCL22 was enhanced in nonstimulated and CD40L-stim-
ulated XS106 cells and cultured fLCs by pretreatment with CGRP, while induction of CXCL9 and
CXCL10 by IFNγ in XS52 cells and fLCs was suppressed in a dose-dependent manner. CGRP8-37,
an antagonist of the CGRPα receptor, blocked the inhibition of the induction of the TH1 chemokines
CXCL9 and CXCL10 seen with CGRP. However, CGRP8-37 did not block the CGRP-induced increase
in production of the TH2 chemokines CCL17 and CCL22, suggesting that CGRP may be working
through two pathways. These results suggest that CGRP may regulate the balance of Th1/Th2
chemokines produced by LC with effects on recruitment of T cell subsets.
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CXCL12-CXCR4 engagement is required for migration and survival of cutaneous dendritic
cells
K Kabashima,1 K Sugita,1 N Shiraishi,1 T Mori,1 A Uemura,1 K Inaba2 and Y Tokura1 1
Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan and
2 Animal Development and Physiology, Kyoto University, Kyoto, Japan
It is established that CCR7 is essential for cutaneous dendritic cell (DC) migration into the
regional lymph nodes. However, complete migratory inhibition cannot be obtained in CCR7-
deficient mice, suggesting that there exist other chemokine receptors involved in this process.
We investigated the role of CXCR4 in cutaneous DC migration using a new CXCR4 specific
antagonist, 4-F-Benzoyl-TN14003. Initially we found that the expression level of CXCR4 on
migrated cutaneous DCs is higher than that on lymphoid organ resident DCs. On the other
hand, the presence of CXCL12 was detected in the LYVE-1+ lymphatic vessels in the skin
after hapten exposure. Moreover, fluorescein isothiocyanate (FITC)-induced cutaneous DC
migration into the draining lymph nodes was impaired by CXCR4 antagonist. Among FITC+
cells, we found that the Langerin+ Langerhans cells (LCs) are CD11chigh+ CD11bint+ and Lan-
gerin- dermal DCs (dDCs) are CD11chigh+ CD11bhigh+ or CD11clow+ CD11bint+, and the migra-
tion of all the DC populations was suppressed by CXCR4 antagonist. The addition of CXCR4
antagonist to the culture of bone marrow-derived DCs suppressed the number of DCs. The
similar effect was found on the number of LCs when epidermal cell suspensions were incu-
bated in the presence of the antagonist, suggesting that CXCR4 engagement is important for
not only migration but also cell survival. Finally, the in vivo significance of CXCR4 was eval-
uated in a contact hypersensitivity model. The hypersensitivity response was impaired by
CXCR4 antagonist administered during the sensitization phase. Accordingly, the dinitroben-
zene sulfonic acid-induced antigen-specific proliferation of immune lymph node cells was
enhanced by CXCL12 added to the culture. These findings demonstrated that CXCL12-CXCR4
engagement on cutaneous DCs plays a crucial role in the initiation of skin immune response
by enhancing cutaneous DC migration and survival.
675
Platelet-activation factor is involved in Langerhans cell migration
A Fukunaga, NM Khaskhley, S Byrne and SE Ullrich Department of Immunology, University
of Texas, MD Anderson Cancer Center, Houston, TX
Epidermal Langerhans cells (LCs) serve as sentinels of the adaptive immune system. When
LCs encounter antigen, they migrate from the skin to draining lymph nodes. Platelet-activa-
tion factor (PAF) is a phospholipid mediator with potent biological effects. During inflam-
mation, PAF mediates recruitment of leukocytes to inflammatory sites, but its role in LC migra-
tion is unclear. Here we tested that hypothesis that PAF induces LC migration. As expected,
applying 2,4-dinitro-fluorobenzene (DNFB) to wild-type (WT) mice activated LC migration.
In contrast, applying DNFB to PAFR-deficient mice failed to induce LC migration. We noted
no significant difference in TNF-alpha-induced LC migration between WT and PAFR-defi-
cient mice. We observed FITC+, CD11c+, Langerin+ cells in the draining lymph nodes of
hapten sensitized mice, confirming that applying FITC induced LC migration. The appear-
ance of Langerin+ cells in the lymph nodes of PAFR deficient mice was significantly depressed.
However, we did not observe any difference in the contact hypersensitivity (CHS) response
generated in WT or PAFR-deficient mice. Recently, three different groups reported three dis-
tinct results of CHS response by depletion of LCs: that is, i) diminished, ii) enhanced, iii)
unchanged response. Thus, LC may not be the only cells that are required for induction of
CHS and it is possible that the hapten-laden dermal dendritic cells constitute the antigen-
presenting cell responsible for CHS. In contrast to LC migration, the migration of dermal den-
dritic cells (FITC+, CD11c+, Langerin-) into the lymph nodes of PAFR-deficient mice was
equivalent to that found in WT mice. These results indicate that PAF is involved in the migra-
tion of LC from the skin to the draining lymph node, but does not appear to play a role in
the migration of dermal dendritic cells after the application of hapten. Moreover, they sug-
gest that LC migration may not be responsible for the generation of CHS, and dermal den-
dritic cells may play an essential role.
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PPAR-alpha inhibits cutaneous inflammation via Langerhans cells by negative cross-talk with
NF-kappaB signalling and cytokine expression
S Dubrac,1 P Stoitzner,1 J Auwerx,2,1 P Fritsch,1 N Romani1 and M Schmuth1 1 Department
of Dermatology, Innsbruck Medical University, Innsbruck, Austria and 2 IGBCM, Strasbourg,
France
Peroxisome proliferator activated receptor (PPAR)-alpha is a transcription factor that is acti-
vated by endogenous fatty acids and lipophilic small agonists (ligands). Ligand binding stim-
ulates epidermal differentiation, inhibits proliferation, and has anti-inflammatory properties;
i.e. ameliorates contact dermatitis. Conversely, PPAR-alpha knock out mice exhibit increased
inflammatory response to allergen exposure. While PPAR-alpha is expressed in immature
Langerhans cells (LC) and translocates to the nucleus upon ligand treatment, in mature LC
PPAR-alpha expression is decreased. Moreover, upon ligand activation LC maturation and
migration is inhibited, IL1-beta and phospho-NF-kappaB expression is decreased, and the
ability of LC to drive T cell proliferation is markedly diminished. Finally, T-cells from draining
lymph nodes of skin treated with a PPAR-alpha ligand show decreased expression of IFN-
gamma, IL-4 and IL-10. Importantly, the above effects of PPAR-alpha activation are abolished
in PPAR-alpha knock out mice. We conclude that PPAR-alpha may be a powerful drug target
for the treatment of inflammatory skin disease.
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CCL27 transgenic mice showed enhanced contact hypersensitivity reaction to repeated chal-
lenges with fluorescein isothiocyanate
S Kagami,1 H Saeki,1 Y Tsunemi,1 K Nakamura,2 T Nakayama,3 O Yoshie,3 M Komine1 and
K Tamaki1 1 Dermatology, Tokyo University, Tokyo, Japan, 2 Dermatology, Fukushima
Medical University, Fukushima, Japan and 3 Microbiology, Kinki University, Osaka, Japan
CCL27 is one of the CC chemokines produced by keratinocytes and is suggested to be involved
in the pathogenesis of inflammatory skin diseases such as atopic dermatitis and psoriasis vul-
garis. To study the effect of CCL27 produced by keratinocytes during inflammation, we cre-
ated transgenic C57BL/6 mice which overexpressed CCL27 in keratinocytes. Since these
mice did not show any phenotypical change, we challenged contact hypersensitivity to oxa-
zolone and fluorescein isothiocyanate. There was no difference in contact hypersensitivity to
oxazolone between non transgenic and transgenic mice; however, contact hypersensitivity to
repeated challenges with fluorescein isothiocyanate was enhanced in transgenic mice. Under
this condition, the numbers of inflammatory cells, mast cells, CCR10-positive cells, CCR4-
positive cells and CLA-positive cells were increased in the lesional skin. Higher serum IgE
levels were also observed in these mice and IL-4 mRNA expression was higher in the lesional
skin. CCL27 modified the inflammation caused by repeated challenges with fluorescein isoth-
iocyanate, by attracting CCR10-positive and CCR4-positive cells into the lesional skin. An
atopic dermatitis-like condition such as infiltration of mast cells and high serum IgE levels were
observed in transgenic mice which were repeatedly challenged with fluorescein isothiocyanate,
indicating that CCL27 may participate in the pathogenesis of atopic dermatitis.
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Topical P2Y12 purinoreceptor antagonists reduce inflammation in irritant and allergic con-
tact dermatitis models
N Katoh, R Tamagawa-Mineoka, T Nara, F Soga, J Asai, K Masuda and S Kishimoto
Dermatology, Kyoto Prefectural University of Medicine, Kyoto, Japan
Platelets are increasingly recognized to be involved in inflammatory process in addition to
their function in hemostasis and thrombosis. We have recently demonstrated that platelet deple-
tion reduces inflammation in a mouse model of chronic contact hypersensitivity induced by
repeated hapten application, in which chemokines released from platelets in the inflamed skin
tissue play an important role. This also suggests the possibility that suppression of platelet activ-
ity at the site of inflammation by topical application of an antiplatelet drug may reduce cuta-
neous inflammatory reaction. In this study, we thus investigate the effect of topical applica-
tion of potent antiplatelet drugs P2Y12 receptor antagonists on both irritant and allergic contact
dermatitis. Topical application of P2Y12 antagonists clopidogrel or MRS2345 significantly
reduced ear thickness and weight in irritant contact dermatitis induced by single or repeated
application of phorbol myristate acetate (PMA) and allergic contact dermatitis induced with
picryl chloride in mice. The change was accompanied by a reduction in inflammatory cells
and IL-1α levels in the dermis. Topical treatment with clopidogrel also reduced the levels of
chemokines such as MIP-1α, TARC, and RANTES in the dermis of both irritant and allergic
contact dermatitis. These results suggest that control of platelet activity with P2Y12 antago-
nists could be beneficial for the treatment of variety of cutaneous inflammatory diseases such
as contact dermatitis and atopic dermatitis.
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CD70/CD27 interaction promotes the survival of Ag-primed CD4+T cells in Th1-type immune
response
Y Ogawa,1 T Kawamura,1 H Yagita,2 K Okumura2 and S Shimada1 1 Dermatology, University of
Yamanashi,Yamanashi, Japan and 2 Immunology, Juntendo University school of medicine,Tokyo, Japan
The CD70/CD27 interaction provides a co-stimulatory signal for T cells.We previously reported
that CD70 is selectively expressed on Th1, but not Th2, cells and required for induction of con-
tact hypersensitivity to DNFB. Here, we investigated its contribution to Th1-mediated DTH model
and Th2-mediated asthma model. First, OVA323-339-specific DO11.10(KJ1-26
+) CD4+ T cells
labeled with CFSE were adoptively transferred into BALB/c mice, and OVA was injected subcu-
taneously with CFA. CD70 mRNA levels in CD4+ T cells recovered from draining lymph nodes
(DLN) were dramatically increased after immunization. CD70+ cells were only detected in the
CFSElow KJ1-26+ activated T cell fraction. Notably, CD70 expression was observed on CD4+ T
cells 3 days after immunization, while its expression on CD11c+ dendritic cells peaked on day
1. To examine the effect of CD27/CD70 signaling in vivo, BALB/c recipients were administered
with control IgG or anti-CD70 mAb at immunization. Anti-CD70 mAb significantly decreased
the number of KJ1-26+ DLN T cells at day 6 compared to control Ig-treated mice. Interestingly,
the percentage of annexin V+ apoptotic cells in KJ1-26+ T cells was significantly lower in con-
trol IgG-treated mice than in anti-CD70 mAb-treated mice, however, treatment with anti-CD70
mAb did not affect the cell division in KJ1-26+ T cells. When DLN cells were restimulated with
OVA323-339 peptide in vitro, the frequency of IFN-γ-secreting cells was significantly reduced in
cultures derived from anti-CD70 mAb-treated mice as compared to control mice. On the other
hand, in asthma model, the administration of anti-CD70 mAb during the induction phase did
not affect the levels of Th2 cytokines in bronchoalveolar lavage fluid and the serum IgE levels.
These findings suggest that CD27 function is controlled by the differentially regulated kinetics
of CD70 expression on DCs and activated CD4+ T cells, and its signaling does not affect T cell
division process, but promotes the survival of T cells in Th1 immune response.
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IL-6 mediates UVB-exacerbated melanoma growth
KQ Lu, DH Nguyen, RR Patel, TS McCormick and KD Cooper Dermatology, University
Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH
We have found that enhanced melanoma tumor growth in UVB-irradiated skin is mediated
by interleukin-6 (IL-6). A large body of work in both human and murine skin shows that UVB
exposure can lead to suppression of immune responses. We have previously demonstrated
that IL-6, a cytokine upregulated in the post-UVB skin microenvironment, is a critical medi-
ator of immunosuppression. In the current study we examined the in vivo growth of B16
melanoma following its subcutaneous injection into UVB-treated skin (single dose 100mJ/cm2)
of C57Bl/6 control mice (WT). UVB-treated WT mice had tumors ~2-fold larger than non-UVB
treated mice (3.47g +/- 0.44 (n=5) vs. 1.82g +/- 0.50, respectively (n=6), p=.02). We hypoth-
esized that factors leading to UV-induced immunosuppression may also contribute to UVB-
enhanced melanoma growth. We have previously reported that IL-6-/- mice (C57Bl/6 back-
ground) do not develop UVB-mediated immunosuppression in contact hypersensitivity
experiments. Therefore, we tested whether UVB-enhanced melanoma growth would be
impaired in mice deficient in IL-6. In the absence of UVB treatment, WT mice developed larger
tumors than IL-6-/- mice (1.82g +/- 0.50 vs. 0.43g +/- 0.06 respectively, n=6, p=.01). Follow-
ing UVB exposure WT mice had a ~10-fold increase in tumor size compared to UVB-treated
IL-6-/- mice (3.59g +/- 0.62 vs. 0.35g +/- 0.07, respectively, n=7, p=.002). Furthermore no
differences in tumor size were observed between UVB-treated and non-UVB treated IL-6-/-
mice (0.43g +/- 0.60 vs. 0.35g +/- 0.07, no-UV vs. UV respectively, n=7), demonstrating that
IL-6 is critically involved in promoting UVB-mediated tumor growth. In conclusion we have
demonstrated that UVB exposure can exacerbate melanoma tumor growth and that this process
may be mediated by production of IL-6, representing an important intervention point for
melanoma.
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Etanercept rapidly modulates multiple inflammatory products of TIP-DCs including TNFα,
iNOS, IL-20, IL-23, and MIP-3α: Pathologic lymphoid structure in psoriasis skin is completely
disorganized within 12 weeks
L Zaba, I Cardinale, P Gilleaudeau, M Sullivan-Whalen, J Fuentes-Duculan, I Novitskaya,
A Khatcherian, MA Lowes and JG Krueger Investigative Dermatology, Rockefeller, New York
City, NY
TNFα iNOS producing dendritic cells (TipDCs) have been recently described as a major patho-
logic myeloid DC subset in the psoriasis plaque. We report here that TipDC inflammatory prod-
ucts are rapidly downregulated during treatment with etanercept, a TNFR-Ig fusion protein,
both in skin biopsies and in vitro monocyte matured DCs (MoDCs). 20 patients with moder-
ate to severe psoriasis were given 50mg of etanercept biweekly. Skin biopsies were obtained
pre-treatment and at weeks 1, 2, 4, and 12. Gene products of TipDCs rapidly downmodulated
in vivo were iNOS (wk2, p=0.01), IL20 (wk1, p=0.05), IL23p40 (wk2, p=0.02), and IL23p19
(wk1, p=0.1) as measured by real time RT-PCR. Products rapidly downmodulated both in vivo
and in MoDCs treated with etanercept (n=6 independent arrays) were IL-1β (wk1, p=0.007),
IL-8 (wk1, p=0.04), and CCL20/MIP3α (wk1, p=0.02). Using double-labeled immunofluores-
cence on skin lesions, we confirmed that TNFα, iNOS, IL-20, and IL23p40 were predomi-
nantly made by CD11c+ cells, and that these inflammatory products decreased substantially
over the course of etanercept treatment. Although TipDC products were rapidly downmodu-
lated within the first two weeks of treatment, the number of CD11c+ and CD83+ cells in the
skin was not significantly reduced until wk4 (p<0.001) and wk12 (p=0.002) respectively. DC
products downregulated later were CCL19 (wk12, p=0.05) and CCL21 (wk12, p=0.15), both
chemokines involved in lymphoid organization, and confocal microscopy confirmed disso-
lution of DC/T-cell lymphoid-like amalgamations in the psoriasis dermis between weeks 4-
12. The timeline of events suggest that etanercept rapidly blocks Tip-DC inflammatory cytokine
production, rendering persistent DC/T-cell interactions ineffectual and inhibiting DC differ-
entiation/maturation.
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Etanercept rapidly modulates IL-17 and IL-22 in psoriasis: Immediate changes in keratinocyte
activation suggests Th17 T cells drive epidermal hyperplasia in psoriasis lesions
L Zaba, I Cardinale, J Duculan-Fuentes, I Novitskaya and JG Krueger Investigational
Dermatology, Rockefeller, New York City, NY
While psoriasis has been classified as a Th1-type inflammatory disease, psoriasis plaques also
contain a population of Th17 T cells, which are critical disease effectors in model autoimmune
diseases. The inducer of Th17 T cells is IL-23, which is strongly up-regulated in psoriasis lesions.
In this study, we treated 20 psoriasis vulgaris patients with etanercept at 50mg twice weekly
for 12 weeks and obtained skin biopsies at baseline, and weeks 1, 2, 4, and 12 of treatment.
The epidermal response was quantified by measuring acanthosis, the level of keratin 16 mRNA,
and Ki67+ keratinocyte nuclei. In parallel, T cell infiltration was quantified by CD3 immunos-
taining and activation of Th1, Th2, and Th17 T cell subsets was assessed by measuring mRNA
levels for interferon-γ, IL-4, and IL-17α/IL-22, respectively, using real-time RT-PCR with expres-
sion values normalized to HARP mRNA. At 1 week of treatment, K16 mRNA and Ki67+ ker-
atinocytes were markedly reduced (p = 0.001) and decreased epidermal acanthosis followed
at week 2 (p=0.001). IL-17 and IL-22 were rapidly down-modulated by wk1 (p=0.07) and wk2
(p=0.03) respectively, while IFNγ mRNA did not decrease until wk12 (p=0.004). IL-4 was up-
regulated 3-fold at wk12 (p=0.04). Hence, TNF/lymphotoxin blockade with etanercept rap-
idly decreases activation of Th17 T cells, and this effect is strongly correlated with reduced
proliferation of epidermal keratinoctyes. At later time points, the activity of Th1 T cells is
decreased and Th2 T cells is increased, indicating some degree of immune deviation as a late
effect. The early modulation of Th17 activation could be a direct effect of etanercept on T cells
or an indirect effect of reduced production of IL-23 from TNF+iNOS+-DCs (TIP-DCs) in psori-
asis lesions. In either case, these data establish rapid effects of etanercept on an adaptive
immune response and they further suggest psoriasis should be classified as a Th17-mediated
disease, with a contribution from Th1 T cells.
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Proteomic profiling of atopic dermatitis patient-derived serums after treating with multiple
affinity removal columns
Y Park,1,2 Y Lyou2 and J Yang1,2 1 Dermatology, Samsung Medical Center, Sungkyunkwan
University School of Medicine, Seoul, South Korea and 2 Clinical research center, Sansung
Biomedical Research Institute, Seoul, South Korea
We conducted proteomic analysis of atopic dermatitis (AD) patient-derived serums to further
identify AD-related proteins after treating with multiple affinity removal columns (MARC). Sev-
eral high-abundance proteins such as albumin, transferrin, IgG, IgA, haptoglobin, and antit-
rypsin were properly depleted by using MARC prior to conducting a two-dimensional elec-
trophoresis analysis. Several groups of abundant proteins in human serum seriously interfere
with the detection of low-abundance proteins in the proteomics studies; therefore, the appli-
cation of MARC would be helpful to gain a new insight when it applies to human serum. As
a result, we found that 57 candidate spots which were up-regulated or down-regulated com-
parative to the normal serum control in a range of pH 3-10 of 2-DE maps and 23 proteins
were identified with a MALDI-TOF analysis. Our current results provided helpful information
regarding to understanding AD as well as the proteomic approach in the serum samples.
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Depletion of regulatory T cells synergizes with DC directed targeting of tumor antigens to
successfully treat established RMA-Tag tumors in mice
V Storn,1,2 K Mahnke,1 S Schallenberg,1,2 TS Johnson,1 T Bedke,1 E Suri-Payer,2 N Garbi,2
B Arnold,2 G Haemmerling2 and AH Enk1 1 Department of Dermatology, University of
Heidelberg, Heidelberg, Germany and 2 German Cancer Research Center, Heidelberg,
Germany
Dendritic cells (DC) express the endocytosis receptor DEC-205 that is recognized by the NLDC
antibody (aDEC). We have previously described that antigens can be coupled to aDEC and
thus targeted to DC in situ. Here, we coupled the tumor antigen Tag to aDEC and treated RMA-
Tag tumor-bearing mice with these conjugates. When the tumors had reached an average diam-
eter of 5 mm the mice were injected with aDEC205-Tag conjugate or Tag protein alone, plus
poly I:C and CpG in weekly intervals. Although tumor growth was initially slowed down after
injection of the aDEC205-Tag conjugates as compared to “Tag-only” untreated mice, it resumed
one week after the last immunization. Analysis of the immune response revealed initially a
strong induction of tumor specific CD8+ cells in aDEC-Tag treated mice. However, when tumor
growth revived increased numbers of CD4+CD25+FoxP3+ regulatory T cells (Tregs) in the
tumor draining lymph node were always noticeable. Thus, to assess the suppressive effects of
Tregs during tumor therapy, anti-CD25 antibodies were used to deplete Tregs from tumor bear-
ing animals during anti-tumor treatment. With this procedure we were able to deplete Tregs
for up to 3 weeks from the animals, without reducing effector T cell numbers. Moreover, by
concomitant injection of aDEC-Tag conjugates we could cure up to 30% of the tumor bear-
ing mice and tumor rejection could be further improved by two consecutive rounds of Treg
depletion. In aggregate our data indicate that deletion of CD25+ Treg during cancer therapy
does not compromise effector T cells, while bolstering the effectiveness of DC based anti-tumor
therapies.
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The induction of FOXP3 expression in CD4+ T cells during a secondary cutaneous immune
response in vivo
K Lacy,1,2 E Agius,1,2 M Vukmanovic-Stejic,1 AH Banham,3 M Rustin2 and AN Akbar1 1
Immunology and Molecular Pathology, University College London, London, United Kingdom,
2 Dermatology, Royal Free Hospital, London, United Kingdom and 3 Nuffield Department of
Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, United
Kingdom
FOXP3 expression has been used as a specific marker to distinguish regulatory T cells from
non-regulatory T cells in mice. However non-regulatory T cells in humans can also upregu-
late this molecule after activation in vitro. It is not known whether this upregulation of FOXP3
also occurs after the stimulation of CD4+ T cells in vivo. We therefore injected tuberculin
PPD into the skin of twenty healthy volunteers to generate a secondary immune response and
biopsied the cutaneous lesions at different times after injection. We found that the peak of pro-
liferation of antigen-specific CD4+ T cells occurred at 7 days of immune challenge. This coin-
cided with the presence of maximal numbers of FOXP3-expressing CD4+ T cells in the perivas-
cular infiltrating populations (~20%). These experiments define the time course of FOXP3
expression during a cutaneous immune response in humans in vivo. Experiments using suc-
tion blister technology to harvest cells from the site of the immune response in the skin are
currently being performed to assess the functional characteristics of the FOXP3 expressing
population.
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Atopic dermatitis derived innate immune signals induce interleukin 12 and skin homing of
Th2 cells
T Volz,1 G Lametschwandtner,2 E Guenova,1 M Werner,1 S Kaesler,1 M Röcken,1
JM Carballido2 and T Biedermann1 1 Dept. of Dermatology, Eberhard Karls University,
Tuebingen, Germany and 2 NIB Research Institute, Vienna, Austria
Inflammation in atopic dermatitis (AD) is closely linked to skin infections with Staphylococ-
cus aureus. A major cell wall component of S. aureus is lipoteichoic acid (LTA) belonging to
the class of “pathogen associated molecular pattern” (PAMP) that bind to Toll-like receptor
(TLR) 2. The role of TLR2 ligands in initiating innate immune responses is still not clear and
has not been investigated for AD. The present studies were carried out to understand TLR2
mediated innate immune signals and the transition to adaptive immune responses in AD. In
dendritic cells (DC), LTA induced TLR2 dependent maturation and Interleukin (IL) 12 pro-
duction. Extensive studies on the consequences of LTA mediated IL-12 production for AD
revealed that IL-12 mediated “cutaneous imprinting” on human memory Th2 cells prior to a
switch to Interferone (IFN)γ production. Immunological imprinting describes the induction of
a tissue specific pattern of homing receptors that is achieved during T cell activation and deter-
mines T cell homing. We could show that IL-12 rapidly upregulated α(1-3)-fucosyltransferase
VII and cutaneous lymphocyte antigen (CLA) even in former CLA- Th2 memory cells. This
CLA expression was functionally relevant as it established Th2 cell rolling on E-Selectin and
migrating into human skin of humanized SCID mice. Demonstrating that S. aureus derived
LTA induced IL-12 that consecutively initiated cutaneous imprinting in Th cells indicates an
important new role of S. aureus in the pathogenesis of AD as well as a general pathway of the
transition of innate immune signals to tissue specific immune responses.
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Ex vivo induction of polyclonal T cell responses against cutaneous T cell lymphoma by autol-
ogous dendritic cells transfected with amplified tumor RNA
X Ni,1 H Richmond,1,3 L Shiue,1 E Shpall2 and M Duvic1 1 Department of Dermatology, MD
Anderson Cancer Center, Houston, TX, 2 Department of Stem Cell Transplantation and Cell
Therapy, MD Anderson Cancer Center, Houston, TX and 3 University of California, Irvine
School of Medicine, Irvine, CA
Sézary Syndrome (SS) is a leukemic variant of cutaneous T cell lymphoma (CTCL), and patients
with SS who relapse after biological response modifiers have few therapeutic options. An
immunotherapeutic approach that enhances the anti-tumor effect may improve their sur-
vival. Studies have shown that dendritic cells (DC) transfected with tumor mRNA stimulate
potent cytotoxic T lymphocyte (CTL) responses in tumor-bearing mice and in metastatic renal
cell cancer patients (Cancer Res 2000, 60:1208; 2003, 63:2127). In this preclinical study, we
first validated the ability of tumor RNA-transfected DCs to stimulate a polyclonal anti-tumor
T cell response in ten patients with SS ex vivo. We established a protocol for amplification of
whole tumor mRNA from Sézary cells. Autologous DCs were generated from CD14+ mono-
cytes of peripheral blood mononuclear cells from patients, and electroporated with amplified
tumor RNA. As a result, autologous DCs transfected with amplified tumor RNA were able to
induce of anti-tumor T cell responses in seven of ten subjects, determined by INF-γ and
Granzyme B secretion using enzyme-linked immunospot (ELISPOT) assays. DCs transfected
with amplified tumor RNA ex vivo induced a 2-20 fold increase in INF-γ-secreting T cells and
1-5 fold increase Granzyme B releasing T cells compared to control untransfected DCs. Inter-
estingly, a nonspecific stimulation of CTLs was also observed with untransfected DCs in all
ten subjects. These data provide a scientific rationale to continue a clinical investigation of
this polyvalent vaccine strategy in the treatment of patients with SS, and potentially, CTCL.
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Predictive diagnostic value of C5-9 immunostaining in autoimmune skin disorders
J Deng,1,2 PM Lamb,3 T Patton1 and E Abell2 1 Dermatology, University of Pittsburgh,
Pittsburgh, PA, PA, 2 Dermatology, Department of Veterans Affair Medical Center, Pittsburgh,
PA and 3 Dermatology, University of california at Davis, sacramento, CA
Well established autoimmune skin disorders are characterized with presence of immunore-
actants on skin components.It has been shown that presence of C5-9 along basement mem-
brane zone could be specific for diagnosis of dermatomyositis. This study was designed to
evaluate the predictive diagnostic value of C5-9 staining in patients with autoimmune skin
disorders by using direct and indirect skin immunofluorescence. Skin specimens were col-
lected from 2016 patients suspected to have immune-mediated skin disorders, and were
processed for routine DIF and IIF for presence of C5-9 along DEJ and IC spaces of epidermis.
151 patients with bullous pemphigoid were included, and all were positive for C3 and C5-9
along BMZ, while 146 positive for IgG along BMZ. Similarly C5-9 was detected among all
46 patients with prodromal bullous pemphigoid, while C3 and IgG were found in 36 and 28
patients respectively. One patient with EBA was positive for IgG, C3 and C5-9 along DEJ. Six
patients with pemphigus had IgG, C3 and C5-9 on IC spaces of epidermis. A total of 175
patients with various forms of lupus erythematosus was included in this study. Lupus band
test was positive on 66 patients, and 109 LE patients were lupus band test negative. Among
these 109 patients, 54 had positive C5-9 staining along DEJ. One dermatomyositis patient had
positive C5-9 staining along BMZ. In addition, 36 patients without autoimmune skin disor-
ders were positive for C5-9 along DEJ. These data suggest positive C5-9 staining is not unique
for particular disease group or specific disease. It intrepretation should be in consideration
with other parameters including dermatopathological findings and clinical presentations.
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Molecular analysis of skin-homing receptors on natural killer cells associated with allergic
contact dermatitis
ME Gainers,1,2 L Descheny,1 SR Barthel,1,2 L Liu1,2 and CJ Dimitroff1,2 1 Dermatology,
Brigham and Women’s Hospital, Boston, MA and 2 Harvard Medical School, Boston, MA
Recent findings suggest that hapten-specific contact hypersensitivity (CHS) can be exerted by
natural killer (NK) cells. This surprising novel function of NK cells has stimulated exploration
of the molecular mediators bestowing dermal tropic activity of NK cells in adaptive immune
responses. Since endothelial E- and P- selectin are critical for effector leukocyte migration to
skin, we believe that NK cell E and P-selectin ligands are essential effector molecules. Though
P-selectin glycoprotein ligand-1 (PSGL-1) has been implicated as a critical effector molecule
on skin-homing leukocytes, PSGL-1 null mice can still elicit robust allergic CHS responses.
The identity of authentic NK cell E-selectin ligands is currently unknown. In this study, we
examined the functional expression of E-selectin ligands on fresh NK cells from mice with
allergic CHS. Using immunomagnetic beads, we purified T and NK cells from skin-draining
lymph nodes (LN) of PSGL-1, CD44, CD43 or α1,3 fucosyltransferases 4/7 null mice exhibit-
ing allergic CHS. Cells were treated with specific glycosidases and proteases and then inves-
tigated by parallel-plate flow chamber analysis on E-selectin-Immunoglobulin (Ig) and by
flow cytometry and Western blotting with E-selectin-Ig to help ascertain whether NK cell E-
selectin ligand activity is imparted by glycoprotein(s) and/or glycolipid(s) and whether the lig-
and(s) is currently known. Interestingly, whereas T cells from skin-draining LN were largely
negative for E-selectin ligand activity, most NK cells exhibited robust E-selectin ligand activ-
ity. NK cell isolates expressed distinct and currently unknown E-selectin glycoprotein ligands
as identified by monoclonal Ab MECA-79. N-glycosidase F and O-sialoglycoprotein endopep-
tidase treatments indicated that the E-selectin-binding determinants on these proteins were
displayed on O-glycans. Our data show that NK cells naturally express skin-homing recep-
tors of unknown identity and are displayed on MECA-79 Ab-reactive membrane proteins.
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Dendritic epidermal T cell and keratinocyte dysregulation in the cutaneous diabetic envi-
ronment
KR Taylor, RE Mills and JM Jameson Immunology, The Scripps Research Institute, La Jolla, CA
Wound healing is a complex, coordinated series of events and deficiencies or abnormalities
at any stage may result in non-healing or chronic wounds. In diabetes, wound healing is delayed
and patients often suffer from chronic infections. The diabetic wound environment has decreased
growth factors that contribute to abnormalities in proper wound healing. In the skin, dendritic
epidermal T cells (DETC) are specialized epithelial T cells that express a canonical γδ T cell
receptor (TCR) that recognizes stressed or damaged keratinocytes. Once activated, DETC
release growth factors that facilitate cutaneous wound healing. We hypothesize that DETC
are dysregulated in the diabetic environment, contributing to deficiencies in growth factor pro-
duction. Using the leptin receptor deficient mouse model of Type 2 diabetes, we have deter-
mined that DETC are present and exhibit their characteristic dendritic morphology. However,
DETC in diabetic mice display decreased levels of T cell activation markers including CD69,
CD25 and the γδ TCR, suggesting that diabetic DETC are in a less responsive state than nor-
mal DETC. Experiments investigating the role of the diabetic environment on the DETC acti-
vation state have found that glucose transporter levels are decreased in diabetic DETC, indi-
cating that the DETC may be insulin resistant. Additionally, diabetic keratinocytes demonstrate
increased apoptosis and DETC antigen presentation, possibly contributing to DETC dysregu-
lation. Taken together, our studies suggest that the diabetic environment, as well as cross-talk
with diabetic keratinocytes, has negative effects on the activation status of DETC, which may
render them unable to properly respond to stressed or damaged epithelial cells. Alterations in
DETC function may influence the production of growth factors and contribute to immune and
repair deficiencies in diabetic patients.
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Regulation of contact hypersensitivity by Ag85B
H Mori,1 K Yamanaka,1 I Kurokawa,1 Y Yasutomi2 and H Mizutani1 1 Departments of
Dermatology, Mie University, Tsu, Mie, Japan and 2 Departments of bioregulation, Mie
University, Tsu, Mie, Japan
Immunomodulation is a potent useful therapy for hypersensitive skin diseases including atopic
dermatitis (AD). Skin infiltrating T helper (Th) cells in AD skin lesions are Th2-type dominant,
and reduced exposure to certain environmental Th1-type- immune responses inducing microbes
may be one of the causes for the occurrence of AD. It has been reported that Ag85B from
Mycobacteria have a potential to induce strong Th1-type immune response in mice as well as
in human. In this study, we have examined the effect of Ag85B derived from Mycobacterium
kansasii on acute phase dermatitis caused by Th2-type immune responses following repeated
application of oxazolone to mice ears. In the skin lesion, repeated challenge of low concen-
tration of hapten converted Th1 cytokine dominant delayed type hypersensitivity to Th2 cytokine
dominant immediate type response with a late phase reaction, which mimics AD skin lesions.
Ag85B-treatment successfully suppressed immediate type responses with reduced lesional IL-
4 production compared with placebo-treatment. No obvious side effect was identified. Pre-
sent results declared Ag85B is a potent therapeutic candidate as a biological response modi-
fier for Th2 dominant allergic diseases including AD.
www.jidonline.org   S115
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A CXCR4 chemokine receptor antagonist enhances antigen-specific, adoptive immunother-
apy for established B16 melanoma tumors
C Lee,2,1 L Fang,1 D Palmer,3 N Restifo3 and S Hwang1 1 Dermatology Branch, CCR,NCI,NIH,
Bethesda, MD, 2 Dermatology, Kaohsiung Medical Univ., Kaohsiung, Taiwan and 3 Surgery
Branch, CCR,NCI,NIH, Bethesda, MD
Adoptive immunotherapy (AI) of melanoma with in vitro-expanded, antigen-specific T cells (ASTC)
holds great promise,yet the large majority of clinical responses have been partial. This may be
due to local activation of survival-enhancing chemokine receptors such as CXCR4,which are
expressed by many cancers, including melanoma. Herein,we compared the in vitro killing of
B16 murine melanoma cells transduced with CXCR4 and luciferase (CXCR4-luc-B16) by trans-
genic CD8+, gp100-specific T cells (PMEL) in the presence of T22,an 18 amino acid CXCR4
antagonist peptide, using a calcein-release killing assay. We also tested the possible synergistic
effects of T22 treatment in combination with two immunotherapeutic regimens that have previ-
ously shown efficacy in mouse cancer models. In vitro,the addition of the CXCR4 ligand,CXCL12
to target CXCR4-luc-B16 cells clearly reduced PMEL T cell killing, which was abrogated by pre-
treatment of cells with T22. Likewise,T22 restored the ability of human ASTC to kill CXCR4+
human melanoma cells in the presence of CXCL12. In vivo, we inoculated mice i.v. with 4x10e5
CXCR4-luc-B16 cells. While anti-CTLA4 mAb (250 ug/mouse) or T22 therapy (40 ug/mouse)
alone resulted in no significant decreases in lung tumor burden, together they yielded a ~50%
decrease in tumor burden (P=0.02). In an AI model, mice were inoculated s.c. with 2.5x10e5
CXCR4-luc-B16 cells in the flank. On d9, mice were treated with IL2, 1x10e6 Il-2/gp100-acti-
vated PMEL cells,and 2x10e7 PFU vaccinia virus encoding gp100. The tumors of mice treated
with the AI regimen showed significant inhibition in growth (compared to untreated mice), which
was further enhanced (P<0.03) by co-treatment with T22 (40 ug/mouse beginning d8). In sum-
mary, T22 restores the sensitivity of chemokine-activated B16 cells to killing by ASTC in vitro and
enhances the efficacy of two different immunotherapy strategies, suggesting novel strategies for
improving cancer therapy in patients.
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Suppressing IgE responses by a gene therapy approach using IgE specific super antigen
T Ota,1 B Duong,1,2 D Aït-Azzouzene1 and D Nemazee1 1 Immunology, The Scripps
Research Institute, La Jolla, CA and 2 Kellogg School of Science and Technology Doctoral
Program in Chemical and Biological Sciences, The Scripps Research Institute, La Jolla, CA
While IgE plays a role in certain types of host defense, IgE is mainly thought to be involved in
pathogenic conditions such as asthma, rhinitis, and atopic dermatitis. Therefore, therapies to
suppress IgE-mediated hypersensitivity responses are being developed, including treatment
with anti-IgE antibodies. However, such therapy is not long lasting, in part because IgE can be
re-synthesized from memory B cells or newly activated B cells. The aim of this study was to
determine if IgE constant region reactive super antigen(Ag) can suppress IgE hypersensitivity
reactions when expressed in vivo using a gene therapy approach. We hypothesized that sus-
tained expression of superAg might neutralize serum IgE and possibly also suppress IgE pro-
ducing B cells and pre-plasma cells. Our superAg is based on a single chain Fv (scFv) bind-
ing site of the Rat anti-mouse IgE clone R1E4. Because R1E4 inhibits the IgE binding to FceR1
and does not bind to the complex of IgE and FceR1, this specificity should not induce ana-
phylaxis. The variable regions of R1E4 were cloned and the superAg was expressed as a scFv
fused to Rat-IgG1 constant region under the control of human ubiqutin promoter. We con-
firmed superAg specificity with transiently transfected 293 cells. IgE superAg was expressed
in vivo as a secreted form using the hydrodynamic injection method of an expression plas-
mid. Around 50% of the mice that received plasmid expressed superAg, which lasted for >2
weeks. SuperAg concentration in the sera was 200-500ng/ml and in some mice, serum IgE
was elevated shortly after injection, likely as the result of the stabilization of serum IgE. How-
ever, after one month, peritoneal mast cells (c-kit+ FceR+) and basophils (c-kit- CD49b+ FceR+)
in spleen had significantly lower levels of bound IgE. These data suggested that the gene ther-
apy approach to IgE was effective and long lasting. Ongoing studies are addressing the superAg
effect on putative IgE memory B cells.
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Immunoprotective properties of a thymic-like rice extract
A Perrin, C Gondran, E Bauza, T Marchand, C Dal Farra and N Domloge Vincience, ISP
Global Research Center, Sophia Antipolis, France
Normal skin exhibits protective activity against environmental threats thanks to its effective
immune system and barrier function. With aging, the skin’s immune system weakens and the
number of Langerhans cells in the skin declines. As immunosenescence plays an active role
in the overall aging process, we were interested in developing a rice extract rich in thymic-
like peptide (TP), and in examining its effects on immune system regulation and skin integrity.
CD1 immunolabeling of Langerhans cells in skin biopsies revealed that skin irradiated with
100 mJ/cm2 and treated with TP for 24 hours, was similar to non-irradiated control skin, in
terms of the number of Langerhans cells and their localization. Hematoxylin-eosin staining of
ex vivo skin samples, treated with TP, showed a skin structure that was better preserved than
that of the control. Moreover, after UVB irradiation, these skin samples revealed a significant
decrease in UV-induced sunburn cells and damage, compared to irradiated untreated control
skin. In order to better characterize the effect of TP on epidermal structure, differentiation and
keratinization marker expression were evaluated by immunostaining studies on cultured human
keratinocytes. These studies revealed an enhancement in filaggrin, pan-keratin, and beta1 inte-
grin expression in TP-treated cells. This effect was seen at different time points. In addition,
fibroblasts treated with TP, and irradiated with 100 mJ/cm2 of UVB, exhibited a decrease of -
27% in TNF-alpha level, 24 hours after UVB irradiation, when compared with the control. This
result confirms the protective effect of TP on the skin against UVB stress. In conclusion, this
rice extract, rich in thymic-like peptide, exhibits very interesting properties for maintaining
skin immune defence function and integrity, and decreasing UVB stress on the skin. Conse-
quently, this peptide can be of great use in products for both sensitive and aged skin, as well
as sun care products.
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Mouse epidermal keratinocytes express Sema4D/CD100 and its receptor CD72 is expressed
on Langerhans cells
T Shimizu,1 Y Tada,2 N Kanda,3 S Watanabe,3 A Hasegawa1 and K Tamaki2 1 Department of
Pathobiology, Nihon University School of Veterinary Medicine, Kanagawa, Japan, 2
Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan and 3
Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan
Semaphorins are secreted or transmembrane proteins that were initially described to regulate
development of neuronal axons. There are currently descriptions of more than 30 types of sem-
aphorin in organisms as diverse as viruses and humans. These proteins are classsified into eight
classes based on their structural elements and amino-acid sequence similarity. Recently, it is
becoming clear that semaphorins play important roles not only in establishing a neurological
synapse, but also in organogenesis, vascular growth and neoplastic transformation. In addi-
tion, a role of semaphorins in the immune cell regulation is emerging. For example,
Sema4D/CD100 which is expressed abundantly on the surface of T cells, is involved in the
activation of B cells and dendritic cells (DCs), whereas Sema4A, which is preferentially expressed
on B cells and DCs, is involved in the activation of T cells and regulating Th1/Th2 balance.
We herein found that Sema4D/CD100 was expressed at mRNA levels in mouse skin ker-
atinocytes (KCs) and mouse KC cell line, PAM212, which was confirmed by RT-PCR. Although
semaphorin expression is reported in various organs or cells, this is the first paper reporting
semaphorin expression in epithelial cells. We could not detect any other vertebrate sema-
phorin mRNA expression in KCs as far as we studied (Sema3A, B, C, D, E, F, G, Sema4A, B,
C, G, Sema5A, B, Sema6A, B, C, D, Sema7A). Interestingly, flow cytometry showed that CD72
protein, which is the ligand for Sema4D, was expressed on the cell surface of cultured Langer-
hans cells. Our results indicate a possible role of semaphorins in the skin immune regulation.
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Corticosteriods but not pimecrolimus affect the skin immune system in infants
S Meindl,1 A Stuetz,2 G Stingl1 and A Elbe-Bürger1 1 Dep. of Dermatology, Medical University
of Vienna, Vienna, Austria and 2 Novartis Institutes for BioMedical Research, Vienna, Austria
Despite demonstrated efficacy and safety of the steroid-free calcineurin inhibitor pimecrolimus
in the treatment of atopic dermatitis in adults, children and infants, use of any immunomod-
ulator in infants is a concern. It has recently been demonstrated that neonatal dendritic cells
are especially sensitive to corticosteroids, and in this study we directly compared the in vitro
effects of pimecrolimus and corticosteroids on the fate and phenotype of keratinocytes and
Langerhans cells (LC) isolated from infant skin. Epidermal cells of infant (<2 years of age) and,
for control purposes, older foreskin, were, both, immediately analyzed upon isolation for LC
frequency by flow cytometry and cultured for 48 hours with beta-methasone-17-valerate (BMV),
pimecrolimus or vehicle, and then analyzed for viability and phenotype. While, generally,
the frequency of LC gradually increase after birth from 0.7% in 1-year-old infants to 2.1% in
children older than 3 years, the analysis of selected maturation markers on infant LC after cul-
ture showed no significant differences compared to adult LC. The percentage of viable epi-
dermal cells after a 48-hour culture period increased (CD45+ cells: 3%±16; CD45- cells:
8%±16) in pimecrolimus cultures, while it decreased (CD45+ cells: 3%±3; CD45- cells:
27%±22) in BMV cultures, compared with controls. The mechanism responsible for the ker-
atinocyte life-enhancing properties of pimecrolimus remains to be investigated. Exposure of
infant epidermal cells to BMV caused a remarkable inhibition of the upregulation of HLA-DR
(30%), CD83 (27%) and CD86 [38%; p<0.001, and dose-dependent (molarity of compounds:
10-6 – 10-9)], and a slight inhibition of the upregulation of CD25 (2%), CD40 (19%) and CD80
(12%) on LC, compared with controls, effects not seen with pimecrolimus. Our data show that
BMV negatively affects LC maturation as well as the viability of epidermal cells in infants, in
contrast to pimecrolimus.
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Adipokines in the pathogenesis of psoriasis
A Johnston,1 JE Gudjonsson,2 AA Sigmarsdottir,1 SI Gunnarsson,1 S Arnadottir,1 JT Steinsson,3
JT Elder4,2 and H Valdimarsson1 1 Immunology, Landspitali University Hospital, Reykjavik,
Iceland, 2 Dermatology, University of Michigan Medical Center, Ann Arbor, MI, 3 Blue
Lagoon Health Center, Grindavik, Iceland and 4 Ann Arbor VA Health System, Ann Arbor, MI
Obesity has been shown to be a significant risk factor for psoriasis and BMI correlates with
disease severity. We are investigating the relationship between obesity and psoriasis focusing
on the role of adipokines such as leptin, resistin, and adiponectin, that may influence the activ-
ity of T cells, antigen presenting cells and keratinocytes, altering the course of psoriasis. Pso-
riasis patients (n=32) were recruited and their height, weight, waist circumference and disease
severity (PASI) were recorded. Fasting serum samples were obtained on enrollment and after
a course of UVB treatment, and leptin, soluble leptin receptor, resistin, adiponectin, IL-8, IL-
18 and IL-22 were determined. Age, sex and BMI-matched healthy controls were also recruited.
On enrollment, there were no significant differences in the serum levels of leptin, leptin recep-
tors, adiponectin, IL-18 or IL-22 between patients and controls. However, serum resistin and
IL-8 were both significantly elevated in the patient group (p≤0.001) and serum resistin corre-
lated with disease severity (r=0.412, p=0.019). After treatment, the reduction in disease sever-
ity was accompanied by significantly decreased serum IL-8 and IL-22 but a rise in circulating
IL-18. Using ex vivo-cultured skin we show that exogenous leptin dose-dependently increased
secretion of the EGF-like growth factor amphiregulin. Although leptin receptors are expressed
by both keratinocytes and the inflammatory infiltrate in psoriasis skin, leptin receptor mRNA
levels were lower in involved compared with normal or uninvolved skin. Resistin did not alter
T cell activation, adhesion molecule or chemokine receptor expression, nor were any signif-
icant alterations in inflammatory cytokine production seen. These data support the view that
certain adipokines are important inflammatory mediators and may be involved in the patho-
genesis of psoriasis in overweight individuals.
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IL-15 serves as a co-stimulator in determining the activity of autoreactive CD8 Tcells in an
experimental mouse model of graft vs. host disease (GvHD)
F Miyagawa,1 Y Tagaya,2 TA Waldmann2 and SI Katz1 1 Dermatology Branch, National
Institutes of Health, Bethesda, MD and 2 Metabolism Branch, National Institutes of Health,
Bethesda, MD
To elucidate the mechanisms controlling peripheral tolerance, we established transgenic (Tg)
mouse strains expressing high or low levels of membrane-bound ovalbumin (mOVA) (K14-
mOVAhigh Tg and K14-mOVAlow Tg mice) as a skin-associated self-antigen. Autoreactive TCR-
Tg CD8 T cells (OT-I cells) adoptively transferred into K14-mOVAhigh Tg mice induced GvHD
while K14-mOVAlow Tg mice did not induce disease. OT-I cells in K14-mOVAhigh Tg mice were
fully activated with full development of effector function. In contrast, transferred OT-I cells in
K14-mOVAlow Tg mice were only partially activated without gain of effector functions. We
previously reported that exogenously administered IL-15 promoted complete maturation of
OT-I cells in K14-mOVAlow Tg mice both in vivo and in vitro and also induced GvHD, sug-
gesting that IL-15 contributes to reversing the peripheral tolerance in these mice. To better
understand the role of IL-15, we used anti-IL-2/IL-15R beta mAb or anti-IL-15mAb in K14-
mOVAhigh Tg mice and found that the GvHD was attenuated suggesting that endogenous IL-
15 plays a physiological role in GvHD. These observations are further supported by results
using K14-mOVAhigh Tg mice on an IL-15KO background. These mice did not develop GvHD
after transfer of OT-I cells. Interestingly, K14-mOVAhigh Tg mice on an IL-15R alpha KO back-
ground did not develop GvHD either, suggesting that IL-15 acted on injected OT-I cells by
way of a trans-presentation mechanism rather than as a soluble factor. Collectively these results
identify IL-15 as a critical co-stimulator that can determine whether peripheral tolerance or
autoimmunity ensues, and suggest that inhibition of IL-15 function may be efficacious in block-
ing expression of autoimmunity where a breach in peripheral tolerance is suspected.
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An IgE-independent mouse model of atopic dermatitis
L Chen,1 R Agha-Majzoub,1 L Overbergh,3 C Mathieu3 and LS Chan1,2,4 1 Dermatol,
University of Illinois, Chicago, IL, 2 Micro/Immunol, University of Illinois, Chicago, IL, 3 Lab
Exp Med & Endocrinol, Catholic Univ of Leuven, Leuven, Belgium and 4 Med Ser, Jesse
Brown VA MedCenter, Chicago, IL
The newly described IgE-independent (“intrinsic”) atopic dermatitis (IEIAD) subset raised the ques-
tion on the role of IgE in the disease pathogenesis. Based on our past successful generation of an
IgE-dependent (“extrinsic”) (IEDAD) model in the K14-IL-4-Tg CByB6 mice, we have generated
an IEIAD model in the K14-IL-4-Tg SKH1 mice, and characterized the model utilizing clinical
observation, pathological examination, immuno-phenotyping, transmission electron microscopy,
ELISA, real time PCR, T cell proliferation, flow cytometry, and B cell functional assays. While the
IEIAD mice had a normal total serum IgE level (114ng/ml, compared to 1,869ng/ml of the IEDAD
mice), the Tg SKH1 mice manifested a chronic inflammatory skin phenotype identical to that of
the IEDAD mice in clinical morphology; histology; infiltration of mononuclear cells, eosinophils,
and mast cells; mast cell degranluation; upregulation of chronic lesional cytokine mRNA expres-
sions of IL-1β, IL-3, IL-4, IL-6, IL-10, IL-12, IL-13, IFN-γ, TNF-α, and TNF-β. We further discov-
ered that inability of CD4+ T cells of the Tg SKH1 mice to upregulate CD40L might account for
this normal IgE level, as these T cells were unable to enhance CD40L expression upon stimula-
tion. By contrast, the B cell abnormality was ruled out as CD19+ B cells from Tg SKH1 mice syn-
thesized comparable amount of IgE in the presence of IL-4 and soluble CD40L compared to Tg
CByB6 mice. Moreover, our studies strongly suggested that a defect in the T cell-specific CD40L
transcriptional factor gene termed early growth response-1 (EGR-1) might be responsible for the
impaired CD40L upregulation as the activation of mRNA of EGR-1 was suppressed in CD4+ T
cells of Tg SKH1 mice compared to Tg CByB6 mice. Consistent with the findings of human sub-
sets of IEIAD and IEDAD, the Tg SKH1 mice had lower levels of skin lesional IL-1β, IL-5, and IL-
13 than that of Tg CByB6 mice. This model may be suitable to study the human “intrinsic” AD.
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Induction of immunomodulatory dendritic cells by transimmunization
KE Hoffmann, J Vasquez, CL Berger, M Girardi, R Tigelaar and RL Edelson Dermatology, Yale
University, New Haven, CT
Extracorporeal Photochemotherapy (ECP) is an effective treatment for cutaneous T cell lym-
phoma (CTCL) and graft-versus-host disease (GVHD). ECP induces monocyte-to-dendritic cell
(DC) differentiation, an effect enhanced by addition of an ex vivo overnight incubation step;
i.e. Transimmunization (TI). TI permits increased uptake of 8-MOP/UVA-induced apoptotic
cells by differentiating DC. To characterize the mechanism by which ECP and TI-generated
DC regulate immune responses, we compared gene expression profiles of patients’ treated
monocyte/DC populations. Peripheral blood leukocytes from 3 patients were procured prior
to, immediately after ECP, and following TI processing, and were then enriched for mono-
cytes/DC. RNA was extracted and compared using Affymetrix total human genome microar-
rays (39,000 genes), and differential gene expression considered as a ≥ 2-fold change and P-
value ≤0.05. TI caused upregulation of genes associated with DC maturation including:
DC-LAMP (36.25x, P≤0.002), CD80 (B7-1, 7.37x, P≤0.009), and CD40 (co-stimulatory mol-
ecule, 2.15x, P≤0.048). Genes associated with a tolerogenic profile were upregulated after
TI, including indoleamine 2,3-dioxygenase (IDO; 36.21x, P≤0.005) and kynurenine 3-
monooxygenase (KMO; 7.09x, P≤ 0.013). Genes associated with stimulation of CD8 T cell-
mediated cytotoxicity were also upregulated by TI: MHC class I (4.99x, P≤0.01), and TNF lig-
and superfamily members 7 (2.38x, P≤0.011) and 9 (2.98x, P≤0.011). Our data reveal that
Transimmunization induces mature DC within 18hr. DC generated by TI express a tolerogenic
genotype, which may be stimulated to evolve into an immunostimulatory/cytotoxic genotype,
characterized by upregulation of MHC class I and TNF ligand superfamily members. We pro-
pose that cellular environment (e.g. presence of tumor-associated antigens and stress signals)
may be the determining factor that influences whether TI-induced DC stimulate anti-tumor
immunity (as in CTCL) or promote tolerance (as in GVHD).
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DC-HIL and syndecan-4 are negative regulators of primary and secondary T cell responses,
raising their potential as therapeutic targets for T cell-mediated diseases
J Chung, PD Cruz and K Ariizumi Dermatology, UT Southwestern Medical Center, Dallas, TX
We discovered DC-HIL as a transmembrane receptor expressed by antigen presenting cells
(APC), then showed, using recombinant DC-HIL protein, that it inhibits T cell receptor-induced
activation of naive T cells (1o response). We next showed inhibition to occur via ligation of
syndecan-4 (SD-4) on activated T cells. Addressing in vivo relevance, we used contact hyper-
sensitivity to show i.p. injection of recombinant DC-HIL or anti-SD-4 Ab (vs. controls) in mice
leads to augmented ear swelling when given at elicitation (but not at sensitization), indicat-
ing these agents can modulate immunity by interfering with normal binding of DC-HIL to
SD-4. To more rigorously confirm inhibitory function, we calibrated DC-HIL/SD-4 expres-
sion via siRNA technology. First, we knocked-down DC-HIL expression on dendritic cells
(DC), pulsed these APC with OVA peptide, co-cultured them with responder CD4+ T cells
from DO.11.10/OVA-transgenic mice, and measured T cell activation via IL-2 secretion and
CD69+ frequency. DC expressing 90%-less DC-HIL (vs. controls) induced 2X higher IL-2
and CD69+ cells. Conversely, we knocked-down SD-4 expression on the CD4+ T cells, co-
cultured them with OVA-pulsed DC, and again measured IL-2 and CD69. T cells expressing
70%-less SD-4 (vs. controls) induced 2X higher IL-2 and CD69+ cells. These outcomes affirm
the inhibitory function of DC-HIL/SD-4 during the inductive/afferent phase of an immune
response. To determine whether inhibition also applies to the 2o/efferent phase, we exam-
ined effects on CD4+ T cells preactivated by splenic APC for 3 days (activation confirmed by
high CD69 expression) that were then reactivated using anti-CD3 Ab in the presence of recom-
binant DC-HIL or control protein. T cells in control panels displayed strong anti-CD3 responses;
such responses were blocked almost completely by DC-HIL. Inhibition of 2o (as well as 1o)
T cell responses fuels momentum towards our goal of targeting DC-HIL and SD-4 to treat T
cell-mediated diseases.
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Reversal of immunosuppression in cutaneous T cell lymphoma by anti-CTLA-4 antibody
CL Berger, M Girardi, R Tigelaar and RL Edelson Dermatology, Yale University, New Haven,
CT
Advanced cutaneous T cell lymphoma (CTCL) is commonly associated with clinically relevant
immunosuppression. Since CTCL cells can be induced to exhibit T regulatory (Treg) function
in vitro, it is possible that the clonally expanded malignant T cells may be directly responsi-
ble for the observed immunosuppression. To determine whether Treg CTCL cells suppress the
normal T cell IFN-γ response to common microbial antigens through a CTLA-4 directed mech-
anism, we tested the effect of addition of a clinically relevant antibody to CTLA-4 (MDX-010).
Using our previously published strategy for Treg induction (Blood 105:1640-47, 2005), CTCL
cells co-cultured for 1-2 months with syngeneic DC were separated from DC by a CD4 mag-
netic bead column. CTCL cells were rendered apoptotic with CD3 antibody and cultured
overnight with DC to permit uptake, antigen processing and presentation. When freshly iso-
lated CTCL cells were added, they were induced to assume a Treg profile. Treg CTCL cells, or
non-induced CTCL cells were added at a 1:1 ratio to normal CD4 T cells stimulated with
tetanus toxoid in the presence or absence of serial dilutions of anti-CTLA-4 antibody for 5
days. Supernatants were measured for IFN-γ secretion by ELISA. The results demonstrated a
dose dependent reversal of Treg CTCL cell immunosuppression. In the absence of CTCL cells,
the average production of IFN-γ was 8.0±2.83 ng/ml (N=4). The addition of induced Treg CTCL
cells significantly (P0.008) inhibited IFN-γ output (1.75±1.6 ng/ml). Complete reversal of
suppression (9.5±0.71 ng/ml) required the addition of 150 µg/ml anti-CTLA-4. The addition
of non-induced CTCL cells to normal T cells responding to tetanus did not result in significant
suppression. These studies reveal that inhibition of normal T cell immune responses by CTCL
cells can be reversed by an antibody to CTLA-4, supporting the premise that CTCL-induced
immunosuppression is mediated, at least in part, through CTLA-4 expression by CTCL cells.
These results suggest that clinical administration of anti-CTLA-4 may enhance immunocom-
petence in advanced CTCL.
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Imiquimod paralyzes regulatory T cells: a novel mechanism of action in the treatment of squa-
mous cell carcinomas
RA Clark, M Muthukuru, C Schanbacher, D Miller, J Kim and T Kupper Department of
Dermatology, Brigham and Women’s Hospital, Boston, MA
Squamous cell carcinomas (SCC) are infiltrated by non-cutaneous T cells whose function
remains largely uncharacterized. We isolated T cells infiltrating human SCC and found that a
significant number were CD4+ CD25hi FOXP3+ regulatory T cells (Treg). Treg lacked expres-
sion of CLA and CCR4 but co-expressed L-selectin and CCR7, a phenotype characteristic of
central memory T cells normally found only in blood or lymph nodes. To confirm Treg num-
bers, we stained frozen sections for CD3 and FOXP3 and counted normal vs. regulatory T cells
in areas of invasive SCC. Up to 50% of the T cells infiltrating SCC were FOXP3+ Treg. Imiquimod
is a topical TLR7/TLR8 agonist effective in the treatment of SCC. SCC treated with imiquimod
prior to excision had drastically lower % FOXP3+ Treg. Pretreatment of Treg in vitro with
imiquimod blocked their ability to suppress T cell proliferation. Using real-time quantitative
PCR, we found expression of TLR7 and TLR8 on CD25hi T cells from both blood and skin. We
analyzed gene expression of untreated and treated CD25hi T cells using microarrays focused
on TLR pathway genes. Preliminary studies show upregulation of multiple TLR pathway genes
in imiquimod-treated T cells, suggesting imiquimod may act directly on Treg. In summary, we
find that SCC are infiltrated by large numbers of FOXP3+ Treg. Imiquimod-treated tumors had
lower percentages of Treg and imiquimod treatment of Treg in vitro blocked their ability to sup-
press. We hypothesize that imiquimod may act to paralyze the suppressive ability of tumor-
associated Treg, allowing an enhanced tumor response. Treg inhibit tumor responses to many
cancers, including malignant melanoma. Inhibition of Treg during tumor immunotherapy has
a distinct advantage over depletion of Treg with anti-CD25 agents because it does not per-
manently destroy the population of Treg needed for self-tolerance. TLR agonists could there-
fore prove useful as additions to immunotherapy in the treatment of many human cancers.
www.jidonline.org   S117
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A novel T cell proliferation pathway: Hyaluronan synthesis is essential
C Mahaffey and M Mummert University of Texas Southwestern Medical Center, Dallas, TX
Hyaluronan (HA) is a glycosaminoglycan composed of N-acetylglucosamine and glucuronic
acid subunits. Previous studies have shown that exogenous HA enhanced mitogen induced
T cell proliferation via HA/CD44 molecular interaction. These results may suggest that CD44
expressed by T cells can bind HA in the extracellular matrix or on the surfaces of antigen
presenting cells for co-stimulation. On the other hand, T cells express mRNAs for HA syn-
thases and actively synthesize HA after mitogen stimulation. Thus, HA may also participate
in T cell proliferation in an autocrine fashion. In this study, we examined the role of HA in T
cell proliferation using the HA synthase inhibitor, 4-methylumbelliferone (4-MU). We found
that 4-MU significantly inhibited the concanavalin A (ConA) induced synthesis of HA by
splenic CD3+ T cells. Moreover,4-MU inhibited the proliferation of T cells cultured with var-
ious stimuli, including ConA, PMA/ionomycin and allogeneic spleen cells. Importantly, 4-
MU was not cytotoxic. Interestingly, 4-MU significantly inhibited the secretion of IL-2, a
cytokine known to be involved in T cell growth. Addition of IL-2 to T cells cultured in the
presence of 4-MU and ConA significantly reversed the block in T cell proliferation showing
that the inhibition of IL-2 played a role in the observed mitotic impairment of T cells. In turn,
these results may suggest that newly synthesized HA is involved in the secretion of IL-2. Sur-
prisingly, an anti-CD44 monoclonal antibody did not significantly reduce mitogen induced
IL-2 secretion nor T cell proliferation. Moreover, 4-MU did not alter the surface expression
of CD44 on T cells or the ability of CD44 on activated T cells to bind to HA. Thus, HA medi-
ated IL-2 secretion and T cell proliferation occurs in a CD44-independent fashion. In sum-
mary, our results strongly suggest that HA synthesized by T cells themselves is critical for their
IL-2 mediated growth and proliferation. Moreover, HA-mediated IL-2 secretion does not
depend on HA/CD44 molecular interaction. Our results have revealed a previously unrec-
ognized role for HA in T cell biology.
704
Etanercept effect on regulatory and effector T cells in psoriasis patients
JV Massari,1 WA Goodman,1 MR Robinson,1 SB Routhouska,1 SR Stevens,2 KD Cooper,1
NJ Korman1 and TS McCormick1 1 Dermatology, Univ Hosp Case Medical Center and Case
Western Reserve University, Cleveland, OH and 2 Amgen, Thousand Oaks, CA
We report that psoriasis treatment with etanercept, a recombinant human TNFα receptor fusion
protein, modifies the phenotype of circulating CD4+CD25high regulatory T cells (Treg). In an
open label translational clinical trial, peripheral blood mononuclear cells (PBMCs) were
obtained from 16 patients with moderate to severe plaque psoriasis at baseline, week 3 or 6
depending on patient response, and week 12. Treg and CD4+CD25- effector T cell (Teff) pop-
ulations were isolated from PBMCs by high-speed flow cytometry sorting, and Treg function
was assessed by 3H thymidine uptake in an allo-MLR assay. Mean fluorescence intensity (MFI)
of CD25 expression on Tregs decreased from 147±60 to 105±43 during treatment (p=0.001,
n=6). By contrast, etanercept therapy did not modify CD25 expression on activated Teff
(CD4+CD25low) cells, which showed a mean MFI of 12.5±5 at baseline, 11.4±5 at 3 or 6 weeks,
and 11.2±5 at 12 weeks (p>0.05, n=6), suggesting a specific effect on the Treg-containing pop-
ulation. Clinical responses were prospectively separated: 10 of 16 patients were considered
early responders, achieving PASI 25 by week 2, and 6 of 16 patients were late responders.
Eighty percent of early responders achieved PASI 75 by week 12 (p=0.0002, n=10). Among 6
late responders, 3 achieved PASI 75 by week 12, although PASI scores of all late responders
were decreased by this time point. Treg function was decreased transiently, but not signifi-
cantly, at 3 weeks in 3 of 4 patients tested in the early responder group and 0 of 3 in the late
responders. No correlation between change in PASI score and Treg suppression was found
(r=0.12, p=0.8), and there was no statistically significant change in Treg function between pre-
treatment and post-treatment samples (p=0.2, n=7). Thus, etanercept may selectively cause
changes in CD25 expression in circulating Treg cells, but not Teff populations, without signif-
icantly altering their suppressive capacity within the peripheral blood.
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A synthetic Nod2 agonist, muramyl dipeptide (MDP)-Lys (L18), and IFN-β synergistically
stimulate the maturation of dendritic cells with augmented IL-12 production and suppress
the growth of established B16F10 melanoma
T Fujimura, Y Ito and S Aiba Dermatology, Tohoku University, graduate school of medicine,
Sendai, Japan
A synthetic Nod2 agonist, muramyl dipeptide (MDP)-Lys (L18), mimics the bacterial peptido-
glycan moiety and acts as a powerful adjuvant that induces cell-mediated immunity. Recently,
we have reported that Nod1 and Nod2 agonists in combination with TLR3, TLR4, and TLR9
agonists synergistically induce IL-12 and IFN-γ production in dendritic cells (DCs) to induce
Th1-lineage immune responses (Infect Immun 73:7967, 2005). In this study, we examined the
effects of IFN-β in combination with MDP-Lys (IFN-MDP-Lys), both of which are currently avail-
able for clinical use in Japan, on the induction of antitumor immunity for malignant melanoma.
The stimulation of human monocyte-derived DCs with IFN-MDP-Lys significantly augmented
the production of IL-12p70 (80 pg/ml), TNF-α (3370 pg/ml), and IL-6 (2717 pg/ml) compared
to that with MDP (IL-12p70 (2.4 pg/ml), TNF-α (174 pg/ml), and IL-6 (842 pg/ml) ) or that with
IFN-β (IL-12p70 (0.24 pg/ml), TNF-α (24 pg/ml), and IL-6 (49 pg/ml)). These synergistic effects
by IFN-MDP-Lys were also demonstrated in the expression of IL-12p35, IL-12p40, TNF-α, IL-
6 and IL-1β mRNA by MoDC using real-time PCR. Interestingly, however, IL-10 mRNA expres-
sion was rather suppressed in MoDC treated with IFN-MDP-Lys. The expression of CD83 and
costimulatory molecules such as CD40, CD80, and CD86 was also upregulated in MoDC treated
with IFN-MDP-Lys, which resulted in their augmented allogeneic T cell stimulation. Finally, we
evaluated the anti-tumor effect of peritumoral injection of IFN-MDP-Lys on established B16F10
melanoma in vivo. The administration of IFN-MDP-Lys significantly suppressed the growth of
B16F10 melanoma in a dose-dependent manner, while the monotherapy of IFN-β or MDP-Lys
did not significantly affect the tumor growth. These findings suggest that IFN-MDP-Lys can be
a promising adjuvant therapy for malignant melanoma.
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Peripheral blood mononuclear cell cytokine expression represents a new indicator for myco-
sis fungoides staging
BF Chong, AJ Wilson, HM Gibson, MS Hafner, Y Luo, C Hedgcock and HK Wong
Dermatology, Henry Ford Hospital, Detroit, MI
Mycosis fungoides (MF) is a cutaneous T cell lymphoma characterized by neoplastic skin-hom-
ing, clonally derived T cells. To better understand the immunopathogenesis of MF, we studied
the functional ability of peripheral blood mononuclear cells (PBMCs) from 11 early and 7 late
stage MF patients with and without Sézary involvement to express cytokine genes in com-
parison to 12 normal and 6 psoriasis patients. In response to stimulation, we found an inverse
correlation between cytokine expression and disease stage. PBMCs from patients with early
stage MF showed the highest ability to up-regulate gene expression for IL-2, IL-4, and IFN-γ
compared to psoriasis, normal, and late MF patients without and with Sézary involvement
(p<0.05 for late MF patients), in descending order. Late MF patients without Sézary involve-
ment exhibited generally increased IL-5, IL-10, IL-13 and IL-17 expression compared to nor-
mal, psoriasis, and late MF patients with Sézary involvement, with early MF patients having
similarly elevated levels of IL-13 and IL-17 compared to late MF patients without Sézary involve-
ment. Late MF patients with Sézary involvement had the lowest levels of IL-2 (p<0.05), IL-4,
IFN-γ, IL-13, and IL-17 compared to normal, psoriasis, early MF, and late MF patients with-
out Sézary involvement. Since IL-17 is involved in the recruitment of circulating T cells and
neutrophils to the skin, decreased IL-17 levels in late MF patients with Sézary involvement
suggests a depressed anti-tumor response. The pattern of cytokine gene expression suggests a
novel progression of MF, from early MF to late MF without Sézary involvement to late MF
with Sézary involvement. The changes in cytokine expression may provide insight into the
defective immunoregulation seen in MF, and are consistent with early disease likely associ-
ated with T cells mounting an immune response to the tumor and late disease reflective of a
dysfunctional immunoregulation dominated by malignant T cells.
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The immunohistological demonstration of cutaneous CD4+CD25+FoxP3+ regulatory T cells
in psoriasis, spongiotic dermatitis and mycosis fungoides
T Hidaka, T Fujimura, Y Ito and S Aiba Tohoku University, graduate school of medicine,
Sendai, Japan
It is well known that regulatory T cells (Tregs), identified by their expression of CD4, CD25, and
Foxp3, play a crucial role in maintaining peripheral tolerance. Recently, it has been demonstrated
that a Treg population resides in normal human skin. This observation strongly suggests the cru-
cial role of Tregs in various inflammatory skin disorders or skin tumors. In this study, we immuno-
histologically examined the presence of CD4+CD25+Foxp3+ Tregs in the lesional skin of pso-
riasis, mycosis fungoides, and spongiotic dermatitis. At first, using TL-Om1, a leukemic cell line
isolated from a patient with ATL that was transfected with human full length Foxp3 cDNA, we
confirmed the specificity of the antibody to FoxP3, which we used throughout the experiments,
and demonstrated that FoxP3 could be stained after formalin fixation. In this study, we investi-
gated the cutaneous expression of Foxp3 in 16 psoriasis patients, 18 spongiotic dermatitis patients,
and 17 mycosis fungoides patients by using formalin-fixed paraffin embedded sections. The dou-
ble staining was performed by using the combination of murine anti-CD3 Ab, anti-CD4 Ab,
anti-CD8 Ab, anti-CD25 Ab with peroxidase-conjugated anti-mouse Igs and that of anti-Foxp3
Ab with alkaline phosphatese-conjugated anti-rabbit Igs. The best immunological staining was
obtained with autoclave heating. These studies demonstrated as follows: 1) more than 40% of
epidermal CD3+, CD4+ or CD25+ cells express Foxp3 in psoriasis and mycosis fungoides, while
less than 30% of epidermal CD3+ or CD4+ cells express FoxP3 in spongiotic dermatitis, 2)
none of the CD8+ cells express FoxP3, 3) from 20% to 30% of dermal CD3+, CD4+ or CD25+
dermal cells express FoxP3 in mycosis fungoides and spongiestic dermatitis while less than 10%
of dermal CD3+, CD4+ or CD25+ cells express FoxP3 in psoriasis. These findings suggest a role
of decreased dermal Tregs in psoriasis in its sustained cutaneous immune response and a rela-
tionship between Tregs and neoplastic T cells in mycosis fungoides.
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Artemin; the member of glial cell line-derived neutrophic factor is induced by substance P
stimulated- fibroblasts : New model of non-neural cell control of skin - derived itch in atopic
dermatitis
H Murota, M Izumi, S Sano and I Katayama Dermatology, OSAKA University, Suita, Japan
Itch is the major symptom of atopic dermatitis, and impairs quality of life in these patients. In
the recent reviews, not only histamine but also other pruritogens are involved in the mecha-
nisms of itch and aggravate atopic dermatitis. Substance P (SP) is thought to be one of pruri-
togens, and is supposed to be a promising candidate for the target of therapeutic intervention
of atopic dermatitis. However, the physiological role and function of substance P in the skin
biology remains controversial, especially in fibroblast. In attempt to resolve this controversy,
we have investigated the expression profiling of genes that are induced by substance P-treat-
ment in normal human dermal fibroblast cell line (NHDF) using macro-gene array. Based on
this study, we focused on de novo artemin, which is a member of the glial cell line-derived
neutrophic factor related family, gene transcription in NHDF after substance P-stimulation.
Besides substance P-treated NHDF, RT-PCR revealed the basal level of artemin mRNA expres-
sion in the normal human keratinocyte and Hacat cell. Furthermore, we verified that dermis
of atopic dermatitis skin lesions exhibit intense immunoreactivity for artemin, while psoriasis
and healthy controls are less intense. Taking into consideration on the functions of artemin
such as chemotactic activity for sympathetic neuron, these results might provide a basis of
understanding the pathogenesis of neurogenic aspect in atopic dermatitis.
S118 Journal of Investigative Dermatology (2007), Volume 127
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Immunomodulation by non-pathogenic gram-negative bacteria operates via TLR2 on DC and
IL-10 producing T cells
TVolz,1 A Gueniche,2 E Guenova,1 S Kaesler,1 L Breton2 and T Biedermann1 1 Dept.of Dermatology,
Eberhard Karls University, Tuebingen, Germany and 2 L’ORÉAL Recherche, Clichy, France
In healthy individuals, non-pathogenic bacteria remain on skin and gut epithelium without
inducing inflammation. Moreover, some strains of non-pathogenic bacteria have been used
to treat or prevent allergic inflammation. One of these strains is the gram-negative bacteria
V.filiformis (Vf), which has been used in atopic patients and proved to be effective compared
to vehicle. The underlying mechanism, however, remained unknown. We therefore investi-
gated the effects of Vf extracts on immunity to disclose a general principle of the immune bal-
ance on epithelia. Initial studies revealed that several Vf preparations led to DC maturation.
However, marked differences were seen regarding cytokine production. Vf lipopolysaccha-
ride (LPS) induced IL-12 in DC and co-cultures of these DC with T cells led to the induction
of IFN-γ producing Th1 cells. Unlike IL-12, IL-10 level remained low in LPS-stimulated DC.
DC activated with Vf bacterial extract secreted only moderate levels of IL-12 but large amounts
of IL-10. Co-cultures of these DC with T cells resulted in the induction of remarkably high
levels of IL-10 together with little IFN-γ in CD4+ T cells, a phenotype characteristic for inducible
regulatory T cells. To investigate the mechanism of IL-10 production, DC from several knock-
out and wild type mice were analyzed. Strikingly, IL-10 production was almost abolished in
DC lacking TLR2 suggesting a hitherto unknown but dominant TLR2 ligand with tolerogenic
activity. Our data demonstrate a possible scenario of immunomodulation by gram-negative
non-pathogenic bacteria such as Vf. They control proinflammatory responses by stimulating
DC to orchestrate the induction of IL-10 producing T cells. We identified TLR2 as the recep-
tor mediating the immuno-dominant activity of these bacteria that have the potential to main-
tain or even restore the immune balance on epithelial surfaces such as in atopic dermatitis
patients. Thus, TLR2 activating compounds of these bacteria could be a new class of immune-
modulators.
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Generation of T cell memory critically depends on cell volume regulation by the taurine
transporter TAUT during T cell activation
M Sobiesiak,2 S Kaesler,1 P Lang,2 K Lang,2 T Wieder,1,2 B Heller-Stilb,3 M Kneilling,1
U Warskulat,3 D Häussinger,3 F Lang2 and T Biedermann1 1 Dept. of Dermatology, University
of Tuebingen, Tuebingen, Germany, 2 Dept. of Physiology, University of Tuebingen,
Tuebingen, Germany and 3 Dept. of Internal Medicine, University of Duesseldorf,
Duesseldorf, Germany
The regulation of whether T cells undergo apoptosis or become memory cells after antigen spe-
cific activation is poorly understood. We hypothesized that the cell volume regulator taurine trans-
porter (TauT) contributes to this process. To characterize the role of TauT for the generation of
immune memory, we analyzed taut-/- in comparison to wildtype (wt) mice. Contact hypersensi-
tivity responses (CHS) to TNCB were significantly reduced in taut-/- mice. Investigating the under-
lying mechanisms for this defect we found no difference in lymph node cells of naïve mice, how-
ever, T cells were significantly reduced in skin draining lymph nodes after CHS induction in taut-/-
mice. This indicates a possible role for TauT in rescuing T cells from activation induced cell death
(AICD). Indeed, after in vitro activation, T cells from taut-/- mice expressed significantly higher lev-
els of the apoptosis marker phosphatidylserine and survival of taut-/- T cells was significantly
decreased indicating enhanced AICD in taut-/- T cells. To prove an in vivo role of TauT for T cell
survival, we adoptively transferred TNCB specific CFSE loaded T cells from taut+/+ or taut-/- mice
into naïve wt recipients. Strikingly, after challenge with TNCB recovery of dividing CFSE+ CD4+
and CD8+ taut-/- T cells was significantly reduced compared to wt indicating increased AICD of
taut-/- T cells. Consequently, the numbers of effector memory T cells
(CD45RBlowCCR7highCD62Lhigh) and central memory T cells (CD45RBlowCCR7lowCD62Llow)
were also significantly decreased in CHS taut-/- mice. In summary, we could show for the first time
that cell volume regulation by TauT is crucial during T cell activation, modulates induction of T
cell apoptosis, and plays a role for T cell survival and the selective process of generation of T lym-
phocyte memory.
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CD3-CD11c+CD4+ splenic DCs can cross present keratinocyte cell membrane-associated
antigen to CD8+ T cells in K14-mOVA Tg mice in vitro
Y Cho, F Miyagawa and SI Katz Dermatology Branch, National Cancer Institute, National
Institutes of Health, Bethesda, MD
Splenic dendritic cells (DCs) can be divided into three groups of CD11c+ cells according to
their CD4 and CD8α antigen expression: CD4+, CD8α+, and double negative DCs. While
CD11c+CD8α+ DCs are best known for their cross-presenting ability, other DCs have been
reported cross present poorly. Using a transgenic mouse model of autoimmune disease against
skin-associated antigen we determined the relative role of each of these subpopulations to
present membrane-associated proteins. The mice express varying amounts of chicken oval-
bumin (OVA) (K14-mOVAhigh and K14-mOVAlow) under the control of a keratin 14 (K14) pro-
moter. When OVA-reactive TCR-Tg CD8+ T cells (OT-I cells) were adoptively transferred,
K14-mOVAhigh mice developed GvHD-like disease while K14-mOVAlow mice did not. Para-
doxically, the DCs from lymph node or spleen of K14-mOVAlow mice were able to activate
and induce proliferation of OT-I cells in vitro while DCs from K14-mOVAhigh mice were not.
To explain this result we identified DC subpopulations that are responsible for the in vitro OT-
I cell priming in K14-mOVAlow mice. Depletion of CD11c+ DCs from splenocytes of K14-
mOVAlow mice totally abrogated OT-I cell proliferation. T cell-depleted splenocytes were
then further depleted of CD4+ and/or CD8α+ DCs and mixed with OT-I cells. While CD8α+
DCs depletion did not affect the proliferation of OT-I cells, CD4+ DC depletion significantly
reduced it. Also depletion of both CD4+ and CD8α+ DCs did not further reduce the prolifer-
ation of OT-I cells compared to the single CD4+ DC depletion. However, even after both CD4+
and CD8α+ DCs depletion, double negative DCs could still induce moderate proliferation of
OT-I cells. These data demonstrate that, in addition to CD11c+CD8α+ DCs, CD4+ and dou-
ble negative DCs are also able to effectively cross present cell membrane-associated antigens
to CD8+ T cell, and CD4+ DCs were most efficient in our K14-mOVA Tg mice model.
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The antimicrobial peptide psoriasin is the major component of vaginal fluids which show
strong antimicrobial activities
M Mildner,1 R Gmeiner,1 A Abtin,1 C Sam,2 R Gläser,3 JM Schröder,3 V Mlitz,1
M Stichenwirth,1 J Pammer,4 A Geusau1 and E Tschachler1,5 1 Department of Dermatology,
Medical University of Vienna, Vienna, Austria, 2 Department of Gynecology, Medical
University of Vienna, Vienna, Austria, 3 Department of Dermatology, University Hospital
Schleswig-Holstein, Kiel, Germany, 4 Department of Pathology, Medical University of Vienna,
Vienna, Austria and 5 CE.R.I.E.S, Neuilly, France
Psoriasin (S100A7) has been shown to be the major Escherichia coli-killing antimicrobial
peptide in the skin. Here we investigated the expression and regulation of psoriasin in mucous
epithelia of the female genital tract. We demonstrate that multilayered vaginal epithelium but
not single layered cervical epithelium strongly expressed psoriasin as determined by immuno-
histochemistry. When vaginal fluids obtained by lavage with 2 ml physiological NaCl-solu-
tions from healthy donors were analyzed by Western blot and ELISA, up to 2 µg/ml of psori-
asin were detected in 4 different donors. In fact psoriasin seemed to comprise about 20% of
the total protein amount measured in vaginal fluids. Using an in vitro 3D-model of human
vaginal epithelium obtained from MatTek Corporation (EpiVaginal™), we could show that
exposure of this model to secreted components of E. coli induced an increase in psoriasin
expression. Finally, we could show that vaginal fluids potently killed E. coli and Neisseria gon-
orrhoeae in an anti-microbial activity assay system. The anti-microbial activity of vaginal flu-
ids on other microorganisms are currently under investigation. Taken together these data
show the high potency of vaginal fluid in anti-microbial defense. Furthermore the high intra-
vaginal amount of psoriasin implicates an important role of this antimicrobial peptide in the
innate immunresponse of the female genital tract.
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CXCL13 and CCL21 are expressed in ectopic lymphoid follicles in cutaneous lymphoprolif-
erative disorders
H Ohmatsu, M Sugaya, T Kadono and K Tamaki Dermatology, University of Tokyo, Tokyo,
Japan
B cell-attracting chemokine 1/CXCL13 and secondary lymphoid tissue chemokine/CCL21 are
expressed within secondary lymphoid organs, regulating homing of lymphocytes and den-
dritic cells to these organs. Ectopic expression of these chemokines in pancreas induces lym-
phoid neogenesis in transgenic mouse models. The importance of CXCL13 and CCL21 in
ectopic lymphoid tissue organization in human diseases is also suggested by their expression
in chronic inflammatory conditions such as rheumatoid arthritis and Sjögren syndrome. The
role of these chemokines in cutaneous lymphoid follicles, however, has not been studied. In
this study, we investigated the expression of CXCL13 and CCL21 in cutaneous lymphoprolif-
erative disorders. Skin and lymph node specimens, originally taken from the patients with
Kimura’s disease (5 cases), pseudolymphoma (6 cases), primary cutaneous diffuse large B-cell
lymphoma (5 cases), primary cutaneous marginal zone B-cell lymphoma (2 cases), primary
cutaneous follicle center lymphoma (4 cases), primary cutaneous T cell lymphoma (7 cases),
lichen planus (5 cases), and reactive lymphadenopathy (2 cases) over a period from 1985 to
2006 in our department were obtained. Using formalin-fixed paraffin-embedded sections, we
performed immunohistochemistry for CXCL13, CCL21, CD21, D2-40, PNAd, CD45RA, and
CD45RO. CXCL13 was positive at the center of lymphoid follicles, which was also rich in
CD21-positve follicular dendritic cells. CXCL13 positive cells were very sparse or almost neg-
ative in cases without apparent follicular formation. CCL21 was expressed in lymphatic ves-
sels in all cases. It was also expressed on the outer side of PNAd+ high endothelial venule-
like vessels, which were frequently seen surrounding lymphoid follicles. In addition, the majority
of T cells infiltrating within and outside cutaneous lymphoid follicles were stained for CD45RA.
We conclude that CXCL13 and CCL21 are essential to the migration of B cells and naive T
cells into the skin and the formation of cutaneous lymphoid follicles.
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Altered expression of the anti-apoptotic protein, Ku-70 in CTCL; a mechanism of malignant
T Cell death evasion?
K Ferenczi,1 TS McCormick,1 A Somani,1 AC Gilliam,1 S Matsuyama2 and KD Cooper1 1
Dermatology, University Hospitals Case Medical Center, Cleveland, OH and 2 Medicine,
Division of Hematology and Oncology, Case Western Reserve University, Cleveland, OH
We have identified high immunostaining for Ku70, an important inhibitor of apoptosis, in the
Pautrier’s microabscesses of CTCL, suggesting a means by which the malignant T cells might
be resistant to apoptosis. Dysfunctional apoptosis in CTCL has been suggested to be related
to defective Fas signaling and upregulation of Bcl-2. Neoplastic T cells, however likely have
multiple mechanisms of evading apoptosis. Ku70, a protein previously known to play a role
in DNA repair, has recently been shown to have a key role in inhibition of apoptosis via
blockade of translocation of the pro-apoptotic protein, Bax, to the mitochondria. In this study
we analyzed the expression of Ku70 in CTCL, normal skin and inflammatory skin conditions,
such as GVHD, contact dermatitis. Confocal analysis of double staining with CD3 and Ku70
in skin revealed co-localization of Ku70 and CD3+ T cells and constitutive Ku70 expression
was noted in normal skin lymphocytes (n=7). In each CTCL patient with robust Pautrier’s
microabscesses (n=3), the intensity of Ku70 immunostaining was higher than within the der-
mal mononuclear cell infiltrate (n=9). In contrast to CTCL, where atypical cells in Pautrier’s
microabscesses in the epidermis are almost all Ku70+, Ku70 immunoreactivity appears dimin-
ished and undetectable in a subset of lymphocytes within the dermal mononuclear cell infil-
trate in contact dermatitis (n=4) and GVHD (n=4) skin lesions. Reduced Ku70 staining in the
dermal lymphocytic infiltrate in CTCL, GVHD and contact dermatitis is consistent with a reac-
tive T cell phenotype undergoing apoptosis under inflammatory conditions. In contrast, high
Ku70 immunostaining in the Pautrier’s microabscesses suggests that Ku70 may be involved -
at least in part- in neoplastic lymphocyte resistance to apoptosis, a characteristic feature of
the malignant T cell clone in CTCL.
www.jidonline.org   S119
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Role of CD4+CD25high+FOXP3+ regulatory T cells in psoriasis
S Chang Dermatology, Asan Medical Center, Seoul, South Korea
T lymphocytes play a central role in the pathogenesis of psoriasis. In previous studies,
CD4+CD25high+regulatory T cells (Tregs) are found to suppress autoimmune reactions and
are deficient in the skin lesions and in the peripheral blood of psoriasis patients. The purpose
of this study was to evaluate change of Tregs in psoriasis related to the clinical course, and to
investigate the role of Treg in the pathogenesis of psoriasis compared to pityriasis lichenoides
(PL), mycosis fungoides (MF) and lymphomatoid papulosis (LyP). Immunohistochemistry was
performed on skin biopsy samples of 22 patients with psoriasis, 6 with pityriasis lichenoides
et varioliformis acuta (PLEVA), 16 with pityriasis lichenoides chronica (PLC), 3 with patch stage
MF, and 2 with LyP compared to 5 normal controls using primary antibodies for CD3, CD4,
CD8, CD30, CD79, cutaneous lymphocyte antigen (CLA), T-cell intracellular antigen-1 (TIA-
1) and FOXP3. Flow cytometry using primary antibodies for CD4, CD8, CD25, and FOXP3,
and reverse transcriptase polymerase chain reaction for foxp3 mRNA were performed in the
peripheral blood mononuclear cells of 18 psoriatic patients and 8 normal volunteers. In results,
FOXP3+ cell fraction was increased in the lesional skin of psoriasis irrespective of the psori-
asis severity compared to the normal skin. However, the skin lesions obtained from psoriasis
of ‘acute course’ had decreased deficient FOXP3+ cells. FOXP3+ Treg populations in the blood
of the ‘acute course’ psoriasis was not different compared to that of ‘chronic course’ psoria-
sis and normal controls. The deficiency of FOXP3+ Treg in the lesional skin may be responsi-
ble for initiation or exacerbation of psoriasis. In addition, deficiency of FOXP3+ cells in PLEVA
compared to PLC indicates that rapid proliferation or activation of CD8+ effecter cells in ‘acute
course’ of PL may be related to deficiency of Tregs.
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Protective effect of Toll like receptor 4 (TLR4) against DMBA induced cutaneous carcino-
genesis in mice
N Yusuf, TH Nasti and CA Elmets Dermatology, UAB, Birmingham, AL
Toll like receptors (TLRs) activate multiple steps in inflammatory reactions that help to coor-
dinate systemic defenses in innate immune responses. They also activate signals that are crit-
ically involved in the initiation of adaptive immune responses. To determine the role of TLRs
in cutaneous skin carcinogenesis, we treated C3H/HeN and C3H/HeJ mice with the carcino-
genic polyaromatic hydrocarbon 7,12-dimethylbenz(a)anthracene (DMBA). In contrast to
C3H/HeN mice, C3H/HeJ mice have a mutation in TLR4 which greatly reduces the function
of the TLR4 receptor. When subjected to a DMBA skin tumorigenesis protocol, the number of
tumors/group was much greater (p<0.001) in TLR4 deficient C3H/HeJ mice relative to the
wild type C3H/HeN mice. Similar results were obtained when the data were evaluated as the
cumulative number of tumors and the number of tumors/tumor bearing mouse. Both C3H/HeN
and C3H/HeJ mice developed a T-cell-mediated immune response to topically applied DMBA.
Interestingly, the cell-mediated immune response was inhibited by in vivo administration of
antibodies to interferon-γ in C3H/HeN mice, but not by antibodies to IL-17. In contrast, the
reaction was inhibited by antibodies to IL-17 in C3H/HeJ mice, but not by antibodies to inter-
feron-γ. Moreover, C3H/HeN mice had elevated circulating levels of interferon-γ following
topical application of DMBA whereas IL-17 was elevated in C3H/HeJ mice. The results of this
study indicate that TLR4 plays an important role in the prevention of DMBA skin tumorigen-
esis and that this is associated with differences in the T-cell subtype activated. Efforts to divert
the cell-mediated immune response from one that is IL-17 mediated to one that is interferon-
γ mediated may prove to be beneficial in the prevention of DMBA-induced cutaneous tumors.
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Incidence of antibody response to CNTO 1275 in patients with psoriasis
C Leonardi,1 GG Krueger,2 C Brodmerkel,3 N Yeilding,3 Y Zhu,3 G Shankar,3 M Reddy3 and
AB Gottlieb4 1 St. Louis University School of Medicine, St. Louis, MO, 2 University of Utah
Health Sciences Center, Salt Lake City, UT, 3 Centocor R & D, Malvern, PA and 4 Tufts
University, Boston, MA
CNTO 1275, a fully human IgG1 monoclonal antibody to IL-12/23p40, inhibits the IL-12/23
pathway, and has shown significant efficacy in patients with psoriasis. The incidence of hyper-
sensitivity reactions and development of antibody (Ab) to study agent (ATSA) were assessed
in patients treated with CNTO 1275 using a specific EIA method. ATSAs were further evalu-
ated using a cell-based neutralization antibody (NAb) assay. Patients received CNTO 1275 as
a SC dose ranging from 0.27 to 2.7mg/kg (n=17) (Phase 1 trial) or at fixed doses of 45 or 90mg
as either a single SC injection or 4 weekly injections (n=301) (Phase 2 trial). At Week 16,
patients with a Physician’s Global Assessment response good, fair, poor, or worse, relative to
baseline (PGA≥3; n=85) received a single injection of their original dose. In the Phase 1 study,
1/17 patients (6%) developed antibodies specific to CNTO 1275 (ASTA-positive). In the Phase
2 study, of the 293 patients treated through Week 52, 12 patients (4%) were ATSA-positive,
250 patients (85%) were ATSA-negative, and 31 patients (11%) were inconclusive due to pos-
sible interference of CNTO 1275 with the ATSA assay. No cases of anaphylaxis, severe aller-
gic reactions, or delayed hypersensitivity were reported in any of the studies. SC injection site
reactions were uncommon and mainly technique-related. No dose-response relationship was
observed relative to ATSA incidence. No injection site reactions were observed in the 13
patients, (including 4 patients who received additional doses of CNTO 1275 after testing pos-
itive) who developed antibodies to CNTO 1275. Retreatment was generally well tolerated. The
effects of ATSA on efficacy are unknown; there was no clear relationship between treatment
response and ATSA or NAb status.
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Effects of CNTO 1275 administration on primate/human antigen-recall and humoral immune
response function
C Brodmerkel,1 Y Zhu,1 T Jiao,1 G Treacy,1 MA Mascelli1 and AB Gottlieb2 1 Centocor R & D,
Malvern, PA and 2 Tufts University, Boston, MA
Agents that inhibit the IL-12/IL-23 pathway are beneficial in the treatment of psoriasis. A fully human
IgG1 monoclonal antibody directed against IL-12/23 via the p40 subunit (CNTO 1275) has demon-
strated significant efficacy in moderate-to-severe psoriasis patients. To determine the effect of IL-
12/23 pathway inhibition on immunocompetency, the antigen-recall response was evaluated in a
preclinical multiple-dose monkey toxicology study and 3 single-dose Phase 1 studies in patients
with the immune-mediated inflammatory disorders, psoriasis and multiple sclerosis (MS). Cynomol-
gus monkeys (n=32) treated with CNTO 1275 22.5 or 45mg/kg SC twice weekly for 26 weeks
were assessed for antibody responsiveness to keyhole limpet hemocyanin (KLH) at Weeks 8, 13,
26, 30, and 38. Monkey exposure to CNTO 1275 was substantially higher than the exposure in
phase 1 studies; antibody titers to KLH in treated animals were comparable to those treated with
placebo. In the Phase 1 studies, patients received a single administration of CNTO 1275 (dose range,
0.09 to 4.5mg/kg IV or SC; n=46) or placebo (n=8), and then were challenged with both pneu-
mococcal and tetanus antigens. Thirty-four of 46 (73.9%) patients who received CNTO 1275 exhib-
ited a normal antibody response (2-fold increase from baseline) to pneumococcal antigen, com-
pared with 4 of 8 patients (50%) who received placebo. Similarly, 12 of 20 (60%) patients who
received treatment with CNTO 1275 exhibited a normal antigen-recall response (4-fold increase
from baseline) to tetanus toxoid exposure. In addition, CNTO 1275 had no impact on the number
of circulating immune cell populations (T-cells, B-cells, natural killer cells). Results from these
studies suggest that single dose administration of CNTO 1275 in patients with psoriasis or MS and
multiple administrations in cynomologous monkeys may not impair normal innate and recall
humoral immune system functions. However, further study is warranted to validate these findings
and evaluate the effects of multiple administrations of CNTO 1275.
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Immunohistochemical changes in lesional tissue and impact on systemic immune markers
following CNTO 1275 treatment in patients with psoriasis
M Reddy,1 G Torres,2 T McCormick,2 C Marano,1 K Cooper,2 N Yeilding,1 M Hsu,1 C Pendley,1
U Prabhakar,1 S Yu1 and C Brodmerkel1 1 Centocor R & D, Malvern, PA and 2 UH Case
Medical Center & Case Western Reserve University, Cleveland, OH
A fully human IgG1 monoclonal antibody to human IL-12/23p40 (CNTO 1275), inhibits the
IL-12/23 pathway and has shown significant efficacy in a Phase 2 study of patients with pso-
riasis when administered as single or multiple doses (45 or 90 mg). A subset of patients was
evaluated for treatment effects on immune markers within psoriatic lesions, peripheral blood,
and in serum. Analyses of: (1) lesion skin biopsies; (2) cell surface markers in peripheral blood;
(3) ex vivoTh1/Th2 cytokine responses from peripheral blood mononuclear cells (PBMCs); and
(4) various inflammatory proteins in the serum were performed at baseline and Week 12.
Results indicated that median epidermal thickness decreased >50% from baseline to Week
12, and markers of cellular proliferation (Ki-67) and T-cell infiltration (CD3), evaluated in
lesional skin biopsies, were also reduced up to 80% in patients treated with CNTO 1275 (all
P≤0.02). Overall serum levels of TNF-α, CCL27, IFN-γ, IL-10, IL-8, and sICAM-1 were not sub-
stantially affected by treatment. There was minimal variation in T-cell subsets expressing
CD45RA, CD45RO, CD25, and CXCR3 after initiation of various doses of CNTO 1275 com-
pared with placebo. A decrease in the percentage of cells expressing CLA was observed with
CNTO 1275 treatment (-15.40%) versus placebo (25.27%, p=0.01). The ability of PBMCs to
generate IFN-γ (Th1 cytokine) and IL-5 (Th2 cytokine) ex vivo in response to polyclonal acti-
vators did not differ between placebo and CNTO 1275 treated patients. Overall, these data
suggest that in contrast to a potent local effect of CNTO 1275 on lesional T-cells and ker-
atinocyte proliferation in psoriasis patients, there appears to be minimal impact on the per-
centage of circulating immune cell populations.
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Enhancement of DNA vaccine efficacy by simple gene gun mediated co-delivery of minute
amounts of a plasmid-encoded helper antigen
WW Leitner, MC Baker, JP Yannie and MC Udey Dermatology Branch, National Institutes of
Health, Bethesda, MD
Nucleic acid-based vaccines are effective in infectious disease models, but have yielded disap-
pointing results in tumor models when tumor-associated self-antigens are employed. The immuno-
genicity of DNA vaccines can be enhanced by incorporating adjuvants into vaccine regimens.
One goal of contemporary vaccine strategies is to achieve immune enhancement while avoid-
ing toxicities associated with the use of conventional adjuvants. Incorporation of helper epi-
topes derived from foreign antigens into vaccines that target tumor self-antigens is one strategy
that can enhance immunogenicity of DNA vaccines without dramatically increasing toxicity, but
this approach raises several concerns. First, construction of fusion cDNA constructs that encode
both tumor antigen and helper antigen epitopes may be difficult, and the fusion proteins that
result will have unpredictable physical and immunological properties. Second, co-production
of equal amounts of highly immunogenic helper antigen and weakly immunogenic tumor anti-
gen in transduced accessory (or other) cells may favor development of responses that are directed
against the immunodominant helper antigen rather than the weaker antigen of interest. To address
these issues, we have assessed the ability of a helper antigen (beta-galactosidase) that is encoded
on one plasmid to augment the response to a self-antigen (T cell receptor) that is encoded on a
separate plasmid and co-delivered into mouse skin on gold particles by gene gun. This approach
allowed us to adjust the relative ratios of helper and tumor antigen plasmids (and hence pro-
teins), and thereby optimize any potential helper effect. Using this strategy, we significantly
enhanced T cell-dependent and T cell lymphoma-specific tumor protection selectively with
very small amounts of helper antigen. These results demonstrate that the ability of helper anti-
gens to enhance responses to weak antigens is clearly dose-dependent, and provide a simple
approach with which to address this key variable in future vaccine trials.
S120 Journal of Investigative Dermatology (2007), Volume 127
ABSTRACTS
721
Decreased T cell recruitment and expansion after cutaneous antigenic challenge of old sub-
jects
K Lacy,1,2 M Vukmanovic-Stejic,1 E Agius,1,2 MH Rustin2 and AN Akbar1 1 Immunology and
Molecular Pathology, University College London, London, United Kingdom and 2
Dermatology, Royal Free Hospital, London, United Kingdom
We previously identified reduced clinical responsiveness in the skin to the intradermal injec-
tion of antigens, despite good peripheral blood T cell responses to antigen, in old individuals
suggesting that a skin-specific defect in immunity occurs during ageing. We have now inves-
tigated possible mechanisms for this by performing skin biopsies at the site of intradermal
injection of candida antigen at 0, 1, 3 and 7 days after injection. In old subjects there was a
significant reduction in the infiltration of CD4+ lymphocytes in the skin that correlated with
reduced clinical score. No differences in the numbers of other cell type, specifically CD14+
monocytes and CD1a and DC-SIGN positive dendritic cells were seen. A significant reduc-
tion of CXCR3 and CCR8 expression was found on CLA+ CD4+ T cells from old subjects, that
may explain, in part, the decreased T cell accumulation after antigenic challenge. Using a
skin suction blister technique, analysis of pro-inflammatory mediator concentrations within
the skin at sites of candida antigen injection revealed a reduction in the levels of TNF-α,
interferon gamma, MCP-1, MIP-1α and RANTES in old individuals. This was associated with
reduced CD4+ T cell activation and proliferation in situ as determined by CD69 and Ki67
expression. Our data suggests that the decreased T cell migration resulting from altered
chemokine receptor expression and also decreased expansion of infiltrating cells associated
with decreased levels of pro-inflammatory cytokines in the skin contribute to the defective
cutaneous response to antigenic challenge during ageing.
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Following the emigration of Langerhans cells, the epidermis of human skin is colonized by
dermal-resident CD14+cells, which acquire the phenotype of Langerhans cells
AE Morelli,2 OA Tkacheva,1 B Janelsins,1 AR Mathers,1 WJ Shufeski,2 JP Rubin,2 LD Falo1 and
AT Larregina1 1 Dermatology, University Of Pittsburgh, Pittsburgh, PA and 2 Surgey,
University of Pittsburgh, Pittsburgh, PA
The mechanisms involved in the replacement of Langerhans cells after their mobilization from
the epidermis are poorly understood. We and others have described that LCs might be replaced
in part by a pool of dermal resident CD14+ precursor cells. Here we analyzed the ability of
human dermal CD14+ cells to colonize the epidermis and to differentiate in situ into LCs fol-
lowing skin emigration of LCs. We used human skin explants, composed of epidermis and a
thin layer of dermis devoid of blood circulation, to analyze the pattern of emigration of LCs
and the re-population of the epidermis by dermal-resident CD14+ cells over a period of 15d.
Three subpopulations of DCs migrated out of the skin during the first 72h of culture: i) CD1a
(low) CD14- (LCs); ii) CD1a- CD14- (DDCs); and iii) CD1a- CD14(low) semi-mature DCs. LCs
and DDCs expressed CCR7 and migrated in response to MIP-3β, a chemokine secreted by
LYVE positive lymphatic endothelial cells. During the following 15d of culture, the epidermis
of the explants was continuously infiltrated by cells arriving from the dermis and expressing
CD14low, Langerinlow and MHC-II(Int) (CD14+ cells). CD14+ cells expressed both CCR6
and CCR7 and migrated to the epidermis in response to MIP-3α or mobilized out of the explants
in response to MIP-3β. Once in the epidermis, CD14+ cells acquired the phenotype of imma-
ture LCs, increasing the expression of Langerin, expressing de novo CD1a and reducing the
levels of CD14, as assessed by fluorescence microscopy in epidermal sheets and by flow cyto-
metric analysis of epidermal cell suspensions obtained on days 5, 7, 10 and 15. We conclude
that in the absence of blood supply the human dermis represents a local reservoir of CD14+
cells with dual ability to repopulate the epidermis and become immature LCs or to migrate
out of the skin via lymphatic vessels in response to different chemokine gradients.
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Norepinephrine modulates cytokine release from LPS-induced human Langerhans cells
E Goyarts,1 M Matsui,1 T Mammone,1 RD Granstein2 and D Maes1 1 Estee Lauder
Companies, Melville, NY and 2 Dept. of Dermatology, Weill Medical College of Cornell Univ.,
New York City, NY
Psychological stress is believed to contribute to the exacerbation of many diseases, including
some skin disorders. One stress hormone, norepinephrine (NE) may suppress cellular immu-
nity by reducing the ability of Langerhans cells (LCs) to be activated. Dendritic cells were
obtained from MatTEK by differentiating cord blood CD34+ progenitors. This cell population
consists of approximately 40% plasmacytoid and 60% myeloid dendritic cells. These den-
dritic cells contain Birbeck granules and have other phenotypic similarities to LCs. To exam-
ine the possible modulatory effect of NE on LPS-induced cytokine production, MatTEK cells
were cultured in 1µg/ml LPS with or without the presence of 10E-6M NE. Control cells were
cultured with and without NE in the absence of LPS. Conditioned supernatants were harvested
after 3 hours and after an additional 21 hours of culture and examined by ELISA for the con-
centration of TNF alpha, IL-12 p40 and IL-10. NE inhibited induction of TNF alpha and IL-12
p40 production, while IL-10 was not affected. Similarly, the presence of forskolin inhibited
LPS-induced TNF alpha and IL-12 p40 production while having no effect on IL-10. In a pre-
liminary experiment, induction of IL-23 p19 by LPS was down-regulated in the presence of
norepinephrine or forskolin. IL-23 is believed to promote the differentiation of CD4+ T cells
required for Tsub>H1 mediated immunity. If the norepinephrine down-regulation of IL-23 pro-
duction by dendritic cells were to be confirmed, this would support the concept that stress-
induced NE may result in decreased Tsub>H1 mediated immunity.
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Langerhans cells represent the predominant source of MFG-E8 in skin
K Nagao,1 M Neutzner,1 WW Leitner,1 M Sardy,1 M Lu,1 BE Clausen2 and MC Udey1 1
NCI/Dermatology Branch, National Institutes of Health, Bethesda, MD and 2 Department of
Cell Biology and Histology, University of Amsterdam, Amsterdam, Netherlands
Milk fat globule protein epidermal growth factor 8 (MFG-E8) is a secreted glycoprotein with
important roles in the uptake of apoptotic cells by phagocytes and in VEGF-induced neo-vas-
cularization. MFG-E8 knockout mice exhibit a lupus erythematosus-like phenotype resulting
from defective clearance of apoptotic cells. MFG-E8 has been reported to be produced by
epidermal Langerhans cells (LC) in vivo as well as keratinocytes in vitro, but its function in
skin has not yet been elucidated. Utilizing an anti-MFG-E8 monoclonal antibody, we could
not confirm that MFG-E8 and LC co-localize in murine ear epidermal sheets. However, we
were able to demonstrate discrete subcellular accumulations of MFG-E8 near the basement
membrane zone (BMZ) in vertical sections of frozen skin. Interestingly, LC in the oral mucosa,
in contrast to LC in the hair-bearing skin, stained for intracellular MFG-E8. Real time-PCR using
mRNA from FACS-sorted cells from normal mouse epidermis and cutaneous lymph nodes
revealed that LC, but not other epidermal cells or dendritic cell subpopulations, contained
high levels of MFG-E8 mRNA. These results indicated that, within epidermis and skin-drain-
ing lymph nodes, MFG-E8 is produced and secreted predominantly by LC. To test this directly,
transgenic mice in which the diphtheria toxin receptor (DTR) is expressed selectively in LC
were studied. Intraperitoneal injection of DT into LC-DTR mice resulted in efficient depletion
of LC from epidermis within 48 hrs and MFG-E8 expression in the BMZ of toxin-treated LC-
DTR mice was abrogated. We hypothesized that LC might release MFG-E8 in epidermis, and
that MFG-E8 might accumulate on apoptotic cells in the skin. However, the subcellular struc-
tures that co-localized with MFG-E8 in the BMZ were not TUNEL-positive. Thus, although the
source of MFG-E8 in skin has been clarified, its function in this tissue remains enigmatic.
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Skin administration of neurokinin-1 receptor agonist favors activation and lymph node hom-
ing of Langerhans cells and induce anti-melanoma immunity
AR Mathers,1 OA Tkacheva,1 B Janelsins,1 WJ Shufeski,2 AE Morelli2 and AT Larregina1 1
Dermatology, University Of Pittsburgh, Pittsburgh, PA and 2 Surgey, University of Pittsburgh,
Pittsburgh, PA
The high number of resident dendritic cells (sDCs) makes the skin an ideal setting for tumor
vaccines. However the individual roles of skin DCs to induce anti-tumor immunity remain
controversial and Langerhans cells (LCs) are being considered as anti-inflammatory cells with
the ability to diminish the intensity of immune responses. Here we tested if delivery of anti-
gen (Ag) to LCs in the presence of appropriate pro-inflammatory stimuli will result in the acti-
vation of immunostimulatory LCs able to induce anti-melanoma immunity. We used the gene
gun (GG) to deliver transgenes encoding luciferase, chicken ovalbumin (OVA), or the melanoma
self-Ag TRP-2 to the skin of C57BL/6 mice and the pro-inflammatory neurokinin-1 receptor
(NK1R) agonist Sar9Met (O2)11-SP injected i.d. as a potential Th1 biasing adjuvant. Skin GG-
delivery resulted in expression of transgenic (tg) Ag exclusively in the epidermis and in skin
draining lymph nodes (sDLNs). GG-immunizations in the presence of the NK1R agonist induced
intense acute inflammation of the skin and sDLNs resulting in significant reduction of the num-
ber of epidermal LCs. This effect was due to the ability of the NK1R agonist to favor the migra-
tion of activated LCs from the epidermis to local sDLNs as demonstrated by the high number
of LCs containing gold particles and co-expressing CD11c, CD11b, MHC-IIhi, and Langerin
in sDLNs, following treatments with the NK1R agonist. Homing of LCs, expressing tg Ag, to
sDLNs resulted in the generation of CD4+Th1 and CD8+CTL effector immunity against OVA,
as analyzed by ELISPOT, in vivo killing, and DTH assays. Skin GG-immunizations encoding
TRP-2 in the presence of the NK1R agonist protected mice against the development of B16
melanomas. We conclude that appropriate inflammatory stimuli provided by local adminis-
tration of the NK1R agonist promotes efficient LC mediated Ag specific immunity that pro-
tects from the development of melanomas.
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Optimizing extracorporeal photopheresis (ECP)-induced monocyte-to- dendritic cell con-
version in a rat model
S Prasad, V Cody, D Hanlon, I Christensen, RL Edelson, C Berger and M Girardi
Dermatology, Yale University School of Medicine, New Haven, CT
With its extensive use as an FDA-approved immunomodulatory therapy, extracorporeal pho-
tophoresis (ECP) has shown efficacy in the treatment of cutaneous T cell lymphoma(CTCL) and
graft-versus-host disease (GVHD). Previously, we have shown that ECP initates monocyte-to-
dendritic cell (DC)differentiation,a phenomenon enhanced by ex vivo overnight incubation
with apoptotic cells. Toward the goal of a rapid, simple and clinically translatable DC-based
therapy for solid tumors using this methodology, we sought to develop a laboratory model
using Fischer 344 rats and a scaled-down benchtop ECP system. Blood obtained by cardiac
puncture was mixed with 8-methoxypsoralen (8-MOP) at 340 ng/ml, and then pumped through
the standard photoactivation module while continually being exposed to UVA light for 30 min-
utes. Flow cytometric analysis with a panel of rat DC markers and scanning electron microscopy
(SEM) were used to evaluate the changes in the profile of the cells at different time points fol-
lowing ECP treatment / overnight (o/n) incubation. Expression of CD11c+CD86+ increased
from 15% (pre-ECP) to 22% (post- ECP) to 78% (post-ECP + o/n incubation). Similarly, MHC-
II+CD86+ cells markedly increased from 6% (pre-ECP) to 12% (post-ECP) to 62% (post-ECP
+ o/n incubation). SEM analysis of ECP-treated cells revealed substantial morphological changes,
including the development of dendritic processes, post-ECP + o/n incubation. We conclude
that ECP is a viable and rapid methodology for the generation of rat DC;something enhanced
by ex vivo o/n incubation, and are now testing this system in the rat FAT7 squamous cell car-
cinoma-inducible model.
www.jidonline.org   S121
ABSTRACTS
727
Characterization, regulation and biological effects of IL-17 isoforms involving T cells and
keratinocytes in psoriasis
H Xin,1 JZ Qin,1 C Conrad,2 G Tonel,2 FO Nestle2 and BJ Nickoloff1 1 Oncology Institute,
Loyola University Medical Center, Maywood, IL and 2 St. John’s Institute of Dermatology,
London, United Kingdom
While psoriasis is classified as a Th1 type cytokine driven disease, recent discovery of a T
helper subset distinct from classical Th1 and Th2 lineages prompted us to explore IL-17+ cells
in human skin. The goal was to delineate importance of Th-17 mediated inflammation in pso-
riatic plaques (PP skin). Using RT-PCR, IL-17D and F, but not IL-17A isoforms were detected in
normal skin (NN skin, n=5) and pre-psoriatic skin (PN skin, n=5), whereas all 3 isoform mRNAs
were present in PP skin (n=6). IL-17A mRNA in PP skin was attributed to immunocytes as no
IL-17A could be detected in cultured keratinocytes (KCs) before or after exposure to several
cytokines; whereas peripheral blood mononuclear cells (PBMC) activated by either PHA, SEB
or anti-CD3/CD28 ab strongly up-regulated IL-17A mRNA and secreted IL-17 protein levels.
KCs constitutively expressed IL-17D and IL-17F mRNAs. To characterize CD4+ T cells within
PP skin, biopsies were minced and émigrés compared to PBMC from identical individuals with
intracellular staining and FACS. PP skin derived CD4+ T cells were characterized by ∼40% of
all T cells containing IFNγ, whereas 4% contained IL-17; with 2% of CD4+ T cells co-express-
ing both IFNγ and IL-17. When compared to PBMC, PP skin was enriched by 6-fold for IL-17+
T cells whereas more equivalent relative frequencies for IFNγ + T cells were found indicating
PP environment is conducive to IL-17 production by CD4+ T cells. Using skin reconstructs com-
posed of human KCs maintained in a 3-D configuration resembling normal epidermis, com-
bined with contracted collagen, addition of IL-17 (50 ng/ml) altered epidermal differentiation
and cornification of KCs. These results indicate distinct IL-17 isoforms derived from both KCs
as well as CD4+ T cells may participate in the pathophysiology of psoriasis. The current Th1
cytokine paradigm for psoriasis should be modified taking into consideration the potential
contribution of the newly recognized function of cytokines such as IL-17.
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Analysis of malignant T cells from CTCL skin lesions supports a multi-step model of disease
pathogenesis
J Shackelton, M Muthukuru, J Kim, T Kupper and RA Clark Department of Dermatology,
Brigham and Women’s Hospital, Boston, MA
In the early stages of CTCL, malignant T cells are confined to skin and are difficult to isolate
and discriminate from benign infiltrating T cells. We have isolated T cells from CTCL skin
lesions and found that they contain a distinct population of T cells not present in normal skin.
These cells had higher forward and side scatter, were CD4+, expressed CLA and CCR4, and
were strongly Th2-biased. High scatter T cells had low but positive CD4 expression, consis-
tent with chronic activation, and increased FOXP3 expression, intermediate between that of
normal and regulatory T cells. In patients with advanced CTCL and an identified T cell clone,
high scatter cells consisted entirely of clonal malignant T cells. Thus, we can isolate the malig-
nant T cells from CTCL skin lesions and discriminate them from benign infiltrating T cells.
Remarkably, even Stage 1A disease skin lesions contained clearly atypical T cells and in early
stages, atypical T cells were polyclonal. We thus have evidence that early, skin-limited stages
of CTCL involve the polyclonal activation of a subset of T cells and may represent a pre-
malignant condition. Advanced stages of CTCL may result from distinct genetic changes lead-
ing to uncontrolled proliferation. In summary, we have isolated the T cells from CTCL skin
lesions and found that atypical T cells are clearly identifiable as a separate population of high
scatter, CD4+ Th-2 biased T cells with a phenotype of chronically activated skin-homing T cells.
Atypical cells in early stages of disease were diverse; only in late stage disease were clonal
populations present. We postulate a two-step mechanism for CTCL pathogenesis in which
early disease represents pre-cancerous chronic activation of a subset of T cells and later dis-
ease represents the development of truly malignant T cell clones. Finally, our ability to dis-
criminate atypical T cells from benign infiltrating T cells will allow for focused, differential
study of malignant CTCL T cells in the future.
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GM-CSF and NF-κB pathways are dysregulated in neutrophils from atopic dermatitis sub-
jects
LG Bankova,1 ME Brummet,2 DN Grigoryev,2 C Cheadle,2 KC Barnes,2 DY Leung3 and
LA Beck1 1 University of Rochester, Rochester, NY, 2 Johns Hopkins University, Baltimore,
MD and 3 National Jewish Medical and Research Center, Denver, CO
We have previously demonstrated that atopic dermatitis (AD) subjects, who are typically colo-
nized with Staphylococcus aureus, produce high amounts of neutrophil (PMN) chemoattractants
locally, but lack PMNs in their skin. PMNs are critical innate immune cells and as such are rel-
evant for both bacterial and viral clearance. As part of the NIAID-funded Atopic Dermatitis Vac-
cinia Network, this study was designed to better understand the molecular basis for this PMN
chemotactic defect. Gene expression profiles of purified, peripheral blood PMNs (95-99% purity)
from 5 AD and 4 nonatopic controls (NA) were generated using Human Whole Genome (55,000
genes) CodeLink Bioarrays and analyzed with Codelink and Significance Analysis of Microar-
rays (SAM) software packages. Genes with false discovery rate q<0.1 and ±1.5 fold change (FC)
were considered significantly up- or down-regulated. Comparative analysis of gene expression
showed that 181 known genes were dysregulated in AD compared to NA neutrophils. Of those,
nine genes belong to the GM-CSF pathway: β-chain of the GM-CSF receptor (-1.94FC), STAT5b
(-1.57FC), JAK3 (-2.10FC), PIP5K1α (-1.99FC), SP1 (-1.52FC), ELF4 (-1.69FC), vav1 (-1.56FC),
vav3 (-2.25FC), and CDC42EP3 (-2.03FC). The NF-κB pathway emerged as another dysregulated
pathway, with five genes in this pathway that were significantly down-regulated – NF-κB2
(p49/p100) (-1.77FC), MyD88 (-1.68FC), TTRAP (-1.52FC), TRAF3 (-1.84FC), and IRAK3 (-
1.87FC). We hypothesize from our data that the neutrophil recruitment defects observed in AD
might be explained by defects in the GM-CSF pathway, as GM-CSF is known to be an important
priming stimulus for neutrophil chemotaxis. The defects found in the NF-κB transcriptional
pathway, relevant for innate immune signaling would provide additional explanations for AD
subjects’ increased susceptibility to cutaneous infections with both bacterial and viral microbes.
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CD40 expression correlates with disease severity in atopic dermatitis
H Gerber,1 IS Grewal,2 R Takiguchi,3 JM Hanifin,3 EL Simpson3 and E Oflazoglu1 1
Translational Biology, Seattle Genetics, Inc, Seattle, WA, 2 Preclinical Therapeutics, Seattle
Genetics, Inc, Seattle, WA and 3 Dermatology, Oregon Health & Science University, Portland,
OR
Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by an infiltration
of inflammatory cells and enhanced expression of co-stimulatory molecules, cytokines and
chemokines. The costimulatory molecule CD40 is expressed by antigen presenting cells (APCs),
including dendritic cells, macrophages and B cells and increased expression of CD40 has been
reported in skin lesions of AD. The exact cell types expressing CD40 and the relationship of
CD40 to disease severity have not been determined. Our objective was to quantify CD40
expression in the skin and peripheral blood of patients with AD of varying disease severity. In
addition, we aimed to identify the cell types expressing CD40 in AD lesional infiltrates. Using
immunohistochemistry and immunofluorescence techniques, we examined lesional and non-
lesional skin biopsies from 30 patients with AD of varying severity. Biopsies from 10 healthy
subjects were used as controls. Peripheral blood cells were analyzed using flow cytometry and
chemokine and IgE analyses were performed using multiplex sandwich enzyme-linked
immunosorbent assays. Our results show lesional skin CD40 levels correlated with disease
severity and with serum PARC levels. Cells expressing CD40 in lesional skin were CD1a+,
CD11b+ and CD19+ antigen presenting cells. In the peripheral blood, the numbers of circu-
lating CD40+ B cells also correlated with disease severity. These findings suggest CD40 may
play an important role in AD disease progression, and therapeutic strategies targeting CD40-
positive cells may provide therapeutic benefit to patients with AD.
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Chemokine receptor CCR4 is necessary for antigen-driven cutaneous accumulation of CD4
T cells under physiological conditions
J Campbell and MA Wurbel Department of Dermatology, Brigham and Women’s Hospital,
Boston, MA
Dual expression of chemokine receptor CCR4 and E-selectin-ligand is characteristic of skin-
tropic CD4 T cells from blood, lymphoid organs and the skin itself. A strong and specific cor-
relation exists among CCR4, its ligand CCL17/TARC, and the cutaneous lymphocyte homing
process. Nevertheless, whether CCR4 function is required for skin-specific trafficking remains
an open question, which we address in this study. We developed anantigen-specific, TCR-
transgenic, murine CD4 T cell adoptive transfer model which induces a mixed Th1 and Th17
cutaneous response. Within the hosts, both CCR4+/+ and CCR4-/- donor CD4 T cells con-
tribute equally well to the circulating E-lig+ pool in response to antigen. However, only CCR4+/+
donor cells accumulate efficiently within the skin. CCR4-/- cells home normally to the peri-
toneum, showing that they do not have a general defect in lymphocyte trafficking. We con-
clude that under physiological conditions, CCR4 is a non-redundant, necessary component
of skin-specific lymphocyte trafficking.
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Serum chemokine profile in patients with bullous pemphigoid
H Nakashima,1 M Fujimoto,2 N Ishiura,1 R Watanabe,1 Y Kuwano,1 N Yazawa,1 H Okochi3
and K Tamaki1 1 Dermatology, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Japan, 2
Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
and 3 Regenerative Medicine, Research Institute, International Medical Center of Japan,
Shinjuku, Japan
Bullous pemphigoid (BP) is an autoimmune inflammatory disease causing blister formation at
the dermo-epidermal junction. Cutaneous infiltration of activated CD4+ T cells and eosinophils
is an early event in blister formation during the disease process, suggesting that the trafficking
of circulating leukocytes through the sites of inflammation is crucial in the pathogenesis of
the disease. While the accumulated evidence suggests that some cytokines are involved in
the pathogenesis, there have been few reports about serum chemokine profile in BP patients.
To determine serum profiles of various chemokine levels and clinical association in BP patients,
concentrations of 10 chemokines including IP-10, MIG, MIP-1α, MIP-1β, RANTES, eotaxin,
MCP-1, MCP-2, MCP-3, and GRO-α were measured in serum samples from 38 patients with
BP, 16 with pemphigus vulgaris (PV), and 17 normal controls using a sandwich immunoas-
say-based multiplex protein array system. While there was no significant increase in any serum
chemokine levels in PV patients, serum levels of IP-10 and MCP-1 were significantly increased
in BP patients compared with healthy controls. Furthermore, serum levels of IP-10, MIG, MCP-
1, and eotaxin in BP patients significantly increased with disease severity determined by the
affected area. These observations suggest that elaborately orchestrated network of chemokines,
especially MCP-1 and IP-10, contributes to the pathomechanism of BP.
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Chemokine expression in fibroblasts in culture: role in wound healing
JN Mansbridge Tecellact, La Jolla, CA
An early event in wound healing is rapid recruitment of neutrophils to the site of injury. This
results partly from release of neutrophil chemoattractants from platelets, but also involves par-
ticipation by other local cells. Chemokine gene expression by neonatal dermal fibroblasts in
three-dimensional, scaffold-based culture was compared with monolayer culture using Illu-
mina arrays. Marked upregulation of the neutrophil recruiting and activating chemokines
CXCL1, CXCL5, CXCL6 and CXCL8 (gro-α, ENA-78, GCP2 and IL-8 respectively) was observed
under three-dimensional conditions. By ELISA, it was found that fibroblasts also secrete large
amounts of the chemokines under these conditions. Expression of the chemokines, as deter-
mined both by transcription arrays and by protein secretion are much more variable than
housekeeping genes in the same experiment, suggesting a particularly sensitive and respon-
sive control system. Since fibroblasts under these culture conditions display a wound-heal-
ing phenotype, it is proposed that the high neutrophil attractant expression reflects the role
of fibroblasts in recruiting polymorphonuclear leukocytes to a site of injury. In wounds, the
antimicrobial activity of neutrophils will prevent establishment of bacterial contamination and
the formation of biofilms. Biofilms, if they do form, are resistant to neutrophil attack and also
to antibiotics and other therapeutic agents. It is proposed that this type of bacterial coloniza-
tion is the basis for the development chronic wounds. In replicatively senescent fibroblasts,
which display a phenotype similar to that shown by fibroblasts in chronic wounds, the secre-
tion of the neutrophil recruiting chemokines declines as the fibroblasts approach senescence.
A similar decline in wound fibroblasts, which have been shown to possess a senescence-like
phenotype in skin prone to develop chronic wounds, would lead to decreased antimicrobial
activity, allowing establishment of bacterial biofilms. Bacterial products inhibit the migration
of keratinocytes in a scratch assay. Such inhibition of migration in a wound would prevent
closure and allow development of a chronic wound.
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CD19 expression in B cells is important for suppression of contact hypersensitivity
R Watanabe,1 M Fujimoto,2 N Ishiura,1 Y Kuwano,1 H Nakashima,1 N Yazawa,1 H Okochi,3
TF Tedder4 and K Tamaki1 1 Department of Dermatology, University of Tokyo, Tokyo, Japan,
2 Department of Dermatology, Kanazawa University Graduate School of Medical Science,
Kanazawa, Japan, 3 Department of Regenerative Medicine, International Medical Center of
Japan, Tokyo, Japan and 4 Department of Immunology, Duke University Medical Center,
Durham, NC
Contact hypersensitivity (CHS) is a cutaneous immune reaction mediated mainly by Ag-spe-
cific effector T cells, and regarded as a model for Th1/Tc1-mediated inflammation. However,
recent reports have suggested pivotal roles of B cells in CHS. CD19 is a member of the Ig
superfamily expressed on B cells and follicular dendritic cells, and serves as a positive B-cell
response regulator which defines signaling thresholds critical for B cell responses. In the cur-
rent study, we assessed the role of the B cell-specific surface molecule CD19 on the devel-
opment of CHS through examining CD19-deficient mice. Although CD19-deficient mice are
hyposensitive to a variety of transmembrane signals, CD19 loss resulted in increased and
prolonged reaction of CHS, suggesting an inhibitory role of CD19 expression in the etiology
of CHS. Sensitized draining lymph nodes and elicited ear lesions from CD19-deficient mice
exhibited Th1/Tc1-shifted cytokine profile with increased IFN-γ expression and decreased IL-
10 expression. Adoptive transfer experiments revealed that CD19 expression in recipient mice
was required for optimal suppression of CHS response, indicating its role in elicitation phase.
Furthermore, spleen B-2 cells, especially marginal zone B cells, from wild type mice were
able to normalize exaggerated CHS reactions in CD19-deficient mice. Thus, CD19 expres-
sion in B cells is critical for termination of CHS responses, possibly through the function of
“regulatory B cells”.
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The antimicrobial peptide psoriasin is highly expressed in human mammary glands during
lactation
M Schmidt,1 M Mildner,1 H Rossiter,1 R Gläser,2 JM Schröder,2 J Pammer,3 V Mlitz,1 A Abtin1
and E Tschachler1,4 1 Department of Dermatology, Medical University of Vienna, Vienna,
Austria, 2 Department of Dermatology, University Hospital Schleswig-Holstein, Kiel,
Germany, 3 Department of Pathology, Medical University of Vienna, Vienna, Austria and 4
CE.R.I.E.S., Neuilly, France
Since the antimicrobial peptide psoriasin has been shown to be secreted by eccrine sweat and
sebaceous glands of the skin, we investigated the expression and regulation of psoriasin in
human breast milk and mammary gland cells in vivo and in vitro. By Western blot analysis
we detected high concentrations of psoriasin in human breast milk. Quantification by ELSIA
confirmed these data and revealed that different samples of human breast milk contained
between 50 and 150 ng/ml psoriasin. Immunohistochemical staining of mammary glands
showed little if any positive psoriasin staining in non-lactating mammary glands. In contrast,
psoriasin expression was strongly induced in lactating human mammary gland epithelium. In
addition to these in vivo data, we could demonstrate that stimulation of primary human
mammary epithelial cells with a cocktail consisting of prolactin, dexametasone and insulin
inducing a lactating phenotype of mammary gland epithelial cells in vitro, led to a strong
induction of both psoriasin mRNA and protein expression. High psoriasin production and
secretion by mammary glands could be an important factor for prevention of E. coli infection
of the breast during the lactation period and the high psoriasin concentration in human
breast milk might also represent an important protective factor for breastfed babies.
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Dermal infiltration of monocytes, but not neutrophils, is required for the generation of con-
tact hypersensitivity
S Takeuchi,1,2 F Takeuchi,1,2 M Furue1 and SI Katz2 1 Dermatology, Graduate School of
Medical Sciences, Kyushu University, Fukuoka, Japan and 2 Dermatology Branch, NCI, NIH,
Bethesda, MD
Contact hypersensitivity (CH) is an acquired immune reaction, however involvement of innate
immune elements, such as neutrophils, has been thought to be required for the full develop-
ment of CH. Through gene expression analyses, we found that murine neutrophil chemoat-
tractants, which share a common chemokine receptor, CXCR2, were highly upregulated in
TNCB-painted epidermis during both induction and elicitation of CH. Therefore, to better
understand the role of innate immunity in CH, we used CXCR2 knockout (KO) mice, in which
neutrophil chemotaxis is significantly impaired. CH in CXCR2 KO mice was comparable to
that seen in control littermates, and there was robust infiltration of cells with polymorphic
nuclei in the challenged dermis in all mice. Infiltrating cells were then characterized using
various myeloid markers (CD11b: pan-myeloid, Gr-1 or Ly-6G: neutrophil and F4/80: mono-
cyte/macrophage). Two different myelocytes, CD11b(+)Gr-1(high)Ly-6G(+)F4/80(-) and
CD11b(+)Gr-1(low)Ly-6G(-)F4/80(+) cells, were found in the challenged dermis of control mice
and were considered to be neutrophils and monocytes, respectively. Interestingly, only mono-
cytes infiltrated the dermis in CXCR2 KO mice, while neutrophils were observed only within
vessels. The myeloperoxidase (MPO) assay in situ, which reflected local neutrophil infiltration,
was significantly lower (1/3~1/4) in CXCR2 KO mice compared to controls, validating the
immunohistochemistry findings. Thus, there was no correlation between intensity of MPO and
CH ear swelling. In keeping with other studies, depletion of Gr-1+ cells resulted in a signifi-
cant decrease (P=0.012) in CH. Interestingly, both monocytes and neutrophils were depleted
in the challenged dermis after Gr-1 mAb treatment. Taken together, we conclude that dermal
infiltration of monocytes, rather than neutrophils, is critical for expression of CH.
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A new mechanism for generating TCR diversity: a TCR Jα-like gene that inserts partial
nucleotide sequences in a D-gene manner
CL Reardon,1 L Hu,2 X Yin,3 W Born,3 B Arden4 and R O’Brien3 1 Dermatology, Carl T.
Hayden VA Medical Center, Phoenix, AZ, 2 University of Colorado HSC, Aurora, CO, 3
National Jewish Medical and Research Center, Denver, CO and 4 University of Heidelberg,
Denver, CO
δ-TCR genes of two murine γδ-T cell hybridomas were found to contain an identical 19-nt
sequence in their non-germline N-regions. To determine if this sequence represented a third
murine TCR Dδ gene, genomic PCR was performed by using it as a primer together with primers
for interspersed repetitive elements (IRE). Sequencing revealed that the 19-nt segment is part
of a 61-nt gene with flanking 5’ and 3’ recombination signaling sequences (RSS). Southern
blot analysis confirmed the presence of this 61-nt gene in the genome of several mouse strains.
The gene is unusual in that the distal 24 nucleotides of its 3’ RSS region are contributed by
the 5’ portion of a B2 IRE sequence that includes an apparently non-functional RNA splice
site within the 3’ nonamer sequence. It has sequence similarities with the Dδ1 gene (81%) at
its 5’ end and with Jα genes (73%) overall. Tyramide-FISH analysis identified the gene to exist
within or adjacent to the murine TCR α/δ locus on chromosome 14. Surveys of available TCR
sequences reveal possible partial insertions of the 61-nt gene in other TCR gene sequences.
Thus, the unique 61-nt gene is Jα gene-like in structure but D gene-like in function.
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Inhibition of skin inflammation and serum IgE levels associated with allergic dermatitis in
mice by ‘natural’ CpG-ODN
K Na, H Lee, M Jeon and T Kim Dermatology, Catholic University of Korea, Seoul, South
Korea
Atopic Dermatitis (AD) is chronic pruritic inflammatory skin disorder characterized by increased
total IgE level, inflammatory cell infiltration, and the elevated expression of Th2 cytokines such
as IL-4 and IL-10. The incident of AD is strikingly arising recently. Oligodeoxynucleotides
(ODN) containing CpG motifs (CpG ODN) have been brought to an attention as immunomod-
ulators that reduce Th2-mediated responses via increasing Th1 responses. Although the appli-
cation of CpG-ODN is considering a powerful immunotherapeutic treatment for the Th-2-
mediated diseases, it recently paid attention in harmful side-effects of the treatment. One of
the reasons might be the stable and ‘none-natural’ synthetic phosphorothioate (PS) backbone
of ODN which provides an extremely high degree of nuclease resistance and greatly stabi-
lizes the ODN against degradation. Therefore, we screened ‘natural’ phosphodiester (PO) form
of CpG-ODN in K12 E. coli chromosomal DNA and found several effective CpG-ODN in
terms of NF-KB activation. One of them was tested to determine the effect on Th2-mediated
skin inflammation. Using a mouse model for AD, we first sensitized the mice with Ova pro-
tein to develop the allergic response and then investigated the preventive effect of PO form
of CpG-ODN on this allergic response. In this model, we found that PO form of CpG-ODN
can also significantly prevent the Th2-mediated responses by inhibiting the skin inflammation,
serum IgE level, and antigen-specific IL-4 production whereas IFN-r expression was less
increased compare to the PS form of CpG-ODN. It suggested that this CpG-ODN might have
a less side-effect which is caused by strong induction of IFN-r bias toward Th1 response. There-
fore, this PO CpG-ODN might serve as a good immunotherapeutic tool for AD since this can
significant decrease Th2-responses without (or less) increasing Th1-responses.
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T cell polarizing capacity of aqueous birch pollen extracts (Bet.-APE) and pollen associated
lipid mediators (PALMs) in vivo
J Gutermuth,1 M Bewersdorff,1 C Traidl-Hoffmann,1 J Ring,2 MJ Mueller,3 H Behrendt1 and
T Jakob1,4 1 ZAUM Center for Allergy and Environment, TUM, Techn. Univ. Munich, Munich,
Germany, 2 Dept. of Dermatology and Allergy Biederstein, Techn. Univ. Munich, Munich,
Germany, 3 Julius v. Sachs Inst. of Biosc., Div. of Pharmac. Biol., Univ. Wuerzburg,
Wuerzburg, Germany and 4 Allergy Research Group, Univ. Medical Center Freiburg,
Freiburg, Germany
We recently demonstrated that pollen not only function as allergen carriers but also as a rich
source of bioactive lipids such as phytoprostanes that can modulate human dendritic cell (DC)
function in a way that results in an enhanced T helper (Th) 2 polarisation in vitro. Here, we ana-
lyzed the immunomodulatory capacities of Bet.-APE and pollen associated phytoprostanes in
the murine system in vitro and in vivo. DCs were generated from BALB/c bone marrow, acti-
vated with LPS ± Bet.-APE or phytoprostanes and analyzed for IL12 secretion by ELISA. OVA-
specific T cell responses were assessed using flow cytometry for IL4/IFN-γ production by DO11.10
OVA-specific CD4 T cells cultured with OVA ± Bet.-APE. To overcome the low frequency of
antigen-specific T cells in naïve mice, OVA specific CD4 T cells were adoptively transferred into
BALB/c mice. 24 hrs later mice were challenged intranasally (i.n.) with OVA ± Bet.-APE or phy-
toprostanes. Th polarisation in vivo was analyzed in draining lymph node cells on the level of
cytokine secretion into culture supernatant and cytokine accumulation in DO11.10 CD4 T cells
following ex vivo restimulation with OVA. In vitro Bet.-APE and E1-phytoprostanes dose-depend-
ently inhibited LPS induced IL-12 secretion of DCs; as well, Bet.-APE induced a Th2 polarisa-
tion. I.n. instillation of Bet.-APE together with OVA lead to increased IL4, IL5, IL13- and decreased
IFN-γ-production by antigen specific T cells in the draining lymph node. In contrast, E1- and F1-
phytoprostanes downregulated both Th1 and Th2 cytokine production in vivo. We conclude that
pollen release water soluble factors with Th2 polarizing capacities in vivo. Identification of the
underlying mechanisms may open new approaches for therapeutic intervention.
740
Blockade of ICAM-1/LFA-1 abrogates stress-triggered inflammation via prevention of den-
dritic cell maturation in the skin
RA Joachim,1 B Handjiski,1 R Paus2 and PC Arck1 1 Center of Internal Medicine and
Dermatology, Charité, University Medicine Berlin, Berlin, Germany and 2 Dpt. of
Dermatology, University of Luebeck, Germany, Luebeck, Germany
The skin is an active immunological organ, and serves as a continuous biosensor of multiple
exogenous stressors. Superimposed on this is the impact of endogenous stressors such as per-
ceived stress, which challenges the skin homeostasis and can trigger or aggravate e.g. immuno-
logically mediated dermatoses. We previously reported that the neuropeptide substance P (SP)
is involved in stress-triggered neurogenic inflammation in murine skin. The close spatial asso-
ciation of SP+ nerve fibers with antigen presenting dendritic cells (DC) in various tissues
raises the question of whether exposure to a SP-dependent stressor (sound) alters skin DC func-
tions. Here, we report that DC in the skin of sound-stressed C57BL/6 mice are skewed towards
maturation. This is mirrored by up-regulated DC expression of MHC class II and intercellular
adhesion molecule-1 (ICAM-1). Since the cross talk between costimulatory molecules on DC,
such as ICAM-1, and leukocyte function-associated antigen-1 (LFA-1), on T cells is crucial for
T cell activation and inflammation, we blocked ICAM-1/LFA-1 mediated intercellular adhe-
sion events in our murine model by systemic antibody administration, which abrogated sonic
stress-induced skin inflammation and reduced stress associated keratinocyte apoptosis and
endothelial expression of ICAM-1. In conclusion, these findings suggest that the adaptation
cascade to perceived stress entails enhanced maturation of murine skin DC. In principle,
such adaptation processes to stress may reflect physiological responses, which may promote
the generation of DC-dependent pathogen-specific immune responses at major portals of
microbial entry, such as the skin. However, chronic adaptation to stress may contribute to the
triggering or aggravation of immunodermatoses by this ICAM-1/LFA-1-dependent effect of
stress on DC maturation/activation.
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Effect of microenvironment established by human skin-derived cells on functions of human
monocyte-derived dendritic cells
BI Tóth,1 H Sereg,1 S Benko,2 P Gogolák,2 CC Zouboulis,3 Rajnavölgyi2 and T Biro1 1
Department of Physiology, University of Debrecen, Debrecen, Hungary, 2 Department of
Immunology, University of Debrecen, Debrecen, Hungary and 3 Departments of
Dermatology and Immunology, Dessau Medical Center, Dessau, Germany
Dendritic cells (DCs) are professional antigen presenting cells of the immune system. Among
them, Langerhans cells of the human epidermis can be identified by their CD1a and CD207
(Langerin) positivity (CD1a+ DCs) whereas DCs located in the dermis generally do not express
CD1a (CD1a– DCs). In vitro, human peripheral blood monocytes can be differentiated to imma-
ture DCs which, depending on the actual donor, exhibit variable CD1a positivity. Recent reports
from our laboratories suggest that the expression of DC-specific CD1a expression is strongly
affected by certain lipids. Therefore, in the current study, our goal was to define how human skin
derived cells (sebocytes of the dermis, keratinocytes of the epidermis) affect cellular functions of
DCs. In the presence of conditioned medium of human immortalized SZ95 sebocytes (CM-SZ95),
DCs developed more pronounced “dendrites” whereas the fraction of CD1a+ cells (assessed by
flow cytometry) was dramatically decreased. However, the presence of CM-SZ95 did not induce
cytotoxicity (measured by glucose-6-phosphate-dehydrogenase release) or apoptosis (mito-
chondrial membrane potential) of the cells; actually, it rather increased cell viability (MTT assay).
In addition, the presence of CM-SZ95 significantly elevated the phagocytic activity of DCs which
is a characteristics feature of CD1a– DCs (over CD1a+ DCs). Finally, in contrast to the effect of
CM-SZ95, conditioned medium of human immortalized epidermal HaCaT keratinocytes rather
increased the fraction of CD1a+ cells. Taken together, our findings that conditioned media of
epidermal and dermal cells differentially alter CD1a expression and functional properties of DCs
strongly argue for the key importance of anatomical microenvironment of the human skin in the
development of various subpopulations of DCs.
742
Dysfunction of a killer activity of Epstein–Barr virus (EBV)-infected natural killer (NK) cells
in patients with chronic active EBV infection
K Tsuji, D Suzuki, T Yamamoto, S Morizane and K Iwatsuki Dermatology, Okayama
University, Okayama, Japan
Background: Cumulative evidence supports that EBV-infected T/NK lymphoproliferative dis-
order (LPD) includes hydroa vacciniforme, hypersensitivity to mosquito bite and chronic active
EBV infection (CAEBV). Purpose: In order to characterize the EBV-infected NK cells, we have
established NK cell lines and examined their phenotypes, expression patterns of viral antigens,
and killer activities. Material and methods: A stable NK-like cell line, designated NKED, was
established from a peripheral blood sample of a patient with CAEBV in culture with IL-2 (50
U/ml). A cytological profile of the NK-like cell line was determined by flow cytometry, immunos-
tain and molecular methods. To examine the cytotoxic function, varying numbers of NKED
were assayed by incubating with 51Cr-labelled K562 cells. Results: Immunoblotting and reverse
transcriptase-polymerase chain reaction (RT-PCR) analyses revealed that NKED cells exhib-
ited an EBV latent infection type II, where EBV gene expression was limited to EBNA 1 and
LMP1. Immunophenotypic analysis demonstrated that NKED cells were positive for CD2, CD7,
CD25, CD30, CD56, but negative for CD3, CD4, CD8, CD19, CD20 and CD21 antigens. The
expression level of NK receptor, CD94 was much lower than that of EBV negative CD56+
aggressive NK lymphoma cells (KHYG). Although NKED cells possessed cytotoxic molecules
including granzyme B, the cells had extremely poor cytotoxic activity against NK cell sensi-
tive K562 target cells. In addition, the secretion of TNF-α after stimulation with PMA was
reduced in NKED cells, as compared with that of KHYG cells. Conclusion: These data suggest
that the expansion of this dysfunctional CD56+ NK cell subset reflects the impaired function
of the total NK cell population.
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Flagellin is the principal inducer of the antimicrobial peptide psoriasin in epidermal ker-
atinocytes exposed to Escherichia coli
A Abtin,1 F Gruber,1 M Mildner,1 L Eckhart1 and E Tschachler1,2 1 Dermatology, Medical
University of Vienna, Vienna, Austria and 2 CE. R. I. E. S., Neuilly, France
Epidermal keratinocytes express antimicrobial peptides as a part of the innate immune response.
Recently it has been shown keratinocytes efficiently kill E. coli by secretion of the antimicro-
bial peptide psoriasin (S100A7). Expression of psoriasin is induced by exposure of keratinocytes
to the culture supernatant of E. coli. To investigate the role of pattern recognition receptors of
the toll-like receptor (TLR) family in the regulation of psoriasin expression, we stimulated
human primary keratinocytes (KC) with ligands for TLR1 through TLR9. Real-time PCR and
immunoblot analysis revealed that the TLR5 ligand flagellin strongly induced the expression
of psoriasin mRNA and protein, respectively, whereas all other TLR ligands had no significant
effect. Supernatant from wild-type E. coli, but not from a flagellin-deficient E. coli strain (∆fliC),
strongly induced psoriasin expression in KC. Moreover, reduction of TLR5 expression by siRNA-
mediated knockdown suppressed the ability of keratinocytes to upregulate psoriasin expres-
sion in response to flagellin or E. coli supernatant. Taken together, our data demonstrate that
bacterial flagellin is essential and sufficient for induction of psoriasin expression by E. coli.
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A genetic mouse model for mastocytosis
A Gerbaulet, J Scholten, T Krieg, K Hartmann and A Roers Department of Dermatology,
University of Cologne, Cologne, Germany
Mastocytosis is characterized by enhanced numbers of mast cells infiltrating into skin and
internal organs and is associated with somatic point mutations in the receptor tyrosine kinase
Kit resulting in constitutive activation of Kit receptor signaling. Activating Kit mutations, how-
ever, do not explain the broad clinical heterogeneity of mastocytosis. We introduced a Bac-
terial Artifical Chromosome (BAC)-based transgene containing the entire kit gene along with
abundant flanking DNA into the mouse genome. The transgenic kit sequence contained the
activating point mutation D814V as well as a loxP-flanked transcriptional/translational “stop”
cassette, allowing Cre-mediated induction of transgene expression. KitD814V-transgenic mice
were bred to the hCMV-Cre-line which expresses Cre in all cell types resulting in expression
of the mutated kit gene under the control of its endogenous regulatory elements. Analysis of
KitD814V hCMV-Cre-double transgenic mice originating from different transgenic founder
animals revealed a phenotypic spectrum ranging from cutaneous mastocytosis and malignant
mast cell tumors to embryonic lethality depending on the respective founder line. We are
presently investigating the cause of embryonic lethality observed in some lines and the effect
of cell type-specific expression of the transgenic kitD814V selectively in mast cells, neuronal
cells or melanocytes. This new mouse model will allow insights into the pathogenesis of mas-
tocytosis and the function of Kit in various cell types. It will also be useful for testing of new
therapeutic approaches for mastocytosis.
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Gene expression analysis of malignant T cells isolated from CTCL skin lesions demonstrates
a marked resistance to apoptosis and evidence of chronic TCR stimulation
M Muthukuru, J Shackelton, J Kim, T Kupper and RA Clark Department of Dermatology,
Brigham and Women’s Hospital, Boston, MA
In the early stages of CTCL, malignant T cells are confined to skin and are therefore difficult
to isolate and study. We have isolated the T cells from CTCL skin lesions and compared their
gene expression to T cells isolated from normal human skin using pathway-focused oligo
microarrays. CTCL skin T cells had upregulation of anti-apoptosis genes (HSPA5, TNFRSF1β
and TGFβI) and downregulation of pro-apoptosis genes (IER-1, GDF15, DCC and TNFRSF1A).
Additionally, we found upregulation of LCK and ZAP-70, genes in the TCR signaling path-
way, suggesting that proliferation of malignant CTCL T cells may be driven through TCR sig-
naling. Flow cytometry study of T cells from CTCL skin showed decreased expression of TNFR-
I and FAS ligand compared to normal skin T cells. After treatment with pro-apoptotic agents
TNFα or FAS ligand, CTCL T cells showed decreased caspase activation, indicating decreased
apoptosis. CTCL T cells also upregulated the anti-apoptotic gene HSPA5 by 20-fold after TNFα
treatment and downregulated the pro-apoptotic gene HSPA5 after FAS-ligand treatment,
changes not seen in T cells isolated from normal human skin. In summary, this is the first
study of gene expression using T cells isolated from CTCL skin lesions. We have compared
gene expression of CTCL skin T cells to that of T cells isolated from normal human skin, the
population of cells they should most resemble. This design allowed us to detect significant
defects in apoptosis in CTCL skin T cells. Anti-apoptosis genes were upregulated, and pro-
apoptotic genes were downregulated in CTCL skin T cells both at baseline and after treat-
ment with pro-apoptotic agents. Cellular studies confirmed that CTCL skin T cells were resist-
ant to apoptosis after treatment with FAS ligand or TNFα. Lastly, we found that TCR signaling
genes are upregulated in CTCL skin T cells, suggesting that proliferation of these cells may be
driven through T cell antigen receptor stimulation
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Human BCC is associated with CD4+CD25+Foxp3+ T cells in an immune microenvironment
that includes immature dendritic cells and expression of TH2 cytokines
H Kaporis,1 E Guttman-Yassky,1 M Lowes,1 A Haider,1 J Duculan-Fuentes,1 K Durabi,1
J Whynot-Ertelt,1 A Khatcherian,1 I Cardinale,1 I Novitskaya,1 JG Krueger1 and JA Carucci2 1
Laboratory for Investigative Dermatology, Rockefeller University, New York, NY and 2
Dermatology, Cornell, New York, NY
Basal cell carcinoma (BCC), the most common human cancer, undergoes regression in select
circumstances. However, tumor eradication is rarely complete and the precise mechanisms
responsible for immune mediated regression remain undefined. In the present study we char-
acterized the immune microenvironment associated with BCC. Nodular BCC, adjacent non
tumor bearing skin, and normal skin were studied, characterizing the immune microenvi-
ronment by immunohistochemistry, immunofluorescence, microarray analysis, and RT-PCR.
Our results demonstrated the following: (1) CD4+CD25+Foxp3+ cells were present in and
around the tumor; (2) Immature myeloid dendritic cells (CD11c+ DCs) were abundant in the
tumor microenvironment; (3) Genomic analysis showed differential expression of immune
response genes in BCC vs. adjacent non tumor bearing skin and BCC vs. normal skin; (4)
BCC showed upregulation of IL-4, IL-10, CCL22, CXCL9, and MIP3α; and, IFNγ, IL-17, TGF-
β, CTACK, and SDF-1 were decreased in BCC compared to normal skin. Our findings suggest
an attenuated state of anti-tumor immune response to BCC, possibly contributing to the per-
sistent yet indolent nature of this tumor and the potential therapeutic benefit of immune
response modifiers. A better understanding of the immune microenvironment may facilitate
development of more potent immune based treatment for this and other human carcinomas.
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Does IL-6 in psoriatic lesions reverse the ability of regulatory T cells to suppress effector T
cell proliferation?
WA Goodman, JV Massari, TS McCormick and KD Cooper Dermatology, Univ Hospitals
Case Medical Center, Case Western Reserve Univ, and VAMC, Cleveland, OH
Our findings that the psoriatic regulatory T cell (Treg)-containing population (CD4+CD25high)
is less able to suppress effector T cell (Teff, CD4+CD25-) proliferation, together with data show-
ing modulation of murine Treg activity by IL-6 (Science 2003), led us to hypothesize that IL-
6 in psoriatic plaques may decrease Treg suppression and allow unrestricted Teff cell prolif-
eration. IL-6 production by cultured primary keratinocytes isolated from lesional psoriasis skin
was 905±38 pg/ml by Luminex cytokine array, whereas uninvolved and normal production
was 9±0 pg/ml and 0pg/ml, respectively, at 48h (n=2). IL-6 producing cells were also numer-
ous in psoriasis dermis by immunohistochemical staining. To determine the effect of IL-6 on
human Treg function, we purified Teff and Treg from peripheral blood of healthy volunteers
by flow cytometry sorting and stimulated Teff proliferation with alloantigen. Whereas Teff
proliferation was suppressed by Treg in co-cultures without IL-6, the addition of rhIL-6 plus
sIL-6R (to maximize response) led to a concentration-dependent reversal of Treg suppression
at both 10ng/ml (p=0.003, n=5) and 100ng/ml (p=0.0007, n=5). Because IL-6 is also a prod-
uct of activated dendritic cells, present within psoriatic lesions, we asked whether supernatants
of cultured DC (shown to contain IL-6 by cytokine array) modified Treg activity. Treg sup-
pressive capacity was reversed in Treg/Teff co-cultures incubated with the DC-conditioned
media (mean 24±5 CPMx10-3 in conditioned media versus 6±4 CPMx10-3 in control media,
p<0.05, n=4). IL-6Rα and gp130 are present on both Teff and Treg cells; therefore, loss of Treg
function may occur by IL-6 signaling to either population. Indeed, Teff cells stimulated with
rhIL-6 rapidly phosphorylated STAT3, assessed by western blot, indicating that Teff cells respond
directly to the cytokine. Thus, high levels of IL-6 present in lesional psoriatic skin may limit
the effectiveness of Treg suppression, thereby sustaining chronic T cell activation.
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Disease severity and biomarkers of Th2 polarity are predictive of atopic dermatitis subjects
risk for eczema herpeticum
LA Beck,1 LR Latchney,1 D Zaccaro2 and DY Leung3 1 University of Rochester, Rochester, NY,
2 Rho Inc., Chapel Hill, NC and 3 National Jewish Medical and Research Center, Denver, CO
This study was carried out to establish a database of clinical information and biological sam-
ples on subjects with atopic dermatitis (AD) with and without a history of eczema herpeticum
(ADEH+ and ADEH-, respectively). The objective was to assess whether disease severity (assessed
by either EASI or Rajka and Langeland (RL) subjective scoring systems) or biomarkers of Th2
polarity (serum total IgE, number of positive RAST tests [% RAST pos] or total eosinophil
count [Eos]) were predictive of susceptibility to eczema herpeticum (EH). This is a multi-cen-
ter registry study recruiting AD subjects (1 to 80 yr) that fulfill the Pediatric Consensus guide-
lines (PMID: 14639390) with and without a history of EH. We are presenting preliminary data
from less than one year of recruitment. Total IgE, Eos and EASI were log 10 transformed and
differences between the two groups were evaluated using the two sample t-test for all out-
comes except for % RAST pos where Fischer’s exact test was used. Clinical assessments of
disease severity, EASI and RL, demonstrated that disease severity was greater (p≤0.003) in
subjects with ADEH+ (mean 13.6; n=36 and mean 6.6; n=37, respectively) than ADEH- (mean
7.0; n=131 and mean 5.6; n=132). Total IgE was also significantly (p<0.001) elevated in ADEH+
(mean 6308 kU/L; n=20) compared with ADEH- subjects (mean 1798 IU/ml; n=70). Simi-
larly, Eos were more elevated (p<0.001) in ADEH+ (mean 592 cells/mm3; n=28) as compared
to ADEH- (mean 330 cells/mm3; n=111) subjects. The % RAST pos was also greater (p<0.04)
in ADEH+ (mean 95%, n=19) vs ADEH- (mean 73%; n=51) subjects. Disease severity as
assessed by either scoring systems (EASI and RL) or biomarkers (total IgE and Eos) is predic-
tive of an AD subject’s risk for EH. Markers of Th2 polarity (total IgE, Eos and % RAST pos)
were also helpful in identifying AD subjects’ at risk for EH.
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Imiquimod induced apoptosis in basal cell carcinomas is associate with expression of Toll-
like receptor 7
C Oh,1,3 Y Huh,1,3 S Jwa,1 M Kim,1 K Kwon,1 R Jalian2 and J Kim2 1 Department of
Dermatology, School of Medicine, Pusan National University, Busan, South Korea, 2 Division
of Dermatology, David Geffen School of Medicine, UCLA, Los Angeles, CA and 3 Medical
Research Institute, Pusan National University Hospital, Busan, South Korea
Imiquimod is a member of a novel class of immune response modifiers, which works by using
the toll-like receptor (TLR)-7. Imiquimod 5% cream has proven to be an effective treatment
for external genital warts, superficial basal cell carcinoma, and actinic keratosis. Although the
exact mechanism of antineoplstic action is unknown, imiquimod acts indirectly via cytokine-
mediated stimulation of cellular immune responses against tumor cells. Imiquimod binds with
TLR-7, which is expressed on several immune cells, such as plasmatoid dendritic cell, B cell,
and is thought to act by inducing cytokines, such as interferon-alpha, interleukin-12, and tumor
necrosis factor alpha. These cytokines trigger the immune system to recognize the presence
of a tumor and the associated lesion is ultimately eradicated. But clinical remission is not
always associated with inflammation, other mechanisms may also be involved. Recently, we
discovered that basal cell carcinoma expressed TLR-7 by itself without immune cells. In addi-
tion expression of TLR-7 was increased in response to imiquimod. In basal cell carcinoma
cell line, imiquimod induced overexpression of TLR-7 at 6-hour incubation and also expres-
sion of proinflammatory cytokine, interferon-alpha. Moreover, apoptosis was induced and
increased after 6-hour incubation with imiquimod. These results indicated that imiquimod
induced apoptosis in basal cell carcinomas is associate with expression of TLR-7. And acti-
vation of ASK-1 was detectable after imiquimod treatment in basal cell carcinoma, suggest-
ing that TLR-7-mediated apoptosis involved in MAP kinase-dependent apoptotic pathway.
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Modulation of dendritic cell function by oxidative stress
C Weigert, K Ghoreschi, J Brück and M Röcken Department of Dermatology, University of
Tuebingen, Tuebingen, Germany
Dendritic cell (DC) differentiation determines the outcome of adaptive immune responses by
directing antigen-specific T helper (Th) cells into interferon γ-producing Th1 cells. Innate sig-
nals that activate DC through Toll-like receptors (TLR) modifiy DC maturation and differenti-
ation. Activation of TLR4 by lipopolysaccharid or of TLR9 by unmethylated CpG oligodeoxynu-
cleotide induces a DC phenotype (DC1) that produces large amounts of IL-12 or IL-23 and
promotes Th1 or Th17 responses. In contrast, IL-12- or IL-23-deficient DC2 induce IL-4-pro-
ducing Th2 cells. Thus, innate stimuli that act on DC regulate immune responses to self or for-
eign antigens resulting in autoimmune diseases or allergy. Yet, under physiological conditions,
DC receive TLR-stimulation during infection, a condition that is frequently associated with
the generation of reactive oxygen species (ROS). Importantly, ROS strongly interfere with intra-
cellular signaling and data on ROS regulation show increasing importance in tumor defense.
Therefore, we analyzed the effects of ROS and ROS scavengers on IL-12 and IL-23, produced
by DC and the development of Th1, Th17 or Th2 responses. H2O2 as well as depletion of
intracellular ROS scavenger modulated the production of IL-12 and IL-23 by DC following
stimulation through TLR4 or TLR9. The capacity of DC to produce IL-12 or IL-23 was sup-
pressed significantly. These effects were compensated by exposure to ROS scavengers such as
glutathione or N-acetylcysteine. Moreover, induction of higher ROS levels in DC enhanced
IL-10 production after TLR activation. Functional analysis showed that TLR4- or TLR9-stimu-
lated DC induce Th1 and Th17 differentiation, whereas in the presence of ROS strong IL-4-
dominated Th2 responses were observed. Thus, intracellular levels of ROS or ROS scavenger
modulate TLR-signaling in DC that determines the differentiation of Th1, Th17 or Th2 responses.
www.jidonline.org   S125
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In vivo monitor tumor-host interaction via a novel technique: dermis-based in vivo cell-
trapped system (in vivo DBCTS)
Y Chen,1,2,3 Y Liu,4 D Lee,1,2 C Huang,3 S Chen,6 S Lin,3 RL Gallo1,2 and C Huang1,2,5 1
Division of Dermatology, Department of Medicine, University of California, San Diego, San
Diego, CA, 2 VA San Diego Healthcare Center, San Diego, CA, 3 Department of Clinical
Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei, Taiwan,
4 Moores Cancer Center, San Diego, CA, 5 La Jolla Institute for Molecular Medicine, San
Diego, CA and 6 Institute of Bioloical Chemistry, Academia Sinica, Taipei, Taiwan
Monitoring in vivo tumor growth that involved in tumor-host interaction is always a burning
issue. We have established a novel technique, dermis-based in vivo cell-trapped system (in
vivo DBCTS), using dead de-epidermized dermis as a supporting matrix to trap tumor cells
and in vivo host cells. We employed two fibrosacroma cell lines (a progressive UV-2237 and
a regressive UV-2240 cell) to evaluate whether this system can be used to observe the immune
cell recruitments during tumor-host cell counteracting. Fibrosacroma cell lines were trapped
in in vivo DBCTS by seeding cells in de-epidermized dorsal dermis and then implanted sub-
cutaneously into C3H/HeN mice. Our data indicated that UV-2240 instead of UV-2237 recruited
a significant CD3+ T cell population three days after in vivo DBCTS implantation. The three-
dimensional distribution of tumor cells and CD3+ T cells can be observe when cells were
trapped in a de-epidermized ear dermis. Furthermore, in vivo DBCTS has been applied for in
vivo culturing a human hepatoma Huh-7 cell line in our laboratory. At the end, we proved
this new system can be applied to in vivo anti-cancer drug screening. Overall, the in vivo
DBCTS will provide an important apparatus for researches on systems biology of in vivo cell-
cell interaction.
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CCR2 and CCR7 regulate B16 murine melanoma cell tumorigenesis in skin
L Fang and ST Hwang Dermatology branch, National Cancer Institute, Bethesda, MD
While tumor cell-derived chemokine receptors (CKRs) play several distinct roles in cancer
biology, including enhancement of lymph node (LN) metastasis via CCR7, the role of host
CKRs in anti-tumor responses is unclear. Our previous studies indicated that tumors do not
form in wild type (WT) C57BL/6 mice following dermal inoculation of 1x10e5 B16 cells
transduced with an empty retroviral vector and luciferase (pLNCX2-luc-B16 cells), allowing
us to screen for tumor formation in age-matched WT, CCR1-, CCR2-, CCR6-, CXCR3-, and
CX3CR1-knockout (KO) mice. Of note, 80% of CCR2 KO mice showed tumors in ear skin after
2 wks, whereas the KO and WT mice did not. By flow cytometry, CD45+ cell numbers in ear
skin dermal suspensions were similar in CCR2 (vs. WT) mice although the frequency of
CD45+CD11c+ cells was reduced by 4-5 fold at CCR2 KO tumor sites. To determine if CCR7
has a role in B16 skin tumorigenesis, we inoculated B16 cells transduced with CCR7 and
luciferase (CCR7-luc-B16) in ear skin of WT mice. Surprisingly, >95% of CCR7-luc-B16 cells-
inoculated mice formed skin tumors that were accompanied by cervical LN metastases.
pLNCX2-luc-B16 cells formed neither tumors nor metastases. Both B16 cell lines formed tumors
in SCID-beige mice, implying that host anti-tumor responses controlled B16 tumor growth.
Both cell lines proliferated in skin of WT mice at the same rate until day 7 when control cells
decreased 10-fold by day 11, possibly as a result of host anti-tumor responses. Proliferation
of adoptively transferred transgenic gp100-specific T cells (active against B16 cells) was
increased in LN that contained metastatic CCR7-B16 cells, indicating that LN metastasis did
not suppress the proliferation of tumor-specific T cells. Flow cytometry of inoculated ear skin
at d7 and d12 indicated no significant difference in frequencies of CD45+, CD4+, CD8+, and
CD49b+ leukocytes. Thus, CCR7 enhances B16 skin tumorigenesis without suppressing pro-
liferation of antigen-specific T cells in metastatic LN. Furthermore, CCR2 expression by host
cells is required to suppress tumor formation after implantation of B16 cells.
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γδ TCR-dependent local regulation of cutaneous malignancy
M Girardi,1 R Filler,1 S Roberts,1 J Lewis,1 A Hayday2 and R Tigelaar1 1 Dermatology, Yale
University School of Medicine, New Haven, CT and 2 Immunobiology, King’s College
London, London, United Kingdom
We have previously shown that mice deficient in all γδ T cells are highly susceptible to two-
stage chemical carcinogenesis, and recently demonstrated that intraepithelial γδT cells express-
ing canonical Vγ5Vδ1 TCRs are positively selected by thymically expressed self agonists. To
examine to which degree the anti-tumor effects are dependent specifically on Vγ5Vδ1 TCR
recognition of corresponding ligand by skin-resident γδT cells, control mice and mice rendered
selectively deficient in Vγ5, Vδ1 or both, were compared for their relative tumor susceptibility
after topical DMBA initiation followed by repetitive TPA promotion. Single-chain deficient ani-
mals manifested tumors at a level indistinguishable from normal controls (5.7±1.1 for Vγ5, and
5.3±0.9 for Vδ1, compare to 4.2±0.8 tumors/mouse for controls; NS). In sharp contrast, mice
lacking both chains, i.e. Vγ5Vδ1-deficient, showed marked tumor development (9.9±1.3; P<0.01
vs Vγ5 or Vδ1-deficiency, P<0.0005 vs controls), and at a level comparable to that of γδ T cell
deficient mice (10.3±1.7; P<0.02 vs Vγ5 or Vδ1-deficiency, P<0.002 vs controls). Furthermore,
FVB.Tac mice, which we previously showed lacked Vγ5Vδ1 positive selection in the thymus
and thus are selectively deficient in Vγ5Vδ1 T cells in the skin, exhibited increased tumor
development relative to controls (5.8±0.6 vs 4.0±0.6; P=0.03). To begin to examine the poten-
tial influence of γδ T cells in the peripheral blood lymphocyte (PBL) compartment on cuta-
neous carcinogenesis, tumor-infiltrating lymphocytes (TIL) were examined for the presence of
the two major peripheral populations of γδ T cells: Vγ1+ (associated with T regulatory function)
and Vγ4+ (associated with a T-cell effector function). In contrast to PBLs where the Vγ1+/ Vγ4+
ratio was 5.1±0.7, this same ratio in TILs was 0.2±0.1 (P=0.006). These data indicate that locally
resident Vγ5Vδ1+ T cells regulate cutaneous carcinogenesis via in a TCR-dependent manner,
and that inflammatory Vγ4+ T cells are preferentially recruited into tumor sites.
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P. acnes induces inflammation via TLR2 and upregulates antimicrobial activity in sebocytes
J Phan,1 M Kanchanapoomi,1 P Liu,1 H Jalian,1 K Gilliland,2 A Nelson,2 D Thiboutot2 and
J Kim1 1 Medicine- Dermatology, UCLA David Geffen School of Medicine, Los Angeles, CA
and 2 Dermatology, The Pennsylvania State University College of Medicine, Hershey, PA
Propionibacterium acnes is one of the major factors contributing to the pathogenesis of acne
via induction of inflammatory mediators. The human sebaceous gland is a common site for
the proliferation of P. acnes, part of the normal skin flora that is significantly increased in the
pilosebaceous units of acne patients. However, there is limited evidence regarding sebocytes
and their involvement in the immune response against P. acnes. Given our previous findings
that demonstrate the ability of P. acnes to activate immune cells in a TLR2-dependent man-
ner, we hypothesized that sebocytes can participate in the innate immune response in a sim-
ilar capacity. To address this question, we examined the mRNA levels of TLR1 through TLR10
using the SV40 immortalized human sebocyte cell line (SEB-1). We found remarkable expres-
sion of TLR2, TLR3, TLR4, and TLR6 at baseline. Stimulation of SEB-1 with P. acnes resulted
in the secretion of the proinflammatory chemokine IL-8, which was found to be TLR2-depend-
ent, suggesting that the expressed TLRs are functional. Interestingly, following P. acnes stimu-
lation, sebocytes were shown to upregulate mRNA levels of DEFB4, which encodes the antimi-
crobial peptide human beta defensin-2 (hBD2), indicating that they may also play a direct
role in the defense against P. acnes. Furthermore, we demonstrated that P. acnes also induced
expression of MC5R (melanocortin-5 receptor), a marker of sebocyte differentiation. Taken
together, these data suggest that sebocytes are active participants in the innate immune response
and that P. acnes, through the expression and activation of TLRs on sebocytes, may lead to
innate host defense mechanisms and sebocyte differentiation.
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A novel subset of skin resident dermal dendritic cells that co-express the pattern precogni-
tion receptors CD209 (DC-SIGN) and CD206 (mannose receptor)
A Loncaric, A Miller, S Krutzik, R Modlin and MT Ochoa Dermatology, UCLA, Los Angeles,
CA
Two main populations of dendritic cells are present in normal skin: Langerhans cells (LC)
mainly in the epidmeris and dermal dendritic cells (DDC) in the dermis. Previously, DDC have
been characterized using a polyclonal antibody that recognizes clotting factor XIIIa, however
this is not a specific marker nor methodology. Presently, DDC in normal skin were investi-
gated using monoclonal antibodies, immunoperoxidase and confocal laser microscopy. We
found that dermal cells expressed specific cell markers for dendritic cells (CD1a, CD1b, CD1c,
CD83, CD11c) and monocyte and macrophage markers (CD209 (DC-SIGN), CD206 (man-
nose receptor), CD14, CD16, CD64, CD68). A major population of dendritic appearing cells
located at the level of the capillaries and in the higher part of the reticular dermis co-expressed
CD209 and CD206 but not the other DC or macrophage markers. Fewer in frequency were
classical monocyte/macrophage markers (CD14, CD16, CD64, CD68) followed by DC (CD1a,
CD1b, CD1c CD83, CD11c). These data identify a novel subset of DDC that coexpress the
pattern recognition receptors CD209 and CD206 that are involved in binding microbial poly-
saccharides.
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Repertoire of peripheral human Foxp3+ CD4+CD25high regulatory T cells is highly diverse
and partially overlap the one of CD4+CD25- T cells
N Fazilleau,1 H Bachelez,2 M Gougeon1 and M Viguier1,2 1 INSERM U668, Institut Pasteur,
Paris, France and 2 INSERM U697, Hopital Saint-Louis, Paris, France
The exact size and diversity of naturally arising regulatory T cell (Treg) repertoire is currently
unknown in humans. The aim of this study was to provide an accurate measure of the alpha-
betaTCR repertoire size of human peripheral blood Treg, i.e the precise number of distinct
alphabetaTCR borne by CD4+CD25high Foxp3+ Treg at the periphery at a given time, and to
compare it to the one of CD4+CD25- T cells.For this, we used an innovating method designed
in our group. After sorting CD4+CD25high and CD4+CD25- T cells from peripheral blood
samples of three healthy donors, we determined, by using real-time PCR, the usage of each
24 Vbeta gene segments, together with the usage of each 13 Jbeta . We controlled by spec-
tratyping that the CDR3 length distribution of Vbeta-Jbeta rearrangements was gaussian and
then performed exhaustive sequencing in some given rearrangements. This allowed us to cal-
culate the size of the TCR Vbeta repertoire. By performing similar quantification in Valpha
12.1+ or Valpha 12.1- CD4+CD25high sorted cells, we were able to calculate the size of the
alphabetaTCR repertoire of Treg. We observed that human Tregs use a large unrestricted alpha-
betaTCR repertoire, which size and diversity are closely similar to the ones of CD4+CD25- T
cells, with a mean estimated size of 3.5 x106 distinct alphabetaTCR. We also observe a 30%
overlap between the repertoires of these two CD4+ subsets. Together with already published
studies in mouse, this work emphasizes the intersection between naturally occurring Treg and
effector T cell peripheral repertoires and provides new insights in the homeostasis and differ-
entiation of Treg.
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Migrating skin DCs play a dominant role in T cell priming in recombinant viral vector medi-
ated genetic immunization
Y He,1,2 J Zhang,1 C Donahue1 and LD Falo1 1 Dermatology, University of Pittsburgh,
Pittsburgh, PA and 2 Immunology, University of Pittsburgh, Pittsburgh, PA
Dendritic cells (DCs) are the most effective antigen presenting cells (APCs) for priming naïve
T cell responses. Skin is rich in readily accessible DCs, which makes it an effective target for
immunization. Although it has been proposed that following acquisition of Ag in the periph-
ery, cutaneous DCs mature and migrate to the draining LN where they directly prime naïve T
cells, direct experimental evidence supporting this paradigm is still lacking. In fact, recent
studies suggest that the primary role of migrating skin DCs is to carry Ag to LN resident blood
derived DCs for subsequent cross-presentation. Understanding this mechanistic distinction
may be critical for the rational design of genetic immunization approaches. We have previ-
ously demonstrated that following genetic immunization with recombinant lentivectors, skin
derived DCs are the primary APCs and are able to direct prime naïve T cells, resulting in
remarkably potent and persistent CD8 T cell immune responses. Based on those results, we
propose that unlike wild type virus infections, immunization with engineered recombinant
viral vectors that are rendered defective in replication and non-cytopathic will enable pro-
cessing and presentation by skin DCs. To directly support this hypothesis, we demonstrate
here that following immunization with engineered recombinant adeno and alpha virus vec-
tors skin migrating DCs are the predominant DC subsets capable of priming CD8 T cell
responses. These results support the classical paradigm of cutaneous immune function and
suggest that Ag presentation by skin DCs contributes to the high potency of viral vector-medi-
ated genetic immunization, stressing the importance of cutaneous DC network in generating
protective and therapeuticT cell responses.
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Restoration of T-cell repertoire after complete remission in advanced cutaneous T-cell lym-
phoma
K Yamanaka,2 RC Fuhlbrigge,1 H Mizutani2 and TS Kupper1 1 Dermatology, Brigham and
Women’s Hospital, Boston, MA and 2 Dermatology, Mie University, Tsu, Japan
We have previously reported that the diversity of the T cell receptor repertoire is significantly
reduced in CTCL. Whether this reduction in Tcr diversity of CTCL patients could recover dur-
ing disease remission has not been reported. In this study, we analyzed the complexity of the
peripheral blood Tcr repertoire in three patients with advanced CTCL in whom clinical remis-
sion occurred after therapy. We used b-variable (BV) complementarity-determining region 3
(CDR3) spectratyping analysis and flow cytometry. In these successfully treated patients, the
CDR3 spectratype patterns recovered dramatically over time, indicating “reconstruction” of
the T-cell receptor repertoire. The CD4/CD8 ratio and the percentage of peripheral blood T
cells in the clonal population also returned to the normal range. However, absolute CD4
counts remained below normal. The mechanism for this durable reduction of CD4 counts is
unknown; possible explanations include disruption in lymphoid architecture, which might
disturb normal lymphoid-tissue homeostasis, or impaired production of lymphocyte precur-
sors which may prevent the replacement of CD4+ T cells. Although the number of patients
examined is limited, these observations indicate that CTCL patients that successfully undergo
clinical remission can regain a diverse T cell repertoire. Persistent suppression of CD4 counts,
however, may indicate that these patients remain at some ongoing risk for infection, and sug-
gests that further investigation is necessary.
761
Effector functions of activated inflammatory dendritic cells
G Stary,1 C Bangert,1 M Tauber,2 R Strohal,2 T Kopp1 and G Stingl1 1 Dermatology, Medical
University of Vienna, Vienna, Austria and 2 Federal Academic Hospital Feldkirch, Feldkirch,
Austria
Imiquimod, a synthetic agonist to toll-like receptor (TLR) 7, is being successfully used for the
treatment of certain skin neoplasms but the exact mechanism(s) by which this compound
induces tumor regression is (are) not yet understood. While treating basal cell carcinoma (BCC)
patients with topical imiquimod, we detected, by immunohistochemistry, sizable numbers of
dendritic cells (DC) of both the myeloid (mDC) and plasmacytoid (pDC) type within the inflam-
matory infiltrate. Surprisingly enough, peritumoral mDC stained positively for perforin and
granzyme B, while infiltrating pDC expressed tumor necrosis factor-related apoptosis-induc-
ing ligand (TRAIL). At the same time, BCC cells expressed the apoptosis-inducing receptor
TRAIL-R1 and were MHC Ilo. The biological relevance of DC-mediated effector functions can
be deduced from our further findings that peripheral blood-derived CD11c+ mDC acquired
anti-perforin and anti-granzyme B reactivity upon TLR 7/8 stimulation and could use these
molecules to effectively lyse MHC Ilo cancer cell lines. The same activation protocol led pDC
to kill MHC I– and TRAIL R1-bearing Jurkat cells in a TRAIL-dependent fashion. While sug-
gesting that mDC and pDC are directly involved in the imiquimod-induced destruction of
BCC lesions by distinct mechanisms, our data add a new facet to the functional spectrum of
DC, ascribing to them a major role not only in the initiation, but also in the effector phase of
the immune response.
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The development of CD8+ TC1 and TIL-17 cells is regulated by specific mechanisms
L Wu, D He, H Kim, H Li, CA Elmets and H Xu Dermatology, University of Alabama at
Birmingham, Birmingham, AL
IL-17 plays important roles in many inflammatory diseases which had been considered to be
mediated by IFN-γ producing CD4+ Th1 and CD8+ Tc1 cells. Our recent studies have demon-
strated that CD8+ IL-17 producing T cells (TIL-17) are distinct from IFN-γ producing Tc1 cells
and play important roles in allergic contact dermatitis. Little, however, is known about mech-
anisms for the development of CD8+ TIL-17 cells. We showed here that IFN-γ and IL-12
increased CD8+ Tc1 but inhibited TIL-17 cells which were up-regulated by IL-23. Moreover,
IL-12 mediated suppression of TIL-17 cells was independent of IFN-γ mediated signals and
could not be reversed by IL-23. A defect in Stat1 or T-bet, signal molecules required for Tc1
cell development, significantly enhanced the differentiation of TIL-17 cells compared to wild
type controls. Whereas IL-23 mediated development of TIL-17 cells was not affected, the defect
did impair the ability of IL-12 in the stimulation of Tc1 and suppression of TIL-17 cells. This
suggests that Stat1 and T-bet may play a role in IL-12 mediated signal pathways for the up-reg-
ulation of CD8+ Tc1 and the down-regulation of TIL-17 cells. Western blot analysis indicated
that IL-12 treatment activated Stat1 and Stat4 whereas IL-23 had little effect on the activation
of Stat1, 3, and 4 in CD8+ T cells. However, IL-23 could activate Stat3 in Stat1 deficient
CD8+ T cells, suggesting that Stat1 may inhibit IL-23 induced activation of Stat3 which has
been reported to be important for the development of CD4+ IL-17 producing T cells. In fur-
ther animal experiments, allergen primed CD8+ T cells from Stat1-/-, IL-12Rβ2-/- or IFN-γR-
/- mice produced a higher level of IL-17 than those from wild type controls. The studies demon-
strate that specific mechanisms regulate CD8 Tc1 and TIL-17 cells and signals required for
Tc1 cells suppress the development of TIL-17 cells. Given important roles of Tc1 and TIL-17
cells in immune responses, these data provide new insights into therapeutic strategies for aller-
gic contact dermatitis.
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Non-invasive skin patch and nasal vaccines: A platform facilitates the analysis of protein
immunogenicity and detection of novel antigens
C Huang,1,4 Y Liu,1 S Lin4 and C Huang2,3 1 Moores Cancer Center, University of
California,San Diego, San Diego, CA, 2 Division of Dermatology, Department of Medicine,
University of California,San Diego, San Diego, CA, 3 VA San Diego Healthcare Center, San
Diego, CA and 4 Department of Clinical Laboratory Sciences and Medical Biotechnology,
National Taiwan University, Taipei, Taiwan
Non-invasive vaccination via skin patch and nasal immunization is a well-established modal-
ity in our laboratory for vaccine delivery. Using an intact E.coli particle as a vector-based vac-
cine system, we are able to construct an E. coil vector-based vaccine targeting an anthrax spore
coat-associated protein (SCAP). Mice produced a detectable SCAP antibody after epicutaneous
and intranasal vaccination with gamma-, or ultraviolet (UV)-irradiated E. coil vectors. More
recently, we develop a model system for speeding up the process of identifying vaccine can-
didates. The model system combined the E. coil vector-based vaccine that can express pro-
tein of interest to immunize mice and an antigen microarray for antibody detection. We chose
a well characterized protein, the C fragment of tetanus toxin C fragment (Tet-C) to demonstrate
the system. The Tet-C was cloned and expressed in E. coli using T7 expression system. The
expression of Tet-C protein was confirmed by mass spectrometry and western blot. Immu-
nization was achieved through intranasal application of UV-irradiated Tet-C expressing E. coli
vector-based vaccine without adding exogenous adjuvants. Since only small amount of blood
can be drawn from a mouse, a microarray that spotted with column purified and directly gel-
eluted Tet-C proteins was fabricated for antibody detection. The anti-Tet-C antibody produc-
tion was detectable six weeks after initial immunization and the titer increased two folds at
week ninth. In conclusion, for future application, this platform can be used to search new
vaccine candidates by separating many unknown proteins of pathogens by 2D electrophore-
sis and spotted it on microarray to detect antibody
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An in vitro system of reverse transmigration of human dendritic cells over immortalized
lymphatic endothelial cells
M Torzicky, M Groeger, H Pehamberger and E Riedl Department of Dermatology, Division of
General Dermatology, Medical University of Vienna, Vienna, Austria
Dendritic cells (DC) serve as sentinels of the immune system. In order to fulfill this task DC
have to migrate form the peripheral tissues after antigen uptake to the T cell areas of the drain-
ing lymph nodes. Reverse transmigration of DC over lymphatic endothelial cells (LEC) repre-
sents a critical step in this process, but the mechanisms of DC-LEC interactions are still poorly
explored. Using immortalized human LEC (hTERT-LEC) we established an in vitro system of
abluminal-to-luminal migration of DC over a LEC monolayer. hTERT-LEC were cultured upside
down on collagen-coated transwells and were subsequently activated with tumor necrosis fac-
tor-α (TNFα) or not. Like human LEC in vivo hTERT-LEC expressed the LEC marker molecule
podoplanin (mean±STD: 97.3±5.3%) and the adhesion molecule CD31 (97.0±1.57%). Stim-
ulation of hTERT-LEC with TNFα enhanced podoplanin mean fluorescence intensity (MFI)
and down-regulated CD31 expression levels in a time dependant manner. The proportion of
hTERT-LEC expressing the adhesion molecules ICAM-1 (13,5% versus 97,8%) and VCAM-1
(5,9% versus 27,6%) significantly increased upon TNFα stimulation. In this system the ablu-
minal-to-luminal migration of monocyte-derived DC over a hTERT-LEC monolayer was ana-
lyzed by FACS and visualized by laser scan microscopy (LSM). Activation of LEC monolayer
with TNF-α led to a fourfold increase of migrated immature DC compared to non-stimulated
TERT-LEC. A considerable proportion of immature DC expressed the chemokine receptors
CXCR4. Accordingly, supplementation of the transmigration system with the chemokine CXCL12
further enhanced DC migration. Interestingly, the addition of TNFα to SDF-1 supplemented
assays decreased DC migration. These data suggest that cam-dependent and chemokine-
dependent mechanisms may differentially regulate DC-LEC interaction and DC transmigra-
tion in this system.
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The Src kinase, Lck regulates differentiation of TH2 T cells
PL Stein, K Kemp and L Guzman Dermatology, Northwestern University, Chicago, IL
The prevailing view of T cell receptor engagement invokes a role for the tyrosine kinase Lck
in initiating the signaling cascade leading to activation of the T cell. Recent studies indicate
that this model is overly simplistic and that the related kinase, Fyn, can provide the necessary
signals. We have used genetically modified mice that lack Lck only in mature T cells to iden-
tify other potential roles for this kinase in regulation of T lymphocytes. Purified CD4+ T cells
from wt or lck mutant mice were cultured under conditions that promote differentiation into
either the proinflammatory (IFNγ secreting) TH1 or anti-inflammatory (IL-4 producing) TH2 lin-
eages. Under TH2 conditions, the mutants fail to produce IL-4, but instead make IFNγ. In con-
trast, the mutants were indistinguishable from wt in a TH1 polarizing environment. Thus Lck
is selectively required for TH2 development. Lck activates the downstream kinase Itk, and itk
mutants also exhibit defective IL-4 production by TH2 cells. However, this can be overcome
by culturing itk mutants with ionomycin to elevate intracellular calcium. In contrast, iono-
mycin does not restore IL-4 synthesis in the Lck deficient cells, indicating that the underlying
defect in lck mutants is distinct from a failure to activate Itk. Differentiation of TH1 and TH2
cells are dependent on expression of the transcription factors Tbet and GATA-3, respectively.
The lck mutant TH2 cells have slightly reduced levels of GATA3 but elevated levels of Tbet rel-
ative to wt cells. This suggests that Tbet may interfere with GATA3 function, which could pre-
clude proper differentiation. Together, these data highlight a previously unappreciated role
for Lck in controlling development of TH2 cells. Moreover they suggest that specific inhibitors
of Lck may have therapeutic benefits for TH2 dominated cutaneous diseases, such as atopic
dermatitis.
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Toll-like receptor-induced IL-15 triggers a vitamin D3-dependent antimicrobial activity in
human macrophages
SR Krutzik,1 J Robles,1 M Hewison,2 K Corcoran,1 D Montoya,1 P Liu,1 J Adams2 and
R Modlin1 1 Medicine, UCLA, Los Angeles, CA and 2 Cedars-Sinai, Los Angeles, CA
Toll-like receptors (TLRs) are an integral component of the innate host defense, triggering mono-
cytes to differentiate into macrophages by secretion of IL-15 and into dendritic cells by secre-
tion of GM-CSF. Here we investigated the cell type and mechanism of the TLR-induced, vita-
min D-dependent antimicrobial activity against intracellular M. tuberculosis. We found that
the TLR2/1-mediated induction of CYP27b1 and the VDR in human monocytes was depend-
ent on IL-15, but not GM-CSF. Furthermore, we found that IL-15 but not GM-CSF was suffi-
cient to induce CYP27b1 and the VDR in monocytes. Next we found that IL-15-derived CD209+
macrophages but not GM-CSF-derived CD1b+ dendritic cells upregulated CYP27b1 activity
as demonstrated by their ability to convert the vitamin D prohormone 25D3 to 1,25D3. Finally,
in IL-15-derived macrophages, 25D3 triggered induction of the antimicrobial peptide cathe-
licidin and an antimicrobial activity against intracellular M. tuberculosis. Together, our data
suggest that the TLR2/1-mediated induction of the vitamin D-dependent antimicrobial path-
way is dependent on the production and direct actions of IL-15.
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Human vitamin D3-induced antimicrobial activity against Mycobacterium tuberculosis is
dependent on cathelicidin
PT Liu, D Tang and RL Modlin Division of Dermatology, University of California, Los Angeles,
Los Angeles, CA
One third of the world’s population is infected with Mycobacterium tuberculosis; however,
little is known about human host defense mechanisms against this bacterium. We have pre-
viously demonstrated that activation of monocytes through TLR2/1 in the presence of suffi-
cient vitamin D3 prohormone (25D3)-induces expression of the antimicrobial peptide cathe-
licidin, mediated through the conversion of 25D3 into the active hormone (1,25D3).
Furthermore, these conditions lead to a VDR-dependent antimicrobial activity against M. tb.;
but the role of cathelicidin is unclear. Furthermore, given that UV absorption in the skin is
responsible for the majority of vitamin D production; modern living has reduced exposure to
UV light resulting in increased incidences of vitamin D deficiency. Low levels of vitamin D
may result in increased susceptibility to infections; therefore understanding the vitamin D-
mediated immune mechanisms may help us develop new therapies. We hypothesize that cathe-
licidin plays a critical role in the 1,25D3-induced antimicrobial activity, and to address this
we utilized the human monocytic cell line THP-1 and siRNA. First, we establish that stimula-
tion of THP-1s with 1,25D3 results in cathelicidin mRNA and protein as well as antimicrobial
activity against M. tb.. Using siRNAs specific for cathelicidin, we efficiently knocked down
the expression of 1,25D3 induced cathelicidin at both the mRNA and protein levels, whereas
a nonspecific siRNA control had no effect. Finally, 1,25D3-induced antimicrobial activity
was completely ablated in the presence of siRNA against cathelicidin. Taken together, these
data demonstrate that cathelicidin is critically for important host defense against M. tb., and
may represent a novel avenue for TB treatment.
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Suppression of chronic picryl chloride-induced contact hypersensitivity responses by IL-4/IL-
13 dual inhibitor but not IL-4 inhibitor
T Morioka,1 K Yamanaka,1 H Mori,1 Y Omoto,1 K Tokime,1 M Kakeda,1 I Kurokawa,1
Y Yasutomi2 and H Mizutani1 1 Mie University, Graduate School of Medicine, Tsu, Japan and
2 Departments of bioregulation, Mie University, Graduate school of Medicine, Tsu, Japan
Atopic dermatitis (AD) is a chronic dermatitis with Th2 type cytokine profile. To control chronic
dermatitis with Th2 type cytokine profile, we have treated AD model mice with repeated elic-
itation of picryl chloride-induced contact hypersensitivities using IL-4 DNA and IL-4 mutant
DNAs those block IL-4/IL-13 (IL-4 double mutant), IL-13 alone (IL-4 single mutant). Mice devel-
oped chronic dermatitis with Th2 cytokine profile 2 weeks after elicitation. Mice treated with
IL-4 and IL-4 single mutant developed dermatitis. However, the dermatitis in IL-4 double mutant
treated mice was significantly suppressed and dermatitis did not exacerbate from second to 5
weeks. In mouse atopic dermatitis models, IL-13 has been pointed as a key cytokine. The
present data strongly suggests suppression of IL-13 alone is insufficient to control Th2 type
chronic dermatitis, but simultaneous suppression of IL-4/IL-13 signal successfully controlled
Th2 type chronic dermatitis. IL-4 double mutant DNA treatment is a potent therapy for con-
trol of atopic dermatitis and related diseases.
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Lysosomal thiol reductase GILT is essential for MHC class II-restricted processing of melanoma
antigen TRP-1
K Hastings,1 K Irvine,2 P Antony,3 N Restifo2 and P Cresswell4 1 Department of Basic Medical
Sciences, University of Arizona College of Medicine, Phoenix, AZ, 2 Surgery Branch, National
Cancer Institute, National Institutes of Health, Bethesda, MD, 3 Johns Hopkins University
School of Medicine, Baltimore, MD and 4 Department of Immunobiology, Yale University
School of Medicine, New Haven, CT
Presentation of tumor antigens in the context of MHC class II is essential for the activation of
CD4+ T lymphocytes, durable CD8+ cytotoxic T lymphocyte responses and effective humoral
responses. Melanocyte differentiation antigens including tyrosinase, tyrosinase-related protein
(TRP)-1, TRP-2 and pmel-17/gp100 are melanosomal integral membrane proteins involved in
melanin biosynthesis. Melanosomal membrane proteins contain a dileucine-based sorting sig-
nal which serves to target these antigens to the endocytic pathway leading to presentation by
MHC class II. Gamma-interferon inducible lysosomal thiol reductase (GILT) is hypothesized
to facilitate the generation of class II binding peptides by reducing proteins in the endocytic
compartment and exposing epitopes for class II binding. Here, we demonstrate that primary
GILT-deficient B cells are unable to process TRP-1 from tumor cell lysates to present a class
II-restricted TRP-1 epitope in vitro. The localization of TRP-1 to the class II loading compart-
ment and the presence of internal disulfide bonds in TRP-1 likely explain this result. Further-
more, in a mouse model of auto-immune vitiligo, the absence of GILT delays the onset of dis-
ease. The onset of vitiligo correlates with T cell activation. A larger number of TRP-1-specific
T cells are seen in the periphery of GILT-deficient mice and may indicate a defect in periph-
eral tolerance in the absence of GILT. Therefore, reduction of melanocyte/melanoma antigens
by GILT is likely to be important in the development of an anti-melanocyte response in vitiligo
and in the immunotherapy of melanoma.
768
The detection of 4 kinds of virus DNA in scleroderma skin tissue
T Ohtsuka Department of Dermatology, Dokkyo Medical University Koshigaya Hospital,
Koshigaya, Japan
Several virus infection have been indicted to be one of the triggers for the occurrence of sys-
temic sclerosis (SSc). In the present study, we tried to detect the DNA for Epstein-Barr (EB)
virus, cytomegalovirus, human parvovirus (HPV) B19 and human herpes visus-6 (HHV6). We
used polymerase chain reaction for the detection. We studied normal controls, SSc, systemic
lupus erythematous, dermatomyositis, morphea and Graft-versus-Host disease. No EB virus
was found in all the subjects studied. The occurrence rate of cytomegalovirus DNA in SSc
(4/47%, 8.5%) showed no significant difference with that of normal controls (5/97%, 5.1%).
The occurrence rate of HPV B19 DNA in SSc (50/97, 51.5%) was significantly elevated com-
pared with that of normal controls (53/97, 54.6%) (P<0.02). The occurrence rate of HHV-6
DNA in SSc (27/29, 93.1%)was significantly elevated compared with that of normal controls
(37/52, 71.2%) (P<0.05). These results showed possible involvement of HPV B19 and/or HHV-
6 DNA for the occurrence of SSc.
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Myxoma virus attenuates cytokine/chemokine production in epidermal dendritic cells in
response to lipopolysaccharide (LPS) and the role of M141R (a viral CD200) in immune reg-
ulation in dendritic cells
T Parikh,1,2 P Dai,3 M Stanford,4 G McFadden,4 S Shuman3 and L Deng1,2 1 Dermatology
Service, Memorial Sloan-Kettering Cancer Center, New York, NY, 2 Dermatology, Weill
Medical College of Cornell University, New York, NY, NY, 3 Molecular Biology Program,
Sloan-Kettering Institute, New York, NY and 4 Microbiology and Immunology Program,
University of Western Ontario and Robarts Research Institute, London, ON, Canada
Myxoma virus is a rabbit specific poxvirus which holds promise as oncolytic therapy for human
cancers . Myxoma and vaccinia virus (used for smallpox vaccination) share similarities in
immunomodulatory genes in their genomes. For example, both encode several known Toll-
like receptor (TLR) inhibitors and secreted CC-chemokine-binding proteins. We conducted a
comparative study of the immunomodulatory effect of myxoma and vaccinia viruses in an
epidermal dendritic cell line XS52, which is derived from Balb/c neonatal mice epidermis.
We found that myxoma virus infection in XS52 cells was nonpermissive. Viral late proteins
were not expressed in infected cells. Myxoma virus exerted less inhibitory effects on the pro-
duction of cytokines/chemokines in response to LPS than vaccinia virus. Myxoma virus infec-
tion alone induced the production of CXCL10. Myxoma infection in primary murine Langer-
hans cells (LCs) significantly attenuated antigen-specific activation of T cells, however, this
effect was less pronounced than vaccinia virus. Western blot analysis revealed that myxoma
but not vaccinia virus infection in XS52 cells or BSC40 cells (a monkey kidney cell line) lead
to activation of NF-κB signaling through degradation of IκBα. Myxoma virus M141R encodes
a viral CD200 which has been implicated in down-regulation of macrophages and T-cell
activation in vivo. Using a myxoma strain with M141R gene deleted, we observed partial
restoration of immune responses in XS52 cells and LCs, which indicate that M141R plays an
inhibitory role in epidermal dendritic cells.
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Cure rate and duration for complete cure in onychomycosis according to the extent of nail
involvement
J Kim, M Kang and H Yu Dermatology, Hanyang University Guri Hospital, Guri City, South
Korea
Onychomycosis is one of the most common diseases of nails, accounting for 50% of all nail
problems and a rise in the prevalence of onychomycosis has been currently noted. Despite
enormous advances in the treatment of onychomycosis in recent years, many factors such as
the extent of involvement, affect the cure rate and duration for complete cure. Complete cure
of onychomycosis requires long-term treatment with a systemic antifungal agent. Therefore,
to assess the complete cure of onychomycosis in terms of cure rate and duration, according
to the extent of nail involvement, it requires a long follow-up. Between December 2000 and
December 2006, 909 patients with onychomycosis were treated with antifungal agents in
our department. Medical records of these patients were reviewed retrospectively to obtain the
following information: diagnosis, age when treatment commenced, sex, presence of other sys-
temic diseases, extent of nail involvement through the photographs, route of administration
(oral, topical, combination therapy), duration for complete cure. After the end of treatment,
patients underwent 2-year-follow-up to examine the relapse or re-infection of onycomycosis.
We found that the extent of nail involvement might influence the cure rate of onycomycosis.
This study provides the data of the cure rate and duration to be recovered according to the
variable factors including extent of nail involvement. Therefore it helps expecting the result
of treatment and making the adequate treatment plan.
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Vaccination with CJ9-gD, a replication-defective and dominant-negative herpes simplex virus
type 1 (HSV-1), induces protective immunity against genital herpes
R Brans and F Yao Surgery/Plastic Surgery, Brigham and Women’s Hospital, Boston, MA
Genital herpes is mainly caused by HSV-2, but recently it has been reported that rising num-
bers of primary infections are due to HSV-1. Thus, there is a great need for a vaccine against
both HSV-1 and HSV-2 genital infections. CJ9-gD is a novel HSV-1 recombinant expressing
UL9-C535C, a dominant-negative form of HSV-1 origin of replication binding protein UL-9,
which is capable of inhibiting both HSV-1 and HSV-2 DNA replication. It also has a deletion
in the essential UL9 gene and encodes an extra copy of the HSV-1 glycoprotein D (gD), the
major antigen of HSV-1, under the control of the tetO-bearing hCMV immediate-early pro-
moter. Thus, CJ9-gD is completely replication-defective, dominant-negative, and expresses
high levels of gD immediately following infection. Additionally, no CJ9-gD viral DNA can be
detected in trigeminal ganglia after corneal or intranasal infection of mice. These unique prop-
erties make CJ9-gD a much safer and more efficient vaccine against HSV than traditional repli-
cation-defective HSV recombinants. We have tested the efficacy of CJ9-gD as a prophylactic
vaccine against wild-type HSV-1 and HSV-2 in a mouse model of genital infection. Immu-
nization with CJ9-gD induced strong immune responses against both HSV-1 and HSV-2. Specif-
ically, after challenge with wild-type HSV-1 or HSV-2, the amounts and duration of challenge
virus replication in the vagina of immunized mice were significantly lower than in mock-vac-
cinated mice. Immunized mice were completely protected from development of local geni-
tal lesions and exhibited no signs of systemic disease after challenge with HSV-1 or HSV-2,
while all mock-vaccinated mice developed severe genital lesions associated with high mor-
tality. In conclusion, we have generated a gD-expressing replication-defective and dominant-
negative HSV-1 recombinant that can elicit strong and effective protective immune responses
in mice against primary genital HSV-1 and HSV-2 disease.
772
Human keratinocytes modulate Treg phenotype and function via ICAM-1 and B7-H1
BJ Nickoloff, Y Geng, GJ Abood and J Qin Pathology, Loyola, Maywood, IL
The ability of skin to influence regulatory T cells (Treg) is poorly understood. Epidermal ker-
atinocytes (KCs) may initiate inflammatory cutaneous reactions via production of pro-inflam-
matory cytokines. To determine if KCs may also dampen or inhibit inflammatory and immune-
mediated reactions, we explored whether KCs can modulate Treg numbers and function. Using
polyclonal T cell activating agent, bacterial superantigen (SEB) the phenotype and function of
Tregs was assessed using either untreated or IFNγ treated KCs as accessory cells. While T cells
exposed to SEB alone expressed low- to no- CD25 or FoxP3, addition of cultured human KCs
enhanced CD25 and FoxP3 levels after four days of coincubation by FACS in CD4+ T cells
(14+/-6% strongly double positive for CD25/FoxP3;n=4). When KCs were pretreated with IFNγ
(10 ng/ml, 48 hrs) then washed and mixed with T cells, a greater induction of Tregs was detected
in CD4+ T cells (35+/-9% CD25/FoxP3 positive) and accompanied by enhanced IL-10 levels.
FoxP3 mRNA level measured by RT-PCR and was consistent with FACS analysis. Functional
activity was assessed by adding CD4+/CD25+ cells purified from co-cultures of T cells with
either KCs or IFNγ treated KCs and SEB, thereby inhibiting autologous CD4+/CD25- cell pro-
liferation when stimulated by allo-antigen presenting cells (approximately 85% inhibtion at
1:4 ratio of Treg:effector T cells). The molecular mechanism for enhanced Tregs was found to
involve direct contact (elimination of FoxP3 expressing Tregs using trans wells) as well as LFA-
1 and ICAM-1 as blocking abs (but not control IgG) reduced Treg production. Screening other
IFNγ inducible surface antigens revealed blocking of B7-H1 augmented Treg production (approx-
imately 1.5-2 fold Tregs in PD-1+ T cells). Thus, skin via epidermal KCs can afford local pro-
tection from T cell mediated assaults by modulating Tregs. Taken together, these results indi-
cate that KCs can modulate the phenotype and function of Tregs and provide new molecular
targets for diseases with altered Tregs and a bacterial infection association, including graft
versus host disease and psoriasis.
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The different roles of E6 and E7 of human papilloma virus 6 in HaCaT cells
Y Dang,1 L Sun,2 H Ma1 and Y Liu2 1 Department of Dermatology, Airforce General Hospital
of Chinese People’s Liberation Army, Beijing, China and 2 Centre of Dermatology of Chinese
PLA, XiJing Hospital,The Fourth Military Medical University, Xi’an, China
High-risk HPV E6 and E7 proteins have the ability to abrogate growth and differentiation con-
trols that would otherwise prevent epithelial cell growth and block viral propagation. In con-
trast, the physiological roles of the low-risk E6 and E7 proteins remain unclear. We are still
not sure whether the low-risk E6 and E7 have the similar ability or not. In order to study the
biological activities of low risk papillomavirus E6 and E7.The retrovirus vector pLXSN-HPV6
–E6 and pBabe-HPV6 –E7 were constructed . After the retrovirus plasmid was packaged by
PA317, the HaCaT cells were infected with these retroviruses and selected with G418 and
puromycin respectively. the controls were their corresponding empty plasmid transduced cells.
Using MTT assay and/or flow cytometer, we detected the cell proliferation and apoptosis.
Cell proliferation of HPV6-E7 transduced HaCaT cells was increased as compared to the con-
trol cells by using MTT assay. Flow cytometry analysis showed HaCaT cells expressing HPV6-
E7 had a significant proportion of cells progressing into the S phage and the percentage of cells
in G1 stage was decreased. In contrast, the growth of HPV6 E6 transduced HaCaT had no dif-
ference compared with the control cells. After the double stain of PI and annexin V FITC, we
can see that less apoptosis cells could be seen in the HPV6 E6-expressing cells group, While
HPV6-E7 expressing cells showed no significant difference to the empty plasmid control. Our
study shows the major role of HPV6 E7 lies in dysregulating cell life cycle whereas the func-
tion of HPV6 E6 is associated with inhibiting apotosis. The results above suggests that HPV6
E6,E7 play different roles in the development of hyperplasia lesion.
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LILRA2 activation impairs differentiation of monocytes into dendritic cells: evidence from
leprosy skin lesions
DJ Lee,1 PA Sieling,1 MT Ochoa,1 RJ Carbone,1 SR Krutzik,1 TH Rea,2 M Colonna3 and
RL Modlin1 1 Medicine, UCLA, Los Angeles, CA, 2 Dermatology, USC, Los Angeles, CA and
3 Pathology and Immunology, Washington University, St. Louis, MO
The leukocyte immunoglobulin-like receptor A2 (LILRA2, previously known as ILT1 or LIR7)
has been shown to alter TLR-induced cytokine production and antimicrobial activity in mono-
cytes. Consistent with the differential expression of LILRA2 mRNA in the different forms of lep-
rosy, we found increased LILRA2 protein expression in skin lesions of the progressive lepro-
matous form vs. the self-healing tuberculoid form. Double immunolabeling of lepromatous
skin lesions revealed that LILRA2 is expressed on CD68+ macrophage-like cells. Treatment of
peripheral blood monocytes with an agonist anti-LILRA2 monoclonal antibody impaired
GM-CSF induced dendritic cell differentiation and maturation in terms of diminished MHC
class II, CD1b, CD40 and CD206, no change in CD209 and increased CD14 expression. Fur-
thermore, anti-LILRA2 treatment inhibited functional DC differentiation, in terms of antigen-
presenting capabilities to CD1- and MHC class II-restricted T cell clones. Given that lepro-
matous leprosy patients exhibit T cell unresponsiveness to Mycobacterium leprae, the the
ability of LILRA2 to inhibit DC differentiation and function provides a potential mechanism
for impaired cell-mediated immunity in leprosy.
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Skin mast cells provide defense against invasive bacterial infection
A Di Nardo, K Yamasaki, RA Doeschner and RL Gallo Medicine-Dermatology Section,
University of California San Diego, La Jolla, CA
Mast cells (MC) express cathelicidins (Caths), peptides that act as antibiotics by killing microbes.
We hypothesized that presence of MC, and their expression of Cath, will influence skin infec-
tions. To evaluate this, MC-deficient mice (c-Kit wsash KO) were compared to normal con-
trols for resistance to invasive Group A Streptococcus (GAS). Compared to controls, C-Kit
wsash KO had 30% larger lesions, 80% more lesional bacteria and 30% more bacteria in the
blood 4 days after subcutaneous (sc) injection with GAS. To determine if these differences were
due to the presence of MC, and determine the relative role of Caths, we reconstituted the skin
of c-Kit wsash KO with MC derived from the bone marrow of either wild type or Cath defi-
cient mice (Cnlp-/-), and challenged them with GAS, 2 weeks after MC transplant. At 48
hours after GAS injection mice that did not receive MC had an average lesion size of 250sqmm.
Mice reconstituted with wild type MC showed lesions comparable with normal (10sqmm)
while the mice reconstituted with Cath deficient MC showed a lesion size of 200sqmm. This
Cath-dependent susceptibility to infection also resulted in greater systemic bacteremia as
spleens recovered from these mice showed an increase in bacterial load. To better define the
role of MC in controlling invasion, we designed a model in which bacterial entry is from the
surface rather than injected. GAS bacteria were grown at 2.1*10E5/ml into a THB gel and
applied for 18 hours to the surface of either C-Kit wsash KO mice or normal littermates. The
gel was removed and skin washed and sampled to measure bacteria. In contrast to the data
obtained when the GAS was injected sc, no significant differences were noticed between
groups, indicating that MC activity is after barrier penetration. On the other hand, mice that
lack Cath in keratinocytes show increased topical GAS survival. These results show for the
first time that MCs in the skin provide defense against bacterial infection, a function mediated
in part by the expression of cathelicidin antimicrobial peptides.
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Chitosan nanoparticles: Agent for topical treatment of cutaneous inflammatory and infec-
tious diseases
AJ Friedman,1,5 J Phan,1 D Tang,1 A Oren,2,4 R Modlin1,2 and J Kim1,4 1 Division of
Dermatology, Department of Medicine, David Geffen School of Medicine, UCLA, Los
Angeles, CA, 2 Microbiology, Immunology, Molecular Genetics, David Geffen School of
Medicine, UCLA, Los Angeles, CA, 3 Dermatology, West Los Angeles Veterans Administration
Medical Center, Los Angeles, CA, 4 Pulmonary & Critical Care Medicine, West Los Angeles
Veterans Administration Medical Center, Los Angeles, CA and 5 Medicine, New York Hospital
of Queens, Queens, NY
Nanoparticles have thus far demonstrated excellent medicinal controlled delivery and stabi-
lization. Using nanoparticles which are nontoxic, biodegradable, and biocompatible as the
actual therapeutic is the ideal next step. We developed and investigated the potential of chi-
tosan nanoparticles as an anti-inflammatory agent, as demonstrated by the suppression of P.
acnes induced inflammatory cytokine IL-12p40. We further demonstrated that not only do chi-
tosan nanoparticles have anti-inflammatory properties, but also antimicrobial action. CFU
assays of P. acnes, E. coli, and S. aureus treated with these nanoparticles demonstrated effec-
tive killing impact with increasing concentrations. We evaluated the mechanism of bacterici-
dal killing of the nanoparticles via SEM/TEM imaging, which demonstrated that chitosan
nanoparticles induced disruption of the bacterial cell membrane. Together, these data suggest
that chitosan nanoparticles could be used for both inflammatory and infectious dermatologi-
cal conditions.
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Pimecrolimus enhances innate immune function of normal human keratinocytes
AS Büchau,1 J Schauber,1 N Au,1 A Stütz2 and RL Gallo1 1 Department of Dermatology,
University of California San Diego and VASDHS, San Diego, CA and 2 Novartis Institutes for
Biomedical Research, Vienna, Austria
Recent studies suggest that innate and adaptive immunity are controlled by distinct and some-
times contrasting mechanisms. Calcineurin inhibitors inhibit elements of the adaptive immune
system, i.e. T-cell activation and cytokine release, and are effective drugs for inhibition of
inflammation in the skin. However, the effects of calcineurin inhibitors on innate immunity
are unknown. Therefore, we asked if the calcineurin inhibitor pimecrolimus affects the innate
immune response of the epidermis by assessing the ability of cultured human keratinocytes
(NHEK) to kill bacteria, express Toll-like receptors (TLRs), and produce antimicrobial peptides
(AMPs). In contrast to its immunosuppressive effects on adaptive immune responses, pime-
crolimus (10nM) increased the ability of NHEK to kill Staphylococcus aureus mprF in culture
(p<0.05), and stimulated an increase in TLR1 (320%, p<0.05) TLR2 (190%, p<0.05), and
TLR6 (440%, p<0.05) as measured by qPCR. In response to the TLR2/6 ligand Malp-2, and
the TLR2/1 ligand LTA, pimecrolimus also increased NHEK expression of cathelicidin AMP
mRNA (890%, p<0.01 and 530%, p<0.05) and enhanced immunostaining for the peptide.
The induction of cathelicidin mRNA by pimecrolimus and Malp-2 was further enhanced by
250% with the addition of 1nM 1,25 vitamin D3. Furthermore, pimecrolimus increased human
beta defensin-2 (HBD2) and HBD3 by 740% (p<0.05) and 800% (p<0.01) each over Malp-2
alone. The response to other TLR ligands remained unchanged. In conclusion, pimecrolimus
surprisingly enhanced the innate immune function of keratinocytes, demonstrating differen-
tial effects on innate immune and adaptive immune responses. Further studies are needed to
validate these findings in vivo, and may possibly provide a novel explanation for the clinical
effects of this drug.
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Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D
dependent mechanism
J Schauber,1 RA Dorschner,1 AB Coda,1 AS Büchau,1 B Brouha,1 PT Liu,2 D Kiken,1
YR Helfrich,3 SW Kang,3 HZ Elalieh,4 A Steinmeyer,5 U Zügel,5 DD Bikle,4 RL Modlin2 and
RL Gallo1 1 Div. Dermatology, UCSD, San Diego, CA, 2 Div. Dermatology, UCLA, Los
Angeles, CA, 3 Dept. Dermatology, University of Michigan, Ann Arbor, MI, 4 Dept. Medicine,
UCSF, San Francisco, CA and 5 Schering AG, Berlin, Germany
The innate immune response to injury or infection relies on the capacity to recognize microbes and
stimulate production of antimicrobial peptides (AMP). In this study we investigated how Toll-like-
receptors (TLR) and AMP are controlled by injury. Keratinocytes surrounding a 24 hr aseptic human
wound increased expression of CD14 (8-fold) and TLR2 (5-fold) by qPCR, accompanying a large
and previously known increase in cathelicidin AMP (hCAP18). hCAP18 and CD14 were known to
be induced by 1,25OH vitamin D3 (1,25D3), and analysis of TLR2 expression revealed this also
was induced by 1,25D3. Topical 1,25D3 application to human skin confirmed these results, show-
ing increased hCAP18 and TLR2 by immunostaining. Furthermore, 1,25D3 enabled keratinocytes
to respond to Malp2 (a TLR2/6 ligand) with increased cathelicidin production which was inhibited
by neutralizing antibody to TLR2. 1,25D3 also increased the ability of keratinocytes to kill S. aureus.
Thus, we hypothesized that 1,25D3 was a signaling molecule during injury. Supporting this, we
found that CYP27B1, the enzyme that converts 25D3 to active 1,25D3, was increased 4-fold in
wounds and induced in response to TGFβ1 (8-fold) or Malp2 (4-fold). Blocking the vitamin D recep-
tor, inhibiting CYP27B1 enzymatic activity, or limiting 25D3 in culture each prevented TGFβ1 from
inducing hCAP18, CD14 or TLR2. Furthermore, mice deficient in CYP27B1 failed to increase CD14
in vivo following injury. Thus, this investigation demonstrates how injury initiates the innate immune
response; vitamin D3 is activated by enzymatic conversion, a process triggered by microbial prod-
ucts or host factors such as TGFβ1. The increase in 1,25D3 then directly increases cathelicidin release
and enables responsiveness to microbial products through induction of TLR2 and CD14.
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IL-1β and the inflammasome but not IL-1α mediate IL-1R-dependent neutrophil recruit-
ment against Staphylococcus aureus skin infection
LS Miller,1 EM Pietras,1 L Uricchio,1 RM O’Connell,1 KA Hirano,1 S Rao,1 AL Cheung,2
G Cheng1 and RL Modlin1 1 Division of Dermatology and Department of Microbiology,
Immunology, and Molecular Genetics, UCLA, Los Angeles, CA and 2 Department of
Microbiology and Immunology, Dartmouth Medical School, Hanover, NH
We previously reported that activation of IL-1R-signaling by resident skin cells is critical for
neutrophil recruitment and host defense against S. aureus skin infections. Here, the differen-
tial contribution of IL-1α, IL-1β, and the inflammasome in mediating IL-1R-dependent neu-
trophil recruitment against S. aureus skin infection was investigated using a mouse model of
cutaneous infection with S. aureus in conjunction with bioluminescent bacteria to track bac-
terial growth. We found that skin lesions of S. aureus-infected IL-1β- and IL-1α/β-deficient
mice were substantially larger (3-4 fold) with higher bacterial counts (10-15 fold) and had a
severe defect in neutrophil recruitment and in myeloperoxidase activity (2 fold) compared with
wildtype control mice or IL-1α-deficient mice (p<0.05). This severe phenotype of skin lesions
of S. aureus-infected IL-1β- and IL-1α/β-deficient mice closely resembled skin lesions of S.
aureus-infected IL-1R-deficient mice. Thus, IL-1β and not IL-1α mediates IL-1R-dependent
neutrophil recruitment and host defense against S. aureus skin infections. Furthermore, mice
deficient in ASC, an inflammasome component that associates with caspase-1 to promote con-
version of pro-IL-1β into active IL-1β, had a similar severe phenotype of skin lesions as IL-1β-
deficient mice after S. aureus skin infection. Taken together, these data provide evidence that
effective neutrophil recruitment and bacterial clearance of S. aureus skin infections is depend-
ent upon inflammasome activation and generation of IL-1β, which subsequently activates IL-
1R-signaling to promote neutrophil recruitment to a site of S. aureus infection in the skin.
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Methicillin-resistant staphylococcus aureus colonization in children with atopic dermatitis
AC Yan,1,2 L Suh,5 K Heydon,4 J Gelfand,3 P Honig1,2 and S Coffin4 1 Section of Dermatology,
Children’s Hospital of Philadelphia, Philadelphia, PA, 2 Departments of Pediatrics and
Dermatology, University of Pennsylvania School of Medicine, Philadelphia, PA, 3 Department
of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, PA, 4
Department of Pediatrics, Children’s Hospital of Philadelphia - University of Pennsylvania
School of Medicine, Philadelphia, PA and 5 Deparment of Pediatrics, University of California
- San Francisco, San Francisco, CA
Children with atopic dermatitis (AD) are more frequently colonized with Staphylococcus aureus
(SA) than children without AD. However, little data exist regarding the prevalence of methi-
cillin-resistant SA (MRSA) among children with AD. An increasing prevalence of community-
associated MRSA (CA-MRSA) has been seen among those presenting to hospitals with serious
bacterial infections. Since many AD patients are treated empirically with antibiotics for sec-
ondary skin infections, an understanding of the epidemiology of bacterial colonization and
superinfection is essential for directing proper treatment in the atopic patient population. An
observational cross-sectional study was conducted at the Children’s Hospital of Philadelphia
in which 54 patients previously diagnosed with AD were enrolled. A detailed patient ques-
tionnaire, a complete cutaneous examination, and an evaluation of eczema severity accord-
ing to the Eczema Area and Severity Index (EASI) were completed at enrollment. Bacterial cul-
tures from the skin and nares were obtained to determine the frequency of colonization with
either methicillin-sensitive SA (MSSA) or MRSA. Although most AD patients studied were col-
onized with SA [43/54 (80%)], MRSA was isolated from only 7 AD patients [7/54 (13%)]. Patients
colonized with SA were more likely to be male, to have been previously hospitalized, to have
used a topical calcineurin inhibitor in combination with a topical steroid, and less likely to have
used topical antibiotics. Bivariable analysis, however, revealed that only previous hospitaliza-
tion was independently associated with an increased risk of MRSA colonization.
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Staphylococcus epidermidis functions as a component of the skin innate immune system by
inhibiting the pathogen group A streptococcus
AL Cogen,1,2 V Nizet2,3 and RL Gallo1,4 1 Medicine, UCSD, San Diego, CA, 2 Pediatrics,
UCSD, San Diego, CA, 3 Skaggs School of Pharmacy and Pharmaceutical Sciences, UCSD,
San Diego, CA and 4 Medicine, VA San Diego Health Care System, San Diego, CA
Staphylococcus epidermidis (Se) is a Gram-positive bacterium that is a leading component of
the normal skin microflora. We hypothesized that Se plays a beneficial role in the ecology of
the cutaneous epithelium. One way that Se could benefit the host is by displacing pathogens
on the skin’s surface. In this study, we investigated the potential of Se to protect against an
invasive bacterial pathogen, Group A Streptococcus (GAS). The presence of Se on normal skin
was shown to inhibit GAS survival when compared to skin that had been previously sanitized
with alcohol. Growth of GAS on agar media was also inhibited upon co-culture with Se. GAS
growth in THB media as measured by OD600 and on agar as measured by radial diffusion
(clear zone of 28.26mm2), was inhibited by the addition of cell-free culture supernatants pre-
pared from Se. Inhibition of GAS due to Se conditioned supernatants was statistically signif-
icant at 6, 8, and 12 hours (p<0.001) compared to growth in the absence of Se or condi-
tioned supernatants prepared from other bacteria such as Staphylococcus aureus. Based on
these observations we hypothesized that Se inhibits GAS through the production of antimi-
crobial peptides, molecules also known as bacteriocins when produced by bacteria. To iso-
late this factor(s), conditioned Se supernatant was purified by HPLC and antimicrobial activ-
ity identified by radial diffusion assay. Maximal activity eluted at 72% acetonitrile/0.1%
trifluoroacetic acid (clear zone of 17.86mm2). MALDI TOF-TOF identified a peptide in this
fraction known as d-haemolysin, a membrane active peptide of unknown function in Se.
Synthetic d-haemolysin had an MIC and MBC of 16 uM when tested with GAS. Overall,
these studies show a novel role of Se in cutaneous protection against infection, suggesting
the first line of defense of the skin may be the resident microflora themselves.
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The expression of membranous β-catenin and presenilin-1 is reduced in HPV-33-induced
bowenoid lesions
G Nakanishi, N Suzuki, T Hamada and K Iwatsuki Dermatology, Okayama University
Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
Human papillomavirus (HPV) is an important etiologic agent in cervical carcinoma and in
some malignant skin tumors including Bowen’s diseases and squamous cell carcinomas.
Recently, it has been reported that Notch signaling pathway and Wnt-β-catenin signaling path-
way are related to HPV-induced malignant transformation in cervical cancer, although they
are not well studied in HPV-induced skin cancers. To characterize the signaling pathway of
HPV-induced malignant skin tumors, we examined bowenoid lesions, verrucous lesions, and
normal skin from the same patient with myelodysplastic syndrome. PCR amplification of the
extracted DNA samples from bowenoid lesions and verrucous lesions demonstrated infec-
tion with oncogenic HPV-33. At first, we examined the expression of Notch ligand, jagged-
1, Notch-1, Notch-2 by immunohistochemical analysis and western blots, but the expression
of Notch and Notch ligand was not significantly different between HPV-33-induced bowenoid
lesions and normal skin. By contrast, immunohistochemistry showed reduced membranous
expression of β-catenin and E-cadherin in HPV-33-induced bowenoid lesions when compared
to those of verrucous lesions. In addition, immunohistochemical analysis demonstrated that
the expression of presenilin-1, that interacts with β-catenin, and cleaves Notch intracellular
domain, was markedly reduced in HPV-33-induced bowenoid lesions when compared to the
verrucous lesions and normal skin. The expression of presenilin-1 was not different between
normal human epidermal keratinocytes (NHEK) with various differentiation stages and a ker-
atinocyte cell line immortalized by HPV-18 (HPV-NHEK), whereas the expression was very
weak in a squamous cell carcinoma cell line, SCC13. These results suggest that reduced expres-
sion of presenilin-1 may result in down-regulation of Notch signaling pathway due to insuf-
ficient cleaved Notch and may be associated with an increase of cytosolic β-catenin in HPV-
33 induced bowenoid lesions.
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Panton-Valentine leukocidin produced by Staphylococcus aureus induces an intense inflam-
mation in the skin
S Morizane,1 O Yamasaki,1 F Kato,2 J Kaneko2 and K Iwatsuki1 1 Dermatology, Okayama
University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama,
Japan and 2 Microbial Biotechnology, Graduate School of Agricultural Science, Tohoku
University, Sendai, Japan
Panton-Valentine leukocidin (PVL) is a two-component (LukF-PV and LukS-PV) leukocidin
produced by S. aureus. It has the specific lytic activity on leukocytes derived from only humans
and rabbits. We have demonstrated that PVL gene-positive strains are associated with multi-
ple furuncles with more intense erythema, although a regulatory system of the toxin produc-
tion remains to be clarified. We have investigated skin changes induced by PVL-positive strains.
The PVL-positive (ATCC49775) and PVL-negative (02-122) strains were used. In addition, the
PVL-overexpressing mutants, or the gene knockout mutants of the S. aureus global regulators,
which controlled the expressions of the toxins were prepared. Western blotting demonstrated
that ATCC49775 and PVL-overexpressing mutants could produce PVL toxin in the culture
fluid. PVL toxin, ATCC49775, the mutants and 02-122 were injected intradermally to rabbits,
and macroscopic and microscopic changes of the injected sites were observed. Injections of
both LukF-PV and LukS-PV components provoked a denser infiltrate of polymorphonuclear
cells and a more intense skin necrosis than that of usual leukocidin (LukF and LukS) most
strains had. Although the injection of bacterial cells also induced the skin reaction, there was
no significant difference in intensity of the skin reactions between ATCC49775, the mutants
and 02-122. Our results indicate that PVL is an essential factor to determine the severity of
cutaneous infections, but there seems to be a regulatory system for the production of PVL
toxin in vivo.
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Detection of pathogen-derived transcripts in crusts
T Yamamoto, A Yamada, K Tsuji and K Iwatsuki Dermatology, Okayama University Graduate
School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama City, Japan
[Background] Various microbial DNA can be detected in crusts and scales, but there has been
no report on detection of the pathogen-derived transcripts. [Purpose] To detect pathogen- and
host-derived mRNAs in crusts, and to establish a noninvasive diagnostic procedure. [Materi-
als and Methods] Crust and scale samples were obtained from cutaneous lesions caused by
viral infections, including 4 patients with herpes simplex (HS), 8 with herpes zoster (HZ) and
5 with hydroa vacciniforme (HV). Control samples were obtained from 3 patients with psori-
asis, 2 with impetigo, 4 with prurigo and 5 with insect bite. Total RNA was extracted from
crusts and/or scales, and converted to cDNA. Virus-derived transcripts specific for the corre-
sponding pathogen were amplified using RT-PCR. Housekeeping gene transcripts such as beta2-
microglobulin and beta-actin mRNA were also studied. An efficient preservative condition of
the crust samples was determined by quantitative RT-PCR for beta2-microglobulin mRNA.
[Results] With extracted RNAs, beta2-microglobulin and beta-actin mRNA were successfully
amplified in all crust/scale samples. HS virus-specific, lytic cycle-related transcript, UL30 was
detected in all 4 HS samples, and Epstein-Barr virus-specific, latent cycle-related transcript,
EBER1 was found in all 5 HV samples. Of 8 HZ samples, varicella zoster virus-specific, lytic
cycle-related transcript, ORF40 was detected in 7 samples. Crust samples that had been stocked
without any pretreatment or preservative for 3 months at room temperature were available for
the present assay. As compared with the fresh materials, the amount of beta2-microglobulin
mRNA in the samples stocked for 5 days in a dry condition were reduced to 51% value, and
to 1.2% value in the same samples stocked in saline. [Conclusions] Pathogen- and host-derived
transcripts contained in crusts can be detected by RT-PCR amplification. Crusts, or dry epi-
dermal necrosis with inflammatory cells may provide beneficial diagnostic information.
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Cathelicidin antimicrobial peptide is expressed in the sebaceous gland
D Lee, K Yamasaki, J Schauber, AS Büchau, RA Dorschner, PF Kotol and RL Gallo
Dermatology, University of California, San Diego, and VA San Diego Health Care System, San
Diego, CA
Although the sebaceous gland (SG) produces and secretes sebum onto skin surface, the func-
tions of this appendage are not well understood. In this study, we sought to determine if
cathelicidin antimicrobial peptide is produced in the SG, thereby establishing its potential to
add to innate immune defense of the skin. Histological sections of human SG as well as the
human immortalized sebocyte cell line (SZ95) were examined. Human cathelicidin hCAP18
mRNA was detected by RT-PCR in SG isolated from normal scalp skin and cathelicidin pro-
tein was detected by immunohistochemistry and by Western blot of isolated SG extracts. In
SZ95 sebocytes, hCAP18 mRNA was also detected and quantified by real-time RT-PCR, and
protein detected by immunofluorescence and ELISA (0.19 ug/ml). The expression of mRNA
and protein in SZ95 was further induced 12-fold and 2.3-fold by 1,25(OH)2 vitamin D3 (100
nM), previously known to induce cathelicidin expression in keratinocytes. SELDI-TOF mass
spectrometry confirmed cathelicidin was processed to the active peptide LL-37. Furthermore,
acid soluble protein extracts of SZ95 showed antimicrobial activity against Staphylococcus
aureus and Propionibacterium acnes, both potential pathogens in the human pilosebaceous
unit. In addition to cathelicidin, in SZ95 sebocytes, human β defensins-1 and -2 mRNA was
also detected. In conclusion, cathelicidin antimicrobial peptide is expressed in the human
sebaceous gland, is enzymatically processed to its active form, and has antimicrobial activity
against two human skin pathogens. These data indicate that sebaceous gland may contribute
to epithelial defense through release of cathelicidins as well as sebum.
786
Delayed diagnosis in leprosy
ID Camacho and AE Burdick Department of Dermatology, Miller School of Medicine,
University of Miami, Miami, FL
Global travel and recent immigration patterns are bringing leprosy to non-endemic areas where
physicians are unfamiliar with the disease. Leprosy manifests in various forms depending on the
individual’s cell-mediated immunity to Mycobacterium leprae. Diagnosis is often delayed, result-
ing in neurological complications and deformities. The University of Miami/Jackson Memorial
Hansen’s Disease Program diagnoses 7 to 10 new patients annually and provides multidrug ther-
apy (MDT): Rifampin, Dapsone and Clofazimine. Two patients whose leprosy was misdiagnosed
for many years are presented. The first is a 43 year-old Indian man presented with a 2 year history
of pain and swelling in both hands and feet. He was diagnosed with rheumatoid arthritis by a
rheumatologist and treated with Methotrexate and Prednisone with mild improvement. A year later,
he developed numbness, worsening edema and a rash of his hands and feet, prompting resump-
tion of Prednisone. On exam, erythematous plaques on the arm, flank, feet and dorsal hands were
observed. Biopsy revealed granulomatous infiltrates in a neurovascular distribution with rare acid-
fast bacilli, consistent with tuberculoid leprosy. MDT was started with improvement of skin lesions.
Prednisone was continued for his type 1 reversal reaction with decreased hand and foot edema
and pain. Second, a 31 year-old Colombian woman presented with a 15 year history of nasal con-
gestion, rhinorrhea and intermittent epistaxis. She had failed medical management for presumed
chronic sinusitis and underwent sinusotomy that revealed extensive nasal cartilage and bone destruc-
tion. Nasal mucosa histology showed granulomatous inflammation with massive infiltration of acid-
fast bacilli in histiocytes and nerves. On exam, scattered indurated pink papules were noted and
a history of lower extremity numbness was obtained. Skin biopsy revealed similar pathology and
slit smears showed a high bacillary index. MDT was started with resolution of nasal symptoms and
skin lesions. Awareness of the diverse presentations of leprosy will promote early diagnosis and
treatment to avoid significant nerve damage and disability.
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An animal model to study the inflammatory properties of Propionibacterium acnes: toward
a new acne treatment of post genomic analysis
T Nakatsuji,1,2 C Huang,3 Y Liu,3 RL Gallo1,2 and C Huang1,2 1 Division of Dermatology,
Department of Medicine, University of California, San Diego, CA, 2 VA San Diego Healthcare
Center, San Diego, CA and 3 Moores Cancer Center, University of California, San Diego, CA
Propionibacterium acnes has been known to play a critical role in the development of acne.
Recent genomic analysis of P. acnes provides us with new insights into the treatment of acne.
An animal model of inflammation induced by P. acnes is important for developing a new
strategy for acne treatments. We report here 1) inflammatory activities of P. acnes using mouse
ear and tissue cage models, and 2) cloning, heterologous expression, and virulence of siali-
dase. Intradermal injection with a living pathogenic strain of P. acnes into mouse ears pro-
duced a 3-fold increase in ear thickness 48 hr after injection. Injected P. acnes migrated and
colonized in the sebaceous gland 48 hr after injection. By contrast, injection with a non-
pathogenic strain of Staphylococcus epidermidis as a control produced a lower increase than
P. acnes. Next, a mouse tissue cage model was employed to culture the bacteria in vivo. The
plastic tissue cage (0.3 x 1 cm) with 0.5 mm holes was implanted under the abdominal skin.
Injected P. acnes grew in the tissue cage and induced a significant increase of microphage
inflammatory protein 2 (MIP-2) levels in the tissue cage fluid. By contrast, injected S. epider-
midis decreased and induced less of an increase in MIP-2 level than that by P. acnes. Lastly,
we chose sialidase as a potential virulence from the P. acnes genome. Recombinant sialidase
was expressed in E. coli. Incubating human sebocytes with the refolded recombinant sialidase
decreased affinity of MAA lectin to the cell surface, suggesting that sialic acids were removed,
and induced a significant morphological change of the cells. The combined results suggest
that our animal model can be used as a strong tool to develop new antibiotics or drugs and
that sialidase has a potential to be a target of a new therapy of acne.
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DNA microarray analysis of local immunity in Condyloma acuminatum lesions
F Wang,2 W Xiang,3 Z Bi3 and Y Wan1 1 Biology, Providence College, Providence, RI, 2 the
Zhongda Hospital of Southeast University, Nanjing, China and 3 the First Affiliated Hospital
of Nanjing Medical University, Nanjing, China
Condyloma acuminatum (CA) is one of the most common sexually transmitted diseases (STD)
caused by human papillomavirus (HPV) in China. Studies have suggested that CA may be attrib-
uted to the poor local immune response to HPV infection at the site of the lesion. In this study,
we analized the levels of cytokines and antibodies in CA local lesions with DNA microarray
technique and Real-time Q-PCR. The results show that 3676 (29.5%) out of total 12473 probe
sets are present, 8517 (68.3%) absent, 280 (2.2%) marginal. The average present signal is
69.7%. The probe sets with number of signal increase, decrease and no change are 1472
(11.8%), 1784 (14.3%), 9217 (73.9) respectively. Compared with the normal control, the inten-
sities of Th1 (IFN-r, IL-12, TNF-α) in CA lesions are lower but Th2 (IL-4, IL-10) type cytokines
are higher, with no change of IL-2, IL-5, IL-13. The transcript level of sIgA, IgA, IgG, IgM is
elevated in CA lesion samples. The data of Real-time Q-PCR are consistent with the DNA
microarray data. Taken together, our study reveals the imbalance of Th1/Th2 response in CA
lesions with immune suppression of Th1 and over-activation of Th2.
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PPAR-gamma is involved in 1,25-dihydroxyvitamin D3-induced beta-defensin-3 and cathe-
licidin expression in normal human keratinocytes
X Dai,1 Y Shirakata,2,1 K Sayama,1 S Tokumaru,1 S Hirakawa,1 M Tohyama,1 L Yang1 and
K Hashimoto1 1 Dermatology, Ehime University Graduate School of Medicine, Toon City,
Japan and 2 Regenerative Medicine Research Center, Ehime University Graduate School of
Medicine, Toon City, Japan
As the epidermis is constantly exposed to a variety of microbial pathogens, the innate immune sys-
tem is formed during differentiation. A major component of this system is a diverse combination of
cationic antimicrobial peptides that include the alpha- and beta-defensin and cathelicidin. Previous
reports have shown that 1,25(OH)2D3 (VD3) induces human beta defensin (hBD)-2 and catheli-
cidin. VD3 signals through vitamin D receptor (VDR) which recognizes vitamin D responsive ele-
ment, and the induction of hBD-2 and cathelicidin is mediated through VDR activation. VD3 has
been known to generate biological response via genomic and nongenomic rapid signal transduc-
tion pathways. We have shown that peroxisome proliferation-activated receptor gamma (PPAR-
gamma) is involved in involucrin expression and plays an important role in the VD3-induced ker-
atinocyte differentiation. Therefore, we investigated whether PPAR-gamma is involved in VD3-induced
hBD and cathelicidin expression. Normal human skin expresses hBD-1, hBD-2, hBD-3 and cathe-
licidin. Normal human keratinocytes were treated with VD3, and the mRNA expression of hBD-1,
hBD-2, hBD-3 and cathelicidin was analyzed by real-time PCR. The mRNA of hBD-1 was upregu-
lated only 3-fold after 48 h, whereas hBD-3 and cathelicidin mRNA was enhanced 10- and 90-fold,
respectively, after 48 h. Overexpression of PPAR-gamma by adenovirus vector increased mRNA
levels of hBD-3 and cathelicidin, 6-fold and 7-fold, respectively, after 72h. On the contrary, infec-
tion with Axdn-PPAR-gamma, which expresses dominant negative mutant form of PPAR-gamma,
reduced hBD-3 expression to 37% and cathelicidin to 43% of the level observed with control vec-
tor induced by VD3. In conclusion, we demonstrate that PPAR-gamma plays an important role in
1,25-dihydroxyvitamin D3-induced hBD-3 and cathelicidin expression in normal human ker-
atinocytes.
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Controlling methicillin resistant staphylococcus aureus and pseudomonas aeruginosa wound
infections with a novel biomaterial
SC Davis1 and L Martineau2 1 Dermatology & Cutaneous Surgery, University of Miami Miller
School of Medicine, Miami, FL and 2 Operational Medicine Section, Defence R&D Canada,
Toronto, ON, Canada
Wound infections, especially those associated with methicillin-resistant Staphylococcus aureus
(MRSA) and Pseudomonas aeruginosa (PSEUD), offer considerable challenges for clinicians.
Our laboratory has recently developed novel composite biomaterials (DRDC) for wound dress-
ing applications, and demonstrated their in vitro bactericidal efficacy. We assessed the prolif-
eration of planktonic and sessile PSEUD and MRSA in porcine full-thickness wounds covered
for up to 48 hrs with either saline- or mafenide acetate-loaded DRDC puffs and meshes. All
biomaterials were applied 4 hrs following bacterial inoculation of the wounds with MRSA and
PSEUD, to allow colonization of the tissues and initiation of biofilm formation. The drug-loaded
biomaterials eradicated both the planktonic and biofilm bacteria in the wounds within 24 hrs
(p<0.05), irrespective of the bacterial strain or architecture of the dressing. While the wound
bioburdens increased in the ensuing 24 hrs, they remained approximately 2 log10 CFU below
(p<0.05) their respective baseline values. Similarly, less than 4 log10 CFU was recovered in
the drug-loaded DRDC biomaterials throughout the study. These data show that the DRDC
puffs and meshes are effective in delivering certain medications, such as antimicrobial agents,
to the wound bed, suggesting considerable value of this material for treating wounds, espe-
cially those with irregular shapes, contours and depths.
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Impaired immune effector functions in condylomata
I Le Poole,1 CJ Denman1 and JL Arbiser2 1 Pathology, Loyola University Chicago, Maywood,
IL and 2 Dermatology, Emory University, Atlanta, GA
HPV infected keratinocytes form condylomata that are ineffectively removed by the host
immune response, despite expression of immunogenic HPV E6 and E7 proteins and an abun-
dance of infiltrating CD8+ T cells. To test the hypothesis that cytotoxic effector functions are
impaired within wart tissue, single and double immunohistochemical detection of immune
associated markers was performed on frozen tissue sections from 5 condylomata versus 5 sam-
ples of circumsized normal skin. Dendritic cell subpopulations were evaluated by antibodies
to HLA-DR, S100, langerin, CD80, CD83 and CD86. Infiltrating T cells were typed by immunos-
taining for CD3, CD4, CD8, CD25 and FoxP3. Epithelial expression of CCL1, TAP1, CD40,
HLA-DR and CAIX was also compared. Evaluation by 2 investigators confirmed the presence
of cytotoxic T cell infiltrates, yet CD4:CD8 ratios were increased in wart tissue. Expression of
CD40 was absent from condylomatous epithelium, representing the most apparent change
among dendritic cell populations in either tissue. Increased numbers of CD3/FoxP3 and
FoxP3/CD25 double stained cells were observed in condylomata, revealing abundant Treg
infiltration. Expression of Treg recruiting chemokine CCL-1 differed, as dendritic suprabasal
cells expressed high levels of the chemokine in control skin, whereas focal expression by basal
keratinocytes was observed in condylomata. Epithelial expression of carbonic anhydrase and
antigen processing associated TAP1 was reduced in condylomata, supporting reduced tar-
getability of infected keratinocytes. Thus reactivity of condyloma infiltrating cytotoxic T cells
with potentially reduced avidity towards infected keratinocytes is further impaired by an abun-
dance of Treg.
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Identification of significant levels of staphylococcal lipoteichoic acid associated with impetig-
inized lesions of atopic dermatitis
A Kozman, N Mousdicas, M Al-Hassani, A Hyatt, M Landis, MP Sheehan, H Spartz and
JB Travers Dermatology, Indiana University, Indianapolis, IN
Staphylococcus aureus infections are known triggers for skin inflammation and can modulate
immune responses. Patients with atopic dermatitis are particularly sensitive to staphylococcal
skin infections, which are known to worsen their skin disease. The mechanisms by which
staphylococcal bacteria can worsen atopic dermatitis is an active area of study. One mecha-
nism could involve bacterial products, including the cell wall lipoprotein lipoteichoic acid
(LTA). Of note, LTA can act as an agonist for the toll-like receptor 2 (TLR2) as well as the platelet-
activating factor receptor (PAF-R). The objective of the present studies was to assess quantita-
tively the amount of staphylococcal bacteria and LTA present on clinically infected atopic
dermatitis lesions and compare with the amount of bacteria present and the amount of skin
inflammation. We enrolled over 20 patients with clinically impetiginized atopic dermatitis
and evaluated the amount of S. aureus bacteria and LTA in wash fluid from a quantitative cul-
ture using a 2.5 cm diameter skin chamber on an infected lesion. The extent of skin disease
was quantitated by EASI, and the patient treated with appropriate care including oral antibi-
otics. The patients were then re-evaluated after two weeks and the clinical EASI evaluation
and wash fluid studies repeated. These studies revealed that the clinical EASI score correlated
with the amount of staphylococcal bacteria and LTA levels. It should be noted that the effec-
tive concentration of LTA found in vivo on many of the patients was adequate to activate TLR2
and PAF-R. These studies suggest that infected atopic dermatitis lesions contain biologically
relevant amounts of LTA which could in part provide a mechanism for the increased inflam-
mation seen during a staphylococcal skin infection.
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Smallpox vaccination provides superior protection not only against secondary poxvirus chal-
lenge but also cutaneous malignancy
L Liu, Q Zhong, T Tian and TS Kupper Dermatology, Brigham and Women’s Hospital, Boston,
MA
During the mid 20th century, world-wide immunization with Vaccinia virus (VV) by skin
scarification, but not subcutaneous (sc) or intramuscular (im) injection, induced vigorous and
long-lasting protective immune responses that succeeded in eliminating naturally occurring
smallpox. Since then, recombinant VV (rVV) vectors have been widely used in other disease
models but with unpredictable success; most of these studies introduced rVV by sc, im, intra-
dermal (id), or intraperitoneal (ip) routes. We hypothesized that skin scarification leads to supe-
rior protection against secondary antigenic challenge compared to other immunization routes.
To test the hypothesis, we systematically characterized the development of immune responses
following smallpox vaccination in a murine model. The data clearly show that skin scarifica-
tion elicited significantly higher serum VV-specific antibody titers and stronger cellular immune
responses than other routes. To assess disease relevant efficacy, mice previously immunized
with VV were later infected epicutaneously with VV. Strikingly, while sc, id, im and ip immu-
nization led to 0.5~2.5-log reduction in skin lesional viral load at day 6 of infection compared
to unimmunized mice, all of the skin-scarified immune mice cleared the virus completely at
that time point. We next tested the role of immunization route in tumor immunity. Mice were
immunized via various routes with rVV expressing ovalbumin peptide Ova258-276, and chal-
lenged subcutaneously with Ova-expressing B16 melanoma cells. Skin scarified immune mice
had significantly delayed tumor growth and enhanced survival than mice immunized via other
routes. These results suggest that generating systemic immunity to tumor or pathogen associ-
ated antigens is therefore dependant not only on the antigenic vector, but also on the tissue
microenvironment into which the vector is introduced. Introducing VV into the epidermis via
scarification appears to be uniquely effective at generating powerful immunity to VV-associ-
ated antigens.
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Alpha-melanocyte -stimulating hormone inhibits the expression and function of keratinocyte
TLR-2
Y Lu, R Prado, J Son, H Chen, C Armstrong and J Ansel Dermatology, University of Colorado
at Denver and Health Sciences Center, Aurora, CO
The neuropeptide alpha-melanocyte-stimulating hormone (α-MSH) has multiple immuno-
suppressive action in the skin. One of the principal mediators of innate immune responser in
many cell types including keratinocytes are toll like receptors (TLRs). In this study we tested
the immuno-modulatory effect of α-MSH on TLR-2 expression and function. Our results indi-
cated that α-MSH inhibits the expression of keratinocyte TLR-2 as well as TLR-2 mediated
induction of keratinocyte IL-8 and TNF-alpha production as determined by real-time PCR
and ELISA. This effect were blocked by pretreatment of cells with the agouti protein α-MSH
receptor-1 antagonist. We then determined of this inhibitory effect of α-MSH on keratinocyte
TLR-2 was mediated by blockade of NF-κB nuclear translocation. Western blot and immuno-
fluorescence studies indicated that pretreatment of cells with α-MSH inhibited NF-κB nuclear
translocation in LTA-TLR-2 activated cells in a dose-dependent manner. Therefore these stud-
ies indicate that α-MSH was capable of inhibiting both TLR-2 expression and function, thus
demonstrating another unique cutaneous immuno-modulatory effect of this neuropeptide.
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Salivary VZV DNA
A Arora,1 N Mendoza,1 S Mehta2 and S Tyring1 1 Center for Clinical Studies, Houston, TX and
2 NASA, Houston, TX
Varicella-zoster virus (VZV) presents as varicella in children but can reactivate from the latent
state as zoster in older individuals. To describe salivary VZV copies in zoster patients with pain
indices, 54 adult shingles patients were included in the study. The patients were divided into
two groups: those with involvement of cervical or trigeminal dermatome and those with involve-
ment of thoracic or lumbar dermatomes. Three saliva samples were collected from each patient:
the first sample was collected during the patient’s first visit to the clinic (before antiviral treat-
ment started); the second, 7 days after; and third, 14 days after treatment began. Salivary DNA
was extracted using a kit from Qiagen Inc., and VZV DNA was detected by real-time PCR. VZV
DNA was detected in the first saliva samples collected from all the patients (54) before antivi-
ral treatment, from 22 patients 1 week after antiviral treatment, and from 5 patients 2 weeks
after the treatment. VZV copies ranged from 3.9 X 101 to 1.4 X 107 copies per ml/saliva.
Larger numbers of VZV copies were found in the patients with pain in trigeminal or cervical
dermatomes (mean = 1.7 X 106) than were found in the ones with pain in the thoracic or lum-
bar dermatomes (mean = 8.5 X 103). In both groups, the number of VZV DNA copies after 7
days of treatment had decreased significantly from their day-1 values (p<0.01). As patients’ pain
decreased, VZV DNA levels in their saliva also decreased. No VZV DNA was detected in 6
non-shingles patients or 14 healthy controls included in the study. Further, in a case study, VZV
was found in the saliva of a patient with pain associated with the prodrome of herpes zoster.
These finding suggests that analysis of saliva samples can be used for the early diagnosis of
shingles patients before vesicles appear, allowing early antiviral treatment and a better under-
standing of VZV infection in patients with shingles. An example of an experimental antiviral
treatment is sorivudine cream, in which trials have shown it to be safe and well-tolerated. Fur-
ther sorivudine demonstrated a 50% reduction in rash area in the first five days of treatment.
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The expression and function of the TLR-2 receptor complex in murine keratinocytes
R Prado, J Son, Y Lu, H Chen, C Armstrong and J Ansel Dermatology, University of Colorado,
Aurora, CO
Toll-like receptors (TLR) have recently been shown to play an important role in innate immu-
nity. Mammalian TLRs were first described in myeloid cells, and later it was demonstrated
that other non-myeloid cells including human keratinocytes express functional TLRs. The pres-
ence of TLR on epithelial cells is especially important since those cells represent the first line
of defense against environmental pathogens. Compared to human keratinocytes, little is known
regarding the expression and function of murine keratinocyte TLR. To determine the validity
and relevance of using a murine model system to examine keratinocyte TLR, we have initi-
ated studies assessing the expression and function of the murine keratinocyte TLR-2 receptor
complex. In this study we examined the expression of TLR-2 and associated TLR-1 and TLR-
6 molecules in murine PAM 212 keratinocytes and the response of these cells to gram posi-
tive bacteria derived lipoteichoic acid (LTA). Our results indicated that PAM 212 constitu-
tively expressed TLR1, TLR2 and TLR6 mRNA as well as the protein for these receptors on the
cell surface. LTA augmented PAM 212 TLR2 expression, which was inhibited by either pre-
incubation of cells with anti-TLR2 antibodies or transfecting cells with dominant negative TLR2
constructs, therefore demonstrating the TLR2 specificity of this response. LTA also induced
increased expression of pro-inflammatory cytokines (IL-1α, IL-1β, IL-6 and TNF-α) and the
murine chemokine KC. Again the TLR2 specificity of these responses was demonstrated by
using TLR2 blocking antibodies as well as transfecting cells with dominant negative TLR2
constructs. Therefore in this study we demonstrated for the first time that the murine keratinocyte
cell line PAM 212 cell expresses functional TLR2, and that this receptor is essential for LTA
mediated cellular responses in these cells. This finding has important implications for our
understanding of the innate immune responses to cutaneous bacterial infections, and supports
the use of a mouse model for the study of keratinocyte TLR mediated immunity in the skin.
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Keratinocytes express functional NOD2 capable of mediating innate immune responses to
gram(+) bacterial wall derived MDP and PGN
J Son, R Prado, Y Lu, H Chen, C Armstrong and J Ansel Dermatology, University of Colorado
at Denver and Health Sciences Center, Aurora, CO
Intracellular nucleotide-binding oligomerization domain (NOD) proteins have recently been
shown to play an important role in innate immunity to microbial components derived from
bacterial peptidoglycan. Although the expression and function of NOD proteins (NOD1 and
NOD2) have been established in macrophages and dendritic cells, the role of NOD in ker-
atinocytes is not known. In this study, we examined the function of NOD2 in murine PAM
212 keratinocyte inflammatory responses induced by muramyl dipeptide (MDP) as well as
Petidoglycan (PGN). MDP and PGN are major cell wall components of gram(+) bacteria. Our
results indicated that MDP increased intracellular Ca++, NF-κB nuclear translocation, p38
activation and increased the expression of anti-microbial peptide genes, as well as pro-inflam-
matory cytokines TNF-α, IL-1, IL-6 and KC. In addition, MDP augmented PAM 212 keratinocyte
NOD2 expression. Murine keratinocytes transfected with a NOD2 dominant negative con-
struct failed to respond to MDP and PGN, therefore demonstrating the NOD2 specificity of
this response. These studies therefore indicate that keratinocytes express functional NOD2 that
may play an important role in host innate immunity in response to gram(+) bacteria in a vari-
ety of skin disorders.
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Murine keratinocytes express functional Toll-like receptor 4
P Song,1,3 R Prado,1 Y Kang,2 J Son,1 H You,3 Y Lu,1 C Armstrong1 and J Ansel1 1 Dermatology,
University of Colorado Health Sciences Center, Aurora, CO, 2 Dermatology, The Catholic
University of Korea, Seoul, South Korea and 3 Pharmacology, Chosun University Medical
School, Gwangju, South Korea
Toll-like receptors (TLRs) have been known to play an important role in innate immune responses
to various microbial derived agents. Recently, we have demonstrated that lipopolysaccharide
(LPS) and lipoteichoic acid (LTA), major biologically active components derived from gram
negative and positive bacteria, respectively, can activate human keratinocytes by TLR4/CD14
dependent mechanism. However, the expression and biological function of TLRs in mouse
keratinocytes remains unclear. The purpose of this study is to determine if the murine ker-
atinocyte TLR system can serve as a model for human keratinocyte TLR responses, in particu-
lar for future cutaneous in vivo studies using live pathogens. In this study we examined the
expression of TLR4, MD2 and CD14 in the murine keratinocyte cell line PAM212. Our results
indicate that TLR4, MD2 and CD14 mRNA was constitutively expressed in PAM212 cells. Like-
wise PAM212 TLR4 and CD14 cell surface expression was detected by immunohistochem-
istry staining. In addition TLR4 mRNA and protein expression in murine PAM212 keratinocytes
was augmented by exposure of cells to LPS. LPS treatment resulted in a rapid intracellular cal-
cium response, NF-κB nuclear translocation and the secretion of proinflammatory cytokines
such as IL-1α, IL-1β, IL-6, TNFα and the murine chemokine KC. The TLR4 specificity of these
responses was demonstrated by pretreating PAM212 cells with TLR4 blocking antibodies or
by using cells transfected with dominant negative TLR4 constructs (TLR4dn). The results of
these studies indicate for the first time that murine PAM212 keratinocytes express functional
TLR4. This supports the potential of a murine model system for examination of the role of ker-
atinocytes in mediating innate immunological responses to cutaneous pathogens.
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Study on the effect of (-)-epigallocatechin-3-gallate (EGCG) on acne lesions and Propioni-
bacterium acnes
D Suh,1 S Min,1 Y Cho,1 M Yoon,1 J Kim1 and I Kim2 1 Dermatology, Seoul National University
College of Medicine, Seoul, South Korea and 2 Molecular Genetics, Seoul National University
College of Medicine, Seoul, South Korea
Many favorable effects of green tea, such as anti-inflammatory and antibacterial effects, low-
ering of plasma cholesterol, reduction of blood pressure and antimutagenic activities, have
been reported. We performed this study to know whether or not (-)-epigallocatechin-3-gal-
late(EGCG) is effective on acne lesions in vivo and Propionibacterium acnes in vitro. The
main pathogenesis of acne has been associated with increased sebum production, inflam-
mation, follicular hyperkeratinization and the action of Propionibacterium acnes within the
follicle. We applied two different kinds of concentration of EGCG to acne lesions of volun-
teers and investigated clinical course. This study revealed that topical EGCG application
decreased the number of acne lesions. Skin biopsies were obtained twice from inflammatory
papules, closed comedone and open comedone (at the beginning of the study as well as at
the last follow-up). We analyzed the expression pattern of transglutaminase 1, 2 and 4 from
the biopsied acne specimens with immunohistochemistry and compared the staining inten-
sity among specimens. Abnormal keratinization and subsequently increased cohesiveness of
follicular corneocyte is one of the most important phenomenon of comedone formation. Our
previous study showed that transglutaminases might be involved in the formation and devel-
opment of acne lesions. In this study, transglutaminase 1 and 2 were increased after EGCG
application while transglutaminase 4 did not show significant changes. In an attempt to eval-
uate the antibacterial effects of green tea to acne lesions, we cultured P. acnes with the treat-
ment of EGCG. EGCG suppressed P. acnes to a great extent. These results suggested the prom-
ising role and action mechanism of EGCG in acne treatment.
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Tocopherols exhibit anti-inflammatory activity and reduce UVB-induced skin erythema and
DNA damage
M Kizoulis, F Liebel, P Lyte, M Southall and CB Lin The Johnson & Johnson Skin Research
Center, CPPW, a division of Johnson & Johnson Consumer Companies, Inc., Skillman, NJ
The Vitamin E family is comprised of eight different forms, four tocopherols (α, β, γ, and δ)
and four tocotrienols (, β, γ, and δ), which are all found in food sources. Although Western
diet contains approximately twice as much γ-tocopherol as α-tocopherol, α is the predomi-
nate form of Vitamin E found in mammalian blood and tissue. Therefore, most of the studies
on the anti-inflammatory and anti-oxidant activity of Vitamin E are focused on α-tocopherol.
Emerging evidence suggest that other tocopherols may have anti-inflammatory and anti-oxi-
dant activity. Therefore we sought to determine whether the different tocopherols (α, γ and δ)
provide differential anti-inflammatory activity and protection from UV-induced skin damage.
δ-tocopherol significantly reduced cytokine release from activated human lymphocytes. α-
and δ-tocopherols were equally potent in reducing UV-induced cytokine release from human
epidermal equivalents. Using CD-1 mice, γ-tocopherol demonstrated anti-inflammatory activ-
ity against contact hypersensitivity, whereas α-tocopherol was effective against irritant der-
matitis. Using Gottingen miniswine, pretreatment with γ- and δ-tocopherol and their mixtures
showed the highest UVB-protective activity, as measured visually for skin erythema, and his-
tologically for DNA damage. These visual protective effects were evident at 24 hours post UVB
and lasted for up to 8 days when the skin lesion was markedly reduced especially in the areas
pretreated with γ- and δ-tocopherols. Interestingly, a 4-hour pretreatment with a γ-tocopherol
enriched mixture, prior to UVB exposure, was sufficient to provide effective protection against
DNA damage. Our results demonstrate that γ- and δ-protect cutaneous tissues from UVB-
induced inflammation, erythema and DNA damage.
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In vivo and in vitro evaluation of phytic acid as topical antioxidant
M Andreassi,1 G Mariotti,2 L Andreassi,2,1 M Centini1,3 and C Anselmi1,3 1 Centre of Cosmetic
Science and Technology, University of Siena, Siena, Italy, 2 Departemt of Dermatology,
University of Siena, Siena, Italy and 3 Department of Pharmaceutical Technology, University
of Siena, Siena, Italy
The use of locally applied antioxidants has been shown as an effective approach for the skin
photo-protection. In a previous investigation we have demonstrated that phytic acid (PA), a
component of most cereal grains and seeds, is able to reduce the erythemal response to UV-
exposure when applied 30 minutes before UV-radiation. PA was used at 0.5 % concentration in
a O/W emulsion containing also inositol at 2.0 % concentration. Before the test and 24 and 48
h after irradiation the extent of the reaction was evaluated with visual scoring as well as with
instrumental measurement of skin redness,TEWL and hydration. In this study we have evaluated
the ability of PA to protect human keratinocytes cultures against UV exposure. PA extracted
from the rice bran was used at 100 µM. The experiments were performed also on ascorbic acid
at the same concentration. Human HaCaT keratinocytes were grown in 3,5 cm2 plates contain-
ing complete medium (DMEM with 10% fetal calf serum). Thirty minutes before UV radiation,
medium was removed and replaced by PBS with or without the antioxidants. The light source
was a 150-Watt xenon arc solar simulator. Series of cultures were irradiated with scalar UV-doses
ranging from 11,56 to 92,48 mJ/cm2. After irradiation PBS solution with or without antioxidants
was removed and replaced with fresh medium. The antioxidant activity was evaluated by MTT
assay after 24 hrs. The solutions containing the active ingredients demonstrated a protective
ability stronger than that of the controls. Particularly PA showed an ability to protect the ker-
atinocytes against UV damage more pronounced than vitamin C. Our investigation has proved
that phytic acid is able to protect human keratinocytes against UV radiation. This means that
epidermal cells are involved in the PA-mediated photoprotection in vivo and represents a fur-
ther support for the use of PA as topical photoprotective agent.
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A topical antioxidant solution containing vitamins C and E with ferulic acid protects human
skin from sunlight damage and DNA mutations associated with skin cancer
JC Murray, JA Burch, MA Iannacchione and SR Pinnell Dermatology, Duke University,
Durham, NC
Sunlight exposure generates oxidative stress in skin that can result in photoaging and skin
cancer. The body naturally uses antioxidants to neutralize oxidation of nucleic acids, proteins
and lipids; but control mechanisms limit protection achieved by oral ingestion. To augment
antioxidant protection, we have developed and reported three generations of topical formu-
lations, each with progressively better protection against solar-simulated radiation. The cur-
rent formulation contains physiologic antioxidants, vitamins C and E, stabilized by a potent
plant antioxidant, ferulic acid; optimized for chemical stability, percutaneous absorption, and
photoprotection (J Invest Dermatol 125:826-832, 2005). In this study, which was conducted
at Duke University Medical Center with the approval of the Duke Institutional Review Board,
two different solutions were applied (2mg/cm2) to back skin of nine human volunteers daily
for four days. One solution was an aqueous solution containing 15% L-ascorbic acid, 1% α-
tocopherol and 0.5% trans ferulic acid (CEferulic); the other, a vehicle control solution. On
day four, the vehicle patch received 2-6MED and the CEferulic patch received 2-10MED of
solar-simulated irradiation, each at 2MED intervals. One day later, skin was evaluated by col-
orimeter for erythema and biopsies of 6MED-irradiated skin were evaluated for sunburn cells.
An additional three subjects who received 3MED were biopsied for immunohistochemistry of
8-oxoguanine, thymine dimers and p53. Colorimeter readings for vehicle vs. CEferulic
(67.4±14.9 vs. 35.8±12.8) and sunburn cell enumeration (31.5±14.3 vs 8.4±7) revealed sig-
nificant (p〈0.01) photoprotection by CEferulic. Immunohistochemistry of DNA mutations
revealed virtually complete protection against UV-generation of 8-oxoguanine, thymine dimers
and p53 by CEferulic. Topical CEferulic provides substantial protection against sunlight-induced
oxidative skin damage, including DNA mutations related to skin cancer.
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Polypodium leucotomos inhibits UVB radiation-induced immunosuppression
JR Siscovick,1 T Zapolanski,1 S Prograis,1 K Carrrigton,1 S Gonzalez,2 W Ding1 and
RD Granstein1 1 Dermatology, Weill Medical College of Cornell University, New York, NY and
2 Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
An extract of the tropical fern Polypodium leucotomos (PL) administered orally to mice low-
ers the incidence of ultraviolet radiation (UVR)-induced non-melanoma skin cancers. UVR-
induced murine skin cancers occur, in part, because of immunosuppression that results from
the UVR exposure. We examined whether PL inhibits the ability of UVB radiation (280-320
nm) to suppress the induction of contact hypersensitivity locally (low-dose UVB) or systemi-
cally (high-dose UVB). C57BL/6 mice were given drinking water containing 1.8 mg/ml PL for
3 weeks or water without PL. In the low-dose model, mice were then shaved on their dorsum
and exposed to 3,500 J/m2 of FS40 sunlamp radiation (with their ears shielded) daily for 4 days.
Control mice were not irradiated. One hr after the last irradiation, they were sensitized to
oxazolone topically at the irradiated site. Upon challenge with oxazolone on the ears 6 days
later, UVR-exposed mice that were given standard drinking water had significantly suppressed
levels of CHS compared to non-UVR exposed mice. However, the presence of PL in the
drinking water significantly inhibited UVB-induced suppression. To examine the ability of PL
to inhibit systemic UVB-induced immunosuppression, a similar experiment was performed
except that mice were given 10,000 J/m2 of UVB radiation once on the shaved dorsum (with
ears shielded) and immunized at a shaved non-exposed site (abdomen) 3 days later. Once
again, upon challenge with oxazolone on the ears 6 days later, UVR-exposed mice that were
given standard drinking water had significantly suppressed levels of CHS compared to non-
UVR exposed mice while the presence of PL in the drinking water significantly inhibited UVB-
induced suppression. The ability of PL to inhibit UVB-induced immune suppression may
explain, in part, its ability to inhibit UVR-induced skin cancer induction in mice.
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Extracorporeal photopheresis has protective effects in both prophylactic and therapeutic
models of contact hypersensitivity
A Maeda,1 A Schwarz,1 A Bullinger,2 D Peritt2 and T Schwarz1 1 Department of Dermatology,
University Kiel, Kiel, Germany and 2 Therakos, Exton, PA
Extracorporeal photopheresis (ECP) involves the ex vivo treatment of autologous leukocytes
with 8-methoxypsoralen and UVA radiation in a closed loop, patient connected system. ECP
is approved for use in CTCL and has demonstrated activity in solid organ transplant rejection,
autoimmune diseases and GvHD. We have previously demonstrated in an experimental murine
model of contact hypersensitivity that 1) the majority of reinfused ECP-treated leukocytes are
retained in the liver and spleen 2) ECP caused inhibition of a hapten immune response in naive
primary recipients and 3) the tolerance could be transferred to naive secondary recipients via
infusion of CD4+ CD25+ regulatory T cells (Treg) in an antigen-specific manner. We now
extend those observations to show that Treg did not develop in splenectomized primary recip-
ients, indicating that the spleen is crucial for the generation of ECP-induced Treg. Injection of
ECP-treated leukocytes inhibits the sensitization when injected into naïve recipients that are
subsequently sensitized. To check whether also the elicitation is inhibited, ECP-exposed leuko-
cytes were injected into already sensitized recipients. Ear challenge was significantly sup-
pressed, indicating that experimental ECP does not only inhibit the induction but also the effec-
tor phase of contact hypersensitivity. Taken together, these data suggest that ECP-treated
leukocytes induce antigen-specific Treg, presumably in the spleen and that ECP has the abil-
ity to inhibit both the induction and the elicitation of immune responses which may explain
the therapeutic activity in humans.
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Morphological study on cutaneous elastic fiber in human skin in vivo
Z Chen, Y Cai, J Zhang and X Zhu Dermatology, People’s Hospital, Peking University, Beijing,
China
To compare the morphological alteration of elastic fibers in sun-protective skin of young vol-
unteers, sun-protective skin of aged people and sun-exposed skin of aged people, Gomori
staining method was used. The results show that elastic fiber network is composed of oxyta-
lan fibers, elaunin fibers and mature elastic fiber in sun-protective normal skin of young vol-
unteers. In sun-protective normal skin of aged people oxytalan fibers are significantly reduced
in papillary dermis, however elastic fibers in the upper and mid-dermis are slightly thickened
and fragmented. In sun-exposed human skin of the elderly few disrupted oxytalan fibers are
observed in the papillary dermis with an accumulation of dystrophic elastotic material in the
upper and reticular dermis. Taken together, the morphological differences of elastic fibers
between intrinsically aged skin and photo aged skin are distinguished. Gomori staining method
may be utilized to evaluate the severity of damage of elastic fibers in intrinsically aged skin
and photo aged skin.
807
UV-induced histone acetylation leads to increased expression of MMP-1 in cultured dermal
fibroblasts
M Kim, C Park, J Shin, J Lee, H Eun and J Chung Department of Dermatology, Seoul National
University College of Medicine, Seoul, South Korea
In this study, we investigated whether UV increases the acetylation of histone and its role of
histone acetylation in UV-induced MMP-1 expression in cultured dermal fibroblasts. Histone
deacetylase (HDAC) inhibitors, TSA and NaBu, induced the acetylation of histone H3 and H4,
and increased MMP-1 expression in cultured dermal fibroblasts. UV irradiation was also found
to induce the acetylation of histone H3 and expression of MMP-1. We found that UV irradi-
ation increased the phosphorylation of Histone H2AX (γ-H2AX), which is known to be a marker
of DNA double strand breaks, and increased p53 protein levels. By using chromatin immuno-
precipitation (ChIP) assay, we demonstrated that UV irradiation increased the binding of γ-
H2AX, p53 and acetylated histone H3 to the MMP-1 promoter (-2127/-1827). Interestingly,
anacardic acid, a histone acetyltransferase p300 inhibitor, inhibited the UV-induced γ-H2AX
and p53, acetylation of histone H3 and expression of MMP-1, and also prevented their bind-
ing to MMP-1 promoter (-2127/-1827). We also observed that UV irradiation inhibited HDAC
activity. Our results suggest that increased histone acetyltransferase p300 and decreased HDAC
activity by UV may lead to increased histone acetylation, and may allow easier access of
transcription factors to the promoter regions to increase MMP-1 expression.
809
The 8-oxo-guanine repair enzyme OGG1 encapsulated in liposomes reduces MMP-1 and
TNF-α in UV irradiated skin cells
KK Dong, N Damaghi, SD Picart, KA Smiles and DB Yarosh AGI Dermatics, Freeport, NY
8-oxo-guanine (8-oxo-G) is ubiquitous oxidative DNA damage prevalent in mitochondrial
DNA. The formation of 8-oxo-G is induced by reactive oxygen species (ROS) from UVA irra-
diation, cigarette smoke, environmental stressors, endogenous enzymatic peroxidation reac-
tions, and normal mitochondrial metabolism. Natural cellular repair of this oxidative damage
entails excision of 8-oxo-G from DNA via the enzyme 8-oxoguanine DNA glycosylase-1
(OGG1). We have encapsulated OGG1 in liposomes and shown that the delivery of this
enzyme into fibroblasts increases the rate of repair of 8-oxo-G, and reduces mitochondrial
toxicity. In addition to damaging DNA, ROS also stimulate the production of tumor necrosis
factor-α (TNF-α) and matrix metalloproteinase-I (MMP-1), two factors known to play roles in
photoaging. In order to establish the cellular effects of 8-oxo-G damage and repair, we ana-
lyzed mRNA synthesis and protein secretion of MMP-1 and TNF-α. Fibroblasts (NHDF) or ker-
atinocytes (NHEK) were irradiated with UV from a solar-simulating UVA340 bulb to induce
MMP-1 and TNF-α. Following irradiation, cells were treated with 1 µg/mL OGG1 liposomes
for up to 48h. mRNA synthesis and protein secretion from NHEK and NHDF were measured
through real-time RT-PCR and ELISA, respectively. There was an increase in MMP-1 secretion
from NHDF after treatment with 25 kJ/m2 UVA. Treatment with OGG1 liposomes caused a
35.6% reduction in the UVA-induced MMP-1 secretion. Additionally, TNF-α mRNA increased
in NHDF after irradiation with 75 kJ/m2 UVA. This induction was reduced by 16% after treat-
ment with OGG1 liposomes. In a separate experiment, irradiation of NHEK with 75 kJ/m2
UVA increased TNF-α mRNA synthesis after 24h and TNF-α secretion after 48h. UVA-induced
TNF-α mRNA synthesis decreased 55% after treatment with OGG1 liposomes, with a simi-
lar reduction in protein secretion. These results suggest that liposomal OGG1 can enhance
DNA repair and reduce the expression of stress response genes.
808
UV- and CpG-ODN-induced S6K activation is mediated by PI3K/AKT/TSC2/mTOR pathway
in cultured keratinocytes and dendritic cells
C Cao,1,2 C Ji,1,6 A Amaral,1 A Dragoi,5 N Kouttab,3 S Hazelwood,3 H Li,6 Z Bi,2 G Hu,2
W Chu,5 K Guan4 and Y Wan1 1 Biology, Providence College, Providence, RI, 2 Nanjing
Medical University, Nanjing, China, 3 Roger Williams Medcial Center, Providence, RI, 4 The
University of Michigan, Ann Arbor, MI, 5 Brown University, Providence, RI and 6 Yunnan
Medical College, Kunming, China
The mTOR pathway is an evolutionarily conserved signaling module regulating cell survival
and growth in response to a variety of environmental cues. Since both UV and CpG-ODNs
induce survival signal in both skin keratinocytes and dendritic cells (DCs), we, in this study,
test whether mTOR and downstream S6K are involved in their effects. We demonstrate that
UV and CpG-ODN induce S6K activation in both cultured DCs (XS106) and keratinocytes
(HaCaT). Using specific inhibitors and gene manipulation methods, we found that while EGFR-
mediated AKT activation is involved in UV- induced mTOR/S6K activation, CpG-ODN-induced
mTOR/S6K activation is dependent on DNA-PK. Furthermore, TSC2 is involved in UV- and
CpG-ODN-induced mTOR/S6K activation, since UV and CpG-ODN induce S6K activation
in TSC2+/+ MEF cells but not in TSC2-/- MEF cells where S6K is over activated. Unexpectedly,
AMPK, together with its upstream p38, which is known as a negative signal against mTOR/S6K
phosphorylation by activating TSC2, are also induced by UV and CpG-ODN. p38 inhibitor
SB203580 and AMPK inhibitor AMPKi reinforce UV-induced S6K activation. PI3K/AKT, Rhed,
mTOR inhibitors as well as TSC2 knockout potentiate UV-induced cell death and abolish CpG-
ODN-induced survival effects in cultured keratinocytes and dendritic cells. Together, our cur-
rent study defines a signal pathway in UV- and CpG-ODN-treated dendritic cells and ker-
atinocytes whereby inactivating phosphorylation of TSC2, downstream of PI3K/AKT activity
lead to Rheb and subsequent mTOR activation which further stimulates translation by phos-
phorylating p70 S6 kinase. p38/AMPK activation in both treated cells contributes as a nega-
tive feedback pathway to mTOR/S6K kinase activation.
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MyD88 mediates UV-induced MMP-1 and IL-6 expression in primary human keratinocytes
Y Lee, H Kim, C Park, S Kim, Y Kim, J Jung, K Kim and J Chung Department of Dermatology,
Seoul National University College of Medicine, ;Laboratory of Cutaneous Aging Research,
Clinical Research Institute, Seoul National University Hospital; Institute of Dermatological
Science, Seoul National University, Seoul, South Korea
Myeloid differentiation factor 88 (MyD88) is an adaptor protein for the Toll-like receptor
(TLR) family and participates in signal transduction by binding to the cytoplasmic Toll/IL-1
receptor (TIR) domains of activated TLR. UV irradiation induces the inflammatory responses
and photoaging in skin. In this study, we demonstrated that expression of MyD88 is increased
in photoaged human skin in vivo, and is increased in acute UV-irradiated human skin in vivo
and primary human keratinocytes in vitro. To determine whether MyD88 is involved in UV-
induced inflammatory genes expression, such as matrix metalloproteases (MMPs) and inter-
leukin-6 (IL-6), human keratinocytes were infected with adenovirus expressing wild type MyD88
(wt MyD88) and dominant negative MyD88 (DN MyD88), and then irradiated by 100 mJ/cm2
of UV. The overexpression of wt MyD88, but not DN MyD88, induces MMP-1 and IL-6 expres-
sions without UV irradiation. Also, UV-induced MMP-1 and IL-6 expressions were prevented
by DN MyD88 overexpression. This inhibition of UV-induced MMP-1 and IL-6 expression by
DN MyD88 overexpression was due to diminished AP-1 and NF-kB activation by DN MyD88.
These data suggest that MyD88 plays a pivotal role in UV-induced inflammatory responses.
810
HIF-1α: a key factor in keratinocyte response to UVB exposure
HR Rezvani,1 S Dedieu,2 S North,2 F Belloc,1 R Rossignol,3 T Letellier,3 H de Verneuil,1
A Taïeb1 and F Mazurier1 1 Inserm U876, Univ Bordeaux2, Bordeaux, France, 2 Inserm 0113,
Univ Bordeaux1, Bordeaux, France and 3 Inserm U668, Univ Bordeaux2, Bordeaux, France
Solar UV radiations are the major risk factor for the development of skin cancer (the most com-
mon malignancy in the world). To develop a strategy for the prevention and the therapy of
skin cancers, relationships between the various cellular signaling pathways that modulate
cellular responses to UV irradiation in skin cells need a more in-depth understanding. Within
the complex group of UV-induced cellular responses, the role of reactive oxygen species (ROS)
appears central with dual effects. On the one hand, increase in ROS levels following UVB irra-
diation lead to cytotoxicity through protein, lipid and DNA oxidation. On the other hand, ROS
act as second messengers mediating the cell response to UVB. We have previously reported
(Rezvani et al., J. Biol. Chem. 2006; Rezvani et al., Cancer Gene Ther. 2006) that reinforce-
ment of the antioxidant defense of epidermis reduces the deleterious effects of UVB-induced
ROS. In the present study, we addressed the possible role of ROS as second messengers after
UVB irradiation and their relationship with a stress-inducible transcription factor, the hypoxia-
inducible factor 1 alpha (HIF-1α). Our data demonstrate i) a biphasic effect of UVB on HIF-
1α, ii) the origins of UVB-induced ROS, iii) the opposite effect of cytoplasmic and mitochon-
drial UVB-induced ROS on HIF-1α expression, iv) the involvement of MAPKs on HIF-1α
stabilization and accumulation, v) the role of HIF-1α in UVB-induced apoptosis and vi) the
putative interconnections of HIF-1α and p53 regulatory pathways. We conclude that the broad
impact of the HIF-1α transcription factor on gene expression could make it a key regulator of
UV-responsive genes and photocarcinogenesis.
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Activation of TRPV1 by UV irradiation mediates UV-induced MMP-1 and -9 expression
Y Lee,1 Y Kim,1 S Kim,2 K Kim1 and J Chung1 1 Department of Dermatology, Seoul National
University College of Medicine, Seoul, South Korea and 2 Department of Physiology and
Biophysics, Seoul National University College of Medicine, Seoul, South Korea
Transient receptor potential vanilloid type 1 (TRPV1) channel is a molecular sensor for detect-
ing adverse stimuli during inflammation and is activated by capsaicin, heat and acid, thus
implicating the channel as a primary cellular sensor for thermal or chemical stimulation.
Although TRPV1 has been localized in the epidermis, the role of TRPV1 in skin has not been
elucidated . Thus, we investigated the role of TRPV1 on UV-induced MMP-1 and -9 expres-
sion in HaCaT cells. By immunohistochemical analysis, western blotting and real time PCR,
we found that UV irradiation increased the expression of TRPV1 mRNA and protein in HaCaT
cells and human skin in vivo. UV increased the calcium influx, which was inhibited by spe-
cific TRPV1 inhibitors (capsazepine and ruthenium red) and transfected TRPV1 siRNA, indi-
cating that UV activated TRPV1. UV-induced MMP-1 and -9 expression were decreased by
treatment of TRPV1 inhibitors in dose- and time- dependent manner or by knockdown of TRPV1
using siRNA in HaCaT cells. Furthermore, pretreatment with TRPV1 agonist (capsaicin) in
HaCaT cells increased UV-induced MMP-1 and -9 expression in a dose-dependent manner.
Therefore, our results suggest that UV irradiation increased TRPV1 expression, and that the
activation of TRPV1 by UV irradiation may mediate UV-induced MMP-1 and -9 expression.
812
Alteration of fat metabolism in subcutaneous fat tissues of photoaged and acutely UV-irra-
diated human skin in vivo
E Kim, Y Kim, C Park and J Chung Department of Dermatology, Seoul National University
College of Medicine; Seoul National University Hospital, Seoul, South Korea
Although subcutaneous fat is a basic component of the skin, the changes of fat metabolism in
photoaged human skin is poorly understood. In this study, we investigated the alteration of fat
metabolism in the subcutaneous fat tissues by photoaging process and acute UV irradiation
in human skin in vivo. We measured the amounts of free fatty acid (FFA) and triglyceride (TG)
in subcutaneous fat tissues of photoaged forearm and intrinsically aged buttock of same aged
individuals (n=5). The amounts of FFA and TG in the forearm were significantly lower than
those in the buttock. We also demonstrated that the expressions of lipogenesis enzymes, such
as fatty acid synthase (FAS), acetyl CoA carboxylase (ACC) and stearoyl CoA desaturase (SCD),
and the transcription factor, sterol regulatory element binding protein (SREBP1), were decreased
significantly in photoaged forearm fat tissues, compared with buttock of the same volunteers.
We found that acute UV irradiation (2 MED) to the buttock skin reduced the amounts of FFA
and TG in the subcutaneous fat tissue 72h post-irradiation, and that UV also decreased dra-
matically the expression of FAS, ACC, SCD and SREBP1 in buttock fat tissue 24h post-treat-
ment. Our results suggest that the fat metabolism in subcutaneous fat tissues may be affected
by UV exposure in human skin.
813
Discrimination of basal cell carcinoma from normal dermal stroma by non-linear optics
S Lin,1 S Wang,1 C Kuo,2 C Dong2 and S Jee1 1 Department of Dermatology, National Taiwan
University Hospital and College of Medicine, Taipei, Taiwan and 2 Department of Physics,
National Taiwan University, Taipei, Taiwan
The non-linear excitation of fluorescence photons using a multiphoton microscope has been
used as an in vivo non-invasive imaging modality in recent years. In biological structures
lacking an inversion, such as collagen, a non-vanishing second order susceptibility can con-
tribute a second harmonic generation (SHG) signals. In this work, we attempt to evaluate the
potential of non-linear optics for guidance of basal cell carcinoma removal. Basal cell carci-
nomas can be identified by masses of autofluorecent cells with relatively large nuclei and
marked peripheral palisading. In normal dermis, SHG from dermal collagen contributes largely
to the signals. However, within the cancer stroma, SHG signals diminish and are replaced by
autofluorescent signals, indicating that normal collagen structures responsible for SHG have
been altered. To better delineate the cancer cells and cancer stroma from normal dermis, a
quantitative multiphoton fluorescence to SHG index (MFSI) is developed. We demonstrate that
this index can be used to differentiate cancer cells and adjacent cancer stroma from normal
dermis. With further development, multiphoton and SHG imaging can be an alternative for
Mohs’ surgery in the real-time guidance of basal cell carcinoma removal.
814
Multiphoton autofluorescence and second harmonic generation microscopy for evaluation
of thermal damage of dermis
M Lin,1 C Chan,2 S Wang,2 S Jee,2 C Dong1 and S Lin2 1 Department of Physics, National
Taiwan University, Taipei, Taiwan and 2 Department of Dermatology, National Taiwan
University Hospital and College of Medicine, Taipei, Taiwan
We attempt to evaluate the potential of multiphoton microscopy for characterizing the degree
of skin thermal damage in this study. Human foreskin is heated at different temperatures for
imaging. Our results show that dermal collagen and elastic fibers display different suscepti-
bility to thermal injury. Morphologically, dermal collagen starts to denature at 60°C while
structural transition of elastic fibers do not occur until 65°C. Interestingly, the thermal dam-
age causes fracture and aggregation of elastic fiber without diminishing its autofluorescence.
With increasing temperatures, the structures of both elastic and collagen fibers deteriorate.
While second harmonic generation (SHG) imaging is helpful in identifying the denaturation
temperature of collagen, autofluorescence (AF) imaging can help to identify the structural alter-
nations of tissue at higher temperatures when SHG signals have decayed. We also employ a
ratiometric approach based on the AF to SHG index of dermis (ASID) to characterize the degree
of dermal thermal damage. Use of the ASID index can bypass the difficulty in analyzing inho-
mogeneous dermal fibers and show that dermal collagen starts to denature at 60 °C. Our results
suggest that with additional developments, multiphoton microscopy has potential to be devel-
oped into an effective in vivo imaging technique to monitor and characterize dermal thermal
damage.
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ATP-sensitive potassium channel as a novel target for protection against UV-induced skin
immunosuppression
C Cao,1,2 C Ji,1,2 A Amaral,1 E Valenti,1 L Beveridge,1 C O’Brien,1 Z Bi,2 G Hu,2 N Kouttab,3
W Chu4 and Y Wan1 1 Biology, Providence College, Providence, RI, 2 Nanjing Medical
University, Nanjing, China, 3 Roger Williams Medical Center, Providence, RI and 4 Brown
University, Providence, RI
Ultraviolet radiation suppresses cellular immunity. One of the mechanisms related to this immuno-
suppression is the apoptosis of dendritic cells (or DCs) in the epidermis. ATP-sensitive potassium
(KATP) channel openers (KCOs) have been shown to exert significant myocardial preservation and
neuroprotection in vitro and in vivo, and our most recent study demonstrates that KCOs protect
against UV-induced keratinocytes cell damage. However, the potential role of those KCOs in pro-
tection against UV-induced immunosuppression or dendritic cell apoptosis is unknown. Using
cultured murine DCs (XS106), we investigated the effects of pinacidil and diazoxide, two classi-
cal KCOs, on UV-induced cell death. Here, we demonstrate for the first time that Kir6.1, Kir 6.2,
SUR1, and SUR2 subunits of KATP channels are functionally expressed in XS106 and monocyte-
derived dendritic cells. Both non-selective KATP channel opener pinacidil and mitoKATP (mito-
chondrial KATP) channel opener diazoxide attenuate UV-induced XS106 cell death. The protec-
tive effects are abolished by both non-selective KATP channel blocker glibenclamide and selective
mitoKATP channel blocker 5-hydroxydecanoate (5-HD). Also, activation of KATP channel with
pinacidil or diazoxide results in suppressive effects on UV-induced JNK and p38 activation that
mediates UV-induced DC cell death. Furthermore, UV-induced mitochondrial membrane poten-
tial loss, cytochrome c release and ultimately apoptotic cell death are also inhibited by precon-
ditioning with pinacidil and diazoxide, and their effects are reversed by glibenclamide and 5-
HD. Taken together, we conclude that mitoKATP is likely to contribute to the protection against
UV-induced DCs cell damage. Our findings suggest that KATP openers such as pinacidil and dia-
zoxide may be utilized to protect against UV-induced skin immunosuppression.
816
All-trans retinoic acid attenuates ultraviolet radiation-induced down-regulation of Aqua-
porin-3 and water permeability in human keratinocytes and fibroblasts
C Cao,1,4 S Wan,3 A Amaral,1 A Lee Couture,1 Z Bi,4 G Hu,4 N Kouttab,2 W Chu3 and Y Wan1
1 Biology, Providence College, Providence, RI, 2 Roger Williams Medical Center, Providence,
RI, 3 Brown University, Providence, RI and 4 Nanjing Medical University, Nanjing, China
One of the major characteristics of human skin photoaging induced by ultraviolet (UV) radi-
ation is the dehydration of the skin. Water movement across the plasma membrane occurs via
two pathways: by diffusion through the lipid bilayer and by membrane-inserted water chan-
nels, or aquaporins (AQPs). In this study, we found that UV induces AQP3 downregulation in
a time- and dose-dependent manner in cultured human skin keratinocytes and fibroblasts.
PD98059 and U0126, known as MEK/ERK inhibitors, inhibit UV-induced downregulation of
AQP3. H2O2 also induces AQP3 downregulation in both types of skin cells. N-acetyl-l-cys-
teine, or NAC, a well known antioxidant, blocks UV-induced AQP3 downregulation and
MEK/ERK activation. All trans-retinoic acid, or atRA, which has shown protective effects against
UV-induced photoaging, induces AQP3 expression. Using existing pharmacological inhibitors,
we observed that EGFR activation, at least in part, is involved in atRA-induced AQP3 upreg-
ulation. AtRA blocks UV-induced downregulation of AQP3 expression and water permeabil-
ity. Taken together, we conclude that UV radiation downregulates AQP3 with a result of reduced
water permeability in cultured skin cells through a reactive oxygen sensitive MEK/ERK path-
way. Anti-oxidant NAC and atRA attenuate UV-induced downregulation of AQP3 and water
permeability. This novel finding provides insight into an understanding of the molecular mech-
anism of UV-induced skin aging and may offer a better explanation of antioxidants such as
NAC and atRA’s protective effects against UV-induced photoaging.
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Epidermal growth factor receptor is a critical mediator of ultraviolet radiation-induced sig-
nal transduction in dendritic cells
C Cao,1,2 C Ji,1,2 A Amaral,1 E Valenti,1 L Beveridge,1 C O’Brien,1 A Sowa,1 Z Bi,2 G Hu,2
N Kouttab,3 W Chu4 and Y Wan1 1 Biology, Providence College, Providence, RI, 2 Nanjing
Medical University, Nanjing, China, 3 Roger Williams Medical Center, Providence, RI and 4
Brown University, Providence, RI
Ultraviolet radiation induces apoptosis and functional maturation in dendritic cells (DCs)
including but likely not limited to Langerhans cells. However, the mechanisms through which
DCs are activated or damaged by UV radiation have not been well characterized. In this study,
we examined the mechanisms of activation and apoptosis of murine DCs (XS106 cell line)
after UV radiation by focusing on epidermal growth factor receptor or EGFR, since our pre-
vious data have demonstrated that in addition to cognate ligands, EGFR is activated by UV
radiation in cultured human skin keratinocytes in vitro and in human skin in vivo. We here
for the first time present that UV induces EGFR transactivation in cultured murine skin DCs
(XS106) as well as monocyte-derived dendritic cells. Pharmacological inhibition of EGFR tyro-
sine kinase significantly inhibits UV-mediated induction of ERK, p38, and JNK MAP kinases,
and their downstream effectors, transcription factors c-Fos and c-Jun. Inhibition of UV acti-
vation of EGFR also suppresses activation of PI3K/AKT and NF-kB-dependent signal trans-
duction pathways. MEF cells devoid of EGFR were used to further investigate EGFR depend-
ence of UV-induced signal transduction. The results show that UV-induced activation of MAPK,
c-Fos, c-Jun, PI3K as well as NF-kB is reduced in EGFR-/- cells compared to wild type MEF
cells. Furthermore, EGFR inhibitors PD153035, AG1478 reduce DCs maturation potential and
enhance apoptosis and cell death induced by UV radiation. Similar results were also observed
in EGFR knock out cells. Taken together, these data demonstrate that EGFR is required in
response to UV radiation for the activation of multiple signaling pathways that are known to
mediate DCs cell survival and maturation.
819
Transient receptor potential vanilloid-1 mediates heat shock-induced matrix metallopro-
teinase-1 expression in human epidermal keratinocytes
W Li, Y Lee, J Kim, S Kang, S Kim, K Kim, C Park and J Chung Department of Dermatology,
Seoul National University, College of Medicine, Laboratory of Cutaneous Aging Research,
Clinical Research Institute, Seoul National University Hospital; Institute of Dermatological
Science, Seoul National University, Seoul, South Korea
Matrix metalloproteinase-1 (MMP-1) is considered to be a key initiator of collagen degrada-
tion in inflammatory responses. Transient receptor potential vanilloid-1 (TRPV1), a heat-
gated channel, was recently found on human keratinocytes and the activation of epidermal
TRPV1 was known to induce release of proinflammatory mediators. However, the functional
consequences of TRPV1 activation in cutaneous physiology and pathology have not been elu-
cidated clearly. The aim of this study was to investigate the role of TRPV1 on the MMP-1 expres-
sion induced by heat shock in human epidermal keratinocytes. Heat shock induced the expres-
sion of MMP-1 mRNA and protein in a temperature-dependent manner in an immortalized
keratinocyte cell line (HaCaT) and normal human epidermal keratinoyctes (NHK). Heat shock-
induced MMP-1 expression was decreased by treatment of the TRPV1 inhibitors (capsazepine
and ruthenium red) or knockdown of TRPV1 using RNA interference in HaCaT cells. Over-
expression of TRPV1 greatly increased heat shock-induced MMP-1 promoter activity in HEK
293 embryonic kidney cells. Furthermore direct activation of TRPV1 by capsaicin, a TRPV1
agonist, increased MMP-1 expression. We found that heat shock induced calcium influx
through TRPV1 and that extracellular calcium is necessary for heat shock-induced MMP-1
expression in HaCaT cells. Taken together, our results suggest that heat shock-induced MMP-
1 expression is mediated by activation of TRPV1 and is dependent on a calcium-dependent
signaling process in human epidermal keratinocytes.
821
Collagen remodeling induced by different non-ablative laser effects: a comparative in vivo
study on mouse model
H Liu, X Chai, Y Dang, Z Wang and Q Ren Institute for Laser Medicine and Bio-Photonics,
Shanghai Jiao-Tong University, Shanghai, China
Purpose: To explore the mechanisms of laser induced collagen remodeling systematically on
a Kunming (KM) mouse model in vivo by comparing the different non-ablative laser effect
using four different laser treatment modalities. Methods: The back skin of KM mice was exposed
by depilation before the laser treatments. Four laser treatment modalities: the 595-nm pulsed
dye laser (10 ms), 1320-nm Nd:YAG laser (0.35 ms), 1064-nm Nd:YAG lasers with Q-switched
(5 ns) and long-pulsed (0.3 ms) mode were irradiated to one side of the mouse dorsal skin
and leave the other side as the control. Then skin histology, fibroblast number and the gene-
sis of type Ι and ΙΙΙ collagen were studied by comparing the treatment site and control site
immediately and at one day, one week, three weeks, four weeks and eight weeks after the
laser treatments, and biochemical examination of hydroxyproline was conducted eight weeks
after laser treatments. Results: All lasers applied showed a statistical improvement in skin elas-
ticity, dermal thickness and synthesis of hydroxyproline compared with their own controls.
The Q-switched 1064-nm laser resulted in greater improvement of skin elasticity, dermal thick-
ness, and higher synthesis of hydroxyproline than the other lasers after two months of treat-
ments, while there was no significant difference among the 595nm, 1320nm and long-pulsed
1064nm lasers. Among the new collagen genesis after the different laser treatments, collagen
type ΙΙΙ increased sharply after the Q-switched 1064-nm laser treatment whereas more col-
lagen type Ι was elicited by the other laser treatment modalities. Conclusions: Our results
demonstrated that the Q-switched 1064-nm laser was more effective compared with the other
three lasers in non-ablative collagen remodeling. photo-mechanical effect using Q-switched
Nd:YAG laser promotes more effectively the synthesis of collagen type ΙΙΙ whereas the photo-
thermal effect favored more the formation of collagen type Ι.
820
Regulation of inflammatory cytokines by HtrA1/PRSS11 serine protease in UVB-irradiated
human keratinocytes
S Yahagi,1 Y Okano,1 AS Zervos3 and H Masaki1,2 1 Nikkol Group Cosmos Technical Center
Co., Ltd., Tokyo, Japan, 2 Nikko Chemicals Co., Ltd., Tokyo, Japan and 3 Biomolecular
Science Center, Burnett College of Biomedical Science, University of Central Florida,
Orlando, FL
HtrA1/PRSS11, a member of the stress-activated family of serine proteases (HtrA’s), is expressed in
various tissues including the skin. Recent immunohistological studies identified HtrA1 in the epi-
dermal region, especially between the granular and cornified layers of the epidermis, however, the
role of HtrA1/PRSS11 in human epidermal tissue is not known. In the epidermis, several serine pro-
teases have been implicated in various diverse functions including activation of other proteases, and
secretion of cytokines/chemokines involved in inflammation. In each case, increase in inflamma-
tory cytokine production caused adverse effects on the skin. This study was designed to elucidate
the relationship between HtrA1/PRSS11 protease and skin alterations caused by UVB-irradiation.
Specifically, we investigated the regulation of inflammatory cytokine production by HtrA1/PRSS11
following UVB-irradiation. The levels of mRNA and protein of HtrA1/PRSS11 in keratinocytes, were
monitored using RT-PCR and Western blot analysis. The results of these experiments demonstrated
that secretion of HtrA1/PRSS11 protein was increased after UVB-irradiation and in the absence of
any changes in the mRNA levels. The role of the increased HtrA1/PRSS11 secretion as a potential
regulator of several inflammatory markers, including PGE2 and IL-1α, was also examined. Ucf-101,
a specific inhibitor of HtrA1/PRSS1, was used to study any role the proteolytic activity of this enzyme
might play in this inflammatory process. The inhibitor was able to substantially decrease the pro-
duction of both, PGE2 and IL-1α, in UVB-irradiated keratinocytes. The results of this study show that
HtrA1/PRSS11, through its proteolytic activity, can stimulate the production of inflammatory-relat-
ing substances. This is the first report to propose a novel role of HtrA1/PRSS11 protease in the epi-
dermis as a specific inducer of inflammation following UVB-irradiation.
818
CpG-DNA protects against UV-induced cell damage through induction of interaction between
EGFR and DNA-PK and DNA-PK dependent AKT activation in both keratinocytes and den-
dritic cells
C Cao,1,2 C Ji,1,2 A Dragoi,4 X Wang,4 A Amaral,1 A Lee-Couture,1 E Valenti,1 L Beveridge,1
C O’Brien,1 A Sowa,1 N Kouttab,3 W Chu4 and Y Wan1 1 Biology, Providence College,
Providence, RI, 2 Nanjing Medical University, Nanjing, China, 3 Roger Williams Medical
Center, Providence, RI and 4 Brown University, Providence, RI
CpG-DNA and its related synthetic CpG oligodeoxynucleotides (CpG-ODNs) play an impor-
tant role in immune cell survival and activation. Existing data have shown that DNA-depend-
ent protein kinase (DNA-PK), as well as DNA-PK mediated AKT activation are involved in this
process. However, the potential role of CpG-ODN in protection against UV-induced skin dam-
age has thus far not been tested. In this study, we found that CpG-DNA protects against UV-
induced cell death in both skin keratinocytes (HaCaT cells) and cultured dendritic cells (XS106,
or DCs). CpG-ODN treatment activates AKT (ser473, thr308) in both HaCaT cells and DCs,
which is abolished by PI3K/AKT inhibitor LY294002. The protective effects against UV radia-
tion and AKT induction of CpG-ODN were not observed in DNA-PK knockout MEF cells.
These data suggest that DNA-PK mediates CpG-ODN-induced AKT activation and its protec-
tive effect. Unexpectedly, UV-induced EGFR activation plus EGFR-mediated AKT activation,
which are known as survival signals against UV radiation, were also not detectable in DNA-
PK knock MEF cells. Immunoprecipitation experiments showed interaction between EGFR and
DNA-PK in a dose-dependent and time-dependent manner following UV treatment in HaCaT
cells, DCs and wild-type MEFs but not in DNA-PK knockout MEFs cells. Collectively, we con-
clude that UV radiation induces interaction of EGFR and DNA-PK and this interaction medi-
ates EGFR activation and downstream AKT activation. Furthermore, CpG-ODN protects against
UV-induced cell death by DNA-PK dependent AKT activation. Our findings suggest that CpG-
ODN may be utilized to prevent from UV-induced skin aging and provide a novel mecha-
nism of DNA-PK’s protective effects against UV radiation.
822
Modulation of epigallocatethi-3-gallate on the intrinsic senescence and gene mutation fre-
quency from UVB or UVA irradiation human fibroblasts
D Luo, J Zhu and J Gao Dermatology and Venereology, the First Affiliated Hospital of Nanjing
Medical University, Nanjing, China
Cell senescence associated β-Galactosidaece, hprt gene mutation frequency and cellular apop-
tosis are the important parameters to evaluate the effect of epigallocatethi-3-gallate (EGCG)
under long-term culture(80 days) or relative long time UVA or UVB irradiation in human skin
fibroblasts. Fibroblasts were separated from infant foreskin and divided into long-term culture
group(A group) and long-term UV irradiation group(B group). A group include control and
EGCG, B group include control, EGCG, UVA, UVB, UVA+EGCG and UVB+EGCG. The cells
were irradiated by 30 mJ/cm2 UVB and 20J/ cm2 UVA every day for 2 weeks. The senescence
associated β-Gal were detected by histochemistryl stain. The hprt gene mutation frequency
were detected by the hprt mutagenesis assay. The apoptosis rate and cell cycle were detected
by Flow Cytometetry. After Cells were cultured with EGCG or DMEM for 80 days, the rate of
senescence cells of EGCG group was lower than the control group(decreased by 47.60%).
Two weeks of UVA/B irradiation could increase the number of senescence cells and the rate
of cellular apoptosis. When cultured with EGCG before UV irradiation, the percentage of
senescence cells and apoptosis rate could be increased further. Long-term UVA/B irradiation
could induce the mutation frequency of human skin fibroblasts and EGCG could decrease
such mutation frequency. EGCG can delay natural cell senescence and decrease the mutation
frequency induced by long-term UVA/B irradiation, but EGCG increase cell senescence and
apoptosis rate under 2 weeks of UV irradiation, which maybe related to the promoting mech-
anisms of EGCG on the mutating cells to proceeding senescence and/or apoptosis.
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Solar irradiation induces DNA damages and caspase 3-dependent apoptosis in pig skin organ
culture : a new ex vivo model to test sunscreen photoprotection
D Bacqueville and A Mavon Laboratoire de Pharmacocinétique Cutanée, Institut de
Recherche Pierre Fabre, Castanet-Tolosan, France
Recent studies have demonstrated that pig skin is highly related to human skin. However, its
relevance as an alternative model to human tissue especially in ultraviolet (UV)-induced
responses remains poorly understood. Therefore, we developed a short-term organ culture by
seeding pig ear skin explants in gelatin-coated cell culture inserts and feeding them using Dul-
becco’s Modified Eagle’s Medium (DMEM) supplemented with pyruvate, glutamine, fungizone
and antibiotics. Immunohistochemical analysis using specific epidermal/dermal markers (cytok-
eratin 10, involucrin, laminin and collagene I) revealed that pig skin structure is similar to that
fresh human skin and that its differentiation is maintained up to 48 hours in culture. There-
after, the explants were irradiated at a 5 DEM equivalent dose by using a solar simulator, and
the UV effects were analyzed 24 hours post-irradiation. Solar irradiation was clearly associ-
ated to sunburn cell formation and DNA damage generation in epidermal basal layers, but
also in the dermal compartment (thymine dimers and DNA fragmentation in situ by immunos-
taining and TUNEL technique, respectively). Interestingly, cell death was correlated to both
p53 tumor suppressor up-regulation and strong activation of the caspase-3 protease in basal
epidermis, and caspase 3-dependent apoptosis was time and dose-dependent in response to
UV exposure (immunohistochemistry, western-blot, and enzymatic assay). These cellular
responses were not observed in non-irradiated skin, and the topical application of a broad
spectrum UVB + A sunscreen at a 2 mg/cm2 concentration afforded an efficient photoprotec-
tion. Altogether, these data suggest that ex vivo pig skin organ culture is a surrogate to human
tissue and a suitable alternative model to assess solar irradiation-induced apoptosis and eval-
uate sun care products.
824
P38 mitogen-activated protein kinase on UVB-induced apoptosis of human keratinocyte
HaCaT cells
X Chen, D Luo, B Zhou and J Xu Department of Dermatology, the First Affiliated Hospital of
Nanjing Medical University, Nanjing, China
This study examined the hypothesis that UVB irradiation promotes HaCaT cells secretion of
inflammatory cytokines such as tumor necrosis factor TNF-α and induces cell apoptosis via
the p38MAPK pathway.The HaCaT cells were divided into four groups: 1).control; 2).UVB;
3).control+SB203580(P38MAPK inhibitor);4).SB203580+UVB; In order to determine the sig-
naling pathways induced by UVB, Western blot analysis was performed for p38 mitogen-acti-
vated protein kinase (MAPK). Flow cytometry was used to detect the apoptosis of the cells.
The TNF-α concentration was determined by ELISA. P38MAPK phosphorylation can be
detectable immediately after UVB irradiation and peaked at one hour. TNF-α secretion and
cell apoptosis were significantly increased at 24h. SB203580 could not inhibit the phospho-
rylation of p38MAPK,but reduced cell secretion of TNF-alpha, and prevented cell apoptosis.
These data suggest p38 MAPK activation is one aspect of the signaling cascade that culmi-
nates in the secretion of TNF-alpha and contributes to cell apoptosis after UVB irradiation.
825
Sargaquinoic acid and Sargachromenol, extract of Sagassum sagamianu, induce apoptosis
in HaCaT cells and mice skin: its potentiation of UVB-induced apoptosis
S Hur,1 B Lee,2 H Lee1 and T Kim1 1 Dermatology, Catholic University of Korea, Seoul, South
Korea and 2 2Department of Applied Chemistry, Hanbat National University, Taejeon, South
Korea
Apoptosis is one of the main types of programmed cell death that plays a crucial role in the
development and homeostasis of human body. In continuously renewing tissues like the skin,
cell proliferation and cell death have to be tightly regulated to ensure the correct tissue func-
tion and to prevent inappropriate excessive cell growth. This study examined the novel apop-
totic effect of Sargaquinoic acid (SA) and Sargachromenol (SC), extract of brown algae Sar-
gassum sagamianum in keratinocytes. On MTT, TUNEL assays, either SA or SC treatment
increased cell death of HaCaT cells in a concentration dependent manner. After SA treat-
ment, UVB (15 mJ/cm2) exposure synergistically enhanced the apoptosis in HaCaT cells. Co-
treatment of UVB and SA/SC showed much higher levels of cleaved caspase-3,-8,-9 and
PARP than SA/SC alone, however, it had no effect on Bcl-2 and Bax expression level. In hair-
less mice, UVB irradiation on SA treated mice synergistically increased apoptosis, as shown
in HaCaT cells in vitro. On TUNEL and immunohistochemistry staining, co-treatment UVB
and SA increased the number of TUNEL-positive cells and induced the activation of caspase-
3 not only in the upper layer of epidermis but also in the basal layer of epidermis. These
results suggest that UVB treatment with SA or SC synergistically increases apoptosis via cas-
pase activation, and SA and SC might be candidates to manipulate the hyperproliferative skin
diseases.
826
Sunbed use induces the photoaging-associated mitochondrial common deletion in previously
unexposed skin
U Krämer,1 V Reimann,1 D Sugiri,1 P Schroeder,1 B Hoffmann,2 K Medve-Koenigs,1 K Jöckel,2
U Ranft1 and J Krutmann1 1 Molecular Aging Research, Institut für umweltmedizinische
Forschung (IUF) at the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany and 2
Biometry and Epidemiology, Institute for Medical Informatics, Medical School University
Duisburg-Essen, Duisburg, Germany
Sunbeds have become very popular and, as one consequence, health effects of their use are
of growing concern. In this regard, exposure to ultraviolet (UV) radiation from sunbeds may
cause premature skin aging. Evidence for this assumption, however, has thus far been elusive.
In the present study we have therefore assessed whether sunbed use induces the generation
of a photoaging-associated large scale mitochondrial DNA mutation in human skin. Fifty-
nine individuals, who voluntarily started to use sunbeds, were observed over 3 months. Punch
biopsies were taken from neck and buttock skin before their first and after their last sunbed
visit. The content of the most frequent large scale deletion of the human mitochondrial genome,
the so called Common Deletion (CD), was determined by quantitative real time PCR. Multi-
ple linear regression analysis was used for statistical analysis. Volunteers without previous
sunbed use showed a 2.56-fold increase (95%CI: 0.97-6.78) of the Common Deletion in neck,
and a 3.58-fold increase (95%CI: 1.44-8.89) in buttock skin samples after sunbed use. Partic-
ipants with previous sunbed use showed no increase. This study demonstrates that sunbed
use causes mtDNA mutagenesis and thus most likely contributes to premature skin aging.
827
Comparision study of UVB and IPL on cell viability and secretion of matrix metalloproteinases
in cultured Chinese fibroblasts
Y Xu, D Wu, B Chen, D Luo and Z Xue Dermatology and Venereology, The First Affiliated
Hospital of Nanjing Medical University, Nanjing, China
Our study was designed to compare the different effects of UVB and IPL on the cell viability
and secretion of MMP-1 and MMP-2 in Chinese fibroblasts. Fibroblasts were isolated from
the infant foreskin and were irradiated by UVB and IPL irradiation, respectively. The cell mor-
phological changes were observed by light microscopy. MTT assay was used to detect cell
proliferation and cellular viability. The proteins of MMP-1 and MMP-2 from cell supernate
were determined by ELISA. We found IPL irradiation showed no noticeable effect on the cell
morphology of fibroblasts, while the fibroblasts were damaged 24h after UVB irradia-
tion(30,60,90mJ/cm2) to different degrees. The cellular activity was increased in fibroblasts
24h and 48h after IPL irradiation. However, the cell proliferation activity of fibroblasts was
decreased 24h after UVB irradiation and this down-regulation effect of UVB was dose-depend-
ent(30,60,90mJ/cm2). And the time-dependence of 30 mJ/cm2 UVB on the fibroblast prolif-
eration was obvious within 24h. And we also found IPL irradiation showed no regulation effect
on MMP-1 and MMP-2 secretion level. However, after irradiated by 30mJ/cm2 UVB, the lev-
els of the MMP-1 and MMP-2 secretion were obviously increased. It comes to a conclusion
that IPL irradiation can induce the cell proliferation and cell viability in cultured Chinese
fibroblasts,but IPL has no regulation on MMP-1and MMP-2 secretion for fibroblasts. Com-
pared to IPL,UVB irradiation could damage fibroblasts, reduce the cell viability and increase
MMP-1,MMP-2 secretion level.
828
Effects of intense pulse light on the collagens of Balb/c mouse skin
Y Cao, D Luo and D Wu Dermatology, the First Affiliated Hospital of Nanjing Medical
University, Nanjing, China
The aim of our present study is to investigate the effects of intense pulse light (IPL) on the col-
lagen expression of Balb/c mouse skin and confirm its molecular mechanisms on photoag-
ing.The dorsal skin of Balb/c mouse was irradiated by IPL(560 nm cutoff filter, 8 x 35 mm spot
size, pulse duration 4.0/4.0 ms, pulse delay 30 ms, fluence 15 J/cm2). Each mouse was given
2 treatments separated by 2 week intervals. Before treatment and from 1 day to 8 weeks (1d,3ds,
5ds, 1wk, 2 wks, 3 wks, 4 wks, 6 wks and 8 wks) after treatment, the irradiated skin speci-
mens were taken at above different time points, respectively. Histopathological changes were
observed by light scope. Quantitative assessment of collagen I and collagen III were meas-
ured using immunohistochemical staining. The mRNA levels of procollagen I, procollagen III,
MMP-1 and MMP-2 were detected by RT-PCR. The histology showed dermis thickening accom-
panied with collagen amount increase and the better organization. The staining of collagen I
and Collagen III were stronger in IPL treated regions than those in non-treated areas from 2 to
8 wks after IPL irradiation(p<0.05).Compared to the sham-irradiation group, the mRNA expres-
sion levels of the procollagen I and procollagen III were also increased from 2w up to 8w
after IPL irradiation (p<0.05) and those up-regulation effects of IPL were time-dependent. The
mRNA expression levels of MMP-1 and MMP-2 were decreased from 2w up to 8w after IPL
irradiation (p<0.05) and this down-regulation effect of IPL was time-dependent. Taken together,
we can conclude that IPL irradiation can not only enhance new collagen production,but also
decrease collagen degradation for photorejuvenation mechanisms in mouse skin.
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Suppression of UV-induced oxidative stress and activation of MAPK proteins and NF-κB
through restoration of MAP kinase phosphatases by dietary grape seed proanthocyanidins
SM Meeran,1 SD Sharma,1 CA Elmets1,2 and SK Katiyar1,2 1 Dermatology, University of
Alabama at Birmingham, Birmingham, AL and 2 Birmingham VA Medical Center,
Birmingham, AL
Dietary grape seed proanthocyanidins (GSPs) inhibit photocarcinogenesis in mice. As UV-
induced oxidative stress and oxidative stress-mediated signaling have been implicated in pho-
tocarcinogenesis, we determined the effect of dietary GSPs on UV-induced oxidative stress
in in vivo, SKH-1 hairless mice. Here, we report that provision of dietary GSPs (0.2 and 0.5%,
w/w) to mice exposed to either acute UV irradiation (120 mJ/cm2) or chronic irradiation of
UV inhibited UV-induced: (i) depletion of antioxidant defense components, such as, glu-
tathione, glutathione peroxidase and catalase, and (ii) the levels of H2O2, lipid peroxidation
and NO in mouse skin. As UV-induced oxidative stress mediates activation of mitogen-acti-
vated protein kinases (MAPK) and nuclear factor-kappa B (NF-κB) signaling pathways, we
determined the effect of dietary GSPs on these pathways. Employing western blot and immuno-
histochemical analysis, we found that treatment of mice with GSPs inhibited UV-induced
phosphorylation of ERK1/2, JNK and p38 proteins of MAPK family. Chronic UV exposure
suppressed the levels of MAP kinase phosphatases in mouse skin compared to non-UV-exposed
control mice; however, the UV-induced suppression of MAP kinase phosphatases was reversed
or restored in mice which were treated with GSPs. GSPs also inhibited UV-induced activa-
tion of NF-κB/p65 through inhibition of degradation of IκBα and activation of IKKα. As NF-
κB-targeted genes play critical roles in inflammation and cellular proliferation, we assessed
the effect of GSPs on proteins encoded by these genes. We found that dietary GSPs resulted
in inhibition of UV-induced expression of PCNA, cyclin D1, iNOS and COX-2 in the skin.
Collectively, our data demonstrate that GSPs have the ability to protect the skin from UV-
induced oxidative stress and activation of MAPK and NF-κB signaling and thus provides the
molecular basis for the photoprotective effects of GSPs in an in vivo animal model.
831
Cellular UVB protection by FO31282, a new, potent arylhydrocarbon receptor antagonist
G Vielhaber,1 E Fritsche,2 C Schaefer,2 O Koch,1 J Abel2 and J Krutmann2 1 Symrise GmbH &
Co KG, Holzminden, Germany and 2 Institut fuer Umweltmedizinische Forschung,
Düsseldorf, Germany
UVB irradiation is the major cause for photocarcinogenesis. Two mechanisms have been iden-
tified: (i) formation of DNA photoproducts in the cell nucleus and (ii) activation of EGF recep-
tor and subsequent downstream signal transduction pathways. Reactive oxygen species have
been thought to primarily induce EGFR downstream signal transduction, but we have recently
shown that also activation of the cytoplasmatic arylhydrocarbon receptor (AhR) by UVB -
induced intracellular formation of the tryptophan dimer and AhR ligand formylindolo[3,2b]car-
bazole (FICZ) is responsible for EGFR signaling. Activated AhR shuttles into the nucleus and
triggers expression of cytochrome P450 (CYP)1A1 which is involved in xenobiotic metabo-
lism. At the same time, ligand binding induces the release of AhR cofactors which leads to
activation of EGFR and downstream targets like cyclooxygenase (COX)-2, which is a key player
in inflammation. In the present study, we developed an efficient protection against UVB induced
AhR activation. Up to date, only 3-methoxy-4-nitroflavone (MNF) has been shown to be an
inhibitor of UVB induced AhR activation. However, nitroaromatic compounds are prohibited
for use in cosmetics. We therefore synthesized and screened a series of new compounds for
inhibition of UVB induced AhR-dependent CYP1A1 expression in HaCaT keratinocytes. The
best candidate, FO31282, inhibited CYP1A1 expression as potently as MNF (IC50 = 2.0 µM)
in the presence and absence of UVB light. The AhR antagonism of FO31282 was reversible
within 48 h. These effects were reproducible in normal human keratinocytes. Moreover, AhR-
dependent COX-2 expression was inhibited by FO312821 (IC50 = 2.6 µM). We expect that
in combination with sunscreens the AhR antagonist FO31282 will provide an improved pro-
tection against UVB-induced damage.
833
Penetration and fluorescence induction of different 5-aminolevulinic acid formulations in
an ex vivo porcine skin model
R Szeimies, C Worlicek and TG Maisch Dept. of Dermatology, Regensburg University
Hospital, Regensburg, Germany
Topical photodynamic therapy is a newly established treatment modality for epithelial skin can-
cer. Of interest is the application of 5-aminolevulinic acid (5-ALA), which is metabolized to pro-
toporphyrin IX (PpIX). The purpose of the study was to investigate skin penetration of different
extratemporaneous 20% 5-ALA formulations as well as fluorescence induction of PpIX using a
new ex vivo porcine skin model. Fluorescence signals of PpIX were detected first at 4 and 6 h
after application of a 5-ALA cream (+ 40% DMSO) on damaged and intact porcine skin respec-
tively. Fluorescence signal intensities of PpIX were lower in order of 5-ALA cream (+ 40% DMSO)
> 5-ALA cream (–DMSO) > 5-ALA in lipophilic ointment > 5-ALA hydrophilic ointment. In case
of the 5-ALA hydrophilic ointment fluorescence intensity was ~ 10x times lower as compared to
the PpIX signal intensity of the 5-ALA cream containing 40% DMSO. In all cases the maxima of
PpIX fluorescence intensity were measured between 18 - 24 h post application. Penetration of 5-
ALA within the lower parts of the epidermis was increased in order of 5-ALA hydrophilic oint-
ment < 5-ALA lipophilic cream < 5-ALA -DMSO < 5-ALA +DMSO. No fluorescence signals were
detected within the dermis. Histological evaluations of untreated skin areas (+/- 5-ALA, without
light) showed no significant degree of necrosis and apoptosis determined by NBTC staining and
TUNEL-assay indicating the porcine skin is still vital up to 24 h. In contrast, illumination (λem=
550-700nm; 40mWcm-2, 24 J/cm-2) of skin areas incubated with the different 5-ALA formula-
tions led to a marked increase of death cells (10 – 45% ± 5) in the epidermis depending on the
penetration depth of the 5-ALA formulations. In the present study it was shown that an ex vivo
porcine skin model is able to discriminate penetration depth and PpIX fluorescence intensities of
different 5-ALA formulations. Furthermore, this model can be used to study phototoxic effects of
new photosensitizers and formulations selected for clinical application.
832
Infrared irradiation reduces UV-induced apoptosis in murine kerationcytes
C Jantschitsch, T Schwarz and A Schwarz Department of Dermatology, University Kiel, Kiel,
Germany
Infrared irradiation (IR) is administered with increasing frequency for cosmetic purposes and
in the wellness business which even includes antiaging strategies. In this setting artificial UV
irradiations are applied quite frequently as well. Although IR is part of the natural solar spec-
trum, not much is known about the interactions between IR and UV radiation. This applies
mostly for the two most important chronic UV effects, photocarcinogenesis and skin aging.
This study was performed to elucidate the interactions between IR and UV radiation with spe-
cial emphasis on carcinogenesis. UV-induced apoptosis is a protective mechanism which
prevents malignant transformation by eliminating UV damaged cells. Hence the impact of IR
on UV-induced apoptosis was investigated. Freshly prepared murine kerationcytes were exposed
to IR (IR-A, 760-1,400 nm) 3 hours before UVB irradiation. Death assay and annexin V stain-
ing performed 24 hours thereafter revealed a significantly reduced apoptotic rate in those cells
which were preexposed to IR. Exposure of cells to IR alone did not have any impact on cell
viability. To evaluate the in vivo relevance of these findings C57BL/6 mice were exposed to IR
followed by UV radiation. Tunel assay performed in biopsies taken 24 hours after exposure
revealed a significantly reduced number of apoptotic keratinocytes in UV irradiated mice
which were preexposed to IR. South-western dot blot analysis with an antibody against pyrim-
idine dimers did not reveal any impact or reduction by IR on the amounts of UV-induced DNA
damage in murine keratinocytes. However, intracellular FACS analysis revealed a pronounced
induction of the antiapoptotic protein bcl-xl by IR. This indicates that IR radiation might inhibit
UVB-induced apoptosis by upregulating antiapoptotic proteins. Whether this effect is associ-
ated with an enhanced risk for UV-induced skin cancer has to be demonstrated in in vivo
photocarcinogenesis studies in the future.
830
Acute UVB signal transduction pathways in human skin
JG Einspahr,1 SP Stratton,1 N McKenzie,1 DS Alberts,1 J Warneke,1 S Salasche,1 RB Nagle,1
BJ Nickoloff,3 G Pestano,2 C Brooks,1 N Haubein,4 J Chatigny,2 S Lett4 and GT Bowden1 1
University of Arizona Cancer Center, Tucson, AZ, 2 Ventana Medical Systems, Tucson, AZ, 3
Cardinal Bernardin Cancer Center, Loyola University of Chicago Medical Center, Maywood,
IL and 4 BioAnalytics Group LLC, Jamesburg, NJ
Acute UVB-irradiation of mouse skin results in activation of PI-3 Kinase and MAPK pathways
leading to altered phosphorylation of c-JUN, CREB, MAPKAP2, p53, increased transcription
of c-FOS and COX-2, and induction of apoptosis. In this study we assessed activation of these
pathways in human skin (N=23). UVB (MED x 4) was applied to unexposed skin using a UV
solar simulator. Punch biopsies (4mm) were taken prior to UVB, at 30 min, 1, and 24 hours
post-UVB and biopsies were fixed in 10% formalin. Proteins were detected by immunohisto-
chemisty and quantified at 200x using an analysis program that evaluates both the % of pos-
itive cells and staining intensity from 0-3+ (Acuity™, The BioAnalytics Group, Jamesburg,
NJ). In agreement with the mouse studies, the earliest UV-induced changes in human epider-
mis were seen in phospho-c-JUN serine 63 (3, 5, and 14-fold at 30 min, 1 and 24 hrs, respec-
tively), phospho-CREB serine 133 (2-3 fold inductions over 24 hrs with peak at 1 hr), and phos-
pho-MAPKAP2 Thr 334 (3, 4, and 2-fold at 30 min, 1 and 24 hrs, respectively). Induction of
Phospho-p53 Serine 15 (13-fold), COX-2 (3-fold), and c-FOS (20-fold) was limited to the 24
hr time-point. Expression of COX-2 was primarily limited to the basal layer. Expression of phos-
pho-p38 Thr180/Tyr182 and phospho-GSKβ serine 9 was induced between 1-24 hrs. Apop-
tosis was increased at 24 hr with a 5-fold induction of activated caspase-3 and a 147-fold
induction of apoptosis based on morphologic criteria stained with H&E. Our data suggest that
UVB may act through MAPK p38 and PI-3 Kinase with phosphorylation of MAPKAP2, GSK-
3β, CREB, c-JUN, and p53 leading to marked induction of c-Fos and COX-2 as well as induc-
tion of apoptosis. Validation of the UV response in humans is essential to the development of
effective skin cancer chemoprevention and prevention strategies.
834
Red light (670 nm) exposure improves wound healing
BJ Erdle,1 S Brouxhon,1 M Kaplan,2 J VanBuskirk1 and AP Pentland1 1 Dermatology,
University Of Rochester, Rochester, NY and 2 Lexmark International (formerly Medical
Science & Technology Center, Eastman Kodak, Rochester, NY), Lexington, KY
Recent work indicates injuries can heal faster if treated by lasers emitting 670 nm red light.
Recently available, inexpensive, 670 nm LED lights have received less attention than lasers,
and may be easier to use for cutaneous wound healing. To evaluate the effect of 670 nm LED
light on wound healing, SKH-1 hairless mice were studied using both incisional and full-thick-
ness burn injury models. Mice were deeply anesthetized while injuries were produced, and
pain control was provided. After awakening, mice with incisional injury received either a 90-
second LED exposure at an intensity of 40 mW/cms2, a 450-second exposure at an intensity
of 8 mW/cm2, or a 37.5-minute exposure at an intensity of 1.6 mW/cm2, so that the total
treatment dose in each group was the same (3.6 J/cm2). Light was administered daily Monday
through Friday. Only high flux light treatment was tested in burn injuries because of the
eschar left by burn injury. Healing in unexposed controls was also evaluated in both wound
models. Healing was assessed after burns by measurement of the eschar area. To assess repair
of incisional injury, the unepithelialized gap remaining on histologic examination was meas-
ured. Mice exposed to 670 nm red light showed significantly faster healing than control mice.
High, medium, and low fluxes of light were all equally effective after incisional injury, decreas-
ing the time to complete re-epithelialization by nearly half. No difference in the inflamma-
tion present was noted in any treatment group. In burn injury, there was improvement in wound
healing initially, but the time to complete repair was unchanged. We conclude that 670 nm
LED red light exposure accelerates healing in skin of SKH-1 hairless mice after incisional
injuries, but is not as effective for burn injuries. These data suggest red light exposure may be
helpful in postoperative wound repair.
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Cis-urocanic acid initiates gene transcription in primary human keratinocytes
K Kaneko,1 U Smetana-Just,1 M Matsui,2 AR Young,1 S John,3 M Norval4 and SL Walker1 1 St
John’s Institute of Dermatology, King’s College London, London, United Kingdom, 2 Clinique
Laboratories, Melville, NY, 3 Immunobiology, King’s College London, London, United
Kingdom and 4 Medical Microbiology, University of Edinburgh, Edinburgh, United Kingdom
Urocanic acid (UCA) is a major epidermal chromophore that undergoes trans to cis photoi-
somerisation upon absorption of solar ultraviolet radiation (UVR). Cis-UCA is a potent inhibitor
of cell-mediated immunity in the skin. Although topical application of cis-UCA to mouse skin
mimics many of the immunomodulatory effects of UVR, the molecular mechanism remains
unclear. Since UVR initiates signal transduction and activates transcription factors that result
in changes of gene expression in keratinocytes, we hypothesised that the immunomodulatory
effects of cis-UCA may be induced by its initiation of gene transcription. RNA was extracted
from primary human keratinocytes treated with trans-, cis-UCA (10µg/ml) or solar simulated
UVR (12J/cm2 ~ 2-3 minimal erythema doses for fair skin), or untreated. At 24hr, the tran-
scriptional profiles were assessed by Affymetrix HG-U133A microarray. Selected genes were
also assessed with TaqMan real time RT-PCR. In addition, cell culture supernatant and nuclear
extract were collected, also at 24hr, after treatment with PBS, trans-UCA (100µg/ml), cis-UCA
(10, 50 and 100µg/ml) or UVR (12J/cm2). Prostanoid release and nuclear factor κB (NF-κB)
activation were measured using ELISA. About 400 genes were induced by UVR, 16 of which
also up-regulated by cis-UCA. In contrast, trans-UCA had no effect on gene expression. The
genes up-regulated by both cis-UCA and UVR were associated with apoptosis, cell growth
arrest, cytokines and oxidative stress. Prostaglandin-endoperoxide synthase 2 was dramati-
cally induced by cis-UCA, resulting in an enhanced secretion of prostaglandin E2 (PGE2) into
the cell culture supernatant. UVR had the same effect as cis-UCA, but trans-UCA had no effects
on PGE2 production. NF-κB activation and lipid peroxidation were induced by cis-UCA and
UVR, but not trans-UCA, suggesting possible upstream events of the gene expression changes.
836
UVB induction of TNF-α is transcriptionally mediated by AP-1 
MM Bashir,1,2 M Sharma1,2 and VP Werth1,2 1 Dept. of Dermatology, University of
Pennsylvania, Philadelphia, PA and 2 VA Medical Center, Philadelphia, PA
Ultraviolet B (UVB) radiation (290-320 nm) is a potent inducer of cutaneous cytokines includ-
ing IL-1α, and TNF-α. UVB and IL-1α synergistically enhance the expression of TNF-α in
human keratinocytes. We previously reported that in a transient transfection assay, induction
of TNF-α was abolished with the TNF-α promoter mutated by one base pair at the AP-1 bind-
ing site. To understand the mechanism of induction of TNF-α, we evaluated whether activa-
tion of TNF-α by UVB ± IL-1α is due to transcriptional activation or message stability. We fur-
ther investigated the role of AP-1 in the upregulation of TNF-α in UVB ± IL-1α treated cells.
We irradiated keratinocytes with a physiological dose of UVB (30 mJ/cm2) and stimulated with
IL-1α. A nuclear run-off assay was done to observe the effect of UVB ± IL-1α on TNF-α gene
transcription. The nuclear run-off results revealed that the transcription rate of TNF-α gene
increased 5-fold in sham + IL-1α (0.27 ± 0.007), 6-fold in UVB (0.31 ± 0.05), and 10-fold (0.66
± 0.03) in UVB + IL-1α-treated cells over sham (0.05 ± 0.03). To determine the TNF-α mRNA
half-life, we treated the keratinocytes with actinomycin D, an inhibitor of RNA synthesis, and
measured TNF-α mRNA levels by Real-Time PCR. The T1/2 of TNF-α mRNA was calculated in
UVB and UVB + IL-1α treated cells. Our results demonstrated that the TNF-α half-life was 60
min for UVB and UVB + IL-1α treated cells. To further investigate the role of AP-1 in induc-
tion of TNF-α, cells were treated with SP600125, an AP-1 inhibitor. Our results clearly indi-
cate that this AP-1 inhibitor suppresses the expression of TNF-α mRNA in endogenous cells
and cells transfected with the TNF-α promoter. In conclusion, the mechanism of UVB and IL-
1α induction of TNF-α mRNA is through AP-1-mediated transcriptional upregulation.
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Variable pulsed light (VPL) reduces treatment pain in patients undergoing photodynamic
therapy(PDT) for actinic keratoses
M Szeimies,1 P Babilas,1 S Hummel,1 M Koller1 and R Knobler2 1 Department of
Dermatology, Regensburg University Hospital, Regensburg, Germany and 2 Department of
Dermatology, Medical University of Vienna, Vienna, Austria
Background: PDT causing selective tissue necrosis upon red light illumination via the induction
of reactive oxygen species after activation of synthesized porphyrins is a treatment for basal cell
carcinoma and actinic keratoses (AK). Since free nerve endings can be often co-stimulated pain
and treatment interruption occurs. The aim of this study was to investigate a modification of the
illumination process using a variable pulse light source (VPL™, Energist Ultra, Energist, U.K.)
with spectral characteristics matching the absorption spectrum of the photosensitizer. Method:
A randomized parallel-group trial was conducted. A total of 25 patients (8 f, 17 m, mean age 73
yrs) were included diagnosed as having proven lesions of actinic keratoses (AK) on the skin and
the scalp. Methyl aminolevulinate (MAL, Metvix, Galderma, France) was applied on the tar-
geted area for 3 hrs, subsequently one side received an illumination with a LED light source (37
J/cm2, duration 12 min), and the contra lateral side received 80 J/cm2 (double pulsed @ 40J/cm2)
with VPL™, with a pulse train of 15 impulses each with duration of 5 ms utilising a 610-950nm
filtered handpiece. Therapeutic outcome was evaluated using a lesion score after 2 weeks and
3 months; pain assessment was made after each treatment side with the use of a visual analogue
scale (VAS). Results: During the initial phases of the treatment patients showed an overall of 238
AK on face and scalp. Two weeks and three months after, there was no significant difference
between the therapeutic outcomes using the different illumination systems. However, pain assess-
ment immediately after PDT revealed a significant lower pain level (4.3 vs. 6.4) for the VPL™
treated side. Conclusions: The use of short pulsed light (variable pulsed light) can thus be con-
sidered as an efficient and useful alternative in the photodynamic treatment of AK where other-
wise pain development can be a limiting factor for the performance of PDT.
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UVB radiation-induced down-regulation of AQP3 attenuates endocytic activity of cultured
dendritic cells
C Ji,1,4,3 C Cao,1 L Beveridge,1 C O’Brien,1 A Sowa,1 L He,4 Z Bi,3 G Hu,3 N Kouttab2 and
Y Wan1 1 Biology, Providence College, Providence, RI, 2 Roger Williams Medical Center,
Providence, RI, 3 the First Affiliated Hospital of Nanjing Medical University, Nanjing, China
and 4 Kunming Medical College, Kunming, China
The endocytic capacity is a fundamental property of immature dendritic cells (DCs) and is instru-
mental in allowing efficient uptake and presentation of incoming antigens. The endocytic activity
is expressed at the highest level in the immature stage and is lost as DCs mature. One of the major
causes to stimulate skin DCs maturation is UVB radiation. Since previous work has demonstrated
that aquaporins (or AQPs) are essential elements of the volume control mechanism that allows
DCs to concentrate macrosolutes taken up via macropinocytosis. In this study, we tested whether
AQP is involved in UVB induced DCs maturation and reduced endocytic activity. We observed
that aquaporin 3 (AQP3), the water channel in human skin, is expressed in cultured human DCs
(XS 106 cell line). Using specific AQP3’s water transport inhibitors, such as CuSO4 and NiCl2, as
well as siRNA knockdown, we found that AQP3 is involved in DC’s endocytosis (Detected by
FITC-dextran methods). Furthermore, UVB radiation, which induces DCs maturation, downregu-
lates AQP3 expression which is involved in reduced endocytosis activity in cultured DCs. In cel-
lular mechanism research, we discovered that exogenous H2O2 alone induces AQP3 downregu-
lation, and a well known anti-oxidant, n-acetyl-l-cysteine (NAC), and MEK/ERK inhibitor PD98095
protect against UV-induced loss of AQP3 and reduced endocytic activity. EGFR inhibitors PD 153035
and PI3K inhibitor LY 294002 potentiate UV-induced AQP3 downregulation. Collectively, our results
demonstrate that AQP3 is highly expressed in human immature DCs, coinciding with the high level
of endocytosis, and is down-regulated via ROS-mediated ERK/AKT pathway upon UV induced mat-
uration with a result of DC`s maturation, coinciding with a down-regulation of endocytosis and
cell migration. Our study implies a new role of AQP3 in endocytosis in DCs.
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Activation of AMPK, a downstream component of p38, regulates UV-induced phosphoryla-
tion and acetylation of p53 in opposite ways in cultured human skin keratinocytes
C Ji,1,4,3 C Cao,1 L Berveridge,1 C O’Brien,1 A Sowa,1 L He,4 Z Bi,3 G Hu,3 N Kouttab2 and
Y Wan1 1 Biology, Providence College, Providence, RI, 2 Roger Williams Medical Center,
Providence, RI, 3 the First Affiliated Hospital of Nanjing Medical University, Nanjing, China
and 4 Kunming Medical College, Kunming, China
p53 tumor suppressor is a central stress response protein, activated by multiple endogenous
and environmental insults including UV radiation. Phosphorylation and acetylation are post-
translational modifications to p53 that affect its overall appearance and activity. AMP-acti-
vated protein kinase or AMPK is an evolutionarily conserved sensor of cellular energy status,
activated by a variety of cellular stresses that deplete ATP. In this study, we tested whether
AMPK is involved in UV- and H2O2-, the major cause of skin aging, induced p53 activation.
We demonstrated that UV and H2O2 induce AMPK activation in a time and dose dependent
manner in cultured human skin keratinocytes (HaCaT cells). EGFR inhibitor PD153035 and
EGFR specific antibody Cetuximab as well as p38 inhibitor SB203580 inhibit UV- and H2O2
-induced AMPK activation. Using AMPKi, a specific inhibitor of AMPK, and SB203580, we
found that while AMPK and its upstream p38 activation mediate UV- and H2O2-induced phos-
phorylation of p53, both negatively regulate UV- and H2O2-induced acetylation of p53. Fur-
thermore, MTT dye assay and Hoechst assay showed that AMPKi and SB203580 decrease
UV- and H2O2-induced cell apoptosis in HaCaT cells. Collectively, our results suggest that
UV-induced p53 phosphorylation is dependent on EGFR/p38/AMPK pathway in cultured ker-
atinocytes. Also, p38 inhibits acetylation of p53, which contributes as an opposite pathway
to p53 activation.
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Differential proteomic analysis of human skin fibroblast before and after UVA radiation
B Chen,2 Z Bi2 and Y Wan1 1 Biology, Providence College, Providence, RI and 2 the First
Affiliated Hospital of Nanjing Medical University, Nanjing, China
To identify the proteomic change of human skin fibroblasts in response to UVA radiation, and
to elucidate the molecular mechanism of reconstruction of fibroblasts after UVA radiation,
protein samples were extracted from the human skin fibroblasts irradiated with UVA at the dose
of 10mJ/cm2 and were separated by immobilized pH gradient two-dimensional (2-D) gel elec-
trophoresis. After Coomassie blue staining, the 2-D electrophoretogram was analyzed using
Imaging Master 2D analysis Software. The differential proteins were cut off from the Coomassie
blue-stained gel and digested in gel with trypsin, and then identified by peptide mass finger-
printing based on MALDI-TOF-MS and database searching. Our results show that: (1) Average
protein spots were 676±21, 693±28 in fibroblasts before and after UVA irradiation respec-
tively, the matched spots were 583±29, 591±27 in both two types of tissues respectively, and
the average matching rate was 86%, 85% respectively. (2) A total of 563±19 protein spots were
matched between electrophoretic maps of fibroblasts before and after UVA irradiation. 17 dif-
ferential protein spots were identified between the two types of the tissues. 1 protein spot was
expressed only in the cells before UVA irradiation and 4 protein spots were expressed only in
the fibroblasts after UVA irradiation. The expression levels of 7 protein spots in the fibroblasts
after UVA irradiation were higher than those before UVA irradiation, and the expression levels
of 5 protein spots in the fibroblasts after UVA irradiation were lower than those before UVA
irradiation. (3) Parts of differential spots were cut off from the Coomassie blue-stained gel, and
15 spots were preliminarily identified. These proteins are associated with stress response,
cytoskeleton, apoptosis, growth inhibition, the maintenance of structural integrity, transla-
tional control, energy metabolism, scavenging of free radicals, protein synthesis and degrada-
tion. These data will be helpful to the further study of UV effect on skin.
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Repetitive exposures to ultraviolet B radiation causes stress-induced premature senescence
of human skin fibroblasts
W Chen,2 Z Bi2 and Y Wan1 1 Biology, Providence College, Providence, RI and 2 the First
Affiliated Hospital of Nanjing Medical University, Nanjing, China
Premature senescence of human skin fibroblasts (HSFs) is induced by exposures to a vari-
ety of oxidative stresses and DNA damaging agents including UV radiation. UV is known
to be related to tumorigenesis of skin. The relationship between UVB-related stress-induced
premature senescence (SIPS) and tumorigenesis is unknown. A SIPS model would be help-
ful for the study such relationship. This study was attempted to establish such a cell model.
HSFs were exposed five times to UVB (10 mJ/cm2) once per day. After 3 days of recovery,
biomarkers of replicative senescence were detected. The results show that with UVB treat-
ments, HSFs become big, flat and irregular. There is an increase in the population of cells
positive for senescence-associated β-galactosidase activity. Positive cells in UVB-radiated
fibroblasts are 82.0%, while in control cells are 33.7%. MTT dye assay shows that with UVB
treatments, there is a loss of replicative potential, compared to control. FACS analysis data
show that G1 phase cells in UVB-radiated fibroblasts increase to 90.72%, while in control
cells are 53.31%. With UVB treatments, the steady-state level of mRNA of fibronectin, one
of senescence-associated genes, is increased in HSFs at 72 h after five exposures to UVB.
Collectively, our results indicate that repetitive exposures to UVB radiation induce SIPS in
HSFs, suggesting that this cell model could be used to further investigate the molecular
and cellular mechanism of UVB-induced premature senescence of HSFs and relationship
between SIPS and tumorigenesis in skin.
843
Chk1 transmits PUVA-induced ATR signalling for premature senescence in primary human
fibroblasts
M Grosse Hovest, T Krieg and G Herrmann Dermatology, University of Cologne, Cologne,
Germany
Accelerated aging of the skin is a common side effect of long-term PUVA therapy. Cellular
senescence, likely linked with aging, is regarded as permanently maintained DNA-damage
response. Previously, we could show that DNA interstrand crosslink formation (ICL) by pho-
toactivated psoralens causes a senescent phenotype of human dermal fibroblasts. We could
demonstrate that ATR kinase signals for this phenotype from telomere-localized DNA-dam-
age foci. Downstream transmission of the initial damage signal is obtained by ATR-depend-
ent phosphorylation of effector proteins. Chk1 and FANCD2 are likely candidates for ATR-
mediated signal transduction for cellular senescence, as they have been identified as effector
proteins of ATR, mediating an S-phase arrest immediately after ICL formation. Now, we have
identified Chk1 kinase as an effector of ATR in PUVA-induced senescence. The kinase Chk1
as substrate of ATR is known to function in its activated, phosphorylated form in cell cycle
control. We find that Chk1 is directly activated after PUVA and its activation persists more
than 28 days after irradiation. Inhibition of Chk1 function by siRNA prior to psoralen pho-
toactivation resulted in increased cell death, although less severe compared to ATR depletion
prior to PUVA irradiation. Initial results of additive depletion of FANCD2 indicate that FANCD2
functions in parallel to Chk1. Accordingly, we observe activation of FANCD2 in response to
PUVA, accompanied by persistent accumulation of FANCD2 at PUVA-induced DNA-dam-
age foci. Depletion of Chk1 in already PUVA-senesced fibroblasts led to restart of DNA-syn-
thesis in 17% of the cells, indicative of a reversal of the PUVA-induced permanent cell cycle
arrest. In summary, we have identified Chk1 as an effector kinase downstream of ATR in the
PUVA-induced DNA damage response that mediates the senescent phenotype of human
fibroblasts after psoralen photoactivation, which function is probably furthered by FANCD2.
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The photoaging-associated common deletion of the mitochondrial genome increases oxida-
tive stress and alters cellular functions in human dermal fibroblasts in a dermal 3D envi-
ronment
P Schroeder,1 TD Maresch,1 M Schneider,1 F Bernerd2 and J Krutmann1 1 Cell Biology, IUF,
Duesseldorf, Germany and 2 L’Oreal Recherche, Clichy, France
It has been proposed that large scale deletions of the mitochondrial genome such as the 4,977
bp “common deletion“ (CD) are of pathogenetic relevance for photoaging of human skin,
because (i) photoaged skin contains increased amounts of the CD and (ii) mtDNA mutagen-
esis can be induced by repetitive UV irradiation. In order to address the question, whether
and how mtDNA mutagenesis affects the function of human dermal fibroblasts, we have made
use of primary human dermal fibroblasts from patients with Kearns-Sayre-Syndrom (KSS, n=2),
which constitutively, i.e. without the need for UV exposure, exhibit high levels of the CD (at
least 1% of their mtDNA molecules). These cells were compared to normal, healthy fibrob-
lasts (n=6) with CD levels below 0.001% for their capacity to form a 3D dermal equivalent.
We have found that KSS cells contracted a type 1 collagen gel significantly faster than equiv-
alent numbers of normal cells (p<0.05). These differences were not due to donor age, site of
origin or passage number of the different fibroblasts strains used but correlated with the amount
of CD present. Staining with reactive oxygen species (ROS) sensitive dyes revealed that KSS
cells produced higher levels of ROS than normal cells. This was of functional relevance because
culture of 3D dermal equivalents under anaerobic conditions or treatment with the antioxi-
dant N-tert-butyl-alpha-phenylnitrone abrogated the difference in collagen contraction between
KSS- and normal dermal equivalents. These studies indicate that CD positive human dermal
fibroblasts have increased oxidative stress which affects their capacity to interact with colla-
gen fibers. Thus, at least in a 3D dermal equivalent model, primary human dermal fibroblasts
carrying the photoaging-associated common deletion display an abnormal phenotype.
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An action spectrum to suppress delayed-type hypersensitivity by inducing Foxp3 and IL-10
Y Shintani and A Morita Dermatology, Nagoya City University Medical School, Nagoya,
Japan
Narrow-band UVB therapy is used more often than psoralen and UVA light (PUVA) therapy
to treat refractory skin diseases. The mechanism of action responsible for the efficacy of nar-
row-band UVB is thought to be the induction of apoptosis in pathogenetically relevant cells.
PUVA therapy and narrow-band UVB therapy, however, generally induce a relatively long
remission period in patients with psoriasis, which cannot be explained simply by the induc-
tion of apoptosis. Therefore, the role of regulatory T cells should also be considered. We pre-
viously reported that narrow-band UVB suppresses delayed-type hypersensitivity (DTH) and
contact hypersensitivity by inducing the production of regulatory T cells. The ultraviolet wave-
length that induces regulatory T cells to DTH, however, was not known. A monochromator
was used to irradiate a mouse DTH model using several UVB wavelengths (290 nm, 300 nm,
310 nm, and 320 nm). All the wavelengths tested significantly suppressed DTH, with 300 nm
inducing maximal suppression. Foxp3 expression in lymph node cells from tolerant mice was
analyzed by real time polymerase chain reaction (mRNA) and FACS analysis (protein). Foxp3
induction was increased 2-fold at 300 nm compared with the controls. Similarly, interleukin
(IL)-10 induction was increased 10-fold at 300 nm. Conversely, IL-17, IL-23, and IL-12 were
suppressed by 40%, 25%, and 30%, respectively, at 300 nm. These data indicate that ultravi-
olet light at a peak wavelength of 300 nm induces Foxp3-expressing T cells (Treg) and sup-
presses Th-17 cells. Besides the induction of Foxp3-expressing Treg, the suppression of Th-17
cells might be important for the ultraviolet light-induced immune suppression.
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Influence of XPB helicase on post-UV recruitment and redistribution of nucleotide excision
repair proteins and histone H2AX and ATM phosphorylation in XP-B cells 
KS Oh,1 YS Kim,2 M Bustin2 and KH Kraemer1 1 Basic Research Laboratory, National Cancer
Institute, Bethesda, MD and 2 Lab of Metabolism, National Cancer Institute, Bethesda, MD
The XPB gene encoding a DNA helicase, is a subunit of the basal transcription factor TFIIH,
and is also involved in nucleotide excision repair (NER). We examined recruitment and redis-
tribution of NER proteins in XP-B cells to determine whether UV irradiation leads to intranu-
clear translocation of repair proteins to the sites of DNA damage. We found delayed recruit-
ment and impaired redistribution of NER proteins along with reduced repair of UV induced
photoproducts. Our results demonstrate that in spite of recruitment, persistence and removal
of DNA repair proteins at sites of damage, subtle functional defects may lead to failure of repair
and a markedly increased frequency of skin cancer in XP-B patients. A specific type of dam-
age is the DNA double strand breaks (DSB) which may be caused by ionizing radiation but
can also arise during replication when a replication fork passes through a region containing
a single-strand break. γ-H2AX, the phosphorylated form of histone H2AX at serine139, is widely
used as a most sensitive damage marker of DSB in nuclear chromatin. When a DSB occurs,
replication of the cell is stopped by one of the checkpoints in the cell cycle. We found that
phosphorylation of H2AX, ATM and Nbs1 was detected and co-localized to UV damage sites
in normal human, XP-B and mouse fibroblasts. These phosphorylated proteins persisted for
more than 24 hours in post UV irradiated XP-B cells but not in normal cells. Prolonged p53
accumulation without induction of Mdm2 did not lead to elevated levels of apotosis in XP-B
cells. Since NER proteins co-localize to UV damage sites in normal human fibroblast and XP-
B cells but not in mouse fibroblast cells our data suggests that UV- induced phosphorylation
of H2AX, ATM and Nbs1 is independent of NER.
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Melanoma cell lines are susceptible to UVA exposure enhancing melanoma progression
W Schuller, M Röcken and M Berneburg Dermatology, University of Tübingen, Tübingen,
Germany
We have previously shown that aging associated mutations of mitochondrial (mt)DNA as well
as senescence mediated growth control is induced in normal melanocytes by repetitive sub-
lethal irradiation with ultraviolet (UV)-A but reduced in malignant melanoma. However, the
question whether UV-A irradiation is involved in tumour progression of melanoma cells by
altering their metabolism has not been adressed. Due to the fact that enhanced glucolysis is
a distinctive marker of cancer progression, we examined the effect of UVA irradiation on aer-
obic glycolysis, the so called Warburg effect. The pentose phosphate pathway (PPP) allows
glucose conversion to ribose for nucleic synthesis and glucose degradation to lactate. The
nonoxidative part of the PPP is controlled by thiamine-dependent transketolase (TK) enzyme
reactions, which have been related to cancer progression. High aerobic glycolysis is associ-
ated with high levels of TKTL1 (transketolase-like 1) expression. As inhibition of transketolase
enzyme reactions suppresses tumour growth and progression, TKTL1 could be a relevant tar-
get for novel anti-transketolase melanoma therapies. We irradiated melanoma cell lines of
different progression levels repetitively with UVA, measuring TK enzyme activity and lactate
levels. Following UVA-irradiation lactate production of melanoma cells correlated with
enhanced transketolase enzyme activity. Incubation with the transketolase inhibitor oxythi-
amine abolished TK activity. Applying real-time PCR we assessed the adhesion molecule
CD171, Akt kinase, and cyclooxygenase-2 (COX-2) levels. mRNA levels of these proteins were
increased after UVA exposure. Western blot analysis revealed increased protein levels of TKTL1.
Thus, UVA exposure increases peptide levels which are involved in tumor migration (CD171)
and tumor progression (Akt and COX-2, TKTL1), suggesting an involvement in melanoma
progression. We postulate a novel concept for the understanding of the physiological changes
in malignant conversion in melanoma cells after UVA exposure.
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All-trans retinoic acid suppresses the expression of histidase in epidermal keratinocytes
L Eckhart,1 M Schmidt,1 V Mlitz,1 A Abtin,1 C Ballaun,1 P Mrass1 and E Tschachler1,2 1
Department of Dermatology, Medical University of Vienna, Vienna, Austria and 2 Centre de
Recherches et d’ Investigations Epidermiques et Sensorielles (CE.R.I.E.S.), Neuilly, France
Histidase (histidine ammonia lyase) converts histidine into urocanic acid, the main UV absorp-
tion factor of the stratum corneum. Here we investigated the transcriptional regulation of his-
tidase expression in epidermal keratinocytes. Quantitative real time-PCR analysis showed
that the epidermis contained higher levels of histidase transcripts than all other tissues inves-
tigated and that keratinocytes strongly expressed histidase. Expression of histidase increased
more than hundred-fold during differentiation of primary keratinocytes in vitro. Genome-wide
microarray analysis showed that histidase was among the genes most strongly induced by shift-
ing keratinocytes from growth in monolayer culture to differentiation in an epidermal equiv-
alent. Irradiation of keratinocytes with UV-A and UV-B did not significantly change the expres-
sion level of histidase. By contrast, all-trans retinoic acid (ATRA) (1 µM) suppressed histidase
expression virtually completely. Taken together, our results show that histidase is transcrip-
tionally upregulated during keratinocyte differentiation and that ATRA but not UV irradiation
modulates the expression level of histidase. Suppression of histidase-mediated production of
urocanic acid may contribute to the increase in UV-sensitivity that is caused by treatment
with retinoids.
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Closure of skin excisions and incisions using a rapid, light-activated technique
M Yao, KE Bujold, RW Redmond and IE Kochevar Wellman Center for Photomedicine,
Massachusetts General Hospital, Harvard Medical School, Boston, MA
Staples and glues are currently employed in sutureless wound closure, but both methods
have drawbacks. We have recently demonstrated that a novel light-activated technique called
photochemical tissue bonding (PTB) seals surgical wounds in porcine skin with healing equiv-
alent to that produced by sutures. In PTB, a dye is applied to the wound surfaces, which are
then placed in contact and illuminated with green laser light to activate the dye. An immedi-
ate water-tight seal results from chemical reactions between proteins on the surfaces without
thermal damage. The dye used, Rose Bengal (RB), is a well-known phototoxic agent in cul-
tured cells. However, enhanced inflammation was not associated with PTB. We sought to
understand this unexpected (but desirable) result. Cell death was assessed in porcine skin
after PTB. Full thickness 2-cm incisions in fresh porcine skin were secured with subcutaneous
sutures before treatment with 0.1% RB and 100 J/cm2 532 nm laser light. Controls received
no light or no RB. Tissue was placed in organ culture for 24 h. Dead cells (pyknotic nuclei,
eosinophilic cytoplasm) were the same (p > 0.05) in the PTB-treated and control epidermis
and dermis. Time-resolved fluorescence confocal microscopy of RB-stained incisions revealed
that RB diffused only ~100 µm from the dermal incision surface, suggesting that RB binds
strongly to extracellular matrix, blocking its uptake by cells. In support of this notion, absorp-
tion spectroscopy showed that RB bound strongly to collagen fibers and keratinocytes cul-
tured on RB-stained collagen gel or amniotic membrane were not affected by 532 nm doses
that are toxic to cells grown on plastic. These results suggest that RB phototoxicity is pre-
vented in PTB because the photoactive dye is not taken up into cells and that decreased inflam-
mation might lead to reduced scarring after closure of skin wounds using PTB.
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Melatonin attenuates the apoptotic pathway in UV-irradiated human keratinocytes
TW Fischer,1,2 MA Zmijewski,2 J Wortsman3 and A Slominski2 1 Department of Dermatology,
Allergology and Venerology, University Hospital Schleswig-Holstein, University of Lübeck,
Lübeck, Germany, 2 Department of Pathology and Laboratory Medicine, University of
Tennessee Health Science Center, Memphis, TN and 3 Department of Internal Medicine,
Southern Illinois University, Springfield, IL
The apoptotic cascade in UV-irradiated keratinocytes is represented by death-receptor and/or
mitochondrial damage dependent caspase as well as poly(ADP-ribose) polymerase (PARP)
activation. To date, none of these pathways have been investigated in detail regarding the pro-
tective effects of melatonin, a well-known antioxidative substance. Recently, evidence for the
significant role of melatonin in cutaneous biology has been given by identification of a mela-
toninergic antioxidative system (MAS) in the skin and its strong protective effects against dif-
ferent aspects of UV-induced cell damage. We therefore have investigated apoptosis on mor-
phological and molecular levels in UV-irradiated HaCaT keratinocytes pre-treated with
melatonin. Keratinocytes, subjected to UV irradiation (50mJ/cm2), were more confluent, showed
less cell blebbing, less dysmorphic shape and nuclear condensation after preincubation with
melatonin compared to irradiated control. The UV-induced mitochondrial membrane poten-
tial (∆ψ) reduction was diminished by preincubation with melatonin. Consequently, melatonin
suppressed activation of initiator caspase 9, but not death receptor-dependent caspase 8. Fur-
thermore, activations of effector caspases 3 and 7 and of PARP were also attenuated by mela-
tonin. Thus, we have shown the antiapoptotic effects of melatonin on a wide range of differ-
ent pathway levels in keratinocytes with the mitochondrial pathway being the most relevant
in UV-exposed HaCaT cells.
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Near infrared radiation is a potent regulator of gene expression in human dermal fibroblasts
P Schroeder, C Calles, S Bruhnke and J Krutmann Cell Biology, IUF, Duesseldorf, Germany
It has been shown, that near infrared radiation (760-1440 nm, Infrared-A, IRA) is able to alter
the expression of matrixmetalloproteinase-1 (MMP-1) in human dermal fibroblasts indicates
that IRA-radiation is able to modulate gene expression in this cell type. In order to further
assess the generegulatory potential IRA, we performed gene expression analysis utilizing
Affymetrix DNA-microarray technology. Primary human dermal fibroblasts from three differ-
ent donors were irradiated with a single dose of IRA (860J/cm^2) and RNA was harvested 24h
afterwards. For each donor, three independent experiments were performed, leading to a total
of 9 paired sets of samples. Unsupervised hierarchical clustering revealed that the difference
between sham und IRA irradiated samples was biased by interindividual differences between
the three donors. In order to correct for that bias and to identify commonly differentially reg-
ulated genes we, in a first step applied a rather coarse filtering strategy, selecting genes which
were regulated in at least three of the nine sample sets. In a second step we selected genes
from that list with a proposed relation to skin ageing, repeated the experiments and per-
formed analysis of these genes by realtime PCR. Step one revealed a total of 599 regulated
genes (250 up- and 349 downregulated). Functional clustering based on Gene-Ontology
assigned these genes to be involved to cell growth, extracellular matrix, stress and signalling.
We next analysed gene expression of 13 genes resulting from step one, which are thought to
play a role in photoaging of skin (BAX, BAD, FASTK, FRSF6B,PIK3P3, PIP5K1B, ITPR3, ITPR2,
ATP1B1, FN1, VCAM1, IL6ST, STAT3). In all cases, the results from step one could be verified,
showing a significant regulation of these genes by IRA (p<0.05). Taken together our data indi-
cate an involvement of IRA in photoaging of the skin beyond the known effect on MMP-1
expression. In addition, we could verify the results of our filtering approach on microarray
data by realtime PCR.
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Transgenic expression of S100A2 in hairless mouse skin: Lack of effect on cutaneous responses
to solar-simulated radiation
Y Li,1 JE Gudjonsson1 and JT Elder1,2 1 Dermatology, University of Michigan, Ann Arbor, MI
and 2 Ann Arbor VA Hospital, Ann Arbor, MI
S100A2 is a member of the S100 gene family, most of which are encoded within the human
EDC. However, S100A2 is absent from the mouse and rat genomes. We have shown that S100A2
is a redox-sensitive protein that undergoes disulfide-mediated cross-linking and translocation
from the nucleus to the cytosol in the context of oxidative stress. We have also shown that nuclear
expression of S100A2 protein is reduced in basal KC of photodamaged skin, with increased cyto-
plasmic staining of the suprabasal layers. Together, these observations suggest that S100A2
might play a role in skin responses to UV light. To test this hypothesis, we expressed S100A2 in
the skin of SKH2/J hairless mice using a bovine keratin 5 promoter, and compared the responses
of TG and WT mice to solar-simulated radiation (SSR, UVA340 bulbs, Q-Panel). Expression of
S100A2 in TG but not WT animals was confirmed by IHC. Cutaneous UV responses were assessed
1 to 7 days after a single dose of SSR (0.5 MED = 520 mJ/cm2). Comparators included clinical
inspection, H&E staining, and IHC for thymine dimers, Ki-67, and p53. We also carried out tran-
scriptional profiling on tail skin using Affymetrix MG430 2.0 arrays (1 day after 1 MED SSR vs.
sham, n = 3 for WT and TG). No significant effects of S100A2 expression were observed in irra-
diated or control mice, despite a robust and reproducible response to SSR characterized by (i) a
rapid increase in thymine dimers, which peaked at 1-2 days then normalized in the epidermis,
but not in the dermis, (ii) pronounced epidermal hyperplasia accompanied by increased nuclear
Ki-67 staining, peaking at 3-4 days; (iii) transition of p53 staining from a basal nuclear pattern to
a suprabasal cytoplasmic pattern by 3-4 days, with restoration of basal nuclear staining by 5-7
days; and (iv) strong induction of multiple transcripts, including keratins 6 and 16, defensin beta
3, Sprr2i and Sprr2f . We conclude that ectopic S100A2 expression does not exert a detectable
effect on cutaneous responses to a single dose of SSR.
852
Selection against large scale mtDNA deletions occurs on the cellular level in normal and CS
cells circumventing apoptotic pathways
Y Kamenisch, W Schuller, J Wenz, M Röcken and M Berneburg Dermatology, University of
Tübingen, Tübingen, Germany
Mutations of mitochondrial DNA are involved in pathologial processes such as cancer and
aging. One of the best described mutations in the mitochondrial genome is the common
deletion, a 4977bp large deletion which can be induced in vitro by UVA irradiation. In nor-
mal fibroblasts and in fibroblasts from patients suffering from Cockayne syndrome (CS), a rare
autosomal recessive disease with progeroid symptoms and sun sensitivity, these mutations
have been shown to increase up to a maximum followed by their disappearance, whereas in
vivo these mutations persist for up to 1.5 years. In order to determine the mechanism by
which these mutations disappear, we induced mitochondrial common deletion in healthy
fibroblasts and fibroblasts of CS patients by repetive UVA radiation at a dose of 8J/m2 and
measured the common deletion by real time PCR in viable adherent as well as in non-viable
cells in the supernatant. In both cell lines repetive UVA radiation induced the common dele-
tion up to a cell specific maximum level. This phenomenon was followed by subsequent dis-
appearance of the common deletion in adherent viable cells. This decrease of the common
deletion in viable cells from normal and CS individuals correlates closely with an increase of
the common deletion in non-viable cells from the supernatant. This shift from deletion rich
viable cells to deletion rich non-viable cells was not associated with apoptosis as measured
by FACS analysis of annexin V. These data indicate that reduction of possibly metabolically
relevant large scale deletions reaching pathological levels are controlled on the cellular level
mainly in an apoptotic independent way.
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Resistance to UV-induced immunosuppression in apoptosis-resistant Bid-knockout mice
S Pradhan,1 C Thrash,1 S Mantena,1 S Katiyar,1 C Elmets1 and L Timares1,2,3 1 Dermatology,
University of Alabama, Birmingham, Birmingham, AL, AL, 2 Cell Biology, University of
Alabama, Birmingham, Birmingham, AL and 3 Pathology, University of Alabama,
Birmingham, Birmingham, AL
UVB irradiation induces skin cancer through multiple mechanisms, including the generation
of DNA mutations in epidermal cells and the development of immunosuppression. Apoptosis
plays an important role in eliminating UV-mutagenized cells but its role in immunosuppres-
sion is not clear. We have shown that Bid (BH3 interacting death domain protein) plays a crit-
ical role in regulating LC apoptosis and that bid -/- (Bid KO) LCs induce exaggerated immune
responses to topical antigens. Therefore, Bid’s role in mediating UV-induced damage responses
and regulating susceptibility to immunosuppression was investigated. We compared multiple
readouts of UVB-induced damage in the epidermis of C57BL/6 wild-type (WT) and Bid KO
mice. Bid KO mice were more sensitive to 24 hour swelling responses; minimal edema response
dose (MED) was 50 mJ/cm2 versus 100 mJ/cm2 for WT mice. In contrast, a marked reduction
in apoptotic cells (TUNEL+) (55%, p<0.005) and 2-fold (p<0.04) greater retention of LC (I-A+)
numbers was observed, indicating that the edema response did not directly correlate with apop-
tosis levels. UV-induced immunosuppression is thought to correlate with the level of DNA dam-
age in LCs. We observed that Bid KO mice were markedly resistant to both local and systemic
UV-tolerance induction to hapten sensitization and contact hypersensitivity. Ear-swelling
responses and immune involvement at skin sensitization sites was equal to or greater than
non-suppressed control responses. In the draining lymph nodes of Bid KO versus WT mice, a
greater percentage of LCs (80% versus 20% Langerin+ CD11c+ cells, respectively) were pres-
ent possessing lower levels of DNA damage (2% versus 28% positive for CPD+, respectively).
LC numbers were identical in untreated Bid and WT mice. These data demonstrate a critical
role of Bid in UV-induced apoptosis, and that resistance to apoptosis potentiates increased
immune activation, not immune down-regulation.
855
Protective effects of pomegranate derived products on UVB-induced DNA damage, PCNA
expression and MMPs in human reconstituted skin
M Abu Zaid, F Afaq, N Khan and H Mukhtar Dermatology, University of Wisconsin,
Madison, WI
Photochemoprevention via the use of botanical antioxidants in affording protection to human
skin against ultraviolet B (UVB) damage is receiving increasing attention. Pomegranate, from
the tree Punica granatum contains anthocyanins and hydrolyzable tannins and possesses strong
anti-oxidant and anti-tumor promoting properties. In this study, we determined the effect of
pomegranate juice (PJ), oil (PO), and byproduct (PB) against UVB-mediated damage using recon-
stituted human skin EpiDermFTTM200. EpiDerm is a three dimensional full thickness reconsti-
tuted human skin equivalent which sustains differentiation and exhibit morphological and meta-
bolic properties similar to human skin. EpiDerm was treated with PJ (1-2 µl/0.1 ml), PO (1-2
µl/0.1 ml) and PB (0.25-0.5 µl/0.1 ml) for 1 hr prior to UVB (60 mJ/cm2) irradiation and was har-
vested 12 hrs post-UVB. Treatment of Epiderm with PJ, PO and PB resulted in a decrease in UVB-
induced (i) sunburn cell formation, (ii) protein oxidation, and (iii) PCNA protein expression. Since
UVB-mediated DNA damage causes mutation of tumor suppressor genes, we assessed the effects
of PJ, PO and PB against UVB-mediated markers of DNA damage. Our results showed that PJ,
PO and PB caused inhibition of UVB-induced cyclobutane pyrimidine dimer and 8-dihydro-2’-
deoxyguanosine. As matrix metalloproteinases (MMPs) are implicated at all stages of skin tumori-
genesis, we next investigated the effect of PJ, PO and PB on UVB-induced MMPs expression.
We found that treatment of Epiderm with PJ, PO and PB resulted in inhibition of UVB-induced
(i) collagenase (MMP-1), (ii) gelatinase (MMP-2, MMP-9), (iii) stromelysin (MMP-3), (iv) mar-
ilysin (MMP-7) and (v) elastase (MMP-12) proteins. Furthermore, PJ, PO and PB also caused a
decrease in UVB-mediated protein expression of c-Fos and phosphorylation of c-Jun, which are
components of AP-1 and regulate MMPs activation. Collectively, these results suggest that all
three pomegranate derived products may be useful against UVB-induced damage to human skin.
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The role of CSN5 in UV-mediated DNA damage
H Liu, DJ Wong and HY Chang Dermatology, Stanford University School of Medicine,
Stanford, CA
The nucleotide excision repair (NER) pathway is essential for the prevention of DNA damage
and skin cancers induced by ultraviolet radiation. CSN5 is the catalytic subunit of the COP9
signalosome and a key regulator of the ubiquitin ligase activities of DDB2 and CSA complexes
that mediate NER. The CSN5 gene resides on the long arm of human chromosome 8, which
is frequently amplified in human squamous cell carcinomas (SCC). However, the role of CSN5
in ultraviolet-induced carcinogenesis remains unclear. Here we show that the CSN5 protein
is over-expressed in 60% of human SCCs. Enforced expression of CSN5, but not a catalyti-
cally inactive mutant, is sufficient to confer protection against apoptosis induced by UV radi-
ation in epithelial cells. To better define the roles of CSN5 in stratified epidermis in vivo, we
generated K5-CSN5 and K5-CSN5(D151N) transgenic mice that express CSN5 or the cat-
alytically inactive CSN5(D151N) in murine epidermis. The role of CSN5 on UV-induced apop-
tosis and DNA repair in our transgenic mouse models will be presented. These studies will
also better define CSN5 as a potential therapeutic target for human epidermal neoplasia and
light-regulated dermatoses.
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Hypoxia-inducible factor-1-alpha expression increases after photodynamic therapy using the
silicon phthalocyanine Pc 4
AH Hsia,1,2 D Santo Domingo,1,2 JD Miller,1,2 KD Cooper1,2 and ED Baron1,2 1 Dermatology,
Case Western Reserve University, Cleveland, OH and 2 Dermatology, University Hospitals
Case Medical Center, Cleveland, OH
We show here that hypoxia inducible-1-alpha (HIF-1α) can potentially be a marker for clinical
response after photodynamic therapy (PDT) with the silicon phthalocyanine Pc 4 of cutaneous T-
cell lymphomas. In dermatology, PDT is currently being applied as a treatment for several hyper-
proliferative diseases such as actinic keratoses and various cutaneous malignancies. Silicon phthalo-
cyanine Pc 4 is a second generation photosensitizer that more efficiently absorbs tissue-penetrating
red light than previously-used photosensitizers. The photodynamic mechanism utilizes oxygen to
generate singlet oxygen, which then acts on cellular substrates-a process that potentially creates
hypoxia in the tissue and also leads to apoptosis. These events can be monitored using HIF-1α as
a hypoxic marker and caspase-3 as an indicator of early apoptosis. The purpose of this study was
to examine changes in these two markers in CTCL patients-post PDT. Punch biopsies of CTCL
lesions (n=5) and control/untreated tissues (n=5) were obtained 24 hours after treatment, and sec-
tions from these samples were immunostained using antibodies against HIF-1α and caspase-3.
The percentage area of positive staining in the epidermis for both markers was determined using
Image-Pro interactive image analysis software on 15 measures per sample. We observed signifi-
cant increases in caspase-3 in the epidermis of post PDT biopsies, with 17.9% noted among clin-
ical responders versus nonresponders, which only showed a 4.5% increase (p<0.001). Interest-
ingly, significant increases were also found for HIF-1α, such that 25.8% of the epidermis in
responders showed positive staining versus 2.3% in nonresponders(p<0.005). In conclusion, we
have shown that Pc 4-PDT treatment leads to significant increases in caspase-3, and we demon-
strate for the first time that HIF1-α expression increases after Pc 4-PDT. This increase is signifi-
cantly more pronounced in clinical responders versus nonresponders.
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Combined exposure to UV and Di-nitro benzene sulfonic acid (DNBS) profoundly modu-
lates Ca++-binding proteins and alters redox signaling
M Bennett,1 L Liu,1 S Liu,2 NC Biljanovska,1 TS McCormick,1 MR Chance,2 KD Cooper1 and
P Karnik1 1 Dermatology, Univ Hosp Case Medical Center and Case Western Reserve Univ,
Cleveland, OH and 2 Proteomics, Univ Hosp Case Medical Center and Case Western
Reserve Univ, Cleveland, OH
Proteomic profiling using two-dimensional difference gel electrophoresis (2D-DIGE) revealed
a marked upregulation of Calmodulin (CaM) when HaCaT cells were treated with UV and
DNBS, but not with either agent alone. This, in conjunction with alterations in redox proteins,
is indicative of overwhelmed oxidative defenses. CaM functions as a cellular sensor of oxida-
tive stress and rapidly restores normal redox conditions, minimizing cellular damage. We
treated HaCaT cells with a single dose of UV, DNBS, or UV/DNBS combined, and compared
to untreated cells. Soluble cytoplasmic proteins extracted from treated HaCaT cells were tagged
with Cy3/5 dyes, co-loaded with Cy2-tagged control extracts, and subjected to 2-D DIGE. 71
differentially expressed proteins were analyzed by LC/MS. We observed significant changes
in expression of proteins involved in calcium homeostasis and the redox system. UV and DNBS
synergistically upregulated CaM, although each agent alone downregulated CaM. This sug-
gests a sharp rise in intracellular calcium after combined exposure. Ca++ is an important reg-
ulator of the redox system and inhibits the enzyme Thioredoxin Reductase (TrxR), which main-
tains low levels of oxidised thioredoxin (Trx), a redox protein which enhances the transcriptional
activities of NFkB. Evidence for accumulation of oxidised Trx was provided by the finding of
increased levels of peroxiredoxins and Trx peroxidase in the combined exposure condition.
Our membrane protein data showing a marked downregulation of Ca++ ATPase pumps, as
well as the upregulation of a ROS-generating, Ca++-dependent NADPH oxidase, are also con-
sistent with increased intracellular Ca++, CaM and net oxidation in the thioredoxin system.
These observations may represent novel insights into mechanisms by which an immune sen-
sitization is converted to immune suppression during combined exposure with UV.
858
Involvement of platelet-activating factor and interleukin-10 in ultraviolet B radiation-induced
immunosuppression
Q Zhang, Q Yi, M Al-Hassani, Y Yao, RL Konger and JB Travers Dermatology, Indiana
University, Indianapolis, IN
Ultraviolet B radiation (UVB) has immunosuppressive effects which have been shown to be a
major risk factor for skin cancer. Platelet-activating factor (PAF) is a group of phosphocholines
with significant biological effects mediated by the PAF receptor (PAF-R). Since UVB stimu-
lates PAF production, and PAF-R activation has been shown to inhibit dinitrofluorobenzene-
induced delayed type hypersensitivity (DTH), the object of the present study was to assess the
mechanisms by which the PAF-R mediates the UVB-induced immunosuppression. We first
demonstrated that UVB suppressed DTH reactions in PAF-R expressing wildtype mice but not
in PAF-R knockout mice. We then found that UVB-induced immunosuppression in wildtype
mice was abrogated by the administration of neutralizing anti-IL-10 antibodies. Since IL-10
was shown to be involved in the UVB-induced immunosuppression, and activation of PAF-Rs
either in keratinocytes or monocytic or dendritic cells could be the source of this cytokine,
the expression levels of IL-10 in skin and lymph nodes were measured in the wildtype and
knockout mice after UVB exposure. Using reverse-transcription real-time polymerase chain
reaction and immunohistochemistry, we found no increased IL-10 expression in the skin of
either genotype following UVB irradiation. However, significant upregulation of IL-10 expres-
sion was detected in lymph nodes in the wildtype but not PAF-R-deficient mice following UVB
irradiation. These studies suggest that IL-10 mediates UVB-induced and PAF-R-mediated
immunosuppression and the responsive lymph nodes but not the skin exposed to UVB-irra-
diation is the source of this cytokine.
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Ultraviolet irradiation induces transcription of cysteine-rich protein 61, a pivotal regulator
of collagen production and degradation in human skin fibroblasts
T Quan, T He, Y Shao, S Kang, JJ Voorhees and GJ Fisher Dermatology, University of
Michigan, Ann Arbor, MI
Alterations of human skin connective tissue structure and function are prominent features of
solar ultraviolet (UV) irradiation-induced premature aging (photoaging). These connective tis-
sue abnormalities largely result from reduced synthesis and elevated degradation of type I
collagen, the most abundant structural protein in skin. Cysteine-rich protein 61 (CYR61) is a
secreted protein that binds to extracellular matrix (ECM), and interacts with several distinct
cell surface integrin receptors, in a cell-dependent manner. CYR61 has diverse functions,
including cell adhesion, motility, and regulation of ECM production. Immunohistology and
laser capture coupled real-time RT/PCR reveal that CYR61 is predominantly expressed by
fibroblasts in the dermis, and is significantly elevated in photoaged, and naturally aged human
skin. Acute UV irradiation (twice the minimal erythema dose of solar-simulated UV irradia-
tion) significantly increases CYR61 mRNA with maximum induction (6.5-fold, n=5, p<0.05)
at 8 hours post UV irradiation. In cultured human skin fibroblasts, CYR61 mRNA and protein
expression are elevated 38-fold and 4-fold, respectively, within two hours following UV irra-
diation (30mJ/cm2, UVB source) (n=3, p<0.05). UV irradiation significantly activates CYR61
promoter activity (3.6-fold, n=3, p<0.05). The stability of CYR61 mRNA and protein is not
altered by UV irradiation, indicating the primary mechanism of CYR61 induction is tran-
scriptional. UV irradiation down-regulates type I procollagen and induces collagen-degrad-
ing matrix metalloproteinase-1 (MMP-1) expression. Similar to UV irradiation, over-expres-
sion of CYR61 reduces type I procollagen (71%, n=4, p<0.05) and increases MMP-1 (4.2-fold,
n=4, p<0.05) levels. These data indicate that CYR61 is transcriptionally-regulated by UV irra-
diation, and that induction of CYR61 mediates, at least in part, altered collagen homeostasis
observed in photoaged human skin.
860
Impaired repair of UV-induced DNA damage in keratinocytes deficient in p53 and p63
B Ferguson-Yates,1,2 H Li,1,2 TK Dong,1,2 JL Hsiao1,2 and DH Oh1,2 1 Department of
Dermatology, University of California, San Francisco, San Francisco, CA and 2 Dermatology
Service, VA Medical Center, San Francisco, CA
While many p53-deficient cell types are impaired in global genomic nucleotide excision repair
of cyclobutane pyrimidine dimers (CPD), human epidermal keratinocytes expressing human
papillomavirus type 16 E6 and E7 are p53-deficient and yet maintain repair of CPD. We hypoth-
esized that the p53 homolog, p63, may substitute for p53 in governing global repair in ker-
atinocytes. Cultured E6/E7 keratinocytes were made p63-deficient using two distinct approaches.
Both PI3-kinase inhibition as well as siRNA that target sequences common to all p63 isoforms
significantly reduced p63 protein and mRNA levels in E6/E7 keratinocytes relative to control
cells. Following ultraviolet radiation, an immunoblot assay was used to monitor global repair
in cells over 24 hours. In E6/E7 keratinocytes, p63 depletion impaired global genomic repair
of CPD relative to control cells. In all cases, repair of pyrimidine(6-4)pyrimidone photoprod-
ucts, the other major ultraviolet radiation-induced DNA lesion, was unaffected. In E6/E7 ker-
atinocytes treated with p63 siRNA, reduced global repair of CPD was associated not with
reduced levels of mRNA encoding DNA damage recognition proteins but rather with decreased
levels of XPC and DDB2 proteins both before and after ultraviolet radiation, suggesting that
p63 post-translationally regulates levels of these proteins. These results indicate that global
repair may be regulated at multiple levels in keratinocytes, and suggest a novel role for p63
in modulating DNA repair in human keratinocytes. The results provide insight into mecha-
nisms of genomic stability in epithelia infected with oncogenic human papilloma viruses and
may further explain the lack of increased skin cancer incidence in Li-Fraumeni syndrome.
861
Effects of jasmonic acid and its methyl jasmonate (MJ) on UVB-induced skin carcinogenesis
Y Wang,1 X Zhou,1 J Moore,1 D Gao,1 E Weistein,2 P Chaudhari,1 M Lebwohl1 and H Wei1
1 Dermatology, Mount Sinai Medical Center, New York, NY and 2 Dermatology, Columbia
University, New Yrok, NY
Jasmonic acid (JA) and its methyl jasmonate (MJ) are naturally occurring regulators of higher
plant development, gene expression and responses to external stimuli. Inhibitors of jasmonate
biosynthesis indicated that plant stress hormone JA works as intermediate in signaling trans-
duction when plants are subjected to environmental stresses such as UV radiation, osmotic
shock, cytotoxic drugs, and heat. They have been reported to be involved in plant programmed
cell death with similarities to animal apoptosis. Intact JA signal pathway is required for defense
against UVB damage since the JA-insensitive mutant jar1 showed the increased sensitivity to
UVB radiation, compared to wild-type plants. The evidence in cancer prevention study has
shown that JA may potentially be a novel anti-cancer drug since it induced death or caused
suppression of cell proliferation in the human cancer cells such as prostate, breast and
melanoma cancer cells. We propose that JA and MJ are potential agents against UVB-induced
skin cancer. Our in vitro data have shown that JA showed low toxicity on keratinocytes A431
cell line and the cell viability can maintain above 60% at <= 3 mM JA. MJ showed similar
trend under 0.5 mM. JA significantly decreased the phosphorylation of EGFR in keratinocytes
A431 induced by EGF (2 ng/ml), UVA (80 kJ/m2) and UVB (50 mJ/cm2) in a does dependent
manner. The 25-week UVB irradiation in vivo study of SKH-1 hairless mice has shown that JA
pre-treatment decreased the tumor number by 20% while MJ pre-treatment significantly reduced
tumor number by 67%. Post-treatment with JA and MJ showed similar effects also and signif-
icantly decreased tumor number by 39% and 44%, respectively. JA and MJ treatment also
delayed the initiation of tumor by one week though they did not show significant effect on
tumor incidence.
862
Estrogen receptor beta expression in nevi during pregnancy
MA Nading,1 LB Nanney,2 AS Boyd1 and DL Ellis1,3 1 Div of Dermatology, Vanderbilt
University School of Medicine, Nashville, TN, 2 Dept of Plastic Surgery, Vanderbilt University
Dept of Cell and Developmental Biology, Nashville, TN and 3 VHA, TN Valley Healthcare
System, Nashville Campus, Nashville, TN
Clinical evidence suggests that melanocytes are estrogen responsive and pregnancy is associ-
ated with increased estrogen levels. We hypothesized that nevi from pregnant patients would
exhibit an increased expression of ERβ and thus an enhanced potential to respond to altered
estrogen levels. Normal, dysplastic, and congenital nevi (n=213) were collected from pregnant
and nonpregnant women 18-45 years of age. Immunohistochemical staining was performed on
nevi using antibodies directed against ERα and ERβ. Our results confirmed that ERβ is the pre-
dominant estrogen receptor in melanocytic cells from all types of nevi regardless of pregnancy
status. ERα was not observed in any of the melanocytic cells tested. By contrast, immunohisto-
chemical staining revealed that positivity for ERβ increased in normal nevi during pregnancy
compared to nonpregnant controls including nevocytes in both the epidermal and dermal micro-
environment (p=0.006 and p=0.001 respectively). Increasing levels of melanocytic atypia were
associated with increased immunoreactivity in nevocytes in the epidermal layer in all samples.
No significant progression in staining intensity was observed during pregnancy. For normal and
congenital nevi, regardless of pregnancy status, the dermal component tended to have greater
ERβ immunoreactivity. Congenital nevi from pregnant women actually showed a slight, but not
statistically significant decrease in ERβ immunoreactivity compared to congenital nevi from
women who were not pregnant. However, significant decreases in ERβ immunoreactivity were
observed in congenital nevi from pregnant women compared to normal and atypical nevi from
pregnant women. Our data suggest that nevi possess the capacity to be estrogen responsive and
factors such as pregnancy and degree of atypia are associated with enhanced levels of ERβ with
the exception of congenital nevi where melanocytes were unique in their response to pregnancy.
863
The V122M variant of the melanocortin 1 receptor is associated with melanoma
M Council,1,2 LA Cornelius1 and AM Bowcock1,2 1 Dermatology, Washington University, St.
Louis, MO and 2 Genetics, Washington University, St. Louis, MO
Recent evidence suggests that the melanocortin 1 receptor (MC1R) is an important genetic
modifier of melanoma risk. We investigated the association between MC1R variation and
melanoma risk in our patient population in a case-control study using cancer-free controls.
Following informed consent, DNA was collected from 110 primary cutaneous melanoma
patients treated at Washington University School of Medicine and 175 healthy Caucasian can-
cer-free controls. Direct sequencing analysis of the entire coding region of the MC1R was
performed. Chi-square analysis was used to determine significant association(s) between MC1R
variants and disease. Ten non-synonymous changes were found in our cohort of melanoma
patients and controls. Two variants (V122M and R160W) were independently associated with
disease (p<0.05 and p<0.01, respectively). Previous investigations have shown that both V122M
and R160W variants result in diminished MC1R function, and our findings have supported
the R160W polymorphism association with melanoma risk. Most importantly, however, no
previous association with melanoma risk has been found for the V122M variant, although it
has been previously reported to be associated with UV sensitivity. Finally, several polymor-
phisms previously described to segregate with melanoma, including V60L, D84E, V92M,
R151C, R163Q, and D294H, when independently evaluated and compared to cancer free
controls, were not found to be associated with disease in our patient population. In conclu-
sion, we are the first to report the association of the V122M variant of the MC1R with melanoma
risk (p<0.05), and propose that its previous association with UV sensitivity is of particular inter-
est. In addition, we did not find an association of previously reported MC1R polymorphisms
with melanoma in our patients when independently evaluated and compared to cancer-free
controls.
864
Effect of Trans-4-Aminomethylcyclohexanecarboxylic acid on the proliferation and melaniza-
tion in cultured normal human melanocytes
S Seo,1 M Jeong,2 M Kim,1 C Hong1 and B Ro1 1 Dermatology, Chung-Ang University, Seoul,
South Korea and 2 Chung-Ang University Hospital Research Center, Seoul, South Korea
Trans-4-aminomethylcyclohexanecarboxylic acid (tranexamic acid) is used as a bleeding con-
trol medication in the case of abnormal hemorrhage caused by fibrinolysis dissolution. It has
also been reported that the tranexamic acid inhibits prostaglandin synthesis and hinders the
pigmentation caused after UV radiation. There is no theoretical background of the mesother-
apy using transexamic acid even though it is used to treat the melasma and the postinflam-
matory hyperpigmentation. Therefore, this study is designed to evaluate the influence of the
tranexamic acid on the viability and morphogenesis of the normal human cultured melanocyte
and melanogenesis. The cultured malnocytes from neonatal foreskin were exposed to UVB
20mJ/cm2, then they were treated by tranexamic acid 0.05µg/ml, 5µg/ml, 0.5mg/ml. After 24
hours the viability of the melanocytes and the melanin concentration has been measured. The
number and the length of the melanocytes’ dendrites, and the activities of tyrosinase, TRP-1
and TRP-2 have also been evaluated. The survival rate of the malanocytes has been decreased
by the treatment of transexamic acid in dose dependent manner (p < 0.05). The melanin syn-
thesis has been increased due to the UVB irradiation but decreased by the treatment of tran-
sexamic acid in dose dependent manner (p < 0.05). The activities of TRP-1 and TRP-2 and
tyrosinase showed increase after 12 hrs, 24 hrs and 48 hrs of UVB irradiation. However, they
were downregulated by the treatment of transexamic acid in dose dependent manner (p <
0.05). Both UVB and the treatment of tranexamic acid did not have any effect on the number
and the length of the dendrites. According to the experiment, this study showed the suppres-
sion of melanogenesis by tranexamic acid.. In conclusion, the use of tranexamic acid is expected
to be a kind of treatment modality of the melasma and hyperpigmentation.
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Therapeutic efficacy of antigen-specific vaccination and toll-like receptor stimulation against
established transplanted and autochthonous melanoma in mice
D Tormo, A Ferrer, P Bosch, E Gaffal and T Tuting Dermatology, Uniklinik Bonn, Bonn,
Germany
Antigen-specific immunotherapeutic approaches for melanoma have been primarily investi-
gated using the transplantable B16 melanoma cell line in mice. To more closely mimic the
clinical situation in patients with melanoma, we use genetically modified mice overexpress-
ing hepatocyte growth factor (HGF) and carrying an oncogenic mutation in the cyclin depend-
ent kinase 4 (CDK4R24C). HGF x CDK4R24C mice rapidly develop multiple invasive
melanomas in the skin following neonatal carcinogen treatment which spontaneously metas-
tasize to lymph nodes and lung. We used a vaccine strategy consisting of recombinant ade-
novirus encoding human tyrosinase-related protein 2 (Ad-hTRP2) and application of CpG
DNA and synthetic dsRNA against engrafted B16 melanoma or primary autochthonous
melanomas in the skin and in the lung of HGF x CDK4R24C mice. Both Ad-hTRP2 vaccina-
tion and peritumoral injections of TLR ligands were required for rejection of established B16
melanoma in the skin. Vaccination with Ad-TRP2 followed by injections of TLR ligands resulted
in delayed growth of autochthonous primary melanomas in the skin and a reduction in the
number of spontaneous lung metastases but did not induce tumor regression. Carcinogen-
treated HGF x CDK4R24C mice bearing multiple autochthonous melanomas did not reject
transplanted B16 melanoma despite treatment with Ad-hTRP2 and TLR ligands. These results
suggest the development of a profound tumor immune tolerance in mice carrying primary
autochthonous melanomas.
867
Histopathologic features in vitiligo
Y Kim,1 Y Kim,1 H Kang,1 S Sohn2 and E Lee1 1 Department of Dermatology, Ajou University,
School of Medicine, Suwon, South Korea and 2 Laboratory of Cell Biology, Ajou University,
School of Medicine, Suwon, South Korea
It is sometimes difficult to differentiate vitiligo from nevus depigmentosus only by clinical
features. We postulated that histologic changes in lesional and perilesional skin might be dif-
ferent in the two conditions. We took biopsies at both lesional and perilesional skin of 100
cases of vitiligo to assess the number of melanocytes, the amount of melanin pigment, der-
mal inflammatory infiltrate, and other changes. We also compared them to 30 cases of nevus
depigmentosus. The general histologic features of vitiligo showed more frequent basal hypopig-
mentation and dermal inflammation than perilesional normal skin. In Fontana-Masson stain-
ing, 16% of vitiligo showed the presence of melanin. The ratio of pigmented area to epider-
mal area was 0.06% in vitiligo, while 17% in perilesional normal skin and 8.9% in nevus
depigmentosus. In NKI/beteb staining, 12% of vitiligo showed the presence of melanocytes
and their average number was 7.68/mm2. The number of melanocytes was also decreased in
nevus depigmentosus but the amount of decrease was much less than that of vitiligo. We also
confirmed the presence of melanocytes in 1 of 3 vitiligo on electron microscopy. In conclu-
sion, there exist a few melanocytes and melanin in some vitiligo. Therefore, the diagnosis of
vitiligo should be made considering these points.
869
Differentiation of melanoma from dysplastic nevi in suspicious pigmented skin lesions by
non-invasive tape stripping
W Wachsman,1,2 M Zapala,4 D Udall,3 A Paik,3 T Hata,3 L Walls,1,2 R Wong,5 N Schork4 and
S Chang5 1 Research, VA San Diego Healthcare System, San Diego, CA, 2 Hem-Onc and
Cancer Center, UCSD, La Jolla, CA, 3 Dermatology, UCSD, La Jolla, CA, 4 Psychiatry, UCSD,
La Jolla, CA and 5 DermTech International, San Diego, CA
The purpose of this study is to determine whether stratum corneum RNA, harvested by tape strip-
ping with Epidermal Genetic Information Retrieval (EGIR), can be used to distinguish melanoma
from dysplastic nevi in suspicious pigmented lesions. Typically, melanoma is identified by histopatho-
logic examination of biopsies in only 3-10% of suspicious pigmented nevi. Studies by several groups
have shown that gene expression profiles of biopsy specimens can be used to distinguish primary
melanoma from dysplastic and benign nevi. Previously, we demonstrated that EGIR-harvested RNA
can be assayed by both quantitative RT-PCR and DNA microarray. Following informed consent,
the suspicious pigmented lesion was tape stripped using EGIR and then biopsied as per standard
of care. The resulting RNA isolated from the EGIR tape was amplified and profiled on the Affymetrix
U133 plus 2.0 GeneChip. Microarray data were normalized by the GCRMA algorithm. Further
analyses by means of an unpaired t-test and ANOVA analysis (p<0.05) identified 212 genes as dif-
ferentially expressed between melanoma, dysplastic nevi and normal skin. Hierarchical clustering
of these genes showed that the melanoma specimens grouped together and were clearly distin-
guished from dysplastic nevi and normal skin. In addition, 88 genes were identified as potential
discriminators between melanoma and dysplastic nevi (p<0.0002, false discovery rate q<0.05).
When these 88 genes were subjected to Ingenuity Pathways analysis many were found to play roles
in melanoma, malignant tumors and cell cycle progression. These findings demonstrate that EGIR-
harvested RNA from suspicious pigmented skin lesions can be used to differentiate melanoma from
dysplastic nevi. Further, these results suggest that the gene expression profile of stratum corneum
is altered, either directly or indirectly, by the presence of melanoma.
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Analysis of facial pigmented lesions using in vivo confocal microscopy and UV digital pho-
tography
T Kuwahara,1 H Akita,2 Y Masuda,1 T Iikura,1 T Yamashita,1 T Hirao1 and K Matsunaga2 1 Life
Science Research Center, SHISEIDO CO., LTD., Yokohama, Japan and 2 Department of
Dermatology, Fujita Health University School of Medicine, Toyoake, Japan
The precise diagnosis of pigmented lesions is important in providing appropriate treatment.
The examination of biopsied tissue is effective, but it is often difficult to obtain it. In this study
various facial pigmented lesions were analyzed using non-invasive methods: in vivo confocal
microscopy and UV digital photography. Cases of melasma, ephelides, solar lentigo and seb-
orrheic keratosis were measured as pigmented lesions. The 3D structure of the epidermis was
reconstructed from a sequence of horizontally sectioned images obtained by in vivo confocal
microscopy. Compared with the normal skin, the thickness of epidermis with solar lentigo
and seborrheic keratosis was significantly thick and remarkable undulation of dermo-epider-
mal junction was observed. We also analyzed the 3D distribution of melanins within the epi-
dermis. Melanin caps were observed along the basal layer. In the case of melasma, the thick-
ness of epidermis was similar to the normal skin and dermo-epidermal junction was flat.
Melanin caps were distributed uniformly in the flat basal layer. Furthermore, for the simple
diagnosis of pigmented lesions, we developed the UV digital camera which can separately
acquire the images in the UVAI, UVAII and UVB ranges. Compared with the visible images,
the UVAI images projected each pigmented lesions more distinctively. On the contrary, the
UVB images showed indistinctive regions in the cases of ephelides, solar lentigo and sebor-
rheic keratosis. Because the UVB light, compared with the UVAI and UVAII lights, relatively
less penetrates into the skin, the UVB images seem to mainly project upper regions in the
skin. We conclude that in vivo confocal microscopy and UV digital photography will be use-
ful tools for the non-invasive diagnosis of pigmented lesions.
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Köebner phenomenon is associated with clinical form of vitiligo in a Brazilian population
C Castro,1,2 LM Nascimento,2 RI Werneck2 and MT Mira2 1 Group for Advanced Molecular
Investigation, Graduate Programe in Health Sciences, Pontifical Catholic University of
Parana, Curitiba, Brazil and 2 Dermatology, Pontifical Catholic University of Parana, Curitiba,
Brazil
Vitiligo is an acquired chronic disease characterized by skin macules devoid of both melanic
pigment and identifiable melanocytes. Different clinical features allow clinicians to classify
vitiligo into three major clinical forms: vulgaris, acrofacialis and segmental. In addition, Köeb-
ner phenomenon (KP) may occur, as defined as the development of vitiligo macules at sites
of specific trauma. The prevalence rate of KP among vitiligo patients has been described by
several studies, the majority of them involving individuals affected by vitiligo “per se”, i.e. the
disease regardless the clinical form. However, results are often discordant, therefore of lim-
ited interpretation. Here we compare the occurrence of KP in a population of 397 independ-
ent individuals affected by vitiligo vulgaris (174; 43.8%), acrofacialis (151; 38.0%) and seg-
mental (69; 17.2%). All individuals were ascertained at the Dermatology Clinic of the Santa
Casa de Misericórdia Hospital and one private dermatology office, both located at Curitiba,
Brazil. All cases have been diagnosed and clinically classified by the same dermatologist.
Affected individuals to whom unambiguous classification was not possible have been excluded
from the study. Occurrence of KP was identified on 107 (61.49%), 40 (26.49%) and 4 (5.55%)
individuals with vitiligo vulgaris, acrofacialis and segmental, respectively. The difference in
the distribution of KP across all clinical forms was found to be highly significant (P = 2.12 x
10-18). In addition, we observed a gradient of chance of occurrence of KP, the highest being
for vulgaris and the lowest, for segmental cases. These observations may help to explain the
different prevalence rates of KP observed for vitiligo, when not accounting for clinical form.
In addition, the occurrence of KP might be of prognostic value for clinical progression of
early diagnosed vitiligo.
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Prognostic significance of ING4 expression in human melanoma
J Li,1 DL Dai,1 M Martinka2 and G Li1 1 Dermatology and Skin Science, the University of
British Columbia, Vancouver, BC, Canada and 2 Pathology,Vancouver Coastal Health
Research Institute, the University of British Columbia, Vancouver, BC, Canada
ING4 is a novel member of the inhibitor of growth (ING) tumor suppressor family. It can phys-
ically interact with p300 and p65 (RelA) subunit of NF-κB, and consequently enhance acety-
lation of p53 and repress transcription of NF-κB responsive genes. Overexpression of ING4
can inhibit tumor cell growth and induce p53-dependent apoptosis. This study investigated
the role of ING4 in melanoma pathogenesis. We established the tissue microarray and eval-
uated expression of ING4 by immunohistochemistry in 50 dysplastic nevi, 101 primary
melanomas, and 49 melanoma metastases. We also analyzed the association of ING4 expres-
sion with melanoma progression and patient survival. Our data showed that ING4 expression
is significantly decreased in primary melanoma and metastatic melanoma when compared
with dysplastic nevi (P<0.001 for both, χ2 test). Furthermore, we found that reduced ING4
staining is associated with melanoma thickness, ulceration and patient’s age. Moreover, reduced
ING4 staining is significantly correlated with poor overall and disease-specific 5-year survival
of primary melanoma patients (P<0.0001 for both, χ2 test). Strikingly, Cox regression analysis
revealed that reduced nuclear ING4 staining is an independent factor for the poor prognosis
of patients with primary melanomas (P=0.01, RR=4.91). Taken together, our data indicate that
ING4 plays an important role in melanoma progression and can potentially be used as a
prognostic marker and a therapeutical target for human melanoma.
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The effects of dickkopf 1 on gene expression and Wnt signaling by keratinocytes: mechanisms
regulating skin pigmentation and thickness
Y Yamaguchi,1,2 T Passeron,1 I Katayama2 and VJ Hearing1 1 Laboratory of Cell Biology,
National Cancer Institute, National Instittutes of Health, Bethesda, MD and 2 Department of
Dermatology, Osaka University, Suita-shi, Japan
The epidermis (containing primarily keratinocytes and melanocytes) overlies the dermis (con-
taining primarily fibroblasts) of human skin. We previously reported that DKK1 secreted by
fibroblasts elicits the hypopigmented phenotype of palmoplantar skin due to suppression of
melanocyte function and growth via the regulation of 2 important signaling factors, MITF and
β-catenin. We now report the effects of DKK1 on the gene expression profiles and Wnt sig-
naling pathways of keratinocytes. Treatment of keratinocytes with DKK1 increased their pro-
liferation and decreased their uptake of melanin. Microarray analysis revealed numerous genes
that are regulated by DKK1 in keratinocytes, expression patterns that were validated by RT-
PCR and Western blotting. Treatment of reconstructed skin by DKK1 induced a thicker and
less pigmented epidermis and reproduced the expression patterns of key proteins (PAR2, β-
catenin and keratin 9) observed in palmoplantar skin. These findings further elucidate why
human skin is thicker and paler on the palms and soles than on the trunk through topo-
graphical/site-specific differences in DKK1 secretion by dermal fibroblasts which affects the
overlying epidermis.
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Stepwise malignant progression of human melanocytes in a skin-like environment
R Lo1,2 and O Witte2 1 Dermatology/Medicine, UCLA, Los Angeles, CA and 2 HHMI, UCLA,
Los Angeles, CA
Accumulation of distinct sets of genetic/epigenetic alterations is thought to contribute to step-
wise progression of human cutaneous melanoma. We investigated the causative roles of
melanoma-associated genetic/epigenetic alterations in human organotypic skin cultures.
Although PTEN deficiency or Braf activation individually supported anchorage-independent
growth, each alteration only conferred hyperplastic growth in a skin-like environment. PTEN
deficiency combined with Braf activation conferred a melanoma in situ-like phenotype but
failed to provide invasive characteristics, in contrast to NRas activation. Further addition of
cell-autonomous TGF-β activation promoted an invasive phenotype. Thus, tissue architecture
phenotypically modulates melanoma-associated genetic/epigenetic alterations, and distinct
stages of human melanoma are genetically tractable.
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Helium-neon laser irradiation stimulates cell proliferation through photostimulatory effects
in mitochondria
H Yu,1 W Hu,2 J Wang,3 C Yu,4 C Lan1 and G Chen1 1 Department of Dermatology, College
of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, 2 Faculty of Biotechnology
and Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University,
Kaohsiung, Taiwan, 3 Faculty of Medicinal and Applied Chemistry, Kaohsiung Medical
University, Kaohsiung, Taiwan and 4 Department of Internal Medicine and Institute of
Molecular Medicine, National Taiwan University Hospital and National Taiwan University
College of Medicine, Taipei, Taiwan
Recent evidences indicated that cellular proliferation could be triggered by the interaction of
helium-neon laser (He-Ne laser, 632.8 nm) with the mitochondrial photoacceptor-cytochrome
c oxidase. Our previous studies demonstrated that He-Ne irradiation induced an increase in
cell proliferation, but not migration, in melanoma cell line A2058 cell. The aim of this study
was to investigate the underlying mechanisms of photostimulatory effects induced by He-Ne
laser. Using A2058 cell as a model for cell proliferation, the photobiologic effects induced by
He-Ne laser were studied. He-Ne irradiation immediately induced an increase in mitochon-
drial membrane potential (∆Ψmt), ATP and cAMP levels via enhanced cytochrome c oxidase
activity. This photostimulatory effect also promoted phosphorylation of Jun N-terminal kinase
(JNK) / activator protein-1 (AP-1) expressions. The He-Ne irradiation-induced A2058 cell pro-
liferation was significantly abrogated by the addition of ∆Ψmt inhibitor and JNK inhibitor.
Moreover, treatment with He-Ne laser resulted in the delayed stimulatory effects on inter-
leukin-8 and transforming growth factor-β1 release from A2058 cells. These results suggest
that He-Ne irradiation elicits photostimulatory effects in mitochondria, a process which involves
JNK/AP-1 activation and enhanced growth factor release, that ultimately leads to A2058 cell
proliferation.
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Effects of patented natural peptides (ZR101) on melanogenesis
D Naaimi, S Bredif, C Baudouin and P Msika R & D Center, Laboratoires Expanscience,
Epernon, France
Skin reacts to ultraviolet exposure by tanning. Moreover, it is well-known that pigmentation
constitutes a skin protection factor. In order to demonstrate the efficacy of natural peptides
(ZR101) on skin natural pigmentation, different parameters including melanin synthesis, tyrosi-
nase activity, melanocytes dendricity and melanosome transfer to keratinocytes were analyzed
in vitro and ex vivo. Cocultures of normal human melanocytes and keratinocytes were treated
with ZR101 and the level of melanin synthesis was evaluated (with or without exposure to
UV) by spectrophotometry analysis. In addition, the direct effect on tyrosinase activity was
also measured by following the conversion of L-dopa to dopaquinone. The potential effect on
dendricity was investigated by a specific labelling of the melanosome (Mel-5). Moreover,
melanosome transfer activity from melanocytes to keratinocytes was evaluated by flow cytom-
etry assay. Finally, the study was completed by a functional ex vivo assay using human skin
explants. ZR101 is able to significantly stimulate the production of melanin, with and with-
out UV (11% and 29% respectively). Under these two conditions, this stimulation was corre-
lated with an increase of the protein contents and metabolic activity. In addition, ZR101 acts
directly on tyrosinase, increasing its activity (+172%). ZR101 is also able to change the mor-
phology of melanocytes by increasing the length and the number of the dendrites (67% and
27% respectively). Moreover, ZR101 enhances the melanosome transfer into keratinocytes
(+28%) and thus improves the distribution of the melanin into keratinocytes. Finally the study
on ex vivo human skin explants demonstrated that ZR101 presents a pigmentation accelera-
tor effect in agreement with in vitro tests. Theses results have demonstrated that natural pep-
tides, ZR101, are able to enhance the innate and photo-induced skin pigmentation. By their
specific and efficient in vitro activities, these natural peptides could promote the tanning in
vivo and thus could strengthen the skin protection against deleterious effect of UV irradiation.
875
Reduction of human melanoma growth by the use of guanosine monophosphate as a trans-
differentiation agent in the xenograft Metamouse® Human Melanoma Model, LOX-GFP
SA Baranowitz,1 H Ma,2 X Li,2 Z Yang2 and RM Hoffman2 1 Epitek, Inc., Medford, NJ and 2
Anticancer, Inc., San Diego, CA
Transdifferentiation, the conversion of cells from one terminally differentiated state to a dif-
ferent terminally differentiated state, has been well studied in pigmented cells. Transdifferen-
tiation has been proposed as a method for treatment of melanoma through conversion of
metastatic cells to benign cells. The nucleoside guanosine, and its phosphate nucleotides, have
shown activity against melanoma and other cancers in cell culture. To test the efficacy of guano-
sine monophosphate as a treatment for melanoma, a well established xenograft model was
used where human LOX melanoma cells transfected with Green Fluorescent Protein were
implanted intradermally into NCr nude mice. There was one control group (n=8) and 3 dif-
ferent dose groups(n=8,8,4). In the experimental groups, guanosine monophosphate was put
in the drinking water on day 3 of the experiment. Tumor size was assessed both by quantita-
tive immunofluorescence of the Green Fluorescent Protein melanoma at 12 and 19 days, and
weight of the excised primary tumor at 19 days. At 10 mg/ml in the drinking water (n=8),
melanoma growth (GFP) was dramatically and significantly reduced (p<0.01). At day 12, by
GFP immunoflorescence, the tumor size was reduced by 60% in males and 28% in females.
At day 19, the weight of the excised tumor was reduced by 50% in males and 33% in females.
These results clearly demonstrate that guanosine monophosphate is an effective agent for
reducing growth of human metastatic melanoma in this xenograft model. Examination of his-
tological sections from control and experimental groups suggested that the growth reduction
was accompanied by conversion of malignant cells to a more benign phenotype by this trans-
differentiation agent.
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Utilization of total body digital photography in melanoma
ZM Pressley,1 L DeLong,1 F Weiss,1 C Curiel-Lewandrowski2 and S Chen1 1 Dermatology,
Emory, Atlanta, GA and 2 Medicine, Arizona, Tucson, AZ
Total body digital photography (TBDP) is increasingly used as an adjunct screening measure
for melanoma. However, its actual utilization and rationale for usage by academic dermatolo-
gists has not been recently documented. A questionnaire was mailed to 113 dermatology depart-
ments across the US. Descriptive analyses were performed using STATA version 9.0. Our response
rate thus far is 38% (43/113), with 58% of questionnaires completed by program directors, 33%
by pigmented lesion clinic directors, and 14% by other dermatology faculty. Sixty-three per-
cent (n=27) of respondents used either TBDP or total body photography (TBP), not digitally
based. In this group, 33% (n=9) utilized TBDP alone, 37% (n=10) used TBP alone and 30%
(n=8) used TBDP in combination with TBP. For those who used TBDP and/ or TBP, 84% (22/27)
responded that full body baseline photographs were most useful for patients with many (>50)
clinically atypical nevi. The 3 most frequently cited reasons for using photographs were that
they reduced patient anxiety (70%), led to fewer biopsies (67%), and helped to find melanoma
early in the curable stage, (67%). Logistical constraints (no photographer, equipment, or image
storage) was cited as the number one reason for not utilizing photographs (75%, 12/16), fol-
lowed by the belief that TBDP is not helpful in the management of patients (63%). Of the der-
matologists who use TBDP, they most frequently offer TBDP to patients with atypical mole syn-
drome (88%, 15/17), followed by history of dysplastic nevi (71%), irregardless of personal history
of melanoma. Of all respondents, 51% (n=22) anticipate using photography more in the next
5 years, of which 27% did not currently use any photography. Reasons cited for anticipating
increased use include that photography helps find melanoma early in the curable stage (59%,
13/22), improves record keeping (55%), and both reduces patient anxiety (50%), and leads to
fewer biopsies (50%). Our results indicate that conflicting beliefs exist about the utility of
TBDP in the management of at-risk patients, thus indicating a need for further studies.
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Overexpression of ankyrin repeat-rich membrane spanning (ARMS) proteins confers apop-
tosis resistance in malignant melanoma
YH Liao,1,2 JS Chen,1 SM Hsu2,3 and PH Huang2,3 1 Department of Dermatology, National
Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan,
2 Graduate Institute of Pathology, National Taiwan University, Taipei, Taiwan and 3
Department of Pathology, National Taiwan University Hospital, College of Medicine,
National Taiwan University, Taipei, Taiwan
ARMS (ankyrin repeat-rich membrane spanning), a transmembrane protein with 11 ankyrin
repeats, or Kidins220 (kinase D-interacting substrate of 220kD), is identified as a downstream
molecule in the neurotrophin-Trk or ephrin-Eph pathways. ARMS is abundantly expressed in
the neural tissues. Because neoplastic melanocytes have been reported to express neuron-
specific markers, we are interested to investigate the role of ARMS in malignant melanoma,
a malignancy of neural-crest origin. We first demonstrated that ARMS was overexpressed in
human melanoma cell lines compared to normal melanocytes, both in RNA and protein level.
Immunohistochemistry staining of 96 melanocytic lesions showed significantly increased
ARMS expression in primary malignant melanomas (94%; P < 0.001) and metastatic melanoma
(65.4%; P = 0.014) compared with benign nevi (38.5%). To investigate the role of ARMS in
the process of melanoma tumorigenesis, mouse melanoma cell line B16-F0 cells with stable
knockdown of ARMS was established by RNA interference. Without significant influences on
basal cell cycle progression and proliferation rate, knockdown of ARMS resulted in a signifi-
cant inhibition on growth of tumor inoculated subcutaneously in NOD/SCID mice. Impor-
tantly, decreased expression of ARMS enhances UVB-induced apoptosis in melanoma cells,
as revealed by flow cytometry. Taken together, the study is the first to establish a link between
overexpression of ARMS and melanoma tumorigenesis. These results suggest that ARMS may
promote melanoma tumorigenesis through preventing apoptotic cell death.
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A new melanin-inducing active ingredient that enhances skin pigmentation and moderates
UV-induced damage
E Bauza, G Bressier, A Perrin, T Marchand, C Gondran, F Portolan, C Dal Farra and
N Domloge Vincience, ISP Global Research Center, Sophia Antipolis, France
Tanned skin has been described as being more resilient to the harmful effects of solar radia-
tion than fair skin. In the field of cosmetics, the use of melanin-inducing active ingredients
provides an interesting way to improve skin tanning while reducing sun-induced skin injuries.
In this study, we characterized the activity of a new melanin-inducing active ingredient (MI)
by using ex vivo skin biopsies submitted or not to UVB irradiation. Melanin content was visu-
alized by Fontana-Masson staining. A time-dependent increase in melanin staining was
observed when skin biopsies were treated for 24, 48, and 72 hours with 1% of MI applied
twice daily. Moreover, MI exhibited a dose-dependent increase in melanin intensity from 1%
to 3%, for a 48-hour treatment. For skin biopsies exposed to UVB-irradiation, a 24-hour treat-
ment with 1% of MI was performed. MI was applied twice, once before and once after irra-
diation with 100 mJ/cm2 of UVB. In these conditions, irradiated skin biopsies showed a greater
melanin intensity than non-irradiated biopsies, and irradiated MI-treated biopsies revealed a
melanin content that was clearly greater than that of irradiated control biopsies. Finally, in
order to evaluate the anti-inflammatory activity of MI, secreted IL-1 beta was measured in
human fibroblasts. 1% or 3% of MI was applied 24 hours before and after irradiation with
100 mJ/cm2 of UVB. Treated fibroblasts exhibited a significant decrease in IL-1 beta level (-
38% and -45% with 1% and 3% of MI, respectively), indicating that this extract can prevent
inflammation, especially under UVB-stress induction. Taken together, these results indicate
that this new melanin-inducing active ingredient can help prevent sun-induced damage by
enhancing skin tanning and limiting UV-induced skin inflammation. The study thus suggests
that this melanin-inducing active ingredient can be of great use in sun care products.
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A new botanical extract that enhances skin tanning. in vivo study
E Bauza, G Oberto, A Berghi, F Portolan, D Peyronel, C Dal Farra and N Domloge Vincience,
ISP Global Research Center, Sophia Antipolis, France
Consumers are increasingly seeking skin care products that offer a nice suntan while pro-
tecting the skin from UV-induced premature aging. In response to this demand, we devel-
oped a new botanical extract that acts specifically on melanin synthesis. As our studies have
demonstrated the remarkable in vitro effects of this botanical extract on enhancing melanin
synthesis, we were interested in investigating its in vivo effects in the following clinical study.
20 healthy volunteers of both sexes, age 25 to 55, participated in this double-blind study. Vol-
unteers applied a cream formula with 1.5% of the botanical extract, or placebo, on the fore-
arm, twice a day for 28 days. Using a mexameter, measurements of melanin content in the
skin were performed at the beginning of the study, after one week, and at the end of the study.
Clinical evaluations were also performed. The new botanical extract showed a rapid action
on enhancing melanin content in the skin of volunteers, as early as within 7 days of the test,
with a highly significant enhancement of melanin content compared to placebo (p=0.00038).
After four weeks, the difference between the botanical extract-treated and placebo sides was
also highly significant (p=0.00054) and the results revealed an increase in melanin of 194%
on the botanical extract-treated side. For the duration of the test, enhancement of the melanin
index reached 244% and was very highly significant (p=0.00005). Moreover, this effect was
observed in more than 80% of volunteers. The improvement of the botanical extract-treated
side was confirmed clinically, and was clearly seen in 75% of volunteers. These results demon-
strate that this new botanical extract significantly enhances melanin content in the skin, and
can be of great use in skin care, sun care, and self tanning products.
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A remarkable new melanin-inducing active ingredient. in vivo studies
G Oberto, A Berghi, E Bauza, F Portolan, C Dal Farra and N Domloge Vincience, ISP Global
Research Center, Sophia Antipolis, France
Consumer interest in tanning products has grown significantly in the last number of years.
Accompanying this growth has been an increasing desire for a natural tanned complexion
without excessive UV exposure or the use of irritating self-tanning products. In line with this
trend, we developed a new melanin-inducing active ingredient . Ex vivo studies have revealed
its remarkable efficacy in inducing melanin in the skin. Therefore, we were interested in study-
ing, in vivo, the tanning effect of this active ingredient, in the following double-blind study.
18 healthy volunteers (16 women and 2 men), age 25 to 55, participated in this study. They
applied a cream formula containing 1.5% of the new active ingredient, or placebo cream,
twice a day, for 4 weeks. The application zones were defined on the top of the arms. Mea-
sures of the melanin index were carried out on D0, D7, and D28, using a Mexameter MX18.
Clinical evaluations were also performed. As early as D7, the results showed a highly signif-
icant increase (p=0.0016) in the melanin index on the active ingredient side. This corresponded
to an improvement of skin tanning of 186%, and was detected in 78% of the volunteers. At
D28, the results showed in 61% of volunteers a significant increase of 147% in the melanin
index on the active ingredient–treated side (p=0.0320). Finally, analysis of the area under curve
(AUC) for the whole duration of the test showed a highly significant improvement of 163% in
the melanin index (p=0.0022). This improvement was observed in 83% of the volunteers. More-
over, clinical examination revealed a visible increase in skin pigmentation in 67% of the vol-
unteers. These studies demonstrate that this new active ingredient rapidly and efficiently induces
melanin content in the skin, and can be of great use in self-tanning and sun care products.
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The whitening effect of Brassicaceae extract on the skin. comparative studies with kojic acid
C Gondran, G Bressier, A Perrin, T Marchand, L Bergeron, C Dal Farra and N Domloge
Vincience, ISP Global Research Center, Sophia Antipolis, France
Developing active ingredients that can whiten the skin or act on pigmentation disorders has
become an important challenge for the cosmetic industry. We were thus interested in study-
ing further the whitening effects of Brassicaceae extract on the skin, and in comparing it with
kojic acid. To do this, histological studies were performed on dark human skin biopsies (type
V). Skin samples were pretreated with 1% and 3% Brassicaceae extract for 24 h, irradiated
with 100 mJ/cm2 of UVB, and then treated with Brassicaceae extract for additional 48 hours.
The extract was applied twice daily. Parallel studies were conducted with kojic acid (1 and 50
mM), a positive control for whitening active ingredients. Skin sections were stained with either
hematoxylin-eosin (H&E) or Fontana-Masson. H&E staining revealed many signs of UV-induced
damage in the irradiated control skin. By contrast, a remarkable decrease in signs of sun dam-
age was observed in Brassicaceae extract-treated skin. Moreover, in these H&E sections, a net
decrease in melanin content was observed in Brassicaceae extract-treated skin, compared to
control skin. Interestingly, skin samples treated with kojic acid exhibited a similar reduced
content of melanin in the skin, but exhibited many signs of UV damage, indicating no pro-
tective effect of kojic acid against UV skin damage. Fontana-Masson staining confirmed the
reduction in melanin content in Brassicaceae extract-treated skin, compared to untreated con-
trol skin. Furthermore, irradiated control skin exhibited an increase in melanin content in the
basal layer of the epidermis, while Brassicaceae extract-treated skin exhibited a noticeable
decrease in melanin content in the basal layer. Surprisingly, kojic acid also reduced melanin
level in non-irradiated and irradiated skin biopsies, but to a lesser degree than Brassicaceae
extract. This histological study provides valuable evidence of the interest of using Brassicaceae
extract in whitening cosmetic products and in sun care products.
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A new melanin-inducing extract. In vitro studies
E Bauza, G Bressier, R Chabert, A Perrin, I Imbert, C Dal Farra and N Domloge Vincience,
ISP Global Research Center, Sophia Antipolis, France
Self tanning has become an important focus of cosmetics and skin care products in recent
years. Consumers increasingly aim to enhance tanning while improving skin protection from
UV damage. In line with this goal, we developed a new melanin-inducing extract and evalu-
ated its effect on stimulating melanin synthesis in vitro and on human ex vivo skin. We also
evaluated its effect on protecting the skin from UV damage and reducing cytokine synthesis
in irradiated cells. Time course studies and dose studies were performed on ex vivo human
skin. These studied showed that, after Fontana Masson staining, melanin-inducing extract
clearly enhanced melanin content in the skin. Melanin staining was darker, and reached the
upper layers of the epidermis in the extract-treated samples, compared to the untreated con-
trol skin. In parallel studies, melanin-inducing extract stimulated melanin synthesis in cultured
B16F10 melanocytes. These cells exhibited a net increase in melanin pigment in their cyto-
plasm. Interestingly, H&E staining showed that, compared to control samples, skin samples
treated with 1% of the melanin-inducing extract exhibited fewer UV damage signs after irra-
diation with 200mJ/cm2 of UVB. Moreover, tyrosinase activity studies revealed an interesting
stimulation by melanin-inducing extract of 20%. Furthermore, ELISA studies showed that
melanin-inducing extract exhibited an anti-inflammatory effect and down-regulated IL-1 beta
in irradiated fibroblasts by 41% (p=0.02089) with 1% of the extract, and by 49% (p=0.01589)
with 3% of the extract. These studies show that this new melanin-inducing extract enhances
melanin synthesis in skin cells, and reduces UV-induced skin damage and inflammation. This
new product can therefore be of great use in skin tanning and sun care products.
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(Cys-Gly)2 dimer peptide exhibits very interesting antioxidant and whitening properties
E Bauza, T Marchand, A Perrin, C Gondran, C Dal Farra and N Domloge Vincience, ISP
Global Research Center, Sophia Antipolis, France
It is well known that UV irradiation results in many harmful effects on the skin, such as oxida-
tive stress, and the dysfunction of melanocytes in the epidermis. Recent studies have suggested
that oxidative stress could be closely linked to melanin synthesis. Therefore, we were inter-
ested in studying the antioxidant and whitening properties of the (Cys-Gly)2 dimer peptide.
For antioxidant studies, cultured fibroblasts were treated with 1% of this peptide for 24 h, irra-
diated with 5 J/cm2 of UVA, and then treated again, either for 24 h to study lipid peroxida-
tion, or for 4 h to study SOD and catalase activity, and protein carbonylation. In parallel, we
studied the whitening effect of the dimer peptide on skin biopsies. Skin samples were treated
twice a day with 1% of the peptide for 24 h, irradiated with 100mJ/cm2 of UVB, and then
were treated again for 24 h. Melanin synthesis was evaluated by Fontana-Masson staining.
Using the same protocol, similar comparative studies were performed in order to evaluate the
whitening effect of the dimer peptide versus that of kojic acid (1mM and 50mM). The results
showed that cells irradiated and treated with the dimer peptide exhibited enhanced enzymatic
activities of +33% for SOD and +23% for catalase, compared to the control. Moreover, these
results were confirmed by a reduction in protein carbonylation (-137%) and lipid peroxida-
tion (-34%). Interestingly, studies on ex vivo skin pigmentation revealed that skin treated with
the dimer peptide exhibited a noticeable decrease in melanin content, in irradiated and unir-
radiated biopsies; and this effect was greater with the dimer peptide than with kojic acid. These
results demonstrate that this dimer peptide exhibits a remarkable antioxidant protective effect
and a whitening effect, and can be of great use in anti-aging and whitening skin care prod-
ucts.
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Melanoma mitotic rate as a predictor of tumor depth
J Herschthal,1 MJ Elgart,3 EV Badiavas2 and G Elgart1 1 Dermatology, University of Miami,
Miami, FL, 2 Pathology, Roger Williams Hospital, Providence, RI and 3 Gulliver Preparatory
School, Miami, FL
Depth measurement of invasive malignant melanoma is a critical criterion for for predicting
patient outcome. In particular, this measurement is used to determine surgical margins and
adjuvant therapy. Unfortunately in practice, melanoma depth is not always straight forward
to evaluate, particularly in cases of inadequate sampling or tumor ulceration. Since previous
studies have favored that melanoma depth is the most important single measure and is the
only criterion which acts consistently as a predictor of melanoma outcome, we were inter-
ested in finding additional prognostic measures using the melanoma depth as the standard.
In addition, since more recent investigations have consistently suggested that mitotic rate does
parallel risk when measured directly, we were interested in comparing the mitotic rate to the
indirect measure of predicted survival, tumor depth. We found that melanoma depth mir-
rored mitotic rate with a least squares correlation of 0.738 in a collection of 20 melanomas
selected for equal numbers of tumors in 5 different depth groups and 0.523 in 199 unselected
tumors. Since the unselected tumors were biased for thin tumors with low mitotic rates which
may account for the lesser correlation in unselected tumors. Future studies may determine the
tumors best suited to this evaluation.
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Low-energy helium-neon laser induces melanocyte proliferation via interaction with type IV
collagen
CE Lan,1 C Wu,2 G Chen1 and H Yu1 1 Dermatology, Kaohsiung Medical University,
Kaohsiung, Taiwan and 2 Faculty of Biomedical Laboratory Science, Kaohsiung Medical
Univeristy, Kaohsiung, Taiwan
Helium-neon laser (He-Ne Laser, 632.8nm) is among the phototherapeutic options for treat-
ment of vitiligo, a disease characterized by skin depigmentation. Our previous study has
revealed that He-Ne laser induces locomotion of the immature melanoblast and promotes
melanogenesis of the more differentiated melanoblasts. Our current study aimed to explore
the effects of He-Ne laser on functional melanocytes (MC), in terms of migration and prolif-
eration. In addition, appropriate interactions between MC and extracellular matrix (ECM) will
also be addressed. Our results demonstrated that cultured MC shows greater locomotion and
weaker attachment on type IV collagen coated plates as compared to other ECM coated plates.
Treatment with He-Ne laser significantly decreased the locomotion of MC while the attach-
ment to type IV collagen significantly increased. The α2β1 integrin expression of MC on type
IV collagen coated plate significantly increased after He-Ne laser irradiation. In addition, the
cell number and mitochondrial activity of MC significantly increased after He-Ne laser treat-
ment. Blocking of α2β1 integrin abrogated the enhancing effects of He-Ne laser irradiation
on MC proliferation. Moreover, mitochondria was identified as the main photoacceptor of MC
to He-Ne laser irradiation via the use of a mitochondrial uncoupling agent. In summary, our
results indicate that He-Ne laser irradiation induces MC proliferation when appropriate ECM
is introduced. Moreover, our findings also suggest that treating vitiligo with He-Ne laser not
only activates the immature MC on the outer root sheath but also induces proliferation of
mature MC from the perilesional area to repopulate vitiliginous epidermis.
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Genome-wide RNAi- A novel method to identify pharmaceutically-tractable regulators of
melanogenesis
A Ganesan,1 H Ho1 and MA White2 1 Dermatology, UC Irvine, Irvine, CA and 2 Cell Biology,
UT Southwestern, Dallas, TX
Vitiligo and melasma are two highly prevalent disorders of pigmentation that are treatment
refractory. A fundamental knowledge of the molecular components required for the synthesis
and secretion of melanin is necessary to understand the pathogenesis of these diseases and
design molecular targeted therapies to treat them. Genome wide siRNA screening was used
to identify a collection of gene targets that support melanin pigmentation in MNT-1 cells. Pre-
liminary data demonstrated that an siRNA directed towards tyrosinase, the rate limiting enzyme
in melanin biosynthesis, can visually and quantitatively inhibit melanin pigmentation in MNT-
1 pigmented melanoma cells. Using a comprehensive genome wide siRNA library and spec-
trophotometric based high throughput screening, we have identified a set of genes that are
absolutely required for melanin synthesis and secretion in MNT-1 melanoma cells. The low
coefficient of variance (12.82) of the data set reflects the specificity and fidelity of the high
throughput approach. Gene annotation data and literature searches were used to classify
gene targets into functional categories. Putative genes involved in transcription, translation,
and secretion were identified. In addition, several novel pathways that regulate melanin biosyn-
thesis were identified. Retesting of putative gene targets demonstrated the low false positive
rate of the screening approach and identified several siRNAs that inhibited pigmentation
more effectively than tyrosinase siRNA. Novel depigmenting agents targeted towards candi-
date target genes identified in the genome wide screen were able to inhibit pigment produc-
tion in MNT-1 cells. Together these data demonstrate that genome wide siRNA screening is
an effective method to identify pharmaceutically tractable gene targets for disorders of pig-
mentation.
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The vascular characteristics of melasma
E Kim, Y Kim, E Lee and H Kang Dermatology, Ajou University School of Medicine, Suwon,
South Korea
The pathogenesis of melasma is not yet fully understood. Previous studies indicated that der-
mal environment such as fibroblasts may have an important role on the development of
melasma. We have investigated the dermal cutaneous vascular characteristics in melasma. The
expression of vascular endothelial growth factor (VEGF), a major angiogenic factor of the
skin, was also investigated in melasma. Erythema intensity of 30 melasma patients was quan-
tified by the increase of the a* parameter using a colorimeter. The values of a* was significantly
higher in the melasma lesion than that of perilesional normal skin. Computer-assisted image
analyses of factor VIIIa related antigen-stained sections revealed a significant increase of both
the number and the size of dermal blood vessels in the 50 lesional skins. There was signifi-
cant relationship between number of vessels and pigmentation in melasma. The expression of
VEGF was significantly increased in melasma. These data suggest that increased vascularity is
one of the major findings in melasma. VEGF may be a major angiogenic factor for altered ves-
sels in melasma.
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Biphasic signalings leading to mitf protein expression in endothelin-1 stimulated human
melanocytes
K Jin,1 EK Nishimura,2 E Akasaka,1 H Nakano,1 K Hanada,1 D Sawamura,1 DE Fisher3 and
G Imokawa1,4 1 Dermatology, Hirosaki University School of Medicine, Hirosaki, Japan, 2
Kanazawa University Cancer Research Institute, Kanazawa, Japan, 3 Dana-Farber Cancer
Institute, Children’s Hospital Boston, Harvard Medical School, Boston, MA and 4 Tokyo
University of Technology School of Bionics, Tokyo, Japan
MITF, one of the WS genes, encodes a tissue-restricted transcription factor of the basic, helix-loop-
helix, leucine-zipper (bHLHzip) type. It modulates melanocytic pigmentation as a transcription fac-
tor by regulating the key melanogenic enzymes and is also associated with melanocyte survival.
We have already reported that endothelin-1 (ET-1) induced phosphorylation of MITF is involved in
the activation of MAPK through PKC activation in cultured human melanocytes. While the ET-1
stimulation also elicited the increased expression of MITF protein, it remains unclarified as to which
pathway of known cAMP-PKA and MAPK-RSK linkages is predominantly associated with the
MITF protein expression. In this study, we analyzed signaling mechanisms underlying MITF pro-
tein expression by focusing on phosphorylation of CRE binding protein (CREB) which is one of MITF
associated transcription factors. An addition of ET-1 to cultured human melanocytes significantly
increased MITF mRNA level at 40-120 min post-incubation which was followed by a marked up-
regulation of MITF protein at 3 h. The increased MITF protein levels were significantly diminished
by PKA or MEK inhibitor. MEK inhibitor or proteasome inhibitor suppressed degradation of MITF
protein, suggesting a slight stimulation of degradation by ET-1 signaling. CREB phosphorylation was
elicited at 5-15min during ET-1 signaling, which was partially abolished by MEK or PKA inhibitor.
The inhibitory effect of MEK inhibitor was much stronger than that of PKA inhibitor in an early phase
of ET-1 signaling, indicating a biphasic phosphorylation of CREB. These findings suggest that the
ET-1 induced MITF expression is mediated via both cAMP-PKA and MAPK-RSK linkages which
have a different time course of activation during ET-1 signaling.
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Histopathological investigation in malignant melanoma: a combination method with sen-
tinel lymph node biopsy and histological examination using D2-40 and Melan-A monoclonal
antibodies in a primary lesion
Y Hanami, H Yanagihori, M Ohtsuka and K Nakamura Department of Dermatology
Fukushima Medical University, Fukushima city, Japan
In malignant melanoma, detection of metastasis on lymph nodes is one of important factors
in prognosis of the patients. Histopathologically, it is often difficult to detect atypical invasion
cells into lymphatic vessels. In this study, we established a detection method of melanoma
cells which invaded into lymphatic vessels in a primary lesion using D2-40 monoclonal anti-
body, lymphatic endothelial marker, and Melan-A monoclonal antibody. Moreover we assessed
an association between lymphatic invasions in a primary lesion and metastasis in lymph nodes
in 63 patients with malignant melanoma (31 males and 32 females, average age 59.8 years
old; 25-86 years old). All patients were treated with resection of a primary lesion at our hos-
pital between 1995 and 2006. Then we examined the histopathology in lymph nodes by sen-
tinel biopsy or total lymphadenectomy. Lymphatic invasions were revealed by double stain-
ing with D2-40 and Melan-A monoclonal antibodies. Statistically the combination method
with histological examination of a primary lesion with double staining and of lymph nodes
was significantly sensitive in regard to identification of micrometastasis compared with the
sentinel lymph node biopsy only. In retrospective survey, this combination method showed
significant difference in survival rate for three years. These results provided the importance of
the assessment of invasion into lymph vessels at a primary lesion in malignant melanoma.
Furthermore this method may be useful in prospective prognosis and selection of treatment
after resection of a primary lesion.
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Histone deacetylase inhibitor, FK228 induced G1 arrest/apoptosis in malignant melanoma
cell lines is triggered by multiple function of MITF
K Futaki,1 Y Furukawa,2 M Ohtsuki,3 H Nakagawa1 and G Imokawa1,4 1 Dermatology, Jikei
University School of Medicine, Tokyo, Japan, 2 Division of Stem Cell Regulation, Jichi
Medical University, Tochigi, Japan, 3 Dermatology, Jichi Medical University, Tochigi, Japan
and 4 School of Bionics, Tokyo University of Technology, Tokyo, Japan
Histone Deacetylase Inhibitors (HDACi) could act as a novel anti-cancer agent for malignant
melanoma because of their action mechanisms distinct from conventional anti-cancer agents.
Here, we examined signaling mechanism(s) involved in HDACi FK228-induced G1 arrest/apop-
tosis in association with newly discovered cell regulatory roles of MITF in 4 human malig-
nant melanoma cell lines. An addition of FK228 at concentrations of 2-10 nM elicited G1
arrest/apoptosis in all cell lines tested at 24-48 hr post-incubation, although there was a dif-
ference in the apoptotic effect among the cell lines, with a tendency that cell lines with a
higher expression of MITF/Bcl2/CDK2 undertook a stronger apoptotic effect. The gene and
protein expressions of MITF were markedly down-regulated by FK228, which was followed
by a significant suppression of CDK2 or CDK4, with both protein levels being well correlated
with each other (r=0.66 or 0.71), while MITF level well correlated with CDK2 (r=0.60) but
not with CDK4 (r=0.0056) or cdc2 (r=0.11) in non-treated cells. In contrast, CDK2 inhibitor
protein p21 (which was not constitutively expressed in non-treated cells) was markedly up-
regulated at 12-24 hr post-incubation with reversed correlation to MITF (r=-0.88), while Bcl2
expression remained almost unaffected in the 4 cell lines. Transfection of MITF siRNA caused
G1 arrest/apoptosis in the 4 cell lines tested, and the apoptotic effect of the siRNA was simi-
lar to that of FK228. These findings suggest that FK228 exerts its anti-melanoma effects via
down-regulation of multiple functions of MITF, which results in the suppression of CDK2 and
the concomitant up-regulation of p21 without any effect on Bcl2 expression.
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The matricellular protein switch as a potential mechanism for melanoma progression
M Fukunaga-Kalabis,1 G Martinez,1 B Perbal2 and M Herlyn1 1 Molecular and Cellular
Oncogenesis Program, The Wistar Institute, Philadelphia, PA and 2 Laboratoire d’Oncologie
Virale et Moléculaire, Université Paris, Paris, France
Matricellular proteins are modulators of cell-matrix interactions and cell function. The group
includes CCN3 (NOV, nephroblastoma overexpressed), which is highly expressed in
melanocytes in vivo. We recently defined CCN3 as a critical player for maintaining normal
homeostasis of melanocytes in skin. CCN3 affects two fundamental features of melanocytic
physiology: It inhibits proliferation of melanocytes and stimulates their adhesion to basement
membrane collagen type IV. Here we report that CCN3 expression is down-regulated in
advanced melanomas. Aggressive melanoma cell lines did not respond to CCN3 inducers
such as keratinocytes-derived IL-1β treatment while less aggressive melanoma cell lines
responded similar to melanocytes. Immunostaining analyses revealed that CCN3 was pres-
ent in melanoma cells close to the epidermis-dermis interface, but not in those that had invaded
deep into the dermis or in lymphnodes. Contrary to our expectations, overexpression of CCN3
in the metastatic melanoma cell line 1205Lu did not affect adhesion to collagen IV. However,
it decreased transcription and activation of matrix metalloproteinases and suppressed inva-
sion of 1205Lu cells. These results suggest that the lack of CCN3 in advanced melanoma con-
tributes to an invasive phenotype. CCN3 is the first member of matricellular proteins family
that is down-regulated in melanoma cells, whereas the major proteins in the same family such
as osteopontin, tenascin C or SPARC are strongly up-regulated. Our data suggest the qualita-
tive and quantitative shift of matricellular proteins contributes to melanoma progression as
well as cadherin class switch.
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Antigenicity and immunogenicity of HMW-MAA-mimotopes
C Hafner,1 S Wagner,2 D Allwardt,1,2 AB Riemer,2,1 O Scheiner,2 H Pehamberger1 and
H Breiteneder2 1 Department of Dermatology, Medical University of Vienna, Vienna, Austria
and 2 Department of Pathophysiology, Medical University of Vienna, Vienna, Austria
The high molecular weight-melanoma-associated antigen (HMW-MAA) is highly expressed
in advanced primary and metastatic melanoma. An epitope of the core protein of the HMW-
MAA is recognized by the murine monoclonal antibody 225.28S. In this study we aimed to
characterize peptides that antigenically mimic this epitope and to determine their efficacy as
components of an HMW-MAA based anti-melanoma vaccine. Therefore, we screened a con-
strained 10mer phage display peptide library against the mAb 225.28S. Selected phage dis-
played peptides were then tested for their specificity for the antibody’s antigen binding site.
DNA sequences coding for specific peptide ligands were determined. Binding of the mAb
225.28S to the HMW-MAA was inhibited in a dose-dependent manner by phage displayed
peptides from 51% to 83% and by synthetic peptides from 38% to 87%. Subsequently, immuno-
genicity of the five mimotopes with the highest inhibition capacity was examined in rabbits.
Immunizations with synthetic mimotopes conjugated to tetanus toxoid resulted in peptide spe-
cific antibodies. Unexpectedly, none of the highly antigenic mimotopes induced HMW-MAA
cross-reactive antibodies. This report describes an example of disparity between antigenicity
and cross-reactive immunogenicity complicating the selection of potential vaccine candidates.
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An intrinsic linkage leading to UVB-induced c-KIT expression in human melanocytes:
p38/CREB/MITF/c-KIT pathway
Y Mizutani,1 N Hayashi,1 M Kawashima1 and G Imokawa1,2 1 Department of Dermatology,
Tokyo Women’s Medical University, Tokyo, Japan and 2 School of Bionics, Tokyo University
of Technology, Tokyo, Japan
Despite the fact that c-KIT plays a modulatory role in several cutaneous pigmentary disorders
such as piebaldism, vitiligo, lentigo senilis and dermatofibroma, precise signaling pathways
leading to the c-KIT expression in human melanocytes have remained unclarified. In this study,
we have attempted to identify a signaling pathway specific for an increased c-KIT expression
in UVB-exposed human melanocytes. UVB irradiation (40-80 mJ/cm2) induced an early
decrease in c-KIT mRNA transcripts at 6-10 h post-incubation and their later increase at 8-18
h post-incubation, which were followed by a decrease in c-KIT protein at 6 h post-incubation
and its subsequent increase at 12-24h post-incubation, respectively. On one hand, MITF pro-
tein decreased early and increased later with a plateau at 12-24h post-incubation. Thus, the
MITF expression following UVB irradiation occurred slightly earlier than did c-KIT expression,
which suggests a consequential contribution of MITF to c-KIT expression. The UVB exposure
also markedly stimulated prolonged phosphorylation of p38, which was accompanied by a
sustained phosphorylation of CREB. Inhibitory analysis revealed that the UVB-increased expres-
sion of c-KIT protein was completely abolished by a treatment with an inhibitor of p38 (SB
203580). The inhibition of p38 also significantly abolished the phosphorylation of CREB as
well as the subsequently increased expression of MITF. Interestingly, in non-UVB exposed
human melanocytes, the inhibitor of MEK rather stimulated phosphorylation of p38/CREB
and MITF genesis, accompanied by an increased expression of c-KIT protein, which indicates
a balanced regulation between ERK1/2 and p38. These findings suggest a novel pathway
involved in a p38/CREB mediated MITF genesis, which was associated with UVB-increased
c-KIT expression in human melanocytes.
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Role of cathepsin K in melanoma invasion and metastasis
MJ Quintanilla-Dieck,1 M Keady,1,2 J Bhawan1,2 and TM Ruenger1 1 Dermatology, Boston
University School of Medicine, Boston, MA and 2 Dermatopathology Section, Boston
University School of Medicine, Boston, MA
Cathepsin K (catK) is a cystein proteinase with strong collagenolytic activity that mediates bone
resorption in osteoclasts. In those cells, it is regulated by the RANK (receptor activator of NFkB)-
RANKL (RANK-ligand) pathway. We recently reported that catK is not expressed in normal
skin but in fibroblasts of scars, suggesting that it is involved in maintaining homeostasis of the
dermal extracellular matrix. As other cathepsins, but not catK, and metalloproteinases have
been described to mediate melanoma invasion, we studied the role of catK in melanoma.
Western blotting demonstrated that cultured primary melanocytes and three melanoma lines
expressed both the pro- and the active form of catK. The melanoma lines expressed various
amounts of RANK and two lines with a higher RANK expression responded to RANKL treat-
ment (40 ng/ml) with an upregulation of catK. Immunostaining revealed very strong catK expres-
sion in 5/6 primary melanomas and 7/7 melanoma metastases. Basal cell (n=3) and squa-
mous cell carcinomas (n=4) did not show catK expression in the tumor, but a strong expression
in the peri-tumoral stroma. In the melanomas, stromal fibroblasts showed variable catK expres-
sion. Treatment with an inhibitor specific for catK greatly reduced MeWo melanoma cell
invasion in an invasion chamber assay with Matrigel basement membrane matrix (5.8-fold; p
< 0.0001). We conclude that catK is strongly expressed in melanoma, at least in part regu-
lated by the RANK-RANKL pathway, and that it might play an important role in melanoma
invasion and metastasis, bone metastasis in particular. Treatment with a catK inhibitor, a class
of medication currently in clinical trials for the treatment of osteoporosis, may be a promis-
ing avenue for the treatment of advanced melanoma.
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Synergistic treatment of melanoma by intratumoral ad-LIGHT and local radiation for the
effective eradication of distant metastasis
Y Xu,1 Y Lee2 and Y Fu2 1 Medicine, Section of Dermatology, Univ. of Chicago Hospitals,
Chicago, IL and 2 pathology, Univ. of Chicago Hospitals, Chicago, IL
Seeking effective therapies for metastatic melanoma remains a daunting challenge. We ear-
lier demonstrated that the over-expression of LIGHT, a TNF superfamily member, in the local
tumor environment could recruit and activate naïve T cells, leading to the rejection of estab-
lished local tumor. Local radiation therapy (RT) was considered an attractive adjuvant method.
In this study, we set out to examine the effectiveness of intratumoral ad-LIGHT injection, local
RT and a combination of both in controlling the growth of primary tumor and distant metas-
tasis by employing B16-CCR7 as a metastatic melanoma model. Over-expression of CCR7
promoted the metastasis of B16 cells to the regional lymph nodes (LNs) around two weeks
after subcutaneous inoculation. Metastatic tumor load can be quantitatively assessed by colony
assays using G418 as a selection marker. Wild-type B6 mice were inoculated with B16-CCR7
cells subcutaneously at day 0 (1x105 cells) and then treated with intratumoral ad-LIGHT to
test whether such treatment can eradicate metastasis. Surprisingly, more metastatic tumor can
be detected in the draining LNs. A local RT was given (day 15 and 16, 12 Gy each), with or
without intratumoral ad-LIGHT on three consecutive days (2x1010 viral particles). The growth
curve of primary tumor was measured biweekly and the inguinal LNs and lungs were har-
vested at day 31 for colony assays. We found that neither Ad-LIGHT nor local RT alone could
reduce distant metastases. Interestingly, a combination of both led to a complete eradication
of metastases in the LNs and lungs even when the primary tumor growth was only partially
retarded. Our preliminary data have demonstrated that local RT, potentially by causing cell
necrosis for more effective antigen presentation, and LIGHT-mediated tumor microenviron-
ment, by recruiting more cytotoxic T cells, can eradicate established distant metastasis in
B16-CCR7, and thus provide a novel therapeutic modality for metastatic melanoma.
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DC-HIL is expressed highly by normal melanocytes and melanoma cells, and cell surface
expression is regulated by ultraviolet radiation, IFN-γ, and TNF-α
M Tomihari, S Hwang, J Chung, PD Cruz and K Ariizumi Dermatology, UT Southwestern
Medical Center, Dallas, TX
Having discovered DC-HIL as a transmembrane protein expressed constitutively by antigen
presenting cells (highly on epidermal Langerhans cells and dendritic cells), we were surprised
to find similar high expression by normal melanocytes and melanoma cells. However, having
additionally noted strong similarity between DC-HIL and the melanosome protein pMel17 in
protein structure and presence of a lysosome/melanosome targeting motif in the intracellular
domain, we warmed to the idea that DC-HIL serves an important function in melanocytes. To
better characterize DC-HIL expression, we examined subcellular localization by direct immuno-
fluorescence using mAbs we generated against DC-HIL. Our first experiments using mouse
B16 melanoma revealed DC-HIL on cell surfaces and intracellularly in melanosomes (stained
concurrently with anti-Mel-5 Ab), lysosomes (anti-LAMP-1 Ab), and other vesicles (no specific
markers). This diverse localization was confirmed by biochemical fractionation and Western
blotting. We then examined effects of melanocyte modulators: conventional doses of UVA and
UVB, upregulated DC-HIL expression up to 3-fold as measured by Western blotting; however,
none of these agents changed the pattern of DC-HIL localization. αMSH induced melanosome
migration toward peripheral dendrites, but DC-HIL did not accompany this movement. We
next shifted to human SK-Mel-28 melanoma, finding DC-HIL localization consistent with that
in mouse B16 melanoma. Finally, we examined primary-cultured normal human melanocytes
using direct immunofluorescence: DC-HIL localization was similar to those in human and
mouse melanoma, and cell surface expression was upregulated 2-5-fold following treatment
with IFNγ or TNFα. These features were affirmed by immunohistochemistry studies of normal
human skin. Our results sustain the concept that DC-HIL serves an important function in nor-
mal melanocytes and melanoma; such function may be modulated by UV radiation and pro-
inflammatory cytokines.
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Intracellular trafficking of TYRP-1 from TGN to early melanosomes is associated with AP-
1and GGAs
J Ogino, H Sohma, T Kamiya, T Yamashita and K Jimbow Sapporo Medical University School
of Medicine, Sapporo, Japan
Tyrosinase-related protein (TYRP)-1 is the most abundant melanosomal protein. We have previously
shown that TYRP-1 is transported from Trans-Golgi network (TGN) to endosomal compartments using
di-leucine motif, associated with cation independent-mannose 6 phosphate receptor (CI-M6PR)and
regulated by ARF (ADP-ribosylation factor). This study further characterizes intracellular trafficking
of TYRP-1 through interaction of adaptor protein (AP)-1, Golgi-associated gamma-adaptin-related
ADP-ribosylation factor -binding proteins (GGAs) and M6PR. Firstly we investigated interaction of
endogeneous TYRP-1 with AP-1 and confirmed the binding of TYRP-1 with AP-1 by co-immuno-
precipitation using MM418 melanoma cells. We then transfected wild-type (wt) TYRP-1 and mutant
(mt) TYRP-1 with mutated di-leucine motif to SKmel-24 amelanotic melanoma cells which lack
endogenous TYRP-1. We found co-localization of Flag-tagged wt TYRP-1 with AP-1, M6PR and
GGA3, which was completely abolished by mt TYRP-1. This co-localization of TYRP-1 with AP-1
was further confirmed by co-immunoprecipitation, showing the binding of Flag tagged TYRP-1 with
AP-1. We thirdly transfected SKmel-24 cells with GFP-tagged GGA1-3 isoforms. Recruitment of AP-
1 from cytosol to membranes is regulated by ARF, and GGAs are components of coats that are mainly
associated with the TGN in an ARF-dependent manner. GGA1-3 isoforms were found to be co-local-
ized with AP-1 and CI-M6PR by cofocal microscopy. Fourthly, we co-transfected SKmel-24 cells with
GFP-tagged GGA1-3 isoforms and Flag tagged TYRP-1 to further confirm the interaction of TYRP-1
with GGAs for coat assembly. Confocal microscopy showed the co-localization of Flag-tagged wild
type TYRP-1 and the GFP tagged GGA1-3 isoforms. This specificity was confirmed by introduction
of GFP tagged mt GGA3, revealing less co-localization between Flag tagged TYRP-1 and GFP-tagged
mt GGA3 than wt GGA3. This is the first report showing the intracellular trafficking of TYRP-1 from
TGN to endosomal compartments is associated with AP-1and GGAs.
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CCl21-mediated in situ melanoma immuno-targeting
V Alexeev and L Novak Dermatology and Cutaneous Biology, Thomas Jefferson University,
Philadelphia, PA
Secondary lymphoid chemokine, CCL21, has been shown in several previous studies to be
capable of attracting immune cells to a tumor, triggering activation of tumor-specific CD8+ T-
cell-dependent immune responses. Here we have demonstrated that this chemokine, when
stably expressed in B16F0 mouse melanoma cells under the control of the ubiquitin pro-
moter, triggers massive infiltration of tumors with CD4+CD25- and CD8+ T-lymphocytes as
well as with CD11c+ dendritic cells, resulting in melanoma-specific immune responses suf-
ficient for the complete rejection of melanomas in syngenic, C57BL6 immuno-competent mice
within 3 weeks of tumor inoculation. Mice rejecting primary CCL21-positive tumors also
acquired strong protective immunity against wild type B16F0 melanoma as determined by
challenge experiments. This melanoma-specific immunologic memory was transferable to
naïve mice via splenocytes and central memory CD8+ T cells. Moreover, we have shown that
in vivo electroporation and transient expression of the chemokine in pre-established wild-type
tumors triggers similar melanoma-specific immune responses that result in rejection of
melanoma in vivo in a CD8+ T-cell-dependent manner. Taken together, our findings suggest
that transient expression of CCL21 in primary cutaneous melanoma can be utilized for the
activation of melanoma-specific immune responses, with the potential for development toward
direct clinical applications.
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Ganglioside GM3 promotes melanoma metastasis by triggering urokinase plasminogen acti-
vator receptor (uPAR) signaling
X Wang,1 J Liu,2 Q Yan,3 P Sun,1 N Ho,1 V Koti,1 N Vashi,1 L Go1 and AS Paller1 1
Dermatology, Northwestern University Medical School, Chicago, IL, 2 Oncology, Dalian
Medical University, Dalian, China and 3 Biochemistry, Dalian Medical University, Dalian,
China
We have recently shown that ganglioside GM3 increases squamous carcinoma cell proliferation
via activation of uPAR/p70S6 kinase signaling, but only if cells are grown in the presence of uPA.
Given the important function of uPA/uPAR signaling in melanoma aggressiveness, we hypothesized
that melanoma invasiveness might be a function of increasing GM3 expression and uPAR stimu-
lation. The ganglioside profile was assessed by thin layer chromatography in two cutaneous melanoma
cell lines, C8161 cells (highly metastatic) and A375P cells (primary, poorly invasive). Cell prolifer-
ation was assessed by MTT analysis; chemotaxis migration assay and quantitative scratch analysis
were performed to detect cell migration; and Matrigel Invasion Chambers were used to evaluate
cell invasion. The metastatic melanoma C8161 cells showed a dramatic increase in one isotype of
GM3, which was subsequently extracted from C8161 cells and purified. Treatment of A375P cells
with the purified GM3 significantly increased their proliferation, migration and invasion. Consis-
tently, blockade of the synthesis of GM3 in C8161 cells by PPPP, a chemical reagent, decreased
cell proliferation and markedly limited cell migration and invasiveness. To elucidate the mecha-
nism of the role of GM3 on metastatic transformation, uPAR expression was modulated. Overex-
pression of uPAR through stable transfection of uPAR cDNA enhanced, while knock down of
uPAR expression with siRNA transfection eradicated C8161 cell proliferation, migration and inva-
sion. The uPAR-facilitated melanoma cell proliferation required the presence of GM3; it was elim-
inated by depletion of GM3 with PPPP treatment and increased by supplementation with purified
GM3. These studies provide evidence for an important role of GM3 isotype expression and uPAR
signaling activation in promoting melanoma cell proliferation, migration and invasiveness.
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Phenotype-based screening of melanogenic regulatory compounds using zebrafish
T Yoon,1 T Choi,2 J Kim,2 D Ko,1 C Kim,3 J Hwang,4 S Ahn,4 S Kim,5 C Kim2 and J Lee2 1
Department of Dermatology, Gyeongsang National University, Jinju, South Korea, 2
Department of Dermatology, Chungnam National University, Daejeon, South Korea, 3
Department of Biology, Chungnam National University, Daejeon, South Korea, 4 Skin
Research Institute, Amore-Pacific Corporation, Yongin, South Korea and 5 Department of
Herbal Pharmacology, Kyung Hee University, Seoul, South Korea
Although many hypo-pigmenting agents are currently available, the demand for novel whiten-
ing agents is increasing. This is partly due to the weak effectiveness and unwanted side effects.
To screen the hypo-pigmenting agents, many methodologies such as cell culture and enzy-
matic assay are routinely used. However, these models have disadvantages in terms of phys-
iological and economical relevance. In this study, we validated zebrafish as a whole-animal
model for phenotype-based screening of melanogenic inhibitors or stimulators. We used both
the well-known melanogenic inhibitors (PTU, arbutin, kojic acid, MBT) and newly devel-
oped small molecule compounds (haginin, YT16i). All the tested compounds produced
inhibitory effects on the pigmentation of zebrafish. These effects were thought to be due to
their inhibitory potential on the tyrosinase activity primarily. In simultaneous in vivo toxicity
test, a newly developed melanogenic inhibitor YT16i showed massive abnormalities in terms
of deformed morphologies and cardiac function. Together, these results provide the rationale
in screening and evaluating the putative melanogenic regulatory compounds. We suggest
that the zebrafish model system is a novel alternative to mammalian models, with the advan-
tages including the rapidness, cost-effectiveness, and physiological relevance.
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Skin physiology examination and in vivo confocal microscope analysis of pigmented lesions
of the face
H Akita,1 T Kuwahara,2 Y Masuda,2 T Iikura,2 T Yamashita,2 T Hirao,2 Y Washimi1 and
K Matsunaga1 1 Dept. of Dermatology, Fujita Health University School of Medicine, Toyoake,
Japan and 2 Life Science Research Center, SHISEIDO CO., LTD., Yokohama, Japan
Recently, rapid advances in laser therapy for the skin have been made. Safer laser therapy has
become possible for various types of facial pigmented lesions. However, it is well-known that
laser therapy for melasma has not been completed yet. To know the characteristics of the pig-
mented lesions, various facial pigmented lesions were analyzed using techniques of skin phys-
iology examinations and a non-invasive instrument for pigmentation in this study. The facial
pigmented lesions (solar lentigo, ephelides, melasma, and seborrheic keratosis) of 26 females
were measured with melanin concentration, skin surface hydration, transepidermal water loss,
skin surface texture and morphology of corneocytes by scanning electron microscopy. In vivo
confocal microscopy was also used to visualize pigmented lesions non-invasively. Melanin
concentration was increased in each pigmented lesions. Skin surface hydration in solar lentigo
and seborrheic keratosis showed a tendency to decrease. With the measurements of transepi-
dermal water loss there were no differences in melasma and ephelides compared with nor-
mal skin, but the significant increase was observed in solar lentigo and seborrheic keratosis.
By scanning electron microscopy villus-like projections of corneocytes were observed in solar
lentigo and seborrheic keratosis. As for in vivo confocal microscopy, melanin caps were
observed along the basal layer in each pigmented lesions. The average thickness of epidermis
with solar lentigo and seborrheic keratosis was significantly thick. In the case of melasma, the
average thickness of epidermis was similar to the normal skin and the dermo-epidermal junc-
tion was flat. The dendrites of melanocyte were also observed. The skin physiology examina-
tion and in vivo confocal microscopy revealed significant differences in physiological func-
tions and melanin localization especially between solar lentigo and melasma.
903
UV signature mutations in melanomas from xeroderma pigmentosum patients
Y Wang,1 J DiGiovanna,1,2 JB Stern,1 T Hornyak,1 M Raffeld1 and KH Kraemer1 1 National
Cancer Institute, Bethesda, MD and 2 Dermatology, Brown Med School, Providence, RI
Exposure to ultraviolet radiation (UV) is recognized an important environmental risk factor
for melanoma. However, the relationship between exposure and risk is complex and there is
little data showing direct effects of UV in melanomas. A 1000-fold increased predisposition
to skin cancers including melanomas is the hallmark of xeroderma pigmentosum (XP). XP is
a rare autosomal recessive disorder with UV hypersensitivity and a deficiency in DNA repair.
Utilizing laser capture microdissection we excised about 300 tumor cells and analyzed DNA
from 59 cutaneous melanomas (51 melanomas in situ and 8 invasive melanomas) from 8 XP
patients studied at NIH. We detected 54 PTEN tumor suppressor gene mutations in 33 (56%)
melanomas. 69% (37/54) of the mutations changed the amino acid sequence and hence likely
altered PTEN function. Further, 42% (14/33) of the melanomas with mutations had multiple
mutations, a feature of UV mutagenesis. Importantly, 89% (48/54) of the mutations were UV
signature mutations (C to T, or T to C) at dipyrimidine sites (p=0.001). In contrast, in the Sanger
database only 48% (86/179) of PTEN mutations in an internal tumor (endometrium cancer)
were UV type mutations. These data provide the first strong evidence that UV damage plays
a direct role in induction of mutations in melanomas in XP patients.
905
Role of nuclear factor- kappa B in melanoma progression
AM DeLuca,2,1 B Ryu1 and RM Alani1 1 Cutaneous Oncology, Johns Hopkins, Baltimore, MD
and 2 College of Medicine, University of Arizona, Tucson, AZ
Gene expression profiling has revolutionized our ability to classify primary human tumors. In
order to gain an improved understanding of the molecular basis of melanoma progression,
we have compared gene expression profiles from a series of human melanoma cell lines rep-
resenting discrete stages of malignant progression. Here we report that unsupervised hierar-
chical clustering of profiling data from melanoma cell lines demonstrates two distinctive molec-
ular subclasses of melanoma, segregating aggressive metastatic tumors from less-aggressive
primary tumors. We specifically identified a group of genes associated with invasive melanoma
that all share common regulation by the Nuclear Factor- Kappa B (NF-κB) transcription fac-
tor. Since constitutive activation of NF-κB can result in over-expression of proinflammatory
mediators, leading to organ damage and carcinogenesis, we suspected that NF-κB itself might
be an important mediator of melanoma development in our system. Since only activated NF-
κB is translocated to the nucleus where it binds DNA to regulate transcription, initial evalu-
ations have focused on the cellular localization of NF-κB in melanoma. Here we provide evi-
dence to suggest that NF-κB activation may be critically important for the progression of human
melanoma. Cell lines from non-invasive radial growth phase melanomas and cell lines from
invasive, more aggressive, vertical growth phase lesions were both evaluated for NF-κB activ-
ity using immunohistochemistry to assess NF-κB localization and functional relevance. We
note that the early non-invasive melanoma cells had exclusive NF-κB localization in the
cytoplasm, whereas the more aggressive, invasive melanoma cells had primary localization
in the nucleus. We suggest that NF-κB may play a role in the progression of melanoma,
allowing cells to gain the capacity to invade and metastasize and expect that NF-κB and its
downstream effectors will be therapeutic targets for advanced melanoma.
904
NAC protects melanocytes against oxidative stress/damage and delays onset of UV-induced
melanoma in mice
MA Cotter,1 P Cassidy1 and D Grossman1,2 1 Dermatology, University of Utah, Salt Lake City,
UT and 2 Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
It is known that UV radiation, the major environmental risk factor for melanoma, is a potent
inducer of oxidative stress which is implicated in the pathogenesis of several cutaneous malig-
nancies. We sought to determine whether a thiol antioxidant, N-Acetyl Cysteine (NAC) could
protect melanocytes from UV-induced oxidative stress/damage in vitro and from UV-induced
melanoma in vivo. In melan-a cells, a mouse melanocyte line, NAC (1-10 mM) conferred pro-
tection from several UV-induced oxidative sequelae including production of intracellular
peroxide, indicated by dihydrodichlorofluorescein fluorescence, formation of the signature
oxidative DNA lesion 8-oxoguanine (8-OG), detected by immunohistochemistry, and deple-
tion of free reduced thiols (primarily glutathione), as measured colorimetrically with Ellman’s
reagent. Mice transgenic for hepatocyte growth factor and Survivin, previously shown to develop
melanoma following a single neonatal dose of UV irradiation (4000 J/m2), were administered
NAC (7 mg/ml, mother’s drinking water) transplacentally and through nursing until two weeks
after birth. Delivery of NAC in this manner reduced thiol depletion and blocked formation of
8-OG in skin following neonatal UV treatment. Mean onset of UV-induced melanocytic tumors
was delayed in NAC-treated (n=23) compared to control (n=19) mice (20 vs. 13 weeks,
p=.0003). Our data highlight the potential importance of oxidative stress in the pathogenesis
of melanoma and suggest that NAC may be useful in chemoprevention of human melanoma.
902
Assessment of cancer worry in patients with high-risk melanoma phenotypes
AM Seidler,1 C Curiel-Lewandrowski,2 ZM Pressley,3 LK DeLong3 and SC Chen3 1 Tufts
University School of Medicine, Boston, MA, 2 Dermatology, University of Arizona, Tucson,
AZ and 3 Dermatology, Emory University, Atlanta, GA
We examined cancer worry in patients at risk for melanoma (MM) to characterize the emo-
tional response to the threat of MM. We surveyed 52 consecutive patients with Atypical Mole
Syndrome (AMS) obtaining total body digital images at Emory and the University of Arizona.
We measured worry about developing new MM using a 4-item modified Breast Cancer Worry
Scale (CWS) (range 4-16) and a 15-item Revised Impact of Events Scale (RIES) (range 0-75).
We used Skindex to examine quality of life impact of AMS. Groups were compared using t-
test, Mann-Whitney U test, and chi-square analysis. Results demonstrated overall cancer worry,
with mean±SD scores of: CWS 8.8±7.1, RIES 14.3±15.7, and emotional impact 27.9±26.5.
Females (n=29) had greater worry than males (n=23), by both CWS (p=0.002) and RIES
(p=0.004). There was no gender difference in symptoms, but females had higher emotional
(p<0.0001) and functional (p=0.003) impact than males. Patients with a history of MM (n=30)
had more worry than those without by CWS (p=0.05), but significant differences were not
detected by RIES or Skindex. Preliminary evidence from 11 patients with family history of
MM demonstrated more worry by both CWS and RIES (median [IQR]) than the rest of the
sample: CWS 10.0 [6.0-13.0] vs. 8.0 [6.0-11.0] and RIES 14.0 [2.3-38.5] vs. 6.0 [1.0-20.0].
Additionally, they showed greater emotional and functional impact (median [IQR]) compared
to the rest of the sample: emotion 36.9 [1.8-57.1] vs. 23.3 [7.1-52.4] and function 10.0 [0.0-
39.2] vs. 3.3 [0.0-16.7]. Education and income had no effect. These patients represent a selected
population, those at highest risk for MM. However, our results point out the need for aware-
ness and sensitivity from dermatologists. Cancer worry may be a predictor of screening prac-
tices, but this requires further investigation. Studies are also warranted to examine worry as
an outcome measure, possibly minimized by new screening techniques.
906
Diarylpropanes as a novel class of potent tyrosinase inhibitors and their biological proper-
ties
Q Jia, J Zhao, M Hong, Y Zhao, M Yimam, T O’Reilly, W Ma and A Padmapriya Unigen
Pharmaceuticals, Inc., Lacey, WA
A natural product extract library was screened for novel tyrosinase inhibitors with lead com-
pounds developed for hyper pigmentation. Twenty plant extracts were identified as inhibitors
of a mushroom tyrosinase in a dose dependent manner and the extracts were fractionated
and de-replicated. Three diarylpropanes were isolated and identified from two species of plants
as potent inhibitors of tyrosinase with IC50 values between 0.24 and 24µM. Molecular mod-
eling analysis of natural and synthetic diarylalkanes showed that the most potent inhibitor 1-
(3-methyl-2,4-dimethoxyphenyl)-3-(2,4-dihydroxyphenyl)propane (UP302) had a very unique
3-dimentional conformation with two aromatic rings superimposed on each other. Such struc-
tural conformation may explain the unexpected potency as a tyrosinase inhibitor. Kinetic stud-
ies of this structure showed that the inhibition is competitive. The inhibition of melanin for-
mation with diarylpropanes was evaluated in two in vitro models. The IC50 value of UP302 for
inhibiting melanin formation in the B16 F1 cell assay was 34µM versus kojic acid 170µM. For-
mulated in 80% propylene glycol at concentrations of 0.05 % and 0.1% UP302 lightened the
tissue and reduced melanin synthesis in the MelanoDerm tissue model containing functional
human melanocytes without affecting melanocyte morphology or overall tissue histology. The
lightening effect of applying 10µl of 0.05% UP302 is of the same magnitude as that produced
by 25µ1 of 1% kojic acid. UP302 was also evaluated for safety with in vitro epidermal skin
irritation, EpiOcular, AMES, and estrogen receptor binding assays; in vivo acute and sub-chronic
oral toxicity tests; and human skin irritation test; with negative findings in all tests. The effi-
cacy on tyrosinase inhibition, melanin reduction and safety profile of diarylpropanes justifies
further development of this type of compound into dermatological and cosmetic ingredients
for hyper pigmentation and skin lightening.
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Therapeutic impact of a novel MAPK-dependent mechanism for melanoma cell survival
controlled by p53 and reactive oxygen species
M Verhaegen,1 WG Wolter,1 Z Nikolovska-Coleska,2 S Wang2 and MS Soengas1 1
Dermatology, University of Michigan, Ann Arbor, MI and 2 Pharmacology and Medicinal
Chemistry, University of Michigan, Ann Arbor, MI
The p53 tumor suppressor is mutated in 50% of human cancers. Intriguingly, inactivating muta-
tions in p53 are rare in melanoma, despite the highly aggressive behavior of this tumor type.
A variety of anticancer drugs can stabilize p53 levels in melanoma cells, but not engage its
proapoptotic functions. Mechanisms that block p53 in melanoma cells are not completely
understood. Defects in p53-dependent apoptosis can be related to the overexpression of anti-
apoptotic factors (such as Mcl-1, Bcl-2 and Bcl-xL), which ultimately prevent the activation
of BAX, a key pro-apoptotic target of p53. Mcl-1, Bcl-2 and/or Bcl-xL may also contribute to
the resistance to a variety of chemotherapeutic drugs, including inhibitors of the MAPK path-
way. Here we report on a genetic and pharmacological approach to identify and overcome
mechanisms of resistance to MEK/ERK antagonists in vitro as well as in vivo. Using a selective
RNA interference approach, we found that the ability of melanoma cells to survive in the
absence of functional MEK relies primarily on Mcl-1. Current synthetic inhibitors of Bcl-2 fam-
ily members do not target Mcl-1 efficiently. Therefore, computer-based drug design and fluo-
rescence polarization methods were developed to generate and validate a bioavailable small
molecule inhibitor with a high affinity for Mcl-1 (and able also to block Bcl-xL and Bcl-2). We
found that this compound, namely TW-37, synergized in a tumor cell specific manner with
MEK inhibitors (U0126 or CI-1040). Surprisingly, we found that p53 was a key effector of the
cytotoxic activity of the TW-37/MEK inhibitor combination. The driver of this p53 activation
was an unexpected feedforward loop involving reactive oxygen species (ROS). Interestingly,
normal melanocytes did not induce p53 or ROS and remained viable. Our results suggest that
this newly identified ROS/p53 feedback loop is a point of vulnerability of melanoma cells
that can be exploited for rational drug design.
908
Activating BRAF mutations in eruptive nevi
A Sekulic,1 M Colgan,2 KA Squillace2 and MR Pittelkow2 1 Dermatology, Mayo Clinic
Scottsdale, Scottsdale, AZ and 2 Dermatology, Mayo Clinc Rochester, Rochester, MN
The goal of this study was to examine the pathogenesis of eruptive nevi seen in association
with use of several immunosuppressive agents including azathioprine. The remarkable fea-
ture of eruptive nevi is the appearance of a large number of nevi over the short period of time
in previously unaffected skin. Several hypotheses regarding the pathophysiology of eruptive
nevi have been proposed including a breakdown of immunosurveillance due to immuno-
suppression and a possible direct effect of the immunosuppressive medications on melanocytes.
The actual mechanism remains unclear. In addition, it is not known whether the activating
BRAF mutations, seen in a high percentage of common benign dermal nevi, play a role in the
setting of eruptive nevi. To address this issue we analyzed the paraffin-derived DNA from a
total of 20 eruptive nevi that arose in a setting of azathioprine treatment. All the nevi were
removed from a single patient over a period of several years due to clinical features of atypia.
Almost all of the eruptive nevi that the patient developed were located in sun-exposed sites.
Paraffin blocks of eruptive nevi were sectioned and nests of nevi cells harvested using laser
capture microdissection. DNA extracted from harvested material was analyzed using a com-
bination of high-sensitivity allele-specific PCR and sequencing. BRAF mutations were detected
in 17/20 (85%) of examined eruptive nevi. Interestingly, all positive samples demonstrated
the identical BRAF mutation, V600E. This data indicates that the molecular mechanism under-
lying the melanocytic proliferation in the setting of eruptive nevi is likely similar to that of com-
mon, benign nevi. Interestingly, a majority of nevi in this patient were located in the sun
exposed areas suggesting a role of UV radiation. This is especially intriguing in light of recent
reports indicating cooperative effects of azathioprine and UVA leading to mutagenic oxida-
tive DNA damage.
909
Fermented rice bran down-regulates MITF gene expression leading to inhibition of α-MSH-
induced melanogenesis in B16F1 melanoma
S Chung,2 M Seo,2 Y Seo,1 S Joung,2 J Park,1 M Seo,2 J Park,2 J Kim1 and C Park1 1 Department
of Chemical and Biochemical Engineering, Dongguk University, Seoul, South Korea and 2
Doosan R & D Center, Yongin, South Korea
Rice bran contains various polyphenolic compounds with strong antioxidative activities such
as ferulic acid. Although it has been known that rice bran prevents melanogenesis, the mech-
anisms have not been fully elucidated. Furthermore, the cytotoxicity of rice bran to melanocytes
may limit its application to human skin. In order to alleviate the cytotoxicity of rice bran, a fer-
mentation process was applied. Biotransformation of a certain component in natural extracts
through fermentation may bring additional biological functions and reduce the toxicity. Co-
fermentation of rice bran with Lactobacillus and Saccharomyces cerevisiae markedly reduced
the cytotoxicity to the B16F1 melanoma cells measured by MTT assay while the Lactobacillus-
fermented rice bran still exhibited cytotoxicity. As previously known, the melanin synthesis
induced by α-MSH was significantly reduced by the fermented rice bran. Immunohistochem-
ical staining results confirmed that the fermented rice bran inhibited the synthesis of melanosome
and melanin in monolayerd cultures. However, cell free tyrosinase inhibition assay revealed
that the fermented rice bran had no inhibitory activity but the intracellular tyrosinase activity
was reduced by fermented rice bran in a dose dependent manner. Consistent with this result,
the increased level of tyrosinase protein induced by α-MSH was gradually decreased with
increasing amount of the fermented rice bran measured by an immunoblot assay. The result
prompted us to analyze the effect of fermented rice bran on the expression of microphthalmia-
associated transcription factor (MITF) which has been known to play a pivotal regulatory role
in melanogenesis and we found that the level of MITF was also significantly decreased by the
fermented rice bran. Taken all together, the fermented rice bran showed the inhibitory effect on
melanogenesis through down-regulation of MITF without causing cytotoxicity.
910
Expression of neuropeptides and their receptors in melasma, lentigo and ota nevus
H Bak,1 S Chang2 and J Choi2 1 University of Ulsan College of Medicine, Asan Medical
Center, Seoul, South Korea and 2 Dermatology, University of Ulsan College of Medicine, Asan
Medical Center, Seoul, South Korea
The pathogenesis of pigmentary diseases including melasma, lentigo and ota nevus is incom-
pletely understood but neuroimmunocutaneous system alteration can be responsible for the
induction and maintenance of those pigmentary diseases. This involvement is suggested by a
number of clinical and histological observations. This study was carried out to examine the
expression of Substance P (SP), calcitonin gene-related peptide(CGRP), somatostatin (SOM),
neutral endopeptidase (NEP), SP receptor, and CGRP receptor in those pigmentary diseases.
A skin biopsy was obtained from patients and normal control subjects. Confocal laser scan-
ning microscopy was performed. The expression of neuropeptides and their receptors were
different in each pigmentary disorder. The SP and CGRP receptors consistently increased in
pigmentary diseases, compared to the normal controls. The increased expression of neu-
ropeptides and their receptors may be involved in the pathogenesis of melasma, lentigo and
ota nevus.
911
Cortactin, a cytoskeleton-associated adaptor protein, in melanocytic tumor progression
X Xu, C Spittle, M Varella-Garcia, R Edwards, S Lessin and H Wu Fox Chase Cancer Center,
Philadelphia, PA
We previously showed that cortactin (CTTN), a family of highly conserved actin-binding pro-
teins important in remodeling cortical actin cytoskeleton, is overexpressed in melanomas (MM)
by immunohistochemical (IHC) staining on human melanocytic lesions using anti-CTTN anti-
body, followed by visual scoring. To further analyze the IHC stains, we used the Automated
Cellular Imaging System to quantitate the percentage and intensity of positive staining. Initial
results confirmed the visual scoring. Increased CTTN expression in MM was also confirmed
by immunofluorescent staining. To study the mechanisms for increased expression, fluores-
cent in situ hybridization was used to determine CTTN gene amplification, since it is known
to be overexpressed as a result of 11q13 amplification in subsets of human cancers. Prelimi-
nary analysis found gene amplification in small numbers of MM, indicating that this may not
be the only mechanism for CTTN overexpression. Expression analysis using Affymetrix U133A
microarrays shows increased mRNA levels in subsets of MM relative to nevi. To provide cor-
relative in vitro data from cultured cells, we are analyzing the expression, protein distribution
and tyrosine phosphorylation patterns in primary melanocyte and MM cell lines. Immuno-
fluorescent studies show colocalization of CTTN with filamentous actin in cell cortex in MM,
but not melanocyte lines. Initial data also show increased tyrosine phosphorylation in MM
cell lines, on tyrosine Y421, a critical residue targeted by src family kinases. Tyrosine phos-
phorylation is also increased upon serum stimulation. CTTN is known to be involved in a
diverse array of cell functions, including cell motility, tumor metastasis, receptor endocytosis,
Golgi and neuronal vesicle formation. We hypothesize that CTTN provides a link between cell
membrane, mechanical enzymes and polymerizing cortical actin filaments for force genera-
tion needed in active remodeling of membrane-cytoskeleton interface, a process that is com-
mon to all the above cell functions. Therefore, CTTN may contribute to MM tumorigenesis.
912
Protein Kinase C-Alpha (PKC-α) knockdown by targeted siRNA inhibits melanoma cell
migration
HR Byers and SJ Boissel Dermatology, Boston Univ Sch Medicine, Boston, MA
Protein Kinase C (PKC) is a multigene family of serine/threonine protein kinases involved in
cell signaling pathways of proliferation and motility. PKC interacts with Rho GTPases in the
regulation of the actin cytoskeleton. The PKC-α isozyme binds the Rho GTPase cdc42, and
both are coordinated with the Rac-phosphatidylinositol-3 kinase (PI3K) signaling pathway in
melanoma cell invasion and migration on extracellular matrix proteins. To further define the
role of PKC-α in melanoma cell motility, we transfected siRNA targeted against PKC-α into
human melanoma cells and performed time-lapse analysis of cell migration and phorbol-
12,13-dibutyrate (PDBu) induced cell spreading on fibronectin followed by Western
immunoblotting. The PKC-α siRNA transfection nearly abrogated PKC-α expression compared
to siRNA controls. It also significantly reduced, but did not abrogate melanoma cell migra-
tion. In contrast, similar siRNA knockdown prior to PDBu stimulation did not block melanoma
cell spreading. These findings indicate that PKC-α plays a role in melanoma cell migration
but not cell spreading. The dissociation of PKC-α signaling of directed migration versus active
membrane spreading may have implications in therapies designed to disrupt melanoma cell
motility by alteration of PKC-α signaling.
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The 3,3,4,4,5,5-hexahydroxystilbene impairs melanoma progression in a metastatic mouse
model
V Paulitschke,1 T Szekeres,2 W Jäger,3 C Gerner,4 O Teufelhofer,4 A Holzweber,1 O Scheiner,5
H Pehamberger1 and R Kunstfeld1 1 General Dermatology, Medical University Vienna,
Vienna, Austria, 2 Medical and Chemical Laboratory Diagnostics, Medical University Vienna,
Vienna, Austria, 3 Clinical Pharmacy and Diagnostics, University of Vienna, Vienna, Austria,
4 Clinic for Internal Medicine I, Medical University Vienna, Vienna, Austria and 5 Institute for
Pathophysiology, Medical University Vienna, Vienna, Austria
Stilbenes, a group of polyphenolic compounds, have been shown to exert beneficial effects
on various malignancies. In an attempt to increase the anti-tumor effects, we generated the
stilbene analogue 3,3,4,4,5,5-hexahydroxystilbene termed M8. In vitro, M8 dramatically
inhibits the proliferation of human melanoma cell including the metastatic M24met melanoma
cell line. Cell cycle analyses reveal that M8 promotes G2/M arrest in the M24met melanoma
cell line. To further evaluate the underlying mechanisms, we performed proteomic analyses
of human melanoma cell lines in vitro. We demonstrated that M8 interferes with pathways
which are critically involved in the regulation of proliferation, apoptosis and tumor cell migra-
tion. In our recently established, spontaneously metastatic human melanoma SCID mouse
model, we demonstrate that M8 significantly impairs tumor growth, inhibits cell proliferation
and induces apoptosis in a dose dependent manner. Furthermore, mice treated with M8 showed
less metastasis to distant lymphnodes compared to littermates receiving solvent. Podoplanin
labeling reveals reduced peritumoral lymphatic vessel density in M8 treated mice. In con-
clusion, M8 exerts pronounced antiproliferative effects on melanoma cells through the induc-
tion of apoptosis and cell cycle arrest at the G2/M boundary. Furhermore, the M8 mediated
inhibition of melanoma metastasis to distant lymph nodes appears to be achieved through
diminution of tumor-associated lymphatic vessels. Our data indicate that M8 is a novel and
potent approach for the treatment of melanoma.
915
C-MYC controls senescence in melanoma cells
MS Soengas, S Mannava, S Patil, V Grachtchouk and M Nikiforov Dermatology, University
of Michigan, Ann Arbor, MI
Activating mutations of the oncoproteins BRAF (V600E) or NRAS (Q61R) are commonly found
in malignant melanomas. Intriguingly, the same genetic changes and often at higher rates are
detected in benign nevi composed mostly of senescent melanocytes. We have previously shown
that in normal melanocytes ectopic expression of BRAFV600E and NRASQ61R induces differ-
ent types of stress responses ultimately leading to the activation of cellular senescence. How onco-
gene-mediated senescence is overcome during melanoma genesis, and whether aggressive
melanoma cells retain the ability to undergo senescence is unclear. Here we report that shRNA-
mediated inhibition of C-MYC in several BRAFV600E- or NRASQ61R-expressing tumor-derived
melanoma cell lines resulted in permanent growth inhibition accompanied by activation of senes-
cence-associated β-galactosidase and formation of senescence-associated heterochromatin foci.
Cell morphology of MYC-depleted BRAFV600E- or NRASQ61R-expressing melanoma cells closely
resembled that of normal melanocytes undergoing senescence induced by BRAFV600E or
NRASQ61R, respectively. Additionally, senescing melanocytes overexpressing either of the above
oncoproteins demonstrate gradual reduction in C-MYC mRNA and protein levels. Reciprocally,
overexpression of C-MYC in normal melanocytes approximately to the levels observed in melanoma
cell lines, delays senescence induced by BRAFV600E and, to lesser extent, by N-RASQ61R, con-
firming and active role of C-MYC in opposing oncogene-induced senescence. Interestingly, senes-
cence-like phenotype induced by depletion of C-MYC was independent of p16INK4A (usually
associated with cellular senescence, but not frequently inactivated in spontaneous melanoma).
Instead, MYCshRNA-induced senescence was found to relay, at least in part, on p27KIP1, a cell
cycle inhibitor and a bona fide MYC-repressed target. Our data suggest that molecular determi-
nants resulting in BRAFV600E- or NRASQ61R-specific senescence programs are preserved in
tumor-derived melanoma cells and are repressed by elevated amounts of C-MYC.
917
Identification of novel small molecule inducers of melanin production
BR McNaughton,1,3 PC Gareiss,2,3 S Jacobs,3 G Scott3 and BL Miller3,2 1 Department of
Chemistry, University of Rochester, Rochester, NY, 2 Department of Biochemistry and
Biophysics, University of Rochester, Rochester, NY and 3 Department of Dermatology,
University of Rochester, Rochester, NY
Melanin is a complex biopolymer synthesized in organelles called melanosomes that are a
unique feature of melanocytes. Regulation of melanin production occurs at multiple points
that primarily involve, but are not exclusive to, the regulation of tyrosinase, the key enzyme
in melanin synthesis. Because over 100 genes are implicated in control of pigmentation, other
regulatory targets are likely to exist. Agents that increase melanin synthesis are of interest
both as tools for the study of melanin production, and because of their potential use as “nat-
ural sunscreens” that stimulate the skin’s resident melanocytes to produce and transfer more
melanin to epidermal keratinocytes, thus decreasing the incidence of skin cancer. Recent
efforts by Orlow and coworkers have demonstrated that combinatorial library screening is a
viable method for the identification of novel regulators of melanogenesis. To that end, we have
synthesized and screened a combinatorial library of 75 organic compounds. Three members
of this library with structures unrelated to the triazine derivatives reported by Orlow et al. were
found to provide a 2-fold increase in pigmentation of mouse melan-A cells with potency com-
parable to forskolin. Additionally, cell dendricity was found to increase significantly in the
presence of melanin-inducing small molecules. We have subsequently employed a proteomic
approach (2-D DIGE) to identify changes in protein expression as a function of small mole-
cule treatment. Expression levels of approximately 80 proteins were altered by the presence
of one library member.
916
BMP-4 regulation of MITF expression in cultured human melanocytes
H Park, C Stachur, F Wang and BA Gilchrest Department of Dermatology, Boston University,
Boston, MA
Bone Morphogenetic Protein-4 (BMP-4), released from keratinocytes and melanocytes, was
recently shown to modulate melanogenesis and to decrease protein levels of tyrosinase, PKC-
β, TRP-1 and MART-1. To further elucidate the mechanisms by which BMP-4 down-regulates
melanogenesis, we examined the effects of BMP-4 on the expression of microphthalmia-
associated transcription factor (MITF), the key transcription factor for these melanogenic pro-
teins. When paired cultures of newborn melanocytes were treated with BMP-4 (25 ng/ml) or
vehicle alone for 24 hrs, BMP-4 reduced the level of MITF protein (p<0.03) by 60-70%. The
mRNA level of MITF-M, the isoform known to regulate the transcription of melanogenic pro-
teins, measured in parallel by semi-quantitative RT-PCR, decreased 30~40% in BMP-4 treated
cells. Moreover, within 24 hrs, BMP-4 decreased the intracellular level (26 ± 4 vs 14 ± 5
pmol/ug vehicle vs BMP-4) of cAMP, the key second messenger that increases transcription
of MITF gene. Because MITF activity is transiently increased by MEKinase-dependent phos-
phorylation, followed by subsequent proteosome mediated degradation, and BMP-4 acts by
initially binding with its cell surface tyrosinase kinase receptor known to activate MEKinase,
we asked whether BMP-4 also acutely activates (phsophorylates) MITF. In paired cultures of
melanocytes treated with BMP-4 (25 ng/ml) for 15 min, 30 min, 1 hr and 4 hrs, there was a
2-4 fold (p<0.03) increase in MITF phosphorylation at 15 and 30 min, but MITF protein level
was decreased by 4 hr. Moreover, pretreatment of melanocytes with MEKinase inhibitor
PD98056 blocked BMP-4 induced MITF phosphorylation. These results demonstrate that BMP-
4 initially activates MITF, but prolonged exposure to BMP-4 decreases both MITF mRNA and
protein levels by decreasing intracellular cAMP level. Thus, acute exposure of melanocytes to
BMP-4 can transiently promote melanogenesis, while longer exposure down-regulates melano-
genesis.
914
Cobalt and copper are candidates as co-carcinogens in the pathogenesis of cutaneous
melanoma
FL Meyskens, S Yang, PJ Farmer, H Anton-culver and D Culver Cancer Center, UC Irvine,
Orange, CA
The complex epidemiology and recent genetic studies of melanoma as well as the limited
evidence for ultraviolet light damage in melanoma cells raises the likelihood that the etio-
logic and pathobiologic factors in melanoma are multi-factorial.Our studies of the role of reac-
tive oxygen species in the pathogenesis of melanoma over the past decade has led us to recon-
sider the role of ultraviolet light and has led us to explore the role of heavy metals in this
process. A systematic experimental exploration of the role of melanin and melanosomes in
melanocytes and melanoma cells using electroparamagnetic resonance, electron microscopy
and other techniques suggests that the conversion of melanin from an anti-oxidant and reduc-
ing agent to a pro-oxidant is an early pathogenic event which is accompanied by melanoso-
mal disruption that serves as an organelle source of free radical generation. The involvement
of selected heavy metals is critical to this process and in conjunction with ultraviolet light can
lead to phenotypic changes in normal human melanocytes that resemble dysplatic nevi
melanocytes in culture. A re-examination of the non-genetic risk factors for melanoma has
identified a large(and neglected) epidemiology that implicates heavy metals and includes
markedly increased risks for melanoma in printers/lithographers(4 large studies), electrical
industry workers(2 large studies), and hip replacements patients(3 large meta-analyses. Clin-
ical observations(imaging studies) and studies that document the importance of metalloth-
ionein expression in primary melanoma and prognosis also offers ancillary support for the
involvement of metals in the pathogenesis of melanoma. Based on these considerations and
studies of heavy metals in a modified JB6 carcinogenesis indicator system, the role of copper
in the melanin synthesis pathway and the binding characteristics of metals to melanin we
propose that the most likely culprits that accounts for a significant contribution to the patho-
genesis of melanoma are Cu+2 and Co+2.
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Dermoscopic patterns and melanoma risk: a pilot case-control study in patients with multi-
ple dysplastic nevi
JB Lipoff,1,2 A Scope,1 SW Dusza,1 SA Oliveria,1 AA Marghoob1 and AC Halpern1 1
Dermatology, Memorial Sloan-Kettering Cancer Center, New York, NY and 2 Albert Einstein
College of Medicine, Bronx, NY
Dysplastic nevi (DN) are markers of melanoma (MM) risk and potential precursors. The purpose
of this case-control pilot study was to identify differences between the dermoscopic patterns of
DN in patients with and without a history of MM. Patients were randomly selected from the Memo-
rial Sloan-Kettering image database of patients undergoing full-body photography for pigmented
lesion surveillance in 2005. Inclusion criteria were age ≥18 at photography, pathological confir-
mation for history of invasive MM, and at least 5 back nevi ≥5 mm in diameter with available der-
moscopic images. Patients with facial and acral MM were excluded. Dermoscopic images of all
back nevi ≥5 mm in diameter were evaluated. The primary outcome was Total Dermoscopy
Score (TDS) by the ABCD rule of dermoscopy. Secondary outcome measures were dermoscopic
global pattern and specific structures. To date, the study has included 119 nevi from 7 males and
3 females with a history of MM (cases) and 74 nevi from the same number of sex and age matched
patients without a history of MM (controls). The average TDS was 4.17 for nevi in cases and 3.75
for nevi in controls. There was a significant difference in frequency of global dermoscopic pattern
for reticular-globular pattern (23% for cases vs. 8% for controls) and multi-component pattern
(10% vs. 4%, respectively), whereas reticular pattern was more frequent in controls (53%) than
cases (21%). Among dermoscopic structures, globules, homogeneous areas, and vascular struc-
tures were more frequent in cases (65%, 82%, 65%, respectively) than in controls (31%, 68%,
42%, respectively); dots were more frequent in controls than in cases (51% vs. 22%, respectively).
Statistical analysis will be reported following review of additional cases. DN in MM patients appear
to have different dermoscopic attributes than in non-MM patients. If further validated, these results
may be informative for better defining DN that are markers of increased MM risk.
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Characterization of UV-induced signaling patterns in melanocytes and malignant melanoma
RH Edwards,1 CS Spittle,2 K Quesnelle,1 R Rooney,4 PA Gimotty,1 R Hammond,1 M Brose,1
SR Lessin2 and M Herlyn3 1 University of Pennsylvania, Philadelphia, PA, 2 Fox Chase Cancer
Center, Philadelphia, PA, 3 The Wistar Institute, Philadelphia, PA and 4 Genome Explorations,
Memphis, TN
Exposure to solar ultraviolet (UV) radiation is epidemiologically linked to risk of developing
malignant melanoma. We hypothesized that UV exposure may select for cells that subvert the
normal response to UV by preventing cell cycle arrest, DNA repair, and proapoptotic signals
normally induced by DNA damage. To test this hypothesis, 5 neonatal foreskin melanocyte
and 5 Wistar melanoma cell lines were exposed to a single dose of solar-simulated UV light
equivalent to 0.5 J/m2 UVA and 36 mJ/cm2 UVB and compared to non-exposed lines. Cells
were harvested 4 hours after treatment and extracted RNAs were hybridized to Affymetrix
U133A expression microarrays. Biostatistical analysis utilized four methodologies: principal
components analysis, Pundit’s square analysis of pairwise comparisons for each cell line, and
Welch’s t-test using either MAS 5.0-normalized or RMA (robust multiarray analysis)-normal-
ized data. Lists of UV-regulated genes for each cell type were generated by identifying genes
with a statistically significant UV effect by at least 2 of 4 methods. Ingenuity Pathway Analy-
sis software was used to generate signaling networks among the gene list for each cell type.
For melanocytes, a high complexity UV-induced signaling network was identified that cen-
tered around a p53 response, and included induction of CDKN1A (p21) and GADD45A.
Diminished expression of several proapoptotic genes including DAPK1, PPP3CA (Calcineurin
A), and HDAC4 highlight an antiapoptotic response that was present together with the p21-
induced proapoptotic and cell cycle arrest signaling. Strikingly, the response in melanoma was
markedly diminished and less complex, with loss of the majority of regulatory patterns pres-
ent in melanocytes. These data suggest that p53-induced signaling is a critical component of
the UV response in melanocytes, and that loss of this central response characterizes malig-
nant melanoma.
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Increased proliferation associated in vivo skin fluorescence and deformation of the rete ridges
pattern are common features of solar lentigines
C Pollefliet,1 L Hellemans,1 H Corstjens,1 L Declercq1 and D Maes2 1 Estee Lauder
Companies, Oevel, Belgium and 2 Estee Lauder Companies, Melville, NY
Solar lentigines or age spots are flat brown patches of skin that appear mostly on the back of
hands, face and forearms around the age of 50. Their development is accelerated by UV
exposure. Less is known about the mechanisms responsible for the formation and develop-
ment of age spots. A clinical study was designed in which age spots and adjacent skin sites
were evaluated with Reflectance Confocal Microscopy. At the same sites skin colour and flu-
orescence (λex/λem= 295/345nm) measurements were performed, the latter being a measure
for epidermal proliferation. Confocal microscopy images revealed an increased density and
number of melanin containing cells in the area of age spots, which agrees with the darker
colour. The penetration of the rete ridges into the dermal papillae was visible in all samples
but the pattern of the penetration at an age spot site was clearly deformed and irregular. This
deformation of the rete ridges pattern was more pronounced at sites with darker pigmenta-
tion, suggesting that the distortion contributes to the progression of the age spot. Fluores-
cence values were higher in the age spots, and correlated to skin pigmentation, which indi-
cates increased epidermal proliferation in age spots. From these data we hypothesise that the
increased proliferation measured in age spots may be associated to the deformation in the
rete ridges pattern, which on his turn may contribute to age spot formation and development.
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Humanized mouse models for studying lymphocyte homing to melanoma
C Weishaupt,1 GF Murphy,2 TS Kupper1 and RC Fuhlbrigge1 1 Dermatology, Brigham and
Women’s Hospital, Boston, MA and 2 Pathology, Brigham and Women’s Hospital, Boston,
MA
Immunohistochemical analysis of human metastatic melanoma has shown that tumor vessels
in general do not express leukocyte adhesion receptors, effectively blocking entry of cyto-
toxic lymphocytes and restricting the anti-tumor immune response. Based on these results,
we hypothesize that modulation of tumor vasculature to express adhesion receptors will
enhance immune response to melanoma resulting in more effective vaccination protocols. To
study vascular adhesion receptor expression and lymphocyte extravasation within melanoma,
we have developed two mouse models of human lymphocyte homing to human melanoma
xenografts. Fresh melanoma metastases obtained from consenting patients were engrafted sub-
cutaneously in NOD/SCID mice. 3 weeks after implantation human vessels inside the tumor
had connected to murine vessels, retaining expression of human CD31 and the histologic
appearance of fresh tissue before engraftment. Alternatively we transplanted human skin on
RAG2-/-JAK3-/- mice. After 3-4 weeks the grafts were healed and appeared histologically sim-
ilar to healthy human skin. A375 melanoma cells injected intracutaneously into the skin
grafts grew to tumor nodules containing both human and murine blood vessels, defined by
species-specific CD31 staining. Both models were used to monitor homing of adoptively trans-
ferred human peripheral blood leukocytes to engrafted tumors. Taken together these models
have proven to be well suited to investigation of human lymphocyte extravasation in human
melanoma tissue in vivo and will promote our understanding of tumor vascular function and
the mechanisms regulating the immune response to metastatic melanoma.
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RNAi knockdown of semaphorin 6D decreases melanosome transfer from melanocytes to
keratinocytes
S Rocha, I Santana, J Nip and L Shore Bioscience, Unilever R & D, Trumbull, CT
One of the main contributors to human skin color is the transfer of melanosomes from basal
melanocytes to keratinocytes. Detailed knowledge of the mechanism of this process and the
factors that play a role in its regulation are unknown. Here we describe the first instance of
modulating melanosome transfer via semaphorins and present a novel means of analyzing
the transfer process. Melanocytes are neural crest-derived cells which form dendrites that trans-
port and transfer melanosomes to keratinocytes. Dendrites are important for efficient
melanosome transfer since one melanocyte makes contact with numerous keratinocytes in the
epidermis. Although mechanisms for melanosome transfer have been proposed, the molecu-
lar mediators involved in melanosome transfer are mainly unknown. The neural crest-derived
origin of melanocytes is interesting in light of semaphorins having a role in neuronal axon
guidance. Along with their receptors, the plexins, semaphorins may be involved in skin pig-
mentation. Semaphorin 6D (Sema6D) is a member of the class 6 of semaphorins and is grouped
into five isoforms through differential splicing (Qu et al., 2002). It has been shown to play a
role in inhibiting axonal extension of NGF-differentiated PC12 cells and to collapse growth
cones of both chick dorsal root ganglion and rat hippocampal neurons. To elucidate the role
of semaphorins in skin pigmentation and melanocyte:keratinocyte interactions, RNA interfer-
ence experiments were performed in keratinocytes to knockdown both the entire semaphorin
class, as well as Sema6D specifically. The results demonstrated that semaphorin knockdown
resulted in significant inhibition of melanosome transfer, as measured in our coculture
melanosome transfer assay. Other interesting observations demonstrated that while melanocytes
can transfer melanosomes to several keratinocytes, keratinocytes accept melanosomes from
only a single melanocyte, regardless of multiple melanocyte contacts. Together, these findings
indicate a role for semaphorins in melanosome transfer and skin pigmentation.
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H2O2-mediated oxidation affects the ca
2+ binding activation of furin convertase
JD Spencer,1 NC Gibbons,1,2 M Böhm3 and KU Schallreuter1,2 1 Department of Biomedical
Sciences, Clinical and Experimental Dermatology, Bradford, United Kingdom, 2 Institute for
Pigmentary Disorders, EM Arndt University Greifswald, Greifswald, Germany and 3
Department of Dermatology, University of Munster, Munster, Germany
The Ca2+-dependent prohormone convertase furin is abundantly expressed in epidermal ker-
atinocytes and melanocytes. This enzyme is involved in the processing of a wide variety of
substrates important for epidermal functions in particular the POMC peptides. Recently we
have shown that POMC peptides such as α-MSH, β-endorphin and ACTH are directly affected
by hydrogen peroxide (H2O2)-mediated oxidation. We therefore asked the question whether
furin would also be a possible target for oxidation by H2O2. Our results show reduced mRNA
expression in a time- and dose-dependent manner after H2O2 exposure. Next we followed
the Ca2+ binding to the enzyme before and after oxidation with H2O2. For this purpose we
used the isotope 45Ca. These results yielded a loss of one Ca2+ from one binding site whereas
the other Ca2+ binding site was unaffected. This finding was supported by computer simula-
tion using HyperchemTM software. The model implicated the loss of one Ca2+ atom from the
enzyme after H2O2 mediated oxidation of the protein. Since epidermal H2O2 levels are in the
mM range in acute vitiligo, we used this model to follow epidermal furin protein expression.
Our in situ results show that furin expression is significantly reduced in acute disease. Protein
expression returned to normal after removal/reduction of epidermal H2O2 by an active pseudo-
catalase PC-KUS. In summary, we provide evidence that the ca2+-dependent furin convertase
is severely affected by H2O2-mediated oxidation at the level of mRNA and protein expression
as well as the loss of one Ca2+ binding site.
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H2O2-mediated oxidation affects epidermal xanthine oxidase
M Shalbaf,1 NC Gibbons,1,2 JM Wood1,2 and KU Schallreuter1,2 1 Biomedical Sciences,
Clinical and Experimental Dermatology, Bradford, United Kingdom and 2 Institute for
Pigmentary Disorders, EM Arndt University, Greifswald, Germany
In vitiligo, the entire human epidermis is under oxidative stress due to mM accumulation of
hydrogen peroxide (H2O2). One of several mechanisms which generate H2O2, is xanthine
oxidase (XO) that is playing an important role in the last two steps of the degradation path-
way of purine bases. This enzyme catalyses the oxidative hydroxylation of hypoxanthine to
xanthine followed by xanthine to uric acid. These catalytic reactions are accompanied by the
generation of H2O2 and superoxide anion. Therefore this enzyme has been considered as a
major biologic source of oxygen-derived free radicals in many organs. The presence of XO in
the human epidermis has not been shown so far. Here we demonstrate for the first time the
presence of XO in the human epidermis of both healthy skin (skin phototype III, Fitzpatrick
classification) and vitiliginous skin using touched down PCR, western blotting, and in situ as
well as in vitro protein expression. Moreover, the presence of this enzyme and its activity are
demonstrated in both epidermal melanocytes and keratinocytes from healthy skin (skin pho-
totype III, Fitzpatrick classification). Enzyme kinetics in the presence and absence of H2O2
indicate that this ROS affects enzyme activities. Computer simulation using HyperchemTM
software demonstrates that the structure of XO is altered by H2O2.
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Characterization of a new mouse model for the detection of melanocyte stem cells
SK Powell, KP Young, M Nelson, RS Plummer and D Lang Medicine, Section of Dermatology,
University of Chicago, Chicago, IL 60637, IL
Pax3 is a necessary transcription factor in melanocyte embryonic development and is expressed
in the melanocyte stem cells (MSCs) of mature hair follicles. Melanocyte stage markers can
mark cells from MSCs (through expression of Dct), to differentiating melanocytes (Dct, Trp1)
to fully differentiated melanocytes (Dct, Trp1, tyrosinase). While these factors are helpful in
identifying each stage, a marker expressed solely in the MSCs such as Pax3 would provide a
valuable tool. Pax3 is co-expressed with Dct in 21.9%+/-2.7 of cells, while Pax3 is only co-
expressed with Trp1 and tyrosinase 9.0%+/-4.2 and 2.9%+/-1.6, respectively. Pax3 expression
is limited to the hair follicle bulge where the MSCs are located. To establish a mouse model
that marks the MSCs with a reporter, we created a stable transgenic line utilizing 1.6 Kb of
promoter sequence 5’ proximal to the Pax3 gene to drive expression of beta-galactosidase.
Our model labels the melanocyte stem cells in the mature hair follicle of mice in a spatially
and temporally restricted expression pattern. Our model will further the understanding of the
melanocyte stem cells in the mature organism and further the possibility of harvesting these
stem cells for autologous stem cell therapy.
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The serine protease corin is a novel modifier of the agouti-signaling pathway
D Enshell-Seijffers, C Lindon and BA Morgan Cutaneous Biology Research Center, Harvard
Med/ MGH, Charlestown, MA
Melanocortin receptors (MCR) are involved in a wide range of physiological functions includ-
ing pigmentation, weight control, energy balance, exocrine gland secretion, thermal regula-
tion and sexual behavior. The activity of MCRs is augmented in response to binding of ago-
nists and decreased by the binding of the endogenous antagonists agouti signaling protein
(ASIP) and agouti-related protein (AgRP). The transient expression of agouti signaling protein
in the dermal papilla (DP) of the hair follicle temporarily suppresses the activity of Mc1R on
melanocytes resident in the hair bulb and results in a provisional switch from eumelanogen-
esis (the production of black pigment) to pheomelanogenesis (the production of yellow pig-
ment). The resultant subapical yellow band on a black background defines the agouti coat
color. In our attempt to understand inductive signaling from the DP in hair follicle morpho-
genesis, corin was identified as a gene specifically expressed in the DP. Analysis of the func-
tion of this transmembrane protease by gene targeting approach reveals that corin is a criti-
cal modifier of the agouti-signaling pathway. In the absence of corin, the subapical yellow
band was extended dramatically leading to a “blond” coat color that can be easily distin-
guished from the typical agouti color. The contribution of corin activity to the pigmentation
of different hair types and to the regulation of known components of the agouti-signaling path-
way were evaluated.
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Transfection with the wild type MC1R normalizes the DNA damage response of human
melanocytes expressing non-functional MC1R
ZA Abdel-Malek,1 AL Kadekaro,1 D Supp,2 N Mosby,1 R Kavanagh,1 S Terzieva,1 A Koshoffer1
and R Boissy1 1 Dermatology, U. of Cincinnati, Cincinnati, OH and 2 Surgery, Shriners’ Burns
Hospital, U. of Cincinnati, Cincinnati, OH
The melanocortin 1 receptor (MC1R) is a major determinant of the diversity of human pig-
mentation and a melanoma susceptibility gene. The MC1R is highly polymorphic, and its
allelic variants R151C, R160W and D294H (R alleles) are strongly associated with red hair
phenotype, poor tanning ability and increased risk for melanoma and non-melanoma skin
cancers. We have shown that natural expression of these alleles in the homozygous or com-
pound heterozygote state renders human melanocytes (HM) refractory to melanocortins and
more prone to UV-induced cytotoxicity. We also reported that treatment of HM expressing
functional MC1R with alpha-melanocyte stimulating hormone (MSH) enhanced the repair of
UV-induced photoproducts, reduced the UV-induced generation of hydrogen peroxide and
apoptosis. These effects that are expected to diminish the damage caused by UV are absent
in HM that are homozygous or compound heterozygous for the R alleles. We have stably trans-
fected HM that are compound heterozygous for R151C and D294H with the wild type MC1R.
The transfected HM demonstrated visible increase in melanin content. Additionally, they
responded to UV with marked reduction in apoptosis, even in the absence of MSH, indicat-
ing activity of the expressed wild type receptor. Treatment of the transfected HM with MSH
inhibited the UV-induced apoptosis even further, reduced hydrogen peroxide generation,
and enhanced nucleotide excision repair. These results provide compelling evidence for the
significance of the functional MC1R in the DNA damage response of HM, and explain how
the MC1R functions as a melanoma susceptibility gene.
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Requirements for T-oligo killing of melanoma cells
X Jiang, M Yaar, I Panova, Y Gao, MS Eller and BA Giclhrest Dermatology, Boston University
School of Medicine, Boston, MA
Telomere homolog oligonucleotides (T-oligos) activate DNA damage responses that lead to
cell cycle arrest, differentiation, apoptosis and/or senescence of melanoma cells, although
the extent of these changes varies with cell line. In 6 established melanoma lines (AN, MU,
WK, RU, MC and EP) within 4 days T-oligo (11 base, 40uM) induced apoptosis of 64±4%,
57±2%, 46±3%, 45±4%, 29±2% and 2±0.3% respectively, compared to the diluent control
(3±0.5%). Within 4 days a more effective T-oligo (16 base, 20 uM) decreased AN cell yields
by 70±2% (p<0.004), but in EP cells there was no difference in cell yields between T-oligo
and a control (complementary) oligonuclotide. When the most and least responsive cell lines
(AN and EP) were incubated with fluorescently labeled T-oligos, within 1 hr, comparable flu-
orescence was present in most nuclei of both lines, excluding differences in penetration as
the explanation for the variable T-oligo effect. Because T-oligo effect is mediated at least in part
through the ATM (ataxia telangiectasia mutated) kinase, with subsequent p53 activation, p16
induction and histone H2AX phosphorylation, we also investigated these events. Interestingly,
within 48 hrs, ATM phosphorylation on serine 1981 in AN cells was >200% of baseline, but
there was no detectable phosphorylation in T-oligo-treated EP cells. Consistently, H2AX phos-
phorylation on serine 139 was >7000% of baseline in AN cells but <180% in EP cells. Because
unlike EP cells, AN cells are p53 null, p53 phosphorylation on serine 15 was examined in EP
cells and compared to another highly T-oligo responsive line (MCF-7, p53 wild type but p16
null, 87±9% decrease in cell yields after T-oligo) and was >700% of baseline in MCF-7 cells
but was not elevated in the non-responsive p53 expressing EP cells. Furthermore, the pro-
apoptotic protein Bax was elevated >400% in AN cells, but not in EP cells. Thus, although T-
oligos can readily induce apoptosis in cells lacking p53 or p16, our results are consistent with
a requirement for pathway activation at or above ATM for therapeutic T-oligo signaling.
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The influence of H2O2-mediated oxidative stress on the regulation of (6R)-L-erythro 5, 6, 7,
8 tetrahydrobiopterin synthesis
B Chavan,1 H Ichinose2 and KU Schallreuter1,3 1 Biomedical Sciences, Clinical and
Experimental Dermatology/Department of Biomedical Sciences, University of Bradford,
Bradford, United Kingdom, 2 Institue for Comprehensive Medical Science, Fujita, Japan and
3 Institute for Pigmentary Disorders, Institute for Pigmentary Disorders in Association with
the EM Arndt University Greifswald, Greifswald, Germany
(6R)-L-erythro 5, 6, 7, 8 tetrahydrobiopterin (6BH4) is an essential cofactor for phenylalanine
hydroxylase, tyrosine hydroxylase, tryptophan hydroxylase and also the nitric oxide syn-
thases therefore regulating catecholamine and serotonin synthesis along with melanogenesis.
Previously it has been reported that the human epidermis holds the full capacity to synthesise
and recycle 6BH4 where GTP Cyclohydrolase I (GTPCHI) is the rate limiting enzyme in the
3 step production of this cofactor. This synthesis is tightly regulated by GTPCHI Feedback
Regulatory Protein (GFRP) which in conjunction with 6BH4 and L-phenylalanine influences
GTPCHI activity. L-phenylalanine increases the enzyme activity whereas 6BH4 has the oppo-
site affect. Here we demonstrate that GFRP is present in both epidermal melanocytes and ker-
atinocytes and it is functionally active regulating GTPCHI activity in these cells. Since it has
been shown that hydrogen peroxide (H2O2) affects 6BH4 synthesis/recycling, we here wanted
to know whether the regulatory protein is also a target to this reactive oxygen species (ROS).
Earlier results showed that transcription of GTPCHI is under control of H2O2. Here we show
that the activity of this key enzyme is controlled by H2O2 with low levels activating the enzyme
and higher levels leading to total inhibition. However, the GTPCHI/GFRP complex was shown
to be highly stable to oxidation with no interference in 6BH4 down-regulation of the enzyme.
In summary, the regulation of 6BH4 by GFRP is not controlled by H2O2 whereas the enzyme
GTPCHI is controlled on its mRNA level as well as its enzyme level.
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Increased melanocytic nevi and nevus density in a G-34T CDKN2A melanoma-prone kin-
dred
SR Florell,1 LJ Meyer,1 KM Boucher,2 LA Cannon-Albright,4 RM Harris,1 WE Samlowski,2
JJ Zone1 and SA Leachman1,3 1 Department of Dermatology, University of Utah, Salt Lake
City, UT, 2 Oncological Sciences, University of Utah, Salt Lake City, UT, 3 Huntsman Cancer
Institute, Salt Lake City, UT and 4 Medical Informatics, University of Utah, Salt Lake City, UT
Cyclin-dependent kinase inhibitor 2A (CDKN2A) is the major melanoma predisposition gene and
mutations of this tumor suppressor have been discovered in 10% of Utah melanoma kindreds. We
previously reported that members of a Utah melanoma prone kindred with a temperature-sensi-
tive V126D CDKN2A mutation accumulated significantly more melanocytic nevi over a 15-year
interval than non-carrier family members or a group of spouse control subjects. These findings sug-
gest that in addition to conferring melanoma susceptibility, this gene may participate in nevus devel-
opment. Moreover, we reported a temperature sensitive nevus distribution in mutation carriers.
Here we report longitudinal nevus phenotype data over a 15-year interval from 31 members of a
second Utah melanoma kindred with a promoter-region (G-34T) CDKN2A mutation that results in
an aberrant initiation codon. The total nevus number (TNN) and total nevus density (TND) data
were analyzed using multiple linear regression with carrier status, age at first visit, and gender as
predictors. Similar to the V126D CDKN2A kindred, G-34T mutation carriers (n = 12) had signifi-
cantly larger TNN and TND over the follow-up interval compared with non-carrier (n = 19; p =
0.04 TNN; p = 0.03 TND) and spouse control subjects (n=13; p = 0.02 TNN; p = 0.03 TND). How-
ever, unlike the V126D kindred, a temperature-sensitive distribution was not observed in the G-
34T kindred; similar changes were seen in TNN and TND in warm (p = 0.99 and p=0.42, respec-
tively) and cold regions (p = 0.18 and 0.23, respectively) among mutation carriers and non-carriers.
These data from a second CDKN2A melanoma kindred confirm our previous observation that
CDKN2A mutations are nevogenic and add additional support to our observation that a temper-
ature-sensitive CDKN2A mutation may confer a temperature-sensitive nevus distribution.
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The novel MEK1/2 inhibitor AZD6244 (ARRY-142886) inhibits the growth of melanomas har-
boring the BRAF V600E mutation in vitro and in vivo
NK Haass, KS Smalley, K Sproesser, R Contractor and M Herlyn The Wistar Institute,
Philadelphia, PA
Disseminated melanoma is highly therapy-resistant. The fact that over 60% of melanomas har-
bor the activating BRAF V600E mutation has raised expectations for the targeted therapy.
Although there are many in vitro data to suggest that targeting the RAF/MEK/ERK pathway
would be a viable strategy, in vivo and early clinical data with first-generation compounds are
less convincing. In this study we investigated the anti-melanoma activity of the novel MEK1/2
inhibitor AZD6244 (ARRY-142886). In 2D cell culture, AZD6244 was cytostatic and reduced
melanoma cell growth in a concentration-dependent fashion. The growth arrest induced by
AZD6244 was associated with G1-phase cell cycle arrest and was reversible upon drug washout
in C8161 (BRAF wt, N-Ras wt) but not 1205Lu cells (BRAF V600E). Prolonged treatment led
to limited apoptosis in BRAF V600E but not BRAF wt cells. We have demonstrated that cul-
turing melanoma cells as 3D collagen-implanted spheroids enhances resistance to the MEK
inhibitor U0126. In this 3D model, AZD6244 is more potent than U0126 at inhibiting cell
growth and preventing the tumor cell invasion into the collagen. The effects of AZD6244 in
the 3D spheroid model are largely cytostatic and reversible, with drug washout leading to re-
growth. Finally we grew 1205Lu cells as tumor xenografts in SCID mice. After tumor estab-
lishment, mice were dosed twice daily with 0, 10 or 30 mg/kg AZD6244 by oral gavage. After
14 days AZD6244 treatment had decreased phospho-ERK in the tumors and significantly sup-
pressed tumor growth. The tumors remained viable, again suggesting that AZD6244 is largely
cytostatic, and not pro-apoptotic. In summary, we have shown that inhibition of MEK with
AZD6244 blocks the growth of melanoma cells harboring the BRAF V600E mutation in vivo
and in vitro. It seems likely that the blockade of this pathway is largely cytostatic and does not
induce significant apoptosis. Further studies are warranted to explore the potential for tumor
regression with AZD6244 using a combination approach.
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Reflectance confocal microscopy correlates of dermoscopically-identified blue white struc-
tures in melanoma
A Scope, JA Lieb, AC Halpern, S Gonzalez and AA Marghoob Dermatology, Memorial Sloan-
Kettering Cancer Center, New York, NY
The study aim was to describe the Reflectance confocal microscopy (RCM) correlates of der-
moscopically-identified blue white structures (BWS), an important dermoscopic criterion for
melanoma (MM) which signifies regression. Six invasive and 5 in situ (MMIS) MM were ana-
lyzed by RCM. Regression was histologically confirmed in all lesions. BWS were apparent on
RCM, and in cases where BWS were discrete on dermoscopy, the corresponding areas in the
lesion were equally discrete on RCM, thus permitting comparison of RCM findings within
and outside BWS; the most striking differences were observed at the Dermal-epidermal junc-
tion (DEJ) level. Severe architectural disarray of the DEJ, defined as complete effacement of
the normal rete meshwork on RCM, was seen more frequently in BWS (n=7, 64%) than in
other areas (n=0). Severe architectural disarray at the DEJ level did not correlate in this series
with invasiveness of MM. There was also greater heterogeneity of brightness on RCM in BWS
than in other areas which was attributable to: non-uniform distribution of single refractive cells
at the basal layer in all cases, bright junctional nests and confluent aggregates in 5 MM (45%),
and proliferation of highly refractive nucleated cells (probably melanocytes) or ill-defined,
plump bright cells (probably melanophages) in the dermal papillae in 8 MM (73%). The den-
sity of single cells at the DEJ in BWS areas was greater than in other areas of the lesions in 8
MM (73%). There were no obvious differences on RCM mosaic images at the level of the super-
ficial epidermis. However, stromal changes observed at the level of the superficial dermis were
notable on RCM in BWS areas, including prominent, scar-like collagen bundles in 5 MM (45%)
and increased vascular flow in 6 MM (55%). Discrete small cells compatible with lympho-
cytes were rarely observed. In conclusion, RCM analysis can shed light into the tissue com-
ponents that contribute to the appearance of BWS on dermoscopy.
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The increased caspase-2 activity can be a new novel marker associated with IFNβ-induced
apoptosis in malignant melanoma
T Kamiya,1 T Okabayashi,2 S Yokota,2 J Ogino,1 T Yamashita,1 N Fujii2 and K Jimbow1 1
Dermatology, Sapporo Medical University, Sapporo, Japan and 2 Microbiology, Sapporo
Medical University, Sapporo, Japan
The management of malignant melanoma is a difficult challenge. Among various therapeutic
approaches, interferon (IFN) may be one of effective anti-melanoma agents, especially IFNβ which
induces an apoptotic effect more effectively than IFNα and IFNγ. In malignant melanoma tumor
necrosis factor-related apoptosis inducing ligand (TRAIL) has been suggested to be a gene stimu-
lating IFN-mediated apoptosis. In order to characterize the signaling pathway involved in apop-
totic processes by IFN, this study characterized the biological effect of IFNβ onto caspase activ-
ity. Apoptosis is generally divided into two signal pathways, one is through apoptosis inducing
ligands such as Fas ligand, TRAIL and TNFα, and the other is through mitochondria. In these path-
ways the involvement of caspase-3, 8, and 9 is essential. However the role of caspase-2 has not
yet been elucidated. In this study, therefore, we are specifically interested in characterizing the
biological role of caspase-2, that can be a new sensitive marker reflecting to IFNβ effect. Firstly
we analyzed the cell growth inhibition of five human malignant melanoma cell lines, MM418,
SKmel-23, MeWo, UT and G361 by gentiana violet staining. Among them, the former four cell
lines revealed the cell growth inhibition by IFNβ, but the last one (G361) was not. TUNEL assay
showed the increase of apoptotic cell population in these four cell lines, corresponding the growth
inhibition by IFNβ. Caspase assay also showed the up-regulation of caspase-3 activity in these cell
lines, but not in G361. We then carried out caspase-2 assay to all of the five cell lines. We found
that the caspase-2 activity was up-regulated in the four cell lines which showed apoptosis by
TUNEL and caspase-3 assays. Again caspase-2 activity was not up-regulated in G361. Thus our
present results clearly indicate that caspase-2 is involved in IFNβ-induced apoptosis and its activ-
ity can be a new novel marker in identifying the cytotoxic effect of IFNβ.
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A role for p120-catenin in melanoma and melanocytes
P Burnett1,2 and A Reynolds2 1 Department of Dermatology, Vanderbilt University, Nashville,
TN and 2 Department of Cancer Biology, Vanderbilt University, Nashville, TN
p120-catenin (p120) is an armadillo-repeat protein that localizes to adherens junctions. p120
has been shown to bind to E-cadherin and stabilize the adherens junction. Additional roles
for p120 in wnt signaling and rho GTPase regulation have been described. p120 has been
shown to be expressed in melanocytes, but its function in this cell type has not been carefully
studied. Similarly, little is known about the expression pattern and role of p120 in melanoma
and melanocytic lesions. Data from melanocytic cell lines and tumors will be presented which
shows that p120 expression is often maintained throughout melanocyte tumorigenesis.
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Targeting methylglyoxal-adducted heat shock protein 27 (MG-Hsp27) for the induction of
melanoma cell apoptosis
GT Wondrak, MK Jacobson and EL Jacobson Department of Pharmacology & Toxicology,
University of Arizona, College of Pharmacy & Arizona Cancer Center, Tucson, AZ
Altered survival signaling is a hallmark of malignant melanoma cells resulting in resistance to
drug-induced apoptosis. Previous studies suggest that cancer cell survival depends on the mod-
ulation of cell death pathways by methylglyoxal (MG), a reactive by-product of glycolysis,
that acts by posttranslational modification and functional alteration of target proteins involved
in cellular survival. Our preliminary data indicate that heat shock protein 27 (Hsp27) is the
exclusive target of MG-adduction in human melanoma and that MG-antagonists selectively
induce apoptosis and chemosensitization in human melanoma cells. Using proteomic two-
dimensional immunodetection followed by mass spectrometric protein sequence analysis, we
have identified methylglyoxal-adducted heat shock protein 27 (MG-Hsp27) in various human
metastatic melanoma cell lines (A375, G361, LOX). Using small molecule methylglyoxal antag-
onists (prototype carbonyl scavengers that inactivate methylglyoxal by covalent adduction),
specific MG-Hsp27 downregulation without changes in total Hsp27 levels was achieved in
melanoma cells as demonstrated by Westernblot analysis. The emerging role of MG-Hsp27 as
an anti-apoptotic mediator of cancer cell survival lead us to investigate the feasibility of anti-
melanoma intervention by pharmacological modulation of MG-Hsp27. Indeed, MG-Hsp27
downregulation was associated with selective dose-dependent induction of apoptosis and cis-
platin-chemosensitization of human melanoma cells. Combined with accumulating evidence
for the involvement of MG-Hsp27 in the glycolytic control of cancer cell survival pathways,
our data suggest that MG-Hsp27 may be a novel molecular target in melanoma and that small
molecule modulation of MG-Hsp27 by specific methylglyoxal antagonists may be useful for
the therapeutic induction of melanoma cell apoptosis. This study was supported in part by
Grants from NIH (CA106677, PO1CA27502, P30-ESO6694) and ABRC (0721).
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The role of p53 in melanocyte development and pigmentation
N Box,1,2 T Terzian,3 G Lozano3 and DR Roop1,2 1 Dermatology, Baylor College of Medicine,
Houston, TX, 2 Dermatology, University of Colorado Health Sciences Center, Aurora, CO and
3 Cancer Genetics, MD Anderson Cancer Center, Houston, TX
The role of the p53 tumor suppressor protein in normal melanocyte development, function
and tumorigenic transformation is not yet fully understood. Nevertheless, a number of stud-
ies have shown a role for p53 in UV stimulated melanogenesis. After UV exposure, p53 sta-
bilization results in increased binding of the p53 transcription factor to pigmentation gene
promoters such as tyrosinase, one of the key enzymes responsible for melanin biosynthesis.
It is known that melanocytes are resistant to p53 dependent apoptosis enabling them to sur-
vive after high doses of UV. In particular, melanocytes retain constitutively high levels of the
anti-apoptotic molecule BcL2 that counteracts Bax, a major pro-apoptotic p53 target. Intrin-
sic anti-apoptotic or survival programming within the melanocyte is consistent with the role
as a protective cell type within the skin and may in part explain the heavy resistance of
melanoma cells to chemotherapeutic strategies aimed at inducing tumor specific apoptosis.
We have examined the role of increased levels of p53 activity during skin development and
in response to DNA damage using Mdm2 and Mdm4 knockout mice. In particular, both
Mdm2 and Mdm4 knockout mice develop a hyperpigmentation phenotype that is attributa-
ble to increased melanocyte cell number during development. We have described the devel-
opmental mechanism of this phenotype with respect to p53 activity. Our data demonstrate
a new role for p53 in influencing melanocyte development and pigmentation, with impli-
cations for tumorigenesis.
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Topical N-undecylenoyl phenylalanine (Sepiwhite®) in combination with niacinamide reduces
the appearance of facial skin hyperpigmented spots
DL Bissett, LR Robinson, CA Berge, J Li, K Miyamoto and T Hakozaki The Procter & Gamble
Company, Cincinnati, OH
N-undecylenoyl phenylalanine (Sepiwhite®) is reported to be an alpha-MSH receptor antag-
onist and to reduce melanin production in melanocytes, based on in vitro testing. In other
testing, niacinamide has been observed to be effective in in vitro cell culture and, in clinical
studies, niacinamide formulations have been shown to reduce the appearance of hyperpig-
mented spots. To determine if a combination of these two will be more effective, double-blind,
10 week, left-right randomized, split-face clinical studies were conducted: one with Cau-
casian female subjects and a second with Japanese female subjects. In both studies, the com-
bination of topical Sepiwhite® in combination with niacinamide (in an emulsion formulation)
was evaluated vs. niacinamide alone (in emulsion formulation) vs. vehicle formulation con-
trol. Hyperpigmented spots were evaluated by quantitative image analysis. There was signif-
icant reduction in the appearance of spots by the combination vs. the niacinamide and vehi-
cle controls. The combination of Sepiwhite® and niacinamide is thus an effective technology
for use on human facial skin.
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Prevention of spontaneous melanoma by whole recombinant yeast vaccine expressing MART-
1
A Tanaka, H Riemann, K Okamura, DA Norris, YG Shellman and M Fujita Dermatology,
University of Colorado DHSC, Aurora, CO
We have previously shown that administration of whole recombinant yeast expressing human
MART-1 (hMART-IT melanoma vaccine) induces protective anti-melanoma immunity in B16F10
mouse model. While transplantable models are good animal models for in vivo studies, they do
not always represent human cancers. Genetically-engineered mouse models with spontaneous
development of malignant melanoma mimic melanoma development in humans and provide
a powerful tool to study the efficacy of tumor vaccines. We used a cross-breeder of a transgenic
(TG) mouse expressing melanocyte-specific H-rasG12V and an Ink4a/Arf knockout (KO) mouse
to determine the preventive effect of hMART-IT. The “TG/KO mouse (cross-breeder)” developed
spontaneous multiple melanomas expressing MART-1 with high penetrance (74%) at around 3-
4 months of age. Subcutaneous administration of hMART-IT induced cytotoxicity against 8B20
tumor line established from the TG/KO melanoma tumor. The in vitro depletion study indicated
the CD4+ T cell-mediated nature of the responses. Unfractionated splenocytes from vaccinated
mice produced IFN-γ, IL-2, IL-12 and TNF-α after the in vitro stimulation with hMART-IT, and
the cytokine production was shown to be induced by MART-1 protein in a dose-dependent man-
ner, indicating the antigen specificity. Furthermore, the weekly administration of hMART-IT sig-
nificantly delayed the development of melanoma and prolonged the survival of TG/KO mice
compared with naïve mice and mice treated with yeast alone. The analysis of melanoma tumors
from vaccinated mice showed diffuse infiltration of CD3+ T cells, CD4+ T cells and CD8+ T cells
but reduced number of foxp3+ cells compared with tumors from naïve mice, suggesting active
immune responses against tumors. Our data demonstrate that vaccination with whole recom-
binant yeast confers active anti-tumor immunity to counter the tumorigenesis of spontaneously
developing malignant melanoma.
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Expression of glycosaminoglycans, proteoglycans and matrix metalloproteinases in juvenile
hyaline fibromatosis
TGTzellos,1 I Klagas,1 E Papakonstantinou,1 A Dionyssopoulos2 and G Karakiulakis1 1 Department
of Pharmacology, Aristotle University of Thessaloniki, Thessaloniki, Greece and 2 Department of
Skin Oncologic Surgery-Plastic Surgery, Aristotle University of Thessaloniki, Thessaloniki, Greece
Juvenile hyaline fibromatosis (JHF) is a rare autosomal recessive disease of early childhood
that is histologically characterized by deposition of hyaline material. The aim of this study
was to investigate the expression of glycosaminoglycans (GAGs), certain proteoglycans (PGs)
and matrix metalloproteinases (MMPs) in tissue specimens of tumour-like lesions obtained
from different areas of the body from a patient with JHF, using as control tissue specimens
from macroscopically normal skin obtained from matched sites. Total GAGs were isolated
from homogenised tissue specimens after lipid extraction and extensive digestion with pronase
and DNase and characterized by treatment with GAG-degrading enzymes followed by elec-
trophoresis on cellulose acetate membranes. Gene expression of PGs was determined by
semi quantitative RT-PCR analysis and the gelatinolytic activity of MMP-2 and MMP-9 in tis-
sue specimens was assessed by gelatin zymography. Our results demonstrated the presence
of hyaluronic acid (HA), heparan sulphate (HS), dermatan sulphate (DS) and chondroitin sul-
phate (CS) in all tissue specimens. The content of CS was increased and, conversely, the
content of HA was decreased in JHF tissue specimens, as compared to controls. RT–PCR
analysis revealed a similar pattern regarding the expression of syndecan, perlecan and ver-
sican in all JHF tissue specimens. Furthermore, we observed the presence of gelatinolytic
activity corresponding to MMP-2 and MMP-9, in the activated and non-activated form in all
tissue samples. These results indicate that JHF is a connective tissue disorder characterised
by alterations in the expression of specific extracellular matrix molecules which may be attrib-
uted to JHF-related mutations. Such molecules may offer an alternative target for pharma-
cological intervention to treat skin lesions associated with JHF.
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Neuronal differentiation of melanoma-Regulation of microtubule associated protein 2 by
Notch signaling and epigenetic mechanisms
ND Maddodi, KM Bhat and V Setaluri Dermatology, University of Wisconsin, Madison, WI
Melanocytic nevi and early primary melanoma lesions, but not metastatic melanomas, are
known exhibit neuronal differentiation and express neuronal microtubule associated protein 2
(MAP2). MAP2 expression in primary melanoma correlates with longer disease-free survival.
Forced expression of MAP2 inhibits melanoma growth in vitro and in vivo, suggesting that MAP2
is a prognostic marker and therapeutically useful protein. Regulation of MAP2 gene in melanoma
is not understood. We showed that in melanoma cells MAP2 promoter is downregulated by
Notch signaling. Since, activating mutations in BRAF are associated with melanoma develop-
ment, we hypothesized that activated BRAF (mBRAF) signaling contributes MAP2 gene activa-
tion in melanoma. To test this, we transfected primary and metastatic melanoma cells with
MAP2 promoter-luciferase and wild type or mBRAF plasmid and found that overexpression of
mBRAF causes 5-7 fold upregulation MAP2 promoter. To test whether, BRAF activates MAP2
promoter by attenuating Notch signaling, we studied the effect of expression of the transcrip-
tional repressor Hes1, a target of Notch, on MAP2 promoter activity. Hes1 inhibited mBRAF-
induced MAP2 promoter activity in a dose-dependent fashion suggesting that mBRAF activates
MAP2 by downregulating Hes1 expression. In support of this, Hes1 is downregulated in metasta-
tic melanoma cells transfected with mBRAF. We also investigated the role of promoter methy-
lation, in MAP2 gene regulation in melanoma. We found that treatment with demethylating
agent 5-aza C resulted in activation MAP2 mRNA expression in metastatic melanoma cells
showing that MAP2 gene is regulated by methylation. In the MAP2 promoter, we identified a
CpG island that is hypermethylated in metastatic melanoma cells. Further, in vitro methylation
of MAP2 promoter significantly reduced the promoter activity. Thus, oncogenic mutations in
BRAF in neoplastic melanocytes and epigenetic changes accompanying melanoma tumor pro-
gression seem to regulate the expression of metastasis suppressor MAP2.
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Developing blood biomarkers of malignant melanoma by gene expression analysis
J Fujita,1 WA Robinson,2 S Robinson,2 L Siconolfi,3 K Storm,3 B Davis,3 CK Edwards,1
DA Norris1 and M Fujita1 1 Dermatology, University of Colorado DHSC, Aurora, CO, 2
Division of Medical Oncology, Department of Medicine, UCDHSC, Aurora, CO and 3 Source
MDx, Boulder, CO
The melanoma staging system reveals an extraordinary heterogeneity of survival. Although the
sentinel lymph node (SLN) status is the most powerful independent prognostic factor predict-
ing survival, SLN biopsy is costly and time-consuming, and the sensitivity is limited. There is a
growing demand for the development of additional prognostic biomarkers using an easily acces-
sible body fluid to screen patients and monitor the disease activity. Peripheral blood is an ideal
sample for the analysis of systemic processes including immune responses and cellular com-
munications. Circulating tumor cells and endothelial cells have been reported in cancer patients.
We hypothesized that gene expression analysis of peripheral blood would reveal characteris-
tic melanoma-related and host response-related profiling in melanoma patients. Because genome-
wide analysis of blood biomarkers of melanoma has not been reported yet, we first performed
cDNA microarray analysis to identify a unique set of candidate genes. Using a panel of 63 genes
selected from the microarray analysis and literature search, we then performed quantitative real-
time PCR analysis of whole blood samples obtained from 87 melanoma patients (stage I to IV)
and 50 normal subjects. Stepwise logistic analysis of gene expression levels was performed
using individual genes showing the best power to discriminate normals from melanoma patients,
as starting points. Additional genes were added in a stepwise fashion and the six gene combi-
nation giving the best discrimination was identified. Using the gene PTPRK as the starting point,
the addition of S100A4, PTEN, C1QB, CTNNB1 and MNDA allowed 46/50 (92%) normals
and 78/87 (90%) melanoma patients to be classified accurately. These data support the hypoth-
esis that gene expression profiles can define subsets of individuals with melanoma and may be
used to stage newly diagnosed patients, and monitor the response of patients to therapy.
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